Citrus Sinensis ID: 008292

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-
Protein Sequence
MPPLKFFMFSLFLIYLLSFQFSFTVAVDREYATHVCSTTANFTRNSTYEKNLNLLLSSIPTNASRGNGFSSGFFNATAGQDPNRVYGLFLCRGDQTTSDCQDCVTFAARDVLQLCPVSKETILWYAECLLRYSDQSIFSTMATSPTVSLLNTQNVTDQGRLNELVGTQMSQVVTQAVSNTKRFATRKANFTTFQTLYSLAQCTPDLSSSDCNTCLRGAVARLPSCCSGKQGGRVLFPSCNVRYELYPFYNESATAPPAPAPVLLSPPPPGSVTTSRGKSGISSSTIIAIVAPIAVTAVLFILGFCFLRRKAKKKYNAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYVSINVIIY
Secondary Structure (PSIPRED)
cccHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccHHHHHHHHHHHHccccccccccccccEEEcccccccccEEEEEEccccccHHHHHHHHHHHHHHHHHccccccEEEEEcccEEEEEcccccccccccccEEEEccccccccHHHHHHHHHHHHHHHHHHHHcccccEEEEEccccccccEEEEEEccccccHHHHHHHHHHHHHHcccccccccccEEEcccEEEEEEccccccccccccccccccccccccccccccccccccccccEEEEEHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccHHHHHHHHcccccccccccccccccEEEEcccccEEEEEEccccccccHHHHHHHHHHHHccccccccEEEcccccccEEEEEEEEcccccccEEcccccccccccHHHHHHHHHHHHHHHHHccccccccEEEccccccccccccccccccccccccccccccccccccccEEEccccccHHHHcccccccccccEEEEEEEEEEEEcccccccccccccccHHHHHHHHcccc
Secondary Structure Prediction (SSPRO)
ccHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccHHHHHHHHHHHHccccccccccccccEEEccccccccEEEEEEEEcccccHHHHHHHHHHHHHHHHHHcccccEEEEEEccEEEEEccccHcccccccccEEEEcccccccHHHHHHHHHHHHHHHHHHHHcccccccccccccccccEEEEEEEEcccccHHHHHHHHHHHHHHcHHHcccccccEEEEccEEEEEEEEccccccccccccccccccccccccccccccccccccHEEEEEEEHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccHEEcHHHHHHHHccccHHccccccccccEEccEcccccEEEEEEccccccccHHHHHHHHHHHHHHHHHHHHHHHHEEcccccEEEEEEEcccccccEEEEcHHHcccccHHHHHHHHHHHHHHHHHHHHccHccEEcccccHHHEEEcccccEEEccHHHcEEcccHcccccccEEEEEccHccHHHHHHccccHHHHHHHHHHHHHHHHcccccccccccccHHHHHHHHHHHHHcc
Coil and Loop (DISEMBL)
MPPLKFFMFSLFLIYLLSFQFSFTVAVDREYATHVcsttanftrnSTYEKNLNLLLSsiptnasrgngfssgffnatagqdpnrVYGLFlcrgdqttsdcqdCVTFAARDVLQLCPVSKETILWYAECLLRysdqsifstmatsptvsllntqnvtdqgRLNELVGTQMSQVVTQAVSNTKRfatrkanfttFQTLYSLaqctpdlsssdcntclrgavarlpsccsgkqggrvlfpscnvryelypfynesatappapapvllsppppgsvttsrgksgisssTIIAIVAPIAVTAVLFILGFCFLRRKAKKkynavpesnadndlttLESLQFDFETIEVATnkfstdnklgeggfgevykgvlpsgqEIAVKRLSKasgqgaeeFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYefvpnksldyflydpekqgqldwsrRYKIIGGIARGILYLHEDSRLRIIHRDLKASNIlldaemnpkisdfgmarifgvdqtqgntsrivgtygymapeyamhgqfsvksdvySFGVLVLEIITgkknsnfyqtdgaadLLSYVSINVIIY
Flexible Loop (DISEMBL)
MPPLKFFMFSLFLIYLLSFQFSFTVAVDREYATHVcsttanftrnsTYEKNLNLLLSSIPTNASRGNGFSSGFFNATAGQDPNRVYGLFLCRGDQTTSDCQDCVTFAARDVLQLCPVSKETILWYAECLLRYSDQSIFSTMATSPTVSLLNTQNVTDQGRLNELVGTQMSQVVTQAVSNTKRFATRKANFTTFQTLYSLAQCTPDLSSSDCNTCLRGAVARLPSCCSGKQGGRVLFPSCNVRYELYPFYNESATAPPAPAPVLLSPPPPGSVTTSRGKSGISSSTIIAIVAPIAVTAVLFILGFCFLRRKAKKKynavpesnadndltTLESLQFDFETIEVATnkfstdnklgeGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLydpekqgqldwsrRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGvdqtqgntSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGkknsnfyqtdgaadllsyVSINVIIY
Low Complexity Region (SEG)
MPPLKFFMFSLFLIYLLSFQFSFTVAVDREYATHVCSTTANFTRNSTYEKNLNLLLSSIPTNASRGNGFSSGFFNATAGQDPNRVYGLFLCRGDQTTSDCQDCVTFAARDVLQLCPVSKETILWYAECLLRYSDQSIFSTMATSPTVSLLNTQNVTDQGRLNELVGTQMSQVVTQAVSNTKRFATRKANFTTFQTLYSLAQCTPDLSSSDCNTCLRGAVARLPSCCSGKQGGRVLFPSCNVRYELYPFYNEsatappapapvllsppppgsvttsrgksgissstiiaivapiavtavLFILGFCFLRRKAKKKYNAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYVSINVIIY
Disordered region (IsUnstruct)
***LKFFMFSLFLIYLLSFQFSFTVAVDREYATHVCSTTANFTRNSTYEKNLNLLLSSIPTNASRGNGFSSGFFNATAGQDPNRVYGLFLCRGDQTTSDCQDCVTFAARDVLQLCPVSKETILWYAECLLRYSDQSIFSTMATSPTVSLLNTQNVTDQGRLNELVGTQMSQVVTQAVSNTKRFATRKANFTTFQTLYSLAQCTPDLSSSDCNTCLRGAVARLPSCCSGKQGGRVLFPSCNVRYELYPFYN*********************************STIIAIVAPIAVTAVLFILGFCFLRRKAKKKYNAV*******DLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVK***********EFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYVSINVII*
Disordered Region (DISOPRED)
****KFFMFSLFLIYLLSFQFSFTVAVDREYATHVCSTTANFTRNSTYEKNLNLLLSSIPTNAS*GNGFSSGFFNATAGQDPNRVYGLFLCRGDQTTSDCQDCVTFAARDVLQLCPVSKETILWYAECLLRYSDQSIFSTMATSPTVSLLNTQNVTDQGRLNELVGTQMSQVVTQAVSNTKRFATRKANFTTFQTLYSLAQCTPDLSSSDCNTCLRGAVARLPSCCSGKQGGRVLFPSCNVRYELYPFYNESA********************************IIAIVAPIAVTAVLFILGFCFLR************************LQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNS****TDGAADLLSYVSINVIIY
Disordered Region (DISEMBL)
MPPLKFFMFSLFLIYLLSFQFSFTVAVDREYATHVCSTTANFTRNSTYEKNLNLLLSSIPTNASRGNGFSSGFFNATAGQDPNRVYGLFLCRGDQTTSDCQDCVTFAARDVLQLCPVSKETILWYAECLLRYSDQSIFSTMATSPTVSLLNTQNVTDQGRLNELVGTQMSQVVTQAVSNTKRFATRKANFTTFQTLYSLAQCTPDLSSSDCNTCLRGAVARLPSCCSGKQGGRVLFPSCNVRYELYPFYNESATAPPAPAPVLLSPP*************ISSSTIIAIVAPIAVTAVLFILGFCFLRRKAKKKYNAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYVSINVIIY
Disordered Region (DISPRO)
MPPLKFFMFSLFLIYLLSFQFSFTVAVDREYATHVCSTTANFTRNSTYEKNLNLLLSSIPTNASRGNGFSSGFFNATAGQDPNRVYGLFLCRGDQTTSDCQDCVTFAARDVLQLCPVSKETILWYAECLLRYSDQSIFSTMATSPTVSLLNTQNVTDQGRLNELVGTQMSQVVTQAVSNTKRFATRKANFTTFQTLYSLAQCTPDLSSSDCNTCLRGAVARLPSCCSGKQGGRVLFPSCNVRYELYPFYNESATAPP***********************ISSSTIIAIVAPIAVTAVLFILGFCFLRRKAK*************DLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYVSINVIIY
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
iiiiiiiHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
SSSSSSSSSSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MPPLKFFMFSLFLIYLLSFQFSFTVAVDREYATHVCSTTANFTRNSTYEKNLNLLLSSIPTNASRGNGFSSGFFNATAGQDPNRVYGLFLCRGDQTTSDCQDCVTFAARDVLQLCPVSKETILWYAECLLRYSDQSIFSTMATSPTVSLLNTQNVTDQGRLNELVGTQMSQVVTQAVSNTKRFATRKANFTTFQTLYSLAQCTPDLSSSDCNTCLRGAVARLPSCCSGKQGGRVLFPSCNVRYELYPFYNESATAPPAPAPVLLSPPPPGSVTTSRGKSGISSSTIIAIVAPIAVTAVLFILGFCFLRRKAKKKYNAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYVSINVIIY
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	571	2.2.26 [Sep-21-2011]
Q8GYA4	669	Cysteine-rich receptor-li	yes	no	0.921	0.786	0.618	0.0
Q9M0X5	675	Cysteine-rich receptor-li	no	no	0.959	0.811	0.579	0.0
Q8W4G6	627	Cysteine-rich receptor-li	no	no	0.914	0.832	0.584	1e-175
O65468	676	Cysteine-rich receptor-li	no	no	0.924	0.781	0.546	1e-171
Q9C5S9	674	Cysteine-rich receptor-li	no	no	0.929	0.787	0.542	1e-162
O65482	830	Putative cysteine-rich re	no	no	0.935	0.643	0.528	1e-162
Q9LZU4	676	Cysteine-rich receptor-li	no	no	0.912	0.770	0.548	1e-161
Q8L7G3	659	Cysteine-rich receptor-li	no	no	0.919	0.796	0.539	1e-160
O65479	666	Putative cysteine-rich re	no	no	0.917	0.786	0.533	1e-159
Q9C5S8	659	Cysteine-rich receptor-li	no	no	0.907	0.786	0.549	1e-158

>sp|Q8GYA4|CRK10_ARATH Cysteine-rich receptor-like protein kinase 10 OS=Arabidopsis thaliana GN=CRK10 PE=1 SV=3

 Score =  652 bits (1681), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 336/543 (61%), Positives = 412/543 (75%), Gaps = 17/543 (3%)

Query: 26  AVDREYATHVCSTTANFTRNSTYEKNLNLLLSSIPTNASRGNGFSSGFFNATAGQDPNRV 85
           A D  Y  H C  TAN+T NSTY  NL  LL+S+   +SR   +S+GF NAT GQ P+RV
Sbjct: 34  AQDPTYVYHTCQNTANYTSNSTYNNNLKTLLASL---SSRNASYSTGFQNATVGQAPDRV 90

Query: 86  YGLFLCRGDQTTSDCQDCVTFAARDVLQLCPVSKETILWYAECLLRYSDQSIFSTMATSP 145
            GLF CRGD +T  C+ CV+FA  D L  CP  KE  L+Y EC+LRYS+Q+I ST+ T+ 
Sbjct: 91  TGLFNCRGDVSTEVCRRCVSFAVNDTLTRCPNQKEATLYYDECVLRYSNQNILSTLITTG 150

Query: 146 TVSLLNTQNVTDQ--GRLNELVGTQMSQVVTQAVSNTKRFATRKANFTTFQTLYSLAQCT 203
            V L+NT+NVT      L++LV   ++Q  T A++++K+F TRK NFT  Q+ Y L QCT
Sbjct: 151 GVILVNTRNVTSNQLDLLSDLVLPTLNQAATVALNSSKKFGTRKNNFTALQSFYGLVQCT 210

Query: 204 PDLSSSDCNTCLRGAVARLPSCCSGKQGGRVLFPSCNVRYELYPFYNESATAPPAPAPVL 263
           PDL+  DC+ CL+  + ++P+    + G R++ PSC  RYE+Y FY ESA  PP P P +
Sbjct: 211 PDLTRQDCSRCLQLVINQIPT---DRIGARIINPSCTSRYEIYAFYTESAVPPPPPPPSI 267

Query: 264 LSP---PPPGSVTTSRGKSGISSSTIIAIVAPIAVTAVLFILGFCFLRRKAKKKYNAVPE 320
            +P    PP S     GK G S   +IAIV PI V  +LFI G+CFL R+A+K Y   P 
Sbjct: 268 STPPVSAPPRS-----GKDGNSKVLVIAIVVPIIVAVLLFIAGYCFLTRRARKSY-YTPS 321

Query: 321 SNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKA 380
           + A +D+TT +SLQ D+ TI+ AT+ F   NK+G+GGFGEVYKG L  G E+AVKRLSK+
Sbjct: 322 AFAGDDITTADSLQLDYRTIQTATDDFVESNKIGQGGFGEVYKGTLSDGTEVAVKRLSKS 381

Query: 381 SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQ 440
           SGQG  EFKNEVVLVAKLQHRNLVRLLGFCL+GEE++LVYE+VPNKSLDYFL+DP K+GQ
Sbjct: 382 SGQGEVEFKNEVVLVAKLQHRNLVRLLGFCLDGEERVLVYEYVPNKSLDYFLFDPAKKGQ 441

Query: 441 LDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500
           LDW+RRYKIIGG+ARGILYLH+DSRL IIHRDLKASNILLDA+MNPKI+DFGMARIFG+D
Sbjct: 442 LDWTRRYKIIGGVARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGLD 501

Query: 501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADL 560
           QT+ NTSRIVGTYGYM+PEYAMHGQ+S+KSDVYSFGVLVLEII+GKKNS+FYQTDGA DL
Sbjct: 502 QTEENTSRIVGTYGYMSPEYAMHGQYSMKSDVYSFGVLVLEIISGKKNSSFYQTDGAHDL 561

Query: 561 LSY 563
           +SY
Sbjct: 562 VSY 564

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: -

>sp|Q9M0X5|CRK25_ARATH Cysteine-rich receptor-like protein kinase 25 OS=Arabidopsis thaliana GN=CRK25 PE=2 SV=1

 Score =  649 bits (1675), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 326/563 (57%), Positives = 405/563 (71%), Gaps = 15/563 (2%)

Query: 8   MFSLFLIYLLSFQFSFTVAVDREYATHVCSTTANFTRNSTYEKNLNLLLSSIPTNASRGN 67
           +FS+FL  +L      TV  D  Y  H+C  T  ++RNS+Y  NL  +LSS+   +S   
Sbjct: 11  LFSVFLFMILK-----TVTSDPTYLYHICPNTTTYSRNSSYLTNLRTVLSSL---SSPNA 62

Query: 68  GFSSGFFNATAGQ--DPNRVYGLFLCRGDQTTSDCQDCVTFAARDVLQLCPVSKETILWY 125
            ++S F NA AG+  D NRVYG+FLCRGD +   C+DCV FAA + LQ CP  K  ++WY
Sbjct: 63  AYASLFDNAAAGEENDSNRVYGVFLCRGDVSAEICRDCVAFAANETLQRCPREKVAVIWY 122

Query: 126 AECLLRYSDQSIFSTMATSPTVSLLNTQNVTDQ--GRLNELVGTQMSQVVTQAVSNTKRF 183
            EC++RYS+QSI   M   P V L N QN+T+    R NE +   +  V  +A  ++++F
Sbjct: 123 DECMVRYSNQSIVGQMRIRPGVFLTNKQNITENQVSRFNESLPALLIDVAVKAALSSRKF 182

Query: 184 ATRKANFTTFQTLYSLAQCTPDLSSSDCNTCLRGAVARLPSCCSGKQGGRVLFPSCNVRY 243
           AT KANFT FQT+YSL QCTPDL++ DC +CLR  +  LP CC    GGRV+ PSC+ RY
Sbjct: 183 ATEKANFTVFQTIYSLVQCTPDLTNQDCESCLRQVINYLPRCCDRSVGGRVIAPSCSFRY 242

Query: 244 ELYPFYNESATAPPAPAPVLLS-PPPPGSVTTSRGKSGISSSTIIAIVAPIAVTAVLFIL 302
           ELYPFYNE+  A P   P   +   PP ++ + +GK    +  + AI  P++V  VL + 
Sbjct: 243 ELYPFYNETIAAAPMAPPPSSTVTAPPLNIPSEKGKGKNLTVIVTAIAVPVSV-CVLLLG 301

Query: 303 GFCF-LRRKAKKKYNAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEV 361
             C+ L R+   K +A  E   ++ +T+ E+LQF F  IE ATNKFS  NKLG GGFGEV
Sbjct: 302 AMCWLLARRRNNKLSAETEDLDEDGITSTETLQFQFSAIEAATNKFSESNKLGHGGFGEV 361

Query: 362 YKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421
           YKG L +G+ +A+KRLS+ S QGAEEFKNEV +VAKLQHRNL +LLG+CL+GEEKILVYE
Sbjct: 362 YKGQLITGETVAIKRLSQGSTQGAEEFKNEVDVVAKLQHRNLAKLLGYCLDGEEKILVYE 421

Query: 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD 481
           FVPNKSLDYFL+D EK+  LDW RRYKII GIARGILYLH DSRL IIHRDLKASNILLD
Sbjct: 422 FVPNKSLDYFLFDNEKRRVLDWQRRYKIIEGIARGILYLHRDSRLTIIHRDLKASNILLD 481

Query: 482 AEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLE 541
           A+M+PKISDFGMARIFGVDQTQ NT RIVGTYGYM+PEYA+HG++SVKSDVYSFGVLVLE
Sbjct: 482 ADMHPKISDFGMARIFGVDQTQANTKRIVGTYGYMSPEYAIHGKYSVKSDVYSFGVLVLE 541

Query: 542 IITGKKNSNFYQTDGAADLLSYV 564
           +ITGKKNS+FY+ DG  DL++YV
Sbjct: 542 LITGKKNSSFYEEDGLGDLVTYV 564

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q8W4G6|CRK15_ARATH Cysteine-rich receptor-like protein kinase 15 OS=Arabidopsis thaliana GN=CRK15 PE=2 SV=2

 Score =  615 bits (1585), Expect = e-175,   Method: Compositional matrix adjust.
 Identities = 315/539 (58%), Positives = 394/539 (73%), Gaps = 17/539 (3%)

Query: 31  YATHVCSTTANFTRNSTYEKNLNLLLSSIPT-NASRGNGFSSGFFNATAGQDPNRVYGLF 89
           Y  H+C  T  ++RNS Y  NL  LLSS+   NAS    +S+GF +A AGQ P+RV GLF
Sbjct: 26  YIKHICPNTTTYSRNSPYLTNLRTLLSSLSAPNAS----YSTGFQSARAGQAPDRVTGLF 81

Query: 90  LCRGDQTTSDCQDCVTFAARDVLQLCPVSKETILWYAECLLRYSDQSIFSTMATSPTVSL 149
           LCRGD + + C++CV F+  D L  CP  ++++ +Y EC+LRYSDQ+I ST+A       
Sbjct: 82  LCRGDVSPAVCRNCVAFSINDTLVQCPSERKSVFYYDECMLRYSDQNILSTLAYDGAWIR 141

Query: 150 LNTQNVTDQGRLN---ELVGTQMSQVVTQAVSNTKRFATRKANFTTFQTLYSLAQCTPDL 206
           +N     DQ ++N   + V + M+Q   +A S+ ++F T KA +T  QTLY L QCTPDL
Sbjct: 142 MNGNISIDQNQMNRFKDFVSSTMNQAAVKAASSPRKFYTVKATWTALQTLYGLVQCTPDL 201

Query: 207 SSSDCNTCLRGAVARLPSCCSGKQGGRVLFPSCNVRYELYPFYNESATAPPAPAPVLLSP 266
           +  DC +CL  ++  +P     K GGR L+ SCN RYEL+ FYNE+ T     AP  L P
Sbjct: 202 TRQDCFSCLESSIKLMPLY---KTGGRTLYSSCNSRYELFAFYNET-TVRTQQAPPPLPP 257

Query: 267 PPPGSVTTSR--GKSGISSSTIIAIVAPIAVTAVLFILGFCFLRRKAKKKYNAVPESNAD 324
                VT+    GKS  S+  ++AIV  I V A+L I G+CF +R      NA P  + D
Sbjct: 258 SSTPLVTSPSLPGKSWNSNVLVVAIVLTILVAALLLIAGYCFAKRVKNSSDNA-PAFDGD 316

Query: 325 NDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQG 384
            D+TT ESLQ D+  I  ATNKFS +NK+G+GGFGEVYKG   +G E+AVKRLSK+SGQG
Sbjct: 317 -DITT-ESLQLDYRMIRAATNKFSENNKIGQGGFGEVYKGTFSNGTEVAVKRLSKSSGQG 374

Query: 385 AEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWS 444
             EFKNEVV+VAKLQHRNLVRLLGF + G E+ILVYE++PNKSLDYFL+DP KQ QLDW+
Sbjct: 375 DTEFKNEVVVVAKLQHRNLVRLLGFSIGGGERILVYEYMPNKSLDYFLFDPAKQNQLDWT 434

Query: 445 RRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG 504
           RRYK+IGGIARGILYLH+DSRL IIHRDLKASNILLDA+MNPK++DFG+ARIFG+DQTQ 
Sbjct: 435 RRYKVIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKLADFGLARIFGMDQTQE 494

Query: 505 NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSY 563
           NTSRIVGT+GYMAPEYA+HGQFSVKSDVYSFGVLVLEII+GKKN++FY+TDGA DL+++
Sbjct: 495 NTSRIVGTFGYMAPEYAIHGQFSVKSDVYSFGVLVLEIISGKKNNSFYETDGAHDLVTH 553

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|O65468|CRK8_ARATH Cysteine-rich receptor-like protein kinase 8 OS=Arabidopsis thaliana GN=CRK8 PE=2 SV=2

 Score =  600 bits (1548), Expect = e-171,   Method: Compositional matrix adjust.
 Identities = 294/538 (54%), Positives = 383/538 (71%), Gaps = 10/538 (1%)

Query: 31  YATHVCSTTANFTRNSTYEKNLNLLLSSIPTNASRGNGFSSGFFNATAGQDPNRVYGLFL 90
           Y  H C     ++ NSTY  NL  LLSS    ASR   +S+GF N  AGQ P+RV GLFL
Sbjct: 39  YLNHDCPNRTTYSSNSTYSTNLKTLLSSF---ASRNASYSTGFQNIRAGQTPDRVTGLFL 95

Query: 91  CRGDQTTSDCQDCVTFAARDVLQLCPVSKETILWYAECLLRYSDQSIFSTMATSPTVSLL 150
           CRGD +   C +CV F+  + L  CP  +E + +Y EC+LRYS ++  ST+     + + 
Sbjct: 96  CRGDLSPEVCSNCVAFSVNESLTRCPNQREAVFYYEECILRYSHKNFLSTVTYEGELIMR 155

Query: 151 NTQNVT----DQGRLNELVGTQMSQVVTQAVSNTKRFATRKANFTTFQTLYSLAQCTPDL 206
           N  N++     + +  +LV + M+Q   +A +++++F+T K   T+ QTLY L QCTPDL
Sbjct: 156 NPNNISSIQNQRDQFIDLVQSNMNQAANEAANSSRKFSTIKTELTSLQTLYGLVQCTPDL 215

Query: 207 SSSDCNTCLRGAVARLPSCCSGKQGGRVLFPSCNVRYELYPFYNESATAPPAPAPVLLSP 266
           +  DC +CL  ++ R+      + G R  +PSCN RYELY FYNE+A   P+P P+    
Sbjct: 216 ARQDCFSCLTSSINRMMPLF--RIGARQFWPSCNSRYELYAFYNETAIGTPSPPPLFPGS 273

Query: 267 PPPGSVTTSRGKSGISSSTIIAIVAPIAVTAVLFILGFCFLRRKAKKKYNAVPESNADND 326
            PP +  +  GKSG +S+ ++  +  +AV   + ++G+CFL ++ KK ++    S   +D
Sbjct: 274 TPPLTSPSIPGKSG-NSTVLVVAIVVLAVLLFIALVGYCFLAQRTKKTFDTASASEVGDD 332

Query: 327 LTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAE 386
           + T +SLQ D+ TI+ ATN F+  NK+G GGFGEVYKG   +G+E+AVKRLSK S QG  
Sbjct: 333 MATADSLQLDYRTIQTATNDFAESNKIGRGGFGEVYKGTFSNGKEVAVKRLSKNSRQGEA 392

Query: 387 EFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRR 446
           EFK EVV+VAKLQHRNLVRLLGF L+GEE+ILVYE++PNKSLD  L+DP KQ QLDW +R
Sbjct: 393 EFKTEVVVVAKLQHRNLVRLLGFSLQGEERILVYEYMPNKSLDCLLFDPTKQTQLDWMQR 452

Query: 447 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT 506
           Y IIGGIARGILYLH+DSRL IIHRDLKASNILLDA++NPKI+DFGMARIFG+DQTQ NT
Sbjct: 453 YNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADINPKIADFGMARIFGLDQTQDNT 512

Query: 507 SRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYV 564
           SRIVGTYGYMAPEYAMHGQFS+KSDVYSFGVLVLEII+G+KNS+F ++DGA DLL++ 
Sbjct: 513 SRIVGTYGYMAPEYAMHGQFSMKSDVYSFGVLVLEIISGRKNSSFDESDGAQDLLTHT 570

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9C5S9|CRK6_ARATH Cysteine-rich receptor-like protein kinase 6 OS=Arabidopsis thaliana GN=CRK6 PE=1 SV=1

 Score =  572 bits (1474), Expect = e-162,   Method: Compositional matrix adjust.
 Identities = 300/553 (54%), Positives = 389/553 (70%), Gaps = 22/553 (3%)

Query: 26  AVDREYATHVCSTTANFTRNSTYEKNLNLLLSSIPT-NASRGNGFSSGFFNATAGQDPNR 84
           A D  Y  H C  T  ++ NSTY  NL  LLSS+ + NAS    +S+GF NATAG+ P+R
Sbjct: 24  AQDPFYLNHYCPNTTTYSSNSTYSTNLRTLLSSLSSRNAS----YSTGFQNATAGKAPDR 79

Query: 85  VYGLFLCRGDQTTSDCQDCVTFAARDVLQLCPVSKETILWYAECLLRYSDQSIFSTMATS 144
           V GLFLCRGD +   C++CV F+    L LCP  +E + +Y +C+LRYS ++I ST  T+
Sbjct: 80  VTGLFLCRGDVSPEVCRNCVAFSVNQTLNLCPKVREAVFYYEQCILRYSHKNILSTAITN 139

Query: 145 PTVSLLNTQNVT--DQGRLN---ELVGTQMSQVVTQAVSNTKRFATRKANFTTFQTLYSL 199
               +L+  N    +Q +++     V + MS+   +A +++++  T     T +Q LY L
Sbjct: 140 EGEFILSNTNTISPNQKQIDGFTSFVSSTMSEAAGKAANSSRKLYTVNTELTAYQNLYGL 199

Query: 200 AQCTPDLSSSDCNTCLRGAVARLPSCCSGKQGGRVLFPSCNVRYELYPFYNESATAPPAP 259
            QCTPDL+ +DC +CL+ ++  +      + G R+ +PSC  RYELYPFYNESA   P  
Sbjct: 200 LQCTPDLTRADCLSCLQSSINGM---ALSRIGARLYWPSCTARYELYPFYNESAIETPPL 256

Query: 260 APVL--------LSPPPPGSVTTSRGKSGISSSTIIAIVAPIAVTAVLFILGFCFLRRKA 311
            P          L   PP S ++  GKSG +S+ ++  V  +AV   + ++G+CFL +K 
Sbjct: 257 PPPPPPPPPRESLVSTPPISSSSLPGKSG-NSTVLVVAVVVLAVLLFIALVGYCFLAKKK 315

Query: 312 KKKYNAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQE 371
           KK ++    S   +D+ T +SLQ D+ TI+ ATN F+  NK+G GGFGEVYKG   +G+E
Sbjct: 316 KKTFDTASASEVGDDMATADSLQLDYRTIQTATNDFAESNKIGRGGFGEVYKGTFSNGKE 375

Query: 372 IAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF 431
           +AVKRLSK S QG  EFK EVV+VAKLQHRNLVRLLGF L+GEE+ILVYE++PNKSLD  
Sbjct: 376 VAVKRLSKNSRQGEAEFKTEVVVVAKLQHRNLVRLLGFSLQGEERILVYEYMPNKSLDCL 435

Query: 432 LYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDF 491
           L+DP KQ QLDW +RY IIGGIARGILYLH+DSRL IIHRDLKASNILLDA++NPKI+DF
Sbjct: 436 LFDPTKQIQLDWMQRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADINPKIADF 495

Query: 492 GMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF 551
           GMARIFG+DQTQ NTSRIVGTYGYMAPEYAMHGQFS+KSDVYSFGVLVLEII+G+KNS+F
Sbjct: 496 GMARIFGLDQTQDNTSRIVGTYGYMAPEYAMHGQFSMKSDVYSFGVLVLEIISGRKNSSF 555

Query: 552 YQTDGAADLLSYV 564
            ++DGA DLL++ 
Sbjct: 556 GESDGAQDLLTHA 568

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|O65482|CRK23_ARATH Putative cysteine-rich receptor-like protein kinase 23 OS=Arabidopsis thaliana GN=CRK23 PE=2 SV=1

 Score =  570 bits (1470), Expect = e-162,   Method: Compositional matrix adjust.
 Identities = 316/598 (52%), Positives = 397/598 (66%), Gaps = 64/598 (10%)

Query: 24  TVAVDREYATHVCSTTANFTRNSTYEKNLNLLLSSIPTNASRGNGFSSGFFNATAGQDPN 83
           T A+D  Y  HVC + A F R+STY  NL  LLS++   +S    +S+GF NATAG+ P+
Sbjct: 134 TSALDPTYVYHVCPSWATFPRSSTYMTNLITLLSTL---SSPSASYSTGFQNATAGKHPD 190

Query: 84  RVYGLFLCRGDQTTSDCQDCVTFAARDVLQLCPVSKETILWYAECLLRYSDQSIFSTMAT 143
           RV GLF CRGD +   C+ CV+FA  +    CP+ KE  L+Y +C LRYS+++I ST  T
Sbjct: 191 RVTGLFNCRGDVSPEVCRRCVSFAVNETSTRCPIEKEVTLYYDQCTLRYSNRNILSTSNT 250

Query: 144 SPTVSLLNTQNVT--DQGRLNELVGTQMSQVVTQAVSNTKRFATRKANFTTFQTLYSLAQ 201
           +  + L N+QN+T  +Q R  +LV T M+Q    A +++KRF  R ANFTT  +LY+L Q
Sbjct: 251 NGGIILANSQNMTSNEQARFKDLVLTTMNQATIAAANSSKRFDARSANFTTLHSLYTLVQ 310

Query: 202 CTPDLSSSDCNTCLRGAVARLPSCCSGKQGGRVLFPSCNVRYELYPFYNESATAPPAPA- 260
           CT DL+  DC +CL+  + +LP+    K GG+ + PSC+ R+EL  FYN+SA   P P  
Sbjct: 311 CTHDLTRQDCLSCLQQIINQLPT---EKIGGQFIVPSCSSRFELCLFYNQSAVTTPQPQQ 367

Query: 261 ----------------------PVL--LSPP---------PPG-------SVTTSRGKSG 280
                                 P++  LS            PG        V+ + GK G
Sbjct: 368 NSAPPPPPTSIPSPRPGLNSRFPLITCLSAVSFEKFKDLLKPGFICILIKIVSENTGKGG 427

Query: 281 ISSSTIIAIVAPIAVTAVLFILGFCFLRRKAKKKYNAVP------------ESNADN--D 326
            SS  IIA+V  I    +LF+  F    ++ KK   A+P            E  A+N   
Sbjct: 428 NSSVIIIAVVVSITALLLLFVAVFSVRTKRRKKMIGAIPLLNVKRKDTEVTEPLAENGDS 487

Query: 327 LTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAE 386
           +TT  SLQFDF+ I  ATN F   NKLG+GGFGEVYKG  PSG ++AVKRLSK SGQG  
Sbjct: 488 ITTAGSLQFDFKAIVAATNNFLPINKLGQGGFGEVYKGTFPSGVQVAVKRLSKTSGQGER 547

Query: 387 EFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRR 446
           EF+NEVV+VAKLQHRNLVRLLG+CLEGEEKILVYEFV NKSLDYFL+D   + QLDW+RR
Sbjct: 548 EFENEVVVVAKLQHRNLVRLLGYCLEGEEKILVYEFVHNKSLDYFLFDTTMKRQLDWTRR 607

Query: 447 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT 506
           YKIIGGIARGILYLH+DSRL IIHRDLKA NILLDA+MNPK++DFGMARIFG+DQT+ NT
Sbjct: 608 YKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDADMNPKVADFGMARIFGMDQTEANT 667

Query: 507 SRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGA-ADLLSY 563
            R+VGTYGYMAPEYAM+GQFS+KSDVYSFGVLV EII+G KNS+ YQ D + ++L++Y
Sbjct: 668 RRVVGTYGYMAPEYAMYGQFSMKSDVYSFGVLVFEIISGMKNSSLYQMDDSVSNLVTY 725

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9LZU4|CRK4_ARATH Cysteine-rich receptor-like protein kinase 4 OS=Arabidopsis thaliana GN=CRK4 PE=2 SV=1

 Score =  569 bits (1466), Expect = e-161,   Method: Compositional matrix adjust.
 Identities = 302/551 (54%), Positives = 387/551 (70%), Gaps = 30/551 (5%)

Query: 31  YATHVC-STTANFTRNSTYEKNLNLLLSSIPTNASRGNGFSSGFFNATAGQDPNRVYGLF 89
           +  H C S+   ++RNSTY  NL    + + + +SR   +S+GF  ATAGQ P+RV GLF
Sbjct: 31  HLNHSCPSSILTYSRNSTYFTNLK---TLLSSLSSRNASYSTGFQTATAGQAPDRVTGLF 87

Query: 90  LCRGDQTTSDCQDCVTFAARDVLQLCPVSKETILWYAECLLRYSDQSIFSTMATSPTVSL 149
           LCRGD +   C++CV F+ ++ L  CP +KE +L+Y EC+LRYS ++I ST+    +  L
Sbjct: 88  LCRGDVSQEVCRNCVAFSVKETLYWCPYNKEVVLYYDECMLRYSHRNILSTVTYDGSAIL 147

Query: 150 LNTQNVT--DQGRLNE---LVGTQMSQVVTQAVSNTKRFATRKANFTTFQTLYSLAQCTP 204
           LN  N++  +Q +++E   LV + ++    +A +++K+F TRK    T Q LY L QCTP
Sbjct: 148 LNGANISSSNQNQVDEFRDLVSSTLNLAAVEAANSSKKFYTRKV--ITPQPLYLLVQCTP 205

Query: 205 DLSSSDCNTCLRGAVARLPSCCSGKQGGRVLFPSCNVRYELYPFYNESATAPPA------ 258
           DL+  DC  CL+ ++  +      + GGR  +PSCN RYE Y FYNE+AT   +      
Sbjct: 206 DLTRQDCLRCLQKSIKGMSLY---RIGGRFFYPSCNSRYENYSFYNETATRSSSPPSLPP 262

Query: 259 ----PAPVLLSPPPPGSVTTSRGKSGISSSTIIAIVAPIAVTAVLFILGFCFLRRKAKKK 314
                  + L+PPP   + + RGK G +SS II +V PI    +LF+  F    +K +  
Sbjct: 263 RSTPQQQLKLAPPP---LISERGK-GRNSSVIIVVVVPIIALLLLFVAFFSLRAKKTRTN 318

Query: 315 YNAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAV 374
           Y   P +   +D+TT  SLQFDF+ IE ATNKF   NKLG+GGFGEVYKG+ PSG ++AV
Sbjct: 319 YEREPLTEESDDITTAGSLQFDFKAIEAATNKFCETNKLGQGGFGEVYKGIFPSGVQVAV 378

Query: 375 KRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYD 434
           KRLSK SGQG  EF NEV++VAKLQHRNLVRLLGFCLE +E+ILVYEFVPNKSLDYF++D
Sbjct: 379 KRLSKTSGQGEREFANEVIVVAKLQHRNLVRLLGFCLERDERILVYEFVPNKSLDYFIFD 438

Query: 435 PEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494
              Q  LDW+RRYKIIGGIARGILYLH+DSRL IIHRDLKA NILL  +MN KI+DFGMA
Sbjct: 439 STMQSLLDWTRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLGDDMNAKIADFGMA 498

Query: 495 RIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQT 554
           RIFG+DQT+ NT RIVGTYGYM+PEYAM+GQFS+KSDVYSFGVLVLEII+GKKNSN YQ 
Sbjct: 499 RIFGMDQTEANTRRIVGTYGYMSPEYAMYGQFSMKSDVYSFGVLVLEIISGKKNSNVYQM 558

Query: 555 DG--AADLLSY 563
           DG  A +L++Y
Sbjct: 559 DGTSAGNLVTY 569

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q8L7G3|CRK7_ARATH Cysteine-rich receptor-like protein kinase 7 OS=Arabidopsis thaliana GN=CRK7 PE=2 SV=1

 Score =  563 bits (1452), Expect = e-160,   Method: Compositional matrix adjust.
 Identities = 293/543 (53%), Positives = 378/543 (69%), Gaps = 18/543 (3%)

Query: 26  AVDREYATHVCSTTANFTRNSTYEKNLNLLLSSIPTNASRGNGFSSGFFNATAGQDPNRV 85
           A D  +  + C     ++ NSTY  NL    + + + +SR   +S+GF NAT GQ  +RV
Sbjct: 23  AQDPRFLAYYCPNATTYSSNSTYLTNLK---TLLSSLSSRNASYSTGFQNATVGQALDRV 79

Query: 86  YGLFLCRGDQTTSDCQDCVTFAARDVLQLCPVSKETILWYAECLLRYSDQSIFSTMATSP 145
            GLFLCRGD +   C++CVTFA  +    CP  +E + +Y EC+LRYS ++I ST  T+ 
Sbjct: 80  TGLFLCRGDVSPEVCRNCVTFAVNNTFSRCPNQREAVFYYEECILRYSHKNILSTAITNE 139

Query: 146 TVSLLNTQNVTD--QGRLNE---LVGTQMSQVVTQAVSNTKRFATRKANFTTFQTLYSLA 200
              +L   N     Q ++N+   LV + M+Q+  +A  N ++F+T K   T  QT Y L 
Sbjct: 140 GEFILRNPNHISPIQNQINQFTNLVLSNMNQIAIEAADNPRKFSTIKTELTALQTFYGLV 199

Query: 201 QCTPDLSSSDCNTCLRGAVARLPSCCSGKQGGRVLFPSCNVRYELYPFYNESATAPPAPA 260
           QCTPDLS  +C  CL  ++ R+P     + G R  +PSCN RYELY FYNE+A   P P 
Sbjct: 200 QCTPDLSRQNCMNCLTSSINRMPF---SRIGARQFWPSCNSRYELYDFYNETAIGTPPPP 256

Query: 261 PVLLSPPPPGSVTTSRGKSGISSSTIIAIVAPIAVTAVLFILGFCFLRRKAKKKYNAVPE 320
              L+        +   KSG S+  ++A+V PI V  ++FI G+CF  ++AKK Y   P 
Sbjct: 257 LPPLA------SPSLSDKSGNSNVVVVAVVVPIIVAVLIFIAGYCFFAKRAKKTYGTTPA 310

Query: 321 SNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKA 380
            + D D TT+ESLQ D+  I+ ATN FS +NK+G GGFG+VYKG   +G E+AVKRLSK 
Sbjct: 311 LDED-DKTTIESLQLDYRAIQAATNDFSENNKIGRGGFGDVYKGTFSNGTEVAVKRLSKT 369

Query: 381 SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQ 440
           S QG  EFKNEVV+VA L+H+NLVR+LGF +E EE+ILVYE+V NKSLD FL+DP K+GQ
Sbjct: 370 SEQGDTEFKNEVVVVANLRHKNLVRILGFSIEREERILVYEYVENKSLDNFLFDPAKKGQ 429

Query: 441 LDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500
           L W++RY IIGGIARGILYLH+DSRL IIHRDLKASNILLDA+MNPKI+DFGMARIFG+D
Sbjct: 430 LYWTQRYHIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGMD 489

Query: 501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADL 560
           QTQ NTSRIVGTYGYM+PEYAM GQFS+KSDVYSFGVLVLEII+G+KN++F +TD A DL
Sbjct: 490 QTQQNTSRIVGTYGYMSPEYAMRGQFSMKSDVYSFGVLVLEIISGRKNNSFIETDDAQDL 549

Query: 561 LSY 563
           +++
Sbjct: 550 VTH 552

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|O65479|CRK20_ARATH Putative cysteine-rich receptor-like protein kinase 20 OS=Arabidopsis thaliana GN=CRK20 PE=2 SV=2

 Score =  563 bits (1452), Expect = e-159,   Method: Compositional matrix adjust.
 Identities = 300/562 (53%), Positives = 379/562 (67%), Gaps = 38/562 (6%)

Query: 22  SFTVAVDRE-YATHVCSTTANFTRNSTYEKNLNLLLSSIPTNASRGNGFSSGFFNATAGQ 80
           SFT +     Y  H CS T  ++ NSTY  NL    + + + +SR   +S+GF NATAGQ
Sbjct: 18  SFTASAQNPFYLYHNCSITTTYSSNSTYSTNLK---TLLSSLSSRNASYSTGFQNATAGQ 74

Query: 81  DPNRVYGLFLCRGDQTTSDCQDCVTFAARDVLQLCPVSKETILWYAECLLRYSDQSIFST 140
            P+ V GLFLCRG+ +   C+ C+  +  + L  CP  +E + +Y +C+LRYS+++I ST
Sbjct: 75  APDMVTGLFLCRGNVSPEVCRSCIALSVNESLSRCPNEREAVFYYEQCMLRYSNRNILST 134

Query: 141 MATSPTVSLLNTQN--VTDQGRLNELVGTQMSQVVTQAVSNTKRFATRKANFTTFQTLYS 198
           + T   V + N +N     Q R  +LV   M+    +A  + KRFA  K +    Q+LY 
Sbjct: 135 LNTDGGVFMQNARNPISVKQDRFRDLVLNPMNLAAIEAARSIKRFAVTKFDLNALQSLYG 194

Query: 199 LAQCTPDLSSSDCNTCLRGAVARLPSCCSGKQGGRVLFPSCNVRYELYPFYNESATAPPA 258
           + QCTPDL+  DC  CL+ ++ ++      K GGR   PSC  RY+ Y FYNE     P 
Sbjct: 195 MVQCTPDLTEQDCLDCLQQSINQV---TYDKIGGRTFLPSCTSRYDNYEFYNEFNVGTPQ 251

Query: 259 PAPVLLSPPPPGSVTTSRGKSGISSSTIIAIVAPIAVTAVLFILGFCFLRRKAKKKYNAV 318
            +    SP P        GK G SS  +IA+V PI V  +LF+  F   R K KK   A+
Sbjct: 252 DS----SPRP--------GKGGNSSVIVIAVVVPITVLFLLFVAFFSVRRAKRKKTIGAI 299

Query: 319 P----------------ESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVY 362
           P                E+   +D+TT  SLQFDF+ I  AT+ F   NKLG+GGFGEVY
Sbjct: 300 PLFKVKRKETEVTEPPAETTDGDDITTAGSLQFDFKAIVAATDIFLPINKLGQGGFGEVY 359

Query: 363 KGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422
           KG  PSG ++AVKRLSK SGQG +EF+NEVV+VAKLQHRNLV+LLG+CLEGEEKILVYEF
Sbjct: 360 KGTFPSGVQVAVKRLSKNSGQGEKEFENEVVVVAKLQHRNLVKLLGYCLEGEEKILVYEF 419

Query: 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA 482
           VPNKSLDYFL+DP  QGQLDWSRRYKIIGGIARGILYLH+DSRL IIHRDLKA NILLDA
Sbjct: 420 VPNKSLDYFLFDPTMQGQLDWSRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDA 479

Query: 483 EMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEI 542
           +MNPK++DFGMARIFG+DQT+ NT R+VGTYGYMAPEYAM+G+FS+KSDVYSFGVLVLEI
Sbjct: 480 DMNPKVADFGMARIFGMDQTEANTRRVVGTYGYMAPEYAMYGKFSMKSDVYSFGVLVLEI 539

Query: 543 ITGKKNSNFYQTDGA-ADLLSY 563
           ++G KNS+  Q DG+ ++L++Y
Sbjct: 540 VSGMKNSSLDQMDGSISNLVTY 561

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9C5S8|CRK5_ARATH Cysteine-rich receptor-like protein kinase 5 OS=Arabidopsis thaliana GN=CRK5 PE=1 SV=1

 Score =  560 bits (1443), Expect = e-158,   Method: Compositional matrix adjust.
 Identities = 301/548 (54%), Positives = 386/548 (70%), Gaps = 30/548 (5%)

Query: 28  DREYATHVCSTTANFTRNSTYEKNLNLLLSSIPTNASRGNGFSSGFFNATAGQDPNRVYG 87
           D  Y  HVC  T   +RNS Y  NL  LL+S+ +N +    FS G  + T GQ+ + V+G
Sbjct: 28  DPTYVGHVC--TNRISRNSIYFSNLQTLLTSLSSNNAY---FSLGSHSLTKGQNSDMVFG 82

Query: 88  LFLCRGDQTTSDCQDCVTFAARDVLQLCPVSKETILWYAECLLRYSDQSIFSTMATSPTV 147
           L+LC+GD +   C++CV FAA+D    CP  KE ++ Y EC+L YSD++IF    T+ T+
Sbjct: 83  LYLCKGDLSPESCRECVIFAAKDTRSRCPGGKEFLIQYDECMLGYSDRNIFMDTVTTTTI 142

Query: 148 SLLNTQNVT-DQG-RLNELVGTQMSQVVTQAVSNT-KRFATRKANFTTFQTLYSLAQCTP 204
              NTQ VT DQ  R N+ V + M +   +A ++T K+FA +K++F++ Q+LY+  QC P
Sbjct: 143 ITWNTQKVTADQSDRFNDAVLSLMKKSAEEAANSTSKKFAVKKSDFSSSQSLYASVQCIP 202

Query: 205 DLSSSDCNTCLRGAVARLPSCCSGKQGGRVLFPSCNVRYELYPFYNES------ATAPPA 258
           DL+S DC  CL+ ++  L      K GGR L PSCN RYE+YPFY E+           A
Sbjct: 203 DLTSEDCVMCLQQSIKEL---YFNKVGGRFLVPSCNSRYEVYPFYKETIEGTVLPPPVSA 259

Query: 259 PAPVLLSPP--PPGSVTTSRGKSGISSSTIIAIVAPIAVTAVLFILGFCFLRRKAKKKYN 316
           P   L+S P  PPG     +GK+       I +   I+V   + +  F    ++AKK Y+
Sbjct: 260 PPLPLVSTPSFPPG-----KGKNSTVIIIAIVVPVAISVLICVAVFSF-HASKRAKKTYD 313

Query: 317 AVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKR 376
             PE   ++D+TT  SLQFDF+ IE AT+KFS  NKLG+GGFG+VYKG LP+G ++AVKR
Sbjct: 314 -TPE---EDDITTAGSLQFDFKVIEAATDKFSMCNKLGQGGFGQVYKGTLPNGVQVAVKR 369

Query: 377 LSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPE 436
           LSK SGQG +EFKNEVV+VAKLQHRNLV+LLGFCLE EEKILVYEFV NKSLDYFL+D  
Sbjct: 370 LSKTSGQGEKEFKNEVVVVAKLQHRNLVKLLGFCLEREEKILVYEFVSNKSLDYFLFDSR 429

Query: 437 KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496
            Q QLDW+ RYKIIGGIARGILYLH+DSRL IIHRDLKA NILLDA+MNPK++DFGMARI
Sbjct: 430 MQSQLDWTTRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDADMNPKVADFGMARI 489

Query: 497 FGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDG 556
           F +DQT+ +T R+VGTYGYM+PEYAM+GQFS+KSDVYSFGVLVLEII+G+KNS+ YQ D 
Sbjct: 490 FEIDQTEAHTRRVVGTYGYMSPEYAMYGQFSMKSDVYSFGVLVLEIISGRKNSSLYQMDA 549

Query: 557 A-ADLLSY 563
           +  +L++Y
Sbjct: 550 SFGNLVTY 557

Involved in multiple distinct defense responses. May function as a disease resistance (R) protein.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	571
255555033	579	ATP binding protein, putative [Ricinus c	0.929	0.917	0.692	0.0
255555035	671	ATP binding protein, putative [Ricinus c	0.961	0.818	0.641	0.0
255555031	674	ATP binding protein, putative [Ricinus c	0.928	0.786	0.653	0.0
224113935	674	predicted protein [Populus trichocarpa]	0.942	0.798	0.653	0.0
359474717	663	PREDICTED: cysteine-rich receptor-like p	0.914	0.787	0.643	0.0
359474715	684	PREDICTED: cysteine-rich receptor-like p	0.964	0.805	0.627	0.0
351721533	667	cysteine-rich protein precursor [Glycine	0.921	0.788	0.633	0.0
359496581	666	PREDICTED: cysteine-rich receptor-like p	0.912	0.782	0.609	0.0
224076504	671	predicted protein [Populus trichocarpa]	0.973	0.828	0.637	0.0
224076444	673	predicted protein [Populus trichocarpa]	0.977	0.829	0.637	0.0

>gi|255555033|ref|XP_002518554.1| ATP binding protein, putative [Ricinus communis] gi|223542399|gb|EEF43941.1| ATP binding protein, putative [Ricinus communis]

 Score =  739 bits (1908), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 379/547 (69%), Positives = 438/547 (80%), Gaps = 16/547 (2%)

Query: 29  REYATHVCSTTANFTRNSTYEKNLNLLLSSIPTNASRGNGFSSGFFNATAGQDPNRVYGL 88
           RE   +VCS T  FT NSTY+ NLN LLSS+  NA+     S GFFN  +GQ P+ VYG 
Sbjct: 27  REPLYYVCSNTTAFTPNSTYQTNLNKLLSSLSNNANN----SIGFFNIPSGQQPDDVYGS 82

Query: 89  FLCRGDQTTSDCQDCVTFAARDVLQLCPVSKETILWYAECLLRYSDQSIFSTMATSPTVS 148
           FLCRGD +T  CQDCVTFA +D+++ CP+ K  I+WY ECLLRY +QS  STM  +P + 
Sbjct: 83  FLCRGDVSTDVCQDCVTFATQDIVKRCPIEKVAIVWYDECLLRYENQSFISTMDQTPGLY 142

Query: 149 LLNTQNVT--DQGRLNELVGTQMSQVVTQA---VSNTKRFATRKANFTTFQTLYSLAQCT 203
           + NTQN++  DQ R N L+ + M+ + T+A    S  K+FA ++ +FT+FQ LYSL QCT
Sbjct: 143 MWNTQNISTSDQVRFNALLASTMNNLATEASTAASGEKKFAVKEDSFTSFQKLYSLVQCT 202

Query: 204 PDLSSSDCNTCLRGAVARLPSCCSGKQGGRVLFPSCNVRYELYPFYNESATAPPAPAPVL 263
           PDLS+SDC  CL+ A++ LPSCC GKQGGRVL+PSCN+RYE+Y F+N +A  PP PAP  
Sbjct: 203 PDLSTSDCGQCLQTAISNLPSCCGGKQGGRVLYPSCNIRYEVYLFFNATALEPPPPAPSP 262

Query: 264 LSPPPP-----GSVTTSRGKSGISSSTIIAIVAPIAVTAVLFILGFCFLRRKAKKKYNAV 318
           + P PP     G+     GK GIS+ TIIAIVAPIAV  VLF LG C+LRR+  KKY AV
Sbjct: 263 VVPLPPPPTGLGAKPQIEGKRGISTVTIIAIVAPIAVATVLFSLGCCYLRRR--KKYEAV 320

Query: 319 PESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLS 378
            E +A N++TT ESLQ D  TIEVATNKFS DNKLGEGGFGEVYKG LP+GQEIAVK+LS
Sbjct: 321 QEDDARNEITTAESLQIDLNTIEVATNKFSADNKLGEGGFGEVYKGTLPNGQEIAVKKLS 380

Query: 379 KASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQ 438
           ++SGQGAEEFKNEV L+AKLQHRNLVRLLGFCLEG EKILVYEFVPNKSLDYFL+DPEKQ
Sbjct: 381 RSSGQGAEEFKNEVALLAKLQHRNLVRLLGFCLEGAEKILVYEFVPNKSLDYFLFDPEKQ 440

Query: 439 GQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498
            QLDWSRRYKIIGGIARGI+YLHEDSRLRIIHRDLKASNILLD  MN KISDFGMARIFG
Sbjct: 441 AQLDWSRRYKIIGGIARGIVYLHEDSRLRIIHRDLKASNILLDRNMNSKISDFGMARIFG 500

Query: 499 VDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAA 558
           VDQTQGNTSRIVGTYGYM+PEYAMHGQFSVKSD+YSFG+LVLEII+GKKNS+FYQ DG  
Sbjct: 501 VDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDMYSFGILVLEIISGKKNSSFYQIDGVD 560

Query: 559 DLLSYVS 565
           DL+SYVS
Sbjct: 561 DLVSYVS 567

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255555035|ref|XP_002518555.1| ATP binding protein, putative [Ricinus communis] gi|223542400|gb|EEF43942.1| ATP binding protein, putative [Ricinus communis]

 Score =  722 bits (1863), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 361/563 (64%), Positives = 430/563 (76%), Gaps = 14/563 (2%)

Query: 9   FSLFLIYLLSFQFSFTVAVDREYATHVCSTTANFTRNSTYEKNLNLLLSSIPTNASRGNG 68
           F + L++LL        A   EY  H CS T  FT NSTY+ NLN     + ++ S    
Sbjct: 7   FPIILLFLLRLAI-IVKAESPEYRYHFCSNTTTFTPNSTYQTNLN----QVLSSLSNNAN 61

Query: 69  FSSGFFNATAGQDPNRVYGLFLCRGDQTTSDCQDCVTFAARDVLQLCPVSKETILWYAEC 128
            S GFFN  +GQ P+ VYG FLCRGD +T  CQDCVTFA +D+++ CP+ K  I+WY +C
Sbjct: 62  NSIGFFNIPSGQQPDDVYGSFLCRGDVSTDVCQDCVTFATQDIVKRCPIEKVAIVWYDQC 121

Query: 129 LLRYSDQSIFSTMATSPTVSLLNTQNVTDQGRLNELVGTQMSQVVTQA---VSNTKRFAT 185
           LLRY +QS  STM  +P V L NTQ+++D  R + L+ T M  + T A    S  K+FA 
Sbjct: 122 LLRYENQSFISTMDQTPGVFLSNTQDISDPDRFDNLLATTMENLATDASSAASGEKKFAA 181

Query: 186 RKANFTTFQTLYSLAQCTPDLSSSDCNTCLRGAVARLPSCCSGKQGGRVLFPSCNVRYEL 245
              NFT FQ LYSL QCTPDLS+  C  CLRGA++ LPSCC GK+G  VL+PSCNVRYE+
Sbjct: 182 TDDNFTAFQKLYSLVQCTPDLSNPGCRQCLRGAISNLPSCCGGKRGANVLYPSCNVRYEV 241

Query: 246 YPFYNESATAPPAPAPVLLSPPP----PGSVTTSRGKSGISSSTIIAIVAPIAVTAVLFI 301
           YPF+N +A  PP P+P    PPP     G+   + G+SGIS+  I+AIVAP+A+  VLF 
Sbjct: 242 YPFFNATAVEPPPPSPSPAVPPPPPTGSGTRPETEGQSGISTVIIVAIVAPVAIAIVLFS 301

Query: 302 LGFCFLRRKAKKKYNAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEV 361
           L +C+LRR+ +KKY+AV E    N++TT+ESLQ D  T+E ATNKFS DNKLGEGGFGEV
Sbjct: 302 LAYCYLRRRPRKKYDAVQEDG--NEITTVESLQIDLNTVEAATNKFSADNKLGEGGFGEV 359

Query: 362 YKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421
           YKG+LP+GQEIAVK+LS++SGQGA+EFKNEVVL+AKLQHRNLVRLLGFCLEG EKILVYE
Sbjct: 360 YKGILPNGQEIAVKKLSRSSGQGAQEFKNEVVLLAKLQHRNLVRLLGFCLEGAEKILVYE 419

Query: 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD 481
           FV NKSLDYFL+DPEKQ QLDWS RYKI+GGIARGILYLHEDS+LRI+HRDLK SNILLD
Sbjct: 420 FVSNKSLDYFLFDPEKQRQLDWSTRYKIVGGIARGILYLHEDSQLRIVHRDLKVSNILLD 479

Query: 482 AEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLE 541
             MNPKISDFG ARIFGVDQ+QGNT RIVGTYGYM+PEYAMHGQFSVKSD+YSFGVL+LE
Sbjct: 480 RNMNPKISDFGTARIFGVDQSQGNTKRIVGTYGYMSPEYAMHGQFSVKSDMYSFGVLILE 539

Query: 542 IITGKKNSNFYQTDGAADLLSYV 564
           II GKKNS+FY+ DGA DL+SYV
Sbjct: 540 IICGKKNSSFYEIDGAGDLVSYV 562

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255555031|ref|XP_002518553.1| ATP binding protein, putative [Ricinus communis] gi|223542398|gb|EEF43940.1| ATP binding protein, putative [Ricinus communis]

 Score =  721 bits (1861), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 353/540 (65%), Positives = 430/540 (79%), Gaps = 10/540 (1%)

Query: 31  YATHVCSTTANFTRNSTYEKNLNLLLSSIPTNASRGNGFSSGFFNATAGQDPNRVYGLFL 90
           Y  HVCS T  F  NSTY+ NLN L  S+  NA+     S GF+N ++GQDP+ +YGLFL
Sbjct: 30  YLYHVCSNTTTFAPNSTYQTNLNQLFPSLSNNANN----SIGFYNRSSGQDPDDIYGLFL 85

Query: 91  CRGDQTTSDCQDCVTFAARDVLQLCPVSKETILWYAECLLRYSDQSIFSTMATSPTVSLL 150
           CRGD +T  CQDCVTFA++D+++ CP+ K  I+WY ECLL Y+++S++S MA  P V LL
Sbjct: 86  CRGDVSTDVCQDCVTFASQDIVKRCPIEKVAIVWYDECLLHYANRSLYSIMAQEPGVFLL 145

Query: 151 NTQNVTDQGRLNELVGTQMSQVVTQAVS---NTKRFATRKANFTTFQTLYSLAQCTPDLS 207
           N QN+ DQ R N L+ T M ++ T+A S     K+FA +  NFT F+ LYSL QCTPDLS
Sbjct: 146 NVQNIADQDRFNNLLATTMGKLATEAASAASGEKKFAVKIDNFTAFEKLYSLVQCTPDLS 205

Query: 208 SSDCNTCLRGAVARLPSCCSGKQGGRVLFPSCNVRYELYPFYNESA---TAPPAPAPVLL 264
           + DC  CL+ A++ LP+CC GK+GGRVL+PSCN+RYE+YPF+N +A     P     V  
Sbjct: 206 NLDCGRCLQAAISNLPTCCDGKRGGRVLYPSCNIRYEVYPFFNVTALEPPPPSPSPVVPP 265

Query: 265 SPPPPGSVTTSRGKSGISSSTIIAIVAPIAVTAVLFILGFCFLRRKAKKKYNAVPESNAD 324
            P   G+   ++GKSG+S+ TI+AIVAP+AV  V F LG C+LRR+A+KKY+A  E +A 
Sbjct: 266 PPTSSGTRPETKGKSGLSTVTIVAIVAPVAVAIVFFFLGCCYLRRRARKKYDAGQEDDAG 325

Query: 325 NDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQG 384
           N++TT+ESLQ D  TIE AT+KFS  NKLGEGGFG+VYKG LP+GQEIAVK+LS++S QG
Sbjct: 326 NEITTVESLQIDLNTIEAATDKFSAANKLGEGGFGKVYKGTLPNGQEIAVKKLSRSSVQG 385

Query: 385 AEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWS 444
           A+EFKNEVVL+AKLQHRNLVRLLGFCLEG EKILVYEFVPNKSLDYFL+D +KQGQLDW 
Sbjct: 386 AQEFKNEVVLLAKLQHRNLVRLLGFCLEGAEKILVYEFVPNKSLDYFLFDAKKQGQLDWQ 445

Query: 445 RRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG 504
            RYKI+GGIARGI+YLHEDS+L+IIHRDLK SNILLD +MNPKISDFGMARIFGVDQTQG
Sbjct: 446 TRYKIVGGIARGIIYLHEDSQLKIIHRDLKVSNILLDKDMNPKISDFGMARIFGVDQTQG 505

Query: 505 NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYV 564
           NT+RIVGTYGYM+PEYAMHG FSVKSD+YSFGVLVLEII GKKNS+FY+  GA+DL+SYV
Sbjct: 506 NTNRIVGTYGYMSPEYAMHGHFSVKSDIYSFGVLVLEIICGKKNSSFYEIHGASDLVSYV 565

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224113935|ref|XP_002316618.1| predicted protein [Populus trichocarpa] gi|222859683|gb|EEE97230.1| predicted protein [Populus trichocarpa]

 Score =  699 bits (1804), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 357/546 (65%), Positives = 434/546 (79%), Gaps = 8/546 (1%)

Query: 24  TVAVDREYATHVCSTTANFTRNSTYEKNLNLLLSSIPTNASRGNGFSSGFFNATAGQDPN 83
           T A D  +    C  T  FTRNSTY+ NLNLLLSS+ +NA+R N   +GF+N +AGQDP+
Sbjct: 20  TQAQDPTFLYPYCPNTTTFTRNSTYQANLNLLLSSLSSNATRNN--INGFYNVSAGQDPD 77

Query: 84  RVYGLFLCRGDQTTSDCQDCVTFAARDVLQLCPVSKETILWYAECLLRYSDQSIFSTMAT 143
            VYG+FLCRGD + S C++CV FAA+DVL+ CP+ K  ++W+ EC LRYS+++IFST+  
Sbjct: 78  AVYGMFLCRGDVSNSVCRNCVNFAAKDVLERCPIEKVAMIWFDECELRYSNRNIFSTVDQ 137

Query: 144 SPTVSLLNTQNVTDQ-GRLNELVGTQMSQVVTQAVS---NTKRFATRKANFTTFQTLYSL 199
             T+ +++  NVT Q  R N+LV T ++ +  +A S     K+FA ++ N+T  Q LY+L
Sbjct: 138 DFTLFMMSPNNVTVQPDRFNQLVETTINDIAARAASAPSGAKKFAVQQVNYTGIQKLYTL 197

Query: 200 AQCTPDLSSSDCNTCLRGAVARLPSCCSGKQGGRVLFPSCNVRYELYPFYNESATAPPAP 259
            QCTPDLS+ DC+ CL+GA+++L +CC+ KQGGRVLF SCN RYELY FYN +A A  AP
Sbjct: 198 VQCTPDLSTPDCSRCLQGAISKLGNCCNRKQGGRVLFASCNFRYELYEFYNATAAAEAAP 257

Query: 260 APVLLSPPPPGSV--TTSRGKSGISSSTIIAIVAPIAVTAVLFILGFCFLRRKAKKKYNA 317
            P  ++  PP +    T +GK G+S+  IIAI+ P+ V+ VLF LGFCFL R+AK   N+
Sbjct: 258 PPPPVALSPPPTSGPETRKGKGGVSTVLIIAILIPVTVSLVLFCLGFCFLSRRAKSNKNS 317

Query: 318 VPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRL 377
             E++  N++T +ESLQFD  +I+ ATN FS DNKLGEGGFGEVYKG LP+GQ IAVKRL
Sbjct: 318 AQENDVGNEITNVESLQFDLSSIQDATNHFSADNKLGEGGFGEVYKGTLPNGQAIAVKRL 377

Query: 378 SKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEK 437
           SK SGQGA EFKNEV+LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF++DPEK
Sbjct: 378 SKGSGQGAAEFKNEVILVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFVFDPEK 437

Query: 438 QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497
           QG LDWS+RYKIIGGIARGILYLHEDSRLR+IHRDLKASNILLD +MN K+SDFGMARIF
Sbjct: 438 QGLLDWSKRYKIIGGIARGILYLHEDSRLRVIHRDLKASNILLDGDMNAKVSDFGMARIF 497

Query: 498 GVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGA 557
           GVDQTQG T+RIVGTYGYM+PEYAMHGQFSVKSD YSFGVL+LEII+GKKNS+FYQT GA
Sbjct: 498 GVDQTQGCTNRIVGTYGYMSPEYAMHGQFSVKSDAYSFGVLILEIISGKKNSSFYQTGGA 557

Query: 558 ADLLSY 563
           ADL SY
Sbjct: 558 ADLASY 563

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359474717|ref|XP_002267916.2| PREDICTED: cysteine-rich receptor-like protein kinase 25-like isoform 1 [Vitis vinifera]

 Score =  698 bits (1802), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 348/541 (64%), Positives = 417/541 (77%), Gaps = 19/541 (3%)

Query: 31  YATHVCSTTANFTRNSTYEKNLNLLLSSIPTNASRGNGFSSGFFNATAGQDPNRV-YGLF 89
           Y  H+C  T  F  NS+YE NLN  LSS+ +NA+R     +GF+N TAG+ P  V YGLF
Sbjct: 24  YLYHICPNTTTFNPNSSYETNLNFALSSLSSNATR----DTGFYNVTAGRTPPDVAYGLF 79

Query: 90  LCRGDQTTSDCQDCVTFAARD-VLQLCPVSKETILWYAECLLRYSDQSIFSTMATSPTVS 148
           LCRGD T+  CQDCV  A  + V Q C   K+ I+WY EC+LRYS++S FS ++ SP VS
Sbjct: 80  LCRGDVTSQVCQDCVATAVNETVRQRCRGFKQAIIWYDECMLRYSNESFFSQVSESPRVS 139

Query: 149 LLNTQNVTDQGRLNELVGTQMSQVVTQAVSNT--KRFATRKANFTTFQTLYSLAQCTPDL 206
           + NTQN+T+  + N+++G  +  + TQAV++   K+FAT++ NFT FQ +YSL QCTPDL
Sbjct: 140 MWNTQNITEPDQFNQVLGDTLDSIRTQAVNDQSGKKFATKEENFTGFQRVYSLVQCTPDL 199

Query: 207 SSSDCNTCLRGAVARLPSCCSGKQGGRVLFPSCNVRYELYPFYNESATAPPAPAPVLLSP 266
           S   C+ CL G +A LP CC GKQG RVLFPSCNVRYELYPFY   A  P  P       
Sbjct: 200 SPDQCDRCLIGTIAILPDCCGGKQGARVLFPSCNVRYELYPFYQSVAAPPSPPPARP--- 256

Query: 267 PPPGSVTTSRGKSGISSSTIIAIVAPIAVTAVLF-ILGFCFLRRKAKKKYNAVPESNADN 325
               S  ++ GK GISS TI+ IV P  V+ V+F IL +CF+RR AKK+Y+ +   N + 
Sbjct: 257 ----SEPSTEGKGGISSKTIVIIVVPTFVSVVIFSILCYCFIRRCAKKRYDTLEAENVEF 312

Query: 326 DLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGA 385
           ++TT +SLQFD  TI+ ATN FS  NK+GEGGFG VYKG L SGQEIA+KRLSK+SGQGA
Sbjct: 313 NITTEQSLQFDLATIQAATNNFSDHNKIGEGGFGAVYKGTLSSGQEIAIKRLSKSSGQGA 372

Query: 386 EEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLY---DPEKQGQLD 442
            EFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE+VPNKSLDYFL+    P K+GQLD
Sbjct: 373 VEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEYVPNKSLDYFLFGLAQPTKRGQLD 432

Query: 443 WSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502
           WSRRYKIIGGIARGILYLHEDSRLR+IHRDLKASN+LLD +MNPKISDFGMARIFGVDQT
Sbjct: 433 WSRRYKIIGGIARGILYLHEDSRLRVIHRDLKASNVLLDGDMNPKISDFGMARIFGVDQT 492

Query: 503 QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLS 562
           QGNT+R+VGTYGYM+PEYAMHG+FSVKSDVYSFGVLVLEII+GK+++ F+++D A DLLS
Sbjct: 493 QGNTNRVVGTYGYMSPEYAMHGRFSVKSDVYSFGVLVLEIISGKRSNCFHESDQAEDLLS 552

Query: 563 Y 563
           Y
Sbjct: 553 Y 553

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359474715|ref|XP_003631522.1| PREDICTED: cysteine-rich receptor-like protein kinase 25-like isoform 2 [Vitis vinifera]

 Score =  696 bits (1797), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 360/574 (62%), Positives = 432/574 (75%), Gaps = 23/574 (4%)

Query: 9   FSLFLIYLLSFQFSFT---VAVDREYATHVCSTTANFTRNSTYEKNLNLLLSSIPTNASR 65
           FS  L++L +   + +   +    +Y  HVCS T     NSTY+ NLN LLSS+ +NA+R
Sbjct: 5   FSRNLLFLCALGLAISCLAIQAAPDYIHHVCSNTTTIQPNSTYQTNLNSLLSSLSSNATR 64

Query: 66  GNGFSSGFFNATAGQDPNRVYGLFLCRGDQTTSDCQDCVTFAARDVLQLCPVSKETILWY 125
            NGF    +NATAGQ P+  YGLFLCRGD    DC+DCV  A+ ++LQ C   K+ I+WY
Sbjct: 65  ANGF----YNATAGQSPDVAYGLFLCRGDVAIDDCRDCVANASAEILQQCSGVKKAIIWY 120

Query: 126 AECLLRYSDQSIFSTMATSPTVSLLNTQNVTDQGRLNELVGTQMSQVVTQAVSNT--KRF 183
            +C+L YS++SIFS +  +P + L N QNVTD G  N+LV   M+   T A ++   K+F
Sbjct: 121 DQCMLHYSNRSIFSRVEENPMLQLYNLQNVTDPGPFNQLVVDTMNATATLAANDESGKKF 180

Query: 184 ATRKANFTTFQTLYSLAQCTPDLSSSDCNTCLRGAVARLPSCCSGKQGGRVLFPSCNVRY 243
           AT++ NFT  QTLYSL QCTPDLS +DC+ CL GA+  L  CCSGKQG R L PSCN RY
Sbjct: 181 ATKEENFTGSQTLYSLVQCTPDLSIADCSKCLEGAIGALSLCCSGKQGARTLTPSCNARY 240

Query: 244 ELYPFYNESA-------TAPPAPAPVLLSPPPPGSVT------TSRGKSGISSSTIIAIV 290
           ELYPFY   A          P  A VLL PPP  S        ++ GK GISS TI+ IV
Sbjct: 241 ELYPFYQLEAGPLAPALAPAPTSATVLLPPPPAPSSKSSATEPSTEGKGGISSKTIVIIV 300

Query: 291 APIAVTAVLF-ILGFCFLRRKAKKKYNAVPESNADNDLTTLESLQFDFETIEVATNKFST 349
            P  V+ V+F IL +CF+RR AKK+Y+ +   N + ++TT +SLQFD  TI+ ATN FS 
Sbjct: 301 VPTFVSVVIFSILCYCFIRRCAKKRYDTLEAENVEFNITTEQSLQFDLATIQAATNNFSD 360

Query: 350 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGF 409
            NK+GEGGFG VYKG L SGQEIA+KRLSK+SGQGA EFKNEVVLVAKLQHRNLVRLLGF
Sbjct: 361 HNKIGEGGFGAVYKGTLSSGQEIAIKRLSKSSGQGAVEFKNEVVLVAKLQHRNLVRLLGF 420

Query: 410 CLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRII 469
           CLEGEEKILVYE+VPNKSLDYFL+DP+K+GQLDWSRRYKIIGGIARGILYLHEDSRLR+I
Sbjct: 421 CLEGEEKILVYEYVPNKSLDYFLFDPDKRGQLDWSRRYKIIGGIARGILYLHEDSRLRVI 480

Query: 470 HRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVK 529
           HRDLKASN+LLD +MNPKISDFGMARIFGVDQTQGNT+R+VGTYGYM+PEYAMHG+FSVK
Sbjct: 481 HRDLKASNVLLDGDMNPKISDFGMARIFGVDQTQGNTNRVVGTYGYMSPEYAMHGRFSVK 540

Query: 530 SDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSY 563
           SDVYSFGVLVLEII+GK+++ F+++D A DLLSY
Sbjct: 541 SDVYSFGVLVLEIISGKRSNCFHESDQAEDLLSY 574

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|351721533|ref|NP_001238492.1| cysteine-rich protein precursor [Glycine max] gi|223452302|gb|ACM89479.1| cysteine-rich protein [Glycine max]

 Score =  683 bits (1763), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 342/540 (63%), Positives = 410/540 (75%), Gaps = 14/540 (2%)

Query: 31  YATHVCSTTANFTRNSTYEKNLNLLLSSIPTNASRGNGFSSGFFNATAG---QDPNRVYG 87
           Y  H CS   N T NS Y+ NL  LL+S+ +NA+     ++ F N T G      +RVYG
Sbjct: 30  YLYHNCSG-GNTTANSAYQLNLRTLLTSLSSNAT-----TTEFSNNTVGLGTSPSDRVYG 83

Query: 88  LFLCRGDQTTSDCQDCVTFAARDVLQLCPVSKETILWYAECLLRYSDQSIFSTMATSPTV 147
           LF+CRGD  ++ CQ CV  A   +   C ++K+ ++WY EC +RYS++S FST+ T P V
Sbjct: 84  LFMCRGDVPSALCQQCVVNATGRLRSQCSLAKQAVIWYDECTVRYSNRSFFSTVDTRPRV 143

Query: 148 SLLNTQNVTDQGRLNELVGTQMSQVVTQAVS---NTKRFATRKANFTTFQTLYSLAQCTP 204
            LLNT N+++Q     L+   +++   +A +     K++A  +AN + FQ+LY LAQCTP
Sbjct: 144 GLLNTANISNQDSFMRLLFQTINRTADEAANFSVGLKKYAVNQANISGFQSLYCLAQCTP 203

Query: 205 DLSSSDCNTCLRGAVARLPSCCSGKQGGRVLFPSCNVRYELYPFYNESATAPPAPAPVLL 264
           DLS  +C +CL G +  LP CC GKQGGRVL+PSCNVRYELYPFY  +A+ P +      
Sbjct: 204 DLSQENCRSCLSGVIGDLPWCCQGKQGGRVLYPSCNVRYELYPFYRVTASPPSSSPSPPT 263

Query: 265 SPPPPGSVTTSRGKSGISSSTIIAIVAPIAVTAVLFILGFCFLRRKAKKKYN-AVPESNA 323
             PP  +   S G SGIS+ TI+AIV PI V  ++FI+G CFL R+A+KK   +V E   
Sbjct: 264 LLPP-PTSPISPGSSGISAGTIVAIVVPITVAVLIFIVGICFLSRRARKKQQGSVKEGKT 322

Query: 324 DNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQ 383
             D+ T++SLQFDF TIE ATNKFS DNKLGEGGFGEVYKG L SGQ +AVKRLSK+SGQ
Sbjct: 323 AYDIPTVDSLQFDFSTIEAATNKFSADNKLGEGGFGEVYKGTLSSGQVVAVKRLSKSSGQ 382

Query: 384 GAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDW 443
           G EEFKNEVV+VAKLQHRNLVRLLGFCL+GEEKILVYE+VPNKSLDY L+DPEKQ +LDW
Sbjct: 383 GGEEFKNEVVVVAKLQHRNLVRLLGFCLQGEEKILVYEYVPNKSLDYILFDPEKQRELDW 442

Query: 444 SRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ 503
            RRYKIIGGIARGI YLHEDSRLRIIHRDLKASNILLD +MNPKISDFGMARIFGVDQTQ
Sbjct: 443 GRRYKIIGGIARGIQYLHEDSRLRIIHRDLKASNILLDGDMNPKISDFGMARIFGVDQTQ 502

Query: 504 GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSY 563
           GNTSRIVGTYGYMAPEYAMHG+FSVKSDVYSFGVL++EI++GKKNS+FYQTDGA DLLSY
Sbjct: 503 GNTSRIVGTYGYMAPEYAMHGEFSVKSDVYSFGVLLMEILSGKKNSSFYQTDGAEDLLSY 562

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359496581|ref|XP_002270035.2| PREDICTED: cysteine-rich receptor-like protein kinase 10-like [Vitis vinifera]

 Score =  670 bits (1729), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 324/532 (60%), Positives = 407/532 (76%), Gaps = 11/532 (2%)

Query: 36  CSTTANFTRNSTYEKNLNLLLSSIPTNASRGNGFSSGFFNATAGQDPNRVYGLFLCRGDQ 95
           C+  +N+  NSTY+ +LN+LL+S+ ++A+  NG    F N TAGQ P+ VYGL+LCRGD 
Sbjct: 33  CTENSNYVPNSTYQSSLNVLLTSLSSDATILNG--RKFHNTTAGQAPDMVYGLYLCRGDV 90

Query: 96  TTSDCQDCVTFAARDVLQLCPVSKETILWYAECLLRYSDQSIFSTMATSPTVSLLNTQNV 155
           T + CQDCV  A++++L  CP  KE + WY +C+LRYS++SIFS M   P +++ N+ ++
Sbjct: 91  TDAVCQDCVQTASQEILTKCPNRKEALSWYDQCMLRYSNRSIFSIMEERPMLTMSNSLDM 150

Query: 156 TDQGRLNELVGTQMSQVVTQAVSNTKR---FATRKANFTTFQTLYSLAQCTPDLSSSDCN 212
            D  R +++V   M  ++ +A  N+     F T +ANF     +Y L QCTPDLS S+C+
Sbjct: 151 DDPDRFDQIVNKTMVGLIEKATHNSSERDMFETGEANFNASTKIYGLVQCTPDLSGSNCS 210

Query: 213 TCLRGAVARLPSCCSGKQGGRVLFPSCNVRYELYPFYNESATAPPAPAPVLLSPPPPGSV 272
           TCL    +R+ +CC GKQG R+L PSCN RYELYPFY + A A P             S+
Sbjct: 211 TCLENIFSRITNCCLGKQGARILVPSCNFRYELYPFYGDLAAATPPAPAPSPL-----SL 265

Query: 273 TTSRGKSGISSSTIIAIVAPIAVTAVLF-ILGFCFLRRKAKKKYNAVPESNADNDLTTLE 331
            +  GK G SS  +IAI+ P+AV+ V+F IL +CF+ RKAKKKY++  E   +ND+TT++
Sbjct: 266 LSPPGKKGNSSQLLIAIIVPVAVSVVIFSILCYCFICRKAKKKYSSTEEEKVENDITTVQ 325

Query: 332 SLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNE 391
           SLQFDF T+E ATN FS DNK+GEGGFG+VYKG L SG+EIA+KRLS++S QGA EFKNE
Sbjct: 326 SLQFDFGTLEAATNNFSDDNKIGEGGFGDVYKGTLSSGKEIAIKRLSRSSAQGAVEFKNE 385

Query: 392 VVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIG 451
           VVLVAKLQHRNLVRLLGFCLEGEEKILVYE+VPNKSLD FL+DP+KQGQLDWSRRYKIIG
Sbjct: 386 VVLVAKLQHRNLVRLLGFCLEGEEKILVYEYVPNKSLDCFLFDPDKQGQLDWSRRYKIIG 445

Query: 452 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVG 511
           GIARGILYLHEDS+L++IHRDLKASN+LLD +MNPKISDFGMARIFG DQT+G+T R+VG
Sbjct: 446 GIARGILYLHEDSQLKVIHRDLKASNVLLDGDMNPKISDFGMARIFGGDQTRGSTKRVVG 505

Query: 512 TYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSY 563
           TYGYM+PEYAM G FS KSDVYSFGVLVLEII+GKK S+FY++D   DLL Y
Sbjct: 506 TYGYMSPEYAMRGHFSAKSDVYSFGVLVLEIISGKKISHFYESDQTEDLLGY 557

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224076504|ref|XP_002304953.1| predicted protein [Populus trichocarpa] gi|222847917|gb|EEE85464.1| predicted protein [Populus trichocarpa]

 Score =  667 bits (1722), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 362/568 (63%), Positives = 430/568 (75%), Gaps = 12/568 (2%)

Query: 1   MPPLKFFMFSLFLIYLLSFQFSFTVAVDREYATHVCSTTANFTRNSTYEKNLNLLLSSIP 60
           M  LKF++    L+ LL+         D  Y  H C      T NSTY  NLNLLLSS+ 
Sbjct: 1   MNSLKFYVI---LLSLLTLAIITLAQDDANYLNHNCQNATTSTINSTYRVNLNLLLSSLA 57

Query: 61  TNASRGNGFSSGFFNATAGQDPNRVYGLFLCRGDQTTSDCQDCVTFAARDVLQLCPVSKE 120
           +NA+R N  ++GF+N + GQ+ ++VYGLF+CRGD + S CQ+CVTFA +D++Q CP+   
Sbjct: 58  SNATRNN--TNGFYNTSFGQNTDQVYGLFICRGDVSNSVCQNCVTFATKDIVQRCPIGIA 115

Query: 121 TILWYAECLLRYSDQSIFSTMATSPTVSLLNTQNVTDQ-GRLNELVGTQMSQVVTQAVS- 178
           +I++Y  C+LRYS+ + FS +  SP  SLLNTQN+T +  R N LVG  ++ +  +A S 
Sbjct: 116 SIVYYDACILRYSNVNFFSKVDQSPGFSLLNTQNITTEPQRFNNLVGAAVNDLAARAASA 175

Query: 179 --NTKRFATRKANFTTFQTLYSLAQCTPDLSSSDCNTCLRGAVARLPSCCSGKQGGRVLF 236
               K+FA  K +F  FQ +YSLAQCTPDLSSSDCN CL  A+A LP+CCS K GGRVLF
Sbjct: 176 PPGAKKFAVNKTSFNAFQNIYSLAQCTPDLSSSDCNRCLSAAIAGLPNCCSSKIGGRVLF 235

Query: 237 PSCNVRYELYPFYNESATAPPAPAPVLLSPPPPGSVTTSRGKSGISSSTIIAIVAPIAVT 296
           PSC + YE+  FY+  ATA  A +P    PP          K G+S+  IIAIV PIAV+
Sbjct: 236 PSCYIHYEITEFYD--ATAVAAESPPPPPPPVALPSPPPPQKGGVSTVLIIAIVIPIAVS 293

Query: 297 AVLFILGFCFLRRKAKKKYNAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEG 356
             LF + FCFLRR A+K  + VPE++  +++TT ESLQFD  TIE ATN FS DNKLGEG
Sbjct: 294 IALFSMCFCFLRR-ARKTRDYVPENDVGDEITTEESLQFDLSTIEAATNNFSADNKLGEG 352

Query: 357 GFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEK 416
           GFGEVYKG LP+GQ+IAVKRLS+ SGQGA EFKNEVVLVAKLQHRNLVR+ GFCLE EEK
Sbjct: 353 GFGEVYKGTLPNGQQIAVKRLSRNSGQGAAEFKNEVVLVAKLQHRNLVRVQGFCLEREEK 412

Query: 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKAS 476
           ILVYEFV NKSLDYFL+DPE+QG LDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKAS
Sbjct: 413 ILVYEFVSNKSLDYFLFDPERQGLLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKAS 472

Query: 477 NILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFG 536
           NILLD +MNPKISDFG+ARIF VDQTQ +T RIVGTYGYM+PEYAMHG+FSVKSDVYSFG
Sbjct: 473 NILLDGDMNPKISDFGLARIFVVDQTQASTIRIVGTYGYMSPEYAMHGRFSVKSDVYSFG 532

Query: 537 VLVLEIITGKKNSNFYQTDGAADLLSYV 564
           VL+LEIITGKKNS+FYQT GA DL+SYV
Sbjct: 533 VLILEIITGKKNSSFYQTGGAVDLVSYV 560

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224076444|ref|XP_002304944.1| predicted protein [Populus trichocarpa] gi|222847908|gb|EEE85455.1| predicted protein [Populus trichocarpa]

 Score =  667 bits (1721), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 362/568 (63%), Positives = 430/568 (75%), Gaps = 10/568 (1%)

Query: 1   MPPLKFFMFSLFLIYLLSFQFSFTVAVDREYATHVCSTTANFTRNSTYEKNLNLLLSSIP 60
           M  LKF++  L L+ L     +   A D  Y  H C      T NSTY  NLNLLLSS+ 
Sbjct: 1   MNSLKFYVILLSLLTLAIITLAQEDA-DANYLNHFCQNATTSTINSTYRVNLNLLLSSLA 59

Query: 61  TNASRGNGFSSGFFNATAGQDPNRVYGLFLCRGDQTTSDCQDCVTFAARDVLQLCPVSKE 120
           +NA+R N  ++GF+N + GQ+ ++VYGLF+CRGD + + CQ+CVTFA +D++Q CPV   
Sbjct: 60  SNATRNN--TNGFYNTSFGQNTDQVYGLFICRGDVSNTVCQNCVTFATKDIVQRCPVGIA 117

Query: 121 TILWYAECLLRYSDQSIFSTMATSPTVSLLNTQNVTDQ-GRLNELVGTQMSQVVTQAVS- 178
           +I++Y  C+LRYS+ + FS +  SP  SLLNTQN+T +  R N LVG  ++ +  +A S 
Sbjct: 118 SIVYYDACILRYSNVNFFSKVDQSPGFSLLNTQNITTEPQRFNNLVGAAVNDLAARAASA 177

Query: 179 --NTKRFATRKANFTTFQTLYSLAQCTPDLSSSDCNTCLRGAVARLPSCCSGKQGGRVLF 236
               K+FA  K +F  FQ +YSLAQCTPDLSSSDCN CL  A+A LP+CCS K GGRVLF
Sbjct: 178 PPGAKKFAVNKTSFNAFQNIYSLAQCTPDLSSSDCNRCLSAAIAGLPNCCSSKIGGRVLF 237

Query: 237 PSCNVRYELYPFYNESATAPPAPAPVLLSPPPPGSVTTSRGKSGISSSTIIAIVAPIAVT 296
           PSC + YE+  FY+  ATA  A +P    PP          K  +S+  IIAIV PIAV+
Sbjct: 238 PSCYIHYEITEFYD--ATAVAAESPPPPPPPVVIPSPPPPQKGSVSTVLIIAIVIPIAVS 295

Query: 297 AVLFILGFCFLRRKAKKKYNAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEG 356
             LF + FCFLRR A+K  + VPE++  +++TT ESLQFD  TIE ATN  S DNKLGEG
Sbjct: 296 IALFCMCFCFLRR-ARKTRDYVPENDVGDEITTEESLQFDLSTIEAATNNCSPDNKLGEG 354

Query: 357 GFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEK 416
           GFGEVYKG LP+GQ+IAVKRLS+ SGQGA EFKNEVVLVAKLQHRNLVRL GFCLE EEK
Sbjct: 355 GFGEVYKGTLPNGQQIAVKRLSRNSGQGAAEFKNEVVLVAKLQHRNLVRLQGFCLEREEK 414

Query: 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKAS 476
           ILVYEFV NKSLDYFL+DPE+QG LDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKAS
Sbjct: 415 ILVYEFVSNKSLDYFLFDPERQGLLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKAS 474

Query: 477 NILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFG 536
           NILLD +MNPKISDFG+ARIF VDQTQ +T+RIVGTYGYM+PEYAMHG+FSVKSDVYSFG
Sbjct: 475 NILLDGDMNPKISDFGLARIFVVDQTQASTNRIVGTYGYMSPEYAMHGRFSVKSDVYSFG 534

Query: 537 VLVLEIITGKKNSNFYQTDGAADLLSYV 564
           VL+LEIITGKKNS+FYQT GA DL+SYV
Sbjct: 535 VLILEIITGKKNSSFYQTGGAPDLVSYV 562

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	571
TAIR|locus:2121676	669	CRK10 "cysteine-rich RLK (RECE	0.462	0.394	0.773	2.6e-171
TAIR|locus:2115728	675	CRK25 "cysteine-rich RLK (RECE	0.465	0.394	0.723	1.5e-164
TAIR|locus:2121651	676	CRK8 "cysteine-rich RLK (RECEP	0.464	0.392	0.715	1.1e-150
TAIR|locus:2121636	659	CRK7 "cysteine-rich RLK (RECEP	0.462	0.400	0.701	5.8e-150
TAIR|locus:2121626	830	CRK23 "cysteine-rich RLK (RECE	0.441	0.303	0.733	1.4e-148
TAIR|locus:2077147	676	CRK4 "cysteine-rich RLK (RECEP	0.464	0.392	0.711	7.5e-148
TAIR|locus:2121686	645	CRK19 "cysteine-rich RLK (RECE	0.464	0.410	0.700	1.3e-143
TAIR|locus:2121691	667	CRK11 "cysteine-rich RLK (RECE	0.462	0.395	0.722	1.5e-140
TAIR|locus:2123111	669	CRK34 "cysteine-rich RLK (RECE	0.439	0.375	0.761	5e-140
TAIR|locus:2141762	665	CRK26 "cysteine-rich RLK (RECE	0.458	0.393	0.639	3.8e-129

TAIR|locus:2121676 CRK10 "cysteine-rich RLK (RECEPTOR-like protein kinase) 10" [Arabidopsis thaliana (taxid:3702)]

 Score = 1096 (390.9 bits), Expect = 2.6e-171, Sum P(2) = 2.6e-171
 Identities = 205/265 (77%), Positives = 238/265 (89%)

Query:   299 LFILGFCFLRRKAKKKYNAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGF 358
             LFI G+CFL R+A+K Y   P + A +D+TT +SLQ D+ TI+ AT+ F   NK+G+GGF
Sbjct:   301 LFIAGYCFLTRRARKSYYT-PSAFAGDDITTADSLQLDYRTIQTATDDFVESNKIGQGGF 359

Query:   359 GEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418
             GEVYKG L  G E+AVKRLSK+SGQG  EFKNEVVLVAKLQHRNLVRLLGFCL+GEE++L
Sbjct:   360 GEVYKGTLSDGTEVAVKRLSKSSGQGEVEFKNEVVLVAKLQHRNLVRLLGFCLDGEERVL 419

Query:   419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNI 478
             VYE+VPNKSLDYFL+DP K+GQLDW+RRYKIIGG+ARGILYLH+DSRL IIHRDLKASNI
Sbjct:   420 VYEYVPNKSLDYFLFDPAKKGQLDWTRRYKIIGGVARGILYLHQDSRLTIIHRDLKASNI 479

Query:   479 LLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVL 538
             LLDA+MNPKI+DFGMARIFG+DQT+ NTSRIVGTYGYM+PEYAMHGQ+S+KSDVYSFGVL
Sbjct:   480 LLDADMNPKIADFGMARIFGLDQTEENTSRIVGTYGYMSPEYAMHGQYSMKSDVYSFGVL 539

Query:   539 VLEIITGKKNSNFYQTDGAADLLSY 563
             VLEII+GKKNS+FYQTDGA DL+SY
Sbjct:   540 VLEIISGKKNSSFYQTDGAHDLVSY 564

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0006995 "cellular response to nitrogen starvation" evidence=RCA

TAIR|locus:2115728 CRK25 "cysteine-rich RLK (RECEPTOR-like protein kinase) 25" [Arabidopsis thaliana (taxid:3702)]

 Score = 1002 (357.8 bits), Expect = 1.5e-164, Sum P(2) = 1.5e-164
 Identities = 194/268 (72%), Positives = 226/268 (84%)

Query:   299 LFILG-FCFL-RRKAKKKYNAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEG 356
             + +LG  C+L  R+   K +A  E   ++ +T+ E+LQF F  IE ATNKFS  NKLG G
Sbjct:   297 VLLLGAMCWLLARRRNNKLSAETEDLDEDGITSTETLQFQFSAIEAATNKFSESNKLGHG 356

Query:   357 GFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEK 416
             GFGEVYKG L +G+ +A+KRLS+ S QGAEEFKNEV +VAKLQHRNL +LLG+CL+GEEK
Sbjct:   357 GFGEVYKGQLITGETVAIKRLSQGSTQGAEEFKNEVDVVAKLQHRNLAKLLGYCLDGEEK 416

Query:   417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKAS 476
             ILVYEFVPNKSLDYFL+D EK+  LDW RRYKII GIARGILYLH DSRL IIHRDLKAS
Sbjct:   417 ILVYEFVPNKSLDYFLFDNEKRRVLDWQRRYKIIEGIARGILYLHRDSRLTIIHRDLKAS 476

Query:   477 NILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFG 536
             NILLDA+M+PKISDFGMARIFGVDQTQ NT RIVGTYGYM+PEYA+HG++SVKSDVYSFG
Sbjct:   477 NILLDADMHPKISDFGMARIFGVDQTQANTKRIVGTYGYMSPEYAIHGKYSVKSDVYSFG 536

Query:   537 VLVLEIITGKKNSNFYQTDGAADLLSYV 564
             VLVLE+ITGKKNS+FY+ DG  DL++YV
Sbjct:   537 VLVLELITGKKNSSFYEEDGLGDLVTYV 564

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000041 "transition metal ion transport" evidence=RCA

GO:0006826 "iron ion transport" evidence=RCA

GO:0010106 "cellular response to iron ion starvation" evidence=RCA

GO:0010167 "response to nitrate" evidence=RCA

GO:0010413 "glucuronoxylan metabolic process" evidence=RCA

GO:0015706 "nitrate transport" evidence=RCA

GO:0045492 "xylan biosynthetic process" evidence=RCA

TAIR|locus:2121651 CRK8 "cysteine-rich RLK (RECEPTOR-like protein kinase) 8" [Arabidopsis thaliana (taxid:3702)]

 Score = 1004 (358.5 bits), Expect = 1.1e-150, Sum P(2) = 1.1e-150
 Identities = 191/267 (71%), Positives = 227/267 (85%)

Query:   299 LFI--LGFCFLRRKAKKKYNAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEG 356
             LFI  +G+CFL ++ KK ++    S   +D+ T +SLQ D+ TI+ ATN F+  NK+G G
Sbjct:   303 LFIALVGYCFLAQRTKKTFDTASASEVGDDMATADSLQLDYRTIQTATNDFAESNKIGRG 362

Query:   357 GFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEK 416
             GFGEVYKG   +G+E+AVKRLSK S QG  EFK EVV+VAKLQHRNLVRLLGF L+GEE+
Sbjct:   363 GFGEVYKGTFSNGKEVAVKRLSKNSRQGEAEFKTEVVVVAKLQHRNLVRLLGFSLQGEER 422

Query:   417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKAS 476
             ILVYE++PNKSLD  L+DP KQ QLDW +RY IIGGIARGILYLH+DSRL IIHRDLKAS
Sbjct:   423 ILVYEYMPNKSLDCLLFDPTKQTQLDWMQRYNIIGGIARGILYLHQDSRLTIIHRDLKAS 482

Query:   477 NILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFG 536
             NILLDA++NPKI+DFGMARIFG+DQTQ NTSRIVGTYGYMAPEYAMHGQFS+KSDVYSFG
Sbjct:   483 NILLDADINPKIADFGMARIFGLDQTQDNTSRIVGTYGYMAPEYAMHGQFSMKSDVYSFG 542

Query:   537 VLVLEIITGKKNSNFYQTDGAADLLSY 563
             VLVLEII+G+KNS+F ++DGA DLL++
Sbjct:   543 VLVLEIISGRKNSSFDESDGAQDLLTH 569

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2121636 CRK7 "cysteine-rich RLK (RECEPTOR-like protein kinase) 7" [Arabidopsis thaliana (taxid:3702)]

 Score = 983 (351.1 bits), Expect = 5.8e-150, Sum P(2) = 5.8e-150
 Identities = 186/265 (70%), Positives = 224/265 (84%)

Query:   299 LFILGFCFLRRKAKKKYNAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGF 358
             +FI G+CF  ++AKK Y   P  + D D TT+ESLQ D+  I+ ATN FS +NK+G GGF
Sbjct:   289 IFIAGYCFFAKRAKKTYGTTPALDED-DKTTIESLQLDYRAIQAATNDFSENNKIGRGGF 347

Query:   359 GEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418
             G+VYKG   +G E+AVKRLSK S QG  EFKNEVV+VA L+H+NLVR+LGF +E EE+IL
Sbjct:   348 GDVYKGTFSNGTEVAVKRLSKTSEQGDTEFKNEVVVVANLRHKNLVRILGFSIEREERIL 407

Query:   419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNI 478
             VYE+V NKSLD FL+DP K+GQL W++RY IIGGIARGILYLH+DSRL IIHRDLKASNI
Sbjct:   408 VYEYVENKSLDNFLFDPAKKGQLYWTQRYHIIGGIARGILYLHQDSRLTIIHRDLKASNI 467

Query:   479 LLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVL 538
             LLDA+MNPKI+DFGMARIFG+DQTQ NTSRIVGTYGYM+PEYAM GQFS+KSDVYSFGVL
Sbjct:   468 LLDADMNPKIADFGMARIFGMDQTQQNTSRIVGTYGYMSPEYAMRGQFSMKSDVYSFGVL 527

Query:   539 VLEIITGKKNSNFYQTDGAADLLSY 563
             VLEII+G+KN++F +TD A DL+++
Sbjct:   528 VLEIISGRKNNSFIETDDAQDLVTH 552

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0034976 "response to endoplasmic reticulum stress" evidence=RCA

TAIR|locus:2121626 CRK23 "cysteine-rich RLK (RECEPTOR-like protein kinase) 23" [Arabidopsis thaliana (taxid:3702)]

 Score = 962 (343.7 bits), Expect = 1.4e-148, Sum P(2) = 1.4e-148
 Identities = 187/255 (73%), Positives = 216/255 (84%)

Query:   312 KKKYNAVPESNADN--DLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSG 369
             K+K   V E  A+N   +TT  SLQFDF+ I  ATN F   NKLG+GGFGEVYKG  PSG
Sbjct:   471 KRKDTEVTEPLAENGDSITTAGSLQFDFKAIVAATNNFLPINKLGQGGFGEVYKGTFPSG 530

Query:   370 QEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLD 429
              ++AVKRLSK SGQG  EF+NEVV+VAKLQHRNLVRLLG+CLEGEEKILVYEFV NKSLD
Sbjct:   531 VQVAVKRLSKTSGQGEREFENEVVVVAKLQHRNLVRLLGYCLEGEEKILVYEFVHNKSLD 590

Query:   430 YFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKIS 489
             YFL+D   + QLDW+RRYKIIGGIARGILYLH+DSRL IIHRDLKA NILLDA+MNPK++
Sbjct:   591 YFLFDTTMKRQLDWTRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDADMNPKVA 650

Query:   490 DFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNS 549
             DFGMARIFG+DQT+ NT R+VGTYGYMAPEYAM+GQFS+KSDVYSFGVLV EII+G KNS
Sbjct:   651 DFGMARIFGMDQTEANTRRVVGTYGYMAPEYAMYGQFSMKSDVYSFGVLVFEIISGMKNS 710

Query:   550 NFYQTDGA-ADLLSY 563
             + YQ D + ++L++Y
Sbjct:   711 SLYQMDDSVSNLVTY 725

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006952 "defense response" evidence=TAS

TAIR|locus:2077147 CRK4 "cysteine-rich RLK (RECEPTOR-like protein kinase) 4" [Arabidopsis thaliana (taxid:3702)]

 Score = 992 (354.3 bits), Expect = 7.5e-148, Sum P(2) = 7.5e-148
 Identities = 190/267 (71%), Positives = 220/267 (82%)

Query:   299 LFILGFCFLRRKAKKKYNAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGF 358
             LF+  F    +K +  Y   P +   +D+TT  SLQFDF+ IE ATNKF   NKLG+GGF
Sbjct:   303 LFVAFFSLRAKKTRTNYEREPLTEESDDITTAGSLQFDFKAIEAATNKFCETNKLGQGGF 362

Query:   359 GEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418
             GEVYKG+ PSG ++AVKRLSK SGQG  EF NEV++VAKLQHRNLVRLLGFCLE +E+IL
Sbjct:   363 GEVYKGIFPSGVQVAVKRLSKTSGQGEREFANEVIVVAKLQHRNLVRLLGFCLERDERIL 422

Query:   419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNI 478
             VYEFVPNKSLDYF++D   Q  LDW+RRYKIIGGIARGILYLH+DSRL IIHRDLKA NI
Sbjct:   423 VYEFVPNKSLDYFIFDSTMQSLLDWTRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNI 482

Query:   479 LLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVL 538
             LL  +MN KI+DFGMARIFG+DQT+ NT RIVGTYGYM+PEYAM+GQFS+KSDVYSFGVL
Sbjct:   483 LLGDDMNAKIADFGMARIFGMDQTEANTRRIVGTYGYMSPEYAMYGQFSMKSDVYSFGVL 542

Query:   539 VLEIITGKKNSNFYQTDG--AADLLSY 563
             VLEII+GKKNSN YQ DG  A +L++Y
Sbjct:   543 VLEIISGKKNSNVYQMDGTSAGNLVTY 569

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006952 "defense response" evidence=TAS

GO:0009751 "response to salicylic acid stimulus" evidence=IEP

GO:0012501 "programmed cell death" evidence=IMP

GO:0042742 "defense response to bacterium" evidence=IEP

TAIR|locus:2121686 CRK19 "cysteine-rich RLK (RECEPTOR-like protein kinase) 19" [Arabidopsis thaliana (taxid:3702)]

 Score = 957 (341.9 bits), Expect = 1.3e-143, Sum P(2) = 1.3e-143
 Identities = 187/267 (70%), Positives = 221/267 (82%)

Query:   299 LFILGFCFLRRKAKKKYNAV-PESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGG 357
             L ++    +R K K+  N   P +   ND+TT  SLQFDF+ IE ATN F   NKLG+GG
Sbjct:   277 LLLVAVFSVRAKNKRTLNEKEPVAEDGNDITTAGSLQFDFKAIEAATNCFLPINKLGQGG 336

Query:   358 FGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 417
             FGEVYKG L SG ++AVKRLSK SGQG +EF+NEVV+VAKLQHRNLV+LLG+CLEGEEKI
Sbjct:   337 FGEVYKGTLSSGLQVAVKRLSKTSGQGEKEFENEVVVVAKLQHRNLVKLLGYCLEGEEKI 396

Query:   418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASN 477
             LVYEFVPNKSLD+FL+D   + +LDW+RRYKIIGGIARGILYLH+DSRL IIHRDLKA N
Sbjct:   397 LVYEFVPNKSLDHFLFDSTMKMKLDWTRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGN 456

Query:   478 ILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGV 537
             ILLD +MNPKI+DFGMARIFG+DQT+  T R+VGTYGYM+PEYAM+GQFS+KSDVYSFGV
Sbjct:   457 ILLDDDMNPKIADFGMARIFGMDQTEAMTRRVVGTYGYMSPEYAMYGQFSMKSDVYSFGV 516

Query:   538 LVLEIITGKKNSNFYQTD-GAADLLSY 563
             LVLEII+G KNS+ YQ D    +L++Y
Sbjct:   517 LVLEIISGMKNSSLYQMDESVGNLVTY 543

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009751 "response to salicylic acid stimulus" evidence=IEP

GO:0042742 "defense response to bacterium" evidence=IEP

GO:0005886 "plasma membrane" evidence=IDA

GO:0010167 "response to nitrate" evidence=RCA

GO:0015706 "nitrate transport" evidence=RCA

TAIR|locus:2121691 CRK11 "cysteine-rich RLK (RECEPTOR-like protein kinase) 11" [Arabidopsis thaliana (taxid:3702)]

 Score = 1017 (363.1 bits), Expect = 1.5e-140, Sum P(2) = 1.5e-140
 Identities = 195/270 (72%), Positives = 230/270 (85%)

Query:   299 LFILGFCFLRRKAKKKYNAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGF 358
             L +LGF   RR+  K Y    ++ +++D++T +SL +DF+TIE ATNKFST NKLGEGGF
Sbjct:   305 LLVLGFVLFRRR--KSYQRT-KTESESDISTTDSLVYDFKTIEAATNKFSTSNKLGEGGF 361

Query:   359 GEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418
             G VYKG L +G ++AVKRLSK SGQG  EF+NE VLV KLQHRNLVRLLGFCLE EE+IL
Sbjct:   362 GAVYKGKLSNGTDVAVKRLSKKSGQGTREFRNEAVLVTKLQHRNLVRLLGFCLEREEQIL 421

Query:   419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNI 478
             +YEFV NKSLDYFL+DPEKQ QLDW+RRYKIIGGIARGILYLH+DSRL+IIHRDLKASNI
Sbjct:   422 IYEFVHNKSLDYFLFDPEKQSQLDWTRRYKIIGGIARGILYLHQDSRLKIIHRDLKASNI 481

Query:   479 LLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVL 538
             LLDA+MNPKI+DFG+A IFGV+QTQGNT+RI GTY YM+PEYAMHGQ+S+KSD+YSFGVL
Sbjct:   482 LLDADMNPKIADFGLATIFGVEQTQGNTNRIAGTYAYMSPEYAMHGQYSMKSDIYSFGVL 541

Query:   539 VLEIITGKKNSNFYQTDG---AADLLSYVS 565
             VLEII+GKKNS  YQ D    A +L++Y S
Sbjct:   542 VLEIISGKKNSGVYQMDETSTAGNLVTYAS 571

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006979 "response to oxidative stress" evidence=IEP;RCA

GO:0009816 "defense response to bacterium, incompatible interaction" evidence=IEP

GO:0016020 "membrane" evidence=ISS

GO:0009611 "response to wounding" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2123111 CRK34 "cysteine-rich RLK (RECEPTOR-like protein kinase) 34" [Arabidopsis thaliana (taxid:3702)]

 Score = 1002 (357.8 bits), Expect = 5.0e-140, Sum P(2) = 5.0e-140
 Identities = 192/252 (76%), Positives = 216/252 (85%)

Query:   310 KAKKKYNAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSG 369
             + KK Y    E  A +++TT  SLQF F+TIE AT+KFS  N +G GGFGEVY+G L SG
Sbjct:   309 RRKKSYKTT-EVQATDEITTTHSLQFSFKTIEAATDKFSDSNMIGRGGFGEVYRGKLSSG 367

Query:   370 QEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLD 429
              E+AVKRLSK SGQGAEEFKNE VLV+KLQH+NLVRLLGFCLEGEEKILVYEFVPNKSLD
Sbjct:   368 PEVAVKRLSKTSGQGAEEFKNEAVLVSKLQHKNLVRLLGFCLEGEEKILVYEFVPNKSLD 427

Query:   430 YFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKIS 489
             YFL+DP KQG+LDW+RRY IIGGIARGILYLH+DSRL IIHRDLKASNILLDA+MNPKI+
Sbjct:   428 YFLFDPAKQGELDWTRRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIA 487

Query:   490 DFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNS 549
             DFGMARIFGVDQ+Q NT RI GT+GYM+PEYAM G FS+KSDVYSFGVLVLEII+GKKNS
Sbjct:   488 DFGMARIFGVDQSQANTRRIAGTFGYMSPEYAMRGHFSMKSDVYSFGVLVLEIISGKKNS 547

Query:   550 NFYQTDGAADLL 561
             +FY  D +   L
Sbjct:   548 SFYNIDDSGSNL 559

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2141762 CRK26 "cysteine-rich RLK (RECEPTOR-like protein kinase) 26" [Arabidopsis thaliana (taxid:3702)]

 Score = 871 (311.7 bits), Expect = 3.8e-129, Sum P(2) = 3.8e-129
 Identities = 170/266 (63%), Positives = 213/266 (80%)

Query:   299 LFILGFCFLRRKAKKKYNAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGF 358
             + ++ F  LRRK   + N+  E+  +N+  + +S++FDF  ++ AT+ FS +NKLGEGGF
Sbjct:   299 VLLVVFLKLRRKENIR-NS--ENKHENENISTDSMKFDFSVLQDATSHFSLENKLGEGGF 355

Query:   359 GEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418
             G VYKGVL  GQ+IAVKRLSK + QG  EFKNE +LVAKLQHRNLV+LLG+ +EG E++L
Sbjct:   356 GAVYKGVLSDGQKIAVKRLSKNAQQGETEFKNEFLLVAKLQHRNLVKLLGYSIEGTERLL 415

Query:   419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNI 478
             VYEF+P+ SLD F++DP +  +L+W  RYKIIGG+ARG+LYLH+DSRLRIIHRDLKASNI
Sbjct:   416 VYEFLPHTSLDKFIFDPIQGNELEWEIRYKIIGGVARGLLYLHQDSRLRIIHRDLKASNI 475

Query:   479 LLDAEMNPKISDFGMARIFGVDQT-QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGV 537
             LLD EM PKI+DFGMAR+F +D T Q  T+RIVGT+GYMAPEY MHGQFS K+DVYSFGV
Sbjct:   476 LLDEEMTPKIADFGMARLFDIDHTTQRYTNRIVGTFGYMAPEYVMHGQFSFKTDVYSFGV 535

Query:   538 LVLEIITGKKNSNFYQTDGAADLLSY 563
             LVLEII+GKKNS F   D   DL+S+
Sbjct:   536 LVLEIISGKKNSGFSSEDSMGDLISF 561

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006826 "iron ion transport" evidence=RCA

GO:0010106 "cellular response to iron ion starvation" evidence=RCA

GO:0010167 "response to nitrate" evidence=RCA

GO:0015706 "nitrate transport" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q8GYA4	CRK10_ARATH	2, ., 7, ., 1, 1, ., -	0.6187	0.9211	0.7862	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	571
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-55
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-55
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	4e-54
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-52
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	6e-51
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	6e-51
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-50
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-43
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-40
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-38
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	4e-38
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	9e-36
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	3e-35
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-34
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	3e-34
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	9e-34
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-33
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-33
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	3e-33
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	5e-33
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-32
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	4e-32
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-31
pfam01657	106	pfam01657, Stress-antifung, Salt stress response/a	1e-31
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	6e-31
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-30
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-30
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	5e-30
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-29
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-29
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-29
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	6e-29
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	7e-29
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	8e-29
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	3e-28
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	4e-28
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-27
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-27
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-27
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	3e-27
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	3e-27
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	5e-27
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	7e-27
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	9e-27
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	1e-26
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-26
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-26
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	3e-26
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	3e-26
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	4e-26
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	5e-26
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	5e-26
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	6e-26
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	6e-26
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	6e-26
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	7e-26
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	7e-26
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-25
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-25
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-25
pfam01657	106	pfam01657, Stress-antifung, Salt stress response/a	4e-25
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	5e-25
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	7e-25
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-24
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-24
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-24
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-24
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-24
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	3e-24
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	3e-24
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	3e-24
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	9e-24
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-23
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-23
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-23
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-23
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	3e-23
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	3e-23
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	4e-23
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	5e-23
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	6e-23
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	8e-23
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-22
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-22
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-22
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-22
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-22
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-22
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	3e-22
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	4e-22
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	4e-22
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	6e-22
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	6e-22
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	6e-22
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	7e-22
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	7e-22
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	8e-22
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-21
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	3e-21
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-21
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	4e-21
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	5e-21
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	6e-21
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	6e-21
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	6e-21
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	9e-21
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-20
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-20
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	3e-20
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	3e-20
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	3e-20
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-20
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	3e-20
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	4e-20
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	5e-20
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	7e-20
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	7e-20
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-19
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-19
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-19
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-19
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-19
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	3e-19
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	3e-19
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	5e-19
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	7e-19
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	7e-19
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	8e-19
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	8e-19
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	9e-19
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-18
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-18
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-18
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-18
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-18
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-18
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-18
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-18
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	3e-18
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	3e-18
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	4e-18
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	5e-18
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	6e-18
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	8e-18
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	8e-18
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	1e-17
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-17
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-17
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-17
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-17
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-17
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-17
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-17
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	4e-17
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	5e-17
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	6e-17
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	6e-17
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	6e-17
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	7e-17
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	8e-17
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	9e-17
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-16
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-16
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-16
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-16
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-16
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-16
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-16
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-16
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-16
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-16
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	3e-16
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	4e-16
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	4e-16
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	4e-16
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	5e-16
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	6e-16
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	6e-16
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	6e-16
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	7e-16
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	8e-16
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	9e-16
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	9e-16
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-15
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-15
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-15
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-15
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-15
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	3e-15
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	3e-15
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-15
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	6e-15
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	6e-15
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	6e-15
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	7e-15
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	7e-15
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-14
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-14
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-14
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-14
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-14
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-14
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-14
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	3e-14
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-14
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	4e-14
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	7e-14
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	7e-14
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	8e-14
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	8e-14
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	9e-14
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-13
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	3e-13
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	3e-13
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	3e-13
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-13
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	3e-13
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	3e-13
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	4e-13
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	4e-13
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	4e-13
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	5e-13
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	5e-13
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	5e-13
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	7e-13
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	7e-13
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	7e-13
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	9e-13
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-12
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-12
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-12
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-12
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-12
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-12
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	3e-12
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	4e-12
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	4e-12
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	5e-12
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	6e-12
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	6e-12
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	6e-12
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	9e-12
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-11
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-11
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	1e-11
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-11
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-11
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-11
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-11
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	3e-11
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-11
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	4e-11
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	5e-11
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	7e-11
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-10
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-10
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-10
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-10
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-10
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-10
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-10
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-10
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	3e-10
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	4e-10
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	6e-10
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	9e-10
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	9e-10
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	9e-10
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	1e-09
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-09
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-09
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-09
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-09
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-09
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	3e-09
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	4e-09
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	6e-09
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	6e-09
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	7e-09
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-08
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	1e-08
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-08
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-08
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-08
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-08
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	6e-08
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-07
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-07
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	3e-07
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	3e-07
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	3e-07
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	4e-07
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	5e-07
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	5e-07
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	5e-07
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	7e-07
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-06
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-06
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	1e-05
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-05
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	1e-05
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	2e-05
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	3e-05
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	4e-05
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-04
COG3642	204	COG3642, COG3642, Mn2+-dependent serine/threonine	3e-04
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	5e-04
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	9e-04
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	0.003

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  187 bits (478), Expect = 1e-55
 Identities = 82/201 (40%), Positives = 106/201 (52%), Gaps = 12/201 (5%)

Query: 350 DNKLGEGGFGEVYKGVL-----PSGQEIAVKRLSK-ASGQGAEEFKNEVVLVAKLQHRNL 403
             KLGEG FGEVYKG L         E+AVK L + AS Q  EEF  E  ++ KL H N+
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
           V+LLG C E E   +V E++    L  +L   + + +L  S        IARG+ YL   
Sbjct: 64  VKLLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLE-- 119

Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMH 523
                IHRDL A N L+   +  KISDFG++R    D         +    +MAPE    
Sbjct: 120 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL-PIRWMAPESLKE 177

Query: 524 GQFSVKSDVYSFGVLVLEIIT 544
           G+F+ KSDV+SFGVL+ EI T
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFT 198

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  187 bits (478), Expect = 1e-55
 Identities = 83/202 (41%), Positives = 110/202 (54%), Gaps = 13/202 (6%)

Query: 350 DNKLGEGGFGEVYKGVL-----PSGQEIAVKRLSK-ASGQGAEEFKNEVVLVAKLQHRNL 403
             KLGEG FGEVYKG L         E+AVK L + AS Q  EEF  E  ++ KL H N+
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63

Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
           V+LLG C E E  ++V E++P   L  +L     +  L  S        IARG+ YL   
Sbjct: 64  VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKE-LSLSDLLSFALQIARGMEYLE-- 120

Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVDQTQGNTSRIVGTYGYMAPEYAM 522
                IHRDL A N L+   +  KISDFG++R ++  D  +    ++     +MAPE   
Sbjct: 121 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL--PIRWMAPESLK 177

Query: 523 HGQFSVKSDVYSFGVLVLEIIT 544
            G+F+ KSDV+SFGVL+ EI T
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFT 199

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  182 bits (464), Expect = 4e-54
 Identities = 75/194 (38%), Positives = 109/194 (56%), Gaps = 11/194 (5%)

Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSK-ASGQGAEEFKNEVVLVAKLQHRNLVRLLGFC 410
           LGEGGFG VY      +G+++A+K + K  S    EE   E+ ++ KL H N+V+L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 411 LEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIH 470
            +     LV E+    SL   L   E +G+L      +I+  I  G+ YLH      IIH
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLK--ENEGKLSEDEILRILLQILEGLEYLHS---NGIIH 115

Query: 471 RDLKASNILLDA-EMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMH-GQFSV 528
           RDLK  NILLD+     K++DFG++++   D++   T  IVGT  YMAPE  +  G +S 
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPEVLLGKGYYSE 173

Query: 529 KSDVYSFGVLVLEI 542
           KSD++S GV++ E+
Sbjct: 174 KSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  179 bits (457), Expect = 2e-52
 Identities = 84/221 (38%), Positives = 113/221 (51%), Gaps = 30/221 (13%)

Query: 352 KLGEGGFGEVYKGVL-----PSGQEIAVKRL-SKASGQGAEEFKNEVVLVAKLQHRNLVR 405
           KLGEG FGEVYKG L      +  ++AVK L   AS +  EEF  E  ++ KL H N+VR
Sbjct: 6   KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65

Query: 406 LLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSR 465
           LLG C +GE   +V E++P   L  FL   +   +L      ++   IA+G+ YL     
Sbjct: 66  LLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYLES--- 120

Query: 466 LRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVDQTQGNTSRIVGTYGY-----MAPE 519
              +HRDL A N L+   +  KISDFG++R I+  D  +          G      MAPE
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYR------KRGGGKLPIKWMAPE 174

Query: 520 YAMHGQFSVKSDVYSFGVLVLEIIT-------GKKNSNFYQ 553
               G+F+ KSDV+SFGVL+ EI T       G  N    +
Sbjct: 175 SLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLE 215

Length = 258

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  175 bits (446), Expect = 6e-51
 Identities = 70/204 (34%), Positives = 108/204 (52%), Gaps = 15/204 (7%)

Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQG-AEEFKNEVVLVAKLQHRNLV 404
           +    KLGEG FG+VY      +G+ +A+K + K   +   E    E+ ++ KL+H N+V
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQL--DWSRRYKIIGGIARGILYLHE 462
           RL     + ++  LV E+     L   L   +K+G+L  D +R Y  +  I   + YLH 
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLL---KKRGRLSEDEARFY--LRQILSALEYLHS 115

Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM 522
                I+HRDLK  NILLD + + K++DFG+AR           +  VGT  YMAPE  +
Sbjct: 116 ---KGIVHRDLKPENILLDEDGHVKLADFGLARQL---DPGEKLTTFVGTPEYMAPEVLL 169

Query: 523 HGQFSVKSDVYSFGVLVLEIITGK 546
              +    D++S GV++ E++TGK
Sbjct: 170 GKGYGKAVDIWSLGVILYELLTGK 193

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  175 bits (446), Expect = 6e-51
 Identities = 73/199 (36%), Positives = 102/199 (51%), Gaps = 12/199 (6%)

Query: 352 KLGEGGFGEVYKGVLPS-GQEIAVKRLSK--ASGQGAEEFKNEVVLVAKLQHRNLVRLLG 408
           KLG G FG VYK      G+ +AVK L K     +  +  + E+ ++ +L H N+VRL+ 
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65

Query: 409 FCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRI 468
              + +   LV E+     L  +L    + G L      KI   I RG+ YLH      I
Sbjct: 66  AFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLHS---NGI 119

Query: 469 IHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE-YAMHGQFS 527
           IHRDLK  NILLD     KI+DFG+A+      +  + +  VGT  YMAPE       + 
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLK--SSSSLTTFVGTPWYMAPEVLLGGNGYG 177

Query: 528 VKSDVYSFGVLVLEIITGK 546
            K DV+S GV++ E++TGK
Sbjct: 178 PKVDVWSLGVILYELLTGK 196

Length = 260

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  174 bits (444), Expect = 1e-50
 Identities = 79/206 (38%), Positives = 110/206 (53%), Gaps = 16/206 (7%)

Query: 351 NKLGEGGFGEVYKGVL--PSGQEI--AVKRLSK-ASGQGAEEFKNEVVLVAKLQHRNLVR 405
            KLGEG FGEVYKG L    G+    AVK L + AS +  ++F  E  ++ KL H N+VR
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 406 LLGFCLEGEEKILVYEFVPNKSLDYFL------YDPEKQGQLDWSRRYKIIGGIARGILY 459
           LLG C E E   LV E++    L  +L      +   ++  L           IA+G+ Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVDQTQGNTSRIVGTYGYMAP 518
           L      + +HRDL A N L+  ++  KISDFG++R ++  D  +  T   +    +MAP
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR-WMAP 176

Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIIT 544
           E    G F+ KSDV+SFGVL+ EI T
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFT 202

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  155 bits (395), Expect = 1e-43
 Identities = 70/203 (34%), Positives = 110/203 (54%), Gaps = 15/203 (7%)

Query: 351 NKLGEGGFGEVYKGVLP-SGQEIAVK--RLSKASGQGAEEFKNEVVLVAKLQHRNLVRLL 407
             LG G FG VY  +   +G+ +AVK   LS  S +  E  + E+ +++ LQH N+VR  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 408 GFCLEGEEK-ILVY-EFVPNKSLDYFLYDPEKQGQLDWS--RRYKIIGGIARGILYLHED 463
           G   + E+  + ++ E+V   SL   L   +K G+L     R+Y     I  G+ YLH  
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLL---KKFGKLPEPVIRKY--TRQILEGLAYLH-- 118

Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMH 523
               I+HRD+K +NIL+D++   K++DFG A+  G  +T   T  + GT  +MAPE    
Sbjct: 119 -SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177

Query: 524 GQFSVKSDVYSFGVLVLEIITGK 546
            ++   +D++S G  V+E+ TGK
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGK 200

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  147 bits (374), Expect = 1e-40
 Identities = 73/198 (36%), Positives = 111/198 (56%), Gaps = 6/198 (3%)

Query: 347 FSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRL 406
           F+ + KLG G FGEV++G+  +   +A+K L        ++F+ EV  + +L+H++L+ L
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67

Query: 407 LGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRL 466
              C  GE   ++ E +   SL  FL  PE Q  L  +    +   +A G+ YL E    
Sbjct: 68  FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQ-VLPVASLIDMACQVAEGMAYLEEQ--- 123

Query: 467 RIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQF 526
             IHRDL A NIL+  ++  K++DFG+AR+   D    +  +I   Y + APE A HG F
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTF 181

Query: 527 SVKSDVYSFGVLVLEIIT 544
           S KSDV+SFG+L+ E+ T
Sbjct: 182 STKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  141 bits (358), Expect = 3e-38
 Identities = 71/206 (34%), Positives = 116/206 (56%), Gaps = 21/206 (10%)

Query: 353 LGEGGFGEVYKGV-LPSGQ----EIAVKRLSKASGQGA-EEFKNEVVLVAKLQHRNLVRL 406
           LG G FG VYKGV +P G+     +A+K L + +   A +E  +E  ++A + H ++VRL
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 407 LGFCLEGEEKILVYEFVPNKSLDYFLYDPE----KQGQLDWSRRYKIIGGIARGILYLHE 462
           LG CL   +  L+ + +P   L  ++ + +     Q  L+W  +      IA+G+ YL E
Sbjct: 75  LGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYLEE 127

Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM 522
               R++HRDL A N+L+    + KI+DFG+A++  VD+ + +         +MA E  +
Sbjct: 128 K---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL 184

Query: 523 HGQFSVKSDVYSFGVLVLEIIT-GKK 547
           H  ++ KSDV+S+GV V E++T G K
Sbjct: 185 HRIYTHKSDVWSYGVTVWELMTFGAK 210

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  140 bits (356), Expect = 4e-38
 Identities = 77/207 (37%), Positives = 109/207 (52%), Gaps = 12/207 (5%)

Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
           E+       + KLG G FGEV+ G      ++AVK L K      E F  E  ++ KL+H
Sbjct: 2   EIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRH 60

Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
             LV+L   C E E   +V E++   SL  FL   E + +L   +   +   IA G+ YL
Sbjct: 61  DKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGK-KLRLPQLVDMAAQIAEGMAYL 119

Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ---TQGNTSRIVGTYGYMA 517
                   IHRDL A NIL+   +  KI+DFG+AR+   D+    +G    I  T    A
Sbjct: 120 E---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT----A 172

Query: 518 PEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           PE A +G+F++KSDV+SFG+L+ EI+T
Sbjct: 173 PEAANYGRFTIKSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  134 bits (340), Expect = 9e-36
 Identities = 71/215 (33%), Positives = 116/215 (53%), Gaps = 24/215 (11%)

Query: 353 LGEGGFGEVYKGVLPSGQE------IAVKRLSKASGQGAEE-FKNEVVLVAKLQHRNLVR 405
           LGEG FG+V+ G     +       +AVK L + +   A + F+ E  L+   QH N+V+
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 406 LLGFCLEGEEKILVYEFVPNKSLDYFL--YDPE---------KQGQLDWSRRYKIIGGIA 454
             G C EG+  I+V+E++ +  L+ FL  + P+           G+L  S+  +I   IA
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVDQTQGNTSRIVGTY 513
            G++YL   +    +HRDL   N L+  ++  KI DFGM+R ++  D  +     ++   
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIR 189

Query: 514 GYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKK 547
            +M PE  M+ +F+ +SDV+SFGV++ EI T GK+
Sbjct: 190 -WMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQ 223

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  132 bits (335), Expect = 3e-35
 Identities = 69/213 (32%), Positives = 106/213 (49%), Gaps = 31/213 (14%)

Query: 346 KFSTDNKLGEGGFGEVYKG-VLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLV 404
            F    K+G+GGFGEVYK     +G+E+A+K +   S +  E+  NE+ ++ K +H N+V
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60

Query: 405 RLLGFCLEGEEKILVYEFVPNKSLD-----YFLYDPEKQGQLDWSRRYKIIGGIARGIL- 458
           +  G  L+ +E  +V EF    SL            E Q           I  + + +L 
Sbjct: 61  KYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQ-----------IAYVCKELLK 109

Query: 459 ---YLHEDSRLRIIHRDLKASNILL--DAEMNPKISDFGMARIFGVDQTQGNTSRIVGTY 513
              YLH      IIHRD+KA+NILL  D E+  K+ DFG++            + +VGT 
Sbjct: 110 GLEYLHS---NGIIHRDIKAANILLTSDGEV--KLIDFGLSAQL---SDTKARNTMVGTP 161

Query: 514 GYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
            +MAPE      +  K+D++S G+  +E+  GK
Sbjct: 162 YWMAPEVINGKPYDYKADIWSLGITAIELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  130 bits (328), Expect = 2e-34
 Identities = 63/204 (30%), Positives = 105/204 (51%), Gaps = 11/204 (5%)

Query: 346 KFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLS--KASGQGAEEFKNEVVLVAKLQHRN 402
            +   + +G G FG VYKG+ L +G  +A+K++S  K   +  +    E+ L+  L+H N
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
           +V+ +G     +   ++ E+  N SL   +   +K G    S     +  + +G+ YLHE
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQII---KKFGPFPESLVAVYVYQVLQGLAYLHE 117

Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM 522
                +IHRD+KA+NIL   +   K++DFG+A           +  +VGT  +MAPE   
Sbjct: 118 QG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGTPYWMAPEVIE 172

Query: 523 HGQFSVKSDVYSFGVLVLEIITGK 546
               S  SD++S G  V+E++TG 
Sbjct: 173 MSGASTASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  130 bits (330), Expect = 3e-34
 Identities = 68/205 (33%), Positives = 106/205 (51%), Gaps = 18/205 (8%)

Query: 351 NKLGEGGFGEVYKGVLP-----SGQEIAVKRLSKASGQGAE--EFKNEVVLVAKLQHRNL 403
            +LGEG FG+V           +G+++AVK L   SG+     +F+ E+ ++  L H N+
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSL-NHSGEEQHRSDFEREIEILRTLDHENI 68

Query: 404 VRLLGFCLEGEEKI--LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH 461
           V+  G C +   +   L+ E++P+ SL  +L     + Q++  R       I +G+ YL 
Sbjct: 69  VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLG 126

Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT--QGNTSRIVGTYGYMAPE 519
                R IHRDL A NIL+++E   KISDFG+A++   D+             + Y APE
Sbjct: 127 S---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APE 182

Query: 520 YAMHGQFSVKSDVYSFGVLVLEIIT 544
                +FS  SDV+SFGV + E+ T
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  129 bits (326), Expect = 9e-34
 Identities = 74/213 (34%), Positives = 114/213 (53%), Gaps = 29/213 (13%)

Query: 353 LGEGGFGEVYKG--VLPSGQE----IAVKRLSK-ASGQGAEEFKNEVVLVAKLQHRNLVR 405
           LGEG FG+VYKG    P+ +     +A+K L + A  +  +EF+ E  L++ LQH N+V 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 406 LLGFCLEGEEKILVYEFVPNKSLDYFL-------------YDPEKQGQLDWSRRYKIIGG 452
           LLG C + +   +++E++ +  L  FL              D   +  LD S    I   
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVD--QTQGNTSRI 509
           IA G+ YL   S    +HRDL A N L+   +  KISDFG++R I+  D  + Q  +   
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189

Query: 510 VGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEI 542
           V    +M PE  ++G+F+ +SD++SFGV++ EI
Sbjct: 190 V---RWMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  128 bits (323), Expect = 1e-33
 Identities = 73/204 (35%), Positives = 102/204 (50%), Gaps = 21/204 (10%)

Query: 351 NKLGEGGFGEVYKGV--LPSGQEI--AVKRLSK-ASGQGAEEFKNEVVLVAKLQHRNLVR 405
            +LG G FG V KGV  + SG+E+  AVK L +     G +EF  E  ++A+L H  +VR
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 406 LLGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQ--LDWSRRYKIIGGIARGILYLHE 462
           L+G C  GE  +LV E  P   L  Y     E       + + +      +A G+ YL  
Sbjct: 61  LIGVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQ------VAMGMAYLES 113

Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTY--GYMAPEY 520
                 +HRDL A N+LL      KISDFGM+R  G        +   G +   + APE 
Sbjct: 114 K---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY-YRATTAGRWPLKWYAPEC 169

Query: 521 AMHGQFSVKSDVYSFGVLVLEIIT 544
             +G+FS KSDV+S+GV + E  +
Sbjct: 170 INYGKFSSKSDVWSYGVTLWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  128 bits (324), Expect = 1e-33
 Identities = 67/204 (32%), Positives = 112/204 (54%), Gaps = 18/204 (8%)

Query: 350 DNKLGEGGFGEVYKGVL--PSGQEI--AVKRL-SKASGQGAEEFKNEVVLVAKLQHRNLV 404
           +  +G G FGEV +G L  P  +EI  A+K L + +S +   +F  E  ++ +  H N++
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68

Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
           RL G   +    +++ E++ N SLD FL   E  G+    +   ++ GIA G+ YL   S
Sbjct: 69  RLEGVVTKSRPVMIITEYMENGSLDKFLR--ENDGKFTVGQLVGMLRGIASGMKYL---S 123

Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIF----GVDQTQGNTSRIVGTYGYMAPEY 520
            +  +HRDL A NIL+++ +  K+SDFG++R          T+G    I  T    APE 
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT----APEA 179

Query: 521 AMHGQFSVKSDVYSFGVLVLEIIT 544
             + +F+  SDV+SFG+++ E+++
Sbjct: 180 IAYRKFTSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  127 bits (320), Expect = 3e-33
 Identities = 69/197 (35%), Positives = 103/197 (52%), Gaps = 25/197 (12%)

Query: 353 LGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE 412
           +G+G FG+V  G    GQ++AVK L K     A+ F  E  ++  L+H NLV+LLG  L+
Sbjct: 14  IGKGEFGDVMLGDY-RGQKVAVKCL-KDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71

Query: 413 GEEKILVYEFVPNKSLDYFLYDP-----EKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
           G    +V E++   SL  +L            QL ++        +  G+ YL E     
Sbjct: 72  GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALD------VCEGMEYLEEK---N 122

Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTY--GYMAPEYAMHGQ 525
            +HRDL A N+L+  ++  K+SDFG+A+    + +QG  S   G     + APE     +
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLAK----EASQGQDS---GKLPVKWTAPEALREKK 175

Query: 526 FSVKSDVYSFGVLVLEI 542
           FS KSDV+SFG+L+ EI
Sbjct: 176 FSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  126 bits (319), Expect = 5e-33
 Identities = 67/196 (34%), Positives = 103/196 (52%), Gaps = 12/196 (6%)

Query: 352 KLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCL 411
           KLG G FGEV++G+  +   +AVK L K      ++F  E  ++ KL+H  L++L   C 
Sbjct: 13  KLGAGQFGEVWEGLWNNTTPVAVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT 71

Query: 412 EGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHR 471
             E   +V E +   SL  +L        L   +   +   +A G+ YL   +    IHR
Sbjct: 72  LEEPIYIVTELMKYGSLLEYLQG-GAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHR 127

Query: 472 DLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT---YGYMAPEYAMHGQFSV 528
           DL A N+L+      K++DFG+AR+   D      +R  G      + APE A++ +FS+
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKEDIY---EAR-EGAKFPIKWTAPEAALYNRFSI 183

Query: 529 KSDVYSFGVLVLEIIT 544
           KSDV+SFG+L+ EI+T
Sbjct: 184 KSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  128 bits (322), Expect = 1e-32
 Identities = 73/213 (34%), Positives = 105/213 (49%), Gaps = 17/213 (7%)

Query: 346 KFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQH-R 401
            +    KLGEG FGEVY       + +A+K L+K      +  E F  E+ ++A L H  
Sbjct: 1   SYRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 402 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH 461
           N+V+L  F  +     LV E+V   SL+  L    ++G L  S    I+  I   + YLH
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118

Query: 462 EDSRLRIIHRDLKASNILLDAEMN-PKISDFGMARIFGVDQT----QGNTSRIVGTYGYM 516
                 IIHRD+K  NILLD +    K+ DFG+A++     +        S  VGT GYM
Sbjct: 119 S---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175

Query: 517 APEYAMH---GQFSVKSDVYSFGVLVLEIITGK 546
           APE  +       S  SD++S G+ + E++TG 
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGL 208

Length = 384

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  123 bits (312), Expect = 4e-32
 Identities = 69/204 (33%), Positives = 108/204 (52%), Gaps = 24/204 (11%)

Query: 353 LGEGGFGEVY----KGVLPSGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVR 405
           LG+G FG+V     K    +G+  A+K L K      +  E    E  +++++ H  +V+
Sbjct: 1   LGKGSFGKVLLVRKKD---TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK 57

Query: 406 LLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQL--DWSRRYKIIGGIARGILYLHE 462
           L  +  + EEK+ LV E+ P   L   L    K+G+   + +R Y     I   + YLH 
Sbjct: 58  LH-YAFQTEEKLYLVLEYAPGGELFSHLS---KEGRFSEERARFY--AAEIVLALEYLH- 110

Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM 522
              L II+RDLK  NILLDA+ + K++DFG+A+    + ++ NT    GT  Y+APE  +
Sbjct: 111 --SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAPEVLL 166

Query: 523 HGQFSVKSDVYSFGVLVLEIITGK 546
              +    D +S GVL+ E++TGK
Sbjct: 167 GKGYGKAVDWWSLGVLLYEMLTGK 190

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  123 bits (310), Expect = 1e-31
 Identities = 64/203 (31%), Positives = 104/203 (51%), Gaps = 21/203 (10%)

Query: 352 KLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGA--EEFKNEVVLVAKLQHRNLVRLLG 408
            LG+G  G VYK    P+G+  A+K++    G     ++   E+  +   +   +V+  G
Sbjct: 8   VLGQGSSGVVYKVRHKPTGKIYALKKI-HVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66

Query: 409 -FCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGIL----YLHED 463
            F  EGE  I V E++   SL   L    K           ++  IAR IL    YLH  
Sbjct: 67  AFYKEGEISI-VLEYMDGGSLADLLKKVGK-----IPEP--VLAYIARQILKGLDYLH-- 116

Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMH 523
           ++  IIHRD+K SN+L++++   KI+DFG++++  ++ T    +  VGT  YM+PE    
Sbjct: 117 TKRHIIHRDIKPSNLLINSKGEVKIADFGISKV--LENTLDQCNTFVGTVTYMSPERIQG 174

Query: 524 GQFSVKSDVYSFGVLVLEIITGK 546
             +S  +D++S G+ +LE   GK
Sbjct: 175 ESYSYAADIWSLGLTLLECALGK 197

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal

 Score =  117 bits (295), Expect = 1e-31
 Identities = 45/104 (43%), Positives = 62/104 (59%), Gaps = 5/104 (4%)

Query: 34  HVCSTTAN---FTRNSTYEKNLNLLLSSIPTNASRGNGFSSGFFNATAGQDPNRVYGLFL 90
           H+CS+  +    T NST+E NLN LLSS+ +NA+  +G   GF   T+G  P+ VYGL  
Sbjct: 2   HLCSSNTSGNYTTANSTFESNLNALLSSLSSNAASSSG--KGFAAGTSGAAPDTVYGLAQ 59

Query: 91  CRGDQTTSDCQDCVTFAARDVLQLCPVSKETILWYAECLLRYSD 134
           CRGD + SDC+ C+  A  ++ + CP  K   +WY  C LRY  
Sbjct: 60  CRGDLSASDCRSCLATAVSELRRCCPNKKGGRIWYDSCFLRYES 103

This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  121 bits (304), Expect = 6e-31
 Identities = 75/207 (36%), Positives = 115/207 (55%), Gaps = 13/207 (6%)

Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
           EV         KLG G FGEV+ G      ++A+K L + S    E F  E  L+ +LQH
Sbjct: 2   EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQH 60

Query: 401 RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
             LVRL  + +  +E I ++ E++ N SL  FL  PE   +L  ++   +   IA G+ +
Sbjct: 61  PRLVRL--YAVVTQEPIYIITEYMENGSLVDFLKTPEGI-KLTINKLIDMAAQIAEGMAF 117

Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTY--GYMA 517
           +    R   IHRDL+A+NIL+   +  KI+DFG+AR+   ++    T+R    +   + A
Sbjct: 118 IE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY---TAREGAKFPIKWTA 171

Query: 518 PEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           PE   +G F++KSDV+SFG+L+ EI+T
Sbjct: 172 PEAINYGTFTIKSDVWSFGILLTEIVT 198

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score =  120 bits (303), Expect = 1e-30
 Identities = 75/221 (33%), Positives = 121/221 (54%), Gaps = 24/221 (10%)

Query: 352 KLGEGGFGEVY----KGVLPSGQE--IAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVR 405
           +LGEG FG+V+      +LP   +  +AVK L +AS    ++F+ E  L+  LQH+++VR
Sbjct: 12  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71

Query: 406 LLGFCLEGEEKILVYEFVPNKSLDYFL--YDPEKQ----------GQLDWSRRYKIIGGI 453
             G C EG   ++V+E++ +  L+ FL  + P+ +          GQL   +   I   I
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131

Query: 454 ARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVDQTQGNTSRIVGT 512
           A G++YL   + L  +HRDL   N L+   +  KI DFGM+R I+  D  +    R +  
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG-GRTMLP 187

Query: 513 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQ 553
             +M PE  ++ +F+ +SD++SFGV++ EI T  K   +YQ
Sbjct: 188 IRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP-WYQ 227

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  119 bits (300), Expect = 2e-30
 Identities = 58/207 (28%), Positives = 101/207 (48%), Gaps = 21/207 (10%)

Query: 351 NKLGEGGFGEVYKGV-LPSGQEIAVKR--LSKASGQGAEEFKNEVVLVAKLQHRNLVRLL 407
            ++G+G FG+VY       G+   +K   LS  S +  E+  NEV ++ KL H N+++  
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65

Query: 408 GFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQ-------LDWSRRYKIIGGIARGILYL 460
               E  +  +V E+     L   +   +K+G+       LDW  +      +   + YL
Sbjct: 66  ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ------LCLALKYL 119

Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEY 520
           H     +I+HRD+K  NI L +    K+ DFG++++         T  +VGT  Y++PE 
Sbjct: 120 HSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTPYYLSPEL 174

Query: 521 AMHGQFSVKSDVYSFGVLVLEIITGKK 547
             +  ++ KSD++S G ++ E+ T K 
Sbjct: 175 CQNKPYNYKSDIWSLGCVLYELCTLKH 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score =  118 bits (298), Expect = 5e-30
 Identities = 77/210 (36%), Positives = 112/210 (53%), Gaps = 22/210 (10%)

Query: 353 LGEGGFGEVYKG----VLPSG---QEIAVKRLSK-ASGQGAEEFKNEVVLVAKLQHRNLV 404
           LG G FGEVY+G    +L  G     +AVK L K A+ Q  +EF  E  L++   H N+V
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQ----LDWSRRYKIIGGIARGILYL 460
           +LLG CL  E + ++ E +    L  +L D   +      L       I   +A+G +YL
Sbjct: 63  KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122

Query: 461 HEDSRLRIIHRDLKASNILL-----DAEMNPKISDFGMAR-IFGVDQTQGNTSRIVGTYG 514
               ++  IHRDL A N L+     DA+   KI DFG+AR I+  D  +     ++    
Sbjct: 123 E---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR- 178

Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           +MAPE  + G+F+ +SDV+SFGVL+ EI+T
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  118 bits (297), Expect = 1e-29
 Identities = 59/195 (30%), Positives = 108/195 (55%), Gaps = 9/195 (4%)

Query: 352 KLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFC 410
           K+GEG  GEVYK     +G+E+A+K++ +   Q  E   NE++++   +H N+V      
Sbjct: 26  KIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKELIINEILIMKDCKHPNIVDYYDSY 84

Query: 411 LEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIH 470
           L G+E  +V E++   SL   +   +   +++  +   +   + +G+ YLH      +IH
Sbjct: 85  LVGDELWVVMEYMDGGSLTDIIT--QNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIH 139

Query: 471 RDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKS 530
           RD+K+ NILL  + + K++DFG A     ++++ N+  +VGT  +MAPE      +  K 
Sbjct: 140 RDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYWMAPEVIKRKDYGPKV 197

Query: 531 DVYSFGVLVLEIITG 545
           D++S G++ +E+  G
Sbjct: 198 DIWSLGIMCIEMAEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score =  117 bits (295), Expect = 1e-29
 Identities = 73/218 (33%), Positives = 108/218 (49%), Gaps = 21/218 (9%)

Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRL-SKASGQGAEEFKNEVV 393
           EV  +  +    LG G FGEVY+G+           ++AVK L    S Q   +F  E +
Sbjct: 2   EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61

Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYD----PEKQGQLDWSRRYKI 449
           +++K  H+N+VRL+G   E   + ++ E +    L  FL +    PE+   L        
Sbjct: 62  IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC 121

Query: 450 IGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP----KISDFGMAR-IFGVDQTQG 504
              +A+G  YL E+     IHRD+ A N LL  +  P    KI+DFGMAR I+     + 
Sbjct: 122 ARDVAKGCKYLEEN---HFIHRDIAARNCLLTCK-GPGRVAKIADFGMARDIYRASYYRK 177

Query: 505 NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEI 542
              R +    +M PE  + G F+ K+DV+SFGVL+ EI
Sbjct: 178 G-GRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEI 214

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  116 bits (293), Expect = 2e-29
 Identities = 73/205 (35%), Positives = 104/205 (50%), Gaps = 24/205 (11%)

Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSKAS----GQGA-EEFKNEVVLVAKLQHRNLVRL 406
           LG G FG VY+G+ L  G   AVK +S A     GQ A ++ + E+ L++KLQH N+V+ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 407 LGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGIL----YLHE 462
           LG   E +   +  E VP  SL   L   +K G         +I    R IL    YLH+
Sbjct: 68  LGTEREEDNLYIFLELVPGGSLAKLL---KKYGSFP----EPVIRLYTRQILLGLEYLHD 120

Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM 522
                 +HRD+K +NIL+D     K++DFGMA+               G+  +MAPE   
Sbjct: 121 R---NTVHRDIKGANILVDTNGVVKLADFGMAK---QVVEFSFAKSFKGSPYWMAPEVIA 174

Query: 523 H-GQFSVKSDVYSFGVLVLEIITGK 546
             G + + +D++S G  VLE+ TGK
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGK 199

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  115 bits (289), Expect = 6e-29
 Identities = 67/197 (34%), Positives = 105/197 (53%), Gaps = 10/197 (5%)

Query: 352 KLGEGGFGEVYKGVLPSGQEIAVKRL-SKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFC 410
           K+G+G FG+VYKGVL    E+AVK   S        +F  E  ++ +  H N+V+L+G C
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 411 LEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIH 470
           ++ +   +V E VP  SL  FL   +   +L   +  ++    A G+ YL  +S+   IH
Sbjct: 62  VQKQPIYIVMELVPGGSLLTFLRKKK--NRLTVKKLLQMSLDAAAGMEYL--ESK-NCIH 116

Query: 471 RDLKASNILLDAEMNPKISDFGMAR--IFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSV 528
           RDL A N L+      KISDFGM+R    G+        +I     + APE   +G+++ 
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI--PIKWTAPEALNYGRYTS 174

Query: 529 KSDVYSFGVLVLEIITG 545
           +SDV+S+G+L+ E  + 
Sbjct: 175 ESDVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score =  116 bits (291), Expect = 7e-29
 Identities = 77/220 (35%), Positives = 127/220 (57%), Gaps = 21/220 (9%)

Query: 353 LGEGGFGEVYKGV-LPSGQEI----AVKRLSKASGQGAE-EFKNEVVLVAKLQHRNLVRL 406
           LG G FG VYKG+ +P G+ +    A+K L++ +G  A  EF +E +++A + H +LVRL
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74

Query: 407 LGFCLEGEEKILVYEFVPNKSLDYFLYDPE----KQGQLDWSRRYKIIGGIARGILYLHE 462
           LG CL    + LV + +P+  L  ++++ +     Q  L+W  +      IA+G++YL E
Sbjct: 75  LGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 127

Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM 522
               R++HRDL A N+L+ +  + KI+DFG+AR+   D+ + N         +MA E   
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184

Query: 523 HGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLL 561
           + +F+ +SDV+S+GV + E++T G K  +   T    DLL
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL 224

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score =  115 bits (288), Expect = 8e-29
 Identities = 73/207 (35%), Positives = 114/207 (55%), Gaps = 13/207 (6%)

Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
           E+         KLG G FGEV+ G      ++AVK L K      E F  E  ++ KL+H
Sbjct: 2   EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTL-KPGTMSPESFLEEAQIMKKLRH 60

Query: 401 RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
             LV+L  + +  EE I +V E++   SL  FL D E +  L       +   +A G+ Y
Sbjct: 61  DKLVQL--YAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRA-LKLPNLVDMAAQVAAGMAY 117

Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTY--GYMA 517
           +    R+  IHRDL+++NIL+   +  KI+DFG+AR+    +    T+R    +   + A
Sbjct: 118 IE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLI---EDNEYTARQGAKFPIKWTA 171

Query: 518 PEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           PE A++G+F++KSDV+SFG+L+ E++T
Sbjct: 172 PEAALYGRFTIKSDVWSFGILLTELVT 198

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  113 bits (286), Expect = 3e-28
 Identities = 66/219 (30%), Positives = 110/219 (50%), Gaps = 19/219 (8%)

Query: 341 EVATNKFSTDNKLGEGGFGEVYKGV---LPSGQ---EIAVKRLSKASGQGAE-EFKNEVV 393
           E+   K +   +LG+G FG VY+G+   +  G+    +A+K +++ +      EF NE  
Sbjct: 2   ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEAS 61

Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYD--PE-----KQGQLDWSRR 446
           ++ +    ++VRLLG    G+  ++V E +    L  +L    PE       G     + 
Sbjct: 62  VMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKF 121

Query: 447 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVDQTQGN 505
            ++   IA G+ YL      + +HRDL A N ++  ++  KI DFGM R I+  D  +  
Sbjct: 122 IQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKG 178

Query: 506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
              ++    +MAPE    G F+ KSDV+SFGV++ E+ T
Sbjct: 179 GKGLLPVR-WMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  112 bits (283), Expect = 4e-28
 Identities = 62/198 (31%), Positives = 100/198 (50%), Gaps = 13/198 (6%)

Query: 353 LGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE 412
           LG G FG V+ G      ++A+K + + +    ++F  E  ++ KL H NLV+L G C +
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70

Query: 413 GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRD 472
                +V E++ N  L  +L + + +   +W     +   +   + YL  +     IHRD
Sbjct: 71  QRPIFIVTEYMANGCLLNYLRERKGKLGTEW--LLDMCSDVCEAMEYLESNG---FIHRD 125

Query: 473 LKASNILLDAEMNPKISDFGMARIFGVDQ---TQGNTSRIVGTYGYMAPEYAMHGQFSVK 529
           L A N L+  +   K+SDFG+AR    DQ   +QG    +     +  PE   + +FS K
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPV----KWAPPEVFDYSRFSSK 181

Query: 530 SDVYSFGVLVLEIITGKK 547
           SDV+SFGVL+ E+ +  K
Sbjct: 182 SDVWSFGVLMWEVFSEGK 199

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score =  111 bits (278), Expect = 1e-27
 Identities = 71/206 (34%), Positives = 107/206 (51%), Gaps = 10/206 (4%)

Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
           E+         KLG G FGEV+ G   +  ++AVK L K      + F  E  L+  LQH
Sbjct: 2   EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQH 60

Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
             LVRL     + E   ++ E++   SL  FL   E  G++   +       IA G+ Y+
Sbjct: 61  DKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEG-GKVLLPKLIDFSAQIAEGMAYI 119

Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTY--GYMAP 518
               R   IHRDL+A+N+L+   +  KI+DFG+AR+   ++    T+R    +   + AP
Sbjct: 120 E---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY---TAREGAKFPIKWTAP 173

Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIIT 544
           E    G F++KSDV+SFG+L+ EI+T
Sbjct: 174 EAINFGSFTIKSDVWSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  111 bits (280), Expect = 2e-27
 Identities = 71/248 (28%), Positives = 114/248 (45%), Gaps = 48/248 (19%)

Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA--SGQGAEEF-KNE 391
           DF+  ++          +GEG F  V       + +E A+K L K     +   ++ K E
Sbjct: 2   DFKFGKI----------IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIE 51

Query: 392 VVLVAKL-QHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLD--WSRRY 447
             ++ +L  H  +++L  +  + EE +  V E+ PN  L  ++    K G LD   +R Y
Sbjct: 52  KEVLTRLNGHPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYI---RKYGSLDEKCTRFY 107

Query: 448 KIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ------ 501
                I   + YLH      IIHRDLK  NILLD +M+ KI+DFG A++   +       
Sbjct: 108 --AAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNK 162

Query: 502 -------TQGNTSRI-----VGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK--- 546
                  +Q   +R      VGT  Y++PE          SD+++ G ++ +++TGK   
Sbjct: 163 GDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPF 222

Query: 547 KNSNFYQT 554
           + SN Y T
Sbjct: 223 RGSNEYLT 230

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  110 bits (278), Expect = 2e-27
 Identities = 71/221 (32%), Positives = 110/221 (49%), Gaps = 18/221 (8%)

Query: 351 NKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKN---EVVLVAKLQHRNLVRL 406
            +LG G  G V K +  P+G+ +AVK +           K    E+ ++ K     +V  
Sbjct: 7   GELGAGNSGVVSKVLHRPTGKIMAVKTIR--LEINEAIQKQILRELDILHKCNSPYIVGF 64

Query: 407 LGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRL 466
            G      +  +  E++   SLD  L   E QG++      KI   + +G+ YLHE    
Sbjct: 65  YGAFYNNGDISICMEYMDGGSLDKIL--KEVQGRIPERILGKIAVAVLKGLTYLHEK--H 120

Query: 467 RIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQF 526
           +IIHRD+K SNIL+++    K+ DFG++    V+ +   T   VGT  YMAPE      +
Sbjct: 121 KIIHRDVKPSNILVNSRGQIKLCDFGVSGQL-VN-SLAKTF--VGTSSYMAPERIQGNDY 176

Query: 527 SVKSDVYSFGVLVLEIITGK---KNSNFYQTDGAADLLSYV 564
           SVKSD++S G+ ++E+ TG+      N    DG  +LL Y+
Sbjct: 177 SVKSDIWSLGLSLIELATGRFPYPPEN-DPPDGIFELLQYI 216

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  110 bits (276), Expect = 3e-27
 Identities = 64/199 (32%), Positives = 101/199 (50%), Gaps = 13/199 (6%)

Query: 352 KLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCL 411
           ++G G FG V+ G     +++A+K + + +    E+F  E  ++ KL H  LV+L G C 
Sbjct: 11  EIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69

Query: 412 EGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHR 471
           E     LV+EF+ +  L  +L    ++G+        +   +  G+ YL   +   +IHR
Sbjct: 70  ERSPICLVFEFMEHGCLSDYLR--AQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHR 124

Query: 472 DLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT---YGYMAPEYAMHGQFSV 528
           DL A N L+      K+SDFGM R    DQ   +T    GT     + +PE     ++S 
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST----GTKFPVKWSSPEVFSFSKYSS 180

Query: 529 KSDVYSFGVLVLEIITGKK 547
           KSDV+SFGVL+ E+ +  K
Sbjct: 181 KSDVWSFGVLMWEVFSEGK 199

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  110 bits (276), Expect = 3e-27
 Identities = 67/203 (33%), Positives = 108/203 (53%), Gaps = 9/203 (4%)

Query: 347 FSTDNKLGEGGFGEVYKGVLPS-GQEIAVKR--LSKASGQGAEEFKNEVVLVAKLQHRNL 403
           F   NK+G+G FG V+K V  +  +  A+K+  LSK + +  EE  +E  ++AKL    +
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61

Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
           +R     L+  +  +V E+  N  L   L     +  L   + ++    I  G+ +LH  
Sbjct: 62  IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGR-PLPEDQVWRFFIQILLGLAHLHSK 120

Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMH 523
              +I+HRD+K+ N+ LDA  N KI D G+A++   +    NT  IVGT  Y++PE    
Sbjct: 121 ---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPELCED 175

Query: 524 GQFSVKSDVYSFGVLVLEIITGK 546
             ++ KSDV++ GV++ E  TGK
Sbjct: 176 KPYNEKSDVWALGVVLYECCTGK 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score =  109 bits (274), Expect = 5e-27
 Identities = 74/207 (35%), Positives = 116/207 (56%), Gaps = 13/207 (6%)

Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
           E+       D KLG+G FGEV+ G      ++A+K L K      E F  E  ++ KL+H
Sbjct: 2   EIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTL-KPGTMMPEAFLQEAQIMKKLRH 60

Query: 401 RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
             LV L  + +  EE I +V EF+   SL  FL + + +  L   +   +   IA G+ Y
Sbjct: 61  DKLVPL--YAVVSEEPIYIVTEFMGKGSLLDFLKEGDGK-YLKLPQLVDMAAQIADGMAY 117

Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTY--GYMA 517
           +    R+  IHRDL+A+NIL+   +  KI+DFG+AR+    +    T+R    +   + A
Sbjct: 118 IE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLI---EDNEYTARQGAKFPIKWTA 171

Query: 518 PEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           PE A++G+F++KSDV+SFG+L+ E++T
Sbjct: 172 PEAALYGRFTIKSDVWSFGILLTELVT 198

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score =  110 bits (275), Expect = 7e-27
 Identities = 72/222 (32%), Positives = 120/222 (54%), Gaps = 28/222 (12%)

Query: 352 KLGEGGFGEVY----KGVLPSGQE--IAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVR 405
           +LGEG FG+V+      + P+  +  +AVK L   +    ++F+ E  L+  LQH ++V+
Sbjct: 12  ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71

Query: 406 LLGFCLEGEEKILVYEFVPNKSLDYFL--YDP-----------EKQGQLDWSRRYKIIGG 452
             G C +G+  I+V+E++ +  L+ FL  + P           + +G+L  S+   I   
Sbjct: 72  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131

Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVD--QTQGNTSRI 509
           IA G++YL   +    +HRDL   N L+ A +  KI DFGM+R ++  D  +  G+T   
Sbjct: 132 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 188

Query: 510 VGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF 551
           +    +M PE  M+ +F+ +SDV+SFGV++ EI T  K   F
Sbjct: 189 I---RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWF 227

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  108 bits (273), Expect = 9e-27
 Identities = 58/212 (27%), Positives = 102/212 (48%), Gaps = 32/212 (15%)

Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVR 405
           F    KLGEG +G VYK +   +GQ +A+K +     +  +E   E+ ++ +     +V+
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYIVK 62

Query: 406 LLGFCLEGEEKILVYEF-----------VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIA 454
             G   +  +  +V E+           + NK+L       E++          I+    
Sbjct: 63  YYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLT------EEEIAA-------ILYQTL 109

Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
           +G+ YLH     + IHRD+KA NILL+ E   K++DFG++       T    + ++GT  
Sbjct: 110 KGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLT--DTMAKRNTVIGTPF 164

Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
           +MAPE      ++ K+D++S G+  +E+  GK
Sbjct: 165 WMAPEVIQEIGYNNKADIWSLGITAIEMAEGK 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score =  109 bits (274), Expect = 1e-26
 Identities = 65/232 (28%), Positives = 112/232 (48%), Gaps = 33/232 (14%)

Query: 341 EVATNKFSTDNKLGEGGFGEVYK----GVLPSGQE---IAVKRLSK-ASGQGAEEFKNEV 392
           E   N       +G+G FG V++    G+LP  +    +AVK L + AS     +F+ E 
Sbjct: 1   EYPRNNIEYVRDIGQGAFGRVFQARAPGLLP-YEPFTMVAVKMLKEEASADMQADFQREA 59

Query: 393 VLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYD------------------ 434
            L+A+  H N+V+LLG C  G+   L++E++    L+ FL                    
Sbjct: 60  ALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARK 119

Query: 435 -PEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493
                  L  + +  I   +A G+ YL E    + +HRDL   N L+   M  KI+DFG+
Sbjct: 120 CGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGL 176

Query: 494 AR-IFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           +R I+  D  + + +  +    +M PE   + +++ +SDV+++GV++ EI +
Sbjct: 177 SRNIYSADYYKASENDAIPIR-WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  108 bits (273), Expect = 2e-26
 Identities = 70/209 (33%), Positives = 110/209 (52%), Gaps = 22/209 (10%)

Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFK----NEVVLVAKLQHR 401
           +    KLGEG +G VYK     +G+ +A+K++        E        E+ L+ +L+H 
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI--RLDNEEEGIPSTALREISLLKELKHP 58

Query: 402 NLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
           N+V+LL      E K+ LV+E+  +  L  +L    + G L  +    I+  + RG+ Y 
Sbjct: 59  NIVKLLDVIH-TERKLYLVFEYC-DMDLKKYLDK--RPGPLSPNLIKSIMYQLLRGLAYC 114

Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEY 520
           H  S  RI+HRDLK  NIL++ +   K++DFG+AR FG+      T  +V T  Y APE 
Sbjct: 115 H--SH-RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT-YTHEVV-TLWYRAPEI 169

Query: 521 AMHGQF---SVKSDVYSFGVLVLEIITGK 546
            +  +    +V  D++S G +  E+ITGK
Sbjct: 170 LLGSKHYSTAV--DIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  108 bits (270), Expect = 2e-26
 Identities = 66/205 (32%), Positives = 106/205 (51%), Gaps = 7/205 (3%)

Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ 399
           E+     +  +KLG G +GEVY+GV       +AVK L K      EEF  E  ++ +++
Sbjct: 2   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIK 60

Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
           H NLV+LLG C       ++ EF+   +L  +L +  +Q +++      +   I+  + Y
Sbjct: 61  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEY 119

Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE 519
           L + +    IHRDL A N L+      K++DFG++R      T    +       + APE
Sbjct: 120 LEKKN---FIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPE 175

Query: 520 YAMHGQFSVKSDVYSFGVLVLEIIT 544
              + +FS+KSDV++FGVL+ EI T
Sbjct: 176 SLAYNKFSIKSDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score =  107 bits (269), Expect = 3e-26
 Identities = 71/207 (34%), Positives = 113/207 (54%), Gaps = 13/207 (6%)

Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
           E+       + KLG+G FGEV+ G       +A+K L K      E F  E  ++ KL+H
Sbjct: 2   EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRH 60

Query: 401 RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
             LV+L  + +  EE I +V E++   SL  FL   E    L   +   +   IA G+ Y
Sbjct: 61  EKLVQL--YAVVSEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAY 117

Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTY--GYMA 517
           +    R+  +HRDL+A+NIL+   +  K++DFG+AR+    +    T+R    +   + A
Sbjct: 118 VE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTA 171

Query: 518 PEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           PE A++G+F++KSDV+SFG+L+ E+ T
Sbjct: 172 PEAALYGRFTIKSDVWSFGILLTELTT 198

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  107 bits (269), Expect = 3e-26
 Identities = 69/200 (34%), Positives = 87/200 (43%), Gaps = 13/200 (6%)

Query: 352 KLGEGGFGEVYKG--VLPSGQEI--AVKRLSKASGQGA-EEFKNEVVLVAKLQHRNLVRL 406
           KLG+G FG V +G      G+ I  AVK L         ++F  E  ++  L H NL+RL
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 407 LGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRL 466
            G  L      +V E  P  SL   L      G    S        IA G+ YL      
Sbjct: 62  YGVVLTHPLM-MVTELAPLGSLLDRLRKD-ALGHFLISTLCDYAVQIANGMRYLESK--- 116

Query: 467 RIIHRDLKASNILLDAEMNPKISDFGMARIFGV--DQTQGNTSRIVGTYGYMAPEYAMHG 524
           R IHRDL A NILL ++   KI DFG+ R      D         V  + + APE     
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV-PFAWCAPESLRTR 175

Query: 525 QFSVKSDVYSFGVLVLEIIT 544
            FS  SDV+ FGV + E+ T
Sbjct: 176 TFSHASDVWMFGVTLWEMFT 195

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score =  107 bits (268), Expect = 4e-26
 Identities = 65/214 (30%), Positives = 118/214 (55%), Gaps = 19/214 (8%)

Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL--PSGQEIAVKRLSKASG---QGAEEFKNEVVLV 395
           E+  +  +    +G G FGEV++G+L  P  +E+AV   +   G   +  ++F +E  ++
Sbjct: 1   EIHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIM 60

Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
            +  H N++RL G   + +  +++ E++ N +LD +L D    G+    +   ++ GIA 
Sbjct: 61  GQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAA 118

Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF-----GVDQTQGNTSRIV 510
           G+ YL   S +  +HRDL A NIL+++ +  K+SDFG++R+      G   T G    I 
Sbjct: 119 GMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIR 175

Query: 511 GTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
            T    APE   + +F+  SDV+SFG+++ E+++
Sbjct: 176 WT----APEAIAYRKFTSASDVWSFGIVMWEVMS 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score =  107 bits (268), Expect = 5e-26
 Identities = 72/228 (31%), Positives = 123/228 (53%), Gaps = 31/228 (13%)

Query: 340 IEVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLS-KASGQGAEEFKNEV 392
           I ++T +F  +  LGE  FG+VYKG L         Q +A+K L  KA G   EEFK+E 
Sbjct: 2   INLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEA 59

Query: 393 VLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLY-------------DPEKQG 439
           ++ ++LQH N+V LLG   + +   +++ +  +  L  FL              D   + 
Sbjct: 60  MMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS 119

Query: 440 QLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFG 498
            L+ +    I+  IA G+ +L   S   ++H+DL   N+L+  ++N KISD G+ R ++ 
Sbjct: 120 TLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYA 176

Query: 499 VD--QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
            D  +  GN+   +    +M+PE  M+G+FS+ SD++S+GV++ E+ +
Sbjct: 177 ADYYKLMGNSLLPI---RWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score =  108 bits (270), Expect = 5e-26
 Identities = 69/209 (33%), Positives = 116/209 (55%), Gaps = 20/209 (9%)

Query: 346 KFSTDNKLGEGGFGEVYKGV-LPSGQEI----AVKRLSKASGQGA-EEFKNEVVLVAKLQ 399
           +F     LG G FG VYKG+ +P G+++    A+K L +A+   A +E  +E  ++A + 
Sbjct: 8   EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 67

Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQ---LDWSRRYKIIGGIAR 455
           + ++ RLLG CL    + L+ + +P   L DY     +  G    L+W  +      IA+
Sbjct: 68  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 120

Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGY 515
           G+ YL E    R++HRDL A N+L+    + KI+DFG+A++ G D+ + +         +
Sbjct: 121 GMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKW 177

Query: 516 MAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           MA E  +H  ++ +SDV+S+GV V E++T
Sbjct: 178 MALESILHRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score =  107 bits (268), Expect = 6e-26
 Identities = 75/221 (33%), Positives = 120/221 (54%), Gaps = 26/221 (11%)

Query: 352 KLGEGGFGEVY----KGVLPSGQEI--AVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVR 405
           +LGEG FG+V+      + P   +I  AVK L  AS    ++F  E  L+  LQH ++V+
Sbjct: 12  ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71

Query: 406 LLGFCLEGEEKILVYEFVPNKSLDYFL--YDPE----KQG----QLDWSRRYKIIGGIAR 455
             G C+EG+  I+V+E++ +  L+ FL  + P+     +G    +L  S+   I   IA 
Sbjct: 72  FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131

Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVD--QTQGNTSRIVGT 512
           G++YL   +    +HRDL   N L+   +  KI DFGM+R ++  D  +  G+T   +  
Sbjct: 132 GMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI-- 186

Query: 513 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQ 553
             +M PE  M+ +F+ +SDV+S GV++ EI T  K   +YQ
Sbjct: 187 -RWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP-WYQ 225

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score =  107 bits (268), Expect = 6e-26
 Identities = 75/220 (34%), Positives = 122/220 (55%), Gaps = 21/220 (9%)

Query: 353 LGEGGFGEVYKGV-LPSGQEI----AVKRLSK-ASGQGAEEFKNEVVLVAKLQHRNLVRL 406
           LG G FG VYKG+ +P G+ +    A+K L +  S +  +E  +E  ++A +    + RL
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74

Query: 407 LGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQ---LDWSRRYKIIGGIARGILYLHE 462
           LG CL    + LV + +P   L DY   + ++ G    L+W  +      IA+G+ YL E
Sbjct: 75  LGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKGMSYLEE 127

Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM 522
              +R++HRDL A N+L+ +  + KI+DFG+AR+  +D+T+ +         +MA E  +
Sbjct: 128 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 184

Query: 523 HGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLL 561
           H +F+ +SDV+S+GV V E++T G K  +        DLL
Sbjct: 185 HRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLL 224

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  106 bits (267), Expect = 6e-26
 Identities = 64/202 (31%), Positives = 106/202 (52%), Gaps = 15/202 (7%)

Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKR-----LSKASGQGAEEFKNEVVLVAKLQHRNLVRL 406
           LG+G FG VY    + +G+E+AVK+      S  + +     + E+ L+  LQH  +V+ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69

Query: 407 LGFCLEGEEKILVY-EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSR 465
            G CL  +E + ++ E++P  S+   L   +  G L  +   K    I  G+ YLH +  
Sbjct: 70  YG-CLRDDETLSIFMEYMPGGSVKDQL---KAYGALTETVTRKYTRQILEGVEYLHSN-- 123

Query: 466 LRIIHRDLKASNILLDAEMNPKISDFGMA-RIFGVDQTQGNTSRIVGTYGYMAPEYAMHG 524
             I+HRD+K +NIL D+  N K+ DFG + R+  +  +      + GT  +M+PE     
Sbjct: 124 -MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGE 182

Query: 525 QFSVKSDVYSFGVLVLEIITGK 546
            +  K+DV+S G  V+E++T K
Sbjct: 183 GYGRKADVWSVGCTVVEMLTEK 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  107 bits (269), Expect = 7e-26
 Identities = 60/208 (28%), Positives = 108/208 (51%), Gaps = 25/208 (12%)

Query: 351 NKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEF----KNEVVLVAKLQHRNLVR 405
            ++GEG +G+VYK     +G+ +A+K++        E F      E+ L+ KL+H N+VR
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKIRME--NEKEGFPITAIREIKLLQKLRHPNIVR 62

Query: 406 LLGFCLEGEEK--ILVYEFVPNKSLDYFLYDPEKQ---GQLDWSRRYK-IIGGIARGILY 459
           L        +    +V+E++ +  L   L  PE +    Q+      K  +  +  G+ Y
Sbjct: 63  LKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQI------KCYMKQLLEGLQY 115

Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE 519
           LH +    I+HRD+K SNIL++ +   K++DFG+AR +    +   T+R++ T  Y  PE
Sbjct: 116 LHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPE 171

Query: 520 YAMHG-QFSVKSDVYSFGVLVLEIITGK 546
             +   ++  + D++S G ++ E+  GK
Sbjct: 172 LLLGATRYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  107 bits (268), Expect = 7e-26
 Identities = 70/212 (33%), Positives = 110/212 (51%), Gaps = 24/212 (11%)

Query: 353 LGEGGFGEV----YKGVLPS-GQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLL 407
           LG+G FG V    Y  +  + G+ +AVK+L  ++ +   +F+ E+ ++  LQH N+V+  
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71

Query: 408 GFCLE-GEEKI-LVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
           G C   G   + LV E++P  SL DY     E+   LD  +       I +G+ YL    
Sbjct: 72  GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER---LDHRKLLLYASQICKGMEYL---G 125

Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ-----TQGNTSRIVGTYGYMAPE 519
             R +HRDL   NIL+++E   KI DFG+ ++   D+      +   S I     + APE
Sbjct: 126 SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIF----WYAPE 181

Query: 520 YAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSN 550
                +FSV SDV+SFGV++ E+ T   K+ +
Sbjct: 182 SLTESKFSVASDVWSFGVVLYELFTYSDKSCS 213

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score =  106 bits (265), Expect = 1e-25
 Identities = 68/208 (32%), Positives = 102/208 (49%), Gaps = 23/208 (11%)

Query: 353 LGEGGFGEVY----KGVLPSGQE--IAVKRLSKASGQGAE-EFKNEVVLVAKLQHRNLVR 405
           LG G FGEV+    KG+   G E  + VK L K   +  + EF+ E+ +  KL H+N+VR
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72

Query: 406 LLGFCLEGEEKILVYEFVPNKSLDYFL------YDPEKQGQLDWSRRYKIIGGIARGILY 459
           LLG C E E   ++ E+     L  FL       +  K   L   ++  +   IA G+ +
Sbjct: 73  LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132

Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG---YM 516
           L   S  R +HRDL A N L+ ++   K+S   +++    D       ++        ++
Sbjct: 133 L---SNARFVHRDLAARNCLVSSQREVKVSLLSLSK----DVYNSEYYKLRNALIPLRWL 185

Query: 517 APEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           APE      FS KSDV+SFGVL+ E+ T
Sbjct: 186 APEAVQEDDFSTKSDVWSFGVLMWEVFT 213

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score =  105 bits (263), Expect = 2e-25
 Identities = 71/211 (33%), Positives = 110/211 (52%), Gaps = 21/211 (9%)

Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
           E+       + KLG G FGEV+        ++AVK + K      E F  E  ++  LQH
Sbjct: 2   EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQH 60

Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQ-----LDWSRRYKIIGGIAR 455
             LV+L     + E   ++ EF+   SL  FL   E   Q     +D+S +      IA 
Sbjct: 61  DKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ------IAE 113

Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTY-- 513
           G+ ++ + +    IHRDL+A+NIL+ A +  KI+DFG+AR+    +    T+R    +  
Sbjct: 114 GMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVI---EDNEYTAREGAKFPI 167

Query: 514 GYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
            + APE    G F++KSDV+SFG+L++EI+T
Sbjct: 168 KWTAPEAINFGSFTIKSDVWSFGILLMEIVT 198

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  104 bits (261), Expect = 3e-25
 Identities = 70/206 (33%), Positives = 103/206 (50%), Gaps = 16/206 (7%)

Query: 351 NKLGEGGFGEVYKGVLPSGQEIAVKRLS------KASGQGAEEFKNEVVLVAKLQHRNLV 404
             LG+G +G VY G+   GQ IAVK++        A+ +  E+ + EV L+  L+H N+V
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
           + LG CL+     +  EFVP  S+   L    + G L      K    I  G+ YLH + 
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSISSIL---NRFGPLPEPVFCKYTKQILDGVAYLHNNC 122

Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIV----GTYGYMAPEY 520
              ++HRD+K +N++L      K+ DFG AR        G  S ++    GT  +MAPE 
Sbjct: 123 ---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179

Query: 521 AMHGQFSVKSDVYSFGVLVLEIITGK 546
                +  KSD++S G  V E+ TGK
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGK 205

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal

 Score = 99.8 bits (249), Expect = 4e-25
 Identities = 45/106 (42%), Positives = 59/106 (55%), Gaps = 6/106 (5%)

Query: 144 SPTVSLLNTQNVTDQGRLNELVGTQMSQVVTQAVS-NTKRFATRKANFTTFQTLYSLAQC 202
           S T     T N T +  LN L    +S + + A S + K FA    +     T+Y LAQC
Sbjct: 6   SNTSGNYTTANSTFESNLNAL----LSSLSSNAASSSGKGFAAG-TSGAAPDTVYGLAQC 60

Query: 203 TPDLSSSDCNTCLRGAVARLPSCCSGKQGGRVLFPSCNVRYELYPF 248
             DLS+SDC +CL  AV+ L  CC  K+GGR+ + SC +RYE YPF
Sbjct: 61  RGDLSASDCRSCLATAVSELRRCCPNKKGGRIWYDSCFLRYESYPF 106

This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  104 bits (261), Expect = 5e-25
 Identities = 68/209 (32%), Positives = 106/209 (50%), Gaps = 22/209 (10%)

Query: 351 NKLGEGGFGEVYKGV-LPSGQEIAVK--RLSKASGQGAEEFKNEVVLVAKLQHRNLVRLL 407
           NK+G G FG+VY  V L +G+ +AVK  R+     +  +E  +E+ ++  L+H NLV+  
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 408 GFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWS--RRYKIIGGIARGILYLHEDSR 465
           G  +  E+  +  E+    +L+  L   E    LD    R Y +   +  G+ YLH    
Sbjct: 66  GVEVHREKVYIFMEYCSGGTLEELL---EHGRILDEHVIRVYTL--QLLEGLAYLHSH-- 118

Query: 466 LRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT----QGNTSRIVGTYGYMAPEYA 521
             I+HRD+K +NI LD     K+ DFG A     + T    +  +  + GT  YMAPE  
Sbjct: 119 -GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQS--LAGTPAYMAPEVI 175

Query: 522 MHGQFSVK---SDVYSFGVLVLEIITGKK 547
             G+       +D++S G +VLE+ TGK+
Sbjct: 176 TGGKGKGHGRAADIWSLGCVVLEMATGKR 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score =  103 bits (259), Expect = 7e-25
 Identities = 69/205 (33%), Positives = 109/205 (53%), Gaps = 12/205 (5%)

Query: 352 KLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCL 411
           +LG G FG V+ G   +  ++A+K +++ +    E+F  E  ++ KL H  LV+L G C 
Sbjct: 11  ELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69

Query: 412 EGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHR 471
           + +   +V EF+ N  L  +L   ++QG+L       +   +  G+ YL  +S    IHR
Sbjct: 70  QQKPLYIVTEFMENGCLLNYLR--QRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHR 124

Query: 472 DLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSD 531
           DL A N L+ +    K+SDFGM R + +D    ++S       +  PE     ++S KSD
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTR-YVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSD 183

Query: 532 VYSFGVLVLEIIT-GK----KNSNF 551
           V+SFGVL+ E+ T GK    K SN+
Sbjct: 184 VWSFGVLMWEVFTEGKMPFEKKSNY 208

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  102 bits (256), Expect = 1e-24
 Identities = 69/199 (34%), Positives = 105/199 (52%), Gaps = 13/199 (6%)

Query: 346 KFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVR 405
           K +    +GEG FG V +G   +GQ++AVK +       A+ F  E  ++ KL H+NLVR
Sbjct: 7   KLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIK--CDVTAQAFLEETAVMTKLHHKNLVR 63

Query: 406 LLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSR 465
           LLG  L     I V E +   +L  FL     +  +   +  +    +A G+ YL     
Sbjct: 64  LLGVILHNGLYI-VMELMSKGNLVNFLRT-RGRALVSVIQLLQFSLDVAEGMEYLESK-- 119

Query: 466 LRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQ 525
            +++HRDL A NIL+  +   K+SDFG+AR   V     + S++     + APE   H +
Sbjct: 120 -KLVHRDLAARNILVSEDGVAKVSDFGLAR---VGSMGVDNSKL--PVKWTAPEALKHKK 173

Query: 526 FSVKSDVYSFGVLVLEIIT 544
           FS KSDV+S+GVL+ E+ +
Sbjct: 174 FSSKSDVWSYGVLLWEVFS 192

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  102 bits (257), Expect = 1e-24
 Identities = 69/208 (33%), Positives = 111/208 (53%), Gaps = 20/208 (9%)

Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKR--LSKASGQGA-------EEFKNEVVLVAKLQHRN 402
           +G G FG VY G+   SG+ +AVK+  L   S           +    E+ L+ +LQH N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
           +V+ LG  L+ +   +  E+VP  S+   L      G  + +     +  I +G+ YLH 
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALL---NNYGAFEETLVRNFVRQILKGLNYLH- 123

Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG--NTSR--IVGTYGYMAP 518
            +R  IIHRD+K +NIL+D +   KISDFG+++    +      N +R  + G+  +MAP
Sbjct: 124 -NR-GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181

Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITGK 546
           E      ++ K+D++S G LV+E++TGK
Sbjct: 182 EVVKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  103 bits (258), Expect = 1e-24
 Identities = 64/209 (30%), Positives = 108/209 (51%), Gaps = 21/209 (10%)

Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKR--LSKASGQGAEEFKNEVVLVAKLQHR 401
             F+    +G+G FGEVYK +   + Q +A+K   L +A  +  E+ + E+  +++ +  
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE-IEDIQQEIQFLSQCRSP 59

Query: 402 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGIL--- 458
            + +  G  L+G +  ++ E+    S    L    K G+LD       I  I R +L   
Sbjct: 60  YITKYYGSFLKGSKLWIIMEYCGGGSCLDLL----KPGKLD----ETYIAFILREVLLGL 111

Query: 459 -YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMA 517
            YLHE+     IHRD+KA+NILL  E + K++DFG++       ++ NT   VGT  +MA
Sbjct: 112 EYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT--FVGTPFWMA 166

Query: 518 PEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
           PE      +  K+D++S G+  +E+  G+
Sbjct: 167 PEVIKQSGYDEKADIWSLGITAIELAKGE 195

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  102 bits (256), Expect = 2e-24
 Identities = 67/201 (33%), Positives = 101/201 (50%), Gaps = 15/201 (7%)

Query: 353 LGEGGFGEVYKGVLPSGQ-EIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCL 411
           LG+G +G VY     S Q  IA+K + +   +  +    E+ L + L+HRN+V+ LG   
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75

Query: 412 EGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGG--IARGILYLHEDSRLRII 469
           E     +  E VP  SL   L    K G L  + +  I     I  G+ YLH+    +I+
Sbjct: 76  ENGFFKIFMEQVPGGSLSALLR--SKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQIV 130

Query: 470 HRDLKASNILLDAEMNP-KISDFGMA-RIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQ-- 525
           HRD+K  N+L++      KISDFG + R+ G++     T    GT  YMAPE    G   
Sbjct: 131 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC---TETFTGTLQYMAPEVIDKGPRG 187

Query: 526 FSVKSDVYSFGVLVLEIITGK 546
           +   +D++S G  ++E+ TGK
Sbjct: 188 YGAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score =  103 bits (258), Expect = 2e-24
 Identities = 71/234 (30%), Positives = 104/234 (44%), Gaps = 37/234 (15%)

Query: 341 EVATNKFSTDNKLGEGGFGEVY------------KGVLPSGQE-----IAVKRLSK-ASG 382
           E      +   KLGEG FGEV+            K    +        +AVK L   AS 
Sbjct: 1   EFPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD 60

Query: 383 QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLY--------D 434
              E+F  EV ++++L   N+ RLLG C       ++ E++ N  L+ FL          
Sbjct: 61  NAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGL 120

Query: 435 PEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494
                 L +S    +   IA G+ YL     L  +HRDL   N L+      KI+DFGM+
Sbjct: 121 ACNSKSLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMS 177

Query: 495 RIFGVDQTQGNTSRIVGT----YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           R    +    +  R+ G       +MA E  + G+F+ KSDV++FGV + EI+T
Sbjct: 178 R----NLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  102 bits (256), Expect = 3e-24
 Identities = 69/216 (31%), Positives = 112/216 (51%), Gaps = 22/216 (10%)

Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRL---SKASGQGAEEFKNE 391
           D+  IE          K+GEG +G VYKG    +GQ +A+K++   S+  G  +   + E
Sbjct: 1   DYTKIE----------KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIR-E 49

Query: 392 VVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIG 451
           + L+ +LQH N+V L    ++     L++EF+ +  L  +L    K   +D       + 
Sbjct: 50  ISLLKELQHPNIVCLQDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLY 108

Query: 452 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVG 511
            I +GIL+ H     R++HRDLK  N+L+D +   K++DFG+AR FG+   +  T  +V 
Sbjct: 109 QILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI-PVRVYTHEVV- 163

Query: 512 TYGYMAPEYAMHGQ-FSVKSDVYSFGVLVLEIITGK 546
           T  Y APE  +    +S   D++S G +  E+ T K
Sbjct: 164 TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  102 bits (255), Expect = 3e-24
 Identities = 61/203 (30%), Positives = 108/203 (53%), Gaps = 23/203 (11%)

Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQG-AEEFKNEVVLVAKLQH---RNLVRLL 407
           +G G +G VY+G  +P+G+ +A+K ++  +      + + EV L+++L+     N+ +  
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68

Query: 408 GFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGIL----YLHED 463
           G  L+G    ++ E+    S+   +    K G +    +Y  I  I R +L    Y+H+ 
Sbjct: 69  GSYLKGPRLWIIMEYAEGGSVRTLM----KAGPIA--EKY--ISVIIREVLVALKYIHKV 120

Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMH 523
               +IHRD+KA+NIL+    N K+ DFG+A +   +Q     S  VGT  +MAPE    
Sbjct: 121 G---VIHRDIKAANILVTNTGNVKLCDFGVAALL--NQNSSKRSTFVGTPYWMAPEVITE 175

Query: 524 GQ-FSVKSDVYSFGVLVLEIITG 545
           G+ +  K+D++S G+ + E+ TG
Sbjct: 176 GKYYDTKADIWSLGITIYEMATG 198

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score =  102 bits (255), Expect = 3e-24
 Identities = 68/225 (30%), Positives = 105/225 (46%), Gaps = 29/225 (12%)

Query: 353 LGEGGFGEVYKGVL----PSGQEIAVK--RLSKASGQGAEEFKNEVVLVAKLQHRNLVRL 406
           LGEG FG V +G L     S  ++AVK  +L   +    EEF +E   +    H N+++L
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66

Query: 407 LGFCLEGEEK------ILVYEFVPNKSLDYFLYDPEKQGQ---LDWSRRYKIIGGIARGI 457
           +G C E          +++  F+ +  L  FL      G    L      K +  IA G+
Sbjct: 67  IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126

Query: 458 LYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVD-QTQGNTSRIVGTYGY 515
            YL   S    IHRDL A N +L  +M   ++DFG+++ I+  D   QG  +++     +
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM--PVKW 181

Query: 516 MAPEYAMHGQFSVKSDVYSFGVLVLEIIT-------GKKNSNFYQ 553
           +A E      ++ KSDV++FGV + EI T       G +N   Y 
Sbjct: 182 IAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYD 226

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  100 bits (251), Expect = 9e-24
 Identities = 67/220 (30%), Positives = 112/220 (50%), Gaps = 28/220 (12%)

Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLS----KASGQGA--EEFKNEVVLVAKLQHRNLVR 405
           LG G F   Y+   + +G  +AVK+++     +S Q    E  + E+ L+A+L H +++R
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 406 LLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSR 465
           +LG   E     L  E++   S+ + L    K G    +        + RG+ YLHE+  
Sbjct: 68  MLGATCEDSHFNLFVEWMAGGSVSHLL---SKYGAFKEAVIINYTEQLLRGLSYLHEN-- 122

Query: 466 LRIIHRDLKASNILLDAE-MNPKISDFGMA-----RIFGVDQTQGNTSRIVGTYGYMAPE 519
            +IIHRD+K +N+L+D+     +I+DFG A     +  G  + QG   +++GT  +MAPE
Sbjct: 123 -QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQG---QLLGTIAFMAPE 178

Query: 520 YAMHGQFSVKSDVYSFGVLVLEIITGK------KNSNFYQ 553
                Q+    DV+S G +++E+ T K      K+SN   
Sbjct: 179 VLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLA 218

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  100 bits (251), Expect = 1e-23
 Identities = 68/214 (31%), Positives = 118/214 (55%), Gaps = 31/214 (14%)

Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRL---SKASGQGAEE-------FKNEVVLVAKLQHR 401
           +G+G +G VY  + + +G+ +AVK++   +  +G+            ++E+  +  L H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 402 NLVRLLGFCLEGEEKILVY-EFVPNKSLDYFLYDPEK-QGQLDWSRRYKIIGGIARGILY 459
           N+V+ LGF    EE + ++ E+VP  S+   L    + + QL      +++ G+A    Y
Sbjct: 69  NIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLA----Y 123

Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR----IFGVDQTQGNTSRIVGTYGY 515
           LH      I+HRDLKA N+L+DA+   KISDFG+++    I+  DQ   N S + G+  +
Sbjct: 124 LHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQ---NMS-MQGSVFW 176

Query: 516 MAPE--YAMHGQFSVKSDVYSFGVLVLEIITGKK 547
           MAPE  ++    +S K D++S G +VLE+  G++
Sbjct: 177 MAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score =  100 bits (250), Expect = 1e-23
 Identities = 64/203 (31%), Positives = 110/203 (54%), Gaps = 21/203 (10%)

Query: 353 LGEGGFGEVYKGVL--PSGQEIAVKRLSKASG---QGAEEFKNEVVLVAKLQHRNLVRLL 407
           +G G FGEV  G L  P  +EI V   +  +G   +   +F +E  ++ +  H N++ L 
Sbjct: 12  IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 408 GFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
           G   + +  ++V E++ N SLD FL   +  GQ    +   ++ GIA G+ YL   S + 
Sbjct: 72  GVVTKSKPVMIVTEYMENGSLDAFLR--KHDGQFTVIQLVGMLRGIASGMKYL---SDMG 126

Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG------YMAPEYA 521
            +HRDL A NIL+++ +  K+SDFG++R+   D     T+R     G      + APE  
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR-----GGKIPIRWTAPEAI 181

Query: 522 MHGQFSVKSDVYSFGVLVLEIIT 544
            + +F+  SDV+S+G+++ E+++
Sbjct: 182 AYRKFTSASDVWSYGIVMWEVMS 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 99.6 bits (248), Expect = 2e-23
 Identities = 62/200 (31%), Positives = 110/200 (55%), Gaps = 13/200 (6%)

Query: 353 LGEGGFGEVYKGVL--PSGQEI--AVKRLSKA-SGQGAEEFKNEVVLVAKLQHRNLVRLL 407
           +G G FGEV +G L  P  +EI  A+K L    + +   +F +E  ++ +  H N++ L 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 408 GFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
           G   +    +++ EF+ N +LD FL   +  GQ    +   ++ GIA G+ YL E   + 
Sbjct: 72  GVVTKSRPVMIITEFMENGALDSFLR--QNDGQFTVIQLVGMLRGIAAGMKYLSE---MN 126

Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVG---TYGYMAPEYAMHG 524
            +HRDL A NIL+++ +  K+SDFG++R    D +    +  +G      + APE   + 
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR 186

Query: 525 QFSVKSDVYSFGVLVLEIIT 544
           +F+  SDV+S+G+++ E+++
Sbjct: 187 KFTSASDVWSYGIVMWEVMS 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score =  100 bits (249), Expect = 2e-23
 Identities = 72/216 (33%), Positives = 111/216 (51%), Gaps = 29/216 (13%)

Query: 352 KLGEGGFGEVYKG--VLPS---GQEIAVKRLSK-ASGQGAEEFKNEVVLVAKLQHRNLVR 405
           +LGE  FG++YKG   LP     Q +A+K L    + Q   EF+ E  L+A+L H N+V 
Sbjct: 12  ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71

Query: 406 LLGFCLEGEEKILVYEFVPNKSLDYFLY--------------DPEKQGQLDWSRRYKIIG 451
           LLG   + +   +++E++    L  FL               D   +  LD      I  
Sbjct: 72  LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131

Query: 452 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVD--QTQGNTSR 508
            IA G+ YL   S    +H+DL A NIL+  +++ KISD G++R I+  D  + Q  +  
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188

Query: 509 IVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
            +    +M PE  M+G+FS  SD++SFGV++ EI +
Sbjct: 189 PIR---WMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 99.6 bits (248), Expect = 3e-23
 Identities = 68/198 (34%), Positives = 106/198 (53%), Gaps = 12/198 (6%)

Query: 353 LGEGGFGEVYKGV-LPSGQEI----AVKRLSKASG-QGAEEFKNEVVLVAKLQHRNLVRL 406
           LG G FG V+KG+ +P G  I    A+K +   SG Q  +E  + ++ +  L H  +VRL
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74

Query: 407 LGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRL 466
           LG C  G    LV +  P  SL    +  + +  LD  R       IA+G+ YL E    
Sbjct: 75  LGIC-PGASLQLVTQLSPLGSL--LDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH--- 128

Query: 467 RIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQF 526
           R++HR+L A NILL ++   +I+DFG+A +   D  +   S       +MA E  + G++
Sbjct: 129 RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRY 188

Query: 527 SVKSDVYSFGVLVLEIIT 544
           + +SDV+S+GV V E+++
Sbjct: 189 THQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =   99 bits (249), Expect = 3e-23
 Identities = 61/206 (29%), Positives = 112/206 (54%), Gaps = 18/206 (8%)

Query: 346 KFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLV 404
           K++   K+G+G  G VY  + + +GQE+A+K+++       E   NE++++ + +H N+V
Sbjct: 20  KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIV 79

Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGIL----YL 460
             L   L G+E  +V E++   SL     D   +  +D       I  + R  L    +L
Sbjct: 80  NYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEG----QIAAVCRECLQALEFL 131

Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEY 520
           H +   ++IHRD+K+ NILL  + + K++DFG       +Q++ +T  +VGT  +MAPE 
Sbjct: 132 HSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEV 186

Query: 521 AMHGQFSVKSDVYSFGVLVLEIITGK 546
                +  K D++S G++ +E++ G+
Sbjct: 187 VTRKAYGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 99.3 bits (248), Expect = 4e-23
 Identities = 58/199 (29%), Positives = 105/199 (52%), Gaps = 13/199 (6%)

Query: 352 KLGEGGFGEVYK-GVLPSGQEIAVKR--LSKASGQGAEEFKNEVVLVAKLQHRNLVRLLG 408
           ++GEG  G V+K     +G+ +A+K+  L +  G    +   E+  +   QH  +V+LL 
Sbjct: 7   RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66

Query: 409 FCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRI 468
               G   +LV E++P+  L   L D E+       + Y  +  + +G+ Y+H      I
Sbjct: 67  VFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRM--LLKGVAYMHA---NGI 120

Query: 469 IHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQ--F 526
           +HRDLK +N+L+ A+   KI+DFG+AR+F  ++ +  + + V T  Y APE  ++G   +
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYRAPEL-LYGARKY 178

Query: 527 SVKSDVYSFGVLVLEIITG 545
               D+++ G +  E++ G
Sbjct: 179 DPGVDLWAVGCIFAELLNG 197

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 98.9 bits (247), Expect = 5e-23
 Identities = 68/201 (33%), Positives = 107/201 (53%), Gaps = 15/201 (7%)

Query: 352 KLGEGGFGEVYKGV-LPSGQEIAVKRL---SKASGQGAEEFKNEVVLVAKLQHRNLVRLL 407
           K+GEG +G VYK     +G+ +A+K++   ++  G  +   + E+ L+ +L H N+VRLL
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR-EISLLKELNHPNIVRLL 64

Query: 408 GFCLEGEEKILVYEFVPNKSLDYFLY-DPEKQGQLDWSRRYKIIGGIARGILYLHEDSRL 466
                  +  LV+EF+    LD   Y D      LD       +  + +GI Y H  S  
Sbjct: 65  DVVHSENKLYLVFEFL---DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH--SH- 118

Query: 467 RIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG-Q 525
           R++HRDLK  N+L+D E   K++DFG+AR FGV   +  T  +V T  Y APE  +   Q
Sbjct: 119 RVLHRDLKPQNLLIDREGALKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEILLGSRQ 176

Query: 526 FSVKSDVYSFGVLVLEIITGK 546
           +S   D++S G +  E++  +
Sbjct: 177 YSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 97.9 bits (244), Expect = 6e-23
 Identities = 68/208 (32%), Positives = 103/208 (49%), Gaps = 19/208 (9%)

Query: 347 FSTDNKLGEGGFGEVYK-GVLPSGQEIAVKR--LSKASGQGAEEFKNEVVLVAKLQHRNL 403
           F    KLG+G +G VYK   L   Q  A+K   L   S +  E+  NE+ ++A + H N+
Sbjct: 2   FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI 61

Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQG-----QLDWSRRYKIIGGIARGIL 458
           +      L+G +  +V E+ P   L   +   +K+      Q  W  R  I   + RG+ 
Sbjct: 62  ISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIW--RIFI--QLLRGLQ 117

Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
            LHE    +I+HRDLK++NILL A    KI D G++++      +      +GT  YMAP
Sbjct: 118 ALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVL----KKNMAKTQIGTPHYMAP 170

Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITGK 546
           E      +S KSD++S G L+ E+ T  
Sbjct: 171 EVWKGRPYSYKSDIWSLGCLLYEMATFA 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 98.5 bits (245), Expect = 8e-23
 Identities = 67/232 (28%), Positives = 110/232 (47%), Gaps = 34/232 (14%)

Query: 341 EVATNKFSTDNKLGEGGFGEV----------YKGVLPSGQE-----IAVKRL-SKASGQG 384
           E    +     KLGEG FGEV          + G      +     +AVK L +  +   
Sbjct: 1   EFPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTA 60

Query: 385 AEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWS 444
             +F  E+ ++++L++ N++RLLG C+  +   ++ E++ N  L+ FL   E +     +
Sbjct: 61  RNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHA 120

Query: 445 RRYKIIG---------GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
                +           IA G+ YL   + L  +HRDL   N L+      KI+DFGM+R
Sbjct: 121 NNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSR 177

Query: 496 -IFGVD--QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
            ++  D  + QG   R V    +MA E  + G+F+  SDV++FGV + E+ T
Sbjct: 178 NLYSGDYYRIQG---RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 97.8 bits (244), Expect = 1e-22
 Identities = 65/203 (32%), Positives = 109/203 (53%), Gaps = 12/203 (5%)

Query: 351 NKLGEGGFGEVYKGV-LPSGQEIAVKR--LSKASGQGAEEFKNEVVLVAKLQHRNLVRLL 407
             +G G    VY  + LP+ +++A+KR  L K      +E + EV  +++  H N+V+  
Sbjct: 7   EVIGVGATAVVYAAICLPNNEKVAIKRIDLEK-CQTSVDELRKEVQAMSQCNHPNVVKYY 65

Query: 408 GFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
              + G+E  LV  ++   SL   +     +G LD +    ++  + +G+ YLH + +  
Sbjct: 66  TSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ-- 123

Query: 468 IIHRDLKASNILLDAEMNPKISDFGM-ARIF-GVDQTQGNTSRIVGTYGYMAPEYAMHGQ 525
            IHRD+KA NILL  + + KI+DFG+ A +  G D+T+      VGT  +MAPE  M   
Sbjct: 124 -IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE-VMEQV 181

Query: 526 --FSVKSDVYSFGVLVLEIITGK 546
             +  K+D++SFG+  +E+ TG 
Sbjct: 182 HGYDFKADIWSFGITAIELATGA 204

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 97.8 bits (243), Expect = 1e-22
 Identities = 70/219 (31%), Positives = 114/219 (52%), Gaps = 19/219 (8%)

Query: 341 EVATNKFSTDNKLGEGGFGEVY----KGVLPSGQE--IAVKRLSK-ASGQGAEEFKNEVV 393
           EVA  K +   +LG+G FG VY    KGV+    E  +A+K +++ AS +   EF NE  
Sbjct: 2   EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 61

Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYD--PEKQGQL-----DWSRR 446
           ++ +    ++VRLLG   +G+  +++ E +    L  +L    PE +           + 
Sbjct: 62  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKM 121

Query: 447 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVDQTQGN 505
            ++ G IA G+ YL+ +   + +HRDL A N ++  +   KI DFGM R I+  D  +  
Sbjct: 122 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 178

Query: 506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
              ++    +M+PE    G F+  SDV+SFGV++ EI T
Sbjct: 179 GKGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 97.3 bits (242), Expect = 1e-22
 Identities = 62/200 (31%), Positives = 105/200 (52%), Gaps = 17/200 (8%)

Query: 353 LGEGGFGEVYKGVL--PSGQE--IAVKRL-SKASGQGAEEFKNEVVLVAKLQHRNLVRLL 407
           LG G FGE+ +G L  PS +E  +A+  L +  S +    F  E + + +  H N+VRL 
Sbjct: 13  LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72

Query: 408 GFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
           G    G   ++V E++ N +LD FL   E  GQL   +   ++ G+A G+ YL E   + 
Sbjct: 73  GVITRGNTMMIVTEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSE---MG 127

Query: 468 IIHRDLKASNILLDAEMNPKISDFGMA---RIFGVDQTQGNTSRIVGTYGYMAPEYAMHG 524
            +H+ L A  +L+++++  KIS F      +   +  T    S ++    + APE   + 
Sbjct: 128 YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVL----WAAPEAIQYH 183

Query: 525 QFSVKSDVYSFGVLVLEIIT 544
            FS  SDV+SFG+++ E+++
Sbjct: 184 HFSSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 97.1 bits (242), Expect = 2e-22
 Identities = 61/216 (28%), Positives = 108/216 (50%), Gaps = 14/216 (6%)

Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLS---KASGQGAEEFKNEVVLVAKLQ 399
              F  + K+G+G F  VYK + L  G+ +A+K++        +  ++   E+ L+ +L 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRR-YKIIGGIARGIL 458
           H N+++ L   +E  E  +V E      L   +   +KQ +L   R  +K    +   + 
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120

Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
           ++H     RI+HRD+K +N+ + A    K+ D G+ R F    T  ++  +VGT  YM+P
Sbjct: 121 HMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSP 175

Query: 519 EYAMHGQ-FSVKSDVYSFGVLVLEIITGKKNSNFYQ 553
           E  +H   ++ KSD++S G L+ E+   +  S FY 
Sbjct: 176 E-RIHENGYNFKSDIWSLGCLLYEMAALQ--SPFYG 208

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 97.1 bits (242), Expect = 2e-22
 Identities = 66/232 (28%), Positives = 99/232 (42%), Gaps = 22/232 (9%)

Query: 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGA--EEFKNEVVLVAKLQHRN 402
            K    ++LGEG  G V K  L +   I   +           ++   E+ +    +   
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 403 LVRLLG-FCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSR-RYKIIGGIARGIL- 458
           +V+  G F  E    I +  E+    SLD      +K+G     R   K++G IA  +L 
Sbjct: 61  IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRG----GRIGEKVLGKIAESVLK 116

Query: 459 ---YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGY 515
              YLH     +IIHRD+K SNILL  +   K+ DFG++                GT  Y
Sbjct: 117 GLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL----AGTFTGTSFY 169

Query: 516 MAPEYAMHGQFSVKSDVYSFGVLVLEIITGK--KNSNFYQTDGAADLLSYVS 565
           MAPE      +S+ SDV+S G+ +LE+   +           G  +LLSY+ 
Sbjct: 170 MAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV 221

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 97.0 bits (241), Expect = 2e-22
 Identities = 62/202 (30%), Positives = 110/202 (54%), Gaps = 11/202 (5%)

Query: 347 FSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGA-EEFKNEVVLVAKLQHRNLV 404
           F+   ++G+G FGEVYKG+    +E+ A+K +     +   E+ + E+ ++++     + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
           R  G  L+G +  ++ E++   S      D  K G L+ +    I+  I +G+ YLH + 
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGSA----LDLLKPGPLEETYIATILREILKGLDYLHSE- 120

Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG 524
             R IHRD+KA+N+LL  + + K++DFG+A      Q + NT   VGT  +MAPE     
Sbjct: 121 --RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQS 176

Query: 525 QFSVKSDVYSFGVLVLEIITGK 546
            +  K+D++S G+  +E+  G+
Sbjct: 177 AYDFKADIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 96.5 bits (240), Expect = 3e-22
 Identities = 71/208 (34%), Positives = 103/208 (49%), Gaps = 30/208 (14%)

Query: 353 LGEGGFGEV----YKGVLP----SGQEIAVKRLSKASGQGAEE-FKNEVVLVAKLQHRNL 403
           LGEG FG+V    Y    P    +G+ +AVK L +  GQ     +K E+ ++  L H N+
Sbjct: 12  LGEGHFGKVSLYCYD---PANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68

Query: 404 VRLLGFCLEGEEKI--LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH 461
           V+  G C E   K   L+ E+VP  SL  +L     + +L+ ++       I  G+ YLH
Sbjct: 69  VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL----PKHKLNLAQLLLFAQQICEGMAYLH 124

Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG-----YM 516
                  IHRDL A N+LLD +   KI DFG+A+       +G+    V   G     + 
Sbjct: 125 SQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV----PEGHEYYRVREDGDSPVFWY 177

Query: 517 APEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           A E     +FS  SDV+SFGV + E++T
Sbjct: 178 AVECLKENKFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 95.5 bits (237), Expect = 4e-22
 Identities = 64/195 (32%), Positives = 103/195 (52%), Gaps = 11/195 (5%)

Query: 353 LGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAE-EFKNEVVLVAKLQHRNLVRLLGFCL 411
           LG+G FGEV+KG L     +AVK   +   Q  + +F +E  ++ +  H N+V+L+G C 
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62

Query: 412 EGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHR 471
           + +   +V E VP    D+  +  +K+ +L   +  K     A G+ YL   +    IHR
Sbjct: 63  QRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117

Query: 472 DLKASNILLDAEMNPKISDFGMARIF--GVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVK 529
           DL A N L+      KISDFGM+R    G+  + G     +    + APE   +G++S +
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPI---KWTAPEALNYGRYSSE 174

Query: 530 SDVYSFGVLVLEIIT 544
           SDV+S+G+L+ E  +
Sbjct: 175 SDVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 96.0 bits (239), Expect = 4e-22
 Identities = 62/214 (28%), Positives = 101/214 (47%), Gaps = 13/214 (6%)

Query: 340 IEVATNKFSTDNKLGEGGFGEVYKGV--LPSGQEI--AVKRLSK-ASGQGAEEFKNEVVL 394
            E+     +    +GEG FG+VY+GV   P  ++I  AVK      S    E+F  E  +
Sbjct: 1   YEIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYI 60

Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIA 454
           + +  H ++V+L+G   E     +V E  P   L  +L     +  LD +        ++
Sbjct: 61  MRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLS 117

Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
             + YL      R +HRD+ A N+L+ +    K+ DFG++R    D++    S+      
Sbjct: 118 TALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE-DESYYKASKGKLPIK 173

Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKK 547
           +MAPE     +F+  SDV+ FGV + EI+  G K
Sbjct: 174 WMAPESINFRRFTSASDVWMFGVCMWEILMLGVK 207

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 95.1 bits (237), Expect = 6e-22
 Identities = 62/207 (29%), Positives = 93/207 (44%), Gaps = 17/207 (8%)

Query: 347 FSTDNKLGEGGFGEVYKGV--LPSGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHR 401
           F     +G+G FG+V   V    + +  A+K ++K             NE  ++ +L H 
Sbjct: 2   FELLRVIGKGAFGKVCI-VQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60

Query: 402 NLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
            LV L  +  + EE + LV + +    L Y L    ++ +    +    I  I   + YL
Sbjct: 61  FLVNLW-YSFQDEENMYLVVDLLLGGDLRYHL---SQKVKFSEEQVKFWICEIVLALEYL 116

Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEY 520
           H      IIHRD+K  NILLD + +  I+DF +A           T+   GT GYMAPE 
Sbjct: 117 HSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKV---TPDTLTTSTSGTPGYMAPEV 170

Query: 521 AMHGQFSVKSDVYSFGVLVLEIITGKK 547
                +SV  D +S GV   E + GK+
Sbjct: 171 LCRQGYSVAVDWWSLGVTAYECLRGKR 197

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 95.8 bits (238), Expect = 6e-22
 Identities = 63/227 (27%), Positives = 103/227 (45%), Gaps = 31/227 (13%)

Query: 346 KFSTDNKLGEGGFGEVYKGV------LPSGQEIAVKRLSKASGQGA-EEFKNEVVLVAKL 398
                  LGEG FG+V K              +AVK L + +      +  +E  L+ ++
Sbjct: 1   NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60

Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQG----QLDWSRRYKIIGG-- 452
            H ++++L G C +    +L+ E+    SL  FL +  K G      D +R    +    
Sbjct: 61  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120

Query: 453 ---------------IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497
                          I+RG+ YL E   ++++HRDL A N+L+      KISDFG++R  
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177

Query: 498 GVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
             + +    S+      +MA E      ++ +SDV+SFGVL+ EI+T
Sbjct: 178 YEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 95.8 bits (238), Expect = 6e-22
 Identities = 69/207 (33%), Positives = 110/207 (53%), Gaps = 26/207 (12%)

Query: 353 LGEGGFGEV----YKGVLP----SGQEIAVKRLSKASGQG-AEEFKNEVVLVAKLQHRNL 403
           LGEG FG+V    Y    P    +G+++AVK L   SG     + K E+ ++  L H N+
Sbjct: 12  LGEGHFGKVELCRYD---PEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 68

Query: 404 VRLLGFCLEGEEK--ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH 461
           V+  G C E       L+ EF+P+ SL  +L  P  + +++  ++ K    I +G+ YL 
Sbjct: 69  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKNKINLKQQLKYAVQICKGMDYL- 125

Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ----TQGNTSRIVGTYGYMA 517
             SR + +HRDL A N+L+++E   KI DFG+ +    D+     + +    V  Y   A
Sbjct: 126 -GSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY---A 180

Query: 518 PEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           PE  +  +F + SDV+SFGV + E++T
Sbjct: 181 PECLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 95.3 bits (237), Expect = 7e-22
 Identities = 64/200 (32%), Positives = 99/200 (49%), Gaps = 15/200 (7%)

Query: 353 LGEGGFGEVYK-GVLPSGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLG 408
           LG+GGFGEV    V  +G+  A K+L K      +G +   NE  ++ K+  R +V L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59

Query: 409 FCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
           +  E ++ + LV   +    L Y +Y+  + G    +R       I  G+ +LH   + R
Sbjct: 60  YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPG-FPEARAIFYAAQIICGLEHLH---QRR 115

Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR-IVGTYGYMAPEYAMHGQF 526
           I++RDLK  N+LLD   N +ISD G+A    V+   G   +   GT GYMAPE      +
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLA----VELKGGKKIKGRAGTPGYMAPEVLQGEVY 171

Query: 527 SVKSDVYSFGVLVLEIITGK 546
               D ++ G  + E+I G+
Sbjct: 172 DFSVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 95.5 bits (238), Expect = 7e-22
 Identities = 62/213 (29%), Positives = 93/213 (43%), Gaps = 27/213 (12%)

Query: 345 NKFSTDNKLGEGGFGEVYKG-VLPSGQEIAVKRLSKASGQGAEEFKN----EVVLVAKLQ 399
           NK+     +GEG +G V K     +G+ +A+K+  K S +  E+ K     EV ++ +L+
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKF-KES-EDDEDVKKTALREVKVLRQLR 58

Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
           H N+V L           LV+E+V    L+         G L        I  + + I Y
Sbjct: 59  HENIVNLKEAFRRKGRLYLVFEYVERTLLELL---EASPGGLPPDAVRSYIWQLLQAIAY 115

Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRI---VGTYGYM 516
            H      IIHRD+K  NIL+      K+ DFG AR           S +   V T  Y 
Sbjct: 116 CH---SHNIIHRDIKPENILVSESGVLKLCDFGFARAL----RARPASPLTDYVATRWYR 168

Query: 517 APE----YAMHGQFSVKSDVYSFGVLVLEIITG 545
           APE       +G   V  DV++ G ++ E++ G
Sbjct: 169 APELLVGDTNYG-KPV--DVWAIGCIMAELLDG 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 95.0 bits (237), Expect = 8e-22
 Identities = 57/204 (27%), Positives = 100/204 (49%), Gaps = 10/204 (4%)

Query: 351 NKLGEGGFGEVYKGV-LPSGQEIAVKRLS--KASGQGAEEFKNEVVLVAKLQHRNLVRLL 407
             +G+G FG V K      G+ +  K +     + +  ++  +EV ++ +L+H N+VR  
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65

Query: 408 G-FCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQ-LDWSRRYKIIGGIARGILYLH--E 462
                   + + +V E+     L   +   +K+ + ++    ++I+  +   +   H   
Sbjct: 66  DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRS 125

Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM 522
           D    ++HRDLK +NI LDA  N K+ DFG+A+I G D +   T   VGT  YM+PE   
Sbjct: 126 DPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT--YVGTPYYMSPEQLN 183

Query: 523 HGQFSVKSDVYSFGVLVLEIITGK 546
           H  +  KSD++S G L+ E+    
Sbjct: 184 HMSYDEKSDIWSLGCLIYELCALS 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 93.0 bits (231), Expect = 3e-21
 Identities = 64/199 (32%), Positives = 103/199 (51%), Gaps = 14/199 (7%)

Query: 352 KLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCL 411
           +LG G FG V  G      ++A+K + + S    +EF  E  ++ KL H  LV+L G C 
Sbjct: 11  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69

Query: 412 EGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHR 471
           +     +V E++ N  L  +L   E   +   S+  ++   +  G+ YL      + IHR
Sbjct: 70  KQRPIYIVTEYMSNGCLLNYLR--EHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHR 124

Query: 472 DLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT---YGYMAPEYAMHGQFSV 528
           DL A N L+D +   K+SDFG++R    D+   +    VG+     +  PE  ++ +FS 
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLLYSKFSS 180

Query: 529 KSDVYSFGVLVLEIIT-GK 546
           KSDV++FGVL+ E+ + GK
Sbjct: 181 KSDVWAFGVLMWEVYSLGK 199

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 93.1 bits (231), Expect = 3e-21
 Identities = 64/203 (31%), Positives = 109/203 (53%), Gaps = 14/203 (6%)

Query: 352 KLGEGGFGEVYKGV--LPSGQ-EIAVKRLSKASGQGA-EEFKNEVVLVAKLQHRNLVRLL 407
           +LG G FG V KGV  +   Q ++A+K L   + +   +E   E  ++ +L +  +VR++
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 408 GFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
           G C E E  +LV E      L+ FL    K+ ++  S   +++  ++ G+ YL   +   
Sbjct: 62  GVC-EAEALMLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVSMGMKYLEGKN--- 115

Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTY--GYMAPEYAMHGQ 525
            +HRDL A N+LL  +   KISDFG+++  G D +    +R  G +   + APE     +
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY-YKARSAGKWPLKWYAPECINFRK 174

Query: 526 FSVKSDVYSFGVLVLEIIT-GKK 547
           FS +SDV+S+G+ + E  + G+K
Sbjct: 175 FSSRSDVWSYGITMWEAFSYGQK 197

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 93.5 bits (233), Expect = 3e-21
 Identities = 59/202 (29%), Positives = 97/202 (48%), Gaps = 18/202 (8%)

Query: 352 KLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKN--EVVLVAKLQHRNLVRLLG 408
           K+GEG +G VYK     +G+ +A+K++               E+ L+ +L H N+++LL 
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65

Query: 409 FCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQ--LDWSRRYKIIGGIARGILYLHEDSRL 466
                 +  LV+EF     +D  LY   K  Q  L  S     +  + +G+ + H     
Sbjct: 66  VFRHKGDLYLVFEF-----MDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SH 117

Query: 467 RIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE--YAMHG 524
            I+HRDLK  N+L++ E   K++DFG+AR FG        +  V T  Y APE       
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFGLARSFGSP--VRPYTHYVVTRWYRAPELLLGD-K 174

Query: 525 QFSVKSDVYSFGVLVLEIITGK 546
            +S   D++S G +  E+++ +
Sbjct: 175 GYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 92.7 bits (230), Expect = 4e-21
 Identities = 67/199 (33%), Positives = 104/199 (52%), Gaps = 19/199 (9%)

Query: 352 KLGEGGFGEVYKGVL---PSGQEIAVKRLSKASGQGA--EEFKNEVVLVAKLQHRNLVRL 406
           +LG G FG V KG+     S + +AVK L   +   A  +E   E  ++ +L +  +VR+
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 407 LGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRL 466
           +G C E E  +LV E      L+ FL   +K   +      +++  ++ G+ YL E +  
Sbjct: 62  IGIC-EAESWMLVMELAELGPLNKFL---QKNKHVTEKNITELVHQVSMGMKYLEETN-- 115

Query: 467 RIIHRDLKASNILLDAEMNPKISDFGMARIFGVD----QTQGNTSRIVGTYGYMAPEYAM 522
             +HRDL A N+LL  +   KISDFG+++  G D    + + +    V  Y   APE   
Sbjct: 116 -FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWY---APECMN 171

Query: 523 HGQFSVKSDVYSFGVLVLE 541
           + +FS KSDV+SFGVL+ E
Sbjct: 172 YYKFSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 93.3 bits (231), Expect = 5e-21
 Identities = 56/202 (27%), Positives = 114/202 (56%), Gaps = 10/202 (4%)

Query: 346 KFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLV 404
           K++   K+G+G  G V+  + + +GQE+A+K+++       E   NE++++ +L++ N+V
Sbjct: 20  KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIV 79

Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
             L   L G+E  +V E++   SL     D   +  +D ++   +     + + +LH + 
Sbjct: 80  NFLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCRECLQALEFLHAN- 134

Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG 524
             ++IHRD+K+ N+LL  + + K++DFG       +Q++ +T  +VGT  +MAPE     
Sbjct: 135 --QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRK 190

Query: 525 QFSVKSDVYSFGVLVLEIITGK 546
            +  K D++S G++ +E++ G+
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 93.2 bits (232), Expect = 6e-21
 Identities = 66/227 (29%), Positives = 111/227 (48%), Gaps = 28/227 (12%)

Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRL-SKASGQGAEEFKNEVV 393
           E+  ++ +    LGEG FG+V K              +AVK L   A+ +   +  +E+ 
Sbjct: 8   ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEME 67

Query: 394 LVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGG 452
           ++  + +H+N++ LLG C +     +V E+  + +L  FL      G+       +    
Sbjct: 68  MMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEE 127

Query: 453 -------------IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFG 498
                        +ARG+ +L   S+ + IHRDL A N+L+  +   KI+DFG+AR I  
Sbjct: 128 TLTQKDLVSFAYQVARGMEFL--ASK-KCIHRDLAARNVLVTEDHVMKIADFGLARDIHH 184

Query: 499 VDQTQGNTS-RIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           +D  +  T+ R+     +MAPE      ++ +SDV+SFGVL+ EI T
Sbjct: 185 IDYYRKTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 93.0 bits (231), Expect = 6e-21
 Identities = 71/234 (30%), Positives = 115/234 (49%), Gaps = 37/234 (15%)

Query: 341 EVATNKFSTDNKLGEGGFGEVY----KGVL----------PSGQE---IAVKRLSKASGQ 383
           E    + +   KLGEG FGEV+    +G+            SG +   +AVK L + + +
Sbjct: 1   EFPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANK 60

Query: 384 GAE-EFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLD 442
            A  +F  E+ ++++L+  N++RLL  C+  +   ++ E++ N  L+ FL   E Q   +
Sbjct: 61  NARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAE 120

Query: 443 WSRRYKIIGG--------IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494
            +    I           IA G+ YL   S L  +HRDL   N L+      KI+DFGM+
Sbjct: 121 KADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMS 177

Query: 495 RIFGVDQTQGNTSRIVG----TYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           R    +   G+  RI G       +M+ E  + G+F+  SDV++FGV + EI+T
Sbjct: 178 R----NLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 92.5 bits (230), Expect = 6e-21
 Identities = 66/207 (31%), Positives = 105/207 (50%), Gaps = 27/207 (13%)

Query: 353 LGEGGFGEVYKGVL--PSGQEI--AVKRLSKASG-QGAEEFKNEVVLVAKLQHRNLVRLL 407
           +G+G FG VY G L    GQ+I  AVK L++ +  +  E+F  E +++    H N++ LL
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 408 GFCLEGE-EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIG---GIARGILYLHED 463
           G CL  E   ++V  ++ +  L  F+        +       +IG    +A+G+ YL   
Sbjct: 63  GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVK-----DLIGFGLQVAKGMEYLASK 117

Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMAR------IFGVDQTQGNTSRIVGTYGYMA 517
              + +HRDL A N +LD     K++DFG+AR       + V    G    +     +MA
Sbjct: 118 ---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPV----KWMA 170

Query: 518 PEYAMHGQFSVKSDVYSFGVLVLEIIT 544
            E     +F+ KSDV+SFGVL+ E++T
Sbjct: 171 LESLQTQKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 92.7 bits (230), Expect = 9e-21
 Identities = 72/229 (31%), Positives = 115/229 (50%), Gaps = 43/229 (18%)

Query: 352 KLGEGGFGEVYKGVLPSGQE-----------------IAVKRL-SKASGQGAEEFKNEVV 393
           KLGEG FGEV+   + + Q+                 +AVK L   A+     +F  EV 
Sbjct: 12  KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71

Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLY-----DPEKQGQ-------- 440
           ++++L+  N++RLLG C++ +   ++ E++ N  L+ FL      D E+ G         
Sbjct: 72  ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131

Query: 441 ---LDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-I 496
              + +S    +   IA G+ YL   S L  +HRDL   N L+   +  KI+DFGM+R +
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188

Query: 497 FGVD--QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEII 543
           +  D  + QG   R V    +MA E  + G+F+  SDV++FGV + EI+
Sbjct: 189 YAGDYYRIQG---RAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 92.1 bits (229), Expect = 1e-20
 Identities = 58/200 (29%), Positives = 101/200 (50%), Gaps = 16/200 (8%)

Query: 351 NKLGEGGFGEVYKG-VLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGF 409
            K+GEG  G V       +G+++AVK++     Q  E   NEVV++   QH N+V +   
Sbjct: 25  VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSS 84

Query: 410 CLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRII 469
            L G+E  +V EF+   +L     D     +++  +   +   + + + +LH      +I
Sbjct: 85  YLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLAVLKALSFLHAQ---GVI 137

Query: 470 HRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR---IVGTYGYMAPEYAMHGQF 526
           HRD+K+ +ILL ++   K+SDFG        Q      R   +VGT  +MAPE      +
Sbjct: 138 HRDIKSDSILLTSDGRVKLSDFGFC-----AQVSKEVPRRKSLVGTPYWMAPEVISRLPY 192

Query: 527 SVKSDVYSFGVLVLEIITGK 546
             + D++S G++V+E++ G+
Sbjct: 193 GTEVDIWSLGIMVIEMVDGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 95.7 bits (238), Expect = 2e-20
 Identities = 74/290 (25%), Positives = 132/290 (45%), Gaps = 33/290 (11%)

Query: 267 PPPGSVTTSRGKSGISSSTIIAIVAPIAVTAVLFILGFCFLRRKAKKKYNAVPESNADND 326
           PP   V  +       + T+ A +  +A+ A     GF F+R +   +   V     +N+
Sbjct: 617 PPCKRVRKTPSWWFYITCTLGAFLV-LALVA----FGFVFIRGRNNLELKRV-----ENE 666

Query: 327 LTTLESLQFDFE-----TIEVATNKFSTDNKLGEGGFGEVYKG-VLPSGQEIAVKRLSKA 380
             T E   FD +     TI    +    +N +  G  G  YKG  + +G +  VK ++  
Sbjct: 667 DGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDV 726

Query: 381 SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQ 440
           +   + E  +    + KLQH N+V+L+G C   +   L++E++  K+L   L +      
Sbjct: 727 NSIPSSEIAD----MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------ 776

Query: 441 LDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500
           L W RR KI  GIA+ + +LH      ++  +L    I++D +  P +    +  +   D
Sbjct: 777 LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD 835

Query: 501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSN 550
                +S       Y+APE       + KSD+Y FG++++E++TGK  ++
Sbjct: 836 TKCFISS------AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPAD 879

Length = 968

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 90.9 bits (225), Expect = 3e-20
 Identities = 59/209 (28%), Positives = 113/209 (54%), Gaps = 12/209 (5%)

Query: 347 FSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGA-EEFKNEVVLVAKLQHRNLV 404
           F+   ++G+G FGEV+KG+    Q++ A+K +     +   E+ + E+ ++++     + 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
           +  G  L+G +  ++ E++   S      D  + G  D  +   ++  I +G+ YLH + 
Sbjct: 66  KYYGSYLKGTKLWIIMEYLGGGSA----LDLLRAGPFDEFQIATMLKEILKGLDYLHSEK 121

Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG 524
           +   IHRD+KA+N+LL  + + K++DFG+A      Q + NT   VGT  +MAPE     
Sbjct: 122 K---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQQS 176

Query: 525 QFSVKSDVYSFGVLVLEIITGK-KNSNFY 552
            +  K+D++S G+  +E+  G+  NS+ +
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPPNSDMH 205

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 90.5 bits (224), Expect = 3e-20
 Identities = 72/223 (32%), Positives = 108/223 (48%), Gaps = 28/223 (12%)

Query: 353 LGEGGFGEVYKGVLPSGQEI---AVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLL 407
           LGEG FG V +G L     I   AVK +  A  +    E+F +E V + +  H N++RL+
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 408 GFCLEGEEK------ILVYEFVPNKSLDYFLYDPEKQGQ---LDWSRRYKIIGGIARGIL 458
           G CL+  E       +++  F+ +  L  FL           L      K +  IA G+ 
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA-RIFGVD-QTQGNTSRIVGTYGYM 516
           YL   S    IHRDL A N +L+  MN  ++DFG++ +I+  D   QG  +++     ++
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM--PVKWI 181

Query: 517 APEYAMHGQFSVKSDVYSFGVLVLEIIT-------GKKNSNFY 552
           A E      ++ KSDV+SFGV + EI T       G +NS  Y
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIY 224

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 90.6 bits (225), Expect = 3e-20
 Identities = 68/200 (34%), Positives = 112/200 (56%), Gaps = 13/200 (6%)

Query: 352 KLGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGAEEFK-NEVVLVAKLQHRNLVRLLGF 409
           KLGEG +  VYKG   +  EI A+K +   + +G       E+ L+ +L+H N+VRL   
Sbjct: 7   KLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHD- 65

Query: 410 CLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRI 468
            +  E K+ LV+E++ +K L  ++     +G LD +        + +GI + HE+   R+
Sbjct: 66  VIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RV 121

Query: 469 IHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT-SRIVGTYGYMAPEYAMHGQ-F 526
           +HRDLK  N+L++     K++DFG+AR FG+     NT S  V T  Y AP+  +  + +
Sbjct: 122 LHRDLKPQNLLINKRGELKLADFGLARAFGIPV---NTFSNEVVTLWYRAPDVLLGSRTY 178

Query: 527 SVKSDVYSFGVLVLEIITGK 546
           S   D++S G ++ E+ITG+
Sbjct: 179 STSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 90.6 bits (225), Expect = 3e-20
 Identities = 60/201 (29%), Positives = 104/201 (51%), Gaps = 23/201 (11%)

Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLL-GFC 410
           LG+G FG+VYK     +G   A K +   S +  E+F  E+ ++++ +H N+V L   + 
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 411 LEGEEKILVYEFVPNKSLDYFLYDPEK---QGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
            E +  IL+ EF    +LD  + + E+   + Q+ +  R      +   + +LH     +
Sbjct: 73  YENKLWILI-EFCDGGALDSIMLELERGLTEPQIRYVCRQ-----MLEALNFLHSH---K 123

Query: 468 IIHRDLKASNILLDAEMNPKISDFGM-ARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQF 526
           +IHRDLKA NILL  + + K++DFG+ A+     Q +      +GT  +MAPE      F
Sbjct: 124 VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR---DTFIGTPYWMAPEVVACETF 180

Query: 527 S-----VKSDVYSFGVLVLEI 542
                  K+D++S G+ ++E+
Sbjct: 181 KDNPYDYKADIWSLGITLIEL 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 90.9 bits (225), Expect = 3e-20
 Identities = 57/202 (28%), Positives = 112/202 (55%), Gaps = 10/202 (4%)

Query: 346 KFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLV 404
           K++   K+G+G  G VY  + + +GQE+A+K+++       E   NE++++ + ++ N+V
Sbjct: 20  KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIV 79

Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
             L   L G+E  +V E++   SL     D   +  +D  +   +     + + +LH + 
Sbjct: 80  NYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALDFLHSN- 134

Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG 524
             ++IHRD+K+ NILL  + + K++DFG       +Q++ +T  +VGT  +MAPE     
Sbjct: 135 --QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRK 190

Query: 525 QFSVKSDVYSFGVLVLEIITGK 546
            +  K D++S G++ +E++ G+
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 90.5 bits (224), Expect = 4e-20
 Identities = 61/203 (30%), Positives = 111/203 (54%), Gaps = 13/203 (6%)

Query: 347 FSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGA-EEFKNEVVLVAKLQHRNLV 404
           F+   K+G+G FGEV+KG+    Q++ A+K +     +   E+ + E+ ++++     + 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 405 RLLGFCLEGEEKILVYEFVPNKS-LDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
           +  G  L+  +  ++ E++   S LD  L +P   G LD ++   I+  I +G+ YLH +
Sbjct: 66  KYYGSYLKDTKLWIIMEYLGGGSALD--LLEP---GPLDETQIATILREILKGLDYLHSE 120

Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMH 523
            +   IHRD+KA+N+LL      K++DFG+A    +  TQ   +  VGT  +MAPE    
Sbjct: 121 KK---IHRDIKAANVLLSEHGEVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPEVIKQ 175

Query: 524 GQFSVKSDVYSFGVLVLEIITGK 546
             +  K+D++S G+  +E+  G+
Sbjct: 176 SAYDSKADIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 90.6 bits (224), Expect = 5e-20
 Identities = 57/202 (28%), Positives = 111/202 (54%), Gaps = 10/202 (4%)

Query: 346 KFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLV 404
           K++   K+G+G  G VY  + + +GQE+A+++++       E   NE++++ + ++ N+V
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80

Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
             L   L G+E  +V E++   SL     D   +  +D  +   +     + + +LH + 
Sbjct: 81  NYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN- 135

Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG 524
             ++IHRD+K+ NILL  + + K++DFG       +Q++   S +VGT  +MAPE     
Sbjct: 136 --QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRK 191

Query: 525 QFSVKSDVYSFGVLVLEIITGK 546
            +  K D++S G++ +E+I G+
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 89.9 bits (223), Expect = 7e-20
 Identities = 67/208 (32%), Positives = 111/208 (53%), Gaps = 19/208 (9%)

Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVK--RLSKASGQGAEEFKNEVVLVAKLQHRNL 403
           F    K+GEG +G VYK     +G+ +A+K  RL   +         E+ L+ +L H N+
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61

Query: 404 VRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQG---QLDWSRRYKIIGGIARGILY 459
           V+LL   +  E K+ LV+EF+ ++ L  F+      G    L  S  ++++ G+A    +
Sbjct: 62  VKLLD-VIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLA----F 115

Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE 519
            H     R++HRDLK  N+L++ E   K++DFG+AR FGV   +  T  +V T  Y APE
Sbjct: 116 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPE 170

Query: 520 YAMHGQF-SVKSDVYSFGVLVLEIITGK 546
             +  ++ S   D++S G +  E++T +
Sbjct: 171 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 89.2 bits (222), Expect = 7e-20
 Identities = 58/209 (27%), Positives = 91/209 (43%), Gaps = 35/209 (16%)

Query: 353 LGEGGFGEVYK-GVLPSGQEIAVKRLSKAS--GQGAEE-FKNEVVLVAKLQHRNLVRLLG 408
           LG GGFG V    V    +  A+K + K      G +E   +E  ++ +  H  +V+L  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-- 58

Query: 409 FCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQL-----------DWSRRYKIIGGIARGI 457
                        F   K + Y L +    G+L           +++ R+  I  +    
Sbjct: 59  ----------YRTFKDKKYI-YMLMEYCLGGELWTILRDRGLFDEYTARF-YIACVVLAF 106

Query: 458 LYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMA 517
            YLH      II+RDLK  N+LLD+    K+ DFG A+     Q    T    GT  Y+A
Sbjct: 107 EYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVA 160

Query: 518 PEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
           PE  ++  +    D +S G+L+ E++TG+
Sbjct: 161 PEIILNKGYDFSVDYWSLGILLYELLTGR 189

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 88.9 bits (221), Expect = 1e-19
 Identities = 65/223 (29%), Positives = 101/223 (45%), Gaps = 30/223 (13%)

Query: 343 ATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKL-QH 400
            T  F     +GEG +G+VYK     +GQ +A+K +        EE K E  ++ K   H
Sbjct: 4   PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIK-IMDIIEDEEEEIKEEYNILRKYSNH 62

Query: 401 RNLVRLLGFCL------EGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYK------ 448
            N+    G  +        ++  LV E     S+   +     +G     +R K      
Sbjct: 63  PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLV-----KGLRKKGKRLKEEWIAY 117

Query: 449 IIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR 508
           I+    RG+ YLHE+   ++IHRD+K  NILL      K+ DFG++    +D T G  + 
Sbjct: 118 ILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSA--QLDSTLGRRNT 172

Query: 509 IVGTYGYMAPE-----YAMHGQFSVKSDVYSFGVLVLEIITGK 546
            +GT  +MAPE           +  +SDV+S G+  +E+  GK
Sbjct: 173 FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 88.8 bits (221), Expect = 2e-19
 Identities = 71/220 (32%), Positives = 103/220 (46%), Gaps = 37/220 (16%)

Query: 336 DFETIEVATNKFSTDNKLGEGGFGEV----YKGVLPSGQEIAVKRLSKA----SGQGAEE 387
           DFE I+           LG G FG V    +K    SG+  A+K LSKA      Q  E 
Sbjct: 2   DFEFIKT----------LGTGSFGRVMLVRHK---GSGKYYALKILSKAKIVKLKQ-VEH 47

Query: 388 FKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQL--DWSR 445
             NE  ++  ++H  LV L G   +     LV E+VP   L   L    K G+     +R
Sbjct: 48  VLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHL---RKSGRFPEPVAR 104

Query: 446 RYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN 505
            Y     +   + YLH    L I++RDLK  N+LLD++   KI+DFG A+       +G 
Sbjct: 105 FY--AAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKR-----VKGR 154

Query: 506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
           T  + GT  Y+APE  +   +    D ++ G+L+ E++ G
Sbjct: 155 TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 89.9 bits (223), Expect = 2e-19
 Identities = 67/213 (31%), Positives = 105/213 (49%), Gaps = 39/213 (18%)

Query: 351 NKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKN----EVVLVAKLQHRNLVR 405
           N++G G  G VYK +  P+G+  A+K +    G   +  +     E+ ++  + H N+V+
Sbjct: 80  NRIGSGAGGTVYKVIHRPTGRLYALKVIY---GNHEDTVRRQICREIEILRDVNHPNVVK 136

Query: 406 LLGFCLEGEEKILVYEFVPNKSLD-------YFLYDPEKQGQLDWSRRYKIIGGIARGIL 458
                    E  ++ EF+   SL+        FL D  +Q          I+ GIA    
Sbjct: 137 CHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQ----------ILSGIA---- 182

Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
           YLH   R  I+HRD+K SN+L+++  N KI+DFG++RI  + QT    +  VGT  YM+P
Sbjct: 183 YLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRI--LAQTMDPCNSSVGTIAYMSP 237

Query: 519 EYA----MHGQFS-VKSDVYSFGVLVLEIITGK 546
           E       HG +     D++S GV +LE   G+
Sbjct: 238 ERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 88.1 bits (218), Expect = 2e-19
 Identities = 68/219 (31%), Positives = 112/219 (51%), Gaps = 19/219 (8%)

Query: 341 EVATNKFSTDNKLGEGGFGEVYKGV---LPSGQ---EIAVKRLSK-ASGQGAEEFKNEVV 393
           EV+  K +   +LG+G FG VY+G    +  G+    +AVK +++ AS +   EF NE  
Sbjct: 2   EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 61

Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLY----DPEK-QGQLDWSRRYK 448
           ++      ++VRLLG   +G+  ++V E + +  L  +L     + E   G+   + +  
Sbjct: 62  VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 121

Query: 449 I--IGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVDQTQGN 505
           I     IA G+ YL+     + +HRDL A N ++  +   KI DFGM R I+  D  +  
Sbjct: 122 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKG 178

Query: 506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
              ++     MAPE    G F+  SD++SFGV++ EI +
Sbjct: 179 GKGLLPVRW-MAPESLKDGVFTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 87.9 bits (218), Expect = 2e-19
 Identities = 65/207 (31%), Positives = 100/207 (48%), Gaps = 25/207 (12%)

Query: 355 EGGFGEVYKGVL---PSGQEIAVKRLSKASGQGAEE-----FKNEVVLVAKLQHRNLVRL 406
           EG FG ++ G+L     G+E  V    K     A E        E  L+  L H+N++ +
Sbjct: 16  EGTFGRIFYGILIDEKPGKEEEV--FVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPI 73

Query: 407 LGFCLEGEEKILVYEFVPNKS-LDYFLYDP---EKQGQLDWSRRYKIIGG--IARGILYL 460
           L  C+E  E   V     N   L  FL      E       S +  +     IA G+ YL
Sbjct: 74  LHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYL 133

Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVD-QTQG-NTSRIVGTYGYMA 517
           H   +  +IH+D+ A N ++D E+  KI+D  ++R +F +D    G N +R V    +MA
Sbjct: 134 H---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK---WMA 187

Query: 518 PEYAMHGQFSVKSDVYSFGVLVLEIIT 544
            E  ++ ++S  SDV+SFGVL+ E++T
Sbjct: 188 LESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 87.3 bits (216), Expect = 3e-19
 Identities = 64/201 (31%), Positives = 104/201 (51%), Gaps = 33/201 (16%)

Query: 353 LGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE 412
           +G+G FG+V  G    G ++AVK +   +   A+ F  E  ++ +L+H NLV+LLG  +E
Sbjct: 14  IGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 70

Query: 413 GEEKI-LVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGG---------IARGILYLH 461
            +  + +V E++   SL DY             SR   ++GG         +   + YL 
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLR-----------SRGRSVLGGDCLLKFSLDVCEAMEYLE 119

Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYA 521
            ++    +HRDL A N+L+  +   K+SDFG+ +      TQ +T ++     + APE  
Sbjct: 120 ANN---FVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQ-DTGKL--PVKWTAPEAL 171

Query: 522 MHGQFSVKSDVYSFGVLVLEI 542
              +FS KSDV+SFG+L+ EI
Sbjct: 172 REKKFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 88.2 bits (218), Expect = 3e-19
 Identities = 66/202 (32%), Positives = 107/202 (52%), Gaps = 23/202 (11%)

Query: 352 KLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLG-F 409
           +LG+G FG+VYK     +G   A K +   S +  E++  E+ ++A   H  +V+LLG F
Sbjct: 19  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78

Query: 410 CLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGIL----YLHEDSR 465
             +G+  I++ EF P  ++D  +       +LD       I  I R +L    YLH    
Sbjct: 79  YWDGKLWIMI-EFCPGGAVDAIML------ELDRGLTEPQIQVICRQMLEALQYLHS--- 128

Query: 466 LRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM--- 522
           ++IIHRDLKA N+LL  + + K++DFG++    V   Q   S  +GT  +MAPE  M   
Sbjct: 129 MKIIHRDLKAGNVLLTLDGDIKLADFGVSAK-NVKTLQRRDS-FIGTPYWMAPEVVMCET 186

Query: 523 --HGQFSVKSDVYSFGVLVLEI 542
                +  K+D++S G+ ++E+
Sbjct: 187 MKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 86.6 bits (214), Expect = 5e-19
 Identities = 63/194 (32%), Positives = 97/194 (50%), Gaps = 11/194 (5%)

Query: 352 KLGEGGFGEVYKGVLPSGQE-IAVKRLSKA-SGQGAEEFKNEVVLVAKLQHRNLVRLLGF 409
           ++G G FGEV+ G L +    +AVK   +        +F  E  ++ +  H N+VRL+G 
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61

Query: 410 CLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRII 469
           C + +   +V E V       FL    +  +L      +++   A G+ YL        I
Sbjct: 62  CTQKQPIYIVMELVQGGDFLTFLRT--EGPRLKVKELIQMVENAAAGMEYLESKH---CI 116

Query: 470 HRDLKASNILLDAEMNPKISDFGMAR--IFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFS 527
           HRDL A N L+  +   KISDFGM+R    GV  + G   +I     + APE   +G++S
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI--PVKWTAPEALNYGRYS 174

Query: 528 VKSDVYSFGVLVLE 541
            +SDV+SFG+L+ E
Sbjct: 175 SESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 87.0 bits (215), Expect = 7e-19
 Identities = 61/196 (31%), Positives = 102/196 (52%), Gaps = 10/196 (5%)

Query: 352 KLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFC 410
           K+GEG  G V       SG+++AVK +     Q  E   NEVV++   QH+N+V +    
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87

Query: 411 LEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIH 470
           L GEE  ++ EF+   +L     D   Q +L+  +   +   + + + YLH      +IH
Sbjct: 88  LVGEELWVLMEFLQGGALT----DIVSQTRLNEEQIATVCESVLQALCYLHSQG---VIH 140

Query: 471 RDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKS 530
           RD+K+ +ILL  +   K+SDFG       D  +  +  +VGT  +MAPE      +  + 
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRTPYGTEV 198

Query: 531 DVYSFGVLVLEIITGK 546
           D++S G++V+E++ G+
Sbjct: 199 DIWSLGIMVIEMVDGE 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 86.7 bits (215), Expect = 7e-19
 Identities = 68/211 (32%), Positives = 103/211 (48%), Gaps = 24/211 (11%)

Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFK-------NEVVLVA 396
            K+     +GEG +G V K     +GQ +A+K+  ++     E+ K        E+ ++ 
Sbjct: 1   EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLES-----EDDKMVKKIAMREIRMLK 55

Query: 397 KLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEK-QGQLDWSRRYKIIGGIAR 455
           +L+H NLV L+      +   LV+EFV +  LD    D EK    LD SR  K +  I R
Sbjct: 56  QLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLD----DLEKYPNGLDESRVRKYLFQILR 111

Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGY 515
           GI + H  +   IIHRD+K  NIL+      K+ DFG AR   +       +  V T  Y
Sbjct: 112 GIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFART--LAAPGEVYTDYVATRWY 166

Query: 516 MAPEYAM-HGQFSVKSDVYSFGVLVLEIITG 545
            APE  +   ++    D+++ G LV E++TG
Sbjct: 167 RAPELLVGDTKYGRAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 87.3 bits (216), Expect = 8e-19
 Identities = 70/217 (32%), Positives = 109/217 (50%), Gaps = 30/217 (13%)

Query: 353 LGEGGFGEVYK----GVLPSGQE----IAVKRLS-KASGQGAEEFKNEVVLVAKL-QHRN 402
           LGEG FG+V +    G+  S  +    +AVK L   A+ +   +  +E+ L+  + +H+N
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFL---------YDPE----KQGQLDWSRRYKI 449
           ++ LLG C +     ++ E+    +L  FL         Y  +     + QL +      
Sbjct: 80  IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139

Query: 450 IGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ--GNTS 507
              +ARG+ YL  +SR R IHRDL A N+L+  +   KI+DFG+AR  GV        TS
Sbjct: 140 AYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIADFGLAR--GVHDIDYYKKTS 194

Query: 508 RIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
                  +MAPE      ++ +SDV+SFG+L+ EI T
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 86.5 bits (214), Expect = 8e-19
 Identities = 61/202 (30%), Positives = 103/202 (50%), Gaps = 19/202 (9%)

Query: 353 LGEGGFGEV------YKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRL 406
           LG+GGFGEV        G + + +++  KRL K SG+     + E++   +  +   +  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEIL---EKVNSPFIVN 57

Query: 407 LGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSR 465
           L +  E +  + LV   +    L Y +Y+  ++G L+  R       I  GIL+LH    
Sbjct: 58  LAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERG-LEMERVIHYSAQITCGILHLHS--- 113

Query: 466 LRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT-SRIVGTYGYMAPEYAMHG 524
           + I++RD+K  N+LLD + N ++SD G+A    V+   G T ++  GT GYMAPE     
Sbjct: 114 MDIVYRDMKPENVLLDDQGNCRLSDLGLA----VELKDGKTITQRAGTNGYMAPEILKEE 169

Query: 525 QFSVKSDVYSFGVLVLEIITGK 546
            +S   D ++ G  + E++ G+
Sbjct: 170 PYSYPVDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 85.8 bits (213), Expect = 9e-19
 Identities = 56/199 (28%), Positives = 100/199 (50%), Gaps = 19/199 (9%)

Query: 351 NKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGF 409
            ++G G +G+VYK   + +G+ +A+K +    G   E  + E+ ++ + +H N+V   G 
Sbjct: 9   QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68

Query: 410 CLEGEEKILVYEFVPNKSLD---YFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRL 466
            L  ++  +V E+    SL         P  + Q+ +  R  +     +G+ YLHE    
Sbjct: 69  YLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETL-----KGLAYLHE---T 120

Query: 467 RIIHRDLKASNILLDAEMNPKISDFGM-ARIFGVDQTQGNTSRIVGTYGYMAPEYA---M 522
             IHRD+K +NILL  + + K++DFG+ A++     T       +GT  +MAPE A    
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFGVSAQL---TATIAKRKSFIGTPYWMAPEVAAVER 177

Query: 523 HGQFSVKSDVYSFGVLVLE 541
            G +  K D+++ G+  +E
Sbjct: 178 KGGYDGKCDIWALGITAIE 196

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 86.4 bits (214), Expect = 1e-18
 Identities = 70/214 (32%), Positives = 111/214 (51%), Gaps = 26/214 (12%)

Query: 345 NKFSTDNKLGEGGFGEVYKGVLPSGQE-IAVK--RLSKASGQGAEEFKNEVVLVAKLQHR 401
           +++    K+GEG +G VYK       E IA+K  RL +           E+ L+ ++QH 
Sbjct: 2   DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61

Query: 402 NLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQ--GQLDWSRRYKIIGG----IA 454
           N+VRL    +  E+++ LV+E+     LD    D +K      D+++  ++I      I 
Sbjct: 62  NIVRLQD-VVHSEKRLYLVFEY-----LDL---DLKKHMDSSPDFAKNPRLIKTYLYQIL 112

Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMARIFGVDQTQGNTSRIVGTY 513
           RGI Y H  S  R++HRDLK  N+L+D   N  K++DFG+AR FG+   +  T  +V T 
Sbjct: 113 RGIAYCH--SH-RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI-PVRTFTHEVV-TL 167

Query: 514 GYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
            Y APE  +    +S   D++S G +  E++  K
Sbjct: 168 WYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 86.3 bits (214), Expect = 1e-18
 Identities = 68/215 (31%), Positives = 99/215 (46%), Gaps = 40/215 (18%)

Query: 353 LGEGGFGEVYKGVL-PSGQEIAVKRL-SKASGQGAEEFKNEVVLVAKLQH-RNLVRLLG- 408
           +G G FG V K +  PSG  +AVKR+ S    +  +    ++ +V +      +V+  G 
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71

Query: 409 --------FCLEGEEKIL--VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIA---- 454
                    C+E  +  L   Y++V           PE+           I+G IA    
Sbjct: 72  LFREGDCWICMELMDISLDKFYKYVYEVLKSVI---PEE-----------ILGKIAVATV 117

Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
           + + YL E+  L+IIHRD+K SNILLD   N K+ DFG   I G        +R  G   
Sbjct: 118 KALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFG---ISGQLVDSIAKTRDAGCRP 172

Query: 515 YMAPEYAMHGQ---FSVKSDVYSFGVLVLEIITGK 546
           YMAPE         + V+SDV+S G+ + E+ TGK
Sbjct: 173 YMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK 207

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 86.2 bits (213), Expect = 1e-18
 Identities = 59/196 (30%), Positives = 100/196 (51%), Gaps = 10/196 (5%)

Query: 352 KLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFC 410
           K+GEG  G V       +G+++AVK++     Q  E   NEVV++    H N+V +    
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88

Query: 411 LEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIH 470
           L G+E  +V EF+   +L     D     +++  +   +   + R + YLH      +IH
Sbjct: 89  LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIH 141

Query: 471 RDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKS 530
           RD+K+ +ILL ++   K+SDFG      V +       +VGT  +MAPE      +  + 
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCA--QVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEV 199

Query: 531 DVYSFGVLVLEIITGK 546
           D++S G++V+E+I G+
Sbjct: 200 DIWSLGIMVIEMIDGE 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 85.5 bits (211), Expect = 2e-18
 Identities = 57/201 (28%), Positives = 102/201 (50%), Gaps = 10/201 (4%)

Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLS---KASGQGAEEFKNEVVLVAKLQHRN 402
           F  + K+G G F EVY+   L   + +A+K++        +  ++   E+ L+ +L H N
Sbjct: 4   FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63

Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRR-YKIIGGIARGILYLH 461
           +++ L   +E  E  +V E      L   +   +KQ +L   R  +K    +   + ++H
Sbjct: 64  VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123

Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYA 521
             SR R++HRD+K +N+ + A    K+ D G+ R F    T  ++  +VGT  YM+PE  
Sbjct: 124 --SR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPERI 178

Query: 522 MHGQFSVKSDVYSFGVLVLEI 542
               ++ KSD++S G L+ E+
Sbjct: 179 HENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 86.2 bits (214), Expect = 2e-18
 Identities = 64/218 (29%), Positives = 109/218 (50%), Gaps = 31/218 (14%)

Query: 352 KLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFK----NEVVLVAKLQHRNLVRL 406
           KLGEG FGEVYK   + +G+ +A+K++   + +  + F      E+ ++ KL+H N+V L
Sbjct: 15  KLGEGTFGEVYKARQIKTGRVVALKKILMHNEK--DGFPITALREIKILKKLKHPNVVPL 72

Query: 407 LGFCLE-----GEEKILVYEFVP--NKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
           +   +E       ++  VY   P  +  L   L +P  +  L  S+    +  +  GI Y
Sbjct: 73  IDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK--LTESQIKCYMLQLLEGINY 130

Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN----------TSRI 509
           LHE+    I+HRD+KA+NIL+D +   KI+DFG+AR +                  T+ +
Sbjct: 131 LHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLV 187

Query: 510 VGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
           V T  Y  PE  +   +++   D++  G +  E+ T +
Sbjct: 188 V-TRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 86.0 bits (213), Expect = 2e-18
 Identities = 76/256 (29%), Positives = 118/256 (46%), Gaps = 27/256 (10%)

Query: 318 VPESNADNDLTTLESLQFDF-ETIEVATNKFSTDNKLGEGGFGEVYK----GVLPSGQ-- 370
           V ES   N+   ++  Q  +    E   N  S    LG G FG+V +    G+  S    
Sbjct: 7   VIESINGNEYVYIDPTQLPYDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVM 66

Query: 371 EIAVKRL-SKASGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSL 428
           ++AVK L   A     E   +E+ +++ L  H N+V LLG C  G   +++ E+     L
Sbjct: 67  KVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDL 126

Query: 429 DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKI 488
             FL   +++  L           +A+G+ +L   +    IHRDL A N+LL      KI
Sbjct: 127 LNFLRR-KRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKI 182

Query: 489 SDFGMARIFGVDQ---TQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT- 544
            DFG+AR    D     +GN    V    +MAPE   +  ++ +SDV+S+G+L+ EI + 
Sbjct: 183 CDFGLARDIMNDSNYVVKGNARLPVK---WMAPESIFNCVYTFESDVWSYGILLWEIFSL 239

Query: 545 GKK-------NSNFYQ 553
           G         +S FY+
Sbjct: 240 GSNPYPGMPVDSKFYK 255

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 84.7 bits (209), Expect = 2e-18
 Identities = 65/204 (31%), Positives = 105/204 (51%), Gaps = 17/204 (8%)

Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRL-----SKASGQGAEEFKNEVVLVAKLQHRNLVRL 406
           LG+G FG VY    + +G+E+A K++     S  + +     + E+ L+  LQH  +V+ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69

Query: 407 LGFCLE--GEEKILVY-EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
            G CL    E+ + ++ E++P  S+   L   +  G L  S   K    I  G+ YLH +
Sbjct: 70  YG-CLRDRAEKTLTIFMEYMPGGSVKDQL---KAYGALTESVTRKYTRQILEGMSYLHSN 125

Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR-IVGTYGYMAPEYAM 522
               I+HRD+K +NIL D+  N K+ DFG ++        G   R + GT  +M+PE   
Sbjct: 126 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS 182

Query: 523 HGQFSVKSDVYSFGVLVLEIITGK 546
              +  K+DV+S G  V+E++T K
Sbjct: 183 GEGYGRKADVWSLGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 84.4 bits (209), Expect = 3e-18
 Identities = 61/209 (29%), Positives = 110/209 (52%), Gaps = 31/209 (14%)

Query: 353 LGEGGFGE--VYK----GVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRL 406
           LG+G FGE  +Y+      L   +E+ + RLS+   + A    NE+V+++ LQH N++  
Sbjct: 8   LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDA---LNEIVILSLLQHPNIIAY 64

Query: 407 LGFCLEGEEKILVYEFVPNKSLDYF----LYDP--EKQGQLDWSRRYKI--IGGIARGIL 458
               ++  +  L+ E      ++Y     LYD    ++GQL +     +  +  I   + 
Sbjct: 65  YNHFMD--DNTLLIE------MEYANGGTLYDKIVRQKGQL-FEEEMVLWYLFQIVSAVS 115

Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
           Y+H+     I+HRD+K  NI L      K+ DFG+++I G + +   T  +VGT  YM+P
Sbjct: 116 YIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMSP 170

Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITGKK 547
           E     +++ KSD+++ G ++ E++T K+
Sbjct: 171 ELCQGVKYNFKSDIWALGCVLYELLTLKR 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 85.3 bits (212), Expect = 3e-18
 Identities = 62/218 (28%), Positives = 104/218 (47%), Gaps = 35/218 (16%)

Query: 346 KFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKN-----EVVLVAKLQ 399
           ++    KLGEG +  VYK     +G+ +A+K++     + A++  N     E+ L+ +L+
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60

Query: 400 HRNLVRLLGFCLEGEEKILVYEFVP--------NKSLDYFLYDPEKQGQLDWSRRYK-II 450
           H N++ LL          LV+EF+         +KS+     D             K  +
Sbjct: 61  HPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPAD------------IKSYM 108

Query: 451 GGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIV 510
               RG+ YLH      I+HRDLK +N+L+ ++   K++DFG+AR FG    +  T ++V
Sbjct: 109 LMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK-MTHQVV 164

Query: 511 GTYGYMAPEYAMHG--QFSVKSDVYSFGVLVLEIITGK 546
            T  Y APE    G   + V  D++S G +  E++   
Sbjct: 165 -TRWYRAPELLF-GARHYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 84.3 bits (208), Expect = 3e-18
 Identities = 67/205 (32%), Positives = 108/205 (52%), Gaps = 19/205 (9%)

Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRL-----SKASGQGAEEFKNEVVLVAKLQHRNLVRL 406
           LG G FGEVY      +G+E+AVK++     S+ + +     + E+ L+  L+H  +V+ 
Sbjct: 10  LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69

Query: 407 LGFCLEGEEKIL--VYEFVPNKSLDYFLYDPEKQGQL--DWSRRYKIIGGIARGILYLHE 462
            G   + EEK L    E++P  S+   L   +  G L  + +RRY     I +G+ YLH 
Sbjct: 70  YGCLRDPEEKKLSIFVEYMPGGSIKDQL---KAYGALTENVTRRYT--RQILQGVSYLHS 124

Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMA-RIFGVDQTQGNTSRIVGTYGYMAPEYA 521
           +    I+HRD+K +NIL D+  N K+ DFG + RI  +  +      + GT  +M+PE  
Sbjct: 125 N---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVI 181

Query: 522 MHGQFSVKSDVYSFGVLVLEIITGK 546
               +  K+DV+S    V+E++T K
Sbjct: 182 SGEGYGRKADVWSVACTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 84.6 bits (210), Expect = 4e-18
 Identities = 68/203 (33%), Positives = 110/203 (54%), Gaps = 19/203 (9%)

Query: 351 NKLGEGGFGEVYKGV-LPSGQEIAVKRLS-KASGQGAEEFK-NEVVLVAKLQ---HRNLV 404
            ++GEG +G VYK   L +G+ +A+K++    S +G       E+ L+ +L+   H N+V
Sbjct: 5   AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64

Query: 405 RLLGFC----LEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
           RLL  C     + E K+ LV+E V ++ L  +L    K G L       ++  + RG+ +
Sbjct: 65  RLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPG-LPPETIKDLMRQLLRGVDF 122

Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE 519
           LH     RI+HRDLK  NIL+ ++   KI+DFG+ARI+  +     TS +V T  Y APE
Sbjct: 123 LHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMAL--TS-VVVTLWYRAPE 176

Query: 520 YAMHGQFSVKSDVYSFGVLVLEI 542
             +   ++   D++S G +  E+
Sbjct: 177 VLLQSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 84.1 bits (208), Expect = 5e-18
 Identities = 70/200 (35%), Positives = 102/200 (51%), Gaps = 15/200 (7%)

Query: 353 LGEGGFGEVYK-GVLPSGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLG 408
           LG+GGFGEV    V  +G+  A K+L K      +G     NE  ++ K+  R +V L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-A 66

Query: 409 FCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
           +  E ++ + LV   +    L + +Y+    G  D  R       I  G+  LH   R R
Sbjct: 67  YAYETKDALCLVLTLMNGGDLKFHIYNMGNPG-FDEERAVFYAAEITCGLEDLH---RER 122

Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR-IVGTYGYMAPEYAMHGQF 526
           I++RDLK  NILLD   + +ISD G+A    V+  +G T R  VGT GYMAPE   + ++
Sbjct: 123 IVYRDLKPENILLDDYGHIRISDLGLA----VEIPEGETIRGRVGTVGYMAPEVVKNERY 178

Query: 527 SVKSDVYSFGVLVLEIITGK 546
           +   D +  G L+ E+I GK
Sbjct: 179 TFSPDWWGLGCLIYEMIEGK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 84.3 bits (208), Expect = 6e-18
 Identities = 59/196 (30%), Positives = 99/196 (50%), Gaps = 10/196 (5%)

Query: 352 KLGEGGFGEV-YKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFC 410
           K+GEG  G V    V  SG+ +AVK++     Q  E   NEVV++   QH N+V +    
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86

Query: 411 LEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIH 470
           L G+E  +V EF+   +L     D     +++  +   +   + + +  LH      +IH
Sbjct: 87  LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLKALSVLHAQG---VIH 139

Query: 471 RDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKS 530
           RD+K+ +ILL  +   K+SDFG      V +       +VGT  +MAPE      +  + 
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCA--QVSKEVPRRKSLVGTPYWMAPELISRLPYGPEV 197

Query: 531 DVYSFGVLVLEIITGK 546
           D++S G++V+E++ G+
Sbjct: 198 DIWSLGIMVIEMVDGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 83.7 bits (207), Expect = 8e-18
 Identities = 46/132 (34%), Positives = 71/132 (53%), Gaps = 13/132 (9%)

Query: 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKAS 476
            +  EF+   SLD      +K G +      KI   +  G+ YL+     RI+HRD+K S
Sbjct: 79  CMCMEFMDCGSLDRIY---KKGGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPS 133

Query: 477 NILLDAEMNPKISDFGMA--RIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYS 534
           NIL+++    K+ DFG++   I  +  T       VGT  YM+PE    G+++VKSDV+S
Sbjct: 134 NILVNSRGQIKLCDFGVSGELINSIADT------FVGTSTYMSPERIQGGKYTVKSDVWS 187

Query: 535 FGVLVLEIITGK 546
            G+ ++E+  GK
Sbjct: 188 LGISIIELALGK 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 83.1 bits (206), Expect = 8e-18
 Identities = 64/206 (31%), Positives = 102/206 (49%), Gaps = 28/206 (13%)

Query: 356 GGFGEVY---KGVLPSGQEIAVKRLSKASGQGA---EEFKNEVVLVAKLQHRNLVRLLGF 409
           G +G V+   K    +G   A+K + KA        ++   E  ++++ Q   +V+L  +
Sbjct: 4   GAYGRVFLAKKKS--TGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY-Y 60

Query: 410 CLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLD--WSRRYKIIGGIARGILYLHEDSRL 466
             +G++ + LV E++P   L   L   E  G LD   +R Y  I  I   + YLH     
Sbjct: 61  SFQGKKNLYLVMEYLPGGDLASLL---ENVGSLDEDVARIY--IAEIVLALEYLH---SN 112

Query: 467 RIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN-------TSRIVGTYGYMAPE 519
            IIHRDLK  NIL+D+  + K++DFG+++  G+ + Q N         RIVGT  Y+APE
Sbjct: 113 GIIHRDLKPDNILIDSNGHLKLTDFGLSK-VGLVRRQINLNDDEKEDKRIVGTPDYIAPE 171

Query: 520 YAMHGQFSVKSDVYSFGVLVLEIITG 545
             +    S   D +S G ++ E + G
Sbjct: 172 VILGQGHSKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 83.1 bits (205), Expect = 1e-17
 Identities = 69/207 (33%), Positives = 105/207 (50%), Gaps = 17/207 (8%)

Query: 353 LGEGGFGEVYK-GVLPSGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLG 408
           LG+GGFGEV    V  +G+  A K+L K      +G     NE  ++ K+  R +V L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL-A 66

Query: 409 FCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
           +  E ++ + LV   +    L + +Y   + G  +  R       I  G+  LH++   R
Sbjct: 67  YAYETKDALCLVLTLMNGGDLKFHIYHMGEAG-FEEGRAVFYAAEICCGLEDLHQE---R 122

Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT-QGNTSRIVGTYGYMAPEYAMHGQF 526
           I++RDLK  NILLD   + +ISD G+A      QT +G     VGT GYMAPE   + ++
Sbjct: 123 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR----VGTVGYMAPEVVKNERY 178

Query: 527 SVKSDVYSFGVLVLEIITGKKNSNFYQ 553
           +   D ++ G L+ E+I G+  S F Q
Sbjct: 179 TFSPDWWALGCLLYEMIAGQ--SPFQQ 203

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 82.8 bits (204), Expect = 1e-17
 Identities = 61/203 (30%), Positives = 100/203 (49%), Gaps = 15/203 (7%)

Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRL-----SKASGQGAEEFKNEVVLVAKLQHRNLVRL 406
           LG+G FG VY      +G+E+AVK++     S  + +     + E+ L+  L H  +V+ 
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69

Query: 407 LGFCLEGEEKIL--VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
            G   +  E+ L    E +P  S+   L   +  G L  +   K    I  G+ YLH + 
Sbjct: 70  YGCLRDPMERTLSIFMEHMPGGSIKDQL---KSYGALTENVTRKYTRQILEGVSYLHSN- 125

Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR-IVGTYGYMAPEYAMH 523
              I+HRD+K +NIL D+  N K+ DFG ++        G   + + GT  +M+PE    
Sbjct: 126 --MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG 183

Query: 524 GQFSVKSDVYSFGVLVLEIITGK 546
             +  K+D++S G  V+E++T K
Sbjct: 184 EGYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 82.6 bits (204), Expect = 2e-17
 Identities = 62/219 (28%), Positives = 107/219 (48%), Gaps = 25/219 (11%)

Query: 353 LGEGGFGEVYK-------GVLPSGQEIAVKRLS-----KASGQGAEEFKNEVVLVAK-LQ 399
           LG G FG VYK         L + +EI V   +     +   +   +  +EV ++ + L+
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIARGIL 458
           H N+VR     LE +   +V + +    L ++F    EK+ +    R + I   +   + 
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127

Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT--SRIVGTYGYM 516
           YLH++ R  I+HRDL  +NI+L  +    I+DFG+A+     Q Q  +  + +VGT  Y 
Sbjct: 128 YLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK-----QKQPESKLTSVVGTILYS 180

Query: 517 APEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTD 555
            PE   +  +  K+DV++FG ++ ++ T      FY T+
Sbjct: 181 CPEIVKNEPYGEKADVWAFGCILYQMCT--LQPPFYSTN 217

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 83.1 bits (205), Expect = 2e-17
 Identities = 67/215 (31%), Positives = 102/215 (47%), Gaps = 34/215 (15%)

Query: 353 LGEGGFGEVYKGVLPSG---QEIAVKRLSK-ASGQGAEEFKNEVVLVAKL-QHRNLVRLL 407
           +GEG FG+V K  +       + A+KR+ + AS     +F  E+ ++ KL  H N++ LL
Sbjct: 15  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74

Query: 408 GFCLEGEEKILVYEFVPNKSLDYFL-------YDP------EKQGQLDWSRRYKIIGGIA 454
           G C       L  E+ P+ +L  FL        DP           L   +       +A
Sbjct: 75  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134

Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
           RG+ YL   S+ + IHRDL A NIL+      KI+DFG++R        G    +  T G
Sbjct: 135 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--------GQEVYVKKTMG 183

Query: 515 -----YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
                +MA E   +  ++  SDV+S+GVL+ EI++
Sbjct: 184 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 82.7 bits (204), Expect = 2e-17
 Identities = 71/232 (30%), Positives = 110/232 (47%), Gaps = 31/232 (13%)

Query: 347 FSTDNKLGEGGFGEVYKGVLP----SGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQ 399
           F+    LG+G FG V +  L     S Q++AVK L KA   S    EEF  E   + +  
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKML-KADIFSSSDIEEFLREAACMKEFD 59

Query: 400 HRNLVRLLGFCLEGEEK------ILVYEFVPNKSLDYFLYDP---EKQGQLDWSRRYKII 450
           H N+++L+G  L    K      +++  F+ +  L  FL      E+   L      + +
Sbjct: 60  HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119

Query: 451 GGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVD-QTQGNTSR 508
             IA G+ YL   S    IHRDL A N +L+  M   ++DFG+++ I+  D   QG  S+
Sbjct: 120 IDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASK 176

Query: 509 IVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-------GKKNSNFYQ 553
           +     ++A E      ++  SDV++FGV + EI+T       G +NS  Y 
Sbjct: 177 L--PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYN 226

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 82.7 bits (204), Expect = 2e-17
 Identities = 67/200 (33%), Positives = 100/200 (50%), Gaps = 15/200 (7%)

Query: 353 LGEGGFGEVYK-GVLPSGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLG 408
           LG+GGFGEV    V  +G+  A K+L K      +G     NE  ++ K+  R +V L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL-A 66

Query: 409 FCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
           +  E ++ + LV   +    L + +Y+    G  D  R       +  G+  L    R R
Sbjct: 67  YAYETKDALCLVLTIMNGGDLKFHIYNMGNPG-FDEQRAIFYAAELCCGLEDLQ---RER 122

Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR-IVGTYGYMAPEYAMHGQF 526
           I++RDLK  NILLD   + +ISD G+A    V   +G T R  VGT GYMAPE   + ++
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLA----VQIPEGETVRGRVGTVGYMAPEVINNEKY 178

Query: 527 SVKSDVYSFGVLVLEIITGK 546
           +   D +  G L+ E+I G+
Sbjct: 179 TFSPDWWGLGCLIYEMIQGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 82.8 bits (204), Expect = 2e-17
 Identities = 61/203 (30%), Positives = 101/203 (49%), Gaps = 19/203 (9%)

Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKN---EVVLVAKLQHRN 402
           FS   ++G G FG VY    + + + +A+K++S +  Q  E++++   EV  + KL+H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
            ++  G  L      LV E+    + D      +   +++ +    +  G  +G+ YLH 
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA---AVTHGALQGLAYLHS 133

Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM 522
            +   +IHRD+KA NILL      K+ DFG A I          +  VGT  +MAPE  +
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVIL 184

Query: 523 ---HGQFSVKSDVYSFGVLVLEI 542
               GQ+  K DV+S G+  +E+
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 81.8 bits (202), Expect = 3e-17
 Identities = 67/203 (33%), Positives = 97/203 (47%), Gaps = 18/203 (8%)

Query: 353 LGEGGFGEVY------KGVLPSGQEIAVKRLSKASG-QGAEEFKNEVVLVAKLQHRNLVR 405
           LG+GGFGEV        G L + +++  KRL K  G +GA   K    ++AK+  R +V 
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKR---ILAKVHSRFIVS 57

Query: 406 LLGFCLEGEEKILVYEFVPNKSLDYFLY--DPEKQGQLDWSRRYKIIGGIARGILYLHED 463
           L        +  LV   +    L Y +Y  D E  G     R       I  G+ +LH+ 
Sbjct: 58  LAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPG-FPEPRACFYTAQIISGLEHLHQR 116

Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMH 523
              RII+RDLK  N+LLD + N +ISD G+A    +   Q  T    GT G+MAPE    
Sbjct: 117 ---RIIYRDLKPENVLLDNDGNVRISDLGLA--VELKDGQSKTKGYAGTPGFMAPELLQG 171

Query: 524 GQFSVKSDVYSFGVLVLEIITGK 546
            ++    D ++ GV + E+I  +
Sbjct: 172 EEYDFSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 81.2 bits (200), Expect = 4e-17
 Identities = 56/201 (27%), Positives = 100/201 (49%), Gaps = 10/201 (4%)

Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLS---KASGQGAEEFKNEVVLVAKLQHRN 402
           F  + K+G G F EVY+   L  G  +A+K++        +   +   E+ L+ +L H N
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63

Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRR-YKIIGGIARGILYLH 461
           +++     +E  E  +V E      L   +   +KQ +L   +  +K    +   + ++H
Sbjct: 64  VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123

Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYA 521
             SR R++HRD+K +N+ + A    K+ D G+ R F    T  ++  +VGT  YM+PE  
Sbjct: 124 --SR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPERI 178

Query: 522 MHGQFSVKSDVYSFGVLVLEI 542
               ++ KSD++S G L+ E+
Sbjct: 179 HENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 81.8 bits (202), Expect = 5e-17
 Identities = 64/203 (31%), Positives = 101/203 (49%), Gaps = 19/203 (9%)

Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKN---EVVLVAKLQHRN 402
           F+   ++G G FG VY    + + + +A+K++S +  Q  E++++   EV  + +L+H N
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76

Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
            +   G  L      LV E+    + D  + +  K+  L       I  G  +G+ YLH 
Sbjct: 77  TIEYKGCYLREHTAWLVMEYCLGSASD--ILEVHKKP-LQEVEIAAICHGALQGLAYLHS 133

Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE--Y 520
             R   IHRD+KA NILL      K++DFG A +     +       VGT  +MAPE   
Sbjct: 134 HER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANS------FVGTPYWMAPEVIL 184

Query: 521 AM-HGQFSVKSDVYSFGVLVLEI 542
           AM  GQ+  K DV+S G+  +E+
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 81.6 bits (202), Expect = 6e-17
 Identities = 67/244 (27%), Positives = 112/244 (45%), Gaps = 46/244 (18%)

Query: 346 KFSTDNKLGEGGFGEVYKGVL---PSGQEIAVKRL--SKASGQG-AEEFKNEVVLVAKLQ 399
           K+  +  +G G +G VYK        G+E A+K+    K    G ++    E+ L+ +L+
Sbjct: 1   KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60

Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQ-LDWSRRYK---------- 448
           H N+V L+   LE  +K +   F      DY  +D     Q + + R+ K          
Sbjct: 61  HENVVSLVEVFLEHADKSVYLLF------DYAEHD---LWQIIKFHRQAKRVSIPPSMVK 111

Query: 449 -IIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP----KISDFGMARIFGVD-QT 502
            ++  I  G+ YLH +    ++HRDLK +NIL+  E       KI D G+AR+F    + 
Sbjct: 112 SLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKP 168

Query: 503 QGNTSRIVGTYGYMAPEYAMHGQFSVKS-DVYSFGVLVLEIITGK----------KNSNF 551
             +   +V T  Y APE  +  +   K+ D+++ G +  E++T +          K SN 
Sbjct: 169 LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNP 228

Query: 552 YQTD 555
           +Q D
Sbjct: 229 FQRD 232

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 80.8 bits (199), Expect = 6e-17
 Identities = 64/203 (31%), Positives = 104/203 (51%), Gaps = 25/203 (12%)

Query: 352 KLGEGGFGEVYK------GVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVR 405
           +LG+G FG+VYK      GVL + + I  K     S +  E++  E+ ++A   H N+V+
Sbjct: 12  ELGDGAFGKVYKAQNKETGVLAAAKVIDTK-----SEEELEDYMVEIDILASCDHPNIVK 66

Query: 406 LL-GFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
           LL  F  E    IL+ EF    ++D  + + E+   L   +   +       + YLHE+ 
Sbjct: 67  LLDAFYYENNLWILI-EFCAGGAVDAVMLELERP--LTEPQIRVVCKQTLEALNYLHEN- 122

Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM-- 522
             +IIHRDLKA NIL   + + K++DFG++      +T       +GT  +MAPE  M  
Sbjct: 123 --KIIHRDLKAGNILFTLDGDIKLADFGVSA--KNTRTIQRRDSFIGTPYWMAPEVVMCE 178

Query: 523 ---HGQFSVKSDVYSFGVLVLEI 542
                 +  K+DV+S G+ ++E+
Sbjct: 179 TSKDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 81.6 bits (201), Expect = 6e-17
 Identities = 61/199 (30%), Positives = 100/199 (50%), Gaps = 19/199 (9%)

Query: 351 NKLGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGAEEFKN---EVVLVAKLQHRNLVRL 406
           +++G G FG VY        E+ AVK++S +  Q  E++++   EV  + +L+H N +  
Sbjct: 27  HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86

Query: 407 LGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRL 466
            G  L+     LV E+    + D      +   +++ +    I  G  +G+ YLH  +  
Sbjct: 87  KGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA---AITHGALQGLAYLHSHN-- 141

Query: 467 RIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM---H 523
            +IHRD+KA NILL      K++DFG A       +  N+   VGT  +MAPE  +    
Sbjct: 142 -MIHRDIKAGNILLTEPGQVKLADFGSASK----SSPANS--FVGTPYWMAPEVILAMDE 194

Query: 524 GQFSVKSDVYSFGVLVLEI 542
           GQ+  K DV+S G+  +E+
Sbjct: 195 GQYDGKVDVWSLGITCIEL 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 81.8 bits (203), Expect = 7e-17
 Identities = 63/229 (27%), Positives = 101/229 (44%), Gaps = 67/229 (29%)

Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKN---------EVVLVAKLQHRN 402
           +G G +G V   V   +G+++A+K++S         F +         E+ L+  L+H N
Sbjct: 8   IGSGAYGVVCSAVDKRTGRKVAIKKISNV-------FDDLIDAKRILREIKLLRHLRHEN 60

Query: 403 LVRLL---------GFCLEGEEKILVYEFVP---------NKSLD-----YFLYDPEKQG 439
           ++ LL          F     +  +V E +           + L      YFLY      
Sbjct: 61  IIGLLDILRPPSPEDF----NDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLY------ 110

Query: 440 QLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499
           Q            I RG+ YLH  +   +IHRDLK SNIL+++  + KI DFG+AR    
Sbjct: 111 Q------------ILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155

Query: 500 DQ-TQGNTSRIVGTYGYMAPEYAMHGQ-FSVKSDVYSFGVLVLEIITGK 546
           D+  +G  +  V T  Y APE  +    ++   D++S G +  E++T K
Sbjct: 156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 81.3 bits (200), Expect = 8e-17
 Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 19/203 (9%)

Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKN---EVVLVAKLQHRN 402
           F+   ++G G FG VY    + + + +A+K++S +  Q  E++++   EV  + +++H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
            +   G  L      LV E+    + D      +   +++ +    I  G  +G+ YLH 
Sbjct: 87  SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA---AITHGALQGLAYLHS 143

Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM 522
            +   +IHRD+KA NILL      K++DFG A I          +  VGT  +MAPE  +
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSASI------ASPANSFVGTPYWMAPEVIL 194

Query: 523 ---HGQFSVKSDVYSFGVLVLEI 542
               GQ+  K DV+S G+  +E+
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIEL 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 81.4 bits (201), Expect = 9e-17
 Identities = 67/228 (29%), Positives = 103/228 (45%), Gaps = 48/228 (21%)

Query: 337 FETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSK--ASGQGAEEFKNEVV 393
           FE     TN++     +G G FG V       +GQ +A+K++ K  ++   A+    E+ 
Sbjct: 6   FEI----TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK 61

Query: 394 LVAKLQHRNLVRLLGFCLEGEEKI-LVYEF-------------VPNKSLDYFLYDPEKQG 439
           L+  L+H N++ L    +   E I  V E              +  + + YFLY      
Sbjct: 62  LLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQ----- 116

Query: 440 QLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499
                        I RG+ Y+H      ++HRDLK SNIL++   + KI DFG+ARI   
Sbjct: 117 -------------ILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI--- 157

Query: 500 DQTQGNTSRIVGTYGYMAPEYAMHGQ-FSVKSDVYSFGVLVLEIITGK 546
            Q    T   V T  Y APE  +  Q + V+ D++S G +  E++ GK
Sbjct: 158 -QDPQMTG-YVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 80.1 bits (197), Expect = 1e-16
 Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 18/205 (8%)

Query: 353 LGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCL 411
           +G G +G+VYKG      ++A  ++   +G   EE K E+ ++ K   HRN+    G  +
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73

Query: 412 E------GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSR 465
           +       ++  LV EF    S+   + +  K   L       I   I RG+ +LH+   
Sbjct: 74  KKNPPGMDDQLWLVMEFCGAGSVTDLIKN-TKGNTLKEEWIAYICREILRGLSHLHQH-- 130

Query: 466 LRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM--- 522
            ++IHRD+K  N+LL      K+ DFG++    +D+T G  +  +GT  +MAPE      
Sbjct: 131 -KVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMAPEVIACDE 187

Query: 523 --HGQFSVKSDVYSFGVLVLEIITG 545
                +  KSD++S G+  +E+  G
Sbjct: 188 NPDATYDFKSDLWSLGITAIEMAEG 212

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 80.3 bits (199), Expect = 1e-16
 Identities = 63/205 (30%), Positives = 97/205 (47%), Gaps = 24/205 (11%)

Query: 352 KLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKN--EVVLVAKLQ-HRNLVRLL 407
           +LG+G FG VY      +G+ +A+K++ K      EE  N  EV  + KL  H N+V+L 
Sbjct: 6   QLGDGTFGSVYLARNKETGELVAIKKM-KKKFYSWEECMNLREVKSLRKLNEHPNIVKLK 64

Query: 408 GFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
               E +E   V+E++   +L Y L    K      S    II  I +G+ ++H   +  
Sbjct: 65  EVFRENDELYFVFEYM-EGNL-YQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHG 119

Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR-----IVGTYGYMAPEYAM 522
             HRDLK  N+L+      KI+DFG+AR   +       SR      V T  Y APE  +
Sbjct: 120 FFHRDLKPENLLVSGPEVVKIADFGLAR--EIR------SRPPYTDYVSTRWYRAPEILL 171

Query: 523 HGQF-SVKSDVYSFGVLVLEIITGK 546
                S   D+++ G ++ E+ T +
Sbjct: 172 RSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 80.4 bits (198), Expect = 1e-16
 Identities = 69/229 (30%), Positives = 115/229 (50%), Gaps = 30/229 (13%)

Query: 341 EVATNKFSTDNKLGEGGFGEVY--------KGVLPSGQEIAVKRL-SKASGQGAEEFKNE 391
           EV  ++      LGEG FG+V         K       ++AVK L S A+ +   +  +E
Sbjct: 14  EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISE 73

Query: 392 VVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL-----------YDPEK-- 437
           + ++  + +H+N++ LLG C +     ++ E+    +L  +L           Y+P +  
Sbjct: 74  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVP 133

Query: 438 QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-I 496
           + QL +         +ARG+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR I
Sbjct: 134 EEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 190

Query: 497 FGVDQTQGNTS-RIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
             +D  +  T+ R+     +MAPE      ++ +SDV+SFGVL+ EI T
Sbjct: 191 HHIDYYKKTTNGRL--PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 79.6 bits (196), Expect = 1e-16
 Identities = 63/218 (28%), Positives = 109/218 (50%), Gaps = 19/218 (8%)

Query: 346 KFSTDNKLGEGGFGEVYKGVLPSGQEIAVKR---LSKASGQGAEEFKNEVVLVAKLQHRN 402
           ++    K+GEG FG++Y     S  E  V +   L+K   +  E  K EV+L+AK++H N
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60

Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIG---GIARGILY 459
           +V       E     +V E+     L   +    +Q  + +S   +I+     I+ G+ +
Sbjct: 61  IVTFFASFQENGRLFIVMEYCDGGDL---MKRINRQRGVLFSED-QILSWFVQISLGLKH 116

Query: 460 LHEDSRLRIIHRDLKASNILLDAE-MNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
           +H+    +I+HRD+K+ NI L    M  K+ DFG+AR          T   VGT  Y++P
Sbjct: 117 IHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTC--VGTPYYLSP 171

Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITGK---KNSNFYQ 553
           E   +  ++ K+D++S G ++ E+ T K   + +N +Q
Sbjct: 172 EICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 79.5 bits (196), Expect = 2e-16
 Identities = 56/208 (26%), Positives = 99/208 (47%), Gaps = 29/208 (13%)

Query: 353 LGEGGFGEVYKGVLPSGQ------EIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRL 406
           +G G FG V+     + Q      +I V++++K     A+   NE  ++  L H N++  
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQ---NECQVLKLLSHPNIIEY 64

Query: 407 LGFCLEGEEKILVYEFVPNKSLDYFLYD------PEKQGQLDWSRRYKIIGGIARGILYL 460
               LE +  ++V E+ P  +L  ++         E            I+    + +L L
Sbjct: 65  YENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDT----------ILHFFVQILLAL 114

Query: 461 HEDSRLRIIHRDLKASNILLDA-EMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE 519
           H      I+HRDLK  NILLD  +M  KI DFG+++I     ++     +VGT  Y++PE
Sbjct: 115 HHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILS---SKSKAYTVVGTPCYISPE 171

Query: 520 YAMHGQFSVKSDVYSFGVLVLEIITGKK 547
                 ++ KSD+++ G ++ E+ + K+
Sbjct: 172 LCEGKPYNQKSDIWALGCVLYELASLKR 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 79.8 bits (197), Expect = 2e-16
 Identities = 71/240 (29%), Positives = 106/240 (44%), Gaps = 66/240 (27%)

Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVL 394
           D E IE          +LG G +G V K   +P+G  +AVKR+ +A+    E        
Sbjct: 2   DLEVIE----------ELGRGAYGVVDKMRHVPTGTIMAVKRI-RATVNSQE-------- 42

Query: 395 VAKLQHR---------------NLVRLLGFCLEGEEKILVYEFVPNKSLDYF---LYDPE 436
               Q R                 V   G  L  E  + +   V + SLD F   +YD  
Sbjct: 43  ----QKRLLMDLDISMRSVDCPYTVTFYG-ALFREGDVWICMEVMDTSLDKFYKKVYDKG 97

Query: 437 KQGQLDWSRRYKIIGGIARGIL----YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 492
                D      I+G IA  I+    YLH   +L +IHRD+K SN+L++     K+ DFG
Sbjct: 98  LTIPED------ILGKIAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFG 149

Query: 493 MA--RIFGVDQTQGNTSRIVGTYGYMAPEY---AMHGQ-FSVKSDVYSFGVLVLEIITGK 546
           ++   +  V +T        G   YMAPE     ++ + + VKSDV+S G+ ++E+ TG+
Sbjct: 150 ISGYLVDSVAKTID-----AGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGR 204

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 80.4 bits (199), Expect = 2e-16
 Identities = 66/230 (28%), Positives = 106/230 (46%), Gaps = 43/230 (18%)

Query: 337 FETIEVATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKN---EV 392
            +T+    +++   + +G G +G+V       +G+++A+K+LS+   Q A   K    E+
Sbjct: 7   NKTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYREL 65

Query: 393 VLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-------------LYDPEKQG 439
            L+  + H N++ LL              F P  SL+ F             L +  K  
Sbjct: 66  RLLKHMDHENVIGLLDV------------FTPASSLEDFQDVYLVTHLMGADLNNIVKCQ 113

Query: 440 QLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499
           +L       ++  I RG+ Y+H      IIHRDLK SNI ++ +   KI DFG+AR    
Sbjct: 114 KLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLAR---- 166

Query: 500 DQTQGNTSRIVGTYGYMAPEYA---MHGQFSVKSDVYSFGVLVLEIITGK 546
             T    +  V T  Y APE     MH   +V  D++S G ++ E++TGK
Sbjct: 167 -HTDDEMTGYVATRWYRAPEIMLNWMHYNQTV--DIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 79.3 bits (195), Expect = 2e-16
 Identities = 60/215 (27%), Positives = 105/215 (48%), Gaps = 26/215 (12%)

Query: 334 QFDFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEV 392
           Q D+E I+          ++G G +G+VYK   L +G+  AVK +    G      + E+
Sbjct: 8   QHDYELIQ----------RVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEI 57

Query: 393 VLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLD--YFLYDPEKQGQLDWSRRYKII 450
            +V + +H N+V   G  L  E+  +  E+    SL   Y +  P  + Q+ +  R  + 
Sbjct: 58  FMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL- 116

Query: 451 GGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIV 510
               +G+ YLH   ++   HRD+K +NILL    + K++DFG+A    +  T       +
Sbjct: 117 ----QGLAYLHSKGKM---HRDIKGANILLTDNGDVKLADFGVAA--KITATIAKRKSFI 167

Query: 511 GTYGYMAPEYAM---HGQFSVKSDVYSFGVLVLEI 542
           GT  +MAPE A    +G ++   D+++ G+  +E+
Sbjct: 168 GTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 79.4 bits (196), Expect = 2e-16
 Identities = 55/197 (27%), Positives = 98/197 (49%), Gaps = 16/197 (8%)

Query: 352 KLGEGGFGEVYKGV-LPSGQEIAVKRL---SKASGQGAEEFKNEVVLVAKLQHRNLVRLL 407
           K+GEG +G V+K     + + +A+KR+       G  +   + E+ L+ +L+H+N+VRL 
Sbjct: 7   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRLY 65

Query: 408 GFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRL 466
              L  ++K+ LV+E+       YF       G +D       +  + +G+ + H     
Sbjct: 66  D-VLHSDKKLTLVFEYCDQDLKKYF---DSCNGDIDPEIVKSFMFQLLKGLAFCHSH--- 118

Query: 467 RIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQ- 525
            ++HRDLK  N+L++     K++DFG+AR FG+       S  V T  Y  P+     + 
Sbjct: 119 NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC--YSAEVVTLWYRPPDVLFGAKL 176

Query: 526 FSVKSDVYSFGVLVLEI 542
           +S   D++S G +  E+
Sbjct: 177 YSTSIDMWSAGCIFAEL 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 78.9 bits (194), Expect = 3e-16
 Identities = 57/215 (26%), Positives = 105/215 (48%), Gaps = 26/215 (12%)

Query: 334 QFDFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEV 392
           Q DFE I+          ++G G +G+VYK   + +G+  A+K +    G+     + E+
Sbjct: 8   QEDFELIQ----------RIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEI 57

Query: 393 VLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLD--YFLYDPEKQGQLDWSRRYKII 450
           +++   +H N+V   G  L  ++  +  EF    SL   Y +  P  + Q+ +  R  + 
Sbjct: 58  IMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL- 116

Query: 451 GGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIV 510
               +G+ YLH   +   +HRD+K +NILL    + K++DFG++    +  T       +
Sbjct: 117 ----QGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSA--QITATIAKRKSFI 167

Query: 511 GTYGYMAPEYAM---HGQFSVKSDVYSFGVLVLEI 542
           GT  +MAPE A     G ++   D+++ G+  +E+
Sbjct: 168 GTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 79.3 bits (195), Expect = 3e-16
 Identities = 65/218 (29%), Positives = 103/218 (47%), Gaps = 34/218 (15%)

Query: 350 DNKLGEGGFGEVYKGVLPSG---QEIAVKRLSK-ASGQGAEEFKNEVVLVAKL-QHRNLV 404
           ++ +GEG FG+V + ++         A+K L + AS     +F  E+ ++ KL  H N++
Sbjct: 7   EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66

Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFL-------YDPE------KQGQLDWSRRYKIIG 451
            LLG C       +  E+ P  +L  FL        DP           L   +  +   
Sbjct: 67  NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126

Query: 452 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVG 511
            +A G+ YL E    + IHRDL A N+L+   +  KI+DFG++R        G    +  
Sbjct: 127 DVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR--------GEEVYVKK 175

Query: 512 TYG-----YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           T G     +MA E   +  ++ KSDV+SFGVL+ EI++
Sbjct: 176 TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 78.3 bits (193), Expect = 4e-16
 Identities = 52/198 (26%), Positives = 91/198 (45%), Gaps = 23/198 (11%)

Query: 356 GGFGEVY--KGVLPSGQEIAVKRLSKASGQGAEEFKN----EVVLVAKLQHRNLVRLLGF 409
           G FG VY  K    +G   A+K L K+      +  N      +++ + +   + +L   
Sbjct: 7   GAFGSVYLAKKRS-TGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65

Query: 410 CLEGEEKILVYEFVPNKSLDYFLYDPEKQGQL--DWSRRYKIIGGIARGILYLHEDSRLR 467
               +   LV E++        +   +  G L  DW+++Y  I  +  G+  LH+     
Sbjct: 66  FQSKDYLYLVMEYLNGGDCASLI---KTLGGLPEDWAKQY--IAEVVLGVEDLHQRG--- 117

Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFS 527
           IIHRD+K  N+L+D   + K++DFG++R    ++      + VGT  Y+APE  +     
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK------KFVGTPDYLAPETILGVGDD 171

Query: 528 VKSDVYSFGVLVLEIITG 545
             SD +S G ++ E + G
Sbjct: 172 KMSDWWSLGCVIFEFLFG 189

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 78.9 bits (194), Expect = 4e-16
 Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 19/206 (9%)

Query: 352 KLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKN--EVVLVAKLQ---HRNLVR 405
           ++G G +G VYK   P SG  +A+K +   + +         EV L+ +L+   H N+VR
Sbjct: 7   EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66

Query: 406 LLGFC----LEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
           L+  C     + E K+ LV+E V      Y    P      +  +   ++    RG+ +L
Sbjct: 67  LMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIK--DLMRQFLRGLDFL 124

Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEY 520
           H +    I+HRDLK  NIL+ +    K++DFG+ARI+     Q   + +V T  Y APE 
Sbjct: 125 HAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVTLWYRAPEV 178

Query: 521 AMHGQFSVKSDVYSFGVLVLEIITGK 546
            +   ++   D++S G +  E+   K
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEMFRRK 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 78.9 bits (194), Expect = 4e-16
 Identities = 64/200 (32%), Positives = 101/200 (50%), Gaps = 15/200 (7%)

Query: 353 LGEGGFGEVYK-GVLPSGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLG 408
           LG+GGFGEV    V  +G+  A KRL K      +G     NE  ++ K+  + +V L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL-A 66

Query: 409 FCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
           +  E ++ + LV   +    L + +Y+    G  +  R       I  G+  LH ++   
Sbjct: 67  YAYETKDALCLVLTIMNGGDLKFHIYNMGNPG-FEEERALFYAAEILCGLEDLHREN--- 122

Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR-IVGTYGYMAPEYAMHGQF 526
            ++RDLK  NILLD   + +ISD G+A    V   +G + R  VGT GYMAPE   + ++
Sbjct: 123 TVYRDLKPENILLDDYGHIRISDLGLA----VKIPEGESIRGRVGTVGYMAPEVLNNQRY 178

Query: 527 SVKSDVYSFGVLVLEIITGK 546
           ++  D +  G L+ E+I G+
Sbjct: 179 TLSPDYWGLGCLIYEMIEGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 78.2 bits (192), Expect = 5e-16
 Identities = 66/215 (30%), Positives = 101/215 (46%), Gaps = 34/215 (15%)

Query: 353 LGEGGFGEVYKGVLPSG---QEIAVKRLSK-ASGQGAEEFKNEVVLVAKL-QHRNLVRLL 407
           +GEG FG+V K  +       + A+KR+ + AS     +F  E+ ++ KL  H N++ LL
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 408 GFCLEGEEKILVYEFVPNKSLDYFL-------YDPE------KQGQLDWSRRYKIIGGIA 454
           G C       L  E+ P+ +L  FL        DP           L   +       +A
Sbjct: 63  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122

Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
           RG+ YL +    + IHRDL A NIL+      KI+DFG++R        G    +  T G
Sbjct: 123 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR--------GQEVYVKKTMG 171

Query: 515 -----YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
                +MA E   +  ++  SDV+S+GVL+ EI++
Sbjct: 172 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 78.1 bits (192), Expect = 6e-16
 Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 20/203 (9%)

Query: 352 KLGEGGFGEVYKG--VLPSGQEIAVKRL---SKASGQGAEEFKNEVVL--VAKLQHRNLV 404
           ++GEG +G+V+K   +   G+ +A+KR+   +   G      +   VL  +   +H N+V
Sbjct: 8   EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67

Query: 405 RLLGFCL----EGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
           RL   C     + E K+ LV+E V      Y    PE     +  +   ++  + RG+ +
Sbjct: 68  RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK--DMMFQLLRGLDF 125

Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE 519
           LH     R++HRDLK  NIL+ +    K++DFG+ARI+     Q   + +V T  Y APE
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWYRAPE 179

Query: 520 YAMHGQFSVKSDVYSFGVLVLEI 542
             +   ++   D++S G +  E+
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEM 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 78.3 bits (193), Expect = 6e-16
 Identities = 61/224 (27%), Positives = 117/224 (52%), Gaps = 29/224 (12%)

Query: 341 EVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFK----NEVVLV 395
           +   +KF    ++GEG +G+VYK     +G+ +A+K++   + +  E F      E+ ++
Sbjct: 3   KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAIREIKIL 60

Query: 396 AKLQHRNLVRL----------LGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSR 445
            +L HRN+V L          L F  +     LV+E++     D+ L    + G + +S 
Sbjct: 61  RQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-----DHDLMGLLESGLVHFSE 115

Query: 446 RY--KIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ 503
            +    +  +  G+ Y H+ + L   HRD+K SNILL+ +   K++DFG+AR++  ++++
Sbjct: 116 DHIKSFMKQLLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESR 172

Query: 504 GNTSRIVGTYGYMAPEYAM-HGQFSVKSDVYSFGVLVLEIITGK 546
             T++++ T  Y  PE  +   ++    DV+S G ++ E+ T K
Sbjct: 173 PYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 78.5 bits (193), Expect = 6e-16
 Identities = 65/228 (28%), Positives = 110/228 (48%), Gaps = 28/228 (12%)

Query: 341 EVATNKFSTDNKLGEGGFGEVY--------KGVLPSGQEIAVKRLS-KASGQGAEEFKNE 391
           E + +K +    LGEG FG+V         K        +AVK L   A+ +   +  +E
Sbjct: 11  EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 70

Query: 392 VVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL-----------YDPEK-- 437
           + ++  + +H+N++ LLG C +     ++ E+    +L  +L           YD  +  
Sbjct: 71  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVP 130

Query: 438 QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-I 496
             Q+ +         +ARG+ YL   +  + IHRDL A N+L+      KI+DFG+AR +
Sbjct: 131 DEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDV 187

Query: 497 FGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
             +D  +  T+  +    +MAPE      ++ +SDV+SFGVL+ EI T
Sbjct: 188 NNIDYYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 78.9 bits (195), Expect = 7e-16
 Identities = 58/225 (25%), Positives = 104/225 (46%), Gaps = 49/225 (21%)

Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQG-AEEFKNEVVLVAKLQHRNLV 404
           +   + +GEG +G V      P+G ++A+K++S    Q   +    E+ ++ + +H N++
Sbjct: 7   YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENII 66

Query: 405 RLL------GFCLEGEEKILVYEFVP-------------NKSLDYFLYDPEKQGQLDWSR 445
            +L       F     +  +V E +              N  + YFLY            
Sbjct: 67  GILDIIRPPSFE-SFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQ----------- 114

Query: 446 RYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN 505
                  I RG+ Y+H  +   ++HRDLK SN+LL+   + KI DFG+ARI   D    +
Sbjct: 115 -------ILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI--ADPEHDH 162

Query: 506 TSRI---VGTYGYMAPEYAMHGQFSVKS-DVYSFGVLVLEIITGK 546
           T  +   V T  Y APE  ++ +   K+ D++S G ++ E+++ +
Sbjct: 163 TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 78.6 bits (194), Expect = 8e-16
 Identities = 72/240 (30%), Positives = 107/240 (44%), Gaps = 57/240 (23%)

Query: 337 FETIEVATNKFSTDNK------LGEGGFGEV---YKGVLPSGQEIAVKRLSKASGQGAEE 387
           F ++EV  + F+   +      +G G  G V   Y  V   GQ +A+K+LS+        
Sbjct: 2   FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDTVT--GQNVAIKKLSRP------- 52

Query: 388 FKN---------EVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF------- 431
           F+N         E+VL+  + H+N++ LL              F P KSL+ F       
Sbjct: 53  FQNVTHAKRAYRELVLMKLVNHKNIIGLLNV------------FTPQKSLEEFQDVYLVM 100

Query: 432 -LYDPEK----QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP 486
            L D       Q  LD  R   ++  +  GI +LH      IIHRDLK SNI++ ++   
Sbjct: 101 ELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTL 157

Query: 487 KISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
           KI DFG+AR  G       T  +V  Y Y APE  +   +    D++S G ++ E+I G 
Sbjct: 158 KILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 77.9 bits (192), Expect = 9e-16
 Identities = 65/210 (30%), Positives = 107/210 (50%), Gaps = 36/210 (17%)

Query: 353 LGEGGFGEVY--KGVLP--SGQEIAVKRLSKASGQGAEEF--KNEVVLVAKLQHRNLVRL 406
           LG+G FG+V+  + +    +GQ  A+K L KA+ +  +    K E  ++A++ H  +V+L
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63

Query: 407 LGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYK-----------IIGGIAR 455
             +  + E K+            Y + D  + G L ++R  K            +  +A 
Sbjct: 64  -HYAFQTEGKL------------YLILDFLRGGDL-FTRLSKEVMFTEEDVKFYLAELAL 109

Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGY 515
            + +LH    L II+RDLK  NILLD E + K++DFG+++   +D  +   S   GT  Y
Sbjct: 110 ALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKKAYS-FCGTVEY 164

Query: 516 MAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
           MAPE       +  +D +SFGVL+ E++TG
Sbjct: 165 MAPEVVNRRGHTQSADWWSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 77.6 bits (192), Expect = 9e-16
 Identities = 65/213 (30%), Positives = 111/213 (52%), Gaps = 36/213 (16%)

Query: 351 NKLGEGGFGEVYKGV-LPSGQEIAVKRL---SKASGQGAEEFK----NEVVLVAKLQHRN 402
           N++ EG +G VY+     +G+ +A+K+L    +  G     F      E+ ++ KLQH N
Sbjct: 11  NRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEG-----FPITSLREINILLKLQHPN 65

Query: 403 LVRL----LGFCLEGEEKI-LVYEFVPN--KSLDYFLYDPEKQGQLDWSRRYK-IIGGIA 454
           +V +    +G      +KI +V E+V +  KSL   +  P  Q ++      K ++  + 
Sbjct: 66  IVTVKEVVVG---SNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEV------KCLMLQLL 116

Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
            G+ +LH++    I+HRDLK SN+LL+     KI DFG+AR +G        +++V T  
Sbjct: 117 SGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS--PLKPYTQLVVTLW 171

Query: 515 YMAPEYAM-HGQFSVKSDVYSFGVLVLEIITGK 546
           Y APE  +   ++S   D++S G +  E++T K
Sbjct: 172 YRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 78.2 bits (193), Expect = 1e-15
 Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 21/208 (10%)

Query: 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGAEEFK---NEVVLVAKLQH 400
             F    ++G+GG+G+V+        EI A+KR+ K+      E +    E  ++   + 
Sbjct: 1   KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60

Query: 401 RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQL--DWSRRYKIIGGIARGI 457
             LV+LL +  + +E + L  E+VP       L +    G L  D +R Y     +A   
Sbjct: 61  EWLVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNN---LGVLSEDHARFY-----MAEMF 111

Query: 458 LYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMA 517
             +     L  IHRDLK  N L+DA  + K++DFG+++      T  N+  +VG+  YMA
Sbjct: 112 EAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGI---VTYANS--VVGSPDYMA 166

Query: 518 PEYAMHGQFSVKSDVYSFGVLVLEIITG 545
           PE      +    D +S G ++ E + G
Sbjct: 167 PEVLRGKGYDFTVDYWSLGCMLYEFLCG 194

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 77.0 bits (189), Expect = 1e-15
 Identities = 68/236 (28%), Positives = 112/236 (47%), Gaps = 32/236 (13%)

Query: 324 DNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASG 382
           D DL+ L      FE +EV          +G G +G+VYKG  + +GQ  A+K +     
Sbjct: 5   DIDLSALRDPAGIFELVEV----------VGNGTYGQVYKGRHVKTGQLAAIKVMDVTED 54

Query: 383 QGAEEFKNEVVLVAKL-QHRNLVRLLGFCLE------GEEKILVYEFVPNKSLDYFLYDP 435
           +  EE K E+ ++ K   HRN+    G  ++       ++  LV EF    S+   + + 
Sbjct: 55  E-EEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNT 113

Query: 436 EKQG-QLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494
           +    + DW     I   I RG+ +LH     ++IHRD+K  N+LL      K+ DFG++
Sbjct: 114 KGNALKEDWIAY--ICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVS 168

Query: 495 RIFGVDQTQGNTSRIVGTYGYMAPEYAM-----HGQFSVKSDVYSFGVLVLEIITG 545
               +D+T G  +  +GT  +MAPE           +  +SD++S G+  +E+  G
Sbjct: 169 A--QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 77.4 bits (191), Expect = 2e-15
 Identities = 65/204 (31%), Positives = 101/204 (49%), Gaps = 23/204 (11%)

Query: 353 LGEGGFGEV----YKGVLPSGQEIAVKRLSK---ASGQGAEEFKNEV-VLVAKLQHRNLV 404
           LG+G FG+V     KG   + +  AVK L K         E    E  VL    +H  L 
Sbjct: 3   LGKGSFGKVLLAELKG---TDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLT 59

Query: 405 RLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
           +L   C + ++++  V E+V    L   ++  ++ G+ D  R       I  G+ +LHE 
Sbjct: 60  QLHS-CFQTKDRLFFVMEYVNGGDL---MFHIQRSGRFDEPRARFYAAEIVLGLQFLHER 115

Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR-IVGTYGYMAPEYAM 522
               II+RDLK  N+LLD+E + KI+DFGM +  G+    G T+    GT  Y+APE   
Sbjct: 116 G---IIYRDLKLDNVLLDSEGHIKIADFGMCK-EGI--LGGVTTSTFCGTPDYIAPEILS 169

Query: 523 HGQFSVKSDVYSFGVLVLEIITGK 546
           +  +    D ++ GVL+ E++ G+
Sbjct: 170 YQPYGPAVDWWALGVLLYEMLAGQ 193

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 77.4 bits (190), Expect = 2e-15
 Identities = 65/233 (27%), Positives = 112/233 (48%), Gaps = 38/233 (16%)

Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVV------L 394
           E++  + +    LGEG FG+V   V+     I   + +K      +  K++        L
Sbjct: 8   ELSRTRLTLGKPLGEGCFGQV---VMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDL 64

Query: 395 VAKLQ-------HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL-----------YD-- 434
           V++++       H+N++ LLG C +     ++ E+    +L  +L           +D  
Sbjct: 65  VSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTC 124

Query: 435 --PEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 492
             PE+Q  L +         +ARG+ YL   +  + IHRDL A N+L+  +   KI+DFG
Sbjct: 125 KLPEEQ--LTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFG 179

Query: 493 MAR-IFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           +AR +  +D  +  T+  +    +MAPE      ++ +SDV+SFGVL+ EI T
Sbjct: 180 LARDVHNIDYYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 76.4 bits (188), Expect = 2e-15
 Identities = 64/221 (28%), Positives = 105/221 (47%), Gaps = 28/221 (12%)

Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVY----KGVLPSGQEIAVKRLSKAS----GQGAEE 387
           +FE + V          LG G +G+V+     G   +G+  A+K L KA+     + AE 
Sbjct: 1   NFELLRV----------LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEH 50

Query: 388 FKNEVVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRR 446
            + E  ++  ++    +  L +  + + K+ L+ ++V    L   LY  E       S  
Sbjct: 51  TRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREH---FTESEV 107

Query: 447 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT 506
              I  I   + +LH+   L II+RD+K  NILLD+E +  ++DFG+++ F  ++ +   
Sbjct: 108 RVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY 164

Query: 507 SRIVGTYGYMAPEYAMHGQ--FSVKSDVYSFGVLVLEIITG 545
           S   GT  YMAPE    G        D +S GVL  E++TG
Sbjct: 165 S-FCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 75.7 bits (186), Expect = 3e-15
 Identities = 63/201 (31%), Positives = 99/201 (49%), Gaps = 19/201 (9%)

Query: 352 KLGEGGFGEVY-----KGV----LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRN 402
           +LG+G FG VY     K V    L   +EI V  L+      A +   E  L++KL H  
Sbjct: 7   RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQ---EAQLLSKLDHPA 63

Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQ-LDWSRRYKIIGGIARGILYLH 461
           +V+     LE +   ++ E+   + LD  L + +  G+ L  ++  +    +  G+ Y+H
Sbjct: 64  IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH 123

Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYA 521
           +    RI+HRDLKA NI L   +  KI DFG++R+         T    GT  YM+PE  
Sbjct: 124 QR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT--FTGTPYYMSPEAL 177

Query: 522 MHGQFSVKSDVYSFGVLVLEI 542
            H  +  KSD++S G ++ E+
Sbjct: 178 KHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 76.3 bits (188), Expect = 3e-15
 Identities = 64/240 (26%), Positives = 104/240 (43%), Gaps = 53/240 (22%)

Query: 333 LQFDFETIEVATNKFSTDNKLGEGGFGEVYKG-VLPSGQEIAVKRLSKASGQGAEEFKN- 390
           L  D +      N      ++G G  G+VYK     +G  +AVK++ +      EE K  
Sbjct: 3   LTIDGQKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--KEENKRI 60

Query: 391 ----EVVL---------------VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF 431
               +VVL               +        + L+  CL+ +    +   +P   L   
Sbjct: 61  LMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMSTCLD-KLLKRIQGPIPEDILG-- 117

Query: 432 LYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDF 491
                           K+   I + + YL E     +IHRD+K SNILLDA  N K+ DF
Sbjct: 118 ----------------KMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDF 159

Query: 492 GMA-RIFGVDQTQGNTSRIVGTYGYMAPEY----AMHGQFSVKSDVYSFGVLVLEIITGK 546
           G++ R+  VD ++  T R  G   YMAPE       + ++ +++DV+S G+ ++E+ TG+
Sbjct: 160 GISGRL--VD-SKAKT-RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 76.3 bits (188), Expect = 3e-15
 Identities = 56/191 (29%), Positives = 94/191 (49%), Gaps = 25/191 (13%)

Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFK----NEVVLVAKLQ 399
           +K+    K+G+G FGEV+K     + Q +A+K++        E F      E+ ++  L+
Sbjct: 12  SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKV--LMENEKEGFPITALREIKILQLLK 69

Query: 400 HRNLVRLLGFCLEGEEK--------ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIG 451
           H N+V L+  C               LV+EF  +  L   L +     +   S   K++ 
Sbjct: 70  HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNK--NVKFTLSEIKKVMK 126

Query: 452 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV---DQTQGNTSR 508
            +  G+ Y+H   R +I+HRD+KA+NIL+  +   K++DFG+AR F +    +    T+R
Sbjct: 127 MLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNR 183

Query: 509 IVGTYGYMAPE 519
           +V T  Y  PE
Sbjct: 184 VV-TLWYRPPE 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 78.3 bits (193), Expect = 6e-15
 Identities = 56/194 (28%), Positives = 92/194 (47%), Gaps = 24/194 (12%)

Query: 368 SGQEIAVKRLSKASGQGAEE---FKNEVVLVAKLQHRNLVRLLGFCLEGEEK----ILVY 420
           +G E+A+K L   + +   +   F+ E  L A+L H N+V LL     GE        V+
Sbjct: 2   TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLD---SGEAPPGLLFAVF 58

Query: 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL 480
           E+VP ++L   L      G L      +++  +   +   H      I+HRDLK  NI++
Sbjct: 59  EYVPGRTLREVL---AADGALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMV 112

Query: 481 ---DAEMNPKISDFGMARIF-GVD----QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDV 532
                  + K+ DFG+  +  GV      T   T+ ++GT  Y APE       +  SD+
Sbjct: 113 SQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDL 172

Query: 533 YSFGVLVLEIITGK 546
           Y++G++ LE +TG+
Sbjct: 173 YAWGLIFLECLTGQ 186

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 74.9 bits (184), Expect = 6e-15
 Identities = 60/202 (29%), Positives = 100/202 (49%), Gaps = 28/202 (13%)

Query: 353 LGEGGFGEVYKG-VLPSGQEIAVKRLS-KASGQGAEEFKNEVVLVAKLQHRNLVRLLG-F 409
           LG G  G VYK   L + + +AVK +    + +  ++  +E+ ++ K     ++   G F
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68

Query: 410 CLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIA----RGILYLHEDSR 465
            +E    I   EF+   SLD +   PE            ++G IA    +G+ YL     
Sbjct: 69  FVENRISICT-EFMDGGSLDVYRKIPEH-----------VLGRIAVAVVKGLTYLWS--- 113

Query: 466 LRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRI-VGTYGYMAPEYAMHG 524
           L+I+HRD+K SN+L++     K+ DFG++      Q   + ++  VGT  YMAPE     
Sbjct: 114 LKILHRDVKPSNMLVNTRGQVKLCDFGVST-----QLVNSIAKTYVGTNAYMAPERISGE 168

Query: 525 QFSVKSDVYSFGVLVLEIITGK 546
           Q+ + SDV+S G+  +E+  G+
Sbjct: 169 QYGIHSDVWSLGISFMELALGR 190

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 74.5 bits (183), Expect = 6e-15
 Identities = 60/220 (27%), Positives = 111/220 (50%), Gaps = 41/220 (18%)

Query: 346 KFSTDNKLGEGGFGEVYKGVL----PSGQEIAVKRL--SKASGQGAEEFKNEVVLVAKLQ 399
           K+    K+GEG FG   K +L      G++  +K +  SK S +  EE + EV +++ ++
Sbjct: 1   KYVKVKKIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMK 57

Query: 400 HRNLVR-------------LLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRR 446
           H N+V+             ++ +C  G+    +Y+ +  +    F   PE Q  LDW  +
Sbjct: 58  HPNIVQYQESFEENGNLYIVMDYCEGGD----LYKKINAQRGVLF---PEDQ-ILDWFVQ 109

Query: 447 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT 506
                 I   + ++H+    +I+HRD+K+ NI L  +   K+ DFG+AR+  ++ T    
Sbjct: 110 ------ICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARV--LNSTVELA 158

Query: 507 SRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
              +GT  Y++PE   +  ++ KSD+++ G ++ E+ T K
Sbjct: 159 RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLK 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 75.4 bits (185), Expect = 7e-15
 Identities = 68/221 (30%), Positives = 100/221 (45%), Gaps = 41/221 (18%)

Query: 353 LGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLV--RLLGF 409
           LG+G FG+V    L   G+  AVK L           K +VVL+       +V  R+L  
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKAL-----------KKDVVLIDDDVECTMVEKRVLAL 51

Query: 410 CLEG-------------EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARG 456
             E              E    V EF+    L + + D   +G+ D  R       I  G
Sbjct: 52  AWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQD---KGRFDLYRATFYAAEIVCG 108

Query: 457 ILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR--IFGVDQTQGNTSRIVGTYG 514
           + +LH      II+RDLK  N++LD + + KI+DFGM +  +FG        S   GT  
Sbjct: 109 LQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG----DNRASTFCGTPD 161

Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTD 555
           Y+APE     +++   D +SFGVL+ E++ G+  S F+  D
Sbjct: 162 YIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQ--SPFHGDD 200

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 75.4 bits (185), Expect = 7e-15
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 19/210 (9%)

Query: 353 LGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFK----NEVVLVAKLQHRNLVRLL 407
           LG+G FG+V+   L  + Q  A+K L K      ++ +     + VL    +H  L  L 
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62

Query: 408 GFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
                 E    V E++    L + +    K    D  R       I  G+ +LH      
Sbjct: 63  CTFQTKENLFFVMEYLNGGDLMFHIQSCHK---FDLPRATFYAAEIICGLQFLHSKG--- 116

Query: 468 IIHRDLKASNILLDAEMNPKISDFGMAR--IFGVDQTQGNTSRIVGTYGYMAPEYAMHGQ 525
           I++RDLK  NILLD + + KI+DFGM +  + G       T    GT  Y+APE  +  +
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG----DAKTCTFCGTPDYIAPEILLGQK 172

Query: 526 FSVKSDVYSFGVLVLEIITGKKNSNFYQTD 555
           ++   D +SFGVL+ E++ G+  S F+  D
Sbjct: 173 YNTSVDWWSFGVLLYEMLIGQ--SPFHGHD 200

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 74.3 bits (182), Expect = 1e-14
 Identities = 69/228 (30%), Positives = 107/228 (46%), Gaps = 19/228 (8%)

Query: 331 ESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFK 389
            S     E++   T+ +     +G+G +G+VYK      G   AVK L   S    EE +
Sbjct: 8   NSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIE 66

Query: 390 NEVVLVAKL-QHRNLVRLLGFCLEGEEKI-----LVYEFVPNKSLDYFLYDPEKQGQ-LD 442
            E  ++  L  H N+V+  G   + ++ +     LV E     S+   +      GQ LD
Sbjct: 67  AEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLD 126

Query: 443 WSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502
            +    I+ G   G+ +LH +   RIIHRD+K +NILL  E   K+ DFG++      + 
Sbjct: 127 EAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL 183

Query: 503 QGNTSRIVGTYGYMAPEYAMHGQ-----FSVKSDVYSFGVLVLEIITG 545
           + NTS  VGT  +MAPE     Q     +  + DV+S G+  +E+  G
Sbjct: 184 RRNTS--VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 74.9 bits (185), Expect = 1e-14
 Identities = 65/227 (28%), Positives = 113/227 (49%), Gaps = 50/227 (22%)

Query: 346 KFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKN---------EVVLV 395
           K+    KLG+G +G V+K +   + + +A+K++  A       F+N         E++ +
Sbjct: 8   KYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDA-------FRNATDAQRTFREIMFL 60

Query: 396 AKL-QHRNLVRLLG-FCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQL-DWSRRYKIIG 451
            +L  H N+V+LL     E ++ I LV+E+     ++  L+   +   L D  +RY I+ 
Sbjct: 61  QELGDHPNIVKLLNVIKAENDKDIYLVFEY-----METDLHAVIRANILEDVHKRY-IMY 114

Query: 452 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRI-- 509
            + + + Y+H  S   +IHRDLK SNILL+++   K++DFG+AR   + + + N      
Sbjct: 115 QLLKALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLAR--SLSELEENPENPVL 169

Query: 510 ---VGTYGYMAPEYAMHGQFSVKSDVYSFGV-------LVLEIITGK 546
              V T  Y APE        + S  Y+ GV       ++ E++ GK
Sbjct: 170 TDYVATRWYRAPE------ILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 74.3 bits (183), Expect = 2e-14
 Identities = 63/211 (29%), Positives = 93/211 (44%), Gaps = 38/211 (18%)

Query: 353 LGEGGFGEV----YKGVLPSGQEIAVKRLSKA---SGQGAEEFKNE--VVLVA-KLQHRN 402
           LG G FG+V    YK    +G+  A+K L K    +    E    E  +   A   +H  
Sbjct: 7   LGRGHFGKVLLAEYK---KTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63

Query: 403 LVRLLGFCLEGEEKI-LVYEFVPNKSL------DYFLYDPEKQGQLDWSRRYKIIGGIAR 455
           LV L   C + E+ +  V E+     L      D F    E +        Y     +  
Sbjct: 64  LVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVF---SEPRAVF-----Y--AACVVL 112

Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI-FGVDQTQGNTSRIVGTYG 514
           G+ YLHE+   +I++RDLK  N+LLD E   KI+DFG+ +   G       TS   GT  
Sbjct: 113 GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR---TSTFCGTPE 166

Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
           ++APE      ++   D +  GVL+ E++ G
Sbjct: 167 FLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 73.1 bits (179), Expect = 2e-14
 Identities = 64/213 (30%), Positives = 107/213 (50%), Gaps = 32/213 (15%)

Query: 353 LGEGGFGEV----YKGVLPSGQEIAVKRLS--KASGQGAEEFKNEVVLVAKLQHRNLVRL 406
           +G+G +GEV    ++     G++  +K+L+   AS +  +  + E  L+++L+H N+V  
Sbjct: 8   VGKGSYGEVSLVRHR---TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIV-A 63

Query: 407 LGFCLEGEEKIL--VYEFVPNKSLDYFLYDPEKQGQL-------DWSRRYKIIGGIARGI 457
                EGE+ +L  V  F     L + L   E++G+L       +W  +      IA  +
Sbjct: 64  YRESWEGEDGLLYIVMGFCEGGDLYHKL--KEQKGKLLPENQVVEWFVQ------IAMAL 115

Query: 458 LYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMA 517
            YLHE     I+HRDLK  N+ L      K+ D G+AR+  ++      S ++GT  YM+
Sbjct: 116 QYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARV--LENQCDMASTLIGTPYYMS 170

Query: 518 PEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSN 550
           PE   +  ++ KSDV++ G  V E+ T K   N
Sbjct: 171 PELFSNKPYNYKSDVWALGCCVYEMATLKHAFN 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 73.5 bits (180), Expect = 2e-14
 Identities = 59/199 (29%), Positives = 98/199 (49%), Gaps = 13/199 (6%)

Query: 352 KLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFK--NEVVLVAKLQHRNLVRLLG 408
           KLGEG +  VYKG+   +GQ +A+K +S  + +G   F    E  L+  L+H N+V L  
Sbjct: 12  KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVP-FTAIREASLLKGLKHANIVLLHD 70

Query: 409 FCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRI 468
                E    V+E++      Y +  P   G L        +  + RG+ Y+H      I
Sbjct: 71  IIHTKETLTFVFEYMHTDLAQYMIQHP---GGLHPYNVRLFMFQLLRGLAYIH---GQHI 124

Query: 469 IHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG-QFS 527
           +HRDLK  N+L+      K++DFG+AR   +  +Q  +S +V T  Y  P+  +    +S
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLARAKSI-PSQTYSSEVV-TLWYRPPDVLLGATDYS 182

Query: 528 VKSDVYSFGVLVLEIITGK 546
              D++  G + +E++ G+
Sbjct: 183 SALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 74.3 bits (183), Expect = 2e-14
 Identities = 65/245 (26%), Positives = 104/245 (42%), Gaps = 55/245 (22%)

Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSKA----SGQGAEEFKN 390
           DFE I+V          +G G FGEV+        ++ A+K L K+      Q A   + 
Sbjct: 2   DFEVIKV----------IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAH-VRA 50

Query: 391 EVVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLD--WSRRY 447
           E  ++A      +V+L  +  + EE + LV E++P   L   L    ++       +R Y
Sbjct: 51  ERDILADADSPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLI---RKDVFPEETARFY 106

Query: 448 KIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA------------- 494
                IA  +L L    +L  IHRD+K  NIL+DA+ + K++DFG+              
Sbjct: 107 -----IAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYL 161

Query: 495 ------------RIFGVDQTQGNTSR--IVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVL 540
                        +   D  Q        VGT  Y+APE      + ++ D +S GV++ 
Sbjct: 162 NDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILY 221

Query: 541 EIITG 545
           E++ G
Sbjct: 222 EMLYG 226

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 73.0 bits (179), Expect = 2e-14
 Identities = 57/213 (26%), Positives = 91/213 (42%), Gaps = 28/213 (13%)

Query: 351 NKLGEGGFGEVYKGVLPSGQEIA---VKRL-SKASGQGAEEFKNEVVLVAKLQHRNLVRL 406
           +++G G FG+V  G    G   A   VK L + A+      F  EV    +L H N+++ 
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60

Query: 407 LGFCLEGEEKILVYEFVPNKSLDYFL--------YDPEKQGQLDWSRRYKIIGGIARGIL 458
           LG C+E    +LV EF P   L  +L           +K          ++   +A G+L
Sbjct: 61  LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQ------RMACEVASGLL 114

Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
           +LH   +   IH DL   N  L A+++ KI D+G+A     +              ++AP
Sbjct: 115 WLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAP 171

Query: 519 EYAMHGQFSV-------KSDVYSFGVLVLEIIT 544
           E        +       KS+++S GV + E+ T
Sbjct: 172 ELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 72.9 bits (179), Expect = 3e-14
 Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 31/209 (14%)

Query: 353 LGEGGFGEVYKGVL---------PSGQEIAVKR-LSKASGQGAEEFKNEVVLVAKLQHRN 402
           LG+G F  +YKGVL           GQE++V   +  +  + +  F     L+++L H++
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
           LV+L G C+  +E I+V E+V    LD FL+  +    L W  +  +   +A  + YL +
Sbjct: 63  LVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLED 119

Query: 463 DSRLRIIHRDLKASNILL----DAEMNP---KISDFGMARIFGVDQTQGNTSRIVGTYGY 515
               +++H ++   NIL+      E      K+SD G+        T  +    V    +
Sbjct: 120 K---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI------TVLSREERVERIPW 170

Query: 516 MAPEYAMHGQFSVKS--DVYSFGVLVLEI 542
           +APE   +GQ S+    D +SFG  +LEI
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEI 199

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 73.2 bits (180), Expect = 3e-14
 Identities = 48/146 (32%), Positives = 76/146 (52%), Gaps = 26/146 (17%)

Query: 409 FCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRI 468
           F  +GE  I + E +   SLD  L   +K G++  +   KI   + RG+ YL E  + +I
Sbjct: 68  FYSDGEISICM-EHMDGGSLDQVL---KKAGRIPENILGKISIAVLRGLTYLRE--KHKI 121

Query: 469 IHRDLKASNILLDAEMNPKISDFG--------MARIFGVDQTQGNTSRIVGTYGYMAPEY 520
           +HRD+K SNIL+++    K+ DFG        MA  F            VGT  YM+PE 
Sbjct: 122 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF------------VGTRSYMSPER 169

Query: 521 AMHGQFSVKSDVYSFGVLVLEIITGK 546
                ++V+SD++S G+ ++E+  G+
Sbjct: 170 LQGTHYTVQSDIWSLGLSLVEMAIGR 195

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 72.3 bits (177), Expect = 4e-14
 Identities = 64/204 (31%), Positives = 100/204 (49%), Gaps = 16/204 (7%)

Query: 352 KLGEGGFGEVYKGVLPSG---QEIAVKRL-SKASGQGAEEFKNEVVLVAKLQHRNLVRLL 407
           ++G G FG+V  G + SG    ++ VK L   AS Q   +F  E      LQH NL++ L
Sbjct: 2   EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61

Query: 408 GFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQL--DWSRRYKIIGGIARGILYLHEDSR 465
           G C E    +LV EF P   L  +L    K   +  D +   ++   IA G+L+LH+++ 
Sbjct: 62  GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120

Query: 466 LRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYA--MH 523
              IH DL   N LL A++  KI D+G++     +       ++     ++APE    +H
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178

Query: 524 GQFSV-----KSDVYSFGVLVLEI 542
           G   V     +S+V+S GV + E+
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 72.4 bits (178), Expect = 7e-14
 Identities = 69/225 (30%), Positives = 108/225 (48%), Gaps = 26/225 (11%)

Query: 351 NKLGEGGFGEVYKGV-LPSGQEIAVK--RLSKASGQGAEEFKNEVVLVAKLQHRNLVRLL 407
           N++GEG +G VY+     SG+ +A+K  R+             E+ L+  L+H N+V L 
Sbjct: 13  NRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELK 72

Query: 408 ----GFCLEGEEKILVYEFVPNK--SLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH 461
               G  L+     LV E+      SL   +  P  + Q+       ++  + RG+ YLH
Sbjct: 73  EVVVGKHLD--SIFLVMEYCEQDLASLLDNMPTPFSESQVK-----CLMLQLLRGLQYLH 125

Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYA 521
           E+    IIHRDLK SN+LL  +   KI+DFG+AR +G+      T ++V T  Y APE  
Sbjct: 126 ENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP-MTPKVV-TLWYRAPELL 180

Query: 522 MHGQFSVKS-DVYSFGVLVLEIITGKK----NSNFYQTDGAADLL 561
           +       + D+++ G ++ E++  K      S   Q D    LL
Sbjct: 181 LGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLL 225

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 72.6 bits (178), Expect = 7e-14
 Identities = 63/202 (31%), Positives = 98/202 (48%), Gaps = 21/202 (10%)

Query: 353 LGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFK----NEVVLVAKLQHRNLVRLL 407
           LG+G FG+V    L  SG+  AVK L K      ++ +     + +L     H  L +L 
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62

Query: 408 GFCLEGEEKIL-VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRL 466
             C +  +++  V EFV    L   ++  +K  + D +R       I   +++LH+    
Sbjct: 63  -CCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAAEITSALMFLHDKG-- 116

Query: 467 RIIHRDLKASNILLDAEMNPKISDFGMAR--IF-GVDQTQGNTSRIVGTYGYMAPEYAMH 523
            II+RDLK  N+LLD E + K++DFGM +  IF G       TS   GT  Y+APE    
Sbjct: 117 -IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-----TTSTFCGTPDYIAPEILQE 170

Query: 524 GQFSVKSDVYSFGVLVLEIITG 545
             +    D ++ GVL+ E++ G
Sbjct: 171 MLYGPSVDWWAMGVLLYEMLCG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 72.8 bits (178), Expect = 8e-14
 Identities = 68/234 (29%), Positives = 109/234 (46%), Gaps = 43/234 (18%)

Query: 336 DFETIEVATNKFSTDNK------LGEGGFGEV---YKGVLPSGQEIAVKRLSK--ASGQG 384
           +F ++E+  + F+   +      +G G  G V   Y  +L   + +A+K+LS+   +   
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTH 66

Query: 385 AEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF--------LYDPE 436
           A+    E+VL+  + H+N++ LL              F P KSL+ F        L D  
Sbjct: 67  AKRAYRELVLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDAN 114

Query: 437 K----QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 492
                Q +LD  R   ++  +  GI +LH      IIHRDLK SNI++ ++   KI DFG
Sbjct: 115 LCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 171

Query: 493 MARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
           +AR  G       T  +V  Y Y APE  +   +    D++S G ++ E+I G 
Sbjct: 172 LARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 72.1 bits (177), Expect = 8e-14
 Identities = 41/97 (42%), Positives = 59/97 (60%), Gaps = 11/97 (11%)

Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR--IFGVDQTQGNTSR-I 509
           IA G+ +LH      II+RDLK  N++LDAE + KI+DFGM +  IFG     G T+R  
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG-----GKTTRTF 161

Query: 510 VGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
            GT  Y+APE   +  +    D ++FGVL+ E++ G+
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 72.6 bits (178), Expect = 9e-14
 Identities = 42/153 (27%), Positives = 74/153 (48%), Gaps = 9/153 (5%)

Query: 391 EVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKII 450
           E +L+  + H +++R+    + G    +V   +P+ S D + Y  ++   L   +   I 
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIE 163

Query: 451 GGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIV 510
             I  G+ YLH     RIIHRD+K  NI ++      I D G A+ F V         + 
Sbjct: 164 KQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQ-FPVVAP--AFLGLA 217

Query: 511 GTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEII 543
           GT    APE     +++ K+D++S G+++ E++
Sbjct: 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 71.3 bits (175), Expect = 2e-13
 Identities = 61/232 (26%), Positives = 111/232 (47%), Gaps = 49/232 (21%)

Query: 350 DNKLGEGGFGEVYKGV-LPSGQEIAVKR--LSKASGQGAEEFKN------------EVVL 394
              LGEG +G+V K     +G+ +A+K+  + + S    ++ +             E+ +
Sbjct: 14  GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73

Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEK----QGQLDWSRRYKII 450
           + +++H N++ L+   +EG+       F+ N  +D    D +K    + +L  S+   I+
Sbjct: 74  MNEIKHENIMGLVDVYVEGD-------FI-NLVMDIMASDLKKVVDRKIRLTESQVKCIL 125

Query: 451 GGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN----- 505
             I  G+  LH+      +HRDL  +NI ++++   KI+DFG+AR +G            
Sbjct: 126 LQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDE 182

Query: 506 --------TSRIVGTYGYMAPEYAMHGQ---FSVKSDVYSFGVLVLEIITGK 546
                   TS++V T  Y APE  M  +   F+V  D++S G +  E++TGK
Sbjct: 183 TMQRREEMTSKVV-TLWYRAPELLMGAEKYHFAV--DMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 69.9 bits (171), Expect = 3e-13
 Identities = 58/210 (27%), Positives = 103/210 (49%), Gaps = 28/210 (13%)

Query: 353 LGEGGFGEVYKG----VLPSGQ----EIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLV 404
           LG+G F +++KG    V   G+    E+ +K L K+    +E F     ++++L H++LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
              G C+ G+E I+V E+V   SLD +L   +    + W  + ++   +A  + +L +  
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLEDKG 120

Query: 465 RLRIIHRDLKASNILL-----DAEMNP---KISDFGMARIFGVDQTQGNTSRIVGTYGYM 516
              + H ++ A N+LL         NP   K+SD G++    V   +    RI     ++
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS--ITVLPKEILLERI----PWV 171

Query: 517 APEYAMHGQ-FSVKSDVYSFGVLVLEIITG 545
            PE   + Q  S+ +D +SFG  + EI +G
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 70.8 bits (173), Expect = 3e-13
 Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 41/213 (19%)

Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSK--ASGQGAEEFKNEVVLVAKLQHRNLVRLLGF 409
           +G G +G V   +   +G ++A+K+L +   S   A+    E+ L+  ++H N++ LL  
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82

Query: 410 CLEGEEKILVYEFVPNKSLD----YFLYDP---------EKQGQLDWSRRYKIIGGIARG 456
                       F P+ SLD    ++L  P          K  +L   R   ++  + +G
Sbjct: 83  ------------FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKG 130

Query: 457 ILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYM 516
           + Y+H      IIHRDLK  N+ ++ +   KI DFG+AR     QT    +  V T  Y 
Sbjct: 131 LKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTGYVVTRWYR 182

Query: 517 APEYA---MHGQFSVKSDVYSFGVLVLEIITGK 546
           APE     MH  ++   D++S G ++ E++TGK
Sbjct: 183 APEVILNWMH--YTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 70.0 bits (172), Expect = 3e-13
 Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 36/210 (17%)

Query: 351 NKLGEGGFGEVYKG-VLPSGQEIAVKRLSKASGQGAEEFKN--EVVLVAKLQ-HRNLVRL 406
            K+GEG F EV K     +G+  A+K + K   +  E+  N  E+  + +L  H N++RL
Sbjct: 5   GKIGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSLEQVNNLREIQALRRLSPHPNILRL 63

Query: 407 LGFCLEGEEK--ILVYEFVPNKSLDYFLYD---------PEKQGQLDWSRRYKIIGGIAR 455
           +    + +     LV+E      +D  LY+         PEK+      + Y  +  + +
Sbjct: 64  IEVLFDRKTGRLALVFEL-----MDMNLYELIKGRKRPLPEKR-----VKSY--MYQLLK 111

Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGY 515
            + ++H   R  I HRD+K  NIL+  +   K++DFG  R  G+      T  I  T  Y
Sbjct: 112 SLDHMH---RNGIFHRDIKPENILIKDD-ILKLADFGSCR--GIYSKPPYTEYI-STRWY 164

Query: 516 MAPEYAM-HGQFSVKSDVYSFGVLVLEIIT 544
            APE  +  G +  K D+++ G +  EI++
Sbjct: 165 RAPECLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 70.8 bits (173), Expect = 3e-13
 Identities = 65/228 (28%), Positives = 104/228 (45%), Gaps = 41/228 (17%)

Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSK--ASGQGAEEFKNEVVL 394
           +TI     ++   + +G G +G V       +G  +AVK+LS+   S   A+    E+ L
Sbjct: 10  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 69

Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-------------LYDPEKQGQL 441
           +  ++H N++ LL              F P +SL+ F             L +  K  +L
Sbjct: 70  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 117

Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
                  +I  I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 118 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 169

Query: 502 TQGNTSRIVGTYGYMAPEYA---MHGQFSVKSDVYSFGVLVLEIITGK 546
           T    +  V T  Y APE     MH  ++   D++S G ++ E++TG+
Sbjct: 170 TDDEMTGYVATRWYRAPEIMLNWMH--YNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 70.8 bits (173), Expect = 3e-13
 Identities = 68/232 (29%), Positives = 108/232 (46%), Gaps = 43/232 (18%)

Query: 337 FETIEVATNKFSTDNK------LGEGGFGEV---YKGVLPSGQEIAVKRLSK--ASGQGA 385
           F +++VA + F+   +      +G G  G V   +  VL  G  +AVK+LS+   +   A
Sbjct: 7   FYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHA 64

Query: 386 EEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF--------LYDPEK 437
           +    E+VL+  + H+N++ LL              F P KSL+ F        L D   
Sbjct: 65  KRAYRELVLLKCVNHKNIISLLNV------------FTPQKSLEEFQDVYLVMELMDANL 112

Query: 438 ----QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493
                 +LD  R   ++  +  GI +LH      IIHRDLK SNI++ ++   KI DFG+
Sbjct: 113 CQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169

Query: 494 ARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
           AR    +     T  +V  Y Y APE  +   +    D++S G ++ E++ G
Sbjct: 170 ARTACTNFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 70.9 bits (173), Expect = 3e-13
 Identities = 69/233 (29%), Positives = 108/233 (46%), Gaps = 43/233 (18%)

Query: 337 FETIEVATNKFSTDNK------LGEGGFGEV---YKGVLPSGQEIAVKRLSK--ASGQGA 385
           F ++EV  + F+   +      +G G  G V   Y  VL   + +A+K+LS+   +   A
Sbjct: 3   FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHA 60

Query: 386 EEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF--------LYDPEK 437
           +    E+VL+  + H+N++ LL              F P KSL+ F        L D   
Sbjct: 61  KRAYRELVLMKCVNHKNIISLLNV------------FTPQKSLEEFQDVYLVMELMDANL 108

Query: 438 ----QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493
               Q +LD  R   ++  +  GI +LH      IIHRDLK SNI++ ++   KI DFG+
Sbjct: 109 CQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165

Query: 494 ARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
           AR  G       T  +V  Y Y APE  +   +    D++S G ++ E++  K
Sbjct: 166 ARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 70.0 bits (171), Expect = 4e-13
 Identities = 60/201 (29%), Positives = 102/201 (50%), Gaps = 15/201 (7%)

Query: 351 NKLGEGGFGEVYKGVLP-SGQEIAVK--RLSKASGQGAEEFKNEVVLVAKLQHRNLVRLL 407
           +KLGEG +  VYKG    +   +A+K  RL    G      + EV L+  L+H N+V L 
Sbjct: 12  DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLH 70

Query: 408 GFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKI-IGGIARGILYLHEDSRL 466
                 +   LV+E++ +K L  +L D    G        K+ +  + RG+ Y H   R 
Sbjct: 71  DIIHTEKSLTLVFEYL-DKDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCH---RR 123

Query: 467 RIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG-Q 525
           +++HRDLK  N+L++     K++DFG+AR   +  T+  ++ +V T  Y  P+  +    
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSI-PTKTYSNEVV-TLWYRPPDILLGSTD 181

Query: 526 FSVKSDVYSFGVLVLEIITGK 546
           +S + D++  G +  E+ TG+
Sbjct: 182 YSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 70.0 bits (171), Expect = 4e-13
 Identities = 59/200 (29%), Positives = 103/200 (51%), Gaps = 13/200 (6%)

Query: 351 NKLGEGGFGEVYKGVLPSGQE-IAVKRLSKASGQGAE-EFKNEVVLVAKLQHRNLVRLLG 408
            KLGEG +  V+KG     +  +A+K +     +GA      EV L+  L+H N+V L  
Sbjct: 12  EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71

Query: 409 FCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKI-IGGIARGILYLHEDSRLR 467
                +   LV+E++ +K L  ++ D    G +      KI +  I RG+ Y H   R +
Sbjct: 72  IVHTDKSLTLVFEYL-DKDLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCH---RRK 124

Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM-HGQF 526
           ++HRDLK  N+L++     K++DFG+AR   V  T+  ++ +V T  Y  P+  +   ++
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARAKSV-PTKTYSNEVV-TLWYRPPDVLLGSSEY 182

Query: 527 SVKSDVYSFGVLVLEIITGK 546
           S + D++  G +  E+ +G+
Sbjct: 183 STQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 70.3 bits (172), Expect = 4e-13
 Identities = 60/219 (27%), Positives = 102/219 (46%), Gaps = 40/219 (18%)

Query: 346 KFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSK--ASGQGAEEFKNEVVLVAKLQHRN 402
           ++++  ++G G +G V   +   +G+++A+K+LS+   S   A+    E+ L+  +QH N
Sbjct: 16  RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHEN 75

Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSL----DYFLYDPEKQGQLDWSRRYK--------II 450
           ++ LL              F    S     D++L  P  Q  L     +         ++
Sbjct: 76  VIGLLDV------------FTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLV 123

Query: 451 GGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIV 510
             +  G+ Y+H      IIHRDLK  N+ ++ +   KI DFG+AR    + T       V
Sbjct: 124 YQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG-----YV 175

Query: 511 GTYGYMAPEYA---MHGQFSVKSDVYSFGVLVLEIITGK 546
            T  Y APE     MH   +V  D++S G ++ E++TGK
Sbjct: 176 VTRWYRAPEVILNWMHYNQTV--DIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 69.3 bits (170), Expect = 5e-13
 Identities = 56/203 (27%), Positives = 97/203 (47%), Gaps = 22/203 (10%)

Query: 352 KLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKN-------EVVLVAKLQHRNL 403
           K+GEG +G V+K     +GQ +A+K+  ++     E+          E+ ++ +L+H NL
Sbjct: 8   KIGEGSYGVVFKCRNRETGQIVAIKKFVES-----EDDPVIKKIALREIRMLKQLKHPNL 62

Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
           V L+       +  LV+E+  +  L+    +P     +      KII    + + + H  
Sbjct: 63  VNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRG---VPEHLIKKIIWQTLQAVNFCH-- 117

Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM- 522
            +   IHRD+K  NIL+  +   K+ DFG ARI  +     + +  V T  Y APE  + 
Sbjct: 118 -KHNCIHRDVKPENILITKQGQIKLCDFGFARI--LTGPGDDYTDYVATRWYRAPELLVG 174

Query: 523 HGQFSVKSDVYSFGVLVLEIITG 545
             Q+    DV++ G +  E++TG
Sbjct: 175 DTQYGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 70.5 bits (173), Expect = 5e-13
 Identities = 66/236 (27%), Positives = 106/236 (44%), Gaps = 43/236 (18%)

Query: 350 DNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLG 408
           D  +G G FG V+    P  G+ +A+K++          F+N V    K   R L ++L 
Sbjct: 5   DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNV-------FQNLVS--CKRVFREL-KMLC 54

Query: 409 FCLEGEEKIL-VYEFVPNKSLDYF--LYDPEKQGQLDWSRRYKIIGG------------- 452
           F     + +L   + +    +D F  +Y   +  Q D    +KII               
Sbjct: 55  FF--KHDNVLSALDILQPPHIDPFEEIYVVTELMQSDL---HKIIVSPQPLSSDHVKVFL 109

Query: 453 --IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIV 510
             I RG+ YLH      I+HRD+K  N+L+++    KI DFG+AR+   D+++  T  +V
Sbjct: 110 YQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV 166

Query: 511 GTYGYMAPEYAMHGQ-FSVKSDVYSFGVLVLEIITGK----KNSNFYQTDGAADLL 561
             Y Y APE  M  + ++   D++S G +  E++  +      S   Q D   DLL
Sbjct: 167 TQY-YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLL 221

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 70.0 bits (171), Expect = 5e-13
 Identities = 58/200 (29%), Positives = 100/200 (50%), Gaps = 15/200 (7%)

Query: 353 LGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGAEEFKNEVV---LVAKLQHRNLVRLLG 408
           LG+G FG+V         E+ A+K L K      ++ +  +V   ++A       +  L 
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67

Query: 409 FCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
            C +  +++  V E+V    L   +Y  ++ G+    +       I+ G+ +LH      
Sbjct: 68  SCFQTVDRLYFVMEYVNGGDL---MYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG--- 121

Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR-IVGTYGYMAPEYAMHGQF 526
           II+RDLK  N++LD+E + KI+DFGM +   VD   G T+R   GT  Y+APE   +  +
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD---GVTTRTFCGTPDYIAPEIIAYQPY 178

Query: 527 SVKSDVYSFGVLVLEIITGK 546
               D +++GVL+ E++ G+
Sbjct: 179 GKSVDWWAYGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 69.8 bits (171), Expect = 7e-13
 Identities = 55/209 (26%), Positives = 100/209 (47%), Gaps = 20/209 (9%)

Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLL---- 407
           LG G  G V+  V     + +AVK++     Q  +    E+ ++ +L H N+V++     
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72

Query: 408 --GFCLEGEEKILVY---EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
             G  L  +   L      ++  + ++  L +  +QG L        +  + RG+ Y+H 
Sbjct: 73  PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIHS 132

Query: 463 DSRLRIIHRDLKASNILLDAE-MNPKISDFGMARIFGVDQT---QGNTSRIVGTYGYMAP 518
            +   ++HRDLK +N+ ++ E +  KI DFG+ARI  VD     +G  S  + T  Y +P
Sbjct: 133 AN---VLHRDLKPANVFINTEDLVLKIGDFGLARI--VDPHYSHKGYLSEGLVTKWYRSP 187

Query: 519 EYAMHGQFSVKS-DVYSFGVLVLEIITGK 546
              +      K+ D+++ G +  E++TGK
Sbjct: 188 RLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 68.5 bits (167), Expect = 7e-13
 Identities = 65/207 (31%), Positives = 100/207 (48%), Gaps = 30/207 (14%)

Query: 353 LGEGGFGEVYKGVL----PSGQEIAVK--RLSKASGQGAEEFKNEVVLVAKLQHRNLVRL 406
           +GEG FG   + +L     S Q+ A+K  RL K+S    E+ + E VL+AK++H N+V  
Sbjct: 8   VGEGSFG---RALLVQHVNSDQKYAMKEIRLPKSS-SAVEDSRKEAVLLAKMKHPNIVAF 63

Query: 407 L-GFCLEGEEKILVYEFVPNKSLDYFLYD------PEKQGQLDWSRRYKIIGGIARGILY 459
              F  +G   I V E+     L   +        PE    L W  +      +  G+ +
Sbjct: 64  KESFEADGHLYI-VMEYCDGGDLMQKIKLQRGKLFPE-DTILQWFVQ------MCLGVQH 115

Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE 519
           +HE    R++HRD+K+ NI L      K+ DFG AR+         T   VGT  Y+ PE
Sbjct: 116 IHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYYVPPE 170

Query: 520 YAMHGQFSVKSDVYSFGVLVLEIITGK 546
              +  ++ KSD++S G ++ E+ T K
Sbjct: 171 IWENMPYNNKSDIWSLGCILYELCTLK 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 69.4 bits (170), Expect = 7e-13
 Identities = 66/212 (31%), Positives = 105/212 (49%), Gaps = 23/212 (10%)

Query: 353 LGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGAEEFKNEV----VLVAKLQHRNLVRLL 407
           LG+G FG+V    L    E  A+K L K      ++ +  +    VL    +H  L  L 
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL- 61

Query: 408 GFC-LEGEEKIL-VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSR 465
            FC  + +E +  V E++    L   ++  +  G+ D +R       I  G+ +LH+   
Sbjct: 62  -FCTFQTKEHLFFVMEYLNGGDL---MFHIQSSGRFDEARARFYAAEIICGLQFLHKKG- 116

Query: 466 LRIIHRDLKASNILLDAEMNPKISDFGMAR--IFGVDQTQGNTSRIVGTYGYMAPEYAMH 523
             II+RDLK  N+LLD + + KI+DFGM +  + G    +G  S   GT  Y+APE    
Sbjct: 117 --IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG----EGKASTFCGTPDYIAPEILKG 170

Query: 524 GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTD 555
            +++   D +SFGVL+ E++ G+  S F+  D
Sbjct: 171 QKYNESVDWWSFGVLLYEMLIGQ--SPFHGED 200

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 69.0 bits (168), Expect = 9e-13
 Identities = 62/199 (31%), Positives = 94/199 (47%), Gaps = 15/199 (7%)

Query: 352 KLGEGGFGEVYKGVLP-SGQEIAVK--RLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLG 408
           KLGEG +  VYKG    +G+ +A+K  RL +  G      + E  L+  L+H N+V L  
Sbjct: 12  KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHANIVLLHD 70

Query: 409 FCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRI 468
                E   LV+E+V      Y    P   G L        +  + RG+ Y+H+     I
Sbjct: 71  IIHTKETLTLVFEYVHTDLCQYMDKHP---GGLHPENVKLFLFQLLRGLSYIHQRY---I 124

Query: 469 IHRDLKASNILLDAEMNPKISDFGMARIFGV-DQTQGNTSRIVGTYGYMAPEYAMHG-QF 526
           +HRDLK  N+L+      K++DFG+AR   V   T  N    V T  Y  P+  +   ++
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNE---VVTLWYRPPDVLLGSTEY 181

Query: 527 SVKSDVYSFGVLVLEIITG 545
           S   D++  G + +E+I G
Sbjct: 182 STCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 58/200 (29%), Positives = 101/200 (50%), Gaps = 13/200 (6%)

Query: 351 NKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAE-EFKNEVVLVAKLQHRNLVRLLG 408
           +KLGEG +  V+KG    +   +A+K +     +GA      EV L+  L+H N+V L  
Sbjct: 11  DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70

Query: 409 FCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKI-IGGIARGILYLHEDSRLR 467
                    LV+E++ +    Y     +  G L      KI +  + RG+ Y H   + +
Sbjct: 71  IIHTERCLTLVFEYLDSDLKQYL----DNCGNLMSMHNVKIFMFQLLRGLSYCH---KRK 123

Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG-QF 526
           I+HRDLK  N+L++ +   K++DFG+AR   V  T+  ++ +V T  Y  P+  +   ++
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLARAKSV-PTKTYSNEVV-TLWYRPPDVLLGSTEY 181

Query: 527 SVKSDVYSFGVLVLEIITGK 546
           S   D++  G ++ E+ TG+
Sbjct: 182 STPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 68.1 bits (166), Expect = 2e-12
 Identities = 56/204 (27%), Positives = 99/204 (48%), Gaps = 18/204 (8%)

Query: 353 LGEGGFGEVYKGVLPSGQE----IAVKRLSKAS----GQGAEEFKNEVVLVAKLQHRNLV 404
           LG G +G+V+     SG +     A+K L KA+     +  E  + E  ++  ++    +
Sbjct: 8   LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 67

Query: 405 RLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
             L +  + + K+ L+ +++    L   L   E+  + +        G I   + +LH  
Sbjct: 68  VTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQ---IYSGEIVLALEHLH-- 122

Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMH 523
            +L II+RD+K  NILLD+  +  ++DFG+++ F  D+ +   S   GT  YMAP+    
Sbjct: 123 -KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS-FCGTIEYMAPDIVRG 180

Query: 524 GQ--FSVKSDVYSFGVLVLEIITG 545
           G        D +S GVL+ E++TG
Sbjct: 181 GDGGHDKAVDWWSMGVLMYELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 68.5 bits (168), Expect = 2e-12
 Identities = 53/236 (22%), Positives = 100/236 (42%), Gaps = 57/236 (24%)

Query: 335 FDFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASG--QGAEEFKNE 391
           FD  +      ++     +G G +G V   +   SG+++A+K++  A      A+    E
Sbjct: 1   FDVGS------RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRE 54

Query: 392 VVLVAKLQHRNLVRLLG-FCLEGEEKILVY-----------------EFVPNKSLDYFLY 433
           + ++   +H N++ +       G +   VY                 + +  + + YFLY
Sbjct: 55  LKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLY 114

Query: 434 DPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493
                              + RG+ Y+H  +   +IHRDLK SN+L++ +   +I DFGM
Sbjct: 115 Q------------------LLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGM 153

Query: 494 ARIFGVDQTQGNTSRI----VGTYGYMAPE--YAMHGQFSVKSDVYSFGVLVLEII 543
           AR  G+  +           V T  Y APE   ++  +++   D++S G +  E++
Sbjct: 154 AR--GLSSSPTEHKYFMTEYVATRWYRAPELLLSLP-EYTTAIDMWSVGCIFAEML 206

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 68.1 bits (166), Expect = 2e-12
 Identities = 60/211 (28%), Positives = 108/211 (51%), Gaps = 17/211 (8%)

Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
           E+  + F   ++LG G  G V+K        I  ++L     + A   +N+++   ++ H
Sbjct: 1   ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPA--IRNQIIRELQVLH 58

Query: 401 R-NLVRLLGFC----LEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
             N   ++GF      +GE  I + E +   SLD  L   +K G++      K+   + +
Sbjct: 59  ECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIK 114

Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGY 515
           G+ YL E  + +I+HRD+K SNIL+++    K+ DFG++    +D      +  VGT  Y
Sbjct: 115 GLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSM---ANSFVGTRSY 168

Query: 516 MAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
           M+PE      +SV+SD++S G+ ++E+  G+
Sbjct: 169 MSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 67.9 bits (166), Expect = 2e-12
 Identities = 63/228 (27%), Positives = 107/228 (46%), Gaps = 24/228 (10%)

Query: 353 LGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGAEEF------KNEVVLVAKLQHRNLVR 405
           LG+G FG+V    L    E+ A+K L K      ++       K  + L AK  H  L  
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAK--HPFLTA 60

Query: 406 LLGFCLEGEEKIL-VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
           L   C + ++++  V E+V    L   ++  ++  + D  R       +   +++LH   
Sbjct: 61  LHC-CFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG 116

Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN-TSRIVGTYGYMAPEYAMH 523
              +I+RDLK  NILLDAE + K++DFGM +        G  T+   GT  Y+APE    
Sbjct: 117 ---VIYRDLKLDNILLDAEGHCKLADFGMCK---EGILNGVTTTTFCGTPDYIAPEILQE 170

Query: 524 GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYVSINVIIY 571
            ++    D ++ GVL+ E++ G+     ++ D   DL   +  + ++Y
Sbjct: 171 LEYGPSVDWWALGVLMYEMMAGQPP---FEADNEDDLFESILHDDVLY 215

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 67.2 bits (164), Expect = 3e-12
 Identities = 62/215 (28%), Positives = 106/215 (49%), Gaps = 36/215 (16%)

Query: 351 NKLGEGGFGEVYKGVL--PSGQEIAVK--RLSKASGQGAEEFK-NEVVLVAKLQHR---- 401
           ++LG+G +G VYK VL  P+G  +A+K  RL        +E K N++++   + H+    
Sbjct: 7   DELGKGNYGSVYK-VLHRPTGVTMAMKEIRLE------LDESKFNQIIMELDILHKAVSP 59

Query: 402 NLVRLLG-FCLEGEEKILVY---EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGI 457
            +V   G F +EG     VY   E++   SLD           +      +I   + +G+
Sbjct: 60  YIVDFYGAFFIEGA----VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGL 115

Query: 458 LYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMA 517
            +L E+    IIHRD+K +N+L++     K+ DFG++        + N    +G   YMA
Sbjct: 116 KFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN----IGCQSYMA 169

Query: 518 PEY------AMHGQFSVKSDVYSFGVLVLEIITGK 546
           PE         +  ++V+SDV+S G+ +LE+  G+
Sbjct: 170 PERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 67.7 bits (165), Expect = 3e-12
 Identities = 62/223 (27%), Positives = 110/223 (49%), Gaps = 33/223 (14%)

Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVY----KGVLPSGQEIAVKRLSKAS----GQGAEE 387
           +FE ++V          LG G +G+V+         +G+  A+K L KA+     +  E 
Sbjct: 1   NFELLKV----------LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEH 50

Query: 388 FKNEVVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRR 446
            + E  ++  ++    +  L +  + E K+ L+ ++V    +   LY  +   + D  R 
Sbjct: 51  TRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSE-DEVRF 109

Query: 447 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT 506
           Y   G I   + +LH   +L I++RD+K  NILLD+E +  ++DFG+++ F + + +  T
Sbjct: 110 Y--SGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF-LSEEKERT 163

Query: 507 SRIVGTYGYMAPEY----AMHGQFSVKSDVYSFGVLVLEIITG 545
               GT  YMAPE       HG+     D +S G+L+ E++TG
Sbjct: 164 YSFCGTIEYMAPEIIRGKGGHGK---AVDWWSLGILIFELLTG 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 66.9 bits (163), Expect = 4e-12
 Identities = 59/198 (29%), Positives = 100/198 (50%), Gaps = 14/198 (7%)

Query: 353 LGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGAEEFKN---EVVLVAKLQHRNLVRLLG 408
           +G+G FG+V +      Q I A+K + KA      E  +   E  ++A++    +V L  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPL-K 59

Query: 409 FCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
           F  +  EK+ LV  F+    L + L   +++G+ D SR       +   +  LH+     
Sbjct: 60  FSFQSPEKLYLVLAFINGGELFHHL---QREGRFDLSRARFYTAELLCALENLHK---FN 113

Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFS 527
           +I+RDLK  NILLD + +  + DFG+ ++   D  + NT    GT  Y+APE  +   ++
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT--FCGTPEYLAPELLLGHGYT 171

Query: 528 VKSDVYSFGVLVLEIITG 545
              D ++ GVL+ E++TG
Sbjct: 172 KAVDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 66.7 bits (163), Expect = 4e-12
 Identities = 58/206 (28%), Positives = 95/206 (46%), Gaps = 31/206 (15%)

Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLG 408
           +G G FG V+      S    A+K ++       +  +   NE  ++ ++ H  ++RL  
Sbjct: 9   VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL-- 66

Query: 409 FCLEGEEKIL--VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGG------IARGILYL 460
           F  E +++ L  + E+VP   L  F Y       L  S R+    G      I   + YL
Sbjct: 67  FWTEHDQRFLYMLMEYVPGGEL--FSY-------LRNSGRFSNSTGLFYASEIVCALEYL 117

Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEY 520
           H      I++RDLK  NILLD E + K++DFG A+     + +  T  + GT  Y+APE 
Sbjct: 118 HS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGTPEYLAPEV 169

Query: 521 AMHGQFSVKSDVYSFGVLVLEIITGK 546
                 +   D ++ G+L+ E++ G 
Sbjct: 170 IQSKGHNKAVDWWALGILIYEMLVGY 195

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 67.0 bits (163), Expect = 5e-12
 Identities = 60/215 (27%), Positives = 109/215 (50%), Gaps = 25/215 (11%)

Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
           E+  + F   ++LG G  G V K        I  ++L     + A   +N+++   ++ H
Sbjct: 1   ELKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPA--IRNQIIRELQVLH 58

Query: 401 R-NLVRLLGFC----LEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIA- 454
             N   ++GF      +GE  I + E +   SLD  L + ++  +       +I+G ++ 
Sbjct: 59  ECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKEAKRIPE-------EILGKVSI 110

Query: 455 ---RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVG 511
              RG+ YL E  + +I+HRD+K SNIL+++    K+ DFG++    +D      +  VG
Sbjct: 111 AVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSM---ANSFVG 164

Query: 512 TYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
           T  YM+PE      +SV+SD++S G+ ++E+  G+
Sbjct: 165 TRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 66.4 bits (162), Expect = 6e-12
 Identities = 57/208 (27%), Positives = 99/208 (47%), Gaps = 21/208 (10%)

Query: 352 KLGEGGFGEVYKGV-LPSGQEIAVKR-LSKASGQGAEEFK-NEVVLVAKLQHRN-LVRLL 407
           K+GEG +G+VYK     +G+ +A+K+   +   +G       E+ L+  L     +VRLL
Sbjct: 8   KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67

Query: 408 GFCLEG-EEKI------LVYEFVPNKSLDYFLYDPEKQGQ-LDWSRRYKIIGGIARGILY 459
              +E  EEK       LV+E++ +    +   +    G+ L        +  + +G+ +
Sbjct: 68  --DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAH 125

Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
            H   +  ++HRDLK  N+L+D +    KI+D G+ R F +   +  T  IV T  Y AP
Sbjct: 126 CH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI-PVKSYTHEIV-TLWYRAP 180

Query: 519 EYAMHG-QFSVKSDVYSFGVLVLEIITG 545
           E  +    +S   D++S G +  E+   
Sbjct: 181 EVLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 67.0 bits (163), Expect = 6e-12
 Identities = 71/245 (28%), Positives = 112/245 (45%), Gaps = 30/245 (12%)

Query: 322 NADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSK- 379
           N DN L   E +      +++    +     +G G FGEV      S Q++ A+K LSK 
Sbjct: 20  NIDNFLNRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKF 79

Query: 380 --ASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL--VYEFVPNKSLDYFL--Y 433
                  +  F  E  ++A      +V+L  FC   ++K L  V E++P   L   +  Y
Sbjct: 80  EMIKRSDSAFFWEERDIMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSNY 137

Query: 434 D-PEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 492
           D PEK     W++ Y      A  +L L     + +IHRD+K  N+LLD   + K++DFG
Sbjct: 138 DVPEK-----WAKFYT-----AEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFG 187

Query: 493 MARIFGVDQT-QGNTSRIVGTYGYMAPEY----AMHGQFSVKSDVYSFGVLVLEIITGKK 547
                 +D+T        VGT  Y++PE        G +  + D +S GV + E++ G  
Sbjct: 188 TC--MKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG-- 243

Query: 548 NSNFY 552
           ++ FY
Sbjct: 244 DTPFY 248

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 66.7 bits (163), Expect = 6e-12
 Identities = 63/211 (29%), Positives = 102/211 (48%), Gaps = 17/211 (8%)

Query: 353 LGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGAEEFKNEV----VLVAKLQHRNLVRLL 407
           +G+G FG+V      +  +  AVK L K +    +E K+ +    VL+  ++H  LV L 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL- 61

Query: 408 GFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRL 466
            +  +  +K+  V ++V    L +F    E+      +R Y     IA  + YLH    L
Sbjct: 62  HYSFQTADKLYFVLDYVNGGEL-FFHLQRERSFPEPRARFYA--AEIASALGYLHS---L 115

Query: 467 RIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQF 526
            II+RDLK  NILLD++ +  ++DFG+ +  G+ +    TS   GT  Y+APE      +
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCK-EGI-EHSKTTSTFCGTPEYLAPEVLRKQPY 173

Query: 527 SVKSDVYSFGVLVLEIITGKKNSNFYQTDGA 557
               D +  G ++ E++ G     FY  D A
Sbjct: 174 DRTVDWWCLGAVLYEMLYGL--PPFYSRDTA 202

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 66.7 bits (163), Expect = 9e-12
 Identities = 73/271 (26%), Positives = 114/271 (42%), Gaps = 38/271 (14%)

Query: 295 VTAVLFILGFCFLRRKAKKKYNAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLG 354
           VTA+++      LR+            N DN L+  E        + +    F     +G
Sbjct: 3   VTALVYDCDIPALRK----------NKNIDNFLSRYEKAAEKITKLRMKAEDFDVIKVIG 52

Query: 355 EGGFGEVYKGVLPSGQEI-AVKRLSKASGQGAEE---FKNEVVLVAKLQHRNLVRLLGFC 410
            G FGEV      S +++ A+K LSK       +   F  E  ++A      +V+L    
Sbjct: 53  RGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQL--HY 110

Query: 411 LEGEEKIL--VYEFVPNKSLDYFL--YD-PEKQGQLDWSRRYKIIGGIARGILYLHEDSR 465
              ++K L  V E++P   L   +  YD PEK     W+R Y      A  +L L     
Sbjct: 111 AFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEK-----WARFY-----TAEVVLALDAIHS 160

Query: 466 LRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM--- 522
           +  IHRD+K  N+LLD   + K++DFG       +         VGT  Y++PE      
Sbjct: 161 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN-GMVRCDTAVGTPDYISPEVLKSQG 219

Query: 523 -HGQFSVKSDVYSFGVLVLEIITGKKNSNFY 552
             G +  + D +S GV + E++ G  ++ FY
Sbjct: 220 GDGYYGRECDWWSVGVFLYEMLVG--DTPFY 248

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 67.5 bits (165), Expect = 1e-11
 Identities = 59/221 (26%), Positives = 95/221 (42%), Gaps = 31/221 (14%)

Query: 352 KLGEGGFGEVYKGVLPS-GQEIAVKRLSKASGQGA---EEFKNEVVLVAKLQHRNLVRLL 407
            +G+GG GEVY    P   + +A+K++ +   +     + F  E  + A L H  +V + 
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68

Query: 408 GFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYK--------IIGGIARGILY 459
             C +G+       ++   +L   L    ++  L      K        I   I   I Y
Sbjct: 69  SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEY 128

Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI----------FGVDQTQGNTS-- 507
           +H  S+  ++HRDLK  NILL       I D+G A              VD+     S  
Sbjct: 129 VH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSM 185

Query: 508 ----RIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
               +IVGT  YMAPE  +    S  +D+Y+ GV++ +++T
Sbjct: 186 TIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 65.8 bits (160), Expect = 1e-11
 Identities = 62/229 (27%), Positives = 106/229 (46%), Gaps = 29/229 (12%)

Query: 352 KLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQG-AEEFKNEVVLVAKLQHRNLVRLLG-F 409
           K+G G +G VYK     G++     L +  G G +     E+ L+ +L+H N++ L   F
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67

Query: 410 CLEGEEKI-LVYEFVPNKSLDYFLYD-----PEKQGQLDWSRRYKIIGGIARGILYLHED 463
               + K+ L++++  +       +       +K  QL       ++  I  GI YLH +
Sbjct: 68  LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 127

Query: 464 SRLRIIHRDLKASNILLDAEMNP-----KISDFGMARIFGVD-QTQGNTSRIVGTYGYMA 517
               ++HRDLK +NIL+  E  P     KI+D G AR+F    +   +   +V T+ Y A
Sbjct: 128 ---WVLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183

Query: 518 PEYAMHGQFSVKS-DVYSFGVLVLEIITGK----------KNSNFYQTD 555
           PE  +  +   K+ D+++ G +  E++T +          K SN Y  D
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 232

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 65.9 bits (160), Expect = 1e-11
 Identities = 60/219 (27%), Positives = 105/219 (47%), Gaps = 19/219 (8%)

Query: 352 KLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQG-AEEFKNEVVLVAKLQHRNLVRLLG-F 409
           K+G G +G VYK     G++     L +  G G +     E+ L+ +L+H N++ L   F
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67

Query: 410 CLEGEEKI-LVYEFVPNKSLDYFLYD-----PEKQGQLDWSRRYKIIGGIARGILYLHED 463
               + K+ L++++  +       +       +K  QL  S    ++  I  GI YLH +
Sbjct: 68  LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127

Query: 464 SRLRIIHRDLKASNILLDAEMNP-----KISDFGMARIFGVD-QTQGNTSRIVGTYGYMA 517
               ++HRDLK +NIL+  E  P     KI+D G AR+F    +   +   +V T+ Y A
Sbjct: 128 ---WVLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183

Query: 518 PEYAMHGQFSVKS-DVYSFGVLVLEIITGKKNSNFYQTD 555
           PE  +  +   K+ D+++ G +  E++T +   +  Q D
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 222

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 65.6 bits (160), Expect = 1e-11
 Identities = 40/94 (42%), Positives = 56/94 (59%), Gaps = 7/94 (7%)

Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IF-GVDQTQGNTSRIV 510
           +ARG+ +L   SR + IHRDL A NILL      KI DFG+AR I+   D  +   +R+ 
Sbjct: 182 VARGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL- 237

Query: 511 GTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
               +MAPE      ++ +SDV+SFGVL+ EI +
Sbjct: 238 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 65.5 bits (159), Expect = 2e-11
 Identities = 61/213 (28%), Positives = 95/213 (44%), Gaps = 41/213 (19%)

Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSK--ASGQGAEEFKNEVVLVAKLQHRNLVRLLGF 409
           +G G +G V         Q++AVK+LS+   S   A     E+ L+  ++H N++ LL  
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82

Query: 410 CLEGEEKILVYEFVPNKSLDYF-------------LYDPEKQGQLDWSRRYKIIGGIARG 456
                       F P  S++ F             L +  K  +L       +I  + RG
Sbjct: 83  ------------FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRG 130

Query: 457 ILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYM 516
           + Y+H      IIHRDLK SN+ ++ +   +I DFG+AR     Q     +  V T  Y 
Sbjct: 131 LKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR-----QADDEMTGYVATRWYR 182

Query: 517 APEYA---MHGQFSVKSDVYSFGVLVLEIITGK 546
           APE     MH   +V  D++S G ++ E++ GK
Sbjct: 183 APEIMLNWMHYNQTV--DIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 65.0 bits (158), Expect = 2e-11
 Identities = 57/199 (28%), Positives = 95/199 (47%), Gaps = 13/199 (6%)

Query: 353 LGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGAEEFKNEVV---LVAKLQHRNLVRLLG 408
           LG+G FG+V         E+ A+K L K      ++ +  +V   ++A       +  L 
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLH 67

Query: 409 FCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
            C +  +++  V E+V    L   +Y  ++ G+            IA G+ +LH      
Sbjct: 68  SCFQTMDRLYFVMEYVNGGDL---MYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG--- 121

Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFS 527
           II+RDLK  N++LD+E + KI+DFGM +    D     T    GT  Y+APE   +  + 
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV--TTKTFCGTPDYIAPEIIAYQPYG 179

Query: 528 VKSDVYSFGVLVLEIITGK 546
              D ++FGVL+ E++ G+
Sbjct: 180 KSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 64.6 bits (157), Expect = 2e-11
 Identities = 57/208 (27%), Positives = 97/208 (46%), Gaps = 16/208 (7%)

Query: 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGAEEFKN----EVVLVAKLQ 399
           NKF     +GEG +G V K      +EI A+K+   +  +  EE K     E+ ++  L+
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDS--EENEEVKETTLRELKMLRTLK 58

Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQL-DWSRRYKIIGGIARGIL 458
             N+V L        +  LV+E+V    L+  L +    G   +  R Y  I  + + I 
Sbjct: 59  QENIVELKEAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVRSY--IYQLIKAIH 114

Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
           + H++    I+HRD+K  N+L+      K+ DFG AR    + +  N +  V T  Y +P
Sbjct: 115 WCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLS-EGSNANYTEYVATRWYRSP 170

Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITGK 546
           E  +   +    D++S G ++ E+  G+
Sbjct: 171 ELLLGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 64.4 bits (157), Expect = 3e-11
 Identities = 60/205 (29%), Positives = 101/205 (49%), Gaps = 24/205 (11%)

Query: 353 LGEGGFGEVYKGVLPSGQE----IAVKRLSKA----SGQGAEEFKNEVVLVAKLQHRNLV 404
           LG+GG+G+V++    +G +     A+K L KA    + +     K E  ++  ++H  +V
Sbjct: 4   LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63

Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQL--DWSRRYKIIGGIARGILYLHE 462
            L+     G +  L+ E++    L   L   E++G    D +  Y  +  I+  + +LH 
Sbjct: 64  DLIYAFQTGGKLYLILEYLSGGELFMHL---EREGIFMEDTACFY--LSEISLALEHLH- 117

Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN--TSRIVGTYGYMAPEY 520
             +  II+RDLK  NILLDA+ + K++DFG+ +    +       T    GT  YMAPE 
Sbjct: 118 --QQGIIYRDLKPENILLDAQGHVKLTDFGLCK----ESIHEGTVTHTFCGTIEYMAPEI 171

Query: 521 AMHGQFSVKSDVYSFGVLVLEIITG 545
            M        D +S G L+ +++TG
Sbjct: 172 LMRSGHGKAVDWWSLGALMYDMLTG 196

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 64.3 bits (156), Expect = 3e-11
 Identities = 63/225 (28%), Positives = 104/225 (46%), Gaps = 25/225 (11%)

Query: 337 FETIEVATNKFSTDNKLGEGGFGEVYKGVL--PSGQEIAVKRLSKASGQGAEEFKNEVVL 394
           F++    ++ +     +G+G +G+V+K VL   +G + AVK L        E      +L
Sbjct: 10  FDSFPDPSDTWEIIETIGKGTYGKVFK-VLNKKNGSKAAVKILDPIHDIDEEIEAEYNIL 68

Query: 395 VAKLQHRNLVRLLGFCLE-----GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKI 449
            A   H N+V+  G   +     G++  LV E     S+   +    K+G+        I
Sbjct: 69  KALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGE---RMEEPI 125

Query: 450 IGGIAR----GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN 505
           I  I      G+ +LH +   + IHRD+K +NILL  E   K+ DFG++      + + N
Sbjct: 126 IAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN 182

Query: 506 TSRIVGTYGYMAPEY-----AMHGQFSVKSDVYSFGVLVLEIITG 545
           TS  VGT  +MAPE       +   +  + DV+S G+  +E+  G
Sbjct: 183 TS--VGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 64.1 bits (156), Expect = 4e-11
 Identities = 46/140 (32%), Positives = 76/140 (54%), Gaps = 13/140 (9%)

Query: 410 CLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQL--DWSRRYKIIGGIARGILYLHEDSRL 466
           C + E ++  V EFV    L   ++  ++Q +L  + +R Y     I+  + +LHE    
Sbjct: 64  CFQTESRLFFVIEFVSGGDL---MFHMQRQRKLPEEHARFYS--AEISLALNFLHERG-- 116

Query: 467 RIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQF 526
            II+RDLK  N+LLDAE + K++D+GM +  G+ +    TS   GT  Y+APE      +
Sbjct: 117 -IIYRDLKLDNVLLDAEGHIKLTDYGMCK-EGI-RPGDTTSTFCGTPNYIAPEILRGEDY 173

Query: 527 SVKSDVYSFGVLVLEIITGK 546
               D ++ GVL+ E++ G+
Sbjct: 174 GFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 63.1 bits (153), Expect = 5e-11
 Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 20/209 (9%)

Query: 353 LGEGGFGEVYK-GVLPSGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRN--LVRL 406
           +G GGFGEVY      +G+  A+K L K      QG     NE ++++ +   +   +  
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 407 LGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSR 465
           + +     +K+  + + +    L Y L    + G             I  G+ ++H  +R
Sbjct: 62  MTYAFHTPDKLCFILDLMNGGDLHYHL---SQHGVFSEKEMRFYATEIILGLEHMH--NR 116

Query: 466 LRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQ 525
             +++RDLK +NILLD   + +ISD G+A  F   +   +    VGT+GYMAPE    G 
Sbjct: 117 F-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEVLQKGT 171

Query: 526 -FSVKSDVYSFGVLVLEIITGKKNSNFYQ 553
            +   +D +S G ++ +++ G  +S F Q
Sbjct: 172 AYDSSADWFSLGCMLFKLLRG--HSPFRQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 63.5 bits (154), Expect = 7e-11
 Identities = 66/209 (31%), Positives = 101/209 (48%), Gaps = 17/209 (8%)

Query: 353 LGEGGFGEVYKGVLPS-GQEIAVKRLSKASGQGAEEFKNEV----VLVAKLQHRNLVRLL 407
           +G+G FG+V      S G   AVK L K +    +E  + +    VL+  L+H  LV L 
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL- 61

Query: 408 GFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRL 466
            +  +  EK+  V ++V    L +F    E+      +R Y     +A  I YLH    L
Sbjct: 62  HYSFQTAEKLYFVLDYVNGGEL-FFHLQRERCFLEPRARFYA--AEVASAIGYLHS---L 115

Query: 467 RIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQF 526
            II+RDLK  NILLD++ +  ++DFG+ +  GV+  +  TS   GT  Y+APE      +
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCK-EGVEP-EETTSTFCGTPEYLAPEVLRKEPY 173

Query: 527 SVKSDVYSFGVLVLEIITGKKNSNFYQTD 555
               D +  G ++ E++ G     FY  D
Sbjct: 174 DRTVDWWCLGAVLYEMLYGL--PPFYSRD 200

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 62.8 bits (153), Expect = 1e-10
 Identities = 55/225 (24%), Positives = 98/225 (43%), Gaps = 62/225 (27%)

Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKN---------EVVLVAKLQHRN 402
           +G G +G V       + +++A+K+++ A       F N         E+ L+  L H N
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANA-------FDNRIDAKRTLREIKLLRHLDHEN 65

Query: 403 LVRLLGFCLEGEEK------ILVYEFV---------PNKSL-----DYFLYDPEKQGQLD 442
           ++ +    +    +       +VYE +          +++L      YFLY         
Sbjct: 66  VIAIKD-IMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQ-------- 116

Query: 443 WSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502
                     + RG+ Y+H  +   ++HRDLK SN+LL+A  + KI DFG+AR     + 
Sbjct: 117 ----------LLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART--TSEK 161

Query: 503 QGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGK 546
               +  V T  Y APE  ++  +++   DV+S G +  E++  K
Sbjct: 162 GDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 62.5 bits (152), Expect = 1e-10
 Identities = 61/211 (28%), Positives = 92/211 (43%), Gaps = 31/211 (14%)

Query: 347 FSTDNKLGEGGFGEV----YKGVLPSGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQ 399
           F     LG G FG V    +KG   +G+  A+K L K      +  +    E  ++ +L 
Sbjct: 20  FEMGETLGTGSFGRVRIAKHKG---TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS 76

Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQL--DWSRRYKIIGGIARGI 457
           H  +V ++    +      + EFV    L   L    K G+   D ++ Y      A  +
Sbjct: 77  HPFIVNMMCSFQDENRVYFLLEFVVGGELFTHL---RKAGRFPNDVAKFYH-----AELV 128

Query: 458 L---YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
           L   YLH      II+RDLK  N+LLD + + K++DFG A+     +    T  + GT  
Sbjct: 129 LAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCGTPE 180

Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
           Y+APE           D ++ GVL+ E I G
Sbjct: 181 YLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 62.0 bits (151), Expect = 1e-10
 Identities = 57/199 (28%), Positives = 100/199 (50%), Gaps = 15/199 (7%)

Query: 352 KLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFK--NEVVLVAKLQHRNLVRLLG 408
           KLGEG +  VYKG    +GQ +A+K +     +GA  F    E  L+  L+H N+V L  
Sbjct: 12  KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA-PFTAIREASLLKDLKHANIVTLHD 70

Query: 409 FCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKI-IGGIARGILYLHEDSRLR 467
                +   LV+E++ +  L  ++   +  G        ++ +  + RG+ Y H   + R
Sbjct: 71  IIHTKKTLTLVFEYL-DTDLKQYM---DDCGGGLSMHNVRLFLFQLLRGLAYCH---QRR 123

Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG-QF 526
           ++HRDLK  N+L+      K++DFG+AR   V  ++  ++ +V T  Y  P+  +   ++
Sbjct: 124 VLHRDLKPQNLLISERGELKLADFGLARAKSV-PSKTYSNEVV-TLWYRPPDVLLGSTEY 181

Query: 527 SVKSDVYSFGVLVLEIITG 545
           S   D++  G +  E+ TG
Sbjct: 182 STSLDMWGVGCIFYEMATG 200

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 62.3 bits (151), Expect = 2e-10
 Identities = 68/228 (29%), Positives = 98/228 (42%), Gaps = 52/228 (22%)

Query: 353 LGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCL 411
           +G+G FG+VY+      + I A+K LSK              +VAK +  + +       
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKK------------EIVAKKEVAHTI------- 41

Query: 412 EGEEKILV--------------YEFVPNKSLDYFLYDPEKQGQLDW---------SRRYK 448
            GE  ILV              + F  +  L Y + D    G+L W           R K
Sbjct: 42  -GERNILVRTLLDESPFIVGLKFSFQTDSDL-YLVTDYMSGGELFWHLQKEGRFSEDRAK 99

Query: 449 IIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR 508
               IA  +L L    +  I++RDLK  NILLDA  +  + DFG+++    D    NT  
Sbjct: 100 FY--IAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT-- 155

Query: 509 IVGTYGYMAPEYAMHGQ-FSVKSDVYSFGVLVLEIITGKKNSNFYQTD 555
             GT  Y+APE  +  + ++   D +S GVLV E+  G   S FY  D
Sbjct: 156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGW--SPFYAED 201

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 61.1 bits (148), Expect = 2e-10
 Identities = 56/203 (27%), Positives = 98/203 (48%), Gaps = 22/203 (10%)

Query: 353 LGEGGFGEVY---KGVLPSGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRN--LV 404
           +G GGFGEVY   K    +G+  A+K L K      QG     NE ++++ +   +   +
Sbjct: 2   IGRGGFGEVYGCRKA--DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59

Query: 405 RLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
             + +     +K+  + + +    L Y L    + G    +        I  G+ ++H  
Sbjct: 60  VCMSYAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFSEAEMRFYAAEIILGLEHMH-- 114

Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMH 523
           +R  +++RDLK +NILLD   + +ISD G+A     D ++      VGT+GYMAPE    
Sbjct: 115 NRF-VVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPEVLQK 169

Query: 524 G-QFSVKSDVYSFGVLVLEIITG 545
           G  +   +D +S G ++ +++ G
Sbjct: 170 GVAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 62.0 bits (150), Expect = 2e-10
 Identities = 45/140 (32%), Positives = 76/140 (54%), Gaps = 13/140 (9%)

Query: 410 CLEGEEKIL-VYEFVPNKSLDYFLYDPEKQGQL--DWSRRYKIIGGIARGILYLHEDSRL 466
           C + E ++  V E+V    L   ++  ++Q +L  + +R Y     I+  + YLHE    
Sbjct: 64  CFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYS--AEISLALNYLHERG-- 116

Query: 467 RIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQF 526
            II+RDLK  N+LLD+E + K++D+GM +  G+ +    TS   GT  Y+APE      +
Sbjct: 117 -IIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGL-RPGDTTSTFCGTPNYIAPEILRGEDY 173

Query: 527 SVKSDVYSFGVLVLEIITGK 546
               D ++ GVL+ E++ G+
Sbjct: 174 GFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 61.9 bits (150), Expect = 2e-10
 Identities = 40/94 (42%), Positives = 57/94 (60%), Gaps = 7/94 (7%)

Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IF-GVDQTQGNTSRIV 510
           +ARG+ +L   SR + IHRDL A NILL      KI DFG+AR I+   D  +  ++R+ 
Sbjct: 183 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL- 238

Query: 511 GTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
               +MAPE      ++ +SDV+SFGVL+ EI +
Sbjct: 239 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 61.7 bits (150), Expect = 2e-10
 Identities = 35/97 (36%), Positives = 55/97 (56%), Gaps = 6/97 (6%)

Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD--QTQGNTSRIV 510
           I  G+ Y+H  +   ++HRDLK  N+L++A+   KI DFG+AR F  +  +  G  +  V
Sbjct: 114 ILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV 170

Query: 511 GTYGYMAPEYAMHGQFSVKS-DVYSFGVLVLEIITGK 546
            T  Y APE  +  Q   K+ DV+S G ++ E++  K
Sbjct: 171 ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 62.8 bits (152), Expect = 3e-10
 Identities = 65/246 (26%), Positives = 108/246 (43%), Gaps = 36/246 (14%)

Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKN---EVVLVAK 397
           E   N++    K+G G FGEV+       QE    +     G    E      EV ++ +
Sbjct: 9   ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRE 68

Query: 398 LQHRNLVRLLG-FCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQ-GQLDWSRRYKIIGGIA 454
           L+H+N+VR +  F  +  +K+ ++ EF     L   +    K  G+++      I   + 
Sbjct: 69  LKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLL 128

Query: 455 RGILYLHE----DSRLRIIHRDLKASNILLD----------AEMN-------PKISDFGM 493
             + Y H      +  R++HRDLK  NI L           A+ N        KI DFG+
Sbjct: 129 HALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGL 188

Query: 494 ARIFGVDQTQGNTSRIVGTYGYMAPEYAMH--GQFSVKSDVYSFGVLVLEIITGK----K 547
           ++  G++         VGT  Y +PE  +H    +  KSD+++ G ++ E+ +GK    K
Sbjct: 189 SKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245

Query: 548 NSNFYQ 553
            +NF Q
Sbjct: 246 ANNFSQ 251

Length = 1021

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 61.0 bits (148), Expect = 4e-10
 Identities = 59/213 (27%), Positives = 101/213 (47%), Gaps = 18/213 (8%)

Query: 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGAEE----FKNEVVLVAKLQ 399
             F   + +G G FGEV      +  +I A+K + K+    A+E    F+ E  +++   
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSV-LLAQETVSFFEEERDILSISN 59

Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
              + +L     + +   LV E+ P   L   L   E Q   D ++ Y     +A  +L 
Sbjct: 60  SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFY-----LAELVLA 114

Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE 519
           +H   ++  +HRD+K  N+L+D   + K++DFG A     ++   N+   VGT  Y+APE
Sbjct: 115 IHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV-NSKLPVGTPDYIAPE 173

Query: 520 Y--AMHG----QFSVKSDVYSFGVLVLEIITGK 546
               M+G     + V+ D +S GV+  E+I G+
Sbjct: 174 VLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 60.8 bits (147), Expect = 6e-10
 Identities = 67/229 (29%), Positives = 106/229 (46%), Gaps = 33/229 (14%)

Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGAEE---FKNE 391
           DFE I+V          +G G FGEV    +   + I A+K L+K       E   F+ E
Sbjct: 2   DFEIIKV----------IGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREE 51

Query: 392 --VVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYK 448
             V++    Q    +  L +  + E  + LV ++     L   L   E +   D +R Y 
Sbjct: 52  RNVLVNGDCQ---WITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY- 107

Query: 449 IIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR 508
               IA  +L +H   +L  +HRD+K  N+LLD   + +++DFG       D T   +S 
Sbjct: 108 ----IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV-QSSV 162

Query: 509 IVGTYGYMAPEY--AMH---GQFSVKSDVYSFGVLVLEIITGKKNSNFY 552
            VGT  Y++PE   AM    G++  + D +S GV + E++ G+  + FY
Sbjct: 163 AVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE--TPFY 209

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 60.2 bits (146), Expect = 9e-10
 Identities = 66/247 (26%), Positives = 112/247 (45%), Gaps = 52/247 (21%)

Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFK--NEVVLVAKLQHRNLVRLLGF 409
           +G+G +G V   +   +G+++A+K+++      ++  +   E+ L+  L+H ++V +   
Sbjct: 8   IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 67

Query: 410 CL-----EGEEKILVYEFV---------PNKSL-----DYFLYDPEKQGQLDWSRRYKII 450
            L     E ++  +V+E +          N  L      +FLY      QL         
Sbjct: 68  MLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLY------QL--------- 112

Query: 451 GGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI-FGVDQTQGNTSRI 509
               R + Y+H  +   + HRDLK  NIL +A+   KI DFG+AR+ F    T    +  
Sbjct: 113 ---LRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 166

Query: 510 VGTYGYMAPEY--AMHGQFSVKSDVYSFGVLVLEIITGK-----KNSNFYQTDGAADLLS 562
           V T  Y APE   +   +++   D++S G +  E++TGK     KN   +Q D   DLL 
Sbjct: 167 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV-VHQLDLITDLLG 225

Query: 563 YVSINVI 569
             S   I
Sbjct: 226 TPSPETI 232

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 60.0 bits (145), Expect = 9e-10
 Identities = 39/94 (41%), Positives = 57/94 (60%), Gaps = 7/94 (7%)

Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IF-GVDQTQGNTSRIV 510
           +A+G+ +L   SR + IHRDL A NILL      KI DFG+AR I+   D  +   +R+ 
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL- 243

Query: 511 GTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
               +MAPE      ++++SDV+SFGVL+ EI +
Sbjct: 244 -PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 60.0 bits (145), Expect = 9e-10
 Identities = 42/138 (30%), Positives = 71/138 (51%), Gaps = 9/138 (6%)

Query: 410 CLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRI 468
           C +   ++ LV E+V    L   ++  ++Q +L           I   + +LHE     I
Sbjct: 64  CFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAEICIALNFLHERG---I 117

Query: 469 IHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSV 528
           I+RDLK  N+LLDA+ + K++D+GM +  G+      TS   GT  Y+APE     ++  
Sbjct: 118 IYRDLKLDNVLLDADGHIKLTDYGMCK-EGL-GPGDTTSTFCGTPNYIAPEILRGEEYGF 175

Query: 529 KSDVYSFGVLVLEIITGK 546
             D ++ GVL+ E++ G+
Sbjct: 176 SVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 60.1 bits (146), Expect = 1e-09
 Identities = 66/262 (25%), Positives = 109/262 (41%), Gaps = 80/262 (30%)

Query: 336 DFETIEVATNKFSTDNKLGEGGFGEV----YKGVLPSGQEIAVKRLSKAS----GQGAEE 387
           DFE+I+V          +G G FGEV     K    +G   A+K+L K+      Q    
Sbjct: 2   DFESIKV----------IGRGAFGEVRLVQKKD---TGHIYAMKKLRKSEMLEKEQ-VAH 47

Query: 388 FKNEVVLVAKLQHRNLVRLLGFCLEGEEK--ILVYEFVPNKSLDYFL--YD--PEKQGQL 441
            + E  ++A+  +  +V+L  +    +E    L+ E++P   +   L   D   E++   
Sbjct: 48  VRAERDILAEADNPWVVKL--YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEE--- 102

Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM-------- 493
             +R Y     IA  IL +    +L  IHRD+K  N+LLDA+ + K+SDFG+        
Sbjct: 103 --TRFY-----IAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155

Query: 494 ----ARIFGVDQTQGNTSR--------------------------IVGTYGYMAPEYAMH 523
                RI  +     +                              VGT  Y+APE  + 
Sbjct: 156 RTEFYRI--LSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ 213

Query: 524 GQFSVKSDVYSFGVLVLEIITG 545
             ++ + D +S GV++ E++ G
Sbjct: 214 TGYNKECDWWSLGVIMYEMLVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 60.4 bits (146), Expect = 1e-09
 Identities = 45/166 (27%), Positives = 75/166 (45%), Gaps = 10/166 (6%)

Query: 391 EVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKII 450
           E  ++  + H ++++L G     +   L+   +P    D + Y   K+  +       I 
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKR-NIAICDILAIE 188

Query: 451 GGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIV 510
             + R I YLHE+   RIIHRD+KA NI ++   +  + DFG A  F VD          
Sbjct: 189 RSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA-CFPVDINANKYYGWA 244

Query: 511 GTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDG 556
           GT    APE      +    D++S G+++ E+ T     + ++ DG
Sbjct: 245 GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH--DSLFEKDG 288

Length = 391

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 60.4 bits (146), Expect = 1e-09
 Identities = 55/207 (26%), Positives = 99/207 (47%), Gaps = 23/207 (11%)

Query: 351 NKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKN-EVVLVAKLQHRNLVRLLG 408
           N +G G FG VY+ + + + +++A+K++ +       ++KN E++++  L H N++ L  
Sbjct: 72  NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKD 126

Query: 409 F----CLEGEEKIL----VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
           +    C +  EK +    V EF+P     Y  +       L           + R + Y+
Sbjct: 127 YYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYI 186

Query: 461 HEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE 519
           H      I HRDLK  N+L+D   +  K+ DFG A+   +   Q + S I   + Y APE
Sbjct: 187 HSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAK--NLLAGQRSVSYICSRF-YRAPE 240

Query: 520 YAMHG-QFSVKSDVYSFGVLVLEIITG 545
             +    ++   D++S G ++ E+I G
Sbjct: 241 LMLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 60.3 bits (146), Expect = 1e-09
 Identities = 34/93 (36%), Positives = 55/93 (59%), Gaps = 4/93 (4%)

Query: 457 ILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG--VDQTQGNTSRIVGTYG 514
           +L +H      +IHRD+K++NILL +    K+ DFG ++++   V    G T    GT  
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRT--FCGTPY 210

Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKK 547
           Y+APE      +S K+D++S GVL+ E++T K+
Sbjct: 211 YVAPEIWRRKPYSKKADMFSLGVLLYELLTLKR 243

Length = 496

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 59.1 bits (143), Expect = 2e-09
 Identities = 38/96 (39%), Positives = 52/96 (54%), Gaps = 14/96 (14%)

Query: 469 IHRDLKASNILLDAEMNPKISDFGMARIFGVDQT---QGNTSRIVGTYGYMAPEYAMHGQ 525
           IHRD+ A N+LL      KI DFG+AR    D     +GN    V    +MAPE      
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPV---KWMAPESIFDCV 290

Query: 526 FSVKSDVYSFGVLVLEIIT-GKK-------NSNFYQ 553
           ++V+SDV+S+G+L+ EI + GK        NS FY+
Sbjct: 291 YTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYK 326

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 58.9 bits (142), Expect = 2e-09
 Identities = 58/199 (29%), Positives = 97/199 (48%), Gaps = 15/199 (7%)

Query: 353 LGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEV----VLVAKLQHRNLVRLL 407
           +G+G FG+V        G+  AVK L K      +E K+ +    VL+  ++H  LV L 
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL- 61

Query: 408 GFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRL 466
            +  +  EK+  V +FV    L + L   +++      R       IA  + YLH    +
Sbjct: 62  HYSFQTTEKLYFVLDFVNGGELFFHL---QRERSFPEPRARFYAAEIASALGYLHS---I 115

Query: 467 RIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQF 526
            I++RDLK  NILLD++ +  ++DFG+ +  G+ Q+   T+   GT  Y+APE      +
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSD-TTTTFCGTPEYLAPEVIRKQPY 173

Query: 527 SVKSDVYSFGVLVLEIITG 545
               D +  G ++ E++ G
Sbjct: 174 DNTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 58.9 bits (142), Expect = 3e-09
 Identities = 51/227 (22%), Positives = 100/227 (44%), Gaps = 40/227 (17%)

Query: 346 KFSTDNKLGEGGFGEVY--------------KGVLPSGQEIA-----VKRLSKASGQGAE 386
            F   + L  G FG+++              +GV  + Q        + +  KA  + A 
Sbjct: 149 HFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAI 208

Query: 387 EFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE---FVPNKSLDYFLYDPEKQGQLDW 443
           + +NE++ + +L H N++++        E+IL  E   ++  +  D+ LY        DW
Sbjct: 209 QLENEILALGRLNHENILKI--------EEILRSEANTYMITQKYDFDLYSFMYDEAFDW 260

Query: 444 SRR------YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497
             R        I+  +   + Y+H+    ++IHRD+K  NI L+ +    + DFG A  F
Sbjct: 261 KDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPF 317

Query: 498 GVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
              + +      VGT    +PE      +   +D++S G+++L++++
Sbjct: 318 E-KEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 58.4 bits (141), Expect = 4e-09
 Identities = 36/95 (37%), Positives = 53/95 (55%), Gaps = 9/95 (9%)

Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT---QGNTSRI 509
           +A+G+ +L   +    IHRDL A NILL      KI DFG+AR    D     +GN    
Sbjct: 223 VAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279

Query: 510 VGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           V    +MAPE   +  ++ +SDV+S+G+L+ EI +
Sbjct: 280 V---KWMAPESIFNCVYTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 57.7 bits (139), Expect = 6e-09
 Identities = 55/204 (26%), Positives = 88/204 (43%), Gaps = 16/204 (7%)

Query: 347 FSTDNKLGEGGFGEVYKGVLPSGQ--EIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHR 401
           F+    LG G FG V      +     +A+KR  K+     +  +   +E  ++  + H 
Sbjct: 32  FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHP 91

Query: 402 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH 461
             V L G   +     LV EFV       FL    K+   D    Y      A+ +L   
Sbjct: 92  FCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRR-NKRFPNDVGCFYA-----AQIVLIFE 145

Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYA 521
               L I++RDLK  N+LLD +   K++DFG A++         T  + GT  Y+APE  
Sbjct: 146 YLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-----VDTRTYTLCGTPEYIAPEIL 200

Query: 522 MHGQFSVKSDVYSFGVLVLEIITG 545
           ++      +D ++ G+ + EI+ G
Sbjct: 201 LNVGHGKAADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 56.8 bits (137), Expect = 6e-09
 Identities = 41/153 (26%), Positives = 70/153 (45%), Gaps = 20/153 (13%)

Query: 352 KLGEGGFGEVYKGVL---PSGQEIAVKRL-SKASGQGAEEFKNEVVLVAKLQHRNLVRLL 407
           ++G G FG+V    +        + VK L + AS +   EF  +      LQH N+++ L
Sbjct: 2   EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61

Query: 408 GFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRR-------YKIIGGIARGILYL 460
           G C+E    +LV+E+     L  +L       Q  W RR        ++   IA G+ ++
Sbjct: 62  GQCVEAIPYLLVFEYCELGDLKSYL------SQEQWHRRNSQLLLLQRMACEIAAGVTHM 115

Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493
           H   +   +H DL   N  L +++  K+ D+G+
Sbjct: 116 H---KHNFLHSDLALRNCFLTSDLTVKVGDYGI 145

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 57.4 bits (138), Expect = 7e-09
 Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 20/210 (9%)

Query: 353 LGEGGFGEVYKGVL----PSGQEIAVKRLSKASGQGAEEFKNEVV--LVAKLQHRNLVRL 406
           LG+G FG+V   +L     SG+  A+K L K      +E  + +    V K      +  
Sbjct: 3   LGKGTFGKV---ILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTS 59

Query: 407 LGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSR 465
           L +  + ++++  V E+V    L +F    E+    D +R Y     I   + YLH    
Sbjct: 60  LKYSFQTKDRLCFVMEYVNGGEL-FFHLSRERVFSEDRTRFYG--AEIVSALDYLHSG-- 114

Query: 466 LRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQ 525
            +I++RDLK  N++LD + + KI+DFG+ +    D     T    GT  Y+APE      
Sbjct: 115 -KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT--FCGTPEYLAPEVLEDND 171

Query: 526 FSVKSDVYSFGVLVLEIITGKKNSNFYQTD 555
           +    D +  GV++ E++ G+    FY  D
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGR--LPFYNQD 199

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 56.9 bits (137), Expect = 1e-08
 Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 15/199 (7%)

Query: 353 LGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGAEEFKNEV----VLVAKLQHRNLVRLL 407
           +G+G FG+V      + ++  AVK L K +    +E K+ +    VL+  ++H  LV L 
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL- 61

Query: 408 GFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRL 466
            F  +  +K+  V +++    L Y L   +++      R       IA  + YLH    L
Sbjct: 62  HFSFQTADKLYFVLDYINGGELFYHL---QRERCFLEPRARFYAAEIASALGYLHS---L 115

Query: 467 RIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQF 526
            I++RDLK  NILLD++ +  ++DFG+ +     +  G TS   GT  Y+APE      +
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPEVLHKQPY 173

Query: 527 SVKSDVYSFGVLVLEIITG 545
               D +  G ++ E++ G
Sbjct: 174 DRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 55.7 bits (134), Expect = 1e-08
 Identities = 59/211 (27%), Positives = 93/211 (44%), Gaps = 32/211 (15%)

Query: 353 LGEGGFGEVYKGVLP---------SGQEIAVKRLSKASGQGAEE----FKNEVVLVAKLQ 399
           LG G   ++Y G+L             E  +K + K       +    F     ++ ++ 
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62

Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
           H+++V L G C+   E I+V EFV    LD F++   K   L    ++K+   +A  + Y
Sbjct: 63  HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMH--RKSDVLTTPWKFKVAKQLASALSY 120

Query: 460 LHEDSRLRIIHRDLKASNILL-----DAEMNP--KISDFGMARIFGVDQTQGNTSRIVGT 512
           L ED  L  +H ++   NILL     D E  P  K+SD G+     V   Q    RI   
Sbjct: 121 L-EDKDL--VHGNVCTKNILLAREGIDGECGPFIKLSDPGIP--ITVLSRQECVERI--- 172

Query: 513 YGYMAPEYAMHGQ-FSVKSDVYSFGVLVLEI 542
             ++APE     +  S+ +D +SFG  + EI
Sbjct: 173 -PWIAPECVEDSKNLSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 56.2 bits (136), Expect = 1e-08
 Identities = 45/215 (20%), Positives = 88/215 (40%), Gaps = 26/215 (12%)

Query: 348 STDNKLGE----GGFGEVYKGVLPSGQEIAVKR--LSKASGQGAEEFKNEVVLVAKLQHR 401
                +G+         + K   P+   +AVK+  L   S +  +  + E++   +LQH 
Sbjct: 1   ELLTLIGKCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHP 59

Query: 402 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH 461
           N++  +   +   E  +V   +   S +  L     +G  + +  + I+  +   + Y+H
Sbjct: 60  NILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAF-ILKDVLNALDYIH 118

Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG------- 514
                  IHR +KAS+ILL  +    +S    +         G   R+V  +        
Sbjct: 119 ---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSM---IKHGKRQRVVHDFPKSSVKNL 172

Query: 515 -YMAPEY---AMHGQFSVKSDVYSFGVLVLEIITG 545
            +++PE     + G ++ KSD+YS G+   E+  G
Sbjct: 173 PWLSPEVLQQNLQG-YNEKSDIYSVGITACELANG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 56.9 bits (137), Expect = 1e-08
 Identities = 30/88 (34%), Positives = 51/88 (57%)

Query: 457 ILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYM 516
           +L L E    +++HRDLK++NI L      K+ DFG ++ +    +    S   GT  Y+
Sbjct: 179 VLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYL 238

Query: 517 APEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           APE     ++S K+D++S GV++ E++T
Sbjct: 239 APELWERKRYSKKADMWSLGVILYELLT 266

Length = 478

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 55.6 bits (134), Expect = 2e-08
 Identities = 68/249 (27%), Positives = 104/249 (41%), Gaps = 73/249 (29%)

Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLV 395
           DFE ++V          +G G FGEV           AV ++ K +GQ         V  
Sbjct: 2   DFEILKV----------IGRGAFGEV-----------AVVKM-KNTGQ---------VYA 30

Query: 396 AKLQHR--NLVRLLGFCLEGEEKILV-----------YEFVPNKSLDYFLYDPEKQGQL- 441
            K+ ++   L R    C   E  +LV           Y F    +L Y + D    G L 
Sbjct: 31  MKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNL-YLVMDYYVGGDLL 89

Query: 442 ------------DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKIS 489
                       D +R Y     +A  +L +    +L  +HRD+K  N+LLD   + +++
Sbjct: 90  TLLSKFEDRLPEDMARFY-----LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLA 144

Query: 490 DFGMARIFGVDQT-QGNTSRIVGTYGYMAPEY--AMH---GQFSVKSDVYSFGVLVLEII 543
           DFG       D T Q N +  VGT  Y++PE   AM    G++  + D +S GV + E++
Sbjct: 145 DFGSCLRLLADGTVQSNVA--VGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEML 202

Query: 544 TGKKNSNFY 552
            G+  + FY
Sbjct: 203 YGE--TPFY 209

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 32/92 (34%), Positives = 48/92 (52%), Gaps = 3/92 (3%)

Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
           +A G+ +L   +    +HRDL A N+L+      KI DFG+AR    D    +       
Sbjct: 248 VANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304

Query: 513 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
             +MAPE   +  ++  SDV+SFG+L+ EI T
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 55.0 bits (132), Expect = 6e-08
 Identities = 32/92 (34%), Positives = 48/92 (52%), Gaps = 3/92 (3%)

Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
           +ARG+ +L   +    +HRDL A N+LL      KI DFG+AR    D    +       
Sbjct: 246 VARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302

Query: 513 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
             +MAPE      ++  SDV+S+G+L+ EI +
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 56/211 (26%), Positives = 99/211 (46%), Gaps = 22/211 (10%)

Query: 353 LGEGGFGEVYKGVL----PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRN--LVRL 406
           LG+G FG+V   +L     +G+  A+K L K      +E  + V     LQ+     +  
Sbjct: 3   LGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 59

Query: 407 LGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSR 465
           L +  +  +++  V E+     L +F    E+    + +R Y     I   + YLH    
Sbjct: 60  LKYAFQTHDRLCFVMEYANGGEL-FFHLSRERVFTEERARFYG--AEIVSALEYLHSRD- 115

Query: 466 LRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR-IVGTYGYMAPEYAMHG 524
             +++RD+K  N++LD + + KI+DFG+ +  G+  + G T +   GT  Y+APE     
Sbjct: 116 --VVYRDIKLENLMLDKDGHIKITDFGLCK-EGI--SDGATMKTFCGTPEYLAPEVLEDN 170

Query: 525 QFSVKSDVYSFGVLVLEIITGKKNSNFYQTD 555
            +    D +  GV++ E++ G+    FY  D
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 199

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 52.9 bits (127), Expect = 2e-07
 Identities = 32/104 (30%), Positives = 52/104 (50%), Gaps = 9/104 (8%)

Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT-SRIVG 511
           I   + YLH      +++RDLK  N++LD + + KI+DFG+ +      + G T     G
Sbjct: 104 IVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCG 157

Query: 512 TYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTD 555
           T  Y+APE      +    D +  GV++ E++ G+    FY  D
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 199

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 52.2 bits (125), Expect = 3e-07
 Identities = 56/190 (29%), Positives = 89/190 (46%), Gaps = 31/190 (16%)

Query: 361 VYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420
           V K + PS ++IA+     AS            L++++ H +L  + G C+ G E I+V 
Sbjct: 48  VLKVLDPSHRDIALAFFETAS------------LMSQVSHIHLAFVHGVCVRGSENIMVE 95

Query: 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNIL- 479
           EFV +  LD  L   + +  + W  +  +   +A  + YL ED  L  +H ++ A NIL 
Sbjct: 96  EFVEHGPLDVCLRKEKGRVPVAW--KITVAQQLASALSYL-EDKNL--VHGNVCAKNILL 150

Query: 480 ----LDAEMNP--KISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDV 532
               L    +P  K+SD G++  F     +    RI     ++APE    G   S  +D 
Sbjct: 151 ARLGLAEGTSPFIKLSDPGVS--FTALSREERVERI----PWIAPECVPGGNSLSTAADK 204

Query: 533 YSFGVLVLEI 542
           +SFG  +LEI
Sbjct: 205 WSFGTTLLEI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 52.3 bits (125), Expect = 3e-07
 Identities = 69/268 (25%), Positives = 115/268 (42%), Gaps = 36/268 (13%)

Query: 297 AVLFILGFCFLRRKAKKKYNAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEG 356
           A+++ L F  LR+            N DN L   +        + +    +     +G G
Sbjct: 5   ALVYDLDFPALRKN----------KNIDNFLNRYKDTINKIRDLRMKAEDYEVVKVIGRG 54

Query: 357 GFGEVYKGVLPSGQEI-AVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG 413
            FGEV      S +++ A+K LSK     +    F  E   +    +   V  L +  + 
Sbjct: 55  AFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114

Query: 414 EEKI-LVYEFVPNKSLDYFL--YD-PEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRII 469
           +  + +V E++P   L   +  YD PEK     W+R Y      A  +L L     +  I
Sbjct: 115 DRYLYMVMEYMPGGDLVNLMSNYDVPEK-----WARFYT-----AEVVLALDAIHSMGFI 164

Query: 470 HRDLKASNILLDAEMNPKISDFGMARIFGVD-QTQGNTSRIVGTYGYMAPEY----AMHG 524
           HRD+K  N+LLD   + K++DFG       +   + +T+  VGT  Y++PE        G
Sbjct: 165 HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA--VGTPDYISPEVLKSQGGDG 222

Query: 525 QFSVKSDVYSFGVLVLEIITGKKNSNFY 552
            +  + D +S GV + E++ G  ++ FY
Sbjct: 223 YYGRECDWWSVGVFLYEMLVG--DTPFY 248

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 52.4 bits (125), Expect = 3e-07
 Identities = 61/227 (26%), Positives = 106/227 (46%), Gaps = 29/227 (12%)

Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGAEE---FKNE 391
           DFE ++V          +G G FGEV    L +  ++ A+K L+K       E   F+ E
Sbjct: 2   DFEILKV----------IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREE 51

Query: 392 VVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKII 450
             ++    ++  +  L +  + E  + LV ++     L   L   E +   D +R Y   
Sbjct: 52  RDVLVNGDNQ-WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY--- 107

Query: 451 GGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIV 510
             +A  ++ +    +L  +HRD+K  NIL+D   + +++DFG       D T   +S  V
Sbjct: 108 --LAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV-QSSVAV 164

Query: 511 GTYGYMAPEY--AMH---GQFSVKSDVYSFGVLVLEIITGKKNSNFY 552
           GT  Y++PE   AM    G++  + D +S GV + E++ G+  + FY
Sbjct: 165 GTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGE--TPFY 209

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 51.4 bits (124), Expect = 4e-07
 Identities = 58/229 (25%), Positives = 100/229 (43%), Gaps = 33/229 (14%)

Query: 325 NDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVL---PSGQEIAVKRLSKAS 381
           N   +L  L    +  E+         KL +G FG+V   VL   P+ +    K +    
Sbjct: 1   NMDKSLSELVQFLKNCEIVKKL-----KLIDGKFGKVS--VLKHKPTQKLFVQKIIK--- 50

Query: 382 GQGAEEFKNEV-VLVAKL--QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQ 438
              A+ F N +  +V +L   + N ++L       +  +L+ +++ +  L   L   +K+
Sbjct: 51  ---AKNF-NAIEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLL---KKE 103

Query: 439 GQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMARIF 497
           G+L  +   KII  +   +  LH   +  IIH D+K  N+L D   +   + D+G+ +I 
Sbjct: 104 GKLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKII 160

Query: 498 GVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
           G            GT  Y +PE      + V  D ++ GVL  E++TGK
Sbjct: 161 GTPSCYD------GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGK 203

Length = 267

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 51.8 bits (124), Expect = 5e-07
 Identities = 56/227 (24%), Positives = 91/227 (40%), Gaps = 21/227 (9%)

Query: 316 NAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVK 375
               E+ + +D  ++  +Q+         N  S+   L  G  GEV+      G E   K
Sbjct: 75  QEPCETTSSSDPASVVRMQY---------NILSS---LTPGSEGEVFVCT-KHGDEQRKK 121

Query: 376 RLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDP 435
            + KA   G +    E+ ++  + HR ++ L+        K  V   +P    D F Y  
Sbjct: 122 VIVKA-VTGGKTPGREIDILKTISHRAIINLIH---AYRWKSTVCMVMPKYKCDLFTY-V 176

Query: 436 EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
           ++ G L   +   I   +   + YLH      IIHRD+K  NI LD   N  + DFG A 
Sbjct: 177 DRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAAC 233

Query: 496 IFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEI 542
                          GT    +PE      +  K+D++S G+++ E+
Sbjct: 234 KLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280

Length = 392

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 51.6 bits (123), Expect = 5e-07
 Identities = 57/210 (27%), Positives = 96/210 (45%), Gaps = 19/210 (9%)

Query: 353 LGEGGFGEVYKGVL----PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRN--LVRL 406
           LG+G FG+V   +L     +G+  A+K L K      +E  + +     LQ+     +  
Sbjct: 3   LGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 59

Query: 407 LGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSR 465
           L +  +  +++  V E+     L +F    E+    D +R Y     I   + YLH  S 
Sbjct: 60  LKYSFQTHDRLCFVMEYANGGEL-FFHLSRERVFSEDRARFYG--AEIVSALDYLH--SE 114

Query: 466 LRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQ 525
             +++RDLK  N++LD + + KI+DFG+ +    D     T    GT  Y+APE      
Sbjct: 115 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAPEVLEDND 172

Query: 526 FSVKSDVYSFGVLVLEIITGKKNSNFYQTD 555
           +    D +  GV++ E++ G+    FY  D
Sbjct: 173 YGRAVDWWGLGVVMYEMMCGR--LPFYNQD 200

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 51.8 bits (124), Expect = 5e-07
 Identities = 66/258 (25%), Positives = 102/258 (39%), Gaps = 71/258 (27%)

Query: 345 NKFSTDNKLGEGGFGEVYKGV--LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRN 402
             F T   +G+G FGEV + V    +G+  A+K L K+     E FK + +   K +   
Sbjct: 1   EDFHTVKVIGKGAFGEV-RLVQKKDTGKIYAMKTLLKS-----EMFKKDQLAHVKAERDV 54

Query: 403 L--------VRLLGFCLEGEEKILVYEFVPNKSLDYFL--YDPEKQGQLDWSRRYKIIGG 452
           L        V L     + +   L+ EF+P   L   L  YD   +   D +R Y     
Sbjct: 55  LAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSE---DVTRFY----- 106

Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF--------------- 497
           +A  +L +    +L  IHRD+K  NIL+D   + K+SDFG++  F               
Sbjct: 107 MAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQG 166

Query: 498 -------------GVDQ---TQGNTSRI--------------VGTYGYMAPEYAMHGQFS 527
                         VD    T  +  +I              VGT  Y+APE  +   + 
Sbjct: 167 KSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG 226

Query: 528 VKSDVYSFGVLVLEIITG 545
            + D +S G ++ E + G
Sbjct: 227 QECDWWSLGAIMFECLIG 244

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 51.1 bits (122), Expect = 7e-07
 Identities = 50/195 (25%), Positives = 97/195 (49%), Gaps = 25/195 (12%)

Query: 367 PSGQEIAVK--RLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVP 424
           P+G  + V+   L   + +  +  +NEVVL    +H N++        G    ++  F+ 
Sbjct: 23  PTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82

Query: 425 NKSLDYFL--YDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA 482
             S +  L  Y PE   +   +    I+ G  RG+ YLH++     IHR++KAS+IL+  
Sbjct: 83  YGSANSLLKTYFPEGMSE---ALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISG 136

Query: 483 EMNPKISDFGMARIFGVDQTQGNTSRIVGTYG--------YMAPEYA---MHGQFSVKSD 531
           +    +S  G++ ++ + +  G  +++V  +         +++PE     ++G ++VKSD
Sbjct: 137 DGLVSLS--GLSHLYSLVR-NGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYG-YNVKSD 192

Query: 532 VYSFGVLVLEIITGK 546
           +YS G+   E+ TG+
Sbjct: 193 IYSVGITACELATGR 207

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 50.0 bits (119), Expect = 2e-06
 Identities = 61/249 (24%), Positives = 104/249 (41%), Gaps = 57/249 (22%)

Query: 336 DFETIEVATNKFSTDNKLGEGGFGEV-YKGVLPSGQEIAVKRLSKASGQGAEE---FKNE 391
           DFE+++V          +G G FGEV       +G   A+K L KA     E+    + E
Sbjct: 2   DFESLKV----------IGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAE 51

Query: 392 VVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIG 451
             ++ +     +V++     +     L+ EF+P   +   L   +   + + ++ Y    
Sbjct: 52  RDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSE-EATQFY---- 106

Query: 452 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG------- 504
            IA  +L +    +L  IHRD+K  N+LLDA+ + K+SDFG+    G+ +          
Sbjct: 107 -IAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCT--GLKKAHRTEFYRNL 163

Query: 505 -------------NTSR---------------IVGTYGYMAPEYAMHGQFSVKSDVYSFG 536
                        N+ R                VGT  Y+APE  M   ++   D +S G
Sbjct: 164 THNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLG 223

Query: 537 VLVLEIITG 545
           V++ E++ G
Sbjct: 224 VIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 50.0 bits (119), Expect = 2e-06
 Identities = 60/249 (24%), Positives = 104/249 (41%), Gaps = 57/249 (22%)

Query: 336 DFETIEVATNKFSTDNKLGEGGFGEV-YKGVLPSGQEIAVKRLSKASGQGAEE---FKNE 391
           DFE+++V          +G G FGEV       +G   A+K L KA     E+    + E
Sbjct: 2   DFESLKV----------IGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAE 51

Query: 392 VVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIG 451
             ++ +     +V++     +     L+ EF+P   +   L   +   + + ++ Y    
Sbjct: 52  RDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTE-EETQFY---- 106

Query: 452 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG------- 504
            IA  +L +    +L  IHRD+K  N+LLD++ + K+SDFG+    G+ +          
Sbjct: 107 -IAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCT--GLKKAHRTEFYRNL 163

Query: 505 -------------NTSR---------------IVGTYGYMAPEYAMHGQFSVKSDVYSFG 536
                        N+ R                VGT  Y+APE  M   ++   D +S G
Sbjct: 164 NHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLG 223

Query: 537 VLVLEIITG 545
           V++ E++ G
Sbjct: 224 VIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 47.9 bits (114), Expect = 1e-05
 Identities = 53/175 (30%), Positives = 69/175 (39%), Gaps = 32/175 (18%)

Query: 347 FSTDNKLGEGGFGEVYKGVLPSGQEIAVKR--LSKASGQGAEE-FKNEVVL------VAK 397
           F    KLGEG FG VYK  L + Q     +  L KA+  GA E + NE V        A 
Sbjct: 134 FVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCAD 193

Query: 398 LQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPE-----------KQGQL--DWS 444
             +  L  +     + +E  LV+ +    +L   +   E           K   L     
Sbjct: 194 FVYGFLEPVSS--KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLE 251

Query: 445 RRYKIIGGIARGILY----LHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMA 494
           R  KII  I R IL+    LH      I+HRD+K  NI+        KI D G A
Sbjct: 252 RENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIIDLGAA 303

Length = 566

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 47.1 bits (112), Expect = 1e-05
 Identities = 27/100 (27%), Positives = 49/100 (49%), Gaps = 16/100 (16%)

Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI-------------FGVDQTQGN 505
           YLH      I+HRDLK  N+L+ +  + K++DFG+++I                D  +  
Sbjct: 116 YLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFL 172

Query: 506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
             ++ GT  Y+APE  +   +    D ++ G+++ E + G
Sbjct: 173 DKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 47.3 bits (112), Expect = 1e-05
 Identities = 56/233 (24%), Positives = 103/233 (44%), Gaps = 36/233 (15%)

Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAK 397
           E I+V+T +F   + LGEG FG+V +      +E    ++ +   +   + K E+  + K
Sbjct: 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEK 181

Query: 398 LQHRN------LVRLLGFCLE--GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKI 449
           ++  +      L+++  +     G   I++ ++ P   LD+ +    K G        +I
Sbjct: 182 VRQADPADRFPLMKIQRYFQNETGHMCIVMPKYGPCL-LDWIM----KHGPFSHRHLAQI 236

Query: 450 IGGIARGILYLHEDSRLRIIHRDLKASNILL---DAEMNP-------------KISDFGM 493
           I      + Y H  + L ++H DLK  NIL+   D  ++P             +I D G 
Sbjct: 237 IFQTGVALDYFH--TELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGG 294

Query: 494 ARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
                 D+    T+ IV T  Y +PE  +   +   +D++S G ++ E+ TGK
Sbjct: 295 C----CDERHSRTA-IVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342

Length = 467

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 45.9 bits (109), Expect = 2e-05
 Identities = 37/196 (18%), Positives = 88/196 (44%), Gaps = 22/196 (11%)

Query: 361 VYKGVLPSGQEIAVKRL---SKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEK- 416
           +YKG+  + +E+ ++      K      +  +NE+  + ++   N++++ GF ++  +  
Sbjct: 36  IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94

Query: 417 ---ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE-DSRLRIIHRD 472
               L+ E+     L   L    K+  L +  +  +     +G+  L++  ++    +++
Sbjct: 95  PRLSLILEYCTRGYLREVLD---KEKDLSFKTKLDMAIDCCKGLYNLYKYTNK---PYKN 148

Query: 473 LKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYA--MHGQFSVKS 530
           L + + L+      KI   G+ +I           + V    Y + +    +  ++++K 
Sbjct: 149 LTSVSFLVTENYKLKIICHGLEKILSSP-----PFKNVNFMVYFSYKMLNDIFSEYTIKD 203

Query: 531 DVYSFGVLVLEIITGK 546
           D+YS GV++ EI TGK
Sbjct: 204 DIYSLGVVLWEIFTGK 219

Length = 283

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 46.0 bits (109), Expect = 3e-05
 Identities = 55/247 (22%), Positives = 97/247 (39%), Gaps = 67/247 (27%)

Query: 353 LGEGGFGEVYKGVLPSGQEI----AVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVR 405
           +G G FGEV    L    +     A+K L KA       A   K E  ++A+  +  +V+
Sbjct: 9   IGIGAFGEVC---LVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVK 65

Query: 406 LLGFCLEGEEKI-LVYEFVPNKSLDYFLYD----PEKQGQLDWSRRYKIIGGIARGILYL 460
           L  +  + ++ +  V +++P   +   L       E     D +R Y  I  +   I  +
Sbjct: 66  LY-YSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEE-----DLARFY--IAELTCAIESV 117

Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA-------------------------- 494
           H   ++  IHRD+K  NIL+D + + K++DFG+                           
Sbjct: 118 H---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPS 174

Query: 495 ---------------RIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLV 539
                          R       +     +VGT  Y+APE  +   ++   D +S GV++
Sbjct: 175 EEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234

Query: 540 LEIITGK 546
            E++ G+
Sbjct: 235 YEMLVGQ 241

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 43.5 bits (103), Expect = 4e-05
 Identities = 31/149 (20%), Positives = 56/149 (37%), Gaps = 19/149 (12%)

Query: 352 KLGEGGFGEVYKGVLPSGQE-IAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLV--RLLG 408
            L  G    VY   L +  E   +K     S +   + + EV ++  L  + L   ++L 
Sbjct: 5   LLKGGLTNRVYL--LGTKDEDYVLKINP--SREKGADREREVAILQLLARKGLPVPKVLA 60

Query: 409 FCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGG-IARGILYLHEDSRLR 467
                    L+ E++  ++LD        + + +       +   +A+    LH+   L 
Sbjct: 61  SGESDGWSYLLMEWIEGETLD-----EVSEEEKEDIAE--QLAELLAK----LHQLPLLV 109

Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARI 496
           + H DL   NIL+D      I D+  A  
Sbjct: 110 LCHGDLHPGNILVDDGKILGIIDWEYAGY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 43.7 bits (103), Expect = 2e-04
 Identities = 20/49 (40%), Positives = 31/49 (63%), Gaps = 3/49 (6%)

Query: 448 KIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496
           K I  +A  + YLH      IIHRDLK  N+L+  E + K++DFG++++
Sbjct: 108 KYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

 Score = 42.3 bits (100), Expect = 3e-04
 Identities = 26/124 (20%), Positives = 45/124 (36%), Gaps = 32/124 (25%)

Query: 389 KNEVVLVAKLQHRNLVRLLGFC------LEGEEKILVYEFVPNKSLDYFLYDPEKQGQLD 442
           + E  ++AK       R  G        ++ +  ++V E++  + L   L          
Sbjct: 47  RREARILAKA------REAGVPVPIVYDVDPDNGLIVMEYIEGELLKDAL---------- 90

Query: 443 WSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI------ 496
              R  ++  + R +  LH+     I+H DL  SNI+L         DFG+         
Sbjct: 91  EEARPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGG-RIYFIDFGLGEFSDEVED 146

Query: 497 FGVD 500
             VD
Sbjct: 147 KAVD 150

Length = 204

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 42.3 bits (99), Expect = 5e-04
 Identities = 55/247 (22%), Positives = 95/247 (38%), Gaps = 63/247 (25%)

Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLG 408
           LG G FGEV     + +    A+K L K    +       K E  ++A+  +  +V+L  
Sbjct: 9   LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68

Query: 409 FCLEGEEKILVYEFVPNKSLDYFLYD----PEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
              + +    V +++P   +   L      PE       +R Y     IA   L +    
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEV-----LARFY-----IAELTLAIESVH 118

Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT-----QGNTSR----------- 508
           ++  IHRD+K  NIL+D + + K++DFG+   F          +G+  R           
Sbjct: 119 KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWD 178

Query: 509 -----------------------------IVGTYGYMAPEYAMHGQFSVKSDVYSFGVLV 539
                                        +VGT  Y+APE  +   ++   D +S GV++
Sbjct: 179 DVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238

Query: 540 LEIITGK 546
            E++ G+
Sbjct: 239 FEMLVGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 41.8 bits (98), Expect = 9e-04
 Identities = 42/161 (26%), Positives = 73/161 (45%), Gaps = 24/161 (14%)

Query: 390 NEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKI 449
           +E  L+ +L H  ++ LL   + G    LV   +P    D + Y   +   L  ++    
Sbjct: 209 HEARLLRRLSHPAVLALLDVRVVGGLTCLV---LPKYRSDLYTYLGARLRPLGLAQ---- 261

Query: 450 IGGIARGIL----YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN 505
           +  +AR +L    Y+H +    IIHRD+K  N+L++   +  + DFG A        +G+
Sbjct: 262 VTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACF-----ARGS 313

Query: 506 TSR-----IVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLE 541
            S      I GT    APE      ++   D++S G+++ E
Sbjct: 314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 39.6 bits (93), Expect = 0.003
 Identities = 61/235 (25%), Positives = 90/235 (38%), Gaps = 55/235 (23%)

Query: 352 KLGEGGFGEVY----KGVLPSGQEIAVKRLSKASGQGAEEFKN---EVVLVAKLQHRNLV 404
            LG+G  G V+    KG   +G+  A+K L K       + K    E  ++A L H  L 
Sbjct: 8   LLGKGDVGRVFLVRLKG---TGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLP 64

Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFL-YDPEKQGQLDWSRRYKIIGGIARGIL---YL 460
            L           LV ++ P   L   L   P K    + +R Y      A  +L   YL
Sbjct: 65  TLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFY-----AAEVLLALEYL 119

Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDF---------GMARIFG------------- 498
           H    L I++RDLK  NILL    +  +SDF                             
Sbjct: 120 H---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSI 176

Query: 499 -----VDQTQGNTSRIVGTYGYMAPEY---AMHGQFSVKSDVYSFGVLVLEIITG 545
                 ++    ++  VGT  Y+APE      HG  +V  D ++ G+L+ E++ G
Sbjct: 177 PSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHG-SAV--DWWTLGILLYEMLYG 228

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	571
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.98
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.98
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.98
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.98
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.98
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.98
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.98
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.98
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.98
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.98
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.98
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.98
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	99.98
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.98
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.98
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.98
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.98
PHA03209	357	serine/threonine kinase US3; Provisional	99.98
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.98
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.98
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.98
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.98
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.98
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.98
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.98
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.98
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.98
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.98
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.98
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.98
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.98
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.98
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.98
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.98
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.98
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.98
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.97
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.97
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.97
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.97
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.97
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.97
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.97
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.97
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.97
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.97
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.97
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.97
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.97
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.97
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.97
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.97
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.97
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.97
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.97
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.97
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.97
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.97
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.97
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.97
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.97
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.97
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.97
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.97
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.97
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.97
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.97
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.97
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.97
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.97
PHA03210	501	serine/threonine kinase US3; Provisional	99.97
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.97
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.97
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.97
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.97
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.97
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.97
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.97
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.97
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.97
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.97
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.97
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.97
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.97
KOG0586	596	consensus Serine/threonine protein kinase [General	99.97
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.97
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.97
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.97
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.97
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.97
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.97
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.97
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.97
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.97
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.97
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.97
PHA02882	294	putative serine/threonine kinase; Provisional	99.97
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.97
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.97
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.97
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.97
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.97
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.97
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.97
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.97
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.97
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.97
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.97
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.97
PLN00009	294	cyclin-dependent kinase A; Provisional	99.97
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.97
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.97
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.97
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.97
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.97
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.97
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.97
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.97
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.97
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.97
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.97
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.97
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.97
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.97
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.97
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.97
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.97
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.97
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.97
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.97
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.96
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.96
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.96
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.96
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.96
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.96
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.96
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.96
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.96
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.96
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.96
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.96
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.96
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.96
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.96
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.96
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.96
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.96
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.96
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.96
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.95
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.95
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.95
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.95
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.95
KOG1152	772	consensus Signal transduction serine/threonine kin	99.95
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.95
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.94
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.94
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.92
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.92
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.92
PF01657	106	Stress-antifung: Salt stress response/antifungal;	99.92
PRK09188	365	serine/threonine protein kinase; Provisional	99.91
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.91
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.91
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.91
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.9
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.89
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.88
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.88
PLN00181	793	protein SPA1-RELATED; Provisional	99.86
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.86
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.86
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.86
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.84
PF01657	106	Stress-antifung: Salt stress response/antifungal;	99.84
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.81
PRK12274	218	serine/threonine protein kinase; Provisional	99.81
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.81
PRK10345	210	hypothetical protein; Provisional	99.79
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.76
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.75
smart00090	237	RIO RIO-like kinase.	99.74
PRK14879	211	serine/threonine protein kinase; Provisional	99.74
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.73
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.73
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.73
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.72
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.72
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.69
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.68
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.64
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.63
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.63
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.6
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.58
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.5
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.5
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.49
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.37
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.35
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.24
KOG1243	690	consensus Protein kinase [General function predict	99.22
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.21
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.21
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.16
KOG3087	229	consensus Serine/threonine protein kinase [General	99.15
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.13
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.99
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.98
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.93
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.91
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.85
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.81
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.72
PRK09902	216	hypothetical protein; Provisional	98.61
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.58
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.55
COG4248	637	Uncharacterized protein with protein kinase and he	98.5
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.45
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.41
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.28
PF01636	239	APH: Phosphotransferase enzyme family This family	98.27
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.26
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.23
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.22
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.16
PLN02876	822	acyl-CoA dehydrogenase	98.05
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.05
PRK10593	297	hypothetical protein; Provisional	98.01
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.95
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.93
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.86
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.85
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.84
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.64
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.63
KOG2270	520	consensus Serine/threonine protein kinase involved	97.4
PRK05231	319	homoserine kinase; Provisional	97.34
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.26
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.25
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.23
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.18
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.08
PLN02236	344	choline kinase	96.98
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.96
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.92
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	96.92
PLN02756	418	S-methyl-5-thioribose kinase	96.73
COG2334	331	Putative homoserine kinase type II (protein kinase	96.38
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.36
PRK12396	409	5-methylribose kinase; Reviewed	96.31
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.31
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.17
PRK11768	325	serine/threonine protein kinase; Provisional	96.14
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	95.94
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.82
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	95.77
PRK06148	1013	hypothetical protein; Provisional	95.73
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.44
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.13
KOG1236	565	consensus Predicted unusual protein kinase [Genera	95.04

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-48  Score=395.41  Aligned_cols=236  Identities=50%  Similarity=0.847  Sum_probs=208.2

Q ss_pred             cccccchHHHHHHhCCCCccccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeE
Q 008292          331 ESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFC  410 (571)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~  410 (571)
                      ....|.+.+++.+|++|...+.||+|+||.||+|.+++|..||||++.........+|.+|+.++.+++|||||+|+|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            34568999999999999999999999999999999999999999988765543245699999999999999999999999


Q ss_pred             EeCC-eeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEe
Q 008292          411 LEGE-EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKIS  489 (571)
Q Consensus       411 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  489 (571)
                      .+.+ +.+||||||++|+|.++|+..... .++|.+|++|+.++|+||+|||+...++||||||||+|||||++.++||+
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls  219 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS  219 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence            9999 499999999999999999865444 89999999999999999999999988899999999999999999999999


Q ss_pred             eccCccccCCCCCccccccc-cccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhc
Q 008292          490 DFGMARIFGVDQTQGNTSRI-VGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYVSINV  568 (571)
Q Consensus       490 DfGla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~  568 (571)
                      |||+++.....  ....... .||.+|+|||++..+..+.|+|||||||+|+||+||+++.+.........+..|+|++|
T Consensus       220 DFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~  297 (361)
T KOG1187|consen  220 DFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL  297 (361)
T ss_pred             CccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence            99999654321  1111112 79999999999999999999999999999999999999988765555666999998877


Q ss_pred             c
Q 008292          569 I  569 (571)
Q Consensus       569 ~  569 (571)
                      .
T Consensus       298 ~  298 (361)
T KOG1187|consen  298 E  298 (361)
T ss_pred             H
Confidence            4

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-45  Score=355.16  Aligned_cols=197  Identities=33%  Similarity=0.560  Sum_probs=178.9

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeeccc--CccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE  421 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e  421 (571)
                      .+|...++||+|+|++||+|+++ ++..||||.+.+.  ..+..+.+..||++|++++|||||++++++..++..+||||
T Consensus        10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME   89 (429)
T KOG0595|consen   10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME   89 (429)
T ss_pred             ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence            57888889999999999999964 5789999999766  56667788999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCC------CceEEeeccCcc
Q 008292          422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE------MNPKISDFGMAR  495 (571)
Q Consensus       422 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~------~~~kl~DfGla~  495 (571)
                      ||.||+|..+++   +.+.+++.....++.|||.||++||+++   ||||||||.||||+..      -.+||+|||+|+
T Consensus        90 yC~gGDLs~yi~---~~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR  163 (429)
T KOG0595|consen   90 YCNGGDLSDYIR---RRGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR  163 (429)
T ss_pred             eCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence            999999999995   4558999999999999999999999998   9999999999999764      358999999999


Q ss_pred             ccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          496 IFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      .+...   ......+|++-|||||++...+|+.|+|+||+|+++||+++|+.||+
T Consensus       164 ~L~~~---~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~  215 (429)
T KOG0595|consen  164 FLQPG---SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFD  215 (429)
T ss_pred             hCCch---hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcc
Confidence            87633   23446799999999999999999999999999999999999999987

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-42  Score=351.39  Aligned_cols=202  Identities=36%  Similarity=0.617  Sum_probs=175.0

Q ss_pred             CCCccccccccCceeEEEEEccCCCeeEEEeecccCcc--CHHHHHHHHHHHhhcCCCceeccceeEEeCC-eeEEEEEe
Q 008292          346 KFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQ--GAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE-EKILVYEF  422 (571)
Q Consensus       346 ~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~  422 (571)
                      ++...+.||+|+||+||+|.++....||||++......  ..++|.+|+.+|.+++|||||+++|+|.+.. ...|||||
T Consensus        42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy  121 (362)
T KOG0192|consen   42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY  121 (362)
T ss_pred             HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence            33445669999999999999955444999999764322  2569999999999999999999999999988 79999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCC-ceEEeeccCccccCCCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM-NPKISDFGMARIFGVDQ  501 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGla~~~~~~~  501 (571)
                      +++|+|..+++.. ....+++..+++|+.|||+||.|||+++.  ||||||||+||||+.++ ++||+|||+++......
T Consensus       122 ~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~  198 (362)
T KOG0192|consen  122 MPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK  198 (362)
T ss_pred             CCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence            9999999999754 46789999999999999999999999863  99999999999999997 99999999998754322


Q ss_pred             CccccccccccCCcccccccc--cCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 008292          502 TQGNTSRIVGTYGYMAPEYAM--HGQFSVKSDVYSFGVLVLEIITGKKNSNFY  552 (571)
Q Consensus       502 ~~~~~~~~~gt~~y~aPE~~~--~~~~s~~~Dv~slGvvl~elltG~~p~~~~  552 (571)
                        ...+...||+.|||||++.  ...|+.|+||||||+++|||+||+.||...
T Consensus       199 --~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~  249 (362)
T KOG0192|consen  199 --TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDL  249 (362)
T ss_pred             --ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCC
Confidence              2233368999999999999  669999999999999999999999998754

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-42  Score=331.56  Aligned_cols=201  Identities=30%  Similarity=0.454  Sum_probs=180.4

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC---ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV  419 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  419 (571)
                      .++|++.+.||+|+||.|+.++.+ .++.+|+|++++..   ....+..++|..+|.+++||.||+++-.|++.+..+||
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            467899999999999999999964 57889999998753   34456788999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCC
Q 008292          420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV  499 (571)
Q Consensus       420 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  499 (571)
                      +||+.||.|...|   ++++.+++..+.-++.+|+.||.|||+.+   ||||||||+|||||.+|+++|+||||++....
T Consensus       104 ld~~~GGeLf~hL---~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~  177 (357)
T KOG0598|consen  104 LDYLNGGELFYHL---QREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK  177 (357)
T ss_pred             EeccCCccHHHHH---HhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence            9999999999999   45678999999999999999999999998   99999999999999999999999999986432


Q ss_pred             CCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 008292          500 DQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFY  552 (571)
Q Consensus       500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~~  552 (571)
                      .  ...+...+||+.|||||++.+..|+..+|+||+|+++|||++|.+||...
T Consensus       178 ~--~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~  228 (357)
T KOG0598|consen  178 D--GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE  228 (357)
T ss_pred             C--CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc
Confidence            2  22344579999999999999999999999999999999999999998643

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-42  Score=331.53  Aligned_cols=211  Identities=30%  Similarity=0.414  Sum_probs=182.8

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeeccc-CccCHHHHHHHHHHHhhcCCCceeccceeEEeCC-eeEEEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA-SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE-EKILVYE  421 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-~~~lv~e  421 (571)
                      .+++..+.||+|..|+|||++++ +++.+|+|.+... .+...+++.+|++++++.+||+||+++|.|.... ...|+||
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE  158 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME  158 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence            34556789999999999999975 5778999999544 3445678999999999999999999999999988 4999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCC
Q 008292          422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ  501 (571)
Q Consensus       422 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  501 (571)
                      ||++|+|+.++.   ..+.+++..+-+++.++++||.|||+.  ++||||||||+||||+..|+|||+|||.++.+-.. 
T Consensus       159 YMDgGSLd~~~k---~~g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-  232 (364)
T KOG0581|consen  159 YMDGGSLDDILK---RVGRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-  232 (364)
T ss_pred             hcCCCCHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence            999999999984   347799999999999999999999963  24999999999999999999999999999876433 


Q ss_pred             CccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCC--CCCCcccHHHHH
Q 008292          502 TQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFY--QTDGAADLLSYV  564 (571)
Q Consensus       502 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~~--~~~~~~~l~~~~  564 (571)
                         .....+||..|||||.+.+..|+.++||||||++++|+.+|+.|+...  ......+|+.++
T Consensus       233 ---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~I  294 (364)
T KOG0581|consen  233 ---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAI  294 (364)
T ss_pred             ---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHH
Confidence               334578999999999999999999999999999999999999998764  234556666665

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-41  Score=345.39  Aligned_cols=200  Identities=30%  Similarity=0.488  Sum_probs=183.4

Q ss_pred             CCCCccccccccCceeEEEEEc-cCCCeeEEEeeccc---CccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY  420 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  420 (571)
                      .+|...+.||+|+|..+|+++. ..|+.||+|++.+.   .....+.+.+||++.+.|+|||||+++++|++.+..|||.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5688899999999999999997 88999999999763   4556778899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCC
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD  500 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  500 (571)
                      |+|++++|.+++.   ..+.+++.++..++.||+.||.|||+++   |+|||||..|+||+++.++||+|||||..+..+
T Consensus        98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~  171 (592)
T KOG0575|consen   98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD  171 (592)
T ss_pred             EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence            9999999999983   5678999999999999999999999987   999999999999999999999999999987543


Q ss_pred             CCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 008292          501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFY  552 (571)
Q Consensus       501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~~  552 (571)
                      .  ......||||.|+|||++....++..+||||+|||+|-||+|++||+-.
T Consensus       172 ~--Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk  221 (592)
T KOG0575|consen  172 G--ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK  221 (592)
T ss_pred             c--cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc
Confidence            2  3445689999999999999999999999999999999999999999753

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=4.6e-42  Score=362.58  Aligned_cols=212  Identities=33%  Similarity=0.539  Sum_probs=184.5

Q ss_pred             HHHHHHhCCCCccccccccCceeEEEEEcc------CCCeeEEEeecccCcc-CHHHHHHHHHHHhhcCCCceeccceeE
Q 008292          338 ETIEVATNKFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSKASGQ-GAEEFKNEVVLVAKLQHRNLVRLLGFC  410 (571)
Q Consensus       338 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~  410 (571)
                      ...++...+.+..++||+|.||.||+|+..      +...||||.++...+. ...+|++|+++++.++|||||+|+|+|
T Consensus       479 ~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC  558 (774)
T KOG1026|consen  479 KVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVC  558 (774)
T ss_pred             ceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEE
Confidence            334555677788899999999999999853      3457999999887655 788999999999999999999999999


Q ss_pred             EeCCeeEEEEEecCCCChhhhhcCCC-------C----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEE
Q 008292          411 LEGEEKILVYEFVPNKSLDYFLYDPE-------K----QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNIL  479 (571)
Q Consensus       411 ~~~~~~~lv~e~~~~g~L~~~l~~~~-------~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIl  479 (571)
                      .+++..+||+|||..|+|.+||....       .    ..+++..+.+.|+.|||.||+||-++.   +|||||..+|+|
T Consensus       559 ~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCL  635 (774)
T KOG1026|consen  559 REGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCL  635 (774)
T ss_pred             ccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhce
Confidence            99999999999999999999996321       1    223888999999999999999999876   999999999999


Q ss_pred             ECCCCceEEeeccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 008292          480 LDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFY  552 (571)
Q Consensus       480 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~~  552 (571)
                      |.++..|||+||||++.+...++........-+.+||+||.|+.++||++||||||||+|||++| |+.|+.-.
T Consensus       636 Vge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~gl  709 (774)
T KOG1026|consen  636 VGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGL  709 (774)
T ss_pred             eccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCccccc
Confidence            99999999999999998766555554444566889999999999999999999999999999999 99997644

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-42  Score=347.54  Aligned_cols=206  Identities=36%  Similarity=0.574  Sum_probs=180.3

Q ss_pred             HHHHhCCCCccccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEE
Q 008292          340 IEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV  419 (571)
Q Consensus       340 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  419 (571)
                      +++..+.++..++||+|.||.||.|.++....||+|.++.. ....+.|.+|+++|++|+|+|||+++|+|..++..+||
T Consensus       201 wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIV  279 (468)
T KOG0197|consen  201 WEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIV  279 (468)
T ss_pred             eeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEE
Confidence            33444556678899999999999999977779999999765 34457888999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCC
Q 008292          420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV  499 (571)
Q Consensus       420 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  499 (571)
                      ||||+.|+|.++|.. ..+..++..+.+.++.|||+||+||++++   +|||||.++||||++++.+||+|||||+....
T Consensus       280 tE~m~~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d  355 (468)
T KOG0197|consen  280 TEYMPKGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGD  355 (468)
T ss_pred             EEecccCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCC
Confidence            999999999999965 35667899999999999999999999987   99999999999999999999999999996654


Q ss_pred             CCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          500 DQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                      +.+.... ...-+..|.|||.+..+.|+.|||||||||+||||+| |+.|+.-
T Consensus       356 ~~Y~~~~-~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~  407 (468)
T KOG0197|consen  356 DEYTASE-GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPG  407 (468)
T ss_pred             CceeecC-CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCC
Confidence            4443322 3345789999999999999999999999999999999 8888643

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.6e-42  Score=318.43  Aligned_cols=205  Identities=27%  Similarity=0.436  Sum_probs=176.0

Q ss_pred             CCCCccccccccCceeEEEEE-ccCCCeeEEEeeccc--CccCHHHHHHHHHHHhhcCCCceecccee-EEeCCe-eEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGF-CLEGEE-KILV  419 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~-~~~~~~-~~lv  419 (571)
                      .+|.++++||+|.||+|||+. +.+|..||.|.+.-.  +.+..+....|+.+|+.++|||||+++++ +.+..+ ..||
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            357788999999999999998 568999999988743  34455678899999999999999999994 444444 7899


Q ss_pred             EEecCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCC-CCeEEecCCCCCEEECCCCceEEeeccCcccc
Q 008292          420 YEFVPNKSLDYFLYDP-EKQGQLDWSRRYKIIGGIARGILYLHEDSR-LRIIHRDLKASNILLDAEMNPKISDFGMARIF  497 (571)
Q Consensus       420 ~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~-~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  497 (571)
                      ||++..|+|..++... .....++++.+|+++.|++.||.++|...+ ..|+||||||.||+|+.+|.+||+||||++.+
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            9999999999988543 344568999999999999999999998431 13999999999999999999999999999988


Q ss_pred             CCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          498 GVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .....  .....+|||.||+||.+.+..|+.||||||+||++|||+.-+.||.-
T Consensus       179 ~s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g  230 (375)
T KOG0591|consen  179 SSKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYG  230 (375)
T ss_pred             cchhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccc
Confidence            64432  33457899999999999999999999999999999999999999853

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-40  Score=325.39  Aligned_cols=195  Identities=33%  Similarity=0.551  Sum_probs=167.5

Q ss_pred             CCCCccccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHh--hcCCCceeccceeEEeCC----eeEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVA--KLQHRNLVRLLGFCLEGE----EKIL  418 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~--~l~h~niv~l~~~~~~~~----~~~l  418 (571)
                      ......+.||+|.||.||||++ +++.||||++...   ..+.|++|-+|.+  .++|+||+++++....++    +++|
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL  285 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL  285 (534)
T ss_pred             CchhhHHHhhcCccceeehhhc-cCceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence            3445668899999999999999 5699999999654   4456677766655  468999999999987766    8899


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC------CCCCeEEecCCCCCEEECCCCceEEeecc
Q 008292          419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED------SRLRIIHRDLKASNILLDAEMNPKISDFG  492 (571)
Q Consensus       419 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~------~~~~ivH~Dlkp~NIll~~~~~~kl~DfG  492 (571)
                      |+||.+.|+|.++|    +...++|....+|+..+++||+|||+.      .+++|+|||||++||||.+|+++.|+|||
T Consensus       286 Vt~fh~kGsL~dyL----~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG  361 (534)
T KOG3653|consen  286 VTEFHPKGSLCDYL----KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG  361 (534)
T ss_pred             EeeeccCCcHHHHH----HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence            99999999999999    677899999999999999999999964      45789999999999999999999999999


Q ss_pred             CccccCCCCCccccccccccCCcccccccccCC-CC-----cchhHHHHHHHHHHHHhCCC
Q 008292          493 MARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQ-FS-----VKSDVYSFGVLVLEIITGKK  547 (571)
Q Consensus       493 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-----~~~Dv~slGvvl~elltG~~  547 (571)
                      +|..+............+||.+|||||++.+.. +.     .+.||||+|.|||||++.-.
T Consensus       362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~  422 (534)
T KOG3653|consen  362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCT  422 (534)
T ss_pred             eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcc
Confidence            999988776666666689999999999996652 22     36899999999999998644

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-40  Score=305.88  Aligned_cols=198  Identities=32%  Similarity=0.436  Sum_probs=179.5

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC---ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY  420 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  420 (571)
                      ++|+..+.||.|+||+|..++.+ +|..+|+|++++..   ..+.+...+|..+|+.+.||.++++.+.+.+.+..+|||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            46788899999999999999965 57889999998653   344566789999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCC
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD  500 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  500 (571)
                      ||++||.|..+|   ++.++++++.+..++.||+.||+|||+.+   |++|||||+|||||.+|.+||+|||.|+...  
T Consensus       124 eyv~GGElFS~L---rk~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~--  195 (355)
T KOG0616|consen  124 EYVPGGELFSYL---RKSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVS--  195 (355)
T ss_pred             eccCCccHHHHH---HhcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEec--
Confidence            999999999999   45678999999999999999999999987   9999999999999999999999999998753  


Q ss_pred             CCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 008292          501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQ  553 (571)
Q Consensus       501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~~~  553 (571)
                         ..+-..||||.|+|||.+..+.+..++|+|||||++|||+.|..||-...
T Consensus       196 ---~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~  245 (355)
T KOG0616|consen  196 ---GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDN  245 (355)
T ss_pred             ---CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCC
Confidence               23556899999999999999999999999999999999999999986543

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.1e-40  Score=319.20  Aligned_cols=201  Identities=27%  Similarity=0.438  Sum_probs=172.6

Q ss_pred             HhCCCCccccccccCceeEEEEEc-cCCCeeEEEeecccCc-------cCHHHHHHHHHHHhhcCCCceeccceeEEeCC
Q 008292          343 ATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASG-------QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE  414 (571)
Q Consensus       343 ~~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~-------~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~  414 (571)
                      ..+.|.+.+.||+|+||.|-+|.. ++|+.||||++.+...       ......++|+++|++++|||||++.+++...+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            346788889999999999999985 5799999999975321       12234679999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCC---CceEEeec
Q 008292          415 EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE---MNPKISDF  491 (571)
Q Consensus       415 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~Df  491 (571)
                      ..||||||++||.|.+++-   .++.+.+..-..++.|++.|+.|||+++   |+||||||+|||+..+   -.+||+||
T Consensus       250 s~YmVlE~v~GGeLfd~vv---~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF  323 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVV---ANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF  323 (475)
T ss_pred             ceEEEEEEecCccHHHHHH---hccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence            9999999999999998883   4566788888899999999999999998   9999999999999766   67999999


Q ss_pred             cCccccCCCCCccccccccccCCcccccccccCC---CCcchhHHHHHHHHHHHHhCCCCCCCC
Q 008292          492 GMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQ---FSVKSDVYSFGVLVLEIITGKKNSNFY  552 (571)
Q Consensus       492 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~~~Dv~slGvvl~elltG~~p~~~~  552 (571)
                      |+|+..+   ....+...|||+.|.|||++.++.   +..|+|+||+||+||-+++|..||.-.
T Consensus       324 GlAK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~  384 (475)
T KOG0615|consen  324 GLAKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEE  384 (475)
T ss_pred             chhhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccc
Confidence            9999765   233456789999999999997653   334889999999999999999999743

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.7e-39  Score=320.61  Aligned_cols=201  Identities=27%  Similarity=0.440  Sum_probs=173.8

Q ss_pred             hCCCCccccccccCceeEEEEE-ccCCCeeEEEeecccC--ccCHHHHHHHHHHHhhcCCCceeccceeEEeC--CeeEE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG--EEKIL  418 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~l  418 (571)
                      .+.|+..++||+|.||.||+++ ..+|+.||+|+++.+.  +.......+||.+|++|+||||++|.+...+.  ...||
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            3567778899999999999999 4679999999998655  44456677999999999999999999998876  67899


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccC
Q 008292          419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG  498 (571)
Q Consensus       419 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  498 (571)
                      |+|||++ +|.-++..  ..-.+++.++..++.|++.||+|+|.++   |+|||||.+|||||.+|.+||+|||||+.+.
T Consensus       196 VFeYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~  269 (560)
T KOG0600|consen  196 VFEYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYT  269 (560)
T ss_pred             EEecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeecc
Confidence            9999976 56666632  3457999999999999999999999988   9999999999999999999999999999887


Q ss_pred             CCCCccccccccccCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          499 VDQTQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       499 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .......++ .+-|+.|.|||.+++. .|+.++|+||.||||.||++|+..+.-
T Consensus       270 ~~~~~~~T~-rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G  322 (560)
T KOG0600|consen  270 PSGSAPYTS-RVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQG  322 (560)
T ss_pred             CCCCccccc-ceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCC
Confidence            665554444 4669999999999875 799999999999999999999998653

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-39  Score=323.83  Aligned_cols=199  Identities=31%  Similarity=0.522  Sum_probs=182.3

Q ss_pred             hCCCCccccccccCceeEEEEE-ccCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      ...|...++||+|..|.||.+. ..+++.||||++........+-+.+|+.+|+..+|+|||.+++.+..+++.|+||||
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy  351 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY  351 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence            4568888999999999999998 457889999999877767778889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT  502 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  502 (571)
                      |++|+|.+.+    ....+++.++..|++++++||+|||.++   |+|||||.+|||++.+|.+||+|||++..+.....
T Consensus       352 m~ggsLTDvV----t~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~  424 (550)
T KOG0578|consen  352 MEGGSLTDVV----TKTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS  424 (550)
T ss_pred             cCCCchhhhh----hcccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence            9999999988    4456999999999999999999999988   99999999999999999999999999998765543


Q ss_pred             ccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          503 QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       503 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                        .....+||+.|||||++....|.+|+||||||++++||+-|++||-+
T Consensus       425 --KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln  471 (550)
T KOG0578|consen  425 --KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN  471 (550)
T ss_pred             --ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC
Confidence              44567999999999999999999999999999999999999999865

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=5.3e-39  Score=322.02  Aligned_cols=197  Identities=30%  Similarity=0.497  Sum_probs=178.3

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeeccc--CccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE  421 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e  421 (571)
                      ++|.+.+.||+|+||.||||+-+ +.+.||+|.+.+.  .++..+.+.+|++++++++||||+.++++|+...+.++|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            46778899999999999999954 5788999998764  34556778999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCC
Q 008292          422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ  501 (571)
Q Consensus       422 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  501 (571)
                      |+.| +|..+|   +..+.++++.+..++.++..||.|||++.   |+|||+||.|||++.++.+|++|||+|+.+..  
T Consensus        82 ~a~g-~L~~il---~~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--  152 (808)
T KOG0597|consen   82 YAVG-DLFTIL---EQDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMST--  152 (808)
T ss_pred             hhhh-hHHHHH---HhccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhccc--
Confidence            9987 999999   45678999999999999999999999987   99999999999999999999999999998754  


Q ss_pred             CccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          502 TQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       502 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      .....+.+.|||-|||||...++.|+..+|+||+||++||+++|++||-
T Consensus       153 ~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~  201 (808)
T KOG0597|consen  153 NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFY  201 (808)
T ss_pred             CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCch
Confidence            2334566889999999999999999999999999999999999999973

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=5.6e-39  Score=300.17  Aligned_cols=198  Identities=27%  Similarity=0.402  Sum_probs=171.9

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC--ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE  421 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e  421 (571)
                      ++|+...++|+|+||.|||++.+ +|+.||||++....  +...+-..+||++|+.++|+|+|.++.+|.......||+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            46778889999999999999976 59999999996543  3334556799999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCC
Q 008292          422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ  501 (571)
Q Consensus       422 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  501 (571)
                      |++..-|.++-+   ....++...+.+++.|+++|+.|+|+++   +|||||||+||||+.++.+||+|||+|+.+... 
T Consensus        82 ~~dhTvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p-  154 (396)
T KOG0593|consen   82 YCDHTVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAP-  154 (396)
T ss_pred             ecchHHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCC-
Confidence            999887776652   3345789999999999999999999988   999999999999999999999999999988632 


Q ss_pred             CccccccccccCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          502 TQGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       502 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                       ....+.-+.|..|.|||.+.+ .+|...+||||+||++.||++|+.-|-
T Consensus       155 -gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~P  203 (396)
T KOG0593|consen  155 -GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWP  203 (396)
T ss_pred             -cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCC
Confidence             223344578999999999987 799999999999999999999998653

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-39  Score=325.96  Aligned_cols=195  Identities=32%  Similarity=0.482  Sum_probs=173.6

Q ss_pred             HHHHHhCCCCccccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEE
Q 008292          339 TIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL  418 (571)
Q Consensus       339 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  418 (571)
                      .|++..+.+..++.||.|+.|.||+|++ .++.||||+++...       +.+|+-|++|+|+||+.|.|+|.....++|
T Consensus       118 ~WeiPFe~IsELeWlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCI  189 (904)
T KOG4721|consen  118 LWEIPFEEISELEWLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCI  189 (904)
T ss_pred             hccCCHHHhhhhhhhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEE
Confidence            3455555566789999999999999999 57899999886432       457889999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccC
Q 008292          419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG  498 (571)
Q Consensus       419 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  498 (571)
                      |||||..|-|.++|.   ....++......|..+||.||.|||.+.   |||||||+-||||..+..|||+|||-++.+.
T Consensus       190 iMEfCa~GqL~~VLk---a~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~  263 (904)
T KOG4721|consen  190 IMEFCAQGQLYEVLK---AGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELS  263 (904)
T ss_pred             eeeccccccHHHHHh---ccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhh
Confidence            999999999999993   5667899999999999999999999986   9999999999999999999999999999765


Q ss_pred             CCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          499 VDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      ..   ...-.++||..|||||+|.+.+.++|+|||||||||||||||..|+.
T Consensus       264 ~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYk  312 (904)
T KOG4721|consen  264 DK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYK  312 (904)
T ss_pred             hh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCcc
Confidence            33   23345789999999999999999999999999999999999999974

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-38  Score=318.80  Aligned_cols=201  Identities=31%  Similarity=0.465  Sum_probs=177.8

Q ss_pred             hCCCCccccccccCceeEEEEEc-cCCCeeEEEeeccc---CccCHHHHHHHHHHHhhc-CCCceeccceeEEeCCeeEE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKIL  418 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~l  418 (571)
                      ..+|...+.||+|+|++|++++. ..++++|||++.+.   .+...+-+..|-..|.+| .||.|++|+..|.+...+|+
T Consensus        72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF  151 (604)
T KOG0592|consen   72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF  151 (604)
T ss_pred             hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence            46788999999999999999995 46899999999753   233345567788888888 89999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccC
Q 008292          419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG  498 (571)
Q Consensus       419 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  498 (571)
                      |+||+++|+|.+++.   +-+.+++.....++.+|+.||+|||+++   ||||||||+|||||.|+++||+|||.|+.+.
T Consensus       152 vLe~A~nGdll~~i~---K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~  225 (604)
T KOG0592|consen  152 VLEYAPNGDLLDLIK---KYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILS  225 (604)
T ss_pred             EEEecCCCcHHHHHH---HhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCC
Confidence            999999999999994   5578999999999999999999999988   9999999999999999999999999999885


Q ss_pred             CCCCc---------cc--cccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          499 VDQTQ---------GN--TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       499 ~~~~~---------~~--~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      .....         ..  ...++||..|.+||.+.++..+..+|||+||||||+|+.|++||.
T Consensus       226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFr  288 (604)
T KOG0592|consen  226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFR  288 (604)
T ss_pred             hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCc
Confidence            43222         11  145899999999999999999999999999999999999999985

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-38  Score=320.02  Aligned_cols=209  Identities=31%  Similarity=0.496  Sum_probs=184.5

Q ss_pred             HHHHhCCCCccccccccCceeEEEEEccCCCeeEEEeecccCcc-CHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEE
Q 008292          340 IEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQ-GAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL  418 (571)
Q Consensus       340 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  418 (571)
                      .+.+.+.+.+.++||+|.||.|..++...+.+||||+++..... ...+|.+||++|.+++||||++++|+|..++..++
T Consensus       533 ~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicm  612 (807)
T KOG1094|consen  533 VEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCM  612 (807)
T ss_pred             hhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHH
Confidence            34556778889999999999999999978899999999876544 45899999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccC
Q 008292          419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG  498 (571)
Q Consensus       419 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  498 (571)
                      ++|||++|+|.+|+...+.. .+.-+...+|+.||+.||+||.+.+   +|||||.++|+|++.++++||+|||+++.+.
T Consensus       613 I~EYmEnGDLnqFl~aheap-t~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~ly  688 (807)
T KOG1094|consen  613 ITEYMENGDLNQFLSAHELP-TAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLY  688 (807)
T ss_pred             HHHHHhcCcHHHHHHhccCc-ccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccc
Confidence            99999999999999654322 2455677889999999999999876   9999999999999999999999999999777


Q ss_pred             CCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh--CCCCCCCC
Q 008292          499 VDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT--GKKNSNFY  552 (571)
Q Consensus       499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt--G~~p~~~~  552 (571)
                      ...+.....+.+-+.+|||||.+..++++.++|||+||+++||+++  .++|++..
T Consensus       689 sg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~l  744 (807)
T KOG1094|consen  689 SGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQL  744 (807)
T ss_pred             cCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhh
Confidence            6666666667788999999999999999999999999999999864  78887644

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=6.6e-38  Score=288.35  Aligned_cols=209  Identities=29%  Similarity=0.469  Sum_probs=176.8

Q ss_pred             CCCCccccccccCceeEEEEEc-cCCCeeEEEeecccCcc--CHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQ--GAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE  421 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e  421 (571)
                      .+|...++||+|.||.||+|+. .+|+.||||+++.....  ......+||+.|+.++|+||+.++++|...+...||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            4677889999999999999994 57999999999765322  23456789999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCC
Q 008292          422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ  501 (571)
Q Consensus       422 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  501 (571)
                      ||+ .+|+..+.+  +...++..++..++.++++|++|+|.+.   |+||||||.|+|++++|.+||+|||+++.+....
T Consensus        82 fm~-tdLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~  155 (318)
T KOG0659|consen   82 FMP-TDLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN  155 (318)
T ss_pred             ecc-ccHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence            995 679888854  4567899999999999999999999998   9999999999999999999999999999887554


Q ss_pred             CccccccccccCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHH
Q 008292          502 TQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYV  564 (571)
Q Consensus       502 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~slGvvl~elltG~~p~~~~~~~~~~~l~~~~  564 (571)
                      .....  .+-|..|.|||.+.+. +|+..+||||.|||+.||+-|.+-+   ..+...|.+..+
T Consensus       156 ~~~~~--~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~f---pG~sDidQL~~I  214 (318)
T KOG0659|consen  156 RIQTH--QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFF---PGDSDIDQLSKI  214 (318)
T ss_pred             ccccc--ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCC---CCCchHHHHHHH
Confidence            43332  2678999999998765 6999999999999999999987643   233344444444

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-38  Score=319.25  Aligned_cols=209  Identities=32%  Similarity=0.542  Sum_probs=180.1

Q ss_pred             chHHHHHHhCCCCccccccccCceeEEEEEccCCCeeEEEeeccc--CccCHHHHHHHHHHHhhcCCCceeccceeEEeC
Q 008292          336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG  413 (571)
Q Consensus       336 ~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~  413 (571)
                      ..++|++..+.+.+.+.||+|.||+||+|.|..  .||||+++..  ..+..+.|++|+..+++-+|.||+-+.|+|...
T Consensus       383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p  460 (678)
T KOG0193|consen  383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP  460 (678)
T ss_pred             cccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence            446788888888899999999999999999853  5899998754  345678999999999999999999999999887


Q ss_pred             CeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccC
Q 008292          414 EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM  493 (571)
Q Consensus       414 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl  493 (571)
                      .. .||..|++|.+|..+++..  ..+++..+.+.|++||++||.|||.++   |||||||++||+|.++++|||+||||
T Consensus       461 ~~-AIiTqwCeGsSLY~hlHv~--etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGL  534 (678)
T KOG0193|consen  461 PL-AIITQWCEGSSLYTHLHVQ--ETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGL  534 (678)
T ss_pred             ce-eeeehhccCchhhhhccch--hhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccc
Confidence            77 9999999999999999754  367899999999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCCccccccccccCCccccccccc---CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 008292          494 ARIFGVDQTQGNTSRIVGTYGYMAPEYAMH---GQFSVKSDVYSFGVLVLEIITGKKNSNFY  552 (571)
Q Consensus       494 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~Dv~slGvvl~elltG~~p~~~~  552 (571)
                      +..-............-|...|||||++..   .+|+..+||||||+|+|||+||..|+...
T Consensus       535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~  596 (678)
T KOG0193|consen  535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQ  596 (678)
T ss_pred             eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCC
Confidence            865433222222333457788999999964   47999999999999999999999998743

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=7.7e-38  Score=314.00  Aligned_cols=217  Identities=24%  Similarity=0.355  Sum_probs=183.4

Q ss_pred             HHhCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC---ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeE
Q 008292          342 VATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI  417 (571)
Q Consensus       342 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  417 (571)
                      ...++|+.++.||+|+||.||.++-+ +|..+|+|++++..   ....+.++.|-.+|...++|.||+|+-.|.+.+.+|
T Consensus       138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY  217 (550)
T KOG0605|consen  138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY  217 (550)
T ss_pred             CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence            34578999999999999999999954 68999999998754   344567788999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCcccc
Q 008292          418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF  497 (571)
Q Consensus       418 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  497 (571)
                      |||||++||++..+|   .+.+.|++.....++.+++-|++-||+.+   +|||||||+|+|||..|++||+||||+.-+
T Consensus       218 LiMEylPGGD~mTLL---~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl  291 (550)
T KOG0605|consen  218 LIMEYLPGGDMMTLL---MRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGL  291 (550)
T ss_pred             EEEEecCCccHHHHH---HhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchh
Confidence            999999999999999   46678999999999999999999999988   999999999999999999999999998533


Q ss_pred             CC----------------------CCCcc----c-------------------cccccccCCcccccccccCCCCcchhH
Q 008292          498 GV----------------------DQTQG----N-------------------TSRIVGTYGYMAPEYAMHGQFSVKSDV  532 (571)
Q Consensus       498 ~~----------------------~~~~~----~-------------------~~~~~gt~~y~aPE~~~~~~~s~~~Dv  532 (571)
                      ..                      .....    .                   ....+|||.|||||++++..|+..+|+
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw  371 (550)
T KOG0605|consen  292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW  371 (550)
T ss_pred             hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence            11                      00000    0                   013579999999999999999999999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCCCCCc-ccHHHHH
Q 008292          533 YSFGVLVLEIITGKKNSNFYQTDGA-ADLLSYV  564 (571)
Q Consensus       533 ~slGvvl~elltG~~p~~~~~~~~~-~~l~~~~  564 (571)
                      ||||||+||||.|.+||.-..+.+. ..++.|-
T Consensus       372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr  404 (550)
T KOG0605|consen  372 WSLGCIMYEMLVGYPPFCSETPQETYRKIVNWR  404 (550)
T ss_pred             HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            9999999999999999975443322 3344443

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-38  Score=308.58  Aligned_cols=202  Identities=31%  Similarity=0.511  Sum_probs=172.2

Q ss_pred             CCCCccccccccCceeEEEEEccC-CCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCC--eeEEEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE--EKILVYE  421 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~--~~~lv~e  421 (571)
                      .++...+.||+|+||+||++...+ |...|||.+...+....+.+.+|+.+|.+++|||||+++|......  .+.+.||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            457778999999999999999754 8999999987664444677899999999999999999999855444  6899999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECC-CCceEEeeccCccccCC-
Q 008292          422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-EMNPKISDFGMARIFGV-  499 (571)
Q Consensus       422 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGla~~~~~-  499 (571)
                      |+++|+|.+++.+.  ++.+++..+.++..||++||+|||+++   ||||||||+||||+. ++.+||+|||+++.... 
T Consensus        97 y~~~GsL~~~~~~~--g~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~  171 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRY--GGKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK  171 (313)
T ss_pred             ccCCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence            99999999999542  227999999999999999999999887   999999999999999 79999999999987653 


Q ss_pred             CCCccccccccccCCcccccccccCC-CCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          500 DQTQGNTSRIVGTYGYMAPEYAMHGQ-FSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       500 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ...........||+.|||||++.++. ...++|||||||++.||+||+.||..
T Consensus       172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~  224 (313)
T KOG0198|consen  172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSE  224 (313)
T ss_pred             cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchh
Confidence            11122334568999999999998643 33599999999999999999999875

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-37  Score=320.10  Aligned_cols=201  Identities=28%  Similarity=0.400  Sum_probs=177.9

Q ss_pred             HHhCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC---ccCHHHHHHHHHHHhhc-CCCceeccceeEEeCCee
Q 008292          342 VATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEK  416 (571)
Q Consensus       342 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~  416 (571)
                      ..-++|...++||+|+||.|+++..+ +++.+|||.+++..   .+..+..+.|..++... +||.++.++..+...+..
T Consensus       365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l  444 (694)
T KOG0694|consen  365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL  444 (694)
T ss_pred             ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence            34568999999999999999999975 57789999998754   45567778888888776 499999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccc
Q 008292          417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI  496 (571)
Q Consensus       417 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  496 (571)
                      ++||||+.||++..+.    ....+++.++.-++..|+.||.|||+++   ||+||||.+|||||.+|.+||+||||++.
T Consensus       445 ~fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe  517 (694)
T KOG0694|consen  445 FFVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKE  517 (694)
T ss_pred             EEEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccc
Confidence            9999999999954443    4567999999999999999999999998   99999999999999999999999999986


Q ss_pred             cCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          497 FGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .-  .....++.++|||.|||||++.+..|+..+|+|||||+||||+.|+.||.-
T Consensus       518 ~m--~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~g  570 (694)
T KOG0694|consen  518 GM--GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPG  570 (694)
T ss_pred             cC--CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCC
Confidence            42  133467789999999999999999999999999999999999999999874

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-37  Score=336.96  Aligned_cols=205  Identities=34%  Similarity=0.561  Sum_probs=177.7

Q ss_pred             HhCCCCccccccccCceeEEEEEccC--CC----eeEEEeeccc-CccCHHHHHHHHHHHhhcCCCceeccceeEEeCCe
Q 008292          343 ATNKFSTDNKLGEGGFGEVYKGVLPS--GQ----EIAVKRLSKA-SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEE  415 (571)
Q Consensus       343 ~~~~~~~~~~LG~G~fg~Vy~~~~~~--g~----~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~  415 (571)
                      ...+....+.||+|.||.||+|...+  |.    .||||.+++. +.+...+|.+|..+|++++|||||+++|+|.+...
T Consensus       690 ~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~  769 (1025)
T KOG1095|consen  690 PRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP  769 (1025)
T ss_pred             ChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC
Confidence            34566677899999999999999643  33    3899999875 45667899999999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeec
Q 008292          416 KILVYEFVPNKSLDYFLYDPE----KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDF  491 (571)
Q Consensus       416 ~~lv~e~~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  491 (571)
                      .+|++|||++|+|..||++.+    ....+...+++.++.|||+|+.||++++   +|||||.++|+||+....+||+||
T Consensus       770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDF  846 (1025)
T KOG1095|consen  770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADF  846 (1025)
T ss_pred             cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEccc
Confidence            999999999999999997542    2456899999999999999999999987   999999999999999999999999


Q ss_pred             cCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 008292          492 GMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSN  550 (571)
Q Consensus       492 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~  550 (571)
                      |||+.+....+........-+.+|||||.+.++.|+.|+|||||||++||++| |..|+.
T Consensus       847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~  906 (1025)
T KOG1095|consen  847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYP  906 (1025)
T ss_pred             chhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCC
Confidence            99996654444443333455689999999999999999999999999999999 888864

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-37  Score=312.21  Aligned_cols=201  Identities=29%  Similarity=0.485  Sum_probs=177.4

Q ss_pred             HhCCCCccccccccCceeEEEEEc-cCCCeeEEEeeccc----Cc-cCHHHHHHHHHHHhhcC-CCceeccceeEEeCCe
Q 008292          343 ATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA----SG-QGAEEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEE  415 (571)
Q Consensus       343 ~~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~----~~-~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~  415 (571)
                      ..++|...+.||+|+||.|+.+.. .+++.||+|++.+.    .. ...+.+.+|+.++++++ ||||++++.++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            356899999999999999999985 46899999977653    22 34556778999999999 9999999999999999


Q ss_pred             eEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCC-CceEEeeccCc
Q 008292          416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE-MNPKISDFGMA  494 (571)
Q Consensus       416 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfGla  494 (571)
                      .++||||+.+|+|.+++.   +.+++.+....+++.|++.|++|+|+++   |+||||||+|||++.+ +++||+|||++
T Consensus        95 ~~ivmEy~~gGdL~~~i~---~~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s  168 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIV---NKGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLS  168 (370)
T ss_pred             EEEEEEecCCccHHHHHH---HcCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccc
Confidence            999999999999999984   3577899999999999999999999987   9999999999999999 99999999999


Q ss_pred             cccCCCCCccccccccccCCcccccccccCC-CC-cchhHHHHHHHHHHHHhCCCCCCC
Q 008292          495 RIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQ-FS-VKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ....  .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+.
T Consensus       169 ~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d  225 (370)
T KOG0583|consen  169 AISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD  225 (370)
T ss_pred             cccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC
Confidence            8763  2223445679999999999999877 86 679999999999999999999986

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-37  Score=299.40  Aligned_cols=206  Identities=26%  Similarity=0.408  Sum_probs=178.9

Q ss_pred             hCCCCccccccccCceeEEEEE-ccCCCeeEEEeecccCc-cCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASG-QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE  421 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e  421 (571)
                      .+.|+..++||.|..++||++. .+.++.||||++..+.. ...+.+++|+..|+.++||||++++..|..+...|+||+
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            4678899999999999999999 56789999999976443 336889999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCC
Q 008292          422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ  501 (571)
Q Consensus       422 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  501 (571)
                      ||.+|++.+++...-.. .+++..+..|++++++||.|||+++   -||||||+.||||+++|.|||+|||.+..+....
T Consensus       105 fMa~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G  180 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG  180 (516)
T ss_pred             hhcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence            99999999998654333 3899999999999999999999998   9999999999999999999999999887553322


Q ss_pred             -Ccccc-ccccccCCccccccccc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 008292          502 -TQGNT-SRIVGTYGYMAPEYAMH--GQFSVKSDVYSFGVLVLEIITGKKNSNFYQ  553 (571)
Q Consensus       502 -~~~~~-~~~~gt~~y~aPE~~~~--~~~s~~~Dv~slGvvl~elltG~~p~~~~~  553 (571)
                       ..... ...+||+.|||||+++.  ..|+.|+||||||++..||.+|.-||.-+.
T Consensus       181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~p  236 (516)
T KOG0582|consen  181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYP  236 (516)
T ss_pred             ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCC
Confidence             11112 56789999999999654  369999999999999999999999997654

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-37  Score=307.81  Aligned_cols=197  Identities=29%  Similarity=0.431  Sum_probs=171.1

Q ss_pred             HhCCCCccccccccCceeEEEEE-ccCCCeeEEEeecccCccCHHHH--HHHHHHHhhcC-CCceeccceeEEeCC-eeE
Q 008292          343 ATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEF--KNEVVLVAKLQ-HRNLVRLLGFCLEGE-EKI  417 (571)
Q Consensus       343 ~~~~~~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~--~~Ei~~l~~l~-h~niv~l~~~~~~~~-~~~  417 (571)
                      ..++|...++||.|+||.||+|+ ...|..||||++++.-.. +++.  .+|++.|++++ ||||+++.+++.+.+ ..+
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~   86 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY   86 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence            34678889999999999999999 457889999999865433 3332  47999999999 999999999999988 899


Q ss_pred             EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCcccc
Q 008292          418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF  497 (571)
Q Consensus       418 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  497 (571)
                      +|||||+ .+|.+++.++  +..+++..+..|+.||++||+|+|.+|   +.||||||+|||+..+..+||+|||+||.+
T Consensus        87 fVfE~Md-~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev  160 (538)
T KOG0661|consen   87 FVFEFMD-CNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREV  160 (538)
T ss_pred             eeHHhhh-hhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccc
Confidence            9999994 6788888653  778999999999999999999999998   999999999999999999999999999987


Q ss_pred             CCCCCccccccccccCCcccccccc-cCCCCcchhHHHHHHHHHHHHhCCCCC
Q 008292          498 GVDQTQGNTSRIVGTYGYMAPEYAM-HGQFSVKSDVYSFGVLVLEIITGKKNS  549 (571)
Q Consensus       498 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~~Dv~slGvvl~elltG~~p~  549 (571)
                      ....   ..+.-+.|..|.|||+++ .+-|+.+.||||+|||++|+.+-+.-|
T Consensus       161 ~Skp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLF  210 (538)
T KOG0661|consen  161 RSKP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLF  210 (538)
T ss_pred             ccCC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccC
Confidence            5332   233457899999999885 568999999999999999999988765

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-38  Score=326.69  Aligned_cols=204  Identities=29%  Similarity=0.509  Sum_probs=178.6

Q ss_pred             hCCCCccccccccCceeEEEEEccC----CCeeEEEeeccc-CccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLPS----GQEIAVKRLSKA-SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL  418 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  418 (571)
                      ....++++.||.|.||.|++|.++-    ...||||.++.. .++.+.+|..|..||.+++||||++|.|+....+..+|
T Consensus       628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMI  707 (996)
T KOG0196|consen  628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMI  707 (996)
T ss_pred             hhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEE
Confidence            4456788999999999999999752    346999999875 45667899999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccC
Q 008292          419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG  498 (571)
Q Consensus       419 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  498 (571)
                      |.|||+||+|+.||+.  +.+++++.++..++++||.||.||.+.+   .|||||.++||||+.+..+|++||||+|.+.
T Consensus       708 iTEyMENGsLDsFLR~--~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvle  782 (996)
T KOG0196|consen  708 ITEYMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  782 (996)
T ss_pred             EhhhhhCCcHHHHHhh--cCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecc
Confidence            9999999999999964  4577999999999999999999999887   9999999999999999999999999999886


Q ss_pred             CCCCccc-cccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 008292          499 VDQTQGN-TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFY  552 (571)
Q Consensus       499 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~~  552 (571)
                      .+..... +....-+.+|.|||.|...+++.+|||||||+++||.++ |++|+-.+
T Consensus       783 dd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdm  838 (996)
T KOG0196|consen  783 DDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM  838 (996)
T ss_pred             cCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccccc
Confidence            5542222 222334789999999999999999999999999999987 99997433

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.3e-36  Score=313.32  Aligned_cols=201  Identities=26%  Similarity=0.362  Sum_probs=173.8

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC---ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY  420 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  420 (571)
                      ++|+..+.||+|+||+||++... +++.||+|++++..   ......+.+|+.++.+++|+||+++++.+.+....++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            46888999999999999999854 58899999997542   233457788999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCC
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD  500 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  500 (571)
                      ||+++|+|.+++.   +...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~  154 (363)
T cd05628          81 EFLPGGDMMTLLM---KKDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA  154 (363)
T ss_pred             cCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence            9999999999984   3457899999999999999999999987   999999999999999999999999998754321


Q ss_pred             CCc---------------------------------cccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCC
Q 008292          501 QTQ---------------------------------GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKK  547 (571)
Q Consensus       501 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~  547 (571)
                      ...                                 ......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~  234 (363)
T cd05628         155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (363)
T ss_pred             ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence            100                                 00123579999999999999999999999999999999999999


Q ss_pred             CCCC
Q 008292          548 NSNF  551 (571)
Q Consensus       548 p~~~  551 (571)
                      ||..
T Consensus       235 Pf~~  238 (363)
T cd05628         235 PFCS  238 (363)
T ss_pred             CCCC
Confidence            9853

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-36  Score=297.13  Aligned_cols=203  Identities=28%  Similarity=0.428  Sum_probs=168.2

Q ss_pred             ccchHHHHHHhCCCCccccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHH--HhhcCCCceeccceeEE
Q 008292          334 QFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVL--VAKLQHRNLVRLLGFCL  411 (571)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~--l~~l~h~niv~l~~~~~  411 (571)
                      ..++-..+...++....+.||+|.||.||+|.+ .|+.||||++...++..   +.+|.++  -..++|+||+.+++.-.
T Consensus       200 GlplLVQRTiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE~S---WfrEtEIYqTvmLRHENILgFIaaD~  275 (513)
T KOG2052|consen  200 GLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDERS---WFRETEIYQTVMLRHENILGFIAADN  275 (513)
T ss_pred             CchhHhHHhhhheeEEEEEecCccccceeeccc-cCCceEEEEecccchhh---hhhHHHHHHHHHhccchhhhhhhccc
Confidence            345555677788999999999999999999999 68999999997655443   3444444  45579999999999876


Q ss_pred             eCC----eeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-----CCCCCeEEecCCCCCEEECC
Q 008292          412 EGE----EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE-----DSRLRIIHRDLKASNILLDA  482 (571)
Q Consensus       412 ~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-----~~~~~ivH~Dlkp~NIll~~  482 (571)
                      .++    ++|||.+|.+.|||.++|    +...++....++++..+|.||++||.     +++|.|.|||||++||||..
T Consensus       276 ~~~gs~TQLwLvTdYHe~GSL~DyL----~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKk  351 (513)
T KOG2052|consen  276 KDNGSWTQLWLVTDYHEHGSLYDYL----NRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK  351 (513)
T ss_pred             cCCCceEEEEEeeecccCCcHHHHH----hhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEcc
Confidence            553    579999999999999999    45789999999999999999999994     57899999999999999999


Q ss_pred             CCceEEeeccCccccCCCC--CccccccccccCCcccccccccC----CC--CcchhHHHHHHHHHHHHh
Q 008292          483 EMNPKISDFGMARIFGVDQ--TQGNTSRIVGTYGYMAPEYAMHG----QF--SVKSDVYSFGVLVLEIIT  544 (571)
Q Consensus       483 ~~~~kl~DfGla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~----~~--s~~~Dv~slGvvl~ellt  544 (571)
                      ++.+.|+|+|||.....+.  .....+..+||.+|||||++...    .|  -..+||||||.|+||+..
T Consensus       352 n~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiar  421 (513)
T KOG2052|consen  352 NGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIAR  421 (513)
T ss_pred             CCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHH
Confidence            9999999999998765432  22234566899999999998543    22  246999999999999975

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-37  Score=316.44  Aligned_cols=206  Identities=35%  Similarity=0.502  Sum_probs=174.7

Q ss_pred             HHHHHHhCCCCccccccccCceeEEEEEccC--C--Ce-eEEEeecc---cCccCHHHHHHHHHHHhhcCCCceecccee
Q 008292          338 ETIEVATNKFSTDNKLGEGGFGEVYKGVLPS--G--QE-IAVKRLSK---ASGQGAEEFKNEVVLVAKLQHRNLVRLLGF  409 (571)
Q Consensus       338 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~--g--~~-vavK~~~~---~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~  409 (571)
                      ..|+...++....++||+|.||.||+|.++.  +  .. ||||..+.   .......+|.+|.++|+.++|||||+++|+
T Consensus       150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGV  229 (474)
T KOG0194|consen  150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGV  229 (474)
T ss_pred             cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence            3455555666677999999999999999643  2  23 89999875   345667899999999999999999999999


Q ss_pred             EEeCCeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEe
Q 008292          410 CLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKIS  489 (571)
Q Consensus       410 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  489 (571)
                      +...+..++|||+++||+|+++|..  ....++..++++++.+.|.||+|||+++   +|||||.++|+|++.++.+||+
T Consensus       230 a~~~~Pl~ivmEl~~gGsL~~~L~k--~~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKIS  304 (474)
T KOG0194|consen  230 AVLEEPLMLVMELCNGGSLDDYLKK--NKKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKIS  304 (474)
T ss_pred             EcCCCccEEEEEecCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeC
Confidence            9999999999999999999999953  2236999999999999999999999988   9999999999999999999999


Q ss_pred             eccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 008292          490 DFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSN  550 (571)
Q Consensus       490 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~  550 (571)
                      ||||++.-.  ..........-+.+|+|||.+....|+.++|||||||++||+++ |..|+.
T Consensus       305 DFGLs~~~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~  364 (474)
T KOG0194|consen  305 DFGLSRAGS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYP  364 (474)
T ss_pred             ccccccCCc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCC
Confidence            999987532  11111112245789999999999999999999999999999999 888864

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=3.7e-36  Score=308.82  Aligned_cols=208  Identities=30%  Similarity=0.447  Sum_probs=171.5

Q ss_pred             HHHhCCCCccccccccCceeEEEEEc------cCCCeeEEEeecccC-ccCHHHHHHHHHHHhhc-CCCceeccceeEEe
Q 008292          341 EVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLE  412 (571)
Q Consensus       341 ~~~~~~~~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~  412 (571)
                      ++..++|++.++||+|+||.||++..      .+++.||||+++... ....+.+.+|+.++.++ +||||+++++++..
T Consensus         3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~   82 (338)
T cd05102           3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK   82 (338)
T ss_pred             ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence            34567899999999999999999973      235679999987543 23346788999999999 89999999998876


Q ss_pred             CC-eeEEEEEecCCCChhhhhcCCCC------------------------------------------------------
Q 008292          413 GE-EKILVYEFVPNKSLDYFLYDPEK------------------------------------------------------  437 (571)
Q Consensus       413 ~~-~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------  437 (571)
                      .+ ..+++|||+++|+|.+++.....                                                      
T Consensus        83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (338)
T cd05102          83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE  162 (338)
T ss_pred             CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence            44 57899999999999988853211                                                      


Q ss_pred             -----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCcccccccccc
Q 008292          438 -----QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT  512 (571)
Q Consensus       438 -----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt  512 (571)
                           ...+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++.+.............++
T Consensus       163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~  239 (338)
T cd05102         163 TDDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP  239 (338)
T ss_pred             ccccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence                 234788899999999999999999987   999999999999999999999999999865433222222233467


Q ss_pred             CCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          513 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       513 ~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                      +.|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus       240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~  279 (338)
T cd05102         240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG  279 (338)
T ss_pred             ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCC
Confidence            88999999999999999999999999999997 9999864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-36  Score=301.19  Aligned_cols=196  Identities=27%  Similarity=0.360  Sum_probs=173.1

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC---ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY  420 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  420 (571)
                      ++|++.+.||+|+||.||++... +++.||+|++....   ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            36888999999999999999965 68899999986532   233467889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCC
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD  500 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  500 (571)
                      ||+++|+|.+++.   ....+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  154 (291)
T cd05612          81 EYVPGGELFSYLR---NSGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR  154 (291)
T ss_pred             eCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence            9999999999884   3456899999999999999999999987   999999999999999999999999999865321


Q ss_pred             CCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                           .....|++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       155 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~  200 (291)
T cd05612         155 -----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFD  200 (291)
T ss_pred             -----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence                 2234689999999999999999999999999999999999999854

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=5.6e-36  Score=312.37  Aligned_cols=200  Identities=25%  Similarity=0.366  Sum_probs=171.7

Q ss_pred             CCCccccccccCceeEEEEEc-cCCCeeEEEeecccC---ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEE
Q 008292          346 KFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE  421 (571)
Q Consensus       346 ~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e  421 (571)
                      .|+..+.||+|+||+||+++. ++++.||+|++.+..   ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            578889999999999999985 467899999997532   2335678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCC
Q 008292          422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ  501 (571)
Q Consensus       422 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  501 (571)
                      |+++|+|.+++.   +...+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++.+....
T Consensus        82 ~~~gg~L~~~l~---~~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~  155 (381)
T cd05626          82 YIPGGDMMSLLI---RMEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH  155 (381)
T ss_pred             cCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence            999999999884   3456889999999999999999999987   9999999999999999999999999986432110


Q ss_pred             Cc---------------------------------------------cccccccccCCcccccccccCCCCcchhHHHHH
Q 008292          502 TQ---------------------------------------------GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFG  536 (571)
Q Consensus       502 ~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG  536 (571)
                      ..                                             ......+||+.|+|||.+.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (381)
T cd05626         156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG  235 (381)
T ss_pred             ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence            00                                             001234799999999999998999999999999


Q ss_pred             HHHHHHHhCCCCCCC
Q 008292          537 VLVLEIITGKKNSNF  551 (571)
Q Consensus       537 vvl~elltG~~p~~~  551 (571)
                      |++|||+||+.||..
T Consensus       236 ~il~elltG~~Pf~~  250 (381)
T cd05626         236 VILFEMLVGQPPFLA  250 (381)
T ss_pred             hHHHHHHhCCCCCcC
Confidence            999999999999864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2e-35  Score=295.97  Aligned_cols=198  Identities=30%  Similarity=0.438  Sum_probs=171.7

Q ss_pred             CCccccccccCceeEEEEEc-cCCCeeEEEeecccC---ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          347 FSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       347 ~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      |+..+.||+|+||+||++.. .+++.||+|.+....   ......+.+|+.++.+++|+||+++++.+.+.+..++||||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            67788999999999999996 478999999986532   22334678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT  502 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  502 (571)
                      +++|+|...+... ....+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||++....... 
T Consensus        82 ~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-  156 (285)
T cd05631          82 MNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-  156 (285)
T ss_pred             cCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence            9999998877432 2346899999999999999999999987   9999999999999999999999999998653221 


Q ss_pred             ccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          503 QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       503 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                        ......|+..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~  203 (285)
T cd05631         157 --TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRK  203 (285)
T ss_pred             --eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCC
Confidence              12234689999999999999999999999999999999999999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-36  Score=306.61  Aligned_cols=196  Identities=27%  Similarity=0.411  Sum_probs=174.0

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC---ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY  420 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  420 (571)
                      ++|++.+.||+|+||.||+++.. +++.||+|++++..   ....+.+.+|+.++..++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            36888999999999999999975 58899999997542   233467889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCC
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD  500 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  500 (571)
                      ||+++++|.+++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.... 
T Consensus        81 e~~~g~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-  153 (333)
T cd05600          81 EYVPGGDFRTLLN---NLGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-  153 (333)
T ss_pred             eCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence            9999999999984   3456899999999999999999999987   99999999999999999999999999976532 


Q ss_pred             CCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                          ......|++.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~  200 (333)
T cd05600         154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSG  200 (333)
T ss_pred             ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCC
Confidence                22345789999999999999999999999999999999999999853

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-36  Score=312.80  Aligned_cols=201  Identities=27%  Similarity=0.347  Sum_probs=172.0

Q ss_pred             CCCCccccccccCceeEEEEEc-cCCCeeEEEeecccC---ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY  420 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  420 (571)
                      ++|.+.++||+|+||.||+++. .+++.||||++.+..   ....+.+++|++++++++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            4688899999999999999985 468899999986532   233467889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCC
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD  500 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  500 (571)
                      ||+++|+|.+++.   ....+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 E~~~gg~L~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  154 (377)
T cd05629          81 EFLPGGDLMTMLI---KYDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ  154 (377)
T ss_pred             eCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence            9999999999884   3456889999999999999999999987   999999999999999999999999999643210


Q ss_pred             CCc-----------c----------------------------------ccccccccCCcccccccccCCCCcchhHHHH
Q 008292          501 QTQ-----------G----------------------------------NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSF  535 (571)
Q Consensus       501 ~~~-----------~----------------------------------~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~sl  535 (571)
                      ...           .                                  .....+||+.|+|||++.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  234 (377)
T cd05629         155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL  234 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence            000           0                                  0012469999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCC
Q 008292          536 GVLVLEIITGKKNSNF  551 (571)
Q Consensus       536 Gvvl~elltG~~p~~~  551 (571)
                      ||++|||+||+.||..
T Consensus       235 Gvil~elltG~~Pf~~  250 (377)
T cd05629         235 GAIMFECLIGWPPFCS  250 (377)
T ss_pred             chhhhhhhcCCCCCCC
Confidence            9999999999999853

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-36  Score=310.32  Aligned_cols=201  Identities=26%  Similarity=0.372  Sum_probs=173.5

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC---ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY  420 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  420 (571)
                      ++|++.+.||+|+||+||+++.. +++.||||+++...   ......+.+|+.++..++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            46888999999999999999964 68899999997532   233456788999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCC
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD  500 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  500 (571)
                      ||+++|+|.+++.   ....+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 E~~~~g~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  154 (364)
T cd05599          81 EYLPGGDMMTLLM---KKDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS  154 (364)
T ss_pred             CCCCCcHHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence            9999999999884   3456899999999999999999999987   999999999999999999999999998754321


Q ss_pred             CCcc------------------------------------ccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh
Q 008292          501 QTQG------------------------------------NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT  544 (571)
Q Consensus       501 ~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt  544 (571)
                      ....                                    .....+||+.|+|||++.+..++.++|||||||++|||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~  234 (364)
T cd05599         155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV  234 (364)
T ss_pred             ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence            1000                                    0112469999999999999999999999999999999999


Q ss_pred             CCCCCCC
Q 008292          545 GKKNSNF  551 (571)
Q Consensus       545 G~~p~~~  551 (571)
                      |+.||..
T Consensus       235 G~~Pf~~  241 (364)
T cd05599         235 GYPPFCS  241 (364)
T ss_pred             CCCCCCC
Confidence            9999853

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3e-36  Score=273.65  Aligned_cols=201  Identities=29%  Similarity=0.448  Sum_probs=178.8

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CCCeeEEEeeccc---CccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV  419 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  419 (571)
                      -++|++.+.||+|.||.||.++.+ ++..||+|++.+.   ......++.+|+++-+.++||||++++++|.+....+|+
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            367889999999999999999964 5778999998653   234456789999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCC
Q 008292          420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV  499 (571)
Q Consensus       420 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  499 (571)
                      +||.++|++...|++ ....++++.....++.|+|.||.|+|..+   |+||||||+|+|++.++.+||+|||-+..-. 
T Consensus       101 lEya~~gel~k~L~~-~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-  175 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQE-GRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP-  175 (281)
T ss_pred             EEecCCchHHHHHHh-cccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence            999999999999964 24567899999999999999999999887   9999999999999999999999999986432 


Q ss_pred             CCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 008292          500 DQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFY  552 (571)
Q Consensus       500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~~  552 (571)
                         .......+||..|.+||...+..++.++|+|++|++.||++.|.+||+..
T Consensus       176 ---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~  225 (281)
T KOG0580|consen  176 ---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQ  225 (281)
T ss_pred             ---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhh
Confidence               34455689999999999999999999999999999999999999999754

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=9e-36  Score=304.59  Aligned_cols=196  Identities=28%  Similarity=0.377  Sum_probs=173.6

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC---ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY  420 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  420 (571)
                      ++|.+.+.||+|+||.||+++.. +++.||+|.++...   ....+.+.+|+.++.+++||||+++++++.+++..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            56888999999999999999965 57899999986532   234567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCC
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD  500 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  500 (571)
                      ||+++|+|.+++.   +...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        98 e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  171 (329)
T PTZ00263         98 EFVVGGELFTHLR---KAGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR  171 (329)
T ss_pred             cCCCCChHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence            9999999999884   3456889999999999999999999987   999999999999999999999999999865322


Q ss_pred             CCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                           .....|++.|+|||.+.+..++.++||||||+++|||+||+.||..
T Consensus       172 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~  217 (329)
T PTZ00263        172 -----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD  217 (329)
T ss_pred             -----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCC
Confidence                 1235789999999999999999999999999999999999999853

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=8.2e-36  Score=311.38  Aligned_cols=200  Identities=26%  Similarity=0.378  Sum_probs=171.4

Q ss_pred             CCCccccccccCceeEEEEEc-cCCCeeEEEeecccC---ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEE
Q 008292          346 KFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE  421 (571)
Q Consensus       346 ~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e  421 (571)
                      .|+..++||+|+||+||+++. .+++.||+|++.+..   ....+.+.+|++++++++||||+++++.+.+++..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            578899999999999999996 467889999987542   2334578899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCC
Q 008292          422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ  501 (571)
Q Consensus       422 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  501 (571)
                      |+++|+|.+++.   +...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+....
T Consensus        82 ~~~gg~L~~~l~---~~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~  155 (382)
T cd05625          82 YIPGGDMMSLLI---RMGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (382)
T ss_pred             CCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence            999999999884   3356889999999999999999999987   9999999999999999999999999975431100


Q ss_pred             C---------------------------------------------ccccccccccCCcccccccccCCCCcchhHHHHH
Q 008292          502 T---------------------------------------------QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFG  536 (571)
Q Consensus       502 ~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG  536 (571)
                      .                                             .......+||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (382)
T cd05625         156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG  235 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence            0                                             0001234789999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCC
Q 008292          537 VLVLEIITGKKNSNF  551 (571)
Q Consensus       537 vvl~elltG~~p~~~  551 (571)
                      |++|||++|+.||..
T Consensus       236 vil~elltG~~Pf~~  250 (382)
T cd05625         236 VILYEMLVGQPPFLA  250 (382)
T ss_pred             HHHHHHHhCCCCCCC
Confidence            999999999999864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1e-35  Score=281.82  Aligned_cols=198  Identities=28%  Similarity=0.420  Sum_probs=168.1

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeecccCccC--HHHHHHHHHHHhhcCCCceeccceeEEeC--CeeEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQG--AEEFKNEVVLVAKLQHRNLVRLLGFCLEG--EEKILV  419 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~--~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~lv  419 (571)
                      ++|+.++.|++|+||.||+|+.+ +++.||+|+++...+..  -..-.+||.+|.+.+|||||.+-.+....  +..+||
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            45778899999999999999964 68889999997654322  22447899999999999999998887654  568999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCC
Q 008292          420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV  499 (571)
Q Consensus       420 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  499 (571)
                      |||++. +|..++..-  ..++...+..-++.|+++|++|||.++   |+|||||++|+|+...|.+||+|||+|+.++.
T Consensus       156 Me~~Eh-DLksl~d~m--~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs  229 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETM--KQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGS  229 (419)
T ss_pred             HHHHHh-hHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcC
Confidence            999965 677777542  257888999999999999999999998   99999999999999999999999999998865


Q ss_pred             CCCccccccccccCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          500 DQTQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       500 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      ..  ...+..+-|..|.|||.+++. .|++..|+||+|||+.||+++++-|.
T Consensus       230 p~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~  279 (419)
T KOG0663|consen  230 PL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFP  279 (419)
T ss_pred             Cc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCC
Confidence            42  234456789999999999875 69999999999999999999998764

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=9.7e-36  Score=305.28  Aligned_cols=197  Identities=26%  Similarity=0.366  Sum_probs=173.0

Q ss_pred             hCCCCccccccccCceeEEEEEccC--CCeeEEEeecccC---ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLPS--GQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL  418 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~~--g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  418 (571)
                      .++|.+.+.||+|+||.||+++.+.  +..||+|++....   ....+.+.+|+.+++.++||||+++++++.+++..++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            3568889999999999999998543  3689999986532   3345678899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccC
Q 008292          419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG  498 (571)
Q Consensus       419 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  498 (571)
                      ||||+++|+|.+++.   ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus       109 v~Ey~~~g~L~~~i~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~  182 (340)
T PTZ00426        109 VLEFVIGGEFFTFLR---RNKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD  182 (340)
T ss_pred             EEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence            999999999999984   3456899999999999999999999987   9999999999999999999999999998653


Q ss_pred             CCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          499 VDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ..     .....||+.|||||++.+..++.++|||||||++|||++|+.||..
T Consensus       183 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~  230 (340)
T PTZ00426        183 TR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYA  230 (340)
T ss_pred             CC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCC
Confidence            21     2245789999999999998999999999999999999999999864

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=7.9e-36  Score=310.88  Aligned_cols=201  Identities=26%  Similarity=0.381  Sum_probs=172.3

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC---ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY  420 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  420 (571)
                      ++|++.++||+|+||.||+++.. +++.||+|++.+..   ......+.+|++++++++|+||+++++.+.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            36889999999999999999954 58899999986532   234567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCC
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD  500 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  500 (571)
                      ||+++|+|.+++.   +...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 E~~~~g~L~~~i~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~  154 (376)
T cd05598          81 DYIPGGDMMSLLI---RLGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (376)
T ss_pred             eCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence            9999999999984   3456889999999999999999999987   999999999999999999999999997533110


Q ss_pred             CC-----------------------------------------ccccccccccCCcccccccccCCCCcchhHHHHHHHH
Q 008292          501 QT-----------------------------------------QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLV  539 (571)
Q Consensus       501 ~~-----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl  539 (571)
                      ..                                         .......+||+.|||||++.+..++.++|||||||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil  234 (376)
T cd05598         155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL  234 (376)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence            00                                         0001234799999999999999999999999999999


Q ss_pred             HHHHhCCCCCCC
Q 008292          540 LEIITGKKNSNF  551 (571)
Q Consensus       540 ~elltG~~p~~~  551 (571)
                      |||++|+.||..
T Consensus       235 yell~G~~Pf~~  246 (376)
T cd05598         235 YEMLVGQPPFLA  246 (376)
T ss_pred             eehhhCCCCCCC
Confidence            999999999864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.5e-35  Score=302.14  Aligned_cols=193  Identities=25%  Similarity=0.325  Sum_probs=167.9

Q ss_pred             ccccccCceeEEEEEc-cCCCeeEEEeecccC---ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEecCCC
Q 008292          351 NKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNK  426 (571)
Q Consensus       351 ~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  426 (571)
                      +.||+|+||.||+++. .+|+.||+|++++..   ......+.+|+.++++++||||+++++.+...+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999986 468899999987542   233456788999999999999999999999999999999999999


Q ss_pred             ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCcccc
Q 008292          427 SLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT  506 (571)
Q Consensus       427 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  506 (571)
                      +|..++.   +...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....  ....
T Consensus        81 ~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~  152 (323)
T cd05571          81 ELFFHLS---RERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GATM  152 (323)
T ss_pred             cHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCcc
Confidence            9988884   3457899999999999999999999987   999999999999999999999999998753211  1122


Q ss_pred             ccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          507 SRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       507 ~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ....||+.|+|||.+.+..++.++|||||||++|||+||+.||..
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~  197 (323)
T cd05571         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN  197 (323)
T ss_pred             cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCC
Confidence            345799999999999999999999999999999999999999853

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=3.9e-35  Score=296.64  Aligned_cols=204  Identities=30%  Similarity=0.475  Sum_probs=170.1

Q ss_pred             hCCCCccccccccCceeEEEEEccC-----------------CCeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceec
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLPS-----------------GQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVR  405 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~~-----------------g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~  405 (571)
                      .++|.+.++||+|+||.||++.+++                 +..||+|.+.... .....++.+|++++.+++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            4578889999999999999997532                 2369999987643 334567899999999999999999


Q ss_pred             cceeEEeCCeeEEEEEecCCCChhhhhcCCC----------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeE
Q 008292          406 LLGFCLEGEEKILVYEFVPNKSLDYFLYDPE----------------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRII  469 (571)
Q Consensus       406 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iv  469 (571)
                      +++++.+.+..++||||+++++|.+++....                ....+++..+++++.||+.||.|||+.+   |+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv  160 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV  160 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence            9999999999999999999999998874321                1234788899999999999999999987   99


Q ss_pred             EecCCCCCEEECCCCceEEeeccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhC--CC
Q 008292          470 HRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG--KK  547 (571)
Q Consensus       470 H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG--~~  547 (571)
                      ||||||+|||++.++.+||+|||+++.+.............++..|+|||++..+.++.++||||||+++|||+++  ..
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~  240 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ  240 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence            9999999999999999999999999865433322223334567899999999989999999999999999999974  45


Q ss_pred             CCC
Q 008292          548 NSN  550 (571)
Q Consensus       548 p~~  550 (571)
                      |+.
T Consensus       241 p~~  243 (304)
T cd05096         241 PYG  243 (304)
T ss_pred             CCC
Confidence            554

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-35  Score=304.14  Aligned_cols=196  Identities=32%  Similarity=0.453  Sum_probs=175.2

Q ss_pred             CCCccccccccCceeEEEEEc-cCCCeeEEEeecccC---ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEE
Q 008292          346 KFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE  421 (571)
Q Consensus       346 ~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e  421 (571)
                      -|+..+.||.|+.|.|-.|++ .+|+.+|||++.+..   ......+.+||.+|+.+.||||+++++++.+.+++|+|.|
T Consensus        13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE   92 (786)
T KOG0588|consen   13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE   92 (786)
T ss_pred             ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence            477889999999999999995 579999999997652   3334578899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCC
Q 008292          422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ  501 (571)
Q Consensus       422 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  501 (571)
                      |+++|.|.+++   ...+++++.+..+++.||+.|+.|.|..+   |+||||||+|+|||.++++||+|||+|..-..  
T Consensus        93 yv~gGELFdyl---v~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~--  164 (786)
T KOG0588|consen   93 YVPGGELFDYL---VRKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVP--  164 (786)
T ss_pred             ecCCchhHHHH---HhhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccC--
Confidence            99999998888   35678999999999999999999999887   99999999999999999999999999976432  


Q ss_pred             CccccccccccCCcccccccccCCCC-cchhHHHHHHHHHHHHhCCCCCC
Q 008292          502 TQGNTSRIVGTYGYMAPEYAMHGQFS-VKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       502 ~~~~~~~~~gt~~y~aPE~~~~~~~s-~~~Dv~slGvvl~elltG~~p~~  550 (571)
                       ......-||++.|.+||++.+.+|. .++||||.|||||.||||+.||+
T Consensus       165 -gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd  213 (786)
T KOG0588|consen  165 -GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD  213 (786)
T ss_pred             -CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC
Confidence             2233456999999999999999986 68999999999999999999997

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2.7e-35  Score=300.26  Aligned_cols=193  Identities=24%  Similarity=0.330  Sum_probs=167.5

Q ss_pred             ccccccCceeEEEEEc-cCCCeeEEEeecccC---ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEecCCC
Q 008292          351 NKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNK  426 (571)
Q Consensus       351 ~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  426 (571)
                      +.||+|+||.||+++. .+|+.||+|+++...   ......+.+|+++++.++||||+++++.+...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            4699999999999995 468899999987542   233456778999999999999999999999999999999999999


Q ss_pred             ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCcccc
Q 008292          427 SLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT  506 (571)
Q Consensus       427 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  506 (571)
                      +|..++.   +...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++......  ...
T Consensus        81 ~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~  152 (323)
T cd05595          81 ELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATM  152 (323)
T ss_pred             cHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Ccc
Confidence            9988873   3456899999999999999999999987   9999999999999999999999999987532211  122


Q ss_pred             ccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          507 SRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       507 ~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ....|++.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~  197 (323)
T cd05595         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN  197 (323)
T ss_pred             ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCC
Confidence            335789999999999999999999999999999999999999853

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8e-36  Score=288.29  Aligned_cols=198  Identities=25%  Similarity=0.474  Sum_probs=178.8

Q ss_pred             CCCCccccccccCceeEEEEEc-cCCCeeEEEeeccc---CccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY  420 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  420 (571)
                      .+|++.+.||+|.||.|-++.. ..|+.||||.+++.   ++++.-.+++||+||..++||||+.++.+|...+..+|||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            4678889999999999999985 68999999999764   4555667899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCC
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD  500 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  500 (571)
                      ||..+|.|.+++   ...+.+++.+...+++||..|+.|.|.+.   ++|||||.+|||||+++++||+||||+..+...
T Consensus       133 EYaS~GeLYDYi---Ser~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~  206 (668)
T KOG0611|consen  133 EYASGGELYDYI---SERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADK  206 (668)
T ss_pred             EecCCccHHHHH---HHhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhccc
Confidence            999999999999   35678999999999999999999999887   999999999999999999999999999876533


Q ss_pred             CCccccccccccCCcccccccccCCCC-cchhHHHHHHHHHHHHhCCCCCCC
Q 008292          501 QTQGNTSRIVGTYGYMAPEYAMHGQFS-VKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                         .....+||++-|.+||.+.+.+|. +.+|-|||||+||-|+.|.-||+-
T Consensus       207 ---kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG  255 (668)
T KOG0611|consen  207 ---KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDG  255 (668)
T ss_pred             ---cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCC
Confidence               234568999999999999999885 689999999999999999999863

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.4e-35  Score=307.63  Aligned_cols=202  Identities=23%  Similarity=0.304  Sum_probs=173.0

Q ss_pred             HHhCCCCccccccccCceeEEEEEcc-CCCeeEEEeeccc---CccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeE
Q 008292          342 VATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI  417 (571)
Q Consensus       342 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  417 (571)
                      ...++|++.+.||+|+||.||+++.. +++.+|+|.+++.   .....+.+.+|+.+++.++||||+++++++.+++..+
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~  119 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY  119 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence            34568999999999999999999965 5788999998642   2233456789999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCcccc
Q 008292          418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF  497 (571)
Q Consensus       418 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  497 (571)
                      +||||+++|+|.+++.    ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++..+
T Consensus       120 lv~Ey~~gg~L~~~l~----~~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~  192 (370)
T cd05621         120 MVMEYMPGGDLVNLMS----NYDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKM  192 (370)
T ss_pred             EEEcCCCCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceec
Confidence            9999999999999883    335788999999999999999999987   999999999999999999999999999876


Q ss_pred             CCCCCccccccccccCCcccccccccC----CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          498 GVDQTQGNTSRIVGTYGYMAPEYAMHG----QFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ..... .......||+.|+|||++...    .++.++||||||+++|||++|+.||..
T Consensus       193 ~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~  249 (370)
T cd05621         193 DETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA  249 (370)
T ss_pred             ccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCC
Confidence            42221 122345799999999998654    378899999999999999999999853

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.7e-35  Score=282.77  Aligned_cols=200  Identities=29%  Similarity=0.466  Sum_probs=168.0

Q ss_pred             CCCCccccccccCceeEEEEEc-cCCCeeEEEeecccCcc--CHHHHHHHHHHHhhcCCCc-eeccceeEEeCC------
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQ--GAEEFKNEVVLVAKLQHRN-LVRLLGFCLEGE------  414 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~h~n-iv~l~~~~~~~~------  414 (571)
                      ..|...++||+|+||+||+|+. .+|+.||+|+++...++  .-....+|+.++++++|+| |+++.+++...+      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            4566678899999999999995 47899999999765442  2245578999999999999 999999998877      


Q ss_pred             eeEEEEEecCCCChhhhhcCCCCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccC
Q 008292          415 EKILVYEFVPNKSLDYFLYDPEKQ-GQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM  493 (571)
Q Consensus       415 ~~~lv~e~~~~g~L~~~l~~~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl  493 (571)
                      ..++|+||++ .+|..++...... ..++...+..++.||++||+|||+++   |+||||||.||||+++|.+||+|||+
T Consensus        91 ~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   91 KLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             eEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence            7889999994 5788877543221 35677889999999999999999987   99999999999999999999999999


Q ss_pred             ccccCCCCCccccccccccCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          494 ARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       494 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      |+.+..+...  .+..++|..|.|||++.+. .|+...||||+||++.||++++.-|.
T Consensus       167 Ara~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFp  222 (323)
T KOG0594|consen  167 ARAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFP  222 (323)
T ss_pred             HHHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCC
Confidence            9976543332  3455789999999999887 79999999999999999999776553

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=2.9e-35  Score=300.60  Aligned_cols=193  Identities=26%  Similarity=0.344  Sum_probs=168.1

Q ss_pred             ccccccCceeEEEEEc-cCCCeeEEEeecccC---ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEecCCC
Q 008292          351 NKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNK  426 (571)
Q Consensus       351 ~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  426 (571)
                      +.||+|+||.||++.. .+++.||+|++++..   ......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999985 468899999997542   334567788999999999999999999999999999999999999


Q ss_pred             ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCcccc
Q 008292          427 SLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT  506 (571)
Q Consensus       427 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  506 (571)
                      +|..++.   ....+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++......  ...
T Consensus        81 ~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~  152 (328)
T cd05593          81 ELFFHLS---RERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATM  152 (328)
T ss_pred             CHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc--ccc
Confidence            9988874   3456899999999999999999999987   9999999999999999999999999987532211  122


Q ss_pred             ccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          507 SRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       507 ~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ....||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~  197 (328)
T cd05593         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN  197 (328)
T ss_pred             ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCC
Confidence            345789999999999999999999999999999999999999853

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-36  Score=296.45  Aligned_cols=199  Identities=27%  Similarity=0.462  Sum_probs=177.5

Q ss_pred             CCCCccccccccCceeEEEEEc-cCCCeeEEEeeccc-CccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA-SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      ..|+..+.||+|.||.||||.. ..++.||+|++... .+...+++++|+.+|..++++||.+++|.+..+...+++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            4567778999999999999995 46888999999754 455678999999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT  502 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  502 (571)
                      +.+|++.+.|   +....+++..+.-++++++.||.|||.++   .+|||||+.|||+..+|.+||+|||.+..+.....
T Consensus        93 ~~gGsv~~lL---~~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~  166 (467)
T KOG0201|consen   93 CGGGSVLDLL---KSGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK  166 (467)
T ss_pred             hcCcchhhhh---ccCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence            9999999998   33445588888889999999999999987   99999999999999999999999999987754433


Q ss_pred             ccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          503 QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       503 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .  ...++||+-|||||++....|+.|+||||||++.+||.+|.+|+.-
T Consensus       167 r--r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~  213 (467)
T KOG0201|consen  167 R--RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSK  213 (467)
T ss_pred             c--cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcc
Confidence            3  3568999999999999988999999999999999999999999754

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-35  Score=297.21  Aligned_cols=190  Identities=28%  Similarity=0.384  Sum_probs=166.6

Q ss_pred             ccccCceeEEEEEcc-CCCeeEEEeeccc---CccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEecCCCCh
Q 008292          353 LGEGGFGEVYKGVLP-SGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL  428 (571)
Q Consensus       353 LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  428 (571)
                      ||+|+||.||++... +++.||+|++++.   .......+.+|+.++.+++||||+++++++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            799999999999965 5788999998653   233456778899999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCcccccc
Q 008292          429 DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR  508 (571)
Q Consensus       429 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  508 (571)
                      .+++.   ....+++..+..++.||++||.|||+++   |+||||||+|||++.++.+||+|||+++......  .....
T Consensus        81 ~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~  152 (312)
T cd05585          81 FHHLQ---REGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNT  152 (312)
T ss_pred             HHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccc
Confidence            99884   3456899999999999999999999987   9999999999999999999999999987542221  12334


Q ss_pred             ccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          509 IVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       509 ~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      ..||+.|+|||.+.+..++.++||||||+++|||+||+.||.
T Consensus       153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~  194 (312)
T cd05585         153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFY  194 (312)
T ss_pred             ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcC
Confidence            578999999999999999999999999999999999999985

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.8e-34  Score=297.92  Aligned_cols=195  Identities=29%  Similarity=0.424  Sum_probs=164.0

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      ++|+..++||+|+||.||+++.. +++.||||++.... ....+.+.+|+++++.++|+||+++++++...+..++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            34566789999999999999964 68999999986543 23356789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT  502 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  502 (571)
                      +++++|....       ..++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.+.....
T Consensus       154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~  223 (353)
T PLN00034        154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD  223 (353)
T ss_pred             CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence            9999985432       3467788899999999999999987   99999999999999999999999999986543221


Q ss_pred             ccccccccccCCccccccccc-----CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          503 QGNTSRIVGTYGYMAPEYAMH-----GQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       503 ~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                        ......|+..|+|||.+..     ...+.++|||||||++|||++|+.||..
T Consensus       224 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~  275 (353)
T PLN00034        224 --PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV  275 (353)
T ss_pred             --cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence              1233578999999998743     2345689999999999999999999863

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2.2e-35  Score=305.58  Aligned_cols=201  Identities=27%  Similarity=0.372  Sum_probs=173.4

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC---ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY  420 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  420 (571)
                      ++|+..+.||+|+||+||+++.. +++.||+|+++...   ......+.+|+.++..++|+||+++++.+.+.+..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            36888999999999999999864 58899999987532   334567888999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCC
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD  500 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  500 (571)
                      ||+++|+|.+++.   +...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~  154 (360)
T cd05627          81 EFLPGGDMMTLLM---KKDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA  154 (360)
T ss_pred             eCCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence            9999999999884   3456899999999999999999999987   999999999999999999999999998754221


Q ss_pred             CCc---------------------------------cccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCC
Q 008292          501 QTQ---------------------------------GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKK  547 (571)
Q Consensus       501 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~  547 (571)
                      ...                                 ......+||+.|+|||++.+..++.++|||||||++|||+||+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~  234 (360)
T cd05627         155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (360)
T ss_pred             cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence            100                                 00123479999999999999999999999999999999999999


Q ss_pred             CCCC
Q 008292          548 NSNF  551 (571)
Q Consensus       548 p~~~  551 (571)
                      ||..
T Consensus       235 Pf~~  238 (360)
T cd05627         235 PFCS  238 (360)
T ss_pred             CCCC
Confidence            9854

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.7e-34  Score=293.54  Aligned_cols=193  Identities=31%  Similarity=0.448  Sum_probs=164.1

Q ss_pred             ccccccCceeEEEEEcc-CCCeeEEEeecccC---ccCHHHHHHHHHHHhh-cCCCceeccceeEEeCCeeEEEEEecCC
Q 008292          351 NKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAK-LQHRNLVRLLGFCLEGEEKILVYEFVPN  425 (571)
Q Consensus       351 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~  425 (571)
                      +.||+|+||.||+++.. +++.||+|.++...   ....+.+..|..++.. .+||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999964 57789999987532   2334455666666664 4899999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCccc
Q 008292          426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN  505 (571)
Q Consensus       426 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  505 (571)
                      |+|..++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~  152 (316)
T cd05592          81 GDLMFHIQ---SSGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GK  152 (316)
T ss_pred             CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cc
Confidence            99998884   3456899999999999999999999987   9999999999999999999999999997543222  22


Q ss_pred             cccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       506 ~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~  198 (316)
T cd05592         153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHG  198 (316)
T ss_pred             cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCC
Confidence            3345789999999999999999999999999999999999999863

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-35  Score=288.30  Aligned_cols=204  Identities=28%  Similarity=0.446  Sum_probs=168.6

Q ss_pred             HHHhCCCCccccccccCceeEEEEEc-cCCCeeEEEeecccC--------------ccCHHHHHHHHHHHhhcCCCceec
Q 008292          341 EVATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS--------------GQGAEEFKNEVVLVAKLQHRNLVR  405 (571)
Q Consensus       341 ~~~~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--------------~~~~~~~~~Ei~~l~~l~h~niv~  405 (571)
                      ...-++|++.+.||+|.||.|-++.. .+++.||||++.+..              -...+...+||.+|++++|||||+
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~  172 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK  172 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence            34457899999999999999999995 468899999996421              112367899999999999999999


Q ss_pred             cceeEEeC--CeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCC
Q 008292          406 LLGFCLEG--EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE  483 (571)
Q Consensus       406 l~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~  483 (571)
                      |+.+..+.  +..|||+||+..|.+...=   .....+.+.+++++++++..||+|||.++   ||||||||+|+||+++
T Consensus       173 LiEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~  246 (576)
T KOG0585|consen  173 LIEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSD  246 (576)
T ss_pred             EEEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCC
Confidence            99988664  5689999999988875332   22333899999999999999999999998   9999999999999999


Q ss_pred             CceEEeeccCccccCCCCC---ccccccccccCCcccccccccCC----CCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          484 MNPKISDFGMARIFGVDQT---QGNTSRIVGTYGYMAPEYAMHGQ----FSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       484 ~~~kl~DfGla~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~----~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      |++||+|||.+..+.....   .......+|||.|||||...++.    .+.+.||||+||+||-|+.|+.||.
T Consensus       247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~  320 (576)
T KOG0585|consen  247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFF  320 (576)
T ss_pred             CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcc
Confidence            9999999999986632211   11234478999999999887632    3567899999999999999999973

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.3e-34  Score=296.40  Aligned_cols=199  Identities=27%  Similarity=0.364  Sum_probs=174.5

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE  421 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e  421 (571)
                      .++|++.+.||+|+||.||+++.. ++..+|+|.+.... ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            468899999999999999999965 57889999887542 3345678999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCC
Q 008292          422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ  501 (571)
Q Consensus       422 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  501 (571)
                      |+++++|.+++.   ....+++..+..++.|++.||.|||+.+  +|+||||||+|||++.++.+||+|||++..+... 
T Consensus        84 ~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-  157 (331)
T cd06649          84 HMDGGSLDQVLK---EAKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  157 (331)
T ss_pred             cCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence            999999999984   3346899999999999999999999753  4999999999999999999999999998765322 


Q ss_pred             CccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          502 TQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       502 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                         ......|++.|+|||++.+..++.++||||||+++|||+||+.||..
T Consensus       158 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~  204 (331)
T cd06649         158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP  204 (331)
T ss_pred             ---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence               22334689999999999999999999999999999999999999864

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1e-34  Score=310.99  Aligned_cols=203  Identities=19%  Similarity=0.261  Sum_probs=175.9

Q ss_pred             CCCccccccccCceeEEEEEcc-C-CCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEec
Q 008292          346 KFSTDNKLGEGGFGEVYKGVLP-S-GQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV  423 (571)
Q Consensus       346 ~~~~~~~LG~G~fg~Vy~~~~~-~-g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  423 (571)
                      .|...+.||+|+||.||++... + ++.|++|.+..........+++|+.+++.++||||+++++++..++..+|||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            4888999999999999999853 3 5778888776555555567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCC
Q 008292          424 PNKSLDYFLYDP-EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT  502 (571)
Q Consensus       424 ~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  502 (571)
                      ++|+|.+++... .....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+.....
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            999999887532 23456889999999999999999999887   99999999999999999999999999987654333


Q ss_pred             ccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          503 QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       503 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .......+||+.|+|||++.+..++.++||||||+++|||+||+.||..
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~  273 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKG  273 (478)
T ss_pred             cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCC
Confidence            2233456799999999999999999999999999999999999999853

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=7.7e-35  Score=297.00  Aligned_cols=193  Identities=30%  Similarity=0.428  Sum_probs=166.8

Q ss_pred             ccccccCceeEEEEEc----cCCCeeEEEeecccC----ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          351 NKLGEGGFGEVYKGVL----PSGQEIAVKRLSKAS----GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       351 ~~LG~G~fg~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      ++||+|+||.||+++.    .+++.||+|+++...    ......+.+|+.+++.++||||+++++.+..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            6799999999999985    357889999987532    23345678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT  502 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  502 (571)
                      +++++|.+++.   +...+.+..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++...... 
T Consensus        82 ~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  154 (323)
T cd05584          82 LSGGELFMHLE---REGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-  154 (323)
T ss_pred             CCCchHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-
Confidence            99999998884   3456788899999999999999999987   9999999999999999999999999987532221 


Q ss_pred             ccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          503 QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       503 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                       .......|++.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~  202 (323)
T cd05584         155 -TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTA  202 (323)
T ss_pred             -CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCC
Confidence             122345789999999999998999999999999999999999999864

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=4.9e-35  Score=303.71  Aligned_cols=206  Identities=22%  Similarity=0.297  Sum_probs=175.0

Q ss_pred             HHHHHHhCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC---ccCHHHHHHHHHHHhhcCCCceeccceeEEeC
Q 008292          338 ETIEVATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG  413 (571)
Q Consensus       338 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~  413 (571)
                      ..++...++|++.+.||+|+||.||+++.+ +++.+|+|++.+..   ....+.+.+|+.+++.++||||+++++.+.++
T Consensus        36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~  115 (371)
T cd05622          36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  115 (371)
T ss_pred             hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence            344555688999999999999999999965 57889999986422   23345678899999999999999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccC
Q 008292          414 EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM  493 (571)
Q Consensus       414 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl  493 (571)
                      +..++||||+++|+|..++.    ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+
T Consensus       116 ~~~~lv~Ey~~gg~L~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~  188 (371)
T cd05622         116 RYLYMVMEYMPGGDLVNLMS----NYDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT  188 (371)
T ss_pred             CEEEEEEcCCCCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCc
Confidence            99999999999999999883    345788899999999999999999987   99999999999999999999999999


Q ss_pred             ccccCCCCCccccccccccCCcccccccccC----CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          494 ARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG----QFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       494 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ++.+..... .......||+.|||||++...    .++.++|||||||++|||++|+.||..
T Consensus       189 a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~  249 (371)
T cd05622         189 CMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA  249 (371)
T ss_pred             eeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCC
Confidence            986643221 122345799999999998654    378999999999999999999999863

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.1e-34  Score=296.05  Aligned_cols=196  Identities=28%  Similarity=0.382  Sum_probs=167.6

Q ss_pred             CCccccccccCceeEEEEEcc-CCCeeEEEeecccC---ccCHHHHHHHHHHH---hhcCCCceeccceeEEeCCeeEEE
Q 008292          347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLV---AKLQHRNLVRLLGFCLEGEEKILV  419 (571)
Q Consensus       347 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l---~~l~h~niv~l~~~~~~~~~~~lv  419 (571)
                      |++.+.||+|+||.||++... +++.||||++++..   ....+.+.+|++++   ..++||||+++++++..++..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            567889999999999999864 68899999997542   23345666776654   567899999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCC
Q 008292          420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV  499 (571)
Q Consensus       420 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  499 (571)
                      |||+++++|...+.    ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05589          81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG  153 (324)
T ss_pred             EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence            99999999988873    346899999999999999999999987   99999999999999999999999999875322


Q ss_pred             CCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          500 DQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .  ........|++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       154 ~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~  203 (324)
T cd05589         154 F--GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPG  203 (324)
T ss_pred             C--CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCC
Confidence            1  1223345789999999999999999999999999999999999999864

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-35  Score=302.79  Aligned_cols=201  Identities=26%  Similarity=0.385  Sum_probs=175.7

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC---ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY  420 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  420 (571)
                      ++|.+.+.||+|+||+||+++.. +++.||+|+++...   ......+.+|++++..++||||+++++.+.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            46888999999999999999965 68899999987532   234567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCC
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD  500 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  500 (571)
                      ||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 e~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  154 (350)
T cd05573          81 EYMPGGDLMNLLIR---KDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA  154 (350)
T ss_pred             cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence            99999999999853   367899999999999999999999987   999999999999999999999999999865433


Q ss_pred             C---------------------------CccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          501 Q---------------------------TQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       501 ~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .                           .........||+.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~  232 (350)
T cd05573         155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYS  232 (350)
T ss_pred             CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCC
Confidence            2                           00122345689999999999999999999999999999999999999864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.7e-34  Score=294.52  Aligned_cols=198  Identities=29%  Similarity=0.380  Sum_probs=169.1

Q ss_pred             CCCccccccccCceeEEEEEcc-CCCeeEEEeecccC---ccCHHHHHHHHHHHhhc-CCCceeccceeEEeCCeeEEEE
Q 008292          346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVY  420 (571)
Q Consensus       346 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~  420 (571)
                      +|.+.+.||+|+||.||+++.. +++.||+|++++..   ....+.+..|..++..+ +|++|+++++++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4778899999999999999865 57789999987542   22334566788888777 5899999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCC
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD  500 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  500 (571)
                      ||+++|+|...+.   ....+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 E~~~~g~L~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~  154 (323)
T cd05616          81 EYVNGGDLMYQIQ---QVGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD  154 (323)
T ss_pred             cCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence            9999999988884   3456899999999999999999999887   999999999999999999999999998754321


Q ss_pred             CCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .  .......||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus       155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~  203 (323)
T cd05616         155 G--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG  203 (323)
T ss_pred             C--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCC
Confidence            1  122345789999999999999999999999999999999999999864

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=9.9e-35  Score=301.79  Aligned_cols=210  Identities=30%  Similarity=0.458  Sum_probs=173.5

Q ss_pred             HHHHHhCCCCccccccccCceeEEEEEc------cCCCeeEEEeecccC-ccCHHHHHHHHHHHhhc-CCCceeccceeE
Q 008292          339 TIEVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKL-QHRNLVRLLGFC  410 (571)
Q Consensus       339 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~  410 (571)
                      .+....++|++.+.||+|+||.||+++.      .++..||+|+++... ....+.+.+|+.+++.+ +|+||+++++++
T Consensus        32 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~  111 (374)
T cd05106          32 KWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGAC  111 (374)
T ss_pred             cccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEe
Confidence            3455567899999999999999999873      234579999997543 33356788999999999 899999999999


Q ss_pred             EeCCeeEEEEEecCCCChhhhhcCCC------------------------------------------------------
Q 008292          411 LEGEEKILVYEFVPNKSLDYFLYDPE------------------------------------------------------  436 (571)
Q Consensus       411 ~~~~~~~lv~e~~~~g~L~~~l~~~~------------------------------------------------------  436 (571)
                      ......++||||+++|+|.+++....                                                      
T Consensus       112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (374)
T cd05106         112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS  191 (374)
T ss_pred             cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence            99999999999999999998874311                                                      


Q ss_pred             -------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCc
Q 008292          437 -------------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ  503 (571)
Q Consensus       437 -------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  503 (571)
                                   ....+++.++++++.||++||.|||+++   |+||||||+|||+++++.+||+|||+++.+......
T Consensus       192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~  268 (374)
T cd05106         192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY  268 (374)
T ss_pred             cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence                         1124788899999999999999999987   999999999999999999999999999865433221


Q ss_pred             cccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          504 GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       504 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                      .......++..|||||++.+..++.++||||||+++|||++ |+.||..
T Consensus       269 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~  317 (374)
T cd05106         269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPG  317 (374)
T ss_pred             eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc
Confidence            11222335678999999999999999999999999999997 9999753

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.5e-34  Score=295.21  Aligned_cols=193  Identities=27%  Similarity=0.376  Sum_probs=166.8

Q ss_pred             ccccccCceeEEEEEcc-CCCeeEEEeecccC---ccCHHHHHHHHHHHhhc-CCCceeccceeEEeCCeeEEEEEecCC
Q 008292          351 NKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPN  425 (571)
Q Consensus       351 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  425 (571)
                      +.||+|+||.||+++.. +++.||+|++++..   ....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999964 57889999997542   23345678899998888 699999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCccc
Q 008292          426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN  505 (571)
Q Consensus       426 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  505 (571)
                      |+|..++.   ....+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 ~~L~~~~~---~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~  152 (327)
T cd05617          81 GDLMFHMQ---RQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DT  152 (327)
T ss_pred             CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Cc
Confidence            99988773   3456899999999999999999999987   9999999999999999999999999987532111  12


Q ss_pred             cccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       506 ~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .....||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~  198 (327)
T cd05617         153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI  198 (327)
T ss_pred             eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCc
Confidence            2345789999999999999999999999999999999999999964

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.5e-34  Score=294.97  Aligned_cols=198  Identities=29%  Similarity=0.385  Sum_probs=169.4

Q ss_pred             CCCccccccccCceeEEEEEcc-CCCeeEEEeecccC---ccCHHHHHHHHHHHhhcCCC-ceeccceeEEeCCeeEEEE
Q 008292          346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHR-NLVRLLGFCLEGEEKILVY  420 (571)
Q Consensus       346 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~-niv~l~~~~~~~~~~~lv~  420 (571)
                      +|++.+.||+|+||.||+|+.. +++.||+|++++..   ....+.+..|++++..++|+ +|+++.+++...+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4778899999999999999965 56789999987532   33456778899999999765 5888889999899999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCC
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD  500 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  500 (571)
                      ||+++|+|..++.   ....+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 E~~~~g~L~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05587          81 EYVNGGDLMYHIQ---QVGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG  154 (324)
T ss_pred             cCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence            9999999998884   3456899999999999999999999987   999999999999999999999999998743211


Q ss_pred             CCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .  .......||+.|+|||++.+..++.++||||||+++|||+||+.||..
T Consensus       155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~  203 (324)
T cd05587         155 G--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG  203 (324)
T ss_pred             C--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCC
Confidence            1  122345789999999999999999999999999999999999999863

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=4.2e-35  Score=304.23  Aligned_cols=201  Identities=24%  Similarity=0.309  Sum_probs=171.7

Q ss_pred             HhCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC---ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEE
Q 008292          343 ATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL  418 (571)
Q Consensus       343 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  418 (571)
                      ..++|++.++||+|+||.||+++.. +++.||+|++++..   ....+.+.+|+.+++.++||||+++++++.+++..++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            3467889999999999999999964 58899999986532   2334567889999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccC
Q 008292          419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG  498 (571)
Q Consensus       419 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  498 (571)
                      ||||+++|+|..++.    ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++....
T Consensus       121 v~Ey~~gg~L~~~l~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~  193 (370)
T cd05596         121 VMEYMPGGDLVNLMS----NYDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD  193 (370)
T ss_pred             EEcCCCCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence            999999999999884    335788889999999999999999987   9999999999999999999999999998654


Q ss_pred             CCCCccccccccccCCcccccccccC----CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          499 VDQTQGNTSRIVGTYGYMAPEYAMHG----QFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       499 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .... .......||+.|+|||.+.+.    .++.++|||||||++|||++|+.||..
T Consensus       194 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~  249 (370)
T cd05596         194 ANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA  249 (370)
T ss_pred             CCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCC
Confidence            3221 122345799999999998653    478999999999999999999999863

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.8e-34  Score=289.07  Aligned_cols=200  Identities=25%  Similarity=0.370  Sum_probs=172.5

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC--ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE  421 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e  421 (571)
                      ++|++.+.||+|+||.||+++.+ +++.||+|+++...  ....+.+.+|+++++.++||||+++++++...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            46889999999999999999975 57889999987542  3345678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCC
Q 008292          422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ  501 (571)
Q Consensus       422 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  501 (571)
                      |++++.+..+..   ....+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++.+....
T Consensus        81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  154 (287)
T cd07848          81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS  154 (287)
T ss_pred             cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence            999988776552   2356899999999999999999999887   9999999999999999999999999998754322


Q ss_pred             CccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          502 TQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       502 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      . .......|++.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       155 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~  203 (287)
T cd07848         155 N-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPG  203 (287)
T ss_pred             c-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCC
Confidence            1 122335689999999999998999999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.8e-34  Score=294.99  Aligned_cols=193  Identities=27%  Similarity=0.386  Sum_probs=167.3

Q ss_pred             ccccccCceeEEEEEcc-CCCeeEEEeecccC---ccCHHHHHHHHHHHhhc-CCCceeccceeEEeCCeeEEEEEecCC
Q 008292          351 NKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPN  425 (571)
Q Consensus       351 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  425 (571)
                      +.||+|+||.||+++.. +++.||+|++++..   ....+.+..|+.++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999964 67889999997542   23345678899999888 799999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCccc
Q 008292          426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN  505 (571)
Q Consensus       426 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  505 (571)
                      |+|..++.   +...+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 g~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~  152 (329)
T cd05588          81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GDT  152 (329)
T ss_pred             CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC--CCc
Confidence            99988873   3457999999999999999999999987   999999999999999999999999998742211  112


Q ss_pred             cccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       506 ~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .....||+.|+|||++.+..++.++||||||+++|||+||+.||+.
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~  198 (329)
T cd05588         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI  198 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence            2345789999999999999999999999999999999999999964

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.3e-34  Score=296.68  Aligned_cols=199  Identities=27%  Similarity=0.390  Sum_probs=170.0

Q ss_pred             CCCccccccccCceeEEEEEc----cCCCeeEEEeecccC----ccCHHHHHHHHHHHhhcC-CCceeccceeEEeCCee
Q 008292          346 KFSTDNKLGEGGFGEVYKGVL----PSGQEIAVKRLSKAS----GQGAEEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEK  416 (571)
Q Consensus       346 ~~~~~~~LG~G~fg~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~  416 (571)
                      +|++.+.||+|+||.||+++.    .+++.||+|++.+..    ....+.+.+|+.++..++ |+||+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            477889999999999999874    357889999986532    233456788999999994 89999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccc
Q 008292          417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI  496 (571)
Q Consensus       417 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  496 (571)
                      ++||||+++|+|.+++.   ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        81 ~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~  154 (332)
T cd05614          81 HLILDYVSGGEMFTHLY---QRDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE  154 (332)
T ss_pred             EEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence            99999999999998884   3456899999999999999999999987   99999999999999999999999999986


Q ss_pred             cCCCCCccccccccccCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          497 FGVDQTQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      +..... .......||+.|+|||.+.+. .++.++||||||+++|||+||+.||..
T Consensus       155 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~  209 (332)
T cd05614         155 FLSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTL  209 (332)
T ss_pred             ccccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCC
Confidence            533222 122345799999999998765 478999999999999999999999864

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.9e-34  Score=295.24  Aligned_cols=201  Identities=27%  Similarity=0.382  Sum_probs=174.4

Q ss_pred             HhCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEE
Q 008292          343 ATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY  420 (571)
Q Consensus       343 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  420 (571)
                      ..++|++.++||+|+||.||++... ++..+++|.+.... ....+.+.+|+++++.++|+||+++++++.+.+..++||
T Consensus         3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   82 (333)
T cd06650           3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   82 (333)
T ss_pred             chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence            3478999999999999999999965 57888999886542 333467899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCC
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD  500 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  500 (571)
                      ||+++++|.+++.   ....+++..+..++.|+++||.|||+..  +|+||||||+|||+++++.+||+|||++..+...
T Consensus        83 e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~  157 (333)
T cd06650          83 EHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  157 (333)
T ss_pred             ecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence            9999999999984   3456889999999999999999999742  3999999999999999999999999998755322


Q ss_pred             CCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 008292          501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFY  552 (571)
Q Consensus       501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~~  552 (571)
                          ......|+..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       158 ----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~  205 (333)
T cd06650         158 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP  205 (333)
T ss_pred             ----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence                122346889999999999989999999999999999999999998643

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=6.1e-35  Score=298.03  Aligned_cols=193  Identities=25%  Similarity=0.328  Sum_probs=166.7

Q ss_pred             ccccccCceeEEEEEc-cCCCeeEEEeecccC---ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEecCCC
Q 008292          351 NKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNK  426 (571)
Q Consensus       351 ~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  426 (571)
                      +.||+|+||.||+++. .+++.||+|+++...   ......+.+|++++..++||||+++.+++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999985 468899999987532   233456788999999999999999999999999999999999999


Q ss_pred             ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCccc
Q 008292          427 SLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE-DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN  505 (571)
Q Consensus       427 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  505 (571)
                      +|..++.   ....+++..+..++.||+.||.|||+ .+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 ~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~  152 (325)
T cd05594          81 ELFFHLS---RERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--AT  152 (325)
T ss_pred             cHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--cc
Confidence            9988873   34568999999999999999999997 55   9999999999999999999999999987532211  12


Q ss_pred             cccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       506 ~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .....||+.|+|||++.+..++.++||||||+++|||+||+.||..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~  198 (325)
T cd05594         153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN  198 (325)
T ss_pred             cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCC
Confidence            2335689999999999999999999999999999999999999853

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2.1e-34  Score=288.08  Aligned_cols=192  Identities=19%  Similarity=0.352  Sum_probs=165.5

Q ss_pred             cccccccCceeEEEEEccCCCeeEEEeecccCccC---HHHHHHHHHHHhhcCCCceeccceeEEe----CCeeEEEEEe
Q 008292          350 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQG---AEEFKNEVVLVAKLQHRNLVRLLGFCLE----GEEKILVYEF  422 (571)
Q Consensus       350 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~---~~~~~~Ei~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~  422 (571)
                      ...||+|++|.||+|.+ +|+.||||+++......   .+.+.+|+.+|.+++||||++++|++.+    ....++||||
T Consensus        25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            36799999999999998 78999999997654333   4678899999999999999999999877    3467899999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT  502 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  502 (571)
                      +++|+|.+++..   ...+++...++++.|++.||.|||+..  +++||||||+|||++.++.+||+|||+++.+.... 
T Consensus       104 ~~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-  177 (283)
T PHA02988        104 CTRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-  177 (283)
T ss_pred             CCCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence            999999999943   456899999999999999999999742  27899999999999999999999999998653221 


Q ss_pred             ccccccccccCCccccccccc--CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 008292          503 QGNTSRIVGTYGYMAPEYAMH--GQFSVKSDVYSFGVLVLEIITGKKNSNFY  552 (571)
Q Consensus       503 ~~~~~~~~gt~~y~aPE~~~~--~~~s~~~Dv~slGvvl~elltG~~p~~~~  552 (571)
                          ....|+..|+|||.+.+  ..++.++||||||+++|||+||+.||+..
T Consensus       178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~  225 (283)
T PHA02988        178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL  225 (283)
T ss_pred             ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCC
Confidence                22467889999999876  68999999999999999999999998643

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-34  Score=295.94  Aligned_cols=201  Identities=25%  Similarity=0.334  Sum_probs=171.7

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeeccc---CccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY  420 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  420 (571)
                      ++|++.+.||+|+||+||+++.. +++.||+|++.+.   .....+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            46888999999999999999964 5889999998652   2233456889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCC
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD  500 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  500 (571)
                      ||+++|+|.+++..  ....+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (331)
T cd05597          81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD  155 (331)
T ss_pred             ecCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence            99999999999843  2456899999999999999999999987   999999999999999999999999998765432


Q ss_pred             CCccccccccccCCccccccccc-----CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          501 QTQGNTSRIVGTYGYMAPEYAMH-----GQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       501 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .. .......||+.|+|||++..     ..++.++||||||+++|||++|+.||..
T Consensus       156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~  210 (331)
T cd05597         156 GT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA  210 (331)
T ss_pred             CC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence            22 11223468999999999863     4578899999999999999999999853

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=2.5e-34  Score=293.87  Aligned_cols=193  Identities=27%  Similarity=0.384  Sum_probs=166.3

Q ss_pred             ccccccCceeEEEEEcc-CCCeeEEEeecccC---ccCHHHHHHHHHHHhhc-CCCceeccceeEEeCCeeEEEEEecCC
Q 008292          351 NKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPN  425 (571)
Q Consensus       351 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  425 (571)
                      +.||+|+||.||++... +++.||+|++++..   ....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999964 57889999987542   23345677888888776 799999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCccc
Q 008292          426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN  505 (571)
Q Consensus       426 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  505 (571)
                      |+|..++.   ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 ~~L~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~  152 (329)
T cd05618          81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DT  152 (329)
T ss_pred             CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Cc
Confidence            99988873   3456899999999999999999999987   9999999999999999999999999987532211  12


Q ss_pred             cccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       506 ~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .....||+.|+|||++.+..++.++||||||+++|||+||+.||..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~  198 (329)
T cd05618         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI  198 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCcc
Confidence            2345789999999999999999999999999999999999999863

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-35  Score=281.56  Aligned_cols=201  Identities=29%  Similarity=0.462  Sum_probs=172.2

Q ss_pred             hCCCCccccccccCceeEEEEEc-cCCCeeEEEeecc--cCccCHHHHHHHHHHHhhcCCCceeccceeEEe-----CCe
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSK--ASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE-----GEE  415 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~-----~~~  415 (571)
                      ..+|...+.||+|.||.|..+.. .+|+.||||++..  ......++..+|+++|+.++|+||+.+++.+..     -+.
T Consensus        21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D  100 (359)
T KOG0660|consen   21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND  100 (359)
T ss_pred             cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence            34566678999999999999995 4689999999973  455566788899999999999999999998866     346


Q ss_pred             eEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCcc
Q 008292          416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR  495 (571)
Q Consensus       416 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  495 (571)
                      .|+|+|+| +.+|...+.   .+..++......++.||++||.|+|+.+   |+||||||+|+|++.+..+||+|||+|+
T Consensus       101 vYiV~elM-etDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR  173 (359)
T KOG0660|consen  101 VYLVFELM-ETDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLAR  173 (359)
T ss_pred             eEEehhHH-hhHHHHHHH---cCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecccccee
Confidence            79999999 678888883   3445999999999999999999999988   9999999999999999999999999999


Q ss_pred             ccCCCCCccccccccccCCcccccccc-cCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          496 IFGVDQTQGNTSRIVGTYGYMAPEYAM-HGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ...........+.-+.|..|.|||.+. ..+|+.+.||||.|||+.||++|+.-|..
T Consensus       174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG  230 (359)
T KOG0660|consen  174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPG  230 (359)
T ss_pred             eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCC
Confidence            875442333445567899999999875 46899999999999999999999997754

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=8e-35  Score=300.85  Aligned_cols=205  Identities=31%  Similarity=0.480  Sum_probs=178.7

Q ss_pred             CCCccccccccCceeEEEEEc-cCCCeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeEEeCC------eeE
Q 008292          346 KFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE------EKI  417 (571)
Q Consensus       346 ~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------~~~  417 (571)
                      .|...+.||+|+||.||+|+. ..|+.||||.++... ....+...+|+++|++++|+|||++++.-....      ..+
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            355668899999999999995 579999999998643 455677889999999999999999999876543      568


Q ss_pred             EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEEC--CCC--ceEEeeccC
Q 008292          418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD--AEM--NPKISDFGM  493 (571)
Q Consensus       418 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~--~~~--~~kl~DfGl  493 (571)
                      +|||||.+|+|...|.++++...+++.+.+.++.++..||.|||+++   |+||||||.||++-  .+|  --||+|||.
T Consensus        94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            99999999999999999999999999999999999999999999987   99999999999983  223  469999999


Q ss_pred             ccccCCCCCccccccccccCCcccccccc-cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 008292          494 ARIFGVDQTQGNTSRIVGTYGYMAPEYAM-HGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDG  556 (571)
Q Consensus       494 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~~Dv~slGvvl~elltG~~p~~~~~~~~  556 (571)
                      |+.+..+.   ....++||..|.+||... .+.|+..+|.|||||++||..||..||.....+.
T Consensus       171 Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk  231 (732)
T KOG4250|consen  171 ARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPK  231 (732)
T ss_pred             cccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCcc
Confidence            99875443   345679999999999988 4889999999999999999999999998776553

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2.1e-34  Score=293.32  Aligned_cols=193  Identities=31%  Similarity=0.431  Sum_probs=166.4

Q ss_pred             ccccccCceeEEEEEcc-CCCeeEEEeeccc---CccCHHHHHHHHHHHhhc-CCCceeccceeEEeCCeeEEEEEecCC
Q 008292          351 NKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPN  425 (571)
Q Consensus       351 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  425 (571)
                      +.||+|+||+||+++.+ +++.||+|++++.   .....+.+..|+.++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999965 5788999998753   233455677888888776 699999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCccc
Q 008292          426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN  505 (571)
Q Consensus       426 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  505 (571)
                      |+|..++.   +...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~i~---~~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~  152 (320)
T cd05590          81 GDLMFHIQ---KSRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KT  152 (320)
T ss_pred             chHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cc
Confidence            99998884   3456899999999999999999999887   9999999999999999999999999987532211  12


Q ss_pred             cccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       506 ~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~  198 (320)
T cd05590         153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEA  198 (320)
T ss_pred             ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCC
Confidence            3345789999999999999999999999999999999999999864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=3.4e-34  Score=289.63  Aligned_cols=200  Identities=29%  Similarity=0.422  Sum_probs=168.7

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccCc-cCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASG-QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE  421 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e  421 (571)
                      .++|.+.++||+|+||+||+++.. +++.||+|+++.... .....+.+|+.+++.++||||+++++++.++...++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            367899999999999999999965 688999999875432 233467789999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCC
Q 008292          422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ  501 (571)
Q Consensus       422 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  501 (571)
                      |++ ++|.+++..  ....+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++......
T Consensus        84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  157 (303)
T cd07869          84 YVH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS  157 (303)
T ss_pred             CCC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence            996 566666632  3356889999999999999999999987   9999999999999999999999999987543221


Q ss_pred             CccccccccccCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          502 TQGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       502 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                        .......+++.|+|||.+.+ ..++.++||||||+++|||+||+.||..
T Consensus       158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~  206 (303)
T cd07869         158 --HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPG  206 (303)
T ss_pred             --ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence              12233467899999998865 4588999999999999999999999864

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.8e-34  Score=294.06  Aligned_cols=193  Identities=28%  Similarity=0.407  Sum_probs=166.2

Q ss_pred             ccccccCceeEEEEEcc-CCCeeEEEeecccC---ccCHHHHHHHHHHHhhc-CCCceeccceeEEeCCeeEEEEEecCC
Q 008292          351 NKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPN  425 (571)
Q Consensus       351 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  425 (571)
                      +.||+|+||.||+|+.. +++.||+|++++..   ....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999965 57899999987542   33445677888888865 799999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCccc
Q 008292          426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN  505 (571)
Q Consensus       426 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  505 (571)
                      ++|...+.   +...+++..+..++.||++||.|||+++   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~  152 (321)
T cd05591          81 GDLMFQIQ---RSRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VT  152 (321)
T ss_pred             CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC--cc
Confidence            99988884   3456899999999999999999999987   9999999999999999999999999987542221  12


Q ss_pred             cccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       506 ~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .....|++.|+|||++.+..++.++||||||+++|||+||+.||..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~  198 (321)
T cd05591         153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEA  198 (321)
T ss_pred             ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCC
Confidence            2345689999999999999999999999999999999999999864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2.1e-34  Score=299.59  Aligned_cols=208  Identities=31%  Similarity=0.442  Sum_probs=172.5

Q ss_pred             HHHhCCCCccccccccCceeEEEEEc------cCCCeeEEEeecccC-ccCHHHHHHHHHHHhhc-CCCceeccceeEEe
Q 008292          341 EVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLE  412 (571)
Q Consensus       341 ~~~~~~~~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~  412 (571)
                      ....++|++.++||+|+||.||+++.      ..+..||||+++... ....+.+.+|+.++..+ +||||+++++++..
T Consensus        31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~  110 (375)
T cd05104          31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV  110 (375)
T ss_pred             ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence            34456788999999999999999973      245679999987533 33456788999999999 89999999999999


Q ss_pred             CCeeEEEEEecCCCChhhhhcCCC--------------------------------------------------------
Q 008292          413 GEEKILVYEFVPNKSLDYFLYDPE--------------------------------------------------------  436 (571)
Q Consensus       413 ~~~~~lv~e~~~~g~L~~~l~~~~--------------------------------------------------------  436 (571)
                      +...++||||+++|+|.+++....                                                        
T Consensus       111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  190 (375)
T cd05104         111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR  190 (375)
T ss_pred             CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence            999999999999999998885321                                                        


Q ss_pred             ----------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCC
Q 008292          437 ----------------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD  500 (571)
Q Consensus       437 ----------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  500 (571)
                                      ....+++..+++++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~  267 (375)
T cd05104         191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRND  267 (375)
T ss_pred             cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence                            1125788999999999999999999887   999999999999999999999999999865433


Q ss_pred             CCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                      ..........++..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus       268 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~  319 (375)
T cd05104         268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPG  319 (375)
T ss_pred             ccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCC
Confidence            22111222345678999999999999999999999999999998 8888753

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2.5e-34  Score=288.39  Aligned_cols=199  Identities=27%  Similarity=0.412  Sum_probs=168.9

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      ++|.+.++||+|+||.||++..+ +++.||+|+++... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            46888999999999999999864 67899999987543 23345678999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT  502 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  502 (571)
                      +++ +|.+++..  ....+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++...... 
T Consensus        85 ~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~-  157 (288)
T cd07871          85 LDS-DLKQYLDN--CGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-  157 (288)
T ss_pred             CCc-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC-
Confidence            985 88887742  2345789999999999999999999987   9999999999999999999999999997543222 


Q ss_pred             ccccccccccCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          503 QGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       503 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                       .......+++.|+|||.+.+ ..++.++||||+|+++|||+||+.||..
T Consensus       158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~  206 (288)
T cd07871         158 -KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPG  206 (288)
T ss_pred             -ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence             11223467899999998875 5689999999999999999999999864

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.8e-34  Score=292.97  Aligned_cols=199  Identities=26%  Similarity=0.426  Sum_probs=166.2

Q ss_pred             CCCccccccccCceeEEEEEcc-CCCeeEEEeecccC--ccCHHHHHHHHHHHhhcCCCceeccceeEEeCC-----eeE
Q 008292          346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE-----EKI  417 (571)
Q Consensus       346 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-----~~~  417 (571)
                      +|++.++||+|+||.||+|+.. +++.||+|+++...  ......+.+|++++++++||||+++++++....     ..+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            4778899999999999999954 68999999987432  233456889999999999999999999886432     479


Q ss_pred             EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCcccc
Q 008292          418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF  497 (571)
Q Consensus       418 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  497 (571)
                      +||||++ ++|.+++.   ....+++..+..++.||++||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 lv~e~~~-~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~  153 (338)
T cd07859          81 VVFELME-SDLHQVIK---ANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA  153 (338)
T ss_pred             EEEecCC-CCHHHHHH---hcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence            9999995 67888773   3456899999999999999999999987   999999999999999999999999999854


Q ss_pred             CCCCCc-cccccccccCCccccccccc--CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          498 GVDQTQ-GNTSRIVGTYGYMAPEYAMH--GQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       498 ~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ...... .......|++.|+|||++.+  ..++.++||||||+++|||+||+.||..
T Consensus       154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~  210 (338)
T cd07859         154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG  210 (338)
T ss_pred             ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCC
Confidence            322211 11234578999999998865  6789999999999999999999999853

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.1e-34  Score=296.77  Aligned_cols=200  Identities=25%  Similarity=0.324  Sum_probs=171.6

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC---ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY  420 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  420 (571)
                      ++|.+.+.||+|+||+||+++.. +++.||+|.+.+..   ......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46889999999999999999964 57889999986522   223455788999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCC
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD  500 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  500 (571)
                      ||+++|+|.+++..  ....+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 Ey~~gg~L~~~l~~--~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  155 (331)
T cd05624          81 DYYVGGDLLTLLSK--FEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD  155 (331)
T ss_pred             eCCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence            99999999999853  2356899999999999999999999887   999999999999999999999999999866433


Q ss_pred             CCccccccccccCCccccccccc-----CCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          501 QTQGNTSRIVGTYGYMAPEYAMH-----GQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       501 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      .. .......|++.|+|||++.+     +.++.++||||||+++|||++|+.||.
T Consensus       156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~  209 (331)
T cd05624         156 GT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY  209 (331)
T ss_pred             Cc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCcc
Confidence            22 12233569999999998865     568899999999999999999999985

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.4e-35  Score=283.17  Aligned_cols=206  Identities=28%  Similarity=0.455  Sum_probs=163.6

Q ss_pred             CCCccccccccCceeEEEEEcc-CCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCe-----eEEE
Q 008292          346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEE-----KILV  419 (571)
Q Consensus       346 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~-----~~lv  419 (571)
                      .|...+++|.|+||.||+|+.. +++.||||++-.+...    -.+|+++|++++|||||+++.+|....+     ..+|
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            4667889999999999999964 4689999988654321    2468999999999999999998875432     3589


Q ss_pred             EEecCCCChhhhhcC-CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCC-CceEEeeccCcccc
Q 008292          420 YEFVPNKSLDYFLYD-PEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE-MNPKISDFGMARIF  497 (571)
Q Consensus       420 ~e~~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfGla~~~  497 (571)
                      ||||+. +|.+.++. ...+..++...+.-+..||.+||.|||+.+   |+||||||.|+|+|.+ |.+||+|||.|+.+
T Consensus       101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            999986 46555532 223566788888889999999999999977   9999999999999987 89999999999987


Q ss_pred             CCCCCccccccccccCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHH
Q 008292          498 GVDQTQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYVS  565 (571)
Q Consensus       498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~slGvvl~elltG~~p~~~~~~~~~~~l~~~~~  565 (571)
                      ......  .+. .-|.-|.|||.+.+. .|+.+.||||.|||+.||+-|+.-|.-   ++..|.+.-+.
T Consensus       177 ~~~epn--iSY-icSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG---~s~~dQL~eIi  239 (364)
T KOG0658|consen  177 VKGEPN--ISY-ICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPG---DSSVDQLVEII  239 (364)
T ss_pred             ccCCCc--eeE-EEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCC---CCHHHHHHHHH
Confidence            544332  223 347889999999875 799999999999999999999987643   44444444443

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=5e-34  Score=290.94  Aligned_cols=198  Identities=29%  Similarity=0.397  Sum_probs=168.9

Q ss_pred             CCCccccccccCceeEEEEEcc-CCCeeEEEeecccC---ccCHHHHHHHHHHHhhcC-CCceeccceeEEeCCeeEEEE
Q 008292          346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEKILVY  420 (571)
Q Consensus       346 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv~  420 (571)
                      +|+..+.||+|+||+||+++.. +|+.||+|++++..   ....+.+..|+.++..+. |++|+++.+++...+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            3677889999999999999864 68899999987532   233456778888888886 567888999998889999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCC
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD  500 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  500 (571)
                      ||+++|+|..++.   ....+++.++..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 Ey~~~g~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~  154 (323)
T cd05615          81 EYVNGGDLMYHIQ---QVGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD  154 (323)
T ss_pred             cCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence            9999999998884   3456899999999999999999999987   999999999999999999999999998754322


Q ss_pred             CCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .  .......||+.|+|||++.+..++.++||||||+++|||+||+.||..
T Consensus       155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~  203 (323)
T cd05615         155 G--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDG  203 (323)
T ss_pred             C--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCC
Confidence            1  122345689999999999999999999999999999999999999864

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-35  Score=308.00  Aligned_cols=208  Identities=33%  Similarity=0.538  Sum_probs=180.2

Q ss_pred             CCccccccccCceeEEEEEc-cCCC----eeEEEeeccc-CccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEE
Q 008292          347 FSTDNKLGEGGFGEVYKGVL-PSGQ----EIAVKRLSKA-SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY  420 (571)
Q Consensus       347 ~~~~~~LG~G~fg~Vy~~~~-~~g~----~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  420 (571)
                      .+..++||+|+||+||+|.+ ++|+    +||+|++... ..+..+++.+|+..|.+++||||++++|+|.... ..||+
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt  776 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT  776 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence            45678999999999999995 4554    5789988654 4556789999999999999999999999998776 88999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCC
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD  500 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  500 (571)
                      +||+.|+|.++++.  .+..+-.+..+.|..|||+||.|||++.   ++||||.++||||..-..+||.|||+++.+..+
T Consensus       777 q~mP~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d  851 (1177)
T KOG1025|consen  777 QLMPLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD  851 (1177)
T ss_pred             HhcccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence            99999999999964  4456888999999999999999999876   999999999999999999999999999998877


Q ss_pred             CCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccH
Q 008292          501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADL  560 (571)
Q Consensus       501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~~~~~~~~~l  560 (571)
                      ..........-.+.|||-|.+....|+.++|||||||++||++| |.+|++-...++..|+
T Consensus       852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dl  912 (1177)
T KOG1025|consen  852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDL  912 (1177)
T ss_pred             cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHH
Confidence            66666666667889999999999999999999999999999999 9999875544444333

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.4e-34  Score=308.45  Aligned_cols=208  Identities=23%  Similarity=0.305  Sum_probs=175.9

Q ss_pred             HHHhCCCCccccccccCceeEEEEEc-cCCCeeEEEeeccc--CccCHHHHHHHHHHHhhcCCCceeccceeEEeCC---
Q 008292          341 EVATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE---  414 (571)
Q Consensus       341 ~~~~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~---  414 (571)
                      +...++|.+.+.||+|+||+||+++. .+|+.||||++...  .......+.+|+.++..++|+||+++.+.+...+   
T Consensus        28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~  107 (496)
T PTZ00283         28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN  107 (496)
T ss_pred             cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence            34457899999999999999999985 47899999998654  2344567889999999999999999988765432   


Q ss_pred             -----eeEEEEEecCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEE
Q 008292          415 -----EKILVYEFVPNKSLDYFLYDPE-KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKI  488 (571)
Q Consensus       415 -----~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl  488 (571)
                           ..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||
T Consensus       108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL  184 (496)
T PTZ00283        108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKL  184 (496)
T ss_pred             cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEE
Confidence                 2579999999999999885432 3456899999999999999999999887   999999999999999999999


Q ss_pred             eeccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          489 SDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       489 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      +|||+++.+.............||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~  247 (496)
T PTZ00283        185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDG  247 (496)
T ss_pred             EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            999999876443333333456799999999999999999999999999999999999999853

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2.3e-34  Score=294.57  Aligned_cols=201  Identities=24%  Similarity=0.319  Sum_probs=170.9

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeeccc---CccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY  420 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  420 (571)
                      ++|++.++||+|+||+||+++.+ .++.+|+|++.+.   .......+.+|+.++..++|+||+++++.+.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            46888999999999999999965 4678999998642   2233445888999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCC
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD  500 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  500 (571)
                      ||+++|+|.+++..  ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 ey~~~g~L~~~l~~--~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~  155 (332)
T cd05623          81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  155 (332)
T ss_pred             eccCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence            99999999999853  2346899999999999999999999987   999999999999999999999999998765322


Q ss_pred             CCccccccccccCCcccccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          501 QTQGNTSRIVGTYGYMAPEYAM-----HGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       501 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .. .......||+.|+|||++.     ...++.++||||||+++|||++|+.||..
T Consensus       156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~  210 (332)
T cd05623         156 GT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA  210 (332)
T ss_pred             Cc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC
Confidence            21 1223457999999999986     34688999999999999999999999853

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=7.8e-35  Score=297.93  Aligned_cols=200  Identities=27%  Similarity=0.384  Sum_probs=172.8

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC---ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY  420 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  420 (571)
                      ++|.+.+.||+|+||+||++... +++.||+|+++...   ....+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            46888999999999999999964 68899999997542   234567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCC
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD  500 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  500 (571)
                      ||+++|+|.+++..  ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 e~~~~~~L~~~l~~--~~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  155 (330)
T cd05601          81 EYQPGGDLLSLLNR--YEDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN  155 (330)
T ss_pred             CCCCCCCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence            99999999999853  2356899999999999999999999987   999999999999999999999999999866433


Q ss_pred             CCccccccccccCCcccccccc------cCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          501 QTQGNTSRIVGTYGYMAPEYAM------HGQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       501 ~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      ... ......||+.|+|||++.      ...++.++||||||+++|||++|+.||.
T Consensus       156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~  210 (330)
T cd05601         156 KMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFH  210 (330)
T ss_pred             Cce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCC
Confidence            221 222346899999999986      4567899999999999999999999985

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.1e-33  Score=327.07  Aligned_cols=204  Identities=26%  Similarity=0.512  Sum_probs=168.8

Q ss_pred             hCCCCccccccccCceeEEEEEc-cCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      ...++..+.||+|+||.||+|+. .++..||||+++......    .+|++.+++++||||++++|++.+.+..++||||
T Consensus       689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey  764 (968)
T PLN00113        689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP----SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY  764 (968)
T ss_pred             HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcccc----HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence            45678889999999999999996 578999999986543221    3468899999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT  502 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  502 (571)
                      +++|+|.++++      .++|.++.+++.|+++||+|||....++|+||||||+||+++.++.+++. ||.......   
T Consensus       765 ~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~---  834 (968)
T PLN00113        765 IEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT---  834 (968)
T ss_pred             CCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc---
Confidence            99999999983      37999999999999999999997655679999999999999999888875 666543221   


Q ss_pred             ccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHH
Q 008292          503 QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYVS  565 (571)
Q Consensus       503 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~~~~~~~~~l~~~~~  565 (571)
                         .....+++.|||||++.+..++.|+|||||||++|||+||+.|++... +....+.+|+.
T Consensus       835 ---~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~-~~~~~~~~~~~  893 (968)
T PLN00113        835 ---DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF-GVHGSIVEWAR  893 (968)
T ss_pred             ---CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc-CCCCcHHHHHH
Confidence               112367899999999999999999999999999999999999985322 22344555543

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=3.1e-34  Score=291.68  Aligned_cols=202  Identities=31%  Similarity=0.542  Sum_probs=169.8

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CCC----eeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQ----EIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI  417 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~----~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  417 (571)
                      ..+|+..+.||+|+||.||+|++. +++    .||+|.++... ....+++.+|+.+++.++||||++++|++... ..+
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~   84 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ   84 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence            356889999999999999999853 333    38999987543 34456888999999999999999999998764 567


Q ss_pred             EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCcccc
Q 008292          418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF  497 (571)
Q Consensus       418 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  497 (571)
                      +++||+++|+|.+++..  ....+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+
T Consensus        85 ~v~e~~~~g~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~  159 (316)
T cd05108          85 LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (316)
T ss_pred             eeeecCCCCCHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccc
Confidence            99999999999998853  2346889999999999999999999987   999999999999999999999999999876


Q ss_pred             CCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          498 GVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                      .............++..|+|||.+.+..++.++||||||+++|||++ |+.|++.
T Consensus       160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~  214 (316)
T cd05108         160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG  214 (316)
T ss_pred             cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence            54332222222334678999999999999999999999999999998 9999854

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=5e-34  Score=289.98  Aligned_cols=193  Identities=30%  Similarity=0.447  Sum_probs=164.8

Q ss_pred             ccccccCceeEEEEEcc-CCCeeEEEeecccC---ccCHHHHHHHHHHHhh-cCCCceeccceeEEeCCeeEEEEEecCC
Q 008292          351 NKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAK-LQHRNLVRLLGFCLEGEEKILVYEFVPN  425 (571)
Q Consensus       351 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~  425 (571)
                      +.||+|+||.||+|+.. +++.||+|+++...   ....+.+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999965 57889999987542   2334556677777775 5899999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCccc
Q 008292          426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN  505 (571)
Q Consensus       426 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  505 (571)
                      |+|..++.   ....+++.++..++.|+++||.|||+++   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~  152 (316)
T cd05619          81 GDLMFHIQ---SCHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AK  152 (316)
T ss_pred             CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cc
Confidence            99999884   3456899999999999999999999987   9999999999999999999999999987532211  12


Q ss_pred             cccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       506 ~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~  198 (316)
T cd05619         153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHG  198 (316)
T ss_pred             eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCC
Confidence            2345789999999999999999999999999999999999999854

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=5.2e-34  Score=282.68  Aligned_cols=201  Identities=28%  Similarity=0.465  Sum_probs=169.9

Q ss_pred             hCCCCccccccccCceeEEEEEcc----CCCeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP----SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL  418 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  418 (571)
                      .++|++.+.||+|+||.||+|.++    .+..||+|.++... ....+.+.+|+.++.+++||||+++++++..++..++
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            456888999999999999999853    35689999987643 2334678899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccC
Q 008292          419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG  498 (571)
Q Consensus       419 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  498 (571)
                      ||||+++|+|.+++..  ....+++..++.++.|++.||+|||+.+   ++||||||+|||++.++.+|++|||.+....
T Consensus        84 v~e~~~~~~L~~~l~~--~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~  158 (266)
T cd05064          84 VTEYMSNGALDSFLRK--HEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK  158 (266)
T ss_pred             EEEeCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence            9999999999999853  2346899999999999999999999887   9999999999999999999999999876532


Q ss_pred             CCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 008292          499 VDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSN  550 (571)
Q Consensus       499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~  550 (571)
                      .... .......++..|+|||.+.+..++.++||||||+++||+++ |+.||.
T Consensus       159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~  210 (266)
T cd05064         159 SEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYW  210 (266)
T ss_pred             ccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcC
Confidence            2111 11112335678999999999999999999999999999875 999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=3.2e-34  Score=292.45  Aligned_cols=193  Identities=27%  Similarity=0.363  Sum_probs=163.7

Q ss_pred             ccccccCceeEEEEEcc-CCCeeEEEeecccC---ccCHHHHHHHHH-HHhhcCCCceeccceeEEeCCeeEEEEEecCC
Q 008292          351 NKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVV-LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPN  425 (571)
Q Consensus       351 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  425 (571)
                      +.||+|+||+||+++.. +|+.||+|++.+..   .....++.+|.. +++.++||||+++++.+...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999964 68899999987532   222344455544 56789999999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCccc
Q 008292          426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN  505 (571)
Q Consensus       426 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  505 (571)
                      |+|..++.   ....+++..+..++.||++||.|||+++   |+||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 g~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~  152 (323)
T cd05575          81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SKT  152 (323)
T ss_pred             CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CCc
Confidence            99998884   3456899999999999999999999987   999999999999999999999999998753211  122


Q ss_pred             cccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       506 ~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .....||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~  198 (323)
T cd05575         153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYS  198 (323)
T ss_pred             cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCC
Confidence            3345789999999999999999999999999999999999999854

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=7.1e-34  Score=283.89  Aligned_cols=194  Identities=32%  Similarity=0.449  Sum_probs=167.4

Q ss_pred             ccccCceeEEEEEcc-CCCeeEEEeecccCc---cCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEecCCCCh
Q 008292          353 LGEGGFGEVYKGVLP-SGQEIAVKRLSKASG---QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL  428 (571)
Q Consensus       353 LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  428 (571)
                      ||+|+||+||+++.. +++.||+|++.....   ...+.+..|+++++.++|+||+++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            799999999999864 688999999865322   2335678899999999999999999999999999999999999999


Q ss_pred             hhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCccccc
Q 008292          429 DYFLYDP-EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTS  507 (571)
Q Consensus       429 ~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  507 (571)
                      ...+... .....+++..++.++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||++..+.....  ...
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence            8877432 23456899999999999999999999987   99999999999999999999999999976543222  223


Q ss_pred             cccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          508 RIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       508 ~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ...|++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  199 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRA  199 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence            35689999999999999999999999999999999999999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2.4e-34  Score=293.58  Aligned_cols=193  Identities=27%  Similarity=0.367  Sum_probs=163.9

Q ss_pred             ccccccCceeEEEEEc-cCCCeeEEEeecccC---ccCHHHHHHHHH-HHhhcCCCceeccceeEEeCCeeEEEEEecCC
Q 008292          351 NKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS---GQGAEEFKNEVV-LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPN  425 (571)
Q Consensus       351 ~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ei~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  425 (571)
                      +.||+|+||+||+++. .+|+.||+|++.+..   ......+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            4699999999999985 468899999986532   223344555554 56779999999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCccc
Q 008292          426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN  505 (571)
Q Consensus       426 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  505 (571)
                      |+|...+.   +...+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~  152 (325)
T cd05604          81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SDT  152 (325)
T ss_pred             CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CCC
Confidence            99988873   4457899999999999999999999987   999999999999999999999999998753211  112


Q ss_pred             cccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       506 ~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .....|++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~  198 (325)
T cd05604         153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYC  198 (325)
T ss_pred             cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCC
Confidence            3345789999999999999999999999999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=3.4e-34  Score=291.99  Aligned_cols=193  Identities=29%  Similarity=0.370  Sum_probs=163.1

Q ss_pred             ccccccCceeEEEEEcc-CCCeeEEEeecccC---ccCHHHHHHHH-HHHhhcCCCceeccceeEEeCCeeEEEEEecCC
Q 008292          351 NKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEV-VLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPN  425 (571)
Q Consensus       351 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  425 (571)
                      +.||+|+||.||+++.. +++.||+|++.+..   ......+..|. .+++.++||||+++++.+.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999964 57889999986532   22234455554 467889999999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCccc
Q 008292          426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN  505 (571)
Q Consensus       426 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  505 (571)
                      ++|...+.   ....+++..+..++.||++||.|||+.+   |+||||||+||+++.++.+||+|||+++.....  ...
T Consensus        81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~  152 (321)
T cd05603          81 GELFFHLQ---RERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EET  152 (321)
T ss_pred             CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CCc
Confidence            99988773   3456888999999999999999999887   999999999999999999999999998753221  122


Q ss_pred             cccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       506 ~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .....|++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  198 (321)
T cd05603         153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYS  198 (321)
T ss_pred             cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCC
Confidence            3345789999999999999999999999999999999999999853

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=6.4e-34  Score=289.26  Aligned_cols=193  Identities=31%  Similarity=0.443  Sum_probs=165.1

Q ss_pred             ccccccCceeEEEEEcc-CCCeeEEEeecccC---ccCHHHHHHHHHHHhh-cCCCceeccceeEEeCCeeEEEEEecCC
Q 008292          351 NKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAK-LQHRNLVRLLGFCLEGEEKILVYEFVPN  425 (571)
Q Consensus       351 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~  425 (571)
                      +.||+|+||.||+++.+ +|+.||+|.++...   ....+.+..|..++.. .+||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999965 57899999987542   2334556778877765 4899999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCccc
Q 008292          426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN  505 (571)
Q Consensus       426 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  505 (571)
                      |+|..++.   ....+++..+..++.|+++||+|||+++   |+||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 g~L~~~i~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~  152 (316)
T cd05620          81 GDLMFHIQ---DKGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DNR  152 (316)
T ss_pred             CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccC--CCc
Confidence            99988884   3456899999999999999999999987   999999999999999999999999998743211  112


Q ss_pred             cccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       506 ~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .....||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~  198 (316)
T cd05620         153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHG  198 (316)
T ss_pred             eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCC
Confidence            3345789999999999999999999999999999999999999863

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8e-34  Score=296.15  Aligned_cols=193  Identities=22%  Similarity=0.292  Sum_probs=166.1

Q ss_pred             hCCCCccccccccCceeEEEEEc-cCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      ..+|++.++||+|+||.||++.. ..++.||+|...      ...+.+|++++++++||||+++++++......++|+|+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            46799999999999999999996 468889999653      23567899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT  502 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  502 (571)
                      +. ++|..++.   ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++...... 
T Consensus       165 ~~-~~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-  236 (391)
T PHA03212        165 YK-TDLYCYLA---AKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-  236 (391)
T ss_pred             CC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc-
Confidence            95 67777773   3346899999999999999999999987   9999999999999999999999999997532211 


Q ss_pred             ccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          503 QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       503 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      ........||+.|+|||++.+..++.++||||||+++|||+||+.|+-
T Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~  284 (391)
T PHA03212        237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLF  284 (391)
T ss_pred             ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence            122234579999999999999999999999999999999999998753

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=5.5e-34  Score=297.65  Aligned_cols=210  Identities=28%  Similarity=0.399  Sum_probs=174.7

Q ss_pred             HHHHHhCCCCccccccccCceeEEEEEcc------CCCeeEEEeecccC-ccCHHHHHHHHHHHhhcC-CCceeccceeE
Q 008292          339 TIEVATNKFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQ-HRNLVRLLGFC  410 (571)
Q Consensus       339 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~  410 (571)
                      .++...++|.+.++||+|+||.||+|+..      .+..||||+++... ....+.+.+|+++++++. ||||+++++++
T Consensus        31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~  110 (400)
T cd05105          31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC  110 (400)
T ss_pred             ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence            34555778999999999999999999852      23469999997543 333567899999999996 99999999999


Q ss_pred             EeCCeeEEEEEecCCCChhhhhcCCC------------------------------------------------------
Q 008292          411 LEGEEKILVYEFVPNKSLDYFLYDPE------------------------------------------------------  436 (571)
Q Consensus       411 ~~~~~~~lv~e~~~~g~L~~~l~~~~------------------------------------------------------  436 (571)
                      .+....+|||||+++|+|.++++...                                                      
T Consensus       111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (400)
T cd05105         111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP  190 (400)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence            99999999999999999998875321                                                      


Q ss_pred             ---------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCC
Q 008292          437 ---------------------------------------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASN  477 (571)
Q Consensus       437 ---------------------------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~N  477 (571)
                                                             ....+++..++.++.||++||.|||+.+   |+||||||+|
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~N  267 (400)
T cd05105         191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARN  267 (400)
T ss_pred             hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHh
Confidence                                                   0124788889999999999999999887   9999999999


Q ss_pred             EEECCCCceEEeeccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          478 ILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       478 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                      ||++.++.+||+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |+.|+..
T Consensus       268 ill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~  342 (400)
T cd05105         268 VLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPG  342 (400)
T ss_pred             EEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcc
Confidence            9999999999999999986543322222233456788999999999999999999999999999997 8888753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=6.5e-34  Score=283.91  Aligned_cols=204  Identities=33%  Similarity=0.572  Sum_probs=173.9

Q ss_pred             hCCCCccccccccCceeEEEEEccC------CCeeEEEeecccCcc-CHHHHHHHHHHHhhcCCCceeccceeEEeCCee
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLPS------GQEIAVKRLSKASGQ-GAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEK  416 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~~------g~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  416 (571)
                      .++|.+.+.||+|+||.||+|...+      ++.|++|.++..... ..+.+.+|++++++++|+||+++++++......
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            3467888999999999999998633      478999998765444 457899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCc
Q 008292          417 ILVYEFVPNKSLDYFLYDP-----------EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN  485 (571)
Q Consensus       417 ~lv~e~~~~g~L~~~l~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~  485 (571)
                      ++||||+++++|.+++...           .....+++..+..++.|++.||.|||+++   ++||||||+||+++.++.
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~  160 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence            9999999999999998532           12345789999999999999999999887   999999999999999999


Q ss_pred             eEEeeccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 008292          486 PKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSN  550 (571)
Q Consensus       486 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~  550 (571)
                      +||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~  226 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWY  226 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCC
Confidence            99999999976533322222223346788999999999999999999999999999999 999974

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-33  Score=283.26  Aligned_cols=199  Identities=31%  Similarity=0.446  Sum_probs=171.7

Q ss_pred             CCCccccccccCceeEEEEEcc-CCCeeEEEeecccC---ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEE
Q 008292          346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE  421 (571)
Q Consensus       346 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e  421 (571)
                      .|++.++||+|+||+||++... +++.||+|++....   ......+.+|+.+++.++||||+++++.+..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            3778899999999999999964 68899999986532   2223457789999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCC
Q 008292          422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ  501 (571)
Q Consensus       422 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  501 (571)
                      |+++|+|..++... ....+++..+..++.|+++||.|||+.+   |+||||||+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE  156 (285)
T ss_pred             ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence            99999999887532 2346899999999999999999999987   9999999999999999999999999987653222


Q ss_pred             CccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          502 TQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       502 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                         ......|++.|+|||.+.+..++.++||||+|+++|||++|+.||..
T Consensus       157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~  203 (285)
T cd05605         157 ---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQ  203 (285)
T ss_pred             ---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCC
Confidence               11234689999999999999999999999999999999999999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=5.5e-34  Score=290.98  Aligned_cols=193  Identities=27%  Similarity=0.369  Sum_probs=162.4

Q ss_pred             ccccccCceeEEEEEcc-CCCeeEEEeecccC---ccCHHHHHHHH-HHHhhcCCCceeccceeEEeCCeeEEEEEecCC
Q 008292          351 NKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEV-VLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPN  425 (571)
Q Consensus       351 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  425 (571)
                      +.||+|+||+||+++.. +++.||+|++.+..   ......+..|. .+++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999965 56789999986532   12223444444 456789999999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCccc
Q 008292          426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN  505 (571)
Q Consensus       426 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  505 (571)
                      ++|.+++.   +...+.+..+..++.||++||.|||+++   |+||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 ~~L~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~--~~~  152 (325)
T cd05602          81 GELFYHLQ---RERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NGT  152 (325)
T ss_pred             CcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccC--CCC
Confidence            99999884   3456788889999999999999999987   999999999999999999999999999754221  122


Q ss_pred             cccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       506 ~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .....||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  198 (325)
T cd05602         153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS  198 (325)
T ss_pred             cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCC
Confidence            3345799999999999999999999999999999999999999853

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.8e-33  Score=294.04  Aligned_cols=193  Identities=24%  Similarity=0.305  Sum_probs=165.4

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEec
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV  423 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  423 (571)
                      ..|.+.+.||+|+||.||++... .++.|+||....      ..+.+|++++++++|+||+++++++..+...++|||++
T Consensus       169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~  242 (461)
T PHA03211        169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY  242 (461)
T ss_pred             CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence            46889999999999999999975 478899996422      34578999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCc
Q 008292          424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ  503 (571)
Q Consensus       424 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  503 (571)
                      . ++|..++..  ....+++..++.++.||++||.|||+++   |+||||||+||||+.++.+||+|||+++.+......
T Consensus       243 ~-~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~  316 (461)
T PHA03211        243 R-SDLYTYLGA--RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST  316 (461)
T ss_pred             C-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence            5 677777642  2346899999999999999999999987   999999999999999999999999999865433222


Q ss_pred             cccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCC
Q 008292          504 GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNS  549 (571)
Q Consensus       504 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~  549 (571)
                      .......||+.|+|||++.+..++.++|||||||++|||++|..|+
T Consensus       317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l  362 (461)
T PHA03211        317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL  362 (461)
T ss_pred             ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence            2223457999999999999999999999999999999999988764

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.7e-33  Score=277.29  Aligned_cols=200  Identities=33%  Similarity=0.492  Sum_probs=171.6

Q ss_pred             CCCCccccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEecC
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVP  424 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  424 (571)
                      ++|++.+.||+|+||.||++.++++..+++|.++.. ....+++.+|+.++++++||||+++++++......++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            457788999999999999999988889999988643 3345678999999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCcc
Q 008292          425 NKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG  504 (571)
Q Consensus       425 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  504 (571)
                      +|+|.+++...  ...+++..+..++.|++.||.|||+++   |+||||+|+||+++.++.+||+|||+++........ 
T Consensus        83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-  156 (256)
T cd05114          83 NGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-  156 (256)
T ss_pred             CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCcee-
Confidence            99999988532  346899999999999999999999887   999999999999999999999999998765322221 


Q ss_pred             ccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          505 NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       505 ~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                      ......++..|+|||.+....++.++||||||+++|||++ |+.|+..
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~  204 (256)
T cd05114         157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEK  204 (256)
T ss_pred             ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCC
Confidence            1122235668999999988899999999999999999999 8888753

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-34  Score=291.31  Aligned_cols=201  Identities=27%  Similarity=0.394  Sum_probs=178.7

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeeccc--CccCHHHHHHHHHHHhhcCCCceeccceeEEeCCe-eEEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEE-KILVY  420 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~-~~lv~  420 (571)
                      ++|...+++|+|+||.++..+.+ +++.+++|++...  ++...+...+|+.++++++|||||.+.+.+.+++. .+|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            56788899999999999998864 5778999988653  34445577899999999999999999999999888 89999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCC
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD  500 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  500 (571)
                      +|++||++.+.+... ++..++++++++|+.|++.|+.|||++.   |+|||||+.||+++.++.|||+|||+|+.++.+
T Consensus        84 ~Y~eGg~l~~~i~~~-k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQ-KGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             eecCCCCHHHHHHHH-hhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            999999999988543 3567899999999999999999999776   999999999999999999999999999998765


Q ss_pred             CCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .  ......+||+.||.||.+.+.+|..|+|||||||++|||++-+++|.-
T Consensus       160 ~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a  208 (426)
T KOG0589|consen  160 D--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKA  208 (426)
T ss_pred             h--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCc
Confidence            4  234457899999999999999999999999999999999999999864

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.4e-33  Score=283.17  Aligned_cols=199  Identities=28%  Similarity=0.458  Sum_probs=164.6

Q ss_pred             CCCCccccccccCceeEEEEEcc--CCCeeEEEeecccC--ccCHHHHHHHHHHHhhc---CCCceeccceeEEe-----
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP--SGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKL---QHRNLVRLLGFCLE-----  412 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~--~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l---~h~niv~l~~~~~~-----  412 (571)
                      ++|++.+.||+|+||.||+++..  +++.||+|+++...  ......+.+|+.+++.+   +||||+++++++..     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            36888999999999999999862  46789999886532  22334566777777665   69999999998853     


Q ss_pred             CCeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeecc
Q 008292          413 GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG  492 (571)
Q Consensus       413 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG  492 (571)
                      ....++||||++ ++|.+++... ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG  155 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence            345789999996 5888887432 2345899999999999999999999987   9999999999999999999999999


Q ss_pred             CccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          493 MARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       493 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      +++.....   .......|++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~  211 (290)
T cd07862         156 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG  211 (290)
T ss_pred             ceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCC
Confidence            99865432   223345689999999999989999999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=3.4e-34  Score=282.87  Aligned_cols=199  Identities=41%  Similarity=0.640  Sum_probs=166.1

Q ss_pred             ccccccccCceeEEEEEcc-----CCCeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          349 TDNKLGEGGFGEVYKGVLP-----SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       349 ~~~~LG~G~fg~Vy~~~~~-----~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      ..+.||+|.||.||+|.+.     .+..|+||.++... ....+.|.+|++.+++++||||++++|++...+..++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            4578999999999999976     25679999996533 33478899999999999999999999999988889999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT  502 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  502 (571)
                      +++|+|.+++... ....+++..++.|+.||++||.|||+++   ++|+||+++||++++++.+||+|||++........
T Consensus        83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~  158 (259)
T PF07714_consen   83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK  158 (259)
T ss_dssp             -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred             ccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence            9999999999643 2457899999999999999999999987   99999999999999999999999999987633222


Q ss_pred             ccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          503 QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       503 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                      ............|+|||.+....++.++||||||+++|||+| |+.|+..
T Consensus       159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~  208 (259)
T PF07714_consen  159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSD  208 (259)
T ss_dssp             EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTT
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            222333456789999999999999999999999999999999 6788653

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.1e-33  Score=287.90  Aligned_cols=193  Identities=32%  Similarity=0.431  Sum_probs=166.3

Q ss_pred             ccccccCceeEEEEEcc-CCCeeEEEeecccC---ccCHHHHHHHHHHHhhc-CCCceeccceeEEeCCeeEEEEEecCC
Q 008292          351 NKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPN  425 (571)
Q Consensus       351 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  425 (571)
                      +.||+|+||+||++... +++.||+|++++..   ....+.+.+|++++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999965 57889999997542   33455677888888877 699999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCccc
Q 008292          426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN  505 (571)
Q Consensus       426 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  505 (571)
                      |+|..++.   +...+++..+..++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++......  ..
T Consensus        81 ~~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~  152 (318)
T cd05570          81 GDLMFHIQ---RSGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VT  152 (318)
T ss_pred             CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Cc
Confidence            99988874   3457899999999999999999999887   9999999999999999999999999987532111  12


Q ss_pred             cccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       506 ~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .....|++.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus       153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~  198 (318)
T cd05570         153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEG  198 (318)
T ss_pred             ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCC
Confidence            2335689999999999999999999999999999999999999853

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.4e-34  Score=292.74  Aligned_cols=193  Identities=31%  Similarity=0.358  Sum_probs=167.7

Q ss_pred             ccccccCceeEEEEEc----cCCCeeEEEeecccC--ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEecC
Q 008292          351 NKLGEGGFGEVYKGVL----PSGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVP  424 (571)
Q Consensus       351 ~~LG~G~fg~Vy~~~~----~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  424 (571)
                      +.||+|+||.||+++.    .+|+.||+|+++...  ......+.+|++++++++||||+++++++...+..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            6799999999999874    357899999997543  2234567789999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCcc
Q 008292          425 NKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG  504 (571)
Q Consensus       425 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  504 (571)
                      +|+|.+++.   +...+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++......  .
T Consensus        82 ~~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~  153 (318)
T cd05582          82 GGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--K  153 (318)
T ss_pred             CCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--C
Confidence            999998884   3456899999999999999999999987   9999999999999999999999999987643221  1


Q ss_pred             ccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          505 NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       505 ~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ......|++.|+|||.+.+..++.++||||||+++|||+||+.||..
T Consensus       154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~  200 (318)
T cd05582         154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQG  200 (318)
T ss_pred             ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCC
Confidence            22345789999999999988999999999999999999999999864

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=6.3e-34  Score=283.72  Aligned_cols=206  Identities=30%  Similarity=0.520  Sum_probs=171.7

Q ss_pred             HHhCCCCccccccccCceeEEEEEcc------CCCeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeEEeCC
Q 008292          342 VATNKFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE  414 (571)
Q Consensus       342 ~~~~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~  414 (571)
                      +..++|+..+.||+|+||.||+|...      .+..||+|+++... .....++.+|+.+++.++||||+++++++.++.
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~   82 (277)
T cd05062           3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ   82 (277)
T ss_pred             ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            45678999999999999999998753      34679999886432 233457889999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhcCCCC-------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceE
Q 008292          415 EKILVYEFVPNKSLDYFLYDPEK-------QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPK  487 (571)
Q Consensus       415 ~~~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k  487 (571)
                      ..++||||+++++|.+++.....       ...+++..++.++.|+++||.|||+.+   ++|+||||+||++++++.+|
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~  159 (277)
T cd05062          83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK  159 (277)
T ss_pred             CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEE
Confidence            99999999999999998854221       234678899999999999999999876   99999999999999999999


Q ss_pred             EeeccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 008292          488 ISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSN  550 (571)
Q Consensus       488 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~  550 (571)
                      |+|||+++.+.............+++.|+|||++.+..++.++||||||+++|||++ |+.|+.
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~  223 (277)
T cd05062         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ  223 (277)
T ss_pred             ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCC
Confidence            999999976543322222222345778999999998999999999999999999999 677764

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.5e-33  Score=310.81  Aligned_cols=204  Identities=26%  Similarity=0.402  Sum_probs=173.0

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC---ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY  420 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  420 (571)
                      ++|++.++||+|+||.||+|... +++.||+|+++...   +...+++.+|++++++++||||+++++++.+++..+++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            57889999999999999999964 58899999987542   223467889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCC--------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeecc
Q 008292          421 EFVPNKSLDYFLYDPE--------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG  492 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~--------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG  492 (571)
                      ||+++++|.+++....        ....+++..+++++.||++||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence            9999999999885321        1234567788999999999999999987   9999999999999999999999999


Q ss_pred             CccccCCCCC----------------ccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          493 MARIFGVDQT----------------QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       493 la~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      +++.......                ........||+.|||||.+.+..++.++||||||+++|||+||+.||..
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~  233 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR  233 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence            9986521110                0011235699999999999999999999999999999999999999854

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.3e-33  Score=275.13  Aligned_cols=204  Identities=25%  Similarity=0.320  Sum_probs=174.9

Q ss_pred             CCCCccccccccCceeEEEEEccC-CCeeEEEeecccC---ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY  420 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  420 (571)
                      +.|+..+.||+|.-|+||.+++++ +..+|+|++.+..   .+...+.+.|-+||+.++||.++.|++.+...+..+++|
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            456678899999999999999764 5789999998754   333456778999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCC-
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV-  499 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~-  499 (571)
                      |||+||+|..+++. +..+.+++..+..++.+++-||+|||..|   ||.|||||+||||.++|++-|+||.|+..... 
T Consensus       157 eyCpGGdL~~Lrqk-Qp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQK-QPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS  232 (459)
T ss_pred             ecCCCccHHHHHhh-CCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence            99999999988854 45667999999999999999999999988   99999999999999999999999998743210 


Q ss_pred             --------------------------------C-C--------------------CccccccccccCCcccccccccCCC
Q 008292          500 --------------------------------D-Q--------------------TQGNTSRIVGTYGYMAPEYAMHGQF  526 (571)
Q Consensus       500 --------------------------------~-~--------------------~~~~~~~~~gt~~y~aPE~~~~~~~  526 (571)
                                                      . .                    ........+||-.|+|||++.+...
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH  312 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH  312 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence                                            0 0                    0011234679999999999999999


Q ss_pred             CcchhHHHHHHHHHHHHhCCCCCCCC
Q 008292          527 SVKSDVYSFGVLVLEIITGKKNSNFY  552 (571)
Q Consensus       527 s~~~Dv~slGvvl~elltG~~p~~~~  552 (571)
                      +.++|+|+|||++|||+.|..||.-.
T Consensus       313 gsAVDWWtfGIflYEmLyG~TPFKG~  338 (459)
T KOG0610|consen  313 GSAVDWWTFGIFLYEMLYGTTPFKGS  338 (459)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcCCC
Confidence            99999999999999999999998643

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.2e-33  Score=282.58  Aligned_cols=203  Identities=34%  Similarity=0.561  Sum_probs=171.7

Q ss_pred             CCCCccccccccCceeEEEEEccC------CCeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLPS------GQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI  417 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~~------g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  417 (571)
                      ++|++.+.||+|+||.||+|....      ...|++|.++... .....++.+|+.++.+++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            467888999999999999998532      2568999886543 233567899999999999999999999999989999


Q ss_pred             EEEEecCCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCC
Q 008292          418 LVYEFVPNKSLDYFLYDPEK-------------QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM  484 (571)
Q Consensus       418 lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~  484 (571)
                      ++|||+++++|.+++.....             ...+++..++.++.|+++||.|||+.+   ++|+||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence            99999999999998854211             145889999999999999999999987   99999999999999999


Q ss_pred             ceEEeeccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 008292          485 NPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSN  550 (571)
Q Consensus       485 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~  550 (571)
                      .+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..||.
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~  228 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYY  228 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCC
Confidence            999999999986543322222333456789999999998999999999999999999998 998875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.3e-33  Score=278.69  Aligned_cols=202  Identities=33%  Similarity=0.531  Sum_probs=174.4

Q ss_pred             HhCCCCccccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       343 ~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      ..++|++.++||+|+||.||+|...++..|++|.+.... ...+.+.+|+.+++.++|+||+++++.+.+....+++|||
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05072           4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY   82 (261)
T ss_pred             chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence            346788999999999999999998888899999886533 3457889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT  502 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  502 (571)
                      +++++|.+++... ....+++..++.++.|+++||+|||+.+   ++||||||+||++++++.+||+|||+++.......
T Consensus        83 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05072          83 MAKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY  158 (261)
T ss_pred             CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence            9999999988542 3456889999999999999999999886   99999999999999999999999999987643222


Q ss_pred             ccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 008292          503 QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSN  550 (571)
Q Consensus       503 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~  550 (571)
                      . ......++..|+|||++....++.++||||||+++|||+| |+.||.
T Consensus       159 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~  206 (261)
T cd05072         159 T-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYP  206 (261)
T ss_pred             e-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCC
Confidence            1 1122345678999999998899999999999999999999 888874

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-33  Score=277.38  Aligned_cols=203  Identities=32%  Similarity=0.509  Sum_probs=174.4

Q ss_pred             HHhCCCCccccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEE
Q 008292          342 VATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE  421 (571)
Q Consensus       342 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e  421 (571)
                      +..++|++.+.||+|++|.||++...+++.|++|.++... ...+++.+|+.++++++|+||+++++++...+..+++||
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (261)
T cd05068           3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE   81 (261)
T ss_pred             cchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence            3456788999999999999999998778889999987543 345778999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCC
Q 008292          422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ  501 (571)
Q Consensus       422 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  501 (571)
                      |+++++|.+++.... ...+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++......
T Consensus        82 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  157 (261)
T cd05068          82 LMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDI  157 (261)
T ss_pred             cccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence            999999999985422 346899999999999999999999887   9999999999999999999999999998765222


Q ss_pred             CccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 008292          502 TQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSN  550 (571)
Q Consensus       502 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~  550 (571)
                      .. .......+..|+|||.+.+..++.++||||||+++|||+| |+.|+.
T Consensus       158 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~  206 (261)
T cd05068         158 YE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYP  206 (261)
T ss_pred             cc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCC
Confidence            11 1111223468999999999999999999999999999999 888874

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.5e-33  Score=281.91  Aligned_cols=203  Identities=33%  Similarity=0.507  Sum_probs=171.1

Q ss_pred             CCCCccccccccCceeEEEEEc-----cCCCeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVL-----PSGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL  418 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  418 (571)
                      +.|++.++||+|+||.||+|..     ..+..|++|.++... .....++.+|+.+++.++||||+++++++..+...++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            4577889999999999999984     246789999987533 3334678899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCC
Q 008292          419 VYEFVPNKSLDYFLYDPE--------------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM  484 (571)
Q Consensus       419 v~e~~~~g~L~~~l~~~~--------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~  484 (571)
                      +|||+++++|.+++....              ....+++.+++.++.|++.||.|||+++   ++||||||+|||+++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence            999999999999884221              1235788999999999999999999987   99999999999999999


Q ss_pred             ceEEeeccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 008292          485 NPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSN  550 (571)
Q Consensus       485 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~  550 (571)
                      .+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~  228 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYY  228 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence            999999999986543332222333445778999999988899999999999999999999 888874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.8e-33  Score=282.23  Aligned_cols=204  Identities=33%  Similarity=0.543  Sum_probs=173.8

Q ss_pred             hCCCCccccccccCceeEEEEEcc------CCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI  417 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  417 (571)
                      .++|.+.+.||+|+||.||++...      ++..+++|.+........+.+.+|++++++++||||+++++++..++..+
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   83 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            457888999999999999999842      34568999987766566678999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCCC----------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceE
Q 008292          418 LVYEFVPNKSLDYFLYDPE----------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPK  487 (571)
Q Consensus       418 lv~e~~~~g~L~~~l~~~~----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k  487 (571)
                      +||||+++++|.+++....          ....+++..++.++.|++.||+|||+++   ++||||||+||++++++.+|
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence            9999999999999885321          2235899999999999999999999887   99999999999999999999


Q ss_pred             EeeccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 008292          488 ISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSN  550 (571)
Q Consensus       488 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~  550 (571)
                      |+|||+++...............++..|+|||.+.+..++.++||||||+++|||+| |+.|+.
T Consensus       161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~  224 (288)
T cd05093         161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWY  224 (288)
T ss_pred             eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            999999986543322222223445778999999999999999999999999999999 888874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.4e-33  Score=292.32  Aligned_cols=200  Identities=23%  Similarity=0.325  Sum_probs=171.3

Q ss_pred             HHhCCCCccccccccCceeEEEEEcc---CCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEE
Q 008292          342 VATNKFSTDNKLGEGGFGEVYKGVLP---SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL  418 (571)
Q Consensus       342 ~~~~~~~~~~~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  418 (571)
                      +...+|.+.+.||+|+||.||++...   .+..|++|.+...     ....+|++++++++||||+++++++......++
T Consensus        89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l  163 (392)
T PHA03207         89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCM  163 (392)
T ss_pred             hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence            34568999999999999999999743   3567999987643     234689999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccC
Q 008292          419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG  498 (571)
Q Consensus       419 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  498 (571)
                      +||++. ++|.+++   .....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.+.
T Consensus       164 v~e~~~-~~l~~~l---~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~  236 (392)
T PHA03207        164 VMPKYK-CDLFTYV---DRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLD  236 (392)
T ss_pred             EehhcC-CCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccC
Confidence            999996 5777777   24567899999999999999999999987   9999999999999999999999999998665


Q ss_pred             CCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 008292          499 VDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQ  553 (571)
Q Consensus       499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~~~  553 (571)
                      ............||+.|+|||++....++.++|||||||++|||++|+.||....
T Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~  291 (392)
T PHA03207        237 AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQ  291 (392)
T ss_pred             cccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence            4333333334679999999999999999999999999999999999999986443

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=2.5e-33  Score=279.86  Aligned_cols=201  Identities=33%  Similarity=0.506  Sum_probs=167.4

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCC----eeEEEeecccCc-cCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQ----EIAVKRLSKASG-QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL  418 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~----~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  418 (571)
                      ++|++.+.||+|+||+||+|.+. +++    ++++|.+..... ....++..|+..+++++||||+++++++. +...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence            46788899999999999999963 344    477787754332 23467788888999999999999999875 455788


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccC
Q 008292          419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG  498 (571)
Q Consensus       419 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  498 (571)
                      ++||+++|+|.+++..  ....+++..+..++.||+.||.|||+.+   ++||||||+|||+++++.+||+|||+++.+.
T Consensus        86 i~e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          86 VTQLSPLGSLLDHVRQ--HRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY  160 (279)
T ss_pred             EEEeCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence            9999999999999853  3356899999999999999999999887   9999999999999999999999999998664


Q ss_pred             CCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          499 VDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                      ............++..|+|||.+.++.++.++||||||+++|||+| |+.|+..
T Consensus       161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~  214 (279)
T cd05111         161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAG  214 (279)
T ss_pred             CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence            3332222334457788999999998999999999999999999998 9988754

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=8.2e-34  Score=292.64  Aligned_cols=211  Identities=27%  Similarity=0.389  Sum_probs=175.6

Q ss_pred             hCCCCccccccccCceeEEEEEc-cCCCeeEEEeecccCccCHHHHHHHHHHHhhcC-C-----CceeccceeEEeCCee
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ-H-----RNLVRLLGFCLEGEEK  416 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h-----~niv~l~~~~~~~~~~  416 (571)
                      .-+|.+.+.||+|+||+|.|+.. ++++.||||+++... ....+-..|+.+|..++ |     -|+|+++++|...++.
T Consensus       185 ~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl  263 (586)
T KOG0667|consen  185 AYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL  263 (586)
T ss_pred             EEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence            34889999999999999999995 468999999997543 33455578999999997 4     3899999999999999


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCC--CceEEeeccCc
Q 008292          417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE--MNPKISDFGMA  494 (571)
Q Consensus       417 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~DfGla  494 (571)
                      +||+|.+ ..+|.+++... +-..++...+..|+.||+.+|.+||+.+   |||+||||+||||.+-  ..+||+|||.+
T Consensus       264 ciVfELL-~~NLYellK~n-~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSS  338 (586)
T KOG0667|consen  264 CIVFELL-STNLYELLKNN-KFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSS  338 (586)
T ss_pred             eeeehhh-hhhHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccc
Confidence            9999988 56899999543 3345899999999999999999999887   9999999999999653  37999999999


Q ss_pred             cccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhc
Q 008292          495 RIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYVSINV  568 (571)
Q Consensus       495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~  568 (571)
                      +.......     .-.-+.-|.|||++++.+|+.+.||||||||+.||+||.+-   +..+...|.+..+.+..
T Consensus       339 c~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PL---fpG~ne~DQl~~I~e~l  404 (586)
T KOG0667|consen  339 CFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPL---FPGDNEYDQLARIIEVL  404 (586)
T ss_pred             cccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccc---cCCCCHHHHHHHHHHHh
Confidence            87543333     22456789999999999999999999999999999999543   34566677777776543

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.5e-33  Score=278.29  Aligned_cols=203  Identities=35%  Similarity=0.576  Sum_probs=178.1

Q ss_pred             HhCCCCccccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       343 ~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      ...+|+..++||+|+||.||+|...++..+++|.++.........+.+|+.+++.++|+||+++++++...+..++||||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL   83 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence            45678889999999999999999888999999999877665677899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT  502 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  502 (571)
                      +++++|.+++.+. ....+++..++.++.|+++||.|||+++   ++|+||+|+||++++++.+||+|||++........
T Consensus        84 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~  159 (261)
T cd05148          84 MEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY  159 (261)
T ss_pred             cccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence            9999999999653 3456899999999999999999999887   99999999999999999999999999986643222


Q ss_pred             ccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          503 QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       503 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                      .  .....++..|+|||.+.+..++.++||||||+++|||++ |+.|+..
T Consensus       160 ~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~  207 (261)
T cd05148         160 L--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPG  207 (261)
T ss_pred             c--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCc
Confidence            1  112345678999999998899999999999999999999 8888754

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=7.1e-33  Score=274.37  Aligned_cols=202  Identities=30%  Similarity=0.525  Sum_probs=172.0

Q ss_pred             hCCCCccccccccCceeEEEEEccC----CCeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLPS----GQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL  418 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  418 (571)
                      .++|++.+.||+|+||.||+|.+..    ...|++|.++... .....++.+|+.++++++||||+++++++...+..++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            3568889999999999999999742    3578999887543 3335678899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccC
Q 008292          419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG  498 (571)
Q Consensus       419 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  498 (571)
                      +|||+++++|.+++..  ....+++..+++++.|++.||.|||+++   |+|+||||+||++++++.+||+|||+++.+.
T Consensus        83 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~  157 (266)
T cd05033          83 ITEYMENGSLDKFLRE--NDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE  157 (266)
T ss_pred             EEEcCCCCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence            9999999999999853  2347899999999999999999999887   9999999999999999999999999998764


Q ss_pred             CCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 008292          499 VDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSN  550 (571)
Q Consensus       499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~  550 (571)
                      ............++..|+|||.+.+..++.++||||||+++|||++ |..|+.
T Consensus       158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~  210 (266)
T cd05033         158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYW  210 (266)
T ss_pred             ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCC
Confidence            2222222222345678999999998999999999999999999998 998874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=7.6e-33  Score=276.04  Aligned_cols=192  Identities=30%  Similarity=0.440  Sum_probs=164.5

Q ss_pred             ccccCceeEEEEEcc-CCCeeEEEeecccC---ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEecCCCCh
Q 008292          353 LGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL  428 (571)
Q Consensus       353 LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  428 (571)
                      ||+|+||.||+++.+ +|+.||+|++....   ......+..|++++++++||||+++.+.+..+...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            799999999999864 58999999986432   12234456799999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCcccccc
Q 008292          429 DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR  508 (571)
Q Consensus       429 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  508 (571)
                      ..++... ....+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||++.......   ....
T Consensus        81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~  153 (277)
T cd05607          81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQ  153 (277)
T ss_pred             HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeec
Confidence            8887432 2345889999999999999999999887   9999999999999999999999999987654321   1223


Q ss_pred             ccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          509 IVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       509 ~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ..|+..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~  196 (277)
T cd05607         154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKD  196 (277)
T ss_pred             cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCC
Confidence            4688999999999998999999999999999999999999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2.7e-33  Score=281.37  Aligned_cols=203  Identities=33%  Similarity=0.546  Sum_probs=173.5

Q ss_pred             CCCCccccccccCceeEEEEEcc------CCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL  418 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  418 (571)
                      .+|...+.||+|+||.||+++..      ++..+++|.++.......+.+.+|+.++++++|+||+++++++..++..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            45778899999999999999742      345688998876665556789999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCc
Q 008292          419 VYEFVPNKSLDYFLYDPE-------------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN  485 (571)
Q Consensus       419 v~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~  485 (571)
                      ||||+++++|.+++....             ....+++..++.++.||+.||+|||+++   |+||||||+||+++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence            999999999999985321             2245899999999999999999999887   999999999999999999


Q ss_pred             eEEeeccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 008292          486 PKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSN  550 (571)
Q Consensus       486 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~  550 (571)
                      +||+|||++................++..|+|||.+.+..++.++||||||+++|||+| |+.|+.
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  227 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWF  227 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            99999999976543322222333456788999999999999999999999999999999 999974

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.9e-33  Score=288.24  Aligned_cols=207  Identities=29%  Similarity=0.446  Sum_probs=170.6

Q ss_pred             HHHhCCCCccccccccCceeEEEEEcc------CCCeeEEEeecccC-ccCHHHHHHHHHHHhhc-CCCceeccceeEEe
Q 008292          341 EVATNKFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLE  412 (571)
Q Consensus       341 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~  412 (571)
                      .+..++|++.+.||+|+||.||++...      .++.||+|+++... ....+.+..|+.++.++ +|+||+++++++..
T Consensus         3 ~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~   82 (337)
T cd05054           3 EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTK   82 (337)
T ss_pred             ccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEec
Confidence            344568999999999999999999632      34789999987543 22345678899999999 89999999998865


Q ss_pred             C-CeeEEEEEecCCCChhhhhcCCCC------------------------------------------------------
Q 008292          413 G-EEKILVYEFVPNKSLDYFLYDPEK------------------------------------------------------  437 (571)
Q Consensus       413 ~-~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------  437 (571)
                      . ...++++||+++++|.+++.....                                                      
T Consensus        83 ~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (337)
T cd05054          83 PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG  162 (337)
T ss_pred             CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence            4 567899999999999988743211                                                      


Q ss_pred             ----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCccccccccccC
Q 008292          438 ----QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTY  513 (571)
Q Consensus       438 ----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~  513 (571)
                          ...+++..+..++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+++.+.............++.
T Consensus       163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~  239 (337)
T cd05054         163 DELYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL  239 (337)
T ss_pred             hHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence                136899999999999999999999887   9999999999999999999999999998764332222233345677


Q ss_pred             CcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 008292          514 GYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSN  550 (571)
Q Consensus       514 ~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~  550 (571)
                      .|+|||++.+..++.++|||||||++|||++ |+.||.
T Consensus       240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~  277 (337)
T cd05054         240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYP  277 (337)
T ss_pred             cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCC
Confidence            8999999999999999999999999999998 999975

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-34  Score=303.19  Aligned_cols=211  Identities=27%  Similarity=0.360  Sum_probs=177.0

Q ss_pred             HHHHHhCCCCccccccccCceeEEEEEccCC-CeeEEEeecccCccCHHHHHHHHHHHhhcC-CCceecccee-EEe---
Q 008292          339 TIEVATNKFSTDNKLGEGGFGEVYKGVLPSG-QEIAVKRLSKASGQGAEEFKNEVVLVAKLQ-HRNLVRLLGF-CLE---  412 (571)
Q Consensus       339 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g-~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~-~~~---  412 (571)
                      .+.+...++++.+.|.+|||+.||.++...+ .++|+|++-..++...+.+++||.+|++|+ |+|||.+++. ...   
T Consensus        31 ~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~  110 (738)
T KOG1989|consen   31 TFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSS  110 (738)
T ss_pred             EEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccC
Confidence            3455667888999999999999999997665 999999998778888999999999999997 9999999993 322   


Q ss_pred             ---CCeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEe
Q 008292          413 ---GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKIS  489 (571)
Q Consensus       413 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  489 (571)
                         .-+.+|.||||++|.|-+++..+.. ..|++.++++|+.|+++|+++||.. +++|||||||-+||||..+++.|||
T Consensus       111 ~~~~~EvllLmEyC~gg~Lvd~mn~Rlq-~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLC  188 (738)
T KOG1989|consen  111 NNGVWEVLLLMEYCKGGSLVDFMNTRLQ-TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLC  188 (738)
T ss_pred             CCceeEEEeehhhccCCcHHHHHHHHHh-ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeC
Confidence               1357899999999999999964433 3499999999999999999999997 5789999999999999999999999


Q ss_pred             eccCccccCCCCCcc-c------cccccccCCccccccc---ccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          490 DFGMARIFGVDQTQG-N------TSRIVGTYGYMAPEYA---MHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       490 DfGla~~~~~~~~~~-~------~~~~~gt~~y~aPE~~---~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      |||.+...-...... .      .-...-|+.|+|||.+   .+...++|+|||+|||+||-|+....||+-
T Consensus       189 DFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~  260 (738)
T KOG1989|consen  189 DFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEE  260 (738)
T ss_pred             cccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCc
Confidence            999987432222110 0      0112358999999987   567899999999999999999999999864

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=6.8e-33  Score=277.57  Aligned_cols=198  Identities=31%  Similarity=0.449  Sum_probs=170.2

Q ss_pred             CCccccccccCceeEEEEEcc-CCCeeEEEeecccCc---cCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASG---QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       347 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      |+..+.||+|+||+||++... +++.||+|.+.....   ...+.+.+|+.++++++|++|+++++.+.+.+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            667789999999999999964 688999999865422   2234577899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT  502 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  502 (571)
                      +++++|.+++... ....+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++....... 
T Consensus        82 ~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  156 (285)
T cd05630          82 MNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-  156 (285)
T ss_pred             cCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-
Confidence            9999999888432 2345899999999999999999999887   9999999999999999999999999987543221 


Q ss_pred             ccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          503 QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       503 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                        ......|+..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~  203 (285)
T cd05630         157 --TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQ  203 (285)
T ss_pred             --cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCC
Confidence              11234689999999999999999999999999999999999999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.1e-33  Score=273.28  Aligned_cols=200  Identities=31%  Similarity=0.484  Sum_probs=170.3

Q ss_pred             CCCCccccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEecC
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVP  424 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  424 (571)
                      .+|++.+.||+|+||.||++.++++..+++|.+.... ...+.+.+|+++++.++||||+++++++......++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            3577889999999999999998777789999886433 344678899999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCcc
Q 008292          425 NKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG  504 (571)
Q Consensus       425 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  504 (571)
                      +++|.+++...  ...+++..++.++.|+++||+|||+.+   ++||||||+||++++++.+||+|||+++........ 
T Consensus        83 ~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-  156 (256)
T cd05059          83 NGCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-  156 (256)
T ss_pred             CCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccccc-
Confidence            99999988532  346899999999999999999999987   999999999999999999999999999765322111 


Q ss_pred             ccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          505 NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       505 ~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                      ......++..|+|||.+.+..++.++||||||+++|||+| |+.|++.
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~  204 (256)
T cd05059         157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYER  204 (256)
T ss_pred             ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCC
Confidence            1112234568999999998999999999999999999999 7888753

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-32  Score=272.27  Aligned_cols=200  Identities=31%  Similarity=0.479  Sum_probs=171.7

Q ss_pred             CCCCccccccccCceeEEEEEc-cCCCeeEEEeecccC-----ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS-----GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL  418 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  418 (571)
                      ++|...+.||+|++|.||++.. .+++.|++|.+....     ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            4688899999999999999985 468899999886432     1224578899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccC
Q 008292          419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG  498 (571)
Q Consensus       419 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  498 (571)
                      ++||+++++|.+++.   ....+++..+..++.|++.||.|||+.+   |+||||+|+||++++++.++|+|||+++...
T Consensus        82 v~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~  155 (263)
T cd06625          82 FMEYMPGGSVKDQLK---AYGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ  155 (263)
T ss_pred             EEEECCCCcHHHHHH---HhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence            999999999998884   3456889999999999999999999987   9999999999999999999999999997653


Q ss_pred             CCCCccc-cccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          499 VDQTQGN-TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       499 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      ....... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+.
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~  208 (263)
T cd06625         156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWA  208 (263)
T ss_pred             ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCcc
Confidence            3211111 123457889999999999999999999999999999999999974

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=5e-34  Score=260.28  Aligned_cols=210  Identities=26%  Similarity=0.314  Sum_probs=177.1

Q ss_pred             HHHhCCCCccccccccCceeEEEEE-ccCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCe----
Q 008292          341 EVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEE----  415 (571)
Q Consensus       341 ~~~~~~~~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~----  415 (571)
                      .+..++|++.++||+|||+-||.++ ..+++.+|+|++.-.+.++.+..++|++..++++||||++++++...+..    
T Consensus        17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~   96 (302)
T KOG2345|consen   17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH   96 (302)
T ss_pred             EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence            4556789999999999999999999 56788999999987777788889999999999999999999998876544    


Q ss_pred             -eEEEEEecCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccC
Q 008292          416 -KILVYEFVPNKSLDYFLYDP-EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM  493 (571)
Q Consensus       416 -~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl  493 (571)
                       .||+++|...|+|.+.+... .++..+++.++++|+.+|++||++||+.. ++++||||||.|||+.+++.++|.|||.
T Consensus        97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS  175 (302)
T KOG2345|consen   97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGS  175 (302)
T ss_pred             eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccC
Confidence             89999999999998877543 34457999999999999999999999975 5799999999999999999999999999


Q ss_pred             ccccCCCCCccc-------cccccccCCcccccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          494 ARIFGVDQTQGN-------TSRIVGTYGYMAPEYAM---HGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       494 a~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~---~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      +...........       ......|..|.|||.+.   +...++++|||||||+||+|+.|..||+.
T Consensus       176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~  243 (302)
T KOG2345|consen  176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER  243 (302)
T ss_pred             ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH
Confidence            875422111100       01123578899999874   45688999999999999999999999973

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-35  Score=274.17  Aligned_cols=195  Identities=27%  Similarity=0.477  Sum_probs=175.4

Q ss_pred             CCccccccccCceeEEEEEcc-CCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEecCC
Q 008292          347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPN  425 (571)
Q Consensus       347 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  425 (571)
                      |.++++||+|+||.||++.++ +|+.+|||++...  ...+++..||.+|++.+.|+||+++|.+.....+|+|||||..
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA  112 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA  112 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence            567789999999999999975 6999999998644  4568889999999999999999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCccc
Q 008292          426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN  505 (571)
Q Consensus       426 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  505 (571)
                      |+..++++  .+++++.+.++..++...++||+|||...   -||||||+.||||+.+|.+||+|||.+..+...  -..
T Consensus       113 GSiSDI~R--~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT--MAK  185 (502)
T KOG0574|consen  113 GSISDIMR--ARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT--MAK  185 (502)
T ss_pred             CcHHHHHH--HhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhh--HHh
Confidence            99999985  35678999999999999999999999765   799999999999999999999999999866422  223


Q ss_pred             cccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       506 ~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      ...+.||+.|||||++..-.|..++||||||++..||.-|++|+.
T Consensus       186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYs  230 (502)
T KOG0574|consen  186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYS  230 (502)
T ss_pred             hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcc
Confidence            456789999999999999999999999999999999999999974

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=4.6e-33  Score=289.59  Aligned_cols=199  Identities=25%  Similarity=0.401  Sum_probs=167.5

Q ss_pred             CCCccccccccCceeEEEEEc-cCCCeeEEEeecccC--ccCHHHHHHHHHHHhhcCCCceeccceeEEeCC-----eeE
Q 008292          346 KFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE-----EKI  417 (571)
Q Consensus       346 ~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-----~~~  417 (571)
                      +|+..++||+|+||.||++.. .+++.||+|++....  ....+++.+|+++++.++|+||+++++++...+     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            477889999999999999996 478999999986532  234467889999999999999999999998776     789


Q ss_pred             EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCcccc
Q 008292          418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF  497 (571)
Q Consensus       418 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  497 (571)
                      +|+||+. ++|.+.+.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 lv~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~  153 (372)
T cd07853          81 VVTELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE  153 (372)
T ss_pred             EEeeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence            9999997 56766663   3457899999999999999999999987   999999999999999999999999999865


Q ss_pred             CCCCCccccccccccCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 008292          498 GVDQTQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFY  552 (571)
Q Consensus       498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~slGvvl~elltG~~p~~~~  552 (571)
                      ...... ......+++.|+|||.+.+. .++.++||||||+++|||++|+.||...
T Consensus       154 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  208 (372)
T cd07853         154 EPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQ  208 (372)
T ss_pred             ccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCC
Confidence            432221 22234678899999998764 5799999999999999999999998643

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-33  Score=284.81  Aligned_cols=199  Identities=30%  Similarity=0.418  Sum_probs=177.5

Q ss_pred             hCCCCccccccccCceeEEEEEccC-CCeeEEEeecccCc---cCHHHHHHHHHHHhhcC-CCceeccceeEEeCCeeEE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSKASG---QGAEEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEKIL  418 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~l  418 (571)
                      ...|++.+.||+|.||.||+++.+. |+.+|+|.+.+...   ...+.+.+|+.+|+++. ||||+.+.+.+.+....++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l  113 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL  113 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence            4578888999999999999999765 99999999976543   34568999999999998 9999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCC----CceEEeeccCc
Q 008292          419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE----MNPKISDFGMA  494 (571)
Q Consensus       419 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~DfGla  494 (571)
                      |||++.||.|.+.+...    .+++.....++.|++.++.|||+.+   |+||||||+|+|+...    +.+|++|||++
T Consensus       114 vmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla  186 (382)
T KOG0032|consen  114 VMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLA  186 (382)
T ss_pred             EEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence            99999999998888543    3999999999999999999999987   9999999999999543    47999999999


Q ss_pred             cccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 008292          495 RIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFY  552 (571)
Q Consensus       495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~~  552 (571)
                      .....   .......+||+.|+|||++....++..+||||+|+++|.|++|..||...
T Consensus       187 ~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~  241 (382)
T KOG0032|consen  187 KFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGE  241 (382)
T ss_pred             eEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCC
Confidence            97654   34556789999999999999999999999999999999999999998754

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=6.8e-33  Score=277.55  Aligned_cols=198  Identities=30%  Similarity=0.433  Sum_probs=170.7

Q ss_pred             CCccccccccCceeEEEEEc-cCCCeeEEEeecccC---ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          347 FSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       347 ~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      |+..+.||+|+||+||++.. .+++.||+|.+....   ....+.+.+|+++++.++|+||+++.+.+..++..+++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            56778999999999999986 468899999986532   22334577899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT  502 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  502 (571)
                      +++++|..++... ....+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+||+|||++....... 
T Consensus        82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-  156 (285)
T cd05632          82 MNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-  156 (285)
T ss_pred             ccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence            9999999887532 2346899999999999999999999887   9999999999999999999999999987643221 


Q ss_pred             ccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          503 QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       503 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                        ......|+..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       157 --~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~  203 (285)
T cd05632         157 --SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRG  203 (285)
T ss_pred             --cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCC
Confidence              11234689999999999989999999999999999999999999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=4.3e-33  Score=274.49  Aligned_cols=200  Identities=31%  Similarity=0.478  Sum_probs=171.5

Q ss_pred             CCCCccccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEecC
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVP  424 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  424 (571)
                      ++|++.+.||+|+||+||++...++..+|+|.++... ...+++.+|+.++.+++||||+++++++......+++|||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            4577889999999999999998777789999887433 345778999999999999999999999998888999999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCcc
Q 008292          425 NKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG  504 (571)
Q Consensus       425 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  504 (571)
                      +++|.+++...  ...+++..++.++.||+.||.|||+.+   ++|+||||+||++++++.+||+|||+++........ 
T Consensus        83 ~~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~-  156 (256)
T cd05113          83 NGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT-  156 (256)
T ss_pred             CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCcee-
Confidence            99999988532  236899999999999999999999887   999999999999999999999999998865432211 


Q ss_pred             ccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          505 NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       505 ~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                      ......++..|++||.+....++.++||||||+++|||+| |+.|+..
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~  204 (256)
T cd05113         157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYER  204 (256)
T ss_pred             ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCc
Confidence            1112235678999999988889999999999999999999 9988753

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=7.7e-33  Score=274.23  Aligned_cols=199  Identities=26%  Similarity=0.432  Sum_probs=172.3

Q ss_pred             hCCCCccccccccCceeEEEEEc-cCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      .++|++.++||+|+||.||+|+. .+++.|++|++..........+++|+.++.+++||||+++++.+..++..++|+||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            35788999999999999999996 56888999998765555566788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT  502 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  502 (571)
                      +++++|.+++.   ....+++..+..++.|+++||.|||+.+   |+||||+|+||+++.++.+||+|||+++.+.....
T Consensus        88 ~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd06646          88 CGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA  161 (267)
T ss_pred             CCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence            99999999884   3456899999999999999999999887   99999999999999999999999999986532211


Q ss_pred             ccccccccccCCcccccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          503 QGNTSRIVGTYGYMAPEYAM---HGQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       503 ~~~~~~~~gt~~y~aPE~~~---~~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                        ......++..|+|||.+.   ...++.++||||||+++|||++|+.|+.
T Consensus       162 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~  210 (267)
T cd06646         162 --KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMF  210 (267)
T ss_pred             --ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCcc
Confidence              122346888999999874   4457889999999999999999999873

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-34  Score=292.16  Aligned_cols=198  Identities=35%  Similarity=0.511  Sum_probs=172.4

Q ss_pred             CCccccccccCceeEEEEEcc--CCC--eeEEEeecccCcc-CHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEE
Q 008292          347 FSTDNKLGEGGFGEVYKGVLP--SGQ--EIAVKRLSKASGQ-GAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE  421 (571)
Q Consensus       347 ~~~~~~LG~G~fg~Vy~~~~~--~g~--~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e  421 (571)
                      ....++||+|.||.|++|.|.  +|+  .||||.++..... ...+|.+|+.+|.+|+|+|+++|+|+..+ ....||+|
T Consensus       112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E  190 (1039)
T KOG0199|consen  112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE  190 (1039)
T ss_pred             HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence            345689999999999999985  344  5899999876654 67899999999999999999999999988 78899999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCC
Q 008292          422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ  501 (571)
Q Consensus       422 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  501 (571)
                      .++.|+|.+.|++ .....+-...+..++.|||+||.||..+.   +|||||..+|+||-....|||+||||.+.+....
T Consensus       191 LaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ne  266 (1039)
T KOG0199|consen  191 LAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENE  266 (1039)
T ss_pred             hcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence            9999999999976 56677888999999999999999999886   9999999999999999999999999999886543


Q ss_pred             Cccc-cccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCC
Q 008292          502 TQGN-TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNS  549 (571)
Q Consensus       502 ~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~  549 (571)
                      .... .....-...|.|||.+....|+.++|||+|||++|||+| |+.||
T Consensus       267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW  316 (1039)
T KOG0199|consen  267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPW  316 (1039)
T ss_pred             cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCC
Confidence            3321 222344678999999999999999999999999999999 77787

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-34  Score=288.39  Aligned_cols=208  Identities=31%  Similarity=0.493  Sum_probs=182.2

Q ss_pred             chHHHHHHhCCCCccccccccCceeEEEEEccC-CCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCC
Q 008292          336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE  414 (571)
Q Consensus       336 ~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~  414 (571)
                      .+++|+....++...++||-|.||.||.|.|+. .-.||||.++.+. ...++|..|..+|+.++|||+|+|+|+|....
T Consensus       258 n~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep  336 (1157)
T KOG4278|consen  258 NADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP  336 (1157)
T ss_pred             CcchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCC
Confidence            346777777788889999999999999999865 5579999997654 45789999999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCc
Q 008292          415 EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA  494 (571)
Q Consensus       415 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla  494 (571)
                      ..|||.|||.+|+|.++|++- +...++...++.++.||..||+||..++   +|||||.++|+|+.++..+||+||||+
T Consensus       337 PFYIiTEfM~yGNLLdYLRec-nr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLs  412 (1157)
T KOG4278|consen  337 PFYIITEFMCYGNLLDYLREC-NRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLS  412 (1157)
T ss_pred             CeEEEEecccCccHHHHHHHh-chhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchh
Confidence            999999999999999999642 3445788889999999999999999887   999999999999999999999999999


Q ss_pred             cccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCC
Q 008292          495 RIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNS  549 (571)
Q Consensus       495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~  549 (571)
                      +.+..+.+.. .....-+..|.|||.+.-..++.|+|||+|||+||||.| |-.|+
T Consensus       413 RlMtgDTYTA-HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPY  467 (1157)
T KOG4278|consen  413 RLMTGDTYTA-HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPY  467 (1157)
T ss_pred             hhhcCCceec-ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCC
Confidence            9986655433 222344789999999999999999999999999999998 87775

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=4.7e-33  Score=277.97  Aligned_cols=204  Identities=33%  Similarity=0.543  Sum_probs=173.1

Q ss_pred             hCCCCccccccccCceeEEEEEcc------CCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI  417 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  417 (571)
                      .+++...++||+|+||.||++...      ++..+++|.++.......+.+.+|+++++.++|+||+++++++..+...+
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL   83 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence            356778899999999999999632      35678999988766666778999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCCCC------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCc
Q 008292          418 LVYEFVPNKSLDYFLYDPEK------------QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN  485 (571)
Q Consensus       418 lv~e~~~~g~L~~~l~~~~~------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~  485 (571)
                      ++|||+++++|.+++.....            ...+++..++.++.|++.||+|||+.+   ++||||||+|||+++++.
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~  160 (280)
T cd05092          84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLV  160 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCC
Confidence            99999999999998854221            135889999999999999999999887   999999999999999999


Q ss_pred             eEEeeccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 008292          486 PKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSN  550 (571)
Q Consensus       486 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~  550 (571)
                      +||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus       161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~  226 (280)
T cd05092         161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWY  226 (280)
T ss_pred             EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCc
Confidence            99999999976543222122223345788999999999999999999999999999999 888873

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=4.3e-33  Score=295.18  Aligned_cols=198  Identities=24%  Similarity=0.426  Sum_probs=161.2

Q ss_pred             HhCCCCccccccccCceeEEEEEc-cCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeC--------
Q 008292          343 ATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG--------  413 (571)
Q Consensus       343 ~~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--------  413 (571)
                      ..++|.+.++||+|+||.||+|.. .+++.||||++....    ....+|+.+++.++||||+++++++...        
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            456799999999999999999996 468899999885432    2345799999999999999999877532        


Q ss_pred             CeeEEEEEecCCCChhhhhcC-CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCC-ceEEeec
Q 008292          414 EEKILVYEFVPNKSLDYFLYD-PEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM-NPKISDF  491 (571)
Q Consensus       414 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Df  491 (571)
                      ...++||||+++ +|..++.. ......+++..+..++.||+.||.|||+.+   |+||||||+||||+.++ .+||+||
T Consensus       140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence            135689999986 55555432 234567899999999999999999999987   99999999999998665 7999999


Q ss_pred             cCccccCCCCCccccccccccCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          492 GMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       492 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      |+++.+....   ......||+.|+|||++.+. .++.++|||||||++|||+||+.||..
T Consensus       216 Gla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~  273 (440)
T PTZ00036        216 GSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSG  273 (440)
T ss_pred             ccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            9998654322   12234679999999998764 689999999999999999999999853

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=8.9e-33  Score=288.44  Aligned_cols=209  Identities=28%  Similarity=0.427  Sum_probs=173.5

Q ss_pred             HHHHhCCCCccccccccCceeEEEEEcc------CCCeeEEEeecccCc-cCHHHHHHHHHHHhhcC-CCceeccceeEE
Q 008292          340 IEVATNKFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSKASG-QGAEEFKNEVVLVAKLQ-HRNLVRLLGFCL  411 (571)
Q Consensus       340 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~  411 (571)
                      +++..++|.+.++||+|+||.||+++++      .++.||+|+++.... ...+.+.+|++++.++. ||||+++++++.
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~  111 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT  111 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence            5566677888999999999999999853      345799999975432 33457889999999997 999999999999


Q ss_pred             eCCeeEEEEEecCCCChhhhhcCCC-------------------------------------------------------
Q 008292          412 EGEEKILVYEFVPNKSLDYFLYDPE-------------------------------------------------------  436 (571)
Q Consensus       412 ~~~~~~lv~e~~~~g~L~~~l~~~~-------------------------------------------------------  436 (571)
                      .....++|+||+++|+|.++++...                                                       
T Consensus       112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (401)
T cd05107         112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP  191 (401)
T ss_pred             cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence            9999999999999999999885321                                                       


Q ss_pred             ----------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCC
Q 008292          437 ----------------------------------------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKAS  476 (571)
Q Consensus       437 ----------------------------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~  476 (571)
                                                              ....+++..++.++.||++||.|||+.+   ++||||||+
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~  268 (401)
T cd05107         192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAAR  268 (401)
T ss_pred             hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcc
Confidence                                                    1124677888999999999999999876   999999999


Q ss_pred             CEEECCCCceEEeeccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          477 NILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       477 NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                      |||+++++.+||+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |+.|+..
T Consensus       269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~  344 (401)
T cd05107         269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPE  344 (401)
T ss_pred             eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCC
Confidence            99999999999999999986532222111223356789999999998899999999999999999998 8888753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.6e-32  Score=272.63  Aligned_cols=201  Identities=31%  Similarity=0.493  Sum_probs=164.6

Q ss_pred             CCccccccccCceeEEEEEccCCC---eeEEEeeccc--CccCHHHHHHHHHHHhhcCCCceeccceeEEeC------Ce
Q 008292          347 FSTDNKLGEGGFGEVYKGVLPSGQ---EIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG------EE  415 (571)
Q Consensus       347 ~~~~~~LG~G~fg~Vy~~~~~~g~---~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~------~~  415 (571)
                      +.+.++||+|+||.||+|++.+..   .||+|.++..  .....+.+.+|+++++.++|+||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            346789999999999999975432   5899988653  234456788999999999999999999987542      24


Q ss_pred             eEEEEEecCCCChhhhhcCC---CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeecc
Q 008292          416 KILVYEFVPNKSLDYFLYDP---EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG  492 (571)
Q Consensus       416 ~~lv~e~~~~g~L~~~l~~~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG  492 (571)
                      .++++||+++|+|..++...   .....+++..+..++.|++.||+|||+++   |+||||||+|||+++++.+||+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence            68999999999998877321   12345899999999999999999999887   9999999999999999999999999


Q ss_pred             CccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 008292          493 MARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSN  550 (571)
Q Consensus       493 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~  550 (571)
                      +++.+.............+++.|++||.+.+..++.++||||||+++|||++ |+.||.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~  216 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYP  216 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCC
Confidence            9987643322112223346778999999999999999999999999999999 788874

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=6.8e-33  Score=272.17  Aligned_cols=195  Identities=31%  Similarity=0.465  Sum_probs=164.7

Q ss_pred             ccccccCceeEEEEEcc-CCCeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEecCCCCh
Q 008292          351 NKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL  428 (571)
Q Consensus       351 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  428 (571)
                      +.||+|+||.||+++.. +++.|++|.+.... ......+.+|++++++++||||+++++++......++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            46999999999999964 68889999876543 33456789999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCcccccc
Q 008292          429 DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR  508 (571)
Q Consensus       429 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  508 (571)
                      .+++..  ....+++..++.++.|++.||.|||+++   |+||||||+||+++.++.+||+|||++..............
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  155 (252)
T cd05084          81 LTFLRT--EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM  155 (252)
T ss_pred             HHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence            999843  2346899999999999999999999887   99999999999999999999999999875432211111111


Q ss_pred             ccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 008292          509 IVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSN  550 (571)
Q Consensus       509 ~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~  550 (571)
                      ...+..|+|||.+.++.++.++||||||+++|||++ |..|+.
T Consensus       156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~  198 (252)
T cd05084         156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYA  198 (252)
T ss_pred             CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence            123457999999999999999999999999999998 888875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=8.9e-33  Score=278.27  Aligned_cols=198  Identities=28%  Similarity=0.487  Sum_probs=174.9

Q ss_pred             CCCCccccccccCceeEEEEEc-cCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEec
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV  423 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  423 (571)
                      .+|+..+.||+|++|.||++.. .+++.|++|.+........+.+.+|+.+++.++|+||+++++.+..+...++||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            5788899999999999999985 468899999998766666678899999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCc
Q 008292          424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ  503 (571)
Q Consensus       424 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  503 (571)
                      ++++|.+++.    ...+++.++..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++........ 
T Consensus       100 ~~~~L~~~~~----~~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-  171 (296)
T cd06654         100 AGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  171 (296)
T ss_pred             CCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc-
Confidence            9999999883    345789999999999999999999887   99999999999999999999999999876533221 


Q ss_pred             cccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          504 GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       504 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                       ......+++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       172 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~  218 (296)
T cd06654         172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN  218 (296)
T ss_pred             -ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence             12234688899999999988899999999999999999999999853

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=7.2e-33  Score=286.77  Aligned_cols=196  Identities=29%  Similarity=0.396  Sum_probs=166.0

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CCCeeEEEeeccc--CccCHHHHHHHHHHHhhcCCCceeccceeEEeCC------
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE------  414 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------  414 (571)
                      .++|+..+.||+|+||.||++... +|+.||+|++...  .......+.+|+.+++.++||||+++++++....      
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   99 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ   99 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence            478999999999999999999864 5889999998653  2334567789999999999999999999886543      


Q ss_pred             eeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCc
Q 008292          415 EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA  494 (571)
Q Consensus       415 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla  494 (571)
                      ..++||||++++ |...+.     ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       100 ~~~lv~e~~~~~-l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a  170 (359)
T cd07876         100 DVYLVMELMDAN-LCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  170 (359)
T ss_pred             eeEEEEeCCCcC-HHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCc
Confidence            468999999764 544442     24788999999999999999999987   999999999999999999999999999


Q ss_pred             cccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          495 RIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      +......   ......||+.|+|||.+.+..++.++||||||+++|||+||+.||..
T Consensus       171 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~  224 (359)
T cd07876         171 RTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQG  224 (359)
T ss_pred             cccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence            7543221   22334689999999999999999999999999999999999999863

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-33  Score=284.73  Aligned_cols=203  Identities=31%  Similarity=0.520  Sum_probs=174.9

Q ss_pred             HHHhCCCCccccccccCceeEEEEEcc---CCC--eeEEEeecc-cCccCHHHHHHHHHHHhhcCCCceeccceeEEeCC
Q 008292          341 EVATNKFSTDNKLGEGGFGEVYKGVLP---SGQ--EIAVKRLSK-ASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE  414 (571)
Q Consensus       341 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~---~g~--~vavK~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~  414 (571)
                      ++..+.....++||+|.||.||+|.+.   .|+  .||||.-+. ......+.|..|..+|+.++||||++++|+|.+ .
T Consensus       385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~  463 (974)
T KOG4257|consen  385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-Q  463 (974)
T ss_pred             eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-c
Confidence            334445556789999999999999953   233  488998876 445667899999999999999999999999975 5


Q ss_pred             eeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCc
Q 008292          415 EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA  494 (571)
Q Consensus       415 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla  494 (571)
                      ..|||||.++.|.|..+|..  +...++......++.||..+|+|||+..   +|||||..+|||+.+..-+||+|||++
T Consensus       464 P~WivmEL~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLS  538 (974)
T KOG4257|consen  464 PMWIVMELAPLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLS  538 (974)
T ss_pred             ceeEEEecccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchh
Confidence            77999999999999999953  4556888899999999999999999986   999999999999999999999999999


Q ss_pred             cccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 008292          495 RIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSN  550 (571)
Q Consensus       495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~  550 (571)
                      +.+..+.+.. .++..-+..|||||.+.-.+++.++|||-|||.+||++. |.+||.
T Consensus       539 R~~ed~~yYk-aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfq  594 (974)
T KOG4257|consen  539 RYLEDDAYYK-ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQ  594 (974)
T ss_pred             hhccccchhh-ccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccc
Confidence            9886554433 335566889999999999999999999999999999987 999986

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=7.5e-33  Score=276.27  Aligned_cols=202  Identities=32%  Similarity=0.548  Sum_probs=168.7

Q ss_pred             hCCCCccccccccCceeEEEEEc-cCCC----eeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQ----EIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI  417 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~-~~g~----~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  417 (571)
                      .++|+..++||+|+||+||+|++ .+++    .||+|.++... ....+++.+|+.++..++|+||+++++++.. ...+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence            45788889999999999999985 3444    47999886543 3345678899999999999999999999875 4567


Q ss_pred             EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCcccc
Q 008292          418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF  497 (571)
Q Consensus       418 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  497 (571)
                      +++||+++|+|.+++..  ....+++..++.++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+++.+
T Consensus        85 l~~~~~~~g~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~  159 (279)
T cd05109          85 LVTQLMPYGCLLDYVRE--NKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (279)
T ss_pred             EEEEcCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence            99999999999998853  2356899999999999999999999987   999999999999999999999999999876


Q ss_pred             CCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          498 GVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                      .............++..|+|||.+.+..++.++||||||+++|||++ |+.|++.
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~  214 (279)
T cd05109         160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG  214 (279)
T ss_pred             ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence            43322211222235678999999999999999999999999999998 8888764

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.6e-32  Score=274.04  Aligned_cols=193  Identities=26%  Similarity=0.392  Sum_probs=168.8

Q ss_pred             CCCCccccccccCceeEEEEEc-cCCCeeEEEeeccc-CccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA-SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      ++|+..++||+|+||.||++.. .+++.|++|.+... .....+++.+|++++.+++||||+++++.+...+..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            3577889999999999999985 46888999998654 233346788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT  502 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  502 (571)
                      +++++|..+.       .+++..+..++.|++.||.|||+.+   |+|+||||+|||++.++.+||+|||++..+...  
T Consensus        81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--  148 (279)
T cd06619          81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--  148 (279)
T ss_pred             CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence            9999996543       4678889999999999999999887   999999999999999999999999999765322  


Q ss_pred             ccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          503 QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       503 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                        ......|+..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~  195 (279)
T cd06619         149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQ  195 (279)
T ss_pred             --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchh
Confidence              22335789999999999999999999999999999999999999853

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=2.3e-32  Score=274.67  Aligned_cols=201  Identities=28%  Similarity=0.440  Sum_probs=173.0

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      .++|++.++||+|+||.||+|+.. +++.+++|.+........+.+.+|+.+++.++|+||+++++.+..+...++||||
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   90 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF   90 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence            357888999999999999999964 5789999999876666677889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT  502 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  502 (571)
                      +++++|..++..  ....+++..+..++.|++.+|.|||+.+   ++||||||+||+++.++.+||+|||++....... 
T Consensus        91 ~~~~~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-  164 (292)
T cd06644          91 CPGGAVDAIMLE--LDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-  164 (292)
T ss_pred             CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc-
Confidence            999999887743  2346899999999999999999999887   9999999999999999999999999987542221 


Q ss_pred             ccccccccccCCcccccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          503 QGNTSRIVGTYGYMAPEYAM-----HGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       503 ~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                       .......+++.|+|||.+.     ...++.++||||||+++|||++|+.|+..
T Consensus       165 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~  217 (292)
T cd06644         165 -QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE  217 (292)
T ss_pred             -cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcc
Confidence             1122346788999999884     34578899999999999999999999753

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=4.4e-33  Score=278.50  Aligned_cols=202  Identities=31%  Similarity=0.493  Sum_probs=169.0

Q ss_pred             CCCccccccccCceeEEEEEcc------CCCeeEEEeecccCcc-CHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEE
Q 008292          346 KFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSKASGQ-GAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL  418 (571)
Q Consensus       346 ~~~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  418 (571)
                      +|++.++||+|+||.||+|...      .+..||+|+++..... ..+.+.+|+.++..++||||+++++++......++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            4667889999999999999853      2467999999754332 34678899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCc
Q 008292          419 VYEFVPNKSLDYFLYDP-------------EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN  485 (571)
Q Consensus       419 v~e~~~~g~L~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~  485 (571)
                      ++||+++++|.+++...             .....+++..+++++.|++.||.|||+++   |+||||||.||++++++.
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence            99999999999887421             11235888999999999999999999887   999999999999999999


Q ss_pred             eEEeeccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 008292          486 PKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSN  550 (571)
Q Consensus       486 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~  550 (571)
                      +||+|||+++...............+++.|+|||.+.++.++.++||||||+++|||+| |..|+.
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~  228 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYC  228 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCC
Confidence            99999999886543322222233446789999999998899999999999999999998 777764

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-32  Score=272.63  Aligned_cols=201  Identities=29%  Similarity=0.458  Sum_probs=166.9

Q ss_pred             CCccccccccCceeEEEEEccC----CCeeEEEeecccC--ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCe-----
Q 008292          347 FSTDNKLGEGGFGEVYKGVLPS----GQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEE-----  415 (571)
Q Consensus       347 ~~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~-----  415 (571)
                      |.+.+.||+|+||.||+|....    +..||+|+++...  ....+.+.+|++.++.++||||+++++++...+.     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            4677899999999999998642    3679999987542  2334678999999999999999999998876554     


Q ss_pred             -eEEEEEecCCCChhhhhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeec
Q 008292          416 -KILVYEFVPNKSLDYFLYDPE---KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDF  491 (571)
Q Consensus       416 -~~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  491 (571)
                       .++++||+++++|..++....   ....+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence             789999999999998874322   2346899999999999999999999887   999999999999999999999999


Q ss_pred             cCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 008292          492 GMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSN  550 (571)
Q Consensus       492 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~  550 (571)
                      |+++...............++..|+|||.+....++.++||||||+++|||++ |..|+.
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~  217 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYP  217 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCC
Confidence            99986643332222222335678999999988899999999999999999999 888874

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.3e-32  Score=278.74  Aligned_cols=198  Identities=28%  Similarity=0.389  Sum_probs=171.2

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      ++|++.+.||+|+||.||+++.. ++..+++|.+.... .....++.+|++++.+++||||+++++.+.+++..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            36888999999999999999964 57788999886542 33345688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT  502 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  502 (571)
                      +++++|.+++.   +...+++..+..++.|+++||.|||+..  +++|+||||+|||++.++.+||+|||++......  
T Consensus        81 ~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--  153 (308)
T cd06615          81 MDGGSLDQVLK---KAGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  153 (308)
T ss_pred             cCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc--
Confidence            99999999984   3356899999999999999999999732  3999999999999999999999999998754322  


Q ss_pred             ccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          503 QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       503 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                        ......++..|+|||.+.+..++.++||||||+++|||+||+.|+..
T Consensus       154 --~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~  200 (308)
T cd06615         154 --MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPP  200 (308)
T ss_pred             --ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence              12234688999999999888899999999999999999999999853

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.8e-32  Score=271.54  Aligned_cols=201  Identities=24%  Similarity=0.439  Sum_probs=172.5

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeeccc---CccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY  420 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  420 (571)
                      ++|++.++||+|+||.||+|+.. +++.|++|.++..   .......+.+|+++++.++||||+++++++.+.+..++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            47889999999999999999964 6889999987642   2233457889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCC
Q 008292          421 EFVPNKSLDYFLYDPE-KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV  499 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  499 (571)
                      ||+++++|..++.... +...+++..++.++.|+++||.|||+++   ++|+||||+||+++.++.++|+|||++..+..
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            9999999998874322 3345889999999999999999999887   99999999999999999999999999886543


Q ss_pred             CCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          500 DQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      ...  ......+++.|+|||.+.+..++.++||||||+++|||++|+.|+.
T Consensus       159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~  207 (267)
T cd08228         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY  207 (267)
T ss_pred             hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCc
Confidence            221  1223467889999999998889999999999999999999999974

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.8e-34  Score=289.74  Aligned_cols=195  Identities=29%  Similarity=0.485  Sum_probs=167.2

Q ss_pred             CCccccccccCceeEEEEEcc-CCCeeEEEeecc----cCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCe--eEEE
Q 008292          347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSK----ASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEE--KILV  419 (571)
Q Consensus       347 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~----~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~--~~lv  419 (571)
                      .+...+||+|.|-+||||.+. +|.+||--.++.    .++...++|..|+.+|+.|+||||++++.++.+...  ..+|
T Consensus        42 ~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i  121 (632)
T KOG0584|consen   42 LKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI  121 (632)
T ss_pred             eehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence            355678999999999999964 577776443322    244556899999999999999999999999988665  7899


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCC-CceEEeeccCccccC
Q 008292          420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE-MNPKISDFGMARIFG  498 (571)
Q Consensus       420 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfGla~~~~  498 (571)
                      .|.+..|+|..++.   +.+.++.+.+..|++||++||.|||++ .|||||||||-+||+|+.+ |.|||+|+|||....
T Consensus       122 TEL~TSGtLr~Y~k---k~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r  197 (632)
T KOG0584|consen  122 TELFTSGTLREYRK---KHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR  197 (632)
T ss_pred             eecccCCcHHHHHH---HhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence            99999999999984   566789999999999999999999998 4789999999999999765 899999999999765


Q ss_pred             CCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          499 VDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      ...    ...+.|||.|||||... ..|.+.+||||||+.++||+|+..|+.
T Consensus       198 ~s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYs  244 (632)
T KOG0584|consen  198 KSH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYS  244 (632)
T ss_pred             ccc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChh
Confidence            333    23378999999999766 899999999999999999999999974

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1e-32  Score=279.61  Aligned_cols=200  Identities=26%  Similarity=0.421  Sum_probs=168.2

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeecccCc-cCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASG-QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      ++|.+.++||+|+||.||+++.+ +++.||+|.++.... .....+.+|+.++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            56888999999999999999864 577899999875432 3345677899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT  502 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  502 (571)
                      +++ +|.+++..  ....+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus        86 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  159 (309)
T cd07872          86 LDK-DLKQYMDD--CGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK  159 (309)
T ss_pred             CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence            985 67776643  2345789999999999999999999987   99999999999999999999999999976432221


Q ss_pred             ccccccccccCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 008292          503 QGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNFY  552 (571)
Q Consensus       503 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slGvvl~elltG~~p~~~~  552 (571)
                        ......+++.|+|||.+.+ ..++.++||||||+++|||+||+.||...
T Consensus       160 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~  208 (309)
T cd07872         160 --TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGS  208 (309)
T ss_pred             --ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence              1223457889999998865 46899999999999999999999998643

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=6e-33  Score=277.07  Aligned_cols=205  Identities=28%  Similarity=0.444  Sum_probs=173.2

Q ss_pred             HhCCCCccccccccCceeEEEEEccC-----CCeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeEEe-CCe
Q 008292          343 ATNKFSTDNKLGEGGFGEVYKGVLPS-----GQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE-GEE  415 (571)
Q Consensus       343 ~~~~~~~~~~LG~G~fg~Vy~~~~~~-----g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~-~~~  415 (571)
                      ..++|.+.+.||+|+||.||+|...+     +..|++|+++... ....+.+.+|+.++++++|+||+++++++.. +..
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            45688899999999999999999765     6789999887542 3445678899999999999999999998876 467


Q ss_pred             eEEEEEecCCCChhhhhcCCCCC-----CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEee
Q 008292          416 KILVYEFVPNKSLDYFLYDPEKQ-----GQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISD  490 (571)
Q Consensus       416 ~~lv~e~~~~g~L~~~l~~~~~~-----~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  490 (571)
                      .++++||+++++|..++......     ..+++..++.++.|++.||+|||+++   ++||||||+||++++++.+||+|
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence            89999999999999988543222     56899999999999999999999887   99999999999999999999999


Q ss_pred             ccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 008292          491 FGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSN  550 (571)
Q Consensus       491 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~  550 (571)
                      ||+++.+.............++..|+|||++.+..++.++||||||+++||+++ |+.|+.
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~  221 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYV  221 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcC
Confidence            999986643332222223345778999999998899999999999999999999 999875

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.4e-33  Score=277.45  Aligned_cols=205  Identities=29%  Similarity=0.493  Sum_probs=173.2

Q ss_pred             HhCCCCccccccccCceeEEEEEccC------CCeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCe
Q 008292          343 ATNKFSTDNKLGEGGFGEVYKGVLPS------GQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEE  415 (571)
Q Consensus       343 ~~~~~~~~~~LG~G~fg~Vy~~~~~~------g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~  415 (571)
                      ..++|.+.+.||+|+||.||++....      +..|++|.+.... ......+.+|+.++..++||||+++++++.....
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   83 (277)
T cd05032           4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP   83 (277)
T ss_pred             chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence            45678889999999999999998642      3679999986543 2334578899999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhcCCC-------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEE
Q 008292          416 KILVYEFVPNKSLDYFLYDPE-------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKI  488 (571)
Q Consensus       416 ~~lv~e~~~~g~L~~~l~~~~-------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl  488 (571)
                      .++||||+++++|.+++....       ....+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||
T Consensus        84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl  160 (277)
T cd05032          84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEE
Confidence            999999999999999885422       1235789999999999999999999887   999999999999999999999


Q ss_pred             eeccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 008292          489 SDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSN  550 (571)
Q Consensus       489 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~  550 (571)
                      +|||+++.+.............++..|+|||.+.++.++.++||||||+++|||+| |+.|+.
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  223 (277)
T cd05032         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQ  223 (277)
T ss_pred             CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCc
Confidence            99999986543332222233456789999999998899999999999999999998 888875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=6.5e-33  Score=278.12  Aligned_cols=207  Identities=29%  Similarity=0.476  Sum_probs=171.1

Q ss_pred             HHHhCCCCccccccccCceeEEEEEcc------CCCeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeEEeC
Q 008292          341 EVATNKFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG  413 (571)
Q Consensus       341 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~  413 (571)
                      ++..++|++.++||+|+||.||+|..+      .+..||+|.++... ......+.+|+.+++.++||||+++++++.+.
T Consensus         2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   81 (288)
T cd05061           2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG   81 (288)
T ss_pred             cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            345678999999999999999999753      24579999886443 22345678899999999999999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhcCCC-------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCce
Q 008292          414 EEKILVYEFVPNKSLDYFLYDPE-------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP  486 (571)
Q Consensus       414 ~~~~lv~e~~~~g~L~~~l~~~~-------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~  486 (571)
                      ...++||||+++|+|.+++....       ....+++..+..++.|++.||.|||+++   |+||||||+||++++++.+
T Consensus        82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~  158 (288)
T cd05061          82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTV  158 (288)
T ss_pred             CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcE
Confidence            99999999999999999985321       1234577888999999999999999887   9999999999999999999


Q ss_pred             EEeeccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 008292          487 KISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSN  550 (571)
Q Consensus       487 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~  550 (571)
                      ||+|||+++...............++..|+|||.+.++.++.++||||||+++|||++ |+.|+.
T Consensus       159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~  223 (288)
T cd05061         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQ  223 (288)
T ss_pred             EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCC
Confidence            9999999986543322222223345678999999999999999999999999999999 677764

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=4.7e-33  Score=281.79  Aligned_cols=207  Identities=30%  Similarity=0.453  Sum_probs=171.1

Q ss_pred             HHHhCCCCccccccccCceeEEEEEcc--------CCCeeEEEeecccC-ccCHHHHHHHHHHHhhc-CCCceeccceeE
Q 008292          341 EVATNKFSTDNKLGEGGFGEVYKGVLP--------SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKL-QHRNLVRLLGFC  410 (571)
Q Consensus       341 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~  410 (571)
                      ++..++|.+.+.||+|+||.||++...        ++..+|+|.++... .....++.+|+.++.++ +||||+++++++
T Consensus        14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (307)
T cd05098          14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC   93 (307)
T ss_pred             eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            344567899999999999999999742        23469999987542 33456788899999999 799999999999


Q ss_pred             EeCCeeEEEEEecCCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCC
Q 008292          411 LEGEEKILVYEFVPNKSLDYFLYDPEK-------------QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASN  477 (571)
Q Consensus       411 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~N  477 (571)
                      ......++||||+++++|.+++.....             ...+++.++++++.|++.||+|||+.+   ++||||||+|
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~N  170 (307)
T cd05098          94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARN  170 (307)
T ss_pred             ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHh
Confidence            999999999999999999999854321             235889999999999999999999887   9999999999


Q ss_pred             EEECCCCceEEeeccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 008292          478 ILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSN  550 (571)
Q Consensus       478 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~  550 (571)
                      |+++.++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.|+.
T Consensus       171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~  244 (307)
T cd05098         171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP  244 (307)
T ss_pred             eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCC
Confidence            9999999999999999876532221111222234568999999999999999999999999999998 777764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=7.4e-33  Score=273.85  Aligned_cols=201  Identities=32%  Similarity=0.500  Sum_probs=171.5

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      ..+|.+.++||+|+||.||++..+ .++.|++|.++.. ....+++.+|+++++.++|+||+++++++...+..+++|||
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (263)
T cd05052           5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   83 (263)
T ss_pred             hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence            346788899999999999999965 5788999998754 33456789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT  502 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  502 (571)
                      +++++|.+++... ....+++..++.++.|+++||+|||+++   ++||||||+||++++++.+||+|||++........
T Consensus        84 ~~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~  159 (263)
T cd05052          84 MTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  159 (263)
T ss_pred             CCCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence            9999999988532 2346899999999999999999999887   99999999999999999999999999986543221


Q ss_pred             ccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 008292          503 QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSN  550 (571)
Q Consensus       503 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~  550 (571)
                      . ......++..|+|||.+.+..++.++||||||+++|||+| |..|+.
T Consensus       160 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~  207 (263)
T cd05052         160 T-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP  207 (263)
T ss_pred             e-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Confidence            1 1112234668999999999999999999999999999998 888874

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-33  Score=266.15  Aligned_cols=205  Identities=25%  Similarity=0.312  Sum_probs=177.9

Q ss_pred             HhCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccCccCH---HHHHHHHHHHhhcCCCceeccceeEEeCCeeEE
Q 008292          343 ATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGA---EEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL  418 (571)
Q Consensus       343 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~---~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  418 (571)
                      .-++|..++.||+|.||.|..++-+ .++.+|+|++++..-...   ..-..|-++|...+||.+..+.-.|...+..++
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF  245 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF  245 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence            3467888999999999999999854 688999999987643333   334568889999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccC
Q 008292          419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG  498 (571)
Q Consensus       419 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  498 (571)
                      ||||..||.|.-+|.   ....+++.+...+-.+|..||.|||+++   ||.||||.+|.|+|.+|++||+|||+++.--
T Consensus       246 VMeyanGGeLf~HLs---rer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I  319 (516)
T KOG0690|consen  246 VMEYANGGELFFHLS---RERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI  319 (516)
T ss_pred             EEEEccCceEeeehh---hhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc
Confidence            999999999988773   4556888888889999999999999987   9999999999999999999999999998532


Q ss_pred             CCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 008292          499 VDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTD  555 (571)
Q Consensus       499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~~~~~  555 (571)
                        .....++..||||.|+|||++....|..++|+|.+||++|||++|+.||-..+.+
T Consensus       320 --~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~  374 (516)
T KOG0690|consen  320 --KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE  374 (516)
T ss_pred             --cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh
Confidence              2334567789999999999999999999999999999999999999998654433

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=6.7e-33  Score=276.39  Aligned_cols=205  Identities=33%  Similarity=0.526  Sum_probs=170.0

Q ss_pred             hCCCCccccccccCceeEEEEEccC------CCeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCee
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLPS------GQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEK  416 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~~------g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  416 (571)
                      .++|.+.+.||+|++|.||++.+.+      +..|++|.+.... ......+.+|+.+++.++|+||+++++++.+....
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            4678899999999999999999753      4678899886543 23345788999999999999999999999998899


Q ss_pred             EEEEEecCCCChhhhhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCC---ceEEe
Q 008292          417 ILVYEFVPNKSLDYFLYDPE----KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM---NPKIS  489 (571)
Q Consensus       417 ~lv~e~~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~  489 (571)
                      ++||||+++++|.+++....    ....+++..+++++.||++||+|||+.+   ++||||||+||+++.++   .+||+
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence            99999999999999885432    1235899999999999999999999987   99999999999998754   59999


Q ss_pred             eccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          490 DFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       490 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                      |||+++.+..............+..|+|||++.+..++.++||||||+++|||++ |+.||+.
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~  224 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPG  224 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence            9999987633222111222234568999999999999999999999999999997 8888753

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.2e-32  Score=276.43  Aligned_cols=202  Identities=30%  Similarity=0.454  Sum_probs=168.7

Q ss_pred             CCCccccccccCceeEEEEEcc------CCCeeEEEeecccCc-cCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEE
Q 008292          346 KFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSKASG-QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL  418 (571)
Q Consensus       346 ~~~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  418 (571)
                      +|.+.+.||+|+||.||+|+..      ....+++|.+..... ...+++.+|+.+++.++||||+++++.+...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4678899999999999999852      235688888865432 334678899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCC
Q 008292          419 VYEFVPNKSLDYFLYDPE---------------------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASN  477 (571)
Q Consensus       419 v~e~~~~g~L~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~N  477 (571)
                      ++||+++++|.+++....                     ....+++..++.++.|++.||.|||+.+   ++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence            999999999999875321                     1235889999999999999999999887   9999999999


Q ss_pred             EEECCCCceEEeeccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 008292          478 ILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSN  550 (571)
Q Consensus       478 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~  550 (571)
                      ||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||+| |+.|+.
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~  231 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP  231 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCC
Confidence            9999999999999999986533322222223345778999999988899999999999999999999 888875

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=3e-32  Score=268.55  Aligned_cols=193  Identities=34%  Similarity=0.516  Sum_probs=162.6

Q ss_pred             cccccCceeEEEEEc---cCCCeeEEEeecccC--ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEecCCC
Q 008292          352 KLGEGGFGEVYKGVL---PSGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNK  426 (571)
Q Consensus       352 ~LG~G~fg~Vy~~~~---~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  426 (571)
                      +||+|+||.||+|.+   +++..+++|+++...  ....+++.+|+.+++.++||||+++++++. .+..++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            689999999999975   357789999986543  234567899999999999999999999875 45678999999999


Q ss_pred             ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCcc-c
Q 008292          427 SLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG-N  505 (571)
Q Consensus       427 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~-~  505 (571)
                      +|.+++.   ....+++..+..++.|++.||+|||+++   |+||||||+||+++.++.+||+|||+++.+....... .
T Consensus        81 ~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  154 (257)
T cd05116          81 PLNKFLQ---KNKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA  154 (257)
T ss_pred             cHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence            9999984   3346899999999999999999999887   9999999999999999999999999998664332211 1


Q ss_pred             cccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       506 ~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                      .....++..|+|||.+....++.++||||||+++|||+| |+.||..
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~  201 (257)
T cd05116         155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKG  201 (257)
T ss_pred             cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence            122334678999999988889999999999999999998 9999863

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1e-32  Score=273.42  Aligned_cols=198  Identities=26%  Similarity=0.450  Sum_probs=172.3

Q ss_pred             CCCCccccccccCceeEEEEEc-cCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEec
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV  423 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  423 (571)
                      ++|...++||+|+||.||+++. .+++.|++|.++.........+.+|+.+++.++||||+++++.+..++..++++||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            4677888999999999999985 468899999987665555567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCc
Q 008292          424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ  503 (571)
Q Consensus       424 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  503 (571)
                      ++++|.+++.   ..+.+++.+++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++..+....  
T Consensus        89 ~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~--  160 (267)
T cd06645          89 GGGSLQDIYH---VTGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI--  160 (267)
T ss_pred             CCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc--
Confidence            9999999884   3456899999999999999999999987   9999999999999999999999999987654221  


Q ss_pred             cccccccccCCcccccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          504 GNTSRIVGTYGYMAPEYAM---HGQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       504 ~~~~~~~gt~~y~aPE~~~---~~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      .......|+..|+|||.+.   ...++.++||||||+++|||++|+.|+.
T Consensus       161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~  210 (267)
T cd06645         161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMF  210 (267)
T ss_pred             cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcc
Confidence            2223456899999999874   4568899999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=2.4e-32  Score=269.36  Aligned_cols=193  Identities=32%  Similarity=0.532  Sum_probs=161.5

Q ss_pred             cccccCceeEEEEEcc---CCCeeEEEeecccCc-cCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEecCCCC
Q 008292          352 KLGEGGFGEVYKGVLP---SGQEIAVKRLSKASG-QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKS  427 (571)
Q Consensus       352 ~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  427 (571)
                      .||+|+||.||+|.+.   .+..||+|++..... ...+.+.+|+.++++++||||+++++++. .+..++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            4899999999999863   355699999876533 33467899999999999999999999875 457899999999999


Q ss_pred             hhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCcc-cc
Q 008292          428 LDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG-NT  506 (571)
Q Consensus       428 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~-~~  506 (571)
                      |.+++..  ....+++..+++++.|+++||.|||+++   ++||||||+||+++.++.+||+|||+++.+....... ..
T Consensus        81 L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  155 (257)
T cd05115          81 LNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR  155 (257)
T ss_pred             HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence            9998853  3456899999999999999999999987   9999999999999999999999999998654332211 11


Q ss_pred             ccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 008292          507 SRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSN  550 (571)
Q Consensus       507 ~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~  550 (571)
                      ....++..|+|||.+....++.++||||||+++|||++ |+.|+.
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~  200 (257)
T cd05115         156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYK  200 (257)
T ss_pred             CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcC
Confidence            12234578999999988889999999999999999996 999985

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.7e-32  Score=272.11  Aligned_cols=198  Identities=29%  Similarity=0.420  Sum_probs=162.3

Q ss_pred             ccccccCceeEEEEEccC---CCeeEEEeecccCc-cCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEecCCC
Q 008292          351 NKLGEGGFGEVYKGVLPS---GQEIAVKRLSKASG-QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNK  426 (571)
Q Consensus       351 ~~LG~G~fg~Vy~~~~~~---g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  426 (571)
                      +.||+|+||.||+|...+   +..+++|.++.... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            468999999999998643   45689998875432 33457889999999999999999999999988999999999999


Q ss_pred             ChhhhhcCCC--CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCcc
Q 008292          427 SLDYFLYDPE--KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG  504 (571)
Q Consensus       427 ~L~~~l~~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  504 (571)
                      +|.+++....  ....+++..+..++.|+++||+|||+.+   ++|+||||+||+++.++++||+|||+++.........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            9999985422  2234677888899999999999999887   9999999999999999999999999987543322222


Q ss_pred             ccccccccCCcccccccccC-------CCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          505 NTSRIVGTYGYMAPEYAMHG-------QFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       505 ~~~~~~gt~~y~aPE~~~~~-------~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                      ......++..|+|||++...       .++.++||||||+++|||++ |+.||..
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~  212 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRH  212 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCC
Confidence            22334578899999988542       35789999999999999996 9999854

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.4e-32  Score=272.64  Aligned_cols=198  Identities=27%  Similarity=0.386  Sum_probs=159.7

Q ss_pred             ccccccCceeEEEEEccC---CCeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEecCCC
Q 008292          351 NKLGEGGFGEVYKGVLPS---GQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNK  426 (571)
Q Consensus       351 ~~LG~G~fg~Vy~~~~~~---g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  426 (571)
                      ++||+|+||.||+|...+   ...+++|.+.... ......+.+|+.+++.++|+||+++++.+......++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            469999999999997543   3467888776443 233456889999999999999999999999999999999999999


Q ss_pred             ChhhhhcCCCC--CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCcc
Q 008292          427 SLDYFLYDPEK--QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG  504 (571)
Q Consensus       427 ~L~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  504 (571)
                      +|.+++.....  ....++.....++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            99999864322  233567888999999999999999987   9999999999999999999999999987543222211


Q ss_pred             ccccccccCCcccccccc-------cCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          505 NTSRIVGTYGYMAPEYAM-------HGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       505 ~~~~~~gt~~y~aPE~~~-------~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                      ......++..|+|||++.       ...++.++||||||+++|||++ |+.|+..
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~  212 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPD  212 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCc
Confidence            122334577899999874       3457889999999999999999 7777653

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.6e-32  Score=274.27  Aligned_cols=197  Identities=28%  Similarity=0.450  Sum_probs=169.9

Q ss_pred             CCccccccccCceeEEEEEcc-CCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEecCC
Q 008292          347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPN  425 (571)
Q Consensus       347 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  425 (571)
                      |++.+.||+|+||.||++... ++..+++|.+........+.+.+|+++++.++||||+++++.+..+...++|+||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            566788999999999999975 4678899988766666667889999999999999999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCccc
Q 008292          426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN  505 (571)
Q Consensus       426 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  505 (571)
                      ++|..++..  ....+++..+..++.|+++||.|||+.+   ++||||||+||+++.++.+||+|||++.......  ..
T Consensus        87 ~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~  159 (282)
T cd06643          87 GAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QR  159 (282)
T ss_pred             CcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc--cc
Confidence            999888743  2456899999999999999999999987   9999999999999999999999999987543221  12


Q ss_pred             cccccccCCcccccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          506 TSRIVGTYGYMAPEYAM-----HGQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       506 ~~~~~gt~~y~aPE~~~-----~~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      .....++..|+|||++.     +..++.++||||||+++|||++|+.|+.
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~  209 (282)
T cd06643         160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHH  209 (282)
T ss_pred             cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCcc
Confidence            23346889999999873     4467889999999999999999999975

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.1e-32  Score=269.09  Aligned_cols=200  Identities=31%  Similarity=0.463  Sum_probs=173.9

Q ss_pred             CCCccccccccCceeEEEEEcc-CCCeeEEEeeccc--CccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       346 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      +|...+.||+|++|.||+++.+ +++.|++|.+...  .....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4677889999999999999964 6889999988643  334456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT  502 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  502 (571)
                      +++++|.+++... ....+++..++.++.|+++||.|||+.+   ++|+||+|+||+++.++.+||+|||+++.+.....
T Consensus        81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~  156 (256)
T cd08529          81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN  156 (256)
T ss_pred             CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence            9999999998642 2457899999999999999999999887   99999999999999999999999999886643222


Q ss_pred             ccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          503 QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       503 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                        ......|++.|+|||++.+..++.++||||||+++|||+||+.|+..
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  203 (256)
T cd08529         157 --FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDA  203 (256)
T ss_pred             --hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence              12234678899999999999999999999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.2e-32  Score=278.15  Aligned_cols=197  Identities=26%  Similarity=0.434  Sum_probs=159.5

Q ss_pred             cccccccCceeEEEEEcc---CCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEe--CCeeEEEEEecC
Q 008292          350 DNKLGEGGFGEVYKGVLP---SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE--GEEKILVYEFVP  424 (571)
Q Consensus       350 ~~~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~  424 (571)
                      .++||+|+||+||+++..   +++.||+|.++...  ....+.+|+.++++++||||+++++++..  +...+++|||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            468999999999999854   46789999886542  23557889999999999999999998864  345789999986


Q ss_pred             CCChhhhhcCC------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEE----CCCCceEEeeccCc
Q 008292          425 NKSLDYFLYDP------EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL----DAEMNPKISDFGMA  494 (571)
Q Consensus       425 ~g~L~~~l~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DfGla  494 (571)
                      + +|..++...      .+...+++..+..++.||+.||.|||+++   |+||||||+|||+    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            5 676665321      12235889999999999999999999987   9999999999999    45678999999999


Q ss_pred             cccCCCCCc-cccccccccCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 008292          495 RIFGVDQTQ-GNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFY  552 (571)
Q Consensus       495 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~slGvvl~elltG~~p~~~~  552 (571)
                      +.+...... .......||+.|+|||++.+. .++.++||||+|+++|||++|+.||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            876433221 223345789999999998764 5899999999999999999999998643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-33  Score=289.09  Aligned_cols=193  Identities=33%  Similarity=0.506  Sum_probs=170.0

Q ss_pred             ccccccCceeEEEEEccC-CCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEecCCCChh
Q 008292          351 NKLGEGGFGEVYKGVLPS-GQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLD  429 (571)
Q Consensus       351 ~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  429 (571)
                      -.||+|.||+||-|+..+ ...+|||.+........+-+++||.+.+.++|.|||+++|.+.++...-|.||-++||+|.
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS  660 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS  660 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence            369999999999999654 5578999998877777788999999999999999999999999999999999999999999


Q ss_pred             hhhcCCCCCCCC--CHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECC-CCceEEeeccCccccCCCCCcccc
Q 008292          430 YFLYDPEKQGQL--DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-EMNPKISDFGMARIFGVDQTQGNT  506 (571)
Q Consensus       430 ~~l~~~~~~~~l--~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGla~~~~~~~~~~~~  506 (571)
                      .+|..  +.+++  ++.++-.+..||++||.|||++.   |||||||-+||||+. .|.+||+|||-++.+..  ....+
T Consensus       661 sLLrs--kWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~T  733 (1226)
T KOG4279|consen  661 SLLRS--KWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCT  733 (1226)
T ss_pred             HHHHh--ccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhcc--CCccc
Confidence            99953  55666  78889999999999999999987   999999999999964 68999999999987642  22334


Q ss_pred             ccccccCCcccccccccC--CCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          507 SRIVGTYGYMAPEYAMHG--QFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       507 ~~~~gt~~y~aPE~~~~~--~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      ..+-||+.|||||++..+  .|..++|||||||++.||.||++||-
T Consensus       734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~  779 (1226)
T KOG4279|consen  734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFV  779 (1226)
T ss_pred             cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCee
Confidence            556799999999999766  48899999999999999999999974

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=4.6e-32  Score=268.37  Aligned_cols=201  Identities=25%  Similarity=0.457  Sum_probs=174.4

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeeccc---CccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY  420 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  420 (571)
                      ++|++.+.||+|+||.||++... +|+.|++|.++..   .....+.+.+|++++++++|+||+++++.+.+.+..+++|
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57889999999999999999976 7899999988642   2333568899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCC
Q 008292          421 EFVPNKSLDYFLYDP-EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV  499 (571)
Q Consensus       421 e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  499 (571)
                      ||+++++|..++... .....+++.+++.++.|+++||.|||+.+   ++||||+|+||+++.++.++|+|||+++.+..
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            999999999888542 23456899999999999999999999887   99999999999999999999999999876533


Q ss_pred             CCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          500 DQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      ...  ......++..|+|||.+.+..++.++||||||+++|||++|+.|+.
T Consensus       159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~  207 (267)
T cd08224         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY  207 (267)
T ss_pred             CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcc
Confidence            221  1223457889999999998899999999999999999999999974

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-33  Score=286.44  Aligned_cols=191  Identities=28%  Similarity=0.389  Sum_probs=159.8

Q ss_pred             ccccCceeEEEEEcc-CCCeeEEEeecccC---ccCHHHHHHHHHHHhhc---CCCceeccceeEEeCCeeEEEEEecCC
Q 008292          353 LGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKL---QHRNLVRLLGFCLEGEEKILVYEFVPN  425 (571)
Q Consensus       353 LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~  425 (571)
                      ||+|+||+||+++.. +++.||+|++.+..   ......+..|..++...   +||||+++++.+...+..++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999964 58899999986532   12233445566666655   699999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCccc
Q 008292          426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN  505 (571)
Q Consensus       426 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  505 (571)
                      |+|..++.   +...+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~l~---~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~  152 (330)
T cd05586          81 GELFWHLQ---KEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KT  152 (330)
T ss_pred             ChHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CC
Confidence            99988884   3456899999999999999999999987   9999999999999999999999999987532221  12


Q ss_pred             cccccccCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          506 TSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       506 ~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .....||+.|+|||.+.+. .++.++||||||+++|||+||+.||..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~  199 (330)
T cd05586         153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYA  199 (330)
T ss_pred             ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCC
Confidence            2345789999999998765 489999999999999999999999753

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=2.8e-32  Score=272.87  Aligned_cols=199  Identities=32%  Similarity=0.488  Sum_probs=169.5

Q ss_pred             CCCccccccccCceeEEEEEcc-CCCeeEEEeecccC--ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       346 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      +|++.+.||+|++|.||+|+.. ++..|++|+++...  ....+.+.+|+.+++.++||||+++++++.+++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4778899999999999999964 68899999986532  33356788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT  502 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  502 (571)
                      ++ ++|.+++........+++..+..++.|+++||.|||+.+   ++|+||+|+||+++.++.+||+|||++........
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  156 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR  156 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence            97 678887754444567899999999999999999999887   99999999999999999999999999976543221


Q ss_pred             ccccccccccCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          503 QGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       503 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                        ......+++.|+|||.+.+. .++.++||||||+++|||+||+.|+.
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~  203 (285)
T cd07861         157 --VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFH  203 (285)
T ss_pred             --cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCC
Confidence              12223568899999988654 57899999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-32  Score=277.56  Aligned_cols=204  Identities=30%  Similarity=0.463  Sum_probs=168.5

Q ss_pred             hCCCCccccccccCceeEEEEEccC---------------CCeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccc
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLPS---------------GQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLL  407 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~~---------------g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~  407 (571)
                      .++|++.++||+|+||.||++....               ...||+|.++... ....+.+.+|++++.+++|+||++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            4578899999999999999987532               2248999987542 33456789999999999999999999


Q ss_pred             eeEEeCCeeEEEEEecCCCChhhhhcCCC---------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCE
Q 008292          408 GFCLEGEEKILVYEFVPNKSLDYFLYDPE---------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNI  478 (571)
Q Consensus       408 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NI  478 (571)
                      +++...+..++||||+++++|.+++....         ....+++..+++++.|++.||.|||+.+   ++|+||||+||
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni  160 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC  160 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence            99999999999999999999999885321         1124688999999999999999999987   99999999999


Q ss_pred             EECCCCceEEeeccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh--CCCCCC
Q 008292          479 LLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT--GKKNSN  550 (571)
Q Consensus       479 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt--G~~p~~  550 (571)
                      ++++++.+||+|||++..+.............++..|+|||.+..+.++.++||||||+++|||++  |..|+.
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~  234 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYS  234 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCc
Confidence            999999999999999976533222222223345778999999998999999999999999999998  455654

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2.2e-32  Score=275.38  Aligned_cols=198  Identities=28%  Similarity=0.506  Sum_probs=175.3

Q ss_pred             CCCCccccccccCceeEEEEEc-cCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEec
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV  423 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  423 (571)
                      .+|+..+.||.|++|.||++.. .+++.|++|.+........+.+.+|+.+++.++||||+++++++..++..++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            4688899999999999999985 578899999987665556678899999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCc
Q 008292          424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ  503 (571)
Q Consensus       424 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  503 (571)
                      ++++|..++.    ...+++.++..++.|++.||+|||+.+   ++||||+|+||+++.++.+||+|||++........ 
T Consensus        99 ~~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-  170 (296)
T cd06655          99 AGGSLTDVVT----ETCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-  170 (296)
T ss_pred             CCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc-
Confidence            9999999883    345899999999999999999999987   99999999999999999999999999886543322 


Q ss_pred             cccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          504 GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       504 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                       ......++..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~  217 (296)
T cd06655         171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN  217 (296)
T ss_pred             -cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence             12234688899999999988999999999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.3e-32  Score=271.92  Aligned_cols=200  Identities=32%  Similarity=0.516  Sum_probs=169.5

Q ss_pred             hCCCCccccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEec
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV  423 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  423 (571)
                      .++|++.++||+|+||.||+|+..+...|++|+++... ...+++.+|+.+++.++||||+++++.+. ....++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM   82 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence            45688999999999999999998777789999987533 34567899999999999999999999874 45678999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCc
Q 008292          424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ  503 (571)
Q Consensus       424 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  503 (571)
                      ++++|.+++... ....+++..+..++.|+++||+|||+.+   ++||||||+||++++++.+||+|||+++.+......
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~  158 (262)
T cd05071          83 SKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  158 (262)
T ss_pred             CCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence            999999998532 2346789999999999999999999887   999999999999999999999999999866433221


Q ss_pred             cccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 008292          504 GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSN  550 (571)
Q Consensus       504 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~  550 (571)
                       ......++..|+|||++.+..++.++||||||+++|||+| |+.|+.
T Consensus       159 -~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~  205 (262)
T cd05071         159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP  205 (262)
T ss_pred             -cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCC
Confidence             1122346678999999998999999999999999999999 777775

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=2.3e-32  Score=274.44  Aligned_cols=196  Identities=32%  Similarity=0.423  Sum_probs=173.1

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC---ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY  420 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  420 (571)
                      ++|.+.+.||+|+||.||++... +++.|++|.+....   ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            46888899999999999999964 58899999986532   234567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCC
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD  500 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  500 (571)
                      ||+++++|.+++.   +...+++..+..++.|+++||.|||+.+   ++|+||+|+||+++.++.+||+|||+++.....
T Consensus        81 e~~~~~~L~~~~~---~~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  154 (290)
T cd05580          81 EYVPGGELFSHLR---KSGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR  154 (290)
T ss_pred             ecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence            9999999999884   3457899999999999999999999987   999999999999999999999999999865432


Q ss_pred             CCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                           .....+++.|+|||.+.+...+.++||||||+++|||++|+.|+..
T Consensus       155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  200 (290)
T cd05580         155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFD  200 (290)
T ss_pred             -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence                 2334688999999999888899999999999999999999999854

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=9.8e-33  Score=279.06  Aligned_cols=206  Identities=29%  Similarity=0.452  Sum_probs=172.3

Q ss_pred             HHhCCCCccccccccCceeEEEEEc--------cCCCeeEEEeecccC-ccCHHHHHHHHHHHhhc-CCCceeccceeEE
Q 008292          342 VATNKFSTDNKLGEGGFGEVYKGVL--------PSGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKL-QHRNLVRLLGFCL  411 (571)
Q Consensus       342 ~~~~~~~~~~~LG~G~fg~Vy~~~~--------~~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~  411 (571)
                      +..++|.+.+.||+|+||.||+++.        .++..|++|.++... .....++.+|+.++..+ +||||+++++++.
T Consensus        12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   91 (304)
T cd05101          12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT   91 (304)
T ss_pred             ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence            4456788899999999999999973        124578999887542 34456789999999999 8999999999999


Q ss_pred             eCCeeEEEEEecCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCE
Q 008292          412 EGEEKILVYEFVPNKSLDYFLYDPE-------------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNI  478 (571)
Q Consensus       412 ~~~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NI  478 (571)
                      .....+++|||+++++|.+++....             ....+++.+++.++.||++||.|||+++   |+||||||+||
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni  168 (304)
T cd05101          92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNV  168 (304)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceE
Confidence            9999999999999999999986422             1235788999999999999999999987   99999999999


Q ss_pred             EECCCCceEEeeccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 008292          479 LLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSN  550 (571)
Q Consensus       479 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~  550 (571)
                      ++++++.+||+|||+++.+.............+++.|+|||++.+..++.++||||||+++|||++ |..|+.
T Consensus       169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~  241 (304)
T cd05101         169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP  241 (304)
T ss_pred             EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcc
Confidence            999999999999999987643332222333345678999999998899999999999999999999 777764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.5e-32  Score=271.09  Aligned_cols=202  Identities=33%  Similarity=0.515  Sum_probs=170.9

Q ss_pred             HhCCCCccccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       343 ~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      ..++|++.++||+|+||.||++..+++..+++|.++.... ..+.+.+|+.++++++|+|++++++++. ....+++|||
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~   81 (260)
T cd05070           4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY   81 (260)
T ss_pred             chHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence            3457888999999999999999988888899999875433 3567899999999999999999999875 4567899999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT  502 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  502 (571)
                      +++++|.+++... ....+++..++.++.|++.||.|||+++   ++||||||+||++++++.+||+|||++..+.....
T Consensus        82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05070          82 MSKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY  157 (260)
T ss_pred             cCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence            9999999998542 2345899999999999999999999987   99999999999999999999999999986543221


Q ss_pred             ccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          503 QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       503 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                      .. .....++..|+|||.+....++.++||||||+++|||++ |+.||..
T Consensus       158 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~  206 (260)
T cd05070         158 TA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPG  206 (260)
T ss_pred             cc-ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCC
Confidence            11 112235668999999988899999999999999999999 8888743

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=3.6e-32  Score=267.44  Aligned_cols=199  Identities=28%  Similarity=0.452  Sum_probs=175.1

Q ss_pred             hCCCCccccccccCceeEEEEEccC-CCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      .++|+..+.||+|+||.||++...+ ++.+++|.++....  .+++.+|++++++++|+||+++++.+......++++||
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~   79 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY   79 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence            3678899999999999999999764 78899999875533  67899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT  502 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  502 (571)
                      +++++|.+++..  ....+++..+..++.|+++||.|||+.+   ++|+||+|+||+++.++.+||+|||++........
T Consensus        80 ~~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (256)
T cd06612          80 CGAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA  154 (256)
T ss_pred             CCCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence            999999999843  3457899999999999999999999887   99999999999999999999999999986543221


Q ss_pred             ccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          503 QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       503 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                        ......++..|+|||.+.+..++.++||||||+++|||++|+.|+..
T Consensus       155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~  201 (256)
T cd06612         155 --KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSD  201 (256)
T ss_pred             --ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence              22234578899999999988999999999999999999999999753

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=6.4e-33  Score=278.76  Aligned_cols=208  Identities=30%  Similarity=0.456  Sum_probs=173.4

Q ss_pred             HHHHhCCCCccccccccCceeEEEEEcc------CCCeeEEEeecccC-ccCHHHHHHHHHHHhhc-CCCceeccceeEE
Q 008292          340 IEVATNKFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKL-QHRNLVRLLGFCL  411 (571)
Q Consensus       340 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~  411 (571)
                      ++...++|+..+.||+|+||.||++...      ....+++|.+.... .....++.+|+.++.++ +|+||+++++++.
T Consensus         7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   86 (293)
T cd05053           7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT   86 (293)
T ss_pred             cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence            3445567888999999999999999863      23578999887542 33345688999999999 8999999999999


Q ss_pred             eCCeeEEEEEecCCCChhhhhcCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCE
Q 008292          412 EGEEKILVYEFVPNKSLDYFLYDP-------------EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNI  478 (571)
Q Consensus       412 ~~~~~~lv~e~~~~g~L~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NI  478 (571)
                      .+...+++|||+++|+|..++...             .....+++..++.++.|++.||.|||+.+   |+||||||+||
T Consensus        87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Ni  163 (293)
T cd05053          87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNV  163 (293)
T ss_pred             CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeE
Confidence            999999999999999999988532             23456899999999999999999999887   99999999999


Q ss_pred             EECCCCceEEeeccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 008292          479 LLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSN  550 (571)
Q Consensus       479 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~  550 (571)
                      ++++++.+||+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |..|+.
T Consensus       164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~  236 (293)
T cd05053         164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP  236 (293)
T ss_pred             EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCC
Confidence            999999999999999986643322222222345678999999998999999999999999999998 888864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=2.4e-32  Score=275.29  Aligned_cols=199  Identities=28%  Similarity=0.485  Sum_probs=175.7

Q ss_pred             hCCCCccccccccCceeEEEEEc-cCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      ..+|.+.+.||+|+||.||+++. .+++.|++|.+........+.+.+|+.+++.++|+||+++++++..++..++||||
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   97 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   97 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence            36788999999999999999995 57899999999766655667788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT  502 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  502 (571)
                      +++++|.+++.    ...+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++........
T Consensus        98 ~~~~~L~~~~~----~~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~  170 (297)
T cd06656          98 LAGGSLTDVVT----ETCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (297)
T ss_pred             cCCCCHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence            99999999883    345789999999999999999999887   99999999999999999999999999876543221


Q ss_pred             ccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          503 QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       503 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                        ......+++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~  217 (297)
T cd06656         171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN  217 (297)
T ss_pred             --CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence              12234678899999999998999999999999999999999999853

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-34  Score=259.72  Aligned_cols=199  Identities=27%  Similarity=0.414  Sum_probs=171.0

Q ss_pred             hCCCCccccccccCceeEEEEEc-cCCCeeEEEeecc--cCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSK--ASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY  420 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  420 (571)
                      ++.|++-+.||+|.|+.|++... ++|+.+++|++..  -+....+++.+|+.+-+.++||||+++.+...+....+||+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            46778889999999999999874 5789999998753  34457789999999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCC---CceEEeeccCcccc
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE---MNPKISDFGMARIF  497 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DfGla~~~  497 (571)
                      |+|.|++|..-+-   +..-+++..+-..++||+++|.|.|.++   |||||+||+|+++-+.   --+||+|||++..+
T Consensus        90 e~m~G~dl~~eIV---~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l  163 (355)
T KOG0033|consen   90 DLVTGGELFEDIV---AREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  163 (355)
T ss_pred             ecccchHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence            9999999954331   2244677788899999999999999988   9999999999999543   45999999999987


Q ss_pred             CCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          498 GVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      +   ........+|||.|||||++...+|+..+|||+-||+||-|+.|..||..
T Consensus       164 ~---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~  214 (355)
T KOG0033|consen  164 N---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD  214 (355)
T ss_pred             C---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC
Confidence            6   22233456899999999999999999999999999999999999999863

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.9e-32  Score=284.22  Aligned_cols=196  Identities=29%  Similarity=0.387  Sum_probs=166.1

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC--ccCHHHHHHHHHHHhhcCCCceeccceeEEeC------C
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG------E  414 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~------~  414 (571)
                      .++|...+.||+|+||.||++... .++.||||++....  ......+.+|+.+++.++||||+++++++...      .
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            468999999999999999999854 57889999987532  33456778999999999999999999987643      3


Q ss_pred             eeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCc
Q 008292          415 EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA  494 (571)
Q Consensus       415 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla  494 (571)
                      ..++||||+++ +|...+.     ..+++..+..++.|+++||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       103 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a  173 (364)
T cd07875         103 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  173 (364)
T ss_pred             eEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCc
Confidence            46999999975 5655552     24788999999999999999999987   999999999999999999999999999


Q ss_pred             cccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          495 RIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      +......   ......++..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       174 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~  227 (364)
T cd07875         174 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG  227 (364)
T ss_pred             cccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCC
Confidence            8653221   12334689999999999999999999999999999999999999853

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2.7e-32  Score=269.97  Aligned_cols=200  Identities=34%  Similarity=0.522  Sum_probs=171.7

Q ss_pred             CCCccccccccCceeEEEEEccCCCeeEEEeecccC------ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEE
Q 008292          346 KFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKAS------GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV  419 (571)
Q Consensus       346 ~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~------~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  419 (571)
                      +|...+.||+|+||+||+|...+++.+|+|.++...      ....+.+.+|++++++++|+||+++++++.+.+..+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            467889999999999999998889999999886432      12235688999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCC
Q 008292          420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV  499 (571)
Q Consensus       420 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  499 (571)
                      +||+++++|.+++.   +...+++..+..++.|++.||+|||+.+   |+|+||+|+||++++++.+||+|||++.....
T Consensus        81 ~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          81 MEFVPGGSISSILN---RFGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             EecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence            99999999999984   3346889999999999999999999887   99999999999999999999999999876532


Q ss_pred             CCC----ccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          500 DQT----QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       500 ~~~----~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ...    ........++..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~  210 (265)
T cd06631         155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLAS  210 (265)
T ss_pred             ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCcccc
Confidence            111    1112234578899999999988999999999999999999999999853

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3e-32  Score=272.94  Aligned_cols=201  Identities=25%  Similarity=0.414  Sum_probs=170.7

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeeccc-CccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA-SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      ++|++.+.||+|+||.||++... ++..|++|.++.. .......+.+|+.++++++|+||+++++.+...+..++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            36788899999999999999975 6889999988653 333356788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT  502 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  502 (571)
                      +++++|..++........+++..+..++.|+++||.|||+..  +|+|+||||+||+++.++.+||+|||++..+...  
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--  156 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS--  156 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence            999999998854333457899999999999999999999642  3999999999999999999999999998765322  


Q ss_pred             ccccccccccCCcccccccccC------CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          503 QGNTSRIVGTYGYMAPEYAMHG------QFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       503 ~~~~~~~~gt~~y~aPE~~~~~------~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                        ......+++.|+|||.+.+.      .++.++||||||+++|||++|+.||..
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~  209 (286)
T cd06622         157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPP  209 (286)
T ss_pred             --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCC
Confidence              12234578899999988544      358899999999999999999999853

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.7e-32  Score=303.65  Aligned_cols=207  Identities=27%  Similarity=0.441  Sum_probs=169.9

Q ss_pred             HHHhCCCCccccccccCceeEEEEEcc-CCCeeEEEeeccc--CccCHHHHHHHHHHHhhcCCCceeccceeEEeC--Ce
Q 008292          341 EVATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG--EE  415 (571)
Q Consensus       341 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~  415 (571)
                      +...++|.+.++||+|+||+||++... .+..|++|.+...  .......+..|+.++..++||||+++++++...  ..
T Consensus         9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~   88 (1021)
T PTZ00266          9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK   88 (1021)
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence            344578999999999999999999964 5678899988643  233456788999999999999999999988654  46


Q ss_pred             eEEEEEecCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCC----CCeEEecCCCCCEEECCC-------
Q 008292          416 KILVYEFVPNKSLDYFLYDP-EKQGQLDWSRRYKIIGGIARGILYLHEDSR----LRIIHRDLKASNILLDAE-------  483 (571)
Q Consensus       416 ~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~----~~ivH~Dlkp~NIll~~~-------  483 (571)
                      .+|||||+++++|..+|... .....+++..++.|+.||+.||.|||+.+.    .+||||||||+||||+.+       
T Consensus        89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i  168 (1021)
T PTZ00266         89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI  168 (1021)
T ss_pred             EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence            89999999999999988542 223579999999999999999999998531    349999999999999642       


Q ss_pred             ----------CceEEeeccCccccCCCCCccccccccccCCccccccccc--CCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          484 ----------MNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMH--GQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       484 ----------~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                                ..+||+|||++..+....   ......||+.|+|||++.+  ..++.++|||||||+||||+||+.||.
T Consensus       169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~  244 (1021)
T PTZ00266        169 TAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH  244 (1021)
T ss_pred             cccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence                      348999999998654322   1234578999999999864  458899999999999999999999985

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2.7e-32  Score=274.84  Aligned_cols=195  Identities=31%  Similarity=0.483  Sum_probs=170.5

Q ss_pred             CCccccccccCceeEEEEEcc-CCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEecCC
Q 008292          347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPN  425 (571)
Q Consensus       347 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  425 (571)
                      |+...+||+|+||.||++... +++.|++|.+........+.+.+|+.++..++||||+++++.+..++..++++||+++
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~  102 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG  102 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence            334457999999999999864 6889999998765555567888999999999999999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCccc
Q 008292          426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN  505 (571)
Q Consensus       426 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  505 (571)
                      ++|..++.    ...+++..++.++.|++.||.|||+.+   ++||||+|+||+++.++.+||+|||++..+.....  .
T Consensus       103 ~~L~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~  173 (297)
T cd06659         103 GALTDIVS----QTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--K  173 (297)
T ss_pred             CCHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc--c
Confidence            99998773    346899999999999999999999887   99999999999999999999999999876543221  1


Q ss_pred             cccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       506 ~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      .....++..|+|||.+.+..++.++||||||+++|||++|+.|+.
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~  218 (297)
T cd06659         174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYF  218 (297)
T ss_pred             ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            223568899999999998899999999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=2.2e-32  Score=269.87  Aligned_cols=202  Identities=35%  Similarity=0.542  Sum_probs=172.9

Q ss_pred             HHhCCCCccccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEE
Q 008292          342 VATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE  421 (571)
Q Consensus       342 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e  421 (571)
                      +..++|++.++||+|+||.||++..++++.|++|.+.... ...+++.+|+.++++++|+||+++++++. .+..+++||
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e   80 (260)
T cd05067           3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE   80 (260)
T ss_pred             cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence            4457788999999999999999998889999999987543 34568899999999999999999999864 456899999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCC
Q 008292          422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ  501 (571)
Q Consensus       422 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  501 (571)
                      |+++++|.+++... ....+++.+++.++.|++.||+|||+.+   ++||||||+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05067          81 YMENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNE  156 (260)
T ss_pred             cCCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence            99999999988542 3457899999999999999999999887   9999999999999999999999999997654222


Q ss_pred             CccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 008292          502 TQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSN  550 (571)
Q Consensus       502 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~  550 (571)
                      .. ......++..|+|||.+....++.++||||||+++|||++ |+.||.
T Consensus       157 ~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~  205 (260)
T cd05067         157 YT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYP  205 (260)
T ss_pred             cc-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCC
Confidence            11 1122345678999999998899999999999999999999 999985

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=2.6e-32  Score=270.83  Aligned_cols=201  Identities=30%  Similarity=0.540  Sum_probs=168.7

Q ss_pred             CCCCccccccccCceeEEEEEccC-C---CeeEEEeeccc-CccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLPS-G---QEIAVKRLSKA-SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV  419 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~~-g---~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  419 (571)
                      ..|++.+.||+|+||.||+|.... +   ..|++|.++.. .....++|.+|+.+++.++||||+++++++.++...++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            347788999999999999999643 3   35999998754 334457899999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCC
Q 008292          420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV  499 (571)
Q Consensus       420 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  499 (571)
                      |||+++++|.+++..  ....+++.+++.++.|++.||.|||+++   ++|+||||+||++++++.+||+|||+++....
T Consensus        84 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  158 (269)
T cd05065          84 TEFMENGALDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED  158 (269)
T ss_pred             EecCCCCcHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence            999999999999853  2456899999999999999999999887   99999999999999999999999999876543


Q ss_pred             CCCccccc-ccc--ccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 008292          500 DQTQGNTS-RIV--GTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSN  550 (571)
Q Consensus       500 ~~~~~~~~-~~~--gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~  550 (571)
                      ........ ...  .+..|+|||.+....++.++||||||+++|||++ |+.|+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~  213 (269)
T cd05065         159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW  213 (269)
T ss_pred             CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCC
Confidence            22211111 111  2457999999999999999999999999999987 999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.4e-32  Score=281.13  Aligned_cols=196  Identities=28%  Similarity=0.419  Sum_probs=166.6

Q ss_pred             HhCCCCccccccccCceeEEEEEc-cCCCeeEEEeecccC--ccCHHHHHHHHHHHhhcCCCceeccceeEEeC------
Q 008292          343 ATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG------  413 (571)
Q Consensus       343 ~~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~------  413 (571)
                      ..++|...+.||+|+||+||++.. .+++.||||++....  ....+.+.+|+.+++.++||||+++++++...      
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF   92 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence            357899999999999999999985 467889999987532  23345677899999999999999999987643      


Q ss_pred             CeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccC
Q 008292          414 EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM  493 (571)
Q Consensus       414 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl  493 (571)
                      ...++++|++ +++|..++.    ...+++..+..++.||++||.|||+++   |+||||||+|||++.++.+||+|||+
T Consensus        93 ~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~  164 (343)
T cd07878          93 NEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGL  164 (343)
T ss_pred             CcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCcc
Confidence            3468999987 788888772    356899999999999999999999987   99999999999999999999999999


Q ss_pred             ccccCCCCCccccccccccCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          494 ARIFGVDQTQGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       494 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ++.....     .....|++.|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus       165 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  218 (343)
T cd07878         165 ARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPG  218 (343)
T ss_pred             ceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence            9865322     223468999999999876 5789999999999999999999999853

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.5e-32  Score=270.70  Aligned_cols=198  Identities=35%  Similarity=0.553  Sum_probs=171.9

Q ss_pred             CCccccccccCceeEEEEEcc-CCCeeEEEeecccCccCHH--HHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEec
Q 008292          347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAE--EFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV  423 (571)
Q Consensus       347 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~--~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  423 (571)
                      |+..+.||+|+||+||+++.. +++.+|+|++.........  ...+|+.++++++||||+++++++.+....+++|||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            467789999999999999965 4568999999876543332  3456999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCc
Q 008292          424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ  503 (571)
Q Consensus       424 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  503 (571)
                      ++++|.+++.   +...+++..++.++.|+++||.+||+.+   ++|+||||+||+++.++.++|+|||.+....  ...
T Consensus        81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~  152 (260)
T PF00069_consen   81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLS--ENN  152 (260)
T ss_dssp             TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEEST--STT
T ss_pred             cccccccccc---cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc--ccc
Confidence            9999999994   4567899999999999999999999987   9999999999999999999999999997541  122


Q ss_pred             cccccccccCCcccccccc-cCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 008292          504 GNTSRIVGTYGYMAPEYAM-HGQFSVKSDVYSFGVLVLEIITGKKNSNFY  552 (571)
Q Consensus       504 ~~~~~~~gt~~y~aPE~~~-~~~~s~~~Dv~slGvvl~elltG~~p~~~~  552 (571)
                      .......++..|+|||.+. +...+.++||||+|+++|+|++|+.|+...
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~  202 (260)
T PF00069_consen  153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES  202 (260)
T ss_dssp             SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            2334457889999999998 889999999999999999999999998754

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-33  Score=273.31  Aligned_cols=205  Identities=31%  Similarity=0.426  Sum_probs=178.5

Q ss_pred             HHhCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC---ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeE
Q 008292          342 VATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI  417 (571)
Q Consensus       342 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  417 (571)
                      +..+.|+.-+.||+|+||.|+-++.+ +|+.+|.|++.+..   .+......+|-.+|.+++.+.||.+--.+...+..+
T Consensus       182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC  261 (591)
T KOG0986|consen  182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC  261 (591)
T ss_pred             ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence            34566888899999999999999854 68999999886432   233445678999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCcccc
Q 008292          418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF  497 (571)
Q Consensus       418 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  497 (571)
                      +|+..|.||+|.-+|++. .+..++++++..++.+|+-||++||+..   ||.|||||+|||||+.|+++|+|+|||..+
T Consensus       262 lVLtlMNGGDLkfHiyn~-g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei  337 (591)
T KOG0986|consen  262 LVLTLMNGGDLKFHIYNH-GNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEI  337 (591)
T ss_pred             EEEEeecCCceeEEeecc-CCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEec
Confidence            999999999999998754 3357999999999999999999999887   999999999999999999999999999987


Q ss_pred             CCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 008292          498 GVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQ  553 (571)
Q Consensus       498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~~~  553 (571)
                      ......   ...+||.+|||||++.++.|+...|+|||||++|||+.|+.||..+.
T Consensus       338 ~~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~K  390 (591)
T KOG0986|consen  338 PEGKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRK  390 (591)
T ss_pred             CCCCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhh
Confidence            543332   22389999999999999999999999999999999999999997543

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.2e-32  Score=294.85  Aligned_cols=200  Identities=25%  Similarity=0.355  Sum_probs=162.8

Q ss_pred             HHHHhCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccCccCHHHHHHHHHHHhhcCCC------ceeccceeEEe
Q 008292          340 IEVATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHR------NLVRLLGFCLE  412 (571)
Q Consensus       340 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~------niv~l~~~~~~  412 (571)
                      ++...++|++.++||+|+||+||++... .++.||||+++... ....++..|+.++.+++|.      +++++++++..
T Consensus       124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~  202 (467)
T PTZ00284        124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN  202 (467)
T ss_pred             cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence            3445688999999999999999999864 57889999986432 2334556777777777554      58888888876


Q ss_pred             C-CeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCCeEEecCCCCCEEECCCC------
Q 008292          413 G-EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED-SRLRIIHRDLKASNILLDAEM------  484 (571)
Q Consensus       413 ~-~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivH~Dlkp~NIll~~~~------  484 (571)
                      . ...++|||++ +++|.+++.   +...+++..+..++.||+.||.|||++ +   ||||||||+|||++.++      
T Consensus       203 ~~~~~~iv~~~~-g~~l~~~l~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~  275 (467)
T PTZ00284        203 ETGHMCIVMPKY-GPCLLDWIM---KHGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPV  275 (467)
T ss_pred             CCceEEEEEecc-CCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccc
Confidence            4 4678999988 667777773   345789999999999999999999974 5   99999999999998765      


Q ss_pred             ----------ceEEeeccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 008292          485 ----------NPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFY  552 (571)
Q Consensus       485 ----------~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~~  552 (571)
                                .+||+|||++....     ......+||+.|+|||++.+..++.++|||||||++|||+||+.||+..
T Consensus       276 ~~~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~  348 (467)
T PTZ00284        276 TNRALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH  348 (467)
T ss_pred             cccccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence                      49999999876422     1223467999999999999999999999999999999999999998753

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-32  Score=269.18  Aligned_cols=203  Identities=35%  Similarity=0.561  Sum_probs=174.7

Q ss_pred             HHhCCCCccccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEE
Q 008292          342 VATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE  421 (571)
Q Consensus       342 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e  421 (571)
                      +..++|.+.++||+|+||.||++..++++.|+||.+.... ...+++.+|+.++++++|+||+++++++......+++||
T Consensus         3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   81 (261)
T cd05034           3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE   81 (261)
T ss_pred             cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence            4457889999999999999999998888889999987543 345788999999999999999999999998889999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCC
Q 008292          422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ  501 (571)
Q Consensus       422 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  501 (571)
                      |+++++|.+++... ....+++..+..++.|++.||.|||+++   ++|+||||+||++++++.+||+|||++..+....
T Consensus        82 ~~~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (261)
T cd05034          82 YMSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDE  157 (261)
T ss_pred             ccCCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchh
Confidence            99999999998542 2346899999999999999999999987   9999999999999999999999999988664321


Q ss_pred             CccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 008292          502 TQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSN  550 (571)
Q Consensus       502 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~  550 (571)
                      .. ......++..|+|||.+.+..++.++||||||+++|||+| |+.|+.
T Consensus       158 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~  206 (261)
T cd05034         158 YT-AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYP  206 (261)
T ss_pred             hh-hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCC
Confidence            11 1112234568999999998899999999999999999999 888874

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=3.6e-32  Score=269.63  Aligned_cols=205  Identities=29%  Similarity=0.411  Sum_probs=171.7

Q ss_pred             HHHhCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEE
Q 008292          341 EVATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV  419 (571)
Q Consensus       341 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  419 (571)
                      +.+++++.....||+|+||.||+|... ++..|++|.+........+.+.+|+.+++.++|+||+++++++..++..+++
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   83 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF   83 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence            345566777789999999999999954 5778999998776666677899999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECC-CCceEEeeccCccccC
Q 008292          420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-EMNPKISDFGMARIFG  498 (571)
Q Consensus       420 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGla~~~~  498 (571)
                      +||+++++|..++.........++..+..++.||++||.|||+.+   |+||||||+||+++. ++.+||+|||++....
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~  160 (268)
T cd06624          84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA  160 (268)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence            999999999999854222212378889999999999999999887   999999999999976 6799999999987653


Q ss_pred             CCCCccccccccccCCcccccccccCC--CCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          499 VDQTQGNTSRIVGTYGYMAPEYAMHGQ--FSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      ....  ......+++.|+|||.+....  ++.++||||||+++|||++|+.|+.
T Consensus       161 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~  212 (268)
T cd06624         161 GINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFI  212 (268)
T ss_pred             cCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCc
Confidence            2211  122345788999999986543  7899999999999999999999975

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=3.6e-32  Score=267.81  Aligned_cols=198  Identities=39%  Similarity=0.562  Sum_probs=171.5

Q ss_pred             ccccccCceeEEEEEccC----CCeeEEEeecccCccC-HHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEecCC
Q 008292          351 NKLGEGGFGEVYKGVLPS----GQEIAVKRLSKASGQG-AEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPN  425 (571)
Q Consensus       351 ~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~~~-~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  425 (571)
                      +.||+|+||.||++....    +..|++|.++...... .+.+.+|++++..++|+||+++++++......+++|||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            479999999999999754    7789999997654433 67889999999999999999999999999999999999999


Q ss_pred             CChhhhhcCCCC------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCC
Q 008292          426 KSLDYFLYDPEK------QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV  499 (571)
Q Consensus       426 g~L~~~l~~~~~------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  499 (571)
                      ++|.+++.....      ...+++..++.++.|+++||+|||+++   ++|+||+|+||++++++.+||+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence            999999864321      367899999999999999999999987   99999999999999999999999999987654


Q ss_pred             CCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          500 DQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                      ...........++..|+|||.+....++.++||||||+++|||++ |+.|+..
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~  210 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPG  210 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCC
Confidence            332222334567889999999988899999999999999999999 5888754

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=4.3e-32  Score=268.81  Aligned_cols=200  Identities=33%  Similarity=0.561  Sum_probs=170.9

Q ss_pred             CCCccccccccCceeEEEEEcc-CCCeeEEEeecccCcc---------CHHHHHHHHHHHhhcCCCceeccceeEEeCCe
Q 008292          346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQ---------GAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEE  415 (571)
Q Consensus       346 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~---------~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~  415 (571)
                      +|.+.+.||+|++|.||+|... +++.+++|.+......         ..+.+.+|+.++++++||||+++++++.+.+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            4677889999999999999864 5788999988654322         12568899999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCcc
Q 008292          416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR  495 (571)
Q Consensus       416 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  495 (571)
                      .++++||+++++|..++.   ....+++..+..++.|++.||+|||+.+   ++||||+|+||++++++.+||+|||+++
T Consensus        81 ~~lv~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~  154 (267)
T cd06628          81 LNIFLEYVPGGSVAALLN---NYGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK  154 (267)
T ss_pred             cEEEEEecCCCCHHHHHH---hccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence            999999999999999984   3356889999999999999999999887   9999999999999999999999999998


Q ss_pred             ccCCCCCcc----ccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          496 IFGVDQTQG----NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       496 ~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .........    ......|+..|+|||.+.+..++.++||||||+++|||++|+.||+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~  214 (267)
T cd06628         155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPD  214 (267)
T ss_pred             ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCC
Confidence            764221111    11234578899999999998999999999999999999999999853

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=3.4e-32  Score=269.40  Aligned_cols=201  Identities=28%  Similarity=0.428  Sum_probs=169.0

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC-----ccCHHHHHHHHHHHhhcCCCceeccceeEEeC--Cee
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS-----GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG--EEK  416 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~  416 (571)
                      .+|++.+.||+|+||.||++... +++.|++|.+....     ....+.+.+|+.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            47888999999999999999964 58899999875322     12345788899999999999999999988764  457


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccc
Q 008292          417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI  496 (571)
Q Consensus       417 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  496 (571)
                      +++|||+++++|.+++.   +...+++...++++.|++.+|.|||+.+   ++|+||+|+||++++++.+||+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~  155 (265)
T cd06652          82 SIFMEHMPGGSIKDQLK---SYGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR  155 (265)
T ss_pred             EEEEEecCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence            89999999999999884   2345788999999999999999999887   99999999999999999999999999876


Q ss_pred             cCCCCC-ccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          497 FGVDQT-QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       497 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ...... ........++..|+|||.+.+..++.++||||||+++|||++|+.|+..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~  211 (265)
T cd06652         156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAE  211 (265)
T ss_pred             cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCc
Confidence            532111 1112234588899999999888899999999999999999999999853

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=5.5e-32  Score=266.28  Aligned_cols=200  Identities=25%  Similarity=0.401  Sum_probs=173.6

Q ss_pred             CCCccccccccCceeEEEEEc-cCCCeeEEEeeccc--CccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          346 KFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       346 ~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      +|+..+.||+|+||.||.++. .+++.+++|.+...  +.....++.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            478889999999999998884 46888999987653  344556788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT  502 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  502 (571)
                      +++++|.+++... ....+++..+..++.|++++|.|||+.+   ++|+||+|+||+++.++.+||+|||++........
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~  156 (256)
T cd08221          81 ANGGTLYDKIVRQ-KGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS  156 (256)
T ss_pred             cCCCcHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence            9999999998532 2456899999999999999999999887   99999999999999999999999999986543321


Q ss_pred             ccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          503 QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       503 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                        ......+++.|+|||.+.+..++.++||||||+++|||++|+.|++.
T Consensus       157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~  203 (256)
T cd08221         157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDA  203 (256)
T ss_pred             --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCC
Confidence              22334688999999999888899999999999999999999999754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.8e-32  Score=278.49  Aligned_cols=206  Identities=30%  Similarity=0.454  Sum_probs=170.1

Q ss_pred             HHhCCCCccccccccCceeEEEEEcc--------CCCeeEEEeecccC-ccCHHHHHHHHHHHhhc-CCCceeccceeEE
Q 008292          342 VATNKFSTDNKLGEGGFGEVYKGVLP--------SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKL-QHRNLVRLLGFCL  411 (571)
Q Consensus       342 ~~~~~~~~~~~LG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~  411 (571)
                      ...++|.+.++||+|+||.||+++..        ....+++|.++... .....++.+|+.+++++ +||||+++++++.
T Consensus         9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (314)
T cd05099           9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT   88 (314)
T ss_pred             ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence            34467888999999999999999742        24568999887543 33456788999999999 6999999999999


Q ss_pred             eCCeeEEEEEecCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCE
Q 008292          412 EGEEKILVYEFVPNKSLDYFLYDPE-------------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNI  478 (571)
Q Consensus       412 ~~~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NI  478 (571)
                      .....+++|||+++|+|.+++....             ....+++.++.+++.|++.||.|||+++   ++||||||+||
T Consensus        89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Ni  165 (314)
T cd05099          89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNV  165 (314)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeE
Confidence            9889999999999999999985422             1245899999999999999999999887   99999999999


Q ss_pred             EECCCCceEEeeccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 008292          479 LLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSN  550 (571)
Q Consensus       479 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~  550 (571)
                      |+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus       166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~  238 (314)
T cd05099         166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYP  238 (314)
T ss_pred             EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCC
Confidence            999999999999999986543222111222234567999999999999999999999999999999 888764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=2.9e-32  Score=274.33  Aligned_cols=204  Identities=32%  Similarity=0.466  Sum_probs=171.8

Q ss_pred             hCCCCccccccccCceeEEEEEccC-----------------CCeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceec
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLPS-----------------GQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVR  405 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~~-----------------g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~  405 (571)
                      .++|++.++||+|+||.||+++..+                 +..|++|.+.... ....+++.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            4578899999999999999988542                 2458999887543 334568899999999999999999


Q ss_pred             cceeEEeCCeeEEEEEecCCCChhhhhcCCC--------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCC
Q 008292          406 LLGFCLEGEEKILVYEFVPNKSLDYFLYDPE--------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASN  477 (571)
Q Consensus       406 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~N  477 (571)
                      +++++..++..++++||+++++|.+++....        ....+++..++.++.|++.||.|||+.+   |+||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence            9999999999999999999999999985422        1236899999999999999999999887   9999999999


Q ss_pred             EEECCCCceEEeeccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh--CCCCCC
Q 008292          478 ILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT--GKKNSN  550 (571)
Q Consensus       478 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt--G~~p~~  550 (571)
                      |+++.++.++|+|||+++...............++..|+|||.+....++.++||||||+++|||++  |..|+.
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~  235 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYE  235 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCC
Confidence            9999999999999999986543332222334456789999999988899999999999999999998  556654

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=2e-32  Score=276.52  Aligned_cols=206  Identities=30%  Similarity=0.459  Sum_probs=172.4

Q ss_pred             HHHhCCCCccccccccCceeEEEEEc------cCCCeeEEEeecccC-ccCHHHHHHHHHHHhhc-CCCceeccceeEEe
Q 008292          341 EVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLE  412 (571)
Q Consensus       341 ~~~~~~~~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~  412 (571)
                      ....++|...+.||+|+||.||++..      ..+..||+|+++... ....+.+.+|+.+++++ +||||+++++++..
T Consensus        31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  110 (302)
T cd05055          31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI  110 (302)
T ss_pred             cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence            34456788999999999999999974      134579999887543 33356789999999999 79999999999999


Q ss_pred             CCeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeecc
Q 008292          413 GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG  492 (571)
Q Consensus       413 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG  492 (571)
                      .+..+++|||+++|+|.+++... ....+++.++..++.|++.||.|||+++   |+|+||||+|||++.++.+||+|||
T Consensus       111 ~~~~~lv~e~~~~~~L~~~i~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg  186 (302)
T cd05055         111 GGPILVITEYCCYGDLLNFLRRK-RESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFG  186 (302)
T ss_pred             CCceEEEEEcCCCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCc
Confidence            99999999999999999998532 2234899999999999999999999887   9999999999999999999999999


Q ss_pred             CccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 008292          493 MARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSN  550 (571)
Q Consensus       493 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~  550 (571)
                      +++.+.............++..|+|||.+.+..++.++||||||+++|||+| |+.|+.
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~  245 (302)
T cd05055         187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYP  245 (302)
T ss_pred             ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcC
Confidence            9986543222111222345678999999999999999999999999999998 888864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2.2e-32  Score=271.61  Aligned_cols=201  Identities=30%  Similarity=0.489  Sum_probs=169.9

Q ss_pred             HhCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccCccCHHHHHHHHHHHhhc-CCCceeccceeEEeC------C
Q 008292          343 ATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEG------E  414 (571)
Q Consensus       343 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~------~  414 (571)
                      +++.|+..+.||+|+||.||+|... +++.|++|++.... ....++.+|+.++.++ +|+||+++++++...      .
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD   82 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence            4567888899999999999999864 57889999986543 4456788999999998 699999999998763      3


Q ss_pred             eeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCc
Q 008292          415 EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA  494 (571)
Q Consensus       415 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla  494 (571)
                      ..+++|||+++++|.+++... ....+++..+..++.|++.||+|||+++   |+|+||+|+||++++++.+||+|||++
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~  158 (272)
T cd06637          83 QLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS  158 (272)
T ss_pred             EEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCc
Confidence            578999999999999988542 3456899999999999999999999987   999999999999999999999999999


Q ss_pred             cccCCCCCccccccccccCCcccccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          495 RIFGVDQTQGNTSRIVGTYGYMAPEYAM-----HGQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      .......  .......|+..|+|||++.     +..++.++||||||+++|||++|+.|+.
T Consensus       159 ~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~  217 (272)
T cd06637         159 AQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC  217 (272)
T ss_pred             eeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence            8653221  2223456889999999986     3468889999999999999999999985

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-32  Score=270.18  Aligned_cols=197  Identities=29%  Similarity=0.486  Sum_probs=173.7

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      ++|+..+.||.|++|.||+++.. +++.|++|.+.... ......+.+|+.+++.++|+||+++++++.++...++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            36788899999999999999964 68899999987543 34456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT  502 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  502 (571)
                      +++++|.+++..    ..+++..+..++.|++.+|.|||+.+   ++|+||+|+||++++++.++|+|||+++.+.... 
T Consensus        81 ~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-  152 (274)
T cd06609          81 CGGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-  152 (274)
T ss_pred             eCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc-
Confidence            999999999842    37899999999999999999999887   9999999999999999999999999998765332 


Q ss_pred             ccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          503 QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       503 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                       .......++..|+|||.+.+..++.++||||||+++|||+||+.|++
T Consensus       153 -~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~  199 (274)
T cd06609         153 -SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLS  199 (274)
T ss_pred             -cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence             12233467889999999998889999999999999999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.7e-32  Score=283.52  Aligned_cols=197  Identities=28%  Similarity=0.380  Sum_probs=166.3

Q ss_pred             HhCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC--ccCHHHHHHHHHHHhhcCCCceeccceeEEeCC-----
Q 008292          343 ATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE-----  414 (571)
Q Consensus       343 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-----  414 (571)
                      ..++|...+.||+|+||.||++... .++.||+|++....  ....+.+.+|+.+++.++||||+++++++....     
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            3568999999999999999999854 58889999987542  233467788999999999999999999886543     


Q ss_pred             -eeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccC
Q 008292          415 -EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM  493 (571)
Q Consensus       415 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl  493 (571)
                       ..++||||+++ +|...+.     ..+++..+..++.|+++||.|||+++   |+||||||+|||++.++.+||+|||+
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~  165 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence             46899999976 4555552     24788999999999999999999987   99999999999999999999999999


Q ss_pred             ccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          494 ARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       494 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ++......   ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       166 ~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  220 (355)
T cd07874         166 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG  220 (355)
T ss_pred             cccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            98653221   12334689999999999999999999999999999999999999863

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-32  Score=267.90  Aligned_cols=201  Identities=26%  Similarity=0.436  Sum_probs=175.5

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      .++|+..+.||+|+||.||++... +++.+++|.+........+.+.+|+.++++++||||+++++.+.++...+++|||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            357888999999999999999964 5778999999876666678899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT  502 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  502 (571)
                      +++++|.+++..  ....+++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.+||+|||++..+.... 
T Consensus        82 ~~~~~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-  155 (262)
T cd06613          82 CGGGSLQDIYQV--TRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-  155 (262)
T ss_pred             CCCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh-
Confidence            999999998843  2356899999999999999999999887   9999999999999999999999999987654221 


Q ss_pred             ccccccccccCCcccccccccC---CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          503 QGNTSRIVGTYGYMAPEYAMHG---QFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       503 ~~~~~~~~gt~~y~aPE~~~~~---~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                       .......++..|+|||.+...   .++.++||||||+++|||+||+.|+..
T Consensus       156 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~  206 (262)
T cd06613         156 -AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFD  206 (262)
T ss_pred             -hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCC
Confidence             112234678899999998776   889999999999999999999999753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=2.7e-32  Score=274.74  Aligned_cols=204  Identities=30%  Similarity=0.476  Sum_probs=169.7

Q ss_pred             hCCCCccccccccCceeEEEEEcc-----------------CCCeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceec
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-----------------SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVR  405 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-----------------~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~  405 (571)
                      .++|++.++||+|+||.||++...                 ++..||+|+++... .....++.+|+.++++++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            357899999999999999998532                 23468999987543 334568899999999999999999


Q ss_pred             cceeEEeCCeeEEEEEecCCCChhhhhcCCC--------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCC
Q 008292          406 LLGFCLEGEEKILVYEFVPNKSLDYFLYDPE--------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASN  477 (571)
Q Consensus       406 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~N  477 (571)
                      +++++..++..+++|||+++++|.+++....        ....+++..++.++.|++.||+|||+.+   ++|+||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N  160 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence            9999999999999999999999999885422        1234778899999999999999999987   9999999999


Q ss_pred             EEECCCCceEEeeccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh--CCCCCC
Q 008292          478 ILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT--GKKNSN  550 (571)
Q Consensus       478 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt--G~~p~~  550 (571)
                      ||++.++.+||+|||+++.+.............++..|++||....+.++.++||||||+++|||+|  |..|+.
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~  235 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYS  235 (296)
T ss_pred             EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcc
Confidence            9999999999999999986543322222223345678999999888899999999999999999998  666764

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2.4e-32  Score=280.99  Aligned_cols=207  Identities=29%  Similarity=0.427  Sum_probs=168.7

Q ss_pred             HHhCCCCccccccccCceeEEEEEc------cCCCeeEEEeecccC-ccCHHHHHHHHHHHhhc-CCCceeccceeEEeC
Q 008292          342 VATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEG  413 (571)
Q Consensus       342 ~~~~~~~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~  413 (571)
                      ...++|++.+.||+|+||.||++..      .+++.||||+++... ......+.+|+.++.++ +||||+++++++...
T Consensus         4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (343)
T cd05103           4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP   83 (343)
T ss_pred             cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence            3456899999999999999999973      356789999997543 23345688999999999 689999999988654


Q ss_pred             -CeeEEEEEecCCCChhhhhcCCCC-------------------------------------------------------
Q 008292          414 -EEKILVYEFVPNKSLDYFLYDPEK-------------------------------------------------------  437 (571)
Q Consensus       414 -~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------  437 (571)
                       ...+++|||+++|+|.+++.....                                                       
T Consensus        84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (343)
T cd05103          84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE  163 (343)
T ss_pred             CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence             457899999999999988753210                                                       


Q ss_pred             ---------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCcccccc
Q 008292          438 ---------QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR  508 (571)
Q Consensus       438 ---------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  508 (571)
                               ...+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++.............
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  240 (343)
T cd05103         164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD  240 (343)
T ss_pred             hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence                     124688889999999999999999987   99999999999999999999999999986533222112222


Q ss_pred             ccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          509 IVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       509 ~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                      ..++..|+|||.+.+..++.++||||||+++|||++ |..|+..
T Consensus       241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~  284 (343)
T cd05103         241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  284 (343)
T ss_pred             CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence            345678999999999999999999999999999997 8888753

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4e-32  Score=271.70  Aligned_cols=200  Identities=32%  Similarity=0.528  Sum_probs=168.3

Q ss_pred             CCCCccccccccCceeEEEEEc-----cCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeC--CeeE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVL-----PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG--EEKI  417 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~  417 (571)
                      +.|++.+.||+|+||.||++..     .+++.|++|++........+.+.+|+++++.++||||+++++++...  ...+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            5688899999999999999974     35788999999876666677899999999999999999999987543  4678


Q ss_pred             EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCcccc
Q 008292          418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF  497 (571)
Q Consensus       418 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  497 (571)
                      +|+||+++++|.+++..  ....+++..++.++.|+++||.|||+++   |+||||||+||++++++.+||+|||+++.+
T Consensus        84 lv~e~~~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~  158 (284)
T cd05081          84 LVMEYLPYGSLRDYLQK--HRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL  158 (284)
T ss_pred             EEEEecCCCCHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence            99999999999999853  2346899999999999999999999987   999999999999999999999999999866


Q ss_pred             CCCCCccc-cccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCC
Q 008292          498 GVDQTQGN-TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNS  549 (571)
Q Consensus       498 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~  549 (571)
                      ........ .....++..|+|||.+.+..++.++||||||+++|||++|..++
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~  211 (284)
T cd05081         159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKS  211 (284)
T ss_pred             cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcC
Confidence            43221111 11122345699999999889999999999999999999987664

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.1e-32  Score=271.85  Aligned_cols=202  Identities=32%  Similarity=0.546  Sum_probs=169.8

Q ss_pred             hCCCCccccccccCceeEEEEEccC-CC----eeEEEeecccCc-cCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLPS-GQ----EIAVKRLSKASG-QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI  417 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~~-g~----~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  417 (571)
                      ..+|++.+.||+|+||.||+|..++ |.    .+++|.+..... ...+++.+|+.++++++||||+++++++.. ...+
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   84 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ   84 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence            3567888999999999999998642 33    588898876543 345678899999999999999999999987 7889


Q ss_pred             EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCcccc
Q 008292          418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF  497 (571)
Q Consensus       418 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  497 (571)
                      +|+||+++|+|.+++..  ....+++..++.++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+++.+
T Consensus        85 ~v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~  159 (279)
T cd05057          85 LITQLMPLGCLLDYVRN--HKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (279)
T ss_pred             EEEecCCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccc
Confidence            99999999999999853  2345899999999999999999999876   999999999999999999999999999876


Q ss_pred             CCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          498 GVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                      .............++..|+|||.+....++.++||||||+++|||++ |+.|++.
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~  214 (279)
T cd05057         160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEG  214 (279)
T ss_pred             cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCC
Confidence            53322222222234678999999988899999999999999999999 9999864

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=3e-32  Score=269.89  Aligned_cols=201  Identities=24%  Similarity=0.442  Sum_probs=173.2

Q ss_pred             CCCCccccccccCceeEEEEEc-cCCCeeEEEeecccC---ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY  420 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  420 (571)
                      ++|++.+.||+|++|.||++.. .+++.++||.+....   ....+++.+|+.+++.++|+||+++++++..++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4678889999999999999995 578999999876532   233467889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCC
Q 008292          421 EFVPNKSLDYFLYDP-EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV  499 (571)
Q Consensus       421 e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  499 (571)
                      ||+++++|.+++... .....+++..++.++.||++||.|||+++   ++|+||+|+||+++.++.++|+|||++..+..
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            999999999988532 23456899999999999999999999887   99999999999999999999999999876543


Q ss_pred             CCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          500 DQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      ...  ......++..|+|||.+.+..++.++||||||+++|||++|+.|+.
T Consensus       159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~  207 (267)
T cd08229         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY  207 (267)
T ss_pred             CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcc
Confidence            221  1223468889999999998899999999999999999999999974

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.8e-32  Score=271.74  Aligned_cols=197  Identities=32%  Similarity=0.476  Sum_probs=165.6

Q ss_pred             CCccccccccCceeEEEEEc-----cCCCeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeEEeC--CeeEE
Q 008292          347 FSTDNKLGEGGFGEVYKGVL-----PSGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG--EEKIL  418 (571)
Q Consensus       347 ~~~~~~LG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~l  418 (571)
                      |+..+.||+|+||+||++..     .++..||+|.++... ....+.+.+|++++++++||||+++++++...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            47889999999999988652     357789999987543 23456788999999999999999999988654  35789


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccC
Q 008292          419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG  498 (571)
Q Consensus       419 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  498 (571)
                      +|||+++++|.+++.    ...+++..++.++.|+++||.|||+++   |+||||||+|||+++++.+||+|||+++.+.
T Consensus        86 v~e~~~~~~l~~~~~----~~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  158 (283)
T cd05080          86 IMEYVPLGSLRDYLP----KHKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  158 (283)
T ss_pred             EecCCCCCCHHHHHH----HcCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence            999999999999984    245899999999999999999999987   9999999999999999999999999998654


Q ss_pred             CCCCccc-cccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          499 VDQTQGN-TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       499 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      ....... .....++..|+|||.+.+..++.++||||||+++|||+||..|+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~  211 (283)
T cd05080         159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQ  211 (283)
T ss_pred             CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCC
Confidence            3221111 112235667999999998899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=3.9e-32  Score=273.75  Aligned_cols=201  Identities=31%  Similarity=0.486  Sum_probs=166.3

Q ss_pred             CCCCccccccccCceeEEEEEccC-CC--eeEEEeeccc-CccCHHHHHHHHHHHhhc-CCCceeccceeEEeCCeeEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLPS-GQ--EIAVKRLSKA-SGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILV  419 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~~-g~--~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv  419 (571)
                      ++|++.+.||+|+||.||+|...+ +.  .+++|.++.. .....+.+.+|+.++.++ +||||+++++++......+++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            578889999999999999998643 33  4688887643 333456788999999999 799999999999999999999


Q ss_pred             EEecCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCce
Q 008292          420 YEFVPNKSLDYFLYDPE-------------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP  486 (571)
Q Consensus       420 ~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~  486 (571)
                      +||+++++|.+++....             ....+++..++.++.|++.||+|||+++   |+||||||+|||+++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence            99999999999985321             1235889999999999999999999887   9999999999999999999


Q ss_pred             EEeeccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          487 KISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       487 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                      ||+|||++.......   .......+..|+|||++....++.++||||||+++|||+| |+.||..
T Consensus       159 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~  221 (297)
T cd05089         159 KIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCG  221 (297)
T ss_pred             EECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence            999999986432111   1111223557999999998899999999999999999998 9999753

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-32  Score=272.84  Aligned_cols=201  Identities=26%  Similarity=0.422  Sum_probs=174.0

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      .++|.+.+.||+|+||.||++... ++..+++|.++.......+.+.+|++++++++|+||+++++.+..+...++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            456888899999999999999964 6889999999776666667899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT  502 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  502 (571)
                      +++++|..++..  ....+++..+..++.|++.||.|||+.+   |+|+||+|+||+++.++.++|+|||++....... 
T Consensus        84 ~~~~~L~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-  157 (280)
T cd06611          84 CDGGALDSIMLE--LERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL-  157 (280)
T ss_pred             cCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc-
Confidence            999999998843  2346899999999999999999999987   9999999999999999999999999987543221 


Q ss_pred             ccccccccccCCcccccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          503 QGNTSRIVGTYGYMAPEYAM-----HGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       503 ~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                       .......+++.|+|||.+.     ...++.++||||||+++|||++|+.|+..
T Consensus       158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~  210 (280)
T cd06611         158 -QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHE  210 (280)
T ss_pred             -cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCccc
Confidence             1223346889999999874     34577899999999999999999999854

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=3.7e-32  Score=272.60  Aligned_cols=204  Identities=29%  Similarity=0.511  Sum_probs=170.9

Q ss_pred             hCCCCccccccccCceeEEEEEcc------CCCeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCee
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEK  416 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  416 (571)
                      .++|+..+.||+|+||.||++..+      ++..|++|+++... .....++.+|+.++++++||||+++++++.+++..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            467889999999999999999853      46789999987543 33456789999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCC
Q 008292          417 ILVYEFVPNKSLDYFLYDPE-------------------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASN  477 (571)
Q Consensus       417 ~lv~e~~~~g~L~~~l~~~~-------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~N  477 (571)
                      ++++||+++++|.+++....                   ....+++..++.++.|++.||.|||+.+   ++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence            99999999999999985321                   1234788999999999999999999887   9999999999


Q ss_pred             EEECCCCceEEeeccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 008292          478 ILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSN  550 (571)
Q Consensus       478 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~  550 (571)
                      |++++++.+||+|||+++.+..............+..|+|||.+.+..++.++||||||+++|||++ |..|+.
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~  234 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYY  234 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999999999876543322222222344678999999998999999999999999999998 877763

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=3.3e-32  Score=271.37  Aligned_cols=196  Identities=29%  Similarity=0.521  Sum_probs=170.0

Q ss_pred             CCCccccccccCceeEEEEEcc-CCCeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEec
Q 008292          346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV  423 (571)
Q Consensus       346 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  423 (571)
                      .|+..+.||+|+||.||+|... +++.||+|.++... ....+.+.+|++++++++||||+++++++..++..++|+||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            4566788999999999999864 57789999887543 344567899999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCc
Q 008292          424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ  503 (571)
Q Consensus       424 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  503 (571)
                      ++++|.+++.    ...+++..+..++.|+++||.|||+++   ++|+||+|+||++++++.+||+|||++..+..... 
T Consensus        85 ~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-  156 (277)
T cd06642          85 GGGSALDLLK----PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-  156 (277)
T ss_pred             CCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch-
Confidence            9999998883    356899999999999999999999887   99999999999999999999999999976543221 


Q ss_pred             cccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          504 GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       504 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                       ......++..|+|||++.+..++.++||||||+++|||+||+.|+.
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~  202 (277)
T cd06642         157 -KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNS  202 (277)
T ss_pred             -hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCc
Confidence             1223457889999999999899999999999999999999999975

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=5.5e-32  Score=273.72  Aligned_cols=200  Identities=23%  Similarity=0.334  Sum_probs=170.0

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC---ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY  420 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  420 (571)
                      ++|+..+.||+|+||.||++... .++.|++|.+....   ....+.+.+|+++++.++||||+++++.+..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            36888999999999999999964 57889999887543   233457889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCC
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD  500 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  500 (571)
                      ||+++++|.+++.   ....+++..+..++.|+++||.|||+.+   ++||||||+||+++.++.+||+|||+++.....
T Consensus        81 e~~~g~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~  154 (305)
T cd05609          81 EYVEGGDCATLLK---NIGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS  154 (305)
T ss_pred             ecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence            9999999999984   3356899999999999999999999887   999999999999999999999999998642111


Q ss_pred             CC-------------ccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          501 QT-------------QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       501 ~~-------------~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      ..             ........++..|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~  217 (305)
T cd05609         155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFF  217 (305)
T ss_pred             ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            00             001112457889999999998899999999999999999999999975

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=3.7e-32  Score=267.67  Aligned_cols=195  Identities=34%  Similarity=0.491  Sum_probs=167.1

Q ss_pred             ccccccCceeEEEEEccC--C--CeeEEEeecccCc-cCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEecCC
Q 008292          351 NKLGEGGFGEVYKGVLPS--G--QEIAVKRLSKASG-QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPN  425 (571)
Q Consensus       351 ~~LG~G~fg~Vy~~~~~~--g--~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  425 (571)
                      ++||+|++|.||++.+.+  +  ..|++|.++.... ...+.+.+|+.++++++||||+++++.+.+ ...++++||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999998643  2  2589999987655 556789999999999999999999999988 888999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCcc-
Q 008292          426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG-  504 (571)
Q Consensus       426 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~-  504 (571)
                      ++|.+++..... ..+++..++.++.|+++||+|||+++   ++|+||+|+||+++.++.+||+|||+++.+....... 
T Consensus        80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence            999999854322 56899999999999999999999887   9999999999999999999999999998764322111 


Q ss_pred             ccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 008292          505 NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSN  550 (571)
Q Consensus       505 ~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~  550 (571)
                      ......++..|+|||++.+..++.++||||||+++|||+| |+.|+.
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~  202 (257)
T cd05040         156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWA  202 (257)
T ss_pred             cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCC
Confidence            1122456788999999999999999999999999999999 999974

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4e-32  Score=267.38  Aligned_cols=197  Identities=33%  Similarity=0.533  Sum_probs=171.8

Q ss_pred             hCCCCccccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEec
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV  423 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  423 (571)
                      .++|++.+.||+|+||.||++.. .|+.|++|.++.... ..+++.+|+.++++++|+||+++++++.+....++||||+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            45788899999999999999997 488999999976544 5678899999999999999999999999989999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCc
Q 008292          424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ  503 (571)
Q Consensus       424 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  503 (571)
                      ++++|.+++... ....+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.+||+|||+++....... 
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-  157 (256)
T cd05039          83 AKGSLVDYLRSR-GRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-  157 (256)
T ss_pred             CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence            999999998532 2236899999999999999999999987   99999999999999999999999999986532211 


Q ss_pred             cccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          504 GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       504 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                          ....+..|+|||.+..+.++.++||||||+++|||++ |+.|+..
T Consensus       158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~  202 (256)
T cd05039         158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR  202 (256)
T ss_pred             ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCC
Confidence                2234568999999998899999999999999999998 8888643

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=8.3e-32  Score=266.26  Aligned_cols=189  Identities=27%  Similarity=0.440  Sum_probs=159.1

Q ss_pred             ccccccCceeEEEEEccC-------------CCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeE
Q 008292          351 NKLGEGGFGEVYKGVLPS-------------GQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI  417 (571)
Q Consensus       351 ~~LG~G~fg~Vy~~~~~~-------------g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  417 (571)
                      +.||+|+||.||+|+...             ...|++|.+..........+.+|+.+++.++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            468999999999998532             2358888877655555668889999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCc-------eEEee
Q 008292          418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN-------PKISD  490 (571)
Q Consensus       418 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~-------~kl~D  490 (571)
                      ++|||+++++|..++..  ....+++..+++++.||++||+|||+.+   |+||||||+|||++.++.       +|++|
T Consensus        81 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d  155 (262)
T cd05077          81 MVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD  155 (262)
T ss_pred             EEEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence            99999999999988843  3456899999999999999999999887   999999999999987664       89999


Q ss_pred             ccCccccCCCCCccccccccccCCcccccccc-cCCCCcchhHHHHHHHHHHHH-hCCCCCC
Q 008292          491 FGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM-HGQFSVKSDVYSFGVLVLEII-TGKKNSN  550 (571)
Q Consensus       491 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~~Dv~slGvvl~ell-tG~~p~~  550 (571)
                      ||++......      ....++..|+|||.+. ...++.++||||||+++|||+ +|+.|+.
T Consensus       156 ~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~  211 (262)
T cd05077         156 PGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLK  211 (262)
T ss_pred             CCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence            9998654211      2235778899999886 467899999999999999998 5777764

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=6.5e-32  Score=270.26  Aligned_cols=200  Identities=31%  Similarity=0.533  Sum_probs=168.2

Q ss_pred             CCCCccccccccCceeEEEEEc-----cCCCeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeEEeC--Cee
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVL-----PSGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG--EEK  416 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~  416 (571)
                      +.|++.++||+|+||.||++++     .++..|++|.++... ....+.+.+|+.+++.++||||+++.+++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            4568889999999999999974     357789999987543 33456789999999999999999999998775  567


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccc
Q 008292          417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI  496 (571)
Q Consensus       417 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  496 (571)
                      ++||||+++++|.+++..  ....+++..++.++.|++.||+|||+++   ++||||||+||+++.++.+||+|||+++.
T Consensus        84 ~lv~e~~~g~~L~~~l~~--~~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPR--NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA  158 (284)
T ss_pred             EEEEEccCCCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence            899999999999999843  2345899999999999999999999987   99999999999999999999999999986


Q ss_pred             cCCCCCc-cccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCC
Q 008292          497 FGVDQTQ-GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNS  549 (571)
Q Consensus       497 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~  549 (571)
                      +...... .......++..|+|||.+.+..++.++||||||+++|||+|++.|.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~  212 (284)
T cd05079         159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSE  212 (284)
T ss_pred             cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCC
Confidence            6432221 1122345677899999999889999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=6.3e-32  Score=270.33  Aligned_cols=198  Identities=28%  Similarity=0.407  Sum_probs=170.0

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC--ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE  421 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e  421 (571)
                      ++|+..+.||+|++|.||+++.+ +++.|++|++....  ....+.+.+|+.+++.++|+||+++++++..+...++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46888899999999999999975 58899999886532  2334567899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCC
Q 008292          422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ  501 (571)
Q Consensus       422 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  501 (571)
                      |+++++|..++.   ....+++..++.++.|+++||.|||+.+   ++||||||+||+++.++.+||+|||++..+....
T Consensus        81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07847          81 YCDHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG  154 (286)
T ss_pred             ccCccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence            999999988763   3346899999999999999999999987   9999999999999999999999999998664322


Q ss_pred             CccccccccccCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          502 TQGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       502 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      .  ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.
T Consensus       155 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~  202 (286)
T cd07847         155 D--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWP  202 (286)
T ss_pred             c--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCC
Confidence            1  1222356788999999876 568899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=6.2e-32  Score=267.68  Aligned_cols=200  Identities=30%  Similarity=0.449  Sum_probs=169.1

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC-----ccCHHHHHHHHHHHhhcCCCceeccceeEEeC--Cee
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS-----GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG--EEK  416 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~  416 (571)
                      .+|...+.||+|+||.||++... ++..|++|+++...     ....+.+.+|+.+++.++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            46888999999999999999864 58899999886432     12345688999999999999999999988753  567


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccc
Q 008292          417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI  496 (571)
Q Consensus       417 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  496 (571)
                      ++++||+++++|.+++.   +...+++...+.++.|++.||+|||+.+   |+||||+|+||+++.++.+||+|||+++.
T Consensus        82 ~l~~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~  155 (266)
T cd06651          82 TIFMEYMPGGSVKDQLK---AYGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (266)
T ss_pred             EEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence            89999999999999884   3345889999999999999999999876   99999999999999999999999999976


Q ss_pred             cCCCCC-ccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          497 FGVDQT-QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       497 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      +..... ........++..|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~  210 (266)
T cd06651         156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWA  210 (266)
T ss_pred             cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCcc
Confidence            532211 111223457889999999999899999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=2.5e-32  Score=274.46  Aligned_cols=196  Identities=29%  Similarity=0.470  Sum_probs=170.6

Q ss_pred             CCccccccccCceeEEEEEcc-CCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEecCC
Q 008292          347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPN  425 (571)
Q Consensus       347 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  425 (571)
                      |.....||+|+||.||++... ++..|++|.+........+.+.+|+.+++.++|+||+++++.+..++..++||||+++
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~  103 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG  103 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence            344567999999999999864 6889999998765555567789999999999999999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCccc
Q 008292          426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN  505 (571)
Q Consensus       426 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  505 (571)
                      ++|.+++.    ...+++..+..++.||+.||.|||+++   |+||||||+||++++++.+||+|||++........  .
T Consensus       104 ~~L~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~  174 (292)
T cd06658         104 GALTDIVT----HTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--K  174 (292)
T ss_pred             CcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--c
Confidence            99999873    345889999999999999999999987   99999999999999999999999999876532221  1


Q ss_pred             cccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       506 ~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .....++..|+|||.+.+..++.++||||||+++|||++|+.|+..
T Consensus       175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~  220 (292)
T cd06658         175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFN  220 (292)
T ss_pred             CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            2234688999999999888999999999999999999999999753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=6.4e-32  Score=264.82  Aligned_cols=194  Identities=32%  Similarity=0.478  Sum_probs=165.9

Q ss_pred             ccccccCceeEEEEEccCCCeeEEEeecccCc-cCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEecCCCChh
Q 008292          351 NKLGEGGFGEVYKGVLPSGQEIAVKRLSKASG-QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLD  429 (571)
Q Consensus       351 ~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  429 (571)
                      +.||+|+||.||+|..+++..+++|.++.... .....+.+|+++++.++||||+++++++......++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            46899999999999988889999999876543 33457889999999999999999999999999999999999999999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCccccccc
Q 008292          430 YFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRI  509 (571)
Q Consensus       430 ~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~  509 (571)
                      +++..  ....+++..++.++.|++.+|.|||+++   ++||||+|+||+++.++.+||+|||++......... .....
T Consensus        81 ~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~  154 (250)
T cd05085          81 SFLRK--KKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLK  154 (250)
T ss_pred             HHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCC
Confidence            98843  2346889999999999999999999887   999999999999999999999999998754322211 11122


Q ss_pred             cccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 008292          510 VGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSN  550 (571)
Q Consensus       510 ~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~  550 (571)
                      .++..|+|||++....++.++||||||+++|||++ |..||.
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~  196 (250)
T cd05085         155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYP  196 (250)
T ss_pred             CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCC
Confidence            34668999999998899999999999999999999 888874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.98  E-value=4.7e-32  Score=271.66  Aligned_cols=197  Identities=30%  Similarity=0.497  Sum_probs=162.4

Q ss_pred             CCCccccccccCceeEEEEEcc-CCCeeEEEeecccC--ccCHHHHHHHHHHHhhc---CCCceeccceeEEeC-----C
Q 008292          346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKL---QHRNLVRLLGFCLEG-----E  414 (571)
Q Consensus       346 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l---~h~niv~l~~~~~~~-----~  414 (571)
                      +|++.+.||+|+||+||++... +++.||+|.++...  ......+.+|+.+++.+   +||||+++++++...     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4778899999999999999865 68899999887532  22234556677777665   799999999988642     3


Q ss_pred             eeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCc
Q 008292          415 EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA  494 (571)
Q Consensus       415 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla  494 (571)
                      ..+++|||+++ +|..++... ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~  155 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA  155 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence            47899999985 787777432 2345899999999999999999999987   999999999999999999999999999


Q ss_pred             cccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          495 RIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      +......   ......++..|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus       156 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~  208 (288)
T cd07863         156 RIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFC  208 (288)
T ss_pred             ccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcC
Confidence            8654222   1223467899999999999999999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.98  E-value=1.1e-31  Score=265.49  Aligned_cols=204  Identities=27%  Similarity=0.455  Sum_probs=176.2

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      ++|++.+.||.|+||+||++... ++..+++|++.... ....+.+.+|+++++.++|+||+++++.+..++..++++|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            46888999999999999999954 67889999986543 33567889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT  502 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  502 (571)
                      +++++|.+++........+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++..+.....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            999999999864333456899999999999999999999887   99999999999999999999999999987654332


Q ss_pred             cc--ccccccccCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          503 QG--NTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       503 ~~--~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ..  ......|+..|+|||++... .++.++||||||+++|||++|+.|+..
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~  209 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSK  209 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccc
Confidence            21  22345688999999998777 789999999999999999999999853

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=1e-33  Score=285.03  Aligned_cols=193  Identities=33%  Similarity=0.472  Sum_probs=166.5

Q ss_pred             CCCccccccccCceeEEEEEc-cCCCeeEEEeeccc---CccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEE
Q 008292          346 KFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE  421 (571)
Q Consensus       346 ~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e  421 (571)
                      .|..++.||.|+||.||.+.. .+.+.||||++.-.   +...+.++..|+..|.+++|||++.+.|++......|||||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            356678999999999999995 46788999999754   33446788999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCC
Q 008292          422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ  501 (571)
Q Consensus       422 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  501 (571)
                      ||-| +-.+++.-  -.+++.+.++..|..+.+.||+|||+++   .||||||+.||||++.|.|||+|||.+....+  
T Consensus       107 YClG-SAsDlleV--hkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P--  178 (948)
T KOG0577|consen  107 YCLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP--  178 (948)
T ss_pred             HHhc-cHHHHHHH--HhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc--
Confidence            9954 44444421  2456889999999999999999999987   99999999999999999999999999976543  


Q ss_pred             CccccccccccCCcccccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          502 TQGNTSRIVGTYGYMAPEYAM---HGQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       502 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                          ...++|||.|||||+|+   .++|+-|+||||||++..||.-.++|.-
T Consensus       179 ----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlF  226 (948)
T KOG0577|consen  179 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF  226 (948)
T ss_pred             ----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCcc
Confidence                23568999999999985   5789999999999999999999999853

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.98  E-value=8.5e-32  Score=265.22  Aligned_cols=188  Identities=28%  Similarity=0.487  Sum_probs=158.6

Q ss_pred             ccccccCceeEEEEEccCCC-----------eeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEE
Q 008292          351 NKLGEGGFGEVYKGVLPSGQ-----------EIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV  419 (571)
Q Consensus       351 ~~LG~G~fg~Vy~~~~~~g~-----------~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  419 (571)
                      +.||+|+||.||+|...+..           .+++|.+...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            46999999999999975433           4777877654333 6788999999999999999999999988 778999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCC-------ceEEeecc
Q 008292          420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM-------NPKISDFG  492 (571)
Q Consensus       420 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-------~~kl~DfG  492 (571)
                      |||+++|+|.+++...  ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++       .+||+|||
T Consensus        79 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          79 EEYVKFGPLDVFLHRE--KNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             EEcCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence            9999999999998532  226899999999999999999999887   99999999999999887       79999999


Q ss_pred             CccccCCCCCccccccccccCCcccccccccC--CCCcchhHHHHHHHHHHHHhC-CCCCCC
Q 008292          493 MARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG--QFSVKSDVYSFGVLVLEIITG-KKNSNF  551 (571)
Q Consensus       493 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~~Dv~slGvvl~elltG-~~p~~~  551 (571)
                      ++.....      .....++..|+|||++...  .++.++||||||+++|||++| ..|+..
T Consensus       154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~  209 (259)
T cd05037         154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLST  209 (259)
T ss_pred             ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCccc
Confidence            9986532      1223466789999998776  789999999999999999994 666643

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.98  E-value=7.8e-32  Score=274.04  Aligned_cols=197  Identities=27%  Similarity=0.433  Sum_probs=158.7

Q ss_pred             cccccccCceeEEEEEcc---CCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEe--CCeeEEEEEecC
Q 008292          350 DNKLGEGGFGEVYKGVLP---SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE--GEEKILVYEFVP  424 (571)
Q Consensus       350 ~~~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~  424 (571)
                      ..+||+|+||+||+++..   ++..||+|.++...  ....+.+|+.++++++||||+++++++..  +...++|+||++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            358999999999999964   35689999886543  23467889999999999999999998854  456789999987


Q ss_pred             CCChhhhhcCC------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEE----CCCCceEEeeccCc
Q 008292          425 NKSLDYFLYDP------EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL----DAEMNPKISDFGMA  494 (571)
Q Consensus       425 ~g~L~~~l~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DfGla  494 (571)
                      + +|.+++...      .....+++..+..++.||+.||.|||+.+   |+||||||+|||+    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            5 565554211      12335889999999999999999999987   9999999999999    56678999999999


Q ss_pred             cccCCCCCc-cccccccccCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 008292          495 RIFGVDQTQ-GNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNFY  552 (571)
Q Consensus       495 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slGvvl~elltG~~p~~~~  552 (571)
                      +.+...... .......+|+.|+|||.+.+ ..++.++||||||+++|||+||+.||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            876433221 12234568999999999876 45899999999999999999999998643

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.98  E-value=6.1e-32  Score=265.97  Aligned_cols=197  Identities=34%  Similarity=0.510  Sum_probs=171.5

Q ss_pred             CCCccccccccCceeEEEEEcc-CCCeeEEEeecccC-----ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEE
Q 008292          346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS-----GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV  419 (571)
Q Consensus       346 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  419 (571)
                      +|+..+.||+|++|.||+|... +++.|++|.+....     .+..+.+.+|+.+++.++|+||+++++++..+...+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4677889999999999999976 78999999886533     23456788999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCC
Q 008292          420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV  499 (571)
Q Consensus       420 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  499 (571)
                      +||+++++|.+++.   +...+++..+..++.|+++||.|||+.+   ++|+||+|+||+++.++.+||+|||++.....
T Consensus        81 ~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632          81 LELVPGGSLAKLLK---KYGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             EEecCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            99999999999984   3346889999999999999999999887   99999999999999999999999999876533


Q ss_pred             CCCccccccccccCCcccccccccCC-CCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          500 DQTQGNTSRIVGTYGYMAPEYAMHGQ-FSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       500 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ..   ......++..|++||.+.... ++.++|+||||+++|||++|+.||..
T Consensus       155 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~  204 (258)
T cd06632         155 FS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQ  204 (258)
T ss_pred             cc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCccc
Confidence            22   123346888999999987776 89999999999999999999999853

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.98  E-value=3.5e-32  Score=274.93  Aligned_cols=202  Identities=33%  Similarity=0.565  Sum_probs=167.1

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CCC----eeEEEeecccCc-cCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQ----EIAVKRLSKASG-QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI  417 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~----~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  417 (571)
                      .++|+..+.||+|+||.||++++. ++.    .|++|.+..... ....++.+|+.+++.++||||+++++++... ...
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~   84 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ   84 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence            356788899999999999999863 344    468888765432 2344788999999999999999999998754 467


Q ss_pred             EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCcccc
Q 008292          418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF  497 (571)
Q Consensus       418 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  497 (571)
                      +++||+++|+|.+++..  ....+++..++.++.|++.||.|||+++   |+|+||||+||+++.++.+||+|||+++.+
T Consensus        85 ~v~e~~~~g~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~  159 (303)
T cd05110          85 LVTQLMPHGCLLDYVHE--HKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (303)
T ss_pred             eeehhcCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccc
Confidence            89999999999998843  2346889999999999999999999887   999999999999999999999999999876


Q ss_pred             CCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          498 GVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                      .............++..|+|||.+.+..++.++||||||+++|||++ |+.|+..
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~  214 (303)
T cd05110         160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG  214 (303)
T ss_pred             cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            43322222223345778999999998999999999999999999998 8888753

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.98  E-value=5.4e-32  Score=270.82  Aligned_cols=198  Identities=30%  Similarity=0.425  Sum_probs=172.2

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      ++|++.++||+|+||+||++... +++.|++|++.... ....+.+.+|+++++.++||||+++++.+......++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            56778899999999999999964 58889999876543 34457889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT  502 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  502 (571)
                      +++++|..++.   +.+.+++..+..++.+++.+|.|||+..  +++||||+|+||+++.++.++|+|||++......  
T Consensus        85 ~~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~--  157 (284)
T cd06620          85 MDCGSLDRIYK---KGGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS--  157 (284)
T ss_pred             CCCCCHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh--
Confidence            99999998884   3456899999999999999999999732  3999999999999999999999999998754221  


Q ss_pred             ccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          503 QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       503 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                        ......|+..|+|||++.+..++.++||||||+++|||+||+.||..
T Consensus       158 --~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~  204 (284)
T cd06620         158 --IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAF  204 (284)
T ss_pred             --ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcc
Confidence              12235689999999999888999999999999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.98  E-value=1.1e-31  Score=265.15  Aligned_cols=200  Identities=28%  Similarity=0.407  Sum_probs=176.3

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeecccCc-cCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASG-QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      ++|++.+.||+|++|.||+++.. +++.|++|++..... ...+.+.+|+..+.+++|+||+++++++......++|+||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            36788899999999999999976 489999999876544 4467899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE-DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ  501 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  501 (571)
                      +++++|.+++..   ...+++..++.++.|++++|.|||+ .+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~  154 (264)
T cd06623          81 MDGGSLADLLKK---VGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL  154 (264)
T ss_pred             cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence            999999999843   3678999999999999999999998 76   9999999999999999999999999998664332


Q ss_pred             CccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 008292          502 TQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFY  552 (571)
Q Consensus       502 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~~  552 (571)
                      ..  .....++..|+|||.+.+..++.++||||||+++|||+||+.|+...
T Consensus       155 ~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~  203 (264)
T cd06623         155 DQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPP  203 (264)
T ss_pred             Cc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence            22  12346788999999999999999999999999999999999998654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.98  E-value=3.3e-32  Score=275.10  Aligned_cols=201  Identities=32%  Similarity=0.490  Sum_probs=166.9

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CCC--eeEEEeeccc-CccCHHHHHHHHHHHhhc-CCCceeccceeEEeCCeeEE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQ--EIAVKRLSKA-SGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKIL  418 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~--~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~l  418 (571)
                      .++|++.+.||+|+||.||++.++ ++.  .+++|.++.. .......+.+|++++.++ +|+||+++++++..++..++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            357888899999999999999964 344  4577777643 233456788999999999 89999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCc
Q 008292          419 VYEFVPNKSLDYFLYDPE-------------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN  485 (571)
Q Consensus       419 v~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~  485 (571)
                      ||||+++++|.+++....             ....+++.+++.++.|+++||+|||+++   ++||||||+|||++.++.
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~  162 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV  162 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence            999999999999985421             1235889999999999999999999887   999999999999999999


Q ss_pred             eEEeeccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 008292          486 PKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSN  550 (571)
Q Consensus       486 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~  550 (571)
                      +||+|||+++.....   .......++..|+|||.+....++.++||||||+++|||+| |+.||.
T Consensus       163 ~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~  225 (303)
T cd05088         163 AKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC  225 (303)
T ss_pred             EEeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcc
Confidence            999999998642111   11111234668999999988889999999999999999998 999874

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.98  E-value=3.3e-32  Score=269.88  Aligned_cols=202  Identities=30%  Similarity=0.565  Sum_probs=170.1

Q ss_pred             hCCCCccccccccCceeEEEEEccC-C---CeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLPS-G---QEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL  418 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~~-g---~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  418 (571)
                      .++|+..+.||+|+||.||+|.... +   ..+++|.++... ....+++.+|++++++++|+||+++.+++...+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            4567888999999999999999642 3   368999887543 3345678999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccC
Q 008292          419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG  498 (571)
Q Consensus       419 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  498 (571)
                      ||||+++++|..++..  ....+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||++....
T Consensus        84 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  158 (268)
T cd05063          84 ITEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE  158 (268)
T ss_pred             EEEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence            9999999999999853  3356899999999999999999999887   9999999999999999999999999997654


Q ss_pred             CCCCccc-cccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 008292          499 VDQTQGN-TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSN  550 (571)
Q Consensus       499 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~  550 (571)
                      ....... ......+..|+|||++....++.++||||||+++|||++ |+.|+.
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~  212 (268)
T cd05063         159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYW  212 (268)
T ss_pred             cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCC
Confidence            3221111 111223567999999998899999999999999999998 999974

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.98  E-value=5.5e-32  Score=266.21  Aligned_cols=200  Identities=26%  Similarity=0.365  Sum_probs=172.8

Q ss_pred             CCCccccccccCceeEEEEEcc-CCCeeEEEeeccc-CccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEec
Q 008292          346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA-SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV  423 (571)
Q Consensus       346 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  423 (571)
                      +|++.++||+|+||.||+++.. +++.+++|.++.. .....+.+.+|+.+++.++|+||+++++.+.+++..+++|||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4678899999999999999964 6888999988643 3344567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCc
Q 008292          424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ  503 (571)
Q Consensus       424 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  503 (571)
                      ++++|.+++.. .....+++..++.++.|++.||.|||+++   |+|+||||+||++++++.++|+|||++..+..... 
T Consensus        81 ~~~~l~~~~~~-~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-  155 (255)
T cd08219          81 DGGDLMQKIKL-QRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-  155 (255)
T ss_pred             CCCcHHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence            99999888743 23456789999999999999999999987   99999999999999999999999999976543221 


Q ss_pred             cccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          504 GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       504 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                       ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||..
T Consensus       156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~  202 (255)
T cd08219         156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQA  202 (255)
T ss_pred             -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCC
Confidence             12234688899999999988999999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=99.98  E-value=7.7e-33  Score=255.29  Aligned_cols=198  Identities=30%  Similarity=0.477  Sum_probs=169.9

Q ss_pred             HhCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC----ccC----HHHHHHHHHHHhhc-CCCceeccceeEEe
Q 008292          343 ATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS----GQG----AEEFKNEVVLVAKL-QHRNLVRLLGFCLE  412 (571)
Q Consensus       343 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~----~~~----~~~~~~Ei~~l~~l-~h~niv~l~~~~~~  412 (571)
                      .-++|...+.||.|..++|-+...+ .|...|+|++....    ...    .+.-..|+.+|+++ .||+|+++.+++..
T Consensus        15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes   94 (411)
T KOG0599|consen   15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES   94 (411)
T ss_pred             HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence            3457888899999999999988864 67889999885321    111    23455799999987 59999999999999


Q ss_pred             CCeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeecc
Q 008292          413 GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG  492 (571)
Q Consensus       413 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG  492 (571)
                      ....++|+|.|+.|.|.++|.   ..-.+++++..+|+.|+.+|++|||.++   ||||||||+|||+|++.++||+|||
T Consensus        95 ~sF~FlVFdl~prGELFDyLt---s~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFG  168 (411)
T KOG0599|consen   95 DAFVFLVFDLMPRGELFDYLT---SKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFG  168 (411)
T ss_pred             cchhhhhhhhcccchHHHHhh---hheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccc
Confidence            999999999999999999993   4557899999999999999999999987   9999999999999999999999999


Q ss_pred             CccccCCCCCccccccccccCCcccccccc------cCCCCcchhHHHHHHHHHHHHhCCCCC
Q 008292          493 MARIFGVDQTQGNTSRIVGTYGYMAPEYAM------HGQFSVKSDVYSFGVLVLEIITGKKNS  549 (571)
Q Consensus       493 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~~Dv~slGvvl~elltG~~p~  549 (571)
                      +++.+...   ......||||+|+|||.+.      ...|+..+|+||.||++|-|+.|-.||
T Consensus       169 Fa~~l~~G---ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPF  228 (411)
T KOG0599|consen  169 FACQLEPG---EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPF  228 (411)
T ss_pred             eeeccCCc---hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCch
Confidence            99987533   3345679999999999883      345888999999999999999999996

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.98  E-value=4.6e-32  Score=268.78  Aligned_cols=202  Identities=30%  Similarity=0.512  Sum_probs=169.9

Q ss_pred             CCCCccccccccCceeEEEEEcc----CCCeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP----SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV  419 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  419 (571)
                      .+|++.+.||+|+||.||+|+..    .+..+++|.++... ....+.+.+|+.++..++||||+++++++..++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            56788899999999999999863    23368999886543 23456889999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCC
Q 008292          420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV  499 (571)
Q Consensus       420 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  499 (571)
                      |||+++++|.+++..  ....+++.+++.++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++.+..
T Consensus        84 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd05066          84 TEYMENGSLDAFLRK--HDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED  158 (267)
T ss_pred             EEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence            999999999999853  2346899999999999999999999887   99999999999999999999999999986643


Q ss_pred             CCCcc-ccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          500 DQTQG-NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       500 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                      ..... ......++..|+|||.+.+..++.++||||||+++||+++ |+.||..
T Consensus       159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~  212 (267)
T cd05066         159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWE  212 (267)
T ss_pred             ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCccc
Confidence            22211 1112233568999999998899999999999999999887 9999753

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.98  E-value=1.2e-31  Score=267.42  Aligned_cols=197  Identities=28%  Similarity=0.508  Sum_probs=171.5

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      ..|+..++||+|+||.||+|... ++..|++|.++... ....+.+.+|+.++++++|+||+++++.+.++...++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            35677889999999999999964 57899999887543 34456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT  502 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  502 (571)
                      +++++|.+++.    ...+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++..+.....
T Consensus        84 ~~~~~L~~~i~----~~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06640          84 LGGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             CCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence            99999999883    346889999999999999999999887   99999999999999999999999999976543221


Q ss_pred             ccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          503 QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       503 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                        ......++..|+|||.+.+..++.++||||||+++|||+||+.|+.
T Consensus       157 --~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~  202 (277)
T cd06640         157 --KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNS  202 (277)
T ss_pred             --ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCC
Confidence              1223457889999999998899999999999999999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.98  E-value=7.4e-32  Score=266.21  Aligned_cols=200  Identities=34%  Similarity=0.527  Sum_probs=168.9

Q ss_pred             hCCCCccccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEec
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV  423 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  423 (571)
                      .++|.+.++||+|++|.||++..+.+..+++|.+.... ...+.+.+|+.++++++|+|++++++++. .+..+++|||+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05069           5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM   82 (260)
T ss_pred             hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence            35688889999999999999998777789999876543 34567889999999999999999998875 45678999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCc
Q 008292          424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ  503 (571)
Q Consensus       424 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  503 (571)
                      ++++|.+++... ....+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.+||+|||+++........
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05069          83 GKGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence            999999998542 2345899999999999999999999887   999999999999999999999999999765432211


Q ss_pred             cccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 008292          504 GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSN  550 (571)
Q Consensus       504 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~  550 (571)
                       ......++..|+|||.+.+..++.++||||||+++|||+| |+.|+.
T Consensus       159 -~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~  205 (260)
T cd05069         159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYP  205 (260)
T ss_pred             -ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCC
Confidence             1112345678999999998999999999999999999999 888874

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.98  E-value=9e-32  Score=263.94  Aligned_cols=195  Identities=33%  Similarity=0.509  Sum_probs=166.4

Q ss_pred             ccccccCceeEEEEEccCCCeeEEEeecccCcc-CHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEecCCCChh
Q 008292          351 NKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQ-GAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLD  429 (571)
Q Consensus       351 ~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  429 (571)
                      ++||+|+||.||++...+++.|++|+++..... ..+.+.+|++++++++|+||+++++++.+....++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            479999999999999877999999998765433 4568899999999999999999999999999999999999999999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCccccccc
Q 008292          430 YFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRI  509 (571)
Q Consensus       430 ~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~  509 (571)
                      +++..  ....+++..++.++.+++.+|.|||+++   ++||||+|+||+++.++.+||+|||+++..............
T Consensus        81 ~~l~~--~~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (251)
T cd05041          81 TFLRK--KKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK  155 (251)
T ss_pred             HHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence            98853  2346789999999999999999999887   999999999999999999999999999765322211111122


Q ss_pred             cccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 008292          510 VGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSN  550 (571)
Q Consensus       510 ~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~  550 (571)
                      .++..|+|||.+.++.++.++||||||+++|||+| |..|+.
T Consensus       156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~  197 (251)
T cd05041         156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYP  197 (251)
T ss_pred             cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCc
Confidence            33567999999988899999999999999999999 777764

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.98  E-value=1.8e-31  Score=275.78  Aligned_cols=193  Identities=24%  Similarity=0.362  Sum_probs=163.8

Q ss_pred             HHhCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEE
Q 008292          342 VATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY  420 (571)
Q Consensus       342 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  420 (571)
                      ....+|++.+.||+|+||.||+++.. +++.||+|.....      ....|+.++++++|+||+++++++..+...++|+
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  136 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL  136 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence            34567999999999999999999965 4678899975432      2356899999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCC
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD  500 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  500 (571)
                      |++. ++|..++..  ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus       137 e~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  210 (357)
T PHA03209        137 PHYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA  210 (357)
T ss_pred             EccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence            9995 577777642  3456899999999999999999999987   999999999999999999999999998743211


Q ss_pred             CCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCC
Q 008292          501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNS  549 (571)
Q Consensus       501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~  549 (571)
                         .......||+.|+|||++.+..++.++||||||+++|||+++..|+
T Consensus       211 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        211 ---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             ---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence               1222356899999999999999999999999999999999976654

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.98  E-value=3.7e-32  Score=278.65  Aligned_cols=208  Identities=29%  Similarity=0.446  Sum_probs=171.2

Q ss_pred             HHHHhCCCCccccccccCceeEEEEEcc--------CCCeeEEEeecccC-ccCHHHHHHHHHHHhhc-CCCceecccee
Q 008292          340 IEVATNKFSTDNKLGEGGFGEVYKGVLP--------SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKL-QHRNLVRLLGF  409 (571)
Q Consensus       340 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~  409 (571)
                      ++....+|.+.+.||+|+||.||++...        .+..|++|.++... ....+++.+|+.++.++ +||||++++++
T Consensus         7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~   86 (334)
T cd05100           7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGA   86 (334)
T ss_pred             cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence            3444567889999999999999999742        12368999887533 33456889999999999 79999999999


Q ss_pred             EEeCCeeEEEEEecCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCC
Q 008292          410 CLEGEEKILVYEFVPNKSLDYFLYDPE-------------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKAS  476 (571)
Q Consensus       410 ~~~~~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~  476 (571)
                      +......++++||+++|+|.+++....             ....+++..++.++.|+++||.|||+++   |+||||||+
T Consensus        87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~  163 (334)
T cd05100          87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAAR  163 (334)
T ss_pred             EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccc
Confidence            999999999999999999999885421             2235888999999999999999999987   999999999


Q ss_pred             CEEECCCCceEEeeccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 008292          477 NILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSN  550 (571)
Q Consensus       477 NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~  550 (571)
                      |||++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.|+.
T Consensus       164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~  238 (334)
T cd05100         164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP  238 (334)
T ss_pred             eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCC
Confidence            99999999999999999986543222222222334567999999999999999999999999999999 777764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.98  E-value=6.7e-32  Score=266.07  Aligned_cols=199  Identities=31%  Similarity=0.398  Sum_probs=174.3

Q ss_pred             CCCccccccccCceeEEEEEcc-CCCeeEEEeecccC---ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEE
Q 008292          346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE  421 (571)
Q Consensus       346 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e  421 (571)
                      +|++.+.||+|+||.||++... +++.|++|.+.+..   ....+.+.+|++++++++||||+++++.+.++...++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4778899999999999999975 58899999987543   2345788999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCC
Q 008292          422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ  501 (571)
Q Consensus       422 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  501 (571)
                      |+++++|.+++..   ...+++..+..++.|+++||.|||+++   ++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  154 (258)
T cd05578          81 LLLGGDLRYHLSQ---KVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT  154 (258)
T ss_pred             CCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence            9999999999843   357899999999999999999999887   9999999999999999999999999987654322


Q ss_pred             CccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 008292          502 TQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQ  553 (571)
Q Consensus       502 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~~~  553 (571)
                         ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.|+....
T Consensus       155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~  203 (258)
T cd05578         155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHS  203 (258)
T ss_pred             ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCC
Confidence               1223467889999999988889999999999999999999999987543

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.98  E-value=1.5e-32  Score=258.50  Aligned_cols=196  Identities=27%  Similarity=0.418  Sum_probs=168.6

Q ss_pred             cccccccCceeEEEEE-ccCCCeeEEEeecccCccCHHHHHHHHHHHhhcC-CCceeccceeEEeCCeeEEEEEecCCCC
Q 008292          350 DNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEKILVYEFVPNKS  427 (571)
Q Consensus       350 ~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~  427 (571)
                      .+.||+|+|+.|-.++ +.+|.++|||++.+.....+.++.+|++++...+ |+||++++++|.+++..|||||-|.||+
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp  162 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP  162 (463)
T ss_pred             HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence            3679999999999888 6789999999999887788889999999998875 9999999999999999999999999999


Q ss_pred             hhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCC---ceEEeeccCccccCCCCC--
Q 008292          428 LDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM---NPKISDFGMARIFGVDQT--  502 (571)
Q Consensus       428 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DfGla~~~~~~~~--  502 (571)
                      |...++   +...+++.++.++..+|+.||.+||.++   |.||||||+|||-.+-.   -+||+||.|..-+.....  
T Consensus       163 lLshI~---~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s  236 (463)
T KOG0607|consen  163 LLSHIQ---KRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS  236 (463)
T ss_pred             HHHHHH---HhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence            988884   5667999999999999999999999998   99999999999986554   379999998764432211  


Q ss_pred             ---ccccccccccCCcccccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          503 ---QGNTSRIVGTYGYMAPEYAM-----HGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       503 ---~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                         .......+|+..|||||+..     ...|..+.|.||||||+|-|++|..||.-
T Consensus       237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG  293 (463)
T KOG0607|consen  237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVG  293 (463)
T ss_pred             CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccC
Confidence               11223468999999999862     23588899999999999999999999853

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=1.3e-32  Score=266.72  Aligned_cols=218  Identities=27%  Similarity=0.359  Sum_probs=181.7

Q ss_pred             HHHhCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccCc---cCHHHHHHHHHHHhhc-CCCceeccceeEEeCCe
Q 008292          341 EVATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASG---QGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEE  415 (571)
Q Consensus       341 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~  415 (571)
                      .+...+|..+..||+|+||.|-.+.-+ +.+.+|||+++++.-   ...+--..|-++|+.. +-|.++++..++..-+.
T Consensus       345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR  424 (683)
T KOG0696|consen  345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR  424 (683)
T ss_pred             ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence            445568889999999999999999864 456799999987532   2233345567777665 56789999999999999


Q ss_pred             eEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCcc
Q 008292          416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR  495 (571)
Q Consensus       416 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  495 (571)
                      +++||||+.||+|-..++   +-+++.+..+..++.+||-||-+||+++   ||.||||..|||||.+|++||+|||+++
T Consensus       425 LyFVMEyvnGGDLMyhiQ---Q~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcK  498 (683)
T KOG0696|consen  425 LYFVMEYVNGGDLMYHIQ---QVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK  498 (683)
T ss_pred             eeeEEEEecCchhhhHHH---HhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccc
Confidence            999999999999987773   5567888999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhcc
Q 008292          496 IFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYVSINVI  569 (571)
Q Consensus       496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~  569 (571)
                      .--  .....+...+||+.|+|||++.-.+|+..+|+|||||+||||+.|+.||+-   ++.++|.+-+-++-.
T Consensus       499 Eni--~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdG---eDE~elF~aI~ehnv  567 (683)
T KOG0696|consen  499 ENI--FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG---EDEDELFQAIMEHNV  567 (683)
T ss_pred             ccc--cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCC---CCHHHHHHHHHHccC
Confidence            532  222345568999999999999999999999999999999999999999874   455667776655533

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.98  E-value=6.8e-32  Score=266.46  Aligned_cols=203  Identities=33%  Similarity=0.528  Sum_probs=172.6

Q ss_pred             HHHhCCCCccccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEE
Q 008292          341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY  420 (571)
Q Consensus       341 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  420 (571)
                      ++..++|++.++||+|+||.||++...++..+++|.++... ...+.+.+|+.+++.++|+||+++.+.+.+ ...+++|
T Consensus         2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~   79 (260)
T cd05073           2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT   79 (260)
T ss_pred             cccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEE
Confidence            34567889999999999999999998778889999886542 345678899999999999999999999877 7789999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCC
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD  500 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  500 (571)
                      ||+++++|.+++... ....+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++..+...
T Consensus        80 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  155 (260)
T cd05073          80 EFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDN  155 (260)
T ss_pred             EeCCCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence            999999999998542 3456889999999999999999999876   999999999999999999999999999765432


Q ss_pred             CCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 008292          501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSN  550 (571)
Q Consensus       501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~  550 (571)
                      ... ......++..|+|||++....++.++||||||+++||++| |+.|+.
T Consensus       156 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~  205 (260)
T cd05073         156 EYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYP  205 (260)
T ss_pred             Ccc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCC
Confidence            211 1122345678999999998899999999999999999999 888875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.98  E-value=1.2e-31  Score=265.59  Aligned_cols=200  Identities=31%  Similarity=0.509  Sum_probs=171.2

Q ss_pred             CCCccccccccCceeEEEEEc-cCCCeeEEEeecccCc------cCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEE
Q 008292          346 KFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASG------QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL  418 (571)
Q Consensus       346 ~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  418 (571)
                      +|+..+.||+|++|.||++.. .+++.|++|.++....      ...+.+++|++++++++|+||+++++++.+++..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477789999999999999985 5688999999865331      134678899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCC-ceEEeeccCcccc
Q 008292          419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM-NPKISDFGMARIF  497 (571)
Q Consensus       419 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGla~~~  497 (571)
                      |+||+++++|.+++.   ....+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++ .+||+|||++..+
T Consensus        81 v~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~  154 (268)
T cd06630          81 FVEWMAGGSVSHLLS---KYGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL  154 (268)
T ss_pred             EEeccCCCcHHHHHH---HhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence            999999999999984   3456889999999999999999999987   99999999999998776 5999999999766


Q ss_pred             CCCCCcc--ccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          498 GVDQTQG--NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       498 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .......  ......++..|+|||.+.+..++.++||||+|+++|||++|+.|+..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~  210 (268)
T cd06630         155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNA  210 (268)
T ss_pred             ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCC
Confidence            4332111  12234678899999999888999999999999999999999999863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.98  E-value=7.1e-33  Score=259.95  Aligned_cols=203  Identities=28%  Similarity=0.429  Sum_probs=167.6

Q ss_pred             CCCCccccccccCceeEEEEEcc---C--CCeeEEEeecccCccC--HHHHHHHHHHHhhcCCCceeccceeEEe-CCee
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP---S--GQEIAVKRLSKASGQG--AEEFKNEVVLVAKLQHRNLVRLLGFCLE-GEEK  416 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~---~--g~~vavK~~~~~~~~~--~~~~~~Ei~~l~~l~h~niv~l~~~~~~-~~~~  416 (571)
                      ..|+...+||+|.||.||++.-.   +  .+.+|+|+++......  ....-+|+.+++.++||||+.+..++.. +...
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            46888899999999999999632   2  3378999997653221  2355789999999999999999999988 7788


Q ss_pred             EEEEEecCCCChhhhhc--CCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCC----CceEEee
Q 008292          417 ILVYEFVPNKSLDYFLY--DPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE----MNPKISD  490 (571)
Q Consensus       417 ~lv~e~~~~g~L~~~l~--~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~D  490 (571)
                      +|++||.+.. |.++++  ...+...++...+..|+.||+.|+.|||++.   |+||||||.||||..+    |.|||+|
T Consensus       104 ~l~fdYAEhD-L~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  104 WLLFDYAEHD-LWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             EEEehhhhhh-HHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence            9999999764 545543  2334467899999999999999999999999   9999999999999877    8999999


Q ss_pred             ccCccccCCCCCcc-ccccccccCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          491 FGMARIFGVDQTQG-NTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       491 fGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ||+++.+...-..- ....++-|..|.|||.+++. .|+.+.||||.|||+.||+|-++-|.-
T Consensus       180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g  242 (438)
T KOG0666|consen  180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG  242 (438)
T ss_pred             ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence            99999886543332 34556789999999999876 689999999999999999998877643

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.98  E-value=9.2e-32  Score=271.53  Aligned_cols=199  Identities=27%  Similarity=0.432  Sum_probs=168.0

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      ++|.+.++||+|+||.||++..+ +++.||+|.++... ......+.+|+.++++++||||+++++++......++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            46888999999999999999864 57889999987543 33345678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT  502 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  502 (571)
                      ++ ++|..++..  ....+++..+..++.||++||.|||+.+   |+|+||||+||++++++.+||+|||++........
T Consensus        86 ~~-~~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  159 (301)
T cd07873          86 LD-KDLKQYLDD--CGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  159 (301)
T ss_pred             cc-cCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence            97 578877743  2346889999999999999999999887   99999999999999999999999999975432221


Q ss_pred             ccccccccccCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          503 QGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       503 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                        ......+++.|+|||.+.+. .++.++||||||+++|||+||+.||..
T Consensus       160 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~  207 (301)
T cd07873         160 --TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPG  207 (301)
T ss_pred             --cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCC
Confidence              12223568899999988654 578899999999999999999999853

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=1.6e-31  Score=271.74  Aligned_cols=202  Identities=26%  Similarity=0.325  Sum_probs=173.2

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeecccCcc---CHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQ---GAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY  420 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  420 (571)
                      ++|+..+.||+|++|.||++... +++.|++|.+......   ..+.+.+|+++++.++|+||+++++.+.+++..++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            36888899999999999999965 4889999998764322   4567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCC
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD  500 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  500 (571)
                      ||+.+++|.+++.. .....+++..+..++.|+++||+|||+.+   ++|+||||+||+++.++.++|+|||++......
T Consensus        81 e~~~~~~L~~~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  156 (316)
T cd05574          81 DYCPGGELFRLLQR-QPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE  156 (316)
T ss_pred             EecCCCCHHHHHHh-CCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence            99999999998853 23457899999999999999999999887   999999999999999999999999998754322


Q ss_pred             CCc---------------------------cccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          501 QTQ---------------------------GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       501 ~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      ...                           .......|+..|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~  233 (316)
T cd05574         157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFK  233 (316)
T ss_pred             ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCC
Confidence            110                           01123467889999999999899999999999999999999999985

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.98  E-value=2e-31  Score=262.67  Aligned_cols=194  Identities=38%  Similarity=0.560  Sum_probs=162.2

Q ss_pred             ccccccCceeEEEEEccC----CCeeEEEeecccCc-cCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEecCC
Q 008292          351 NKLGEGGFGEVYKGVLPS----GQEIAVKRLSKASG-QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPN  425 (571)
Q Consensus       351 ~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  425 (571)
                      ++||+|+||.||+|.+..    +..+++|.+..... ...+++.+|+.+++.++|+||+++++++. ++..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            479999999999998532    26799999876543 24567889999999999999999999875 5568999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCccc
Q 008292          426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN  505 (571)
Q Consensus       426 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  505 (571)
                      ++|.+++..   ...+++..++.++.|++.+|.|||..+   ++|+||||+|||++.++.+||+|||+++.+........
T Consensus        80 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~  153 (257)
T cd05060          80 GPLLKYLKK---RREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR  153 (257)
T ss_pred             CcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence            999999953   336899999999999999999999887   99999999999999999999999999986643322111


Q ss_pred             -cccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          506 -TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       506 -~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                       .....++..|+|||.+.+..++.++||||||+++|||++ |+.||+.
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~  201 (257)
T cd05060         154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGE  201 (257)
T ss_pred             cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCccc
Confidence             111223568999999998999999999999999999998 9999854

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.98  E-value=7.1e-32  Score=270.03  Aligned_cols=198  Identities=32%  Similarity=0.453  Sum_probs=169.5

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeecccCc--cCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASG--QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE  421 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e  421 (571)
                      ++|+..++||+|+||.||++..+ +++.|++|++.....  ...+.+.+|+++++.++||||+++++++..+...++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            46788899999999999999975 588999998865332  235678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCC
Q 008292          422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ  501 (571)
Q Consensus       422 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  501 (571)
                      |+++++|..+..   ....+++..++.++.|+++||+|||+.+   ++|+||+|+||++++++.+||+|||++..+....
T Consensus        81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07846          81 FVDHTVLDDLEK---YPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  154 (286)
T ss_pred             cCCccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence            999999988763   2345899999999999999999999887   9999999999999999999999999988654322


Q ss_pred             CccccccccccCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          502 TQGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       502 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      .  ......++..|+|||++.+ ..++.++||||||+++|||++|++|+.
T Consensus       155 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~  202 (286)
T cd07846         155 E--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFP  202 (286)
T ss_pred             c--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCC
Confidence            1  1223457889999998875 457889999999999999999998875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.98  E-value=1.3e-31  Score=266.14  Aligned_cols=199  Identities=30%  Similarity=0.496  Sum_probs=168.8

Q ss_pred             CCCccccccccCceeEEEEEc-cCCCeeEEEeecccCc----------cCHHHHHHHHHHHhhcCCCceeccceeEEeCC
Q 008292          346 KFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASG----------QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE  414 (571)
Q Consensus       346 ~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~----------~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~  414 (571)
                      +|...+.||+|+||.||+|.. .+++.|++|.++....          ...+.+.+|+.+++.++|+||+++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            467788999999999999985 4688999998753211          11246788999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCc
Q 008292          415 EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA  494 (571)
Q Consensus       415 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla  494 (571)
                      ..++||||+++++|.+++..   ...+++..+..++.|++.||.|||+++   ++||||+|+||+++.++.+||+|||++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~  155 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRT---YGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS  155 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence            99999999999999999843   357899999999999999999999887   999999999999999999999999999


Q ss_pred             cccCCCCCccccccccccCCcccccccccCC--CCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          495 RIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQ--FSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      +...............++..|+|||.+....  ++.++||||||+++|||++|+.|+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~  213 (272)
T cd06629         156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWS  213 (272)
T ss_pred             ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCc
Confidence            7653222222223346788999999987654  8899999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.98  E-value=1.5e-31  Score=268.85  Aligned_cols=198  Identities=29%  Similarity=0.497  Sum_probs=174.1

Q ss_pred             CCCCccccccccCceeEEEEEc-cCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEec
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV  423 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  423 (571)
                      ++|...+.||+|+||.||++.. .++..|++|.+........+.+.+|+.++++++||||+++++.+...+..++|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            6788899999999999999985 467889999987655555678899999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCc
Q 008292          424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ  503 (571)
Q Consensus       424 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  503 (571)
                      ++++|.+++.    ...+++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.+||+|||++........ 
T Consensus        99 ~~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-  170 (293)
T cd06647          99 AGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  170 (293)
T ss_pred             CCCcHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc-
Confidence            9999999883    345789999999999999999999887   99999999999999999999999999876543222 


Q ss_pred             cccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          504 GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       504 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                       ......+++.|++||.+....++.++||||||+++|||++|+.||..
T Consensus       171 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~  217 (293)
T cd06647         171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN  217 (293)
T ss_pred             -ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence             12234688899999999888899999999999999999999999853

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.98  E-value=1.9e-31  Score=264.63  Aligned_cols=197  Identities=22%  Similarity=0.369  Sum_probs=157.7

Q ss_pred             ccccccCceeEEEEEccCCC---eeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEecCCC
Q 008292          351 NKLGEGGFGEVYKGVLPSGQ---EIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNK  426 (571)
Q Consensus       351 ~~LG~G~fg~Vy~~~~~~g~---~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  426 (571)
                      ++||+|+||.||++...++.   .+++|.++... ....+.+.+|+.+++.++||||+++++.+.+....++||||+++|
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            36999999999999854433   45666665433 334568899999999999999999999999999999999999999


Q ss_pred             ChhhhhcCCCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCccc
Q 008292          427 SLDYFLYDPEK-QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN  505 (571)
Q Consensus       427 ~L~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  505 (571)
                      +|.+++..... ....++..+..++.||++||+|||+.+   ++||||||+|||++.++.+||+|||++...........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            99999864321 234677788899999999999999887   99999999999999999999999999864322221222


Q ss_pred             cccccccCCccccccccc-------CCCCcchhHHHHHHHHHHHHhC-CCCCC
Q 008292          506 TSRIVGTYGYMAPEYAMH-------GQFSVKSDVYSFGVLVLEIITG-KKNSN  550 (571)
Q Consensus       506 ~~~~~gt~~y~aPE~~~~-------~~~s~~~Dv~slGvvl~elltG-~~p~~  550 (571)
                      .....++..|+|||++..       ..++.++||||||+++|||+++ ..|+.
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~  210 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYS  210 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Confidence            234567889999998743       3467899999999999999975 55664

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.98  E-value=8.5e-32  Score=268.00  Aligned_cols=189  Identities=28%  Similarity=0.408  Sum_probs=157.2

Q ss_pred             cccccCceeEEEEEccC-------------------------CCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceecc
Q 008292          352 KLGEGGFGEVYKGVLPS-------------------------GQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRL  406 (571)
Q Consensus       352 ~LG~G~fg~Vy~~~~~~-------------------------g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l  406 (571)
                      +||+|+||.||+|.+..                         ...|++|++.........++.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999997421                         13478888876544445678899999999999999999


Q ss_pred             ceeEEeCCeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCC--
Q 008292          407 LGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM--  484 (571)
Q Consensus       407 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~--  484 (571)
                      ++++.+....++||||+++|+|..++..  ....+++..+..++.||++||+|||+++   |+||||||+|||++.++  
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~  156 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA  156 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence            9999999999999999999999998843  3456889999999999999999999886   99999999999997643  


Q ss_pred             -----ceEEeeccCccccCCCCCccccccccccCCccccccccc-CCCCcchhHHHHHHHHHHHH-hCCCCCCC
Q 008292          485 -----NPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEII-TGKKNSNF  551 (571)
Q Consensus       485 -----~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slGvvl~ell-tG~~p~~~  551 (571)
                           .+||+|||++......      ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.|+..
T Consensus       157 ~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~  224 (274)
T cd05076         157 EGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKE  224 (274)
T ss_pred             cCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccc
Confidence                 3899999988643211      12346788999998865 56899999999999999995 68888753

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.98  E-value=1.4e-31  Score=273.43  Aligned_cols=199  Identities=19%  Similarity=0.268  Sum_probs=164.2

Q ss_pred             cccccccc--CceeEEEEEc-cCCCeeEEEeecccC--ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEec
Q 008292          349 TDNKLGEG--GFGEVYKGVL-PSGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV  423 (571)
Q Consensus       349 ~~~~LG~G--~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  423 (571)
                      +.++||+|  +|++||++.. ++|+.||+|+++...  ....+.+++|+.+++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            45789999  7899999986 468899999987542  233456788999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCC-
Q 008292          424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT-  502 (571)
Q Consensus       424 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~-  502 (571)
                      ++|+|.+++... ....+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+++.||+.......... 
T Consensus        82 ~~~~l~~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~  157 (327)
T cd08227          82 AYGSAKDLICTH-FMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR  157 (327)
T ss_pred             CCCcHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence            999999988432 2335899999999999999999999887   99999999999999999999999987543321110 


Q ss_pred             ----ccccccccccCCccccccccc--CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          503 ----QGNTSRIVGTYGYMAPEYAMH--GQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       503 ----~~~~~~~~gt~~y~aPE~~~~--~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                          ........++..|+|||++.+  ..++.++||||||+++|||++|+.||..
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  212 (327)
T cd08227         158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD  212 (327)
T ss_pred             ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence                001122346778999999876  4689999999999999999999999863

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.98  E-value=1.1e-31  Score=266.18  Aligned_cols=197  Identities=37%  Similarity=0.564  Sum_probs=165.0

Q ss_pred             ccccccCceeEEEEEccC-------CCeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          351 NKLGEGGFGEVYKGVLPS-------GQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       351 ~~LG~G~fg~Vy~~~~~~-------g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      +.||+|+||.||+|+..+       +..+++|.+.... .....++.+|+.+++.++||||+++++++...+..+++|||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            468999999999998642       2568999886543 24456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCC-----ceEEeeccC
Q 008292          423 VPNKSLDYFLYDPE----KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM-----NPKISDFGM  493 (571)
Q Consensus       423 ~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-----~~kl~DfGl  493 (571)
                      +++++|.+++....    ....+++.+++.++.|++.||.|||+.+   ++|+||+|+||+++.++     .+||+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence            99999999986422    2234788999999999999999999877   99999999999999887     899999999


Q ss_pred             ccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 008292          494 ARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSN  550 (571)
Q Consensus       494 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~  550 (571)
                      ++...............++..|+|||.+.++.++.++||||||+++|||+| |+.|+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~  215 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYP  215 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCc
Confidence            976543322222223345778999999999999999999999999999998 998874

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.98  E-value=1.9e-31  Score=267.78  Aligned_cols=200  Identities=28%  Similarity=0.427  Sum_probs=166.7

Q ss_pred             hCCCCccccccccCceeEEEEEc-cCCCeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE  421 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e  421 (571)
                      +++|.+.+.||+|+||.||+|.. .+++.|++|+++... ......+.+|+.+++.++|+||+++.+++..+...++|+|
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e   83 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE   83 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence            46789999999999999999985 468899999986543 2333467889999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCC
Q 008292          422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ  501 (571)
Q Consensus       422 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  501 (571)
                      |+. ++|..++..  ....+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||+++......
T Consensus        84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  157 (291)
T cd07870          84 YMH-TDLAQYMIQ--HPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPS  157 (291)
T ss_pred             ccc-CCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence            996 566655532  2345788889999999999999999887   9999999999999999999999999987543221


Q ss_pred             CccccccccccCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          502 TQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       502 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .  ......+++.|+|||.+.+. .++.++||||||+++|||+||+.||+.
T Consensus       158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~  206 (291)
T cd07870         158 Q--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPG  206 (291)
T ss_pred             C--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            1  12233568899999998754 578899999999999999999999864

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.97  E-value=2.2e-31  Score=264.92  Aligned_cols=202  Identities=30%  Similarity=0.459  Sum_probs=169.9

Q ss_pred             CCCCccccccccCceeEEEEEcc------CCCeeEEEeecccCcc-CHHHHHHHHHHHhhcCCCceeccceeEEeCCeeE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSKASGQ-GAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI  417 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  417 (571)
                      ++|+..+.||+|+||.||+++.+      +.+.|++|.+...... ..+++.+|++++++++|+||+++++++.+....+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            57888999999999999999954      2456899988654433 4578999999999999999999999999988999


Q ss_pred             EEEEecCCCChhhhhcCCCCC------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeec
Q 008292          418 LVYEFVPNKSLDYFLYDPEKQ------GQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDF  491 (571)
Q Consensus       418 lv~e~~~~g~L~~~l~~~~~~------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  491 (571)
                      +||||+++++|.+++......      ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.++|+||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence            999999999999998543211      26899999999999999999999887   999999999999999999999999


Q ss_pred             cCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 008292          492 GMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSN  550 (571)
Q Consensus       492 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~  550 (571)
                      |+++....... .......++..|+|||.+.+...+.++||||||+++|||++ |..|+.
T Consensus       162 ~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~  220 (275)
T cd05046         162 SLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFY  220 (275)
T ss_pred             ccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence            99875432211 12223356778999999988889999999999999999999 777764

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.97  E-value=2e-31  Score=262.37  Aligned_cols=195  Identities=31%  Similarity=0.470  Sum_probs=166.2

Q ss_pred             CCCCccccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEe-CCeeEEEEEec
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE-GEEKILVYEFV  423 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~  423 (571)
                      ++|.+.+.||+|+||.||++.. .|..|++|.++..  ...+.+.+|+.++++++|+||+++++++.. +...++++||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            4688889999999999999987 4788999988643  235678999999999999999999997654 45689999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCc
Q 008292          424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ  503 (571)
Q Consensus       424 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  503 (571)
                      ++++|.+++... ....+++..++.++.|++.||+|||+++   ++||||||+||++++++.+||+|||+++......  
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--  156 (256)
T cd05082          83 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  156 (256)
T ss_pred             CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence            999999988532 2345889999999999999999999887   9999999999999999999999999987543221  


Q ss_pred             cccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          504 GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       504 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                         ....++..|+|||++.+..++.++||||||+++|||++ |+.|+..
T Consensus       157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~  202 (256)
T cd05082         157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR  202 (256)
T ss_pred             ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence               12234568999999998899999999999999999998 8888753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.97  E-value=1.9e-31  Score=263.44  Aligned_cols=193  Identities=31%  Similarity=0.475  Sum_probs=157.7

Q ss_pred             ccccccCceeEEEEEcc----CCCeeEEEeeccc-CccCHHHHHHHHHHHhhcCCCceeccceeEEe-CCeeEEEEEecC
Q 008292          351 NKLGEGGFGEVYKGVLP----SGQEIAVKRLSKA-SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE-GEEKILVYEFVP  424 (571)
Q Consensus       351 ~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~~  424 (571)
                      +.||+|+||.||+|.+.    +...|++|++... .....+.+.+|+.+++.++||||+++++++.. +...++++||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999853    2357899988543 23345678899999999999999999998764 456789999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCc-
Q 008292          425 NKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ-  503 (571)
Q Consensus       425 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~-  503 (571)
                      +++|.+++..  ....+++..++.++.|+++||.|||+.+   ++||||||+|||+++++.+||+|||+++.+...... 
T Consensus        81 ~~~L~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~  155 (262)
T cd05058          81 HGDLRNFIRS--ETHNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS  155 (262)
T ss_pred             CCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence            9999999853  2334678888999999999999999886   999999999999999999999999999765322111 


Q ss_pred             -cccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCC
Q 008292          504 -GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKN  548 (571)
Q Consensus       504 -~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p  548 (571)
                       .......++..|+|||.+.+..++.++||||||+++|||++|+.|
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~  201 (262)
T cd05058         156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP  201 (262)
T ss_pred             ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCC
Confidence             111223457789999999888999999999999999999996554

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.8e-32  Score=269.13  Aligned_cols=203  Identities=24%  Similarity=0.368  Sum_probs=175.7

Q ss_pred             CCCCccccccccCceeEEEEEc-cCCCeeEEEeecccCc--cCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASG--QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE  421 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e  421 (571)
                      .-|...+.||+|.|..|-.+++ -.|.+||||++.+..-  .....+..|++.|+.++|||||+++.+.......|||+|
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            4577889999999999998884 4799999999987543  334578899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEE-CCCCceEEeeccCccccCCC
Q 008292          422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL-DAEMNPKISDFGMARIFGVD  500 (571)
Q Consensus       422 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll-~~~~~~kl~DfGla~~~~~~  500 (571)
                      .-++|+|.+++...+  ..+.+....+++.||..|+.|.|+..   +|||||||+||.+ ..-|-+||.|||++..+.+.
T Consensus        98 LGD~GDl~DyImKHe--~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG  172 (864)
T KOG4717|consen   98 LGDGGDLFDYIMKHE--EGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG  172 (864)
T ss_pred             ecCCchHHHHHHhhh--ccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence            999999999986433  34889999999999999999999876   9999999999976 45688999999999877543


Q ss_pred             CCccccccccccCCcccccccccCCCC-cchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 008292          501 QTQGNTSRIVGTYGYMAPEYAMHGQFS-VKSDVYSFGVLVLEIITGKKNSNFYQTD  555 (571)
Q Consensus       501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~~Dv~slGvvl~elltG~~p~~~~~~~  555 (571)
                      .   .....||++.|-|||++++..|. +++||||||||||.|++|+.||+-.++.
T Consensus       173 ~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS  225 (864)
T KOG4717|consen  173 K---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS  225 (864)
T ss_pred             c---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch
Confidence            3   34556999999999999999886 6799999999999999999999865443

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.97  E-value=3.7e-31  Score=263.77  Aligned_cols=196  Identities=29%  Similarity=0.502  Sum_probs=170.4

Q ss_pred             CCCccccccccCceeEEEEEc-cCCCeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEec
Q 008292          346 KFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV  423 (571)
Q Consensus       346 ~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  423 (571)
                      -|+..++||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.++.+++||||+++++++..++..++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            467788999999999999985 467899999886433 334567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCc
Q 008292          424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ  503 (571)
Q Consensus       424 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  503 (571)
                      ++++|..++.    ...+++..+..++.|++.++.|||+.+   ++|+||+|+||+++.++.++|+|||++..+..... 
T Consensus        85 ~~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-  156 (277)
T cd06641          85 GGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-  156 (277)
T ss_pred             CCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence            9999999883    346899999999999999999999987   99999999999999999999999999876533211 


Q ss_pred             cccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          504 GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       504 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                       ......++..|+|||.+.+..++.++||||||+++|||++|+.|+.
T Consensus       157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~  202 (277)
T cd06641         157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHS  202 (277)
T ss_pred             -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCC
Confidence             1223457889999999988889999999999999999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.97  E-value=3.1e-31  Score=260.90  Aligned_cols=200  Identities=24%  Similarity=0.392  Sum_probs=172.2

Q ss_pred             CCCccccccccCceeEEEEEc-cCCCeeEEEeeccc--CccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          346 KFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       346 ~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      +|++.+.||+|+||.+|++.. .+|+.|++|++...  .....+++.+|+.++++++||||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            578889999999999999985 46889999998643  233456889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT  502 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  502 (571)
                      +++++|.+++.. .....+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~~l~~~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~  156 (256)
T cd08218          81 CEGGDLYKKINA-QRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE  156 (256)
T ss_pred             CCCCcHHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence            999999988843 22345789999999999999999999887   99999999999999999999999999976543221


Q ss_pred             ccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          503 QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       503 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                        ......|++.|+|||++.+..++.++||||||++++||++|+.|+..
T Consensus       157 --~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~  203 (256)
T cd08218         157 --LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEA  203 (256)
T ss_pred             --hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccC
Confidence              12234578899999999999999999999999999999999999753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.97  E-value=2.3e-31  Score=264.21  Aligned_cols=194  Identities=32%  Similarity=0.504  Sum_probs=160.8

Q ss_pred             ccccccCceeEEEEEccC-CC--eeEEEeecccC-ccCHHHHHHHHHHHhhc-CCCceeccceeEEeCCeeEEEEEecCC
Q 008292          351 NKLGEGGFGEVYKGVLPS-GQ--EIAVKRLSKAS-GQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPN  425 (571)
Q Consensus       351 ~~LG~G~fg~Vy~~~~~~-g~--~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  425 (571)
                      +.||+|+||.||+|+.++ +.  .+++|.++... ....+.+.+|++++.++ +||||+++++++......+++|||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            468999999999999754 43  46888887532 34456788999999999 799999999999999999999999999


Q ss_pred             CChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeecc
Q 008292          426 KSLDYFLYDPE-------------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG  492 (571)
Q Consensus       426 g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG  492 (571)
                      ++|.+++....             ....+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence            99999885421             1235789999999999999999999887   9999999999999999999999999


Q ss_pred             CccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 008292          493 MARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSN  550 (571)
Q Consensus       493 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~  550 (571)
                      ++......   ........+..|+|||++....++.++||||||+++|||++ |+.||.
T Consensus       158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~  213 (270)
T cd05047         158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC  213 (270)
T ss_pred             Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCcc
Confidence            98632211   11111233567999999988899999999999999999997 999974

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.5e-31  Score=263.04  Aligned_cols=200  Identities=29%  Similarity=0.445  Sum_probs=169.1

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeeccc-----CccCHHHHHHHHHHHhhcCCCceeccceeEEeC--Cee
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA-----SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG--EEK  416 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~  416 (571)
                      .+|++.+.||+|+||.||++... +++.|++|.+...     .......+++|++++++++|+||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            46888999999999999999964 5889999987532     123345788999999999999999999998764  457


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccc
Q 008292          417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI  496 (571)
Q Consensus       417 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  496 (571)
                      ++++||+++++|.+++.   ....+++.....++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~~~---~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  155 (264)
T cd06653          82 SIFVEYMPGGSIKDQLK---AYGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (264)
T ss_pred             EEEEEeCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence            89999999999998884   3345889999999999999999999887   99999999999999999999999999986


Q ss_pred             cCCCCC-ccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          497 FGVDQT-QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       497 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      ...... ........++..|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~  210 (264)
T cd06653         156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWA  210 (264)
T ss_pred             cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence            532111 111223468889999999998889999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.97  E-value=3.2e-31  Score=260.95  Aligned_cols=200  Identities=28%  Similarity=0.375  Sum_probs=170.2

Q ss_pred             CCCccccccccCceeEEEEEcc-CCCeeEEEeecccC--ccCHHHHHHHHHHHhhcCCCceeccceeEEe-CCeeEEEEE
Q 008292          346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE-GEEKILVYE  421 (571)
Q Consensus       346 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~-~~~~~lv~e  421 (571)
                      .|++.+.||+|++|.||+++.+ +++.|++|++....  ....+.+.+|++++++++|+|++++++.+.. ....+++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4778899999999999999964 57889999986532  3345678899999999999999999988764 345789999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCC
Q 008292          422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ  501 (571)
Q Consensus       422 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  501 (571)
                      |+++++|.+++... ....+++.+++.++.|++.|+++||+.+   ++||||+|+||+++.++.++|+|||++..+....
T Consensus        81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~  156 (257)
T cd08223          81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC  156 (257)
T ss_pred             ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence            99999999988542 3456899999999999999999999987   9999999999999999999999999998664322


Q ss_pred             CccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          502 TQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       502 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .  ......+++.|+|||.+.+..++.++||||||++++||++|+.|+..
T Consensus       157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~  204 (257)
T cd08223         157 D--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNA  204 (257)
T ss_pred             C--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence            1  22334678999999999999999999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.97  E-value=2.2e-31  Score=270.40  Aligned_cols=205  Identities=26%  Similarity=0.426  Sum_probs=169.1

Q ss_pred             CCCccccccccCceeEEEEEcc---CCCeeEEEeecccC---ccCHHHHHHHHHHHhhcCCCceeccceeEEeC--CeeE
Q 008292          346 KFSTDNKLGEGGFGEVYKGVLP---SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG--EEKI  417 (571)
Q Consensus       346 ~~~~~~~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~  417 (571)
                      +|++.++||+|+||.||+|+..   +++.||+|.+....   ....+.+.+|+.++.+++||||+++++++.+.  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4778889999999999999964   47899999997633   44456778899999999999999999999988  7899


Q ss_pred             EEEEecCCCChhhhhcCC-C-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECC----CCceEEeec
Q 008292          418 LVYEFVPNKSLDYFLYDP-E-KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA----EMNPKISDF  491 (571)
Q Consensus       418 lv~e~~~~g~L~~~l~~~-~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~----~~~~kl~Df  491 (571)
                      +||||+++ +|.+++... . ....+++..++.++.|++.||.|||+.+   |+||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999976 555554321 1 2236899999999999999999999887   999999999999999    899999999


Q ss_pred             cCccccCCCCC-ccccccccccCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 008292          492 GMARIFGVDQT-QGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQT  554 (571)
Q Consensus       492 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~slGvvl~elltG~~p~~~~~~  554 (571)
                      |+++.+..... ........++..|+|||.+.+. .++.++||||||++++||++|+.|+.....
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~  221 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA  221 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence            99986643322 1122345678899999988764 588999999999999999999999875443

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.97  E-value=2.4e-31  Score=261.77  Aligned_cols=199  Identities=31%  Similarity=0.532  Sum_probs=170.8

Q ss_pred             CCCCccccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEecC
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVP  424 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  424 (571)
                      .+|++.+.||+|+||.||++.+.++..+++|.++... ....++.+|++++++++||||+++++++......++++||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            4677889999999999999998778899999886543 335678999999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCcc
Q 008292          425 NKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG  504 (571)
Q Consensus       425 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  504 (571)
                      +++|.+++..  ....++++.++.++.|++.+|+|||+.+   ++|+||||+||+++.++.+||+|||+++........ 
T Consensus        83 ~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-  156 (256)
T cd05112          83 HGCLSDYLRA--QRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT-  156 (256)
T ss_pred             CCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCccc-
Confidence            9999998853  2346889999999999999999999887   999999999999999999999999998765322211 


Q ss_pred             ccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 008292          505 NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSN  550 (571)
Q Consensus       505 ~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~  550 (571)
                      ......++..|+|||.+.++.++.++||||||+++|||++ |+.|++
T Consensus       157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~  203 (256)
T cd05112         157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYE  203 (256)
T ss_pred             ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCC
Confidence            1112235678999999998899999999999999999998 888875

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.97  E-value=2.8e-31  Score=262.35  Aligned_cols=200  Identities=32%  Similarity=0.495  Sum_probs=173.0

Q ss_pred             CCCccccccccCceeEEEEEcc-CCCeeEEEeecccCcc--CHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQ--GAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       346 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      +|...+.||+|+||.||++... +++.|++|.++.....  ..+.+.+|+.++++++|+||+++++.+...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            4778899999999999999864 6889999998765443  567899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT  502 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  502 (571)
                      +++++|.+++..   ...+++..+..++.|+++||.|||+.+   |+|+||+|+||++++++.+||+|||++........
T Consensus        81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~  154 (264)
T cd06626          81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT  154 (264)
T ss_pred             CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence            999999999843   345789999999999999999999987   99999999999999999999999999987643322


Q ss_pred             ccc--cccccccCCcccccccccCC---CCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          503 QGN--TSRIVGTYGYMAPEYAMHGQ---FSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       503 ~~~--~~~~~gt~~y~aPE~~~~~~---~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ...  .....++..|+|||.+....   .+.++||||||+++|||++|+.||..
T Consensus       155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~  208 (264)
T cd06626         155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSE  208 (264)
T ss_pred             cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccC
Confidence            111  12346788999999998766   88999999999999999999999853

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.97  E-value=2.3e-31  Score=266.49  Aligned_cols=200  Identities=28%  Similarity=0.405  Sum_probs=172.2

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeeccc--CccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE  421 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e  421 (571)
                      ++|++.++||+|++|.||++..+ +++.|++|+++..  .....+.+.+|++++++++|+||+++++++..++..+++||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36888999999999999999975 5788999988653  23445788999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCC
Q 008292          422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ  501 (571)
Q Consensus       422 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  501 (571)
                      |++++.+..+..   +...+++..+..++.|++.||.|||+++   ++|+||+|+||++++++.+||+|||++.......
T Consensus        81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~  154 (288)
T cd07833          81 YVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP  154 (288)
T ss_pred             cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence            999887776652   3345899999999999999999999987   9999999999999999999999999998765433


Q ss_pred             CccccccccccCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          502 TQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       502 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .. ......++..|+|||++... .++.++||||||+++|||++|+.|+..
T Consensus       155 ~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~  204 (288)
T cd07833         155 AS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPG  204 (288)
T ss_pred             cc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            21 12234678899999999888 889999999999999999999998863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.97  E-value=1.4e-31  Score=267.88  Aligned_cols=209  Identities=26%  Similarity=0.418  Sum_probs=172.2

Q ss_pred             hHHHHHHhCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccCccCHHHHHHHHHHHhhc-CCCceeccceeEE---
Q 008292          337 FETIEVATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCL---  411 (571)
Q Consensus       337 ~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~---  411 (571)
                      ++.+....++|++.+.||+|+||.||+++.. +++.+++|.++... ....++.+|+.+++++ +||||+++++++.   
T Consensus        10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   88 (286)
T cd06638          10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD   88 (286)
T ss_pred             eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence            3445556789999999999999999999864 57889999876432 2346788899999999 6999999999885   


Q ss_pred             --eCCeeEEEEEecCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEE
Q 008292          412 --EGEEKILVYEFVPNKSLDYFLYDP-EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKI  488 (571)
Q Consensus       412 --~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl  488 (571)
                        .++..++||||+++++|.+++... .....+++..+..++.|+++||.|||+.+   |+||||||+||++++++.+||
T Consensus        89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl  165 (286)
T cd06638          89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKL  165 (286)
T ss_pred             cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEE
Confidence              345689999999999999887532 23456889999999999999999999887   999999999999999999999


Q ss_pred             eeccCccccCCCCCccccccccccCCccccccccc-----CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          489 SDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMH-----GQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       489 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      +|||+++.+.....  ......|++.|+|||++..     ..++.++||||||+++|||++|+.|+..
T Consensus       166 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~  231 (286)
T cd06638         166 VDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLAD  231 (286)
T ss_pred             ccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCC
Confidence            99999876543221  1223468899999998753     4578899999999999999999999753

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-32  Score=274.13  Aligned_cols=207  Identities=30%  Similarity=0.490  Sum_probs=177.4

Q ss_pred             cccccccCceeEEEEEc-cCCCeeEEEeeccc--CccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEecCCC
Q 008292          350 DNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNK  426 (571)
Q Consensus       350 ~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  426 (571)
                      .+.||.|.||+||-|+. ++|+.||||++.+.  ..+...++++|+.||..+.||.||.+.-.|+..+..++|||-+.|.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            47899999999999996 57999999999764  3445578999999999999999999999999999999999999777


Q ss_pred             ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCC---CceEEeeccCccccCCCCCc
Q 008292          427 SLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE---MNPKISDFGMARIFGVDQTQ  503 (571)
Q Consensus       427 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DfGla~~~~~~~~~  503 (571)
                      -|+-+|.  ...+.+++.....++.||+.||.|||.++   |+|.||||+|||+.+.   -++||+|||.|+.++.... 
T Consensus       649 MLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF-  722 (888)
T KOG4236|consen  649 MLEMILS--SEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF-  722 (888)
T ss_pred             HHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhh-
Confidence            6766663  34567888888889999999999999988   9999999999999654   3799999999998864432 


Q ss_pred             cccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHH
Q 008292          504 GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYVSI  566 (571)
Q Consensus       504 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~~~~~~~~~l~~~~~~  566 (571)
                        ....+||+.|+|||++.++.|...-|+||.|||+|--++|.-||+  ++++..|.++.+.-
T Consensus       723 --RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFN--EdEdIndQIQNAaF  781 (888)
T KOG4236|consen  723 --RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFN--EDEDINDQIQNAAF  781 (888)
T ss_pred             --hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCC--CccchhHHhhcccc
Confidence              335689999999999999999999999999999999999999986  35566677765533

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.6e-32  Score=295.27  Aligned_cols=206  Identities=26%  Similarity=0.337  Sum_probs=179.6

Q ss_pred             hHHHHHHhCCCCccccccccCceeEEEEEcc-CCCeeEEEeeccc---CccCHHHHHHHHHHHhhcCCCceeccceeEEe
Q 008292          337 FETIEVATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE  412 (571)
Q Consensus       337 ~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~  412 (571)
                      ...++...++|.+++.||+|+||.|..++.+ .++.+|+|++.+-   ......-|++|-.+|..-+.+=|+.+.-.|.+
T Consensus        67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD  146 (1317)
T KOG0612|consen   67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD  146 (1317)
T ss_pred             HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence            3455666789999999999999999999975 5778899999873   23445678899999998889999999999999


Q ss_pred             CCeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeecc
Q 008292          413 GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG  492 (571)
Q Consensus       413 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG  492 (571)
                      ....|+|||||+||+|-.++.   +-..+++..+..++..|.-||.-||+.|   +|||||||+|||||..|++||+|||
T Consensus       147 ~~~LYlVMdY~pGGDlltLlS---k~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFG  220 (1317)
T KOG0612|consen  147 ERYLYLVMDYMPGGDLLTLLS---KFDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFG  220 (1317)
T ss_pred             ccceEEEEecccCchHHHHHh---hcCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccch
Confidence            999999999999999999994   3337899999999999999999999887   9999999999999999999999999


Q ss_pred             CccccCCCCCccccccccccCCcccccccc----c-CCCCcchhHHHHHHHHHHHHhCCCCC
Q 008292          493 MARIFGVDQTQGNTSRIVGTYGYMAPEYAM----H-GQFSVKSDVYSFGVLVLEIITGKKNS  549 (571)
Q Consensus       493 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~s~~~Dv~slGvvl~elltG~~p~  549 (571)
                      .+-.++.+.. ......+|||.|++||++.    + +.|++.+|+||+||++|||+.|..||
T Consensus       221 sClkm~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPF  281 (1317)
T KOG0612|consen  221 SCLKMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPF  281 (1317)
T ss_pred             hHHhcCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcc
Confidence            9987764433 2345578999999999984    2 57999999999999999999999997

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.97  E-value=1.5e-31  Score=265.57  Aligned_cols=201  Identities=28%  Similarity=0.439  Sum_probs=167.7

Q ss_pred             hCCCCccccccccCceeEEEEEccCC----CeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLPSG----QEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL  418 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~~g----~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  418 (571)
                      .++|...++||+|+||.||+|...+.    ..|++|...... ....+.+.+|+.++++++||||+++++++.+ +..++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l   83 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI   83 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence            35678889999999999999986432    468899887554 3455688999999999999999999998875 45789


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccC
Q 008292          419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG  498 (571)
Q Consensus       419 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  498 (571)
                      ||||+++++|.+++..  ....+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++...
T Consensus        84 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~  158 (270)
T cd05056          84 VMELAPLGELRSYLQV--NKYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE  158 (270)
T ss_pred             EEEcCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecc
Confidence            9999999999999843  2345899999999999999999999887   9999999999999999999999999987654


Q ss_pred             CCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          499 VDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                      ..... ......++..|+|||.+....++.++||||||+++|||++ |+.||..
T Consensus       159 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~  211 (270)
T cd05056         159 DESYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQG  211 (270)
T ss_pred             cccce-ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCC
Confidence            33211 1122234568999999988889999999999999999996 9999753

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=3.1e-31  Score=264.21  Aligned_cols=197  Identities=28%  Similarity=0.524  Sum_probs=170.5

Q ss_pred             CCCccccccccCceeEEEEEc-cCCCeeEEEeeccc-CccCHHHHHHHHHHHhhcC---CCceeccceeEEeCCeeEEEE
Q 008292          346 KFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA-SGQGAEEFKNEVVLVAKLQ---HRNLVRLLGFCLEGEEKILVY  420 (571)
Q Consensus       346 ~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~---h~niv~l~~~~~~~~~~~lv~  420 (571)
                      .|+..+.||+|+||.||+|.. .+++.|++|.++.. .....+++.+|+.++++++   |||++++++++..+...++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            477788999999999999996 56889999998754 3445677889999999997   999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCC
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD  500 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  500 (571)
                      ||+++++|.+++.    ...+++..++.++.|+++||.|||+.+   |+|+||+|+||++++++.++|+|||++..+...
T Consensus        82 e~~~~~~L~~~~~----~~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06917          82 EYAEGGSVRTLMK----AGPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN  154 (277)
T ss_pred             ecCCCCcHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence            9999999999883    237899999999999999999999887   999999999999999999999999999866433


Q ss_pred             CCccccccccccCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          501 QTQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       501 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .  .......|+..|+|||.+.++ .++.++||||||+++|||++|+.|+..
T Consensus       155 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~  204 (277)
T cd06917         155 S--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSD  204 (277)
T ss_pred             c--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCC
Confidence            2  122334688899999988654 578999999999999999999999853

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.97  E-value=1.4e-31  Score=264.07  Aligned_cols=188  Identities=28%  Similarity=0.474  Sum_probs=158.7

Q ss_pred             ccccccCceeEEEEEccC--------CCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          351 NKLGEGGFGEVYKGVLPS--------GQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       351 ~~LG~G~fg~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      +.||+|+||.||+|....        ..+|++|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            469999999999998532        234888888665555567889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCc--------eEEeeccCc
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN--------PKISDFGMA  494 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~--------~kl~DfGla  494 (571)
                      +++|+|..++...  ...+++..++.++.||+.||+|||+.+   |+||||||+||+++.++.        ++++|||++
T Consensus        81 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          81 VKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             CCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence            9999999998532  336899999999999999999999887   999999999999987765        699999988


Q ss_pred             cccCCCCCccccccccccCCcccccccccC-CCCcchhHHHHHHHHHHHHhCC-CCC
Q 008292          495 RIFGVDQTQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK-KNS  549 (571)
Q Consensus       495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~slGvvl~elltG~-~p~  549 (571)
                      .....      .....++..|+|||++.+. .++.++||||||+++|||++|. .|+
T Consensus       156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~  206 (258)
T cd05078         156 ITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPL  206 (258)
T ss_pred             cccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCCh
Confidence            65432      2234578899999999764 5899999999999999999995 444

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5.8e-33  Score=281.19  Aligned_cols=198  Identities=26%  Similarity=0.425  Sum_probs=173.8

Q ss_pred             CCCccccccccCceeEEEEEccCCC-eeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEecC
Q 008292          346 KFSTDNKLGEGGFGEVYKGVLPSGQ-EIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVP  424 (571)
Q Consensus       346 ~~~~~~~LG~G~fg~Vy~~~~~~g~-~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  424 (571)
                      .|.++..||.|+||.||+++.++.. ..|.|.+...++...+++.-||+||+..+||+||+|++.+...+.+||..|||.
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~  112 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG  112 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence            3556678999999999999987544 346788888888889999999999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCcc
Q 008292          425 NKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG  504 (571)
Q Consensus       425 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  504 (571)
                      ||-.+.++..  -+..+++.++..+++|++.||.|||++.   |||||||+.|||++-+|.++|+|||.+....  ....
T Consensus       113 GGAVDaimlE--L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~--~t~q  185 (1187)
T KOG0579|consen  113 GGAVDAIMLE--LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNK--STRQ  185 (1187)
T ss_pred             CchHhHHHHH--hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccch--hHHh
Confidence            9999988743  4567999999999999999999999987   9999999999999999999999999987542  2223


Q ss_pred             ccccccccCCccccccc-----ccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          505 NTSRIVGTYGYMAPEYA-----MHGQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       505 ~~~~~~gt~~y~aPE~~-----~~~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      ....+.|||.|||||+.     .+.+|..++||||||++|.||..+.+|..
T Consensus       186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHh  236 (1187)
T KOG0579|consen  186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHH  236 (1187)
T ss_pred             hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcc
Confidence            34567899999999987     46689999999999999999999999864

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.97  E-value=2.7e-31  Score=265.37  Aligned_cols=202  Identities=33%  Similarity=0.506  Sum_probs=170.6

Q ss_pred             CCCCccccccccCceeEEEEEcc-----CCCeeEEEeecccCcc-CHHHHHHHHHHHhhcCCCceeccceeEEe--CCee
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-----SGQEIAVKRLSKASGQ-GAEEFKNEVVLVAKLQHRNLVRLLGFCLE--GEEK  416 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-----~g~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~~~~  416 (571)
                      +.|...+.||+|+||.||++++.     ++..+|+|.++..... ..+.+.+|+++++.++|+||+++++++..  +...
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            45777899999999999999853     3678999999765443 46789999999999999999999999877  5578


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccc
Q 008292          417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI  496 (571)
Q Consensus       417 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  496 (571)
                      +++|||+++++|.+++...  ...+++..++.++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||++..
T Consensus        84 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV  158 (284)
T ss_pred             EEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence            9999999999999998532  235899999999999999999999887   99999999999999999999999999987


Q ss_pred             cCCCCCcc-ccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          497 FGVDQTQG-NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       497 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ........ ......++..|++||.+.+..++.++||||||+++|||+||+.|+..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~  214 (284)
T cd05038         159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQS  214 (284)
T ss_pred             cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCccc
Confidence            65322211 11122445679999999888999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.97  E-value=2.6e-31  Score=262.29  Aligned_cols=192  Identities=30%  Similarity=0.458  Sum_probs=166.7

Q ss_pred             ccccCceeEEEEEcc-CCCeeEEEeecccCc---cCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEecCCCCh
Q 008292          353 LGEGGFGEVYKGVLP-SGQEIAVKRLSKASG---QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL  428 (571)
Q Consensus       353 LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  428 (571)
                      ||+|+||.||+++.. +|+.+++|.+.....   ...+.+.+|++++++++||||+++++.+..+...++++||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999976 489999999875433   4456788999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCC------
Q 008292          429 DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT------  502 (571)
Q Consensus       429 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~------  502 (571)
                      .+++..   ...+++..+..++.|+++||.|||+.+   ++|+||+|+||++++++.+||+|||++........      
T Consensus        81 ~~~l~~---~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  154 (265)
T cd05579          81 ASLLEN---VGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD  154 (265)
T ss_pred             HHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence            999843   347899999999999999999999887   99999999999999999999999999875432211      


Q ss_pred             ccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          503 QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       503 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      ........++..|++||.......+.++||||||+++|||++|+.|+.
T Consensus       155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~  202 (265)
T cd05579         155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFH  202 (265)
T ss_pred             cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence            112233467889999999988889999999999999999999999975

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.97  E-value=2.9e-31  Score=266.46  Aligned_cols=199  Identities=28%  Similarity=0.444  Sum_probs=167.5

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeecccCc-cCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASG-QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      ++|+..+.||+|++|.||++..+ +++.|++|.+..... .....+.+|+++++.++|+||+++++++.+.+..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            57888999999999999999965 678999999875432 2234567899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT  502 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  502 (571)
                      +++ +|.+++..  ....+++..+..++.|+++||.|||+.+   |+||||||+||++++++.+||+|||+++.......
T Consensus        85 ~~~-~L~~~~~~--~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  158 (291)
T cd07844          85 LDT-DLKQYMDD--CGGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK  158 (291)
T ss_pred             CCC-CHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence            985 88888743  2346889999999999999999999887   99999999999999999999999999875432211


Q ss_pred             ccccccccccCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          503 QGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       503 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .  .....++..|+|||.+.+ ..++.++||||+|+++|||++|+.||..
T Consensus       159 ~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~  206 (291)
T cd07844         159 T--YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPG  206 (291)
T ss_pred             c--ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            1  122346788999998875 4588999999999999999999999853

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.97  E-value=5.8e-31  Score=259.98  Aligned_cols=192  Identities=29%  Similarity=0.402  Sum_probs=167.4

Q ss_pred             ccccCceeEEEEEcc-CCCeeEEEeecccC---ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEecCCCCh
Q 008292          353 LGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL  428 (571)
Q Consensus       353 LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  428 (571)
                      ||.|++|.||+++.. +++.+++|++.+..   ....+.+.+|+++++.++||||+++++.+.++...++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            699999999999975 48899999986533   23446789999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCcccccc
Q 008292          429 DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR  508 (571)
Q Consensus       429 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  508 (571)
                      .+++..   ...+++..+..++.|+++||.|||+.+   ++|+||+|+||+++.++.+||+|||++.......   ....
T Consensus        81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~  151 (262)
T cd05572          81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT  151 (262)
T ss_pred             HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence            999843   345899999999999999999999987   9999999999999999999999999998664332   1223


Q ss_pred             ccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 008292          509 IVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQ  553 (571)
Q Consensus       509 ~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~~~  553 (571)
                      ..++..|++||.+.+..++.++|+||||+++|||++|+.|+....
T Consensus       152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  196 (262)
T cd05572         152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD  196 (262)
T ss_pred             ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence            467889999999988889999999999999999999999986443

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.97  E-value=4.9e-31  Score=264.17  Aligned_cols=201  Identities=28%  Similarity=0.487  Sum_probs=175.2

Q ss_pred             HhCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEE
Q 008292          343 ATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE  421 (571)
Q Consensus       343 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e  421 (571)
                      ..+.|+..+.||+|++|.||++..+ ++..+++|+++.... ..+.+.+|+++++.++|+||+++++.+......++++|
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   95 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME   95 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence            3456888899999999999999976 688999999976544 56778899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCC
Q 008292          422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ  501 (571)
Q Consensus       422 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  501 (571)
                      |+++++|.+++....  ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        96 ~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  170 (286)
T cd06614          96 YMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK  170 (286)
T ss_pred             ccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence            999999999995422  37899999999999999999999877   9999999999999999999999999987553222


Q ss_pred             CccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          502 TQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       502 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .  ......++..|++||.+.+..++.++||||||+++|||++|+.|+..
T Consensus       171 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~  218 (286)
T cd06614         171 S--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLR  218 (286)
T ss_pred             h--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCC
Confidence            1  12234578899999999888899999999999999999999999764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.97  E-value=7.3e-31  Score=256.78  Aligned_cols=199  Identities=34%  Similarity=0.543  Sum_probs=175.9

Q ss_pred             CCCccccccccCceeEEEEEcc-CCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEecC
Q 008292          346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVP  424 (571)
Q Consensus       346 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  424 (571)
                      +|...+.||+|++|.||++... +++.+++|++........+.+.+|+.++++++|+||+++++++......++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            3677889999999999999975 688999999987665567789999999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCcc
Q 008292          425 NKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG  504 (571)
Q Consensus       425 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  504 (571)
                      +++|.+++...  ...+++..+..++.|++++|.+||+.+   ++||||+|+||++++++.++|+|||.+........  
T Consensus        81 ~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--  153 (253)
T cd05122          81 GGSLKDLLKST--NQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--  153 (253)
T ss_pred             CCcHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence            99999988432  257899999999999999999999976   99999999999999999999999999986643321  


Q ss_pred             ccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 008292          505 NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFY  552 (571)
Q Consensus       505 ~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~~  552 (571)
                       .....++..|++||.+....++.++||||||++++||++|+.|+...
T Consensus       154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  200 (253)
T cd05122         154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSEL  200 (253)
T ss_pred             -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence             23456888999999998888999999999999999999999998643

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.97  E-value=2.1e-31  Score=266.43  Aligned_cols=197  Identities=26%  Similarity=0.454  Sum_probs=165.8

Q ss_pred             CCCccccccccCceeEEEEEcc-CCCeeEEEeecccC--ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       346 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      +|+..+.||+|+||.||+++.. +|+.|++|+++...  ......+.+|+.++++++||||+++++++.+....++++||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4778899999999999999964 68899999986532  22335678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT  502 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  502 (571)
                      +++ +|.+++..  ....+++..++.++.||++||.|||+.+   |+||||||+||+++.++.+||+|||+++.+.....
T Consensus        81 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  154 (284)
T cd07839          81 CDQ-DLKKYFDS--CNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR  154 (284)
T ss_pred             CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence            975 67666632  2456899999999999999999999987   99999999999999999999999999986543221


Q ss_pred             ccccccccccCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          503 QGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       503 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                        ......++..|+|||.+.+. .++.++||||||+++|||+||+.|+.
T Consensus       155 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~  201 (284)
T cd07839         155 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF  201 (284)
T ss_pred             --CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCc
Confidence              11233568899999998765 47899999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.97  E-value=3.9e-31  Score=264.58  Aligned_cols=198  Identities=28%  Similarity=0.467  Sum_probs=170.0

Q ss_pred             CCCccccccccCceeEEEEEcc-CCCeeEEEeecccC--ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       346 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      +|++.+.||+|++|.||++... +|+.|++|++....  ....+.+.+|+.++++++||||+++++++..+...++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4778899999999999999964 68899999987644  33456789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT  502 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  502 (571)
                      + +++|.+++...  ...+++.+++.++.||+++|.|||+.+   ++|+||||+||++++++.++|+|||++........
T Consensus        81 ~-~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (286)
T cd07832          81 M-PSDLSEVLRDE--ERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP  154 (286)
T ss_pred             c-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence            9 99999988532  356899999999999999999999887   99999999999999999999999999987643321


Q ss_pred             ccccccccccCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          503 QGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       503 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                       .......++..|+|||.+.+. .++.++||||+|++++||+||+.|+.
T Consensus       155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~  202 (286)
T cd07832         155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFP  202 (286)
T ss_pred             -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcC
Confidence             112234688999999988654 46899999999999999999977664

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.97  E-value=5.9e-31  Score=262.32  Aligned_cols=192  Identities=30%  Similarity=0.439  Sum_probs=164.7

Q ss_pred             ccccCceeEEEEEcc-CCCeeEEEeecccC---ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEecCCCCh
Q 008292          353 LGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL  428 (571)
Q Consensus       353 LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  428 (571)
                      ||+|+||+||++... +|+.|++|.+....   ....+.+.+|+++++.++||||+++++.+...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            699999999999854 68899999886532   22344567899999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCcccccc
Q 008292          429 DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR  508 (571)
Q Consensus       429 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  508 (571)
                      .+++... ....+++..+..++.|++.||.|||+.+   ++||||+|+||++++++.+||+|||++.......   ....
T Consensus        81 ~~~l~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~  153 (277)
T cd05577          81 KYHIYNV-GEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKG  153 (277)
T ss_pred             HHHHHHc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC---cccc
Confidence            9988542 2246899999999999999999999987   9999999999999999999999999987653211   1223


Q ss_pred             ccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          509 IVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       509 ~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ..++..|+|||.+.+..++.++||||||++++||++|+.||..
T Consensus       154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  196 (277)
T cd05577         154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQ  196 (277)
T ss_pred             ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCC
Confidence            4577899999999888899999999999999999999999854

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.97  E-value=2.2e-31  Score=263.33  Aligned_cols=199  Identities=30%  Similarity=0.430  Sum_probs=173.2

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      ++|+..+.||+|++|.||++..+ +++.+++|++.... ....+++.+|++++++++||||+++++.+......++++||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            35778889999999999999975 58889999987653 34456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE-DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ  501 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  501 (571)
                      +++++|.+++...  ...+++..+.+++.|++++|+|||+ .+   ++|+||+|+||++++++.+||+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~  155 (265)
T cd06605          81 MDGGSLDKILKEV--QGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL  155 (265)
T ss_pred             cCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence            9999999998532  2678999999999999999999998 65   9999999999999999999999999987653221


Q ss_pred             CccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 008292          502 TQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFY  552 (571)
Q Consensus       502 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~~  552 (571)
                      .    ....++..|+|||.+.+..++.++||||||+++|||++|+.|+...
T Consensus       156 ~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~  202 (265)
T cd06605         156 A----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE  202 (265)
T ss_pred             h----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence            1    1156788999999999999999999999999999999999998643

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.97  E-value=4.9e-31  Score=262.12  Aligned_cols=201  Identities=29%  Similarity=0.457  Sum_probs=164.8

Q ss_pred             CCccccccccCceeEEEEEcc----CCCeeEEEeeccc--CccCHHHHHHHHHHHhhcCCCceeccceeEEeCC------
Q 008292          347 FSTDNKLGEGGFGEVYKGVLP----SGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE------  414 (571)
Q Consensus       347 ~~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------  414 (571)
                      |.+.+.||+|+||.||+|.+.    .+..||||+++..  .....+++.+|++++++++||||+++++++...+      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            566789999999999999853    3678999988654  2334567889999999999999999999886543      


Q ss_pred             eeEEEEEecCCCChhhhhcCC---CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeec
Q 008292          415 EKILVYEFVPNKSLDYFLYDP---EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDF  491 (571)
Q Consensus       415 ~~~lv~e~~~~g~L~~~l~~~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  491 (571)
                      ..++++||+++|+|..++...   .+...+++...+.++.|++.||+|||+.+   |+||||||+||++++++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence            247899999999998876422   12235788999999999999999999887   999999999999999999999999


Q ss_pred             cCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 008292          492 GMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSN  550 (571)
Q Consensus       492 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~  550 (571)
                      |+++...............+++.|++||.+....++.++||||||+++|||++ |+.|+.
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~  217 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYA  217 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCC
Confidence            99986543322222223345678999999999999999999999999999999 788864

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.97  E-value=3.3e-31  Score=264.81  Aligned_cols=206  Identities=29%  Similarity=0.474  Sum_probs=170.7

Q ss_pred             HHHHHHhCCCCccccccccCceeEEEEEc-cCCCeeEEEeecccCccCHHHHHHHHHHHhhc-CCCceeccceeEEe---
Q 008292          338 ETIEVATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLE---  412 (571)
Q Consensus       338 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~---  412 (571)
                      ..+..+.+.|++.+.||+|+||+||++.. .+++.+++|.+.... ....++..|+.++.++ +|+||+++++++..   
T Consensus         9 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~   87 (282)
T cd06636           9 SALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSP   87 (282)
T ss_pred             hhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccc
Confidence            33444567889999999999999999996 467889999886543 3345788899999998 69999999999863   


Q ss_pred             ---CCeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEe
Q 008292          413 ---GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKIS  489 (571)
Q Consensus       413 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  489 (571)
                         ....+++|||+++|+|.+++... ....+++..++.++.|+++||.|||+.+   |+|+||+|+||++++++.++|+
T Consensus        88 ~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~  163 (282)
T cd06636          88 PGHDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLV  163 (282)
T ss_pred             cCCCCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEe
Confidence               35679999999999999988542 3345888899999999999999999987   9999999999999999999999


Q ss_pred             eccCccccCCCCCccccccccccCCcccccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          490 DFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM-----HGQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       490 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      |||++.......  .......|+..|+|||.+.     ...++.++||||||+++|||++|+.||.
T Consensus       164 dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~  227 (282)
T cd06636         164 DFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLC  227 (282)
T ss_pred             eCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCcc
Confidence            999987653221  1223356889999999875     3468889999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=3.7e-33  Score=303.78  Aligned_cols=204  Identities=31%  Similarity=0.438  Sum_probs=172.9

Q ss_pred             HhCCCCccccccccCceeEEEEEc-cCCCeeEEEeecccC--ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEE
Q 008292          343 ATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV  419 (571)
Q Consensus       343 ~~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  419 (571)
                      .+-++....+||.|.||.||.+.. .+|+..|+|.++...  ......+.+|..++..++|||+|+++|+-.+.++.+|.
T Consensus      1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred             ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence            345677778999999999999994 568889999876533  34456788999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCC
Q 008292          420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV  499 (571)
Q Consensus       420 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  499 (571)
                      ||||++|+|.+.+.   .+...++.....+..|++.|+.|||+++   ||||||||.||+|+.+|.+|++|||.|..+..
T Consensus      1313 MEyC~~GsLa~ll~---~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLE---HGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred             HHHhccCcHHHHHH---hcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecC
Confidence            99999999999983   3334566666778899999999999998   99999999999999999999999999998765


Q ss_pred             CC--CccccccccccCCcccccccccC---CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 008292          500 DQ--TQGNTSRIVGTYGYMAPEYAMHG---QFSVKSDVYSFGVLVLEIITGKKNSNFY  552 (571)
Q Consensus       500 ~~--~~~~~~~~~gt~~y~aPE~~~~~---~~s~~~Dv~slGvvl~elltG~~p~~~~  552 (571)
                      ..  .........||+.|||||++.+.   ....+.||||+|||+.||+||++||..+
T Consensus      1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~ 1444 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAEL 1444 (1509)
T ss_pred             chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhc
Confidence            42  12223456899999999999764   3567899999999999999999998654

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.97  E-value=7.3e-31  Score=260.33  Aligned_cols=201  Identities=27%  Similarity=0.467  Sum_probs=168.5

Q ss_pred             CCCccccccccCceeEEEEEccC--CCeeEEEeeccc----------CccCHHHHHHHHHHHhh-cCCCceeccceeEEe
Q 008292          346 KFSTDNKLGEGGFGEVYKGVLPS--GQEIAVKRLSKA----------SGQGAEEFKNEVVLVAK-LQHRNLVRLLGFCLE  412 (571)
Q Consensus       346 ~~~~~~~LG~G~fg~Vy~~~~~~--g~~vavK~~~~~----------~~~~~~~~~~Ei~~l~~-l~h~niv~l~~~~~~  412 (571)
                      .|++.+.||+|+||.||++....  ++.+++|.+...          ......++.+|+.++.+ ++||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            37788999999999999999754  678999987532          12233456778888865 799999999999999


Q ss_pred             CCeeEEEEEecCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeec
Q 008292          413 GEEKILVYEFVPNKSLDYFLYDP-EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDF  491 (571)
Q Consensus       413 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  491 (571)
                      ++..+++|||+++++|.+++... .....+++..++.++.|++.+|.|||+..  +++|+||+|+||+++.++.+||+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence            99999999999999998877431 23456899999999999999999999632  3999999999999999999999999


Q ss_pred             cCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          492 GMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       492 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      |++.......   ......++..|++||.+.+..++.++||||||+++|||++|+.|+..
T Consensus       159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~  215 (269)
T cd08528         159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS  215 (269)
T ss_pred             cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccc
Confidence            9998654332   22345688899999999998999999999999999999999999743

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.97  E-value=5.4e-31  Score=265.40  Aligned_cols=197  Identities=29%  Similarity=0.437  Sum_probs=166.9

Q ss_pred             CCCccccccccCceeEEEEEcc-CCCeeEEEeecccCcc-----CHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEE
Q 008292          346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQ-----GAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV  419 (571)
Q Consensus       346 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-----~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  419 (571)
                      +|+..+.||+|++|.||+|... +++.|++|+++.....     ....+.+|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4677889999999999999964 6889999999764322     234677899999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCC
Q 008292          420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV  499 (571)
Q Consensus       420 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  499 (571)
                      |||+ +++|.+++...  ...+++..++.++.||++||.|||+++   ++|+||+|+||+++.++.+||+|||+++....
T Consensus        81 ~e~~-~~~L~~~i~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          81 FEFM-ETDLEKVIKDK--SIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS  154 (298)
T ss_pred             Eccc-CCCHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence            9999 89999998532  236899999999999999999999987   99999999999999999999999999987643


Q ss_pred             CCCccccccccccCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          500 DQTQGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       500 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      ...  ......+++.|+|||.+.+ ..++.++||||||+++|||++|..|+.
T Consensus       155 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~  204 (298)
T cd07841         155 PNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLP  204 (298)
T ss_pred             CCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCcccc
Confidence            321  1222346778999998854 467899999999999999999976654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=3.6e-31  Score=284.70  Aligned_cols=202  Identities=22%  Similarity=0.385  Sum_probs=158.2

Q ss_pred             HhCCCCccccccccCceeEEEEEccC--CCeeEEE--------------eec---ccCccCHHHHHHHHHHHhhcCCCce
Q 008292          343 ATNKFSTDNKLGEGGFGEVYKGVLPS--GQEIAVK--------------RLS---KASGQGAEEFKNEVVLVAKLQHRNL  403 (571)
Q Consensus       343 ~~~~~~~~~~LG~G~fg~Vy~~~~~~--g~~vavK--------------~~~---~~~~~~~~~~~~Ei~~l~~l~h~ni  403 (571)
                      ..++|++.++||+|+||+||++..+.  +...++|              .+.   .........+.+|+.++++++||||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            45789999999999999999987532  2222222              111   1112234568899999999999999


Q ss_pred             eccceeEEeCCeeEEEEEecCCCChhhhhcCCC--CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEEC
Q 008292          404 VRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPE--KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD  481 (571)
Q Consensus       404 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~  481 (571)
                      +++++++...+..++++|++.+ +|.+++....  .........+..++.||+.||.|||+++   |+||||||+|||++
T Consensus       226 v~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~  301 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLN  301 (501)
T ss_pred             CcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEC
Confidence            9999999999999999999854 5555553221  1222345677889999999999999987   99999999999999


Q ss_pred             CCCceEEeeccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCC
Q 008292          482 AEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNS  549 (571)
Q Consensus       482 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~  549 (571)
                      .++.+||+|||+++.+..... .......||..|+|||++.+..++.++|||||||++|||++|+.++
T Consensus       302 ~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p  368 (501)
T PHA03210        302 CDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP  368 (501)
T ss_pred             CCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence            999999999999987643222 1222357999999999999999999999999999999999988643

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.97  E-value=4.8e-31  Score=263.63  Aligned_cols=201  Identities=27%  Similarity=0.382  Sum_probs=164.2

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC-ccCHHHHHHHHHH-HhhcCCCceeccceeEEeCCeeEEEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS-GQGAEEFKNEVVL-VAKLQHRNLVRLLGFCLEGEEKILVYE  421 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~-l~~l~h~niv~l~~~~~~~~~~~lv~e  421 (571)
                      ++|++.+.||+|+||.||+++.. +|+.||+|+++... .....++..|+.+ ++.++||||+++++++..+...+++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            46888999999999999999965 68999999987543 2233455556664 566789999999999999999999999


Q ss_pred             ecCCCChhhhhcC-CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCC
Q 008292          422 FVPNKSLDYFLYD-PEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD  500 (571)
Q Consensus       422 ~~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  500 (571)
                      |++ ++|.+++.. ......+++..++.++.||+.||.|||++.  +++||||||+||+++.++.+||+|||+++.+...
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS  157 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence            997 677777643 223457899999999999999999999861  3999999999999999999999999999865322


Q ss_pred             CCccccccccccCCccccccccc----CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          501 QTQGNTSRIVGTYGYMAPEYAMH----GQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       501 ~~~~~~~~~~gt~~y~aPE~~~~----~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .   ......++..|+|||.+.+    ..++.++||||||+++|||++|+.|+..
T Consensus       158 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~  209 (283)
T cd06617         158 V---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS  209 (283)
T ss_pred             c---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence            1   1223457889999998854    4578899999999999999999999863

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.97  E-value=4.5e-32  Score=250.41  Aligned_cols=198  Identities=27%  Similarity=0.450  Sum_probs=163.4

Q ss_pred             CCCccccccccCceeEEEEEcc-CCCeeEEEeecccC-ccCHHHHHHHHHHHhhcC-CCceeccceeEEeCCeeEEEEEe
Q 008292          346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       346 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      +++.+..||.|+.|+|++...+ .|...|||.+.+.. .+..+++...++++.+-. .|+||+.+|+|......++.||.
T Consensus        93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel  172 (391)
T KOG0983|consen   93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL  172 (391)
T ss_pred             HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence            3445678999999999999975 58889999997653 445567777777766554 89999999999999999999998


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT  502 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  502 (571)
                      | ...++.++.  +..+++++..+-++...+.+||.||.++.  +|+|||+||+|||+|+.|++||+|||++..+-... 
T Consensus       173 M-s~C~ekLlk--rik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk-  246 (391)
T KOG0983|consen  173 M-STCAEKLLK--RIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK-  246 (391)
T ss_pred             H-HHHHHHHHH--HhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc-
Confidence            8 445666663  23456888888899999999999998765  69999999999999999999999999997664332 


Q ss_pred             ccccccccccCCccccccccc---CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          503 QGNTSRIVGTYGYMAPEYAMH---GQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       503 ~~~~~~~~gt~~y~aPE~~~~---~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                        ..++..|-+.|||||.+..   ..|..++||||||+.++||.||+.|+..
T Consensus       247 --AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~  296 (391)
T KOG0983|consen  247 --AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKG  296 (391)
T ss_pred             --ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCC
Confidence              3345578889999999954   4688999999999999999999999864

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=3.6e-32  Score=241.54  Aligned_cols=212  Identities=27%  Similarity=0.386  Sum_probs=172.4

Q ss_pred             hHHHHHHhCCCCccccccccCceeEEEEEc-cCCCeeEEEeecccC-ccCHHHHHHHHHHHhh-cCCCceeccceeEEeC
Q 008292          337 FETIEVATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS-GQGAEEFKNEVVLVAK-LQHRNLVRLLGFCLEG  413 (571)
Q Consensus       337 ~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~-l~h~niv~l~~~~~~~  413 (571)
                      ...+++..+.+.....||+|++|.|-+-++ .+|...|+|+++... .+..++..+|+.+..+ ...|.+|.++|...+.
T Consensus        38 ~~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~re  117 (282)
T KOG0984|consen   38 DRNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFRE  117 (282)
T ss_pred             cCccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcc
Confidence            334667777778888999999999988884 589999999997543 3445566778876544 5799999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhcC-CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeecc
Q 008292          414 EEKILVYEFVPNKSLDYFLYD-PEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG  492 (571)
Q Consensus       414 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG  492 (571)
                      ...++.||.| ..+|+.|-.. ..++..+++..+-+|+..+.+||.|||++-  .+||||+||+||||+.+|++||+|||
T Consensus       118 gdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFG  194 (282)
T KOG0984|consen  118 GDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFG  194 (282)
T ss_pred             ccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccc
Confidence            9999999988 5677766432 135677999999999999999999999854  69999999999999999999999999


Q ss_pred             CccccCCCCCccccccccccCCccccccccc----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 008292          493 MARIFGVDQTQGNTSRIVGTYGYMAPEYAMH----GQFSVKSDVYSFGVLVLEIITGKKNSNFYQT  554 (571)
Q Consensus       493 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~~~Dv~slGvvl~elltG~~p~~~~~~  554 (571)
                      .+-.+..+...   +.-.|-..|||||.+..    ..|+-|+||||||+.+.||.+++.|++.+..
T Consensus       195 IsG~L~dSiAk---t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t  257 (282)
T KOG0984|consen  195 ISGYLVDSIAK---TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT  257 (282)
T ss_pred             cceeehhhhHH---HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence            99876433221   12346678999999843    3689999999999999999999999987643

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.97  E-value=4.3e-31  Score=265.24  Aligned_cols=208  Identities=29%  Similarity=0.414  Sum_probs=171.7

Q ss_pred             HHHHHHhCCCCccccccccCceeEEEEEc-cCCCeeEEEeecccCccCHHHHHHHHHHHhhc-CCCceeccceeEEeCC-
Q 008292          338 ETIEVATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGE-  414 (571)
Q Consensus       338 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~-  414 (571)
                      ..+..+.++|.+.+.||+|+||.||++.. .+++.+++|.+.... ...+.+.+|+.++.++ +||||+++++++...+ 
T Consensus        15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~   93 (291)
T cd06639          15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADK   93 (291)
T ss_pred             ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence            34445578899999999999999999996 468889999886532 2346778899999998 8999999999987543 


Q ss_pred             ----eeEEEEEecCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEe
Q 008292          415 ----EKILVYEFVPNKSLDYFLYDP-EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKIS  489 (571)
Q Consensus       415 ----~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  489 (571)
                          ..++|+||+++++|.+++... .....+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+
T Consensus        94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl~  170 (291)
T cd06639          94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLV  170 (291)
T ss_pred             cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEe
Confidence                579999999999999887532 23456899999999999999999999887   9999999999999999999999


Q ss_pred             eccCccccCCCCCccccccccccCCcccccccccC-----CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          490 DFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG-----QFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       490 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      |||+++........  .....|+..|+|||.+...     .++.++||||||+++|||++|+.|+..
T Consensus       171 dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~  235 (291)
T cd06639         171 DFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFD  235 (291)
T ss_pred             ecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCC
Confidence            99998865432211  1234678899999987543     368999999999999999999999753

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.97  E-value=6.3e-31  Score=263.30  Aligned_cols=196  Identities=28%  Similarity=0.462  Sum_probs=170.8

Q ss_pred             CCCccccccccCceeEEEEEc-cCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEecC
Q 008292          346 KFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVP  424 (571)
Q Consensus       346 ~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  424 (571)
                      .|...+.||+|++|.||++.. .+++.+++|++........+.+.+|+.+++.++||||+++++++..++..++++||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            345567999999999999985 4688899999876555556678899999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCcc
Q 008292          425 NKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG  504 (571)
Q Consensus       425 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  504 (571)
                      +++|.+++..    ..+++..+..++.|++.||+|||+++   |+||||+|+||+++.++.++|+|||++........  
T Consensus       100 ~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--  170 (285)
T cd06648         100 GGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--  170 (285)
T ss_pred             CCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc--
Confidence            9999998843    46899999999999999999999987   99999999999999999999999998875533221  


Q ss_pred             ccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          505 NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       505 ~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      ......|+..|+|||.+.+..++.++||||||+++|||++|+.|+.
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~  216 (285)
T cd06648         171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYF  216 (285)
T ss_pred             ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCc
Confidence            1223458889999999988889999999999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.97  E-value=6.5e-31  Score=258.53  Aligned_cols=199  Identities=40%  Similarity=0.596  Sum_probs=169.1

Q ss_pred             CCccccccccCceeEEEEEccC-----CCeeEEEeecccCcc-CHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEE
Q 008292          347 FSTDNKLGEGGFGEVYKGVLPS-----GQEIAVKRLSKASGQ-GAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY  420 (571)
Q Consensus       347 ~~~~~~LG~G~fg~Vy~~~~~~-----g~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  420 (571)
                      +.+.+.||+|+||.||+++..+     +..|++|+++..... ..+.+.+|+.++..++|+||+++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            3567899999999999999753     378999999765433 5678999999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCC
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD  500 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  500 (571)
                      ||+++++|.+++.... ...+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||+++.....
T Consensus        81 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       81 EYMEGGDLLDYLRKNR-PKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             eccCCCCHHHHHHhhh-hccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence            9999999999985321 112899999999999999999999987   999999999999999999999999999866443


Q ss_pred             CCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 008292          501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSN  550 (571)
Q Consensus       501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~  550 (571)
                      ...... ...+++.|+|||.+....++.++||||||++++||++ |+.|+.
T Consensus       157 ~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~  206 (258)
T smart00219      157 DYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYP  206 (258)
T ss_pred             cccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence            221111 2236789999999988889999999999999999999 777765

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.97  E-value=7e-31  Score=258.22  Aligned_cols=199  Identities=26%  Similarity=0.421  Sum_probs=171.0

Q ss_pred             CCCccccccccCceeEEEEEc-cCCCeeEEEeeccc--CccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          346 KFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       346 ~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      +|...+.||+|++|.||++.. .+++.+++|++...  .....+.+.+|++++++++||||+++++.+..++..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            477889999999999999986 46788999998654  234457889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCC-CceEEeeccCccccCCCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE-MNPKISDFGMARIFGVDQ  501 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfGla~~~~~~~  501 (571)
                      +++++|.+++... ....+++..+..++.|++++|.|||+++   ++|+||+|+||+++++ +.+||+|||++.......
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (256)
T cd08220          81 APGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS  156 (256)
T ss_pred             CCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence            9999999998532 2345899999999999999999999987   9999999999999865 468999999998654322


Q ss_pred             CccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          502 TQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       502 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                         ......++..|+|||.+.+..++.++||||||+++|||++|+.|++.
T Consensus       157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~  203 (256)
T cd08220         157 ---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEA  203 (256)
T ss_pred             ---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCccc
Confidence               12234678899999999988899999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.97  E-value=8.4e-31  Score=261.57  Aligned_cols=191  Identities=28%  Similarity=0.407  Sum_probs=157.6

Q ss_pred             cccccCceeEEEEEcc-CCCeeEEEeecccCc---cCHHHHHHHHHHHh---hcCCCceeccceeEEeCCeeEEEEEecC
Q 008292          352 KLGEGGFGEVYKGVLP-SGQEIAVKRLSKASG---QGAEEFKNEVVLVA---KLQHRNLVRLLGFCLEGEEKILVYEFVP  424 (571)
Q Consensus       352 ~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~Ei~~l~---~l~h~niv~l~~~~~~~~~~~lv~e~~~  424 (571)
                      .||+|+||.||++... +++.+|+|.+.+...   .....+.+|..++.   ..+||||+.+++.+..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999964 588999998865321   11233444544433   3479999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCcc
Q 008292          425 NKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG  504 (571)
Q Consensus       425 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  504 (571)
                      +++|.+++.   ....+++..+..++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||++.......   
T Consensus        81 ~~~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---  151 (279)
T cd05633          81 GGDLHYHLS---QHGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---  151 (279)
T ss_pred             CCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence            999998884   3456999999999999999999999987   9999999999999999999999999987553221   


Q ss_pred             ccccccccCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 008292          505 NTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNFY  552 (571)
Q Consensus       505 ~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slGvvl~elltG~~p~~~~  552 (571)
                       .....|+..|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus       152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~  199 (279)
T cd05633         152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQH  199 (279)
T ss_pred             -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCC
Confidence             123468999999998864 56899999999999999999999998643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.97  E-value=8.4e-31  Score=261.98  Aligned_cols=200  Identities=31%  Similarity=0.507  Sum_probs=169.7

Q ss_pred             CCCccccccccCceeEEEEEcc-CCCeeEEEeecccCc-cCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEec
Q 008292          346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASG-QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV  423 (571)
Q Consensus       346 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  423 (571)
                      +|+..++||+|++|.||+|+.. +|+.|++|+++.... ...+.+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            4788899999999999999975 688999999876533 33567788999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCc
Q 008292          424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ  503 (571)
Q Consensus       424 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  503 (571)
                      ++ +|.+++........+++..+..++.|++.||.|||+.+   ++||||+|+||++++++.+||+|||+++....... 
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-  155 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-  155 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence            85 78777754444456899999999999999999999887   99999999999999999999999999976543221 


Q ss_pred             cccccccccCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          504 GNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       504 ~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                       ......++..|++||.+.+. .++.++||||||+++|||++|+.|+..
T Consensus       156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~  203 (284)
T cd07836         156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPG  203 (284)
T ss_pred             -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence             11223568899999988654 578999999999999999999999864

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-31  Score=233.14  Aligned_cols=212  Identities=27%  Similarity=0.430  Sum_probs=172.9

Q ss_pred             CCCccccccccCceeEEEEEcc-CCCeeEEEeecccC--ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       346 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      +|...++||+|.||+||+++.. .++.||+|+++.++  +..-....+||-+++.++|.|||+++++...++...+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            5667789999999999999964 57889999987543  22335668899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT  502 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  502 (571)
                      +. .+|..+..  .-++.++.+....++.|+++||.+.|+++   +.||||||.|.||+.+|++|++|||+++.++.+..
T Consensus        83 cd-qdlkkyfd--slng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr  156 (292)
T KOG0662|consen   83 CD-QDLKKYFD--SLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR  156 (292)
T ss_pred             hh-HHHHHHHH--hcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence            95 45666552  34677899999999999999999999988   99999999999999999999999999998875543


Q ss_pred             ccccccccccCCcccccccccCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHH
Q 008292          503 QGNTSRIVGTYGYMAPEYAMHGQ-FSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYVSI  566 (571)
Q Consensus       503 ~~~~~~~~gt~~y~aPE~~~~~~-~s~~~Dv~slGvvl~elltG~~p~~~~~~~~~~~l~~~~~~  566 (571)
                      ..  +..+-|..|.+|.++.+.+ |+...|+||-||++.|+....+|.-. ..+..+.|.+..|.
T Consensus       157 cy--saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfp-g~dvddqlkrif~~  218 (292)
T KOG0662|consen  157 CY--SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP-GNDVDDQLKRIFRL  218 (292)
T ss_pred             ee--eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCC-CCcHHHHHHHHHHH
Confidence            22  3345689999999998764 88899999999999999987777432 22333344444443

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.97  E-value=8.7e-31  Score=268.69  Aligned_cols=199  Identities=26%  Similarity=0.475  Sum_probs=165.6

Q ss_pred             hCCCCccccccccCceeEEEEEc-cCCCeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeEEeCC-----ee
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE-----EK  416 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-----~~  416 (571)
                      +++|++.++||+|+||.||+|+. .+|+.||+|+++... ......+.+|+.++++++|+||+++++++....     ..
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            46899999999999999999985 468899999986532 234466788999999999999999999876543     47


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccc
Q 008292          417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI  496 (571)
Q Consensus       417 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  496 (571)
                      ++++||+++ +|...+    ....+++..+..++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||+++.
T Consensus        84 ~lv~e~~~~-~l~~~~----~~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~  155 (336)
T cd07849          84 YIVQELMET-DLYKLI----KTQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI  155 (336)
T ss_pred             EEEehhccc-CHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence            899999975 776666    3356899999999999999999999987   99999999999999999999999999976


Q ss_pred             cCCCCCc-cccccccccCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          497 FGVDQTQ-GNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       497 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      ....... .......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~  211 (336)
T cd07849         156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFP  211 (336)
T ss_pred             ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            5432211 11223467899999998754 568999999999999999999999884

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.97  E-value=1.1e-30  Score=261.78  Aligned_cols=201  Identities=28%  Similarity=0.393  Sum_probs=170.6

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeecccCc-cCHHHHHHHHHHHhhcCCCceeccceeEEeC--CeeEEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASG-QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG--EEKILVY  420 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~lv~  420 (571)
                      ++|+..+.||.|++|.||++... +++.+++|.+..... ....++.+|++++++++||||+++++++.+.  ...++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            36788899999999999999974 578899998875432 3456789999999999999999999988654  3679999


Q ss_pred             EecCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCC
Q 008292          421 EFVPNKSLDYFLYDP-EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV  499 (571)
Q Consensus       421 e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  499 (571)
                      ||+++++|.+++... .....+++..+..++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            999999998876421 23456889999999999999999999987   99999999999999999999999999875432


Q ss_pred             CCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 008292          500 DQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFY  552 (571)
Q Consensus       500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~~  552 (571)
                      ..    .....++..|+|||.+.+..++.++||||||+++|||++|+.|+...
T Consensus       158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  206 (287)
T cd06621         158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE  206 (287)
T ss_pred             cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence            21    12345788999999999999999999999999999999999998754

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.97  E-value=1.5e-30  Score=255.69  Aligned_cols=201  Identities=32%  Similarity=0.498  Sum_probs=175.3

Q ss_pred             CCCccccccccCceeEEEEEcc-CCCeeEEEeecccCc--cCHHHHHHHHHHHhhcCCCceeccceeEEeC--CeeEEEE
Q 008292          346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASG--QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG--EEKILVY  420 (571)
Q Consensus       346 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~lv~  420 (571)
                      +|...+.||+|++|.||+|... +++.|++|++.....  ...+.+.+|+.++++++|+||+++++.+...  ...++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4677889999999999999975 688999999876542  4567889999999999999999999999988  8899999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCC
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD  500 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  500 (571)
                      ||+++++|.+++..   ...+++..++.++.|++++|.|||+.+   ++|+||+|+||+++.++.+||+|||.+......
T Consensus        81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  154 (260)
T cd06606          81 EYVSGGSLSSLLKK---FGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI  154 (260)
T ss_pred             EecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence            99999999999843   337899999999999999999999977   999999999999999999999999999876544


Q ss_pred             CCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 008292          501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFY  552 (571)
Q Consensus       501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~~  552 (571)
                      ..........++..|+|||.+.....+.++||||||++++||++|+.|+...
T Consensus       155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  206 (260)
T cd06606         155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSEL  206 (260)
T ss_pred             cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            3211123456888999999998888999999999999999999999998653

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.97  E-value=7.5e-31  Score=262.41  Aligned_cols=199  Identities=29%  Similarity=0.474  Sum_probs=167.9

Q ss_pred             CCCccccccccCceeEEEEEcc-CCCeeEEEeecccC--ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       346 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      +|+..+.||+|++|.||+++.. +++.|+||+++...  ....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4778899999999999999864 68899999886543  23346788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT  502 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  502 (571)
                      +. ++|..++... ....+++..+..++.|+++||+|||+.+   ++|+||+|+||+++.++.+||+|||++..+.....
T Consensus        81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~  155 (284)
T cd07860          81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  155 (284)
T ss_pred             cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence            96 5788877432 3456899999999999999999999887   99999999999999999999999999876543221


Q ss_pred             ccccccccccCCcccccccccCC-CCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          503 QGNTSRIVGTYGYMAPEYAMHGQ-FSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       503 ~~~~~~~~gt~~y~aPE~~~~~~-~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                        ......++..|+|||.+.+.. ++.++||||||+++|||+||+.||..
T Consensus       156 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~  203 (284)
T cd07860         156 --TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG  203 (284)
T ss_pred             --ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence              122235678999999887654 68899999999999999999998753

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.97  E-value=1e-30  Score=262.35  Aligned_cols=199  Identities=28%  Similarity=0.390  Sum_probs=168.8

Q ss_pred             CCCccccccccCceeEEEEEc----cCCCeeEEEeecccC----ccCHHHHHHHHHHHhhc-CCCceeccceeEEeCCee
Q 008292          346 KFSTDNKLGEGGFGEVYKGVL----PSGQEIAVKRLSKAS----GQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEK  416 (571)
Q Consensus       346 ~~~~~~~LG~G~fg~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~  416 (571)
                      +|++.+.||+|+||.||++..    .+|+.||+|+++...    ....+.+.+|+.++.++ +|+||+++++.+..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            467789999999999999985    368899999987532    23346788999999999 599999999999998899


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccc
Q 008292          417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI  496 (571)
Q Consensus       417 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  496 (571)
                      ++|+||+++++|.+++.   ....+++..+..++.|+++||.|||+.+   ++||||+|+|||++.++.+||+|||+++.
T Consensus        81 ~lv~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~  154 (290)
T cd05613          81 HLILDYINGGELFTHLS---QRERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE  154 (290)
T ss_pred             EEEEecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence            99999999999999884   3456889999999999999999999887   99999999999999999999999999986


Q ss_pred             cCCCCCccccccccccCCcccccccccC--CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          497 FGVDQTQGNTSRIVGTYGYMAPEYAMHG--QFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ...... .......|+..|+|||.+...  .++.++||||||+++|||++|+.|+..
T Consensus       155 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~  210 (290)
T cd05613         155 FHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV  210 (290)
T ss_pred             cccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCc
Confidence            543221 122234688999999998753  477899999999999999999999864

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=1.9e-31  Score=272.40  Aligned_cols=199  Identities=28%  Similarity=0.449  Sum_probs=176.3

Q ss_pred             hCCCCccccccccCceeEEEEEc-cCCCeeEEEeecccC--ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY  420 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  420 (571)
                      ...|.+.+.||+|.|+.|..++. ..+..||||.+.+..  ......+.+|+++|..++|||||+++.+.......++||
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~  134 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM  134 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence            45788999999999999999995 468999999998753  233355789999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCC
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD  500 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  500 (571)
                      ||..+|.+.+++.   +.+...+.....++.|+.++++|+|+++   |||||||++||||+.+.++||+|||++..+...
T Consensus       135 eya~~ge~~~yl~---~~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~  208 (596)
T KOG0586|consen  135 EYASGGELFDYLV---KHGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDYG  208 (596)
T ss_pred             EeccCchhHHHHH---hcccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeeccc
Confidence            9999999999993   5566777888899999999999999998   999999999999999999999999999887533


Q ss_pred             CCccccccccccCCcccccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          501 QTQGNTSRIVGTYGYMAPEYAMHGQF-SVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       501 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                         ......+|++.|.|||++.+.++ .+++|+||+|+++|-|+.|..||+.
T Consensus       209 ---~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG  257 (596)
T KOG0586|consen  209 ---LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDG  257 (596)
T ss_pred             ---ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCC
Confidence               23445799999999999988776 4789999999999999999999984

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.97  E-value=1.4e-30  Score=263.62  Aligned_cols=194  Identities=31%  Similarity=0.457  Sum_probs=164.9

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeecccCc---cCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASG---QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY  420 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  420 (571)
                      +.|+..++||+|+||+||+|+.. +++.|++|.+.....   ...+++.+|+++++.++||||+++.+++.+.+..++|+
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            55888899999999999999964 688999998865432   23356889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCC
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD  500 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  500 (571)
                      ||++ |++.+++..  ....+++..+..++.|++.||.|||+.+   |+||||+|+||+++.++.+||+|||++......
T Consensus        95 e~~~-g~l~~~~~~--~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~  168 (307)
T cd06607          95 EYCL-GSASDILEV--HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA  168 (307)
T ss_pred             HhhC-CCHHHHHHH--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence            9997 456555532  2346899999999999999999999887   999999999999999999999999998754321


Q ss_pred             CCccccccccccCCcccccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          501 QTQGNTSRIVGTYGYMAPEYAM---HGQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       501 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                            ....++..|+|||.+.   ...++.++||||||+++|||+||+.|+.
T Consensus       169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~  215 (307)
T cd06607         169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF  215 (307)
T ss_pred             ------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCC
Confidence                  2245788999999874   4568899999999999999999999975

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.97  E-value=1.4e-30  Score=257.16  Aligned_cols=205  Identities=27%  Similarity=0.441  Sum_probs=170.8

Q ss_pred             CCCccccccccCceeEEEEEc-cCCCeeEEEeeccc--CccCHHHHHHHHHHHhhcCCCceeccceeEEe--CCeeEEEE
Q 008292          346 KFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE--GEEKILVY  420 (571)
Q Consensus       346 ~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~~~~~lv~  420 (571)
                      +|++.+.||.|+||.||++.. .++..+++|.+...  .....+.+.+|+.++++++|+||+++++++..  +...+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            477889999999999999985 46788999988643  23345678899999999999999999998764  34578999


Q ss_pred             EecCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHcCC--CCCeEEecCCCCCEEECCCCceEEeeccCcccc
Q 008292          421 EFVPNKSLDYFLYDP-EKQGQLDWSRRYKIIGGIARGILYLHEDS--RLRIIHRDLKASNILLDAEMNPKISDFGMARIF  497 (571)
Q Consensus       421 e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  497 (571)
                      ||+++++|.+++... .....+++..++.++.||++||.|||..+  ..+++|+||+|+||++++++.+||+|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999888532 23457899999999999999999999332  234999999999999999999999999999876


Q ss_pred             CCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 008292          498 GVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFY  552 (571)
Q Consensus       498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~~  552 (571)
                      ......  .....+++.|+|||.+.+..++.++||||||+++|+|++|+.|+...
T Consensus       161 ~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  213 (265)
T cd08217         161 GHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR  213 (265)
T ss_pred             cCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCc
Confidence            433221  22346889999999999889999999999999999999999998643

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.97  E-value=1.8e-30  Score=261.12  Aligned_cols=200  Identities=26%  Similarity=0.391  Sum_probs=165.2

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC--ccCHHHHHHHHHHHhhcC-CCceeccceeEEeCCe-----
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEE-----  415 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~-----  415 (571)
                      ++|++.+.||+|+||.||++... +++.|++|.++...  ......+.+|+.+++.++ ||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46888999999999999999964 68899999876543  223467888999999995 6999999999887665     


Q ss_pred             eEEEEEecCCCChhhhhcCCCC--CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECC-CCceEEeecc
Q 008292          416 KILVYEFVPNKSLDYFLYDPEK--QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-EMNPKISDFG  492 (571)
Q Consensus       416 ~~lv~e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfG  492 (571)
                      .++||||+++ +|.+++.....  ...+++..++.++.||++||.|||+++   |+||||+|+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence            7999999986 78777643222  356899999999999999999999887   999999999999998 8899999999


Q ss_pred             CccccCCCCCccccccccccCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          493 MARIFGVDQTQGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       493 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      +++.+.....  ......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||.
T Consensus       157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~  213 (295)
T cd07837         157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFP  213 (295)
T ss_pred             cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCC
Confidence            9986533221  1122356788999998865 457899999999999999999998875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.97  E-value=6.8e-31  Score=263.97  Aligned_cols=193  Identities=29%  Similarity=0.451  Sum_probs=168.6

Q ss_pred             cccccccCceeEEEEEc-cCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEecCCCCh
Q 008292          350 DNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL  428 (571)
Q Consensus       350 ~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  428 (571)
                      ..+||+|+||.||++.. .+++.|++|++........+.+.+|+.+++.++|+||+++++.+..++..+++|||+++++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            46799999999999986 46889999998665555567789999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCcccccc
Q 008292          429 DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR  508 (571)
Q Consensus       429 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  508 (571)
                      .+++.    ...+++..+..++.|++.+|+|||+.+   ++|+||+|+||+++.++.++|+|||++........  ....
T Consensus       105 ~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~  175 (292)
T cd06657         105 TDIVT----HTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKS  175 (292)
T ss_pred             HHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc--cccc
Confidence            98873    345899999999999999999999987   99999999999999999999999999875533221  1223


Q ss_pred             ccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          509 IVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       509 ~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ..++..|+|||.+....++.++||||||+++|||++|+.|+..
T Consensus       176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~  218 (292)
T cd06657         176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN  218 (292)
T ss_pred             cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            4678899999999888899999999999999999999999753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.97  E-value=1.7e-30  Score=259.15  Aligned_cols=191  Identities=29%  Similarity=0.426  Sum_probs=158.1

Q ss_pred             cccccCceeEEEEEc-cCCCeeEEEeecccCc---cCHHHHHHHHH---HHhhcCCCceeccceeEEeCCeeEEEEEecC
Q 008292          352 KLGEGGFGEVYKGVL-PSGQEIAVKRLSKASG---QGAEEFKNEVV---LVAKLQHRNLVRLLGFCLEGEEKILVYEFVP  424 (571)
Q Consensus       352 ~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~Ei~---~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  424 (571)
                      .||+|+||.||++.. .+++.||+|.+.+...   .....+.+|..   +++...||+|+++++.+...+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999986 4588999998865321   11223344433   4444679999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCcc
Q 008292          425 NKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG  504 (571)
Q Consensus       425 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  504 (571)
                      +++|..++.   +...+++..+..++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||++..+....   
T Consensus        81 g~~L~~~l~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---  151 (278)
T cd05606          81 GGDLHYHLS---QHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---  151 (278)
T ss_pred             CCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence            999998883   3457999999999999999999999887   9999999999999999999999999987553221   


Q ss_pred             ccccccccCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 008292          505 NTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFY  552 (571)
Q Consensus       505 ~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~slGvvl~elltG~~p~~~~  552 (571)
                       .....|+..|+|||.+.++ .++.++||||+|+++|||++|+.||...
T Consensus       152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~  199 (278)
T cd05606         152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH  199 (278)
T ss_pred             -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence             1234689999999998754 6899999999999999999999998644

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.97  E-value=1.1e-30  Score=262.68  Aligned_cols=199  Identities=28%  Similarity=0.418  Sum_probs=167.6

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC--ccCHHHHHHHHHHHhhcCCCceeccceeEEeC--CeeEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG--EEKILV  419 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~lv  419 (571)
                      ++|+..+.||+|+||.||+|+.+ +++.+++|.++...  ......+.+|+.++.+++||||+++++++...  ...++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            46888899999999999999975 57889999987543  22334677899999999999999999998877  789999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCC
Q 008292          420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV  499 (571)
Q Consensus       420 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  499 (571)
                      +||+++ +|.+++..  ....+++..++.++.|++.||+|||+.+   ++|+||+|+||+++.++.+||+|||+++.+..
T Consensus        85 ~e~~~~-~L~~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  158 (293)
T cd07843          85 MEYVEH-DLKSLMET--MKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS  158 (293)
T ss_pred             ehhcCc-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence            999974 88887743  2236899999999999999999999987   99999999999999999999999999986643


Q ss_pred             CCCccccccccccCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          500 DQTQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       500 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ...  ......+++.|+|||.+.+. .++.++||||||+++|||++|+.|+..
T Consensus       159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~  209 (293)
T cd07843         159 PLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPG  209 (293)
T ss_pred             Ccc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCC
Confidence            321  12234578899999988754 468999999999999999999999864

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.97  E-value=1.6e-30  Score=255.90  Aligned_cols=200  Identities=26%  Similarity=0.415  Sum_probs=170.8

Q ss_pred             CCCccccccccCceeEEEEEcc-CCCeeEEEeecccC--ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       346 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      +|...+.||+|+||.||++..+ +|..+++|.+....  ....+.+.+|+.+++.++|+||+++++.+......++++||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4778899999999999999965 57889999986532  23456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCC-ceEEeeccCccccCCCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM-NPKISDFGMARIFGVDQ  501 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGla~~~~~~~  501 (571)
                      +++++|.+++... ....+++..+..++.|+++||.|||+.+   ++|+||+|+||++++++ .+||+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (257)
T cd08225          81 CDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM  156 (257)
T ss_pred             CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence            9999999988532 2345799999999999999999999887   99999999999999886 46999999998664322


Q ss_pred             CccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          502 TQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       502 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .  ......|++.|+|||.+.+..++.++||||||+++|||++|+.|+..
T Consensus       157 ~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~  204 (257)
T cd08225         157 E--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEG  204 (257)
T ss_pred             c--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            1  12234578899999999888999999999999999999999999753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.97  E-value=6.5e-31  Score=258.49  Aligned_cols=193  Identities=35%  Similarity=0.555  Sum_probs=164.9

Q ss_pred             CCCCccccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEecC
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVP  424 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  424 (571)
                      ++|++.+.||+|+||.||++.. +++.|++|.++...  ..+.+.+|+.++++++||||+++++++.. +..+++|||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILH-NGLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcC-CCcEEEEECCC
Confidence            4678899999999999999986 67889999986532  34678899999999999999999998865 45799999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCcc
Q 008292          425 NKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG  504 (571)
Q Consensus       425 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  504 (571)
                      +++|.+++... ....+++..++.++.|+++||.|||+.+   ++||||||+||+++.++.+||+|||+++......   
T Consensus        82 ~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---  154 (254)
T cd05083          82 KGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---  154 (254)
T ss_pred             CCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence            99999998542 2346889999999999999999999887   9999999999999999999999999987542211   


Q ss_pred             ccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 008292          505 NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSN  550 (571)
Q Consensus       505 ~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~  550 (571)
                        .....+..|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus       155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~  199 (254)
T cd05083         155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYP  199 (254)
T ss_pred             --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCc
Confidence              12234568999999998899999999999999999998 888874

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.97  E-value=3.4e-30  Score=255.50  Aligned_cols=191  Identities=25%  Similarity=0.376  Sum_probs=159.6

Q ss_pred             hCCCCccccc--cccCceeEEEEEc-cCCCeeEEEeecccCccCHHHHHHHHHHHhhc-CCCceeccceeEEeCCeeEEE
Q 008292          344 TNKFSTDNKL--GEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILV  419 (571)
Q Consensus       344 ~~~~~~~~~L--G~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv  419 (571)
                      .++|++.+.+  |+|+||.||+++. .++..+++|.+........     |+.....+ +||||+++++.+...+..++|
T Consensus        13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv   87 (267)
T PHA03390         13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLI   87 (267)
T ss_pred             HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEEE
Confidence            4566666666  9999999999995 4678899998865422211     22222222 799999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCC-ceEEeeccCccccC
Q 008292          420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM-NPKISDFGMARIFG  498 (571)
Q Consensus       420 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGla~~~~  498 (571)
                      |||+++++|.+++..   ...+++..+..++.|+++||.|||+.+   ++||||||+||+++.++ .++|+|||+++...
T Consensus        88 ~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~  161 (267)
T PHA03390         88 MDYIKDGDLFDLLKK---EGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG  161 (267)
T ss_pred             EEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence            999999999999843   347899999999999999999999987   99999999999999998 99999999987653


Q ss_pred             CCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          499 VDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ..      ....++..|+|||++.+..++.++||||||+++|||++|+.|+..
T Consensus       162 ~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~  208 (267)
T PHA03390        162 TP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKE  208 (267)
T ss_pred             CC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence            22      123578899999999999999999999999999999999999873

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.97  E-value=1.8e-30  Score=259.58  Aligned_cols=197  Identities=31%  Similarity=0.491  Sum_probs=166.4

Q ss_pred             CCccccccccCceeEEEEEcc-CCCeeEEEeecccC--ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEec
Q 008292          347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV  423 (571)
Q Consensus       347 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  423 (571)
                      |+..++||+|++|.||++... +|..|++|++....  ....+.+.+|++++++++||||+++++++.+++..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            567789999999999999864 78999999987543  233467889999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCc
Q 008292          424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ  503 (571)
Q Consensus       424 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  503 (571)
                      + ++|.+++... ....+++..++.++.|+++||.|||+++   ++||||+|+||+++.++.++|+|||+++.+......
T Consensus        81 ~-~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~  155 (283)
T cd07835          81 D-LDLKKYMDSS-PLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT  155 (283)
T ss_pred             C-cCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence            5 6888887432 2246899999999999999999999886   999999999999999999999999999765332211


Q ss_pred             cccccccccCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          504 GNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       504 ~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                        .....++..|+|||++.+. .++.++||||||+++|||+||+.||.
T Consensus       156 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~  201 (283)
T cd07835         156 --YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFP  201 (283)
T ss_pred             --cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCC
Confidence              1223567899999988664 57899999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=2e-31  Score=267.67  Aligned_cols=205  Identities=28%  Similarity=0.419  Sum_probs=174.7

Q ss_pred             HHHHHhCCCCccccccccCceeEEEEEccCCCeeEEEeecc--cCccCHHHHHHHHHHHhhcC-CCceeccceeEEeCCe
Q 008292          339 TIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSK--ASGQGAEEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEE  415 (571)
Q Consensus       339 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~  415 (571)
                      .+.+....|++.++||.||.+.||++...+.+.+|+|++..  .+.+...-|.+||.+|.+++ |.+|++|++|-..++.
T Consensus       355 ~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~  434 (677)
T KOG0596|consen  355 IIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGY  434 (677)
T ss_pred             eEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCce
Confidence            34556778999999999999999999988888899887753  56677788999999999996 9999999999999999


Q ss_pred             eEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCcc
Q 008292          416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR  495 (571)
Q Consensus       416 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  495 (571)
                      .|||||+= ..+|..+|... ......| .+..+..||+.++.++|+++   |||.||||.|+|+- .|.+||+|||+|.
T Consensus       435 lYmvmE~G-d~DL~kiL~k~-~~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~  507 (677)
T KOG0596|consen  435 LYMVMECG-DIDLNKILKKK-KSIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIAN  507 (677)
T ss_pred             EEEEeecc-cccHHHHHHhc-cCCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhc
Confidence            99999964 67899999532 2222334 77788999999999999998   99999999999984 4689999999999


Q ss_pred             ccCCCCCccccccccccCCcccccccccCC-----------CCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          496 IFGVDQTQGNTSRIVGTYGYMAPEYAMHGQ-----------FSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      .+..+.........+||+.||+||.+....           .++++||||+|||||+|+.|+.||.
T Consensus       508 aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~  573 (677)
T KOG0596|consen  508 AIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFG  573 (677)
T ss_pred             ccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchH
Confidence            988777666666779999999999985432           5689999999999999999999985

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.97  E-value=1.1e-30  Score=262.74  Aligned_cols=204  Identities=18%  Similarity=0.216  Sum_probs=153.5

Q ss_pred             HHhCCCCccccccccCceeEEEEEccCC----CeeEEEeecccCccCHH-----------HHHHHHHHHhhcCCCceecc
Q 008292          342 VATNKFSTDNKLGEGGFGEVYKGVLPSG----QEIAVKRLSKASGQGAE-----------EFKNEVVLVAKLQHRNLVRL  406 (571)
Q Consensus       342 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~g----~~vavK~~~~~~~~~~~-----------~~~~Ei~~l~~l~h~niv~l  406 (571)
                      +..++|.+.++||+|+||.||+|...++    ..+++|...........           ....+...+..++|+||+++
T Consensus         9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~   88 (294)
T PHA02882          9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY   88 (294)
T ss_pred             cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence            4457899999999999999999996543    45566654332221111           11223344566789999999


Q ss_pred             ceeEEeCC----eeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECC
Q 008292          407 LGFCLEGE----EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA  482 (571)
Q Consensus       407 ~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~  482 (571)
                      ++++....    ..++++|++.. ++.+.+.   .....++..+..++.|+++||+|||+.+   |+||||||+|||++.
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~  161 (294)
T PHA02882         89 YGCGSFKRCRMYYRFILLEKLVE-NTKEIFK---RIKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDG  161 (294)
T ss_pred             EEeeeEecCCceEEEEEEehhcc-CHHHHHH---hhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcC
Confidence            99766544    23677777643 4555542   2233578889999999999999999887   999999999999999


Q ss_pred             CCceEEeeccCccccCCCCCc-----cccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 008292          483 EMNPKISDFGMARIFGVDQTQ-----GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFY  552 (571)
Q Consensus       483 ~~~~kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~~  552 (571)
                      ++.+||+|||+++.+......     .......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus       162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~  236 (294)
T PHA02882        162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGF  236 (294)
T ss_pred             CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcc
Confidence            999999999999876432111     1122346999999999999999999999999999999999999999754

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.97  E-value=2e-30  Score=259.37  Aligned_cols=198  Identities=27%  Similarity=0.445  Sum_probs=167.3

Q ss_pred             CCccccccccCceeEEEEEcc-CCCeeEEEeecccC--ccCHHHHHHHHHHHhhcCCCceeccceeEEeC--CeeEEEEE
Q 008292          347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG--EEKILVYE  421 (571)
Q Consensus       347 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~lv~e  421 (571)
                      |++.++||+|++|.||+++.. +++.+++|++....  ....+.+.+|+.++++++|+|++++++++...  +..++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            567789999999999999965 57899999997653  34456788999999999999999999999888  78999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCC
Q 008292          422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ  501 (571)
Q Consensus       422 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  501 (571)
                      |+++ +|.+++..  ....+++..++.++.|+++||+|||+.+   ++|+||+|+||++++++.+||+|||++.......
T Consensus        81 ~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~  154 (287)
T cd07840          81 YMDH-DLTGLLDS--PEVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN  154 (287)
T ss_pred             cccc-cHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence            9975 78877743  2257899999999999999999999887   9999999999999999999999999998664432


Q ss_pred             CccccccccccCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          502 TQGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       502 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .. ......++..|+|||.+.+ ..++.++||||||+++|||+||+.|++.
T Consensus       155 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~  204 (287)
T cd07840         155 SA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQG  204 (287)
T ss_pred             cc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCC
Confidence            21 1223356788999998765 4688999999999999999999999753

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.97  E-value=1.3e-30  Score=264.04  Aligned_cols=202  Identities=28%  Similarity=0.448  Sum_probs=165.2

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC--ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCe------
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEE------  415 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------  415 (571)
                      ++|+..++||+|+||.||++... +++.||+|.+....  ......+.+|++++++++||||+++++++.....      
T Consensus        12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   91 (310)
T cd07865          12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK   91 (310)
T ss_pred             hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence            46889999999999999999964 68899999886432  2233456789999999999999999999876543      


Q ss_pred             --eEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccC
Q 008292          416 --KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM  493 (571)
Q Consensus       416 --~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl  493 (571)
                        .++||||+.+ +|...+..  ....+++.+++.++.||++||.|||+++   ++|+||||+||+++.++.+||+|||+
T Consensus        92 ~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~  165 (310)
T cd07865          92 GSFYLVFEFCEH-DLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGL  165 (310)
T ss_pred             ceEEEEEcCCCc-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCC
Confidence              4999999975 67766632  2346899999999999999999999987   99999999999999999999999999


Q ss_pred             ccccCCCCCc--cccccccccCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 008292          494 ARIFGVDQTQ--GNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFY  552 (571)
Q Consensus       494 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~slGvvl~elltG~~p~~~~  552 (571)
                      +..+......  .......++..|+|||.+.+. .++.++||||||+++|||+||+.|+...
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~  227 (310)
T cd07865         166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGN  227 (310)
T ss_pred             cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence            9866432221  112234578889999988664 4788999999999999999999988643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.5e-30  Score=258.54  Aligned_cols=202  Identities=31%  Similarity=0.488  Sum_probs=170.3

Q ss_pred             HhCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccCccCHHHHHHHHHHHhhc-CCCceeccceeEEeCC------
Q 008292          343 ATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGE------  414 (571)
Q Consensus       343 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~------  414 (571)
                      ..++|++.+.||+|++|.||++..+ +++.+++|++..... ..+++.+|+.+++++ +|+||+++++++....      
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            4578999999999999999999974 578899998875443 346789999999999 6999999999997654      


Q ss_pred             eeEEEEEecCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccC
Q 008292          415 EKILVYEFVPNKSLDYFLYDPE-KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM  493 (571)
Q Consensus       415 ~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl  493 (571)
                      ..++||||+++++|.+++.... ....+++..+..++.|+++||.|||+.+   ++|+||+|+||+++.++.+||+|||+
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~  159 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV  159 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence            4799999999999998885422 2467899999999999999999999887   99999999999999999999999999


Q ss_pred             ccccCCCCCccccccccccCCccccccccc-----CCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          494 ARIFGVDQTQGNTSRIVGTYGYMAPEYAMH-----GQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       494 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      +.......  .......++..|+|||.+..     ..++.++||||||+++|||++|+.|+.
T Consensus       160 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~  219 (275)
T cd06608         160 SAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLC  219 (275)
T ss_pred             ceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCcc
Confidence            87653222  12223468889999998753     357789999999999999999999985

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=6.3e-32  Score=263.92  Aligned_cols=205  Identities=31%  Similarity=0.440  Sum_probs=171.1

Q ss_pred             HhCCCCccccccccCceeEEEEE-ccCCCeeEEEeecc--cCc-----cCHHHHHHHHHHHhhcCCCceeccceeEE-eC
Q 008292          343 ATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSK--ASG-----QGAEEFKNEVVLVAKLQHRNLVRLLGFCL-EG  413 (571)
Q Consensus       343 ~~~~~~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~--~~~-----~~~~~~~~Ei~~l~~l~h~niv~l~~~~~-~~  413 (571)
                      ..++|-.+++||+|+|+.||++. +...+.||+|+-..  ...     .-.+...+|.+|.+.+.||.||++++++. +.
T Consensus       461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt  540 (775)
T KOG1151|consen  461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT  540 (775)
T ss_pred             hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence            34567788999999999999998 45678899997532  221     12234668999999999999999999985 55


Q ss_pred             CeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECC---CCceEEee
Q 008292          414 EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA---EMNPKISD  490 (571)
Q Consensus       414 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~D  490 (571)
                      +..+-|+||++|.+|+-+|   .....++++++..|+.||..||.||.+. +++|||-||||.||||.+   .|.+||+|
T Consensus       541 dsFCTVLEYceGNDLDFYL---KQhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITD  616 (775)
T KOG1151|consen  541 DSFCTVLEYCEGNDLDFYL---KQHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITD  616 (775)
T ss_pred             ccceeeeeecCCCchhHHH---HhhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeee
Confidence            6789999999999999998   3556789999999999999999999987 578999999999999954   47899999


Q ss_pred             ccCccccCCCCCc-----cccccccccCCccccccccc----CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          491 FGMARIFGVDQTQ-----GNTSRIVGTYGYMAPEYAMH----GQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       491 fGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~----~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      |||++.+..+.+.     ..++...||..|++||.+.-    ...+.|+||||+|||+|..+.|++||..
T Consensus       617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGh  686 (775)
T KOG1151|consen  617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGH  686 (775)
T ss_pred             cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCC
Confidence            9999998765443     23556789999999998743    3578899999999999999999999864

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.97  E-value=2.3e-30  Score=265.71  Aligned_cols=200  Identities=28%  Similarity=0.472  Sum_probs=166.3

Q ss_pred             HhCCCCccccccccCceeEEEEEcc-CCCeeEEEeeccc--CccCHHHHHHHHHHHhhc-CCCceeccceeEEeC--Cee
Q 008292          343 ATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEG--EEK  416 (571)
Q Consensus       343 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~--~~~  416 (571)
                      ..++|++.+.||+|+||.||+|... +++.+++|++...  .......+.+|+.+++++ +||||+++++++...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            3567888999999999999999965 5788999988542  233445677899999999 999999999988653  367


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccc
Q 008292          417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI  496 (571)
Q Consensus       417 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  496 (571)
                      ++||||++ ++|..++..    ..+++..+..++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||+++.
T Consensus        85 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~  156 (337)
T cd07852          85 YLVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS  156 (337)
T ss_pred             EEEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence            99999997 588887732    27889999999999999999999887   99999999999999999999999999986


Q ss_pred             cCCCCCc---cccccccccCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          497 FGVDQTQ---GNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       497 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      +......   .......|+..|+|||.+.+ ..++.++||||||+++|||+||+.||.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~  214 (337)
T cd07852         157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFP  214 (337)
T ss_pred             cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCC
Confidence            6433221   12233468889999998765 567899999999999999999999875

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.97  E-value=2.2e-30  Score=265.49  Aligned_cols=200  Identities=24%  Similarity=0.415  Sum_probs=167.6

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC--ccCHHHHHHHHHHHhhcCCCceeccceeEEe----CCee
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE----GEEK  416 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~----~~~~  416 (571)
                      .++|++.+.||+|++|.||++... +++.|++|++....  ......+.+|+.++++++||||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            368889999999999999999954 68899999987543  2345677889999999999999999998763    3467


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccc
Q 008292          417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI  496 (571)
Q Consensus       417 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  496 (571)
                      ++||||+. ++|.+++.   ....+++..+..++.||++||.|||+.+   |+||||||+||++++++.+||+|||+++.
T Consensus        84 ~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~  156 (334)
T cd07855          84 YVVMDLME-SDLHHIIH---SDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG  156 (334)
T ss_pred             EEEEehhh-hhHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence            99999996 58888874   3455899999999999999999999887   99999999999999999999999999976


Q ss_pred             cCCCCCc--cccccccccCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          497 FGVDQTQ--GNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       497 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      .......  .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~  213 (334)
T cd07855         157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFP  213 (334)
T ss_pred             ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccC
Confidence            5432221  11223468889999998865 468899999999999999999999984

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.97  E-value=5.4e-30  Score=251.69  Aligned_cols=202  Identities=25%  Similarity=0.399  Sum_probs=175.7

Q ss_pred             CCCccccccccCceeEEEEEcc-CCCeeEEEeecccCc--cCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASG--QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       346 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      +|+..+.||+|+||.||++... ++..+++|++.....  ...+.+.+|+++++.++|+|++++++.+..+...++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4778899999999999999964 588999999876433  4567788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCC
Q 008292          423 VPNKSLDYFLYDPE-KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ  501 (571)
Q Consensus       423 ~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  501 (571)
                      +++++|.+++.... ....+++..+..++.+++.||.|||+.+   ++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            99999999885421 2467899999999999999999999987   9999999999999999999999999998654332


Q ss_pred             CccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 008292          502 TQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFY  552 (571)
Q Consensus       502 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~~  552 (571)
                        .......|++.|+|||.+.+..++.++||||+|+++++|++|+.|+...
T Consensus       158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~  206 (258)
T cd08215         158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE  206 (258)
T ss_pred             --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCC
Confidence              1223346888999999999889999999999999999999999998654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.97  E-value=2.5e-30  Score=267.08  Aligned_cols=197  Identities=30%  Similarity=0.412  Sum_probs=166.7

Q ss_pred             HhCCCCccccccccCceeEEEEEc-cCCCeeEEEeeccc--CccCHHHHHHHHHHHhhcCCCceeccceeEEeC------
Q 008292          343 ATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG------  413 (571)
Q Consensus       343 ~~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~------  413 (571)
                      ..++|+..+.||+|+||.||++.. .+++.||+|++...  .....+.+.+|+.++++++|+||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            357899999999999999999995 46889999998653  233445677899999999999999999988643      


Q ss_pred             CeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccC
Q 008292          414 EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM  493 (571)
Q Consensus       414 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl  493 (571)
                      ...++||||+.+ +|.+.+..     .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus        94 ~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~  164 (353)
T cd07850          94 QDVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  164 (353)
T ss_pred             CcEEEEEeccCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence            246999999964 77776632     2888999999999999999999987   99999999999999999999999999


Q ss_pred             ccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          494 ARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       494 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ++.......   .....++..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       165 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~  219 (353)
T cd07850         165 ARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPG  219 (353)
T ss_pred             ceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCC
Confidence            986543221   2234578899999999999999999999999999999999999854

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=3.1e-30  Score=254.52  Aligned_cols=188  Identities=26%  Similarity=0.370  Sum_probs=159.0

Q ss_pred             ccccccCceeEEEEEcc-CCCeeEEEeecccCc---cCHHHHHHHHHH-HhhcCCCceeccceeEEeCCeeEEEEEecCC
Q 008292          351 NKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASG---QGAEEFKNEVVL-VAKLQHRNLVRLLGFCLEGEEKILVYEFVPN  425 (571)
Q Consensus       351 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~Ei~~-l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  425 (571)
                      +.||+|+||.||++... +++.||+|.+++...   .....+..|..+ ....+|+||+++++.+..++..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            57999999999999864 588999999875432   122234445444 4456899999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCccc
Q 008292          426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN  505 (571)
Q Consensus       426 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  505 (571)
                      ++|..++.   ....+++..+..++.|+++||.|||+.+   ++||||+|+||++++++.+||+|||+++....      
T Consensus        82 ~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------  149 (260)
T cd05611          82 GDCASLIK---TLGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------  149 (260)
T ss_pred             CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence            99999984   3356899999999999999999999987   99999999999999999999999999875432      


Q ss_pred             cccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       506 ~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      .....++..|+|||.+.+..++.++||||||+++|||+||+.|+.
T Consensus       150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~  194 (260)
T cd05611         150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFH  194 (260)
T ss_pred             cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCC
Confidence            223457889999999988889999999999999999999999985

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.97  E-value=1.6e-30  Score=259.12  Aligned_cols=201  Identities=30%  Similarity=0.468  Sum_probs=174.1

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeeccc---CccCHHHHHHHHHHHhhcC-CCceeccceeEEeCCeeEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEKILV  419 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv  419 (571)
                      ++|...+.||+|+||.||+++.. +++.|++|++...   .....+.+.+|++++.+++ |+||+++++++..++..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            46888899999999999999965 6889999998653   2233467889999999998 99999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCC
Q 008292          420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV  499 (571)
Q Consensus       420 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  499 (571)
                      |||+++++|.+++.   +...+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~l~---~~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~  154 (280)
T cd05581          81 LEYAPNGELLQYIR---KYGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP  154 (280)
T ss_pred             EcCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence            99999999999984   3447999999999999999999999887   99999999999999999999999999986643


Q ss_pred             CCCc------------------cccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          500 DQTQ------------------GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       500 ~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ....                  .......++..|+|||.+....++.++||||||++++|+++|+.|+..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~  224 (280)
T cd05581         155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRG  224 (280)
T ss_pred             ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCC
Confidence            3221                  122334678899999999888899999999999999999999999864

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=4.6e-30  Score=251.90  Aligned_cols=198  Identities=30%  Similarity=0.479  Sum_probs=173.5

Q ss_pred             CCCccccccccCceeEEEEEcc-CCCeeEEEeecccCc--cCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASG--QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       346 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      +|+..+.||+|++|.||+++.. +++.|++|.+.....  ...+.+.+|++++.+++|+|++++++++.++...++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4778899999999999999864 578899999976543  4557889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT  502 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  502 (571)
                      +++++|.+++..   ...+++..+..++.|++.+|.|||+.+   |+||||+|+||+++.++.+||+|||++........
T Consensus        81 ~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (254)
T cd06627          81 AENGSLRQIIKK---FGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK  154 (254)
T ss_pred             CCCCcHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence            999999998843   367899999999999999999999887   99999999999999999999999999987643322


Q ss_pred             ccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          503 QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       503 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .  .....++..|+|||......++.++||||+|+++|||++|+.|+..
T Consensus       155 ~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~  201 (254)
T cd06627         155 D--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYD  201 (254)
T ss_pred             c--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence            1  2234678899999999888899999999999999999999999753

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.97  E-value=2.6e-30  Score=260.91  Aligned_cols=204  Identities=26%  Similarity=0.427  Sum_probs=168.3

Q ss_pred             HHHhCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC--ccCHHHHHHHHHHHhhcCCCceeccceeEEeCC---
Q 008292          341 EVATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE---  414 (571)
Q Consensus       341 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~---  414 (571)
                      +...++|++.+.||+|+||.||+|..+ +++.|++|+++...  ......+.+|+++++.++||||+++++++.+..   
T Consensus         3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~   82 (302)
T cd07864           3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL   82 (302)
T ss_pred             hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence            345678999999999999999999975 58899999987543  233456788999999999999999999987655   


Q ss_pred             -------eeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceE
Q 008292          415 -------EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPK  487 (571)
Q Consensus       415 -------~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k  487 (571)
                             ..++|+||+++ ++..++..  ....+++..+..++.||+.||+|||+.+   |+|+||+|+||++++++.+|
T Consensus        83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~k  156 (302)
T cd07864          83 DFKKDKGAFYLVFEYMDH-DLMGLLES--GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIK  156 (302)
T ss_pred             hccccCCcEEEEEcccCc-cHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEE
Confidence                   68999999986 56565532  2346899999999999999999999987   99999999999999999999


Q ss_pred             EeeccCccccCCCCCccccccccccCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          488 ISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       488 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      |+|||++..+..... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+..
T Consensus       157 l~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~  220 (302)
T cd07864         157 LADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQA  220 (302)
T ss_pred             eCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence            999999986643321 11122345778999998865 4578999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.97  E-value=3.8e-30  Score=258.79  Aligned_cols=200  Identities=29%  Similarity=0.435  Sum_probs=165.1

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC--ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE  421 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e  421 (571)
                      ++|+..+.||+|++|+||+|... +++.|++|++....  ....+.+.+|++++++++||||+++++++.++...++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46888999999999999999965 68899999886543  2334678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECC-CCceEEeeccCccccCCC
Q 008292          422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-EMNPKISDFGMARIFGVD  500 (571)
Q Consensus       422 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGla~~~~~~  500 (571)
                      |+++ +|.+++.. .....+++..+..++.||+.||+|||+++   ++|+||+|+||+++. ++.+||+|||++......
T Consensus        82 ~~~~-~l~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~  156 (294)
T PLN00009         82 YLDL-DLKKHMDS-SPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP  156 (294)
T ss_pred             cccc-cHHHHHHh-CCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence            9964 67666632 22334678888999999999999999887   999999999999985 567999999999765432


Q ss_pred             CCccccccccccCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          501 QTQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       501 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ..  ......+++.|+|||.+.+. .++.++||||||+++|||+||+.||..
T Consensus       157 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~  206 (294)
T PLN00009        157 VR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPG  206 (294)
T ss_pred             cc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            21  11223568899999988664 578999999999999999999999853

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.97  E-value=3e-30  Score=261.52  Aligned_cols=199  Identities=30%  Similarity=0.466  Sum_probs=165.5

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccCc--cCHHHHHHHHHHHhhcCCCceeccceeEEeC--CeeEE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASG--QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG--EEKIL  418 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~l  418 (571)
                      .++|++.+.||+|+||.||++... +|+.||+|+++....  .....+.+|+.++++++|+||+++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            357889999999999999999964 588999999865432  2233567899999999999999999998765  46799


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccC
Q 008292          419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG  498 (571)
Q Consensus       419 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  498 (571)
                      ||||+++ +|.+++..  ....+++..+..++.||++||.|||+.+   ++||||||+||+++.++.+||+|||++....
T Consensus        86 v~e~~~~-~l~~~l~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~  159 (309)
T cd07845          86 VMEYCEQ-DLASLLDN--MPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG  159 (309)
T ss_pred             EEecCCC-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence            9999975 78777743  2356899999999999999999999987   9999999999999999999999999998764


Q ss_pred             CCCCccccccccccCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          499 VDQTQGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       499 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      ....  ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.
T Consensus       160 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~  210 (309)
T cd07845         160 LPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLP  210 (309)
T ss_pred             CccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCC
Confidence            3221  1122345788999998865 467899999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.97  E-value=3.5e-30  Score=253.17  Aligned_cols=199  Identities=32%  Similarity=0.464  Sum_probs=172.4

Q ss_pred             CCCccccccccCceeEEEEEc-cCCCeeEEEeecccC--ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          346 KFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       346 ~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      +|++.++||+|++|.||+++. .+++.+++|.+....  .....++.+|+++++.++|+||+++.+++.+....++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            477889999999999999985 467889999987543  33456778899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCC
Q 008292          423 VPNKSLDYFLYDP-EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ  501 (571)
Q Consensus       423 ~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  501 (571)
                      +++++|.+++... .....+++..++.++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||+++..... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            9999999988542 12356899999999999999999999887   999999999999999999999999999876443 


Q ss_pred             CccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          502 TQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       502 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                         ......++..|++||.+.+..++.++|+||||+++|||++|+.|++.
T Consensus       157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~  203 (256)
T cd08530         157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEA  203 (256)
T ss_pred             ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence               12223578899999999999999999999999999999999999864

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.97  E-value=6.4e-30  Score=260.06  Aligned_cols=193  Identities=31%  Similarity=0.471  Sum_probs=163.9

Q ss_pred             CCCccccccccCceeEEEEEcc-CCCeeEEEeecccCc---cCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEE
Q 008292          346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASG---QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE  421 (571)
Q Consensus       346 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e  421 (571)
                      .|+..+.||+|+||.||+++.. ++..|++|++.....   ...+.+.+|++++++++|||++++++++.++...++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            3667889999999999999954 688999999865432   334578899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCC
Q 008292          422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ  501 (571)
Q Consensus       422 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  501 (571)
                      |+++ +|.+.+..  ....+++..+..++.|++.||.|||+.+   |+||||+|+||+++.++.+||+|||++.....  
T Consensus       106 ~~~g-~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~--  177 (317)
T cd06635         106 YCLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP--  177 (317)
T ss_pred             CCCC-CHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC--
Confidence            9975 66666532  2456899999999999999999999887   99999999999999999999999999875432  


Q ss_pred             CccccccccccCCcccccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          502 TQGNTSRIVGTYGYMAPEYAM---HGQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       502 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                          .....++..|+|||.+.   .+.++.++||||||+++|||++|+.|+.
T Consensus       178 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~  225 (317)
T cd06635         178 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF  225 (317)
T ss_pred             ----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence                12345788999999874   4578999999999999999999999964

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.6e-30  Score=284.08  Aligned_cols=209  Identities=32%  Similarity=0.448  Sum_probs=175.1

Q ss_pred             HHHHHhCCCCccccccccCceeEEEEEcc----C----CCeeEEEeeccc-CccCHHHHHHHHHHHhhc-CCCceeccce
Q 008292          339 TIEVATNKFSTDNKLGEGGFGEVYKGVLP----S----GQEIAVKRLSKA-SGQGAEEFKNEVVLVAKL-QHRNLVRLLG  408 (571)
Q Consensus       339 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~----~----g~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~  408 (571)
                      .+++..+++.+.+.||+|.||.|++|...    .    ...||||.++.. .....+.+..|+++|+.+ +|+||+.++|
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            66777777778889999999999999842    1    346899999764 345667899999999998 5999999999


Q ss_pred             eEEeCCeeEEEEEecCCCChhhhhcCCC-----------CC--CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCC
Q 008292          409 FCLEGEEKILVYEFVPNKSLDYFLYDPE-----------KQ--GQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKA  475 (571)
Q Consensus       409 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp  475 (571)
                      +|.+....++|+||++.|+|.++|+..+           ..  ..+...+.+.++.|||.||+||++..   +|||||.+
T Consensus       370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAa  446 (609)
T KOG0200|consen  370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAA  446 (609)
T ss_pred             eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhh
Confidence            9999999999999999999999996543           00  23889999999999999999999876   99999999


Q ss_pred             CCEEECCCCceEEeeccCccccCCCCCcc-ccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 008292          476 SNILLDAEMNPKISDFGMARIFGVDQTQG-NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSN  550 (571)
Q Consensus       476 ~NIll~~~~~~kl~DfGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~  550 (571)
                      +|||+..+..+||+|||+++......... ..+...-+.+|||||.+....|+.|+|||||||+||||+| |..|+.
T Consensus       447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp  523 (609)
T KOG0200|consen  447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYP  523 (609)
T ss_pred             hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCC
Confidence            99999999999999999999654433322 1111114667999999999999999999999999999999 777764

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.97  E-value=1e-30  Score=252.18  Aligned_cols=209  Identities=26%  Similarity=0.388  Sum_probs=180.5

Q ss_pred             HHHHHHhCCCCccccccccCceeEEEEEcc------CCCeeEEEeecc-cCccCHHHHHHHHHHHhhcCCCceeccceeE
Q 008292          338 ETIEVATNKFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSK-ASGQGAEEFKNEVVLVAKLQHRNLVRLLGFC  410 (571)
Q Consensus       338 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~  410 (571)
                      .++.+...+++....+-+|.||.||+|.+.      +.+.|.+|.++. .++.+...+..|--++..+.|||+..+.+++
T Consensus       277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~  356 (563)
T KOG1024|consen  277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS  356 (563)
T ss_pred             HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence            344555667888889999999999999754      345688888865 4556667888999999999999999999998


Q ss_pred             Ee-CCeeEEEEEecCCCChhhhhc-----CCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCC
Q 008292          411 LE-GEEKILVYEFVPNKSLDYFLY-----DPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM  484 (571)
Q Consensus       411 ~~-~~~~~lv~e~~~~g~L~~~l~-----~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~  484 (571)
                      .+ .+..++++.++.-|+|..||.     +......++..+...++.|++.||+|||.++   |||.||.++|.+||+..
T Consensus       357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~L  433 (563)
T KOG1024|consen  357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQL  433 (563)
T ss_pred             eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhhe
Confidence            76 456789999999999999997     5555567888899999999999999999987   99999999999999999


Q ss_pred             ceEEeeccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCC
Q 008292          485 NPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNS  549 (571)
Q Consensus       485 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~  549 (571)
                      ++||+|=.++|.+.+..+.........+.+||+||.+.+.+|+.++|||||||++|||+| |+.|+
T Consensus       434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Py  499 (563)
T KOG1024|consen  434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPY  499 (563)
T ss_pred             eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCc
Confidence            999999999998877776665555566789999999999999999999999999999999 88886

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.97  E-value=6.5e-30  Score=256.31  Aligned_cols=199  Identities=30%  Similarity=0.407  Sum_probs=167.9

Q ss_pred             CCCccccccccCceeEEEEEc----cCCCeeEEEeecccC----ccCHHHHHHHHHHHhhc-CCCceeccceeEEeCCee
Q 008292          346 KFSTDNKLGEGGFGEVYKGVL----PSGQEIAVKRLSKAS----GQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEK  416 (571)
Q Consensus       346 ~~~~~~~LG~G~fg~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~  416 (571)
                      +|++.+.||+|++|.||+++.    .+++.|+||.+++..    ....+.+.+|+.++.++ +||||+++++.+..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            367788999999999999884    356789999987532    23345688999999999 599999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccc
Q 008292          417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI  496 (571)
Q Consensus       417 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  496 (571)
                      ++||||+++++|..++.   ....+++..+..++.|++++|.|||+.+   ++||||+|+||+++.++.++|+|||+++.
T Consensus        81 ~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~  154 (288)
T cd05583          81 HLILDYVNGGELFTHLY---QREHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE  154 (288)
T ss_pred             EEEEecCCCCcHHHHHh---hcCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence            99999999999998884   3356889999999999999999999876   99999999999999999999999999876


Q ss_pred             cCCCCCccccccccccCCcccccccccCC--CCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          497 FGVDQTQGNTSRIVGTYGYMAPEYAMHGQ--FSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      +...... ......|+..|+|||.+.+..  .+.++||||||+++|||++|+.|+..
T Consensus       155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~  210 (288)
T cd05583         155 FLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTV  210 (288)
T ss_pred             ccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCccc
Confidence            5433211 122345788999999987665  78899999999999999999999853

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.97  E-value=5.6e-30  Score=262.62  Aligned_cols=199  Identities=27%  Similarity=0.415  Sum_probs=163.9

Q ss_pred             CCCC-ccccccccCceeEEEEEcc-CCCeeEEEeecccCccC--------------HHHHHHHHHHHhhcCCCceeccce
Q 008292          345 NKFS-TDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQG--------------AEEFKNEVVLVAKLQHRNLVRLLG  408 (571)
Q Consensus       345 ~~~~-~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~--------------~~~~~~Ei~~l~~l~h~niv~l~~  408 (571)
                      ++|. +.+.||+|+||+||++... +++.||+|+++......              ...+.+|+++++.++|+||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            4554 4577999999999999954 68899999886543221              125778999999999999999999


Q ss_pred             eEEeCCeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEE
Q 008292          409 FCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKI  488 (571)
Q Consensus       409 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl  488 (571)
                      ++..++..++||||++ ++|.+++.   ....+++.....++.|+++||.|||+.+   |+|+||+|+||+++.++.+||
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl  160 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVD---RKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI  160 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence            9999999999999997 58888873   3456899999999999999999999887   999999999999999999999


Q ss_pred             eeccCccccCCCCC------------ccccccccccCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          489 SDFGMARIFGVDQT------------QGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       489 ~DfGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      +|||+++.......            ........++..|+|||.+.+. .++.++||||||+++|||+||+.|+.
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~  235 (335)
T PTZ00024        161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFP  235 (335)
T ss_pred             CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            99999986541110            1111223467889999998764 47899999999999999999999875

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=6.2e-31  Score=266.83  Aligned_cols=217  Identities=24%  Similarity=0.350  Sum_probs=178.9

Q ss_pred             HhCCCCccccccccCceeEEEEEc-cCCCeeEEEeecccC---ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEE
Q 008292          343 ATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL  418 (571)
Q Consensus       343 ~~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  418 (571)
                      ...-|..++.||-|+||.|.++.. +....+|+|.+++.+   .......+.|-+||+..+.+=||+|+-.|.+.+.+|+
T Consensus       627 dKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYF  706 (1034)
T KOG0608|consen  627 DKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYF  706 (1034)
T ss_pred             cccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEE
Confidence            345578889999999999999884 456678999998764   3444567889999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccC
Q 008292          419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG  498 (571)
Q Consensus       419 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  498 (571)
                      ||||++||++-.+|   -+.+.+.+..+..++.++..|+++.|..+   +|||||||+|||||.+|.+||+||||+.-+.
T Consensus       707 VMdYIPGGDmMSLL---IrmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfR  780 (1034)
T KOG0608|consen  707 VMDYIPGGDMMSLL---IRMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFR  780 (1034)
T ss_pred             EEeccCCccHHHHH---HHhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccce
Confidence            99999999998887   34567888888889999999999999887   9999999999999999999999999984331


Q ss_pred             CCC--------C--------------------------------ccccccccccCCcccccccccCCCCcchhHHHHHHH
Q 008292          499 VDQ--------T--------------------------------QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVL  538 (571)
Q Consensus       499 ~~~--------~--------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvv  538 (571)
                      ...        .                                .......+||+.|+|||++....++...|+||.|||
T Consensus       781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvi  860 (1034)
T KOG0608|consen  781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVI  860 (1034)
T ss_pred             eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHH
Confidence            100        0                                000123579999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCCCCC-CCcccHHHHHH
Q 008292          539 VLEIITGKKNSNFYQT-DGAADLLSYVS  565 (571)
Q Consensus       539 l~elltG~~p~~~~~~-~~~~~l~~~~~  565 (571)
                      ||||+.|+.||-...+ +....+++|-.
T Consensus       861 l~em~~g~~pf~~~tp~~tq~kv~nw~~  888 (1034)
T KOG0608|consen  861 LYEMLVGQPPFLADTPGETQYKVINWRN  888 (1034)
T ss_pred             HHHHhhCCCCccCCCCCcceeeeeehhh
Confidence            9999999999965433 33344555543

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.97  E-value=6.2e-30  Score=263.27  Aligned_cols=200  Identities=29%  Similarity=0.436  Sum_probs=167.4

Q ss_pred             HHHHHHhCCCCccccccccCceeEEEEEc-cCCCeeEEEeecccC--ccCHHHHHHHHHHHhhcCCCceeccceeEEeC-
Q 008292          338 ETIEVATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG-  413 (571)
Q Consensus       338 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-  413 (571)
                      .++....++|.+.+.||+|+||.||++.. .+++.||+|+++...  ....+.+.+|+.++.+++||||+++++++... 
T Consensus        10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~   89 (345)
T cd07877          10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR   89 (345)
T ss_pred             HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence            34555678999999999999999999985 568899999987532  23346778899999999999999999988643 


Q ss_pred             -----CeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEE
Q 008292          414 -----EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKI  488 (571)
Q Consensus       414 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl  488 (571)
                           ...+++++++ +++|.+++.    ...+++..+..++.|+++||+|||+.+   |+||||||+||++++++.+||
T Consensus        90 ~~~~~~~~~lv~~~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl  161 (345)
T cd07877          90 SLEEFNDVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKI  161 (345)
T ss_pred             cccccccEEEEehhc-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEE
Confidence                 2357788876 788888773    346899999999999999999999987   999999999999999999999


Q ss_pred             eeccCccccCCCCCccccccccccCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          489 SDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       489 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      +|||+++....     ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.
T Consensus       162 ~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  219 (345)
T cd07877         162 LDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP  219 (345)
T ss_pred             ecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            99999875422     1223467889999998866 568899999999999999999999985

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.97  E-value=6.6e-30  Score=262.26  Aligned_cols=199  Identities=26%  Similarity=0.427  Sum_probs=166.7

Q ss_pred             hCCCCccccccccCceeEEEEEc-cCCCeeEEEeeccc--CccCHHHHHHHHHHHhhcCCCceeccceeEEeCC-----e
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE-----E  415 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-----~  415 (571)
                      .++|.+.+.||+|+||+||+++. .+++.|+||.++..  .......+.+|+.+++.++|+||+++++++....     .
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            45789999999999999999995 46889999998753  2333456778999999999999999999886543     4


Q ss_pred             eEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCcc
Q 008292          416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR  495 (571)
Q Consensus       416 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  495 (571)
                      .++++||+. ++|.+++.   ....+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||+++
T Consensus        84 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~  156 (337)
T cd07858          84 VYIVYELMD-TDLHQIIR---SSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR  156 (337)
T ss_pred             EEEEEeCCC-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence            799999996 67877773   3457899999999999999999999887   9999999999999999999999999998


Q ss_pred             ccCCCCCccccccccccCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          496 IFGVDQTQGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ......  .......++..|+|||.+.. ..++.++||||||+++|||++|+.||..
T Consensus       157 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~  211 (337)
T cd07858         157 TTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPG  211 (337)
T ss_pred             ccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCC
Confidence            654321  11223457889999998865 5689999999999999999999999854

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.97  E-value=8.5e-30  Score=254.37  Aligned_cols=195  Identities=25%  Similarity=0.362  Sum_probs=160.8

Q ss_pred             CCccccccccCceeEEEEEcc-CCCeeEEEeecccC-ccCHHHHHHHHHHHhhcC-CCceeccceeEEeC--CeeEEEEE
Q 008292          347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQ-HRNLVRLLGFCLEG--EEKILVYE  421 (571)
Q Consensus       347 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e  421 (571)
                      |++.++||+|+||.||+++.. +++.|++|+++... ........+|+.++.++. |+||+++++++.+.  +..++|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            567789999999999999954 68899999987542 222234457888888885 99999999999987  78999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCC
Q 008292          422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ  501 (571)
Q Consensus       422 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  501 (571)
                      |+++ +|.+++..  ....+++..++.++.|++.||.|||+.+   ++||||+|+||+++. +.+||+|||+++.+....
T Consensus        81 ~~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~  153 (282)
T cd07831          81 LMDM-NLYELIKG--RKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP  153 (282)
T ss_pred             cCCc-cHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence            9974 77666643  2356899999999999999999999987   999999999999999 999999999998664322


Q ss_pred             CccccccccccCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          502 TQGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       502 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .   .....++..|+|||.+.. +.++.++||||||+++|||++|+.||..
T Consensus       154 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~  201 (282)
T cd07831         154 P---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPG  201 (282)
T ss_pred             C---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCC
Confidence            1   122457889999997654 5678999999999999999999999853

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.97  E-value=3.9e-30  Score=257.81  Aligned_cols=200  Identities=30%  Similarity=0.402  Sum_probs=163.2

Q ss_pred             CCCccccccccCceeEEEEEcc-CCCeeEEEeecccC-ccCHHHHHHHHHHHhhcC-CCceeccceeEEeCCeeEEEEEe
Q 008292          346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       346 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      +|...++||+|+||.||++... +++.||+|++.... ......+.+|+.++.++. |+||+++++++..+...+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            4556788999999999999964 57899999987543 234557889999999996 99999999999998899999999


Q ss_pred             cCCCChhhhhcC--CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCC
Q 008292          423 VPNKSLDYFLYD--PEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD  500 (571)
Q Consensus       423 ~~~g~L~~~l~~--~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  500 (571)
                      +.. ++..+...  ......+++..+..++.|+++||+|||+..  +++||||||+||+++.++.+||+|||+++.+...
T Consensus        85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  161 (288)
T cd06616          85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS  161 (288)
T ss_pred             ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence            864 44433211  123356899999999999999999999742  3999999999999999999999999999765432


Q ss_pred             CCccccccccccCCcccccccccC---CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          501 QTQGNTSRIVGTYGYMAPEYAMHG---QFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       501 ~~~~~~~~~~gt~~y~aPE~~~~~---~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ..   .....|+..|+|||.+.+.   .++.++||||||+++|||++|+.||..
T Consensus       162 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  212 (288)
T cd06616         162 IA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPK  212 (288)
T ss_pred             Cc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchh
Confidence            21   1233578899999998766   689999999999999999999999753

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.97  E-value=7.3e-30  Score=262.49  Aligned_cols=197  Identities=26%  Similarity=0.437  Sum_probs=166.7

Q ss_pred             HHhCCCCccccccccCceeEEEEEc-cCCCeeEEEeecccC--ccCHHHHHHHHHHHhhcCCCceeccceeEEeCC----
Q 008292          342 VATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE----  414 (571)
Q Consensus       342 ~~~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----  414 (571)
                      ...++|++.+.||+|+||.||++.. .++..||||++....  ....+.+.+|+.++++++||||+++++++....    
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07880          12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR   91 (343)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence            3467899999999999999999985 468899999986432  233456889999999999999999999887653    


Q ss_pred             --eeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeecc
Q 008292          415 --EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG  492 (571)
Q Consensus       415 --~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG  492 (571)
                        ..++||||+ +++|..++.    ...+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||
T Consensus        92 ~~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg  163 (343)
T cd07880          92 FHDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG  163 (343)
T ss_pred             cceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecc
Confidence              358999998 778888773    346899999999999999999999887   9999999999999999999999999


Q ss_pred             CccccCCCCCccccccccccCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          493 MARIFGVDQTQGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       493 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ++......     .....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus       164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~  218 (343)
T cd07880         164 LARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKG  218 (343)
T ss_pred             cccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            99764321     123356889999998876 4688999999999999999999999863

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.97  E-value=8.9e-30  Score=260.48  Aligned_cols=198  Identities=29%  Similarity=0.460  Sum_probs=169.3

Q ss_pred             CCCccccccccCceeEEEEEcc-CCCeeEEEeecccC--ccCHHHHHHHHHHHhhcCCCceeccceeEEeCC-----eeE
Q 008292          346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE-----EKI  417 (571)
Q Consensus       346 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-----~~~  417 (571)
                      +|.+.+.||+|++|.||+++.. +++.|++|++....  ....+.+.+|+.+++.++|+||+++++++...+     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4778899999999999999965 48899999987643  344567889999999999999999999988775     789


Q ss_pred             EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCcccc
Q 008292          418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF  497 (571)
Q Consensus       418 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  497 (571)
                      ++|||++ ++|..++.   ....+++..++.++.|+++||.|||+.+   |+||||||+|||++.++.++|+|||++...
T Consensus        81 lv~e~~~-~~l~~~l~---~~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~  153 (330)
T cd07834          81 IVTELME-TDLHKVIK---SPQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV  153 (330)
T ss_pred             EEecchh-hhHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence            9999998 47888774   3347899999999999999999999987   999999999999999999999999999876


Q ss_pred             CCCCC-ccccccccccCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          498 GVDQT-QGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       498 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      ..... ........++..|+|||.+.+. .++.++||||||+++|||++|+.||.
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~  208 (330)
T cd07834         154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFP  208 (330)
T ss_pred             cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcC
Confidence            43321 0112334578899999999887 89999999999999999999999884

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.97  E-value=1.9e-32  Score=251.98  Aligned_cols=201  Identities=29%  Similarity=0.427  Sum_probs=163.3

Q ss_pred             CCCCccccccccCceeEEEEEc-cCCCeeEEEeecccCc-cCHHHHHHHHHHHhh-cCCCceeccceeEEeCCeeEEEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASG-QGAEEFKNEVVLVAK-LQHRNLVRLLGFCLEGEEKILVYE  421 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~-l~h~niv~l~~~~~~~~~~~lv~e  421 (571)
                      ++++.+..||.|.||+|+|-.+ +.|+..|||+++.... .+.+++..|.+...+ -+.||||+++|.+..+...||.||
T Consensus        64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME  143 (361)
T KOG1006|consen   64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME  143 (361)
T ss_pred             chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence            4455667899999999999886 4699999999986543 556677788776544 478999999999999999999999


Q ss_pred             ecCCCChhhhh---cCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccC
Q 008292          422 FVPNKSLDYFL---YDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG  498 (571)
Q Consensus       422 ~~~~g~L~~~l---~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  498 (571)
                      .| ..+|+.+-   +. .++..+++.-+-.|..-+.+||.||.+.-  .|||||+||+||||+..|.+||+|||++..+.
T Consensus       144 LM-d~SlDklYk~vy~-vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv  219 (361)
T KOG1006|consen  144 LM-DISLDKLYKRVYS-VQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLV  219 (361)
T ss_pred             HH-hhhHHHHHHHHHH-HHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHH
Confidence            98 45665442   22 24456888888889999999999998754  69999999999999999999999999997653


Q ss_pred             CCCCccccccccccCCcccccccccC--CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 008292          499 VDQTQGNTSRIVGTYGYMAPEYAMHG--QFSVKSDVYSFGVLVLEIITGKKNSNFY  552 (571)
Q Consensus       499 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~~Dv~slGvvl~elltG~~p~~~~  552 (571)
                      .+.   ..+.-.|-..|||||.+...  .|..+|||||||++|+|+.||+.|+.-+
T Consensus       220 ~Si---AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w  272 (361)
T KOG1006|consen  220 DSI---AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKW  272 (361)
T ss_pred             HHH---HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchH
Confidence            222   22334677889999999643  4889999999999999999999998754

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.97  E-value=9.9e-30  Score=258.24  Aligned_cols=198  Identities=20%  Similarity=0.232  Sum_probs=163.0

Q ss_pred             ccccccccCceeEEEEEccCCCeeEEEeeccc--CccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEecCCC
Q 008292          349 TDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNK  426 (571)
Q Consensus       349 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  426 (571)
                      +.+.+|.|+++.|+++.. +++.||+|+++..  .....+.+.+|+++++.++|+||+++++++.+.+..+++|||++++
T Consensus         6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~   84 (314)
T cd08216           6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG   84 (314)
T ss_pred             hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence            344555666666666665 7899999998754  3445678999999999999999999999999999999999999999


Q ss_pred             ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCC----
Q 008292          427 SLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT----  502 (571)
Q Consensus       427 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~----  502 (571)
                      +|.+++... ....+++..+..++.|+++||.|||+++   |+||||||+||+++.++.+||+|||.+..+.....    
T Consensus        85 ~l~~~l~~~-~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~  160 (314)
T cd08216          85 SCEDLLKTH-FPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV  160 (314)
T ss_pred             CHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence            999998542 2345889999999999999999999987   99999999999999999999999999875532111    


Q ss_pred             -ccccccccccCCccccccccc--CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          503 -QGNTSRIVGTYGYMAPEYAMH--GQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       503 -~~~~~~~~gt~~y~aPE~~~~--~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                       ........++..|+|||.+..  ..++.++||||||+++|||++|+.||..
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~  212 (314)
T cd08216         161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKD  212 (314)
T ss_pred             cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence             111223456778999999866  3588999999999999999999999863

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.7e-29  Score=247.42  Aligned_cols=191  Identities=33%  Similarity=0.450  Sum_probs=166.5

Q ss_pred             ccccCceeEEEEEcc-CCCeeEEEeecccCc---cCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEecCCCCh
Q 008292          353 LGEGGFGEVYKGVLP-SGQEIAVKRLSKASG---QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL  428 (571)
Q Consensus       353 LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  428 (571)
                      ||+|+||.||++... +++.+++|.++....   ...+.+.+|++++++++|+||+++++.+..++..+++|||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999965 588999999876432   2456789999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCcccccc
Q 008292          429 DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR  508 (571)
Q Consensus       429 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  508 (571)
                      .+++.   ....+++..+..++.|+++||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......  .....
T Consensus        81 ~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~  152 (250)
T cd05123          81 FSHLS---KEGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNT  152 (250)
T ss_pred             HHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccC
Confidence            99984   2346899999999999999999999977   9999999999999999999999999997654322  12234


Q ss_pred             ccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          509 IVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       509 ~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ..++..|++||.+.+...+.++|+||||+++|||++|+.|+..
T Consensus       153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~  195 (250)
T cd05123         153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYA  195 (250)
T ss_pred             CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence            4678899999999888899999999999999999999999853

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.97  E-value=1.1e-29  Score=255.64  Aligned_cols=201  Identities=28%  Similarity=0.465  Sum_probs=164.4

Q ss_pred             HhCCCCccccccccCceeEEEEEccC-CCeeEEEeecccC-ccCHHHHHHHHHHHhhcC-CCceeccceeEEeCCeeEEE
Q 008292          343 ATNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEKILV  419 (571)
Q Consensus       343 ~~~~~~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv  419 (571)
                      ..++|++.+.||+|++|.||+++.++ ++.|+||.++... .....++..|+.++.+.. |+||+++++++.++...+++
T Consensus        13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v   92 (296)
T cd06618          13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC   92 (296)
T ss_pred             CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence            34678889999999999999999764 8899999987543 233455667777666665 99999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCC
Q 008292          420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV  499 (571)
Q Consensus       420 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  499 (571)
                      |||+++ +|..++..  ....+++..+..++.|+++||.|||+..  +|+||||+|+||++++++.+||+|||++..+..
T Consensus        93 ~e~~~~-~l~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~  167 (296)
T cd06618          93 MELMST-CLDKLLKR--IQGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVD  167 (296)
T ss_pred             eeccCc-CHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence            999854 66666532  2347899999999999999999999742  399999999999999999999999999876532


Q ss_pred             CCCccccccccccCCcccccccccCC----CCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          500 DQTQGNTSRIVGTYGYMAPEYAMHGQ----FSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       500 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ...   .....++..|+|||.+....    ++.++||||||+++|||++|+.||..
T Consensus       168 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  220 (296)
T cd06618         168 SKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN  220 (296)
T ss_pred             CCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCc
Confidence            221   12235778999999986553    78999999999999999999999864

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.97  E-value=8e-30  Score=258.29  Aligned_cols=202  Identities=29%  Similarity=0.434  Sum_probs=164.5

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccCc--cCHHHHHHHHHHHhhcCCCceeccceeEEeCC------
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASG--QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE------  414 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------  414 (571)
                      .++|++.++||+|+||.||+++.. +++.+++|++.....  .....+.+|+++++.++||||+++++++.+..      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            468999999999999999999964 688999998865332  22346788999999999999999999876543      


Q ss_pred             --eeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeecc
Q 008292          415 --EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG  492 (571)
Q Consensus       415 --~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG  492 (571)
                        ..++|+||+.+ +|...+..  ....+++..+..++.|+++||.|||+.+   |+|+||||+||++++++.+||+|||
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg  160 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG  160 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence              45899999975 56555532  2346899999999999999999999987   9999999999999999999999999


Q ss_pred             CccccCCCCCcc---------ccccccccCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          493 MARIFGVDQTQG---------NTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       493 la~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      +++.........         ......+++.|+|||.+.+. .++.++||||||+++|||++|+.|+..
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~  229 (311)
T cd07866         161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQG  229 (311)
T ss_pred             cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCC
Confidence            998654322111         11233567889999987654 588999999999999999999999863

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.97  E-value=1.7e-29  Score=252.71  Aligned_cols=197  Identities=29%  Similarity=0.485  Sum_probs=163.8

Q ss_pred             CCccccccccCceeEEEEEcc-CCCeeEEEeecccCc--cCHHHHHHHHHHHhhc---CCCceeccceeEEeCCe-----
Q 008292          347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASG--QGAEEFKNEVVLVAKL---QHRNLVRLLGFCLEGEE-----  415 (571)
Q Consensus       347 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l---~h~niv~l~~~~~~~~~-----  415 (571)
                      |++.+.||+|+||.||+++.+ +++.|++|+++....  .....+.+|+.++.++   +|+||+++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            567789999999999999976 488999999975322  2234566788777665   59999999999988776     


Q ss_pred             eEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCcc
Q 008292          416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR  495 (571)
Q Consensus       416 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  495 (571)
                      .+++|||+++ +|.+++... ....+++..++.++.|+++||.|||+.+   ++|+||+|+||+++.++.+||+|||++.
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~-~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~  155 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKC-PKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR  155 (287)
T ss_pred             eEEEehhccc-CHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence            8999999975 788777432 2236899999999999999999999987   9999999999999999999999999998


Q ss_pred             ccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          496 IFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .+.....   .....++..|+|||.+.+..++.++||||||+++|||++|+.|+..
T Consensus       156 ~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~  208 (287)
T cd07838         156 IYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRG  208 (287)
T ss_pred             eccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccC
Confidence            7643321   1223578899999999999999999999999999999999888753

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1.5e-29  Score=260.04  Aligned_cols=194  Identities=27%  Similarity=0.465  Sum_probs=163.2

Q ss_pred             hCCCCccccccccCceeEEEEEc-cCCCeeEEEeeccc--CccCHHHHHHHHHHHhhcCCCceeccceeEEeCC------
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE------  414 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------  414 (571)
                      .++|...+.||+|+||.||+|+. .+|+.||+|++...  .......+.+|+.+++.++||||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            46899999999999999999995 46899999998653  2233456889999999999999999999987543      


Q ss_pred             eeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCc
Q 008292          415 EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA  494 (571)
Q Consensus       415 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla  494 (571)
                      ..++|+||+.. +|..++     ...+++..+..++.|+++||+|||+.+   ++||||||+||+++.++.+||+|||++
T Consensus        94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~  164 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA  164 (342)
T ss_pred             eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence            45899999964 666554     235889999999999999999999987   999999999999999999999999998


Q ss_pred             cccCCCCCccccccccccCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          495 RIFGVDQTQGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      +.....     .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus       165 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~  217 (342)
T cd07879         165 RHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKG  217 (342)
T ss_pred             cCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCC
Confidence            754221     123457888999999876 4688999999999999999999999864

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.96  E-value=1.7e-29  Score=252.16  Aligned_cols=197  Identities=29%  Similarity=0.450  Sum_probs=167.9

Q ss_pred             CCccccccccCceeEEEEEcc-CCCeeEEEeecccCc--cCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEec
Q 008292          347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASG--QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV  423 (571)
Q Consensus       347 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  423 (571)
                      |+..+.||+|++|.||++... +++.+++|+++....  .....+.+|+.++++++|+||+++++++..++..++++||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            456789999999999999964 688899999875433  24567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCc
Q 008292          424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ  503 (571)
Q Consensus       424 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  503 (571)
                      ++ +|.+++..  +...+++..++.++.|+++||.|||+.+   |+|+||+|+||+++.++.+||+|||.+........ 
T Consensus        81 ~~-~l~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~-  153 (283)
T cd05118          81 DT-DLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR-  153 (283)
T ss_pred             CC-CHHHHHHh--hcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc-
Confidence            75 77777743  2357899999999999999999999987   99999999999999999999999999987654331 


Q ss_pred             cccccccccCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          504 GNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       504 ~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                       ......++..|+|||.+.+. .++.++||||||+++|||+||+.||..
T Consensus       154 -~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~  201 (283)
T cd05118         154 -PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPG  201 (283)
T ss_pred             -cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence             11223577889999998776 789999999999999999999988753

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.96  E-value=1.7e-29  Score=258.16  Aligned_cols=196  Identities=31%  Similarity=0.464  Sum_probs=166.2

Q ss_pred             HhCCCCccccccccCceeEEEEEcc-CCCeeEEEeeccc--CccCHHHHHHHHHHHhhcCCCceeccceeEEe-CCeeEE
Q 008292          343 ATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE-GEEKIL  418 (571)
Q Consensus       343 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~-~~~~~l  418 (571)
                      .+++|++.+.||+|+||.||++... +++.|++|++.+.  .....+.+.+|++++..++||||+++.+++.. ....++
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l   87 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF   87 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence            5678999999999999999999854 7889999988643  22345678899999999999999999998876 557889


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccC
Q 008292          419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG  498 (571)
Q Consensus       419 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  498 (571)
                      ++||+ +++|..++.    ...+++..+..++.|+++||.|||+.+   |+||||+|+||++++++.+||+|||++....
T Consensus        88 v~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~  159 (328)
T cd07856          88 VTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQD  159 (328)
T ss_pred             Eeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccccC
Confidence            99998 568888773    346788889999999999999999987   9999999999999999999999999987543


Q ss_pred             CCCCccccccccccCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          499 VDQTQGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       499 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ..     .....++..|+|||.+.+ ..++.++||||||+++|||+||+.||..
T Consensus       160 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~  208 (328)
T cd07856         160 PQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPG  208 (328)
T ss_pred             CC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            21     122356788999998766 5789999999999999999999999854

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.96  E-value=9.8e-30  Score=261.48  Aligned_cols=199  Identities=26%  Similarity=0.436  Sum_probs=165.4

Q ss_pred             hCCCCccccccccCceeEEEEEc-cCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeC---------
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG---------  413 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~---------  413 (571)
                      ..+|...+.||+|+||.||+|.. .+++.|++|++........+.+.+|++++++++||||+++++++...         
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            36889999999999999999996 46889999998776666677889999999999999999999876543         


Q ss_pred             -----CeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECC-CCceE
Q 008292          414 -----EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-EMNPK  487 (571)
Q Consensus       414 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~k  487 (571)
                           ...++|+||++ ++|..++.    ...+++..+..++.||++||.|||+.+   |+||||||+||+++. ++.+|
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k  155 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK  155 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence                 34689999997 58887773    346899999999999999999999887   999999999999974 55789


Q ss_pred             EeeccCccccCCCCCc-cccccccccCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          488 ISDFGMARIFGVDQTQ-GNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       488 l~DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      |+|||+++.+...... .......++..|+|||.+.. ..++.++||||||+++|||++|+.||.
T Consensus       156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~  220 (342)
T cd07854         156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFA  220 (342)
T ss_pred             ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCC
Confidence            9999999765432111 11123357889999998754 568889999999999999999999985

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.96  E-value=3.6e-29  Score=254.11  Aligned_cols=192  Identities=32%  Similarity=0.475  Sum_probs=162.3

Q ss_pred             CCccccccccCceeEEEEEcc-CCCeeEEEeecccCc---cCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASG---QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       347 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      |...++||+|+||+||+|+.. +++.|++|++.....   ...+.+.+|+++++.++|||++++++++.++...++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            556678999999999999964 688899999865332   2335688899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT  502 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  502 (571)
                      +.+ ++.+++..  ....+++..+..++.||+.+|.|||+.+   ++|+||+|+||+++.++.+||+|||++....    
T Consensus       103 ~~~-~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~----  172 (313)
T cd06633         103 CLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS----  172 (313)
T ss_pred             CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccC----
Confidence            964 66666532  2356899999999999999999999887   9999999999999999999999999986422    


Q ss_pred             ccccccccccCCcccccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          503 QGNTSRIVGTYGYMAPEYAM---HGQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       503 ~~~~~~~~gt~~y~aPE~~~---~~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                        ......|+..|+|||.+.   ...++.++||||||+++|||++|+.|+.
T Consensus       173 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~  221 (313)
T cd06633         173 --PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF  221 (313)
T ss_pred             --CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence              122346788999999984   4678899999999999999999999974

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.96  E-value=2.1e-30  Score=281.22  Aligned_cols=197  Identities=32%  Similarity=0.520  Sum_probs=158.4

Q ss_pred             HHhCCCCccccccccCceeEEEEEcc-CCCeeEEEeeccc-CccCHHHHHHHHHHHhhcCCCceeccceeEEe-------
Q 008292          342 VATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA-SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE-------  412 (571)
Q Consensus       342 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~-------  412 (571)
                      .-..+|++.+.||+||||.|||++.+ ||+.+|||++... +......+.+|++++++++|||||+++..+.+       
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            45568889999999999999999965 8999999998754 34445678899999999999999998853221       


Q ss_pred             -----------------------------------------------------------------------C--------
Q 008292          413 -----------------------------------------------------------------------G--------  413 (571)
Q Consensus       413 -----------------------------------------------------------------------~--------  413 (571)
                                                                                             +        
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                                                   0        


Q ss_pred             ---------------------------------CeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 008292          414 ---------------------------------EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL  460 (571)
Q Consensus       414 ---------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yL  460 (571)
                                                       ...||-||||+..+|..++.+..-..  .....++++++|++||.|+
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYI  713 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYI  713 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHH
Confidence                                             01357888888888888874321111  4677899999999999999


Q ss_pred             HcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccC----------------CCCCccccccccccCCcccccccccC
Q 008292          461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG----------------VDQTQGNTSRIVGTYGYMAPEYAMHG  524 (571)
Q Consensus       461 H~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~~~  524 (571)
                      |+.+   ||||||||.||++++++.|||+|||++....                ........+..+||.-|+|||.+.+.
T Consensus       714 H~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~  790 (1351)
T KOG1035|consen  714 HDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT  790 (1351)
T ss_pred             HhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence            9988   9999999999999999999999999998621                01111234567899999999998654


Q ss_pred             ---CCCcchhHHHHHHHHHHHH
Q 008292          525 ---QFSVKSDVYSFGVLVLEII  543 (571)
Q Consensus       525 ---~~s~~~Dv~slGvvl~ell  543 (571)
                         .|+.|+||||||||++||+
T Consensus       791 ~~~~Yn~KiDmYSLGIVlFEM~  812 (1351)
T KOG1035|consen  791 SSNKYNSKIDMYSLGIVLFEML  812 (1351)
T ss_pred             ccccccchhhhHHHHHHHHHHh
Confidence               5999999999999999998

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=6.3e-31  Score=261.02  Aligned_cols=204  Identities=27%  Similarity=0.354  Sum_probs=179.0

Q ss_pred             HHhCCCCccccccccCceeEEEEEccCCC-eeEEEeeccc---CccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeE
Q 008292          342 VATNKFSTDNKLGEGGFGEVYKGVLPSGQ-EIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI  417 (571)
Q Consensus       342 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~-~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  417 (571)
                      +.-.+++....||-|+||.|-.+..++.. .+|+|.+++.   .....+.+..|-.+|...+.|.||+++-.|.+.+..|
T Consensus       417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvY  496 (732)
T KOG0614|consen  417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVY  496 (732)
T ss_pred             cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhh
Confidence            33456677788999999999999875444 3888888764   3455567788999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCcccc
Q 008292          418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF  497 (571)
Q Consensus       418 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  497 (571)
                      +.||-|-||.|-..|.   +.+.++......++.-+.+|++|||.++   ||.|||||+|.+|+.+|-+||.|||+|+.+
T Consensus       497 mLmEaClGGElWTiLr---dRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki  570 (732)
T KOG0614|consen  497 MLMEACLGGELWTILR---DRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKI  570 (732)
T ss_pred             hhHHhhcCchhhhhhh---hcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHh
Confidence            9999999999999994   5677888889999999999999999988   999999999999999999999999999987


Q ss_pred             CCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 008292          498 GVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQT  554 (571)
Q Consensus       498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~~~~  554 (571)
                      ...   ..+-.++||+.|.|||+++++....++|.||||+++|||+||++||+-.++
T Consensus       571 ~~g---~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dp  624 (732)
T KOG0614|consen  571 GSG---RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDP  624 (732)
T ss_pred             ccC---CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCch
Confidence            543   345678999999999999999999999999999999999999999986443

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.96  E-value=2.3e-29  Score=257.29  Aligned_cols=197  Identities=23%  Similarity=0.330  Sum_probs=161.0

Q ss_pred             cccccc--CceeEEEEEc-cCCCeeEEEeecccC--ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEecCC
Q 008292          351 NKLGEG--GFGEVYKGVL-PSGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPN  425 (571)
Q Consensus       351 ~~LG~G--~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  425 (571)
                      ..||+|  +||+||+++. .+|+.||+|++....  ....+.+++|+.+++.++||||+++++++..++..++|+||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            467777  8999999996 478999999986532  23356788999999999999999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCcc-
Q 008292          426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG-  504 (571)
Q Consensus       426 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~-  504 (571)
                      ++|.+++.... ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+|++||+.+.......... 
T Consensus        84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~  159 (328)
T cd08226          84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK  159 (328)
T ss_pred             CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence            99999885422 235889999999999999999999887   9999999999999999999999998654332111100 


Q ss_pred             ----ccccccccCCcccccccccC--CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          505 ----NTSRIVGTYGYMAPEYAMHG--QFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       505 ----~~~~~~gt~~y~aPE~~~~~--~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                          ......++..|+|||++.+.  .++.++||||||+++|||++|+.||..
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~  212 (328)
T cd08226         160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQD  212 (328)
T ss_pred             ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence                01112345679999998764  478999999999999999999999864

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.96  E-value=3.8e-29  Score=249.88  Aligned_cols=197  Identities=28%  Similarity=0.398  Sum_probs=164.7

Q ss_pred             CCccccccccCceeEEEEEcc-CCCeeEEEeecccCc-cCHHHHHHHHHHHhhcC-CCceeccceeEEeCCeeEEEEEec
Q 008292          347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASG-QGAEEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEKILVYEFV  423 (571)
Q Consensus       347 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~  423 (571)
                      |.+.+.||+|++|+||+|+.. +++.|++|++..... .......+|+..+.+++ |+||+++++++.+++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            567789999999999999975 478899999865432 22234457899999999 999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCc
Q 008292          424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ  503 (571)
Q Consensus       424 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  503 (571)
                       +++|.+.+.... ...+++..+..++.|++.+|.|||+++   ++|+||+|+||++++++.++|+|||++........ 
T Consensus        81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-  154 (283)
T cd07830          81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-  154 (283)
T ss_pred             -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence             788888774322 346899999999999999999999987   99999999999999999999999999976543221 


Q ss_pred             cccccccccCCcccccccc-cCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          504 GNTSRIVGTYGYMAPEYAM-HGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       504 ~~~~~~~gt~~y~aPE~~~-~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                        .....++..|+|||.+. ...++.++||||||+++|||++|+.|+..
T Consensus       155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~  201 (283)
T cd07830         155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPG  201 (283)
T ss_pred             --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCC
Confidence              12345788999999875 45688999999999999999999988753

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.96  E-value=3.6e-29  Score=256.27  Aligned_cols=199  Identities=26%  Similarity=0.396  Sum_probs=162.6

Q ss_pred             CCCccccccccCceeEEEEEcc-C--CCeeEEEeecccC--ccCHHHHHHHHHHHhhc-CCCceeccceeEEeC----Ce
Q 008292          346 KFSTDNKLGEGGFGEVYKGVLP-S--GQEIAVKRLSKAS--GQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEG----EE  415 (571)
Q Consensus       346 ~~~~~~~LG~G~fg~Vy~~~~~-~--g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~----~~  415 (571)
                      +|++.+.||+|+||.||+++.. .  +..||+|+++...  ....+.+.+|+.++.++ +||||+++++.+...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4677889999999999999964 3  6789999986532  22346778899999999 599999999876433    34


Q ss_pred             eEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCcc
Q 008292          416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR  495 (571)
Q Consensus       416 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  495 (571)
                      .++++||+. ++|.+++.   ....+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        81 ~~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~  153 (332)
T cd07857          81 LYLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR  153 (332)
T ss_pred             EEEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence            678888886 67888773   3456899999999999999999999887   9999999999999999999999999998


Q ss_pred             ccCCCCCc--cccccccccCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          496 IFGVDQTQ--GNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       496 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .+......  .......|+..|+|||.+.+ ..++.++||||||+++|||++|+.|+..
T Consensus       154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~  212 (332)
T cd07857         154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKG  212 (332)
T ss_pred             ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCC
Confidence            65432211  11233568999999998765 4689999999999999999999998864

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.96  E-value=2.4e-29  Score=254.80  Aligned_cols=194  Identities=32%  Similarity=0.474  Sum_probs=163.3

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeeccc---CccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY  420 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  420 (571)
                      +.|...+.||+|+||.||+|+.. +++.+++|.+...   .....+++.+|+++++.++|+|++++++++......++||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            34667789999999999999964 5788999988643   2233456788999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCC
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD  500 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  500 (571)
                      ||+. |+|...+..  ....+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.+||+|||++......
T Consensus        95 e~~~-~~l~~~~~~--~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  168 (308)
T cd06634          95 EYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  168 (308)
T ss_pred             EccC-CCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence            9997 567666532  2345889999999999999999999887   999999999999999999999999998765321


Q ss_pred             CCccccccccccCCcccccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          501 QTQGNTSRIVGTYGYMAPEYAM---HGQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       501 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                            ....++..|+|||.+.   ...++.++||||||+++|||++|+.|+.
T Consensus       169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~  215 (308)
T cd06634         169 ------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF  215 (308)
T ss_pred             ------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCc
Confidence                  2345788999999874   3568889999999999999999999974

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.96  E-value=3.2e-29  Score=250.07  Aligned_cols=197  Identities=32%  Similarity=0.500  Sum_probs=168.1

Q ss_pred             CCccccccccCceeEEEEEcc-CCCeeEEEeecccC--ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEec
Q 008292          347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV  423 (571)
Q Consensus       347 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  423 (571)
                      |+..+.||+|++|.||+++.. +++.+++|.+....  ....+.+.+|+.++++++|+||+++++++.+.+..++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            456788999999999999975 58999999987653  334567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCc
Q 008292          424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ  503 (571)
Q Consensus       424 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  503 (571)
                      + ++|.+++...  ...+++..+..++.|+++||.|||+++   |+||||+|+||++++++.+||+|||+++....... 
T Consensus        81 ~-~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-  153 (282)
T cd07829          81 D-MDLKKYLDKR--PGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-  153 (282)
T ss_pred             C-cCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence            8 5898888432  246899999999999999999999987   99999999999999999999999999986543222 


Q ss_pred             cccccccccCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          504 GNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       504 ~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                       ......++..|+|||.+.+. .++.++||||||+++|||++|+.|+..
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~  201 (282)
T cd07829         154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPG  201 (282)
T ss_pred             -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence             12223457789999998776 889999999999999999999988754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.9e-29  Score=238.76  Aligned_cols=204  Identities=26%  Similarity=0.368  Sum_probs=174.6

Q ss_pred             HHHhCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC---ccCHHHHHHHHHHHhh-cCCCceeccceeEEeCCe
Q 008292          341 EVATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAK-LQHRNLVRLLGFCLEGEE  415 (571)
Q Consensus       341 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~-l~h~niv~l~~~~~~~~~  415 (571)
                      ....++|...+.||+|+|..|-.++++ ..+.+|+|++++.-   .+..+-.+.|-.+... -+||.+|-+..++.....
T Consensus       246 ~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesr  325 (593)
T KOG0695|consen  246 GLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESR  325 (593)
T ss_pred             ccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccce
Confidence            344578999999999999999999965 56789999998642   3333444556555544 479999999999999999


Q ss_pred             eEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCcc
Q 008292          416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR  495 (571)
Q Consensus       416 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  495 (571)
                      .++|.||++||+|--.+   .++.+++++.+..+..+|.-||.|||+.+   ||.||||..|||||.+|.+||+|+|+++
T Consensus       326 lffvieyv~ggdlmfhm---qrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmck  399 (593)
T KOG0695|consen  326 LFFVIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCK  399 (593)
T ss_pred             EEEEEEEecCcceeeeh---hhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhh
Confidence            99999999999996666   45677999999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 008292          496 IFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFY  552 (571)
Q Consensus       496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~~  552 (571)
                      .--  .....++..+|||.|+|||.+.+..|...+|+|+|||+++||+.|+.||+.-
T Consensus       400 e~l--~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdiv  454 (593)
T KOG0695|consen  400 EGL--GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIV  454 (593)
T ss_pred             cCC--CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCccee
Confidence            532  2234567789999999999999999999999999999999999999999854

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=1.7e-29  Score=266.21  Aligned_cols=208  Identities=28%  Similarity=0.491  Sum_probs=177.9

Q ss_pred             chHHHHHHhCCCCccccccccCceeEEEEEc-cCCCeeEEEeecccCccCHHHHHHHHHHHhhc-CCCceeccceeEEe-
Q 008292          336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLE-  412 (571)
Q Consensus       336 ~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~-  412 (571)
                      +++.+...++.|++.+.||.|.+|.||+++. ++++.+|+|++.... ...++++.|.++++.. .|||++.++|++.. 
T Consensus        10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~   88 (953)
T KOG0587|consen   10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKK   88 (953)
T ss_pred             chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence            3444445577899999999999999999994 578899999887654 3456778888888877 59999999999875 


Q ss_pred             ----CCeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEE
Q 008292          413 ----GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKI  488 (571)
Q Consensus       413 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl  488 (571)
                          ++.+|||||||.+|+..+++.+-. +..+.|..+..|++.++.||.+||.+.   ++|||||-.|||++.++.|||
T Consensus        89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKL  164 (953)
T KOG0587|consen   89 DPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKL  164 (953)
T ss_pred             cCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEE
Confidence                567899999999999999986544 778999999999999999999999876   999999999999999999999


Q ss_pred             eeccCccccCCCCCccccccccccCCccccccccc-----CCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          489 SDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMH-----GQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       489 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      .|||++..+.  ..........||+.|||||++.-     ..|+.++|+||||++..||--|.+|.-
T Consensus       165 vDFGvSaQld--sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~  229 (953)
T KOG0587|consen  165 VDFGVSAQLD--STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLC  229 (953)
T ss_pred             eeeeeeeeee--cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCcc
Confidence            9999998764  33445556789999999999943     357789999999999999999999963

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.96  E-value=1e-29  Score=237.73  Aligned_cols=194  Identities=25%  Similarity=0.335  Sum_probs=162.2

Q ss_pred             hCCCCcc-ccccccCceeEEEEEcc-CCCeeEEEeecccCccCHHHHHHHHHHHhhc-CCCceeccceeEEe----CCee
Q 008292          344 TNKFSTD-NKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLE----GEEK  416 (571)
Q Consensus       344 ~~~~~~~-~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~----~~~~  416 (571)
                      +++|++. ++||-|-.|.|-.+..+ +++++|+|++...     ...++|+++.-.. .|||||.+++++..    ...+
T Consensus        60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL  134 (400)
T KOG0604|consen   60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL  134 (400)
T ss_pred             hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence            4455543 68999999999998864 6889999998543     3346788875544 69999999998864    3567


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECC---CCceEEeeccC
Q 008292          417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA---EMNPKISDFGM  493 (571)
Q Consensus       417 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfGl  493 (571)
                      .+|||.|+||.|...+.+ +....+++.++-.|+.||..|+.|||+.+   |.||||||+|+|...   |-.+||+|||+
T Consensus       135 LiVmE~meGGeLfsriq~-~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGF  210 (400)
T KOG0604|consen  135 LIVMECMEGGELFSRIQD-RGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGF  210 (400)
T ss_pred             EeeeecccchHHHHHHHH-cccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccccc
Confidence            899999999999988854 34556999999999999999999999987   999999999999964   45799999999


Q ss_pred             ccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCC
Q 008292          494 ARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNS  549 (571)
Q Consensus       494 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~  549 (571)
                      |+.-.   ........+-|+.|.|||++-..+|....|+||+||++|-|++|.+||
T Consensus       211 AK~t~---~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPF  263 (400)
T KOG0604|consen  211 AKETQ---EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF  263 (400)
T ss_pred             ccccC---CCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcc
Confidence            98632   233445668899999999999999999999999999999999999997

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.96  E-value=5e-29  Score=245.90  Aligned_cols=199  Identities=28%  Similarity=0.414  Sum_probs=164.1

Q ss_pred             CCCccccccccCceeEEEEEccC-CCeeEEEeeccc-----CccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEE
Q 008292          346 KFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSKA-----SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV  419 (571)
Q Consensus       346 ~~~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  419 (571)
                      +|.+.++||+|+||.||+++... +..+++|.++..     ......++..|+.++++++||||+++++++.+.+..++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            47788999999999999998643 444555555431     122334567899999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccC
Q 008292          420 YEFVPNKSLDYFLYDP-EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG  498 (571)
Q Consensus       420 ~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  498 (571)
                      +||+++++|..++... .....+++..++.++.|+++||.|||+.+   ++|+||+|+||++++ +.+||+|||+++...
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence            9999999999887532 23457899999999999999999999887   999999999999975 569999999987653


Q ss_pred             CCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          499 VDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      ....  ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.|+.
T Consensus       157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~  206 (260)
T cd08222         157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFE  206 (260)
T ss_pred             CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            3221  1223457889999999988889999999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.96  E-value=9.5e-29  Score=240.61  Aligned_cols=179  Identities=21%  Similarity=0.216  Sum_probs=151.8

Q ss_pred             cCceeEEEEEcc-CCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEecCCCChhhhhcC
Q 008292          356 GGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYD  434 (571)
Q Consensus       356 G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~  434 (571)
                      |.+|.||++... +++.+|+|+++....     +.+|...+....||||+++++++.+.+..+++|||+++|+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-----~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-----YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh-----hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            889999999964 678999999876532     23445555566799999999999999999999999999999988843


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCccccccccccCC
Q 008292          435 PEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG  514 (571)
Q Consensus       435 ~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~  514 (571)
                         ...+++..+..++.|+++||.|||+.+   |+||||||+||+++.++.++|+|||++..+....     ....++..
T Consensus        79 ---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~  147 (237)
T cd05576          79 ---FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENM  147 (237)
T ss_pred             ---hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCcc
Confidence               345899999999999999999999887   9999999999999999999999999886553221     12345678


Q ss_pred             cccccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       515 y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      |+|||.+....++.++||||+|+++|||++|+.|+.
T Consensus       148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~  183 (237)
T cd05576         148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVE  183 (237)
T ss_pred             ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhh
Confidence            999999988889999999999999999999997654

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.96  E-value=7.5e-29  Score=261.96  Aligned_cols=204  Identities=24%  Similarity=0.330  Sum_probs=154.1

Q ss_pred             HhCCCCccccccccCceeEEEEEc-----------------cCCCeeEEEeecccCccCHHH--------------HHHH
Q 008292          343 ATNKFSTDNKLGEGGFGEVYKGVL-----------------PSGQEIAVKRLSKASGQGAEE--------------FKNE  391 (571)
Q Consensus       343 ~~~~~~~~~~LG~G~fg~Vy~~~~-----------------~~g~~vavK~~~~~~~~~~~~--------------~~~E  391 (571)
                      ..++|++.++||+|+||+||+|..                 .+++.||||++........++              ...|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            367899999999999999999963                 235679999986543322223              3346


Q ss_pred             HHHHhhcCCCce-----eccceeEEe--------CCeeEEEEEecCCCChhhhhcCCC---------------------C
Q 008292          392 VVLVAKLQHRNL-----VRLLGFCLE--------GEEKILVYEFVPNKSLDYFLYDPE---------------------K  437 (571)
Q Consensus       392 i~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~---------------------~  437 (571)
                      +.++.+++|.++     ++++++|..        ....+|||||+++++|.++++...                     .
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777777777654     677887753        346799999999999999886421                     1


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCccccccccccCCccc
Q 008292          438 QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMA  517 (571)
Q Consensus       438 ~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a  517 (571)
                      ...+++..+..++.|++++|.|||+.+   |+||||||+|||++.++.+||+|||+++.+...... ......+++.|+|
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~a  378 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSP  378 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeC
Confidence            123567888999999999999999887   999999999999999999999999999765332211 1112335789999


Q ss_pred             ccccccCCC----------------------CcchhHHHHHHHHHHHHhCCC-CCC
Q 008292          518 PEYAMHGQF----------------------SVKSDVYSFGVLVLEIITGKK-NSN  550 (571)
Q Consensus       518 PE~~~~~~~----------------------s~~~Dv~slGvvl~elltG~~-p~~  550 (571)
                      ||.+.....                      ..+.||||+||+++||++|.. |+.
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~  434 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA  434 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence            998854321                      234799999999999999986 553

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.96  E-value=8.7e-29  Score=274.47  Aligned_cols=145  Identities=29%  Similarity=0.397  Sum_probs=130.0

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC---ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY  420 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  420 (571)
                      ++|.+.++||+|+||.||++... +++.||||+++...   ......+.+|+.++..++|+||+++++.+......+|||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            57888999999999999999975 68899999987543   223467889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCcc
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR  495 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  495 (571)
                      ||+++++|..++..   ...+++..++.++.||+.||.|||..+   |+||||||+||||+.++.+||+|||+++
T Consensus        84 Ey~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999999843   346889999999999999999999886   9999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.96  E-value=4.1e-29  Score=257.02  Aligned_cols=195  Identities=29%  Similarity=0.472  Sum_probs=165.8

Q ss_pred             HhCCCCccccccccCceeEEEEEcc-CCCeeEEEeeccc--CccCHHHHHHHHHHHhhcCCCceeccceeEEeCCe----
Q 008292          343 ATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEE----  415 (571)
Q Consensus       343 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~----  415 (571)
                      ..++|.+.+.||+|++|.||+++.. +++.|++|++...  .....+.+.+|+.++++++|+||+++++++...+.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            3568999999999999999999975 5788999988653  22334567789999999999999999998876554    


Q ss_pred             --eEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccC
Q 008292          416 --KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM  493 (571)
Q Consensus       416 --~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl  493 (571)
                        .++|+||+ +++|.+++.    ...+++..+..++.|+++||.|||+.+   |+||||+|+||++++++.+||+|||+
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~----~~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~  164 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVK----CQKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL  164 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence              89999998 568988873    356899999999999999999999887   99999999999999999999999999


Q ss_pred             ccccCCCCCccccccccccCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          494 ARIFGVDQTQGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       494 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      +......     .....++..|+|||.+.+ ..++.++||||||+++|||+||+.||.
T Consensus       165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~  217 (343)
T cd07851         165 ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFP  217 (343)
T ss_pred             ccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence            9865322     223357888999998865 367899999999999999999999985

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.6e-30  Score=239.95  Aligned_cols=200  Identities=26%  Similarity=0.413  Sum_probs=163.2

Q ss_pred             CCccccccccCceeEEEEEc-cCCCeeEEEeeccc--CccCHHHHHHHHHHHhhcCCCceeccceeEEeC-----CeeEE
Q 008292          347 FSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG-----EEKIL  418 (571)
Q Consensus       347 ~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-----~~~~l  418 (571)
                      .+..+.||-|.||.||.++. ++|+.|++|++...  +-...+.+.+|+++|..++|.|++..++.....     ++.|+
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV  134 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV  134 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence            34467899999999999996 47999999988642  223456788999999999999999999876543     24577


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccC
Q 008292          419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG  498 (571)
Q Consensus       419 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  498 (571)
                      +.|.|. .+|..++-   ....++...+.-++.||++||.|||+.+   |.||||||.|.|+++|..+||+|||+++...
T Consensus       135 ~TELmQ-SDLHKIIV---SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee  207 (449)
T KOG0664|consen  135 LTELMQ-SDLHKIIV---SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWD  207 (449)
T ss_pred             HHHHHH-hhhhheec---cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccc
Confidence            788774 45666652   3456888889999999999999999987   9999999999999999999999999999876


Q ss_pred             CCCCccccccccccCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 008292          499 VDQTQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQT  554 (571)
Q Consensus       499 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~slGvvl~elltG~~p~~~~~~  554 (571)
                      .+.....+ ..+-|..|.|||.+++. +|+.+.||||.||++.||+..+.-|+-..+
T Consensus       208 ~d~~~hMT-qEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~P  263 (449)
T KOG0664|consen  208 QRDRLNMT-HEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGP  263 (449)
T ss_pred             hhhhhhhH-HHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccCh
Confidence            65554433 34568899999999875 699999999999999999998887765443

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.4e-28  Score=252.92  Aligned_cols=196  Identities=28%  Similarity=0.389  Sum_probs=162.1

Q ss_pred             hCCCCccccccccCceeEEEEEc-cCCCeeEEEeecccCccCHHHHHHHHHHHhh-cCCCceeccceeEEeCCeeEEEEE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAK-LQHRNLVRLLGFCLEGEEKILVYE  421 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~-l~h~niv~l~~~~~~~~~~~lv~e  421 (571)
                      ++.|.....+|.|+|+.|-++.. .+++..++|++.+...    +-.+|+.++.. -+||||+++.+.+.++.+.++|||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e  396 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME  396 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence            45677778899999999999985 4678899999976522    22456655544 479999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEE-CCCCceEEeeccCccccCCC
Q 008292          422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL-DAEMNPKISDFGMARIFGVD  500 (571)
Q Consensus       422 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll-~~~~~~kl~DfGla~~~~~~  500 (571)
                      .+.++-+.+.+.   ...... ..+..|+.+|+.++.|||+++   +|||||||+|||+ ++.++++|+|||.++....+
T Consensus       397 ~l~g~ell~ri~---~~~~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~  469 (612)
T KOG0603|consen  397 LLDGGELLRRIR---SKPEFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS  469 (612)
T ss_pred             hccccHHHHHHH---hcchhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence            999998766653   222233 677789999999999999987   9999999999999 58899999999999876543


Q ss_pred             CCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 008292          501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTD  555 (571)
Q Consensus       501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~~~~~  555 (571)
                           ....+-|..|.|||++....+++++||||||++|||||+|+.|+.-...+
T Consensus       470 -----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~  519 (612)
T KOG0603|consen  470 -----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG  519 (612)
T ss_pred             -----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch
Confidence                 22346688999999999999999999999999999999999999765433

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.95  E-value=1.2e-27  Score=229.97  Aligned_cols=198  Identities=34%  Similarity=0.493  Sum_probs=171.4

Q ss_pred             CCccccccccCceeEEEEEccC-CCeeEEEeecccCcc-CHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEecC
Q 008292          347 FSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSKASGQ-GAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVP  424 (571)
Q Consensus       347 ~~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  424 (571)
                      |...+.||+|++|.||++...+ ++.+++|.+...... ..+.+.+|++.+++++|+|++++++++...+..++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            4567889999999999999765 889999999876554 67789999999999999999999999999899999999999


Q ss_pred             CCChhhhhcCCCCCCC-CCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCc
Q 008292          425 NKSLDYFLYDPEKQGQ-LDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ  503 (571)
Q Consensus       425 ~g~L~~~l~~~~~~~~-l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  503 (571)
                      +++|.+++...   .. +++..+..++.+++.++.+||+.+   ++|+||+|+||+++.++.++|+|||.+........ 
T Consensus        81 ~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-  153 (225)
T smart00221       81 GGDLFDYLRKK---GGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-  153 (225)
T ss_pred             CCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-
Confidence            99999998432   23 789999999999999999999886   99999999999999999999999999987643321 


Q ss_pred             cccccccccCCccccccc-ccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          504 GNTSRIVGTYGYMAPEYA-MHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       504 ~~~~~~~gt~~y~aPE~~-~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .......++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus       154 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      154 ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            122334677889999988 667788899999999999999999999853

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=2.1e-29  Score=230.24  Aligned_cols=212  Identities=26%  Similarity=0.470  Sum_probs=166.4

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC--ccCHHHHHHHHHHHhhcCCCceeccceeEEeC--------
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG--------  413 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--------  413 (571)
                      +.|....+||+|.||.||+++.+ .|++||+|++-..+  +..-..-.+|+++|..++|+|++.++..|...        
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            45677789999999999999964 57788988764322  22234557899999999999999999988542        


Q ss_pred             CeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccC
Q 008292          414 EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM  493 (571)
Q Consensus       414 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl  493 (571)
                      ...++||.+++. +|..+|.+  ...+++..++.+++.++..||.|+|...   |+|||+||.|+||+.++.+||+|||+
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl  170 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL  170 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence            236899999965 56667733  2356889999999999999999999876   99999999999999999999999999


Q ss_pred             ccccCCCCCc--cccccccccCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHH
Q 008292          494 ARIFGVDQTQ--GNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYVS  565 (571)
Q Consensus       494 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slGvvl~elltG~~p~~~~~~~~~~~l~~~~~  565 (571)
                      ++.+......  ...+..+-|+.|.+||.+++ .+++++.|||.-||++.||+||..-++-   +.....+..+.
T Consensus       171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqg---nteqqql~~Is  242 (376)
T KOG0669|consen  171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQG---NTEQQQLHLIS  242 (376)
T ss_pred             ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccC---ChHHHHHHHHH
Confidence            9877543322  12233456899999998876 5799999999999999999999886543   33334444443

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.95  E-value=4.4e-27  Score=228.33  Aligned_cols=186  Identities=34%  Similarity=0.502  Sum_probs=164.1

Q ss_pred             CceeEEEEEcc-CCCeeEEEeecccCccC-HHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEecCCCChhhhhcC
Q 008292          357 GFGEVYKGVLP-SGQEIAVKRLSKASGQG-AEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYD  434 (571)
Q Consensus       357 ~fg~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~  434 (571)
                      +||.||+++.. +++.+++|++....... .+.+.+|++.+++++|+||+++++.+......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999976 48999999998765554 78999999999999999999999999999999999999999999998843


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCccccccccccCC
Q 008292          435 PEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG  514 (571)
Q Consensus       435 ~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~  514 (571)
                         ...+++..++.++.++++++.+||+.+   ++|+||+|+||++++++.++|+|||.+.......   ......++..
T Consensus        81 ---~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~  151 (244)
T smart00220       81 ---RGRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE  151 (244)
T ss_pred             ---ccCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence               223899999999999999999999986   9999999999999999999999999998764332   2234467889


Q ss_pred             cccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       515 y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      |++||.+....++.++||||||++++||++|+.|+..
T Consensus       152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~  188 (244)
T smart00220      152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPG  188 (244)
T ss_pred             CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            9999999888899999999999999999999999865

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.95  E-value=3.5e-28  Score=219.32  Aligned_cols=205  Identities=21%  Similarity=0.414  Sum_probs=168.5

Q ss_pred             hCCCCccccccccCceeEEEEE-ccCCCeeEEEeecccCccCHHHHHHHHHHHhhcC-CCceeccceeEEeCC--eeEEE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ-HRNLVRLLGFCLEGE--EKILV  419 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~--~~~lv  419 (571)
                      .++|++.+++|+|.++.||.|. ..++++++||++++..   .+.+++|+++|..++ ||||+++++...+..  ...||
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi  113 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI  113 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence            3578889999999999999999 4678899999997643   467899999999998 999999999987754  45799


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCC-CceEEeeccCccccC
Q 008292          420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE-MNPKISDFGMARIFG  498 (571)
Q Consensus       420 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfGla~~~~  498 (571)
                      +||+.+.+...+-      ..++...+...+.++++||.|.|+.|   |+|||+||.|++||.. ..++|+|+|+|..+.
T Consensus       114 FE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH  184 (338)
T KOG0668|consen  114 FEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  184 (338)
T ss_pred             hhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcC
Confidence            9999998887654      35777889999999999999999988   9999999999999975 579999999998765


Q ss_pred             CCCCccccccccccCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHH
Q 008292          499 VDQTQGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYV  564 (571)
Q Consensus       499 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slGvvl~elltG~~p~~~~~~~~~~~l~~~~  564 (571)
                      +...   .+..+.+.-|.-||.+.+ ..|...-|+|||||++.+|+..+.||-. ..+..+.|++.+
T Consensus       185 p~~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFh-G~dN~DQLVkIa  247 (338)
T KOG0668|consen  185 PGKE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH-GHDNYDQLVKIA  247 (338)
T ss_pred             CCce---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccC-CCCCHHHHHHHH
Confidence            4432   223456778899998875 4578889999999999999999999853 333344454443

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.95  E-value=4.2e-28  Score=244.55  Aligned_cols=195  Identities=28%  Similarity=0.435  Sum_probs=165.3

Q ss_pred             CCCCccccccccCceeEEEEEccC-CCeeEEEeecccC--------ccCHHHHHHHHHHHhhcC---CCceeccceeEEe
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSKAS--------GQGAEEFKNEVVLVAKLQ---HRNLVRLLGFCLE  412 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~--------~~~~~~~~~Ei~~l~~l~---h~niv~l~~~~~~  412 (571)
                      ..|...+.||+|+||.|+.+.++. ...|+||.+.+..        ....-.+-.||.||..++   |+||++++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            458889999999999999999764 5678899886532        111123567999999998   9999999999999


Q ss_pred             CCeeEEEEEecC-CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeec
Q 008292          413 GEEKILVYEFVP-NKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDF  491 (571)
Q Consensus       413 ~~~~~lv~e~~~-~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  491 (571)
                      ++.++|+||-.. +-+|.+++   +.+..+++.+...|+.|++-|+++||+.+   |||||||-+||.++.+|-+||+||
T Consensus       641 dd~yyl~te~hg~gIDLFd~I---E~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf  714 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFI---EFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF  714 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhh---hccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence            999999999774 44777777   45667999999999999999999999998   999999999999999999999999


Q ss_pred             cCccccCCCCCccccccccccCCcccccccccCCCCcc-hhHHHHHHHHHHHHhCCCCC
Q 008292          492 GMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVK-SDVYSFGVLVLEIITGKKNS  549 (571)
Q Consensus       492 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~-~Dv~slGvvl~elltG~~p~  549 (571)
                      |.+.....    .....++||..|.|||++.+.+|--| -|||++|++||-++...-|+
T Consensus       715 gsaa~~ks----gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy  769 (772)
T KOG1152|consen  715 GSAAYTKS----GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY  769 (772)
T ss_pred             cchhhhcC----CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence            99976532    23345789999999999999887654 79999999999999888775

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.95  E-value=3e-27  Score=255.96  Aligned_cols=199  Identities=25%  Similarity=0.301  Sum_probs=140.9

Q ss_pred             HhCCCCccccccccCceeEEEEEcc-C----CCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceecccee------EE
Q 008292          343 ATNKFSTDNKLGEGGFGEVYKGVLP-S----GQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGF------CL  411 (571)
Q Consensus       343 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~----g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~------~~  411 (571)
                      ..++|...++||+|+||.||+|++. +    +..||+|++......  +...+|  .+....+.++..++..      ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            4578999999999999999999975 4    688999987643221  111111  1122223333333222      23


Q ss_pred             eCCeeEEEEEecCCCChhhhhcCCCC-----------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCC
Q 008292          412 EGEEKILVYEFVPNKSLDYFLYDPEK-----------------QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLK  474 (571)
Q Consensus       412 ~~~~~~lv~e~~~~g~L~~~l~~~~~-----------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk  474 (571)
                      .+...++|+||+++++|.+++.....                 ........+..++.||+.||+|||+++   |+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence            45678999999999999988853210                 011123446679999999999999887   9999999


Q ss_pred             CCCEEECC-CCceEEeeccCccccCCCCCccccccccccCCcccccccccC----------------------CCCcchh
Q 008292          475 ASNILLDA-EMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG----------------------QFSVKSD  531 (571)
Q Consensus       475 p~NIll~~-~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~s~~~D  531 (571)
                      |+|||+++ ++.+||+|||+++.+..... .......+++.|||||.+...                      .++.++|
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            99999986 57999999999986543221 223345789999999966322                      2345679


Q ss_pred             HHHHHHHHHHHHhCCCCC
Q 008292          532 VYSFGVLVLEIITGKKNS  549 (571)
Q Consensus       532 v~slGvvl~elltG~~p~  549 (571)
                      ||||||++|||+++..|.
T Consensus       362 VwSlGviL~el~~~~~~~  379 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRS  379 (566)
T ss_pred             cHHHHHHHHHHHhCcCCC
Confidence            999999999999977654

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.94  E-value=4.7e-28  Score=234.19  Aligned_cols=216  Identities=24%  Similarity=0.309  Sum_probs=173.7

Q ss_pred             HHHHHHhCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccCccCHHHHHHHHHHHhhcCC--Cc----eeccceeE
Q 008292          338 ETIEVATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH--RN----LVRLLGFC  410 (571)
Q Consensus       338 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h--~n----iv~l~~~~  410 (571)
                      ...+..+++|.+...+|+|.||.|-+...+ .+..||||+++... .-.+.-+-|+++|.++.+  |+    ++.+.++|
T Consensus        82 ~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF  160 (415)
T KOG0671|consen   82 QVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWF  160 (415)
T ss_pred             EeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh
Confidence            334455789999999999999999999864 46789999986543 334556779999999842  33    78888889


Q ss_pred             EeCCeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECC--------
Q 008292          411 LEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA--------  482 (571)
Q Consensus       411 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~--------  482 (571)
                      .-.+..+||+|.+ |-++.+||.. .+-.+++...+..|+.|+++++++||+..   ++|-||||+|||+.+        
T Consensus       161 dyrghiCivfell-G~S~~dFlk~-N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~  235 (415)
T KOG0671|consen  161 DYRGHICIVFELL-GLSTFDFLKE-NNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYN  235 (415)
T ss_pred             hccCceEEEEecc-ChhHHHHhcc-CCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEec
Confidence            9999999999987 6688899843 23456889999999999999999999987   999999999999832        


Q ss_pred             ------------CCceEEeeccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          483 ------------EMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       483 ------------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                                  +..+||+|||.|..-..     ..+.++.|..|.|||++++-.++..+||||+||||.||.||..-|.
T Consensus       236 ~k~~~~~~r~~ks~~I~vIDFGsAtf~~e-----~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFq  310 (415)
T KOG0671|consen  236 PKKKVCFIRPLKSTAIKVIDFGSATFDHE-----HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQ  310 (415)
T ss_pred             cCCccceeccCCCcceEEEecCCcceecc-----CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecc
Confidence                        23489999999975332     2356788999999999999999999999999999999999999887


Q ss_pred             CCCCCCcccHHHHH
Q 008292          551 FYQTDGAADLLSYV  564 (571)
Q Consensus       551 ~~~~~~~~~l~~~~  564 (571)
                      -.+.-+...+++-+
T Consensus       311 tHen~EHLaMMerI  324 (415)
T KOG0671|consen  311 THENLEHLAMMERI  324 (415)
T ss_pred             cCCcHHHHHHHHHh
Confidence            65543434444433

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.94  E-value=2.2e-27  Score=249.25  Aligned_cols=197  Identities=28%  Similarity=0.404  Sum_probs=159.4

Q ss_pred             CCccccccccCcee-EEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhc-CCCceeccceeEEeCCeeEEEEEecC
Q 008292          347 FSTDNKLGEGGFGE-VYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVP  424 (571)
Q Consensus       347 ~~~~~~LG~G~fg~-Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  424 (571)
                      |...+.+|.|+-|+ ||+|.+ +|+.||||++-..   ......+||..|+.- +|||||++++.-.+.+..||..|.| 
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-  585 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-  585 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence            45567889999865 899999 7899999988543   234557899999876 6999999999999999999999999 


Q ss_pred             CCChhhhhcCCCCCC-CCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECC---C--CceEEeeccCccccC
Q 008292          425 NKSLDYFLYDPEKQG-QLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA---E--MNPKISDFGMARIFG  498 (571)
Q Consensus       425 ~g~L~~~l~~~~~~~-~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~--~~~kl~DfGla~~~~  498 (571)
                      ..+|++++....... .......+.++.|+++||++||+.+   ||||||||.||||+.   +  ..++|+|||+++.+.
T Consensus       586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence            568988885421111 1111345778899999999999876   999999999999965   2  479999999999886


Q ss_pred             CCCCcc-ccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhC-CCCCCC
Q 008292          499 VDQTQG-NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG-KKNSNF  551 (571)
Q Consensus       499 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG-~~p~~~  551 (571)
                      .+.... ......||-+|+|||.+....-+.++||||+||++|+.++| ..||..
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd  717 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGD  717 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCc
Confidence            554332 34567899999999999998889999999999999999996 778853

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.92  E-value=2.4e-24  Score=203.93  Aligned_cols=183  Identities=39%  Similarity=0.645  Sum_probs=158.2

Q ss_pred             ccccCceeEEEEEccC-CCeeEEEeecccCcc-CHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEecCCCChhh
Q 008292          353 LGEGGFGEVYKGVLPS-GQEIAVKRLSKASGQ-GAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDY  430 (571)
Q Consensus       353 LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  430 (571)
                      ||+|.+|.||++...+ ++.+++|++...... ..+.+.+|+..++.++|++|+++++++......++++||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999754 889999998765432 35678999999999999999999999999999999999999999999


Q ss_pred             hhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECC-CCceEEeeccCccccCCCCCccccccc
Q 008292          431 FLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-EMNPKISDFGMARIFGVDQTQGNTSRI  509 (571)
Q Consensus       431 ~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGla~~~~~~~~~~~~~~~  509 (571)
                      ++....  ..+++..+..++.++++++.+||+.+   ++|+||+|.||+++. ++.++|+|||.+........  .....
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~  153 (215)
T cd00180          81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI  153 (215)
T ss_pred             HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence            984321  46899999999999999999999987   999999999999999 89999999999986543321  12234


Q ss_pred             cccCCcccccccccC-CCCcchhHHHHHHHHHHH
Q 008292          510 VGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEI  542 (571)
Q Consensus       510 ~gt~~y~aPE~~~~~-~~s~~~Dv~slGvvl~el  542 (571)
                      .+...|++||.+... ..+.++|+|++|+++++|
T Consensus       154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l  187 (215)
T cd00180         154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL  187 (215)
T ss_pred             cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence            577899999998877 888999999999999998

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.92  E-value=2.7e-26  Score=235.21  Aligned_cols=198  Identities=26%  Similarity=0.431  Sum_probs=175.6

Q ss_pred             hCCCCccccccccCceeEEEEEc-cCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      .++|...+.+|.|+||.|||++. ..++..|+|.++........-++.||.+++.-+||||+.++|.+...+..|+.|||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy   93 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY   93 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence            45788889999999999999995 46889999999887777778889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT  502 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  502 (571)
                      +.+|+|++.-+   -.+.+++.++....+..++||+|||+.+   -+|||||-.|||+++.+.+|++|||.+..+...  
T Consensus        94 cgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat--  165 (829)
T KOG0576|consen   94 CGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT--  165 (829)
T ss_pred             cCCCcccceee---ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh--
Confidence            99999988763   4678999999999999999999999987   799999999999999999999999999876432  


Q ss_pred             ccccccccccCCccccccc---ccCCCCcchhHHHHHHHHHHHHhCCCCC
Q 008292          503 QGNTSRIVGTYGYMAPEYA---MHGQFSVKSDVYSFGVLVLEIITGKKNS  549 (571)
Q Consensus       503 ~~~~~~~~gt~~y~aPE~~---~~~~~s~~~Dv~slGvvl~elltG~~p~  549 (571)
                      ........||+.|||||+.   ..+.|..++|||++|+...|+---+.|-
T Consensus       166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqppl  215 (829)
T KOG0576|consen  166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPL  215 (829)
T ss_pred             hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcc
Confidence            2334557899999999987   4567999999999999999998877773

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.92  E-value=2.6e-25  Score=210.48  Aligned_cols=193  Identities=30%  Similarity=0.391  Sum_probs=159.2

Q ss_pred             CCCCccccccccCceeEEEEEc-cCCCeeEEEeecc--cCccCHHHHHHHHHHHhhcCCCceeccceeEEeCC------e
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSK--ASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE------E  415 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------~  415 (571)
                      .+|...+.+|.|.- .|..+-. -.++.|++|++..  ......++..+|..++..++|+||++++.++.-..      +
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            46667778888877 4444432 2578999998754  23455677789999999999999999999987543      4


Q ss_pred             eEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCcc
Q 008292          416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR  495 (571)
Q Consensus       416 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  495 (571)
                      .++|||+| ..+|..+++     ..++-+++..+..|++.|+.|||+.+   |+||||||+||++..+..+||.|||+++
T Consensus        96 ~y~v~e~m-~~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar  166 (369)
T KOG0665|consen   96 VYLVMELM-DANLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR  166 (369)
T ss_pred             HHHHHHhh-hhHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence            68999999 457777663     34677889999999999999999987   9999999999999999999999999998


Q ss_pred             ccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          496 IFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      .-+.+   ...+..+.|.-|.|||++.+..+.+.+||||+||++.||++|+.-|.
T Consensus       167 ~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~  218 (369)
T KOG0665|consen  167 TEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFP  218 (369)
T ss_pred             ccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEec
Confidence            65433   23445677889999999999899999999999999999999998664

>PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function

Probab=99.92  E-value=2.7e-25  Score=186.56  Aligned_cols=103  Identities=45%  Similarity=0.857  Sum_probs=78.4

Q ss_pred             cccCC-C-Cccc-CCCchHHHHHHHHHHhcccccCCCCCCCCCceeeccCCCCCcEEEEEeccCCCCccchHHHHHHHHH
Q 008292           33 THVCS-T-TANF-TRNSTYEKNLNLLLSSIPTNASRGNGFSSGFFNATAGQDPNRVYGLFLCRGDQTTSDCQDCVTFAAR  109 (571)
Q Consensus        33 ~~~C~-~-~~~~-~~~s~~~~nl~~l~~~l~~~~~~~~~~~~~f~~~~~g~~~~~vyg~~~C~~D~~~~~C~~Cl~~a~~  109 (571)
                      |+.|+ + .++| +++++|++||+.||..|.++++.++  +.+|++++.|.++++|||++||++|+++.+|..||+.|+.
T Consensus         1 ~~~Cs~~~~~~~~~~~~~f~~~l~~ll~~l~~~a~~~~--~~~f~~~~~~~~~~~vYgl~qC~~Dls~~dC~~Cl~~a~~   78 (106)
T PF01657_consen    1 WHFCSSNTNNNYTTDNSTFEQNLNSLLSSLVSNAASSS--SKGFATGSAGSGPDTVYGLAQCRGDLSPSDCRACLADAVA   78 (106)
T ss_dssp             ---E---SSB----TT-THHHHHHHHHHHHHHHGGGTT---TEEEEEE--ST---EEEEEEE-TTS-HHHHHHHHHHHHC
T ss_pred             CCcCCCCCCCCcCCCCchHHHHHHHHHHHHHHHHhhcc--ccCcEEeecCCCCCeEEEEEEcCCCCChhhhHHHHHHHHH
Confidence            56798 4 4567 6788899999999999999986321  4689999989999999999999999999999999999999


Q ss_pred             HHhhhCCCCceeEEEcceeEEEEcCCcc
Q 008292          110 DVLQLCPVSKETILWYAECLLRYSDQSI  137 (571)
Q Consensus       110 ~~~~~C~~~~~a~~~~~~C~~ry~~~~f  137 (571)
                      ++..+|+.+++|+||++.|+||||+++|
T Consensus        79 ~~~~~C~~~~g~~v~~~~C~lRY~~~~F  106 (106)
T PF01657_consen   79 NISSCCPGSRGGRVWYDSCFLRYENYPF  106 (106)
T ss_dssp             CHHHHTTSBSSEEEEESSEEEEEESS--
T ss_pred             HHHHhCCCCceEEEECCCEEEEEECCCC
Confidence            9999999999999999999999999998

The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D.

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.91  E-value=3.3e-24  Score=217.51  Aligned_cols=171  Identities=19%  Similarity=0.221  Sum_probs=131.9

Q ss_pred             HHHHHHhCCCCccccccccCceeEEEEEcc--CCCeeEEEeeccc-----CccCHHHHHHHHHHHhhcCCCceeccceeE
Q 008292          338 ETIEVATNKFSTDNKLGEGGFGEVYKGVLP--SGQEIAVKRLSKA-----SGQGAEEFKNEVVLVAKLQHRNLVRLLGFC  410 (571)
Q Consensus       338 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~--~g~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~  410 (571)
                      .......++|.+.+.||+|+||+||++..+  +++.||||++...     .....+.+.+|+++|++++|+|+++.+.. 
T Consensus        11 ~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~-   89 (365)
T PRK09188         11 DQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA-   89 (365)
T ss_pred             cccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE-
Confidence            344556788999999999999999999864  5777899987533     12234578999999999999999853322 


Q ss_pred             EeCCeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecC-CCCCEEECCCCceEEe
Q 008292          411 LEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDL-KASNILLDAEMNPKIS  489 (571)
Q Consensus       411 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dl-kp~NIll~~~~~~kl~  489 (571)
                        ....++||||+++++|....    ...      ...++.|++++|.|||+++   |+|||| ||+|||++.++++||+
T Consensus        90 --~~~~~LVmE~~~G~~L~~~~----~~~------~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLi  154 (365)
T PRK09188         90 --TGKDGLVRGWTEGVPLHLAR----PHG------DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVI  154 (365)
T ss_pred             --cCCcEEEEEccCCCCHHHhC----ccc------hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEE
Confidence              24679999999999996321    111      1467889999999999987   999999 9999999999999999


Q ss_pred             eccCccccCCCCCccc------cccccccCCcccccccccC
Q 008292          490 DFGMARIFGVDQTQGN------TSRIVGTYGYMAPEYAMHG  524 (571)
Q Consensus       490 DfGla~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~  524 (571)
                      |||+++.+........      .....+++.|+|||.+...
T Consensus       155 DFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        155 DFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             ECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            9999997654321111      1345788899999998544

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.91  E-value=1.5e-24  Score=212.79  Aligned_cols=213  Identities=23%  Similarity=0.397  Sum_probs=170.9

Q ss_pred             HHHHhCCCCccccccccCceeEEEEEcc----CCCeeEEEeecccCccCHHHHHHHHHHHhhcC-CCceeccceeEEeCC
Q 008292          340 IEVATNKFSTDNKLGEGGFGEVYKGVLP----SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ-HRNLVRLLGFCLEGE  414 (571)
Q Consensus       340 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~  414 (571)
                      +....+.|..+++||+|.|++||++.+.    ..+.||+|.+...+.  -..+.+|+++|..+. +.||+++.+++..++
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            3344567899999999999999999953    467899999876543  356889999999985 999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCC-CceEEeeccC
Q 008292          415 EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE-MNPKISDFGM  493 (571)
Q Consensus       415 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfGl  493 (571)
                      ...+|+||++.....++..      .++...+..++..+.+||.++|.++   ||||||||+|+|.+.. +.-.|.|||+
T Consensus       109 ~v~ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL  179 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL  179 (418)
T ss_pred             eeEEEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence            9999999999999988873      3678889999999999999999998   9999999999999754 5678999999


Q ss_pred             ccccCCC---------------C---------------------------CccccccccccCCccccccccc-CCCCcch
Q 008292          494 ARIFGVD---------------Q---------------------------TQGNTSRIVGTYGYMAPEYAMH-GQFSVKS  530 (571)
Q Consensus       494 a~~~~~~---------------~---------------------------~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~  530 (571)
                      +......               .                           .....-...||++|.|||++.. ...++++
T Consensus       180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai  259 (418)
T KOG1167|consen  180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI  259 (418)
T ss_pred             HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence            9621100               0                           0000112359999999999865 4678899


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHH
Q 008292          531 DVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYV  564 (571)
Q Consensus       531 Dv~slGvvl~elltG~~p~~~~~~~~~~~l~~~~  564 (571)
                      ||||.|||++-+++++.||-- ..++...|.+.+
T Consensus       260 Diws~GVI~Lslls~~~PFf~-a~dd~~al~ei~  292 (418)
T KOG1167|consen  260 DIWSAGVILLSLLSRRYPFFK-AKDDADALAEIA  292 (418)
T ss_pred             ceeeccceeehhhcccccccc-CccccchHHHHH
Confidence            999999999999999999853 334444454443

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=8.4e-24  Score=210.14  Aligned_cols=131  Identities=27%  Similarity=0.404  Sum_probs=107.0

Q ss_pred             CCCCccccccccCceeEEEEEc-cCCCeeEEEeecccCccCHHHHHHHHHHHhhcC-----C---CceeccceeEEe---
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ-----H---RNLVRLLGFCLE---  412 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----h---~niv~l~~~~~~---  412 (571)
                      .+|.+.++||.|.|++||++.. .+.+.||+|+.+.+. .-.+....||++|++++     |   .+||+|++.|..   
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            7889999999999999999985 456789999987543 33456678999999884     3   369999999965   


Q ss_pred             -CCeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEE
Q 008292          413 -GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL  480 (571)
Q Consensus       413 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll  480 (571)
                       +.+.+||+|++ |.+|..++.. ..-.-++...+.+|++||+.||.|||.+.  +|||-||||+|||+
T Consensus       157 NG~HVCMVfEvL-GdnLLklI~~-s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl  221 (590)
T KOG1290|consen  157 NGQHVCMVFEVL-GDNLLKLIKY-SNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL  221 (590)
T ss_pred             CCcEEEEEehhh-hhHHHHHHHH-hCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence             56789999999 4556555532 23345888999999999999999999876  79999999999998

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.91  E-value=1.2e-24  Score=201.32  Aligned_cols=194  Identities=24%  Similarity=0.414  Sum_probs=153.3

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccCccCHHHHHHHHHHHhhc-CCCceecccee-EEeCCeeEEEE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKL-QHRNLVRLLGF-CLEGEEKILVY  420 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~-~~~~~~~~lv~  420 (571)
                      .+.|.+.+.||+|.||.+-.+.++ +.+.+++|-+... .....+|.+|...--.| .|.||+.-+++ |...+.+++++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q  101 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ  101 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence            357888999999999999999975 5678888887543 23457788887655445 58999887764 45566778999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEEC--CCCceEEeeccCccccC
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD--AEMNPKISDFGMARIFG  498 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~DfGla~~~~  498 (571)
                      ||++.|+|.+-+    ....+.+.-..+++.|++.|+.|||+++   +||||||.+||||-  +..++||+|||+.+..+
T Consensus       102 E~aP~gdL~snv----~~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g  174 (378)
T KOG1345|consen  102 EFAPRGDLRSNV----EAAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG  174 (378)
T ss_pred             ccCccchhhhhc----CcccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC
Confidence            999999998776    2345778888899999999999999998   99999999999993  33489999999987543


Q ss_pred             CCCCccccccccccCCcccccccccC-----CCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          499 VDQTQGNTSRIVGTYGYMAPEYAMHG-----QFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       499 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      ..     .....-+..|-+||.....     ...+.+|||.||++++.++||+.||+
T Consensus       175 ~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQ  226 (378)
T KOG1345|consen  175 TT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQ  226 (378)
T ss_pred             ce-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcch
Confidence            21     1222345678999976432     34677999999999999999999998

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.90  E-value=8.6e-25  Score=218.14  Aligned_cols=217  Identities=21%  Similarity=0.246  Sum_probs=175.3

Q ss_pred             HHHHHHhCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccCccCHHHHHHHHHHHhhcCC------CceeccceeE
Q 008292          338 ETIEVATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH------RNLVRLLGFC  410 (571)
Q Consensus       338 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h------~niv~l~~~~  410 (571)
                      ...+....+|.+....|+|-|++|.++... .|..||||++...... .+.=..|+++|.+|+.      -|+++|+-.|
T Consensus       425 ~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F  503 (752)
T KOG0670|consen  425 RIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLFRHF  503 (752)
T ss_pred             ehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHHHHh
Confidence            345667788999999999999999999964 4789999999754322 2333679999999953      4799999999


Q ss_pred             EeCCeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCC-CceEEe
Q 008292          411 LEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE-MNPKIS  489 (571)
Q Consensus       411 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~  489 (571)
                      ...++++||+|-+ .-+|.++|.....+..|....+..++.|+..||..|...+   |+|.||||.|||+++. ..+|||
T Consensus       504 ~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLC  579 (752)
T KOG0670|consen  504 KHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLC  579 (752)
T ss_pred             hhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeec
Confidence            9999999999977 5678999976666667888889999999999999999876   9999999999999875 568999


Q ss_pred             eccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHH
Q 008292          490 DFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYVSI  566 (571)
Q Consensus       490 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~~~~~~~~~l~~~~~~  566 (571)
                      |||.|........   +.. .-+..|.|||++++-+|+...|+||.||.||||.||+.-|.-   ....+++++.-.
T Consensus       580 DfGSA~~~~enei---tPY-LVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG---~TNN~MLrl~me  649 (752)
T KOG0670|consen  580 DFGSASFASENEI---TPY-LVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPG---RTNNQMLRLFME  649 (752)
T ss_pred             cCccccccccccc---cHH-HHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCC---CCcHHHHHHHHH
Confidence            9999976543322   222 224579999999999999999999999999999999997643   334456665543

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.89  E-value=1.7e-22  Score=205.40  Aligned_cols=203  Identities=24%  Similarity=0.327  Sum_probs=164.7

Q ss_pred             CCCccccccccCceeEEEEEccCC--CeeEEEeecccCccCHHHHHHHHHHHhhcCC----CceeccceeE-EeCCeeEE
Q 008292          346 KFSTDNKLGEGGFGEVYKGVLPSG--QEIAVKRLSKASGQGAEEFKNEVVLVAKLQH----RNLVRLLGFC-LEGEEKIL  418 (571)
Q Consensus       346 ~~~~~~~LG~G~fg~Vy~~~~~~g--~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h----~niv~l~~~~-~~~~~~~l  418 (571)
                      +|.+.++||+|+||.||++...+.  ..+|+|............+..|+.++..+.+    +++..+++.. ......++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            799999999999999999996553  4688887765433333367888998888873    5788888888 46677899


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCC-----CceEEeeccC
Q 008292          419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE-----MNPKISDFGM  493 (571)
Q Consensus       419 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-----~~~kl~DfGl  493 (571)
                      ||+.+ |.+|.++..... .+.++..+.++++.|++.+|++||+.+   ++||||||.|+++...     ..+.|.|||+
T Consensus        99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl  173 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL  173 (322)
T ss_pred             EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence            99977 788988774333 578999999999999999999999988   9999999999999754     4699999999


Q ss_pred             cc--ccCCCCC----ccc--cccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 008292          494 AR--IFGVDQT----QGN--TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQ  553 (571)
Q Consensus       494 a~--~~~~~~~----~~~--~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~~~  553 (571)
                      ++  .+.....    ...  .....||.+|.+++.+.+.+.+++.|+||++.++.|++.|..||....
T Consensus       174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~  241 (322)
T KOG1164|consen  174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALE  241 (322)
T ss_pred             CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcccc
Confidence            98  4322211    111  123559999999999999999999999999999999999999986543

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.88  E-value=3.6e-23  Score=188.45  Aligned_cols=202  Identities=22%  Similarity=0.334  Sum_probs=167.1

Q ss_pred             HhCCCCccccccccCceeEEEEE-ccCCCeeEEEeecccCccCHHHHHHHHHHHhhcCC-CceeccceeEEeCCeeEEEE
Q 008292          343 ATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH-RNLVRLLGFCLEGEEKILVY  420 (571)
Q Consensus       343 ~~~~~~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h-~niv~l~~~~~~~~~~~lv~  420 (571)
                      ...+|..+++||.|+||.+|.|. ..+|++||||.-+....  ..++..|.++...+++ ..|..+..+..+.....+||
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM   90 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM   90 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence            35789999999999999999999 67899999998754332  2456778888888886 56777777878888889999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECC---CCceEEeeccCcccc
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA---EMNPKISDFGMARIF  497 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfGla~~~  497 (571)
                      |.+ |-+|++++.  .....++.++.+.++.|++.-++|+|.++   +|||||||+|.|..-   ..++.|+|||+++.+
T Consensus        91 dLL-GPsLEdLfn--fC~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky  164 (341)
T KOG1163|consen   91 DLL-GPSLEDLFN--FCSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY  164 (341)
T ss_pred             ecc-CccHHHHHH--HHhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhh
Confidence            988 778887763  23456889999999999999999999988   999999999999853   457999999999977


Q ss_pred             CCCCCc-----cccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 008292          498 GVDQTQ-----GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFY  552 (571)
Q Consensus       498 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~~  552 (571)
                      ......     .......||.+|.+-..+.+.+.+.+.|+-|+|.+|..+..|..||+-.
T Consensus       165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQgl  224 (341)
T KOG1163|consen  165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGL  224 (341)
T ss_pred             ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCccccc
Confidence            432221     1223467999999999999899999999999999999999999999753

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.88  E-value=3e-22  Score=190.45  Aligned_cols=200  Identities=24%  Similarity=0.355  Sum_probs=167.4

Q ss_pred             CCCCccccccccCceeEEEEE-ccCCCeeEEEeecccCccCHHHHHHHHHHHhhcC-CCceeccceeEEeCCeeEEEEEe
Q 008292          345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      -.|++.++||+|+||.++.|+ +-+++.||||.-...+  ...+++.|.+..+.|. .++|...+-+-.++....||+|.
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL  105 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL  105 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence            478899999999999999999 4589999999765443  2356777887777775 68888888888888888999998


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECC-----CCceEEeeccCcccc
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-----EMNPKISDFGMARIF  497 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~DfGla~~~  497 (571)
                      + |-+|+++..  ..+..++.+++..++.|++.-++|+|++.   +|.|||||+|+||..     ...+.|+|||+|+.+
T Consensus       106 L-GPSLEDLFD--~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y  179 (449)
T KOG1165|consen  106 L-GPSLEDLFD--LCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY  179 (449)
T ss_pred             h-CcCHHHHHH--HhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence            8 778887762  34667999999999999999999999998   999999999999953     346899999999987


Q ss_pred             CCCCCcc-----ccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 008292          498 GVDQTQG-----NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFY  552 (571)
Q Consensus       498 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~~  552 (571)
                      .......     .....-||.+||+-...++.+-+.+.|+-|||-++++.|.|..||+-.
T Consensus       180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGL  239 (449)
T KOG1165|consen  180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL  239 (449)
T ss_pred             cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccc
Confidence            5433221     234467999999999999999999999999999999999999999743

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.86  E-value=1.8e-22  Score=229.39  Aligned_cols=148  Identities=20%  Similarity=0.275  Sum_probs=113.4

Q ss_pred             hcCC-CceeccceeE-------EeCCeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCe
Q 008292          397 KLQH-RNLVRLLGFC-------LEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRI  468 (571)
Q Consensus       397 ~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i  468 (571)
                      .++| +||+++++++       ......++++||+ +++|.+++..  ....+++.+++.++.||++||.|||+++   |
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---I  101 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN--PDRSVDAFECFHVFRQIVEIVNAAHSQG---I  101 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc--ccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence            3456 5888888877       2334567888987 6699999953  2356899999999999999999999987   9


Q ss_pred             EEecCCCCCEEECC-------------------CCceEEeeccCccccCCCCC--------------ccccccccccCCc
Q 008292          469 IHRDLKASNILLDA-------------------EMNPKISDFGMARIFGVDQT--------------QGNTSRIVGTYGY  515 (571)
Q Consensus       469 vH~Dlkp~NIll~~-------------------~~~~kl~DfGla~~~~~~~~--------------~~~~~~~~gt~~y  515 (571)
                      +||||||+||||+.                   ++.+||+|||+++.......              ........||+.|
T Consensus       102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y  181 (793)
T PLN00181        102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY  181 (793)
T ss_pred             eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence            99999999999954                   44566666666653211000              0001124578899


Q ss_pred             ccccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          516 MAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       516 ~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      ||||++.+..++.++|||||||+||||++|..|+.
T Consensus       182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~  216 (793)
T PLN00181        182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSRE  216 (793)
T ss_pred             EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchh
Confidence            99999999999999999999999999999988864

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.86  E-value=1.1e-20  Score=191.34  Aligned_cols=201  Identities=36%  Similarity=0.524  Sum_probs=169.2

Q ss_pred             CCccccccccCceeEEEEEccCCCeeEEEeecccCcc---CHHHHHHHHHHHhhcCCC-ceeccceeEEeCCeeEEEEEe
Q 008292          347 FSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQ---GAEEFKNEVVLVAKLQHR-NLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       347 ~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~---~~~~~~~Ei~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~  422 (571)
                      |...+.||.|+||.||++...  ..+++|.+......   ....+.+|+.+++.+.|+ +++++.+.+......++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            567788999999999999976  78899988765433   367899999999999988 799999999777778999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCC-ceEEeeccCccccCCCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM-NPKISDFGMARIFGVDQ  501 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGla~~~~~~~  501 (571)
                      +.++++.+++........+.......++.|++.++.|+|+.+   ++|||+||+||+++..+ .+++.|||+++.+....
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            999999977632211136889999999999999999999987   99999999999999988 79999999998654333


Q ss_pred             Ccc----ccccccccCCccccccccc---CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 008292          502 TQG----NTSRIVGTYGYMAPEYAMH---GQFSVKSDVYSFGVLVLEIITGKKNSNFY  552 (571)
Q Consensus       502 ~~~----~~~~~~gt~~y~aPE~~~~---~~~s~~~Dv~slGvvl~elltG~~p~~~~  552 (571)
                      ...    ......|+..|++||.+..   ...+...|+||+|++++++++|..|+...
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~  214 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGE  214 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence            221    2355689999999999987   68889999999999999999999995543

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.86  E-value=1e-21  Score=185.46  Aligned_cols=173  Identities=14%  Similarity=0.191  Sum_probs=135.0

Q ss_pred             HHHhCCCCccccccccCceeEEEEEccCCCeeEEEeecccCccCHH---H------HHHHHHHHhhcCCCceeccceeEE
Q 008292          341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAE---E------FKNEVVLVAKLQHRNLVRLLGFCL  411 (571)
Q Consensus       341 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~---~------~~~Ei~~l~~l~h~niv~l~~~~~  411 (571)
                      ....++|+..+.||.|+||.||.... ++..+++|.+.........   .      +++|+..+.+++|++|..+.+++.
T Consensus        27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~  105 (232)
T PRK10359         27 DFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL  105 (232)
T ss_pred             HHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence            35678999999999999999999666 6778999999754333222   2      688999999999999999988866


Q ss_pred             eC--------CeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCC
Q 008292          412 EG--------EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE  483 (571)
Q Consensus       412 ~~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~  483 (571)
                      ..        ...+|+|||++|.+|.++..       ++.    ....+++.+|..||+.+   ++|||++|+||+++++
T Consensus       106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~  171 (232)
T PRK10359        106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKN  171 (232)
T ss_pred             ecccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCC
Confidence            43        35789999999999987641       222    24568999999999987   9999999999999998


Q ss_pred             CceEEeeccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHH
Q 008292          484 MNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEII  543 (571)
Q Consensus       484 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ell  543 (571)
                      + ++|+|||.......+...              ..+.+...+..++|+|+||+.+..+.
T Consensus       172 g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        172 G-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             C-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence            8 999999988654211110              11345556778999999999886653

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.86  E-value=2.7e-21  Score=180.54  Aligned_cols=139  Identities=17%  Similarity=0.171  Sum_probs=108.8

Q ss_pred             cccccccCceeEEEEEccCCCeeEEEeecccCcc--C-------H-----------------HHHHHHHHHHhhcCCCce
Q 008292          350 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQ--G-------A-----------------EEFKNEVVLVAKLQHRNL  403 (571)
Q Consensus       350 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~--~-------~-----------------~~~~~Ei~~l~~l~h~ni  403 (571)
                      ...||+|+||+||+|..++|+.||||+++.....  .       .                 .....|++.+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4689999999999999888999999999754211  1       1                 122359999999988877


Q ss_pred             eccceeEEeCCeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHH-HcCCCCCeEEecCCCCCEEECC
Q 008292          404 VRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL-HEDSRLRIIHRDLKASNILLDA  482 (571)
Q Consensus       404 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~ivH~Dlkp~NIll~~  482 (571)
                      .......  ....+|||||++++++.....   ....+++.....++.|++.+|.+| |+.+   |+||||||+|||++ 
T Consensus        82 ~~p~~~~--~~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-  152 (190)
T cd05147          82 PCPEPIL--LKSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-  152 (190)
T ss_pred             CCCcEEE--ecCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence            4433322  223489999999987754431   235688999999999999999999 6776   99999999999998 


Q ss_pred             CCceEEeeccCcccc
Q 008292          483 EMNPKISDFGMARIF  497 (571)
Q Consensus       483 ~~~~kl~DfGla~~~  497 (571)
                      ++.++|+|||++...
T Consensus       153 ~~~v~LiDFG~a~~~  167 (190)
T cd05147         153 DGKLYIIDVSQSVEH  167 (190)
T ss_pred             CCcEEEEEccccccC
Confidence            478999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.84  E-value=2.7e-20  Score=174.39  Aligned_cols=140  Identities=20%  Similarity=0.224  Sum_probs=111.2

Q ss_pred             cccccccCceeEEEEEccCCCeeEEEeecccCcc---------------------C-----HHHHHHHHHHHhhcCCCce
Q 008292          350 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQ---------------------G-----AEEFKNEVVLVAKLQHRNL  403 (571)
Q Consensus       350 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~---------------------~-----~~~~~~Ei~~l~~l~h~ni  403 (571)
                      ...||+|++|+||+|...+|+.||||+++.....                     .     ...++.|...+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            4689999999999999878999999998754211                     0     1224678999999999987


Q ss_pred             eccceeEEeCCeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEEecCCCCCEEECC
Q 008292          404 VRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE-DSRLRIIHRDLKASNILLDA  482 (571)
Q Consensus       404 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlkp~NIll~~  482 (571)
                      .....+...  ..+|||||++++++.....   ....++......++.|++.++.+||+ .+   |+||||||+|||++ 
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-  152 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-  152 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence            554444332  3489999999886543321   23457788899999999999999998 76   99999999999998 


Q ss_pred             CCceEEeeccCccccC
Q 008292          483 EMNPKISDFGMARIFG  498 (571)
Q Consensus       483 ~~~~kl~DfGla~~~~  498 (571)
                      ++.++|+|||++..+.
T Consensus       153 ~~~~~liDFG~a~~~~  168 (190)
T cd05145         153 DGKPYIIDVSQAVELD  168 (190)
T ss_pred             CCCEEEEEcccceecC
Confidence            8899999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function

Probab=99.84  E-value=4.1e-21  Score=161.23  Aligned_cols=101  Identities=45%  Similarity=0.783  Sum_probs=77.0

Q ss_pred             eEeec---cccC-CchhHHHHHHHHHHHHHHHHhhcc-CCceeeeecccCCccceeEEEEeecCCCccchhhHHHHHHhc
Q 008292          147 VSLLN---TQNV-TDQGRLNELVGTQMSQVVTQAVSN-TKRFATRKANFTTFQTLYSLAQCTPDLSSSDCNTCLRGAVAR  221 (571)
Q Consensus       147 ~~~~~---~~~~-~~~~~f~~~~~~ll~~l~~~a~~~-~~~~a~~~~~~~~~~~vy~l~QC~~Dls~~~C~~Cl~~~~~~  221 (571)
                      |..|+   .++. ++...|..+++++|..|...|+.+ +.+|++++. ..+..+||||+||++|+++.||..||+.++..
T Consensus         1 ~~~Cs~~~~~~~~~~~~~f~~~l~~ll~~l~~~a~~~~~~~f~~~~~-~~~~~~vYgl~qC~~Dls~~dC~~Cl~~a~~~   79 (106)
T PF01657_consen    1 WHFCSSNTNNNYTTDNSTFEQNLNSLLSSLVSNAASSSSKGFATGSA-GSGPDTVYGLAQCRGDLSPSDCRACLADAVAN   79 (106)
T ss_dssp             ---E---SSB----TT-THHHHHHHHHHHHHHHGGGTT-TEEEEEE---ST---EEEEEEE-TTS-HHHHHHHHHHHHCC
T ss_pred             CCcCCCCCCCCcCCCCchHHHHHHHHHHHHHHHHhhccccCcEEeec-CCCCCeEEEEEEcCCCCChhhhHHHHHHHHHH
Confidence            35676   3344 455669999999999999998865 479999976 45678999999999999999999999999999


Q ss_pred             cccCCCCCcccEEEccccccccccCcc
Q 008292          222 LPSCCSGKQGGRVLFPSCNVRYELYPF  248 (571)
Q Consensus       222 ~~~~c~~~~g~~v~~~~C~lry~~~~f  248 (571)
                      ++.+|+++.||+|++++|+||||.++|
T Consensus        80 ~~~~C~~~~g~~v~~~~C~lRY~~~~F  106 (106)
T PF01657_consen   80 ISSCCPGSRGGRVWYDSCFLRYENYPF  106 (106)
T ss_dssp             HHHHTTSBSSEEEEESSEEEEEESS--
T ss_pred             HHHhCCCCceEEEECCCEEEEEECCCC
Confidence            999999999999999999999999987

The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D.

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.81  E-value=5.1e-20  Score=170.40  Aligned_cols=106  Identities=25%  Similarity=0.230  Sum_probs=92.4

Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCccc
Q 008292          426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN  505 (571)
Q Consensus       426 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  505 (571)
                      |+|.+++..  .+..+++.+++.++.||++||.|||+++         ||+|||++.++.+|+  ||+++......    
T Consensus         1 GsL~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~----   63 (176)
T smart00750        1 VSLADILEV--RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ----   63 (176)
T ss_pred             CcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence            688888843  2456999999999999999999999864         999999999999999  99987654321    


Q ss_pred             cccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       506 ~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                         ..|++.|||||++.+..++.++||||||+++|||+||+.|+..
T Consensus        64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~  106 (176)
T smart00750       64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNE  106 (176)
T ss_pred             ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccc
Confidence               2578999999999999999999999999999999999999854

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.81  E-value=2.1e-19  Score=166.14  Aligned_cols=185  Identities=16%  Similarity=0.146  Sum_probs=138.8

Q ss_pred             CccccccccCceeEEEEEccCCCeeEEEeecccCcc----CHHHHHHHHHHHhhcC-CCceeccceeEEeCCeeEEEEEe
Q 008292          348 STDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQ----GAEEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       348 ~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~----~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      .+...|++|+||+|+.+.- .+.+++.+.+.....-    ....+++|+++|+++. |+++.+++++    ...+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            3567899999999997666 6778887777654321    1225789999999995 4788888886    456999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecC-CCCCEEECCCCceEEeeccCccccCCCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDL-KASNILLDAEMNPKISDFGMARIFGVDQ  501 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dl-kp~NIll~~~~~~kl~DfGla~~~~~~~  501 (571)
                      +.|.+|...+.    .      ....++.|++++|.++|+++   |+|||| ||.|||++.++.++|+|||++.......
T Consensus        80 I~G~~L~~~~~----~------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~  146 (218)
T PRK12274         80 LAGAAMYQRPP----R------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA  146 (218)
T ss_pred             ecCccHHhhhh----h------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence            99999865431    1      11357789999999999988   999999 7999999999999999999998654322


Q ss_pred             Cc----cc-------cccccccCCccccccccc-CCCC-cchhHHHHHHHHHHHHhCCCCCC
Q 008292          502 TQ----GN-------TSRIVGTYGYMAPEYAMH-GQFS-VKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       502 ~~----~~-------~~~~~gt~~y~aPE~~~~-~~~s-~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      ..    ..       ......++.|++|+...- ...+ ...++++-|..+|.++|+..+.-
T Consensus       147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~  208 (218)
T PRK12274        147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW  208 (218)
T ss_pred             hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence            10    00       111235778888875432 2334 57899999999999999998753

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.81  E-value=1.3e-20  Score=174.60  Aligned_cols=193  Identities=23%  Similarity=0.345  Sum_probs=152.9

Q ss_pred             ccccccccCceeEEEEEccCCCeeEEEeecc--cCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEecCCC
Q 008292          349 TDNKLGEGGFGEVYKGVLPSGQEIAVKRLSK--ASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNK  426 (571)
Q Consensus       349 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  426 (571)
                      ..-+|.+...|..|+|+++ |..+++|++..  ......++|.+|.-.|+.+.||||+.++|.|.......++..||+.|
T Consensus       194 l~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g  272 (448)
T KOG0195|consen  194 LITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG  272 (448)
T ss_pred             hhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence            3457888999999999994 55666777653  23344568899999999999999999999999999999999999999


Q ss_pred             ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEe--eccCccccCCCCCcc
Q 008292          427 SLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKIS--DFGMARIFGVDQTQG  504 (571)
Q Consensus       427 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~--DfGla~~~~~~~~~~  504 (571)
                      +|...|++. ..-.++..+..+++.+|++|++|||+.. +-|.---|.++.|+||++.+.+|+  |--++.         
T Consensus       273 slynvlhe~-t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsf---------  341 (448)
T KOG0195|consen  273 SLYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSF---------  341 (448)
T ss_pred             HHHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeee---------
Confidence            999999753 3345677899999999999999999975 334455699999999999988774  322211         


Q ss_pred             ccccccccCCcccccccccCCCC---cchhHHHHHHHHHHHHhCCCCCCCCC
Q 008292          505 NTSRIVGTYGYMAPEYAMHGQFS---VKSDVYSFGVLVLEIITGKKNSNFYQ  553 (571)
Q Consensus       505 ~~~~~~gt~~y~aPE~~~~~~~s---~~~Dv~slGvvl~elltG~~p~~~~~  553 (571)
                      ........+.||+||.+..++..   +++|+|||.+++|||.|.+.||....
T Consensus       342 qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadls  393 (448)
T KOG0195|consen  342 QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLS  393 (448)
T ss_pred             eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCC
Confidence            11112356899999999776543   57999999999999999999986543

>PRK10345 hypothetical protein; Provisional

Probab=99.79  E-value=8.7e-19  Score=165.16  Aligned_cols=138  Identities=21%  Similarity=0.310  Sum_probs=107.4

Q ss_pred             CCccccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhc-----CCCceeccceeEEeCC---e-eE
Q 008292          347 FSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKL-----QHRNLVRLLGFCLEGE---E-KI  417 (571)
Q Consensus       347 ~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-----~h~niv~l~~~~~~~~---~-~~  417 (571)
                      +...+.||+|+||.||.  .++....+||++........+.+.+|+.+++.+     +||||++++|++.+..   . ..
T Consensus         4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~   81 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD   81 (210)
T ss_pred             cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence            45568899999999996  433333478988765455567899999999999     6799999999998864   2 34


Q ss_pred             EEEEe--cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHH-HHHHcCCCCCeEEecCCCCCEEECC----CCceEEee
Q 008292          418 LVYEF--VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGI-LYLHEDSRLRIIHRDLKASNILLDA----EMNPKISD  490 (571)
Q Consensus       418 lv~e~--~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L-~yLH~~~~~~ivH~Dlkp~NIll~~----~~~~kl~D  490 (571)
                      +|+||  .++++|.+++.+    ..+++.  ..++.|++.++ +|||+++   |+||||||+|||++.    +.+++|+|
T Consensus        82 ~I~e~~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiD  152 (210)
T PRK10345         82 VIADFDGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCD  152 (210)
T ss_pred             EEecCCCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEE
Confidence            78999  557999999943    235555  35677888777 9999987   999999999999974    34799999


Q ss_pred             ccCcc
Q 008292          491 FGMAR  495 (571)
Q Consensus       491 fGla~  495 (571)
                      |+-+.
T Consensus       153 g~G~~  157 (210)
T PRK10345        153 NIGES  157 (210)
T ss_pred             CCCCc
Confidence            54443

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.76  E-value=2.4e-19  Score=193.98  Aligned_cols=200  Identities=26%  Similarity=0.378  Sum_probs=158.6

Q ss_pred             CccccccccCceeEEEEEcc-CCCeeEEEeec----c-cCcc-CHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEE
Q 008292          348 STDNKLGEGGFGEVYKGVLP-SGQEIAVKRLS----K-ASGQ-GAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY  420 (571)
Q Consensus       348 ~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~----~-~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  420 (571)
                      ...+.+|.|.+|.|+..+.. ..+..+.|..+    . ..+. ....+..|.-+-..++|+|++..+....+.....-.|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            45678999999977776632 23333333322    1 1111 1122566777778899999998888877777666669


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCC
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD  500 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  500 (571)
                      ||+++ +|..++.   ....+...++..++.|++.|+.|||..+   |.|||||++|+++..++.+||+|||.+..+..+
T Consensus       401 E~~~~-Dlf~~~~---~~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~  473 (601)
T KOG0590|consen  401 EYCPY-DLFSLVM---SNGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP  473 (601)
T ss_pred             hcccH-HHHHHHh---cccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence            99999 9988883   3357888999999999999999999988   999999999999999999999999999877554


Q ss_pred             CCc--cccccccccCCcccccccccCCCCcc-hhHHHHHHHHHHHHhCCCCCCCCCC
Q 008292          501 QTQ--GNTSRIVGTYGYMAPEYAMHGQFSVK-SDVYSFGVLVLEIITGKKNSNFYQT  554 (571)
Q Consensus       501 ~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~-~Dv~slGvvl~elltG~~p~~~~~~  554 (571)
                      ...  ......+|+..|+|||++.+.+|.+. .||||.|+++..|++|+.||.....
T Consensus       474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~  530 (601)
T KOG0590|consen  474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKK  530 (601)
T ss_pred             cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccc
Confidence            443  44566789999999999999999875 8999999999999999999976543

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.75  E-value=1.8e-19  Score=186.00  Aligned_cols=186  Identities=29%  Similarity=0.334  Sum_probs=153.7

Q ss_pred             cccccCceeEEEEE----ccCCCeeEEEeecccCccC--HHHHHHHHHHHhhcC-CCceeccceeEEeCCeeEEEEEecC
Q 008292          352 KLGEGGFGEVYKGV----LPSGQEIAVKRLSKASGQG--AEEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEKILVYEFVP  424 (571)
Q Consensus       352 ~LG~G~fg~Vy~~~----~~~g~~vavK~~~~~~~~~--~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~  424 (571)
                      .+|+|.||.|+.+.    .+.|..+++|.+++.....  ......|-.++...+ ||.++++.-.+......+++++|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            37999999999765    3457778999887654221  113456777888887 9999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCcc
Q 008292          425 NKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG  504 (571)
Q Consensus       425 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  504 (571)
                      +|.|...+.   +...+++.........++-+++++|+.+   |+|||+|++||+++.+|.+|+.|||+++..-....  
T Consensus        81 gg~lft~l~---~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~--  152 (612)
T KOG0603|consen   81 GGDLFTRLS---KEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI--  152 (612)
T ss_pred             cchhhhccc---cCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh--
Confidence            999977763   3445677777778888999999999887   99999999999999999999999999986532221  


Q ss_pred             ccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          505 NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       505 ~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                          .+||..|||||++.  .....+|.||||++++||+||-.||..
T Consensus       153 ----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~  193 (612)
T KOG0603|consen  153 ----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG  193 (612)
T ss_pred             ----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence                18999999999988  667889999999999999999999865

>smart00090 RIO RIO-like kinase

Probab=99.74  E-value=1.2e-17  Score=161.30  Aligned_cols=143  Identities=19%  Similarity=0.218  Sum_probs=110.8

Q ss_pred             CCCCccccccccCceeEEEEE--ccCCCeeEEEeecccCcc------------------------CHHHHHHHHHHHhhc
Q 008292          345 NKFSTDNKLGEGGFGEVYKGV--LPSGQEIAVKRLSKASGQ------------------------GAEEFKNEVVLVAKL  398 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~--~~~g~~vavK~~~~~~~~------------------------~~~~~~~Ei~~l~~l  398 (571)
                      .-|++.+.||+|++|.||+|.  ..+|+.||+|+++.....                        ....+.+|+.++.++
T Consensus        28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L  107 (237)
T smart00090       28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL  107 (237)
T ss_pred             chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            357888999999999999998  568999999998753210                        012356899999999


Q ss_pred             CCCc--eeccceeEEeCCeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCC
Q 008292          399 QHRN--LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKAS  476 (571)
Q Consensus       399 ~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~  476 (571)
                      .+..  +.++++.    ...++||||+++.+|.....   ....+.......++.||+.++.+||+.+  +|+||||||+
T Consensus       108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~  178 (237)
T smart00090      108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEY  178 (237)
T ss_pred             HhcCCCCCeeeEe----cCceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChh
Confidence            7633  3333332    24589999999988866542   2334566677889999999999999875  4999999999


Q ss_pred             CEEECCCCceEEeeccCcccc
Q 008292          477 NILLDAEMNPKISDFGMARIF  497 (571)
Q Consensus       477 NIll~~~~~~kl~DfGla~~~  497 (571)
                      ||+++ +++++|+|||++...
T Consensus       179 NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      179 NILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             hEEEE-CCCEEEEEChhhhcc
Confidence            99999 889999999998754

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.74  E-value=1.9e-17  Score=157.98  Aligned_cols=134  Identities=22%  Similarity=0.329  Sum_probs=113.5

Q ss_pred             ccccccCceeEEEEEccCCCeeEEEeecccCcc--------CHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          351 NKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQ--------GAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       351 ~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~--------~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      +.||+|++|.||+|.. .|..+++|+.......        ....+.+|+.++..++|++|.....++...+..+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999987 6788999976543211        124577899999999999998888888788888999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccc
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI  496 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  496 (571)
                      ++|++|.+++...      .+ .+..++.+++.+|.+||+.+   ++|+|++|+|||++ ++.++|+|||++..
T Consensus        81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999988421      12 78889999999999999987   99999999999999 78899999999875

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.73  E-value=2.8e-17  Score=155.21  Aligned_cols=143  Identities=20%  Similarity=0.213  Sum_probs=111.4

Q ss_pred             HHHHhCCCCccccccccCceeEEEEEccCCCeeEEEeecccCcc----------------------CHHHHHHHHHHHhh
Q 008292          340 IEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQ----------------------GAEEFKNEVVLVAK  397 (571)
Q Consensus       340 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~----------------------~~~~~~~Ei~~l~~  397 (571)
                      +......|...+.||+|+||.||++..++|+.|+||++......                      .......|+.++..
T Consensus        10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   89 (198)
T cd05144          10 LVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA   89 (198)
T ss_pred             HHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence            33344457888999999999999999888999999987543210                      11235678889999


Q ss_pred             cCCCc--eeccceeEEeCCeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCC
Q 008292          398 LQHRN--LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKA  475 (571)
Q Consensus       398 l~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp  475 (571)
                      +.|++  +.+.++    ....++||||+++++|.....         ......++.++++++.++|+.+   |+||||+|
T Consensus        90 l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p  153 (198)
T cd05144          90 LYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYKHG---IIHGDLSE  153 (198)
T ss_pred             HHHcCCCCCceee----cCCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHHCC---CCcCCCCc
Confidence            88874  344433    345689999999999876541         0235678899999999999977   99999999


Q ss_pred             CCEEECCCCceEEeeccCccccC
Q 008292          476 SNILLDAEMNPKISDFGMARIFG  498 (571)
Q Consensus       476 ~NIll~~~~~~kl~DfGla~~~~  498 (571)
                      +||++++++.++|+|||++....
T Consensus       154 ~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         154 FNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             ccEEEcCCCcEEEEECCccccCC
Confidence            99999999999999999997554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.73  E-value=1.1e-18  Score=188.61  Aligned_cols=198  Identities=19%  Similarity=0.226  Sum_probs=149.9

Q ss_pred             CCCccccccccCceeEEEEEccCCCeeEEEeecccC-ccCHHHHHHHHHH--HhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          346 KFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKAS-GQGAEEFKNEVVL--VAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       346 ~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~-~~~~~~~~~Ei~~--l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      ++...+.||.+.|=.|.+++.++|. |+||++-+.. ....+.|.++++-  ...++|||.+++..+-....-.|||-+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            5677889999999999999998888 8888875543 4445555554433  4456899999999887777778899998


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCC-CC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV-DQ  501 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~-~~  501 (571)
                      ..+ +|.+.+   ....-+...+...|+.|++.||...|..+   |+|||||.+||||++.+.+.|+||...+.-.. ..
T Consensus       103 vkh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD  175 (1431)
T KOG1240|consen  103 VKH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED  175 (1431)
T ss_pred             Hhh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence            855 455555   23344677788889999999999999987   99999999999999999999999987753321 11


Q ss_pred             Cccccccccc----cCCcccccccccC----------C-CCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          502 TQGNTSRIVG----TYGYMAPEYAMHG----------Q-FSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       502 ~~~~~~~~~g----t~~y~aPE~~~~~----------~-~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                      ..........    -..|+|||.+...          . .+++.||||+||++.||++ |+++|+.
T Consensus       176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L  241 (1431)
T KOG1240|consen  176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL  241 (1431)
T ss_pred             CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH
Confidence            1111111222    2369999988542          2 6789999999999999998 6777753

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.73  E-value=9e-18  Score=185.21  Aligned_cols=201  Identities=19%  Similarity=0.225  Sum_probs=159.2

Q ss_pred             HHHHhCCCCccccccccCceeEEEEEccCCCeeEEEeecccCccC---HHHHHHHHHHHhhcCCCceeccceeEEeCCee
Q 008292          340 IEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQG---AEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEK  416 (571)
Q Consensus       340 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~---~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  416 (571)
                      .++...+|.+.+.||+|+||+||+|...+|+.||+|+-+..+.-.   ..+++..++ +.  --+.|+.+.....-.+.-
T Consensus       693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk-~~--~~~~~~~~~~a~~~~~~S  769 (974)
T KOG1166|consen  693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLK-PQ--MLPSIMHISSAHVFQNAS  769 (974)
T ss_pred             eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhc-hh--hhcchHHHHHHHccCCcc
Confidence            345567788899999999999999998889999999987765322   123333222 10  124455566666667788


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECC-------CCceEEe
Q 008292          417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-------EMNPKIS  489 (571)
Q Consensus       417 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-------~~~~kl~  489 (571)
                      +||+||.+.|+|.+++.   ..+.++|...+.++.|+++.+++||..+   |||+||||+|.||..       .--++|+
T Consensus       770 ~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lI  843 (974)
T KOG1166|consen  770 VLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLI  843 (974)
T ss_pred             eeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEE
Confidence            99999999999999994   5567899999999999999999999987   999999999999932       3358999


Q ss_pred             eccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCC
Q 008292          490 DFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNS  549 (571)
Q Consensus       490 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~  549 (571)
                      |||.+-.+..-.........++|-.+--+|...+..++..+|.|.|.-+++-||.|+.--
T Consensus       844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q  903 (974)
T KOG1166|consen  844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME  903 (974)
T ss_pred             ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH
Confidence            999987554333333445567888899999999999999999999999999999998754

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.72  E-value=3.4e-17  Score=154.72  Aligned_cols=131  Identities=22%  Similarity=0.361  Sum_probs=107.7

Q ss_pred             cccccCceeEEEEEccCCCeeEEEeecccCc--------cCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEec
Q 008292          352 KLGEGGFGEVYKGVLPSGQEIAVKRLSKASG--------QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV  423 (571)
Q Consensus       352 ~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~--------~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  423 (571)
                      .||+|+||.||+|.+ ++..|++|.......        ...+++.+|++++..++|+++.....++...+..+++|||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999996 678899998654221        11356778999999999988776666666777789999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCcccc
Q 008292          424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF  497 (571)
Q Consensus       424 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  497 (571)
                      +|++|.+++...   .      . .++.+++++|.+||+.+   ++|+|++|+||+++ ++.++++|||+++..
T Consensus        80 ~g~~l~~~~~~~---~------~-~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        80 EGKPLKDVIEEG---N------D-ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             CCccHHHHHhhc---H------H-HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            999998887321   0      0 78999999999999987   99999999999999 889999999998753

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.72  E-value=3.1e-17  Score=178.13  Aligned_cols=138  Identities=21%  Similarity=0.349  Sum_probs=112.5

Q ss_pred             hCCCCccccccccCceeEEEEEccCCCeeEEEe-ecccC-------ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCe
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKR-LSKAS-------GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEE  415 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~-~~~~~-------~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~  415 (571)
                      ...|...++||+|+||+||+|.+... .+++|+ +.+..       ....+++.+|++++..++|++++....++.+...
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~  410 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE  410 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence            44556789999999999999997544 344443 22211       1123568899999999999999988888888778


Q ss_pred             eEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCcc
Q 008292          416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR  495 (571)
Q Consensus       416 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  495 (571)
                      .++||||+++++|.+++.           ....++.+++++|.+||+.+   ++||||||+|||+ +++.++|+|||+++
T Consensus       411 ~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~  475 (535)
T PRK09605        411 KTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGK  475 (535)
T ss_pred             CEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccc
Confidence            899999999999998873           35678999999999999987   9999999999999 67799999999997


Q ss_pred             cc
Q 008292          496 IF  497 (571)
Q Consensus       496 ~~  497 (571)
                      ..
T Consensus       476 ~~  477 (535)
T PRK09605        476 YS  477 (535)
T ss_pred             cC
Confidence            64

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.69  E-value=5.1e-17  Score=158.23  Aligned_cols=201  Identities=19%  Similarity=0.309  Sum_probs=130.7

Q ss_pred             CCCccccccccCceeEEEEEcc-CCCeeEEEeeccc---CccCHHHHHHHHHHHhhcCC----------CceeccceeEE
Q 008292          346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQH----------RNLVRLLGFCL  411 (571)
Q Consensus       346 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h----------~niv~l~~~~~  411 (571)
                      .+...+.||.|+++.||.++.. +|+++++|++...   .....+++++|.-....+.+          -.++..++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            3456788999999999999975 4899999987532   33456777777766655433          12222222221


Q ss_pred             ---------eCC--------eeEEEEEecCCCChhhhhc---CCC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEE
Q 008292          412 ---------EGE--------EKILVYEFVPNKSLDYFLY---DPE-KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIH  470 (571)
Q Consensus       412 ---------~~~--------~~~lv~e~~~~g~L~~~l~---~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH  470 (571)
                               ...        +.+++|+-+ .++|..++.   ... ....+....++.+..|+.+.+++||..+   ++|
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH  168 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH  168 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred             EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence                     111        225677766 567766642   111 1122344556777899999999999998   999


Q ss_pred             ecCCCCCEEECCCCceEEeeccCccccCCCCCccccccccccCCccccccccc--------CCCCcchhHHHHHHHHHHH
Q 008292          471 RDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMH--------GQFSVKSDVYSFGVLVLEI  542 (571)
Q Consensus       471 ~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~~~Dv~slGvvl~el  542 (571)
                      +||+|+|++++++|.++|+||+.....+.....     ...+..|.+||....        -.++.+.|.|+||+++|.|
T Consensus       169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l  243 (288)
T PF14531_consen  169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL  243 (288)
T ss_dssp             ST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred             cccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence            999999999999999999999987754432211     234577999997643        2578899999999999999


Q ss_pred             HhCCCCCCCCCCC
Q 008292          543 ITGKKNSNFYQTD  555 (571)
Q Consensus       543 ltG~~p~~~~~~~  555 (571)
                      ++|..|++....+
T Consensus       244 WC~~lPf~~~~~~  256 (288)
T PF14531_consen  244 WCGRLPFGLSSPE  256 (288)
T ss_dssp             HHSS-STCCCGGG
T ss_pred             HHccCCCCCCCcc
Confidence            9999999865443

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.68  E-value=1.1e-17  Score=169.66  Aligned_cols=124  Identities=29%  Similarity=0.468  Sum_probs=109.3

Q ss_pred             eeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCc
Q 008292          415 EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA  494 (571)
Q Consensus       415 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla  494 (571)
                      ..+|.|+++...+|.+|+.........++...+.++.|++.+++|   ++   .+|+|+||.||+...+..+||.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence            468999999999999999766667778899999999999999999   45   899999999999999999999999998


Q ss_pred             cccCCCC----CccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh
Q 008292          495 RIFGVDQ----TQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT  544 (571)
Q Consensus       495 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt  544 (571)
                      .......    .....+...||..||+||.+.+.+|+.|+||||||++|+||++
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence            7654333    2224556789999999999999999999999999999999998

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.64  E-value=1.6e-15  Score=135.93  Aligned_cols=135  Identities=21%  Similarity=0.195  Sum_probs=114.3

Q ss_pred             ccccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhcCC--CceeccceeEEeCCeeEEEEEecCCC
Q 008292          349 TDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH--RNLVRLLGFCLEGEEKILVYEFVPNK  426 (571)
Q Consensus       349 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g  426 (571)
                      +.+.||+|.++.||++...+ ..+++|.......  ...+.+|+..+..++|  .++.+++++...++..++++||++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            45789999999999999844 7899998865443  5678899999999987  48889888888778899999999988


Q ss_pred             ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccc
Q 008292          427 SLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI  496 (571)
Q Consensus       427 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  496 (571)
                      .+..+          +......++.+++++|.+||.....+++|+|++|+||++++++.+++.|||.++.
T Consensus        79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            77533          5566778899999999999986545699999999999999989999999999864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.63  E-value=7.1e-16  Score=159.62  Aligned_cols=168  Identities=26%  Similarity=0.446  Sum_probs=133.0

Q ss_pred             HhhcCCCceeccceeEEeCCeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCC
Q 008292          395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLK  474 (571)
Q Consensus       395 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk  474 (571)
                      |+.+.|.|+.+++|.+.++...++|.+|+..|+|.+.+..  ...++++.-...++.+|++||.|||...  -..|+.++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~   76 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK   76 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence            4568999999999999999999999999999999999954  3557899999999999999999999753  23999999


Q ss_pred             CCCEEECCCCceEEeeccCccccCCCCCccccccccccCCcccccccccC-------CCCcchhHHHHHHHHHHHHhCCC
Q 008292          475 ASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG-------QFSVKSDVYSFGVLVLEIITGKK  547 (571)
Q Consensus       475 p~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~s~~~Dv~slGvvl~elltG~~  547 (571)
                      +.|.++|....+||+|||+.................-..-|.|||.+...       ..+.+.||||||++++|+++.+.
T Consensus        77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~  156 (484)
T KOG1023|consen   77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG  156 (484)
T ss_pred             cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence            99999999999999999998765321111111112234579999988653       14678999999999999999999


Q ss_pred             CCCCCCC-CCcccHHHHHHH
Q 008292          548 NSNFYQT-DGAADLLSYVSI  566 (571)
Q Consensus       548 p~~~~~~-~~~~~l~~~~~~  566 (571)
                      ||+.... ++..+++.++.+
T Consensus       157 ~~~~~~~~~~~~eii~~~~~  176 (484)
T KOG1023|consen  157 PFDLRNLVEDPDEIILRVKK  176 (484)
T ss_pred             ccccccccCChHHHHHHHHh
Confidence            9986432 222456655544

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.63  E-value=1.5e-15  Score=141.93  Aligned_cols=137  Identities=20%  Similarity=0.245  Sum_probs=97.2

Q ss_pred             cccccccCceeEEEEEccCCCeeEEEeecccCcc--CHHH----------------------HHHHHHHHhhcCCCc--e
Q 008292          350 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQ--GAEE----------------------FKNEVVLVAKLQHRN--L  403 (571)
Q Consensus       350 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~--~~~~----------------------~~~Ei~~l~~l~h~n--i  403 (571)
                      .+.||+|+||+||++...+++.||||+++.....  ....                      ...|...+..+.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            4679999999999999888999999988653221  1111                      134555555554433  3


Q ss_pred             eccceeEEeCCeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEEecCCCCCEEECC
Q 008292          404 VRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE-DSRLRIIHRDLKASNILLDA  482 (571)
Q Consensus       404 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlkp~NIll~~  482 (571)
                      .+.++.    ...++||||++++.+......   ..... .....++.+++.++.++|. .+   |+|+||||+||+++ 
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~---~~~~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLK---DVRLL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhh---hhhhc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence            333332    346899999999654321100   00011 5678899999999999998 65   99999999999999 


Q ss_pred             CCceEEeeccCccccC
Q 008292          483 EMNPKISDFGMARIFG  498 (571)
Q Consensus       483 ~~~~kl~DfGla~~~~  498 (571)
                      ++.++|+|||.+....
T Consensus       150 ~~~~~liDfg~a~~~~  165 (187)
T cd05119         150 DGKVYIIDVPQAVEID  165 (187)
T ss_pred             CCcEEEEECccccccc
Confidence            8899999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.60  E-value=6.1e-15  Score=142.77  Aligned_cols=135  Identities=21%  Similarity=0.269  Sum_probs=104.4

Q ss_pred             ccccc-ccCceeEEEEEccCCCeeEEEeecccC-------------ccCHHHHHHHHHHHhhcCCCce--eccceeEEeC
Q 008292          350 DNKLG-EGGFGEVYKGVLPSGQEIAVKRLSKAS-------------GQGAEEFKNEVVLVAKLQHRNL--VRLLGFCLEG  413 (571)
Q Consensus       350 ~~~LG-~G~fg~Vy~~~~~~g~~vavK~~~~~~-------------~~~~~~~~~Ei~~l~~l~h~ni--v~l~~~~~~~  413 (571)
                      ...|| .|+.|+||+... ++..++||++....             ......+.+|+.++.+++|++|  ++.+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            35687 888999999887 47788998875311             1223567889999999999885  6677664432


Q ss_pred             C----eeEEEEEecCC-CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEE
Q 008292          414 E----EKILVYEFVPN-KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKI  488 (571)
Q Consensus       414 ~----~~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl  488 (571)
                      .    ..++|+|++++ .+|.+++..    ..++..    .+.+|+.+|.+||+.+   |+||||||.|||++.++.++|
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~L  183 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWL  183 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEE
Confidence            2    23599999997 689888732    234443    3568999999999988   999999999999999999999


Q ss_pred             eeccCccc
Q 008292          489 SDFGMARI  496 (571)
Q Consensus       489 ~DfGla~~  496 (571)
                      +|||.+..
T Consensus       184 IDfg~~~~  191 (239)
T PRK01723        184 IDFDRGEL  191 (239)
T ss_pred             EECCCccc
Confidence            99999875

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.58  E-value=1.3e-15  Score=165.21  Aligned_cols=165  Identities=24%  Similarity=0.363  Sum_probs=117.1

Q ss_pred             hCCCCccccccccCceeEEEEEccC-CCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      ..+|..++.|..|++|.||..+++. .+.+|+|+-+...     -+++   ++.....|.+|                  
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l-----ilRn---ilt~a~npfvv------------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL-----ILRN---ILTFAGNPFVV------------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhcccccch-----hhhc---cccccCCccee------------------
Confidence            3578889999999999999998764 4567774322110     0011   22222233322                  


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT  502 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  502 (571)
                         |+-...+.   .-+.++..        ++.+++|||+.+   |+|||+||+|.+|+.-|++|+.|||+++.......
T Consensus       136 ---gDc~tllk---~~g~lPvd--------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a  198 (1205)
T KOG0606|consen  136 ---GDCATLLK---NIGPLPVD--------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA  198 (1205)
T ss_pred             ---chhhhhcc---cCCCCcch--------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence               33333331   12233322        277899999887   99999999999999999999999999875421111


Q ss_pred             -------------ccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          503 -------------QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       503 -------------~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                                   .......+||+.|+|||++..+.|...+|+|++|+|+||.+-|..||.-
T Consensus       199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffG  260 (1205)
T KOG0606|consen  199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG  260 (1205)
T ss_pred             chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccC
Confidence                         1112346899999999999999999999999999999999999999864

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.50  E-value=3.2e-15  Score=162.01  Aligned_cols=206  Identities=24%  Similarity=0.351  Sum_probs=163.5

Q ss_pred             CCCCccccccccCceeEEEEEccC--CCeeEEEeecccC--ccCHHHHHHHHHHHhhcC-CCceeccceeEEeCCeeEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLPS--GQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEKILV  419 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~~--g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv  419 (571)
                      ..|...+.||+|.|+.|-......  ...+++|.+....  ....+.+..|..+-..+. |+|++.+++...+.+..++.
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            456677789999999998877543  3446666665443  333455566777777776 99999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH-cCCCCCeEEecCCCCCEEECCCC-ceEEeeccCcccc
Q 008292          420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH-EDSRLRIIHRDLKASNILLDAEM-NPKISDFGMARIF  497 (571)
Q Consensus       420 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH-~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGla~~~  497 (571)
                      .||..++++...+... .....+....-.++.|+..++.|+| ..+   +.|+||||+|.+++..+ ..|++|||+|..+
T Consensus       100 ~~~s~g~~~f~~i~~~-~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~  175 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHP-DSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY  175 (601)
T ss_pred             cCcccccccccccccC-CccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence            9999999998776211 1113455566778999999999999 766   99999999999999999 9999999999877


Q ss_pred             CC-CCCccccccccc-cCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 008292          498 GV-DQTQGNTSRIVG-TYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQT  554 (571)
Q Consensus       498 ~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~s~~~Dv~slGvvl~elltG~~p~~~~~~  554 (571)
                      .. ..........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++....
T Consensus       176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~  235 (601)
T KOG0590|consen  176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSR  235 (601)
T ss_pred             cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccc
Confidence            65 444444555678 9999999998874 556789999999999999999999987544

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.50  E-value=6.1e-14  Score=137.12  Aligned_cols=144  Identities=25%  Similarity=0.360  Sum_probs=104.3

Q ss_pred             CCCceeccceeEEeC---------------------------CeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHH
Q 008292          399 QHRNLVRLLGFCLEG---------------------------EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIG  451 (571)
Q Consensus       399 ~h~niv~l~~~~~~~---------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~  451 (571)
                      +|||||++.++|.+.                           ...|+||.-.+ .+|.+++.    ....+.....-++.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~----~~~~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLW----TRHRSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHh----cCCCchHHHHHHHH
Confidence            699999998877641                           23567877663 46777774    33456666777899


Q ss_pred             HHHHHHHHHHcCCCCCeEEecCCCCCEEE--CCCC--ceEEeeccCccccCCC----CCccccccccccCCccccccccc
Q 008292          452 GIARGILYLHEDSRLRIIHRDLKASNILL--DAEM--NPKISDFGMARIFGVD----QTQGNTSRIVGTYGYMAPEYAMH  523 (571)
Q Consensus       452 ~ia~~L~yLH~~~~~~ivH~Dlkp~NIll--~~~~--~~kl~DfGla~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~  523 (571)
                      |+++|+.|||+++   |.|||+|++||||  |+|.  .+.|+|||++-.-+..    .+.+..-..-|.-.-||||+...
T Consensus       349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta  425 (598)
T KOG4158|consen  349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA  425 (598)
T ss_pred             HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence            9999999999988   9999999999998  4444  4788999987432110    11111112346677899998753


Q ss_pred             CC------CCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          524 GQ------FSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       524 ~~------~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      .+      --.|+|.|+.|.+.||+++..-||-
T Consensus       426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY  458 (598)
T KOG4158|consen  426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFY  458 (598)
T ss_pred             CCCCceeeccchhhhhhhhhhHHHHhccCCccc
Confidence            32      2358999999999999999988873

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.49  E-value=8.7e-14  Score=146.31  Aligned_cols=141  Identities=21%  Similarity=0.269  Sum_probs=98.6

Q ss_pred             cccccccCceeEEEEEccCCCeeEEEeecccCccCH----------------------------------------HHHH
Q 008292          350 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGA----------------------------------------EEFK  389 (571)
Q Consensus       350 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~----------------------------------------~~~~  389 (571)
                      .+.||.|++|+||+|++++|+.||||+.++......                                        -+|.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            468999999999999999999999999865321110                                        0244


Q ss_pred             HHHHHHhhcC----CCceeccceeE-EeCCeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHH-HHHHHHcC
Q 008292          390 NEVVLVAKLQ----HRNLVRLLGFC-LEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR-GILYLHED  463 (571)
Q Consensus       390 ~Ei~~l~~l~----h~niv~l~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~-~L~yLH~~  463 (571)
                      +|...+.+++    |.+-+.+-..+ ......+|||||++|++|.++.....  ...   ...+++.++++ .+..+|..
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~--~~~---~~~~ia~~~~~~~l~ql~~~  276 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE--AGL---DRKALAENLARSFLNQVLRD  276 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh--cCC---CHHHHHHHHHHHHHHHHHhC
Confidence            4555555442    22222222222 22456799999999999987763211  112   23456666666 46788887


Q ss_pred             CCCCeEEecCCCCCEEECCCCceEEeeccCccccC
Q 008292          464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG  498 (571)
Q Consensus       464 ~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  498 (571)
                      +   ++|+|++|.||+++++++++|.|||++..+.
T Consensus       277 g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       277 G---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             C---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            7   9999999999999999999999999998764

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.37  E-value=2.3e-12  Score=118.22  Aligned_cols=131  Identities=21%  Similarity=0.179  Sum_probs=97.3

Q ss_pred             cccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceec-cceeEEeCCeeEEEEEecCCCCh
Q 008292          350 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVR-LLGFCLEGEEKILVYEFVPNKSL  428 (571)
Q Consensus       350 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~-l~~~~~~~~~~~lv~e~~~~g~L  428 (571)
                      .+.|+.|.++.||+++.. +..+++|....... ....+..|++++..+.+.++++ ++.+  .....++||||+++.++
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEecCCCcc
Confidence            467899999999999874 77899998765432 2235678999999887665543 4433  33446899999999887


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC--CCCeEEecCCCCCEEECCCCceEEeeccCccc
Q 008292          429 DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS--RLRIIHRDLKASNILLDAEMNPKISDFGMARI  496 (571)
Q Consensus       429 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  496 (571)
                      ....        .   ....++.+++++|+.||...  ...++|+|++|.||+++ ++.++++|||.+..
T Consensus        79 ~~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          79 LTED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            5421        0   11235678999999999875  23469999999999999 66899999998763

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.35  E-value=1.1e-12  Score=139.47  Aligned_cols=145  Identities=16%  Similarity=0.186  Sum_probs=92.4

Q ss_pred             hCCCCccccccccCceeEEEEEccC-CCeeEEEeecccCcc----------------------------------CHHHH
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSKASGQ----------------------------------GAEEF  388 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~----------------------------------~~~~~  388 (571)
                      ...|+. +.||.|++|+||++++++ |+.||||+.++....                                  ..+.+
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            445666 789999999999999987 999999999754211                                  01122


Q ss_pred             HHHHH------HHhhcC----CCceeccceeEEe-CCeeEEEEEecCCCChhhhhcCCCCCC---CCCHHHHHHHHHHHH
Q 008292          389 KNEVV------LVAKLQ----HRNLVRLLGFCLE-GEEKILVYEFVPNKSLDYFLYDPEKQG---QLDWSRRYKIIGGIA  454 (571)
Q Consensus       389 ~~Ei~------~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~---~l~~~~~~~i~~~ia  454 (571)
                      .+|++      .+.+++    +.+.+.+-.++.+ ....+|||||++|+.+.++..-...+.   .+.......++.|+ 
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-  276 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-  276 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-
Confidence            23333      333332    3333333333322 446689999999999976421111110   12222233333333 


Q ss_pred             HHHHHHHcCCCCCeEEecCCCCCEEECCCC----ceEEeeccCccccCC
Q 008292          455 RGILYLHEDSRLRIIHRDLKASNILLDAEM----NPKISDFGMARIFGV  499 (571)
Q Consensus       455 ~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DfGla~~~~~  499 (571)
                            +..+   ++|+|+||.||+++.++    ++++.|||+...+..
T Consensus       277 ------f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        277 ------FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             ------HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                  3455   99999999999999988    999999999987643

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.24  E-value=8.2e-11  Score=109.04  Aligned_cols=135  Identities=16%  Similarity=0.155  Sum_probs=97.7

Q ss_pred             ccccccCceeEEEEEccC-------CCeeEEEeecccC------------c----------cCHHHHH----HHHHHHhh
Q 008292          351 NKLGEGGFGEVYKGVLPS-------GQEIAVKRLSKAS------------G----------QGAEEFK----NEVVLVAK  397 (571)
Q Consensus       351 ~~LG~G~fg~Vy~~~~~~-------g~~vavK~~~~~~------------~----------~~~~~~~----~Ei~~l~~  397 (571)
                      ..||.|.-+.||.|...+       +..+|||+.+...            +          ...+.+.    +|.+.|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999998643       4789999775210            0          1122333    78888888


Q ss_pred             cCCC--ceeccceeEEeCCeeEEEEEecCCCChhh-hhcCCCCCCCCCHHHHHHHHHHHHHHHHHH-HcCCCCCeEEecC
Q 008292          398 LQHR--NLVRLLGFCLEGEEKILVYEFVPNKSLDY-FLYDPEKQGQLDWSRRYKIIGGIARGILYL-HEDSRLRIIHRDL  473 (571)
Q Consensus       398 l~h~--niv~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~ivH~Dl  473 (571)
                      +...  ++.+++++    ...+|||||+.++.+.. .+    +...++.++...+..+++.+|..| |..+   |||+||
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L----kd~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDL  151 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL----KDAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADL  151 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh----hccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence            8643  45555543    56789999998764422 22    222345566777889999999999 7776   999999


Q ss_pred             CCCCEEECCCCceEEeeccCcccc
Q 008292          474 KASNILLDAEMNPKISDFGMARIF  497 (571)
Q Consensus       474 kp~NIll~~~~~~kl~DfGla~~~  497 (571)
                      ++.|||++ ++.+.|+|||.+...
T Consensus       152 s~~NIL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         152 SEYNMLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             CHHHEEEE-CCcEEEEECCCceeC
Confidence            99999997 467999999988654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.22  E-value=8.7e-11  Score=123.23  Aligned_cols=165  Identities=18%  Similarity=0.230  Sum_probs=124.6

Q ss_pred             cCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEecCCCChhhhhcCCCCCCCCCHHHH
Q 008292          367 PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRR  446 (571)
Q Consensus       367 ~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~  446 (571)
                      .++.+|.|...+.......+...+-++.|+.+|||||++++......+..|||+|-+.  .|...+.      .+.....
T Consensus        35 ~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk------~l~~~~v  106 (690)
T KOG1243|consen   35 ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLK------ELGKEEV  106 (690)
T ss_pred             ccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHH------HhHHHHH
Confidence            4678888888876666445667888999999999999999999999999999999874  3444442      1235566


Q ss_pred             HHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCccccccccccCCcccccccccCCC
Q 008292          447 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQF  526 (571)
Q Consensus       447 ~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  526 (571)
                      ..-+.||+.||.|||+.+  .++|++|.-..|+|+..|..||++|.++........  .......--.|..|+.+.... 
T Consensus       107 ~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~-  181 (690)
T KOG1243|consen  107 CLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE-  181 (690)
T ss_pred             HHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc-
Confidence            678899999999999766  599999999999999999999999998864321111  011111222466676543332 


Q ss_pred             CcchhHHHHHHHHHHHHhC
Q 008292          527 SVKSDVYSFGVLVLEIITG  545 (571)
Q Consensus       527 s~~~Dv~slGvvl~elltG  545 (571)
                       -..|.|-||++++|++.|
T Consensus       182 -~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  182 -WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             -cchhhhhHHHHHHHHhCc
Confidence             346999999999999999

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.21  E-value=1e-10  Score=104.59  Aligned_cols=131  Identities=22%  Similarity=0.343  Sum_probs=101.5

Q ss_pred             ccccccCceeEEEEEccCCCeeEEEe-ecccC-------ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          351 NKLGEGGFGEVYKGVLPSGQEIAVKR-LSKAS-------GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       351 ~~LG~G~fg~Vy~~~~~~g~~vavK~-~~~~~-------~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      ..+++|+-+.++.+.+. |..+++|. +++.-       .-..++-.+|..++.+++--.|.-.+-+..+.+...|+|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            46789999999999874 44456653 33211       11224567899999999877777777777888899999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccc
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI  496 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  496 (571)
                      ++|..|.+.+...          ...++..+-.-+.-||..+   |+|+||.++||++..++ +.++||||+..
T Consensus        81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9999999888432          2456677777788899988   99999999999997765 99999999864

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.21  E-value=1.4e-10  Score=111.13  Aligned_cols=143  Identities=19%  Similarity=0.275  Sum_probs=109.8

Q ss_pred             cccccccCceeEEEEEccCCCeeEEEeecccCc-cCHHHHHHHHHHHhhcCCC--ceeccceeEEeCC---eeEEEEEec
Q 008292          350 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASG-QGAEEFKNEVVLVAKLQHR--NLVRLLGFCLEGE---EKILVYEFV  423 (571)
Q Consensus       350 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~--niv~l~~~~~~~~---~~~lv~e~~  423 (571)
                      .+.|+.|..+.||++...+|+.+++|....... .....+..|.+++..+++.  ++.+++.+.....   ..++||||+
T Consensus         3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i   82 (223)
T cd05154           3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV   82 (223)
T ss_pred             ceecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence            357899999999999987778999998765432 2456788999999998764  3566677665532   568999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC---------------------------------------
Q 008292          424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS---------------------------------------  464 (571)
Q Consensus       424 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~---------------------------------------  464 (571)
                      ++.++...+.    ...++..+...++.++++.|..||+..                                       
T Consensus        83 ~G~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (223)
T cd05154          83 DGRVLRDRLL----RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME  158 (223)
T ss_pred             CCEecCCCCC----CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence            9998876542    135677778888888888888888521                                       


Q ss_pred             --------------CCCeEEecCCCCCEEECC--CCceEEeeccCccc
Q 008292          465 --------------RLRIIHRDLKASNILLDA--EMNPKISDFGMARI  496 (571)
Q Consensus       465 --------------~~~ivH~Dlkp~NIll~~--~~~~kl~DfGla~~  496 (571)
                                    ...++|+|++|.||++++  ++.+.|+||+.+..
T Consensus       159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                          245799999999999998  66789999998763

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.16  E-value=3.7e-11  Score=124.91  Aligned_cols=200  Identities=24%  Similarity=0.313  Sum_probs=155.0

Q ss_pred             hCCCCccccccc--cCceeEEEEEc---cCCCeeEEEeecc--cCccCHHHHHHHHHHHhhcC-CCceeccceeEEeCCe
Q 008292          344 TNKFSTDNKLGE--GGFGEVYKGVL---PSGQEIAVKRLSK--ASGQGAEEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEE  415 (571)
Q Consensus       344 ~~~~~~~~~LG~--G~fg~Vy~~~~---~~g~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~  415 (571)
                      ...+...+.+|.  |.+|.||.+..   .++..+|+|+-+.  ..+.....=.+|+....+++ |+|.++....+..++.
T Consensus       113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~  192 (524)
T KOG0601|consen  113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI  192 (524)
T ss_pred             hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc
Confidence            345667788999  99999999986   3578889987443  22233333356676666664 9999998888888999


Q ss_pred             eEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHH----HHHHHHcCCCCCeEEecCCCCCEEECCC-CceEEee
Q 008292          416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR----GILYLHEDSRLRIIHRDLKASNILLDAE-MNPKISD  490 (571)
Q Consensus       416 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~----~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~D  490 (571)
                      .++-.|.+. .+|..+.+.  ....++...++....+...    ||.++|...   ++|-|+||.||++..+ ...+++|
T Consensus       193 lfiqtE~~~-~sl~~~~~~--~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~d  266 (524)
T KOG0601|consen  193 LFIQTELCG-ESLQSYCHT--PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTD  266 (524)
T ss_pred             ceeeecccc-chhHHhhhc--ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCC
Confidence            999999885 667666643  3444677788888888888    999999887   9999999999999999 8999999


Q ss_pred             ccCccccCCCCCcc---ccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          491 FGMARIFGVDQTQG---NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       491 fGla~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      ||+...+.......   ...+..|...|++||.+ .+-++.++|||++|.++.|-.+|.....
T Consensus       267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~  328 (524)
T KOG0601|consen  267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPS  328 (524)
T ss_pred             cceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhccccc
Confidence            99998876543221   11233678899999955 5578899999999999999998877643

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.15  E-value=3.6e-10  Score=100.59  Aligned_cols=143  Identities=24%  Similarity=0.335  Sum_probs=107.4

Q ss_pred             ccccccccCceeEEEEEccCCCeeEEE-eeccc-------CccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEE
Q 008292          349 TDNKLGEGGFGEVYKGVLPSGQEIAVK-RLSKA-------SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY  420 (571)
Q Consensus       349 ~~~~LG~G~fg~Vy~~~~~~g~~vavK-~~~~~-------~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  420 (571)
                      ....|-||+-+.|+++.+ .|+...|| ++.+.       ..-...+.++|+++|.+.+--.|.-..-++.+.....|+|
T Consensus        11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            456789999999999998 67776666 33332       1223456788999999987767666666777788889999


Q ss_pred             EecCC-CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCC---ceEEeeccCccc
Q 008292          421 EFVPN-KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM---NPKISDFGMARI  496 (571)
Q Consensus       421 e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DfGla~~  496 (571)
                      ||+++ .++.+++....... ...+....++.+|-+.+.-||.+.   |+|+||..+||+|.+++   .+.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence            99987 46777775432222 223333678888999999999987   99999999999997665   358999999864

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.13  E-value=5.6e-11  Score=114.10  Aligned_cols=154  Identities=24%  Similarity=0.288  Sum_probs=117.6

Q ss_pred             HHHhhcCCCceeccceeEEeCC-----eeEEEEEecCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCC
Q 008292          393 VLVAKLQHRNLVRLLGFCLEGE-----EKILVYEFVPNKSLDYFLYDPE-KQGQLDWSRRYKIIGGIARGILYLHEDSRL  466 (571)
Q Consensus       393 ~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~  466 (571)
                      .-|-.+.|.|||++..++.+.+     ...++.|||..|++..+|++-. .+..+......+|+.||+.||.|||+- .|
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~P  197 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DP  197 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CC
Confidence            3445567999999999886543     4688999999999999996533 334577788889999999999999986 57


Q ss_pred             CeEEecCCCCCEEECCCCceEEeeccCccccCC---CCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHH
Q 008292          467 RIIHRDLKASNILLDAEMNPKISDFGMARIFGV---DQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEII  543 (571)
Q Consensus       467 ~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~---~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ell  543 (571)
                      +|+|+++..+-|++..++-+||.----. ....   ...........+-++|.+||+-.....+.++|||+||+..+||.
T Consensus       198 piihgnlTc~tifiq~ngLIkig~~ap~-s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema  276 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNGLIKIGSVAPD-STHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA  276 (458)
T ss_pred             ccccCCcchhheeecCCceEEecccCcc-ccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence            8999999999999999998888532111 1100   01111223345678999999887778888999999999999998


Q ss_pred             hCCCC
Q 008292          544 TGKKN  548 (571)
Q Consensus       544 tG~~p  548 (571)
                      .|..-
T Consensus       277 ilEiq  281 (458)
T KOG1266|consen  277 ILEIQ  281 (458)
T ss_pred             Hheec
Confidence            87754

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.99  E-value=1.9e-10  Score=119.69  Aligned_cols=196  Identities=23%  Similarity=0.240  Sum_probs=147.4

Q ss_pred             HHhCCCCccccccccCceeEEEEEcc--CCCeeEEEeecccCccCHHHH--HHHHHHHhhc-CCCceeccceeEEeCCee
Q 008292          342 VATNKFSTDNKLGEGGFGEVYKGVLP--SGQEIAVKRLSKASGQGAEEF--KNEVVLVAKL-QHRNLVRLLGFCLEGEEK  416 (571)
Q Consensus       342 ~~~~~~~~~~~LG~G~fg~Vy~~~~~--~g~~vavK~~~~~~~~~~~~~--~~Ei~~l~~l-~h~niv~l~~~~~~~~~~  416 (571)
                      ....+|..+..||.|.|+.|++...+  ++..+++|.+.........++  ..|+.+...+ .|.++++....+..-...
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~  341 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG  341 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence            34567888999999999999998743  567889998876543333332  2466666555 488888888777777778


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCC-CceEEeeccCcc
Q 008292          417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE-MNPKISDFGMAR  495 (571)
Q Consensus       417 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfGla~  495 (571)
                      ++--||+.++++...+   .....+++..++++..|++.++.++|+..   ++|+|++|+||++..+ +.-++.|||++.
T Consensus       342 ~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t  415 (524)
T KOG0601|consen  342 YIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWT  415 (524)
T ss_pred             cCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccc
Confidence            8999999999887655   22344677888999999999999999876   9999999999999876 788999999986


Q ss_pred             ccCCCCCccccccccccCCcc--cccccccCCCCcchhHHHHHHHHHHHHhCCCC
Q 008292          496 IFGVDQTQGNTSRIVGTYGYM--APEYAMHGQFSVKSDVYSFGVLVLEIITGKKN  548 (571)
Q Consensus       496 ~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p  548 (571)
                      .+.....     .....-+++  +|+......+-.+.|++|||.-+.|.++|..-
T Consensus       416 ~~~~~~~-----~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l  465 (524)
T KOG0601|consen  416 RLAFSSG-----VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL  465 (524)
T ss_pred             ccceecc-----cccccccccccchhhccccccccccccccccccccccccCccc
Confidence            4321111     111223444  45555566788999999999999999998764

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.98  E-value=2.5e-09  Score=98.80  Aligned_cols=125  Identities=26%  Similarity=0.355  Sum_probs=82.1

Q ss_pred             eEEEEEccCCCeeEEEeecccC-------------cc-------------CHHHHHHHHHHHhhcCCCc--eeccceeEE
Q 008292          360 EVYKGVLPSGQEIAVKRLSKAS-------------GQ-------------GAEEFKNEVVLVAKLQHRN--LVRLLGFCL  411 (571)
Q Consensus       360 ~Vy~~~~~~g~~vavK~~~~~~-------------~~-------------~~~~~~~Ei~~l~~l~h~n--iv~l~~~~~  411 (571)
                      .||.|...+|..+|||+.+...             ..             .....++|.+.|.++...+  +.+++++  
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~--   78 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY--   78 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence            4899998899999999775310             00             0134678999999998764  5555544  


Q ss_pred             eCCeeEEEEEecC--CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHH-HHcCCCCCeEEecCCCCCEEECCCCceEE
Q 008292          412 EGEEKILVYEFVP--NKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY-LHEDSRLRIIHRDLKASNILLDAEMNPKI  488 (571)
Q Consensus       412 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~y-LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  488 (571)
                        ....|||||++  |..+..+...     .++......++.+++..+.. +|..+   |+|+||.+.|||++++ .+.|
T Consensus        79 --~~~~ivME~I~~~G~~~~~l~~~-----~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i  147 (188)
T PF01163_consen   79 --NRNVIVMEYIGEDGVPLPRLKDV-----DLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI  147 (188)
T ss_dssp             --ETTEEEEE--EETTEEGGCHHHC-----GGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred             --eCCEEEEEecCCCccchhhHHhc-----cccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence              25589999999  6556544321     11133455677778776665 46766   9999999999999888 8999


Q ss_pred             eeccCcccc
Q 008292          489 SDFGMARIF  497 (571)
Q Consensus       489 ~DfGla~~~  497 (571)
                      +|||.+...
T Consensus       148 IDf~qav~~  156 (188)
T PF01163_consen  148 IDFGQAVDS  156 (188)
T ss_dssp             --GTTEEET
T ss_pred             EecCcceec
Confidence            999988653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.93  E-value=1.4e-08  Score=103.76  Aligned_cols=169  Identities=22%  Similarity=0.331  Sum_probs=128.3

Q ss_pred             ceeEEEEEc-cCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEe----CCeeEEEEEecCC-CChhhh
Q 008292          358 FGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE----GEEKILVYEFVPN-KSLDYF  431 (571)
Q Consensus       358 fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~-g~L~~~  431 (571)
                      -.+.||+.. .+|..|++|++.............-+++++++.|+|||++..++..    +...++||+|.++ ++|.+.
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            357788873 4899999999954333333233456788999999999999998873    4467999999987 466554


Q ss_pred             hcCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCC
Q 008292          432 LYDP------------EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV  499 (571)
Q Consensus       432 l~~~------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  499 (571)
                      -...            ..+...++..+|.++.|++.||.++|+.|   +.-+-|.+++||++.+.+++|+..|....+..
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            4321            23345788999999999999999999988   88899999999999999999999888766543


Q ss_pred             CCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCC
Q 008292          500 DQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKN  548 (571)
Q Consensus       500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p  548 (571)
                      +...                -+   +--.+-|.=.||.+++.|.||...
T Consensus       446 d~~~----------------~l---e~~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  446 DPTE----------------PL---ESQQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCCc----------------ch---hHHhhhhHHHHHHHHHHHhhcccc
Confidence            3310                01   112356999999999999999655

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.91  E-value=1.6e-08  Score=99.15  Aligned_cols=139  Identities=17%  Similarity=0.142  Sum_probs=99.1

Q ss_pred             ccccCceeEEEEEccCCCeeEEEeecccCc-----------cCHHHHHHHHHHHhhcCCCce--eccceeEEe-----CC
Q 008292          353 LGEGGFGEVYKGVLPSGQEIAVKRLSKASG-----------QGAEEFKNEVVLVAKLQHRNL--VRLLGFCLE-----GE  414 (571)
Q Consensus       353 LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~-----------~~~~~~~~Ei~~l~~l~h~ni--v~l~~~~~~-----~~  414 (571)
                      +-+-....|.+..+ +|+.+.||+......           .....+.+|...+.++...+|  .+.+++...     ..
T Consensus        30 v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~  108 (268)
T PRK15123         30 FRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR  108 (268)
T ss_pred             EecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence            33333344667666 678899997743221           111247789998888855444  344555543     23


Q ss_pred             eeEEEEEecCCC-ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECC-------CCce
Q 008292          415 EKILVYEFVPNK-SLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-------EMNP  486 (571)
Q Consensus       415 ~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-------~~~~  486 (571)
                      ..+||+|++++. +|.+++.+.. ....+......++.+++..+.-||..+   |+|+|++++|||++.       +..+
T Consensus       109 ~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~  184 (268)
T PRK15123        109 TSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKL  184 (268)
T ss_pred             eeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceE
Confidence            468999999986 8888873211 234566777889999999999999998   999999999999975       4689


Q ss_pred             EEeeccCccc
Q 008292          487 KISDFGMARI  496 (571)
Q Consensus       487 kl~DfGla~~  496 (571)
                      .|+||+.++.
T Consensus       185 ~LIDl~r~~~  194 (268)
T PRK15123        185 SVIDLHRAQI  194 (268)
T ss_pred             EEEECCcccc
Confidence            9999998853

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.85  E-value=9.5e-10  Score=120.37  Aligned_cols=206  Identities=21%  Similarity=0.241  Sum_probs=145.0

Q ss_pred             HHhCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC---ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeE
Q 008292          342 VATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI  417 (571)
Q Consensus       342 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  417 (571)
                      ...+.+.+.+-+-.|.++.++-..-. .|...+.|......   ....+....+-.++-..+||-+++..--+.......
T Consensus       801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~  880 (1205)
T KOG0606|consen  801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP  880 (1205)
T ss_pred             CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence            34456777778888999998876632 23333333332221   122223333333333345677776666666677889


Q ss_pred             EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCcccc
Q 008292          418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF  497 (571)
Q Consensus       418 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  497 (571)
                      |+++|+.+++|...|+..   +..+.+-....+..+...+++||...   +.|+|++|.|+|+..++..+++|||.....
T Consensus       881 L~~~~~~~~~~~Skl~~~---~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v  954 (1205)
T KOG0606|consen  881 LVGHYLNGGDLPSKLHNS---GCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKV  954 (1205)
T ss_pred             hhhHHhccCCchhhhhcC---CCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccc
Confidence            999999999999888542   34454455556677888999999865   899999999999999999999999844322


Q ss_pred             CCC---------------------CC----c----cccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCC
Q 008292          498 GVD---------------------QT----Q----GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKN  548 (571)
Q Consensus       498 ~~~---------------------~~----~----~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p  548 (571)
                      ..-                     ..    .    .......+|+.|.+||...+......+|+|++|++++|.++|..|
T Consensus       955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen  955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred             ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence            100                     00    0    012235689999999999999999999999999999999999999


Q ss_pred             CCCCC
Q 008292          549 SNFYQ  553 (571)
Q Consensus       549 ~~~~~  553 (571)
                      ++...
T Consensus      1035 ~na~t 1039 (1205)
T KOG0606|consen 1035 FNAET 1039 (1205)
T ss_pred             CCCcc
Confidence            87543

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.81  E-value=3.8e-08  Score=93.52  Aligned_cols=135  Identities=21%  Similarity=0.264  Sum_probs=95.3

Q ss_pred             CCccccccccCceeEEEEEccCCCeeEEEeecccC----------------------ccCHHHHHHHHHHHhhcCCC--c
Q 008292          347 FSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKAS----------------------GQGAEEFKNEVVLVAKLQHR--N  402 (571)
Q Consensus       347 ~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~----------------------~~~~~~~~~Ei~~l~~l~h~--n  402 (571)
                      ..+..+||-|.-+.||.|..++|.+++||.-+...                      .......++|.+.|.++...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            35568999999999999999999999999543210                      01123457888999888655  6


Q ss_pred             eeccceeEEeCCeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECC
Q 008292          403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA  482 (571)
Q Consensus       403 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~  482 (571)
                      |.+.+++    +...+|||+++|-.|...-        ++.+..-.++..|++-+..+-..+   +||+|+++-||++++
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~  237 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTE  237 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEec
Confidence            6666654    5668999999987664332        122223333444444444443444   999999999999999


Q ss_pred             CCceEEeeccCccc
Q 008292          483 EMNPKISDFGMARI  496 (571)
Q Consensus       483 ~~~~kl~DfGla~~  496 (571)
                      ||.+.++||--+..
T Consensus       238 dg~~~vIDwPQ~v~  251 (304)
T COG0478         238 DGDIVVIDWPQAVP  251 (304)
T ss_pred             CCCEEEEeCccccc
Confidence            99999999976653

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.72  E-value=5.1e-08  Score=103.44  Aligned_cols=140  Identities=18%  Similarity=0.292  Sum_probs=90.6

Q ss_pred             ccccccCceeEEEEEccCCCeeEEEeecccCccCH------------------------------H----------HHHH
Q 008292          351 NKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGA------------------------------E----------EFKN  390 (571)
Q Consensus       351 ~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~------------------------------~----------~~~~  390 (571)
                      +.|+.++-|+||+|++++|+.||||+.++.-....                              +          ++.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            68999999999999999999999998865321110                              0          1233


Q ss_pred             HHHHHhhcC-----CCceeccceeEE-eCCeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHH-HHHHHcC
Q 008292          391 EVVLVAKLQ-----HRNLVRLLGFCL-EGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARG-ILYLHED  463 (571)
Q Consensus       391 Ei~~l~~l~-----h~niv~l~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~-L~yLH~~  463 (571)
                      |...+.+++     .++| ++=.++. -....+|+|||++|..+.++..-  +...++.+.+..   .++++ +..+-..
T Consensus       211 EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l--~~~g~d~k~ia~---~~~~~f~~q~~~d  284 (517)
T COG0661         211 EAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAAL--KSAGIDRKELAE---LLVRAFLRQLLRD  284 (517)
T ss_pred             HHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHH--HhcCCCHHHHHH---HHHHHHHHHHHhc
Confidence            444444332     2332 2222232 34667899999999988877421  123344333322   22222 2222223


Q ss_pred             CCCCeEEecCCCCCEEECCCCceEEeeccCccccCC
Q 008292          464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV  499 (571)
Q Consensus       464 ~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  499 (571)
                      +   ++|.|.+|.||+++.++++.+.|||+...+..
T Consensus       285 g---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         285 G---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             C---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            4   99999999999999999999999999876643

>PRK09902 hypothetical protein; Provisional

Probab=98.61  E-value=5.9e-07  Score=83.61  Aligned_cols=139  Identities=16%  Similarity=0.133  Sum_probs=102.9

Q ss_pred             ccccCceeEEEEEccCCCeeEEEeeccc------CccCHHHHHHHHHHHhhcCCCc--eeccceeEEeC----CeeEEEE
Q 008292          353 LGEGGFGEVYKGVLPSGQEIAVKRLSKA------SGQGAEEFKNEVVLVAKLQHRN--LVRLLGFCLEG----EEKILVY  420 (571)
Q Consensus       353 LG~G~fg~Vy~~~~~~g~~vavK~~~~~------~~~~~~~~~~Ei~~l~~l~h~n--iv~l~~~~~~~----~~~~lv~  420 (571)
                      -|+||-+-|++-.+ +|..+-+|+-...      .+.....|.+|...+.++...+  +.+.+......    -..+||+
T Consensus        26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            46788889999777 4557888877521      1446678999999999886433  44444222221    1357999


Q ss_pred             EecCC-CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCc--eEEeeccCccc
Q 008292          421 EFVPN-KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN--PKISDFGMARI  496 (571)
Q Consensus       421 e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~DfGla~~  496 (571)
                      |-+++ .+|.+++.+. ...+.+......++.++++.+.-||..+   +.|+|+.++||+++.++.  ++++||.-++.
T Consensus       105 e~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        105 EDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            98765 5888887332 2235677788899999999999999988   999999999999986667  99999987653

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.58  E-value=2.9e-07  Score=87.16  Aligned_cols=106  Identities=27%  Similarity=0.329  Sum_probs=83.1

Q ss_pred             HHHHHHHHHHHhhcCCCc--eeccceeEEeCC----eeEEEEEecCCC-ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHH
Q 008292          385 AEEFKNEVVLVAKLQHRN--LVRLLGFCLEGE----EKILVYEFVPNK-SLDYFLYDPEKQGQLDWSRRYKIIGGIARGI  457 (571)
Q Consensus       385 ~~~~~~Ei~~l~~l~h~n--iv~l~~~~~~~~----~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L  457 (571)
                      .....+|...+..+....  +.+.+++.....    ..++|+|++++. +|.+++...   ...+......++.++++.+
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~---~~~~~~~~~~ll~~l~~~i  131 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW---EQLDPSQRRELLRALARLI  131 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh---cccchhhHHHHHHHHHHHH
Confidence            346778888887775443  455666655532    358999999984 798888431   2256677888999999999


Q ss_pred             HHHHcCCCCCeEEecCCCCCEEECCCC---ceEEeeccCccc
Q 008292          458 LYLHEDSRLRIIHRDLKASNILLDAEM---NPKISDFGMARI  496 (571)
Q Consensus       458 ~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DfGla~~  496 (571)
                      .-||+.+   |+|+|++++|||++.+.   .+.++||+-++.
T Consensus       132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            9999998   99999999999999887   899999998764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.55  E-value=1.2e-06  Score=84.22  Aligned_cols=138  Identities=18%  Similarity=0.232  Sum_probs=85.3

Q ss_pred             ccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCc--eeccceeEEeCCeeEEEEEecCCCC-
Q 008292          351 NKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRN--LVRLLGFCLEGEEKILVYEFVPNKS-  427 (571)
Q Consensus       351 ~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~-  427 (571)
                      .+||+|..+.||+.   .+..+++|......  ......+|.++++.+..-.  +.+.+++....+...+|||+++|.. 
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            57899999999983   25567788876533  3456788999998886544  3566777777777889999999963 


Q ss_pred             hhhhh---------------------cCCCCCCCCCHHHHH-HHHH----------HHHH-HHHHHHc-CCCCCeEEecC
Q 008292          428 LDYFL---------------------YDPEKQGQLDWSRRY-KIIG----------GIAR-GILYLHE-DSRLRIIHRDL  473 (571)
Q Consensus       428 L~~~l---------------------~~~~~~~~l~~~~~~-~i~~----------~ia~-~L~yLH~-~~~~~ivH~Dl  473 (571)
                      +...+                     |.... ......... ++..          .+.+ ...+|.. ...+.++|+|+
T Consensus        82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~-~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~  160 (226)
T TIGR02172        82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKC-DTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF  160 (226)
T ss_pred             hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCC-CCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence            22111                     11000 011111100 0000          0011 1122221 12345799999


Q ss_pred             CCCCEEECCCCceEEeeccCcc
Q 008292          474 KASNILLDAEMNPKISDFGMAR  495 (571)
Q Consensus       474 kp~NIll~~~~~~kl~DfGla~  495 (571)
                      .|.||++++++ +.|+||+.+.
T Consensus       161 ~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       161 QIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCCcEEEcCCC-cEEEechhcC
Confidence            99999999888 9999999875

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.50  E-value=1.3e-06  Score=87.35  Aligned_cols=192  Identities=16%  Similarity=0.229  Sum_probs=125.4

Q ss_pred             CccccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhc-CCCceeccceeEE-------eCCeeEEE
Q 008292          348 STDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCL-------EGEEKILV  419 (571)
Q Consensus       348 ~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~-------~~~~~~lv  419 (571)
                      ...+.||+|+-+.+|-.-  +-..-+.|+..........+   .+..|... .||-+-.-+.+-.       .+...-+.
T Consensus        14 ~~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl   88 (637)
T COG4248          14 PPGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL   88 (637)
T ss_pred             CCCccccCCccceeeecc--hhhchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence            345789999999998632  22223456665443322222   22333333 4654433122211       12225577


Q ss_pred             EEecCCCChhhhhcCC----CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCcc
Q 008292          420 YEFVPNKSLDYFLYDP----EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR  495 (571)
Q Consensus       420 ~e~~~~g~L~~~l~~~----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  495 (571)
                      |+.+++.-=-..+++.    ..-...+|.-.++.++.++.+.+-||+.+   -+-+|++++|+|+.+++.+.|.|=..-.
T Consensus        89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfq  165 (637)
T COG4248          89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQ  165 (637)
T ss_pred             cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEccccee
Confidence            7777665222222221    22335789999999999999999999998   8899999999999999999998865443


Q ss_pred             ccCCCCCccccccccccCCcccccccc-----cCCCCcchhHHHHHHHHHHHHhC-CCCCC
Q 008292          496 IFGVDQTQGNTSRIVGTYGYMAPEYAM-----HGQFSVKSDVYSFGVLVLEIITG-KKNSN  550 (571)
Q Consensus       496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~Dv~slGvvl~elltG-~~p~~  550 (571)
                      ...   .....-..+|...|.+||...     +..-+...|.|.||+++++|+.| +.||.
T Consensus       166 i~~---ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPys  223 (637)
T COG4248         166 INA---NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYS  223 (637)
T ss_pred             ecc---CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCC
Confidence            321   112223457889999999764     33456679999999999999987 77875

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.45  E-value=1.9e-06  Score=80.57  Aligned_cols=139  Identities=14%  Similarity=0.171  Sum_probs=92.8

Q ss_pred             HHhCCCCccccccccCceeEEEEEccCCCeeEEEeecccCccCHHH---------HHHHHHHHhhcCCCce---ecccee
Q 008292          342 VATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEE---------FKNEVVLVAKLQHRNL---VRLLGF  409 (571)
Q Consensus       342 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~---------~~~Ei~~l~~l~h~ni---v~l~~~  409 (571)
                      +...+|+..+.+-......|.+-.. +|..+++|..+.......+.         ..+++..+.+++...+   ..++.+
T Consensus        28 i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~  106 (229)
T PF06176_consen   28 ILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA  106 (229)
T ss_pred             HHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence            4567788888888777777777766 67889999886543322222         2334444444433322   222222


Q ss_pred             EE-----eCCeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCC
Q 008292          410 CL-----EGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM  484 (571)
Q Consensus       410 ~~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~  484 (571)
                      ..     -....+|+|||++|..|.++.       .+++    .+...+.+.+.-||+.|   ++|+|.+|.|+++++++
T Consensus       107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~-------~i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~  172 (229)
T PF06176_consen  107 AEKKIFRYTSSYVLLMEYIEGVELNDIE-------DIDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG  172 (229)
T ss_pred             eeeeeccceeEEEEEEEEecCeecccch-------hcCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc
Confidence            22     123457999999998886554       1222    24466778899999998   99999999999998654


Q ss_pred             ceEEeeccCccc
Q 008292          485 NPKISDFGMARI  496 (571)
Q Consensus       485 ~~kl~DfGla~~  496 (571)
                       +++.||+..+.
T Consensus       173 -i~iID~~~k~~  183 (229)
T PF06176_consen  173 -IRIIDTQGKRM  183 (229)
T ss_pred             -EEEEECccccc
Confidence             99999987653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.41  E-value=1.3e-06  Score=82.54  Aligned_cols=150  Identities=19%  Similarity=0.229  Sum_probs=94.2

Q ss_pred             HHHHHhCCCCccc---cccccCceeEEEEEccCCCeeEEEeecccCccCH-------------------HH-----HHHH
Q 008292          339 TIEVATNKFSTDN---KLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGA-------------------EE-----FKNE  391 (571)
Q Consensus       339 ~~~~~~~~~~~~~---~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~-------------------~~-----~~~E  391 (571)
                      .+....++..+..   .|..|.-..||+|...++..+|||+++.......                   .+     ...|
T Consensus        39 ~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kE  118 (268)
T COG1718          39 TLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKE  118 (268)
T ss_pred             HHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHH
Confidence            3444444444444   4566777889999988899999999864321111                   00     1234


Q ss_pred             HHHHhhcC--CCceeccceeEEeCCeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeE
Q 008292          392 VVLVAKLQ--HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRII  469 (571)
Q Consensus       392 i~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iv  469 (571)
                      ..-|.++.  +-.+.+.+++    ....|||||+....+..-.   .+...+...+...+..++++.+.-|-...  ++|
T Consensus       119 f~NL~R~~eAGVrvP~Pi~~----~~nVLvMEfIg~~g~pAP~---LkDv~~e~~e~~~~~~~~v~~~~~l~~~a--~LV  189 (268)
T COG1718         119 FRNLKRAYEAGVRVPEPIAF----RNNVLVMEFIGDDGLPAPR---LKDVPLELEEAEGLYEDVVEYMRRLYKEA--GLV  189 (268)
T ss_pred             HHHHHHHHHcCCCCCCceee----cCCeEEEEeccCCCCCCCC---cccCCcCchhHHHHHHHHHHHHHHHHHhc--Ccc
Confidence            44444442  2223333333    2457999999765221111   12223334466777888888888886632  499


Q ss_pred             EecCCCCCEEECCCCceEEeeccCccccC
Q 008292          470 HRDLKASNILLDAEMNPKISDFGMARIFG  498 (571)
Q Consensus       470 H~Dlkp~NIll~~~~~~kl~DfGla~~~~  498 (571)
                      |+||+.-|||+. ++.+.|+|||-+....
T Consensus       190 HgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         190 HGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             cccchhhheEEE-CCeEEEEECccccccC
Confidence            999999999999 8899999999887554

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.28  E-value=3.9e-06  Score=88.93  Aligned_cols=142  Identities=14%  Similarity=0.228  Sum_probs=90.5

Q ss_pred             cccccccCceeEEEEEccCCCeeEEEeecccCccCH-------------------------------H------HHHHHH
Q 008292          350 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGA-------------------------------E------EFKNEV  392 (571)
Q Consensus       350 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~-------------------------------~------~~~~Ei  392 (571)
                      .+.||..+.|+||++++++|+.||||+-++.-+...                               +      +|.+|.
T Consensus       166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            468999999999999999999999998764321110                               0      133444


Q ss_pred             HHHhh----cCCCce---eccceeEEe-CCeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC
Q 008292          393 VLVAK----LQHRNL---VRLLGFCLE-GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS  464 (571)
Q Consensus       393 ~~l~~----l~h~ni---v~l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~  464 (571)
                      +-..+    ++|-++   |.+=.++.+ ....+|+|||++|..+.+...  .....++...+..-+.++..-+-+-|  |
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~--i~~~gi~~~~i~~~l~~~~~~qIf~~--G  321 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDA--IDKRGISPHDILNKLVEAYLEQIFKT--G  321 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHH--HHHcCCCHHHHHHHHHHHHHHHHHhc--C
Confidence            33333    234441   112222222 346789999999988766532  12334555555444444332222222  3


Q ss_pred             CCCeEEecCCCCCEEECC----CCceEEeeccCccccC
Q 008292          465 RLRIIHRDLKASNILLDA----EMNPKISDFGMARIFG  498 (571)
Q Consensus       465 ~~~ivH~Dlkp~NIll~~----~~~~kl~DfGla~~~~  498 (571)
                         ++|+|-+|.||++++    +..+.+-|||+...+.
T Consensus       322 ---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  322 ---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             ---CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence               999999999999984    6789999999987654

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.27  E-value=4.5e-06  Score=80.45  Aligned_cols=143  Identities=22%  Similarity=0.237  Sum_probs=84.6

Q ss_pred             cccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCc--eeccceeEEeC---CeeEEEEEecC
Q 008292          350 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRN--LVRLLGFCLEG---EEKILVYEFVP  424 (571)
Q Consensus       350 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n--iv~l~~~~~~~---~~~~lv~e~~~  424 (571)
                      ++.|+.|..+.||+....+ ..+++|.....  .....+.+|..+++.+....  +.+++......   ...+++|++++
T Consensus         2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            4578999999999999866 68999987654  44567788988888875433  45666644332   34689999999


Q ss_pred             CCChhh----------------hh---cCC-CCCCCCCHHH---------HHHH------------HHHHHH-HHHHHHc
Q 008292          425 NKSLDY----------------FL---YDP-EKQGQLDWSR---------RYKI------------IGGIAR-GILYLHE  462 (571)
Q Consensus       425 ~g~L~~----------------~l---~~~-~~~~~l~~~~---------~~~i------------~~~ia~-~L~yLH~  462 (571)
                      +..+..                .+   +.. .....+.+..         ....            ...+.+ .+..+++
T Consensus        79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (239)
T PF01636_consen   79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA  158 (239)
T ss_dssp             SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence            988877                11   011 0111111110         0000            111222 2333332


Q ss_pred             ----CCCCCeEEecCCCCCEEEC-CCCceEEeeccCcc
Q 008292          463 ----DSRLRIIHRDLKASNILLD-AEMNPKISDFGMAR  495 (571)
Q Consensus       463 ----~~~~~ivH~Dlkp~NIll~-~~~~~kl~DfGla~  495 (571)
                          .....++|+|+.|+|||++ +++.+.|+||+.+.
T Consensus       159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence                2345699999999999999 66667899999875

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.26  E-value=1.8e-07  Score=99.05  Aligned_cols=97  Identities=25%  Similarity=0.479  Sum_probs=75.7

Q ss_pred             HHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCC-------ccccccccccCCcccccccc
Q 008292          450 IGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT-------QGNTSRIVGTYGYMAPEYAM  522 (571)
Q Consensus       450 ~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~  522 (571)
                      +.+++.||.|+|...  ++||++|.|++|.++.++.+||+.|+.+........       .....-..-...|.|||++.
T Consensus       105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            445669999999754  799999999999999999999999998765433111       01111123456899999999


Q ss_pred             cCCCCcchhHHHHHHHHHHHHhCCCC
Q 008292          523 HGQFSVKSDVYSFGVLVLEIITGKKN  548 (571)
Q Consensus       523 ~~~~s~~~Dv~slGvvl~elltG~~p  548 (571)
                      +...+.++|+||+|+++|-+..|.++
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~  208 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKS  208 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcc
Confidence            99999999999999999999955554

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.23  E-value=1.7e-07  Score=98.17  Aligned_cols=189  Identities=17%  Similarity=0.124  Sum_probs=134.5

Q ss_pred             hCCCCccccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCc-eeccceeEEeCCeeEEEEEe
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRN-LVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~  422 (571)
                      +..+...+.+++++++.++|.+-...+....+.+...     ....-++++|.+++||| .+..++-+..++..++++++
T Consensus       241 ~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i  315 (829)
T KOG0576|consen  241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRI  315 (829)
T ss_pred             ccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhh
Confidence            3444455678899999999877433333345554332     45567899999999999 77777777667778999999


Q ss_pred             cCCC-ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCC
Q 008292          423 VPNK-SLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ  501 (571)
Q Consensus       423 ~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  501 (571)
                      +..+ +-....  ......+..-+...+.+.-++++++||+..   -+|+|    ||+..+ +..|..||+....+....
T Consensus       316 ~s~~rs~~~~~--~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~  385 (829)
T KOG0576|consen  316 CSTGRSSALEM--TVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM  385 (829)
T ss_pred             hcCCccccccC--ChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc
Confidence            9877 221111  011122333445556677788999999764   48998    777655 678999999987664332


Q ss_pred             CccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          502 TQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       502 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                         ......+++.|+|||+.....+..+.|+|++|+-..++--|-.|..
T Consensus       386 ---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  386 ---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             ---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence               3345678999999999999999999999999987777777777643

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.22  E-value=1.4e-05  Score=77.98  Aligned_cols=139  Identities=17%  Similarity=0.146  Sum_probs=84.4

Q ss_pred             ccccCc-eeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhcC-CCceeccceeEEeCCeeEEEEEecCCCChhh
Q 008292          353 LGEGGF-GEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEKILVYEFVPNKSLDY  430 (571)
Q Consensus       353 LG~G~f-g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  430 (571)
                      |-.|.. ..||+...+ +..+.+|+.....   ..++..|+++++.+. +--+.+++++....+..++|||+++|.++..
T Consensus         6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~   81 (244)
T cd05150           6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA   81 (244)
T ss_pred             cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence            444555 789998764 4778888875443   345677888888774 3345567777666667899999999988764


Q ss_pred             hhc-------------------CCCC-CCCCCH--HHHHHHHH--------------------HHHHHHHHHHc----CC
Q 008292          431 FLY-------------------DPEK-QGQLDW--SRRYKIIG--------------------GIARGILYLHE----DS  464 (571)
Q Consensus       431 ~l~-------------------~~~~-~~~l~~--~~~~~i~~--------------------~ia~~L~yLH~----~~  464 (571)
                      ...                   .... ...+..  ........                    .+...+..|-.    ..
T Consensus        82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  161 (244)
T cd05150          82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE  161 (244)
T ss_pred             hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence            321                   1000 001110  00000000                    01111222211    12


Q ss_pred             CCCeEEecCCCCCEEECCCCceEEeeccCcc
Q 008292          465 RLRIIHRDLKASNILLDAEMNPKISDFGMAR  495 (571)
Q Consensus       465 ~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  495 (571)
                      .+.++|+|+.|.|||+++++.+.|+||+.+.
T Consensus       162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             ceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            3559999999999999998778999999875

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.16  E-value=9.3e-06  Score=75.41  Aligned_cols=105  Identities=23%  Similarity=0.211  Sum_probs=82.9

Q ss_pred             HHHHHHHhhcCC-CceeccceeEEeCCeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC
Q 008292          389 KNEVVLVAKLQH-RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR  467 (571)
Q Consensus       389 ~~Ei~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~  467 (571)
                      .+|..++..+++ +++.+++|+|    ..+++.||.+.+++...-..-..-...+|..+.+|+.++++.+++|++.....
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            458888888886 6999999998    34789999988766421100011234699999999999999999998754445


Q ss_pred             eEEecCCCCCEEECCCCceEEeeccCcccc
Q 008292          468 IIHRDLKASNILLDAEMNPKISDFGMARIF  497 (571)
Q Consensus       468 ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  497 (571)
                      +...|++++|+-+++++++|+.|...+...
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            899999999999999999999999887544

Proteins in this uncharacterised family are described as transmembrane proteins.

>PLN02876 acyl-CoA dehydrogenase

Probab=98.05  E-value=4.9e-05  Score=87.06  Aligned_cols=79  Identities=13%  Similarity=0.313  Sum_probs=57.3

Q ss_pred             cccccccCceeEEEEEccCC---CeeEEEeecccC-ccCHHHHHHHHHHHhhcC-CCce--eccceeEEeC---CeeEEE
Q 008292          350 DNKLGEGGFGEVYKGVLPSG---QEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQ-HRNL--VRLLGFCLEG---EEKILV  419 (571)
Q Consensus       350 ~~~LG~G~fg~Vy~~~~~~g---~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-h~ni--v~l~~~~~~~---~~~~lv  419 (571)
                      .+.|+.|.+..+|+....++   ..+++|+..... ......+.+|.++++.+. |.+|  .+++.++.+.   ...++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            46789999999999876554   367777764432 233457889999999985 6664  7777777654   357899


Q ss_pred             EEecCCCCh
Q 008292          420 YEFVPNKSL  428 (571)
Q Consensus       420 ~e~~~~g~L  428 (571)
                      |||++|..+
T Consensus       123 ME~v~G~~~  131 (822)
T PLN02876        123 MEYLEGRIF  131 (822)
T ss_pred             EEecCCccc
Confidence            999998654

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.05  E-value=5.6e-05  Score=70.56  Aligned_cols=133  Identities=22%  Similarity=0.362  Sum_probs=92.8

Q ss_pred             CccccccccCceeEEEEEccCCCeeEEEeecccC----------------ccCHHHHHHHHHHHhhcC------CCceec
Q 008292          348 STDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKAS----------------GQGAEEFKNEVVLVAKLQ------HRNLVR  405 (571)
Q Consensus       348 ~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~----------------~~~~~~~~~Ei~~l~~l~------h~niv~  405 (571)
                      +....||+|+.=.||.  ++++....||+.....                .....+..+|+.-...+.      +.+|.+
T Consensus         4 ~~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r   81 (199)
T PF10707_consen    4 SESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR   81 (199)
T ss_pred             CCCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence            4456899999999986  5667778889887655                223456677776665555      788999


Q ss_pred             cceeEEeCCeeEEEEEecCC--C----ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEE
Q 008292          406 LLGFCLEGEEKILVYEFVPN--K----SLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNIL  479 (571)
Q Consensus       406 l~~~~~~~~~~~lv~e~~~~--g----~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIl  479 (571)
                      ++|+.......-+|+|.+.+  |    +|.+++    +...++. ...+.+.+.   ..||-++.   |+.+||+|+||+
T Consensus        82 ~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l----~~~~~~~-~~~~~L~~f---~~~l~~~~---Iv~~dl~~~NIv  150 (199)
T PF10707_consen   82 FYGFVETNLGLGLVVELIRDADGNISPTLEDYL----KEGGLTE-ELRQALDEF---KRYLLDHH---IVIRDLNPHNIV  150 (199)
T ss_pred             EeEEEecCCceEEEEEEEECCCCCcCccHHHHH----HcCCccH-HHHHHHHHH---HHHHHHcC---CeecCCCcccEE
Confidence            99999999999999998854  2    466666    3344555 444444444   45555554   999999999999


Q ss_pred             ECCCC----ceEEee-ccC
Q 008292          480 LDAEM----NPKISD-FGM  493 (571)
Q Consensus       480 l~~~~----~~kl~D-fGl  493 (571)
                      +....    .+.|+| ||-
T Consensus       151 ~~~~~~~~~~lvlIDG~G~  169 (199)
T PF10707_consen  151 VQRRDSGEFRLVLIDGLGE  169 (199)
T ss_pred             EEecCCCceEEEEEeCCCC
Confidence            95332    466666 443

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PRK10593 hypothetical protein; Provisional

Probab=98.01  E-value=0.00011  Score=73.74  Aligned_cols=80  Identities=13%  Similarity=0.096  Sum_probs=58.2

Q ss_pred             CCCccccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhcCC---CceeccceeEEeC---CeeEEE
Q 008292          346 KFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH---RNLVRLLGFCLEG---EEKILV  419 (571)
Q Consensus       346 ~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h---~niv~l~~~~~~~---~~~~lv  419 (571)
                      +....+.||.|..+.||+....++ .+.+|..+..  .....+..|.+.|+.+..   -.+.++++++..+   +..+||
T Consensus        15 ~~~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV   91 (297)
T PRK10593         15 KLSRVECISEQPYAALWALYDSQG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL   91 (297)
T ss_pred             hhheeeecCCccceeEEEEEcCCC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence            445567899999999999887555 4666764331  133578899999988853   3577788777543   568999


Q ss_pred             EEecCCCCh
Q 008292          420 YEFVPNKSL  428 (571)
Q Consensus       420 ~e~~~~g~L  428 (571)
                      ||+++++++
T Consensus        92 mE~i~G~~~  100 (297)
T PRK10593         92 LERLRGVSV  100 (297)
T ss_pred             EeccCCEec
Confidence            999998765

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.95  E-value=7.5e-05  Score=72.34  Aligned_cols=73  Identities=19%  Similarity=0.279  Sum_probs=45.1

Q ss_pred             ccccccCce-eEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCC---ceeccceeEEeC---CeeEEEEEec
Q 008292          351 NKLGEGGFG-EVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHR---NLVRLLGFCLEG---EEKILVYEFV  423 (571)
Q Consensus       351 ~~LG~G~fg-~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~---niv~l~~~~~~~---~~~~lv~e~~  423 (571)
                      +.|+.|+.. .||+.    +..+++|..+..  .....+.+|.+++..+...   -+.+.++.....   ...+++|+++
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i   76 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL   76 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence            457777765 58874    235677765432  2345788999999877532   233334333221   1347899999


Q ss_pred             CCCChh
Q 008292          424 PNKSLD  429 (571)
Q Consensus       424 ~~g~L~  429 (571)
                      +|.++.
T Consensus        77 ~G~~l~   82 (235)
T cd05155          77 EGETAT   82 (235)
T ss_pred             cCCCCC
Confidence            997764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.93  E-value=0.00014  Score=75.12  Aligned_cols=76  Identities=13%  Similarity=0.182  Sum_probs=54.4

Q ss_pred             cccccccCceeEEEEEccCC-CeeEEEeeccc-------CccCHHHHHHHHHHHhhcC---CCceeccceeEEeCCeeEE
Q 008292          350 DNKLGEGGFGEVYKGVLPSG-QEIAVKRLSKA-------SGQGAEEFKNEVVLVAKLQ---HRNLVRLLGFCLEGEEKIL  418 (571)
Q Consensus       350 ~~~LG~G~fg~Vy~~~~~~g-~~vavK~~~~~-------~~~~~~~~~~Ei~~l~~l~---h~niv~l~~~~~~~~~~~l  418 (571)
                      .+.||.|.+..||++...+| +.|+||.-...       .+...+++..|.+.|..+.   ..++.+++.+  +.+..++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            35789999999999998777 48999974321       1234567777888887753   2456666666  4456789


Q ss_pred             EEEecCCCC
Q 008292          419 VYEFVPNKS  427 (571)
Q Consensus       419 v~e~~~~g~  427 (571)
                      ||||+++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999998743

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.86  E-value=8.1e-05  Score=73.08  Aligned_cols=139  Identities=15%  Similarity=0.081  Sum_probs=80.1

Q ss_pred             cccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCcee-ccceeEEeCCeeEEEEEecCCCChhh
Q 008292          352 KLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLV-RLLGFCLEGEEKILVYEFVPNKSLDY  430 (571)
Q Consensus       352 ~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~g~L~~  430 (571)
                      .+..|-...+|+... ++..+++|..............+|..+++.+....+. ++++..    ..++|+||++|..+..
T Consensus         3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~----~~~~v~e~i~G~~~~~   77 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN----EHWLLVEWLEGEVITL   77 (256)
T ss_pred             cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe----CCEEEEEeccCccccc
Confidence            355677788998874 5678888876543322212357788888888654443 333332    2368999999876642


Q ss_pred             h-----------------hcCCC-CCCCCCHHH-HHHHHHH---------HHHHHHHHHcC-----CCCCeEEecCCCCC
Q 008292          431 F-----------------LYDPE-KQGQLDWSR-RYKIIGG---------IARGILYLHED-----SRLRIIHRDLKASN  477 (571)
Q Consensus       431 ~-----------------l~~~~-~~~~l~~~~-~~~i~~~---------ia~~L~yLH~~-----~~~~ivH~Dlkp~N  477 (571)
                      -                 +|... ....++... +..+..+         +.+.+..+-..     ....++|+|+.|.|
T Consensus        78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N  157 (256)
T TIGR02721        78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN  157 (256)
T ss_pred             ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence            1                 11111 111122221 1111111         11112222111     12358999999999


Q ss_pred             EEECCCCceEEeeccCccc
Q 008292          478 ILLDAEMNPKISDFGMARI  496 (571)
Q Consensus       478 Ill~~~~~~kl~DfGla~~  496 (571)
                      |++++++ +.|+||..+..
T Consensus       158 il~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       158 LVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             EEEeCCC-CEEEeccccCc
Confidence            9999877 79999998864

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.85  E-value=0.00012  Score=70.73  Aligned_cols=140  Identities=20%  Similarity=0.266  Sum_probs=81.8

Q ss_pred             ccccccCceeEEEEEccC--CCeeEEEeecccCccCHHHHHHHHHHHhhcCCCcee-ccceeEEeCCeeEEEEEecCCCC
Q 008292          351 NKLGEGGFGEVYKGVLPS--GQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLV-RLLGFCLEGEEKILVYEFVPNKS  427 (571)
Q Consensus       351 ~~LG~G~fg~Vy~~~~~~--g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~g~  427 (571)
                      +.|..|-...+|+....+  +..|++|+....... ..+..+|+.++..+...+++ ++++...    ..++|||++|.+
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~   78 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT   78 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence            567778888999998764  678889977643222 12335788888888544443 3333322    248999999877


Q ss_pred             hhhh-----------------hcCCCCC--------CCC-CHHHHHHHHH----------------------HHHHHHHH
Q 008292          428 LDYF-----------------LYDPEKQ--------GQL-DWSRRYKIIG----------------------GIARGILY  459 (571)
Q Consensus       428 L~~~-----------------l~~~~~~--------~~l-~~~~~~~i~~----------------------~ia~~L~y  459 (571)
                      +...                 +|.....        ... .+..+..+..                      .+.+-+..
T Consensus        79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  158 (235)
T cd05157          79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW  158 (235)
T ss_pred             CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence            6321                 0111110        111 1222222211                      11111112


Q ss_pred             H----HcC-CCCCeEEecCCCCCEEECC-CCceEEeeccCcc
Q 008292          460 L----HED-SRLRIIHRDLKASNILLDA-EMNPKISDFGMAR  495 (571)
Q Consensus       460 L----H~~-~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGla~  495 (571)
                      |    ... ....++|+|+.+.|||+++ ++.+.|+||..+.
T Consensus       159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~  200 (235)
T cd05157         159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG  200 (235)
T ss_pred             HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence            2    111 2345999999999999998 5789999998875

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.84  E-value=0.00012  Score=65.53  Aligned_cols=129  Identities=19%  Similarity=0.278  Sum_probs=86.7

Q ss_pred             CccccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceec-cceeEEeCCeeEEEEEecCCC
Q 008292          348 STDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVR-LLGFCLEGEEKILVYEFVPNK  426 (571)
Q Consensus       348 ~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~-l~~~~~~~~~~~lv~e~~~~g  426 (571)
                      ...+.|++|++|.||+|.+. |..+|+|+-+.++  ....++.|.++|..++-.++.+ ++.+    ++..+.|||+.|-
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~y----g~~~i~me~i~G~   97 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFY----GEDFIRMEYIDGR   97 (201)
T ss_pred             hhhhhhhcccccEEEEeecc-CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEe----chhhhhhhhhcCc
Confidence            45678999999999999994 5588888766543  4577889999999888766544 3333    2334559999998


Q ss_pred             ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCC-CCCEEECCCCceEEeeccCccc
Q 008292          427 SLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLK-ASNILLDAEMNPKISDFGMARI  496 (571)
Q Consensus       427 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk-p~NIll~~~~~~kl~DfGla~~  496 (571)
                      .|.+.-..      .+.+++..++    +.---|-..+   |-|+.|. |...+|-.++.+.|+||..|..
T Consensus        98 ~L~~~~~~------~~rk~l~~vl----E~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          98 PLGKLEIG------GDRKHLLRVL----EKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             chhhhhhc------ccHHHHHHHH----HHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            88765521      1334444433    3323343334   8888886 4444444555899999999874

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.64  E-value=0.0004  Score=64.37  Aligned_cols=125  Identities=28%  Similarity=0.418  Sum_probs=88.2

Q ss_pred             CCCCccccccccCc-eeEEEEEccCCCeeEEEeecc---cCc------------------cCHHHHHHHHHHHhhcC---
Q 008292          345 NKFSTDNKLGEGGF-GEVYKGVLPSGQEIAVKRLSK---ASG------------------QGAEEFKNEVVLVAKLQ---  399 (571)
Q Consensus       345 ~~~~~~~~LG~G~f-g~Vy~~~~~~g~~vavK~~~~---~~~------------------~~~~~~~~Ei~~l~~l~---  399 (571)
                      .+++..+.||.|.- |.||++++ +|+.+|+|.++.   ...                  .....|..|.+...+++   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            56778899999999 99999999 688999999421   100                  11235778888777664   


Q ss_pred             CCce--eccceeEEeCC------------------eeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 008292          400 HRNL--VRLLGFCLEGE------------------EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY  459 (571)
Q Consensus       400 h~ni--v~l~~~~~~~~------------------~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~y  459 (571)
                      +.++  |+.+||..-..                  ...||.||++...            .+    ..+-+.+|.+-|..
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~----~~~~~~~~~~dl~~  179 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PL----QIRDIPQMLRDLKI  179 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------cc----chhHHHHHHHHHHH
Confidence            4566  89999874321                  1246777775432            11    22345667777888


Q ss_pred             HHcCCCCCeEEecCCCCCEEECCCCceEEeeccCc
Q 008292          460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA  494 (571)
Q Consensus       460 LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla  494 (571)
                      +|..+   |+-+|+++.|..     .-||+|||.+
T Consensus       180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence            99887   999999999986     3489999864

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.63  E-value=0.00033  Score=70.30  Aligned_cols=143  Identities=20%  Similarity=0.177  Sum_probs=85.8

Q ss_pred             cccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCc--eecccee------EEeCCeeEEEEE
Q 008292          350 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRN--LVRLLGF------CLEGEEKILVYE  421 (571)
Q Consensus       350 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n--iv~l~~~------~~~~~~~~lv~e  421 (571)
                      .+.|..|....+|+.... +..+++|+...   ...+.+..|+.++..+.+.+  +.+++..      ....+..+++++
T Consensus        19 i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          19 FEGISAGIENTNYFVTTD-SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             eecccCccccceEEEEeC-CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            456777877899998764 44788888764   23456777888888875433  3444331      122345689999


Q ss_pred             ecCCCChhh----hh----------cCCC---CC-----CCCCHHHHH----------HHHHHHHHHHHHHHc----CCC
Q 008292          422 FVPNKSLDY----FL----------YDPE---KQ-----GQLDWSRRY----------KIIGGIARGILYLHE----DSR  465 (571)
Q Consensus       422 ~~~~g~L~~----~l----------~~~~---~~-----~~l~~~~~~----------~i~~~ia~~L~yLH~----~~~  465 (571)
                      |++|..+..    ..          |...   ..     ....|....          .....+...+.++..    ...
T Consensus        95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~  174 (296)
T cd05153          95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP  174 (296)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence            999877532    00          1000   00     111221110          011123334445443    123


Q ss_pred             CCeEEecCCCCCEEECCCCceEEeeccCccc
Q 008292          466 LRIIHRDLKASNILLDAEMNPKISDFGMARI  496 (571)
Q Consensus       466 ~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  496 (571)
                      ..++|+|+.|.||++++++.+.|.||+.+..
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            4599999999999999987778999998753

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.40  E-value=0.0012  Score=65.90  Aligned_cols=143  Identities=19%  Similarity=0.220  Sum_probs=96.1

Q ss_pred             CccccccccCceeEEEEEccCCCeeEEEeecccC----------------------ccCHHH----HHHHHHHHhhcCCC
Q 008292          348 STDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKAS----------------------GQGAEE----FKNEVVLVAKLQHR  401 (571)
Q Consensus       348 ~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~----------------------~~~~~~----~~~Ei~~l~~l~h~  401 (571)
                      .+...|..|.-..||.+.-.+|..+|||+++..-                      ...++.    ...|++-|.+++..
T Consensus       147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a  226 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA  226 (520)
T ss_pred             ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence            3446788899999999999999999999875310                      000111    23456666666544


Q ss_pred             ceeccceeEEeCCeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEEC
Q 008292          402 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD  481 (571)
Q Consensus       402 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~  481 (571)
                      .|.-.--...  ...+|||+|+....-   -....+...++...+..+-.|++.-|.-|-+..  ++||.||.--|+|+.
T Consensus       227 GIP~PePIlL--k~hVLVM~FlGrdgw---~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh  299 (520)
T KOG2270|consen  227 GIPCPEPILL--KNHVLVMEFLGRDGW---AAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH  299 (520)
T ss_pred             CCCCCCceee--ecceEeeeeccCCCC---cCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE
Confidence            3321111111  234799999964322   212234556777788888899999999997766  699999999999984


Q ss_pred             CCCceEEeeccCccccC
Q 008292          482 AEMNPKISDFGMARIFG  498 (571)
Q Consensus       482 ~~~~~kl~DfGla~~~~  498 (571)
                       +|.+.|+|.+-+....
T Consensus       300 -dG~lyiIDVSQSVE~D  315 (520)
T KOG2270|consen  300 -DGKLYIIDVSQSVEHD  315 (520)
T ss_pred             -CCEEEEEEccccccCC
Confidence             5689999998876543

>PRK05231 homoserine kinase; Provisional

Probab=97.34  E-value=0.0028  Score=64.34  Aligned_cols=142  Identities=17%  Similarity=0.191  Sum_probs=77.9

Q ss_pred             cccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCc--eeccce------eEEeCCeeEEEEE
Q 008292          350 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRN--LVRLLG------FCLEGEEKILVYE  421 (571)
Q Consensus       350 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n--iv~l~~------~~~~~~~~~lv~e  421 (571)
                      .+.|+.|...++|+....+| .+++|+...   ...+.+..|+.++..+...+  +.+.+.      +....+..++++|
T Consensus        27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~  102 (319)
T PRK05231         27 LKGIAEGIENSNFFLTTTQG-EYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT  102 (319)
T ss_pred             cchhccccccceEEEEeCCC-cEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence            45677787789999887555 688888752   22344445556665553222  223332      1123456789999


Q ss_pred             ecCCCChhh-----h---------hcCCCC--------CCCCCH-HHHHH------------HHHH-HHHHHHHHHcC--
Q 008292          422 FVPNKSLDY-----F---------LYDPEK--------QGQLDW-SRRYK------------IIGG-IARGILYLHED--  463 (571)
Q Consensus       422 ~~~~g~L~~-----~---------l~~~~~--------~~~l~~-~~~~~------------i~~~-ia~~L~yLH~~--  463 (571)
                      |++|..+..     .         +|....        ...+.| .....            .+.+ +...+..+...  
T Consensus       103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  182 (319)
T PRK05231        103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW  182 (319)
T ss_pred             ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence            999875421     1         111000        001112 11111            1111 11122333211  


Q ss_pred             --CCCCeEEecCCCCCEEECCCCceEEeeccCcc
Q 008292          464 --SRLRIIHRDLKASNILLDAEMNPKISDFGMAR  495 (571)
Q Consensus       464 --~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  495 (571)
                        -+..++|+|+.|.||+++++...-|+||+.+.
T Consensus       183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             ccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence              23469999999999999876556899999885

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.26  E-value=0.0026  Score=64.02  Aligned_cols=141  Identities=26%  Similarity=0.316  Sum_probs=83.8

Q ss_pred             ccccccCceeEEEEEccC-------CCeeEEEeecccCccCHHHHHHHHHHHhhcCCCcee-ccceeEEeCCeeEEEEEe
Q 008292          351 NKLGEGGFGEVYKGVLPS-------GQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLV-RLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       351 ~~LG~G~fg~Vy~~~~~~-------g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~  422 (571)
                      +.|..|-...+|+....+       ++.+++|+...... ...+..+|.+++..+....+. ++++++.    ..+|+||
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e~   78 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEEF   78 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhhe
Confidence            445566667899888654       57888998765432 234557788888887544433 4444443    2468999


Q ss_pred             cCCCChhhh-h----------------cCCCCCC------CC--CHHHHHH--------------------------HHH
Q 008292          423 VPNKSLDYF-L----------------YDPEKQG------QL--DWSRRYK--------------------------IIG  451 (571)
Q Consensus       423 ~~~g~L~~~-l----------------~~~~~~~------~l--~~~~~~~--------------------------i~~  451 (571)
                      ++|..+... +                |......      ..  -+..+..                          +..
T Consensus        79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (302)
T cd05156          79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE  158 (302)
T ss_pred             eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence            998776431 1                1111110      00  0111111                          112


Q ss_pred             HHHHHHHHHHc------CCCCCeEEecCCCCCEEECCC----CceEEeeccCccc
Q 008292          452 GIARGILYLHE------DSRLRIIHRDLKASNILLDAE----MNPKISDFGMARI  496 (571)
Q Consensus       452 ~ia~~L~yLH~------~~~~~ivH~Dlkp~NIll~~~----~~~kl~DfGla~~  496 (571)
                      .+.+-+..|..      .....++|+|+.+.|||++++    +.++|+||..+..
T Consensus       159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~  213 (302)
T cd05156         159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY  213 (302)
T ss_pred             HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence            22233344432      234569999999999999885    8899999998864

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.25  E-value=0.0033  Score=63.47  Aligned_cols=143  Identities=20%  Similarity=0.198  Sum_probs=82.2

Q ss_pred             cccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCc--eecccee------EEeCCeeEEEEE
Q 008292          350 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRN--LVRLLGF------CLEGEEKILVYE  421 (571)
Q Consensus       350 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n--iv~l~~~------~~~~~~~~lv~e  421 (571)
                      .+.++.|....+|+....+| .+++|+.....  ..+++..|++++..+....  +.+++..      ....+..++++|
T Consensus        27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e  103 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE  103 (307)
T ss_pred             ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence            45677777789999876544 57788765421  2345566777777664322  3343331      112345689999


Q ss_pred             ecCCCChhhh--------------hcCCCCC------C---CCCHHHHH------------HHHHHHHHHHHHHHc----
Q 008292          422 FVPNKSLDYF--------------LYDPEKQ------G---QLDWSRRY------------KIIGGIARGILYLHE----  462 (571)
Q Consensus       422 ~~~~g~L~~~--------------l~~~~~~------~---~l~~~~~~------------~i~~~ia~~L~yLH~----  462 (571)
                      |++|..+...              +|.....      .   .-.|....            .....+.+.+++|..    
T Consensus       104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~  183 (307)
T TIGR00938       104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR  183 (307)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence            9998654211              1110000      0   01121110            011123344555532    


Q ss_pred             CCCCCeEEecCCCCCEEECCCCceEEeeccCcc
Q 008292          463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMAR  495 (571)
Q Consensus       463 ~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  495 (571)
                      .....++|+|+++.||++++++...|+||+.+.
T Consensus       184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            223569999999999999988777899999874

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.23  E-value=0.00032  Score=68.75  Aligned_cols=147  Identities=18%  Similarity=0.238  Sum_probs=96.8

Q ss_pred             ccccchHHHHHHhC---CCCccccccccCceeEEEEEccCCCeeEEEeeccc-----------------Ccc-----CHH
Q 008292          332 SLQFDFETIEVATN---KFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKA-----------------SGQ-----GAE  386 (571)
Q Consensus       332 ~~~~~~~~~~~~~~---~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~-----------------~~~-----~~~  386 (571)
                      ...+++--+....+   -+++.++||-|.-+.||.+...+|+..++|.-+..                 ...     .+-
T Consensus        76 y~GyDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRl  155 (465)
T KOG2268|consen   76 YAGYDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRL  155 (465)
T ss_pred             eccchHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHH
Confidence            33445544443332   36778999999999999999999999998843211                 000     011


Q ss_pred             HHHHHHHHHhhcCCC--ceeccceeEEeCCeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC
Q 008292          387 EFKNEVVLVAKLQHR--NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS  464 (571)
Q Consensus       387 ~~~~Ei~~l~~l~h~--niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~  464 (571)
                      ...+|...|+.+...  -|.+.+++    +..++|||++.+-.|...-+      ..+..++.   ..+..-+--|-.++
T Consensus       156 aa~kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly---~~lm~~Iv~la~~G  222 (465)
T KOG2268|consen  156 AATKEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRH------VEDPPTLY---DDLMGLIVRLANHG  222 (465)
T ss_pred             HHHHHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeee------cCChHHHH---HHHHHHHHHHHHcC
Confidence            235677777777532  24444443    45689999999888865431      12333333   33333344565666


Q ss_pred             CCCeEEecCCCCCEEECCCCceEEeeccCc
Q 008292          465 RLRIIHRDLKASNILLDAEMNPKISDFGMA  494 (571)
Q Consensus       465 ~~~ivH~Dlkp~NIll~~~~~~kl~DfGla  494 (571)
                         +||+|..--||++++++.++++||--.
T Consensus       223 ---lIHgDFNEFNimv~dd~~i~vIDFPQm  249 (465)
T KOG2268|consen  223 ---LIHGDFNEFNIMVKDDDKIVVIDFPQM  249 (465)
T ss_pred             ---ceecccchheeEEecCCCEEEeechHh
Confidence               999999999999999999999999754

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.18  E-value=0.004  Score=61.68  Aligned_cols=31  Identities=26%  Similarity=0.538  Sum_probs=26.0

Q ss_pred             CCeEEecCCCCCEEECCCCc-eEEeeccCccc
Q 008292          466 LRIIHRDLKASNILLDAEMN-PKISDFGMARI  496 (571)
Q Consensus       466 ~~ivH~Dlkp~NIll~~~~~-~kl~DfGla~~  496 (571)
                      +.++|+|+++.|||++++++ .-|.||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            45899999999999997555 46999998864

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.08  E-value=0.003  Score=62.70  Aligned_cols=76  Identities=18%  Similarity=0.283  Sum_probs=47.8

Q ss_pred             CCccccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhcC---CCceeccceeEEeCCeeEEEEEec
Q 008292          347 FSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ---HRNLVRLLGFCLEGEEKILVYEFV  423 (571)
Q Consensus       347 ~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~  423 (571)
                      .+..+.|+.|....+|+.. .+++.+.||.-..   .....|..|.+-|+.|.   --.+.+.+++....+..+|++||+
T Consensus        19 i~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l   94 (288)
T PF03881_consen   19 ITSIEPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL   94 (288)
T ss_dssp             --EEEEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred             eeeeEecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence            3455678989999999988 4778899998762   22346777877777773   445778888887777889999999


Q ss_pred             CCC
Q 008292          424 PNK  426 (571)
Q Consensus       424 ~~g  426 (571)
                      +.+
T Consensus        95 ~~~   97 (288)
T PF03881_consen   95 EMG   97 (288)
T ss_dssp             ---
T ss_pred             cCC
Confidence            877

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PLN02236 choline kinase

Probab=96.98  E-value=0.0057  Score=62.71  Aligned_cols=140  Identities=22%  Similarity=0.283  Sum_probs=81.8

Q ss_pred             cccccCceeEEEEEccC-----CCeeEEEeecccCccCHHHHHHHHHHHhhcCCCcee-ccceeEEeCCeeEEEEEecCC
Q 008292          352 KLGEGGFGEVYKGVLPS-----GQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLV-RLLGFCLEGEEKILVYEFVPN  425 (571)
Q Consensus       352 ~LG~G~fg~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~  425 (571)
                      .|-.|-.-.+|+....+     ++.|++|+.....+.... -.+|..++..+...++. ++++.+..+    .|.||+++
T Consensus        43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g  117 (344)
T PLN02236         43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA  117 (344)
T ss_pred             EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence            44446677888887532     367888988665433333 36788888888655443 445554332    58999988


Q ss_pred             CChhhh-----------------hcCCC-CC-C-CCCHHHHHHHHHHH-----------------HHHHHHH----Hc-C
Q 008292          426 KSLDYF-----------------LYDPE-KQ-G-QLDWSRRYKIIGGI-----------------ARGILYL----HE-D  463 (571)
Q Consensus       426 g~L~~~-----------------l~~~~-~~-~-~l~~~~~~~i~~~i-----------------a~~L~yL----H~-~  463 (571)
                      .++...                 +|... .. . ...+.++.++..++                 ...+..|    .. .
T Consensus       118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~  197 (344)
T PLN02236        118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD  197 (344)
T ss_pred             CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence            776421                 11111 00 1 11233333333221                 1112222    21 2


Q ss_pred             CCCCeEEecCCCCCEEECC-CCceEEeeccCccc
Q 008292          464 SRLRIIHRDLKASNILLDA-EMNPKISDFGMARI  496 (571)
Q Consensus       464 ~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGla~~  496 (571)
                      ....++|+|+++.|||+++ ++.+.|+||..+..
T Consensus       198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             CCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            2345899999999999986 46899999998864

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.96  E-value=0.0066  Score=61.65  Aligned_cols=74  Identities=16%  Similarity=0.207  Sum_probs=48.7

Q ss_pred             ccccccCceeEEEEEccCC-CeeEEEeecc-------cCccCHHHHHHHHHHHhhcC--CC-ceeccceeEEeCCeeEEE
Q 008292          351 NKLGEGGFGEVYKGVLPSG-QEIAVKRLSK-------ASGQGAEEFKNEVVLVAKLQ--HR-NLVRLLGFCLEGEEKILV  419 (571)
Q Consensus       351 ~~LG~G~fg~Vy~~~~~~g-~~vavK~~~~-------~~~~~~~~~~~Ei~~l~~l~--h~-niv~l~~~~~~~~~~~lv  419 (571)
                      +.||.|....||++..++| +.|+||.-..       ..+-..++..-|.+.|....  -| .+.+++.+  +.+...+|
T Consensus         1 ~EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~v   78 (370)
T TIGR01767         1 QEVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTV   78 (370)
T ss_pred             CcCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceeh
Confidence            3589999999999998655 5799995421       22444556666777776543  24 34444433  55667799


Q ss_pred             EEecCCC
Q 008292          420 YEFVPNK  426 (571)
Q Consensus       420 ~e~~~~g  426 (571)
                      ||+++..
T Consensus        79 MEdL~~~   85 (370)
T TIGR01767        79 MEDLSHH   85 (370)
T ss_pred             HhhCccc
Confidence            9999653

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.92  E-value=0.011  Score=59.26  Aligned_cols=138  Identities=22%  Similarity=0.334  Sum_probs=76.8

Q ss_pred             eeEEEEEccCCCeeEEEeec-ccCccCHHHHHHHHHHHhhcCC--CceeccceeEEeCC--eeEEEEEecCCCChhhhhc
Q 008292          359 GEVYKGVLPSGQEIAVKRLS-KASGQGAEEFKNEVVLVAKLQH--RNLVRLLGFCLEGE--EKILVYEFVPNKSLDYFLY  433 (571)
Q Consensus       359 g~Vy~~~~~~g~~vavK~~~-~~~~~~~~~~~~Ei~~l~~l~h--~niv~l~~~~~~~~--~~~lv~e~~~~g~L~~~l~  433 (571)
                      -.+|..... ++++++++-. ...........+|..+++.+.-  .-+.+.++.|.++.  ..+.||+|++|..+...+.
T Consensus        39 n~t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~  117 (321)
T COG3173          39 NDTFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALP  117 (321)
T ss_pred             cceEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCC
Confidence            334444432 7778887221 1222334556778888877643  23445566776665  6699999998843322110


Q ss_pred             CCC----------------------------------CCCCC-CHHHHHHH--------HHHHHHHHHHHHcC-----CC
Q 008292          434 DPE----------------------------------KQGQL-DWSRRYKI--------IGGIARGILYLHED-----SR  465 (571)
Q Consensus       434 ~~~----------------------------------~~~~l-~~~~~~~i--------~~~ia~~L~yLH~~-----~~  465 (571)
                      ...                                  ...++ .|...++.        +-....-..+|+.+     +.
T Consensus       118 ~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~  197 (321)
T COG3173         118 PESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGP  197 (321)
T ss_pred             cccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCC
Confidence            000                                  00000 11111100        01112223444332     33


Q ss_pred             CCeEEecCCCCCEEECCCCceEEeeccCcccc
Q 008292          466 LRIIHRDLKASNILLDAEMNPKISDFGMARIF  497 (571)
Q Consensus       466 ~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  497 (571)
                      +.++|+|+.+.||++++++-+-|.||+++..-
T Consensus       198 ~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         198 PVLVHGDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             ceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence            56999999999999999988999999998753

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=96.92  E-value=0.0026  Score=72.14  Aligned_cols=155  Identities=22%  Similarity=0.220  Sum_probs=112.1

Q ss_pred             HHHHHHHHHhhcCCCceeccceeEEeCCeeE----EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHc
Q 008292          387 EFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI----LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE  462 (571)
Q Consensus       387 ~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~----lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~  462 (571)
                      ....|+..+.++.|+|++.++++-.+....-    +..|++..-++...++   ....++....+.+..++.+||.|+|+
T Consensus       228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q---~v~~i~~~~~r~~~~~~~~GL~~~h~  304 (1351)
T KOG1035|consen  228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ---SVGSIPLETLRILHQKLLEGLAYLHS  304 (1351)
T ss_pred             HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh---hccccCHHHHHHHHHHHhhhHHHHHH
Confidence            3445777888899999999999887654332    4456777777776663   44567888899999999999999998


Q ss_pred             CCCCCeEEecCCCC---CEEECCCCceEEe--eccCccccCCCCCccccccccccCCcccccccccCCCCc--chhHHHH
Q 008292          463 DSRLRIIHRDLKAS---NILLDAEMNPKIS--DFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSV--KSDVYSF  535 (571)
Q Consensus       463 ~~~~~ivH~Dlkp~---NIll~~~~~~kl~--DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~--~~Dv~sl  535 (571)
                      ..   ..|.-|..+   +.-.+.++.+.++  ||+.++.+......   ....-+..|.+||.........  ..|+|.+
T Consensus       305 ~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~l  378 (1351)
T KOG1035|consen  305 LS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWCL  378 (1351)
T ss_pred             hc---cceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHHH
Confidence            75   666656555   5556677777777  99888765432211   1123355688888876665544  4799999


Q ss_pred             HHHHHHHHhCCCCCC
Q 008292          536 GVLVLEIITGKKNSN  550 (571)
Q Consensus       536 Gvvl~elltG~~p~~  550 (571)
                      |..+..+..|..+..
T Consensus       379 gll~~~~~~~~~i~~  393 (1351)
T KOG1035|consen  379 GLLLLQLSQGEDISE  393 (1351)
T ss_pred             HHHHhhhhhcCcccc
Confidence            999999999988754

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.73  E-value=0.021  Score=59.09  Aligned_cols=74  Identities=12%  Similarity=0.131  Sum_probs=49.5

Q ss_pred             ccccccccCceeEEEEEccCCCeeEEEeecc----cC---ccCHHHHHHHHHHHhhcC---CCceeccceeEEeCCeeEE
Q 008292          349 TDNKLGEGGFGEVYKGVLPSGQEIAVKRLSK----AS---GQGAEEFKNEVVLVAKLQ---HRNLVRLLGFCLEGEEKIL  418 (571)
Q Consensus       349 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~----~~---~~~~~~~~~Ei~~l~~l~---h~niv~l~~~~~~~~~~~l  418 (571)
                      ..+.||.|....||+...+ +..++||+-..    ..   +...++-..|...|+.+.   ..++.+++.++.  +..++
T Consensus        36 ~~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vl  112 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALI  112 (418)
T ss_pred             eEEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEE
Confidence            3567899999999998874 55688987541    11   123344445566665543   346777887765  55788


Q ss_pred             EEEecCC
Q 008292          419 VYEFVPN  425 (571)
Q Consensus       419 v~e~~~~  425 (571)
                      +||++++
T Consensus       113 vME~L~~  119 (418)
T PLN02756        113 GMRYLEP  119 (418)
T ss_pred             EEeecCC
Confidence            9999977

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.38  E-value=0.042  Score=55.63  Aligned_cols=140  Identities=21%  Similarity=0.296  Sum_probs=82.7

Q ss_pred             cccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCc------eeccceeE----EeCCeeEEEEE
Q 008292          352 KLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRN------LVRLLGFC----LEGEEKILVYE  421 (571)
Q Consensus       352 ~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n------iv~l~~~~----~~~~~~~lv~e  421 (571)
                      .|.+ .-..+|+....+|+. ++|+....  ....++..|+..+..+.-..      |..+-|-.    ..+....-+++
T Consensus        33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~  108 (331)
T COG2334          33 GLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE  108 (331)
T ss_pred             cccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence            3444 456789888877766 88887665  45667778888888774222      22222211    11236678999


Q ss_pred             ecCCCChhh-hh--------------c----C-----CCCCCCCCHHH-------------HHHHHHHHHHHHHHHHcC-
Q 008292          422 FVPNKSLDY-FL--------------Y----D-----PEKQGQLDWSR-------------RYKIIGGIARGILYLHED-  463 (571)
Q Consensus       422 ~~~~g~L~~-~l--------------~----~-----~~~~~~l~~~~-------------~~~i~~~ia~~L~yLH~~-  463 (571)
                      |++|..+.. ..              +    +     +.......|..             ......++...+..+.+. 
T Consensus       109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~  188 (331)
T COG2334         109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL  188 (331)
T ss_pred             ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence            999988873 10              0    0     00011223320             011223344444444432 


Q ss_pred             ---CC---CCeEEecCCCCCEEECCCCc-eEEeeccCcc
Q 008292          464 ---SR---LRIIHRDLKASNILLDAEMN-PKISDFGMAR  495 (571)
Q Consensus       464 ---~~---~~ivH~Dlkp~NIll~~~~~-~kl~DfGla~  495 (571)
                         -.   ..+||+|+.|.||+++++.. +.+.||+.+.
T Consensus       189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             hhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence               11   22899999999999999885 8999999875

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.36  E-value=0.037  Score=55.84  Aligned_cols=29  Identities=28%  Similarity=0.347  Sum_probs=25.5

Q ss_pred             CCeEEecCCCCCEEECCCCceEEeeccCcc
Q 008292          466 LRIIHRDLKASNILLDAEMNPKISDFGMAR  495 (571)
Q Consensus       466 ~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  495 (571)
                      ..++|+|+.+.||+++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            46999999999999987 678999999764

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.31  E-value=0.014  Score=60.14  Aligned_cols=74  Identities=12%  Similarity=0.144  Sum_probs=50.3

Q ss_pred             cccccccCceeEEEEEccC-CCeeEEEeec------ccCccCHHHHHHHHHHHhhcC--CC-ceeccceeEEeCCeeEEE
Q 008292          350 DNKLGEGGFGEVYKGVLPS-GQEIAVKRLS------KASGQGAEEFKNEVVLVAKLQ--HR-NLVRLLGFCLEGEEKILV  419 (571)
Q Consensus       350 ~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~------~~~~~~~~~~~~Ei~~l~~l~--h~-niv~l~~~~~~~~~~~lv  419 (571)
                      .+.||.|.-.-||++..++ ++.|+||.-.      ...+-..++..-|.+.|+...  -| .+.+++.+  +.+...+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            4678999999999999743 5679998542      122445667777777777653  24 34445543  55566789


Q ss_pred             EEecCC
Q 008292          420 YEFVPN  425 (571)
Q Consensus       420 ~e~~~~  425 (571)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            999864

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.31  E-value=0.00072  Score=78.10  Aligned_cols=159  Identities=12%  Similarity=-0.066  Sum_probs=108.1

Q ss_pred             HHHHHHHhhcCCCceeccceeEEe--CCeeEEEEEecCCCChhhhhcCCCC-CCCCCHHHHHHHHHHHHHHHHHHHcC--
Q 008292          389 KNEVVLVAKLQHRNLVRLLGFCLE--GEEKILVYEFVPNKSLDYFLYDPEK-QGQLDWSRRYKIIGGIARGILYLHED--  463 (571)
Q Consensus       389 ~~Ei~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~--  463 (571)
                      ..|...+++..|+++.....-...  ..+.+.+++|+..|.+...+-+..+ ...++..-......+......-.|..  
T Consensus      1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred             hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence            345555666789887765543332  3456889999999999887754322 22333333332333323333443332  


Q ss_pred             CCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHH
Q 008292          464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEII  543 (571)
Q Consensus       464 ~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ell  543 (571)
                      ...-.+|++||+-|.+|..+.++|++++|+.+...+..  .......+++-|+.|+....-.++.++|+|..|+.+|++-
T Consensus      1357 lg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~--sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVL--SFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred             CCccchhhhhhhhccceecCCcccccccccccccCchH--hhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence            22347999999999999999999999999998432221  2223346778899999888889999999999999999988


Q ss_pred             hCCCCC
Q 008292          544 TGKKNS  549 (571)
Q Consensus       544 tG~~p~  549 (571)
                      -|..++
T Consensus      1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred             cccHHH
Confidence            887664

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.17  E-value=0.033  Score=56.78  Aligned_cols=141  Identities=17%  Similarity=0.267  Sum_probs=79.7

Q ss_pred             ccccccCceeEEEEEccC----CCeeEEEeecccCccCHHHHHHHHHHHhhcCCCcee-ccceeEEeCCeeEEEEEecCC
Q 008292          351 NKLGEGGFGEVYKGVLPS----GQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLV-RLLGFCLEGEEKILVYEFVPN  425 (571)
Q Consensus       351 ~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~  425 (571)
                      +.|..|=.-.+|+....+    +..|++|+.....+. .-+-.+|..+++.+...++- ++++++..+    +|.+|+++
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g   94 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINA   94 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcC
Confidence            344446667788876533    237888887654432 22336788888888665553 455554222    58999987


Q ss_pred             CChhh--h---------------hcCCC-C-CC-CCCHHHHHHHHHHHH----------------------HHHH----H
Q 008292          426 KSLDY--F---------------LYDPE-K-QG-QLDWSRRYKIIGGIA----------------------RGIL----Y  459 (571)
Q Consensus       426 g~L~~--~---------------l~~~~-~-~~-~l~~~~~~~i~~~ia----------------------~~L~----y  459 (571)
                      ..|..  +               +|... . .. .--|..+.++..++.                      +-+.    .
T Consensus        95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~  174 (330)
T PLN02421         95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI  174 (330)
T ss_pred             CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence            66532  1               11111 0 11 112333333322221                      1111    1


Q ss_pred             HHc-CCCCCeEEecCCCCCEEECC-CCceEEeeccCccc
Q 008292          460 LHE-DSRLRIIHRDLKASNILLDA-EMNPKISDFGMARI  496 (571)
Q Consensus       460 LH~-~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGla~~  496 (571)
                      +.. ..+.-++|.|+.+.|||+++ ++.++++||..|..
T Consensus       175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            111 12234899999999999974 57899999998864

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.14  E-value=0.1  Score=53.14  Aligned_cols=72  Identities=13%  Similarity=0.096  Sum_probs=46.0

Q ss_pred             cCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCc--eeccc---e--eEEeCCeeEEEEEecCCCCh
Q 008292          356 GGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRN--LVRLL---G--FCLEGEEKILVYEFVPNKSL  428 (571)
Q Consensus       356 G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n--iv~l~---~--~~~~~~~~~lv~e~~~~g~L  428 (571)
                      +.-..||+....++..+++|+.+.. .....++..|++.+..+....  ++..+   |  ....++..+.++++++|...
T Consensus        36 s~eN~vy~v~~~~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~  114 (325)
T PRK11768         36 SYENRVYQFGDEDGRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRAP  114 (325)
T ss_pred             cccceEEEEecCCCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence            3346799988878888999987533 235667778888887764321  22212   2  12234567789999988653

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=95.94  E-value=0.012  Score=55.94  Aligned_cols=123  Identities=21%  Similarity=0.260  Sum_probs=60.4

Q ss_pred             CCeeEEEeecccCccCHHHHHHHHHHHhhcCCCce-eccceeEEeCCeeEEEEEecCCCChhhh-hc-------------
Q 008292          369 GQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNL-VRLLGFCLEGEEKILVYEFVPNKSLDYF-LY-------------  433 (571)
Q Consensus       369 g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~-------------  433 (571)
                      ++.|+||+..... .....-.+|..+++.+...++ .++++.+..    .+|.||+++..|..- +.             
T Consensus         2 ~~~~~~Ri~g~~t-~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~----g~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~   76 (211)
T PF01633_consen    2 PEKYLVRIPGEGT-ENFIDRENENEALKLLSEAGLGPKIIYFFEN----GRVEEFIEGRTLSPEDFRNPEILKRIAKLLA   76 (211)
T ss_dssp             TSEEEEEEEESCG-CSHHHHHHHHHHHHHHHHTTSSS-EEEEETT----EEEEE--SSEE--CGGGGSHHHHHHHHHHHH
T ss_pred             CCEEEEEeCCCCc-ccccCHHHHHHHHHHHHHcCCCCeEEEEcCC----CcEEEEecccccChhhccChHHHHHHHHHHH
Confidence            4678888876653 334555788888888865444 445554422    357799977665321 11             


Q ss_pred             ---CC----CCCCCCCHHHHHHH----------------------HHHHHHHHHHHH----c-CCCCCeEEecCCCCCEE
Q 008292          434 ---DP----EKQGQLDWSRRYKI----------------------IGGIARGILYLH----E-DSRLRIIHRDLKASNIL  479 (571)
Q Consensus       434 ---~~----~~~~~l~~~~~~~i----------------------~~~ia~~L~yLH----~-~~~~~ivH~Dlkp~NIl  479 (571)
                         ..    .....--|..+..+                      +..+.+-+..+.    . .....+.|.|+.+.|||
T Consensus        77 ~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil  156 (211)
T PF01633_consen   77 KLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNIL  156 (211)
T ss_dssp             HHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEE
T ss_pred             HHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEE
Confidence               00    01111112222222                      011112222221    1 11234899999999999


Q ss_pred             E-CCCCceEEeeccCccc
Q 008292          480 L-DAEMNPKISDFGMARI  496 (571)
Q Consensus       480 l-~~~~~~kl~DfGla~~  496 (571)
                      + +.++.++|+||..+..
T Consensus       157 ~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  157 INNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             ETSSSSCEEE--GTT-EE
T ss_pred             eccCCCeEEEecHHHHhh
Confidence            9 8889999999988753

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.82  E-value=0.06  Score=54.12  Aligned_cols=70  Identities=20%  Similarity=0.212  Sum_probs=54.6

Q ss_pred             eEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCcc
Q 008292          416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR  495 (571)
Q Consensus       416 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  495 (571)
                      .+++|++. |+++..       .....+++.+.|+.+.+..+.-|..+-  ++-|||+.-.||||+ +|++-|+||-++|
T Consensus       301 ~yl~~kdh-gt~is~-------ik~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfklsR  369 (488)
T COG5072         301 LYLHFKDH-GTPISI-------IKADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKLSR  369 (488)
T ss_pred             EEEEEecC-Cceeee-------eecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeeeee
Confidence            35666654 444422       123478899999999888888887654  799999999999999 9999999999998


Q ss_pred             c
Q 008292          496 I  496 (571)
Q Consensus       496 ~  496 (571)
                      .
T Consensus       370 l  370 (488)
T COG5072         370 L  370 (488)
T ss_pred             c
Confidence            4

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=95.77  E-value=0.094  Score=52.94  Aligned_cols=32  Identities=25%  Similarity=0.346  Sum_probs=28.3

Q ss_pred             CCCeEEecCCCCCEEECCCCceEEeeccCccc
Q 008292          465 RLRIIHRDLKASNILLDAEMNPKISDFGMARI  496 (571)
Q Consensus       465 ~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  496 (571)
                      +..++|+|+.+.|||+++++.+.|+||..+..
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            34699999999999999999999999988753

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PRK06148 hypothetical protein; Provisional

Probab=95.73  E-value=0.1  Score=61.34  Aligned_cols=141  Identities=21%  Similarity=0.288  Sum_probs=77.5

Q ss_pred             ccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhc-------CCCceeccc-eeE----E--eCC-e
Q 008292          351 NKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKL-------QHRNLVRLL-GFC----L--EGE-E  415 (571)
Q Consensus       351 ~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-------~h~niv~l~-~~~----~--~~~-~  415 (571)
                      +.|+ |..-.+|+.+..+|..+++|+.+...  .......|...|..+       .-|.+++-. |-.    .  ++. .
T Consensus        31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~--~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~  107 (1013)
T PRK06148         31 TPLD-GERDLNFRLTTDDGADYILKIVNPSE--PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR  107 (1013)
T ss_pred             eecC-CcCCceEEEEeCCCCeEEEEEcCCcc--chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence            3453 34577888887788899999987643  223444455555444       223333322 111    1  111 3


Q ss_pred             eEEEEEecCCCChhhhhc---------------------C---CCCCCCCCHHH-----------------HHHHHHHHH
Q 008292          416 KILVYEFVPNKSLDYFLY---------------------D---PEKQGQLDWSR-----------------RYKIIGGIA  454 (571)
Q Consensus       416 ~~lv~e~~~~g~L~~~l~---------------------~---~~~~~~l~~~~-----------------~~~i~~~ia  454 (571)
                      .+-+++|++|..+.+...                     +   ......+.|..                 ...++.++.
T Consensus       108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~  187 (1013)
T PRK06148        108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL  187 (1013)
T ss_pred             EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence            567899999987755110                     0   00111122211                 112222333


Q ss_pred             HHHH-----HHHcCCCCCeEEecCCCCCEEECCCC--ceE-EeeccCcc
Q 008292          455 RGIL-----YLHEDSRLRIIHRDLKASNILLDAEM--NPK-ISDFGMAR  495 (571)
Q Consensus       455 ~~L~-----yLH~~~~~~ivH~Dlkp~NIll~~~~--~~k-l~DfGla~  495 (571)
                      +...     .|.+ -+..+||+|+.+.|||++.++  ++. |+|||.+.
T Consensus       188 ~~~~~~v~p~l~~-Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~  235 (1013)
T PRK06148        188 ARFERNVAPRLAA-LPAQVIHNDANDYNILVDADDGERISGLIDFGDAV  235 (1013)
T ss_pred             HHHHHHHHHHHhc-CCcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence            3222     1222 234599999999999999875  555 99999875

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.44  E-value=0.15  Score=48.09  Aligned_cols=76  Identities=17%  Similarity=0.254  Sum_probs=50.7

Q ss_pred             cccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhc---CCCceeccceeEEeCCeeEEEEEecCCC
Q 008292          350 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKL---QHRNLVRLLGFCLEGEEKILVYEFVPNK  426 (571)
Q Consensus       350 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~g  426 (571)
                      .+++.-|.--..|.... ...++.||+-..   .....|..|+.-|..+   +--.|.+.+.+-.+....++|+||++-+
T Consensus        21 r~~v~gG~inea~~v~d-g~~~~FvK~n~~---~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~   96 (286)
T COG3001          21 REEVSGGDINEAWRLRD-GTDPFFVKCNQR---EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTG   96 (286)
T ss_pred             ccccCCccccceeEeec-CCcceEEEecch---hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCC
Confidence            34555555555555444 456788886432   2335667777666555   4455777888888888999999999987


Q ss_pred             Chh
Q 008292          427 SLD  429 (571)
Q Consensus       427 ~L~  429 (571)
                      .++
T Consensus        97 ~~d   99 (286)
T COG3001          97 PLD   99 (286)
T ss_pred             CCC
Confidence            765

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.13  E-value=0.12  Score=48.39  Aligned_cols=117  Identities=15%  Similarity=0.160  Sum_probs=72.3

Q ss_pred             cCceeEEEEEccCCCeeEEEeecccCcc-CHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEecCCCChhhhhcC
Q 008292          356 GGFGEVYKGVLPSGQEIAVKRLSKASGQ-GAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYD  434 (571)
Q Consensus       356 G~fg~Vy~~~~~~g~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~  434 (571)
                      ++-.+.-+++-+-|. ..+|+++...-. ...-|.++..+++++  ..|+++..-  .+-..-++.|.+-.-..      
T Consensus        73 ~gNsTl~~~kt~iG~-L~lKKi~slp~~~~~~~y~nky~v~Arm--hGilrL~ND--n~~~yGvIlE~Cy~~~i------  141 (308)
T PF07387_consen   73 NGNSTLLIGKTKIGP-LFLKKIRSLPCCINDALYFNKYRVFARM--HGILRLKND--NNYKYGVILERCYKIKI------  141 (308)
T ss_pred             CCceEEEEeccccch-hhhhhccCCCcccchhhhhhhhhHHHHh--hheeEeecC--CCceeEEEEeeccCccc------
Confidence            344455555443333 345555433222 456678888888876  356666632  33455688887732110      


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCc
Q 008292          435 PEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA  494 (571)
Q Consensus       435 ~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla  494 (571)
                            .    -..++..-++.|.-.|+.. ...+|+|-.|+||+-|..|.+||.|-+..
T Consensus       142 ------~----~~N~i~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~L  190 (308)
T PF07387_consen  142 ------N----FSNFITAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCL  190 (308)
T ss_pred             ------c----hhHHHHHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhh
Confidence                  0    1122222356778889653 46999999999999999999999998754

The function of this family is unknown.

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=95.04  E-value=0.061  Score=54.87  Aligned_cols=62  Identities=18%  Similarity=0.143  Sum_probs=42.0

Q ss_pred             eeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECC
Q 008292          415 EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA  482 (571)
Q Consensus       415 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~  482 (571)
                      ...|+=+|.+|-++..++.    ....+++...+++.-..+++.-+-.-.  .++|.|+.|.||++..
T Consensus       319 ~~vl~E~~~~Gl~v~~~v~----~~~~pe~l~kkva~lg~~AllkMl~vD--NFvHaDlHPGNVlirf  380 (565)
T KOG1236|consen  319 DLVLVETYERGLSVLRFVK----WKSQPEALVKKVAKLGVNALLKMLIVD--NFVHADLHPGNVLIRF  380 (565)
T ss_pred             cceeeeeccccccHHhhhh----cccChHHHHHHHHHHHHHHHHHHHHhh--cceecccCCCcEEEEe
Confidence            3457777888888888883    333444556666666666665543322  3999999999999943

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	571
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-48
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-46
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		5e-41
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-40
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-40
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-39
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		3e-39
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		4e-39
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-25
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-25
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		3e-25
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		3e-25
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		6e-25
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-23
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-23
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-23
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		4e-23
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		4e-23
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		4e-23
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		5e-23
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		5e-23
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		5e-23
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		6e-23
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		6e-23
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		6e-23
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		6e-23
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		6e-23
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		6e-23
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		7e-23
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		8e-23
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		9e-23
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		9e-23
2pl0_A	289	Lck Bound To Imatinib Length = 289		9e-23
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		9e-23
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		9e-23
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-22
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-22
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-22
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-22
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-22
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		1e-22
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-22
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-22
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-22
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-22
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-22
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-22
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-22
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-22
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-22
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-22
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		3e-22
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-22
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		4e-22
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		4e-22
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		4e-22
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		5e-22
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		5e-22
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		5e-22
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-22
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		9e-22
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-21
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-21
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-21
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-21
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-21
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-21
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-21
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-21
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-21
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-21
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-21
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		3e-21
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-21
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-21
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		3e-21
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		3e-21
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		3e-21
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		3e-21
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		3e-21
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		4e-21
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		4e-21
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		4e-21
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		4e-21
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		4e-21
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		4e-21
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-21
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		4e-21
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		4e-21
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		4e-21
4h58_A	275	Braf In Complex With Compound 3 Length = 275		4e-21
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		4e-21
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		4e-21
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		5e-21
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		5e-21
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-21
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		6e-21
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		6e-21
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		6e-21
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		6e-21
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		6e-21
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		7e-21
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		7e-21
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		8e-21
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		8e-21
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		8e-21
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		8e-21
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-20
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-20
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-20
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-20
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-20
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-20
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-20
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-20
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-20
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-20
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-20
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-20
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-20
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-20
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-20
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-20
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-20
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-20
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-20
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-20
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-20
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-20
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-20
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-20
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-20
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		3e-20
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		3e-20
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-20
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		5e-20
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		5e-20
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		5e-20
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		5e-20
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		6e-20
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		6e-20
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		6e-20
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		6e-20
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		7e-20
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		7e-20
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		7e-20
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		7e-20
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		7e-20
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		8e-20
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		8e-20
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-19
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-19
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-19
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-19
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-19
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-19
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-19
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-19
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-19
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-19
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		2e-19
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-19
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-19
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-19
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-19
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-19
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-19
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-19
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-19
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-19
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-19
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-19
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		3e-19
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		3e-19
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		3e-19
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-19
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-19
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-19
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		4e-19
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		4e-19
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-19
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		4e-19
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-19
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-19
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		5e-19
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		5e-19
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		5e-19
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		5e-19
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		6e-19
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		6e-19
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		6e-19
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		6e-19
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		6e-19
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		6e-19
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		6e-19
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		6e-19
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		6e-19
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		6e-19
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		6e-19
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		6e-19
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		6e-19
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		8e-19
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		8e-19
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		8e-19
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		8e-19
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		8e-19
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		9e-19
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-18
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-18
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-18
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-18
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-18
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		3e-18
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		3e-18
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		4e-18
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		4e-18
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		4e-18
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		4e-18
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		4e-18
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		5e-18
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		5e-18
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		5e-18
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		6e-18
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		6e-18
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		6e-18
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		7e-18
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		7e-18
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		8e-18
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		8e-18
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		8e-18
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		8e-18
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		8e-18
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		9e-18
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		9e-18
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		9e-18
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		9e-18
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		9e-18
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-17
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-17
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-17
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-17
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-17
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-17
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-17
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-17
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-17
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-17
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-17
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-17
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-17
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-17
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-17
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-17
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		3e-17
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		3e-17
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		3e-17
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		3e-17
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		3e-17
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		3e-17
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-17
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-17
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		3e-17
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		3e-17
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		3e-17
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		3e-17
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		3e-17
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		3e-17
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		4e-17
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		4e-17
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		4e-17
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		4e-17
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		4e-17
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		4e-17
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		5e-17
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		5e-17
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		6e-17
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		8e-17
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-17
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		8e-17
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		8e-17
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		9e-17
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		9e-17
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-16
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-16
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-16
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-16
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-16
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-16
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		1e-16
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-16
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-16
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-16
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-16
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-16
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-16
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-16
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-16
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-16
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-16
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-16
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-16
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-16
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-16
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-16
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-16
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-16
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-16
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-16
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		3e-16
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		3e-16
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-16
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		3e-16
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		3e-16
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-16
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-16
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		3e-16
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-16
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		4e-16
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		4e-16
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-16
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		4e-16
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		4e-16
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		4e-16
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-16
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		4e-16
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		4e-16
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		5e-16
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		5e-16
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		5e-16
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-16
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		5e-16
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		6e-16
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		6e-16
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		6e-16
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		7e-16
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		8e-16
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		8e-16
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		8e-16
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-15
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-15
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-15
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-15
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-15
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-15
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-15
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-15
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-15
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-15
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-15
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-15
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-15
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-15
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-15
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-15
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-15
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-15
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-15
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-15
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-15
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-15
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-15
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-15
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-15
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-15
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-15
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-15
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-15
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		3e-15
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		3e-15
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		3e-15
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		3e-15
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		3e-15
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		4e-15
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		4e-15
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		4e-15
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		4e-15
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		4e-15
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		4e-15
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		5e-15
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		5e-15
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-15
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		5e-15
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		5e-15
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		6e-15
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		6e-15
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		6e-15
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		7e-15
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		7e-15
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		9e-15
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		9e-15
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		9e-15
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		9e-15
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-14
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-14
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-14
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-14
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-14
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-14
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-14
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-14
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-14
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-14
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-14
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-14
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-14
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-14
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-14
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-14
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-14
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-14
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-14
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-14
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-14
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-14
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-14
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-14
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-14
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-14
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-14
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-14
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-14
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-14
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-14
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-14
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-14
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-14
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-14
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-14
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-14
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-14
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-14
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-14
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-14
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-14
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-14
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-14
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		3e-14
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-14
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-14
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-14
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		3e-14
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-14
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		3e-14
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-14
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		3e-14
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		3e-14
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-14
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		4e-14
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		4e-14
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-14
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		4e-14
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		4e-14
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-14
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		5e-14
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-14
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		5e-14
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-14
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		5e-14
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-14
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		5e-14
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		5e-14
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		5e-14
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		5e-14
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-14
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		6e-14
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-14
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		6e-14
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-14
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		7e-14
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		7e-14
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		7e-14
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		8e-14
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		8e-14
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		9e-14
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		9e-14
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-13
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-13
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-13
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-13
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-13
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-13
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-13
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-13
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-13
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		1e-13
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-13
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-13
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-13
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-13
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-13
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-13
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-13
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-13
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-13
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-13
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-13
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-13
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-13
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-13
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-13
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-13
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-13
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-13
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-13
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-13
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		3e-13
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		3e-13
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-13
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-13
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		3e-13
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		4e-13
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-13
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		4e-13
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		4e-13
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		4e-13
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		4e-13
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-13
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		4e-13
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		5e-13
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		5e-13
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		5e-13
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		5e-13
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		5e-13
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		5e-13
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		5e-13
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		5e-13
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		5e-13
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		5e-13
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		6e-13
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-13
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-13
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		6e-13
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		6e-13
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		6e-13
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		6e-13
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-13
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		6e-13
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		6e-13
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-13
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		7e-13
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		7e-13
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		7e-13
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		7e-13
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		7e-13
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		7e-13
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		7e-13
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		7e-13
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		8e-13
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-13
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		8e-13
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		8e-13
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		8e-13
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		8e-13
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		8e-13
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		8e-13
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		8e-13
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		8e-13
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		8e-13
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		8e-13
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		8e-13
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		8e-13
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		9e-13
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		9e-13
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		9e-13
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		9e-13
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		9e-13
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		9e-13
2oza_B	366	Structure Of P38alpha Complex Length = 366		9e-13
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-12
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-12
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-12
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-12
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		1e-12
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-12
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-12
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-12
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-12
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-12
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-12
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-12
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-12
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-12
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-12
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-12
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-12
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-12
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-12
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-12
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-12
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-12
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-12
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-12
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-12
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-12
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-12
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-12
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		1e-12
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-12
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-12
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-12
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-12
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-12
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-12
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-12
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-12
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-12
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-12
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-12
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-12
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-12
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-12
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-12
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-12
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-12
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-12
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-12
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-12
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-12
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-12
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-12
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-12
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-12
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-12
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-12
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-12
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-12
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-12
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-12
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-12
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-12
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-12
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-12
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-12
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-12
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		2e-12
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-12
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-12
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-12
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-12
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-12
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-12
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-12
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-12
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-12
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-12
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-12
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-12
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-12
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-12
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-12
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-12
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		3e-12
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-12
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		3e-12
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-12
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		3e-12
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		3e-12
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		3e-12
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		3e-12
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		3e-12
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-12
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		3e-12
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		3e-12
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		3e-12
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-12
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		3e-12
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		3e-12
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-12
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		3e-12
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		3e-12
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		3e-12
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		4e-12
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-12
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		4e-12
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		4e-12
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		4e-12
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		4e-12
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		5e-12
4exu_A	371	Mapk13, Inactive Form Length = 371		5e-12
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		5e-12
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		5e-12
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		6e-12
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		6e-12
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		6e-12
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-12
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		7e-12
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-12
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		7e-12
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		7e-12
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		7e-12
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		7e-12
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		8e-12
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		8e-12
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		8e-12
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		8e-12
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		8e-12
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		8e-12
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		8e-12
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		8e-12
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		8e-12
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		8e-12
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		8e-12
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		8e-12
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		9e-12
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		9e-12
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		9e-12
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		9e-12
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		9e-12
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		9e-12
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-11
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-11
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		1e-11
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-11
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-11
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		1e-11
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		1e-11
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-11
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-11
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		1e-11
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-11
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-11
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-11
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-11
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-11
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-11
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-11
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-11
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-11
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-11
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-11
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-11
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-11
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-11
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-11
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-11
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-11
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-11
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-11
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-11
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-11
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-11
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-11
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-11
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-11
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-11
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-11
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-11
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-11
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-11
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		3e-11
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		3e-11
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		3e-11
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		3e-11
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-11
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		3e-11
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		4e-11
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		4e-11
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		4e-11
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		4e-11
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		4e-11
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		4e-11
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		4e-11
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-11
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		4e-11
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		4e-11
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		4e-11
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-11
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		5e-11
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		5e-11
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		5e-11
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		5e-11
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		5e-11
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		5e-11
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		5e-11
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		5e-11
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		5e-11
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		5e-11
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		6e-11
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		6e-11
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		6e-11
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		6e-11
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		6e-11
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		6e-11
3g51_A	325	Structural Diversity Of The Active Conformation Of		6e-11
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		7e-11
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		7e-11
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-11
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		8e-11
3soa_A	444	Full-Length Human Camkii Length = 444		8e-11
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		8e-11
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-10
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-10
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-10
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-10
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-10
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		1e-10
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-10
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-10
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-10
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		2e-10
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-10
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-10
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-10
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		3e-10
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		3e-10
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		3e-10
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		3e-10
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		3e-10
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		4e-10
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		4e-10
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		4e-10
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		5e-10
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		7e-10
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		7e-10
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		8e-10
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		9e-10
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		9e-10
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		1e-09
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-09
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		1e-09
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-09
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-09
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-09
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-09
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-09
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-09
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-09
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-09
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-09
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-09
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-09
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		3e-09
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		3e-09
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		3e-09
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		3e-09
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-09
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		3e-09
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-09
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		3e-09
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-09
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		3e-09
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		3e-09
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-09
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		4e-09
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		4e-09
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		4e-09
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-09
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-09
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		5e-09
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		5e-09
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		6e-09
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		6e-09
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		6e-09
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		7e-09
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		7e-09
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		7e-09
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		7e-09
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		7e-09
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		8e-09
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		8e-09
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		8e-09
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		8e-09
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		8e-09
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		9e-09
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		1e-08
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-08
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		1e-08
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-08
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		1e-08
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-08
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		1e-08
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		1e-08
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-08
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-08
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-08
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		1e-08
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-08
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-08
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		1e-08
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		1e-08
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-08
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-08
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-08
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-08
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-08
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-08
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-08
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-08
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-08
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-08
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-08
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-08
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-08
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-08
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-08
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-08
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-08
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		3e-08
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		3e-08
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		3e-08
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		3e-08
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		3e-08
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		3e-08
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		3e-08
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		3e-08
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		3e-08
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		3e-08
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		3e-08
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		3e-08
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-08
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		3e-08
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-08
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		3e-08
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-08
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		3e-08
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		3e-08
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		3e-08
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		3e-08
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		4e-08
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		4e-08
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		4e-08
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		4e-08
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		4e-08
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		4e-08
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		5e-08
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		5e-08
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		5e-08
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		5e-08
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		6e-08
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		6e-08
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		6e-08
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		6e-08
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		7e-08
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		7e-08
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		8e-08
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		1e-07
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-07
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-07
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-07
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-07
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-07
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-07
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-07
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		2e-07
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		2e-07
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		2e-07
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-07
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		2e-07
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-07
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-07
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		2e-07
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-07
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-07
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-07
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		2e-07
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		3e-07
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		3e-07
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-07
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		3e-07
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		3e-07
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		3e-07
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-07
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		3e-07
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		3e-07
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		3e-07
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		3e-07
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-07
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		3e-07
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		3e-07
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		3e-07
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		3e-07
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		3e-07
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		3e-07
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		3e-07
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		3e-07
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-07
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		4e-07
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		4e-07
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-07
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		4e-07
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		4e-07
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		5e-07
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		5e-07
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		5e-07
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		5e-07
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		6e-07
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		7e-07
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		7e-07
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		7e-07
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		8e-07
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		8e-07
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		8e-07
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		8e-07
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		8e-07
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-06
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-06
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-06
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		1e-06
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		1e-06
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		1e-06

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  191 bits (484), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 105/262 (40%), Positives = 160/262 (61%), Gaps = 6/262 (2%)
Query: 308 RRKAKKKYNAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLP 367
           R+K +  +  VP +  D ++   +  +F    ++VA++ FS  N LG GGFG+VYKG L 
Sbjct: 2   RKKPQDHFFDVP-AEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA 60
Query: 368 SGQEIAVKRLSKASGQGAE-EFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNK 426
            G  +AVKRL +   QG E +F+ EV +++   HRNL+RL GFC+   E++LVY ++ N 
Sbjct: 61  DGTLVAVKRLKEERXQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANG 120
Query: 427 SLDYFLYD-PEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN 485
           S+   L + PE Q  LDW +R +I  G ARG+ YLH+    +IIHRD+KA+NILLD E  
Sbjct: 121 SVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFE 180
Query: 486 PKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
             + DFG+A++          + + GT G++APEY   G+ S K+DV+ +GV++LE+ITG
Sbjct: 181 AVVGDFGLAKLMDYKDXHVXXA-VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG 239
Query: 546 KKNSNFYQ--TDGAADLLSYVS 565
           ++  +  +   D    LL +V 
Sbjct: 240 QRAFDLARLANDDDVMLLDWVK 261

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  184 bits (466), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 98/236 (41%), Positives = 146/236 (61%), Gaps = 5/236 (2%)
Query: 334 QFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAE-EFKNEV 392
           +F    ++VA++ F   N LG GGFG+VYKG L  G  +AVKRL +   QG E +F+ EV
Sbjct: 19  RFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTEV 78
Query: 393 VLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYD-PEKQGQLDWSRRYKIIG 451
            +++   HRNL+RL GFC+   E++LVY ++ N S+   L + PE Q  LDW +R +I  
Sbjct: 79  EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIAL 138
Query: 452 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVG 511
           G ARG+ YLH+    +IIHRD+KA+NILLD E    + DFG+A++          + + G
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXA-VRG 197
Query: 512 TYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQ--TDGAADLLSYVS 565
             G++APEY   G+ S K+DV+ +GV++LE+ITG++  +  +   D    LL +V 
Sbjct: 198 XIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  165 bits (418), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 102/221 (46%), Positives = 131/221 (59%), Gaps = 15/221 (6%)
Query: 335 FDFETIEVATNKFST------DNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEF 388
           F F  ++  TN F         NK+GEGGFG VYKG + +   +AVK+L+       EE 
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 73
Query: 389 KN----EVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWS 444
           K     E+ ++AK QH NLV LLGF  +G++  LVY ++PN SL   L   +    L W 
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133
Query: 445 RRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG 504
            R KI  G A GI +LHE+     IHRD+K++NILLD     KISDFG+AR         
Sbjct: 134 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 505 NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
             SRIVGT  YMAPE A+ G+ + KSD+YSFGV++LEIITG
Sbjct: 191 MXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITG 230

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  164 bits (414), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 101/221 (45%), Positives = 130/221 (58%), Gaps = 15/221 (6%)
Query: 335 FDFETIEVATNKFST------DNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEF 388
           F F  ++  TN F         NK+GEGGFG VYKG + +   +AVK+L+       EE 
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 67
Query: 389 KN----EVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWS 444
           K     E+ ++AK QH NLV LLGF  +G++  LVY ++PN SL   L   +    L W 
Sbjct: 68  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 127
Query: 445 RRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG 504
            R KI  G A GI +LHE+     IHRD+K++NILLD     KISDFG+AR         
Sbjct: 128 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV 184
Query: 505 NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
              RIVGT  YMAPE A+ G+ + KSD+YSFGV++LEIITG
Sbjct: 185 MXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITG 224

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  164 bits (414), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 101/221 (45%), Positives = 130/221 (58%), Gaps = 15/221 (6%)
Query: 335 FDFETIEVATNKFST------DNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEF 388
           F F  ++  TN F         NK+GEGGFG VYKG + +   +AVK+L+       EE 
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 73
Query: 389 KN----EVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWS 444
           K     E+ ++AK QH NLV LLGF  +G++  LVY ++PN SL   L   +    L W 
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133
Query: 445 RRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG 504
            R KI  G A GI +LHE+     IHRD+K++NILLD     KISDFG+AR         
Sbjct: 134 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 505 NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
              RIVGT  YMAPE A+ G+ + KSD+YSFGV++LEIITG
Sbjct: 191 MXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITG 230

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  160 bits (405), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 101/221 (45%), Positives = 127/221 (57%), Gaps = 15/221 (6%)
Query: 335 FDFETIEVATNKFST------DNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEE- 387
           F F  ++  TN F         NK GEGGFG VYKG + +   +AVK+L+       EE 
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 64
Query: 388 ---FKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWS 444
              F  E+ + AK QH NLV LLGF  +G++  LVY + PN SL   L   +    L W 
Sbjct: 65  KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWH 124
Query: 445 RRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG 504
            R KI  G A GI +LHE+     IHRD+K++NILLD     KISDFG+AR         
Sbjct: 125 XRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV 181
Query: 505 NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
             SRIVGT  Y APE A+ G+ + KSD+YSFGV++LEIITG
Sbjct: 182 XXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITG 221

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  159 bits (403), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 96/239 (40%), Positives = 146/239 (61%), Gaps = 6/239 (2%)
Query: 310 KAKKKYNAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSG 369
           K  K  N++ ++ + + L   ES +     +E ATN F     +G G FG+VYKGVL  G
Sbjct: 4   KYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDG 63
Query: 370 QEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLD 429
            ++A+KR +  S QG EEF+ E+  ++  +H +LV L+GFC E  E IL+Y+++ N +L 
Sbjct: 64  AKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLK 123
Query: 430 YFLYDPE-KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKI 488
             LY  +     + W +R +I  G ARG+ YLH  +   IIHRD+K+ NILLD    PKI
Sbjct: 124 RHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKI 180
Query: 489 SDFGMARIFGVDQTQGNTSRIV-GTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
           +DFG+++  G +  Q +   +V GT GY+ PEY + G+ + KSDVYSFGV++ E++  +
Sbjct: 181 TDFGISKK-GTELDQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR 238

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  159 bits (402), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 96/239 (40%), Positives = 146/239 (61%), Gaps = 6/239 (2%)
Query: 310 KAKKKYNAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSG 369
           K  K  N++ ++ + + L   ES +     +E ATN F     +G G FG+VYKGVL  G
Sbjct: 4   KYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDG 63
Query: 370 QEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLD 429
            ++A+KR +  S QG EEF+ E+  ++  +H +LV L+GFC E  E IL+Y+++ N +L 
Sbjct: 64  AKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLK 123
Query: 430 YFLYDPE-KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKI 488
             LY  +     + W +R +I  G ARG+ YLH  +   IIHRD+K+ NILLD    PKI
Sbjct: 124 RHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKI 180
Query: 489 SDFGMARIFGVDQTQGNTSRIV-GTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
           +DFG+++  G +  Q +   +V GT GY+ PEY + G+ + KSDVYSFGV++ E++  +
Sbjct: 181 TDFGISKK-GTELGQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR 238

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score =  114 bits (286), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 77/221 (34%), Positives = 127/221 (57%), Gaps = 21/221 (9%)
Query: 353 LGEGGFGEVYKGV-LPSGQ----EIAVKRLSKASGQGAE-EFKNEVVLVAKLQHRNLVRL 406
           LG G FG VYKG+ +P G+     +A+K L++ +G  A  EF +E +++A + H +LVRL
Sbjct: 46  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 105
Query: 407 LGFCLEGEEKILVYEFVPNKSLDYFLYDPE----KQGQLDWSRRYKIIGGIARGILYLHE 462
           LG CL    + LV + +P+  L  ++++ +     Q  L+W  +      IA+G++YL E
Sbjct: 106 LGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 158
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM 522
               R++HRDL A N+L+ +  + KI+DFG+AR+   D+ + N         +MA E   
Sbjct: 159 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 215
Query: 523 HGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLS 562
           + +F+ +SDV+S+GV + E++T G K  +   T    DLL 
Sbjct: 216 YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE 256

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 77/221 (34%), Positives = 127/221 (57%), Gaps = 21/221 (9%)
Query: 353 LGEGGFGEVYKGV-LPSGQ----EIAVKRLSKASGQGAE-EFKNEVVLVAKLQHRNLVRL 406
           LG G FG VYKG+ +P G+     +A+K L++ +G  A  EF +E +++A + H +LVRL
Sbjct: 23  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 82
Query: 407 LGFCLEGEEKILVYEFVPNKSLDYFLYDPEK----QGQLDWSRRYKIIGGIARGILYLHE 462
           LG CL    + LV + +P+  L  ++++ +     Q  L+W  +      IA+G++YL E
Sbjct: 83  LGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 135
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM 522
               R++HRDL A N+L+ +  + KI+DFG+AR+   D+ + N         +MA E   
Sbjct: 136 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 192
Query: 523 HGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLS 562
           + +F+ +SDV+S+GV + E++T G K  +   T    DLL 
Sbjct: 193 YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE 233

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  113 bits (282), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 73/228 (32%), Positives = 122/228 (53%), Gaps = 10/228 (4%)
Query: 323 ADNDLTTLESLQF----DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLS 378
           +D D+ T E+L F    D + +++     +   K+G G FG V++     G ++AVK L 
Sbjct: 11  SDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILM 69
Query: 379 KAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPE 436
           +     +   EF  EV ++ +L+H N+V  +G   +     +V E++   SL   L+   
Sbjct: 70  EQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSG 129
Query: 437 KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496
            + QLD  RR  +   +A+G+ YLH +    I+HR+LK+ N+L+D +   K+ DFG++R+
Sbjct: 130 AREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188
Query: 497 FGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
                T  ++    GT  +MAPE       + KSDVYSFGV++ E+ T
Sbjct: 189 KA--STFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELAT 234

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  113 bits (282), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 73/228 (32%), Positives = 120/228 (52%), Gaps = 10/228 (4%)
Query: 323 ADNDLTTLESLQF----DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLS 378
           +D D+ T E+L F    D + +++     +   K+G G FG V++     G ++AVK L 
Sbjct: 11  SDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILM 69
Query: 379 KAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPE 436
           +     +   EF  EV ++ +L+H N+V  +G   +     +V E++   SL   L+   
Sbjct: 70  EQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSG 129
Query: 437 KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496
            + QLD  RR  +   +A+G+ YLH +    I+HRDLK+ N+L+D +   K+ DFG++R+
Sbjct: 130 AREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL 188
Query: 497 FGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
                     +   GT  +MAPE       + KSDVYSFGV++ E+ T
Sbjct: 189 KASXFLXSKXA--AGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELAT 234

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  112 bits (280), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 79/233 (33%), Positives = 118/233 (50%), Gaps = 27/233 (11%)
Query: 340 IEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKAS----GQGAEEFKNEVVLV 395
           +E+   + + +  +G GGFG+VY+     G E+AVK           Q  E  + E  L 
Sbjct: 2   LEIDFAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLF 60
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQL--DWSRRYKIIGGI 453
           A L+H N++ L G CL+     LV EF     L+  L        +  +W+ +      I
Sbjct: 61  AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQ------I 114
Query: 454 ARGILYLHEDSRLRIIHRDLKASNILLDAEMNP--------KISDFGMARIFGVDQTQGN 505
           ARG+ YLH+++ + IIHRDLK+SNIL+  ++          KI+DFG+AR    +  +  
Sbjct: 115 ARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR----EWHRTT 170
Query: 506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAA 558
                G Y +MAPE      FS  SDV+S+GVL+ E++TG+    F   DG A
Sbjct: 171 KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE--VPFRGIDGLA 221

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 73/221 (33%), Positives = 120/221 (54%), Gaps = 24/221 (10%)
Query: 352 KLGEGGFGEVY----KGVLPSGQE--IAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVR 405
           +LGEG FG+V+      +LP   +  +AVK L +AS    ++F+ E  L+  LQH+++VR
Sbjct: 25  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 84
Query: 406 LLGFCLEGEEKILVYEFVPNKSLDYFL--YDPEKQ----------GQLDWSRRYKIIGGI 453
             G C EG   ++V+E++ +  L+ FL  + P+ +          G L   +   +   +
Sbjct: 85  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 144
Query: 454 ARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVDQTQGNTSRIVGT 512
           A G++YL   + L  +HRDL   N L+   +  KI DFGM+R I+  D  +    R +  
Sbjct: 145 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG-GRTMLP 200
Query: 513 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQ 553
             +M PE  ++ +F+ +SDV+SFGV++ EI T  K   +YQ
Sbjct: 201 IRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP-WYQ 240

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 73/221 (33%), Positives = 120/221 (54%), Gaps = 24/221 (10%)
Query: 352 KLGEGGFGEVY----KGVLPSGQE--IAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVR 405
           +LGEG FG+V+      +LP   +  +AVK L +AS    ++F+ E  L+  LQH+++VR
Sbjct: 19  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 78
Query: 406 LLGFCLEGEEKILVYEFVPNKSLDYFL--YDPEKQ----------GQLDWSRRYKIIGGI 453
             G C EG   ++V+E++ +  L+ FL  + P+ +          G L   +   +   +
Sbjct: 79  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 138
Query: 454 ARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVDQTQGNTSRIVGT 512
           A G++YL   + L  +HRDL   N L+   +  KI DFGM+R I+  D  +    R +  
Sbjct: 139 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG-GRTMLP 194
Query: 513 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQ 553
             +M PE  ++ +F+ +SDV+SFGV++ EI T  K   +YQ
Sbjct: 195 IRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP-WYQ 234

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 73/221 (33%), Positives = 120/221 (54%), Gaps = 24/221 (10%)
Query: 352 KLGEGGFGEVY----KGVLPSGQE--IAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVR 405
           +LGEG FG+V+      +LP   +  +AVK L +AS    ++F+ E  L+  LQH+++VR
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 406 LLGFCLEGEEKILVYEFVPNKSLDYFL--YDPEKQ----------GQLDWSRRYKIIGGI 453
             G C EG   ++V+E++ +  L+ FL  + P+ +          G L   +   +   +
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 454 ARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVDQTQGNTSRIVGT 512
           A G++YL   + L  +HRDL   N L+   +  KI DFGM+R I+  D  +    R +  
Sbjct: 168 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG-GRTMLP 223
Query: 513 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQ 553
             +M PE  ++ +F+ +SDV+SFGV++ EI T  K   +YQ
Sbjct: 224 IRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP-WYQ 263

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score =  106 bits (264), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 72/206 (34%), Positives = 113/206 (54%), Gaps = 11/206 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
           EV         +LG G FGEV+ G      ++AVK L + S    + F  E  L+ +LQH
Sbjct: 10  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQH 68
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
           + LVRL     + E   ++ E++ N SL  FL  P    +L  ++   +   IA G+ ++
Sbjct: 69  QRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDMAAQIAEGMAFI 126
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTY--GYMAP 518
            E +    IHRDL+A+NIL+   ++ KI+DFG+AR+    +    T+R    +   + AP
Sbjct: 127 EERN---YIHRDLRAANILVSDTLSCKIADFGLARLI---EDNEXTAREGAKFPIKWTAP 180
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIIT 544
           E   +G F++KSDV+SFG+L+ EI+T
Sbjct: 181 EAINYGTFTIKSDVWSFGILLTEIVT 206

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score =  106 bits (264), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 72/206 (34%), Positives = 113/206 (54%), Gaps = 11/206 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
           EV         +LG G FGEV+ G      ++AVK L + S    + F  E  L+ +LQH
Sbjct: 11  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQH 69
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
           + LVRL     + E   ++ E++ N SL  FL  P    +L  ++   +   IA G+ ++
Sbjct: 70  QRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDMAAQIAEGMAFI 127
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTY--GYMAP 518
            E +    IHRDL+A+NIL+   ++ KI+DFG+AR+    +    T+R    +   + AP
Sbjct: 128 EERN---YIHRDLRAANILVSDTLSCKIADFGLARLI---EDNEXTAREGAKFPIKWTAP 181
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIIT 544
           E   +G F++KSDV+SFG+L+ EI+T
Sbjct: 182 EAINYGTFTIKSDVWSFGILLTEIVT 207

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score =  106 bits (264), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 72/206 (34%), Positives = 113/206 (54%), Gaps = 11/206 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
           EV         +LG G FGEV+ G      ++AVK L + S    + F  E  L+ +LQH
Sbjct: 9   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQH 67
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
           + LVRL     + E   ++ E++ N SL  FL  P    +L  ++   +   IA G+ ++
Sbjct: 68  QRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDMAAQIAEGMAFI 125
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTY--GYMAP 518
            E +    IHRDL+A+NIL+   ++ KI+DFG+AR+    +    T+R    +   + AP
Sbjct: 126 EERN---YIHRDLRAANILVSDTLSCKIADFGLARLI---EDNEXTAREGAKFPIKWTAP 179
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIIT 544
           E   +G F++KSDV+SFG+L+ EI+T
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  105 bits (263), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 72/206 (34%), Positives = 113/206 (54%), Gaps = 11/206 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
           EV         +LG G FGEV+ G      ++AVK L + S    + F  E  L+ +LQH
Sbjct: 9   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQH 67
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
           + LVRL     + E   ++ E++ N SL  FL  P    +L  ++   +   IA G+ ++
Sbjct: 68  QRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDMAAQIAEGMAFI 125
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTY--GYMAP 518
            E +    IHRDL+A+NIL+   ++ KI+DFG+AR+    +    T+R    +   + AP
Sbjct: 126 EERN---YIHRDLRAANILVSDTLSCKIADFGLARLI---EDNEXTAREGAKFPIKWTAP 179
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIIT 544
           E   +G F++KSDV+SFG+L+ EI+T
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score =  105 bits (263), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 72/206 (34%), Positives = 114/206 (55%), Gaps = 11/206 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
           EV         +LG G FGEV+ G      ++AVK L + S    + F  E  L+ +LQH
Sbjct: 18  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQH 76
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
           + LVRL     + E   ++ E++ N SL  FL  P    +L  ++   +   IA G+ ++
Sbjct: 77  QRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDMAAQIAEGMAFI 134
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTY--GYMAP 518
            E +    IHRDL+A+NIL+   ++ KI+DFG+AR+   ++    T+R    +   + AP
Sbjct: 135 EERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX---TAREGAKFPIKWTAP 188
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIIT 544
           E   +G F++KSDV+SFG+L+ EI+T
Sbjct: 189 EAINYGTFTIKSDVWSFGILLTEIVT 214

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score =  105 bits (263), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 71/207 (34%), Positives = 115/207 (55%), Gaps = 13/207 (6%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
           E+         +LG G FGEV+ G      ++A+K L K      E F  E  ++ KL+H
Sbjct: 5   EIPRESLQLIKRLGNGQFGEVWMGTWNGNTKVAIKTL-KPGTMSPESFLEEAQIMKKLKH 63
Query: 401 RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
             LV+L  + +  EE I +V E++   SL  FL D E +  L       +   +A G+ Y
Sbjct: 64  DKLVQL--YAVVSEEPIYIVTEYMNKGSLLDFLKDGEGRA-LKLPNLVDMAAQVAAGMAY 120
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTY--GYMA 517
           +    R+  IHRDL+++NIL+   +  KI+DFG+AR+   ++    T+R    +   + A
Sbjct: 121 IE---RMNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEX---TARQGAKFPIKWTA 174
Query: 518 PEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           PE A++G+F++KSDV+SFG+L+ E++T
Sbjct: 175 PEAALYGRFTIKSDVWSFGILLTELVT 201

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score =  105 bits (263), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 72/206 (34%), Positives = 114/206 (55%), Gaps = 11/206 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
           EV         +LG G FGEV+ G      ++AVK L + S    + F  E  L+ +LQH
Sbjct: 17  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQH 75
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
           + LVRL     + E   ++ E++ N SL  FL  P    +L  ++   +   IA G+ ++
Sbjct: 76  QRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDMAAQIAEGMAFI 133
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTY--GYMAP 518
            E +    IHRDL+A+NIL+   ++ KI+DFG+AR+   ++    T+R    +   + AP
Sbjct: 134 EERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX---TAREGAKFPIKWTAP 187
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIIT 544
           E   +G F++KSDV+SFG+L+ EI+T
Sbjct: 188 EAINYGTFTIKSDVWSFGILLTEIVT 213

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score =  105 bits (263), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 73/208 (35%), Positives = 113/208 (54%), Gaps = 15/208 (7%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
           E+       + KLG+G FGEV+ G       +A+K L K      E F  E  ++ KL+H
Sbjct: 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRH 238
Query: 401 RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
             LV+L  + +  EE I +V E++   SL  FL   E    L   +   +   IA G+ Y
Sbjct: 239 EKLVQL--YAVVSEEPIYIVTEYMSKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAY 295
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ---TQGNTSRIVGTYGYM 516
           +    R+  +HRDL+A+NIL+   +  K++DFG+AR+   ++    QG    I  T    
Sbjct: 296 VE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT---- 348
Query: 517 APEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           APE A++G+F++KSDV+SFG+L+ E+ T
Sbjct: 349 APEAALYGRFTIKSDVWSFGILLTELTT 376

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score =  105 bits (263), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 72/206 (34%), Positives = 114/206 (55%), Gaps = 11/206 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
           EV         +LG G FGEV+ G      ++AVK L + S    + F  E  L+ +LQH
Sbjct: 15  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQH 73
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
           + LVRL     + E   ++ E++ N SL  FL  P    +L  ++   +   IA G+ ++
Sbjct: 74  QRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDMAAQIAEGMAFI 131
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTY--GYMAP 518
            E +    IHRDL+A+NIL+   ++ KI+DFG+AR+   ++    T+R    +   + AP
Sbjct: 132 EERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX---TAREGAKFPIKWTAP 185
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIIT 544
           E   +G F++KSDV+SFG+L+ EI+T
Sbjct: 186 EAINYGTFTIKSDVWSFGILLTEIVT 211

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score =  105 bits (263), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 72/206 (34%), Positives = 113/206 (54%), Gaps = 11/206 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
           EV         +LG G FGEV+ G      ++AVK L + S    + F  E  L+ +LQH
Sbjct: 9   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQH 67
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
           + LVRL     + E   ++ E++ N SL  FL  P    +L  ++   +   IA G+ ++
Sbjct: 68  QRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDMAAQIAEGMAFI 125
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTY--GYMAP 518
            E +    IHRDL+A+NIL+   ++ KI+DFG+AR+    +    T+R    +   + AP
Sbjct: 126 EERN---YIHRDLRAANILVSDTLSCKIADFGLARLI---EDNEYTAREGAKFPIKWTAP 179
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIIT 544
           E   +G F++KSDV+SFG+L+ EI+T
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score =  105 bits (262), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 73/211 (34%), Positives = 114/211 (54%), Gaps = 15/211 (7%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAK 397
           +  E+       + KLG+G FGEV+ G       +A+K L K      E F  E  ++ K
Sbjct: 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKK 235
Query: 398 LQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARG 456
           L+H  LV+L  + +  EE I +V E++   SL  FL   E    L   +   +   IA G
Sbjct: 236 LRHEKLVQL--YAVVSEEPIYIVTEYMSKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASG 292
Query: 457 ILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ---TQGNTSRIVGTY 513
           + Y+    R+  +HRDL+A+NIL+   +  K++DFG+AR+   ++    QG    I  T 
Sbjct: 293 MAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT- 348
Query: 514 GYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
              APE A++G+F++KSDV+SFG+L+ E+ T
Sbjct: 349 ---APEAALYGRFTIKSDVWSFGILLTELTT 376

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score =  105 bits (262), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 72/206 (34%), Positives = 113/206 (54%), Gaps = 11/206 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
           EV         +LG G FGEV+ G      ++AVK L + S    + F  E  L+ +LQH
Sbjct: 4   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQH 62
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
           + LVRL     + E   ++ E++ N SL  FL  P    +L  ++   +   IA G+ ++
Sbjct: 63  QRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDMAAQIAEGMAFI 120
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTY--GYMAP 518
            E +    IHRDL+A+NIL+   ++ KI+DFG+AR+    +    T+R    +   + AP
Sbjct: 121 EERN---YIHRDLRAANILVSDTLSCKIADFGLARLI---EDNEYTAREGAKFPIKWTAP 174
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIIT 544
           E   +G F++KSDV+SFG+L+ EI+T
Sbjct: 175 EAINYGTFTIKSDVWSFGILLTEIVT 200

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score =  105 bits (262), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 72/206 (34%), Positives = 113/206 (54%), Gaps = 11/206 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
           EV         +LG G FGEV+ G      ++AVK L + S    + F  E  L+ +LQH
Sbjct: 15  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQH 73
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
           + LVRL     + E   ++ E++ N SL  FL  P    +L  ++   +   IA G+ ++
Sbjct: 74  QRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDMAAQIAEGMAFI 131
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTY--GYMAP 518
            E +    IHRDL+A+NIL+   ++ KI+DFG+AR+    +    T+R    +   + AP
Sbjct: 132 EERN---YIHRDLRAANILVSDTLSCKIADFGLARLI---EDNEYTAREGAKFPIKWTAP 185
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIIT 544
           E   +G F++KSDV+SFG+L+ EI+T
Sbjct: 186 EAINYGTFTIKSDVWSFGILLTEIVT 211

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score =  105 bits (262), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 72/206 (34%), Positives = 113/206 (54%), Gaps = 11/206 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
           EV         +LG G FGEV+ G      ++AVK L + S    + F  E  L+ +LQH
Sbjct: 14  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQH 72
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
           + LVRL     + E   ++ E++ N SL  FL  P    +L  ++   +   IA G+ ++
Sbjct: 73  QRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDMAAQIAEGMAFI 130
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTY--GYMAP 518
            E +    IHRDL+A+NIL+   ++ KI+DFG+AR+    +    T+R    +   + AP
Sbjct: 131 EERN---YIHRDLRAANILVSDTLSCKIADFGLARLI---EDNEYTAREGAKFPIKWTAP 184
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIIT 544
           E   +G F++KSDV+SFG+L+ EI+T
Sbjct: 185 EAINYGTFTIKSDVWSFGILLTEIVT 210

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score =  105 bits (261), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 71/210 (33%), Positives = 115/210 (54%), Gaps = 13/210 (6%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAK 397
           +  E+       + KLG+G FGEV+ G       +A+K L K      E F  E  ++ K
Sbjct: 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKK 318
Query: 398 LQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARG 456
           L+H  LV+L  + +  EE I +V E++   SL  FL   E    L   +   +   IA G
Sbjct: 319 LRHEKLVQL--YAVVSEEPIYIVTEYMSKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASG 375
Query: 457 ILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTY--G 514
           + Y+    R+  +HRDL+A+NIL+   +  K++DFG+AR+   ++    T+R    +   
Sbjct: 376 MAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIK 429
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           + APE A++G+F++KSDV+SFG+L+ E+ T
Sbjct: 430 WTAPEAALYGRFTIKSDVWSFGILLTELTT 459

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score =  105 bits (261), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 73/211 (34%), Positives = 114/211 (54%), Gaps = 15/211 (7%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAK 397
           +  E+       + KLG+G FGEV+ G       +A+K L K      E F  E  ++ K
Sbjct: 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKK 235
Query: 398 LQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARG 456
           L+H  LV+L  + +  EE I +V E++   SL  FL   E    L   +   +   IA G
Sbjct: 236 LRHEKLVQL--YAVVSEEPIYIVGEYMSKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASG 292
Query: 457 ILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ---TQGNTSRIVGTY 513
           + Y+    R+  +HRDL+A+NIL+   +  K++DFG+AR+   ++    QG    I  T 
Sbjct: 293 MAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT- 348
Query: 514 GYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
              APE A++G+F++KSDV+SFG+L+ E+ T
Sbjct: 349 ---APEAALYGRFTIKSDVWSFGILLTELTT 376

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score =  105 bits (261), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 72/206 (34%), Positives = 114/206 (55%), Gaps = 11/206 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
           EV         +LG G FGEV+ G      ++AVK L + S    + F  E  L+ +LQH
Sbjct: 19  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQH 77
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
           + LVRL     + E   ++ E++ N SL  FL  P    +L  ++   +   IA G+ ++
Sbjct: 78  QRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDMAAQIAEGMAFI 135
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTY--GYMAP 518
            E +    IHRDL+A+NIL+   ++ KI+DFG+AR+   ++    T+R    +   + AP
Sbjct: 136 EERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY---TAREGAKFPIKWTAP 189
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIIT 544
           E   +G F++KSDV+SFG+L+ EI+T
Sbjct: 190 EAINYGTFTIKSDVWSFGILLTEIVT 215

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score =  105 bits (261), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 71/207 (34%), Positives = 114/207 (55%), Gaps = 13/207 (6%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
           E+       + KLG+G FGEV+ G       +A+K L K      E F  E  ++ KL+H
Sbjct: 4   EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRH 62
Query: 401 RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
             LV+L  + +  EE I +V E++   SL  FL   E    L   +   +   IA G+ Y
Sbjct: 63  EKLVQL--YAVVSEEPIXIVTEYMSKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAY 119
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTY--GYMA 517
           +    R+  +HRDL+A+NIL+   +  K++DFG+AR+   ++    T+R    +   + A
Sbjct: 120 VE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEX---TARQGAKFPIKWTA 173
Query: 518 PEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           PE A++G+F++KSDV+SFG+L+ E+ T
Sbjct: 174 PEAALYGRFTIKSDVWSFGILLTELTT 200

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score =  105 bits (261), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 76/227 (33%), Positives = 123/227 (54%), Gaps = 29/227 (12%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL--PSG----QEIAVKRLS-KASGQGAEEFKNEVV 393
           E++ +      +LGE  FG+VYKG L  P+     Q +A+K L  KA G   EEF++E +
Sbjct: 22  EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAM 81
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLY--DPEKQ-GQLDWSRRYK-- 448
           L A+LQH N+V LLG   + +   +++ +  +  L  FL    P    G  D  R  K  
Sbjct: 82  LRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSA 141
Query: 449 --------IIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGV 499
                   ++  IA G+ YL   S   ++H+DL   N+L+  ++N KISD G+ R ++  
Sbjct: 142 LEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAA 198
Query: 500 D--QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           D  +  GN+   +    +MAPE  M+G+FS+ SD++S+GV++ E+ +
Sbjct: 199 DYYKLLGNS---LLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 73/208 (35%), Positives = 113/208 (54%), Gaps = 15/208 (7%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
           E+       + KLG+G FGEV+ G       +A+K L K      E F  E  ++ KL+H
Sbjct: 7   EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRH 65
Query: 401 RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
             LV+L  + +  EE I +V E++   SL  FL   E    L   +   +   IA G+ Y
Sbjct: 66  EKLVQL--YAVVSEEPIYIVTEYMSKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAY 122
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ---TQGNTSRIVGTYGYM 516
           +    R+  +HRDL+A+NIL+   +  K++DFG+AR+   ++    QG    I  T    
Sbjct: 123 VE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT---- 175
Query: 517 APEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           APE A++G+F++KSDV+SFG+L+ E+ T
Sbjct: 176 APEAALYGRFTIKSDVWSFGILLTELTT 203

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 72/223 (32%), Positives = 120/223 (53%), Gaps = 28/223 (12%)
Query: 351 NKLGEGGFGEVYKG----VLPSGQE--IAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLV 404
            +LGEG FG+V+      + P+  +  +AVK L   +    ++F+ E  L+  LQH ++V
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFL--YDP-----------EKQGQLDWSRRYKIIG 451
           +  G C +G+  I+V+E++ +  L+ FL  + P           + +G+L  S+   I  
Sbjct: 81  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 452 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVD--QTQGNTSR 508
            IA G++YL   +    +HRDL   N L+ A +  KI DFGM+R ++  D  +  G+T  
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 197
Query: 509 IVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF 551
            +    +M PE  M+ +F+ +SDV+SFGV++ EI T  K   F
Sbjct: 198 PI---RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWF 237

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 71/207 (34%), Positives = 114/207 (55%), Gaps = 13/207 (6%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
           E+       + KLG+G FGEV+ G       +A+K L K      E F  E  ++ KL+H
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRH 72
Query: 401 RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
             LV+L  + +  EE I +V E++   SL  FL   E    L   +   +   IA G+ Y
Sbjct: 73  EKLVQL--YAVVSEEPIYIVIEYMSKGSLLDFLKG-EMGKYLRLPQLVDMAAQIASGMAY 129
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTY--GYMA 517
           +    R+  +HRDL+A+NIL+   +  K++DFG+AR+   ++    T+R    +   + A
Sbjct: 130 VE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEX---TARQGAKFPIKWTA 183
Query: 518 PEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           PE A++G+F++KSDV+SFG+L+ E+ T
Sbjct: 184 PEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 73/208 (35%), Positives = 113/208 (54%), Gaps = 15/208 (7%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
           E+       + KLG+G FGEV+ G       +A+K L K      E F  E  ++ KL+H
Sbjct: 3   EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRH 61
Query: 401 RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
             LV+L  + +  EE I +V E++   SL  FL   E    L   +   +   IA G+ Y
Sbjct: 62  EKLVQL--YAVVSEEPIYIVTEYMSKGSLLDFLKG-EMGKYLRLPQLVDMAAQIASGMAY 118
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ---TQGNTSRIVGTYGYM 516
           +    R+  +HRDL+A+NIL+   +  K++DFG+AR+   ++    QG    I  T    
Sbjct: 119 VE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT---- 171
Query: 517 APEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           APE A++G+F++KSDV+SFG+L+ E+ T
Sbjct: 172 APEAALYGRFTIKSDVWSFGILLTELTT 199

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 74/221 (33%), Positives = 118/221 (53%), Gaps = 26/221 (11%)
Query: 352 KLGEGGFGEVYKG----VLPSGQEI--AVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVR 405
           +LGEG FG+V+      + P   +I  AVK L  AS    ++F  E  L+  LQH ++V+
Sbjct: 20  ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 79
Query: 406 LLGFCLEGEEKILVYEFVPNKSLDYFL--YDPE--------KQGQLDWSRRYKIIGGIAR 455
             G C+EG+  I+V+E++ +  L+ FL  + P+           +L  S+   I   IA 
Sbjct: 80  FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAA 139
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVD--QTQGNTSRIVGT 512
           G++YL   +    +HRDL   N L+   +  KI DFGM+R ++  D  +  G+T   +  
Sbjct: 140 GMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI-- 194
Query: 513 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQ 553
             +M PE  M+ +F+ +SDV+S GV++ EI T  K   +YQ
Sbjct: 195 -RWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP-WYQ 233

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 76/227 (33%), Positives = 123/227 (54%), Gaps = 29/227 (12%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL--PSG----QEIAVKRLS-KASGQGAEEFKNEVV 393
           E++ +      +LGE  FG+VYKG L  P+     Q +A+K L  KA G   EEF++E +
Sbjct: 5   EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAM 64
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLY--DPEKQ-GQLDWSRRYK-- 448
           L A+LQH N+V LLG   + +   +++ +  +  L  FL    P    G  D  R  K  
Sbjct: 65  LRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSA 124
Query: 449 --------IIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGV 499
                   ++  IA G+ YL   S   ++H+DL   N+L+  ++N KISD G+ R ++  
Sbjct: 125 LEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAA 181
Query: 500 D--QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           D  +  GN+   +    +MAPE  M+G+FS+ SD++S+GV++ E+ +
Sbjct: 182 DYYKLLGNSLLPI---RWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 73/208 (35%), Positives = 113/208 (54%), Gaps = 15/208 (7%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
           E+       + KLG+G FGEV+ G       +A+K L K      E F  E  ++ KL+H
Sbjct: 5   EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRH 63
Query: 401 RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
             LV+L  + +  EE I +V E++   SL  FL   E    L   +   +   IA G+ Y
Sbjct: 64  EKLVQL--YAVVSEEPIYIVTEYMSKGSLLDFLKG-EMGKYLRLPQLVDMAAQIASGMAY 120
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ---TQGNTSRIVGTYGYM 516
           +    R+  +HRDL+A+NIL+   +  K++DFG+AR+   ++    QG    I  T    
Sbjct: 121 VE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT---- 173
Query: 517 APEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           APE A++G+F++KSDV+SFG+L+ E+ T
Sbjct: 174 APEAALYGRFTIKSDVWSFGILLTELTT 201

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 73/208 (35%), Positives = 113/208 (54%), Gaps = 15/208 (7%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
           E+       + KLG+G FGEV+ G       +A+K L K      E F  E  ++ KL+H
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRH 72
Query: 401 RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
             LV+L  + +  EE I +V E++   SL  FL   E    L   +   +   IA G+ Y
Sbjct: 73  EKLVQL--YAVVSEEPIYIVIEYMSKGSLLDFLKG-EMGKYLRLPQLVDMAAQIASGMAY 129
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ---TQGNTSRIVGTYGYM 516
           +    R+  +HRDL+A+NIL+   +  K++DFG+AR+   ++    QG    I  T    
Sbjct: 130 VE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT---- 182
Query: 517 APEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           APE A++G+F++KSDV+SFG+L+ E+ T
Sbjct: 183 APEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 73/208 (35%), Positives = 113/208 (54%), Gaps = 15/208 (7%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
           E+       + KLG+G FGEV+ G       +A+K L K      E F  E  ++ KL+H
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRH 72
Query: 401 RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
             LV+L  + +  EE I +V E++   SL  FL   E    L   +   +   IA G+ Y
Sbjct: 73  EKLVQL--YAVVSEEPIYIVTEYMSKGSLLDFLKG-EMGKYLRLPQLVDMAAQIASGMAY 129
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ---TQGNTSRIVGTYGYM 516
           +    R+  +HRDL+A+NIL+   +  K++DFG+AR+   ++    QG    I  T    
Sbjct: 130 VE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT---- 182
Query: 517 APEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           APE A++G+F++KSDV+SFG+L+ E+ T
Sbjct: 183 APEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 73/211 (34%), Positives = 114/211 (54%), Gaps = 15/211 (7%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAK 397
           +  E+       + KLG+G FGEV+ G       +A+K L K      E F  E  ++ K
Sbjct: 11  DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKK 69
Query: 398 LQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARG 456
           L+H  LV+L  + +  EE I +V E++   SL  FL   E    L   +   +   IA G
Sbjct: 70  LRHEKLVQL--YAVVSEEPIYIVCEYMSKGSLLDFLKG-EMGKYLRLPQLVDMAAQIASG 126
Query: 457 ILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ---TQGNTSRIVGTY 513
           + Y+    R+  +HRDL+A+NIL+   +  K++DFG+AR+   ++    QG    I  T 
Sbjct: 127 MAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT- 182
Query: 514 GYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
              APE A++G+F++KSDV+SFG+L+ E+ T
Sbjct: 183 ---APEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 72/211 (34%), Positives = 113/211 (53%), Gaps = 15/211 (7%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAK 397
           +  E+       + KLG+G FGEV+ G       +A+K L K      E F  E  ++ K
Sbjct: 178 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGNMSPEAFLQEAQVMKK 236
Query: 398 LQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARG 456
           L+H  LV+L  + +  EE I +V E++   SL  FL   E    L   +   +   IA G
Sbjct: 237 LRHEKLVQL--YAVVSEEPIYIVTEYMSKGSLLDFLKG-EMGKYLRLPQLVDMAAQIASG 293
Query: 457 ILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ---TQGNTSRIVGTY 513
           + Y+    R+  +HRDL+A+NIL+   +  K++DFG+ R+   ++    QG    I  T 
Sbjct: 294 MAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWT- 349
Query: 514 GYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
              APE A++G+F++KSDV+SFG+L+ E+ T
Sbjct: 350 ---APEAALYGRFTIKSDVWSFGILLTELTT 377

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 77/243 (31%), Positives = 129/243 (53%), Gaps = 34/243 (13%)
Query: 342 VATNKFSTDNKLGEGGFGEVYKGVLPSGQE-IAVKRLSKASGQGA-------EEFKNEVV 393
           +A N+   + ++G+GGFG V+KG L   +  +A+K L     +G        +EF+ EV 
Sbjct: 16  LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGI 453
           +++ L H N+V+L G  L      +V EFVP   L + L D  K   + WS + +++  I
Sbjct: 76  IMSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDI 131
Query: 454 ARGILYLHEDSRLRIIHRDLKASNILL-----DAEMNPKISDFGMARIFGVDQTQGNTSR 508
           A GI Y+ ++    I+HRDL++ NI L     +A +  K++DFG+++     Q+  + S 
Sbjct: 132 ALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSG 185
Query: 509 IVGTYGYMAPEY--AMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYVSI 566
           ++G + +MAPE   A    ++ K+D YSF +++  I+TG         +G  D  SY  I
Sbjct: 186 LLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTG---------EGPFDEYSYGKI 236
Query: 567 NVI 569
             I
Sbjct: 237 KFI 239

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 119/213 (55%), Gaps = 12/213 (5%)
Query: 339 TIEVATNKFSTDNKLGEGGFGEVYKGVLP--SGQE---IAVKRLSKASGQGAE-EFKNEV 392
           T E+  +  +    +G G FGEVYKG+L   SG++   +A+K L     +    +F  E 
Sbjct: 38  TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEA 97
Query: 393 VLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGG 452
            ++ +  H N++RL G   + +  +++ E++ N +LD FL   EK G+    +   ++ G
Sbjct: 98  GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR--EKDGEFSVLQLVGMLRG 155
Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD-QTQGNTSRIVG 511
           IA G+ YL   + +  +HRDL A NIL+++ +  K+SDFG++R+   D +    TS    
Sbjct: 156 IAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 212
Query: 512 TYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
              + APE   + +F+  SDV+SFG+++ E++T
Sbjct: 213 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMT 245

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 71/212 (33%), Positives = 108/212 (50%), Gaps = 10/212 (4%)
Query: 335 FDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVL 394
           +D +  E+         +LG G FGEV+ G   +  ++AVK L K      + F  E  L
Sbjct: 3   WDKDAWEIPRESIKLVKRLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANL 61
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIA 454
           +  LQH  LVRL       E   ++ E++   SL  FL   E  G++   +       IA
Sbjct: 62  MKTLQHDKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEG-GKVLLPKLIDFSAQIA 120
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTY- 513
            G+ Y+    R   IHRDL+A+N+L+   +  KI+DFG+AR+    +    T+R    + 
Sbjct: 121 EGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVI---EDNEYTAREGAKFP 174
Query: 514 -GYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
             + APE    G F++KSDV+SFG+L+ EI+T
Sbjct: 175 IKWTAPEAINFGCFTIKSDVWSFGILLYEIVT 206

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 71/207 (34%), Positives = 114/207 (55%), Gaps = 13/207 (6%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
           E+       + KLG+G FGEV+ G       +A+K L K      E F  E  ++ KL+H
Sbjct: 11  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRH 69
Query: 401 RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
             LV+L  + +  EE I +V E++   SL  FL   E    L   +   +   IA G+ Y
Sbjct: 70  EKLVQL--YAVVSEEPIYIVTEYMNKGSLLDFLKG-ETGKYLRLPQLVDMSAQIASGMAY 126
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTY--GYMA 517
           +    R+  +HRDL+A+NIL+   +  K++DFG+AR+   ++    T+R    +   + A
Sbjct: 127 VE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEW---TARQGAKFPIKWTA 180
Query: 518 PEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           PE A++G+F++KSDV+SFG+L+ E+ T
Sbjct: 181 PEAALYGRFTIKSDVWSFGILLTELTT 207

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 73/208 (35%), Positives = 113/208 (54%), Gaps = 15/208 (7%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
           E+       + KLG+G FGEV+ G       +A+K L K      E F  E  ++ KL+H
Sbjct: 11  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRH 69
Query: 401 RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
             LV+L  + +  EE I +V E++   SL  FL   E    L   +   +   IA G+ Y
Sbjct: 70  EKLVQL--YAVVSEEPIYIVTEYMNKGSLLDFLKG-ETGKYLRLPQLVDMSAQIASGMAY 126
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ---TQGNTSRIVGTYGYM 516
           +    R+  +HRDL+A+NIL+   +  K++DFG+AR+   ++    QG    I  T    
Sbjct: 127 VE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT---- 179
Query: 517 APEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           APE A++G+F++KSDV+SFG+L+ E+ T
Sbjct: 180 APEAALYGRFTIKSDVWSFGILLTELTT 207

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 71/206 (34%), Positives = 113/206 (54%), Gaps = 11/206 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
           EV         +LG G FGEV+ G      ++AVK L + S    + F  E  L+ +LQH
Sbjct: 5   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQH 63
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
           + LVRL     + E   ++ E++ N SL  FL  P    +L  ++   +   IA G+ ++
Sbjct: 64  QRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDMAAQIAEGMAFI 121
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTY--GYMAP 518
            E +    IHR+L+A+NIL+   ++ KI+DFG+AR+    +    T+R    +   + AP
Sbjct: 122 EERN---YIHRNLRAANILVSDTLSCKIADFGLARLI---EDNEYTAREGAKFPIKWTAP 175
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIIT 544
           E   +G F++KSDV+SFG+L+ EI+T
Sbjct: 176 EAINYGTFTIKSDVWSFGILLTEIVT 201

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 72/208 (34%), Positives = 113/208 (54%), Gaps = 15/208 (7%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
           E+       + KLG+G FGEV+ G       +A+K L K      E F  E  ++ K++H
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKIRH 72
Query: 401 RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
             LV+L  + +  EE I +V E++   SL  FL   E    L   +   +   IA G+ Y
Sbjct: 73  EKLVQL--YAVVSEEPIYIVTEYMSKGSLLDFLKG-EMGKYLRLPQLVDMAAQIASGMAY 129
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ---TQGNTSRIVGTYGYM 516
           +    R+  +HRDL+A+NIL+   +  K++DFG+AR+   ++    QG    I  T    
Sbjct: 130 VE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT---- 182
Query: 517 APEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           APE A++G+F++KSDV+SFG+L+ E+ T
Sbjct: 183 APEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 77/227 (33%), Positives = 115/227 (50%), Gaps = 12/227 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
           E+         KLG G FGEV+ G   +  ++AVK L K      + F  E  L+  LQH
Sbjct: 8   EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQH 66
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
             LVRL     + E   ++ EF+   SL  FL   E  G++   +       IA G+ Y+
Sbjct: 67  DKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEG-GKVLLPKLIDFSAQIAEGMAYI 125
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTY--GYMAP 518
               R   IHRDL+A+N+L+   +  KI+DFG+AR+    +    T+R    +   + AP
Sbjct: 126 E---RKNYIHRDLRAANVLVSESLMCKIADFGLARVI---EDNEYTAREGAKFPIKWTAP 179
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYVS 565
           E    G F++KS+V+SFG+L+ EI+T  K    Y     AD++S +S
Sbjct: 180 EAINFGCFTIKSNVWSFGILLYEIVTYGKIP--YPGRTNADVMSALS 224

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 73/208 (35%), Positives = 112/208 (53%), Gaps = 15/208 (7%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
           E+       + KLG+G FGEV+ G       +A+K L K      E F  E  ++ KL+H
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRH 72
Query: 401 RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
             LV+L  + +  EE I +V E++   SL  FL   E    L   +   +   IA G+ Y
Sbjct: 73  EKLVQL--YAVVSEEPIYIVTEYMSKGSLLDFLKG-EMGKYLRLPQLVDMAAQIASGMAY 129
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ---TQGNTSRIVGTYGYM 516
           +    R+  +HRDL A+NIL+   +  K++DFG+AR+   ++    QG    I  T    
Sbjct: 130 VE---RMNYVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT---- 182
Query: 517 APEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           APE A++G+F++KSDV+SFG+L+ E+ T
Sbjct: 183 APEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score =  102 bits (255), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 72/208 (34%), Positives = 112/208 (53%), Gaps = 15/208 (7%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
           E+       + KLG+G FGEV+ G       +A+K L K      E F  E  ++ KL+H
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRH 72
Query: 401 RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
             LV+L  + +  EE I +V E++    L  FL   E    L   +   +   IA G+ Y
Sbjct: 73  EKLVQL--YAVVSEEPIYIVMEYMSKGCLLDFLKG-EMGKYLRLPQLVDMAAQIASGMAY 129
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ---TQGNTSRIVGTYGYM 516
           +    R+  +HRDL+A+NIL+   +  K++DFG+AR+   ++    QG    I  T    
Sbjct: 130 VE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT---- 182
Query: 517 APEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           APE A++G+F++KSDV+SFG+L+ E+ T
Sbjct: 183 APEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score =  102 bits (255), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 77/243 (31%), Positives = 128/243 (52%), Gaps = 34/243 (13%)
Query: 342 VATNKFSTDNKLGEGGFGEVYKGVLPSGQE-IAVKRLSKASGQGA-------EEFKNEVV 393
           +A N+   + ++G+GGFG V+KG L   +  +A+K L     +G        +EF+ EV 
Sbjct: 16  LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGI 453
           +++ L H N+V+L G  L      +V EFVP   L + L D  K   + WS + +++  I
Sbjct: 76  IMSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDI 131
Query: 454 ARGILYLHEDSRLRIIHRDLKASNILL-----DAEMNPKISDFGMARIFGVDQTQGNTSR 508
           A GI Y+ ++    I+HRDL++ NI L     +A +  K++DFG ++     Q+  + S 
Sbjct: 132 ALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ-----QSVHSVSG 185
Query: 509 IVGTYGYMAPEY--AMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYVSI 566
           ++G + +MAPE   A    ++ K+D YSF +++  I+TG         +G  D  SY  I
Sbjct: 186 LLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTG---------EGPFDEYSYGKI 236
Query: 567 NVI 569
             I
Sbjct: 237 KFI 239

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score =  102 bits (254), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 72/208 (34%), Positives = 112/208 (53%), Gaps = 15/208 (7%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
           E+       + KLG+G FGEV+ G       +A+K L K      E F  E  ++ KL+H
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRH 72
Query: 401 RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
             LV+L  + +  EE I +V E++    L  FL   E    L   +   +   IA G+ Y
Sbjct: 73  EKLVQL--YAVVSEEPIYIVTEYMSKGCLLDFLKG-EMGKYLRLPQLVDMAAQIASGMAY 129
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ---TQGNTSRIVGTYGYM 516
           +    R+  +HRDL+A+NIL+   +  K++DFG+AR+   ++    QG    I  T    
Sbjct: 130 VE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT---- 182
Query: 517 APEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           APE A++G+F++KSDV+SFG+L+ E+ T
Sbjct: 183 APEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  102 bits (254), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 71/206 (34%), Positives = 112/206 (54%), Gaps = 11/206 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
           EV         +LG G  GEV+ G      ++AVK L + S    + F  E  L+ +LQH
Sbjct: 9   EVPRETLKLVERLGAGQAGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQH 67
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
           + LVRL     + E   ++ E++ N SL  FL  P    +L  ++   +   IA G+ ++
Sbjct: 68  QRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDMAAQIAEGMAFI 125
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTY--GYMAP 518
            E +    IHRDL+A+NIL+   ++ KI+DFG+AR+    +    T+R    +   + AP
Sbjct: 126 EERN---YIHRDLRAANILVSDTLSCKIADFGLARLI---EDAEXTAREGAKFPIKWTAP 179
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIIT 544
           E   +G F++KSDV+SFG+L+ EI+T
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score =  101 bits (252), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 113/210 (53%), Gaps = 11/210 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKG--VLPSGQEIAVKRLSKASG---QGAEEFKNEVVLV 395
           E+     S D  +G G FGEV  G   LPS +EI+V   +   G   +   +F  E  ++
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
            +  H N++RL G   + +  ++V E++ N SLD FL   +   Q    +   ++ GIA 
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR--KHDAQFTVIQLVGMLRGIAS 158
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT-YG 514
           G+ YL   S +  +HRDL A NIL+++ +  K+SDFG+AR+   D     T+R       
Sbjct: 159 GMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIR 215
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           + +PE   + +F+  SDV+S+G+++ E+++
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  101 bits (252), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 76/243 (31%), Positives = 128/243 (52%), Gaps = 34/243 (13%)
Query: 342 VATNKFSTDNKLGEGGFGEVYKGVLPSGQE-IAVKRLSKASGQGA-------EEFKNEVV 393
           +A N+   + ++G+GGFG V+KG L   +  +A+K L     +G        +EF+ EV 
Sbjct: 16  LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGI 453
           +++ L H N+V+L G  L      +V EFVP   L + L D  K   + WS + +++  I
Sbjct: 76  IMSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDI 131
Query: 454 ARGILYLHEDSRLRIIHRDLKASNILL-----DAEMNPKISDFGMARIFGVDQTQGNTSR 508
           A GI Y+ ++    I+HRDL++ NI L     +A +  K++DF +++     Q+  + S 
Sbjct: 132 ALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ-----QSVHSVSG 185
Query: 509 IVGTYGYMAPEY--AMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYVSI 566
           ++G + +MAPE   A    ++ K+D YSF +++  I+TG         +G  D  SY  I
Sbjct: 186 LLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTG---------EGPFDEYSYGKI 236
Query: 567 NVI 569
             I
Sbjct: 237 KFI 239

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 117/210 (55%), Gaps = 20/210 (9%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEI----AVKRLSKASGQGA-EEFKNEVVLVAKL 398
            +F     LG G FG VYKG+ +P G+++    A+K L +A+   A +E  +E  ++A +
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVP-NKSLDYFLYDPEKQGQ---LDWSRRYKIIGGIA 454
            + ++ RLLG CL    + L+ + +P    LDY     +  G    L+W  +      IA
Sbjct: 76  DNPHVCRLLGICLTSTVQ-LIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQ------IA 128
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
           +G+ YL ED RL  +HRDL A N+L+    + KI+DFG+A++ G ++ + +         
Sbjct: 129 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 185
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           +MA E  +H  ++ +SDV+S+GV V E++T
Sbjct: 186 WMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 113/210 (53%), Gaps = 11/210 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKG--VLPSGQEIAVKRLSKASG---QGAEEFKNEVVLV 395
           E+     S D  +G G FGEV  G   LPS +EI+V   +   G   +   +F  E  ++
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
            +  H N++RL G   + +  ++V E++ N SLD FL   +   Q    +   ++ GIA 
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR--KHDAQFTVIQLVGMLRGIAS 158
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVG-TYG 514
           G+ YL   S +  +HRDL A NIL+++ +  K+SDFG++R+   D     T+R       
Sbjct: 159 GMKYL---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 215
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           + +PE   + +F+  SDV+S+G+++ E+++
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 113/210 (53%), Gaps = 11/210 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKG--VLPSGQEIAVKRLSKASG---QGAEEFKNEVVLV 395
           E+     S D  +G G FGEV  G   LPS +EI+V   +   G   +   +F  E  ++
Sbjct: 12  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 71
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
            +  H N++RL G   + +  ++V E++ N SLD FL   +   Q    +   ++ GIA 
Sbjct: 72  GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR--KHDAQFTVIQLVGMLRGIAS 129
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT-YG 514
           G+ YL   S +  +HRDL A NIL+++ +  K+SDFG++R+   D     T+R       
Sbjct: 130 GMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 186
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           + +PE   + +F+  SDV+S+G+++ E+++
Sbjct: 187 WTSPEAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 111/209 (53%), Gaps = 9/209 (4%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
           E+   + +   ++G G FG VYKG       + +  ++  + Q  + FKNEV ++ K +H
Sbjct: 8   EIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 67
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
            N++  +G+  + +  I V ++    SL + L+  E + ++   +   I    ARG+ YL
Sbjct: 68  VNILLFMGYSTKPQLAI-VTQWCEGSSLYHHLHASETKFEM--KKLIDIARQTARGMDYL 124
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEY 520
           H  S   IIHRDLK++NI L  +   KI DFG+A +           ++ G+  +MAPE 
Sbjct: 125 HAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 181
Query: 521 AM---HGQFSVKSDVYSFGVLVLEIITGK 546
                   +S +SDVY+FG+++ E++TG+
Sbjct: 182 IRMQDSNPYSFQSDVYAFGIVLYELMTGQ 210

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 117/210 (55%), Gaps = 20/210 (9%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEI----AVKRLSKASGQGA-EEFKNEVVLVAKL 398
            +F     LG G FG VYKG+ +P G+++    A+K L +A+   A +E  +E  ++A +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVP-NKSLDYFLYDPEKQGQ---LDWSRRYKIIGGIA 454
            + ++ RLLG CL    + L+ + +P    LDY     +  G    L+W  +      IA
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQ------IA 127
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
           +G+ YL ED RL  +HRDL A N+L+    + KI+DFG+A++ G ++ + +         
Sbjct: 128 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           +MA E  +H  ++ +SDV+S+GV V E++T
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 113/210 (53%), Gaps = 11/210 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKG--VLPSGQEIAVKRLSKASG---QGAEEFKNEVVLV 395
           E+     S D  +G G FGEV  G   LPS +EI+V   +   G   +   +F  E  ++
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
            +  H N++RL G   + +  ++V E++ N SLD FL   +   Q    +   ++ GIA 
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR--KHDAQFTVIQLVGMLRGIAS 158
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVG-TYG 514
           G+ YL   S +  +HRDL A NIL+++ +  K+SDFG++R+   D     T+R       
Sbjct: 159 GMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 215
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           + +PE   + +F+  SDV+S+G+++ E+++
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 113/210 (53%), Gaps = 11/210 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKG--VLPSGQEIAVKRLSKASG---QGAEEFKNEVVLV 395
           E+     S D  +G G FGEV  G   LPS +EI+V   +   G   +   +F  E  ++
Sbjct: 29  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 88
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
            +  H N++RL G   + +  ++V E++ N SLD FL   +   Q    +   ++ GIA 
Sbjct: 89  GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR--KHDAQFTVIQLVGMLRGIAS 146
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT-YG 514
           G+ YL   S +  +HRDL A NIL+++ +  K+SDFG++R+   D     T+R       
Sbjct: 147 GMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 203
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           + +PE   + +F+  SDV+S+G+++ E+++
Sbjct: 204 WTSPEAIAYRKFTSASDVWSYGIVLWEVMS 233

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 113/210 (53%), Gaps = 11/210 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKG--VLPSGQEIAVKRLSKASG---QGAEEFKNEVVLV 395
           E+     S D  +G G FGEV  G   LPS +EI+V   +   G   +   +F  E  ++
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
            +  H N++RL G   + +  ++V E++ N SLD FL   +   Q    +   ++ GIA 
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR--KHDAQFTVIQLVGMLRGIAS 158
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVG-TYG 514
           G+ YL   S +  +HRDL A NIL+++ +  K+SDFG++R+   D     T+R       
Sbjct: 159 GMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 215
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           + +PE   + +F+  SDV+S+G+++ E+++
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 113/210 (53%), Gaps = 11/210 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKG--VLPSGQEIAVKRLSKASG---QGAEEFKNEVVLV 395
           E+     S D  +G G FGEV  G   LPS +EI+V   +   G   +   +F  E  ++
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
            +  H N++RL G   + +  ++V E++ N SLD FL   +   Q    +   ++ GIA 
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR--KHDAQFTVIQLVGMLRGIAS 158
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVG-TYG 514
           G+ YL   S +  +HRDL A NIL+++ +  K+SDFG++R+   D     T+R       
Sbjct: 159 GMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 215
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           + +PE   + +F+  SDV+S+G+++ E+++
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 113/210 (53%), Gaps = 11/210 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKG--VLPSGQEIAVKRLSKASG---QGAEEFKNEVVLV 395
           E+     S D  +G G FGEV  G   LPS +EI+V   +   G   +   +F  E  ++
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
            +  H N++RL G   + +  ++V E++ N SLD FL   +   Q    +   ++ GIA 
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR--KHDAQFTVIQLVGMLRGIAS 158
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVG-TYG 514
           G+ YL   S +  +HRDL A NIL+++ +  K+SDFG++R+   D     T+R       
Sbjct: 159 GMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 215
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           + +PE   + +F+  SDV+S+G+++ E+++
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 113/210 (53%), Gaps = 11/210 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKG--VLPSGQEIAVKRLSKASG---QGAEEFKNEVVLV 395
           E+     S D  +G G FGEV  G   LPS +EI+V   +   G   +   +F  E  ++
Sbjct: 39  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 98
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
            +  H N++RL G   + +  ++V E++ N SLD FL   +   Q    +   ++ GIA 
Sbjct: 99  GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR--KHDAQFTVIQLVGMLRGIAS 156
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVG-TYG 514
           G+ YL   S +  +HRDL A NIL+++ +  K+SDFG++R+   D     T+R       
Sbjct: 157 GMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 213
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           + +PE   + +F+  SDV+S+G+++ E+++
Sbjct: 214 WTSPEAIAYRKFTSASDVWSYGIVLWEVMS 243

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 117/210 (55%), Gaps = 20/210 (9%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEI----AVKRLSKASGQGA-EEFKNEVVLVAKL 398
            +F     LG G FG VYKG+ +P G+++    A+K L +A+   A +E  +E  ++A +
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVP-NKSLDYFLYDPEKQGQ---LDWSRRYKIIGGIA 454
            + ++ RLLG CL    + L+ + +P    LDY     +  G    L+W  +      IA
Sbjct: 69  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 121
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
           +G+ YL ED RL  +HRDL A N+L+    + KI+DFG+A++ G ++ + +         
Sbjct: 122 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 178
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           +MA E  +H  ++ +SDV+S+GV V E++T
Sbjct: 179 WMALESILHRIYTHQSDVWSYGVTVWELMT 208

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 117/210 (55%), Gaps = 20/210 (9%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEI----AVKRLSKASGQGA-EEFKNEVVLVAKL 398
            +F     LG G FG VYKG+ +P G+++    A+K L +A+   A +E  +E  ++A +
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVP-NKSLDYFLYDPEKQGQ---LDWSRRYKIIGGIA 454
            + ++ RLLG CL    + L+ + +P    LDY     +  G    L+W  +      IA
Sbjct: 76  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 128
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
           +G+ YL ED RL  +HRDL A N+L+    + KI+DFG+A++ G ++ + +         
Sbjct: 129 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 185
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           +MA E  +H  ++ +SDV+S+GV V E++T
Sbjct: 186 WMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 117/210 (55%), Gaps = 20/210 (9%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEI----AVKRLSKASGQGA-EEFKNEVVLVAKL 398
            +F     LG G FG VYKG+ +P G+++    A+K L +A+   A +E  +E  ++A +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVP-NKSLDYFLYDPEKQGQ---LDWSRRYKIIGGIA 454
            + ++ RLLG CL    + L+ + +P    LDY     +  G    L+W  +      IA
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 127
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
           +G+ YL ED RL  +HRDL A N+L+    + KI+DFG+A++ G ++ + +         
Sbjct: 128 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           +MA E  +H  ++ +SDV+S+GV V E++T
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 112/210 (53%), Gaps = 11/210 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKG--VLPSGQEIAVKRLSKASG---QGAEEFKNEVVLV 395
           E+     S D  +G G FGEV  G   LPS +EI+V   +   G   +   +F  E  ++
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
            +  H N++RL G   + +  ++V E++ N SLD FL   +   Q    +   ++ GIA 
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR--KHDAQFTVIQLVGMLRGIAS 158
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT-YG 514
           G+ YL   S +  +HRDL A NIL+++ +  K+SDFG+ R+   D     T+R       
Sbjct: 159 GMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIR 215
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           + +PE   + +F+  SDV+S+G+++ E+++
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 117/210 (55%), Gaps = 20/210 (9%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEI----AVKRLSKASGQGA-EEFKNEVVLVAKL 398
            +F     LG G FG VYKG+ +P G+++    A+K L +A+   A +E  +E  ++A +
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVP-NKSLDYFLYDPEKQGQ---LDWSRRYKIIGGIA 454
            + ++ RLLG CL    + L+ + +P    LDY     +  G    L+W  +      IA
Sbjct: 79  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 131
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
           +G+ YL ED RL  +HRDL A N+L+    + KI+DFG+A++ G ++ + +         
Sbjct: 132 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 188
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           +MA E  +H  ++ +SDV+S+GV V E++T
Sbjct: 189 WMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 117/210 (55%), Gaps = 20/210 (9%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEI----AVKRLSKASGQGA-EEFKNEVVLVAKL 398
            +F     LG G FG VYKG+ +P G+++    A+K L +A+   A +E  +E  ++A +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVP-NKSLDYFLYDPEKQGQ---LDWSRRYKIIGGIA 454
            + ++ RLLG CL    + L+ + +P    LDY     +  G    L+W  +      IA
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 127
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
           +G+ YL ED RL  +HRDL A N+L+    + KI+DFG+A++ G ++ + +         
Sbjct: 128 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           +MA E  +H  ++ +SDV+S+GV V E++T
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 117/210 (55%), Gaps = 20/210 (9%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEI----AVKRLSKASGQGA-EEFKNEVVLVAKL 398
            +F     LG G FG VYKG+ +P G+++    A+K L +A+   A +E  +E  ++A +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVP-NKSLDYFLYDPEKQGQ---LDWSRRYKIIGGIA 454
            + ++ RLLG CL    + L+ + +P    LDY     +  G    L+W  +      IA
Sbjct: 78  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 130
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
           +G+ YL ED RL  +HRDL A N+L+    + KI+DFG+A++ G ++ + +         
Sbjct: 131 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 187
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           +MA E  +H  ++ +SDV+S+GV V E++T
Sbjct: 188 WMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 117/210 (55%), Gaps = 20/210 (9%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEI----AVKRLSKASGQGA-EEFKNEVVLVAKL 398
            +F     LG G FG VYKG+ +P G+++    A+K L +A+   A +E  +E  ++A +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVP-NKSLDYFLYDPEKQGQ---LDWSRRYKIIGGIA 454
            + ++ RLLG CL    + L+ + +P    LDY     +  G    L+W  +      IA
Sbjct: 77  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 129
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
           +G+ YL ED RL  +HRDL A N+L+    + KI+DFG+A++ G ++ + +         
Sbjct: 130 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 186
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           +MA E  +H  ++ +SDV+S+GV V E++T
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 117/210 (55%), Gaps = 20/210 (9%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEI----AVKRLSKASGQGA-EEFKNEVVLVAKL 398
            +F     LG G FG VYKG+ +P G+++    A+K L +A+   A +E  +E  ++A +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVP-NKSLDYFLYDPEKQGQ---LDWSRRYKIIGGIA 454
            + ++ RLLG CL    + L+ + +P    LDY     +  G    L+W  +      IA
Sbjct: 78  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 130
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
           +G+ YL ED RL  +HRDL A N+L+    + KI+DFG+A++ G ++ + +         
Sbjct: 131 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 187
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           +MA E  +H  ++ +SDV+S+GV V E++T
Sbjct: 188 WMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 112/217 (51%), Gaps = 21/217 (9%)
Query: 335 FDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVL 394
           ++ +  E+       + KLG G FGEV+        ++AVK + K      E F  E  +
Sbjct: 5   WEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANV 63
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQ-----LDWSRRYKI 449
           +  LQH  LV+L     + E   ++ EF+   SL  FL   E   Q     +D+S     
Sbjct: 64  MKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFS----- 117
Query: 450 IGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRI 509
              IA G+ ++ + +    IHRDL+A+NIL+ A +  KI+DFG+AR+    +    T+R 
Sbjct: 118 -AQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVI---EDNEYTARE 170
Query: 510 VGTY--GYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
              +   + APE    G F++KSDV+SFG+L++EI+T
Sbjct: 171 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 207

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 117/210 (55%), Gaps = 20/210 (9%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEI----AVKRLSKASGQGA-EEFKNEVVLVAKL 398
            +F     LG G FG VYKG+ +P G+++    A+K L +A+   A +E  +E  ++A +
Sbjct: 21  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 80
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVP-NKSLDYFLYDPEKQGQ---LDWSRRYKIIGGIA 454
            + ++ RLLG CL    + L+ + +P    LDY     +  G    L+W  +      IA
Sbjct: 81  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 133
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
           +G+ YL ED RL  +HRDL A N+L+    + KI+DFG+A++ G ++ + +         
Sbjct: 134 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 190
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           +MA E  +H  ++ +SDV+S+GV V E++T
Sbjct: 191 WMALESILHRIYTHQSDVWSYGVTVWELMT 220

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 117/210 (55%), Gaps = 20/210 (9%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEI----AVKRLSKASGQGA-EEFKNEVVLVAKL 398
            +F     LG G FG VYKG+ +P G+++    A+K L +A+   A +E  +E  ++A +
Sbjct: 25  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 84
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVP-NKSLDYFLYDPEKQGQ---LDWSRRYKIIGGIA 454
            + ++ RLLG CL    + L+ + +P    LDY     +  G    L+W  +      IA
Sbjct: 85  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 137
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
           +G+ YL ED RL  +HRDL A N+L+    + KI+DFG+A++ G ++ + +         
Sbjct: 138 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 194
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           +MA E  +H  ++ +SDV+S+GV V E++T
Sbjct: 195 WMALESILHRIYTHQSDVWSYGVTVWELMT 224

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 113/217 (52%), Gaps = 21/217 (9%)
Query: 335 FDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVL 394
           ++ +  E+       + KLG G FGEV+        ++AVK + K      E F  E  +
Sbjct: 178 WEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANV 236
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQ-----LDWSRRYKI 449
           +  LQH  LV+L     + E   ++ EF+   SL  FL   E   Q     +D+S +   
Sbjct: 237 MKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ--- 292
Query: 450 IGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRI 509
              IA G+ ++ + +    IHRDL+A+NIL+ A +  KI+DFG+AR+    +    T+R 
Sbjct: 293 ---IAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVI---EDNEYTARE 343
Query: 510 VGTY--GYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
              +   + APE    G F++KSDV+SFG+L++EI+T
Sbjct: 344 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 380

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 117/210 (55%), Gaps = 20/210 (9%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEI----AVKRLSKASGQGA-EEFKNEVVLVAKL 398
            +F     LG G FG VYKG+ +P G+++    A+K L +A+   A +E  +E  ++A +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVP-NKSLDYFLYDPEKQGQ---LDWSRRYKIIGGIA 454
            + ++ RLLG CL    + L+ + +P    LDY     +  G    L+W  +      IA
Sbjct: 78  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 130
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
           +G+ YL ED RL  +HRDL A N+L+    + KI+DFG+A++ G ++ + +         
Sbjct: 131 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 187
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           +MA E  +H  ++ +SDV+S+GV V E++T
Sbjct: 188 WMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 117/210 (55%), Gaps = 20/210 (9%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEI----AVKRLSKASGQGA-EEFKNEVVLVAKL 398
            +F     LG G FG VYKG+ +P G+++    A+K L +A+   A +E  +E  ++A +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVP-NKSLDYFLYDPEKQGQ---LDWSRRYKIIGGIA 454
            + ++ RLLG CL    + L+ + +P    LDY     +  G    L+W  +      IA
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 127
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
           +G+ YL ED RL  +HRDL A N+L+    + KI+DFG+A++ G ++ + +         
Sbjct: 128 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           +MA E  +H  ++ +SDV+S+GV V E++T
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 117/210 (55%), Gaps = 20/210 (9%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEI----AVKRLSKASGQGA-EEFKNEVVLVAKL 398
            +F     LG G FG VYKG+ +P G+++    A+K L +A+   A +E  +E  ++A +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVP-NKSLDYFLYDPEKQGQ---LDWSRRYKIIGGIA 454
            + ++ RLLG CL    + L+ + +P    LDY     +  G    L+W  +      IA
Sbjct: 78  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 130
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
           +G+ YL ED RL  +HRDL A N+L+    + KI+DFG+A++ G ++ + +         
Sbjct: 131 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 187
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           +MA E  +H  ++ +SDV+S+GV V E++T
Sbjct: 188 WMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 117/210 (55%), Gaps = 20/210 (9%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEI----AVKRLSKASGQGA-EEFKNEVVLVAKL 398
            +F     LG G FG VYKG+ +P G+++    A+K L +A+   A +E  +E  ++A +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVP-NKSLDYFLYDPEKQGQ---LDWSRRYKIIGGIA 454
            + ++ RLLG CL    + L+ + +P    LDY     +  G    L+W  +      IA
Sbjct: 77  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 129
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
           +G+ YL ED RL  +HRDL A N+L+    + KI+DFG+A++ G ++ + +         
Sbjct: 130 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 186
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           +MA E  +H  ++ +SDV+S+GV V E++T
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 117/210 (55%), Gaps = 20/210 (9%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEI----AVKRLSKASGQGA-EEFKNEVVLVAKL 398
            +F     LG G FG VYKG+ +P G+++    A+K L +A+   A +E  +E  ++A +
Sbjct: 40  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 99
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVP-NKSLDYFLYDPEKQGQ---LDWSRRYKIIGGIA 454
            + ++ RLLG CL    + L+ + +P    LDY     +  G    L+W  +      IA
Sbjct: 100 DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 152
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
           +G+ YL ED RL  +HRDL A N+L+    + KI+DFG+A++ G ++ + +         
Sbjct: 153 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 209
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           +MA E  +H  ++ +SDV+S+GV V E++T
Sbjct: 210 WMALESILHRIYTHQSDVWSYGVTVWELMT 239

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 112/209 (53%), Gaps = 9/209 (4%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
           E+   + +   ++G G FG VYKG       + +  ++  + Q  + FKNEV ++ K +H
Sbjct: 4   EIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 63
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
            N++  +G+  + +  I V ++    SL + L+  E + ++   +   I    A+G+ YL
Sbjct: 64  VNILLFMGYSTKPQLAI-VTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYL 120
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEY 520
           H  S   IIHRDLK++NI L  ++  KI DFG+A +           ++ G+  +MAPE 
Sbjct: 121 HAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 177
Query: 521 AM---HGQFSVKSDVYSFGVLVLEIITGK 546
                   +S +SDVY+FG+++ E++TG+
Sbjct: 178 IRMQDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 117/210 (55%), Gaps = 20/210 (9%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEI----AVKRLSKASGQGA-EEFKNEVVLVAKL 398
            +F     LG G FG VYKG+ +P G+++    A+K L +A+   A +E  +E  ++A +
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVP-NKSLDYFLYDPEKQGQ---LDWSRRYKIIGGIA 454
            + ++ RLLG CL    + L+ + +P    LDY     +  G    L+W  +      IA
Sbjct: 82  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 134
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
           +G+ YL ED RL  +HRDL A N+L+    + KI+DFG+A++ G ++ + +         
Sbjct: 135 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 191
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           +MA E  +H  ++ +SDV+S+GV V E++T
Sbjct: 192 WMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 112/209 (53%), Gaps = 9/209 (4%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
           E+   + +   ++G G FG VYKG       + +  ++  + Q  + FKNEV ++ K +H
Sbjct: 9   EIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 68
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
            N++  +G+  + +  I V ++    SL + L+  E + ++   +   I    A+G+ YL
Sbjct: 69  VNILLFMGYSTKPQLAI-VTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYL 125
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEY 520
           H  S   IIHRDLK++NI L  ++  KI DFG+A +           ++ G+  +MAPE 
Sbjct: 126 HAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 182
Query: 521 AM---HGQFSVKSDVYSFGVLVLEIITGK 546
                   +S +SDVY+FG+++ E++TG+
Sbjct: 183 IRMQDKNPYSFQSDVYAFGIVLYELMTGQ 211

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 112/209 (53%), Gaps = 9/209 (4%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
           E+   + +   ++G G FG VYKG       + +  ++  + Q  + FKNEV ++ K +H
Sbjct: 6   EIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 65
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
            N++  +G+  + +  I V ++    SL + L+  E + ++   +   I    A+G+ YL
Sbjct: 66  VNILLFMGYSTKPQLAI-VTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYL 122
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEY 520
           H  S   IIHRDLK++NI L  ++  KI DFG+A +           ++ G+  +MAPE 
Sbjct: 123 HAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 179
Query: 521 AM---HGQFSVKSDVYSFGVLVLEIITGK 546
                   +S +SDVY+FG+++ E++TG+
Sbjct: 180 IRMQDKNPYSFQSDVYAFGIVLYELMTGQ 208

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 112/209 (53%), Gaps = 9/209 (4%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
           E+   + +   ++G G FG VYKG       + +  ++  + Q  + FKNEV ++ K +H
Sbjct: 9   EIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 68
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
            N++  +G+  + +  I V ++    SL + L+  E + ++   +   I    A+G+ YL
Sbjct: 69  VNILLFMGYSTKPQLAI-VTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYL 125
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEY 520
           H  S   IIHRDLK++NI L  ++  KI DFG+A +           ++ G+  +MAPE 
Sbjct: 126 HAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 182
Query: 521 AM---HGQFSVKSDVYSFGVLVLEIITGK 546
                   +S +SDVY+FG+++ E++TG+
Sbjct: 183 IRMQDKNPYSFQSDVYAFGIVLYELMTGQ 211

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 112/210 (53%), Gaps = 11/210 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKG--VLPSGQEIAVKRLSKASG---QGAEEFKNEVVLV 395
           E+     S D  +G G FGEV  G   LPS +EI+V   +   G   +   +F  E  ++
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
            +  H N++RL G   + +  ++V E + N SLD FL   +   Q    +   ++ GIA 
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLR--KHDAQFTVIQLVGMLRGIAS 158
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVG-TYG 514
           G+ YL   S +  +HRDL A NIL+++ +  K+SDFG++R+   D     T+R       
Sbjct: 159 GMKYL---SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 215
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           + +PE   + +F+  SDV+S+G+++ E+++
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 112/210 (53%), Gaps = 11/210 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKG--VLPSGQEIAVKRLSKASG---QGAEEFKNEVVLV 395
           E+     S D  +G G FGEV  G   LPS +EI+V   +   G   +   +F  E  ++
Sbjct: 12  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 71
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
            +  H N++RL G   + +  ++V E + N SLD FL   +   Q    +   ++ GIA 
Sbjct: 72  GQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLR--KHDAQFTVIQLVGMLRGIAS 129
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT-YG 514
           G+ YL   S +  +HRDL A NIL+++ +  K+SDFG++R+   D     T+R       
Sbjct: 130 GMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 186
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           + +PE   + +F+  SDV+S+G+++ E+++
Sbjct: 187 WTSPEAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 112/209 (53%), Gaps = 9/209 (4%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
           E+   + +   ++G G FG VYKG       + +  ++  + Q  + FKNEV ++ K +H
Sbjct: 31  EIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 90
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
            N++  +G+  + +  I V ++    SL + L+  E + ++   +   I    A+G+ YL
Sbjct: 91  VNILLFMGYSTKPQLAI-VTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYL 147
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEY 520
           H  S   IIHRDLK++NI L  ++  KI DFG+A +           ++ G+  +MAPE 
Sbjct: 148 HAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 204
Query: 521 AM---HGQFSVKSDVYSFGVLVLEIITGK 546
                   +S +SDVY+FG+++ E++TG+
Sbjct: 205 IRMQDKNPYSFQSDVYAFGIVLYELMTGQ 233

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 75/223 (33%), Positives = 108/223 (48%), Gaps = 27/223 (12%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSKASGQGAE-EFKNEVV 393
           EV     +    LG G FGEVY+G +      PS  ++AVK L +   +  E +F  E +
Sbjct: 41  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 100
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYD----PEKQGQLDWSRRYKI 449
           +++KL H+N+VR +G  L+   + ++ E +    L  FL +    P +   L       +
Sbjct: 101 IISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 160
Query: 450 IGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP----KISDFGMARIFGVDQTQGN 505
              IA G  YL E+     IHRD+ A N LL     P    KI DFGMAR    D  + +
Sbjct: 161 ARDIACGCQYLEEN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR----DIYRAS 212
Query: 506 TSRIVG----TYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
             R  G       +M PE  M G F+ K+D +SFGVL+ EI +
Sbjct: 213 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 75/223 (33%), Positives = 108/223 (48%), Gaps = 27/223 (12%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSKASGQGAE-EFKNEVV 393
           EV     +    LG G FGEVY+G +      PS  ++AVK L +   +  E +F  E +
Sbjct: 27  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 86
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYD----PEKQGQLDWSRRYKI 449
           +++KL H+N+VR +G  L+   + ++ E +    L  FL +    P +   L       +
Sbjct: 87  IISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 146
Query: 450 IGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP----KISDFGMARIFGVDQTQGN 505
              IA G  YL E+     IHRD+ A N LL     P    KI DFGMAR    D  + +
Sbjct: 147 ARDIACGCQYLEEN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR----DIYRAS 198
Query: 506 TSRIVG----TYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
             R  G       +M PE  M G F+ K+D +SFGVL+ EI +
Sbjct: 199 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 116/210 (55%), Gaps = 20/210 (9%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEI----AVKRLSKASGQGA-EEFKNEVVLVAKL 398
            +F     LG G FG VYKG+ +P G+++    A+K L +A+   A +E  +E  ++A +
Sbjct: 12  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 71
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVP-NKSLDYFLYDPEKQGQ---LDWSRRYKIIGGIA 454
            + ++ RLLG CL    + L+ + +P    LDY     +  G    L+W  +      IA
Sbjct: 72  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 124
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
            G+ YL ED RL  +HRDL A N+L+    + KI+DFG+A++ G ++ + +         
Sbjct: 125 EGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 181
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           +MA E  +H  ++ +SDV+S+GV V E++T
Sbjct: 182 WMALESILHRIYTHQSDVWSYGVTVWELMT 211

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 99.0 bits (245), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 111/209 (53%), Gaps = 9/209 (4%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
           E+   + +   ++G G FG VYKG       + +  ++  + Q  + FKNEV ++ K +H
Sbjct: 4   EIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 63
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
            N++  +G+    +  I V ++    SL + L+  E + ++   +   I    A+G+ YL
Sbjct: 64  VNILLFMGYSTAPQLAI-VTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYL 120
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEY 520
           H  S   IIHRDLK++NI L  ++  KI DFG+A +           ++ G+  +MAPE 
Sbjct: 121 HAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 177
Query: 521 AM---HGQFSVKSDVYSFGVLVLEIITGK 546
                   +S +SDVY+FG+++ E++TG+
Sbjct: 178 IRMQDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 98.6 bits (244), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 116/210 (55%), Gaps = 20/210 (9%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEI----AVKRLSKASGQGA-EEFKNEVVLVAKL 398
            +F     LG G FG VYKG+ +P G+++    A+K L +A+   A +E  +E  ++A +
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVP-NKSLDYFLYDPEKQGQ---LDWSRRYKIIGGIA 454
            + ++ RLLG CL    + L+ + +P    LDY     +  G    L+W  +      IA
Sbjct: 79  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 131
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
           +G+ YL ED RL  +HRDL A N+L+    + KI+DFG A++ G ++ + +         
Sbjct: 132 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 188
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           +MA E  +H  ++ +SDV+S+GV V E++T
Sbjct: 189 WMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 112/210 (53%), Gaps = 11/210 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKG--VLPSGQEIAVKRLSKASG---QGAEEFKNEVVLV 395
           E+     S D  +G G FGEV  G   LPS +EI+V   +   G   +   +F  E  ++
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
            +  H N++RL G   + +  ++V E + N SLD FL   +   Q    +   ++ GIA 
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLR--KHDAQFTVIQLVGMLRGIAS 158
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVG-TYG 514
           G+ YL   S +  +HRDL A NIL+++ +  K+SDFG++R+   D     T+R       
Sbjct: 159 GMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 215
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           + +PE   + +F+  SDV+S+G+++ E+++
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 112/209 (53%), Gaps = 9/209 (4%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
           E+   + +   ++G G FG VYKG       + +  ++  + Q  + FKNEV ++ K +H
Sbjct: 32  EIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 91
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
            N++  +G+  + +  I V ++    SL + L+  E + ++   +   I    A+G+ YL
Sbjct: 92  VNILLFMGYSTKPQLAI-VTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYL 148
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEY 520
           H  S   IIHRDLK++NI L  ++  KI DFG+A +           ++ G+  +MAPE 
Sbjct: 149 HAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 205
Query: 521 AM---HGQFSVKSDVYSFGVLVLEIITGK 546
                   +S +SDVY+FG+++ E++TG+
Sbjct: 206 IRMQDKNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 116/210 (55%), Gaps = 20/210 (9%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEI----AVKRLSKASGQGA-EEFKNEVVLVAKL 398
            +F     LG G FG VYKG+ +P G+++    A+K L +A+   A +E  +E  ++A +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVP-NKSLDYFLYDPEKQGQ---LDWSRRYKIIGGIA 454
            + ++ RLLG CL    + L+ + +P    LDY     +  G    L+W  +      IA
Sbjct: 77  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 129
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
           +G+ YL ED RL  +HRDL A N+L+    + KI+DFG A++ G ++ + +         
Sbjct: 130 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 186
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           +MA E  +H  ++ +SDV+S+GV V E++T
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 116/210 (55%), Gaps = 20/210 (9%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEI----AVKRLSKASGQGA-EEFKNEVVLVAKL 398
            +F     LG G FG VYKG+ +P G+++    A+K L +A+   A +E  +E  ++A +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVP-NKSLDYFLYDPEKQGQ---LDWSRRYKIIGGIA 454
            + ++ RLLG CL    + L+ + +P    LDY     +  G    L+W  +      IA
Sbjct: 77  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 129
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
           +G+ YL ED RL  +HRDL A N+L+    + KI+DFG A++ G ++ + +         
Sbjct: 130 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 186
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           +MA E  +H  ++ +SDV+S+GV V E++T
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 114/213 (53%), Gaps = 17/213 (7%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
           E+   + +   ++G G FG VYKG       + +  ++  + Q  + FKNEV ++ K +H
Sbjct: 20  EIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 79
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
            N++  +G+  + +  I V ++    SL + L+  E + ++   +   I    ARG+ YL
Sbjct: 80  VNILLFMGYSTKPQLAI-VTQWCEGSSLYHHLHASETKFEM--KKLIDIARQTARGMDYL 136
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA----RIFGVDQTQGNTSRIVGTYGYM 516
           H  S   IIHRDLK++NI L  +   KI DFG+A    R  G  Q +    ++ G+  +M
Sbjct: 137 HAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFE----QLSGSILWM 189
Query: 517 APEYAM---HGQFSVKSDVYSFGVLVLEIITGK 546
           APE         +S +SDVY+FG+++ E++TG+
Sbjct: 190 APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 116/210 (55%), Gaps = 20/210 (9%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEI----AVKRLSKASGQGA-EEFKNEVVLVAKL 398
            +F     LG G FG VYKG+ +P G+++    A+K L +A+   A +E  +E  ++A +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVP-NKSLDYFLYDPEKQGQ---LDWSRRYKIIGGIA 454
            + ++ RLLG CL    + L+ + +P    LDY     +  G    L+W  +      IA
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 127
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
           +G+ YL ED RL  +HRDL A N+L+    + KI+DFG A++ G ++ + +         
Sbjct: 128 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 184
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           +MA E  +H  ++ +SDV+S+GV V E++T
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 116/210 (55%), Gaps = 20/210 (9%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEI----AVKRLSKASGQGA-EEFKNEVVLVAKL 398
            +F     LG G FG VYKG+ +P G+++    A+K L +A+   A +E  +E  ++A +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVP-NKSLDYFLYDPEKQGQ---LDWSRRYKIIGGIA 454
            + ++ RLLG CL    + L+ + +P    LDY     +  G    L+W  +      IA
Sbjct: 77  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 129
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
           +G+ YL ED RL  +HRDL A N+L+    + KI+DFG A++ G ++ + +         
Sbjct: 130 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 186
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           +MA E  +H  ++ +SDV+S+GV V E++T
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 69/202 (34%), Positives = 109/202 (53%), Gaps = 16/202 (7%)
Query: 353 LGEGGFGEVYKGVLP-----SGQEIAVKRLSKASG-QGAEEFKNEVVLVAKLQHRNLVRL 406
           LGEG FG+V           +G+++AVK L   SG     + K E+ ++  L H N+V+ 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 407 LGFCLE--GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
            G C E  G    L+ EF+P+ SL  +L  P+ + +++  ++ K    I +G+ YL   S
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYL--GS 132
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTS--RIVGTYGYMAPEYAM 522
           R + +HRDL A N+L+++E   KI DFG+ +    D+        R    + Y APE  M
Sbjct: 133 R-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APECLM 190
Query: 523 HGQFSVKSDVYSFGVLVLEIIT 544
             +F + SDV+SFGV + E++T
Sbjct: 191 QSKFYIASDVWSFGVTLHELLT 212

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 116/210 (55%), Gaps = 20/210 (9%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEI----AVKRLSKASGQGA-EEFKNEVVLVAKL 398
            +F     LG G FG VYKG+ +P G+++    A+K L +A+   A +E  +E  ++A +
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVP-NKSLDYFLYDPEKQGQ---LDWSRRYKIIGGIA 454
            + ++ RLLG CL    + L+ + +P    LDY     +  G    L+W  +      IA
Sbjct: 82  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 134
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
           +G+ YL ED RL  +HRDL A N+L+    + KI+DFG A++ G ++ + +         
Sbjct: 135 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 191
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           +MA E  +H  ++ +SDV+S+GV V E++T
Sbjct: 192 WMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 69/202 (34%), Positives = 109/202 (53%), Gaps = 16/202 (7%)
Query: 353 LGEGGFGEVYKGVLP-----SGQEIAVKRLSKASG-QGAEEFKNEVVLVAKLQHRNLVRL 406
           LGEG FG+V           +G+++AVK L   SG     + K E+ ++  L H N+V+ 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 407 LGFCLE--GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
            G C E  G    L+ EF+P+ SL  +L  P+ + +++  ++ K    I +G+ YL   S
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYL--GS 144
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT--SRIVGTYGYMAPEYAM 522
           R + +HRDL A N+L+++E   KI DFG+ +    D+        R    + Y APE  M
Sbjct: 145 R-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APECLM 202
Query: 523 HGQFSVKSDVYSFGVLVLEIIT 544
             +F + SDV+SFGV + E++T
Sbjct: 203 QSKFYIASDVWSFGVTLHELLT 224

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 72/215 (33%), Positives = 110/215 (51%), Gaps = 27/215 (12%)
Query: 335 FDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVL 394
           ++ +  E+       + KLG G FGEV+        ++AVK + K      E F  E  +
Sbjct: 172 WEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANV 230
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQ-----LDWSRRYKI 449
           +  LQH  LV+L     + E   ++ EF+   SL  FL   E   Q     +D+S +   
Sbjct: 231 MKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ--- 286
Query: 450 IGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRI 509
              IA G+ ++ + +    IHRDL+A+NIL+ A +  KI+DFG+AR+       G    I
Sbjct: 287 ---IAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARV-------GAKFPI 333
Query: 510 VGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
             T    APE    G F++KSDV+SFG+L++EI+T
Sbjct: 334 KWT----APEAINFGSFTIKSDVWSFGILLMEIVT 364

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 116/210 (55%), Gaps = 20/210 (9%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEI----AVKRLSKASGQGA-EEFKNEVVLVAKL 398
            +F     L  G FG VYKG+ +P G+++    A+K L +A+   A +E  +E  ++A +
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVP-NKSLDYFLYDPEKQGQ---LDWSRRYKIIGGIA 454
            + ++ RLLG CL    + L+ + +P    LDY     +  G    L+W  +      IA
Sbjct: 82  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 134
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
           +G+ YL ED RL  +HRDL A N+L+    + KI+DFG+A++ G ++ + +         
Sbjct: 135 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 191
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           +MA E  +H  ++ +SDV+S+GV V E++T
Sbjct: 192 WMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 113/213 (53%), Gaps = 17/213 (7%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
           E+   + +   ++G G FG VYKG       + +  ++  + Q  + FKNEV ++ K +H
Sbjct: 20  EIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 79
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
            N++  +G+    +  I V ++    SL + L+  E + ++   +   I    ARG+ YL
Sbjct: 80  VNILLFMGYSTAPQLAI-VTQWCEGSSLYHHLHASETKFEM--KKLIDIARQTARGMDYL 136
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA----RIFGVDQTQGNTSRIVGTYGYM 516
           H  S   IIHRDLK++NI L  +   KI DFG+A    R  G  Q +    ++ G+  +M
Sbjct: 137 HAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFE----QLSGSILWM 189
Query: 517 APEYAM---HGQFSVKSDVYSFGVLVLEIITGK 546
           APE         +S +SDVY+FG+++ E++TG+
Sbjct: 190 APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 74/223 (33%), Positives = 107/223 (47%), Gaps = 27/223 (12%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSKASGQGAE-EFKNEVV 393
           EV     +    LG G FGEVY+G +      PS  ++AVK L +   +  E +F  E +
Sbjct: 26  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 85
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYD----PEKQGQLDWSRRYKI 449
           +++K  H+N+VR +G  L+   + ++ E +    L  FL +    P +   L       +
Sbjct: 86  IISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 145
Query: 450 IGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP----KISDFGMARIFGVDQTQGN 505
              IA G  YL E+     IHRD+ A N LL     P    KI DFGMAR    D  + +
Sbjct: 146 ARDIACGCQYLEEN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR----DIYRAS 197
Query: 506 TSRIVG----TYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
             R  G       +M PE  M G F+ K+D +SFGVL+ EI +
Sbjct: 198 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 74/223 (33%), Positives = 107/223 (47%), Gaps = 27/223 (12%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSKASGQGAE-EFKNEVV 393
           EV     +    LG G FGEVY+G +      PS  ++AVK L +   +  E +F  E +
Sbjct: 26  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 85
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYD----PEKQGQLDWSRRYKI 449
           +++K  H+N+VR +G  L+   + ++ E +    L  FL +    P +   L       +
Sbjct: 86  IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 145
Query: 450 IGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP----KISDFGMARIFGVDQTQGN 505
              IA G  YL E+     IHRD+ A N LL     P    KI DFGMAR    D  + +
Sbjct: 146 ARDIACGCQYLEEN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR----DIYRAS 197
Query: 506 TSRIVG----TYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
             R  G       +M PE  M G F+ K+D +SFGVL+ EI +
Sbjct: 198 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 74/223 (33%), Positives = 107/223 (47%), Gaps = 27/223 (12%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSKASGQGAE-EFKNEVV 393
           EV     +    LG G FGEVY+G +      PS  ++AVK L +   +  E +F  E +
Sbjct: 33  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 92
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYD----PEKQGQLDWSRRYKI 449
           +++K  H+N+VR +G  L+   + ++ E +    L  FL +    P +   L       +
Sbjct: 93  IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 152
Query: 450 IGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP----KISDFGMARIFGVDQTQGN 505
              IA G  YL E+     IHRD+ A N LL     P    KI DFGMAR    D  + +
Sbjct: 153 ARDIACGCQYLEEN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR----DIYRAS 204
Query: 506 TSRIVG----TYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
             R  G       +M PE  M G F+ K+D +SFGVL+ EI +
Sbjct: 205 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 74/223 (33%), Positives = 107/223 (47%), Gaps = 27/223 (12%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSKASGQGAE-EFKNEVV 393
           EV     +    LG G FGEVY+G +      PS  ++AVK L +   +  E +F  E +
Sbjct: 41  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 100
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYD----PEKQGQLDWSRRYKI 449
           +++K  H+N+VR +G  L+   + ++ E +    L  FL +    P +   L       +
Sbjct: 101 IISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 160
Query: 450 IGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP----KISDFGMARIFGVDQTQGN 505
              IA G  YL E+     IHRD+ A N LL     P    KI DFGMAR    D  + +
Sbjct: 161 ARDIACGCQYLEEN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR----DIYRAS 212
Query: 506 TSRIVG----TYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
             R  G       +M PE  M G F+ K+D +SFGVL+ EI +
Sbjct: 213 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 116/210 (55%), Gaps = 20/210 (9%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEI----AVKRLSKASGQGA-EEFKNEVVLVAKL 398
            +F     LG G FG VYKG+ +P G+++    A+  L +A+   A +E  +E  ++A +
Sbjct: 49  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASV 108
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVP-NKSLDYFLYDPEKQGQ---LDWSRRYKIIGGIA 454
            + ++ RLLG CL    + L+ + +P    LDY     +  G    L+W  +      IA
Sbjct: 109 DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 161
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
           +G+ YL ED RL  +HRDL A N+L+    + KI+DFG+A++ G ++ + +         
Sbjct: 162 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 218
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           +MA E  +H  ++ +SDV+S+GV V E++T
Sbjct: 219 WMALESILHRIYTHQSDVWSYGVTVWELMT 248

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 115/213 (53%), Gaps = 17/213 (7%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
           E+   + +   ++G G FG VYKG       + +  ++  + Q  + FKNEV ++ K +H
Sbjct: 4   EIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 63
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
            N++  +G+  + +  I V ++    SL + L+  E + ++   +   I    A+G+ YL
Sbjct: 64  VNILLFMGYSTKPQLAI-VTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYL 120
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA----RIFGVDQTQGNTSRIVGTYGYM 516
           H  S   IIHRDLK++NI L  ++  KI DFG+A    R  G  Q +    ++ G+  +M
Sbjct: 121 HAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFE----QLSGSILWM 173
Query: 517 APEYAM---HGQFSVKSDVYSFGVLVLEIITGK 546
           APE         +S +SDVY+FG+++ E++TG+
Sbjct: 174 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 74/223 (33%), Positives = 106/223 (47%), Gaps = 27/223 (12%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSKASGQGAE-EFKNEVV 393
           EV     +    LG G FGEVY+G +      PS  ++AVK L +   +  E +F  E +
Sbjct: 67  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 126
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYD----PEKQGQLDWSRRYKI 449
           +++K  H+N+VR +G  L+   + ++ E +    L  FL +    P +   L       +
Sbjct: 127 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 186
Query: 450 IGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP----KISDFGMARIFGVDQTQGN 505
              IA G  YL E+     IHRD+ A N LL     P    KI DFGMAR    D  +  
Sbjct: 187 ARDIACGCQYLEEN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR----DIYRAG 238
Query: 506 TSRIVG----TYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
             R  G       +M PE  M G F+ K+D +SFGVL+ EI +
Sbjct: 239 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 116/210 (55%), Gaps = 20/210 (9%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEI----AVKRLSKASGQGA-EEFKNEVVLVAKL 398
            +F     L  G FG VYKG+ +P G+++    A+K L +A+   A +E  +E  ++A +
Sbjct: 15  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVP-NKSLDYFLYDPEKQGQ---LDWSRRYKIIGGIA 454
            + ++ RLLG CL    + L+ + +P    LDY     +  G    L+W  +      IA
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 127
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
           +G+ YL ED RL  +HRDL A N+L+    + KI+DFG+A++ G ++ + +         
Sbjct: 128 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           +MA E  +H  ++ +SDV+S+GV V E++T
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 74/223 (33%), Positives = 107/223 (47%), Gaps = 27/223 (12%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSKASGQGAE-EFKNEVV 393
           EV     +    LG G FGEVY+G +      PS  ++AVK L +   +  E +F  E +
Sbjct: 27  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 86
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYD----PEKQGQLDWSRRYKI 449
           +++K  H+N+VR +G  L+   + ++ E +    L  FL +    P +   L       +
Sbjct: 87  IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 146
Query: 450 IGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP----KISDFGMARIFGVDQTQGN 505
              IA G  YL E+     IHRD+ A N LL     P    KI DFGMAR    D  + +
Sbjct: 147 ARDIACGCQYLEEN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR----DIYRAS 198
Query: 506 TSRIVG----TYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
             R  G       +M PE  M G F+ K+D +SFGVL+ EI +
Sbjct: 199 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 74/223 (33%), Positives = 107/223 (47%), Gaps = 27/223 (12%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSKASGQGAE-EFKNEVV 393
           EV     +    LG G FGEVY+G +      PS  ++AVK L +   +  E +F  E +
Sbjct: 43  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 102
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYD----PEKQGQLDWSRRYKI 449
           +++K  H+N+VR +G  L+   + ++ E +    L  FL +    P +   L       +
Sbjct: 103 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 162
Query: 450 IGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP----KISDFGMARIFGVDQTQGN 505
              IA G  YL E+     IHRD+ A N LL     P    KI DFGMAR    D  + +
Sbjct: 163 ARDIACGCQYLEEN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR----DIYRAS 214
Query: 506 TSRIVG----TYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
             R  G       +M PE  M G F+ K+D +SFGVL+ EI +
Sbjct: 215 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 74/223 (33%), Positives = 107/223 (47%), Gaps = 27/223 (12%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSKASGQGAE-EFKNEVV 393
           EV     +    LG G FGEVY+G +      PS  ++AVK L +   +  E +F  E +
Sbjct: 18  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 77
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYD----PEKQGQLDWSRRYKI 449
           +++K  H+N+VR +G  L+   + ++ E +    L  FL +    P +   L       +
Sbjct: 78  IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 137
Query: 450 IGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP----KISDFGMARIFGVDQTQGN 505
              IA G  YL E+     IHRD+ A N LL     P    KI DFGMAR    D  + +
Sbjct: 138 ARDIACGCQYLEEN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR----DIYRAS 189
Query: 506 TSRIVG----TYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
             R  G       +M PE  M G F+ K+D +SFGVL+ EI +
Sbjct: 190 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 116/210 (55%), Gaps = 20/210 (9%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEI----AVKRLSKASGQGA-EEFKNEVVLVAKL 398
            +F     L  G FG VYKG+ +P G+++    A+K L +A+   A +E  +E  ++A +
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVP-NKSLDYFLYDPEKQGQ---LDWSRRYKIIGGIA 454
            + ++ RLLG CL    + L+ + +P    LDY     +  G    L+W  +      IA
Sbjct: 82  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 134
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
           +G+ YL ED RL  +HRDL A N+L+    + KI+DFG+A++ G ++ + +         
Sbjct: 135 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 191
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           +MA E  +H  ++ +SDV+S+GV V E++T
Sbjct: 192 WMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 115/213 (53%), Gaps = 17/213 (7%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
           E+   + +   ++G G FG VYKG       + +  ++  + Q  + FKNEV ++ K +H
Sbjct: 24  EIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 83
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
            N++  +G+  + +  I V ++    SL + L+  E + ++   +   I    A+G+ YL
Sbjct: 84  VNILLFMGYSTKPQLAI-VTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYL 140
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA----RIFGVDQTQGNTSRIVGTYGYM 516
           H  S   IIHRDLK++NI L  ++  KI DFG+A    R  G  Q +    ++ G+  +M
Sbjct: 141 HAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFE----QLSGSILWM 193
Query: 517 APEYAM---HGQFSVKSDVYSFGVLVLEIITGK 546
           APE         +S +SDVY+FG+++ E++TG+
Sbjct: 194 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 226

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 75/223 (33%), Positives = 107/223 (47%), Gaps = 27/223 (12%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSKA-SGQGAEEFKNEVV 393
           EV     +    LG G FGEVY+G +      PS  ++AVK L +  S Q   +F  E +
Sbjct: 41  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEAL 100
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYD----PEKQGQLDWSRRYKI 449
           +++K  H+N+VR +G  L+   + ++ E +    L  FL +    P +   L       +
Sbjct: 101 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 160
Query: 450 IGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP----KISDFGMARIFGVDQTQGN 505
              IA G  YL E+     IHRD+ A N LL     P    KI DFGMAR    D  + +
Sbjct: 161 ARDIACGCQYLEEN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR----DIYRAS 212
Query: 506 TSRIVG----TYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
             R  G       +M PE  M G F+ K+D +SFGVL+ EI +
Sbjct: 213 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 74/223 (33%), Positives = 106/223 (47%), Gaps = 27/223 (12%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSKASGQGAE-EFKNEVV 393
           EV     +    LG G FGEVY+G +      PS  ++AVK L +   +  E +F  E +
Sbjct: 44  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 103
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYD----PEKQGQLDWSRRYKI 449
           +++K  H+N+VR +G  L+   + ++ E +    L  FL +    P +   L       +
Sbjct: 104 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 163
Query: 450 IGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP----KISDFGMARIFGVDQTQGN 505
              IA G  YL E+     IHRD+ A N LL     P    KI DFGMAR    D  +  
Sbjct: 164 ARDIACGCQYLEEN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR----DIYRAG 215
Query: 506 TSRIVG----TYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
             R  G       +M PE  M G F+ K+D +SFGVL+ EI +
Sbjct: 216 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 74/223 (33%), Positives = 107/223 (47%), Gaps = 27/223 (12%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSKASGQGAE-EFKNEVV 393
           EV     +    LG G FGEVY+G +      PS  ++AVK L +   +  E +F  E +
Sbjct: 53  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 112
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYD----PEKQGQLDWSRRYKI 449
           +++K  H+N+VR +G  L+   + ++ E +    L  FL +    P +   L       +
Sbjct: 113 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 172
Query: 450 IGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP----KISDFGMARIFGVDQTQGN 505
              IA G  YL E+     IHRD+ A N LL     P    KI DFGMAR    D  + +
Sbjct: 173 ARDIACGCQYLEEN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR----DIYRAS 224
Query: 506 TSRIVG----TYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
             R  G       +M PE  M G F+ K+D +SFGVL+ EI +
Sbjct: 225 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 115/213 (53%), Gaps = 17/213 (7%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
           E+   + +   ++G G FG VYKG       + +  ++  + Q  + FKNEV ++ K +H
Sbjct: 32  EIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 91
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
            N++  +G+  + +  I V ++    SL + L+  E + ++   +   I    A+G+ YL
Sbjct: 92  VNILLFMGYSTKPQLAI-VTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYL 148
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA----RIFGVDQTQGNTSRIVGTYGYM 516
           H  S   IIHRDLK++NI L  ++  KI DFG+A    R  G  Q +    ++ G+  +M
Sbjct: 149 HAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFE----QLSGSILWM 201
Query: 517 APEYAM---HGQFSVKSDVYSFGVLVLEIITGK 546
           APE         +S +SDVY+FG+++ E++TG+
Sbjct: 202 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 72/218 (33%), Positives = 118/218 (54%), Gaps = 15/218 (6%)
Query: 353 LGEGGFGEVYKGV-LPSGQ----EIAVKRLSK-ASGQGAEEFKNEVVLVAKLQHRNLVRL 406
           LG G FG VYKG+ +P G+     +A+K L +  S +  +E  +E  ++A +    + RL
Sbjct: 25  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRL 84
Query: 407 LGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSR 465
           LG CL    + LV + +P   L D+     E +G+L           IA+G+ YL +   
Sbjct: 85  LGICLTSTVQ-LVTQLMPYGCLLDHVR---ENRGRLGSQDLLNWCMQIAKGMSYLED--- 137
Query: 466 LRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQ 525
           +R++HRDL A N+L+ +  + KI+DFG+AR+  +D+T+ +         +MA E  +  +
Sbjct: 138 VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRRR 197
Query: 526 FSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLS 562
           F+ +SDV+S+GV V E++T G K  +        DLL 
Sbjct: 198 FTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE 235

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 110/216 (50%), Gaps = 19/216 (8%)
Query: 339 TIEVATNKFSTDNKLGEGGFGEVYKGVL--PSGQEIAVKRLSKASG---QGAEEFKNEVV 393
           T E+  ++   +  +G G  GEV  G L  P  +++ V   +  +G   +   +F +E  
Sbjct: 43  TREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEAS 102
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGI 453
           ++ +  H N++RL G    G   ++V E++ N SLD FL      GQ    +   ++ G+
Sbjct: 103 IMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR--THDGQFTIMQLVGMLRGV 160
Query: 454 ARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTY 513
             G+ YL   S L  +HRDL A N+L+D+ +  K+SDFG++R+   D     T+    T 
Sbjct: 161 GAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTT----TG 213
Query: 514 G-----YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           G     + APE      FS  SDV+SFGV++ E++ 
Sbjct: 214 GKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 114/218 (52%), Gaps = 7/218 (3%)
Query: 328 TTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSKASGQGAE 386
           T+++    +++  E+     +  +KLG G +GEVY+GV       +AVK L K      E
Sbjct: 1   TSMDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVE 59
Query: 387 EFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRR 446
           EF  E  ++ +++H NLV+LLG C       ++ EF+   +L  +L +  +Q +++    
Sbjct: 60  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQ-EVNAVVL 118
Query: 447 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT 506
             +   I+  + YL + +    IHRDL A N L+      K++DFG++R+   D    + 
Sbjct: 119 LYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 175
Query: 507 SRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
                   + APE   + +FS+KSDV++FGVL+ EI T
Sbjct: 176 GAKFPI-KWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 114/218 (52%), Gaps = 7/218 (3%)
Query: 328 TTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSKASGQGAE 386
           T+++    +++  E+     +  +KLG G +GEVY+GV       +AVK L K      E
Sbjct: 1   TSMDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVE 59
Query: 387 EFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRR 446
           EF  E  ++ +++H NLV+LLG C       ++ EF+   +L  +L +  +Q +++    
Sbjct: 60  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVL 118
Query: 447 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT 506
             +   I+  + YL + +    IHRDL A N L+      K++DFG++R+   D    + 
Sbjct: 119 LYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 175
Query: 507 SRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
                   + APE   + +FS+KSDV++FGVL+ EI T
Sbjct: 176 GAKFPI-KWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 114/212 (53%), Gaps = 13/212 (6%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKG--VLPSGQEI--AVKRL-SKASGQGAEEFKNEVVLV 395
           E+  +    +  +G G FGEV  G   LP  +EI  A+K L S  + +   +F +E  ++
Sbjct: 29  EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIM 88
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
            +  H N++ L G   +    +++ EF+ N SLD FL   +  GQ    +   ++ GIA 
Sbjct: 89  GQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR--QNDGQFTVIQLVGMLRGIAA 146
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVG---T 512
           G+ YL +   +  +HRDL A NIL+++ +  K+SDFG++R    D +    +  +G    
Sbjct: 147 GMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIP 203
Query: 513 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
             + APE   + +F+  SDV+S+G+++ E+++
Sbjct: 204 IRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 235

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 70/219 (31%), Positives = 114/219 (52%), Gaps = 19/219 (8%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY----KGVLPSGQE--IAVKRLSKASGQGAE-EFKNEVV 393
           EVA  K +   +LG+G FG VY    KGV+    E  +A+K +++A+      EF NE  
Sbjct: 14  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 73
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYD--PEKQ-----GQLDWSRR 446
           ++ +    ++VRLLG   +G+  +++ E +    L  +L    PE +          S+ 
Sbjct: 74  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 133
Query: 447 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVDQTQGN 505
            ++ G IA G+ YL+ +   + +HRDL A N ++  +   KI DFGM R I+  D  +  
Sbjct: 134 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 190
Query: 506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
              ++    +M+PE    G F+  SDV+SFGV++ EI T
Sbjct: 191 GKGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 70/219 (31%), Positives = 114/219 (52%), Gaps = 19/219 (8%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY----KGVLPSGQE--IAVKRLSKASGQGAE-EFKNEVV 393
           EVA  K +   +LG+G FG VY    KGV+    E  +A+K +++A+      EF NE  
Sbjct: 12  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 71
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYD--PEKQ-----GQLDWSRR 446
           ++ +    ++VRLLG   +G+  +++ E +    L  +L    PE +          S+ 
Sbjct: 72  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 131
Query: 447 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVDQTQGN 505
            ++ G IA G+ YL+ +   + +HRDL A N ++  +   KI DFGM R I+  D  +  
Sbjct: 132 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 188
Query: 506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
              ++    +M+PE    G F+  SDV+SFGV++ EI T
Sbjct: 189 GKGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 70/219 (31%), Positives = 114/219 (52%), Gaps = 19/219 (8%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY----KGVLPSGQE--IAVKRLSKASGQGAE-EFKNEVV 393
           EVA  K +   +LG+G FG VY    KGV+    E  +A+K +++A+      EF NE  
Sbjct: 43  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 102
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYD--PEKQ-----GQLDWSRR 446
           ++ +    ++VRLLG   +G+  +++ E +    L  +L    PE +          S+ 
Sbjct: 103 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 162
Query: 447 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVDQTQGN 505
            ++ G IA G+ YL+ +   + +HRDL A N ++  +   KI DFGM R I+  D  +  
Sbjct: 163 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 219
Query: 506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
              ++    +M+PE    G F+  SDV+SFGV++ EI T
Sbjct: 220 GKGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 257

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 70/219 (31%), Positives = 114/219 (52%), Gaps = 19/219 (8%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY----KGVLPSGQE--IAVKRLSKASGQGAE-EFKNEVV 393
           EVA  K +   +LG+G FG VY    KGV+    E  +A+K +++A+      EF NE  
Sbjct: 14  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 73
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYD--PEKQ-----GQLDWSRR 446
           ++ +    ++VRLLG   +G+  +++ E +    L  +L    PE +          S+ 
Sbjct: 74  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 133
Query: 447 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVDQTQGN 505
            ++ G IA G+ YL+ +   + +HRDL A N ++  +   KI DFGM R I+  D  +  
Sbjct: 134 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 190
Query: 506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
              ++    +M+PE    G F+  SDV+SFGV++ EI T
Sbjct: 191 GKGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 70/219 (31%), Positives = 114/219 (52%), Gaps = 19/219 (8%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY----KGVLPSGQE--IAVKRLSKASGQGAE-EFKNEVV 393
           EVA  K +   +LG+G FG VY    KGV+    E  +A+K +++A+      EF NE  
Sbjct: 15  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 74
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYD--PEKQ-----GQLDWSRR 446
           ++ +    ++VRLLG   +G+  +++ E +    L  +L    PE +          S+ 
Sbjct: 75  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 134
Query: 447 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVDQTQGN 505
            ++ G IA G+ YL+ +   + +HRDL A N ++  +   KI DFGM R I+  D  +  
Sbjct: 135 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 191
Query: 506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
              ++    +M+PE    G F+  SDV+SFGV++ EI T
Sbjct: 192 GKGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 110/218 (50%), Gaps = 17/218 (7%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY----KGVLPSGQE--IAVKRLSKASGQGAE-EFKNEVV 393
           EVA  K +   +LG+G FG VY    KGV+    E  +A+K +++A+      EF NE  
Sbjct: 15  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 74
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYD--PEKQ-----GQLDWSRR 446
           ++ +    ++VRLLG   +G+  +++ E +    L  +L    PE +          S+ 
Sbjct: 75  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 134
Query: 447 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT 506
            ++ G IA G+ YL+ +   + +HRDL A N ++  +   KI DFGM R           
Sbjct: 135 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKG 191
Query: 507 SRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
            + +    +M+PE    G F+  SDV+SFGV++ EI T
Sbjct: 192 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 70/219 (31%), Positives = 114/219 (52%), Gaps = 19/219 (8%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY----KGVLPSGQE--IAVKRLSKASGQGAE-EFKNEVV 393
           EVA  K +   +LG+G FG VY    KGV+    E  +A+K +++A+      EF NE  
Sbjct: 21  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 80
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYD--PEKQ-----GQLDWSRR 446
           ++ +    ++VRLLG   +G+  +++ E +    L  +L    PE +          S+ 
Sbjct: 81  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 140
Query: 447 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVDQTQGN 505
            ++ G IA G+ YL+ +   + +HRDL A N ++  +   KI DFGM R I+  D  +  
Sbjct: 141 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 197
Query: 506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
              ++    +M+PE    G F+  SDV+SFGV++ EI T
Sbjct: 198 GKGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 73/223 (32%), Positives = 107/223 (47%), Gaps = 27/223 (12%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSKASGQGAE-EFKNEVV 393
           EV     +    LG G FGEVY+G +      PS  ++AVK L +   +  E +F  E +
Sbjct: 27  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 86
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYD----PEKQGQLDWSRRYKI 449
           +++K  H+N+VR +G  L+   + ++ E +    L  FL +    P +   L       +
Sbjct: 87  IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 146
Query: 450 IGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP----KISDFGMARIFGVDQTQGN 505
              IA G  YL E+     IHRD+ A N LL     P    KI DFGMA+    D  + +
Sbjct: 147 ARDIACGCQYLEEN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAQ----DIYRAS 198
Query: 506 TSRIVG----TYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
             R  G       +M PE  M G F+ K+D +SFGVL+ EI +
Sbjct: 199 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 110/216 (50%), Gaps = 19/216 (8%)
Query: 339 TIEVATNKFSTDNKLGEGGFGEVYKGVL--PSGQEIAVKRLSKASG---QGAEEFKNEVV 393
           T E+  ++   +  +G G  GEV  G L  P  +++ V   +  +G   +   +F +E  
Sbjct: 43  TREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEAS 102
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGI 453
           ++ +  H N++RL G    G   ++V E++ N SLD FL      GQ    +   ++ G+
Sbjct: 103 IMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR--THDGQFTIMQLVGMLRGV 160
Query: 454 ARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTY 513
             G+ YL   S L  +HRDL A N+L+D+ +  K+SDFG++R+   D     T+    T 
Sbjct: 161 GAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTT----TG 213
Query: 514 G-----YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           G     + APE      FS  SDV+SFGV++ E++ 
Sbjct: 214 GKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 110/218 (50%), Gaps = 17/218 (7%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY----KGVLPSGQE--IAVKRLSKASGQGAE-EFKNEVV 393
           EVA  K +   +LG+G FG VY    KGV+    E  +A+K +++A+      EF NE  
Sbjct: 6   EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 65
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYD--PEKQ-----GQLDWSRR 446
           ++ +    ++VRLLG   +G+  +++ E +    L  +L    PE +          S+ 
Sbjct: 66  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 125
Query: 447 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT 506
            ++ G IA G+ YL+ +   + +HRDL A N ++  +   KI DFGM R           
Sbjct: 126 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKG 182
Query: 507 SRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
            + +    +M+PE    G F+  SDV+SFGV++ EI T
Sbjct: 183 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 220

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 95.5 bits (236), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 70/219 (31%), Positives = 114/219 (52%), Gaps = 19/219 (8%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY----KGVLPSGQE--IAVKRLSKASGQGAE-EFKNEVV 393
           EVA  K +   +LG+G FG VY    KGV+    E  +A+K +++A+      EF NE  
Sbjct: 8   EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 67
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYD--PEKQ-----GQLDWSRR 446
           ++ +    ++VRLLG   +G+  +++ E +    L  +L    PE +          S+ 
Sbjct: 68  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 127
Query: 447 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVDQTQGN 505
            ++ G IA G+ YL+ +   + +HRDL A N ++  +   KI DFGM R I+  D  +  
Sbjct: 128 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 184
Query: 506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
              ++    +M+PE    G F+  SDV+SFGV++ EI T
Sbjct: 185 GKGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 110/210 (52%), Gaps = 7/210 (3%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSKASGQGAEEFKNEVVL 394
           +++  E+     +  +KLG G +GEVY+GV       +AVK L K      EEF  E  +
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAV 67
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIA 454
           + +++H NLV+LLG C       ++ EF+   +L  +L +  +Q +++      +   I+
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQIS 126
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
             + YL + +    IHRDL A N L+      K++DFG++R+   D    +         
Sbjct: 127 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI-K 182
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           + APE   + +FS+KSDV++FGVL+ EI T
Sbjct: 183 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 114/224 (50%), Gaps = 14/224 (6%)
Query: 347 FSTDNKLGEGGFGEVYKG-VLPSGQEIAVKRLSKASGQGA---EEFKNEVVLVAKLQHRN 402
           F   N LG+G F  VY+   + +G E+A+K + K +   A   +  +NEV +  +L+H +
Sbjct: 13  FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPS 72
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
           ++ L  +  +     LV E   N  ++ +L +  K    + +R +  +  I  G+LYLH 
Sbjct: 73  ILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHF--MHQIITGMLYLHS 130
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM 522
                I+HRDL  SN+LL   MN KI+DFG+A    +   +  T  + GT  Y++PE A 
Sbjct: 131 HG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYISPEIAT 185
Query: 523 HGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYVSI 566
                ++SDV+S G +   ++ G+     + TD   + L+ V +
Sbjct: 186 RSAHGLESDVWSLGCMFYTLLIGRPP---FDTDTVKNTLNKVVL 226

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 110/210 (52%), Gaps = 7/210 (3%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSKASGQGAEEFKNEVVL 394
           +++  E+     +  +KLG G +GEVY+GV       +AVK L K      EEF  E  +
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAV 62
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIA 454
           + +++H NLV+LLG C       ++ EF+   +L  +L +  +Q +++      +   I+
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQIS 121
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
             + YL + +    IHRDL A N L+      K++DFG++R+   D    +         
Sbjct: 122 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-K 177
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           + APE   + +FS+KSDV++FGVL+ EI T
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 110/210 (52%), Gaps = 7/210 (3%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSKASGQGAEEFKNEVVL 394
           +++  E+     +  +KLG G +GEVY+GV       +AVK L K      EEF  E  +
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAV 62
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIA 454
           + +++H NLV+LLG C       ++ EF+   +L  +L +  +Q +++      +   I+
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQIS 121
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
             + YL + +    IHRDL A N L+      K++DFG++R+   D    +         
Sbjct: 122 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-K 177
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           + APE   + +FS+KSDV++FGVL+ EI T
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 67/200 (33%), Positives = 101/200 (50%), Gaps = 13/200 (6%)
Query: 351 NKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFC 410
            ++G G FG V+ G   +  ++A+K + +      E+F  E  ++ KL H  LV+L G C
Sbjct: 13  QEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 411 LEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIH 470
           LE     LV+EF+ +  L  +L    ++G         +   +  G+ YL E S   +IH
Sbjct: 72  LEQAPICLVFEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAS---VIH 126
Query: 471 RDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT---YGYMAPEYAMHGQFS 527
           RDL A N L+      K+SDFGM R    DQ   +T    GT     + +PE     ++S
Sbjct: 127 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTKFPVKWASPEVFSFSRYS 182
Query: 528 VKSDVYSFGVLVLEIITGKK 547
            KSDV+SFGVL+ E+ +  K
Sbjct: 183 SKSDVWSFGVLMWEVFSEGK 202

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 110/210 (52%), Gaps = 7/210 (3%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSKASGQGAEEFKNEVVL 394
           +++  E+     +  +KLG G +GEVY+GV       +AVK L K      EEF  E  +
Sbjct: 8   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAV 66
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIA 454
           + +++H NLV+LLG C       ++ EF+   +L  +L +  +Q +++      +   I+
Sbjct: 67  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQIS 125
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
             + YL + +    IHRDL A N L+      K++DFG++R+   D    +         
Sbjct: 126 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-K 181
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           + APE   + +FS+KSDV++FGVL+ EI T
Sbjct: 182 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 211

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 110/210 (52%), Gaps = 7/210 (3%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSKASGQGAEEFKNEVVL 394
           +++  E+     +  +KLG G +GEVY+GV       +AVK L K      EEF  E  +
Sbjct: 5   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAV 63
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIA 454
           + +++H NLV+LLG C       ++ EF+   +L  +L +  +Q +++      +   I+
Sbjct: 64  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQIS 122
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
             + YL + +    IHRDL A N L+      K++DFG++R+   D    +         
Sbjct: 123 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI-K 178
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           + APE   + +FS+KSDV++FGVL+ EI T
Sbjct: 179 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 110/210 (52%), Gaps = 7/210 (3%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSKASGQGAEEFKNEVVL 394
           +++  E+     +  +KLG G +GEVY+GV       +AVK L K      EEF  E  +
Sbjct: 17  NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAV 75
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIA 454
           + +++H NLV+LLG C       ++ EF+   +L  +L +  +Q +++      +   I+
Sbjct: 76  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQIS 134
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
             + YL + +    IHRDL A N L+      K++DFG++R+   D    +         
Sbjct: 135 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-K 190
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           + APE   + +FS+KSDV++FGVL+ EI T
Sbjct: 191 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 220

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 110/210 (52%), Gaps = 7/210 (3%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSKASGQGAEEFKNEVVL 394
           +++  E+     +  +KLG G +GEVY+GV       +AVK L K      EEF  E  +
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAV 64
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIA 454
           + +++H NLV+LLG C       ++ EF+   +L  +L +  +Q +++      +   I+
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQIS 123
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
             + YL + +    IHRDL A N L+      K++DFG++R+   D    +         
Sbjct: 124 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-K 179
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           + APE   + +FS+KSDV++FGVL+ EI T
Sbjct: 180 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 112/214 (52%), Gaps = 7/214 (3%)
Query: 332 SLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSKASGQGAEEFKN 390
           ++  +++  E+     +  +KLG G +GEVY+GV       +AVK L K      EEF  
Sbjct: 2   AMDPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLK 60
Query: 391 EVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKII 450
           E  ++ +++H NLV+LLG C       ++ EF+   +L  +L +  +Q +++      + 
Sbjct: 61  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMA 119
Query: 451 GGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIV 510
             I+  + YL + +    IHRDL A N L+      K++DFG++R+   D    +     
Sbjct: 120 TQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 176
Query: 511 GTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
               + APE   + +FS+KSDV++FGVL+ EI T
Sbjct: 177 PI-KWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 110/210 (52%), Gaps = 7/210 (3%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSKASGQGAEEFKNEVVL 394
           +++  E+     +  +KLG G +GEVY+GV       +AVK L K      EEF  E  +
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAV 67
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIA 454
           + +++H NLV+LLG C       ++ EF+   +L  +L +  +Q +++      +   I+
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQIS 126
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
             + YL + +    IHRDL A N L+      K++DFG++R+   D    +         
Sbjct: 127 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-K 182
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           + APE   + +FS+KSDV++FGVL+ EI T
Sbjct: 183 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/219 (31%), Positives = 113/219 (51%), Gaps = 19/219 (8%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY----KGVLPSGQE--IAVKRLSKASGQGAE-EFKNEVV 393
           EVA  K +   +LG+G FG VY    KGV+    E  +A+K +++A+      EF NE  
Sbjct: 8   EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 67
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYD--PEKQ-----GQLDWSRR 446
           ++ +    ++VRLLG   +G+  +++ E +    L  +L    PE +          S+ 
Sbjct: 68  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 127
Query: 447 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVDQTQGN 505
            ++ G IA G+ YL+ +   + +HRDL A N  +  +   KI DFGM R I+  D  +  
Sbjct: 128 IQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKG 184
Query: 506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
              ++    +M+PE    G F+  SDV+SFGV++ EI T
Sbjct: 185 GKGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 113/210 (53%), Gaps = 11/210 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL--PSGQEI--AVKRLSKA-SGQGAEEFKNEVVLV 395
           E+  +    +  +G G FGEV  G L  P  +EI  A+K L    + +   +F +E  ++
Sbjct: 25  EIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIM 84
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
            +  H N++ L G   + +  +++ E++ N SLD FL   +  G+    +   ++ GI  
Sbjct: 85  GQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLR--KNDGRFTVIQLVGMLRGIGS 142
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVG-TYG 514
           G+ YL   S +  +HRDL A NIL+++ +  K+SDFGM+R+   D     T+R       
Sbjct: 143 GMKYL---SDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIR 199
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           + APE   + +F+  SDV+S+G+++ E+++
Sbjct: 200 WTAPEAIAYRKFTSASDVWSYGIVMWEVMS 229

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 105/201 (52%), Gaps = 13/201 (6%)
Query: 352 KLGEGGFGEV----YKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRL 406
           +LG+G FG V    Y  +   +G+ +AVK+L  ++ +   +F+ E+ ++  LQH N+V+ 
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 407 LGFCLEGEEK--ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
            G C     +   L+ EF+P  SL  +L   + + ++D  +  +    I +G+ YL    
Sbjct: 80  KGVCYSAGRRNLKLIMEFLPYGSLREYLQ--KHKERIDHIKLLQYTSQICKGMEYL---G 134
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRI-VGTYGYMAPEYAMH 523
             R IHRDL   NIL++ E   KI DFG+ ++   D+              + APE    
Sbjct: 135 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 194
Query: 524 GQFSVKSDVYSFGVLVLEIIT 544
            +FSV SDV+SFGV++ E+ T
Sbjct: 195 SKFSVASDVWSFGVVLYELFT 215

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 106/205 (51%), Gaps = 7/205 (3%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ 399
           E+     +  +KLG G FGEVY+GV       +AVK L K      EEF  E  ++ +++
Sbjct: 7   EMERTDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIK 65
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
           H NLV+LLG C       ++ EF+   +L  +L +  +Q ++       +   I+  + Y
Sbjct: 66  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEY 124
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE 519
           L + +    IHRDL A N L+      K++DFG++R+   D    +         + APE
Sbjct: 125 LEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI-KWTAPE 180
Query: 520 YAMHGQFSVKSDVYSFGVLVLEIIT 544
              + +FS+KSDV++FGVL+ EI T
Sbjct: 181 SLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 111/210 (52%), Gaps = 7/210 (3%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSKASGQGAEEFKNEVVL 394
           +++  E+     +  +KLG G +GEVY+GV       +AVK L K      EEF  E  +
Sbjct: 5   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAV 63
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIA 454
           + +++H NLV+LLG C       ++ EF+   +L  +L +  +Q +++      +   I+
Sbjct: 64  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQIS 122
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
             + YL + +    IHRDL A N L+      K++DFG++R+   D T    +       
Sbjct: 123 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAPAGAKFPIK 178
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           + APE   + +FS+KSDV++FGVL+ EI T
Sbjct: 179 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 109/210 (51%), Gaps = 7/210 (3%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSKASGQGAEEFKNEVVL 394
           +++  E+     +  +KLG G +GEVY+GV       +AVK L K      EEF  E  +
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAV 62
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIA 454
           + +++H NLV+LLG C       ++ EF+   +L  +L +  +Q ++       +   I+
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQIS 121
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
             + YL + +    IHRDL A N L+      K++DFG++R+   D    +         
Sbjct: 122 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-K 177
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           + APE   + +FS+KSDV++FGVL+ EI T
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 109/210 (51%), Gaps = 7/210 (3%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSKASGQGAEEFKNEVVL 394
           +++  E+     +  +KLG G +GEVY+GV       +AVK L K      EEF  E  +
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAV 62
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIA 454
           + +++H NLV+LLG C       ++ EF+   +L  +L +  +Q ++       +   I+
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQIS 121
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
             + YL + +    IHRDL A N L+      K++DFG++R+   D    +         
Sbjct: 122 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-K 177
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           + APE   + +FS+KSDV++FGVL+ EI T
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 111/210 (52%), Gaps = 7/210 (3%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSKASGQGAEEFKNEVVL 394
           +++  E+     +  +KLG G +GEVY+GV       +AVK L K      EEF  E  +
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAV 64
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIA 454
           + +++H NLV+LLG C       ++ EF+   +L  +L +  +Q +++      +   I+
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQIS 123
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
             + YL + +    IHRDL A N L+      K++DFG++R+   D T    +       
Sbjct: 124 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAPAGAKFPIK 179
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           + APE   + +FS+KSDV++FGVL+ EI T
Sbjct: 180 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 109/210 (51%), Gaps = 7/210 (3%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSKASGQGAEEFKNEVVL 394
           +++  E+     +  +KLG G +GEVY+GV       +AVK L K      EEF  E  +
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAV 62
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIA 454
           + +++H NLV+LLG C       ++ EF+   +L  +L +  +Q ++       +   I+
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQIS 121
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
             + YL + +    IHRDL A N L+      K++DFG++R+   D    +         
Sbjct: 122 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-K 177
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           + APE   + +FS+KSDV++FGVL+ EI T
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 109/210 (51%), Gaps = 7/210 (3%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSKASGQGAEEFKNEVVL 394
           +++  E+     +  +KLG G +GEVY+GV       +AVK L K      EEF  E  +
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAV 67
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIA 454
           + +++H NLV+LLG C       ++ EF+   +L  +L +  +Q ++       +   I+
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQIS 126
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
             + YL + +    IHRDL A N L+      K++DFG++R+   D    +         
Sbjct: 127 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-K 182
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           + APE   + +FS+KSDV++FGVL+ EI T
Sbjct: 183 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 110/209 (52%), Gaps = 9/209 (4%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
           E+  ++     ++G G FG VYKG       + + ++   + +  + F+NEV ++ K +H
Sbjct: 32  EIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRH 91
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
            N++  +G+ +  +   +V ++    SL   L+  E + Q+   +   I    A+G+ YL
Sbjct: 92  VNILLFMGY-MTKDNLAIVTQWCEGSSLYKHLHVQETKFQM--FQLIDIARQTAQGMDYL 148
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEY 520
           H  +   IIHRD+K++NI L   +  KI DFG+A +           +  G+  +MAPE 
Sbjct: 149 HAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEV 205
Query: 521 AM---HGQFSVKSDVYSFGVLVLEIITGK 546
                +  FS +SDVYS+G+++ E++TG+
Sbjct: 206 IRMQDNNPFSFQSDVYSYGIVLYELMTGE 234

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 109/210 (51%), Gaps = 7/210 (3%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSKASGQGAEEFKNEVVL 394
           +++  E+     +  +KLG G +GEVY+GV       +AVK L K      EEF  E  +
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAV 62
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIA 454
           + +++H NLV+LLG C       ++ EF+   +L  +L +  +Q ++       +   I+
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQIS 121
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
             + YL + +    IHRDL A N L+      K++DFG++R+   D    +         
Sbjct: 122 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-K 177
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           + APE   + +FS+KSDV++FGVL+ EI T
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 100/200 (50%), Gaps = 13/200 (6%)
Query: 351 NKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFC 410
            ++G G FG V+ G   +  ++A+K + +      E+F  E  ++ KL H  LV+L G C
Sbjct: 11  QEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 411 LEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIH 470
           LE     LV+EF+ +  L  +L    ++G         +   +  G+ YL E     +IH
Sbjct: 70  LEQAPICLVFEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 124
Query: 471 RDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT---YGYMAPEYAMHGQFS 527
           RDL A N L+      K+SDFGM R    DQ   +T    GT     + +PE     ++S
Sbjct: 125 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTKFPVKWASPEVFSFSRYS 180
Query: 528 VKSDVYSFGVLVLEIITGKK 547
            KSDV+SFGVL+ E+ +  K
Sbjct: 181 SKSDVWSFGVLMWEVFSEGK 200

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 77/269 (28%), Positives = 122/269 (45%), Gaps = 34/269 (12%)
Query: 317 AVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVK 375
           + PE+N + +L + +  + + +  + A   F     LG+G FG VY       + I A+K
Sbjct: 7   SAPENNPEEELASKQKNE-ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALK 65
Query: 376 RLSKASGQGA---EEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
            L KA  + A    + + EV + + L+H N++RL G+  +     L+ E+ P   L    
Sbjct: 66  VLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVY 122
Query: 433 YDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 492
            + +K  + D  R    I  +A  + Y H     R+IHRD+K  N+LL +    KI+DFG
Sbjct: 123 RELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG 179
Query: 493 MARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKK--NSN 550
               + V       + + GT  Y+ PE         K D++S GVL  E + GK    +N
Sbjct: 180 ----WSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 235
Query: 551 FYQ-----------------TDGAADLLS 562
            YQ                 T+GA DL+S
Sbjct: 236 TYQETYKRISRVEFTFPDFVTEGARDLIS 264

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 112/212 (52%), Gaps = 13/212 (6%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL--PSGQE--IAVKRLSKA-SGQGAEEFKNEVVLV 395
           E+  +    +  +G G FGEV +G L  P  +E  +A+K L    + +   EF +E  ++
Sbjct: 12  EIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIM 71
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
            + +H N++RL G        +++ EF+ N +LD FL      GQ    +   ++ GIA 
Sbjct: 72  GQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLR--LNDGQFTVIQLVGMLRGIAS 129
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVG---T 512
           G+ YL E   +  +HRDL A NIL+++ +  K+SDFG++R    + +    +  +G    
Sbjct: 130 GMRYLAE---MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIP 186
Query: 513 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
             + APE     +F+  SD +S+G+++ E+++
Sbjct: 187 IRWTAPEAIAFRKFTSASDAWSYGIVMWEVMS 218

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 113/210 (53%), Gaps = 11/210 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL--PSGQEI--AVKRLSKA-SGQGAEEFKNEVVLV 395
           E+  +    +  +G G FGEV  G L  P  +EI  A+K L    + +   +F +E  ++
Sbjct: 10  EIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIM 69
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
            +  H N++ L G   + +  +++ E++ N SLD FL   +  G+    +   ++ GI  
Sbjct: 70  GQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLR--KNDGRFTVIQLVGMLRGIGS 127
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT-YG 514
           G+ YL   S +  +HRDL A NIL+++ +  K+SDFGM+R+   D     T+R       
Sbjct: 128 GMKYL---SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIR 184
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           + APE   + +F+  SDV+S+G+++ E+++
Sbjct: 185 WTAPEAIAYRKFTSASDVWSYGIVMWEVMS 214

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 113/212 (53%), Gaps = 13/212 (6%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKG--VLPSGQEI--AVKRL-SKASGQGAEEFKNEVVLV 395
           E+  +    +  +G G FGEV  G   LP  +EI  A+K L S  + +   +F +E  ++
Sbjct: 3   EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIM 62
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
            +  H N++ L G   +    +++ EF+ N SLD FL   +  GQ    +   ++ GIA 
Sbjct: 63  GQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR--QNDGQFTVIQLVGMLRGIAA 120
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVG---T 512
           G+ YL +   +  +HR L A NIL+++ +  K+SDFG++R    D +    +  +G    
Sbjct: 121 GMKYLAD---MNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIP 177
Query: 513 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
             + APE   + +F+  SDV+S+G+++ E+++
Sbjct: 178 IRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 209

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 113/210 (53%), Gaps = 11/210 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL--PSGQEI--AVKRLSKA-SGQGAEEFKNEVVLV 395
           E+  +    +  +G G FGEV  G L  P  +EI  A+K L    + +   +F +E  ++
Sbjct: 4   EIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIM 63
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
            +  H N++ L G   + +  +++ E++ N SLD FL   +  G+    +   ++ GI  
Sbjct: 64  GQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLR--KNDGRFTVIQLVGMLRGIGS 121
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT-YG 514
           G+ YL   S +  +HRDL A NIL+++ +  K+SDFGM+R+   D     T+R       
Sbjct: 122 GMKYL---SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIR 178
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           + APE   + +F+  SDV+S+G+++ E+++
Sbjct: 179 WTAPEAIAYRKFTSASDVWSYGIVMWEVMS 208

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 113/210 (53%), Gaps = 11/210 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKG--VLPSGQE--IAVKRLSKA-SGQGAEEFKNEVVLV 395
           E+  +  + +  +G G FGEV  G   LP  +E  +A+K L    + +   +F  E  ++
Sbjct: 18  EIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIM 77
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
            +  H N++ L G   + +  ++V E++ N SLD FL   +  GQ    +   ++ GI+ 
Sbjct: 78  GQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLK--KNDGQFTVIQLVGMLRGISA 135
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVG-TYG 514
           G+ YL   S +  +HRDL A NIL+++ +  K+SDFG++R+   D     T+R       
Sbjct: 136 GMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 192
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           + APE     +F+  SDV+S+G+++ E+++
Sbjct: 193 WTAPEAIAFRKFTSASDVWSYGIVMWEVVS 222

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 100/200 (50%), Gaps = 13/200 (6%)
Query: 351 NKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFC 410
            ++G G FG V+ G   +  ++A+K + +      E+F  E  ++ KL H  LV+L G C
Sbjct: 13  QEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 411 LEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIH 470
           LE     LV+EF+ +  L  +L    ++G         +   +  G+ YL E     +IH
Sbjct: 72  LEQAPICLVFEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 126
Query: 471 RDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT---YGYMAPEYAMHGQFS 527
           RDL A N L+      K+SDFGM R    DQ   +T    GT     + +PE     ++S
Sbjct: 127 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTKFPVKWASPEVFSFSRYS 182
Query: 528 VKSDVYSFGVLVLEIITGKK 547
            KSDV+SFGVL+ E+ +  K
Sbjct: 183 SKSDVWSFGVLMWEVFSEGK 202

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 70/205 (34%), Positives = 110/205 (53%), Gaps = 11/205 (5%)
Query: 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLS-KASGQGAEEFK-NEVVLVAKLQHRN 402
            K+    K+GEG +G VYK     G+ +A+KR+   A  +G       E+ L+ +L H N
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
           +V L+          LV+EF+  K L   L D  K G  D S+    +  + RG+ + H+
Sbjct: 81  IVSLIDVIHSERCLTLVFEFM-EKDLKKVL-DENKTGLQD-SQIKIYLYQLLRGVAHCHQ 137
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM 522
               RI+HRDLK  N+L++++   K++DFG+AR FG+   +  T  +V T  Y AP+  M
Sbjct: 138 H---RILHRDLKPQNLLINSDGALKLADFGLARAFGI-PVRSYTHEVV-TLWYRAPDVLM 192
Query: 523 -HGQFSVKSDVYSFGVLVLEIITGK 546
              ++S   D++S G +  E+ITGK
Sbjct: 193 GSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 112/212 (52%), Gaps = 13/212 (6%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL--PSGQE--IAVKRLSKA-SGQGAEEFKNEVVLV 395
           E+  +    +  +G G FGEV +G L  P  +E  +A+K L    + +   EF +E  ++
Sbjct: 10  EIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIM 69
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
            + +H N++RL G        +++ EF+ N +LD FL      GQ    +   ++ GIA 
Sbjct: 70  GQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLR--LNDGQFTVIQLVGMLRGIAS 127
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVG---T 512
           G+ YL E   +  +HRDL A NIL+++ +  K+SDFG++R    + +    +  +G    
Sbjct: 128 GMRYLAE---MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIP 184
Query: 513 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
             + APE     +F+  SD +S+G+++ E+++
Sbjct: 185 IRWTAPEAIAFRKFTSASDAWSYGIVMWEVMS 216

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 106/205 (51%), Gaps = 7/205 (3%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ 399
           E+     +  +KLG G +GEVY+GV       +AVK L K      EEF  E  ++ +++
Sbjct: 7   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIK 65
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
           H NLV+LLG C       ++ EF+   +L  +L +  +Q ++       +   I+  + Y
Sbjct: 66  HPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEY 124
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE 519
           L + +    IHRDL A N L+      K++DFG++R+   D    +         + APE
Sbjct: 125 LEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI-KWTAPE 180
Query: 520 YAMHGQFSVKSDVYSFGVLVLEIIT 544
              + +FS+KSDV++FGVL+ EI T
Sbjct: 181 SLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 70/205 (34%), Positives = 110/205 (53%), Gaps = 11/205 (5%)
Query: 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLS-KASGQGAEEFK-NEVVLVAKLQHRN 402
            K+    K+GEG +G VYK     G+ +A+KR+   A  +G       E+ L+ +L H N
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
           +V L+          LV+EF+  K L   L D  K G  D S+    +  + RG+ + H+
Sbjct: 81  IVSLIDVIHSERCLTLVFEFM-EKDLKKVL-DENKTGLQD-SQIKIYLYQLLRGVAHCHQ 137
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM 522
               RI+HRDLK  N+L++++   K++DFG+AR FG+   +  T  +V T  Y AP+  M
Sbjct: 138 H---RILHRDLKPQNLLINSDGALKLADFGLARAFGI-PVRSYTHEVV-TLWYRAPDVLM 192
Query: 523 -HGQFSVKSDVYSFGVLVLEIITGK 546
              ++S   D++S G +  E+ITGK
Sbjct: 193 GSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 101/200 (50%), Gaps = 13/200 (6%)
Query: 351 NKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFC 410
            ++G G FG V+ G   +  ++A+K + + +    E+F  E  ++ KL H  LV+L G C
Sbjct: 16  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVC 74
Query: 411 LEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIH 470
           LE     LV+EF+ +  L  +L    ++G         +   +  G+ YL E     +IH
Sbjct: 75  LEQAPICLVFEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 129
Query: 471 RDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT---YGYMAPEYAMHGQFS 527
           RDL A N L+      K+SDFGM R    DQ   +T    GT     + +PE     ++S
Sbjct: 130 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTKFPVKWASPEVFSFSRYS 185
Query: 528 VKSDVYSFGVLVLEIITGKK 547
            KSDV+SFGVL+ E+ +  K
Sbjct: 186 SKSDVWSFGVLMWEVFSEGK 205

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 352 KLGEGGFGEV----YKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRL 406
           +LG+G FG V    Y  +   +G+ +AVK+L  ++ +   +F+ E+ ++  LQH N+V+ 
Sbjct: 48  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 107
Query: 407 LGFCLEGEEK--ILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
            G C     +   L+ E++P  SL DY     E+   +D  +  +    I +G+ YL   
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL--- 161
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRI-VGTYGYMAPEYAM 522
              R IHRDL   NIL++ E   KI DFG+ ++   D+              + APE   
Sbjct: 162 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 221
Query: 523 HGQFSVKSDVYSFGVLVLEIIT 544
             +FSV SDV+SFGV++ E+ T
Sbjct: 222 ESKFSVASDVWSFGVVLYELFT 243

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 72/221 (32%), Positives = 114/221 (51%), Gaps = 9/221 (4%)
Query: 326 DLTTLESLQFD-FETIEVATNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSKASGQ 383
           DL T E+L F   +  E+     +  +KLG G +GEVY GV       +AVK L + + +
Sbjct: 13  DLGT-ENLYFQSMDKWEMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTME 71
Query: 384 GAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDW 443
             EEF  E  ++ +++H NLV+LLG C       +V E++P  +L  +L +  ++     
Sbjct: 72  -VEEFLKEAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAV 130
Query: 444 SRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ 503
              Y +   I+  + YL + +    IHRDL A N L+      K++DFG++R+   D   
Sbjct: 131 VLLY-MATQISSAMEYLEKKN---FIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYT 186
Query: 504 GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
            +         + APE   +  FS+KSDV++FGVL+ EI T
Sbjct: 187 AHAGAKFPI-KWTAPESLAYNTFSIKSDVWAFGVLLWEIAT 226

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 352 KLGEGGFGEV----YKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRL 406
           +LG+G FG V    Y  +   +G+ +AVK+L  ++ +   +F+ E+ ++  LQH N+V+ 
Sbjct: 22  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 81
Query: 407 LGFCLEGEEK--ILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
            G C     +   L+ E++P  SL DY     E+   +D  +  +    I +G+ YL   
Sbjct: 82  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL--- 135
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRI-VGTYGYMAPEYAM 522
              R IHRDL   NIL++ E   KI DFG+ ++   D+              + APE   
Sbjct: 136 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 195
Query: 523 HGQFSVKSDVYSFGVLVLEIIT 544
             +FSV SDV+SFGV++ E+ T
Sbjct: 196 ESKFSVASDVWSFGVVLYELFT 217

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 352 KLGEGGFGEV----YKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRL 406
           +LG+G FG V    Y  +   +G+ +AVK+L  ++ +   +F+ E+ ++  LQH N+V+ 
Sbjct: 16  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 75
Query: 407 LGFCLEGEEK--ILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
            G C     +   L+ E++P  SL DY     E+   +D  +  +    I +G+ YL   
Sbjct: 76  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL--- 129
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRI-VGTYGYMAPEYAM 522
              R IHRDL   NIL++ E   KI DFG+ ++   D+              + APE   
Sbjct: 130 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 189
Query: 523 HGQFSVKSDVYSFGVLVLEIIT 544
             +FSV SDV+SFGV++ E+ T
Sbjct: 190 ESKFSVASDVWSFGVVLYELFT 211

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 352 KLGEGGFGEV----YKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRL 406
           +LG+G FG V    Y  +   +G+ +AVK+L  ++ +   +F+ E+ ++  LQH N+V+ 
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 407 LGFCLEGEEK--ILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
            G C     +   L+ E++P  SL DY     E+   +D  +  +    I +G+ YL   
Sbjct: 80  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAER---IDHIKLLQYTSQICKGMEYL--- 133
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRI-VGTYGYMAPEYAM 522
              R IHRDL   NIL++ E   KI DFG+ ++   D+              + APE   
Sbjct: 134 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 193
Query: 523 HGQFSVKSDVYSFGVLVLEIIT 544
             +FSV SDV+SFGV++ E+ T
Sbjct: 194 ESKFSVASDVWSFGVVLYELFT 215

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 352 KLGEGGFGEV----YKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRL 406
           +LG+G FG V    Y  +   +G+ +AVK+L  ++ +   +F+ E+ ++  LQH N+V+ 
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 407 LGFCLEGEEK--ILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
            G C     +   L+ E++P  SL DY     E+   +D  +  +    I +G+ YL   
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL--- 130
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRI-VGTYGYMAPEYAM 522
              R IHRDL   NIL++ E   KI DFG+ ++   D+              + APE   
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 190
Query: 523 HGQFSVKSDVYSFGVLVLEIIT 544
             +FSV SDV+SFGV++ E+ T
Sbjct: 191 ESKFSVASDVWSFGVVLYELFT 212

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 352 KLGEGGFGEV----YKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRL 406
           +LG+G FG V    Y  +   +G+ +AVK+L  ++ +   +F+ E+ ++  LQH N+V+ 
Sbjct: 21  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 80
Query: 407 LGFCLEGEEK--ILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
            G C     +   L+ E++P  SL DY     E+   +D  +  +    I +G+ YL   
Sbjct: 81  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL--- 134
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRI-VGTYGYMAPEYAM 522
              R IHRDL   NIL++ E   KI DFG+ ++   D+              + APE   
Sbjct: 135 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 194
Query: 523 HGQFSVKSDVYSFGVLVLEIIT 544
             +FSV SDV+SFGV++ E+ T
Sbjct: 195 ESKFSVASDVWSFGVVLYELFT 216

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 111/219 (50%), Gaps = 19/219 (8%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY----KGVLPSGQE--IAVKRLSKASGQGAE-EFKNEVV 393
           EVA  K +   +LG+G FG VY    KGV+    E  +A+K +++A+      EF NE  
Sbjct: 21  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 80
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQ-------GQLDWSRR 446
           ++ +    ++VRLLG   +G+  +++ E +    L  +L                  S+ 
Sbjct: 81  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 140
Query: 447 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVDQTQGN 505
            ++ G IA G+ YL+ +   + +HRDL A N ++  +   KI DFGM R I+  D  +  
Sbjct: 141 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 197
Query: 506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
              ++    +M+PE    G F+  SDV+SFGV++ EI T
Sbjct: 198 GKGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 352 KLGEGGFGEV----YKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRL 406
           +LG+G FG V    Y  +   +G+ +AVK+L  ++ +   +F+ E+ ++  LQH N+V+ 
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 407 LGFCLEGEEK--ILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
            G C     +   L+ E++P  SL DY     E+   +D  +  +    I +G+ YL   
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL--- 130
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRI-VGTYGYMAPEYAM 522
              R IHRDL   NIL++ E   KI DFG+ ++   D+              + APE   
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 190
Query: 523 HGQFSVKSDVYSFGVLVLEIIT 544
             +FSV SDV+SFGV++ E+ T
Sbjct: 191 ESKFSVASDVWSFGVVLYELFT 212

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 101/200 (50%), Gaps = 13/200 (6%)
Query: 351 NKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFC 410
            ++G G FG V+ G   +  ++A+K + + S    ++F  E  ++ KL H  LV+L G C
Sbjct: 33  QEIGSGQFGLVHLGYWLNKDKVAIKTIKEGS-MSEDDFIEEAEVMMKLSHPKLVQLYGVC 91
Query: 411 LEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIH 470
           LE     LV+EF+ +  L  +L    ++G         +   +  G+ YL E     +IH
Sbjct: 92  LEQAPICLVFEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 146
Query: 471 RDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT---YGYMAPEYAMHGQFS 527
           RDL A N L+      K+SDFGM R    DQ   +T    GT     + +PE     ++S
Sbjct: 147 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTKFPVKWASPEVFSFSRYS 202
Query: 528 VKSDVYSFGVLVLEIITGKK 547
            KSDV+SFGVL+ E+ +  K
Sbjct: 203 SKSDVWSFGVLMWEVFSEGK 222

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 111/219 (50%), Gaps = 19/219 (8%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY----KGVLPSGQE--IAVKRLSKASGQGAE-EFKNEVV 393
           EVA  K +   +LG+G FG VY    KGV+    E  +A+K +++A+      EF NE  
Sbjct: 11  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 70
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQ-------GQLDWSRR 446
           ++ +    ++VRLLG   +G+  +++ E +    L  +L                  S+ 
Sbjct: 71  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 130
Query: 447 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVDQTQGN 505
            ++ G IA G+ YL+ +   + +HRDL A N ++  +   KI DFGM R I+  D  +  
Sbjct: 131 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 187
Query: 506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
              ++    +M+PE    G F+  SDV+SFGV++ EI T
Sbjct: 188 GKGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 352 KLGEGGFGEV----YKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRL 406
           +LG+G FG V    Y  +   +G+ +AVK+L  ++ +   +F+ E+ ++  LQH N+V+ 
Sbjct: 15  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 74
Query: 407 LGFCLEGEEK--ILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
            G C     +   L+ E++P  SL DY     E+   +D  +  +    I +G+ YL   
Sbjct: 75  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL--- 128
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRI-VGTYGYMAPEYAM 522
              R IHRDL   NIL++ E   KI DFG+ ++   D+              + APE   
Sbjct: 129 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 188
Query: 523 HGQFSVKSDVYSFGVLVLEIIT 544
             +FSV SDV+SFGV++ E+ T
Sbjct: 189 ESKFSVASDVWSFGVVLYELFT 210

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 352 KLGEGGFGEV----YKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRL 406
           +LG+G FG V    Y  +   +G+ +AVK+L  ++ +   +F+ E+ ++  LQH N+V+ 
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 407 LGFCLEGEEK--ILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
            G C     +   L+ E++P  SL DY     E+   +D  +  +    I +G+ YL   
Sbjct: 80  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL--- 133
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRI-VGTYGYMAPEYAM 522
              R IHRDL   NIL++ E   KI DFG+ ++   D+              + APE   
Sbjct: 134 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 193
Query: 523 HGQFSVKSDVYSFGVLVLEIIT 544
             +FSV SDV+SFGV++ E+ T
Sbjct: 194 ESKFSVASDVWSFGVVLYELFT 215

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 352 KLGEGGFGEV----YKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRL 406
           +LG+G FG V    Y  +   +G+ +AVK+L  ++ +   +F+ E+ ++  LQH N+V+ 
Sbjct: 24  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 83
Query: 407 LGFCLEGEEK--ILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
            G C     +   L+ E++P  SL DY     E+   +D  +  +    I +G+ YL   
Sbjct: 84  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL--- 137
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRI-VGTYGYMAPEYAM 522
              R IHRDL   NIL++ E   KI DFG+ ++   D+              + APE   
Sbjct: 138 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 197
Query: 523 HGQFSVKSDVYSFGVLVLEIIT 544
             +FSV SDV+SFGV++ E+ T
Sbjct: 198 ESKFSVASDVWSFGVVLYELFT 219

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 77/269 (28%), Positives = 121/269 (44%), Gaps = 34/269 (12%)
Query: 317 AVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVK 375
           + PE+N + +L + +  + + +  + A   F     LG+G FG VY       + I A+K
Sbjct: 7   SAPENNPEEELASKQKNE-ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALK 65
Query: 376 RLSKASGQGA---EEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
            L KA  + A    + + EV + + L+H N++RL G+  +     L+ E+ P   L    
Sbjct: 66  VLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVY 122
Query: 433 YDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 492
            + +K  + D  R    I  +A  + Y H     R+IHRD+K  N+LL +    KI+DFG
Sbjct: 123 RELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG 179
Query: 493 MARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKK--NSN 550
               + V         + GT  Y+ PE         K D++S GVL  E + GK    +N
Sbjct: 180 ----WSVHAPSSRRDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 235
Query: 551 FYQ-----------------TDGAADLLS 562
            YQ                 T+GA DL+S
Sbjct: 236 TYQETYKRISRVEFTFPDFVTEGARDLIS 264

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 352 KLGEGGFGEV----YKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRL 406
           +LG+G FG V    Y  +   +G+ +AVK+L  ++ +   +F+ E+ ++  LQH N+V+ 
Sbjct: 23  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 82
Query: 407 LGFCLEGEEK--ILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
            G C     +   L+ E++P  SL DY     E+   +D  +  +    I +G+ YL   
Sbjct: 83  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL--- 136
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRI-VGTYGYMAPEYAM 522
              R IHRDL   NIL++ E   KI DFG+ ++   D+              + APE   
Sbjct: 137 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 196
Query: 523 HGQFSVKSDVYSFGVLVLEIIT 544
             +FSV SDV+SFGV++ E+ T
Sbjct: 197 ESKFSVASDVWSFGVVLYELFT 218

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 112/217 (51%), Gaps = 7/217 (3%)
Query: 329 TLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSKASGQGAEE 387
           T+  +  +++  E+     +  +KLG G +GEVY+GV       +AVK L K      EE
Sbjct: 204 TIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEE 262
Query: 388 FKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRY 447
           F  E  ++ +++H NLV+LLG C       ++ EF+   +L  +L +  +Q ++      
Sbjct: 263 FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLL 321
Query: 448 KIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTS 507
            +   I+  + YL + +    IHR+L A N L+      K++DFG++R+   D    +  
Sbjct: 322 YMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 378
Query: 508 RIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
                  + APE   + +FS+KSDV++FGVL+ EI T
Sbjct: 379 AKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 414

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 107/206 (51%), Gaps = 23/206 (11%)
Query: 352 KLGEGGFGEV----YKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRL 406
           +LG+G FG V    Y  +   +G+ +AVK+L  ++ +   +F+ E+ ++  LQH N+V+ 
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 407 LGFCLEGEEK--ILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
            G C     +   L+ E++P  SL DY     E+   +D  +  +    I +G+ YL   
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL--- 130
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ-----TQGNTSRIVGTYGYMAP 518
              R IHRDL   NIL++ E   KI DFG+ ++   D+      +   S I     + AP
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF----WYAP 186
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIIT 544
           E     +FSV SDV+SFGV++ E+ T
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 352 KLGEGGFGEV----YKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRL 406
           +LG+G FG V    Y  +   +G+ +AVK+L  ++ +   +F+ E+ ++  LQH N+V+ 
Sbjct: 35  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 407 LGFCLEGEEK--ILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
            G C     +   L+ E++P  SL DY     E+   +D  +  +    I +G+ YL   
Sbjct: 95  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL--- 148
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRI-VGTYGYMAPEYAM 522
              R IHRDL   NIL++ E   KI DFG+ ++   D+              + APE   
Sbjct: 149 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 208
Query: 523 HGQFSVKSDVYSFGVLVLEIIT 544
             +FSV SDV+SFGV++ E+ T
Sbjct: 209 ESKFSVASDVWSFGVVLYELFT 230

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 352 KLGEGGFGEV----YKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRL 406
           +LG+G FG V    Y  +   +G+ +AVK+L  ++ +   +F+ E+ ++  LQH N+V+ 
Sbjct: 35  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 407 LGFCLEGEEK--ILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
            G C     +   L+ E++P  SL DY     E+   +D  +  +    I +G+ YL   
Sbjct: 95  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL--- 148
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRI-VGTYGYMAPEYAM 522
              R IHRDL   NIL++ E   KI DFG+ ++   D+              + APE   
Sbjct: 149 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 208
Query: 523 HGQFSVKSDVYSFGVLVLEIIT 544
             +FSV SDV+SFGV++ E+ T
Sbjct: 209 ESKFSVASDVWSFGVVLYELFT 230

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 115/217 (52%), Gaps = 7/217 (3%)
Query: 329 TLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSKASGQGAEE 387
           T+  +  +++  E+     +  +KLG G +GEVY+GV       +AVK L + + +  EE
Sbjct: 243 TVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEE 301
Query: 388 FKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRY 447
           F  E  ++ +++H NLV+LLG C       ++ EF+   +L  +L +  +Q +++     
Sbjct: 302 FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLL 360
Query: 448 KIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTS 507
            +   I+  + YL + +    IHR+L A N L+      K++DFG++R+   D    +  
Sbjct: 361 YMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 417
Query: 508 RIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
                  + APE   + +FS+KSDV++FGVL+ EI T
Sbjct: 418 AKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 453

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 106/205 (51%), Gaps = 7/205 (3%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ 399
           E+     +  +KLG G +GEVY+GV       +AVK L K      EEF  E  ++ +++
Sbjct: 7   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIK 65
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
           H NLV+LLG C       ++ EF+   +L  +L +  +Q ++       +   I+  + Y
Sbjct: 66  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEY 124
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE 519
           L + +    IHRDL A N L+      K++DFG++R+   D    +         + APE
Sbjct: 125 LEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPI-KWTAPE 180
Query: 520 YAMHGQFSVKSDVYSFGVLVLEIIT 544
              + +FS+KSDV++FGVL+ EI T
Sbjct: 181 SLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 99/200 (49%), Gaps = 13/200 (6%)
Query: 351 NKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFC 410
            ++G G FG V+ G   +  ++A+K + +      E+F  E  ++ KL H  LV+L G C
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 411 LEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIH 470
           LE     LV EF+ +  L  +L    ++G         +   +  G+ YL E     +IH
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 127
Query: 471 RDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT---YGYMAPEYAMHGQFS 527
           RDL A N L+      K+SDFGM R    DQ   +T    GT     + +PE     ++S
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTKFPVKWASPEVFSFSRYS 183
Query: 528 VKSDVYSFGVLVLEIITGKK 547
            KSDV+SFGVL+ E+ +  K
Sbjct: 184 SKSDVWSFGVLMWEVFSEGK 203

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 114/233 (48%), Gaps = 33/233 (14%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYK----GVLPSGQ--EIAVKRL-SKASGQGAEEFKNEVV 393
           E   N       +GEG FG V++    G+LP      +AVK L  +AS     +F+ E  
Sbjct: 43  EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 102
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL--YDPEKQGQL---DWSRRYK 448
           L+A+  + N+V+LLG C  G+   L++E++    L+ FL    P     L   D S R +
Sbjct: 103 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 162
Query: 449 ----------------IIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 492
                           I   +A G+ YL E    + +HRDL   N L+   M  KI+DFG
Sbjct: 163 VSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFG 219
Query: 493 MAR-IFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           ++R I+  D  + + +  +    +M PE   + +++ +SDV+++GV++ EI +
Sbjct: 220 LSRNIYSADYYKADGNDAIPI-RWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 113/215 (52%), Gaps = 21/215 (9%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKG--VLPSGQEIAVKRLSKASG---QGAEEFKNEVVLV 395
           E+  +    +  +G G FGEV  G   LP  +++AV   +   G   +   +F  E  ++
Sbjct: 39  ELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIM 98
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
            +  H N+V L G    G+  ++V EF+ N +LD FL   +  GQ    +   ++ GIA 
Sbjct: 99  GQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLR--KHDGQFTVIQLVGMLRGIAA 156
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG- 514
           G+ YL +   +  +HRDL A NIL+++ +  K+SDFG++R+      + +   +  T G 
Sbjct: 157 GMRYLAD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVI-----EDDPEAVYTTTGG 208
Query: 515 -----YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
                + APE   + +F+  SDV+S+G+++ E+++
Sbjct: 209 KIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 243

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 112/207 (54%), Gaps = 20/207 (9%)
Query: 346 KFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLV 404
           K++   K+G+G  G VY  + + +GQE+A+++++       E   NE++++ + ++ N+V
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80
Query: 405 RLLGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIARGIL----Y 459
             L   L G+E  +V E++   SL D        +GQ         I  + R  L    +
Sbjct: 81  NYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQ---------IAAVCRECLQALEF 131
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE 519
           LH +   ++IHRD+K+ NILL  + + K++DFG       +Q++ +T  +VGT  +MAPE
Sbjct: 132 LHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPE 186
Query: 520 YAMHGQFSVKSDVYSFGVLVLEIITGK 546
                 +  K D++S G++ +E+I G+
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 111/207 (53%), Gaps = 20/207 (9%)
Query: 346 KFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLV 404
           K++   K+G+G  G VY  + + +GQE+A+++++       E   NE++++ + ++ N+V
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80
Query: 405 RLLGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIARGIL----Y 459
             L   L G+E  +V E++   SL D        +GQ         I  + R  L    +
Sbjct: 81  NYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQ---------IAAVCRECLQALEF 131
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE 519
           LH +   ++IHRD+K+ NILL  + + K++DFG       +Q++   S +VGT  +MAPE
Sbjct: 132 LHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSEMVGTPYWMAPE 186
Query: 520 YAMHGQFSVKSDVYSFGVLVLEIITGK 546
                 +  K D++S G++ +E+I G+
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 67/202 (33%), Positives = 106/202 (52%), Gaps = 20/202 (9%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAV----KRLSKASG-QGAEEFKNEVVLVAKLQHRNLVRL 406
           LG G FG V+KGV +P G+ I +    K +   SG Q  +   + ++ +  L H ++VRL
Sbjct: 39  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 98
Query: 407 LGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQ---LDWSRRYKIIGGIARGILYLHE 462
           LG C  G    LV +++P  SL D+        G    L+W  +      IA+G+ YL E
Sbjct: 99  LGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ------IAKGMYYLEE 151
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM 522
                ++HR+L A N+LL +    +++DFG+A +   D  Q   S       +MA E   
Sbjct: 152 HG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIH 208
Query: 523 HGQFSVKSDVYSFGVLVLEIIT 544
            G+++ +SDV+S+GV V E++T
Sbjct: 209 FGKYTHQSDVWSYGVTVWELMT 230

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 111/207 (53%), Gaps = 20/207 (9%)
Query: 346 KFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLV 404
           K++   K+G+G  G VY  + + +GQE+A+++++       E   NE++++ + ++ N+V
Sbjct: 22  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 81
Query: 405 RLLGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIARGIL----Y 459
             L   L G+E  +V E++   SL D        +GQ         I  + R  L    +
Sbjct: 82  NYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQ---------IAAVCRECLQALEF 132
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE 519
           LH +   ++IHRD+K+ NILL  + + K++DFG       +Q++   S +VGT  +MAPE
Sbjct: 133 LHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSXMVGTPYWMAPE 187
Query: 520 YAMHGQFSVKSDVYSFGVLVLEIITGK 546
                 +  K D++S G++ +E+I G+
Sbjct: 188 VVTRKAYGPKVDIWSLGIMAIEMIEGE 214

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 67/202 (33%), Positives = 106/202 (52%), Gaps = 20/202 (9%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAV----KRLSKASG-QGAEEFKNEVVLVAKLQHRNLVRL 406
           LG G FG V+KGV +P G+ I +    K +   SG Q  +   + ++ +  L H ++VRL
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 407 LGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQ---LDWSRRYKIIGGIARGILYLHE 462
           LG C  G    LV +++P  SL D+        G    L+W  +      IA+G+ YL E
Sbjct: 81  LGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ------IAKGMYYLEE 133
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM 522
                ++HR+L A N+LL +    +++DFG+A +   D  Q   S       +MA E   
Sbjct: 134 HG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIH 190
Query: 523 HGQFSVKSDVYSFGVLVLEIIT 544
            G+++ +SDV+S+GV V E++T
Sbjct: 191 FGKYTHQSDVWSYGVTVWELMT 212

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 111/207 (53%), Gaps = 20/207 (9%)
Query: 346 KFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLV 404
           K++   K+G+G  G VY  + + +GQE+A+++++       E   NE++++ + ++ N+V
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80
Query: 405 RLLGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIARGIL----Y 459
             L   L G+E  +V E++   SL D        +GQ         I  + R  L    +
Sbjct: 81  NYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQ---------IAAVCRECLQALEF 131
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE 519
           LH +   ++IHRD+K+ NILL  + + K++DFG       +Q++   S +VGT  +MAPE
Sbjct: 132 LHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSXMVGTPYWMAPE 186
Query: 520 YAMHGQFSVKSDVYSFGVLVLEIITGK 546
                 +  K D++S G++ +E+I G+
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 107/206 (51%), Gaps = 23/206 (11%)
Query: 352 KLGEGGFGEV----YKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRL 406
           +LG+G FG V    Y  +   +G+ +AVK+L  ++ +   +F+ E+ ++  LQH N+V+ 
Sbjct: 18  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 77
Query: 407 LGFCLEGEEK--ILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
            G C     +   L+ E++P  SL DY     E+   +D  +  +    I +G+ YL   
Sbjct: 78  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL--- 131
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ-----TQGNTSRIVGTYGYMAP 518
              R IHR+L   NIL++ E   KI DFG+ ++   D+      +   S I     + AP
Sbjct: 132 GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIF----WYAP 187
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIIT 544
           E     +FSV SDV+SFGV++ E+ T
Sbjct: 188 ESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 120/266 (45%), Gaps = 34/266 (12%)
Query: 320 ESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLS 378
           E+N + +L + +  + + +  + A   F     LG+G FG VY       + I A+K L 
Sbjct: 1   ENNPEEELASKQKNE-ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLF 59
Query: 379 KASGQGA---EEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDP 435
           KA  + A    + + EV + + L+H N++RL G+  +     L+ E+ P   L     + 
Sbjct: 60  KAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYREL 116
Query: 436 EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
           +K  + D  R    I  +A  + Y H     R+IHRD+K  N+LL +    KI+DFG   
Sbjct: 117 QKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG--- 170
Query: 496 IFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKK--NSNFYQ 553
            + V       + + GT  Y+ PE         K D++S GVL  E + GK    +N YQ
Sbjct: 171 -WSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 229
Query: 554 -----------------TDGAADLLS 562
                            T+GA DL+S
Sbjct: 230 ETYKRISRVEFTFPDFVTEGARDLIS 255

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 73/243 (30%), Positives = 108/243 (44%), Gaps = 33/243 (13%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGA---EEFKNEVVLVAKL 398
           A   F     LG+G FG VY       + I A+K L KA  + A    + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGIL 458
           +H N++RL G+  +     L+ E+ P   L     + +K  + D  R    I  +A  + 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
           Y H     R+IHRD+K  N+LL +    KI+DFG    + V       + + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTELCGTLDYLPP 175
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITGKK--NSNFYQ-----------------TDGAAD 559
           E         K D++S GVL  E + GK    +N YQ                 T+GA D
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 235
Query: 560 LLS 562
           L+S
Sbjct: 236 LIS 238

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 105/211 (49%), Gaps = 19/211 (9%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCL 411
           LG+G FG+  K     +G+ + +K L +   +    F  EV ++  L+H N+++ +G   
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 412 EGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHR 471
           + +    + E++   +L   +       Q  WS+R      IA G+ YLH    + IIHR
Sbjct: 78  KDKRLNFITEYIKGGTLRGIIK--SMDSQYPWSQRVSFAKDIASGMAYLHS---MNIIHR 132
Query: 472 DLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR------------IVGTYGYMAPE 519
           DL + N L+    N  ++DFG+AR+   ++TQ    R            +VG   +MAPE
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192
Query: 520 YAMHGQFSVKSDVYSFGVLVLEIITGKKNSN 550
                 +  K DV+SFG+++ EII G+ N++
Sbjct: 193 MINGRSYDEKVDVFSFGIVLCEII-GRVNAD 222

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 73/243 (30%), Positives = 108/243 (44%), Gaps = 33/243 (13%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGA---EEFKNEVVLVAKL 398
           A   F     LG+G FG VY       + I A+K L KA  + A    + + EV + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGIL 458
           +H N++RL G+  +     L+ E+ P   L     + +K  + D  R    I  +A  + 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
           Y H     R+IHRD+K  N+LL +    KI+DFG    + V       + + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 178
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITGKK--NSNFYQ-----------------TDGAAD 559
           E         K D++S GVL  E + GK    +N YQ                 T+GA D
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 238
Query: 560 LLS 562
           L+S
Sbjct: 239 LIS 241

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 73/243 (30%), Positives = 108/243 (44%), Gaps = 33/243 (13%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGA---EEFKNEVVLVAKL 398
           A   F     LG+G FG VY       + I A+K L KA  + A    + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGIL 458
           +H N++RL G+  +     L+ E+ P   L     + +K  + D  R    I  +A  + 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
           Y H     R+IHRD+K  N+LL +    KI+DFG    + V       + + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 175
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITGKK--NSNFYQ-----------------TDGAAD 559
           E         K D++S GVL  E + GK    +N YQ                 T+GA D
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 235
Query: 560 LLS 562
           L+S
Sbjct: 236 LIS 238

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 73/243 (30%), Positives = 108/243 (44%), Gaps = 33/243 (13%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGA---EEFKNEVVLVAKL 398
           A   F     LG+G FG VY       + I A+K L KA  + A    + + EV + + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGIL 458
           +H N++RL G+  +     L+ E+ P   L     + +K  + D  R    I  +A  + 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
           Y H     R+IHRD+K  N+LL +    KI+DFG    + V       + + GT  Y+ P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 180
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITGKK--NSNFYQ-----------------TDGAAD 559
           E         K D++S GVL  E + GK    +N YQ                 T+GA D
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 240
Query: 560 LLS 562
           L+S
Sbjct: 241 LIS 243

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 73/243 (30%), Positives = 108/243 (44%), Gaps = 33/243 (13%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGA---EEFKNEVVLVAKL 398
           A   F     LG+G FG VY       + I A+K L KA  + A    + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGIL 458
           +H N++RL G+  +     L+ E+ P   L     + +K  + D  R    I  +A  + 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
           Y H     R+IHRD+K  N+LL +    KI+DFG    + V       + + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPP 175
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITGKK--NSNFYQ-----------------TDGAAD 559
           E         K D++S GVL  E + GK    +N YQ                 T+GA D
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 235
Query: 560 LLS 562
           L+S
Sbjct: 236 LIS 238

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 73/243 (30%), Positives = 108/243 (44%), Gaps = 33/243 (13%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGA---EEFKNEVVLVAKL 398
           A   F     LG+G FG VY       + I A+K L KA  + A    + + EV + + L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGIL 458
           +H N++RL G+  +     L+ E+ P   L     + +K  + D  R    I  +A  + 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
           Y H     R+IHRD+K  N+LL +    KI+DFG    + V       + + GT  Y+ P
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPP 176
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITGKK--NSNFYQ-----------------TDGAAD 559
           E         K D++S GVL  E + GK    +N YQ                 T+GA D
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 236
Query: 560 LLS 562
           L+S
Sbjct: 237 LIS 239

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 73/243 (30%), Positives = 108/243 (44%), Gaps = 33/243 (13%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGA---EEFKNEVVLVAKL 398
           A   F     LG+G FG VY       + I A+K L KA  + A    + + EV + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGIL 458
           +H N++RL G+  +     L+ E+ P   L     + +K  + D  R    I  +A  + 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
           Y H     R+IHRD+K  N+LL +    KI+DFG    + V       + + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGTLDYLPP 178
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITGKK--NSNFYQ-----------------TDGAAD 559
           E         K D++S GVL  E + GK    +N YQ                 T+GA D
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 238
Query: 560 LLS 562
           L+S
Sbjct: 239 LIS 241

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 21/203 (10%)
Query: 353 LGEGGFGEVYKGVLPSGQE-IAVKRLS-KASGQGAEEFKNEVVLVAKLQHRNLVRLLGFC 410
           LGEG +GEV   V    +E +AVK +  K +    E  K E+ + A L H N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGHR 74
Query: 411 LEGEEKILVYEFVPNKSL------DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
            EG  + L  E+     L      D  + +P+ Q         +    +  G++YLH   
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ---------RFFHQLMAGVVYLH--- 122
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG 524
            + I HRD+K  N+LLD   N KISDFG+A +F  +  +   +++ GT  Y+APE     
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 525 QFSVKS-DVYSFGVLVLEIITGK 546
           +F  +  DV+S G+++  ++ G+
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 73/243 (30%), Positives = 108/243 (44%), Gaps = 33/243 (13%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGA---EEFKNEVVLVAKL 398
           A   F     LG+G FG VY       + I A+K L KA  + A    + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGIL 458
           +H N++RL G+  +     L+ E+ P   L     + +K  + D  R    I  +A  + 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
           Y H     R+IHRD+K  N+LL +    KI+DFG    + V       + + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPP 175
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITGKK--NSNFYQ-----------------TDGAAD 559
           E         K D++S GVL  E + GK    +N YQ                 T+GA D
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 235
Query: 560 LLS 562
           L+S
Sbjct: 236 LIS 238

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 73/243 (30%), Positives = 108/243 (44%), Gaps = 33/243 (13%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGA---EEFKNEVVLVAKL 398
           A   F     LG+G FG VY       + I A+K L KA  + A    + + EV + + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGIL 458
           +H N++RL G+  +     L+ E+ P   L     + +K  + D  R    I  +A  + 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
           Y H     R+IHRD+K  N+LL +    KI+DFG    + V       + + GT  Y+ P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPP 180
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITGKK--NSNFYQ-----------------TDGAAD 559
           E         K D++S GVL  E + GK    +N YQ                 T+GA D
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 240
Query: 560 LLS 562
           L+S
Sbjct: 241 LIS 243

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 73/243 (30%), Positives = 108/243 (44%), Gaps = 33/243 (13%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGA---EEFKNEVVLVAKL 398
           A   F     LG+G FG VY       + I A+K L KA  + A    + + EV + + L
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGIL 458
           +H N++RL G+  +     L+ E+ P   L     + +K  + D  R    I  +A  + 
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 121
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
           Y H     R+IHRD+K  N+LL +    KI+DFG    + V       + + GT  Y+ P
Sbjct: 122 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 174
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITGKK--NSNFYQ-----------------TDGAAD 559
           E         K D++S GVL  E + GK    +N YQ                 T+GA D
Sbjct: 175 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 234
Query: 560 LLS 562
           L+S
Sbjct: 235 LIS 237

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 73/243 (30%), Positives = 108/243 (44%), Gaps = 33/243 (13%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGA---EEFKNEVVLVAKL 398
           A   F     LG+G FG VY       + I A+K L KA  + A    + + EV + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGIL 458
           +H N++RL G+  +     L+ E+ P   L     + +K  + D  R    I  +A  + 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
           Y H     R+IHRD+K  N+LL +    KI+DFG    + V       + + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 178
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITGKK--NSNFYQ-----------------TDGAAD 559
           E         K D++S GVL  E + GK    +N YQ                 T+GA D
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 238
Query: 560 LLS 562
           L+S
Sbjct: 239 LIS 241

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 73/243 (30%), Positives = 108/243 (44%), Gaps = 33/243 (13%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGA---EEFKNEVVLVAKL 398
           A   F     LG+G FG VY       + I A+K L KA  + A    + + EV + + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGIL 458
           +H N++RL G+  +     L+ E+ P   +   L   +K  + D  R    I  +A  + 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL---QKLSKFDEQRTATYITELANALS 127
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
           Y H     R+IHRD+K  N+LL +    KI+DFG    + V       + + GT  Y+ P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 180
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITGKK--NSNFYQ-----------------TDGAAD 559
           E         K D++S GVL  E + GK    +N YQ                 T+GA D
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 240
Query: 560 LLS 562
           L+S
Sbjct: 241 LIS 243

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 73/243 (30%), Positives = 108/243 (44%), Gaps = 33/243 (13%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGA---EEFKNEVVLVAKL 398
           A   F     LG+G FG VY       + I A+K L KA  + A    + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGIL 458
           +H N++RL G+  +     L+ E+ P   L     + +K  + D  R    I  +A  + 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
           Y H     R+IHRD+K  N+LL +    KI+DFG    + V       + + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGTLDYLPP 175
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITGKK--NSNFYQ-----------------TDGAAD 559
           E         K D++S GVL  E + GK    +N YQ                 T+GA D
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 235
Query: 560 LLS 562
           L+S
Sbjct: 236 LIS 238

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 73/243 (30%), Positives = 108/243 (44%), Gaps = 33/243 (13%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGA---EEFKNEVVLVAKL 398
           A   F     LG+G FG VY       + I A+K L KA  + A    + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGIL 458
           +H N++RL G+  +     L+ E+ P   L     + +K  + D  R    I  +A  + 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
           Y H     R+IHRD+K  N+LL +    KI+DFG    + V       + + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTXLCGTLDYLPP 175
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITGKK--NSNFYQ-----------------TDGAAD 559
           E         K D++S GVL  E + GK    +N YQ                 T+GA D
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 235
Query: 560 LLS 562
           L+S
Sbjct: 236 LIS 238

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 73/243 (30%), Positives = 108/243 (44%), Gaps = 33/243 (13%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGA---EEFKNEVVLVAKL 398
           A   F     LG+G FG VY       + I A+K L KA  + A    + + EV + + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGIL 458
           +H N++RL G+  +     L+ E+ P   L     + +K  + D  R    I  +A  + 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
           Y H     R+IHRD+K  N+LL +    KI+DFG    + V       + + GT  Y+ P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 180
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITGKK--NSNFYQ-----------------TDGAAD 559
           E         K D++S GVL  E + GK    +N YQ                 T+GA D
Sbjct: 181 EXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 240
Query: 560 LLS 562
           L+S
Sbjct: 241 LIS 243

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 73/243 (30%), Positives = 107/243 (44%), Gaps = 33/243 (13%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGA---EEFKNEVVLVAKL 398
           A   F     LG+G FG VY       + I A+K L KA  + A    + + EV + + L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGIL 458
           +H N++RL G+  +     L+ E+ P   L     + +K  + D  R    I  +A  + 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
           Y H     R+IHRD+K  N+LL +    KI+DFG    + V         + GT  Y+ P
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRDTLCGTLDYLPP 176
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITGKK--NSNFYQ-----------------TDGAAD 559
           E         K D++S GVL  E + GK    +N YQ                 T+GA D
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 236
Query: 560 LLS 562
           L+S
Sbjct: 237 LIS 239

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 73/243 (30%), Positives = 107/243 (44%), Gaps = 33/243 (13%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGA---EEFKNEVVLVAKL 398
           A   F     LG+G FG VY       + I A+K L KA  + A    + + EV + + L
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGIL 458
           +H N++RL G+  +     L+ E+ P   L     + +K  + D  R    I  +A  + 
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 124
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
           Y H     R+IHRD+K  N+LL +    KI+DFG    + V         + GT  Y+ P
Sbjct: 125 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLPP 177
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITGKK--NSNFYQ-----------------TDGAAD 559
           E         K D++S GVL  E + GK    +N YQ                 T+GA D
Sbjct: 178 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 237
Query: 560 LLS 562
           L+S
Sbjct: 238 LIS 240

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 73/243 (30%), Positives = 108/243 (44%), Gaps = 33/243 (13%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGA---EEFKNEVVLVAKL 398
           A   F     LG+G FG VY       + I A+K L KA  + A    + + EV + + L
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGIL 458
           +H N++RL G+  +     L+ E+ P   L     + +K  + D  R    I  +A  + 
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 126
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
           Y H     R+IHRD+K  N+LL +    KI+DFG    + V       + + GT  Y+ P
Sbjct: 127 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 179
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITGKK--NSNFYQ-----------------TDGAAD 559
           E         K D++S GVL  E + GK    +N YQ                 T+GA D
Sbjct: 180 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 239
Query: 560 LLS 562
           L+S
Sbjct: 240 LIS 242

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 112/207 (54%), Gaps = 20/207 (9%)
Query: 346 KFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLV 404
           K++   K+G+G  G VY  + + +GQE+A+++++       E   NE++++ + ++ N+V
Sbjct: 22  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 81
Query: 405 RLLGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIARGIL----Y 459
             L   L G+E  +V E++   SL D        +GQ         I  + R  L    +
Sbjct: 82  NYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQ---------IAAVCRECLQALEF 132
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE 519
           LH +   ++IHR++K+ NILL  + + K++DFG       +Q++ +T  +VGT  +MAPE
Sbjct: 133 LHSN---QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPE 187
Query: 520 YAMHGQFSVKSDVYSFGVLVLEIITGK 546
                 +  K D++S G++ +E+I G+
Sbjct: 188 VVTRKAYGPKVDIWSLGIMAIEMIEGE 214

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 109/206 (52%), Gaps = 13/206 (6%)
Query: 345 NKFSTDNKLGEGGFGEVYKGVLPSGQ---EIAVKRLSKASGQG-AEEFKNEVVLVAKLQH 400
           N    D +LG G FG V +GV    +   ++A+K L + + +   EE   E  ++ +L +
Sbjct: 10  NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN 69
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
             +VRL+G C + E  +LV E      L  FL    K+ ++  S   +++  ++ G+ YL
Sbjct: 70  PYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYL 126
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTY--GYMAP 518
            E +    +HRDL A N+LL      KISDFG+++  G D +   T+R  G +   + AP
Sbjct: 127 EEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY-YTARSAGKWPLKWYAP 182
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIIT 544
           E     +FS +SDV+S+GV + E ++
Sbjct: 183 ECINFRKFSSRSDVWSYGVTMWEALS 208

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 73/243 (30%), Positives = 108/243 (44%), Gaps = 33/243 (13%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGA---EEFKNEVVLVAKL 398
           A   F     LG+G FG VY       + I A+K L KA  + A    + + EV + + L
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGIL 458
           +H N++RL G+  +     L+ E+ P   L     + +K  + D  R    I  +A  + 
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 119
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
           Y H     R+IHRD+K  N+LL +    KI+DFG    + V       + + GT  Y+ P
Sbjct: 120 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 172
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITGKK--NSNFYQ-----------------TDGAAD 559
           E         K D++S GVL  E + GK    +N YQ                 T+GA D
Sbjct: 173 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 232
Query: 560 LLS 562
           L+S
Sbjct: 233 LIS 235

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 73/243 (30%), Positives = 107/243 (44%), Gaps = 33/243 (13%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGA---EEFKNEVVLVAKL 398
           A   F     LG+G FG VY       + I A+K L KA  + A    + + EV + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGIL 458
           +H N++RL G+  +     L+ E+ P   L     + +K  + D  R    I  +A  + 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
           Y H     R+IHRD+K  N+LL +    KI+DFG    + V         + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLPP 178
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITGKK--NSNFYQ-----------------TDGAAD 559
           E         K D++S GVL  E + GK    +N YQ                 T+GA D
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 238
Query: 560 LLS 562
           L+S
Sbjct: 239 LIS 241

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 116/210 (55%), Gaps = 14/210 (6%)
Query: 347 FSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLS-KASGQGAEEFKNEVVLVAKLQHRNLV 404
           F+  +++G+G FGEVYKG+    +E+ A+K +  + +    E+ + E+ ++++     + 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 405 RLLGFCLEGEEKILVYEFVPNKS-LDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
           R  G  L+  +  ++ E++   S LD       K G L+ +    I+  I +G+ YLH +
Sbjct: 81  RYFGSYLKSTKLWIIMEYLGGGSALDLL-----KPGPLEETYIATILREILKGLDYLHSE 135
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMH 523
              R IHRD+KA+N+LL  + + K++DFG+A    +  TQ   +  VGT  +MAPE    
Sbjct: 136 ---RKIHRDIKAANVLLSEQGDVKLADFGVAG--QLTDTQIKRNXFVGTPFWMAPEVIKQ 190
Query: 524 GQFSVKSDVYSFGVLVLEIITGK-KNSNFY 552
             +  K+D++S G+  +E+  G+  NS+ +
Sbjct: 191 SAYDFKADIWSLGITAIELAKGEPPNSDLH 220

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 109/212 (51%), Gaps = 16/212 (7%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFK-NEVVLVAKLQH 400
           ++++F    KLG G +  VYKG+   +G  +A+K +   S +G       E+ L+ +L+H
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKII----GGIARG 456
            N+VRL        +  LV+EF+ N    Y   D    G         ++      + +G
Sbjct: 63  ENIVRLYDVIHTENKLTLVFEFMDNDLKKYM--DSRTVGNTPRGLELNLVKYFQWQLLQG 120
Query: 457 ILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT-SRIVGTYGY 515
           + + HE+   +I+HRDLK  N+L++     K+ DFG+AR FG+     NT S  V T  Y
Sbjct: 121 LAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV---NTFSSEVVTLWY 174
Query: 516 MAPEYAMHGQ-FSVKSDVYSFGVLVLEIITGK 546
            AP+  M  + +S   D++S G ++ E+ITGK
Sbjct: 175 RAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 73/243 (30%), Positives = 107/243 (44%), Gaps = 33/243 (13%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGA---EEFKNEVVLVAKL 398
           A   F     LG+G FG VY       + I A+K L KA  + A    + + EV + + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGIL 458
           +H N++RL G+  +     L+ E+ P   +   L   +K  + D  R    I  +A  + 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL---QKLSKFDEQRTATYITELANALS 127
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
           Y H     R+IHRD+K  N+LL +    KI+DFG    + V         + GT  Y+ P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLXGTLDYLPP 180
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITGKK--NSNFYQ-----------------TDGAAD 559
           E         K D++S GVL  E + GK    +N YQ                 T+GA D
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 240
Query: 560 LLS 562
           L+S
Sbjct: 241 LIS 243

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 73/243 (30%), Positives = 107/243 (44%), Gaps = 33/243 (13%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGA---EEFKNEVVLVAKL 398
           A   F     LG+G FG VY       + I A+K L KA  + A    + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGIL 458
           +H N++RL G+  +     L+ E+ P   L     + +K  + D  R    I  +A  + 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
           Y H     R+IHRD+K  N+LL +    KI+DFG    + V         + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLPP 175
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITGKK--NSNFYQ-----------------TDGAAD 559
           E         K D++S GVL  E + GK    +N YQ                 T+GA D
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 235
Query: 560 LLS 562
           L+S
Sbjct: 236 LIS 238

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 109/217 (50%), Gaps = 14/217 (6%)
Query: 340 IEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ 399
           +E+   + +   +LG G FG V  G      ++AVK + + S    +EF  E   + KL 
Sbjct: 3   MELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLS 61
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
           H  LV+  G C +     +V E++ N  L  +L    K   L+ S+  ++   +  G+ +
Sbjct: 62  HPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKG--LEPSQLLEMCYDVCEGMAF 119
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT---YGYM 516
           L      + IHRDL A N L+D ++  K+SDFGM R    DQ   +    VGT     + 
Sbjct: 120 LESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS----VGTKFPVKWS 172
Query: 517 APEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFY 552
           APE   + ++S KSDV++FG+L+ E+ + GK   + Y
Sbjct: 173 APEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLY 209

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 73/243 (30%), Positives = 107/243 (44%), Gaps = 33/243 (13%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGA---EEFKNEVVLVAKL 398
           A   F     LG+G FG VY       + I A+K L KA  + A    + + EV + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGIL 458
           +H N++RL G+  +     L+ E+ P   L     + +K  + D  R    I  +A  + 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
           Y H     R+IHRD+K  N+LL +    KI+DFG    + V         + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRDDLCGTLDYLPP 178
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITGKK--NSNFYQ-----------------TDGAAD 559
           E         K D++S GVL  E + GK    +N YQ                 T+GA D
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 238
Query: 560 LLS 562
           L+S
Sbjct: 239 LIS 241

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/243 (29%), Positives = 108/243 (44%), Gaps = 33/243 (13%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGA---EEFKNEVVLVAKL 398
           A   F     LG+G FG VY       + I A+K L KA  + A    + + EV + + L
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGIL 458
           +H N++RL G+  +     L+ E+ P   L     + +K  + D  R    I  +A  + 
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 124
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
           Y H     R+IHRD+K  N+LL +    KI++FG    + V       + + GT  Y+ P
Sbjct: 125 YCHSK---RVIHRDIKPENLLLGSAGELKIANFG----WSVHAPSSRRTTLCGTLDYLPP 177
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITGKK--NSNFYQ-----------------TDGAAD 559
           E         K D++S GVL  E + GK    +N YQ                 T+GA D
Sbjct: 178 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 237
Query: 560 LLS 562
           L+S
Sbjct: 238 LIS 240

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 101/196 (51%), Gaps = 10/196 (5%)
Query: 352 KLGEGGFGEV-YKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFC 410
           K+GEG  G V       SG+++AVK +     Q  E   NEVV++   QH N+V +    
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111
Query: 411 LEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIH 470
           L GEE  ++ EF+   +L     D   Q +L+  +   +   + + + YLH      +IH
Sbjct: 112 LVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLHAQG---VIH 164
Query: 471 RDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKS 530
           RD+K+ +ILL  +   K+SDFG       D  +     +VGT  +MAPE      ++ + 
Sbjct: 165 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKX--LVGTPYWMAPEVISRSLYATEV 222
Query: 531 DVYSFGVLVLEIITGK 546
           D++S G++V+E++ G+
Sbjct: 223 DIWSLGIMVIEMVDGE 238

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 101/203 (49%), Gaps = 21/203 (10%)
Query: 353 LGEGGFGEVYKGVLPSGQE-IAVKRLS-KASGQGAEEFKNEVVLVAKLQHRNLVRLLGFC 410
           LGEG +GEV   V    +E +AVK +  K +    E  K E+ +   L H N+V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 411 LEGEEKILVYEFVPNKSL------DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
            EG  + L  E+     L      D  + +P+ Q         +    +  G++YLH   
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ---------RFFHQLMAGVVYLH--- 121
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG 524
            + I HRD+K  N+LLD   N KISDFG+A +F  +  +   +++ GT  Y+APE     
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 525 QFSVKS-DVYSFGVLVLEIITGK 546
           +F  +  DV+S G+++  ++ G+
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/243 (29%), Positives = 109/243 (44%), Gaps = 33/243 (13%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGA---EEFKNEVVLVAKL 398
           A   F     LG+G FG VY     + + I A+K L KA  + A    + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGIL 458
           +H N++RL G+  +     L+ E+ P   L     + +K  + D  R    I  +A  + 
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
           Y H     ++IHRD+K  N+LL +    KI+DFG    + V       + + GT  Y+ P
Sbjct: 123 YCHSK---KVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGTLDYLPP 175
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITGKK--NSNFYQ-----------------TDGAAD 559
           E         K D++S GVL  E + GK    +N YQ                 T+GA D
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFTFPDFVTEGARD 235
Query: 560 LLS 562
           L+S
Sbjct: 236 LIS 238

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 101/203 (49%), Gaps = 21/203 (10%)
Query: 353 LGEGGFGEVYKGVLPSGQE-IAVKRLS-KASGQGAEEFKNEVVLVAKLQHRNLVRLLGFC 410
           LGEG +GEV   V    +E +AVK +  K +    E  K E+ +   L H N+V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 411 LEGEEKILVYEFVPNKSL------DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
            EG  + L  E+     L      D  + +P+ Q         +    +  G++YLH   
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ---------RFFHQLMAGVVYLH--- 121
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG 524
            + I HRD+K  N+LLD   N KISDFG+A +F  +  +   +++ GT  Y+APE     
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 525 QFSVKS-DVYSFGVLVLEIITGK 546
           +F  +  DV+S G+++  ++ G+
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 109/206 (52%), Gaps = 13/206 (6%)
Query: 345 NKFSTDNKLGEGGFGEVYKGVLPSGQ---EIAVKRLSKASGQG-AEEFKNEVVLVAKLQH 400
           N    D +LG G FG V +GV    +   ++A+K L + + +   EE   E  ++ +L +
Sbjct: 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN 395
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
             +VRL+G C + E  +LV E      L  FL    K+ ++  S   +++  ++ G+ YL
Sbjct: 396 PYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYL 452
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTY--GYMAP 518
            E +    +HR+L A N+LL      KISDFG+++  G D +   T+R  G +   + AP
Sbjct: 453 EEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY-YTARSAGKWPLKWYAP 508
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIIT 544
           E     +FS +SDV+S+GV + E ++
Sbjct: 509 ECINFRKFSSRSDVWSYGVTMWEALS 534

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 72/243 (29%), Positives = 108/243 (44%), Gaps = 33/243 (13%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGA---EEFKNEVVLVAKL 398
           A   F     LG+G FG VY       + I A+K L KA  + A    + + EV + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGIL 458
           +H N++RL G+  +     L+ E+ P   L     + +K  + D  R    I  +A  + 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
           Y H     R+IHRD+K  N+LL +    KI++FG    + V       + + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIANFG----WSVHAPSSRRTTLCGTLDYLPP 178
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITGKK--NSNFYQ-----------------TDGAAD 559
           E         K D++S GVL  E + GK    +N YQ                 T+GA D
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 238
Query: 560 LLS 562
           L+S
Sbjct: 239 LIS 241

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 101/203 (49%), Gaps = 21/203 (10%)
Query: 353 LGEGGFGEVYKGVLPSGQE-IAVKRLS-KASGQGAEEFKNEVVLVAKLQHRNLVRLLGFC 410
           LGEG +GEV   V    +E +AVK +  K +    E  K E+ +   L H N+V+  G  
Sbjct: 13  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 72
Query: 411 LEGEEKILVYEFVPNKSL------DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
            EG  + L  E+     L      D  + +P+ Q         +    +  G++YLH   
Sbjct: 73  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ---------RFFHQLMAGVVYLHG-- 121
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG 524
            + I HRD+K  N+LLD   N KISDFG+A +F  +  +   +++ GT  Y+APE     
Sbjct: 122 -IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 525 QFSVKS-DVYSFGVLVLEIITGK 546
           +F  +  DV+S G+++  ++ G+
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGE 203

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 101/203 (49%), Gaps = 21/203 (10%)
Query: 353 LGEGGFGEVYKGVLPSGQE-IAVKRLS-KASGQGAEEFKNEVVLVAKLQHRNLVRLLGFC 410
           LGEG +GEV   V    +E +AVK +  K +    E  K E+ +   L H N+V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 411 LEGEEKILVYEFVPNKSL------DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
            EG  + L  E+     L      D  + +P+ Q         +    +  G++YLH   
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ---------RFFHQLMAGVVYLH--- 121
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG 524
            + I HRD+K  N+LLD   N KISDFG+A +F  +  +   +++ GT  Y+APE     
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 525 QFSVKS-DVYSFGVLVLEIITGK 546
           +F  +  DV+S G+++  ++ G+
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 101/203 (49%), Gaps = 21/203 (10%)
Query: 353 LGEGGFGEVYKGVLPSGQE-IAVKRLS-KASGQGAEEFKNEVVLVAKLQHRNLVRLLGFC 410
           LGEG +GEV   V    +E +AVK +  K +    E  K E+ +   L H N+V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 411 LEGEEKILVYEFVPNKSL------DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
            EG  + L  E+     L      D  + +P+ Q         +    +  G++YLH   
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ---------RFFHQLMAGVVYLHG-- 122
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG 524
            + I HRD+K  N+LLD   N KISDFG+A +F  +  +   +++ GT  Y+APE     
Sbjct: 123 -IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 525 QFSVKS-DVYSFGVLVLEIITGK 546
           +F  +  DV+S G+++  ++ G+
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 101/203 (49%), Gaps = 21/203 (10%)
Query: 353 LGEGGFGEVYKGVLPSGQE-IAVKRLS-KASGQGAEEFKNEVVLVAKLQHRNLVRLLGFC 410
           LGEG +GEV   V    +E +AVK +  K +    E  K E+ +   L H N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 411 LEGEEKILVYEFVPNKSL------DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
            EG  + L  E+     L      D  + +P+ Q         +    +  G++YLH   
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ---------RFFHQLMAGVVYLH--- 122
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG 524
            + I HRD+K  N+LLD   N KISDFG+A +F  +  +   +++ GT  Y+APE     
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 525 QFSVKS-DVYSFGVLVLEIITGK 546
           +F  +  DV+S G+++  ++ G+
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 101/203 (49%), Gaps = 21/203 (10%)
Query: 353 LGEGGFGEVYKGVLPSGQE-IAVKRLS-KASGQGAEEFKNEVVLVAKLQHRNLVRLLGFC 410
           LGEG +GEV   V    +E +AVK +  K +    E  K E+ +   L H N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 411 LEGEEKILVYEFVPNKSL------DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
            EG  + L  E+     L      D  + +P+ Q         +    +  G++YLH   
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ---------RFFHQLMAGVVYLH--- 122
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG 524
            + I HRD+K  N+LLD   N KISDFG+A +F  +  +   +++ GT  Y+APE     
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 525 QFSVKS-DVYSFGVLVLEIITGK 546
           +F  +  DV+S G+++  ++ G+
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 101/203 (49%), Gaps = 21/203 (10%)
Query: 353 LGEGGFGEVYKGVLPSGQE-IAVKRLS-KASGQGAEEFKNEVVLVAKLQHRNLVRLLGFC 410
           LGEG +GEV   V    +E +AVK +  K +    E  K E+ +   L H N+V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 411 LEGEEKILVYEFVPNKSL------DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
            EG  + L  E+     L      D  + +P+ Q         +    +  G++YLH   
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ---------RFFHQLMAGVVYLH--- 121
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG 524
            + I HRD+K  N+LLD   N KISDFG+A +F  +  +   +++ GT  Y+APE     
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 525 QFSVKS-DVYSFGVLVLEIITGK 546
           +F  +  DV+S G+++  ++ G+
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 101/203 (49%), Gaps = 21/203 (10%)
Query: 353 LGEGGFGEVYKGVLPSGQE-IAVKRLS-KASGQGAEEFKNEVVLVAKLQHRNLVRLLGFC 410
           LGEG +GEV   V    +E +AVK +  K +    E  K E+ +   L H N+V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 411 LEGEEKILVYEFVPNKSL------DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
            EG  + L  E+     L      D  + +P+ Q         +    +  G++YLH   
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ---------RFFHQLMAGVVYLH--- 121
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG 524
            + I HRD+K  N+LLD   N KISDFG+A +F  +  +   +++ GT  Y+APE     
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 525 QFSVKS-DVYSFGVLVLEIITGK 546
           +F  +  DV+S G+++  ++ G+
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 101/203 (49%), Gaps = 21/203 (10%)
Query: 353 LGEGGFGEVYKGVLPSGQE-IAVKRLS-KASGQGAEEFKNEVVLVAKLQHRNLVRLLGFC 410
           LGEG +GEV   V    +E +AVK +  K +    E  K E+ +   L H N+V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 411 LEGEEKILVYEFVPNKSL------DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
            EG  + L  E+     L      D  + +P+ Q         +    +  G++YLH   
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ---------RFFHQLMAGVVYLH--- 121
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG 524
            + I HRD+K  N+LLD   N KISDFG+A +F  +  +   +++ GT  Y+APE     
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRR 181
Query: 525 QFSVKS-DVYSFGVLVLEIITGK 546
           +F  +  DV+S G+++  ++ G+
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 101/203 (49%), Gaps = 21/203 (10%)
Query: 353 LGEGGFGEVYKGVLPSGQE-IAVKRLS-KASGQGAEEFKNEVVLVAKLQHRNLVRLLGFC 410
           LGEG +GEV   V    +E +AVK +  K +    E  K E+ +   L H N+V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 411 LEGEEKILVYEFVPNKSL------DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
            EG  + L  E+     L      D  + +P+ Q         +    +  G++YLH   
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ---------RFFHQLMAGVVYLHG-- 122
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG 524
            + I HRD+K  N+LLD   N KISDFG+A +F  +  +   +++ GT  Y+APE     
Sbjct: 123 -IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 525 QFSVKS-DVYSFGVLVLEIITGK 546
           +F  +  DV+S G+++  ++ G+
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 101/203 (49%), Gaps = 21/203 (10%)
Query: 353 LGEGGFGEVYKGVLPSGQE-IAVKRLS-KASGQGAEEFKNEVVLVAKLQHRNLVRLLGFC 410
           LGEG +GEV   V    +E +AVK +  K +    E  K E+ +   L H N+V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 411 LEGEEKILVYEFVPNKSL------DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
            EG  + L  E+     L      D  + +P+ Q         +    +  G++YLH   
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ---------RFFHQLMAGVVYLHG-- 122
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG 524
            + I HRD+K  N+LLD   N KISDFG+A +F  +  +   +++ GT  Y+APE     
Sbjct: 123 -IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRR 181
Query: 525 QFSVKS-DVYSFGVLVLEIITGK 546
           +F  +  DV+S G+++  ++ G+
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 101/203 (49%), Gaps = 21/203 (10%)
Query: 353 LGEGGFGEVYKGVLPSGQE-IAVKRLS-KASGQGAEEFKNEVVLVAKLQHRNLVRLLGFC 410
           LGEG +GEV   V    +E +AVK +  K +    E  K E+ +   L H N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 411 LEGEEKILVYEFVPNKSL------DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
            EG  + L  E+     L      D  + +P+ Q         +    +  G++YLH   
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ---------RFFHQLMAGVVYLH--- 122
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG 524
            + I HRD+K  N+LLD   N KISDFG+A +F  +  +   +++ GT  Y+APE     
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 525 QFSVKS-DVYSFGVLVLEIITGK 546
           +F  +  DV+S G+++  ++ G+
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 101/203 (49%), Gaps = 21/203 (10%)
Query: 353 LGEGGFGEVYKGVLPSGQE-IAVKRLS-KASGQGAEEFKNEVVLVAKLQHRNLVRLLGFC 410
           LGEG +GEV   V    +E +AVK +  K +    E  K E+ +   L H N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 411 LEGEEKILVYEFVPNKSL------DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
            EG  + L  E+     L      D  + +P+ Q         +    +  G++YLH   
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ---------RFFHQLMAGVVYLH--- 122
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG 524
            + I HRD+K  N+LLD   N KISDFG+A +F  +  +   +++ GT  Y+APE     
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 525 QFSVKS-DVYSFGVLVLEIITGK 546
           +F  +  DV+S G+++  ++ G+
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 101/203 (49%), Gaps = 21/203 (10%)
Query: 353 LGEGGFGEVYKGVLPSGQE-IAVKRLS-KASGQGAEEFKNEVVLVAKLQHRNLVRLLGFC 410
           LGEG +GEV   V    +E +AVK +  K +    E  K E+ +   L H N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 411 LEGEEKILVYEFVPNKSL------DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
            EG  + L  E+     L      D  + +P+ Q         +    +  G++YLH   
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ---------RFFHQLMAGVVYLH--- 122
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG 524
            + I HRD+K  N+LLD   N KISDFG+A +F  +  +   +++ GT  Y+APE     
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 525 QFSVKS-DVYSFGVLVLEIITGK 546
           +F  +  DV+S G+++  ++ G+
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 101/203 (49%), Gaps = 21/203 (10%)
Query: 353 LGEGGFGEVYKGVLPSGQE-IAVKRLS-KASGQGAEEFKNEVVLVAKLQHRNLVRLLGFC 410
           LGEG +GEV   V    +E +AVK +  K +    E  K E+ +   L H N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 411 LEGEEKILVYEFVPNKSL------DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
            EG  + L  E+     L      D  + +P+ Q         +    +  G++YLH   
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ---------RFFHQLMAGVVYLH--- 122
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG 524
            + I HRD+K  N+LLD   N KISDFG+A +F  +  +   +++ GT  Y+APE     
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 525 QFSVKS-DVYSFGVLVLEIITGK 546
           +F  +  DV+S G+++  ++ G+
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 65/201 (32%), Positives = 100/201 (49%), Gaps = 17/201 (8%)
Query: 353 LGEGGFGEVYKGVLPSGQE-IAVKRLS-KASGQGAEEFKNEVVLVAKLQHRNLVRLLGFC 410
           LGEG +GEV   V    +E +AVK +  K +    E  K E+ +   L H N+V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 411 LEGEEKILVYEFVPNKSL-DYFLYD---PEKQGQLDWSRRYKIIGGIARGILYLHEDSRL 466
            EG  + L  E+     L D    D   PE   Q       +    +  G++YLH    +
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-------RFFHQLMAGVVYLHG---I 123
Query: 467 RIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQF 526
            I HRD+K  N+LLD   N KISDFG+A +F  +  +   +++ GT  Y+APE     +F
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 527 SVKS-DVYSFGVLVLEIITGK 546
             +  DV+S G+++  ++ G+
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGE 204

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 72/243 (29%), Positives = 107/243 (44%), Gaps = 33/243 (13%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGA---EEFKNEVVLVAKL 398
           A   F     LG+G FG VY       + I A+K L KA  + A    + + EV + + L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGIL 458
           +H N++RL G+  +     L+ E+ P   L     + +K  + D  R    I  +A  + 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
           Y H     R+IHRD+K  N+LL +    KI+DFG    +         + + GT  Y+ P
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSCHAPSSRRTTLSGTLDYLPP 176
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITGKK--NSNFYQ-----------------TDGAAD 559
           E         K D++S GVL  E + GK    +N YQ                 T+GA D
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 236
Query: 560 LLS 562
           L+S
Sbjct: 237 LIS 239

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 101/203 (49%), Gaps = 21/203 (10%)
Query: 353 LGEGGFGEVYKGVLPSGQE-IAVKRLS-KASGQGAEEFKNEVVLVAKLQHRNLVRLLGFC 410
           LGEG +GEV   V    +E +AVK +  K +    E  K E+ +   L H N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 74
Query: 411 LEGEEKILVYEFVPNKSL------DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
            EG  + L  E+     L      D  + +P+ Q         +    +  G++YLH   
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ---------RFFHQLMAGVVYLH--- 122
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG 524
            + I HRD+K  N+LLD   N KISDFG+A +F  +  +   +++ GT  Y+APE     
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRR 182
Query: 525 QFSVKS-DVYSFGVLVLEIITGK 546
           +F  +  DV+S G+++  ++ G+
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 65/201 (32%), Positives = 100/201 (49%), Gaps = 17/201 (8%)
Query: 353 LGEGGFGEVYKGVLPSGQE-IAVKRLS-KASGQGAEEFKNEVVLVAKLQHRNLVRLLGFC 410
           LGEG +GEV   V    +E +AVK +  K +    E  K E+ +   L H N+V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 411 LEGEEKILVYEFVPNKSL-DYFLYD---PEKQGQLDWSRRYKIIGGIARGILYLHEDSRL 466
            EG  + L  E+     L D    D   PE   Q       +    +  G++YLH    +
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-------RFFHQLMAGVVYLHG---I 123
Query: 467 RIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQF 526
            I HRD+K  N+LLD   N KISDFG+A +F  +  +   +++ GT  Y+APE     +F
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 527 SVKS-DVYSFGVLVLEIITGK 546
             +  DV+S G+++  ++ G+
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGE 204

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 81/265 (30%), Positives = 120/265 (45%), Gaps = 34/265 (12%)
Query: 308 RRKAKKKYNA---VPESNADNDLTTLESLQFDF-ETIEVATNKFSTDNKLGEGGFGEVYK 363
           + K K KY     + ES   N  T ++  Q  + E  E   N       LG G FG+V +
Sbjct: 5   KYKQKPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVE 64
Query: 364 G-VLPSGQE-----IAVKRL-SKASGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEE 415
                 G+E     +AVK L S A     E   +E+ +++ L QH N+V LLG C  G  
Sbjct: 65  ATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124
Query: 416 KILVYEFVPNKSLDYFL-----------YDPEKQGQLDWSRR--YKIIGGIARGILYLHE 462
            +++ E+     L  FL           Y+P    +   S R        +A+G+ +L  
Sbjct: 125 VLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFLAS 184
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ---TQGNTSRIVGTYGYMAPE 519
            +    IHRD+ A N+LL      KI DFG+AR    D     +GN    V    +MAPE
Sbjct: 185 KN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV---KWMAPE 238
Query: 520 YAMHGQFSVKSDVYSFGVLVLEIIT 544
                 ++V+SDV+S+G+L+ EI +
Sbjct: 239 SIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 115/210 (54%), Gaps = 14/210 (6%)
Query: 347 FSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLS-KASGQGAEEFKNEVVLVAKLQHRNLV 404
           F+   ++G+G FGEV+KG+    Q++ A+K +  + +    E+ + E+ ++++     + 
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 84
Query: 405 RLLGFCLEGEEKILVYEFVPNKS-LDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
           +  G  L+G +  ++ E++   S LD       + G  D  +   ++  I +G+ YLH +
Sbjct: 85  KYYGSYLKGSKLWIIMEYLGGGSALDLL-----RAGPFDEFQIATMLKEILKGLDYLHSE 139
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMH 523
            +   IHRD+KA+N+LL  + + K++DFG+A      Q + NT   VGT  +MAPE    
Sbjct: 140 KK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQQ 194
Query: 524 GQFSVKSDVYSFGVLVLEIITGK-KNSNFY 552
             +  K+D++S G+  +E+  G+  NS+ +
Sbjct: 195 SAYDSKADIWSLGITAIELAKGEPPNSDMH 224

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 80/259 (30%), Positives = 118/259 (45%), Gaps = 28/259 (10%)
Query: 308 RRKAKKKYNA---VPESNADNDLTTLESLQFDF-ETIEVATNKFSTDNKLGEGGFGEVYK 363
           + K K KY     + ES   N  T ++  Q  + E  E   N       LG G FG+V +
Sbjct: 5   KYKQKPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVE 64
Query: 364 G-VLPSGQE-----IAVKRL-SKASGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEE 415
                 G+E     +AVK L S A     E   +E+ +++ L QH N+V LLG C  G  
Sbjct: 65  ATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124
Query: 416 KILVYEFVPNKSLDYFL-------YDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRI 468
            +++ E+     L  FL        D E    L+          +A+G+ +L   +    
Sbjct: 125 VLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLASKN---C 181
Query: 469 IHRDLKASNILLDAEMNPKISDFGMARIFGVDQ---TQGNTSRIVGTYGYMAPEYAMHGQ 525
           IHRD+ A N+LL      KI DFG+AR    D     +GN    V    +MAPE      
Sbjct: 182 IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV---KWMAPESIFDCV 238
Query: 526 FSVKSDVYSFGVLVLEIIT 544
           ++V+SDV+S+G+L+ EI +
Sbjct: 239 YTVQSDVWSYGILLWEIFS 257

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 112/219 (51%), Gaps = 19/219 (8%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKG----VLPSGQE--IAVKRLSK-ASGQGAEEFKNEVV 393
           EV+  K +   +LG+G FG VY+G    ++    E  +AVK +++ AS +   EF NE  
Sbjct: 13  EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 72
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSR-------R 446
           ++      ++VRLLG   +G+  ++V E + +  L  +L     + + +  R        
Sbjct: 73  VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 132
Query: 447 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVDQTQGN 505
            ++   IA G+ YL+     + +HRDL A N ++  +   KI DFGM R I+  D  +  
Sbjct: 133 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKG 189
Query: 506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
              ++    +MAPE    G F+  SD++SFGV++ EI +
Sbjct: 190 GKGLLPVR-WMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 108/218 (49%), Gaps = 17/218 (7%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKG----VLPSGQE--IAVKRLSK-ASGQGAEEFKNEVV 393
           EV+  K +   +LG+G FG VY+G    ++    E  +AVK +++ AS +   EF NE  
Sbjct: 13  EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 72
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSR-------R 446
           ++      ++VRLLG   +G+  ++V E + +  L  +L     + + +  R        
Sbjct: 73  VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 132
Query: 447 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT 506
            ++   IA G+ YL+     + +HRDL A N ++  +   KI DFGM R           
Sbjct: 133 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKG 189
Query: 507 SRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
            + +    +MAPE    G F+  SD++SFGV++ EI +
Sbjct: 190 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 108/218 (49%), Gaps = 17/218 (7%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKG----VLPSGQE--IAVKRLSK-ASGQGAEEFKNEVV 393
           EV+  K +   +LG+G FG VY+G    ++    E  +AVK +++ AS +   EF NE  
Sbjct: 13  EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 72
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSR-------R 446
           ++      ++VRLLG   +G+  ++V E + +  L  +L     + + +  R        
Sbjct: 73  VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 132
Query: 447 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT 506
            ++   IA G+ YL+     + +HRDL A N ++  +   KI DFGM R           
Sbjct: 133 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKG 189
Query: 507 SRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
            + +    +MAPE    G F+  SD++SFGV++ EI +
Sbjct: 190 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 108/218 (49%), Gaps = 17/218 (7%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKG----VLPSGQE--IAVKRLSK-ASGQGAEEFKNEVV 393
           EV+  K +   +LG+G FG VY+G    ++    E  +AVK +++ AS +   EF NE  
Sbjct: 10  EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 69
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSR-------R 446
           ++      ++VRLLG   +G+  ++V E + +  L  +L     + + +  R        
Sbjct: 70  VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 129
Query: 447 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT 506
            ++   IA G+ YL+     + +HRDL A N ++  +   KI DFGM R           
Sbjct: 130 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKG 186
Query: 507 SRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
            + +    +MAPE    G F+  SD++SFGV++ EI +
Sbjct: 187 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 224

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 106/204 (51%), Gaps = 21/204 (10%)
Query: 353 LGEGGFGEVYKGVL--PSGQEI--AVKRLSKASGQG-AEEFKNEVVLVAKLQHRNLVRLL 407
           +G G FG VY G L    G++I  AVK L++ +  G   +F  E +++    H N++ LL
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 408 GFCLEGE-EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIG---GIARGILYLHED 463
           G CL  E   ++V  ++ +  L  F+ +      +       +IG    +A+G+ YL   
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK-----DLIGFGLQVAKGMKYL--- 148
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT---YGYMAPEY 520
           +  + +HRDL A N +LD +   K++DFG+AR    D+   +     G      +MA E 
Sbjct: 149 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM-YDKEXXSVHNKTGAKLPVKWMALES 207
Query: 521 AMHGQFSVKSDVYSFGVLVLEIIT 544
               +F+ KSDV+SFGVL+ E++T
Sbjct: 208 LQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 108/211 (51%), Gaps = 20/211 (9%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRL---SKASGQGAEEFKNEVVLVAKL 398
           + +++    KLGEG +GEVYK +   + + +A+KR+    +  G      + EV L+ +L
Sbjct: 32  SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR-EVSLLKEL 90
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGIL 458
           QHRN++ L           L++E+  N    Y   +P+   ++  S  Y++I G+     
Sbjct: 91  QHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVN---- 146
Query: 459 YLHEDSRLRIIHRDLKASNILL---DAEMNP--KISDFGMARIFGVDQTQGNTSRIVGTY 513
           + H  SR R +HRDLK  N+LL   DA   P  KI DFG+AR FG+   Q  T  I+ T 
Sbjct: 147 FCH--SR-RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF-THEII-TL 201
Query: 514 GYMAPEYAMHGQ-FSVKSDVYSFGVLVLEII 543
            Y  PE  +  + +S   D++S   +  E++
Sbjct: 202 WYRPPEILLGSRHYSTSVDIWSIACIWAEML 232

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 80/244 (32%), Positives = 123/244 (50%), Gaps = 33/244 (13%)
Query: 320 ESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQ-EIAVKRLS 378
           E + ++DL     L++D+E  E           LG+G +G VY G   S Q  IA+K + 
Sbjct: 7   EGDCESDL-----LEYDYEYDENGDRVV-----LGKGTYGIVYAGRDLSNQVRIAIKEIP 56
Query: 379 KASGQGAEEFKNEVVLVAKLQHRNLVRLLG-FCLEGEEKILVYEFVPNKSLDYFLYDPEK 437
           +   + ++    E+ L   L+H+N+V+ LG F   G  KI + E VP  SL   L    K
Sbjct: 57  ERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFM-EQVPGGSLSALLRS--K 113
Query: 438 QGQLDWSRRYKIIG----GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP-KISDFG 492
            G L  + +   IG     I  G+ YLH++   +I+HRD+K  N+L++      KISDFG
Sbjct: 114 WGPLKDNEQ--TIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFG 168
Query: 493 MA-RIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQ--FSVKSDVYSFGVLVLEIITGKKNS 549
            + R+ G++     T    GT  YMAPE    G   +   +D++S G  ++E+ TGK   
Sbjct: 169 TSKRLAGINPC---TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK--P 223
Query: 550 NFYQ 553
            FY+
Sbjct: 224 PFYE 227

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 100/203 (49%), Gaps = 21/203 (10%)
Query: 353 LGEGGFGEVYKGVLPSGQE-IAVKRLS-KASGQGAEEFKNEVVLVAKLQHRNLVRLLGFC 410
           LGEG  GEV   V    +E +AVK +  K +    E  K E+ +   L H N+V+  G  
Sbjct: 14  LGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 411 LEGEEKILVYEFVPNKSL------DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
            EG  + L  E+     L      D  + +P+ Q         +    +  G++YLH   
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ---------RFFHQLMAGVVYLHG-- 122
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG 524
            + I HRD+K  N+LLD   N KISDFG+A +F  +  +   +++ GT  Y+APE     
Sbjct: 123 -IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 525 QFSVKS-DVYSFGVLVLEIITGK 546
           +F  +  DV+S G+++  ++ G+
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 112/219 (51%), Gaps = 19/219 (8%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKG----VLPSGQE--IAVKRLSK-ASGQGAEEFKNEVV 393
           EV+  K +   +LG+G FG VY+G    ++    E  +AVK +++ AS +   EF NE  
Sbjct: 12  EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 71
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSR-------R 446
           ++      ++VRLLG   +G+  ++V E + +  L  +L     + + +  R        
Sbjct: 72  VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 131
Query: 447 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVDQTQGN 505
            ++   IA G+ YL+     + +HRDL A N ++  +   KI DFGM R I+  D  +  
Sbjct: 132 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKG 188
Query: 506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
              ++    +MAPE    G F+  SD++SFGV++ EI +
Sbjct: 189 GKGLLPVR-WMAPESLKDGVFTTSSDMWSFGVVLWEITS 226

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 112/203 (55%), Gaps = 13/203 (6%)
Query: 347 FSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLS-KASGQGAEEFKNEVVLVAKLQHRNLV 404
           F+   K+G+G FGEV+KG+    Q++ A+K +  + +    E+ + E+ ++++     + 
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 88
Query: 405 RLLGFCLEGEEKILVYEFVPNKS-LDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
           +  G  L+  +  ++ E++   S LD  L +P   G LD ++   I+  I +G+ YLH +
Sbjct: 89  KYYGSYLKDTKLWIIMEYLGGGSALD--LLEP---GPLDETQIATILREILKGLDYLHSE 143
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMH 523
            +   IHRD+KA+N+LL      K++DFG+A      Q + NT   VGT  +MAPE    
Sbjct: 144 KK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQ 198
Query: 524 GQFSVKSDVYSFGVLVLEIITGK 546
             +  K+D++S G+  +E+  G+
Sbjct: 199 SAYDSKADIWSLGITAIELARGE 221

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/255 (30%), Positives = 116/255 (45%), Gaps = 28/255 (10%)
Query: 312 KKKYNA---VPESNADNDLTTLESLQFDF-ETIEVATNKFSTDNKLGEGGFGEVYKG-VL 366
           K KY     + ES   N  T ++  Q  + E  E   N       LG G FG+V +    
Sbjct: 1   KPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAF 60
Query: 367 PSGQE-----IAVKRL-SKASGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILV 419
             G+E     +AVK L S A     E   +E+ +++ L QH N+V LLG C  G   +++
Sbjct: 61  GLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVI 120
Query: 420 YEFVPNKSLDYFL-------YDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRD 472
            E+     L  FL        D E    L+          +A+G+ +L   +    IHRD
Sbjct: 121 TEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLASKN---CIHRD 177
Query: 473 LKASNILLDAEMNPKISDFGMARIFGVDQ---TQGNTSRIVGTYGYMAPEYAMHGQFSVK 529
           + A N+LL      KI DFG+AR    D     +GN    V    +MAPE      ++V+
Sbjct: 178 VAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV---KWMAPESIFDCVYTVQ 234
Query: 530 SDVYSFGVLVLEIIT 544
           SDV+S+G+L+ EI +
Sbjct: 235 SDVWSYGILLWEIFS 249

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 106/207 (51%), Gaps = 27/207 (13%)
Query: 353 LGEGGFGEVYKGVL--PSGQEI--AVKRLSKASGQG-AEEFKNEVVLVAKLQHRNLVRLL 407
           +G G FG VY G L    G++I  AVK L++ +  G   +F  E +++    H N++ LL
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 116
Query: 408 GFCLEGE-EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIG---GIARGILYLHED 463
           G CL  E   ++V  ++ +  L  F+ +      +       +IG    +A+G+ YL   
Sbjct: 117 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK-----DLIGFGLQVAKGMKYL--- 168
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMAR------IFGVDQTQGNTSRIVGTYGYMA 517
           +  + +HRDL A N +LD +   K++DFG+AR       + V    G    +     +MA
Sbjct: 169 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV----KWMA 224
Query: 518 PEYAMHGQFSVKSDVYSFGVLVLEIIT 544
            E     +F+ KSDV+SFGVL+ E++T
Sbjct: 225 LESLQTQKFTTKSDVWSFGVLLWELMT 251

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 113/212 (53%), Gaps = 19/212 (8%)
Query: 342 VATNKFSTDNKLGEGGFGEVY--KGVLPSGQEIAVKRLSK---ASGQGAEEFKNEVVLVA 396
           + ++++     LG+G FGEV   K  + +GQE AVK +SK         E    EV L+ 
Sbjct: 29  IFSDRYKGQRVLGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKESLLREVQLLK 87
Query: 397 KLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARG 456
           +L H N+++L  F  +     LV E      L   +   ++  ++D +R   II  +  G
Sbjct: 88  QLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSG 144
Query: 457 ILYLHEDSRLRIIHRDLKASNILLDA---EMNPKISDFGMARIFGVDQTQGNTSRIVGTY 513
           I Y+H++   +I+HRDLK  N+LL++   + N +I DFG++  F   +   +    +GT 
Sbjct: 145 ITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK---IGTA 198
Query: 514 GYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
            Y+APE  +HG +  K DV+S GV++  +++G
Sbjct: 199 YYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 229

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 106/207 (51%), Gaps = 27/207 (13%)
Query: 353 LGEGGFGEVYKGVL--PSGQEI--AVKRLSKASGQG-AEEFKNEVVLVAKLQHRNLVRLL 407
           +G G FG VY G L    G++I  AVK L++ +  G   +F  E +++    H N++ LL
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 408 GFCLEGE-EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIG---GIARGILYLHED 463
           G CL  E   ++V  ++ +  L  F+ +      +       +IG    +A+G+ YL   
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK-----DLIGFGLQVAKGMKYL--- 148
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMAR------IFGVDQTQGNTSRIVGTYGYMA 517
           +  + +HRDL A N +LD +   K++DFG+AR       + V    G    +     +MA
Sbjct: 149 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV----KWMA 204
Query: 518 PEYAMHGQFSVKSDVYSFGVLVLEIIT 544
            E     +F+ KSDV+SFGVL+ E++T
Sbjct: 205 LESLQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 112/203 (55%), Gaps = 13/203 (6%)
Query: 347 FSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLS-KASGQGAEEFKNEVVLVAKLQHRNLV 404
           F+   K+G+G FGEV+KG+    Q++ A+K +  + +    E+ + E+ ++++     + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 405 RLLGFCLEGEEKILVYEFVPNKS-LDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
           +  G  L+  +  ++ E++   S LD  L +P   G LD ++   I+  I +G+ YLH +
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALD--LLEP---GPLDETQIATILREILKGLDYLHSE 123
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMH 523
            +   IHRD+KA+N+LL      K++DFG+A      Q + NT   VGT  +MAPE    
Sbjct: 124 KK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQ 178
Query: 524 GQFSVKSDVYSFGVLVLEIITGK 546
             +  K+D++S G+  +E+  G+
Sbjct: 179 SAYDSKADIWSLGITAIELARGE 201

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 108/208 (51%), Gaps = 29/208 (13%)
Query: 353 LGEGGFGEVYKGVL--PSGQEI--AVKRLSKASGQG-AEEFKNEVVLVAKLQHRNLVRLL 407
           +G G FG VY G L    G++I  AVK L++ +  G   +F  E +++    H N++ LL
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 115
Query: 408 GFCLEGE-EKILVYEFVPNKSLDYFL----YDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
           G CL  E   ++V  ++ +  L  F+    ++P  +  + +  +      +A+G+ YL  
Sbjct: 116 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKYL-- 167
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMAR------IFGVDQTQGNTSRIVGTYGYM 516
            +  + +HRDL A N +LD +   K++DFG+AR       + V    G    +     +M
Sbjct: 168 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV----KWM 222
Query: 517 APEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           A E     +F+ KSDV+SFGVL+ E++T
Sbjct: 223 ALESLQTQKFTTKSDVWSFGVLLWELMT 250

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 106/207 (51%), Gaps = 27/207 (13%)
Query: 353 LGEGGFGEVYKGVL--PSGQEI--AVKRLSKASGQG-AEEFKNEVVLVAKLQHRNLVRLL 407
           +G G FG VY G L    G++I  AVK L++ +  G   +F  E +++    H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 408 GFCLEGE-EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIG---GIARGILYLHED 463
           G CL  E   ++V  ++ +  L  F+ +      +       +IG    +A+G+ YL   
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK-----DLIGFGLQVAKGMKYL--- 149
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMAR------IFGVDQTQGNTSRIVGTYGYMA 517
           +  + +HRDL A N +LD +   K++DFG+AR       + V    G    +     +MA
Sbjct: 150 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV----KWMA 205
Query: 518 PEYAMHGQFSVKSDVYSFGVLVLEIIT 544
            E     +F+ KSDV+SFGVL+ E++T
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 106/207 (51%), Gaps = 27/207 (13%)
Query: 353 LGEGGFGEVYKGVL--PSGQEI--AVKRLSKASGQG-AEEFKNEVVLVAKLQHRNLVRLL 407
           +G G FG VY G L    G++I  AVK L++ +  G   +F  E +++    H N++ LL
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 89
Query: 408 GFCLEGE-EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIG---GIARGILYLHED 463
           G CL  E   ++V  ++ +  L  F+ +      +       +IG    +A+G+ YL   
Sbjct: 90  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK-----DLIGFGLQVAKGMKYL--- 141
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMAR------IFGVDQTQGNTSRIVGTYGYMA 517
           +  + +HRDL A N +LD +   K++DFG+AR       + V    G    +     +MA
Sbjct: 142 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV----KWMA 197
Query: 518 PEYAMHGQFSVKSDVYSFGVLVLEIIT 544
            E     +F+ KSDV+SFGVL+ E++T
Sbjct: 198 LESLQTQKFTTKSDVWSFGVLLWELMT 224

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 110/206 (53%), Gaps = 21/206 (10%)
Query: 351 NKLGEGGFGEV----YKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVR 405
           ++LG+G FG V    Y  +   +G  +AVK+L  +      +F+ E+ ++  L    +V+
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 406 LLGFCL-EGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
             G     G + + LV E++P+  L  FL     + +LD SR       I +G+ YL   
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQ--RHRARLDASRLLLYSSQICKGMEYL--G 144
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT-----QGNTSRIVGTYGYMAP 518
           SR R +HRDL A NIL+++E + KI+DFG+A++  +D+      +   S I     + AP
Sbjct: 145 SR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF----WYAP 199
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIIT 544
           E      FS +SDV+SFGV++ E+ T
Sbjct: 200 ESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 108/208 (51%), Gaps = 29/208 (13%)
Query: 353 LGEGGFGEVYKGVL--PSGQEI--AVKRLSKASGQG-AEEFKNEVVLVAKLQHRNLVRLL 407
           +G G FG VY G L    G++I  AVK L++ +  G   +F  E +++    H N++ LL
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 408 GFCLEGE-EKILVYEFVPNKSLDYFL----YDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
           G CL  E   ++V  ++ +  L  F+    ++P  +  + +  +      +A+G+ YL  
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKYL-- 147
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMAR------IFGVDQTQGNTSRIVGTYGYM 516
            +  + +HRDL A N +LD +   K++DFG+AR       + V    G    +     +M
Sbjct: 148 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV----KWM 202
Query: 517 APEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           A E     +F+ KSDV+SFGVL+ E++T
Sbjct: 203 ALESLQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 110/206 (53%), Gaps = 21/206 (10%)
Query: 351 NKLGEGGFGEV----YKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVR 405
           ++LG+G FG V    Y  +   +G  +AVK+L  +      +F+ E+ ++  L    +V+
Sbjct: 16  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 75
Query: 406 LLGFCL-EGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
             G     G + + LV E++P+  L  FL     + +LD SR       I +G+ YL   
Sbjct: 76  YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQ--RHRARLDASRLLLYSSQICKGMEYL--G 131
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT-----QGNTSRIVGTYGYMAP 518
           SR R +HRDL A NIL+++E + KI+DFG+A++  +D+      +   S I     + AP
Sbjct: 132 SR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF----WYAP 186
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIIT 544
           E      FS +SDV+SFGV++ E+ T
Sbjct: 187 ESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 113/212 (53%), Gaps = 19/212 (8%)
Query: 342 VATNKFSTDNKLGEGGFGEVY--KGVLPSGQEIAVKRLSK---ASGQGAEEFKNEVVLVA 396
           + ++++     LG+G FGEV   K  + +GQE AVK +SK         E    EV L+ 
Sbjct: 23  IFSDRYKGQRVLGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKESLLREVQLLK 81
Query: 397 KLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARG 456
           +L H N+++L  F  +     LV E      L   +   ++  ++D +R   II  +  G
Sbjct: 82  QLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSG 138
Query: 457 ILYLHEDSRLRIIHRDLKASNILLDA---EMNPKISDFGMARIFGVDQTQGNTSRIVGTY 513
           I Y+H++   +I+HRDLK  N+LL++   + N +I DFG++  F   +   +    +GT 
Sbjct: 139 ITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK---IGTA 192
Query: 514 GYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
            Y+APE  +HG +  K DV+S GV++  +++G
Sbjct: 193 YYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 106/207 (51%), Gaps = 27/207 (13%)
Query: 353 LGEGGFGEVYKGVL--PSGQEI--AVKRLSKASGQG-AEEFKNEVVLVAKLQHRNLVRLL 407
           +G G FG VY G L    G++I  AVK L++ +  G   +F  E +++    H N++ LL
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 408 GFCLEGE-EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIG---GIARGILYLHED 463
           G CL  E   ++V  ++ +  L  F+ +      +       +IG    +A+G+ YL   
Sbjct: 93  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK-----DLIGFGLQVAKGMKYL--- 144
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMAR------IFGVDQTQGNTSRIVGTYGYMA 517
           +  + +HRDL A N +LD +   K++DFG+AR       + V    G    +     +MA
Sbjct: 145 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV----KWMA 200
Query: 518 PEYAMHGQFSVKSDVYSFGVLVLEIIT 544
            E     +F+ KSDV+SFGVL+ E++T
Sbjct: 201 LESLQTQKFTTKSDVWSFGVLLWELMT 227

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 106/207 (51%), Gaps = 27/207 (13%)
Query: 353 LGEGGFGEVYKGVL--PSGQEI--AVKRLSKASGQG-AEEFKNEVVLVAKLQHRNLVRLL 407
           +G G FG VY G L    G++I  AVK L++ +  G   +F  E +++    H N++ LL
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 408 GFCLEGE-EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIG---GIARGILYLHED 463
           G CL  E   ++V  ++ +  L  F+ +      +       +IG    +A+G+ YL   
Sbjct: 95  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK-----DLIGFGLQVAKGMKYL--- 146
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMAR------IFGVDQTQGNTSRIVGTYGYMA 517
           +  + +HRDL A N +LD +   K++DFG+AR       + V    G    +     +MA
Sbjct: 147 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV----KWMA 202
Query: 518 PEYAMHGQFSVKSDVYSFGVLVLEIIT 544
            E     +F+ KSDV+SFGVL+ E++T
Sbjct: 203 LESLQTQKFTTKSDVWSFGVLLWELMT 229

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 106/207 (51%), Gaps = 27/207 (13%)
Query: 353 LGEGGFGEVYKGVL--PSGQEI--AVKRLSKASGQG-AEEFKNEVVLVAKLQHRNLVRLL 407
           +G G FG VY G L    G++I  AVK L++ +  G   +F  E +++    H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 408 GFCLEGE-EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIG---GIARGILYLHED 463
           G CL  E   ++V  ++ +  L  F+ +      +       +IG    +A+G+ YL   
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK-----DLIGFGLQVAKGMKYL--- 149
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMAR------IFGVDQTQGNTSRIVGTYGYMA 517
           +  + +HRDL A N +LD +   K++DFG+AR       + V    G    +     +MA
Sbjct: 150 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV----KWMA 205
Query: 518 PEYAMHGQFSVKSDVYSFGVLVLEIIT 544
            E     +F+ KSDV+SFGVL+ E++T
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 107/212 (50%), Gaps = 15/212 (7%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY---KGVLPSGQEIAVKRL---SKASGQGAEEFKNEVVL 394
           ++   ++   +KLG GG   VY     +L    ++A+K +    +   +  + F+ EV  
Sbjct: 7   KIINERYKIVDKLGGGGMSTVYLAEDTIL--NIKVAIKAIFIPPREKEETLKRFEREVHN 64
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIA 454
            ++L H+N+V ++    E +   LV E++   +L  ++   E  G L           I 
Sbjct: 65  SSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQIL 121
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
            GI + H+   +RI+HRD+K  NIL+D+    KI DFG+A+    + +   T+ ++GT  
Sbjct: 122 DGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQ 177
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
           Y +PE A        +D+YS G+++ E++ G+
Sbjct: 178 YFSPEQAKGEATDECTDIYSIGIVLYEMLVGE 209

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 110/206 (53%), Gaps = 21/206 (10%)
Query: 351 NKLGEGGFGEV----YKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVR 405
           ++LG+G FG V    Y  +   +G  +AVK+L  +      +F+ E+ ++  L    +V+
Sbjct: 17  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 76
Query: 406 LLGFCL-EGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
             G     G + + LV E++P+  L  FL     + +LD SR       I +G+ YL   
Sbjct: 77  YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQ--RHRARLDASRLLLYSSQICKGMEYL--G 132
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT-----QGNTSRIVGTYGYMAP 518
           SR R +HRDL A NIL+++E + KI+DFG+A++  +D+      +   S I     + AP
Sbjct: 133 SR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF----WYAP 187
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIIT 544
           E      FS +SDV+SFGV++ E+ T
Sbjct: 188 ESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 100/195 (51%), Gaps = 11/195 (5%)
Query: 351 NKLGEGGFGEVYKGVLPSGQE-IAVKRLSKASGQGAE-EFKNEVVLVAKLQHRNLVRLLG 408
            ++G G FGEV+ G L +    +AVK   +      + +F  E  ++ +  H N+VRL+G
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 409 FCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRI 468
            C + +   +V E V  +  D+  +   +  +L      +++G  A G+ YL        
Sbjct: 180 VCTQKQPIYIVMELV--QGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---C 234
Query: 469 IHRDLKASNILLDAEMNPKISDFGMAR--IFGVDQTQGNTSRIVGTYGYMAPEYAMHGQF 526
           IHRDL A N L+  +   KISDFGM+R    GV    G   ++     + APE   +G++
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQV--PVKWTAPEALNYGRY 292
Query: 527 SVKSDVYSFGVLVLE 541
           S +SDV+SFG+L+ E
Sbjct: 293 SSESDVWSFGILLWE 307

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 123/229 (53%), Gaps = 19/229 (8%)
Query: 321 SNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLS- 378
           S   + L  +++L+ D E +      F+   K+G+G FGEV+KG+    Q++ A+K +  
Sbjct: 4   SPVQSGLPGMQNLKADPEEL------FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDL 57
Query: 379 KASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKS-LDYFLYDPEK 437
           + +    E+ + E+ ++++     + +  G  L+  +  ++ E++   S LD  L +P  
Sbjct: 58  EEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD--LLEP-- 113
Query: 438 QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497
            G LD ++   I+  I +G+ YLH + +   IHRD+KA+N+LL      K++DFG+A   
Sbjct: 114 -GPLDETQIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAG-- 167
Query: 498 GVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
            +  TQ   +  VGT  +MAPE      +  K+D++S G+  +E+  G+
Sbjct: 168 QLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGE 216

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 110/206 (53%), Gaps = 21/206 (10%)
Query: 351 NKLGEGGFGEV----YKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVR 405
           ++LG+G FG V    Y  +   +G  +AVK+L  +      +F+ E+ ++  L    +V+
Sbjct: 13  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 72
Query: 406 LLGFCL-EGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
             G     G  ++ LV E++P+  L  FL     + +LD SR       I +G+ YL   
Sbjct: 73  YRGVSYGPGRPELRLVMEYLPSGCLRDFLQ--RHRARLDASRLLLYSSQICKGMEYL--G 128
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG-----YMAP 518
           SR R +HRDL A NIL+++E + KI+DFG+A++  +D+       +V   G     + AP
Sbjct: 129 SR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK----DXXVVREPGQSPIFWYAP 183
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIIT 544
           E      FS +SDV+SFGV++ E+ T
Sbjct: 184 ESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 81/262 (30%), Positives = 117/262 (44%), Gaps = 30/262 (11%)
Query: 308 RRKAKKKYNA---VPESNADNDLTTLESLQFDF-ETIEVATNKFSTDNKLGEGGFGEVYK 363
           + K K KY     + ES   N  T ++  Q  + E  E   N       LG G FG+V +
Sbjct: 5   KYKQKPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVE 64
Query: 364 G-VLPSGQE-----IAVKRL-SKASGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEE 415
                 G+E     +AVK L S A     E   +E+ +++ L QH N+V LLG C  G  
Sbjct: 65  ATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124
Query: 416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRL--------- 466
            +++ E+     L  FL    K   L+    + I    A     LH  S++         
Sbjct: 125 VLVITEYCCYGDLLNFLR--RKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS 182
Query: 467 -RIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ---TQGNTSRIVGTYGYMAPEYAM 522
              IHRD+ A N+LL      KI DFG+AR    D     +GN    V    +MAPE   
Sbjct: 183 KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV---KWMAPESIF 239
Query: 523 HGQFSVKSDVYSFGVLVLEIIT 544
              ++V+SDV+S+G+L+ EI +
Sbjct: 240 DCVYTVQSDVWSYGILLWEIFS 261

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 109/205 (53%), Gaps = 23/205 (11%)
Query: 353 LGEGGFGEVYKGVL--PSGQEI--AVKRLSKASGQG-AEEFKNEVVLVAKLQHRNLVRLL 407
           +G G FG VY G L    G++I  AVK L++ +  G   +F  E +++    H N++ LL
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 408 GFCLEGE-EKILVYEFVPNKSLDYFL----YDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
           G CL  E   ++V  ++ +  L  F+    ++P  +  + +  +      +A+G+ +L  
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKFL-- 150
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT---YGYMAPE 519
            +  + +HRDL A N +LD +   K++DFG+AR   +D+   +     G      +MA E
Sbjct: 151 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM-LDKEFDSVHNKTGAKLPVKWMALE 208
Query: 520 YAMHGQFSVKSDVYSFGVLVLEIIT 544
                +F+ KSDV+SFGVL+ E++T
Sbjct: 209 SLQTQKFTTKSDVWSFGVLLWELMT 233

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 77/231 (33%), Positives = 117/231 (50%), Gaps = 28/231 (12%)
Query: 333 LQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQ-EIAVKRLSKASGQGAEEFKNE 391
           L++D+E  E           LG+G +G VY G   S Q  IA+K + +   + ++    E
Sbjct: 1   LEYDYEYDENGDRVV-----LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEE 55
Query: 392 VVLVAKLQHRNLVRLLG-FCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKII 450
           + L   L+H+N+V+ LG F   G  KI + E VP  SL   L    K G L  + +   I
Sbjct: 56  IALHKHLKHKNIVQYLGSFSENGFIKIFM-EQVPGGSLSALLRS--KWGPLKDNEQ--TI 110
Query: 451 G----GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMA-RIFGVDQTQG 504
           G     I  G+ YLH++   +I+HRD+K  N+L++      KISDFG + R+ G++    
Sbjct: 111 GFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC-- 165
Query: 505 NTSRIVGTYGYMAPEYAMHGQ--FSVKSDVYSFGVLVLEIITGKKNSNFYQ 553
            T    GT  YMAPE    G   +   +D++S G  ++E+ TGK    FY+
Sbjct: 166 -TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK--PPFYE 213

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 100/196 (51%), Gaps = 10/196 (5%)
Query: 352 KLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFC 410
           K+GEG  G V       +G+++AVK++     Q  E   NEVV++    H N+V +    
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSY 111
Query: 411 LEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIH 470
           L G+E  +V EF+   +L     D     +++  +   +   + R + YLH      +IH
Sbjct: 112 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIH 164
Query: 471 RDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKS 530
           RD+K+ +ILL ++   K+SDFG      V +       +VGT  +MAPE      +  + 
Sbjct: 165 RDIKSDSILLTSDGRIKLSDFGFC--AQVSKEVPKRKXLVGTPYWMAPEVISRLPYGTEV 222
Query: 531 DVYSFGVLVLEIITGK 546
           D++S G++V+E+I G+
Sbjct: 223 DIWSLGIMVIEMIDGE 238

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 112/219 (51%), Gaps = 19/219 (8%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKG----VLPSGQE--IAVKRLSK-ASGQGAEEFKNEVV 393
           EV+  K +   +LG+G FG VY+G    ++    E  +AVK +++ AS +   EF NE  
Sbjct: 13  EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 72
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSR-------R 446
           ++      ++VRLLG   +G+  ++V E + +  L  +L     + + +  R        
Sbjct: 73  VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 132
Query: 447 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVDQTQGN 505
            ++   IA G+ YL+     + +HR+L A N ++  +   KI DFGM R I+  D  +  
Sbjct: 133 IQMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKG 189
Query: 506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
              ++    +MAPE    G F+  SD++SFGV++ EI +
Sbjct: 190 GKGLLPVR-WMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 112/219 (51%), Gaps = 19/219 (8%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKG----VLPSGQE--IAVKRLSK-ASGQGAEEFKNEVV 393
           EV+  K +   +LG+G FG VY+G    ++    E  +AVK +++ AS +   EF NE  
Sbjct: 14  EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 73
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSR-------R 446
           ++      ++VRLLG   +G+  ++V E + +  L  +L     + + +  R        
Sbjct: 74  VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 133
Query: 447 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVDQTQGN 505
            ++   IA G+ YL+     + +HR+L A N ++  +   KI DFGM R I+  D  +  
Sbjct: 134 IQMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKG 190
Query: 506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
              ++    +MAPE    G F+  SD++SFGV++ EI +
Sbjct: 191 GKGLLPVR-WMAPESLKDGVFTTSSDMWSFGVVLWEITS 228

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 105/204 (51%), Gaps = 21/204 (10%)
Query: 353 LGEGGFGEVYKGVL--PSGQEI--AVKRLSKASGQG-AEEFKNEVVLVAKLQHRNLVRLL 407
           +G G FG VY G L    G++I  AVK L++ +  G   +F  E +++    H N++ LL
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 408 GFCLEGE-EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIG---GIARGILYLHED 463
           G CL  E   ++V  ++ +  L  F+ +      +       +IG    +A+G+ +L   
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK-----DLIGFGLQVAKGMKFL--- 147
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIF---GVDQTQGNTSRIVGTYGYMAPEY 520
           +  + +HRDL A N +LD +   K++DFG+AR       D     T   +    +MA E 
Sbjct: 148 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALES 206
Query: 521 AMHGQFSVKSDVYSFGVLVLEIIT 544
               +F+ KSDV+SFGVL+ E++T
Sbjct: 207 LQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 113/212 (53%), Gaps = 19/212 (8%)
Query: 342 VATNKFSTDNKLGEGGFGEVY--KGVLPSGQEIAVKRLSK---ASGQGAEEFKNEVVLVA 396
           + ++++     LG+G FGEV   K  + +GQE AVK +SK         E    EV L+ 
Sbjct: 46  IFSDRYKGQRVLGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKESLLREVQLLK 104
Query: 397 KLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARG 456
           +L H N+++L  F  +     LV E      L   +   ++  ++D +R   II  +  G
Sbjct: 105 QLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSG 161
Query: 457 ILYLHEDSRLRIIHRDLKASNILLDA---EMNPKISDFGMARIFGVDQTQGNTSRIVGTY 513
           I Y+H++   +I+HRDLK  N+LL++   + N +I DFG++  F   +   +    +GT 
Sbjct: 162 ITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK---IGTA 215
Query: 514 GYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
            Y+APE  +HG +  K DV+S GV++  +++G
Sbjct: 216 YYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 246

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 104/214 (48%), Gaps = 18/214 (8%)
Query: 335 FDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVL 394
            D++ IEV       +  +G G FG V K      +++A+K++   S + A  F  E+  
Sbjct: 6   IDYKEIEV-------EEVVGRGAFGVVCKAKW-RAKDVAIKQIESESERKA--FIVELRQ 55
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIA 454
           ++++ H N+V+L G CL      LV E+    SL   L+  E       +         +
Sbjct: 56  LSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCS 113
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMARIFGVDQTQGNTSRIVGTY 513
           +G+ YLH      +IHRDLK  N+LL A     KI DFG A        Q + +   G+ 
Sbjct: 114 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA-----CDIQTHMTNNKGSA 168
Query: 514 GYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKK 547
            +MAPE      +S K DV+S+G+++ E+IT +K
Sbjct: 169 AWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRK 202

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 107/205 (52%), Gaps = 23/205 (11%)
Query: 353 LGEGGFGEVYKGVL--PSGQEI--AVKRLSKASGQG-AEEFKNEVVLVAKLQHRNLVRLL 407
           +G G FG VY G L    G++I  AVK L++ +  G   +F  E +++    H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 408 GFCLEGE-EKILVYEFVPNKSLDYFL----YDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
           G CL  E   ++V  ++ +  L  F+    ++P  +  + +  +      +A+G+ +L  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKFL-- 149
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF---GVDQTQGNTSRIVGTYGYMAPE 519
            +  + +HRDL A N +LD +   K++DFG+AR       D     T   +    +MA E
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALE 207
Query: 520 YAMHGQFSVKSDVYSFGVLVLEIIT 544
                +F+ KSDV+SFGVL+ E++T
Sbjct: 208 SLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 113/212 (53%), Gaps = 19/212 (8%)
Query: 342 VATNKFSTDNKLGEGGFGEVY--KGVLPSGQEIAVKRLSK---ASGQGAEEFKNEVVLVA 396
           + ++++     LG+G FGEV   K  + +GQE AVK +SK         E    EV L+ 
Sbjct: 47  IFSDRYKGQRVLGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKESLLREVQLLK 105
Query: 397 KLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARG 456
           +L H N+++L  F  +     LV E      L   +   ++  ++D +R   II  +  G
Sbjct: 106 QLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSG 162
Query: 457 ILYLHEDSRLRIIHRDLKASNILLDA---EMNPKISDFGMARIFGVDQTQGNTSRIVGTY 513
           I Y+H++   +I+HRDLK  N+LL++   + N +I DFG++  F   +   +    +GT 
Sbjct: 163 ITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK---IGTA 216
Query: 514 GYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
            Y+APE  +HG +  K DV+S GV++  +++G
Sbjct: 217 YYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 247

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 104/214 (48%), Gaps = 18/214 (8%)
Query: 335 FDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVL 394
            D++ IEV       +  +G G FG V K      +++A+K++   S + A  F  E+  
Sbjct: 5   IDYKEIEV-------EEVVGRGAFGVVCKAKW-RAKDVAIKQIESESERKA--FIVELRQ 54
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIA 454
           ++++ H N+V+L G CL      LV E+    SL   L+  E       +         +
Sbjct: 55  LSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCS 112
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMARIFGVDQTQGNTSRIVGTY 513
           +G+ YLH      +IHRDLK  N+LL A     KI DFG A        Q + +   G+ 
Sbjct: 113 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA-----CDIQTHMTNNKGSA 167
Query: 514 GYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKK 547
            +MAPE      +S K DV+S+G+++ E+IT +K
Sbjct: 168 AWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRK 201

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 104/203 (51%), Gaps = 11/203 (5%)
Query: 346 KFSTDNKLGEGGFGEVYKGVLPSGQEIAVK--RLSKASGQGAEEFKNEVVLVAKLQHRNL 403
           K+    K+GEG +G VYK     G+  A+K  RL K           E+ ++ +L+H N+
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
           V+L       +  +LV+E + ++ L   L   E  G L+       +  +  GI Y H+ 
Sbjct: 63  VKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM- 522
              R++HRDLK  N+L++ E   KI+DFG+AR FG+   +  T  IV T  Y AP+  M 
Sbjct: 120 ---RVLHRDLKPQNLLINREGELKIADFGLARAFGI-PVRKYTHEIV-TLWYRAPDVLMG 174
Query: 523 HGQFSVKSDVYSFGVLVLEIITG 545
             ++S   D++S G +  E++ G
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 108/218 (49%), Gaps = 17/218 (7%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKG----VLPSGQE--IAVKRLSK-ASGQGAEEFKNEVV 393
           EV+  K +   +LG+G FG VY+G    ++    E  +AVK +++ AS +   EF NE  
Sbjct: 13  EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 72
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSR-------R 446
           ++      ++VRLLG   +G+  ++V E + +  L  +L     + + +  R        
Sbjct: 73  VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 132
Query: 447 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT 506
            ++   IA G+ YL+     + +HRDL A N ++  +   KI DFGM R           
Sbjct: 133 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKG 189
Query: 507 SRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
            + +    +MAPE    G F+  SD++SFGV++ EI +
Sbjct: 190 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 107/205 (52%), Gaps = 23/205 (11%)
Query: 353 LGEGGFGEVYKGVL--PSGQEI--AVKRLSKASGQG-AEEFKNEVVLVAKLQHRNLVRLL 407
           +G G FG VY G L    G++I  AVK L++ +  G   +F  E +++    H N++ LL
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 102
Query: 408 GFCLEGE-EKILVYEFVPNKSLDYFL----YDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
           G CL  E   ++V  ++ +  L  F+    ++P  +  + +  +      +A+G+ +L  
Sbjct: 103 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKFL-- 154
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF---GVDQTQGNTSRIVGTYGYMAPE 519
            +  + +HRDL A N +LD +   K++DFG+AR       D     T   +    +MA E
Sbjct: 155 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALE 212
Query: 520 YAMHGQFSVKSDVYSFGVLVLEIIT 544
                +F+ KSDV+SFGVL+ E++T
Sbjct: 213 SLQTQKFTTKSDVWSFGVLLWELMT 237

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 107/205 (52%), Gaps = 23/205 (11%)
Query: 353 LGEGGFGEVYKGVL--PSGQEI--AVKRLSKASGQG-AEEFKNEVVLVAKLQHRNLVRLL 407
           +G G FG VY G L    G++I  AVK L++ +  G   +F  E +++    H N++ LL
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 408 GFCLEGE-EKILVYEFVPNKSLDYFL----YDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
           G CL  E   ++V  ++ +  L  F+    ++P  +  + +  +      +A+G+ +L  
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKFL-- 150
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF---GVDQTQGNTSRIVGTYGYMAPE 519
            +  + +HRDL A N +LD +   K++DFG+AR       D     T   +    +MA E
Sbjct: 151 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALE 208
Query: 520 YAMHGQFSVKSDVYSFGVLVLEIIT 544
                +F+ KSDV+SFGVL+ E++T
Sbjct: 209 SLQTQKFTTKSDVWSFGVLLWELMT 233

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 107/205 (52%), Gaps = 23/205 (11%)
Query: 353 LGEGGFGEVYKGVL--PSGQEI--AVKRLSKASGQG-AEEFKNEVVLVAKLQHRNLVRLL 407
           +G G FG VY G L    G++I  AVK L++ +  G   +F  E +++    H N++ LL
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 408 GFCLEGE-EKILVYEFVPNKSLDYFL----YDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
           G CL  E   ++V  ++ +  L  F+    ++P  +  + +  +      +A+G+ +L  
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKFL-- 208
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF---GVDQTQGNTSRIVGTYGYMAPE 519
            +  + +HRDL A N +LD +   K++DFG+AR       D     T   +    +MA E
Sbjct: 209 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALE 266
Query: 520 YAMHGQFSVKSDVYSFGVLVLEIIT 544
                +F+ KSDV+SFGVL+ E++T
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELMT 291

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 100/195 (51%), Gaps = 11/195 (5%)
Query: 351 NKLGEGGFGEVYKGVLPSGQE-IAVKRLSKASGQGAE-EFKNEVVLVAKLQHRNLVRLLG 408
            ++G G FGEV+ G L +    +AVK   +      + +F  E  ++ +  H N+VRL+G
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 409 FCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRI 468
            C + +   +V E V  +  D+  +   +  +L      +++G  A G+ YL        
Sbjct: 180 VCTQKQPIYIVMELV--QGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---C 234
Query: 469 IHRDLKASNILLDAEMNPKISDFGMAR--IFGVDQTQGNTSRIVGTYGYMAPEYAMHGQF 526
           IHRDL A N L+  +   KISDFGM+R    GV    G   ++     + APE   +G++
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQV--PVKWTAPEALNYGRY 292
Query: 527 SVKSDVYSFGVLVLE 541
           S +SDV+SFG+L+ E
Sbjct: 293 SSESDVWSFGILLWE 307

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 107/205 (52%), Gaps = 23/205 (11%)
Query: 353 LGEGGFGEVYKGVL--PSGQEI--AVKRLSKASGQG-AEEFKNEVVLVAKLQHRNLVRLL 407
           +G G FG VY G L    G++I  AVK L++ +  G   +F  E +++    H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 408 GFCLEGE-EKILVYEFVPNKSLDYFL----YDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
           G CL  E   ++V  ++ +  L  F+    ++P  +  + +  +      +A+G+ +L  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKFL-- 149
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF---GVDQTQGNTSRIVGTYGYMAPE 519
            +  + +HRDL A N +LD +   K++DFG+AR       D     T   +    +MA E
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALE 207
Query: 520 YAMHGQFSVKSDVYSFGVLVLEIIT 544
                +F+ KSDV+SFGVL+ E++T
Sbjct: 208 SLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/199 (33%), Positives = 104/199 (52%), Gaps = 16/199 (8%)
Query: 353 LGEGGFGEVYK-GVLPSGQEIAVKRLSKASGQGAEE--FKNEVVLVAKLQHRNLVRLLGF 409
           LG+G FGEV K     + QE AVK ++KAS +  +      EV L+ KL H N+++L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 410 CLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRII 469
             +     +V E      L   +   ++  + D +R   II  +  GI Y+H+ +   I+
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIKQVFSGITYMHKHN---IV 143
Query: 470 HRDLKASNILLDA---EMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQF 526
           HRDLK  NILL++   + + KI DFG++  F   Q        +GT  Y+APE  + G +
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTKMKDRIGTAYYIAPE-VLRGTY 199
Query: 527 SVKSDVYSFGVLVLEIITG 545
             K DV+S GV++  +++G
Sbjct: 200 DEKCDVWSAGVILYILLSG 218

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/199 (33%), Positives = 104/199 (52%), Gaps = 16/199 (8%)
Query: 353 LGEGGFGEVYK-GVLPSGQEIAVKRLSKASGQGAEE--FKNEVVLVAKLQHRNLVRLLGF 409
           LG+G FGEV K     + QE AVK ++KAS +  +      EV L+ KL H N+++L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 410 CLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRII 469
             +     +V E      L   +   ++  + D +R   II  +  GI Y+H+ +   I+
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIKQVFSGITYMHKHN---IV 143
Query: 470 HRDLKASNILLDA---EMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQF 526
           HRDLK  NILL++   + + KI DFG++  F   Q        +GT  Y+APE  + G +
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTKMKDRIGTAYYIAPE-VLRGTY 199
Query: 527 SVKSDVYSFGVLVLEIITG 545
             K DV+S GV++  +++G
Sbjct: 200 DEKCDVWSAGVILYILLSG 218

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 74/245 (30%), Positives = 117/245 (47%), Gaps = 28/245 (11%)
Query: 331 ESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLP----SGQEIAVK--RLSKASGQG 384
           E LQ   E + +  N       LGEG FG V +G L     +  ++AVK  +L  +S + 
Sbjct: 20  EELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQRE 79
Query: 385 AEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEK-----ILVYEFVPNKSLD-YFLYDPEKQ 438
            EEF +E   +    H N++RLLG C+E   +     +++  F+    L  Y LY   + 
Sbjct: 80  IEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLET 139
Query: 439 G--QLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA-R 495
           G   +      K +  IA G+ YL   S    +HRDL A N +L  +M   ++DFG++ +
Sbjct: 140 GPKHIPLQTLLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKK 196
Query: 496 IFGVD-QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-------GKK 547
           I+  D   QG  +++     ++A E      ++ KSDV++FGV + EI T       G +
Sbjct: 197 IYSGDYYRQGRIAKM--PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQ 254
Query: 548 NSNFY 552
           N   Y
Sbjct: 255 NHEMY 259

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 112/203 (55%), Gaps = 13/203 (6%)
Query: 347 FSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLS-KASGQGAEEFKNEVVLVAKLQHRNLV 404
           F+   K+G+G FGEV+KG+    Q++ A+K +  + +    E+ + E+ ++++     + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 405 RLLGFCLEGEEKILVYEFVPNKS-LDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
           +  G  L+  +  ++ E++   S LD  L +P   G LD ++   I+  I +G+ YLH +
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALD--LLEP---GPLDETQIATILREILKGLDYLHSE 123
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMH 523
            +   IHRD+KA+N+LL      K++DFG+A    +  TQ   +  VGT  +MAPE    
Sbjct: 124 KK---IHRDIKAANVLLSEHGEVKLADFGVAG--QLTDTQIKRNXFVGTPFWMAPEVIKQ 178
Query: 524 GQFSVKSDVYSFGVLVLEIITGK 546
             +  K+D++S G+  +E+  G+
Sbjct: 179 SAYDSKADIWSLGITAIELARGE 201

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/199 (33%), Positives = 104/199 (52%), Gaps = 16/199 (8%)
Query: 353 LGEGGFGEVYK-GVLPSGQEIAVKRLSKASGQGAEE--FKNEVVLVAKLQHRNLVRLLGF 409
           LG+G FGEV K     + QE AVK ++KAS +  +      EV L+ KL H N+++L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 410 CLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRII 469
             +     +V E      L   +   ++  + D +R   II  +  GI Y+H+ +   I+
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIKQVFSGITYMHKHN---IV 143
Query: 470 HRDLKASNILLDA---EMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQF 526
           HRDLK  NILL++   + + KI DFG++  F   Q        +GT  Y+APE  + G +
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTKMKDRIGTAYYIAPE-VLRGTY 199
Query: 527 SVKSDVYSFGVLVLEIITG 545
             K DV+S GV++  +++G
Sbjct: 200 DEKCDVWSAGVILYILLSG 218

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 100/201 (49%), Gaps = 10/201 (4%)
Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRL---SKASGQGAEEFKNEVVLVAKLQHRN 402
           F  + K+G G F EVY+   L  G  +A+K++        +   +   E+ L+ +L H N
Sbjct: 34  FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRR-YKIIGGIARGILYLH 461
           +++     +E  E  +V E      L   +   +KQ +L   R  +K    +   + ++H
Sbjct: 94  VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH 153
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYA 521
             SR R++HRD+K +N+ + A    K+ D G+ R F    T  ++  +VGT  YM+PE  
Sbjct: 154 --SR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPERI 208
Query: 522 MHGQFSVKSDVYSFGVLVLEI 542
               ++ KSD++S G L+ E+
Sbjct: 209 HENGYNFKSDIWSLGCLLYEM 229

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 104/203 (51%), Gaps = 11/203 (5%)
Query: 346 KFSTDNKLGEGGFGEVYKGVLPSGQEIAVK--RLSKASGQGAEEFKNEVVLVAKLQHRNL 403
           K+    K+GEG +G VYK     G+  A+K  RL K           E+ ++ +L+H N+
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
           V+L       +  +LV+E + ++ L   L   E  G L+       +  +  GI Y H+ 
Sbjct: 63  VKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM- 522
              R++HRDLK  N+L++ E   KI+DFG+AR FG+   +  T  +V T  Y AP+  M 
Sbjct: 120 ---RVLHRDLKPQNLLINREGELKIADFGLARAFGI-PVRKYTHEVV-TLWYRAPDVLMG 174
Query: 523 HGQFSVKSDVYSFGVLVLEIITG 545
             ++S   D++S G +  E++ G
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 104/203 (51%), Gaps = 11/203 (5%)
Query: 346 KFSTDNKLGEGGFGEVYKGVLPSGQEIAVK--RLSKASGQGAEEFKNEVVLVAKLQHRNL 403
           K+    K+GEG +G VYK     G+  A+K  RL K           E+ ++ +L+H N+
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
           V+L       +  +LV+E + ++ L   L   E  G L+       +  +  GI Y H+ 
Sbjct: 63  VKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM- 522
              R++HRDLK  N+L++ E   KI+DFG+AR FG+   +  T  +V T  Y AP+  M 
Sbjct: 120 ---RVLHRDLKPQNLLINREGELKIADFGLARAFGI-PVRKYTHEVV-TLWYRAPDVLMG 174
Query: 523 HGQFSVKSDVYSFGVLVLEIITG 545
             ++S   D++S G +  E++ G
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 80/263 (30%), Positives = 117/263 (44%), Gaps = 32/263 (12%)
Query: 308 RRKAKKKYNA---VPESNADNDLTTLESLQFDF-ETIEVATNKFSTDNKLGEGGFGEVYK 363
           + K K KY     + ES   N  T ++  Q  + E  E   N       LG G FG+V +
Sbjct: 5   KYKQKPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVE 64
Query: 364 G-VLPSGQE-----IAVKRL-SKASGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEE 415
                 G+E     +AVK L S A     E   +E+ +++ L QH N+V LLG C  G  
Sbjct: 65  ATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124
Query: 416 KILVYEFVPNKSLDYFLY--------DPE---KQGQLDWSRRYKIIGGIARGILYLHEDS 464
            +++ E+     L  FL         DP        L           +A+G+ +L   +
Sbjct: 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFLASKN 184
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ---TQGNTSRIVGTYGYMAPEYA 521
               IHRD+ A N+LL      KI DFG+AR    D     +GN    V    +MAPE  
Sbjct: 185 ---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV---KWMAPESI 238
Query: 522 MHGQFSVKSDVYSFGVLVLEIIT 544
               ++V+SDV+S+G+L+ EI +
Sbjct: 239 FDCVYTVQSDVWSYGILLWEIFS 261

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 110/216 (50%), Gaps = 19/216 (8%)
Query: 342 VATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKN--EVVLVAKL 398
           +AT+++    ++G G +G VYK   P SG  +A+K +   +G+         EV L+ +L
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRL 60
Query: 399 Q---HRNLVRLLGFCL----EGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKII 450
           +   H N+VRL+  C     + E K+ LV+E V ++ L  +L      G L       ++
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPG-LPAETIKDLM 118
Query: 451 GGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIV 510
               RG+ +LH +    I+HRDLK  NIL+ +    K++DFG+ARI+     Q   + +V
Sbjct: 119 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY---QMALAPVV 172
Query: 511 GTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
            T  Y APE  +   ++   D++S G +  E+   K
Sbjct: 173 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 111/212 (52%), Gaps = 19/212 (8%)
Query: 342 VATNKFSTDNKLGEGGFGEVY--KGVLPSGQEIAVKRLSK---ASGQGAEEFKNEVVLVA 396
           + ++++     LG+G FGEV   K  + +GQE AVK +SK         E    EV L+ 
Sbjct: 23  IFSDRYKGQRVLGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKESLLREVQLLK 81
Query: 397 KLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARG 456
           +L H N+ +L  F  +     LV E      L   +   ++  ++D +R   II  +  G
Sbjct: 82  QLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSG 138
Query: 457 ILYLHEDSRLRIIHRDLKASNILLDA---EMNPKISDFGMARIFGVDQTQGNTSRIVGTY 513
           I Y H++   +I+HRDLK  N+LL++   + N +I DFG++  F   +   +    +GT 
Sbjct: 139 ITYXHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDK---IGTA 192
Query: 514 GYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
            Y+APE  +HG +  K DV+S GV++  +++G
Sbjct: 193 YYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 111/217 (51%), Gaps = 14/217 (6%)
Query: 342 VATNKFSTDNKLGEGGFGEVYKGVLPS--GQEI--AVKRLSK-ASGQGAEEFKNEVVLVA 396
           +A      +  LGEG FGEVY+GV  +  G++I  AVK   K  +    E+F +E V++ 
Sbjct: 5   IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMK 64
Query: 397 KLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARG 456
            L H ++V+L+G  +E E   ++ E  P   L ++L   +   ++     Y +   I + 
Sbjct: 65  NLDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL--QICKA 121
Query: 457 ILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVDQTQGNTSRIVGTYGY 515
           + YL     +  +HRD+   NIL+ +    K+ DFG++R I   D  + + +R+     +
Sbjct: 122 MAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKW 176
Query: 516 MAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFY 552
           M+PE     +F+  SDV+ F V + EI++  K   F+
Sbjct: 177 MSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFW 213

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 111/217 (51%), Gaps = 14/217 (6%)
Query: 342 VATNKFSTDNKLGEGGFGEVYKGVLPS--GQEI--AVKRLSK-ASGQGAEEFKNEVVLVA 396
           +A      +  LGEG FGEVY+GV  +  G++I  AVK   K  +    E+F +E V++ 
Sbjct: 9   IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMK 68
Query: 397 KLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARG 456
            L H ++V+L+G  +E E   ++ E  P   L ++L   +   ++     Y +   I + 
Sbjct: 69  NLDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL--QICKA 125
Query: 457 ILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVDQTQGNTSRIVGTYGY 515
           + YL     +  +HRD+   NIL+ +    K+ DFG++R I   D  + + +R+     +
Sbjct: 126 MAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKW 180
Query: 516 MAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFY 552
           M+PE     +F+  SDV+ F V + EI++  K   F+
Sbjct: 181 MSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFW 217

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 109/216 (50%), Gaps = 19/216 (8%)
Query: 342 VATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKN--EVVLVAKL 398
           +AT+++    ++G G +G VYK   P SG  +A+K +   +G+         EV L+ +L
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRL 60
Query: 399 Q---HRNLVRLLGFCL----EGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKII 450
           +   H N+VRL+  C     + E K+ LV+E V ++ L  +L      G L       ++
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPG-LPAETIKDLM 118
Query: 451 GGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIV 510
               RG+ +LH +    I+HRDLK  NIL+ +    K++DFG+ARI+     Q     +V
Sbjct: 119 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY---QMALDPVV 172
Query: 511 GTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
            T  Y APE  +   ++   D++S G +  E+   K
Sbjct: 173 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 111/217 (51%), Gaps = 14/217 (6%)
Query: 342 VATNKFSTDNKLGEGGFGEVYKGVLPS--GQEI--AVKRLSK-ASGQGAEEFKNEVVLVA 396
           +A      +  LGEG FGEVY+GV  +  G++I  AVK   K  +    E+F +E V++ 
Sbjct: 21  IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMK 80
Query: 397 KLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARG 456
            L H ++V+L+G  +E E   ++ E  P   L ++L   +   ++     Y +   I + 
Sbjct: 81  NLDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL--QICKA 137
Query: 457 ILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVDQTQGNTSRIVGTYGY 515
           + YL     +  +HRD+   NIL+ +    K+ DFG++R I   D  + + +R+     +
Sbjct: 138 MAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKW 192
Query: 516 MAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFY 552
           M+PE     +F+  SDV+ F V + EI++  K   F+
Sbjct: 193 MSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFW 229

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 99/196 (50%), Gaps = 10/196 (5%)
Query: 352 KLGEGGFGEV-YKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFC 410
           K+GEG  G V    V  SG+ +AVK++     Q  E   NEVV++   QH N+V +    
Sbjct: 27  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 411 LEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIH 470
           L G+E  +V EF+   +L     D     +++  +   +   + + +  LH      +IH
Sbjct: 87  LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIH 139
Query: 471 RDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKS 530
           RD+K+ +ILL  +   K+SDFG      V +       +VGT  +MAPE      +  + 
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEV 197
Query: 531 DVYSFGVLVLEIITGK 546
           D++S G++V+E++ G+
Sbjct: 198 DIWSLGIMVIEMVDGE 213

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 99/196 (50%), Gaps = 10/196 (5%)
Query: 352 KLGEGGFGEV-YKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFC 410
           K+GEG  G V    V  SG+ +AVK++     Q  E   NEVV++   QH N+V +    
Sbjct: 36  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 95
Query: 411 LEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIH 470
           L G+E  +V EF+   +L     D     +++  +   +   + + +  LH      +IH
Sbjct: 96  LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIH 148
Query: 471 RDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKS 530
           RD+K+ +ILL  +   K+SDFG      V +       +VGT  +MAPE      +  + 
Sbjct: 149 RDIKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEV 206
Query: 531 DVYSFGVLVLEIITGK 546
           D++S G++V+E++ G+
Sbjct: 207 DIWSLGIMVIEMVDGE 222

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 103/208 (49%), Gaps = 11/208 (5%)
Query: 337 FETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVA 396
           + + E+     +   +LG G FG V  G      ++A+K + + S    +EF  E  ++ 
Sbjct: 16  YGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMM 74
Query: 397 KLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARG 456
            L H  LV+L G C +     ++ E++ N  L  +L +   + Q    +  ++   +   
Sbjct: 75  NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEA 132
Query: 457 ILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG-- 514
           + YL      + +HRDL A N L++ +   K+SDFG++R    D+    TS +   +   
Sbjct: 133 MEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---ETSSVGSKFPVR 186
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEI 542
           +  PE  M+ +FS KSD+++FGVL+ EI
Sbjct: 187 WSPPEVLMYSKFSSKSDIWAFGVLMWEI 214

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 99/196 (50%), Gaps = 10/196 (5%)
Query: 352 KLGEGGFGEV-YKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFC 410
           K+GEG  G V    V  SG+ +AVK++     Q  E   NEVV++   QH N+V +    
Sbjct: 31  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 90
Query: 411 LEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIH 470
           L G+E  +V EF+   +L     D     +++  +   +   + + +  LH      +IH
Sbjct: 91  LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIH 143
Query: 471 RDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKS 530
           RD+K+ +ILL  +   K+SDFG      V +       +VGT  +MAPE      +  + 
Sbjct: 144 RDIKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEV 201
Query: 531 DVYSFGVLVLEIITGK 546
           D++S G++V+E++ G+
Sbjct: 202 DIWSLGIMVIEMVDGE 217

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 102/201 (50%), Gaps = 10/201 (4%)
Query: 347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVR 405
           F    KLGEG +G VYK +   +GQ +A+K++   S    +E   E+ ++ +    ++V+
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPHVVK 88
Query: 406 LLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSR 465
             G   +  +  +V E+    S+   +    +   L       I+    +G+ YLH    
Sbjct: 89  YYGSYFKNTDLWIVMEYCGAGSVSDIIR--LRNKTLTEDEIATILQSTLKGLEYLH---F 143
Query: 466 LRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQ 525
           +R IHRD+KA NILL+ E + K++DFG+A        + N   ++GT  +MAPE      
Sbjct: 144 MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNX--VIGTPFWMAPEVIQEIG 201
Query: 526 FSVKSDVYSFGVLVLEIITGK 546
           ++  +D++S G+  +E+  GK
Sbjct: 202 YNCVADIWSLGITAIEMAEGK 222

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 107/216 (49%), Gaps = 20/216 (9%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKG--VLPSGQEIAVKRLSKASGQGAEEFKN--EVVLVAKL 398
           A  ++    ++GEG +G+V+K   +   G+ +A+KR+   +G+         EV ++  L
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 399 Q---HRNLVRLLGFCL----EGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKII 450
           +   H N+VRL   C     + E K+ LV+E V      Y    PE     +  +   ++
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK--DMM 126
Query: 451 GGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIV 510
             + RG+ +LH     R++HRDLK  NIL+ +    K++DFG+ARI+     Q   + +V
Sbjct: 127 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVV 180
Query: 511 GTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
            T  Y APE  +   ++   D++S G +  E+   K
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 99/196 (50%), Gaps = 10/196 (5%)
Query: 352 KLGEGGFGEV-YKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFC 410
           K+GEG  G V    V  SG+ +AVK++     Q  E   NEVV++   QH N+V +    
Sbjct: 38  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 97
Query: 411 LEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIH 470
           L G+E  +V EF+   +L     D     +++  +   +   + + +  LH      +IH
Sbjct: 98  LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIH 150
Query: 471 RDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKS 530
           RD+K+ +ILL  +   K+SDFG      V +       +VGT  +MAPE      +  + 
Sbjct: 151 RDIKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEV 208
Query: 531 DVYSFGVLVLEIITGK 546
           D++S G++V+E++ G+
Sbjct: 209 DIWSLGIMVIEMVDGE 224

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/239 (28%), Positives = 105/239 (43%), Gaps = 33/239 (13%)
Query: 347 FSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGA---EEFKNEVVLVAKLQHRN 402
           F     LG+G FG VY       + I A+K L K   + A    + + EV + + L+H N
Sbjct: 14  FDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
           ++RL G+  +     L+ E+ P   L     + +K  + D  R    I  +A  + Y H 
Sbjct: 74  ILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSRFDEQRTATYITELANALSYCHS 130
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM 522
               R+IHRD+K  N+LL +    KI+DFG    + V       + + GT  Y+ PE   
Sbjct: 131 K---RVIHRDIKPENLLLGSNGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEMIE 183
Query: 523 HGQFSVKSDVYSFGVLVLEIITGKK--NSNFYQ-----------------TDGAADLLS 562
                 K D++S GVL  E + G     ++ YQ                 T+GA DL+S
Sbjct: 184 GRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVTEGARDLIS 242

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 101/205 (49%), Gaps = 9/205 (4%)
Query: 339 TIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKL 398
           + E+     +   +LG G FG V  G      ++A+K + + S    +EF  E  ++  L
Sbjct: 3   SWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNL 61
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGIL 458
            H  LV+L G C +     ++ E++ N  L  +L +   + Q    +  ++   +   + 
Sbjct: 62  SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAME 119
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ-TQGNTSRIVGTYGYMA 517
           YL      + +HRDL A N L++ +   K+SDFG++R    D+ T    S+    +    
Sbjct: 120 YLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWS--P 174
Query: 518 PEYAMHGQFSVKSDVYSFGVLVLEI 542
           PE  M+ +FS KSD+++FGVL+ EI
Sbjct: 175 PEVLMYSKFSSKSDIWAFGVLMWEI 199

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 102/206 (49%), Gaps = 11/206 (5%)
Query: 339 TIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKL 398
           + E+     +   +LG G FG V  G      ++A+K + + S    +EF  E  ++  L
Sbjct: 2   SWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNL 60
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGIL 458
            H  LV+L G C +     ++ E++ N  L  +L +   + Q    +  ++   +   + 
Sbjct: 61  SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAME 118
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG--YM 516
           YL      + +HRDL A N L++ +   K+SDFG++R    D+    TS +   +   + 
Sbjct: 119 YLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY---TSSVGSKFPVRWS 172
Query: 517 APEYAMHGQFSVKSDVYSFGVLVLEI 542
            PE  M+ +FS KSD+++FGVL+ EI
Sbjct: 173 PPEVLMYSKFSSKSDIWAFGVLMWEI 198

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 104/223 (46%), Gaps = 34/223 (15%)
Query: 345 NKFSTDNKLGEGGFGEVYKGVLPSG---QEIAVKRLSK-ASGQGAEEFKNEVVLVAKL-Q 399
           N     + +GEG FG+V K  +       + A+KR+ + AS     +F  E+ ++ KL  
Sbjct: 15  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 74
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLY-------DP------EKQGQLDWSRR 446
           H N++ LLG C       L  E+ P+ +L  FL        DP           L   + 
Sbjct: 75  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 134
Query: 447 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT 506
                 +ARG+ YL   S+ + IHRDL A NIL+      KI+DFG++R        G  
Sbjct: 135 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--------GQE 183
Query: 507 SRIVGTYG-----YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
             +  T G     +MA E   +  ++  SDV+S+GVL+ EI++
Sbjct: 184 VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 102/210 (48%), Gaps = 17/210 (8%)
Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA-SGQGAEEFKNEVVLVAKLQHRNLV 404
           +    +LG GGFG V + +   +G+++A+K+  +  S +  E +  E+ ++ KL H N+V
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 405 RL------LGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGIL 458
                   L      +  +L  E+     L  +L   E    L       ++  I+  + 
Sbjct: 76  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALR 135
Query: 459 YLHEDSRLRIIHRDLKASNILLDA---EMNPKISDFGMARIFGVDQTQGNTSRIVGTYGY 515
           YLHE+   RIIHRDLK  NI+L      +  KI D G A+   +DQ +  T   VGT  Y
Sbjct: 136 YLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK--ELDQGELCTE-FVGTLQY 189
Query: 516 MAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
           +APE     +++V  D +SFG L  E ITG
Sbjct: 190 LAPELLEQKKYTVTVDYWSFGTLAFECITG 219

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 102/206 (49%), Gaps = 11/206 (5%)
Query: 339 TIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKL 398
           + E+     +   +LG G FG V  G      ++A+K + + S    +EF  E  ++  L
Sbjct: 3   SWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNL 61
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGIL 458
            H  LV+L G C +     ++ E++ N  L  +L +   + Q    +  ++   +   + 
Sbjct: 62  SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAME 119
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG--YM 516
           YL      + +HRDL A N L++ +   K+SDFG++R    D+    TS +   +   + 
Sbjct: 120 YLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY---TSSVGSKFPVRWS 173
Query: 517 APEYAMHGQFSVKSDVYSFGVLVLEI 542
            PE  M+ +FS KSD+++FGVL+ EI
Sbjct: 174 PPEVLMYSKFSSKSDIWAFGVLMWEI 199

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKN---EVVLVAKLQHRN 402
           FS   ++G G FG VY    + + + +A+K++S +  Q  E++++   EV  + KL+H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
            ++  G  L      LV E+    + D      +   +++ +    +  G  +G+ YLH 
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA---AVTHGALQGLAYLHS 133
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM 522
            +   +IHRD+KA NILL      K+ DFG A I          +  VGT  +MAPE  +
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVIL 184
Query: 523 ---HGQFSVKSDVYSFGVLVLEIITGK 546
               GQ+  K DV+S G+  +E+   K
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERK 211

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 107/216 (49%), Gaps = 20/216 (9%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKG--VLPSGQEIAVKRLSKASGQGAEEFKN--EVVLVAKL 398
           A  ++    ++GEG +G+V+K   +   G+ +A+KR+   +G+         EV ++  L
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 399 Q---HRNLVRLLGFCL----EGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKII 450
           +   H N+VRL   C     + E K+ LV+E V      Y    PE     +  +   ++
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK--DMM 126
Query: 451 GGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIV 510
             + RG+ +LH     R++HRDLK  NIL+ +    K++DFG+ARI+     Q   + +V
Sbjct: 127 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVV 180
Query: 511 GTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
            T  Y APE  +   ++   D++S G +  E+   K
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 103/208 (49%), Gaps = 11/208 (5%)
Query: 337 FETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVA 396
           + + E+     +   +LG G FG V  G      ++A+K + + S    +EF  E  ++ 
Sbjct: 16  YGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMM 74
Query: 397 KLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARG 456
            L H  LV+L G C +     ++ E++ N  L  +L +   + Q    +  ++   +   
Sbjct: 75  NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEA 132
Query: 457 ILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG-- 514
           + YL      + +HRDL A N L++ +   K+SDFG++R    D+    TS +   +   
Sbjct: 133 MEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY---TSSVGSKFPVR 186
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEI 542
           +  PE  M+ +FS KSD+++FGVL+ EI
Sbjct: 187 WSPPEVLMYSKFSSKSDIWAFGVLMWEI 214

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 102/210 (48%), Gaps = 17/210 (8%)
Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA-SGQGAEEFKNEVVLVAKLQHRNLV 404
           +    +LG GGFG V + +   +G+++A+K+  +  S +  E +  E+ ++ KL H N+V
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 76
Query: 405 RL------LGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGIL 458
                   L      +  +L  E+     L  +L   E    L       ++  I+  + 
Sbjct: 77  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALR 136
Query: 459 YLHEDSRLRIIHRDLKASNILLDA---EMNPKISDFGMARIFGVDQTQGNTSRIVGTYGY 515
           YLHE+   RIIHRDLK  NI+L      +  KI D G A+   +DQ +  T   VGT  Y
Sbjct: 137 YLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK--ELDQGELCTE-FVGTLQY 190
Query: 516 MAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
           +APE     +++V  D +SFG L  E ITG
Sbjct: 191 LAPELLEQKKYTVTVDYWSFGTLAFECITG 220

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 104/223 (46%), Gaps = 34/223 (15%)
Query: 345 NKFSTDNKLGEGGFGEVYKGVLPSG---QEIAVKRLSK-ASGQGAEEFKNEVVLVAKL-Q 399
           N     + +GEG FG+V K  +       + A+KR+ + AS     +F  E+ ++ KL  
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLY-------DP------EKQGQLDWSRR 446
           H N++ LLG C       L  E+ P+ +L  FL        DP           L   + 
Sbjct: 85  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 447 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT 506
                 +ARG+ YL   S+ + IHRDL A NIL+      KI+DFG++R        G  
Sbjct: 145 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--------GQE 193
Query: 507 SRIVGTYG-----YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
             +  T G     +MA E   +  ++  SDV+S+GVL+ EI++
Sbjct: 194 VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKN---EVVLVAKLQHRN 402
           FS   ++G G FG VY    + + + +A+K++S +  Q  E++++   EV  + KL+H N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
            ++  G  L      LV E+    + D      +   +++ +    +  G  +G+ YLH 
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA---AVTHGALQGLAYLHS 172
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM 522
            +   +IHRD+KA NILL      K+ DFG A I          +  VGT  +MAPE  +
Sbjct: 173 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVIL 223
Query: 523 ---HGQFSVKSDVYSFGVLVLEIITGK 546
               GQ+  K DV+S G+  +E+   K
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIELAERK 250

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 107/216 (49%), Gaps = 20/216 (9%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKG--VLPSGQEIAVKRLSKASGQGAEEFKN--EVVLVAKL 398
           A  ++    ++GEG +G+V+K   +   G+ +A+KR+   +G+         EV ++  L
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 399 Q---HRNLVRLLGFCL----EGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKII 450
           +   H N+VRL   C     + E K+ LV+E V      Y    PE     +  +   ++
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK--DMM 126
Query: 451 GGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIV 510
             + RG+ +LH     R++HRDLK  NIL+ +    K++DFG+ARI+     Q   + +V
Sbjct: 127 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVV 180
Query: 511 GTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
            T  Y APE  +   ++   D++S G +  E+   K
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 98/194 (50%), Gaps = 11/194 (5%)
Query: 351 NKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFC 410
            +LG G FG V  G      ++A+K + + S    +EF  E  ++  L H  LV+L G C
Sbjct: 10  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 411 LEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIH 470
            +     ++ E++ N  L  +L +   + Q    +  ++   +   + YL      + +H
Sbjct: 69  TKQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYLESK---QFLH 123
Query: 471 RDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG--YMAPEYAMHGQFSV 528
           RDL A N L++ +   K+SDFG++R    D+    TS +   +   +  PE  M+ +FS 
Sbjct: 124 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY---TSSVGSKFPVRWSPPEVLMYSKFSS 180
Query: 529 KSDVYSFGVLVLEI 542
           KSD+++FGVL+ EI
Sbjct: 181 KSDIWAFGVLMWEI 194

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 103/208 (49%), Gaps = 11/208 (5%)
Query: 337 FETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVA 396
           + + E+     +   +LG G FG V  G      ++A+K + + S    +EF  E  ++ 
Sbjct: 7   YGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMM 65
Query: 397 KLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARG 456
            L H  LV+L G C +     ++ E++ N  L  +L +   + Q    +  ++   +   
Sbjct: 66  NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEA 123
Query: 457 ILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG-- 514
           + YL      + +HRDL A N L++ +   K+SDFG++R    D+    TS +   +   
Sbjct: 124 MEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY---TSSVGSKFPVR 177
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEI 542
           +  PE  M+ +FS KSD+++FGVL+ EI
Sbjct: 178 WSPPEVLMYSKFSSKSDIWAFGVLMWEI 205

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 99/196 (50%), Gaps = 10/196 (5%)
Query: 352 KLGEGGFGEV-YKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFC 410
           K+GEG  G V    V  SG+ +AVK++     Q  E   NEVV++   QH N+V +    
Sbjct: 158 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 217
Query: 411 LEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIH 470
           L G+E  +V EF+   +L   +       +++  +   +   + + +  LH      +IH
Sbjct: 218 LVGDELWVVMEFLEGGALTDIVT----HTRMNEEQIAAVCLAVLQALSVLHAQG---VIH 270
Query: 471 RDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKS 530
           RD+K+ +ILL  +   K+SDFG      V +       +VGT  +MAPE      +  + 
Sbjct: 271 RDIKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEV 328
Query: 531 DVYSFGVLVLEIITGK 546
           D++S G++V+E++ G+
Sbjct: 329 DIWSLGIMVIEMVDGE 344

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/239 (28%), Positives = 104/239 (43%), Gaps = 33/239 (13%)
Query: 347 FSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGA---EEFKNEVVLVAKLQHRN 402
           F     LG+G FG VY       + I A+K L K   + A    + + EV + + L+H N
Sbjct: 14  FDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
           ++RL G+  +     L+ E+ P   L     + +K  + D  R    I  +A  + Y H 
Sbjct: 74  ILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSRFDEQRTATYITELANALSYCHS 130
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM 522
               R+IHRD+K  N+LL +    KI+DFG    + V         + GT  Y+ PE   
Sbjct: 131 K---RVIHRDIKPENLLLGSNGELKIADFG----WSVHAPSSRRDTLCGTLDYLPPEMIE 183
Query: 523 HGQFSVKSDVYSFGVLVLEIITGKK--NSNFYQ-----------------TDGAADLLS 562
                 K D++S GVL  E + G     ++ YQ                 T+GA DL+S
Sbjct: 184 GRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVTEGARDLIS 242

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 109/216 (50%), Gaps = 19/216 (8%)
Query: 342 VATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKN--EVVLVAKL 398
           +AT+++    ++G G +G VYK   P SG  +A+K +   +G+         EV L+ +L
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRL 60
Query: 399 Q---HRNLVRLLGFCL----EGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKII 450
           +   H N+VRL+  C     + E K+ LV+E V ++ L  +L      G L       ++
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPG-LPAETIKDLM 118
Query: 451 GGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIV 510
               RG+ +LH +    I+HRDLK  NIL+ +    K++DFG+ARI+     Q     +V
Sbjct: 119 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY---QMALFPVV 172
Query: 511 GTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
            T  Y APE  +   ++   D++S G +  E+   K
Sbjct: 173 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 112/208 (53%), Gaps = 19/208 (9%)
Query: 347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRL---SKASGQGAEEFKNEVVLVAKLQHRN 402
           F    K+GEG +G VYK     +G+ +A+K++   ++  G  +   + E+ L+ +L H N
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 63
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQG---QLDWSRRYKIIGGIARGILY 459
           +V+LL       +  LV+EF+ ++ L  F+      G    L  S  ++++ G+A    +
Sbjct: 64  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA----F 118
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE 519
            H     R++HRDLK  N+L++ E   K++DFG+AR FGV   +  T  +V T  Y APE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPE 173
Query: 520 YAMHGQ-FSVKSDVYSFGVLVLEIITGK 546
             +  + +S   D++S G +  E++T +
Sbjct: 174 ILLGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 72/203 (35%), Positives = 94/203 (46%), Gaps = 16/203 (7%)
Query: 351 NKLGEGGFGEVYKGVL--PSGQ--EIAVKRLSK---ASGQGAEEFKNEVVLVAKLQHRNL 403
            KLG+G FG V +G    PSG+   +AVK L     +  +  ++F  EV  +  L HRNL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
           +RL G  L    K +V E  P  SL   L   +    L    RY +   +A G+ YL   
Sbjct: 74  IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 130
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIF--GVDQTQGNTSRIVGTYGYMAPEYA 521
              R IHRDL A N+LL      KI DFG+ R      D       R V  + + APE  
Sbjct: 131 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV-PFAWCAPESL 186
Query: 522 MHGQFSVKSDVYSFGVLVLEIIT 544
               FS  SD + FGV + E+ T
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFT 209

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 113/213 (53%), Gaps = 19/213 (8%)
Query: 342 VATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRL---SKASGQGAEEFKNEVVLVAK 397
           V    F    K+GEG +G VYK     +G+ +A+K++   ++  G  +   + E+ L+ +
Sbjct: 4   VDMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKE 62
Query: 398 LQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQG---QLDWSRRYKIIGGIA 454
           L H N+V+LL       +  LV+EF+ ++ L  F+      G    L  S  ++++ G+A
Sbjct: 63  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 121
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
               + H     R++HRDLK  N+L++ E   K++DFG+AR FGV   +  T  +V T  
Sbjct: 122 ----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLW 172
Query: 515 YMAPEYAMHGQ-FSVKSDVYSFGVLVLEIITGK 546
           Y APE  +  + +S   D++S G +  E++T +
Sbjct: 173 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 99/196 (50%), Gaps = 10/196 (5%)
Query: 352 KLGEGGFGEV-YKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFC 410
           K+GEG  G V    V  SG+ +AVK++     Q  E   NEVV++   QH N+V +    
Sbjct: 81  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 140
Query: 411 LEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIH 470
           L G+E  +V EF+   +L     D     +++  +   +   + + +  LH      +IH
Sbjct: 141 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIH 193
Query: 471 RDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKS 530
           RD+K+ +ILL  +   K+SDFG      V +       +VGT  +MAPE      +  + 
Sbjct: 194 RDIKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEV 251
Query: 531 DVYSFGVLVLEIITGK 546
           D++S G++V+E++ G+
Sbjct: 252 DIWSLGIMVIEMVDGE 267

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 111/206 (53%), Gaps = 15/206 (7%)
Query: 347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRL---SKASGQGAEEFKNEVVLVAKLQHRN 402
           F    K+GEG +G VYK     +G+ +A+K++   ++  G  +   + E+ L+ +L H N
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 63
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQG-QLDWSRRYKIIGGIARGILYLH 461
           +V+LL       +  LV+EF+ ++ L  F+      G  L   + Y  +  + +G+ + H
Sbjct: 64  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFCH 120
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYA 521
                R++HRDLK  N+L++ E   K++DFG+AR FGV   +  T  +V T  Y APE  
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 175
Query: 522 MHGQ-FSVKSDVYSFGVLVLEIITGK 546
           +  + +S   D++S G +  E++T +
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 111/206 (53%), Gaps = 15/206 (7%)
Query: 347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRL---SKASGQGAEEFKNEVVLVAKLQHRN 402
           F    K+GEG +G VYK     +G+ +A+K++   ++  G  +   + E+ L+ +L H N
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 62
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQG-QLDWSRRYKIIGGIARGILYLH 461
           +V+LL       +  LV+EF+ ++ L  F+      G  L   + Y  +  + +G+ + H
Sbjct: 63  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFCH 119
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYA 521
                R++HRDLK  N+L++ E   K++DFG+AR FGV   +  T  +V T  Y APE  
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 174
Query: 522 MHGQ-FSVKSDVYSFGVLVLEIITGK 546
           +  + +S   D++S G +  E++T +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 111/206 (53%), Gaps = 15/206 (7%)
Query: 347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRL---SKASGQGAEEFKNEVVLVAKLQHRN 402
           F    K+GEG +G VYK     +G+ +A+K++   ++  G  +   + E+ L+ +L H N
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 62
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQG-QLDWSRRYKIIGGIARGILYLH 461
           +V+LL       +  LV+EF+ ++ L  F+      G  L   + Y  +  + +G+ + H
Sbjct: 63  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFCH 119
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYA 521
                R++HRDLK  N+L++ E   K++DFG+AR FGV   +  T  +V T  Y APE  
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 174
Query: 522 MHGQ-FSVKSDVYSFGVLVLEIITGK 546
           +  + +S   D++S G +  E++T +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 111/206 (53%), Gaps = 15/206 (7%)
Query: 347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRL---SKASGQGAEEFKNEVVLVAKLQHRN 402
           F    K+GEG +G VYK     +G+ +A+K++   ++  G  +   + E+ L+ +L H N
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 64
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQG-QLDWSRRYKIIGGIARGILYLH 461
           +V+LL       +  LV+EF+ ++ L  F+      G  L   + Y  +  + +G+ + H
Sbjct: 65  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFCH 121
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYA 521
                R++HRDLK  N+L++ E   K++DFG+AR FGV   +  T  +V T  Y APE  
Sbjct: 122 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 176
Query: 522 MHGQ-FSVKSDVYSFGVLVLEIITGK 546
           +  + +S   D++S G +  E++T +
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 111/206 (53%), Gaps = 15/206 (7%)
Query: 347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRL---SKASGQGAEEFKNEVVLVAKLQHRN 402
           F    K+GEG +G VYK     +G+ +A+K++   ++  G  +   + E+ L+ +L H N
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 63
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQG-QLDWSRRYKIIGGIARGILYLH 461
           +V+LL       +  LV+EF+ ++ L  F+      G  L   + Y  +  + +G+ + H
Sbjct: 64  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFCH 120
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYA 521
                R++HRDLK  N+L++ E   K++DFG+AR FGV   +  T  +V T  Y APE  
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 175
Query: 522 MHGQ-FSVKSDVYSFGVLVLEIITGK 546
           +  + +S   D++S G +  E++T +
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 112/208 (53%), Gaps = 19/208 (9%)
Query: 347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRL---SKASGQGAEEFKNEVVLVAKLQHRN 402
           F    K+GEG +G VYK     +G+ +A+K++   ++  G  +   + E+ L+ +L H N
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 70
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQG---QLDWSRRYKIIGGIARGILY 459
           +V+LL       +  LV+EF+ ++ L  F+      G    L  S  ++++ G+A    +
Sbjct: 71  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA----F 125
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE 519
            H     R++HRDLK  N+L++ E   K++DFG+AR FGV   +  T  +V T  Y APE
Sbjct: 126 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPE 180
Query: 520 YAMHGQ-FSVKSDVYSFGVLVLEIITGK 546
             +  + +S   D++S G +  E++T +
Sbjct: 181 ILLGXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 72/203 (35%), Positives = 94/203 (46%), Gaps = 16/203 (7%)
Query: 351 NKLGEGGFGEVYKGVL--PSGQ--EIAVKRLSK---ASGQGAEEFKNEVVLVAKLQHRNL 403
            KLG+G FG V +G    PSG+   +AVK L     +  +  ++F  EV  +  L HRNL
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
           +RL G  L    K +V E  P  SL   L   +    L    RY +   +A G+ YL   
Sbjct: 84  IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 140
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIF--GVDQTQGNTSRIVGTYGYMAPEYA 521
              R IHRDL A N+LL      KI DFG+ R      D       R V  + + APE  
Sbjct: 141 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV-PFAWCAPESL 196
Query: 522 MHGQFSVKSDVYSFGVLVLEIIT 544
               FS  SD + FGV + E+ T
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFT 219

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 111/206 (53%), Gaps = 15/206 (7%)
Query: 347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRL---SKASGQGAEEFKNEVVLVAKLQHRN 402
           F    K+GEG +G VYK     +G+ +A+K++   ++  G  +   + E+ L+ +L H N
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 70
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQG-QLDWSRRYKIIGGIARGILYLH 461
           +V+LL       +  LV+EF+ ++ L  F+      G  L   + Y  +  + +G+ + H
Sbjct: 71  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFCH 127
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYA 521
                R++HRDLK  N+L++ E   K++DFG+AR FGV   +  T  +V T  Y APE  
Sbjct: 128 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 182
Query: 522 MHGQ-FSVKSDVYSFGVLVLEIITGK 546
           +  + +S   D++S G +  E++T +
Sbjct: 183 LGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 78/257 (30%), Positives = 116/257 (45%), Gaps = 38/257 (14%)
Query: 320 ESNADNDLTTLESLQFDF-ETIEVATNKFSTDNKLGEGGFGEVYKG-VLPSGQE-----I 372
           ES   N  T ++  Q  + E  E   N       LG G FG+V +      G+E     +
Sbjct: 5   ESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKV 64
Query: 373 AVKRL-SKASGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDY 430
           AVK L S A     E   +E+ +++ L QH N+V LLG C  G   +++ E+     L  
Sbjct: 65  AVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLN 124
Query: 431 FL---------------YDPE----KQGQ-LDWSRRYKIIGGIARGILYLHEDSRLRIIH 470
           FL                DPE    + G+ L+          +A+G+ +L   +    IH
Sbjct: 125 FLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKN---CIH 181
Query: 471 RDLKASNILLDAEMNPKISDFGMARIFGVDQ---TQGNTSRIVGTYGYMAPEYAMHGQFS 527
           RD+ A N+LL      KI DFG+AR    D     +GN    V    +MAPE      ++
Sbjct: 182 RDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV---KWMAPESIFDCVYT 238
Query: 528 VKSDVYSFGVLVLEIIT 544
           V+SDV+S+G+L+ EI +
Sbjct: 239 VQSDVWSYGILLWEIFS 255

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 72/203 (35%), Positives = 94/203 (46%), Gaps = 16/203 (7%)
Query: 351 NKLGEGGFGEVYKGVL--PSGQ--EIAVKRLSK---ASGQGAEEFKNEVVLVAKLQHRNL 403
            KLG+G FG V +G    PSG+   +AVK L     +  +  ++F  EV  +  L HRNL
Sbjct: 18  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
           +RL G  L    K +V E  P  SL   L   +    L    RY +   +A G+ YL   
Sbjct: 78  IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 134
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIF--GVDQTQGNTSRIVGTYGYMAPEYA 521
              R IHRDL A N+LL      KI DFG+ R      D       R V  + + APE  
Sbjct: 135 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAPESL 190
Query: 522 MHGQFSVKSDVYSFGVLVLEIIT 544
               FS  SD + FGV + E+ T
Sbjct: 191 KTRTFSHASDTWMFGVTLWEMFT 213

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 111/206 (53%), Gaps = 15/206 (7%)
Query: 347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRL---SKASGQGAEEFKNEVVLVAKLQHRN 402
           F    K+GEG +G VYK     +G+ +A+K++   ++  G  +   + E+ L+ +L H N
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 63
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQG-QLDWSRRYKIIGGIARGILYLH 461
           +V+LL       +  LV+EF+ ++ L  F+      G  L   + Y  +  + +G+ + H
Sbjct: 64  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLSFCH 120
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYA 521
                R++HRDLK  N+L++ E   K++DFG+AR FGV   +  T  +V T  Y APE  
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 175
Query: 522 MHGQ-FSVKSDVYSFGVLVLEIITGK 546
           +  + +S   D++S G +  E++T +
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 72/203 (35%), Positives = 94/203 (46%), Gaps = 16/203 (7%)
Query: 351 NKLGEGGFGEVYKGVL--PSGQ--EIAVKRLSK---ASGQGAEEFKNEVVLVAKLQHRNL 403
            KLG+G FG V +G    PSG+   +AVK L     +  +  ++F  EV  +  L HRNL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
           +RL G  L    K +V E  P  SL   L   +    L    RY +   +A G+ YL   
Sbjct: 74  IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 130
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIF--GVDQTQGNTSRIVGTYGYMAPEYA 521
              R IHRDL A N+LL      KI DFG+ R      D       R V  + + APE  
Sbjct: 131 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAPESL 186
Query: 522 MHGQFSVKSDVYSFGVLVLEIIT 544
               FS  SD + FGV + E+ T
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFT 209

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 110/208 (52%), Gaps = 21/208 (10%)
Query: 349 TDNKLGEGGFGEVYKG-VLPSGQ---EIAVKRLSKASG-QGAEEFKNEVVLVAKLQHRNL 403
           +D  +G+G FG VY G  +   Q   + A+K LS+ +  Q  E F  E +L+  L H N+
Sbjct: 25  SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 404 VRLLGFCL--EGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH 461
           + L+G  L  EG   +L+  ++ +  L  F+  P++   +     + +   +ARG+ YL 
Sbjct: 85  LALIGIMLPPEGLPHVLL-PYMCHGDLLQFIRSPQRNPTVKDLISFGL--QVARGMEYLA 141
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ-----TQGNTSRIVGTYGYM 516
           E    + +HRDL A N +LD     K++DFG+AR   +D+      Q   +R+     + 
Sbjct: 142 EQ---KFVHRDLAARNCMLDESFTVKVADFGLARDI-LDREYYSVQQHRHARL--PVKWT 195
Query: 517 APEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           A E     +F+ KSDV+SFGVL+ E++T
Sbjct: 196 ALESLQTYRFTTKSDVWSFGVLLWELLT 223

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 108/232 (46%), Gaps = 28/232 (12%)
Query: 326 DLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGA 385
           DL+ L      FE +E+          +G G +G+VYKG      ++A  ++   +G   
Sbjct: 15  DLSALRDPAGIFELVEL----------VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE 64
Query: 386 EEFKNEVVLVAKL-QHRNLVRLLGFCLE------GEEKILVYEFVPNKSLDYFLYDPEKQ 438
           EE K E+ ++ K   HRN+    G  ++       ++  LV EF    S+   + +  K 
Sbjct: 65  EEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN-TKG 123
Query: 439 GQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498
             L       I   I RG+ +LH+    ++IHRD+K  N+LL      K+ DFG++    
Sbjct: 124 NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVS--AQ 178
Query: 499 VDQTQGNTSRIVGTYGYMAPEYAM-----HGQFSVKSDVYSFGVLVLEIITG 545
           +D+T G  +  +GT  +MAPE           +  KSD++S G+  +E+  G
Sbjct: 179 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 72/203 (35%), Positives = 94/203 (46%), Gaps = 16/203 (7%)
Query: 351 NKLGEGGFGEVYKGVL--PSGQ--EIAVKRLSK---ASGQGAEEFKNEVVLVAKLQHRNL 403
            KLG+G FG V +G    PSG+   +AVK L     +  +  ++F  EV  +  L HRNL
Sbjct: 18  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
           +RL G  L    K +V E  P  SL   L   +    L    RY +   +A G+ YL   
Sbjct: 78  IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 134
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIF--GVDQTQGNTSRIVGTYGYMAPEYA 521
              R IHRDL A N+LL      KI DFG+ R      D       R V  + + APE  
Sbjct: 135 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAPESL 190
Query: 522 MHGQFSVKSDVYSFGVLVLEIIT 544
               FS  SD + FGV + E+ T
Sbjct: 191 KTRTFSHASDTWMFGVTLWEMFT 213

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 72/203 (35%), Positives = 94/203 (46%), Gaps = 16/203 (7%)
Query: 351 NKLGEGGFGEVYKGVL--PSGQ--EIAVKRLSK---ASGQGAEEFKNEVVLVAKLQHRNL 403
            KLG+G FG V +G    PSG+   +AVK L     +  +  ++F  EV  +  L HRNL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
           +RL G  L    K +V E  P  SL   L   +    L    RY +   +A G+ YL   
Sbjct: 74  IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 130
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIF--GVDQTQGNTSRIVGTYGYMAPEYA 521
              R IHRDL A N+LL      KI DFG+ R      D       R V  + + APE  
Sbjct: 131 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAPESL 186
Query: 522 MHGQFSVKSDVYSFGVLVLEIIT 544
               FS  SD + FGV + E+ T
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFT 209

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 72/203 (35%), Positives = 94/203 (46%), Gaps = 16/203 (7%)
Query: 351 NKLGEGGFGEVYKGVL--PSGQ--EIAVKRLSK---ASGQGAEEFKNEVVLVAKLQHRNL 403
            KLG+G FG V +G    PSG+   +AVK L     +  +  ++F  EV  +  L HRNL
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
           +RL G  L    K +V E  P  SL   L   +    L    RY +   +A G+ YL   
Sbjct: 84  IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 140
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIF--GVDQTQGNTSRIVGTYGYMAPEYA 521
              R IHRDL A N+LL      KI DFG+ R      D       R V  + + APE  
Sbjct: 141 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAPESL 196
Query: 522 MHGQFSVKSDVYSFGVLVLEIIT 544
               FS  SD + FGV + E+ T
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFT 219

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 104/223 (46%), Gaps = 34/223 (15%)
Query: 345 NKFSTDNKLGEGGFGEVYKGVLPSG---QEIAVKRLSK-ASGQGAEEFKNEVVLVAKL-Q 399
           N     + +GEG FG+V K  +       + A+KR+ + AS     +F  E+ ++ KL  
Sbjct: 22  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 81
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLY-------DP------EKQGQLDWSRR 446
           H N++ LLG C       L  E+ P+ +L  FL        DP           L   + 
Sbjct: 82  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 141
Query: 447 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT 506
                 +ARG+ YL   S+ + IHR+L A NIL+      KI+DFG++R        G  
Sbjct: 142 LHFAADVARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSR--------GQE 190
Query: 507 SRIVGTYG-----YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
             +  T G     +MA E   +  ++  SDV+S+GVL+ EI++
Sbjct: 191 VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 101/214 (47%), Gaps = 19/214 (8%)
Query: 341 EVATNKFSTDN-----KLGEGGFGEVYKGVLPSGQEI-AVKRL--SKASGQGAE-EFKNE 391
           E+   KF+ D+      LG+G FG VY       + I A+K L  S+   +G E + + E
Sbjct: 5   EMPKRKFTIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRRE 64
Query: 392 VVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIG 451
           + + + L+H N++R+  +  + +   L+ EF P   L   L   +K G+ D  R    + 
Sbjct: 65  IEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSATFME 121
Query: 452 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVG 511
            +A  + Y HE    ++IHRD+K  N+L+  +   KI+DFG    + V         + G
Sbjct: 122 ELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFG----WSVHAPSLRRRXMCG 174
Query: 512 TYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
           T  Y+ PE         K D++  GVL  E + G
Sbjct: 175 TLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 208

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 111/208 (53%), Gaps = 19/208 (9%)
Query: 347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRL---SKASGQGAEEFKNEVVLVAKLQHRN 402
           F    K+GEG +G VYK     +G+ +A+K++   ++  G  +   + E+ L+ +L H N
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 62
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQG---QLDWSRRYKIIGGIARGILY 459
           +V+LL       +  LV+E V ++ L  F+      G    L  S  ++++ G+A    +
Sbjct: 63  IVKLLDVIHTENKLYLVFEHV-HQDLKTFMDASALTGIPLPLIKSYLFQLLQGLA----F 117
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE 519
            H     R++HRDLK  N+L++ E   K++DFG+AR FGV   +  T  +V T  Y APE
Sbjct: 118 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPE 172
Query: 520 YAMHGQ-FSVKSDVYSFGVLVLEIITGK 546
             +  + +S   D++S G +  E++T +
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 110/223 (49%), Gaps = 27/223 (12%)
Query: 331 ESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFK 389
           E ++ D +  EV    +    +LG+G FG+VYK     +G   A K +   S +  E++ 
Sbjct: 1   EHVRRDLDPNEV----WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYI 56
Query: 390 NEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKI 449
            E+ ++A   H  +V+LLG      +  ++ EF P  ++D  +       +LD       
Sbjct: 57  VEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIML------ELDRGLTEPQ 110
Query: 450 IGGIARGIL----YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM-ARIFGVDQTQG 504
           I  + R +L    +LH     RIIHRDLKA N+L+  E + +++DFG+ A+     +T  
Sbjct: 111 IQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL---KTLQ 164
Query: 505 NTSRIVGTYGYMAPEYAM-----HGQFSVKSDVYSFGVLVLEI 542
                +GT  +MAPE  M        +  K+D++S G+ ++E+
Sbjct: 165 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 207

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 100/200 (50%), Gaps = 31/200 (15%)
Query: 353 LGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE 412
           +G+G FG+V  G    G ++AVK +   +   A+ F  E  ++ +L+H NLV+LLG  +E
Sbjct: 201 IGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 413 GEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGG---------IARGILYLHE 462
            +  + +V E++   SL  +L           SR   ++GG         +   + YL  
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLR----------SRGRSVLGGDCLLKFSLDVCEAMEYLEG 307
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM 522
           ++    +HRDL A N+L+  +   K+SDFG+ +     Q  G          + APE   
Sbjct: 308 NN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP-----VKWTAPEALR 359
Query: 523 HGQFSVKSDVYSFGVLVLEI 542
             +FS KSDV+SFG+L+ EI
Sbjct: 360 EKKFSTKSDVWSFGILLWEI 379

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 111/223 (49%), Gaps = 27/223 (12%)
Query: 331 ESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFK 389
           E ++ D +  EV    +    +LG+G FG+VYK     +G   A K +   S +  E++ 
Sbjct: 9   EHVRRDLDPNEV----WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYI 64
Query: 390 NEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKI 449
            E+ ++A   H  +V+LLG      +  ++ EF P  ++D  +       +LD       
Sbjct: 65  VEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIML------ELDRGLTEPQ 118
Query: 450 IGGIARGIL----YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM-ARIFGVDQTQG 504
           I  + R +L    +LH     RIIHRDLKA N+L+  E + +++DFG+ A+     Q + 
Sbjct: 119 IQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRD 175
Query: 505 NTSRIVGTYGYMAPEYAM-----HGQFSVKSDVYSFGVLVLEI 542
           +    +GT  +MAPE  M        +  K+D++S G+ ++E+
Sbjct: 176 S---FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 215

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 101/214 (47%), Gaps = 19/214 (8%)
Query: 341 EVATNKFSTDN-----KLGEGGFGEVYKGVLPSGQEI-AVKRL--SKASGQGAE-EFKNE 391
           E+   KF+ D+      LG+G FG VY       + I A+K L  S+   +G E + + E
Sbjct: 6   EMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRRE 65
Query: 392 VVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIG 451
           + + + L+H N++R+  +  + +   L+ EF P   L   L   +K G+ D  R    + 
Sbjct: 66  IEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSATFME 122
Query: 452 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVG 511
            +A  + Y HE    ++IHRD+K  N+L+  +   KI+DFG    + V         + G
Sbjct: 123 ELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFG----WSVHAPSLRRRXMCG 175
Query: 512 TYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
           T  Y+ PE         K D++  GVL  E + G
Sbjct: 176 TLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 209

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 113/230 (49%), Gaps = 32/230 (13%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY--------KGVLPSGQEIAVKRL-SKASGQGAEEFKNE 391
           E+  ++      LGEG FG+V         K       ++AVK L S A+ +   +  +E
Sbjct: 24  ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 83
Query: 392 VVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL---------------YDP 435
           + ++  + +H+N++ LLG C +     ++ E+    +L  +L               ++P
Sbjct: 84  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNP 143
Query: 436 EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
           E+Q  L           +ARG+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR
Sbjct: 144 EEQ--LSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 198
Query: 496 -IFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
            I  +D  +  T+  +    +MAPE      ++ +SDV+SFGVL+ EI T
Sbjct: 199 DIHHIDXXKKTTNGRL-PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 103/196 (52%), Gaps = 23/196 (11%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVK-----RLSKASGQGAEEFKNEVVLVAKLQHRNLVRL 406
           LGEG FG+V       +GQ++A+K      L+K+  QG    + E+  +  L+H ++++L
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRLLRHPHIIKL 78
Query: 407 LGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRL 466
                  +E I+V E+  N+  DY +   +   Q   +RR+     I   + Y H   R 
Sbjct: 79  YDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQ--EARRF--FQQIISAVEYCH---RH 131
Query: 467 RIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRI-VGTYGYMAPEYAMHGQ 525
           +I+HRDLK  N+LLD  +N KI+DFG++ I     T GN  +   G+  Y APE  + G+
Sbjct: 132 KIVHRDLKPENLLLDEHLNVKIADFGLSNIM----TDGNFLKTSCGSPNYAAPE-VISGK 186
Query: 526 FSV--KSDVYSFGVLV 539
                + DV+S GV++
Sbjct: 187 LYAGPEVDVWSCGVIL 202

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/196 (33%), Positives = 103/196 (52%), Gaps = 23/196 (11%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVK-----RLSKASGQGAEEFKNEVVLVAKLQHRNLVRL 406
           LGEG FG+V       +GQ++A+K      L+K+  QG  E   E+  +  L+H ++++L
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLRHPHIIKL 69
Query: 407 LGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRL 466
                  +E I+V E+  N+  DY +   +   Q   +RR+     I   + Y H   R 
Sbjct: 70  YDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQ--EARRF--FQQIISAVEYCH---RH 122
Query: 467 RIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRI-VGTYGYMAPEYAMHGQ 525
           +I+HRDLK  N+LLD  +N KI+DFG++ I     T GN  +   G+  Y APE  + G+
Sbjct: 123 KIVHRDLKPENLLLDEHLNVKIADFGLSNIM----TDGNFLKTSCGSPNYAAPE-VISGK 177
Query: 526 FSV--KSDVYSFGVLV 539
                + DV+S GV++
Sbjct: 178 LYAGPEVDVWSCGVIL 193

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 103/196 (52%), Gaps = 23/196 (11%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVK-----RLSKASGQGAEEFKNEVVLVAKLQHRNLVRL 406
           LGEG FG+V       +GQ++A+K      L+K+  QG    + E+  +  L+H ++++L
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRLLRHPHIIKL 79
Query: 407 LGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRL 466
                  +E I+V E+  N+  DY +   +   Q   +RR+     I   + Y H   R 
Sbjct: 80  YDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQ--EARRF--FQQIISAVEYCH---RH 132
Query: 467 RIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRI-VGTYGYMAPEYAMHGQ 525
           +I+HRDLK  N+LLD  +N KI+DFG++ I     T GN  +   G+  Y APE  + G+
Sbjct: 133 KIVHRDLKPENLLLDEHLNVKIADFGLSNIM----TDGNFLKTSCGSPNYAAPE-VISGK 187
Query: 526 FSV--KSDVYSFGVLV 539
                + DV+S GV++
Sbjct: 188 LYAGPEVDVWSCGVIL 203

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 100/200 (50%), Gaps = 31/200 (15%)
Query: 353 LGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE 412
           +G+G FG+V  G    G ++AVK +   +   A+ F  E  ++ +L+H NLV+LLG  +E
Sbjct: 14  IGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 413 GEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGG---------IARGILYLHE 462
            +  + +V E++   SL  +L           SR   ++GG         +   + YL  
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLR----------SRGRSVLGGDCLLKFSLDVCEAMEYLEG 120
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM 522
           ++    +HRDL A N+L+  +   K+SDFG+ +     Q  G          + APE   
Sbjct: 121 NN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP-----VKWTAPEALR 172
Query: 523 HGQFSVKSDVYSFGVLVLEI 542
             +FS KSDV+SFG+L+ EI
Sbjct: 173 EKKFSTKSDVWSFGILLWEI 192

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 113/228 (49%), Gaps = 28/228 (12%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY--------KGVLPSGQEIAVKRL-SKASGQGAEEFKNE 391
           E+  ++      LGEG FG+V         K       ++AVK L S A+ +   +  +E
Sbjct: 9   ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 68
Query: 392 VVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL-----------YDPEKQG 439
           + ++  + +H+N++ LLG C +     ++ E+    +L  +L           Y+P    
Sbjct: 69  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNP 128
Query: 440 QLDWSRRYKIIGG--IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-I 496
           +   S +  +     +ARG+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR I
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 185
Query: 497 FGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
             +D  +  T+  +    +MAPE      ++ +SDV+SFGVL+ EI T
Sbjct: 186 HHIDYYKKTTNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 103/196 (52%), Gaps = 23/196 (11%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVK-----RLSKASGQGAEEFKNEVVLVAKLQHRNLVRL 406
           LGEG FG+V       +GQ++A+K      L+K+  QG    + E+  +  L+H ++++L
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRLLRHPHIIKL 73
Query: 407 LGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRL 466
                  +E I+V E+  N+  DY +   +   Q   +RR+     I   + Y H   R 
Sbjct: 74  YDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQ--EARRF--FQQIISAVEYCH---RH 126
Query: 467 RIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRI-VGTYGYMAPEYAMHGQ 525
           +I+HRDLK  N+LLD  +N KI+DFG++ I     T GN  +   G+  Y APE  + G+
Sbjct: 127 KIVHRDLKPENLLLDEHLNVKIADFGLSNIM----TDGNFLKTSCGSPNYAAPE-VISGK 181
Query: 526 FSV--KSDVYSFGVLV 539
                + DV+S GV++
Sbjct: 182 LYAGPEVDVWSCGVIL 197

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 110/206 (53%), Gaps = 15/206 (7%)
Query: 347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRL---SKASGQGAEEFKNEVVLVAKLQHRN 402
           F    K+GEG +G VYK     +G+ +A+K++   ++  G  +   + E+ L+ +L H N
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 63
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQG-QLDWSRRYKIIGGIARGILYLH 461
           +V+LL       +  LV+EF+ ++ L  F+      G  L   + Y  +  + +G+ + H
Sbjct: 64  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFCH 120
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYA 521
                R++HRDLK  N+L++ E   K++DFG+AR FGV   +     +V T  Y APE  
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPEIL 175
Query: 522 MHGQ-FSVKSDVYSFGVLVLEIITGK 546
           +  + +S   D++S G +  E++T +
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 110/206 (53%), Gaps = 15/206 (7%)
Query: 347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRL---SKASGQGAEEFKNEVVLVAKLQHRN 402
           F    K+GEG +G VYK     +G+ +A+K++   ++  G  +   + E+ L+ +L H N
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 62
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQG-QLDWSRRYKIIGGIARGILYLH 461
           +V+LL       +  LV+EF+ ++ L  F+      G  L   + Y  +  + +G+ + H
Sbjct: 63  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFCH 119
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYA 521
                R++HRDLK  N+L++ E   K++DFG+AR FGV   +     +V T  Y APE  
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPEIL 174
Query: 522 MHGQ-FSVKSDVYSFGVLVLEIITGK 546
           +  + +S   D++S G +  E++T +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 110/206 (53%), Gaps = 15/206 (7%)
Query: 347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRL---SKASGQGAEEFKNEVVLVAKLQHRN 402
           F    K+GEG +G VYK     +G+ +A+K++   ++  G  +   + E+ L+ +L H N
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 63
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQG-QLDWSRRYKIIGGIARGILYLH 461
           +V+LL       +  LV+EF+ ++ L  F+      G  L   + Y  +  + +G+ + H
Sbjct: 64  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFCH 120
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYA 521
                R++HRDLK  N+L++ E   K++DFG+AR FGV   +     +V T  Y APE  
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPEIL 175
Query: 522 MHGQ-FSVKSDVYSFGVLVLEIITGK 546
           +  + +S   D++S G +  E++T +
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 110/206 (53%), Gaps = 15/206 (7%)
Query: 347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRL---SKASGQGAEEFKNEVVLVAKLQHRN 402
           F    K+GEG +G VYK     +G+ +A+K++   ++  G  +   + E+ L+ +L H N
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 62
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQG-QLDWSRRYKIIGGIARGILYLH 461
           +V+LL       +  LV+EF+ ++ L  F+      G  L   + Y  +  + +G+ + H
Sbjct: 63  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFCH 119
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYA 521
                R++HRDLK  N+L++ E   K++DFG+AR FGV   +     +V T  Y APE  
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPEIL 174
Query: 522 MHGQ-FSVKSDVYSFGVLVLEIITGK 546
           +  + +S   D++S G +  E++T +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 110/206 (53%), Gaps = 15/206 (7%)
Query: 347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRL---SKASGQGAEEFKNEVVLVAKLQHRN 402
           F    K+GEG +G VYK     +G+ +A+K++   ++  G  +   + E+ L+ +L H N
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 63
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQG-QLDWSRRYKIIGGIARGILYLH 461
           +V+LL       +  LV+EF+ ++ L  F+      G  L   + Y  +  + +G+ + H
Sbjct: 64  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFCH 120
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYA 521
                R++HRDLK  N+L++ E   K++DFG+AR FGV   +     +V T  Y APE  
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPEIL 175
Query: 522 MHGQ-FSVKSDVYSFGVLVLEIITGK 546
           +  + +S   D++S G +  E++T +
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 110/206 (53%), Gaps = 15/206 (7%)
Query: 347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRL---SKASGQGAEEFKNEVVLVAKLQHRN 402
           F    K+GEG +G VYK     +G+ +A+K++   ++  G  +   + E+ L+ +L H N
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 64
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQG-QLDWSRRYKIIGGIARGILYLH 461
           +V+LL       +  LV+EF+ ++ L  F+      G  L   + Y  +  + +G+ + H
Sbjct: 65  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFCH 121
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYA 521
                R++HRDLK  N+L++ E   K++DFG+AR FGV   +     +V T  Y APE  
Sbjct: 122 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPEIL 176
Query: 522 MHGQ-FSVKSDVYSFGVLVLEIITGK 546
           +  + +S   D++S G +  E++T +
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 110/206 (53%), Gaps = 15/206 (7%)
Query: 347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRL---SKASGQGAEEFKNEVVLVAKLQHRN 402
           F    K+GEG +G VYK     +G+ +A+K++   ++  G  +   + E+ L+ +L H N
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 63
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQG-QLDWSRRYKIIGGIARGILYLH 461
           +V+LL       +  LV+EF+ ++ L  F+      G  L   + Y  +  + +G+ + H
Sbjct: 64  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFCH 120
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYA 521
                R++HRDLK  N+L++ E   K++DFG+AR FGV   +     +V T  Y APE  
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPEIL 175
Query: 522 MHGQ-FSVKSDVYSFGVLVLEIITGK 546
           +  + +S   D++S G +  E++T +
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 110/206 (53%), Gaps = 15/206 (7%)
Query: 347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRL---SKASGQGAEEFKNEVVLVAKLQHRN 402
           F    K+GEG +G VYK     +G+ +A+ ++   ++  G  +   + E+ L+ +L H N
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIR-EISLLKELNHPN 63
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQG-QLDWSRRYKIIGGIARGILYLH 461
           +V+LL       +  LV+EF+ ++ L  F+      G  L   + Y  +  + +G+ + H
Sbjct: 64  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFCH 120
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYA 521
                R++HRDLK  N+L++ E   K++DFG+AR FGV   +  T  +V T  Y APE  
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 175
Query: 522 MHGQ-FSVKSDVYSFGVLVLEIITGK 546
           +  + +S   D++S G +  E++T +
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 110/206 (53%), Gaps = 15/206 (7%)
Query: 347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRL---SKASGQGAEEFKNEVVLVAKLQHRN 402
           F    K+GEG +G VYK     +G+ +A+ ++   ++  G  +   + E+ L+ +L H N
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIR-EISLLKELNHPN 62
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQG-QLDWSRRYKIIGGIARGILYLH 461
           +V+LL       +  LV+EF+ ++ L  F+      G  L   + Y  +  + +G+ + H
Sbjct: 63  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFCH 119
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYA 521
                R++HRDLK  N+L++ E   K++DFG+AR FGV   +  T  +V T  Y APE  
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 174
Query: 522 MHGQ-FSVKSDVYSFGVLVLEIITGK 546
           +  + +S   D++S G +  E++T +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 106/205 (51%), Gaps = 13/205 (6%)
Query: 347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRL---SKASGQGAEEFKNEVVLVAKLQHRN 402
           F    K+GEG +G VYK     +G+ +A+K++   ++  G  +   + E+ L+ +L H N
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 63
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
           +V+LL       +  LV+EF+     D+          L   + Y  +  + +G+ + H 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSY--LFQLLQGLAFCHS 121
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM 522
               R++HRDLK  N+L++ E   K++DFG+AR FGV   +     +V T  Y APE  +
Sbjct: 122 H---RVLHRDLKPENLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPEILL 176
Query: 523 HGQ-FSVKSDVYSFGVLVLEIITGK 546
             + +S   D++S G +  E++T +
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 110/206 (53%), Gaps = 15/206 (7%)
Query: 347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRL---SKASGQGAEEFKNEVVLVAKLQHRN 402
           F    K+GEG +G VYK     +G+ +A+K++   ++  G  +   + E+ L+ +L H N
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 66
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQG-QLDWSRRYKIIGGIARGILYLH 461
           +V+LL       +  LV+EF+ ++ L  F+      G  L   + Y  +  + +G+ + H
Sbjct: 67  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFCH 123
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYA 521
                R++HRDLK  N+L++ E   K++DFG+AR FGV   +     +V T  Y APE  
Sbjct: 124 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPEIL 178
Query: 522 MHGQ-FSVKSDVYSFGVLVLEIITGK 546
           +  + +S   D++S G +  E++T +
Sbjct: 179 LGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 110/206 (53%), Gaps = 15/206 (7%)
Query: 347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRL---SKASGQGAEEFKNEVVLVAKLQHRN 402
           F    K+GEG +G VYK     +G+ +A+K++   ++  G  +   + E+ L+ +L H N
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 65
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQG-QLDWSRRYKIIGGIARGILYLH 461
           +V+LL       +  LV+EF+ ++ L  F+      G  L   + Y  +  + +G+ + H
Sbjct: 66  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFCH 122
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYA 521
                R++HRDLK  N+L++ E   K++DFG+AR FGV   +     +V T  Y APE  
Sbjct: 123 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPEIL 177
Query: 522 MHGQ-FSVKSDVYSFGVLVLEIITGK 546
           +  + +S   D++S G +  E++T +
Sbjct: 178 LGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 113/228 (49%), Gaps = 28/228 (12%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY--------KGVLPSGQEIAVKRL-SKASGQGAEEFKNE 391
           E+  ++      LGEG FG+V         K       ++AVK L S A+ +   +  +E
Sbjct: 24  ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 83
Query: 392 VVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL-----------YDPEKQG 439
           + ++  + +H+N++ LLG C +     ++ E+    +L  +L           Y+P    
Sbjct: 84  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNP 143
Query: 440 QLDWSRRYKIIGG--IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-I 496
           +   S +  +     +ARG+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR I
Sbjct: 144 EEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 200
Query: 497 FGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
             +D  +  T+  +    +MAPE      ++ +SDV+SFGVL+ EI T
Sbjct: 201 HHIDYYKKTTNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 111/208 (53%), Gaps = 19/208 (9%)
Query: 347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRL---SKASGQGAEEFKNEVVLVAKLQHRN 402
           F    K+GEG +G VYK     +G+ +A+K++   ++  G  +   + E+ L+ +L H N
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 66
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQG---QLDWSRRYKIIGGIARGILY 459
           +V+LL       +  LV+EF+ ++ L  F+      G    L  S  ++++ G+A    +
Sbjct: 67  IVKLLDVIHTENKLYLVFEFL-HQDLKTFMDASALTGIPLPLIKSYLFQLLQGLA----F 121
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE 519
            H     R++HRDLK  N+L++ E   K++DFG+AR FGV   +     +V T  Y APE
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 176
Query: 520 YAMHGQ-FSVKSDVYSFGVLVLEIITGK 546
             +  + +S   D++S G +  E++T +
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 100/200 (50%), Gaps = 31/200 (15%)
Query: 353 LGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE 412
           +G+G FG+V  G    G ++AVK +   +   A+ F  E  ++ +L+H NLV+LLG  +E
Sbjct: 29  IGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 413 GEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGG---------IARGILYLHE 462
            +  + +V E++   SL  +L           SR   ++GG         +   + YL  
Sbjct: 86  EKGGLYIVTEYMAKGSLVDYLR----------SRGRSVLGGDCLLKFSLDVCEAMEYLEG 135
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM 522
           ++    +HRDL A N+L+  +   K+SDFG+ +     Q  G          + APE   
Sbjct: 136 NN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP-----VKWTAPEALR 187
Query: 523 HGQFSVKSDVYSFGVLVLEI 542
             +FS KSDV+SFG+L+ EI
Sbjct: 188 EKKFSTKSDVWSFGILLWEI 207

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 111/208 (53%), Gaps = 19/208 (9%)
Query: 347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRL---SKASGQGAEEFKNEVVLVAKLQHRN 402
           F    K+GEG +G VYK     +G+ +A+K++   ++  G  +   + E+ L+ +L H N
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 67
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQG---QLDWSRRYKIIGGIARGILY 459
           +V+LL       +  LV+EF+ ++ L  F+      G    L  S  ++++ G+A    +
Sbjct: 68  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA----F 122
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE 519
            H     R++HRDLK  N+L++ E   K++DFG+AR FGV   +     +V T  Y APE
Sbjct: 123 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 177
Query: 520 YAMHGQ-FSVKSDVYSFGVLVLEIITGK 546
             +  + +S   D++S G +  E++T +
Sbjct: 178 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 113/228 (49%), Gaps = 28/228 (12%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY--------KGVLPSGQEIAVKRL-SKASGQGAEEFKNE 391
           E+  ++      LGEG FG+V         K       ++AVK L S A+ +   +  +E
Sbjct: 17  ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 76
Query: 392 VVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL-----------YDPEKQG 439
           + ++  + +H+N++ LLG C +     ++ E+    +L  +L           Y+P    
Sbjct: 77  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 136
Query: 440 QLDWSRRYKIIGG--IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-I 496
           +   S +  +     +ARG+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR I
Sbjct: 137 EEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 193
Query: 497 FGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
             +D  +  T+  +    +MAPE      ++ +SDV+SFGVL+ EI T
Sbjct: 194 HHIDYYKKTTNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 110/206 (53%), Gaps = 15/206 (7%)
Query: 347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRL---SKASGQGAEEFKNEVVLVAKLQHRN 402
           F    K+GEG +G VYK     +G+ +A+K++   ++  G  +   + E+ L+ +L H N
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 64
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQG-QLDWSRRYKIIGGIARGILYLH 461
           +V+LL       +  LV+EF+ ++ L  F+      G  L   + Y  +  + +G+ + H
Sbjct: 65  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFCH 121
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYA 521
                R++HRDLK  N+L++ E   K++DFG+AR FGV   +     +V T  Y APE  
Sbjct: 122 SH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPEIL 176
Query: 522 MHGQ-FSVKSDVYSFGVLVLEIITGK 546
           +  + +S   D++S G +  E++T +
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 99/200 (49%), Gaps = 31/200 (15%)
Query: 353 LGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE 412
           +G+G FG+V  G    G ++AVK +   +   A+ F  E  ++ +L+H NLV+LLG  +E
Sbjct: 20  IGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 76
Query: 413 GEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGG---------IARGILYLHE 462
            +  + +V E++   SL  +L           SR   ++GG         +   + YL  
Sbjct: 77  EKGGLYIVTEYMAKGSLVDYLR----------SRGRSVLGGDCLLKFSLDVCEAMEYLEG 126
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM 522
           ++    +HRDL A N+L+  +   K+SDFG+ +     Q  G          + APE   
Sbjct: 127 NN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP-----VKWTAPEALR 178
Query: 523 HGQFSVKSDVYSFGVLVLEI 542
              FS KSDV+SFG+L+ EI
Sbjct: 179 EAAFSTKSDVWSFGILLWEI 198

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 111/208 (53%), Gaps = 19/208 (9%)
Query: 347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRL---SKASGQGAEEFKNEVVLVAKLQHRN 402
           F    K+GEG +G VYK     +G+ +A+K++   ++  G  +   + E+ L+ +L H N
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 66
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQG---QLDWSRRYKIIGGIARGILY 459
           +V+LL       +  LV+EF+ ++ L  F+      G    L  S  ++++ G+A    +
Sbjct: 67  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA----F 121
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE 519
            H     R++HRDLK  N+L++ E   K++DFG+AR FGV   +     +V T  Y APE
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 176
Query: 520 YAMHGQ-FSVKSDVYSFGVLVLEIITGK 546
             +  + +S   D++S G +  E++T +
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 110/206 (53%), Gaps = 15/206 (7%)
Query: 347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRL---SKASGQGAEEFKNEVVLVAKLQHRN 402
           F    K+GEG +G VYK     +G+ +A+K++   ++  G  +   + E+ L+ +L H N
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 65
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQG-QLDWSRRYKIIGGIARGILYLH 461
           +V+LL       +  LV+EF+ ++ L  F+      G  L   + Y  +  + +G+ + H
Sbjct: 66  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFCH 122
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYA 521
                R++HRDLK  N+L++ E   K++DFG+AR FGV   +     +V T  Y APE  
Sbjct: 123 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPEIL 177
Query: 522 MHGQ-FSVKSDVYSFGVLVLEIITGK 546
           +  + +S   D++S G +  E++T +
Sbjct: 178 LGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 110/206 (53%), Gaps = 15/206 (7%)
Query: 347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRL---SKASGQGAEEFKNEVVLVAKLQHRN 402
           F    K+GEG +G VYK     +G+ +A+K++   ++  G  +   + E+ L+ +L H N
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 65
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQG-QLDWSRRYKIIGGIARGILYLH 461
           +V+LL       +  LV+EF+ ++ L  F+      G  L   + Y  +  + +G+ + H
Sbjct: 66  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFCH 122
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYA 521
                R++HRDLK  N+L++ E   K++DFG+AR FGV   +     +V T  Y APE  
Sbjct: 123 SH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPEIL 177
Query: 522 MHGQ-FSVKSDVYSFGVLVLEIITGK 546
           +  + +S   D++S G +  E++T +
Sbjct: 178 LGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 110/236 (46%), Gaps = 25/236 (10%)
Query: 331 ESLQFDFETIEVATNKFSTDNKLGEGGFGEVYK----GVLPSG--QEIAVKRLSKASGQG 384
           E L +D    E   ++      LG G FG+V +    G+  +   + +AVK L + +   
Sbjct: 15  ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 74
Query: 385 AEE-FKNEV-VLVAKLQHRNLVRLLGFCLE-GEEKILVYEFVPNKSLDYFL------YDP 435
                 +E+ +L+    H N+V LLG C + G   +++ EF    +L  +L      + P
Sbjct: 75  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 134
Query: 436 EKQGQLDWSRRYKIIGG-------IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKI 488
            K+   D  + +  +         +A+G+ +L   +  + IHRDL A NILL  +   KI
Sbjct: 135 YKEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKI 191
Query: 489 SDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
            DFG+AR    D              +MAPE      ++++SDV+SFGVL+ EI +
Sbjct: 192 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 247

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 110/206 (53%), Gaps = 15/206 (7%)
Query: 347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRL---SKASGQGAEEFKNEVVLVAKLQHRN 402
           F    K+GEG +G VYK     +G+ +A+K++   ++  G  +   + E+ L+ +L H N
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 64
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQG-QLDWSRRYKIIGGIARGILYLH 461
           +V+LL       +  LV+EF+ ++ L  F+      G  L   + Y  +  + +G+ + H
Sbjct: 65  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFCH 121
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYA 521
                R++HRDLK  N+L++ E   K++DFG+AR FGV   +     +V T  Y APE  
Sbjct: 122 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPEIL 176
Query: 522 MHGQ-FSVKSDVYSFGVLVLEIITGK 546
           +  + +S   D++S G +  E++T +
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 113/228 (49%), Gaps = 28/228 (12%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY--------KGVLPSGQEIAVKRL-SKASGQGAEEFKNE 391
           E+  ++      LGEG FG+V         K       ++AVK L S A+ +   +  +E
Sbjct: 13  ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 72
Query: 392 VVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL-----------YDPEKQG 439
           + ++  + +H+N++ LLG C +     ++ E+    +L  +L           Y+P    
Sbjct: 73  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 132
Query: 440 QLDWSRRYKIIGG--IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-I 496
           +   S +  +     +ARG+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR I
Sbjct: 133 EEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 189
Query: 497 FGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
             +D  +  T+  +    +MAPE      ++ +SDV+SFGVL+ EI T
Sbjct: 190 HHIDYYKKTTNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 102/212 (48%), Gaps = 15/212 (7%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAE---EFKNEVVLVAKLQ 399
           ++++     LG GG  EV+    L   +++AVK L     +       F+ E    A L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 400 HRNLVRLL----GFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
           H  +V +          G    +V E+V   +L   ++    +G +   R  ++I    +
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQ 127
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVDQTQGNTSRIVGTYG 514
            + + H++    IIHRD+K +NIL+ A    K+ DFG+AR I     +   T+ ++GT  
Sbjct: 128 ALNFSHQNG---IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQ 184
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
           Y++PE A       +SDVYS G ++ E++TG+
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 113/228 (49%), Gaps = 28/228 (12%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY--------KGVLPSGQEIAVKRL-SKASGQGAEEFKNE 391
           E+  ++      LGEG FG+V         K       ++AVK L S A+ +   +  +E
Sbjct: 65  ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 124
Query: 392 VVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL-----------YDPEKQG 439
           + ++  + +H+N++ LLG C +     ++ E+    +L  +L           Y+P    
Sbjct: 125 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 184
Query: 440 QLDWSRRYKIIGG--IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-I 496
           +   S +  +     +ARG+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR I
Sbjct: 185 EEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 241
Query: 497 FGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
             +D  +  T+  +    +MAPE      ++ +SDV+SFGVL+ EI T
Sbjct: 242 HHIDYYKKTTNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 104/201 (51%), Gaps = 21/201 (10%)
Query: 352 KLGEGGFGEVYKGVLPSGQEIAV----KRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLL 407
           +LG+G FG+VYK      +E +V    K +   S +  E++  E+ ++A   H N+V+LL
Sbjct: 44  ELGDGAFGKVYKA---QNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLL 100
Query: 408 -GFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRL 466
             F  E    IL+ EF    ++D  + + E+   L  S+   +       + YLH++   
Sbjct: 101 DAFYYENNLWILI-EFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYLHDN--- 154
Query: 467 RIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM---- 522
           +IIHRDLKA NIL   + + K++DFG++      +T       +GT  +MAPE  M    
Sbjct: 155 KIIHRDLKAGNILFTLDGDIKLADFGVSA--KNTRTIQRRDSFIGTPYWMAPEVVMCETS 212
Query: 523 -HGQFSVKSDVYSFGVLVLEI 542
               +  K+DV+S G+ ++E+
Sbjct: 213 KDRPYDYKADVWSLGITLIEM 233

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 113/228 (49%), Gaps = 28/228 (12%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY--------KGVLPSGQEIAVKRL-SKASGQGAEEFKNE 391
           E+  ++      LGEG FG+V         K       ++AVK L S A+ +   +  +E
Sbjct: 24  ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 83
Query: 392 VVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL-----------YDPEKQG 439
           + ++  + +H+N++ LLG C +     ++ E+    +L  +L           Y+P    
Sbjct: 84  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 143
Query: 440 QLDWSRRYKIIGG--IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-I 496
           +   S +  +     +ARG+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR I
Sbjct: 144 EEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 200
Query: 497 FGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
             +D  +  T+  +    +MAPE      ++ +SDV+SFGVL+ EI T
Sbjct: 201 HHIDYYKKTTNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 113/228 (49%), Gaps = 28/228 (12%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY--------KGVLPSGQEIAVKRL-SKASGQGAEEFKNE 391
           E+  ++      LGEG FG+V         K       ++AVK L S A+ +   +  +E
Sbjct: 16  ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 75
Query: 392 VVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL-----------YDPEKQG 439
           + ++  + +H+N++ LLG C +     ++ E+    +L  +L           Y+P    
Sbjct: 76  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 135
Query: 440 QLDWSRRYKIIGG--IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-I 496
           +   S +  +     +ARG+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR I
Sbjct: 136 EEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 192
Query: 497 FGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
             +D  +  T+  +    +MAPE      ++ +SDV+SFGVL+ EI T
Sbjct: 193 HHIDYYKKTTNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 106/205 (51%), Gaps = 13/205 (6%)
Query: 347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRL---SKASGQGAEEFKNEVVLVAKLQHRN 402
           F    K+GEG +G VYK     +G+ +A+K++   ++  G  +   + E+ L+ +L H N
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 65
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
           +V+LL       +  LV+EF+     D+          L   + Y  +  + +G+ + H 
Sbjct: 66  IVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSY--LFQLLQGLAFCHS 123
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM 522
               R++HRDLK  N+L++ E   K++DFG+AR FGV   +     +V T  Y APE  +
Sbjct: 124 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPEILL 178
Query: 523 HGQ-FSVKSDVYSFGVLVLEIITGK 546
             + +S   D++S G +  E++T +
Sbjct: 179 GCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 113/228 (49%), Gaps = 28/228 (12%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY--------KGVLPSGQEIAVKRL-SKASGQGAEEFKNE 391
           E+  ++      LGEG FG+V         K       ++AVK L S A+ +   +  +E
Sbjct: 24  ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 83
Query: 392 VVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL-----------YDPEKQG 439
           + ++  + +H+N++ LLG C +     ++ E+    +L  +L           Y+P    
Sbjct: 84  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNP 143
Query: 440 QLDWSRRYKIIGG--IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-I 496
           +   S +  +     +ARG+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR I
Sbjct: 144 EEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 200
Query: 497 FGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
             +D  +  T+  +    +MAPE      ++ +SDV+SFGVL+ EI T
Sbjct: 201 HHIDYYKKTTNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/230 (29%), Positives = 111/230 (48%), Gaps = 32/230 (13%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY--------KGVLPSGQEIAVKRL-SKASGQGAEEFKNE 391
           E   +K +    LGEG FG+V         K        +AVK L   A+ +   +  +E
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 392 VVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL-----------YD----P 435
           + ++  + +H+N++ LLG C +     ++ E+    +L  +L           YD    P
Sbjct: 91  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 150
Query: 436 EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
           E+Q  + +         +ARG+ YL   +  + IHRDL A N+L+      KI+DFG+AR
Sbjct: 151 EEQ--MTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205
Query: 496 -IFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
            I  +D  +  T+  +    +MAPE      ++ +SDV+SFGVL+ EI T
Sbjct: 206 DINNIDXXKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 106/205 (51%), Gaps = 13/205 (6%)
Query: 347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRL---SKASGQGAEEFKNEVVLVAKLQHRN 402
           F    K+GEG +G VYK     +G+ +A+K++   ++  G  +   + E+ L+ +L H N
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 66
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
           +V+LL       +  LV+EF+     D+          L   + Y  +  + +G+ + H 
Sbjct: 67  IVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSY--LFQLLQGLAFCHS 124
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM 522
               R++HRDLK  N+L++ E   K++DFG+AR FGV   +     +V T  Y APE  +
Sbjct: 125 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPEILL 179
Query: 523 HGQ-FSVKSDVYSFGVLVLEIITGK 546
             + +S   D++S G +  E++T +
Sbjct: 180 GCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 109/236 (46%), Gaps = 25/236 (10%)
Query: 331 ESLQFDFETIEVATNKFSTDNKLGEGGFGEVYK----GVLPSG--QEIAVKRLSKASGQG 384
           E L +D    E   ++      LG G FG+V +    G+  +   + +AVK L + +   
Sbjct: 13  ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 72
Query: 385 AEE-FKNEV-VLVAKLQHRNLVRLLGFCLE-GEEKILVYEFVPNKSLDYFL------YDP 435
                 +E+ +L+    H N+V LLG C + G   +++ EF    +L  +L      + P
Sbjct: 73  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 132
Query: 436 EKQGQLDWSRRYKIIGG-------IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKI 488
            K    D  + +  +         +A+G+ +L   +  + IHRDL A NILL  +   KI
Sbjct: 133 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKI 189
Query: 489 SDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
            DFG+AR    D              +MAPE      ++++SDV+SFGVL+ EI +
Sbjct: 190 CDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 107/229 (46%), Gaps = 30/229 (13%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY--------KGVLPSGQEIAVKRL-SKASGQGAEEFKNE 391
           E   +K +    LGEG FG+V         K        +AVK L   A+ +   +  +E
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 392 VVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL-----------YD----P 435
           + ++  + +H+N++ LLG C +     ++ E+    +L  +L           YD    P
Sbjct: 91  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 150
Query: 436 EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
           E+Q  + +         +ARG+ YL   +  + IHRDL A N+L+      KI+DFG+AR
Sbjct: 151 EEQ--MTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205
Query: 496 IFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
                    NT+       +MAPE      ++ +SDV+SFGVL+ EI T
Sbjct: 206 DINNIDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/230 (29%), Positives = 111/230 (48%), Gaps = 32/230 (13%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY--------KGVLPSGQEIAVKRL-SKASGQGAEEFKNE 391
           E   +K +    LGEG FG+V         K        +AVK L   A+ +   +  +E
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 392 VVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL-----------YD----P 435
           + ++  + +H+N++ LLG C +     ++ E+    +L  +L           YD    P
Sbjct: 91  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVP 150
Query: 436 EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
           E+Q  + +         +ARG+ YL   +  + IHRDL A N+L+      KI+DFG+AR
Sbjct: 151 EEQ--MTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205
Query: 496 -IFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
            I  +D  +  T+  +    +MAPE      ++ +SDV+SFGVL+ EI T
Sbjct: 206 DINNIDXXKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 109/236 (46%), Gaps = 25/236 (10%)
Query: 331 ESLQFDFETIEVATNKFSTDNKLGEGGFGEVYK----GVLPSG--QEIAVKRLSKASGQG 384
           E L +D    E   ++      LG G FG+V +    G+  +   + +AVK L + +   
Sbjct: 4   ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 63
Query: 385 AEE-FKNEV-VLVAKLQHRNLVRLLGFCLE-GEEKILVYEFVPNKSLDYFL------YDP 435
                 +E+ +L+    H N+V LLG C + G   +++ EF    +L  +L      + P
Sbjct: 64  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 123
Query: 436 EKQGQLDWSRRYKIIGG-------IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKI 488
            K    D  + +  +         +A+G+ +L   +  + IHRDL A NILL  +   KI
Sbjct: 124 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKI 180
Query: 489 SDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
            DFG+AR    D              +MAPE      ++++SDV+SFGVL+ EI +
Sbjct: 181 CDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 105/207 (50%), Gaps = 33/207 (15%)
Query: 352 KLGEGGFGEVYKGVLPSGQEIAV----KRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLL 407
           +LG+G FG+VYK      +E +V    K +   S +  E++  E+ ++A   H N+V+LL
Sbjct: 44  ELGDGAFGKVYKA---QNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLL 100
Query: 408 -GFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRL 466
             F  E    IL+ EF    ++D  + + E+   L  S+   +       + YLH++   
Sbjct: 101 DAFYYENNLWILI-EFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYLHDN--- 154
Query: 467 RIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRI------VGTYGYMAPEY 520
           +IIHRDLKA NIL   + + K++DFG+        +  NT  I      +GT  +MAPE 
Sbjct: 155 KIIHRDLKAGNILFTLDGDIKLADFGV--------SAKNTRXIQRRDSFIGTPYWMAPEV 206
Query: 521 AM-----HGQFSVKSDVYSFGVLVLEI 542
            M        +  K+DV+S G+ ++E+
Sbjct: 207 VMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 110/219 (50%), Gaps = 22/219 (10%)
Query: 342 VATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEF-----KNEVVLV 395
           +AT+++    ++G G +G VYK   P SG  +A+K +   +G G           EV L+
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 396 AKLQ---HRNLVRLLGFCL----EGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRY 447
            +L+   H N+VRL+  C     + E K+ LV+E V ++ L  +L      G L      
Sbjct: 66  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPG-LPAETIK 123
Query: 448 KIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTS 507
            ++    RG+ +LH +    I+HRDLK  NIL+ +    K++DFG+ARI+     Q   +
Sbjct: 124 DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY---QMALT 177
Query: 508 RIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
            +V T  Y APE  +   ++   D++S G +  E+   K
Sbjct: 178 PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 105/207 (50%), Gaps = 33/207 (15%)
Query: 352 KLGEGGFGEVYKGVLPSGQEIAV----KRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLL 407
           +LG+G FG+VYK      +E +V    K +   S +  E++  E+ ++A   H N+V+LL
Sbjct: 44  ELGDGAFGKVYKA---QNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLL 100
Query: 408 -GFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRL 466
             F  E    IL+ EF    ++D  + + E+   L  S+   +       + YLH++   
Sbjct: 101 DAFYYENNLWILI-EFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYLHDN--- 154
Query: 467 RIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRI------VGTYGYMAPEY 520
           +IIHRDLKA NIL   + + K++DFG+        +  NT  I      +GT  +MAPE 
Sbjct: 155 KIIHRDLKAGNILFTLDGDIKLADFGV--------SAKNTRXIQRRDXFIGTPYWMAPEV 206
Query: 521 AM-----HGQFSVKSDVYSFGVLVLEI 542
            M        +  K+DV+S G+ ++E+
Sbjct: 207 VMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 109/236 (46%), Gaps = 25/236 (10%)
Query: 331 ESLQFDFETIEVATNKFSTDNKLGEGGFGEVYK----GVLPSG--QEIAVKRLSKASGQG 384
           E L +D    E   ++      LG G FG+V +    G+  +   + +AVK L + +   
Sbjct: 4   ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 63
Query: 385 AEE-FKNEV-VLVAKLQHRNLVRLLGFCLE-GEEKILVYEFVPNKSLDYFL------YDP 435
                 +E+ +L+    H N+V LLG C + G   +++ EF    +L  +L      + P
Sbjct: 64  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVP 123
Query: 436 EKQGQLDWSRRYKIIGG-------IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKI 488
            K    D  + +  +         +A+G+ +L   +  + IHRDL A NILL  +   KI
Sbjct: 124 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKI 180
Query: 489 SDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
            DFG+AR    D              +MAPE      ++++SDV+SFGVL+ EI +
Sbjct: 181 CDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 71/244 (29%), Positives = 108/244 (44%), Gaps = 61/244 (25%)
Query: 335 FDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVL 394
            DF+ IE+          +G GGFG+V+K       +  V R  K + + AE    EV  
Sbjct: 12  MDFKEIEL----------IGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAE---REVKA 58
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVP---NKSLDYFLYDPE--------------- 436
           +AKL H N+V   G C +G      +++ P   + SL+   YDPE               
Sbjct: 59  LAKLDHVNIVHYNG-CWDG------FDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFI 111
Query: 437 -----KQGQLD-W--SRR---------YKIIGGIARGILYLHEDSRLRIIHRDLKASNIL 479
                 +G L+ W   RR          ++   I +G+ Y+H     ++IHRDLK SNI 
Sbjct: 112 QMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLIHRDLKPSNIF 168
Query: 480 LDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLV 539
           L      KI DFG+      D   G  +R  GT  YM+PE      +  + D+Y+ G+++
Sbjct: 169 LVDTKQVKIGDFGLVTSLKND---GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLIL 225
Query: 540 LEII 543
            E++
Sbjct: 226 AELL 229

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 103/214 (48%), Gaps = 19/214 (8%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAE---EFKNEVVLVAKLQ 399
           ++++     LG GG  EV+    L   +++AVK L     +       F+ E    A L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 400 HRNLVRLL----GFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
           H  +V +          G    +V E+V   +L   ++    +G +   R  ++I    +
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQ 127
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF---GVDQTQGNTSRIVGT 512
            + + H++    IIHRD+K +NI++ A    K+ DFG+AR     G   TQ  T+ ++GT
Sbjct: 128 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ--TAAVIGT 182
Query: 513 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
             Y++PE A       +SDVYS G ++ E++TG+
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 109/206 (52%), Gaps = 15/206 (7%)
Query: 347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRL---SKASGQGAEEFKNEVVLVAKLQHRN 402
           F    K+GEG +G VYK     +G+ +A+K++   ++  G  +   + E+ L+ +L H N
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 66
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQG-QLDWSRRYKIIGGIARGILYLH 461
           +V+LL       +  LV+EF+ +  L  F+      G  L   + Y  +  + +G+ + H
Sbjct: 67  IVKLLDVIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFCH 123
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYA 521
                R++HRDLK  N+L++ E   K++DFG+AR FGV   +     +V T  Y APE  
Sbjct: 124 SH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPEIL 178
Query: 522 MHGQ-FSVKSDVYSFGVLVLEIITGK 546
           +  + +S   D++S G +  E++T +
Sbjct: 179 LGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 103/214 (48%), Gaps = 19/214 (8%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAE---EFKNEVVLVAKLQ 399
           ++++     LG GG  EV+    L   +++AVK L     +       F+ E    A L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 400 HRNLVRLL----GFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
           H  +V +          G    +V E+V   +L   ++    +G +   R  ++I    +
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQ 127
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF---GVDQTQGNTSRIVGT 512
            + + H++    IIHRD+K +NI++ A    K+ DFG+AR     G   TQ  T+ ++GT
Sbjct: 128 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ--TAAVIGT 182
Query: 513 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
             Y++PE A       +SDVYS G ++ E++TG+
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 100/189 (52%), Gaps = 13/189 (6%)
Query: 367 PSGQEIAVKRLSKASGQGA-EEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPN 425
           P  +++A+KR++    Q + +E   E+  +++  H N+V      +  +E  LV + +  
Sbjct: 33  PKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSG 92
Query: 426 KS-LDYFLY----DPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL 480
            S LD   +       K G LD S    I+  +  G+ YLH++ +   IHRD+KA NILL
Sbjct: 93  GSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILL 149
Query: 481 DAEMNPKISDFGMARIF--GVDQTQGNTSR-IVGTYGYMAPEYAMHGQ-FSVKSDVYSFG 536
             + + +I+DFG++     G D T+    +  VGT  +MAPE     + +  K+D++SFG
Sbjct: 150 GEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFG 209
Query: 537 VLVLEIITG 545
           +  +E+ TG
Sbjct: 210 ITAIELATG 218

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 110/208 (52%), Gaps = 19/208 (9%)
Query: 347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRL---SKASGQGAEEFKNEVVLVAKLQHRN 402
           F    K+GEG +G VYK     +G+ +A+K++   ++  G  +   + E+ L+ +L H N
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 64
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQG---QLDWSRRYKIIGGIARGILY 459
           +V+LL       +  LV+EF+ +  L  F+      G    L  S  ++++ G+A    +
Sbjct: 65  IVKLLDVIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLA----F 119
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE 519
            H     R++HRDLK  N+L++ E   K++DFG+AR FGV   +     +V T  Y APE
Sbjct: 120 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 174
Query: 520 YAMHGQ-FSVKSDVYSFGVLVLEIITGK 546
             +  + +S   D++S G +  E++T +
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 109/236 (46%), Gaps = 25/236 (10%)
Query: 331 ESLQFDFETIEVATNKFSTDNKLGEGGFGEVYK----GVLPSG--QEIAVKRLSKASGQG 384
           E L +D    E   ++      LG G FG+V +    G+  +   + +AVK L + +   
Sbjct: 13  ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 72
Query: 385 AEE-FKNEV-VLVAKLQHRNLVRLLGFCLE-GEEKILVYEFVPNKSLDYFL------YDP 435
                 +E+ +L+    H N+V LLG C + G   +++ EF    +L  +L      + P
Sbjct: 73  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 132
Query: 436 EKQGQLDWSRRYKIIGG-------IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKI 488
            K    D  + +  +         +A+G+ +L   +  + IHRDL A NILL  +   KI
Sbjct: 133 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKI 189
Query: 489 SDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
            DFG+AR    D              +MAPE      ++++SDV+SFGVL+ EI +
Sbjct: 190 CDFGLARDIYKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 100/189 (52%), Gaps = 13/189 (6%)
Query: 367 PSGQEIAVKRLSKASGQGA-EEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPN 425
           P  +++A+KR++    Q + +E   E+  +++  H N+V      +  +E  LV + +  
Sbjct: 38  PKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSG 97
Query: 426 KS-LDYFLY----DPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL 480
            S LD   +       K G LD S    I+  +  G+ YLH++ +   IHRD+KA NILL
Sbjct: 98  GSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILL 154
Query: 481 DAEMNPKISDFGMARIF--GVDQTQGNTSR-IVGTYGYMAPEYAMHGQ-FSVKSDVYSFG 536
             + + +I+DFG++     G D T+    +  VGT  +MAPE     + +  K+D++SFG
Sbjct: 155 GEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFG 214
Query: 537 VLVLEIITG 545
           +  +E+ TG
Sbjct: 215 ITAIELATG 223

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 108/232 (46%), Gaps = 21/232 (9%)
Query: 331 ESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKG------VLPSGQEIAVKRLSKASGQG 384
           E L +D    E   ++ +    LG G FG+V +          + + +AVK L + +   
Sbjct: 13  ERLPYDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHS 72
Query: 385 AEE-FKNEV-VLVAKLQHRNLVRLLGFCLE-GEEKILVYEFVPNKSLDYFL------YDP 435
                 +E+ +L+    H N+V LLG C + G   +++ EF    +L  +L      + P
Sbjct: 73  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 132
Query: 436 EKQGQLDWSRRYKIIG---GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 492
            K    D+     +I     +A+G+ +L   +  + IHRDL A NILL  +   KI DFG
Sbjct: 133 YKDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFG 189
Query: 493 MARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           +AR    D              +MAPE      ++++SDV+SFGVL+ EI +
Sbjct: 190 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 107/234 (45%), Gaps = 23/234 (9%)
Query: 331 ESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKG------VLPSGQEIAVKRLSKASGQG 384
           E L +D    E   ++      LG G FG+V +          + + +AVK L + +   
Sbjct: 15  ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHS 74
Query: 385 AEE-FKNEV-VLVAKLQHRNLVRLLGFCLE-GEEKILVYEFVPNKSLDYFL--------- 432
                 +E+ +L+    H N+V LLG C + G   +++ EF    +L  +L         
Sbjct: 75  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 134
Query: 433 YDPEKQGQLDWSRRYKIIGG--IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISD 490
           Y PE   +   +  + I     +A+G+ +L   +  + IHRDL A NILL  +   KI D
Sbjct: 135 YKPEDLYKDFLTLEHLIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICD 191
Query: 491 FGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           FG+AR    D              +MAPE      ++++SDV+SFGVL+ EI +
Sbjct: 192 FGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 68/230 (29%), Positives = 111/230 (48%), Gaps = 32/230 (13%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY--------KGVLPSGQEIAVKRL-SKASGQGAEEFKNE 391
           E   +K +    LGEG FG+V         K        +AVK L   A+ +   +  +E
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 392 VVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL-----------YD----P 435
           + ++  + +H+N++ LLG C +     ++ E+    +L  +L           YD    P
Sbjct: 91  MEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 150
Query: 436 EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
           E+Q  + +         +ARG+ YL   +  + IHRDL A N+L+      KI+DFG+AR
Sbjct: 151 EEQ--MTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205
Query: 496 -IFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
            I  +D  +  T+  +    +MAPE      ++ +SDV+SFGVL+ EI T
Sbjct: 206 DINNIDYYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 93/198 (46%), Gaps = 12/198 (6%)
Query: 353 LGEGGFGEVYKG-VLPSGQEIAVKRLSK---ASGQGAEEFKNEVVLVAKLQHRNLVRLLG 408
           LGEG F  V     L + +E A+K L K              E  ++++L H   V+L  
Sbjct: 45  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 103
Query: 409 FCLEGEEKILV-YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
           FC + +EK+     +  N  L  ++    K G  D +        I   + YLH      
Sbjct: 104 FCFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSALEYLHGKG--- 157
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFS 527
           IIHRDLK  NILL+ +M+ +I+DFG A++   +  Q   +  VGT  Y++PE        
Sbjct: 158 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 217
Query: 528 VKSDVYSFGVLVLEIITG 545
             SD+++ G ++ +++ G
Sbjct: 218 KSSDLWALGCIIYQLVAG 235

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 68/230 (29%), Positives = 111/230 (48%), Gaps = 32/230 (13%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY--------KGVLPSGQEIAVKRL-SKASGQGAEEFKNE 391
           E   +K +    LGEG FG+V         K        +AVK L   A+ +   +  +E
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSE 90
Query: 392 VVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL-----------YD----P 435
           + ++  + +H+N++ LLG C +     ++ E+    +L  +L           YD    P
Sbjct: 91  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 150
Query: 436 EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
           E+Q  + +         +ARG+ YL   +  + IHRDL A N+L+      KI+DFG+AR
Sbjct: 151 EEQ--MTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205
Query: 496 -IFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
            I  +D  +  T+  +    +MAPE      ++ +SDV+SFGVL+ EI T
Sbjct: 206 DINNIDYYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 107/226 (47%), Gaps = 37/226 (16%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVL 394
           +TI     ++ T + +G G +G V     + SG +IAVK+LS+   S   A+    E+ L
Sbjct: 44  KTIWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRL 103
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-------------LYDPEKQGQL 441
           +  ++H N++ LL              F P  SL+ F             L +  K  +L
Sbjct: 104 LKHMKHENVIGLLDV------------FTPATSLEEFNDVYLVTHLMGADLNNIVKCQKL 151
Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
                  +I  I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 152 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 203
Query: 502 TQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
           T    +  V T  Y APE  ++   +++  D++S G ++ E++TG+
Sbjct: 204 TDDEMTGYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 109/236 (46%), Gaps = 25/236 (10%)
Query: 331 ESLQFDFETIEVATNKFSTDNKLGEGGFGEVYK----GVLPSG--QEIAVKRLSKASGQG 384
           E L +D    E   ++      LG G FG+V +    G+  +   + +AVK L + +   
Sbjct: 13  ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 72
Query: 385 AEE-FKNEV-VLVAKLQHRNLVRLLGFCLE-GEEKILVYEFVPNKSLDYFL------YDP 435
                 +E+ +L+    H N+V LLG C + G   +++ EF    +L  +L      + P
Sbjct: 73  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 132
Query: 436 EKQGQLDWSRRYKIIGG-------IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKI 488
            K    D  + +  +         +A+G+ +L   +  + IHRDL A NILL  +   KI
Sbjct: 133 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKI 189
Query: 489 SDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
            DFG+AR    D              +MAPE      ++++SDV+SFGVL+ EI +
Sbjct: 190 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 109/206 (52%), Gaps = 15/206 (7%)
Query: 347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRL---SKASGQGAEEFKNEVVLVAKLQHRN 402
           F    K+GEG +G VYK     +G+ +A+K++   ++  G  +   + E+ L+ +L H N
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 66
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQG-QLDWSRRYKIIGGIARGILYLH 461
           +V+LL       +  LV+E V ++ L  F+      G  L   + Y  +  + +G+ + H
Sbjct: 67  IVKLLDVIHTENKLYLVFEHV-DQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFCH 123
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYA 521
                R++HRDLK  N+L++ E   K++DFG+AR FGV   +     +V T  Y APE  
Sbjct: 124 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPEIL 178
Query: 522 MHGQ-FSVKSDVYSFGVLVLEIITGK 546
           +  + +S   D++S G +  E++T +
Sbjct: 179 LGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 102/206 (49%), Gaps = 24/206 (11%)
Query: 356 GGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE- 414
           G FG V+K  L + + +AVK       Q  +  + EV  +  ++H N+++ +G    G  
Sbjct: 35  GRFGCVWKAQLLN-EYVAVKIFPIQDKQSWQN-EYEVYSLPGMKHENILQFIGAEKRGTS 92
Query: 415 ---EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED-------S 464
              +  L+  F    SL  FL    K   + W+    I   +ARG+ YLHED        
Sbjct: 93  VDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIAETMARGLAYLHEDIPGLKDGH 148
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG 524
           +  I HRD+K+ N+LL   +   I+DFG+A  F   ++ G+T   VGT  YMAPE  + G
Sbjct: 149 KPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPE-VLEG 207
Query: 525 QFS------VKSDVYSFGVLVLEIIT 544
             +      ++ D+Y+ G+++ E+ +
Sbjct: 208 AINFQRDAFLRIDMYAMGLVLWELAS 233

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 103/214 (48%), Gaps = 19/214 (8%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAE---EFKNEVVLVAKLQ 399
           ++++     LG GG  EV+    L   +++AVK L     +       F+ E    A L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 400 HRNLVRLLGF----CLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
           H  +V +          G    +V E+V   +L   ++    +G +   R  ++I    +
Sbjct: 71  HPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQ 127
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF---GVDQTQGNTSRIVGT 512
            + + H++    IIHRD+K +NI++ A    K+ DFG+AR     G   TQ  T+ ++GT
Sbjct: 128 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ--TAAVIGT 182
Query: 513 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
             Y++PE A       +SDVYS G ++ E++TG+
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 105/212 (49%), Gaps = 20/212 (9%)
Query: 342 VATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAE---EFKNEVVLVAK 397
           V    +   + LG G FG+V  G    +G ++AVK L++   +  +   + + E+  +  
Sbjct: 13  VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKL 72
Query: 398 LQHRNLVRLLGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIARG 456
            +H ++++L        +  +V E+V    L DY      K G+LD     ++   I  G
Sbjct: 73  FRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYIC----KNGRLDEKESRRLFQQILSG 128
Query: 457 ILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRI-VGTYGY 515
           + Y H   R  ++HRDLK  N+LLDA MN KI+DFG++ +     + G   R   G+  Y
Sbjct: 129 VDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM----SDGEFLRXSCGSPNY 181
Query: 516 MAPEYAMHGQF--SVKSDVYSFGVLVLEIITG 545
            APE  + G+     + D++S GV++  ++ G
Sbjct: 182 AAPE-VISGRLYAGPEVDIWSSGVILYALLCG 212

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 109/236 (46%), Gaps = 25/236 (10%)
Query: 331 ESLQFDFETIEVATNKFSTDNKLGEGGFGEVYK----GVLPSG--QEIAVKRLSKASGQG 384
           E L +D    E   ++      LG G FG+V +    G+  +   + +AVK L + +   
Sbjct: 4   ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 63
Query: 385 AEE-FKNEV-VLVAKLQHRNLVRLLGFCLE-GEEKILVYEFVPNKSLDYFL------YDP 435
                 +E+ +L+    H N+V LLG C + G   +++ EF    +L  +L      + P
Sbjct: 64  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVP 123
Query: 436 EKQGQLDWSRRYKIIGG-------IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKI 488
            K    D  + +  +         +A+G+ +L   +  + IHRDL A NILL  +   KI
Sbjct: 124 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKI 180
Query: 489 SDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
            DFG+AR    D              +MAPE      ++++SDV+SFGVL+ EI +
Sbjct: 181 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 110/232 (47%), Gaps = 21/232 (9%)
Query: 331 ESLQFDFETIEVATNKFSTDNKLGEGGFGEVYK----GV--LPSGQEIAVKRLSKASGQG 384
           E L +D    E   ++ +    LG G FG+V +    G+    + + +AVK L + +   
Sbjct: 13  ERLPYDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHS 72
Query: 385 AEE-FKNEV-VLVAKLQHRNLVRLLGFCLE-GEEKILVYEFVPNKSLDYFL------YDP 435
                 +E+ +L+    H N+V LLG C + G   +++ EF    +L  +L      + P
Sbjct: 73  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 132
Query: 436 EKQGQLDWSRRYKIIG---GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 492
            K    D+     +I     +A+G+ +L   +  + IHRDL A NILL  +   KI DFG
Sbjct: 133 YKDLYKDFLTLEHLIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFG 189
Query: 493 MARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           +AR    D              +MAPE      ++++SDV+SFGVL+ EI +
Sbjct: 190 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 68/230 (29%), Positives = 111/230 (48%), Gaps = 32/230 (13%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY--------KGVLPSGQEIAVKRL-SKASGQGAEEFKNE 391
           E   +K +    LGEG FG+V         K        +AVK L   A+ +   +  +E
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 392 VVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL-----------YD----P 435
           + ++  + +H+N++ LLG C +     ++ E+    +L  +L           YD    P
Sbjct: 91  MEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 150
Query: 436 EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
           E+Q  + +         +ARG+ YL   +  + IHRDL A N+L+      KI+DFG+AR
Sbjct: 151 EEQ--MTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205
Query: 496 -IFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
            I  +D  +  T+  +    +MAPE      ++ +SDV+SFGVL+ EI T
Sbjct: 206 DINNIDYYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 72/247 (29%), Positives = 114/247 (46%), Gaps = 37/247 (14%)
Query: 332 SLQFD-FETIEVATNKFSTDN-----KLGEGGFGEVYKGVL------PSGQEIAVKRLSK 379
           SL  D F+ +E    +F   N      LGEG FG+V K              +AVK L +
Sbjct: 4   SLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKE 63
Query: 380 -ASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQ 438
            AS     +  +E  ++ ++ H ++++L G C +    +L+ E+    SL  FL +  K 
Sbjct: 64  NASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKV 123
Query: 439 G-------------QLDWSRRYKIIGG--------IARGILYLHEDSRLRIIHRDLKASN 477
           G              LD      +  G        I++G+ YL E   ++++HRDL A N
Sbjct: 124 GPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAARN 180
Query: 478 ILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGV 537
           IL+      KISDFG++R    + +    S+      +MA E      ++ +SDV+SFGV
Sbjct: 181 ILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGV 240
Query: 538 LVLEIIT 544
           L+ EI+T
Sbjct: 241 LLWEIVT 247

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 109/236 (46%), Gaps = 25/236 (10%)
Query: 331 ESLQFDFETIEVATNKFSTDNKLGEGGFGEVYK----GVLPSG--QEIAVKRLSKASGQG 384
           E L +D    E   ++      LG G FG+V +    G+  +   + +AVK L + +   
Sbjct: 4   ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 63
Query: 385 AEE-FKNEV-VLVAKLQHRNLVRLLGFCLE-GEEKILVYEFVPNKSLDYFL------YDP 435
                 +E+ +L+    H N+V LLG C + G   +++ EF    +L  +L      + P
Sbjct: 64  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVP 123
Query: 436 EKQGQLDWSRRYKIIGG-------IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKI 488
            K    D  + +  +         +A+G+ +L   +  + IHRDL A NILL  +   KI
Sbjct: 124 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKI 180
Query: 489 SDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
            DFG+AR    D              +MAPE      ++++SDV+SFGVL+ EI +
Sbjct: 181 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 109/236 (46%), Gaps = 25/236 (10%)
Query: 331 ESLQFDFETIEVATNKFSTDNKLGEGGFGEVYK----GVLPSG--QEIAVKRLSKASGQG 384
           E L +D    E   ++      LG G FG+V +    G+  +   + +AVK L + +   
Sbjct: 50  ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 109
Query: 385 AEE-FKNEV-VLVAKLQHRNLVRLLGFCLE-GEEKILVYEFVPNKSLDYFL------YDP 435
                 +E+ +L+    H N+V LLG C + G   +++ EF    +L  +L      + P
Sbjct: 110 EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 169
Query: 436 EKQGQLDWSRRYKIIGG-------IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKI 488
            K    D  + +  +         +A+G+ +L   +  + IHRDL A NILL  +   KI
Sbjct: 170 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKI 226
Query: 489 SDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
            DFG+AR    D              +MAPE      ++++SDV+SFGVL+ EI +
Sbjct: 227 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 99/205 (48%), Gaps = 24/205 (11%)
Query: 353 LGEGGFGEVYKGVLP-----SGQEIAVKRLSKASG-QGAEEFKNEVVLVAKLQHRNLVRL 406
           LGEG FG+V           +G+ +AVK L    G Q    +K E+ ++  L H ++++ 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 407 LGFCLEGEEKIL--VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
            G C +  EK L  V E+VP  SL  +L     +  +  ++       I  G+ YLH   
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLHSQ- 136
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG-----YMAPE 519
               IHR+L A N+LLD +   KI DFG+A+       +G+    V   G     + APE
Sbjct: 137 --HYIHRNLAARNVLLDNDRLVKIGDFGLAKAV----PEGHEYYRVREDGDSPVFWYAPE 190
Query: 520 YAMHGQFSVKSDVYSFGVLVLEIIT 544
                +F   SDV+SFGV + E++T
Sbjct: 191 CLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 103/214 (48%), Gaps = 19/214 (8%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAE---EFKNEVVLVAKLQ 399
           ++++     LG GG  EV+    L   +++AVK L     +       F+ E    A L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 400 HRNLVRLL----GFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
           H  +V +          G    +V E+V   +L   ++    +G +   R  ++I    +
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQ 127
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF---GVDQTQGNTSRIVGT 512
            + + H++    IIHRD+K +NI++ A    K+ DFG+AR     G   TQ  T+ ++GT
Sbjct: 128 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ--TAAVIGT 182
Query: 513 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
             Y++PE A       +SDVYS G ++ E++TG+
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 68/230 (29%), Positives = 111/230 (48%), Gaps = 32/230 (13%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY--------KGVLPSGQEIAVKRLSK-ASGQGAEEFKNE 391
           E   +K +    LGEG FG+V         K        +AVK L   A+ +   +  +E
Sbjct: 77  EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 136
Query: 392 VVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL-----------YD----P 435
           + ++  + +H+N++ LLG C +     ++ E+    +L  +L           YD    P
Sbjct: 137 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 196
Query: 436 EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
           E+Q  + +         +ARG+ YL   +  + IHRDL A N+L+      KI+DFG+AR
Sbjct: 197 EEQ--MTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 251
Query: 496 -IFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
            I  +D  +  T+  +    +MAPE      ++ +SDV+SFGVL+ EI T
Sbjct: 252 DINNIDYYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 99/205 (48%), Gaps = 24/205 (11%)
Query: 353 LGEGGFGEVYKGVLP-----SGQEIAVKRLSKASG-QGAEEFKNEVVLVAKLQHRNLVRL 406
           LGEG FG+V           +G+ +AVK L    G Q    +K E+ ++  L H ++++ 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 407 LGFCLEGEEKIL--VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
            G C +  EK L  V E+VP  SL  +L     +  +  ++       I  G+ YLH   
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLHAQ- 136
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG-----YMAPE 519
               IHR+L A N+LLD +   KI DFG+A+       +G+    V   G     + APE
Sbjct: 137 --HYIHRNLAARNVLLDNDRLVKIGDFGLAKAV----PEGHEYYRVREDGDSPVFWYAPE 190
Query: 520 YAMHGQFSVKSDVYSFGVLVLEIIT 544
                +F   SDV+SFGV + E++T
Sbjct: 191 CLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 103/211 (48%), Gaps = 27/211 (12%)
Query: 352 KLGEGGFGEVYKGVLPSGQ-EIAVKRLSKASGQGA-------------EEFKNEVVLVAK 397
           KLG G +GEV      +G  E A+K + K+                  EE  NE+ L+  
Sbjct: 43  KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 398 LQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGI 457
           L H N+++L     + +   LV EF     L   + +  K  + D +    I+  I  GI
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAAN---IMKQILSGI 159
Query: 458 LYLHEDSRLRIIHRDLKASNILLDAE---MNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
            YLH+ +   I+HRD+K  NILL+ +   +N KI DFG++  F  D    +    +GT  
Sbjct: 160 CYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDR---LGTAY 213
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
           Y+APE  +  +++ K DV+S GV++  ++ G
Sbjct: 214 YIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 72/247 (29%), Positives = 114/247 (46%), Gaps = 37/247 (14%)
Query: 332 SLQFD-FETIEVATNKFSTDN-----KLGEGGFGEVYKGVL------PSGQEIAVKRLSK 379
           SL  D F+ +E    +F   N      LGEG FG+V K              +AVK L +
Sbjct: 4   SLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKE 63
Query: 380 -ASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQ 438
            AS     +  +E  ++ ++ H ++++L G C +    +L+ E+    SL  FL +  K 
Sbjct: 64  NASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKV 123
Query: 439 G-------------QLDWSRRYKIIGG--------IARGILYLHEDSRLRIIHRDLKASN 477
           G              LD      +  G        I++G+ YL E   ++++HRDL A N
Sbjct: 124 GPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAARN 180
Query: 478 ILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGV 537
           IL+      KISDFG++R    + +    S+      +MA E      ++ +SDV+SFGV
Sbjct: 181 ILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGV 240
Query: 538 LVLEIIT 544
           L+ EI+T
Sbjct: 241 LLWEIVT 247

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/230 (29%), Positives = 111/230 (48%), Gaps = 32/230 (13%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY--------KGVLPSGQEIAVKRL-SKASGQGAEEFKNE 391
           E   +K +    LGEG FG+V         K        +AVK L   A+ +   +  +E
Sbjct: 23  EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 82
Query: 392 VVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL-----------YD----P 435
           + ++  + +H+N++ LLG C +     ++ E+    +L  +L           YD    P
Sbjct: 83  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 142
Query: 436 EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
           E+Q  + +         +ARG+ YL   +  + IHRDL A N+L+      KI+DFG+AR
Sbjct: 143 EEQ--MTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 197
Query: 496 -IFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
            I  +D  +  T+  +    +MAPE      ++ +SDV+SFGVL+ EI T
Sbjct: 198 DINNIDYYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/230 (29%), Positives = 111/230 (48%), Gaps = 32/230 (13%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY--------KGVLPSGQEIAVKRL-SKASGQGAEEFKNE 391
           E   +K +    LGEG FG+V         K        +AVK L   A+ +   +  +E
Sbjct: 18  EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 77
Query: 392 VVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL-----------YD----P 435
           + ++  + +H+N++ LLG C +     ++ E+    +L  +L           YD    P
Sbjct: 78  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 137
Query: 436 EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
           E+Q  + +         +ARG+ YL   +  + IHRDL A N+L+      KI+DFG+AR
Sbjct: 138 EEQ--MTFKDLVSCTYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLAR 192
Query: 496 -IFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
            I  +D  +  T+  +    +MAPE      ++ +SDV+SFGVL+ EI T
Sbjct: 193 DINNIDYYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 104/204 (50%), Gaps = 19/204 (9%)
Query: 350 DNKLGEGGFGEVYKG---VLPSGQEIAVKRLSKASGQGA--EEFKNEVVLVAKLQHRNLV 404
           D +LG G FG V KG   +    + +AVK L   +   A  +E   E  ++ +L +  +V
Sbjct: 32  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 91
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
           R++G C E E  +LV E      L+ +L   ++   +      +++  ++ G+ YL E +
Sbjct: 92  RMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN 147
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ----TQGNTSRIVGTYGYMAPEY 520
               +HRDL A N+LL  +   KISDFG+++    D+     Q +    V  Y   APE 
Sbjct: 148 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY---APEC 201
Query: 521 AMHGQFSVKSDVYSFGVLVLEIIT 544
             + +FS KSDV+SFGVL+ E  +
Sbjct: 202 INYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 104/204 (50%), Gaps = 19/204 (9%)
Query: 350 DNKLGEGGFGEVYKG---VLPSGQEIAVKRLSKASGQGA--EEFKNEVVLVAKLQHRNLV 404
           D +LG G FG V KG   +    + +AVK L   +   A  +E   E  ++ +L +  +V
Sbjct: 32  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 91
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
           R++G C E E  +LV E      L+ +L   ++   +      +++  ++ G+ YL E +
Sbjct: 92  RMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN 147
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ----TQGNTSRIVGTYGYMAPEY 520
               +HRDL A N+LL  +   KISDFG+++    D+     Q +    V  Y   APE 
Sbjct: 148 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY---APEC 201
Query: 521 AMHGQFSVKSDVYSFGVLVLEIIT 544
             + +FS KSDV+SFGVL+ E  +
Sbjct: 202 INYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 104/204 (50%), Gaps = 19/204 (9%)
Query: 350 DNKLGEGGFGEVYKG---VLPSGQEIAVKRLSKASGQGA--EEFKNEVVLVAKLQHRNLV 404
           D +LG G FG V KG   +    + +AVK L   +   A  +E   E  ++ +L +  +V
Sbjct: 12  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
           R++G C E E  +LV E      L+ +L   ++   +      +++  ++ G+ YL E +
Sbjct: 72  RMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN 127
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ----TQGNTSRIVGTYGYMAPEY 520
               +HRDL A N+LL  +   KISDFG+++    D+     Q +    V  Y   APE 
Sbjct: 128 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY---APEC 181
Query: 521 AMHGQFSVKSDVYSFGVLVLEIIT 544
             + +FS KSDV+SFGVL+ E  +
Sbjct: 182 INYYKFSSKSDVWSFGVLMWEAFS 205

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/230 (29%), Positives = 111/230 (48%), Gaps = 32/230 (13%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY--------KGVLPSGQEIAVKRLSK-ASGQGAEEFKNE 391
           E   +K +    LGEG FG+V         K        +AVK L   A+ +   +  +E
Sbjct: 20  EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 79
Query: 392 VVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL-----------YD----P 435
           + ++  + +H+N++ LLG C +     ++ E+    +L  +L           YD    P
Sbjct: 80  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 139
Query: 436 EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
           E+Q  + +         +ARG+ YL   +  + IHRDL A N+L+      KI+DFG+AR
Sbjct: 140 EEQ--MTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 194
Query: 496 -IFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
            I  +D  +  T+  +    +MAPE      ++ +SDV+SFGVL+ EI T
Sbjct: 195 DINNIDYYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 104/200 (52%), Gaps = 19/200 (9%)
Query: 353 LGEGGFGEVY--KGVLPSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLG 408
           +G+G F +V   + +L +G+E+A+K + K   +    ++   EV ++  L H N+V+L  
Sbjct: 20  IGKGNFAKVKLARHIL-TGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE 78
Query: 409 FCLEGEEKI-LVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRL 466
             +E E+ + L+ E+     + DY +      G++           I   + Y H+    
Sbjct: 79  -VIETEKTLYLIMEYASGGEVFDYLV----AHGRMKEKEARSKFRQIVSAVQYCHQK--- 130
Query: 467 RIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQF 526
           RI+HRDLKA N+LLDA+MN KI+DFG +  F V    G      G+  Y APE     ++
Sbjct: 131 RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG---GKLDTFCGSPPYAAPELFQGKKY 187
Query: 527 S-VKSDVYSFGVLVLEIITG 545
              + DV+S GV++  +++G
Sbjct: 188 DGPEVDVWSLGVILYTLVSG 207

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 103/214 (48%), Gaps = 19/214 (8%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAE---EFKNEVVLVAKLQ 399
           ++++     LG GG  EV+    L   +++AVK L     +       F+ E    A L 
Sbjct: 28  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 87
Query: 400 HRNLVRLL----GFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
           H  +V +          G    +V E+V   +L   ++    +G +   R  ++I    +
Sbjct: 88  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQ 144
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF---GVDQTQGNTSRIVGT 512
            + + H++    IIHRD+K +NI++ A    K+ DFG+AR     G   TQ  T+ ++GT
Sbjct: 145 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ--TAAVIGT 199
Query: 513 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
             Y++PE A       +SDVYS G ++ E++TG+
Sbjct: 200 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 233

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 105/202 (51%), Gaps = 15/202 (7%)
Query: 350 DNKLGEGGFGEVYKG---VLPSGQEIAVKRLSKASGQGA--EEFKNEVVLVAKLQHRNLV 404
           D +LG G FG V KG   +    + +AVK L   +   A  +E   E  ++ +L +  +V
Sbjct: 16  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 75
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
           R++G C E E  +LV E      L+ +L   ++   +      +++  ++ G+ YL E +
Sbjct: 76  RMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN 131
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTY--GYMAPEYAM 522
               +HRDL A N+LL  +   KISDFG+++    D+     ++  G +   + APE   
Sbjct: 132 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENX-YKAQTHGKWPVKWYAPECIN 187
Query: 523 HGQFSVKSDVYSFGVLVLEIIT 544
           + +FS KSDV+SFGVL+ E  +
Sbjct: 188 YYKFSSKSDVWSFGVLMWEAFS 209

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 104/204 (50%), Gaps = 19/204 (9%)
Query: 350 DNKLGEGGFGEVYKG---VLPSGQEIAVKRLSKASGQGA--EEFKNEVVLVAKLQHRNLV 404
           D +LG G FG V KG   +    + +AVK L   +   A  +E   E  ++ +L +  +V
Sbjct: 10  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 69
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
           R++G C E E  +LV E      L+ +L   ++   +      +++  ++ G+ YL E +
Sbjct: 70  RMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN 125
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ----TQGNTSRIVGTYGYMAPEY 520
               +HRDL A N+LL  +   KISDFG+++    D+     Q +    V  Y   APE 
Sbjct: 126 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY---APEC 179
Query: 521 AMHGQFSVKSDVYSFGVLVLEIIT 544
             + +FS KSDV+SFGVL+ E  +
Sbjct: 180 INYYKFSSKSDVWSFGVLMWEAFS 203

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 104/204 (50%), Gaps = 19/204 (9%)
Query: 350 DNKLGEGGFGEVYKG---VLPSGQEIAVKRLSKASGQGA--EEFKNEVVLVAKLQHRNLV 404
           D +LG G FG V KG   +    + +AVK L   +   A  +E   E  ++ +L +  +V
Sbjct: 30  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 89
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
           R++G C E E  +LV E      L+ +L   ++   +      +++  ++ G+ YL E +
Sbjct: 90  RMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN 145
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ----TQGNTSRIVGTYGYMAPEY 520
               +HRDL A N+LL  +   KISDFG+++    D+     Q +    V  Y   APE 
Sbjct: 146 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY---APEC 199
Query: 521 AMHGQFSVKSDVYSFGVLVLEIIT 544
             + +FS KSDV+SFGVL+ E  +
Sbjct: 200 INYYKFSSKSDVWSFGVLMWEAFS 223

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 111/236 (47%), Gaps = 26/236 (11%)
Query: 331 ESLQFDFETIEVATNKFSTDNKLGEGGFGEVYK----GVLPSG--QEIAVKRLSKASGQG 384
           E L +D    E   ++ +    LG G FG+V +    G+  +   + +AVK L + +   
Sbjct: 14  ERLPYDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 73
Query: 385 AEE-FKNEV-VLVAKLQHRNLVRLLGFCLE-GEEKILVYEFVPNKSLDYFL------YDP 435
                 +E+ +L+    H N+V LLG C + G   +++ EF    +L  +L      + P
Sbjct: 74  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 133
Query: 436 EKQGQLDWSRRYKIIGG-------IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKI 488
            K  + D  + +  +         +A+G+ +L   +  + IHRDL A NILL  +   KI
Sbjct: 134 YKTPE-DLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKI 189
Query: 489 SDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
            DFG+AR    D              +MAPE      ++++SDV+SFGVL+ EI +
Sbjct: 190 CDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 96/198 (48%), Gaps = 10/198 (5%)
Query: 353 LGEGGFGEVYKGVLPSGQEIAV-KRLSKASGQGAEE--FKNEVVLVAKLQHRNLVRLLGF 409
           +G G +G   K    S  +I V K L   S   AE+    +EV L+ +L+H N+VR    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 410 CLEGEEKIL--VYEFVPNKSLDYFLYDPEKQGQ-LDWSRRYKIIGGIARGILYLHE--DS 464
            ++     L  V E+     L   +    K+ Q LD     +++  +   +   H   D 
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG 524
              ++HRDLK +N+ LD + N K+ DFG+ARI   D +   T   VGT  YM+PE     
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYMSPEQMNRM 191
Query: 525 QFSVKSDVYSFGVLVLEI 542
            ++ KSD++S G L+ E+
Sbjct: 192 SYNEKSDIWSLGCLLYEL 209

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 111/230 (48%), Gaps = 32/230 (13%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY--------KGVLPSGQEIAVKRL-SKASGQGAEEFKNE 391
           E   +K +    LGEG FG+V         K        +AVK L   A+ +   +  +E
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 392 VVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL-----------YD----P 435
           + ++  + +H+N++ LLG C +     ++ E+    +L  +L           YD    P
Sbjct: 91  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 150
Query: 436 EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
           E+Q  + +         +ARG+ YL   +  + IHRDL A N+L+      +I+DFG+AR
Sbjct: 151 EEQ--MTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLAR 205
Query: 496 -IFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
            I  +D  +  T+  +    +MAPE      ++ +SDV+SFGVL+ EI T
Sbjct: 206 DINNIDYYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 103/200 (51%), Gaps = 19/200 (9%)
Query: 353 LGEGGFGEVY--KGVLPSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLG 408
           +G+G F +V   + +L +G+E+A+K + K   +    ++   EV ++  L H N+V+L  
Sbjct: 23  IGKGNFAKVKLARHIL-TGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE 81
Query: 409 FCLEGEEKI-LVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRL 466
             +E E+ + L+ E+     + DY +      G++           I   + Y H+    
Sbjct: 82  -VIETEKTLYLIMEYASGGEVFDYLV----AHGRMKEKEARSKFRQIVSAVQYCHQK--- 133
Query: 467 RIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQF 526
           RI+HRDLKA N+LLDA+MN KI+DFG +  F V    G      G   Y APE     ++
Sbjct: 134 RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG---GKLDAFCGAPPYAAPELFQGKKY 190
Query: 527 S-VKSDVYSFGVLVLEIITG 545
              + DV+S GV++  +++G
Sbjct: 191 DGPEVDVWSLGVILYTLVSG 210

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 104/204 (50%), Gaps = 19/204 (9%)
Query: 350 DNKLGEGGFGEVYKG---VLPSGQEIAVKRLSKASGQGA--EEFKNEVVLVAKLQHRNLV 404
           D +LG G FG V KG   +    + +AVK L   +   A  +E   E  ++ +L +  +V
Sbjct: 16  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 75
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
           R++G C E E  +LV E      L+ +L   ++   +      +++  ++ G+ YL E +
Sbjct: 76  RMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN 131
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ----TQGNTSRIVGTYGYMAPEY 520
               +HRDL A N+LL  +   KISDFG+++    D+     Q +    V  Y   APE 
Sbjct: 132 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY---APEC 185
Query: 521 AMHGQFSVKSDVYSFGVLVLEIIT 544
             + +FS KSDV+SFGVL+ E  +
Sbjct: 186 INYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 113/247 (45%), Gaps = 37/247 (14%)
Query: 332 SLQFD-FETIEVATNKFSTDN-----KLGEGGFGEVYKGVL------PSGQEIAVKRLSK 379
           SL  D F+ +E    +F   N      LGEG FG+V K              +AVK L +
Sbjct: 4   SLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKE 63
Query: 380 -ASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQ 438
            AS     +  +E  ++ ++ H ++++L G C +    +L+ E+    SL  FL +  K 
Sbjct: 64  NASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKV 123
Query: 439 G-------------QLDWSRRYKIIGG--------IARGILYLHEDSRLRIIHRDLKASN 477
           G              LD      +  G        I++G+ YL E S   ++HRDL A N
Sbjct: 124 GPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMS---LVHRDLAARN 180
Query: 478 ILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGV 537
           IL+      KISDFG++R    + +    S+      +MA E      ++ +SDV+SFGV
Sbjct: 181 ILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGV 240
Query: 538 LVLEIIT 544
           L+ EI+T
Sbjct: 241 LLWEIVT 247

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 104/204 (50%), Gaps = 19/204 (9%)
Query: 350 DNKLGEGGFGEVYKG---VLPSGQEIAVKRLSKASGQGA--EEFKNEVVLVAKLQHRNLV 404
           D +LG G FG V KG   +    + +AVK L   +   A  +E   E  ++ +L +  +V
Sbjct: 22  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
           R++G C E E  +LV E      L+ +L   ++   +      +++  ++ G+ YL E +
Sbjct: 82  RMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN 137
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ----TQGNTSRIVGTYGYMAPEY 520
               +HRDL A N+LL  +   KISDFG+++    D+     Q +    V  Y   APE 
Sbjct: 138 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY---APEC 191
Query: 521 AMHGQFSVKSDVYSFGVLVLEIIT 544
             + +FS KSDV+SFGVL+ E  +
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFS 215

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 100/205 (48%), Gaps = 24/205 (11%)
Query: 353 LGEGGFGEVYKGVLP-----SGQEIAVKRLSKASG-QGAEEFKNEVVLVAKLQHRNLVRL 406
           LGEG FG+V           +G+ +AVK L   +G Q    +K E+ ++  L H ++++ 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 407 LGFCLE-GEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
            G C + G   + LV E+VP  SL  +L     +  +  ++       I  G+ YLH   
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLHAQ- 153
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG-----YMAPE 519
               IHRDL A N+LLD +   KI DFG+A+       +G+    V   G     + APE
Sbjct: 154 --HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV----PEGHEXYRVREDGDSPVFWYAPE 207
Query: 520 YAMHGQFSVKSDVYSFGVLVLEIIT 544
                +F   SDV+SFGV + E++T
Sbjct: 208 CLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 99/203 (48%), Gaps = 26/203 (12%)
Query: 353 LGEGGFGEVY--KGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFC 410
           LG G F EV+  K  L +G+  A+K + K+        +NE+ ++ K++H N+V L    
Sbjct: 17  LGSGAFSEVFLVKQRL-TGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 411 LEGEEKILVYEFVP-----NKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSR 465
                  LV + V      ++ L+  +Y  EK   L       +I  +   + YLHE+  
Sbjct: 76  ESTTHYYLVMQLVSGGELFDRILERGVYT-EKDASL-------VIQQVLSAVKYLHENG- 126
Query: 466 LRIIHRDLKASNIL-LDAEMNPKI--SDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM 522
             I+HRDLK  N+L L  E N KI  +DFG++++    +  G  S   GT GY+APE   
Sbjct: 127 --IVHRDLKPENLLYLTPEENSKIMITDFGLSKM----EQNGIMSTACGTPGYVAPEVLA 180
Query: 523 HGQFSVKSDVYSFGVLVLEIITG 545
              +S   D +S GV+   ++ G
Sbjct: 181 QKPYSKAVDCWSIGVITYILLCG 203

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 101/205 (49%), Gaps = 24/205 (11%)
Query: 353 LGEGGFGEVYKGVLP-----SGQEIAVKRLSKASG-QGAEEFKNEVVLVAKLQHRNLVRL 406
           LGEG FG+V           +G+ +AVK L +  G Q    ++ E+ ++  L H ++V+ 
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 407 LGFCL-EGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
            G C  +GE+ + LV E+VP  SL  +L     +  +  ++       I  G+ YLH   
Sbjct: 77  KGCCEDQGEKSVQLVMEYVPLGSLRDYL----PRHCVGLAQLLLFAQQICEGMAYLHAQ- 131
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG-----YMAPE 519
               IHR L A N+LLD +   KI DFG+A+       +G+    V   G     + APE
Sbjct: 132 --HYIHRALAARNVLLDNDRLVKIGDFGLAKAV----PEGHEYYRVREDGDSPVFWYAPE 185
Query: 520 YAMHGQFSVKSDVYSFGVLVLEIIT 544
                +F   SDV+SFGV + E++T
Sbjct: 186 CLKECKFYYASDVWSFGVTLYELLT 210

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 76/228 (33%), Positives = 113/228 (49%), Gaps = 18/228 (7%)
Query: 333 LQFDF-ETIEVATNKFSTDNKLGEGGFGEVYK-GVLPSGQEIAVKRLSKASGQ---GAEE 387
           LQ+ + E   V  N F     LG+GGFGEV    V  +G+  A K+L K   +   G   
Sbjct: 171 LQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAM 230
Query: 388 FKNEVVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRR 446
             NE  ++ K+  R +V L  +  E ++ + LV   +    L + +Y   + G    +R 
Sbjct: 231 ALNEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAG-FPEARA 288
Query: 447 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT 506
                 I  G+  LH   R RI++RDLK  NILLD   + +ISD G+A    V   +G T
Sbjct: 289 VFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLA----VHVPEGQT 341
Query: 507 SR-IVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQ 553
            +  VGT GYMAPE   + +++   D ++ G L+ E+I G+  S F Q
Sbjct: 342 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ--SPFQQ 387

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 103/206 (50%), Gaps = 23/206 (11%)
Query: 350 DNKLGEGGFGEVYKG---VLPSGQEIAVKRLSKASGQGA--EEFKNEVVLVAKLQHRNLV 404
           D +LG G FG V KG   +    + +AVK L   +   A  +E   E  ++ +L +  +V
Sbjct: 374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 433
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
           R++G C E E  +LV E      L+ +L   ++   +      +++  ++ G+ YL E +
Sbjct: 434 RMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN 489
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD------QTQGNTSRIVGTYGYMAP 518
               +HRDL A N+LL  +   KISDFG+++    D      QT G          + AP
Sbjct: 490 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW-----PVKWYAP 541
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIIT 544
           E   + +FS KSDV+SFGVL+ E  +
Sbjct: 542 ECINYYKFSSKSDVWSFGVLMWEAFS 567

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 101/205 (49%), Gaps = 24/205 (11%)
Query: 353 LGEGGFGEVYKGVLP-----SGQEIAVKRLSKASG-QGAEEFKNEVVLVAKLQHRNLVRL 406
           LGEG FG+V           +G+ +AVK L +  G Q    ++ E+ ++  L H ++V+ 
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 407 LGFCL-EGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
            G C  +GE+ + LV E+VP  SL  +L     +  +  ++       I  G+ YLH   
Sbjct: 76  KGCCEDQGEKSVQLVMEYVPLGSLRDYL----PRHCVGLAQLLLFAQQICEGMAYLHAQ- 130
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG-----YMAPE 519
               IHR L A N+LLD +   KI DFG+A+       +G+    V   G     + APE
Sbjct: 131 --HYIHRALAARNVLLDNDRLVKIGDFGLAKAV----PEGHEYYRVREDGDSPVFWYAPE 184
Query: 520 YAMHGQFSVKSDVYSFGVLVLEIIT 544
                +F   SDV+SFGV + E++T
Sbjct: 185 CLKECKFYYASDVWSFGVTLYELLT 209

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 105/228 (46%), Gaps = 15/228 (6%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEE--FKNEVVLVAKLQ 399
           +  K+     +GEG +G V K     +G+ +A+K+  ++      +     E+ L+ +L+
Sbjct: 23  SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR 82
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
           H NLV LL  C + +   LV+EFV +  LD     P     LD+    K +  I  GI +
Sbjct: 83  HENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFP---NGLDYQVVQKYLFQIINGIGF 139
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE 519
            H  +   IIHRD+K  NIL+      K+ DFG AR         +    V T  Y APE
Sbjct: 140 CHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDE--VATRWYRAPE 194
Query: 520 YAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYVSI 566
             +   ++    DV++ G LV E+  G+     +  D   D L ++ +
Sbjct: 195 LLVGDVKYGKAVDVWAIGCLVTEMFMGEP---LFPGDSDIDQLYHIMM 239

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/255 (27%), Positives = 118/255 (46%), Gaps = 38/255 (14%)
Query: 322 NADNDLTTLESLQFDFE-TIEVATNKFSTDNKLGEGGFGEVYK----GVLPSGQ--EIAV 374
           ++DN+   ++  +++++   E           LG G FG+V      G+  +G   ++AV
Sbjct: 21  SSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAV 80
Query: 375 KRL-SKASGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
           K L  KA     E   +E+ ++ +L  H N+V LLG C       L++E+     L  +L
Sbjct: 81  KMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYL 140
Query: 433 -----------YDPEKQGQLDWSRRYKIIG---------GIARGILYLHEDSRLRIIHRD 472
                       + E Q +L+      ++           +A+G+ +L   S    +HRD
Sbjct: 141 RSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRD 197
Query: 473 LKASNILLDAEMNPKISDFGMARIFGVDQ---TQGNTSRIVGTYGYMAPEYAMHGQFSVK 529
           L A N+L+      KI DFG+AR    D     +GN    V    +MAPE    G +++K
Sbjct: 198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVK---WMAPESLFEGIYTIK 254
Query: 530 SDVYSFGVLVLEIIT 544
           SDV+S+G+L+ EI +
Sbjct: 255 SDVWSYGILLWEIFS 269

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 73/221 (33%), Positives = 110/221 (49%), Gaps = 16/221 (7%)
Query: 333 LQFDF-ETIEVATNKFSTDNKLGEGGFGEVYK-GVLPSGQEIAVKRLSKASGQ---GAEE 387
           LQ+ + E   V  N F     LG+GGFGEV    V  +G+  A K+L K   +   G   
Sbjct: 171 LQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAM 230
Query: 388 FKNEVVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRR 446
             NE  ++ K+  R +V L  +  E ++ + LV   +    L + +Y   + G    +R 
Sbjct: 231 ALNEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAG-FPEARA 288
Query: 447 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT 506
                 I  G+  LH   R RI++RDLK  NILLD   + +ISD G+A    V   +G T
Sbjct: 289 VFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLA----VHVPEGQT 341
Query: 507 SR-IVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
            +  VGT GYMAPE   + +++   D ++ G L+ E+I G+
Sbjct: 342 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 103/206 (50%), Gaps = 23/206 (11%)
Query: 350 DNKLGEGGFGEVYKG---VLPSGQEIAVKRLSKASGQGA--EEFKNEVVLVAKLQHRNLV 404
           D +LG G FG V KG   +    + +AVK L   +   A  +E   E  ++ +L +  +V
Sbjct: 375 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 434
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
           R++G C E E  +LV E      L+ +L   ++   +      +++  ++ G+ YL E +
Sbjct: 435 RMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN 490
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD------QTQGNTSRIVGTYGYMAP 518
               +HRDL A N+LL  +   KISDFG+++    D      QT G          + AP
Sbjct: 491 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW-----PVKWYAP 542
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIIT 544
           E   + +FS KSDV+SFGVL+ E  +
Sbjct: 543 ECINYYKFSSKSDVWSFGVLMWEAFS 568

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 109/240 (45%), Gaps = 13/240 (5%)
Query: 311 AKKKYNAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQ 370
           A  K +A P ++ D     L+ +  D         ++     LG+GGF + Y+      +
Sbjct: 9   AIAKPSAKPSAHVDPKSAPLKEIP-DVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTK 67
Query: 371 EIAVKRLSKAS----GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNK 426
           E+   ++   S        E+   E+ +   L + ++V   GF  + +   +V E    +
Sbjct: 68  EVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRR 127
Query: 427 SLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP 486
           SL        ++   +   RY +   I +G+ YLH +   R+IHRDLK  N+ L+ +M+ 
Sbjct: 128 SL--LELHKRRKAVTEPEARYFMRQTI-QGVQYLHNN---RVIHRDLKLGNLFLNDDMDV 181
Query: 487 KISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
           KI DFG+A     D  +  T  + GT  Y+APE       S + D++S G ++  ++ GK
Sbjct: 182 KIGDFGLATKIEFDGERKKT--LCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/252 (27%), Positives = 115/252 (45%), Gaps = 29/252 (11%)
Query: 325 NDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLP----SGQEIAVKRLSK- 379
           + L   + L+   E + +   +F+    LG+G FG V +  L     S  ++AVK L   
Sbjct: 3   DSLGISDELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKAD 62
Query: 380 -ASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEK------ILVYEFVPNKSLDYFL 432
             +    EEF  E   + +  H ++ +L+G  L    K      +++  F+ +  L  FL
Sbjct: 63  IIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFL 122
Query: 433 YDP---EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKIS 489
                 E    L      + +  IA G+ YL   S    IHRDL A N +L  +M   ++
Sbjct: 123 LASRIGENPFNLPLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVA 179
Query: 490 DFGMAR-IFGVD-QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT--- 544
           DFG++R I+  D   QG  S++     ++A E      ++V SDV++FGV + EI+T   
Sbjct: 180 DFGLSRKIYSGDYYRQGCASKL--PVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQ 237
Query: 545 ----GKKNSNFY 552
               G +N+  Y
Sbjct: 238 TPYAGIENAEIY 249

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 109/227 (48%), Gaps = 34/227 (14%)
Query: 346 KFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHR 401
           K+    KLG+G +G V+K +   +G+ +AVK++  A   S      F+  ++L     H 
Sbjct: 10  KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHE 69
Query: 402 NLVRLLGFCLEGEEK--ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
           N+V LL       ++   LV+++     ++  L+   +   L+   +  ++  + + I Y
Sbjct: 70  NIVNLLNVLRADNDRDVYLVFDY-----METDLHAVIRANILEPVHKQYVVYQLIKVIKY 124
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF-------------------GVD 500
           LH      ++HRD+K SNILL+AE + K++DFG++R F                     D
Sbjct: 125 LHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFD 181
Query: 501 QTQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
             Q   +  V T  Y APE  +   +++   D++S G ++ EI+ GK
Sbjct: 182 DDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 93/198 (46%), Gaps = 12/198 (6%)
Query: 353 LGEGGFGEVYKG-VLPSGQEIAVKRLSK---ASGQGAEEFKNEVVLVAKLQHRNLVRLLG 408
           LGEG F  V     L + +E A+K L K              E  ++++L H   V+L  
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 98
Query: 409 FCLEGEEKILV-YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
           F  + +EK+     +  N  L  ++    K G  D +        I   + YLH      
Sbjct: 99  FTFQDDEKLYFGLSYAKNGCLLKYI---RKIGSFDETCTRFYTAEIVSALEYLHGKG--- 152
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFS 527
           IIHRDLK  NILL+ +M+ +I+DFG A++   +  Q   +  VGT  Y++PE       S
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAS 212
Query: 528 VKSDVYSFGVLVLEIITG 545
             SD+++ G ++ +++ G
Sbjct: 213 KSSDLWALGCIIYQLVAG 230

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 110/230 (47%), Gaps = 32/230 (13%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY--------KGVLPSGQEIAVKRL-SKASGQGAEEFKNE 391
           E   +K +    LGEG FG+V         K        +AVK L   A+ +   +  +E
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 392 VVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL-----------YD----P 435
           + ++  + +H+N++ LLG C +     ++  +    +L  +L           YD    P
Sbjct: 91  MEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVP 150
Query: 436 EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
           E+Q  + +         +ARG+ YL   +  + IHRDL A N+L+      KI+DFG+AR
Sbjct: 151 EEQ--MTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205
Query: 496 -IFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
            I  +D  +  T+  +    +MAPE      ++ +SDV+SFGVL+ EI T
Sbjct: 206 DINNIDYYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 37/226 (16%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVL 394
           +TI     ++   + +G G +G V       +G  +AVK+LS+   S   A+    E+ L
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-------------LYDPEKQGQL 441
           +  ++H N++ LL              F P +SL+ F             L +  K  +L
Sbjct: 71  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCAKL 118
Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
                  +I  I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 119 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 170
Query: 502 TQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
           T    +  V T  Y APE  ++   ++   D++S G ++ E++TG+
Sbjct: 171 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 100/210 (47%), Gaps = 36/210 (17%)
Query: 352 KLGEGGFGEVY---KGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLG 408
           KLG G +GEV      V    + I + R +  S     +   EV ++  L H N+++L  
Sbjct: 44  KLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKL-- 101
Query: 409 FCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQL--DWSRRYK--------IIGGIARGIL 458
                      Y+F  +K   Y + +  K G+L  +   R K        II  +  G+ 
Sbjct: 102 -----------YDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVT 150
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNP---KISDFGMARIFGVDQTQGNTSRIVGTYGY 515
           YLH+ +   I+HRDLK  N+LL+++      KI DFG++ +F   + Q      +GT  Y
Sbjct: 151 YLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF---ENQKKMKERLGTAYY 204
Query: 516 MAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
           +APE  +  ++  K DV+S GV++  ++ G
Sbjct: 205 IAPE-VLRKKYDEKCDVWSIGVILFILLAG 233

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 110/233 (47%), Gaps = 43/233 (18%)
Query: 336 DFETIEVATNKFSTDNK------LGEGGFGEV---YKGVLPSGQEIAVKRLSKA--SGQG 384
           +F ++E+  + F+   +      +G G  G V   Y  +L   + +A+K+LS+   +   
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTH 66
Query: 385 AEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF--------LYDPE 436
           A+    E+VL+  + H+N++ LL              F P KSL+ F        L D  
Sbjct: 67  AKRAYRELVLMKVVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDAN 114
Query: 437 K----QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 492
                Q +LD  R   ++  +  GI +LH      IIHRDLK SNI++ ++   KI DFG
Sbjct: 115 LSQVIQMELDHERMSYLLYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFG 171
Query: 493 MARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
           +AR  G   T    +  V T  Y APE  +   +    D++S GV++ E+I G
Sbjct: 172 LARTAG---TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 106/211 (50%), Gaps = 18/211 (8%)
Query: 343 ATNKFSTDNK---LGEGGFGEVYK-GVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKL 398
           A N F T +K   LG G FG+V+K     +G ++A K +     +  EE KNE+ ++ +L
Sbjct: 84  AVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL 143
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIARGI 457
            H NL++L        + +LV E+V    L D  + +     +LD       +  I  GI
Sbjct: 144 DHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELD---TILFMKQICEGI 200
Query: 458 LYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
            ++H+   + I+H DLK  NIL    DA+   KI DFG+AR +   + +       GT  
Sbjct: 201 RHMHQ---MYILHLDLKPENILCVNRDAK-QIKIIDFGLARRY---KPREKLKVNFGTPE 253
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
           ++APE   +   S  +D++S GV+   +++G
Sbjct: 254 FLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 108/205 (52%), Gaps = 27/205 (13%)
Query: 353 LGEGGFGEV-----YKGVLPSGQEIAVKRLSKASGQGAE---EFKNEVVLVAKLQHRNLV 404
           LGEG FG+V     YK    + Q++A+K +S+   + ++     + E+  +  L+H +++
Sbjct: 17  LGEGSFGKVKLATHYK----TQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHII 72
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
           +L        + ++V E+   +  DY +   +K+   D  RR+     I   I Y H   
Sbjct: 73  KLYDVITTPTDIVMVIEYAGGELFDYIV--EKKRMTEDEGRRF--FQQIICAIEYCH--- 125
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRI-VGTYGYMAPEYAMH 523
           R +I+HRDLK  N+LLD  +N KI+DFG++ I     T GN  +   G+  Y APE  ++
Sbjct: 126 RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIM----TDGNFLKTSCGSPNYAAPE-VIN 180
Query: 524 GQFSV--KSDVYSFGVLVLEIITGK 546
           G+     + DV+S G+++  ++ G+
Sbjct: 181 GKLYAGPEVDVWSCGIVLYVMLVGR 205

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 100/216 (46%), Gaps = 19/216 (8%)
Query: 339 TIEVATNKFSTDN-----KLGEGGFGEVYKGVLPSGQEI-AVKRL--SKASGQGAE-EFK 389
           T ++ T  F+ D+      LG+G FG VY         I A+K L  S+   +G E + +
Sbjct: 12  TPDILTRHFTIDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLR 71
Query: 390 NEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKI 449
            E+ + A L H N++RL  +  +     L+ E+ P   L   L   +K    D  R   I
Sbjct: 72  REIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKEL---QKSCTFDEQRTATI 128
Query: 450 IGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRI 509
           +  +A  ++Y H     ++IHRD+K  N+LL  +   KI+DFG    + V         +
Sbjct: 129 MEELADALMYCHGK---KVIHRDIKPENLLLGLKGELKIADFG----WSVHAPSLRRKTM 181
Query: 510 VGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
            GT  Y+ PE       + K D++  GVL  E++ G
Sbjct: 182 CGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVG 217

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 99/208 (47%), Gaps = 12/208 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQE----IAVKRLSKASGQGA-EEFKNEVVLV 395
           E+   +      +GEG FG+V++G+  S +     +A+K     +     E+F  E + +
Sbjct: 6   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 65
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
            +  H ++V+L+G   E    I++ E      L  FL    ++  LD +        ++ 
Sbjct: 66  RQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFLQ--VRKFSLDLASLILYAYQLST 122
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGY 515
            + YL      R +HRD+ A N+L+ +    K+ DFG++R +  D T    S+      +
Sbjct: 123 ALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTXXKASKGKLPIKW 178
Query: 516 MAPEYAMHGQFSVKSDVYSFGVLVLEII 543
           MAPE     +F+  SDV+ FGV + EI+
Sbjct: 179 MAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 99/208 (47%), Gaps = 12/208 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQE----IAVKRLSKASGQGA-EEFKNEVVLV 395
           E+   +      +GEG FG+V++G+  S +     +A+K     +     E+F  E + +
Sbjct: 6   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 65
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
            +  H ++V+L+G   E    I++ E      L  FL    ++  LD +        ++ 
Sbjct: 66  RQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFLQ--VRKFSLDLASLILYAYQLST 122
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGY 515
            + YL      R +HRD+ A N+L+ A    K+ DFG++R +  D T    S+      +
Sbjct: 123 ALAYLESK---RFVHRDIAARNVLVSATDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKW 178
Query: 516 MAPEYAMHGQFSVKSDVYSFGVLVLEII 543
           MAPE     +F+  SDV+ FGV + EI+
Sbjct: 179 MAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 37/226 (16%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVL 394
           +TI     ++   + +G G +G V       +G  +AVK+LS+   S   A+    E+ L
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-------------LYDPEKQGQL 441
           +  ++H N++ LL              F P +SL+ F             L +  K  +L
Sbjct: 71  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 118
Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
                  +I  I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 119 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 170
Query: 502 TQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
           T    +  V T  Y APE  ++   ++   D++S G ++ E++TG+
Sbjct: 171 TDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 103/223 (46%), Gaps = 19/223 (8%)
Query: 340 IEVATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFK----NEVVL 394
           I++    F     LG+G FG+V+      + Q  A+K L K      ++ +     + VL
Sbjct: 13  IKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVL 72
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIA 454
               +H  L  +       E    V E++    L   +Y  +   + D SR       I 
Sbjct: 73  SLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRATFYAAEII 129
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR--IFGVDQTQGNTSRIVGT 512
            G+ +LH      I++RDLK  NILLD + + KI+DFGM +  + G       T+   GT
Sbjct: 130 LGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLG----DAKTNEFCGT 182
Query: 513 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTD 555
             Y+APE  +  +++   D +SFGVL+ E++ G+  S F+  D
Sbjct: 183 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ--SPFHGQD 223

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 105/215 (48%), Gaps = 32/215 (14%)
Query: 353 LGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLL----G 408
           +G G +G VYKG L   + +AVK  S A+ Q     KN +  V  ++H N+ R +     
Sbjct: 21  IGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKN-IYRVPLMEHDNIARFIVGDER 78
Query: 409 FCLEGE-EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH------ 461
              +G  E +LV E+ PN SL  +L         DW    ++   + RG+ YLH      
Sbjct: 79  VTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWVSSCRLAHSVTRGLAYLHTELPRG 134
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMA-RIFG---VDQTQGNTSRI--VGTYGY 515
           +  +  I HRDL + N+L+  +    ISDFG++ R+ G   V   + + + I  VGT  Y
Sbjct: 135 DHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRY 194
Query: 516 MAPEYAMHGQFSVKS--------DVYSFGVLVLEI 542
           MAPE  + G  +++         D+Y+ G++  EI
Sbjct: 195 MAPE-VLEGAVNLRDXESALKQVDMYALGLIYWEI 228

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 14/207 (6%)
Query: 346 KFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRL---SKASGQGAEEFKNEVVLVAKLQHR 401
           K+    K+GEG +G V+K       EI A+KR+       G  +   + E+ L+ +L+H+
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHK 61
Query: 402 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH 461
           N+VRL       ++  LV+EF       YF       G LD       +  + +G+ + H
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYF---DSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYA 521
             +   ++HRDLK  N+L++     K++DFG+AR FG+   +  ++ +V T  Y  P+  
Sbjct: 119 SRN---VLHRDLKPQNLLINRNGELKLADFGLARAFGI-PVRCYSAEVV-TLWYRPPDVL 173
Query: 522 MHGQ-FSVKSDVYSFGVLVLEIITGKK 547
              + +S   D++S G +  E+    +
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAAR 200

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 95/198 (47%), Gaps = 10/198 (5%)
Query: 353 LGEGGFGEVYKGVLPSGQEIAV-KRLSKASGQGAEE--FKNEVVLVAKLQHRNLVRLLGF 409
           +G G +G   K    S  +I V K L   S   AE+    +EV L+ +L+H N+VR    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 410 CLEGEEKIL--VYEFVPNKSLDYFLYDPEKQGQ-LDWSRRYKIIGGIARGILYLHE--DS 464
            ++     L  V E+     L   +    K+ Q LD     +++  +   +   H   D 
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG 524
              ++HRDLK +N+ LD + N K+ DFG+ARI   D +       VGT  YM+PE     
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA--FVGTPYYMSPEQMNRM 191
Query: 525 QFSVKSDVYSFGVLVLEI 542
            ++ KSD++S G L+ E+
Sbjct: 192 SYNEKSDIWSLGCLLYEL 209

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 37/226 (16%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVL 394
           +TI     ++   + +G G +G V       +G  +AVK+LS+   S   A+    E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-------------LYDPEKQGQL 441
           +  ++H N++ LL              F P +SL+ F             L +  K  +L
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
                  +I  I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 174
Query: 502 TQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
           T    +  V T  Y APE  ++   ++   D++S G ++ E++TG+
Sbjct: 175 TDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 353 LGEGGFGEVYKG-VLPSGQEIAVKRLSK---ASGQGAEEFKNEVVLVAKLQHRNLVRLLG 408
           LGEG F  V     L + +E A+K L K              E  ++++L H   V+L  
Sbjct: 18  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 76
Query: 409 FCLEGEEKILV-YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
           F  + +EK+     +  N  L  ++    K G  D +        I   + YLH      
Sbjct: 77  FTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSALEYLHGKG--- 130
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFS 527
           IIHRDLK  NILL+ +M+ +I+DFG A++   +  Q   +  VGT  Y++PE        
Sbjct: 131 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 190
Query: 528 VKSDVYSFGVLVLEIITG 545
             SD+++ G ++ +++ G
Sbjct: 191 KSSDLWALGCIIYQLVAG 208

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 72/251 (28%), Positives = 115/251 (45%), Gaps = 42/251 (16%)
Query: 313 KKYNAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEV---YKGVLPSG 369
           K YN + +S  DN   ++E     F  ++    ++     +G G  G V   Y  VL   
Sbjct: 35  KHYN-MSKSKVDNQFYSVEVGDSTFTVLK----RYQNLKPIGSGAQGIVCAAYDAVL--D 87
Query: 370 QEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKS 427
           + +A+K+LS+   +   A+    E+VL+  + H+N++ LL              F P K+
Sbjct: 88  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV------------FTPQKT 135
Query: 428 LDYF--------LYDPEK----QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKA 475
           L+ F        L D       Q +LD  R   ++  +  GI +LH      IIHRDLK 
Sbjct: 136 LEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKP 192
Query: 476 SNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSF 535
           SNI++ ++   KI DFG+AR  G   T    +  V T  Y APE  +   +    D++S 
Sbjct: 193 SNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV 249
Query: 536 GVLVLEIITGK 546
           G ++ E++  K
Sbjct: 250 GCIMGEMVRHK 260

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 110/233 (47%), Gaps = 43/233 (18%)
Query: 336 DFETIEVATNKFSTDNK------LGEGGFGEV---YKGVLPSGQEIAVKRLSKA--SGQG 384
           +F ++E+  + F+   +      +G G  G V   Y  +L   + +A+K+LS+   +   
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVVAAYDAIL--ERNVAIKKLSRPFQNQTH 66
Query: 385 AEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF--------LYDPE 436
           A+    E+VL+  + H+N++ LL              F P KSL+ F        L D  
Sbjct: 67  AKRAYRELVLMKVVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDAN 114
Query: 437 K----QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 492
                Q +LD  R   ++  +  GI +LH      IIHRDLK SNI++ ++   KI DFG
Sbjct: 115 LSQVIQMELDHERMSYLLYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFG 171
Query: 493 MARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
           +AR  G   T    +  V T  Y APE  +   +    D++S GV++ E+I G
Sbjct: 172 LARTAG---TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 95/198 (47%), Gaps = 10/198 (5%)
Query: 353 LGEGGFGEVYKGVLPSGQEIAV-KRLSKASGQGAEE--FKNEVVLVAKLQHRNLVRLLGF 409
           +G G +G   K    S  +I V K L   S   AE+    +EV L+ +L+H N+VR    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 410 CLEGEEKIL--VYEFVPNKSLDYFLYDPEKQGQ-LDWSRRYKIIGGIARGILYLHE--DS 464
            ++     L  V E+     L   +    K+ Q LD     +++  +   +   H   D 
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG 524
              ++HRDLK +N+ LD + N K+ DFG+ARI   D+        VGT  YM+PE     
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFA--KEFVGTPYYMSPEQMNRM 191
Query: 525 QFSVKSDVYSFGVLVLEI 542
            ++ KSD++S G L+ E+
Sbjct: 192 SYNEKSDIWSLGCLLYEL 209

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 37/226 (16%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVL 394
           +TI     ++   + +G G +G V       +G  +AVK+LS+   S   A+    E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-------------LYDPEKQGQL 441
           +  ++H N++ LL              F P +SL+ F             L +  K  +L
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
                  +I  I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 174
Query: 502 TQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
           T    +  V T  Y APE  ++   ++   D++S G ++ E++TG+
Sbjct: 175 TDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 353 LGEGGFGEVYKG-VLPSGQEIAVKRLSK---ASGQGAEEFKNEVVLVAKLQHRNLVRLLG 408
           LGEG F  V     L + +E A+K L K              E  ++++L H   V+L  
Sbjct: 15  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 73
Query: 409 FCLEGEEKILV-YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
           F  + +EK+     +  N  L  ++    K G  D +        I   + YLH      
Sbjct: 74  FTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSALEYLHGKG--- 127
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFS 527
           IIHRDLK  NILL+ +M+ +I+DFG A++   +  Q   +  VGT  Y++PE        
Sbjct: 128 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 187
Query: 528 VKSDVYSFGVLVLEIITG 545
             SD+++ G ++ +++ G
Sbjct: 188 KSSDLWALGCIIYQLVAG 205

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 110/230 (47%), Gaps = 32/230 (13%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY--------KGVLPSGQEIAVKRL-SKASGQGAEEFKNE 391
           E   +K +    LGEG FG+V         K        +AVK L   A+ +   +  +E
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 392 VVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL-----------YD----P 435
           + ++  + +H+N++ LLG C +     ++  +    +L  +L           YD    P
Sbjct: 91  MEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVP 150
Query: 436 EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
           E+Q  + +         +ARG+ YL   +  + IHRDL A N+L+      KI+DFG+AR
Sbjct: 151 EEQ--MTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205
Query: 496 -IFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
            I  +D  +  T+  +    +MAPE      ++ +SDV+SFGVL+ EI T
Sbjct: 206 DINNIDYYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 353 LGEGGFGEVYKG-VLPSGQEIAVKRLSK---ASGQGAEEFKNEVVLVAKLQHRNLVRLLG 408
           LGEG F  V     L + +E A+K L K              E  ++++L H   V+L  
Sbjct: 17  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 75
Query: 409 FCLEGEEKILV-YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
           F  + +EK+     +  N  L  ++    K G  D +        I   + YLH      
Sbjct: 76  FTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSALEYLHGKG--- 129
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFS 527
           IIHRDLK  NILL+ +M+ +I+DFG A++   +  Q   +  VGT  Y++PE        
Sbjct: 130 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 189
Query: 528 VKSDVYSFGVLVLEIITG 545
             SD+++ G ++ +++ G
Sbjct: 190 KSSDLWALGCIIYQLVAG 207

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 104/201 (51%), Gaps = 21/201 (10%)
Query: 353 LGEGGFGEVY--KGVLPSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLG 408
           +G+G F +V   + +L +G+E+AVK + K   +    ++   EV ++  L H N+V+L  
Sbjct: 22  IGKGNFAKVKLARHIL-TGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 409 FCLEGEEKI-LVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRL 466
             +E E+ + LV E+     + DY +      G++           I   + Y H+    
Sbjct: 81  -VIETEKTLYLVMEYASGGEVFDYLV----AHGRMKEKEARAKFRQIVSAVQYCHQKF-- 133
Query: 467 RIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT-SRIVGTYGYMAPEYAMHGQ 525
            I+HRDLKA N+LLDA+MN KI+DFG +  F    T GN      G+  Y APE     +
Sbjct: 134 -IVHRDLKAENLLLDADMNIKIADFGFSNEF----TFGNKLDTFCGSPPYAAPELFQGKK 188
Query: 526 FS-VKSDVYSFGVLVLEIITG 545
           +   + DV+S GV++  +++G
Sbjct: 189 YDGPEVDVWSLGVILYTLVSG 209

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 353 LGEGGFGEVYKG-VLPSGQEIAVKRLSK---ASGQGAEEFKNEVVLVAKLQHRNLVRLLG 408
           LGEG F  V     L + +E A+K L K              E  ++++L H   V+L  
Sbjct: 16  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 74
Query: 409 FCLEGEEKILV-YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
           F  + +EK+     +  N  L  ++    K G  D +        I   + YLH      
Sbjct: 75  FTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSALEYLHGKG--- 128
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFS 527
           IIHRDLK  NILL+ +M+ +I+DFG A++   +  Q   +  VGT  Y++PE        
Sbjct: 129 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 188
Query: 528 VKSDVYSFGVLVLEIITG 545
             SD+++ G ++ +++ G
Sbjct: 189 KSSDLWALGCIIYQLVAG 206

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 37/226 (16%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVL 394
           +TI     ++   + +G G +G V       +G  +AVK+LS+   S   A+    E+ L
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-------------LYDPEKQGQL 441
           +  ++H N++ LL              F P +SL+ F             L +  K  +L
Sbjct: 71  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 118
Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
                  +I  I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 119 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 170
Query: 502 TQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
           T    +  V T  Y APE  ++   ++   D++S G ++ E++TG+
Sbjct: 171 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 353 LGEGGFGEVYKG-VLPSGQEIAVKRLSK---ASGQGAEEFKNEVVLVAKLQHRNLVRLLG 408
           LGEG F  V     L + +E A+K L K              E  ++++L H   V+L  
Sbjct: 22  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 80
Query: 409 FCLEGEEKILV-YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
           F  + +EK+     +  N  L  ++    K G  D +        I   + YLH      
Sbjct: 81  FTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSALEYLHGKG--- 134
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFS 527
           IIHRDLK  NILL+ +M+ +I+DFG A++   +  Q   +  VGT  Y++PE        
Sbjct: 135 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 194
Query: 528 VKSDVYSFGVLVLEIITG 545
             SD+++ G ++ +++ G
Sbjct: 195 KSSDLWALGCIIYQLVAG 212

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 101/215 (46%), Gaps = 26/215 (12%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQE----IAVKRLSKASGQGA-EEFKNEVVLV 395
           E+   +      +GEG FG+V++G+  S +     +A+K     +     E+F  E + +
Sbjct: 6   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 65
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
            +  H ++V+L+G   E    I++ E      L  FL            R+Y +   +A 
Sbjct: 66  RQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFLQ----------VRKYSL--DLAS 112
Query: 456 GILYLHEDSRL-------RIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR 508
            ILY ++ S         R +HRD+ A N+L+ +    K+ DFG++R +  D T    S+
Sbjct: 113 LILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASK 171
Query: 509 IVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEII 543
                 +MAPE     +F+  SDV+ FGV + EI+
Sbjct: 172 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 353 LGEGGFGEVYKG-VLPSGQEIAVKRLSK---ASGQGAEEFKNEVVLVAKLQHRNLVRLLG 408
           LGEG F  V     L + +E A+K L K              E  ++++L H   V+L  
Sbjct: 37  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 95
Query: 409 FCLEGEEKILV-YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
           F  + +EK+     +  N  L  ++    K G  D +        I   + YLH      
Sbjct: 96  FTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSALEYLHGKG--- 149
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFS 527
           IIHRDLK  NILL+ +M+ +I+DFG A++   +  Q   +  VGT  Y++PE        
Sbjct: 150 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAC 209
Query: 528 VKSDVYSFGVLVLEIITG 545
             SD+++ G ++ +++ G
Sbjct: 210 KSSDLWALGCIIYQLVAG 227

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 101/215 (46%), Gaps = 26/215 (12%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQE----IAVKRLSKASGQGA-EEFKNEVVLV 395
           E+   +      +GEG FG+V++G+  S +     +A+K     +     E+F  E + +
Sbjct: 6   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 65
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
            +  H ++V+L+G   E    I++ E      L  FL            R+Y +   +A 
Sbjct: 66  RQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFLQ----------VRKYSL--DLAS 112
Query: 456 GILYLHEDSRL-------RIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR 508
            ILY ++ S         R +HRD+ A N+L+ +    K+ DFG++R +  D T    S+
Sbjct: 113 LILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASK 171
Query: 509 IVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEII 543
                 +MAPE     +F+  SDV+ FGV + EI+
Sbjct: 172 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 104/201 (51%), Gaps = 21/201 (10%)
Query: 353 LGEGGFGEVY--KGVLPSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLG 408
           +G+G F +V   + +L +G+E+AVK + K   +    ++   EV ++  L H N+V+L  
Sbjct: 22  IGKGNFAKVKLARHIL-TGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 409 FCLEGEEKI-LVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRL 466
             +E E+ + LV E+     + DY +      G++           I   + Y H+    
Sbjct: 81  -VIETEKTLYLVMEYASGGEVFDYLV----AHGRMKEKEARAKFRQIVSAVQYCHQKF-- 133
Query: 467 RIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT-SRIVGTYGYMAPEYAMHGQ 525
            I+HRDLKA N+LLDA+MN KI+DFG +  F    T GN      G+  Y APE     +
Sbjct: 134 -IVHRDLKAENLLLDADMNIKIADFGFSNEF----TFGNKLDTFCGSPPYAAPELFQGKK 188
Query: 526 FS-VKSDVYSFGVLVLEIITG 545
           +   + DV+S GV++  +++G
Sbjct: 189 YDGPEVDVWSLGVILYTLVSG 209

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 353 LGEGGFGEVYKG-VLPSGQEIAVKRLSK---ASGQGAEEFKNEVVLVAKLQHRNLVRLLG 408
           LGEG F  V     L + +E A+K L K              E  ++++L H   V+L  
Sbjct: 37  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 95
Query: 409 FCLEGEEKILV-YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
           F  + +EK+     +  N  L  ++    K G  D +        I   + YLH      
Sbjct: 96  FTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSALEYLHGKG--- 149
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFS 527
           IIHRDLK  NILL+ +M+ +I+DFG A++   +  Q   +  VGT  Y++PE        
Sbjct: 150 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 209
Query: 528 VKSDVYSFGVLVLEIITG 545
             SD+++ G ++ +++ G
Sbjct: 210 KSSDLWALGCIIYQLVAG 227

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 101/215 (46%), Gaps = 26/215 (12%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQE----IAVKRLSKASGQGA-EEFKNEVVLV 395
           E+   +      +GEG FG+V++G+  S +     +A+K     +     E+F  E + +
Sbjct: 34  EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 93
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
            +  H ++V+L+G   E    I++ E      L  FL            R+Y +   +A 
Sbjct: 94  RQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFLQ----------VRKYSL--DLAS 140
Query: 456 GILYLHEDSRL-------RIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR 508
            ILY ++ S         R +HRD+ A N+L+ +    K+ DFG++R +  D T    S+
Sbjct: 141 LILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASK 199
Query: 509 IVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEII 543
                 +MAPE     +F+  SDV+ FGV + EI+
Sbjct: 200 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 234

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 353 LGEGGFGEVYKG-VLPSGQEIAVKRLSK---ASGQGAEEFKNEVVLVAKLQHRNLVRLLG 408
           LGEG F  V     L + +E A+K L K              E  ++++L H   V+L  
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 96
Query: 409 FCLEGEEKILV-YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
           F  + +EK+     +  N  L  ++    K G  D +        I   + YLH      
Sbjct: 97  FTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSALEYLHGKG--- 150
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFS 527
           IIHRDLK  NILL+ +M+ +I+DFG A++   +  Q   +  VGT  Y++PE        
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 210
Query: 528 VKSDVYSFGVLVLEIITG 545
             SD+++ G ++ +++ G
Sbjct: 211 KSSDLWALGCIIYQLVAG 228

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 37/226 (16%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVL 394
           +TI     ++   + +G G +G V       +G  +AVK+LS+   S   A+    E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-------------LYDPEKQGQL 441
           +  ++H N++ LL              F P +SL+ F             L +  K  +L
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
                  +I  I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 174
Query: 502 TQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
           T    +  V T  Y APE  ++   ++   D++S G ++ E++TG+
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 94/198 (47%), Gaps = 12/198 (6%)
Query: 353 LGEGGFGEVYKGVLPSGQEIAVKRLSKAS----GQGAEEFKNEVVLVAKLQHRNLVRLLG 408
           LG+GGF + ++      +E+   ++   S        E+   E+ +   L H+++V   G
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 409 FCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRI 468
           F  + +   +V E    +SL   L+   K      +R Y  +  I  G  YLH   R R+
Sbjct: 89  FFEDNDFVFVVLELCRRRSL-LELHKRRKALTEPEARYY--LRQIVLGCQYLH---RNRV 142
Query: 469 IHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSV 528
           IHRDLK  N+ L+ ++  KI DFG+A     D  +  T  + GT  Y+APE       S 
Sbjct: 143 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHSF 200
Query: 529 KSDVYSFGVLVLEIITGK 546
           + DV+S G ++  ++ GK
Sbjct: 201 EVDVWSIGCIMYTLLVGK 218

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 105/228 (46%), Gaps = 41/228 (17%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVL 394
           +TI     ++   + +G G +G V       +G  +AVK+LS+   S   A+    E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-------------LYDPEKQGQL 441
           +  ++H N++ LL              F P +SL+ F             L +  K  +L
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
                  +I  I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 174
Query: 502 TQGNTSRIVGTYGYMAPEY---AMHGQFSVKSDVYSFGVLVLEIITGK 546
           T    +  V T  Y APE    AMH   +V  D++S G ++ E++TG+
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNAMHYNQTV--DIWSVGCIMAELLTGR 220

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 108/233 (46%), Gaps = 43/233 (18%)
Query: 337 FETIEVATNKFSTDNK------LGEGGFGEV---YKGVLPSGQEIAVKRLSKA--SGQGA 385
           F ++EV  + F+   +      +G G  G V   Y  VL   + +A+K+LS+   +   A
Sbjct: 10  FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHA 67
Query: 386 EEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF--------LYDPEK 437
           +    E+VL+  + H+N++ LL              F P K+L+ F        L D   
Sbjct: 68  KRAYRELVLMKXVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANL 115
Query: 438 ----QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493
               Q +LD  R   ++  +  GI +LH      IIHRDLK SNI++ ++   KI DFG+
Sbjct: 116 XQVIQMELDHERMSYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGL 172
Query: 494 ARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
           AR  G   T    +  V T  Y APE  +   +    D++S G ++ E++  K
Sbjct: 173 ARTAG---TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 99/208 (47%), Gaps = 22/208 (10%)
Query: 347 FSTDNKLGEGGFGEVYKGVLP----SGQEIAVKRLSKASGQGAEE-FKNEVVLVAKLQHR 401
           F     LG G F EV   VL     +G+  AVK + K + +G E   +NE+ ++ K++H 
Sbjct: 24  FEFKETLGTGAFSEV---VLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHE 80
Query: 402 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH 461
           N+V L           LV + V    L   + +     + D S    +I  +   + YLH
Sbjct: 81  NIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDAST---LIRQVLDAVYYLH 137
Query: 462 EDSRLRIIHRDLKASNILL---DAEMNPKISDFGMARIFGVDQTQGNT-SRIVGTYGYMA 517
              R+ I+HRDLK  N+L    D E    ISDFG++++ G    +G+  S   GT GY+A
Sbjct: 138 ---RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEG----KGDVMSTACGTPGYVA 190
Query: 518 PEYAMHGQFSVKSDVYSFGVLVLEIITG 545
           PE      +S   D +S GV+   ++ G
Sbjct: 191 PEVLAQKPYSKAVDCWSIGVIAYILLCG 218

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 353 LGEGGFGEVYKG-VLPSGQEIAVKRLSK---ASGQGAEEFKNEVVLVAKLQHRNLVRLLG 408
           LGEG F  V     L + +E A+K L K              E  ++++L H   V+L  
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 98
Query: 409 FCLEGEEKILV-YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
           F  + +EK+     +  N  L  ++    K G  D +        I   + YLH      
Sbjct: 99  FTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSALEYLHGKG--- 152
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFS 527
           IIHRDLK  NILL+ +M+ +I+DFG A++   +  Q   +  VGT  Y++PE        
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 212
Query: 528 VKSDVYSFGVLVLEIITG 545
             SD+++ G ++ +++ G
Sbjct: 213 KSSDLWALGCIIYQLVAG 230

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 71/234 (30%), Positives = 108/234 (46%), Gaps = 41/234 (17%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKG--VLPSGQEIAVKRLSKASGQGAEEFKNEVV 393
           DFE I V          LG+G FG+V K    L S +  A+K++ + + +      +EV+
Sbjct: 7   DFEEIAV----------LGQGAFGQVVKARNALDS-RYYAIKKI-RHTEEKLSTILSEVM 54
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKS-----LDY----FLYDPEKQGQLDWS 444
           L+A L H+ +VR     LE    +     V  KS     ++Y     LYD      L+  
Sbjct: 55  LLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQ 114
Query: 445 RR--YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR------- 495
           R   +++   I   + Y+H      IIHRDLK  NI +D   N KI DFG+A+       
Sbjct: 115 RDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLD 171
Query: 496 IFGVDQ-----TQGNTSRIVGTYGYMAPEYAM-HGQFSVKSDVYSFGVLVLEII 543
           I  +D      +  N +  +GT  Y+A E     G ++ K D+YS G++  E+I
Sbjct: 172 ILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 94/198 (47%), Gaps = 12/198 (6%)
Query: 353 LGEGGFGEVYKGVLPSGQEIAVKRLSKAS----GQGAEEFKNEVVLVAKLQHRNLVRLLG 408
           LG+GGF + ++      +E+   ++   S        E+   E+ +   L H+++V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 409 FCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRI 468
           F  + +   +V E    +SL   L+   K      +R Y  +  I  G  YLH   R R+
Sbjct: 85  FFEDNDFVFVVLELCRRRSL-LELHKRRKALTEPEARYY--LRQIVLGCQYLH---RNRV 138
Query: 469 IHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSV 528
           IHRDLK  N+ L+ ++  KI DFG+A     D  +  T  + GT  Y+APE       S 
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHSF 196
Query: 529 KSDVYSFGVLVLEIITGK 546
           + DV+S G ++  ++ GK
Sbjct: 197 EVDVWSIGCIMYTLLVGK 214

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 353 LGEGGFGE-VYKGVLPSGQEIAVKRLSK---ASGQGAEEFKNEVVLVAKLQHRNLVRLLG 408
           LGEG F   V    L + +E A+K L K              E  ++++L H   V+L  
Sbjct: 38  LGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 96
Query: 409 FCLEGEEKILV-YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
           F  + +EK+     +  N  L  ++    K G  D +        I   + YLH      
Sbjct: 97  FTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSALEYLHGKG--- 150
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFS 527
           IIHRDLK  NILL+ +M+ +I+DFG A++   +  Q   +  VGT  Y++PE        
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 210
Query: 528 VKSDVYSFGVLVLEIITG 545
             SD+++ G ++ +++ G
Sbjct: 211 KSSDLWALGCIIYQLVAG 228

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 94/198 (47%), Gaps = 12/198 (6%)
Query: 353 LGEGGFGEVYKGVLPSGQEIAVKRLSKAS----GQGAEEFKNEVVLVAKLQHRNLVRLLG 408
           LG+GGF + ++      +E+   ++   S        E+   E+ +   L H+++V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 409 FCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRI 468
           F  + +   +V E    +SL   L+   K      +R Y  +  I  G  YLH   R R+
Sbjct: 85  FFEDNDFVFVVLELCRRRSL-LELHKRRKALTEPEARYY--LRQIVLGCQYLH---RNRV 138
Query: 469 IHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSV 528
           IHRDLK  N+ L+ ++  KI DFG+A     D  +  T  + GT  Y+APE       S 
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHSF 196
Query: 529 KSDVYSFGVLVLEIITGK 546
           + DV+S G ++  ++ GK
Sbjct: 197 EVDVWSIGCIMYTLLVGK 214

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 353 LGEGGFGEVYKG-VLPSGQEIAVKRLSK---ASGQGAEEFKNEVVLVAKLQHRNLVRLLG 408
           LGEG F  V     L + +E A+K L K              E  ++++L H   V+L  
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 96
Query: 409 FCLEGEEKILV-YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
           F  + +EK+     +  N  L  ++    K G  D +        I   + YLH      
Sbjct: 97  FTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSALEYLHGKG--- 150
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFS 527
           IIHRDLK  NILL+ +M+ +I+DFG A++   +  Q   +  VGT  Y++PE        
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 210
Query: 528 VKSDVYSFGVLVLEIITG 545
             SD+++ G ++ +++ G
Sbjct: 211 KSSDLWALGCIIYQLVAG 228

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 37/226 (16%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVL 394
           +TI     ++   + +G G +G V       +G  +AVK+LS+   S   A+    E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-------------LYDPEKQGQL 441
           +  ++H N++ LL              F P +SL+ F             L +  K  +L
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKXQKL 122
Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
                  +I  I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR-----H 174
Query: 502 TQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
           T    +  V T  Y APE  ++   ++   D++S G ++ E++TG+
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 353 LGEGGFGEVYKG-VLPSGQEIAVKRLSK---ASGQGAEEFKNEVVLVAKLQHRNLVRLLG 408
           LGEG F  V     L + +E A+K L K              E  ++++L H   V+L  
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 98
Query: 409 FCLEGEEKILV-YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
           F  + +EK+     +  N  L  ++    K G  D +        I   + YLH      
Sbjct: 99  FTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSALEYLHGKG--- 152
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFS 527
           IIHRDLK  NILL+ +M+ +I+DFG A++   +  Q   +  VGT  Y++PE        
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 212
Query: 528 VKSDVYSFGVLVLEIITG 545
             SD+++ G ++ +++ G
Sbjct: 213 KSSDLWALGCIIYQLVAG 230

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 353 LGEGGFGEVYKG-VLPSGQEIAVKRLSK---ASGQGAEEFKNEVVLVAKLQHRNLVRLLG 408
           LGEG F  V     L + +E A+K L K              E  ++++L H   V+L  
Sbjct: 41  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 99
Query: 409 FCLEGEEKILV-YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
           F  + +EK+     +  N  L  ++    K G  D +        I   + YLH      
Sbjct: 100 FTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSALEYLHGKG--- 153
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFS 527
           IIHRDLK  NILL+ +M+ +I+DFG A++   +  Q   +  VGT  Y++PE        
Sbjct: 154 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 213
Query: 528 VKSDVYSFGVLVLEIITG 545
             SD+++ G ++ +++ G
Sbjct: 214 KSSDLWALGCIIYQLVAG 231

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 37/226 (16%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVL 394
           +TI     ++   + +G G +G V       +G  +AVK+LS+   S   A+    E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-------------LYDPEKQGQL 441
           +  ++H N++ LL              F P +SL+ F             L +  K  +L
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKXQKL 122
Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
                  +I  I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 174
Query: 502 TQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
           T    +  V T  Y APE  ++   ++   D++S G ++ E++TG+
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 353 LGEGGFGEVYKG-VLPSGQEIAVKRLSK---ASGQGAEEFKNEVVLVAKLQHRNLVRLLG 408
           LGEG F  V     L + +E A+K L K              E  ++++L H   V+L  
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 96
Query: 409 FCLEGEEKILV-YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
           F  + +EK+     +  N  L  ++    K G  D +        I   + YLH      
Sbjct: 97  FTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSALEYLHGKG--- 150
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFS 527
           IIHRDLK  NILL+ +M+ +I+DFG A++   +  Q   +  VGT  Y++PE        
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEKSAC 210
Query: 528 VKSDVYSFGVLVLEIITG 545
             SD+++ G ++ +++ G
Sbjct: 211 KSSDLWALGCIIYQLVAG 228

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 353 LGEGGFGEVYKG-VLPSGQEIAVKRLSK---ASGQGAEEFKNEVVLVAKLQHRNLVRLLG 408
           LGEG F  V     L + +E A+K L K              E  ++++L H   V+L  
Sbjct: 41  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 99
Query: 409 FCLEGEEKILV-YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
           F  + +EK+     +  N  L  ++    K G  D +        I   + YLH      
Sbjct: 100 FTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSALEYLHGKG--- 153
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFS 527
           IIHRDLK  NILL+ +M+ +I+DFG A++   +  Q   +  VGT  Y++PE        
Sbjct: 154 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAC 213
Query: 528 VKSDVYSFGVLVLEIITG 545
             SD+++ G ++ +++ G
Sbjct: 214 KSSDLWALGCIIYQLVAG 231

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 101/215 (46%), Gaps = 26/215 (12%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQE----IAVKRLSKASGQGA-EEFKNEVVLV 395
           E+   +      +GEG FG+V++G+  S +     +A+K     +     E+F  E + +
Sbjct: 3   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 62
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
            +  H ++V+L+G   E    I++ E      L  FL            R+Y +   +A 
Sbjct: 63  RQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFLQ----------VRKYSL--DLAS 109
Query: 456 GILYLHEDSRL-------RIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR 508
            ILY ++ S         R +HRD+ A N+L+ +    K+ DFG++R +  D T    S+
Sbjct: 110 LILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASK 168
Query: 509 IVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEII 543
                 +MAPE     +F+  SDV+ FGV + EI+
Sbjct: 169 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 203

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 108/204 (52%), Gaps = 27/204 (13%)
Query: 353 LGEGGFGEVY--KGVLPSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLG 408
           +G+G F +V   + +L +G+E+AVK + K   +    ++   EV ++  L H N+V+L  
Sbjct: 15  IGKGNFAKVKLARHIL-TGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 73
Query: 409 FCLEGEEKI-LVYEFVPN-KSLDYFL---YDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
             +E E+ + LV E+    +  DY +   +  EK+ +  + +       I   + Y H+ 
Sbjct: 74  -VIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQ-------IVSAVQYCHQK 125
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT-SRIVGTYGYMAPEYAM 522
               I+HRDLKA N+LLDA+MN KI+DFG +  F    T GN      G+  Y APE   
Sbjct: 126 F---IVHRDLKAENLLLDADMNIKIADFGFSNEF----TFGNKLDTFCGSPPYAAPELFQ 178
Query: 523 HGQFS-VKSDVYSFGVLVLEIITG 545
             ++   + DV+S GV++  +++G
Sbjct: 179 GKKYDGPEVDVWSLGVILYTLVSG 202

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 353 LGEGGFGEVYKG-VLPSGQEIAVKRLSK---ASGQGAEEFKNEVVLVAKLQHRNLVRLLG 408
           LGEG F  V     L + +E A+K L K              E  ++++L H   V+L  
Sbjct: 43  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 101
Query: 409 FCLEGEEKILV-YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
           F  + +EK+     +  N  L  ++    K G  D +        I   + YLH      
Sbjct: 102 FTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSALEYLHGKG--- 155
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFS 527
           IIHRDLK  NILL+ +M+ +I+DFG A++   +  Q   +  VGT  Y++PE        
Sbjct: 156 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 215
Query: 528 VKSDVYSFGVLVLEIITG 545
             SD+++ G ++ +++ G
Sbjct: 216 KSSDLWALGCIIYQLVAG 233

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 104/201 (51%), Gaps = 21/201 (10%)
Query: 353 LGEGGFGEVY--KGVLPSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLG 408
           +G+G F +V   + +L +G+E+AV+ + K   +    ++   EV ++  L H N+V+L  
Sbjct: 22  IGKGNFAKVKLARHIL-TGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 409 FCLEGEEKI-LVYEFVPN-KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRL 466
             +E E+ + LV E+    +  DY +      G++           I   + Y H+    
Sbjct: 81  -VIETEKTLYLVMEYASGGEVFDYLV----AHGRMKEKEARAKFRQIVSAVQYCHQKF-- 133
Query: 467 RIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT-SRIVGTYGYMAPEYAMHGQ 525
            I+HRDLKA N+LLDA+MN KI+DFG +  F    T GN      G+  Y APE     +
Sbjct: 134 -IVHRDLKAENLLLDADMNIKIADFGFSNEF----TFGNKLDEFCGSPPYAAPELFQGKK 188
Query: 526 FS-VKSDVYSFGVLVLEIITG 545
           +   + DV+S GV++  +++G
Sbjct: 189 YDGPEVDVWSLGVILYTLVSG 209

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 353 LGEGGFGEVYKG-VLPSGQEIAVKRLSK---ASGQGAEEFKNEVVLVAKLQHRNLVRLLG 408
           LGEG F  V     L + +E A+K L K              E  ++++L H   V+L  
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 98
Query: 409 FCLEGEEKILV-YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
           F  + +EK+     +  N  L  ++    K G  D +        I   + YLH      
Sbjct: 99  FTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSALEYLHGKG--- 152
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFS 527
           IIHRDLK  NILL+ +M+ +I+DFG A++   +  Q   +  VGT  Y++PE        
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 212
Query: 528 VKSDVYSFGVLVLEIITG 545
             SD+++ G ++ +++ G
Sbjct: 213 KSSDLWALGCIIYQLVAG 230

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 101/215 (46%), Gaps = 26/215 (12%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQE----IAVKRLSKASGQGA-EEFKNEVVLV 395
           E+   +      +GEG FG+V++G+  S +     +A+K     +     E+F  E + +
Sbjct: 11  EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 70
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
            +  H ++V+L+G   E    I++ E      L  FL            R+Y +   +A 
Sbjct: 71  RQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFLQ----------VRKYSL--DLAS 117
Query: 456 GILYLHEDSRL-------RIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR 508
            ILY ++ S         R +HRD+ A N+L+ +    K+ DFG++R +  D T    S+
Sbjct: 118 LILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASK 176
Query: 509 IVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEII 543
                 +MAPE     +F+  SDV+ FGV + EI+
Sbjct: 177 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 211

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 104/226 (46%), Gaps = 37/226 (16%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVL 394
           +TI     ++   + +G G +G V       +G  +AVK+LSK   S   A+    E+ L
Sbjct: 27  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRL 86
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-------------LYDPEKQGQL 441
           +  ++H N++ LL              F P +SL+ F             L +  K  +L
Sbjct: 87  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 134
Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
                  +I  I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 135 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 186
Query: 502 TQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
           T    +  V T  Y APE  ++   ++   D++S G ++ E++TG+
Sbjct: 187 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 101/215 (46%), Gaps = 26/215 (12%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQE----IAVKRLSKASGQGA-EEFKNEVVLV 395
           E+   +      +GEG FG+V++G+  S +     +A+K     +     E+F  E + +
Sbjct: 8   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 67
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
            +  H ++V+L+G   E    I++ E      L  FL            R+Y +   +A 
Sbjct: 68  RQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFLQ----------VRKYSL--DLAS 114
Query: 456 GILYLHEDSRL-------RIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR 508
            ILY ++ S         R +HRD+ A N+L+ +    K+ DFG++R +  D T    S+
Sbjct: 115 LILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASK 173
Query: 509 IVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEII 543
                 +MAPE     +F+  SDV+ FGV + EI+
Sbjct: 174 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 208

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 37/226 (16%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVL 394
           +TI     ++   + +G G +G V       +G  +AVK+LS+   S   A+    E+ L
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 80
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-------------LYDPEKQGQL 441
           +  ++H N++ LL              F P +SL+ F             L +  K  +L
Sbjct: 81  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 128
Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
                  +I  I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 129 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 180
Query: 502 TQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
           T    +  V T  Y APE  ++   ++   D++S G ++ E++TG+
Sbjct: 181 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 99/199 (49%), Gaps = 16/199 (8%)
Query: 353 LGEGGFGEVYKGVLPSGQE-IAVKRLSKASGQGAE-EFKNEVVLVAKLQHRNLVRLLGFC 410
           LG G F EV        Q+ +A+K ++K + +G E   +NE+ ++ K++H N+V L    
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 411 LEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIH 470
             G    L+ + V    L   + +     + D SR   +I  +   + YLH+   L I+H
Sbjct: 86  ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LIFQVLDAVKYLHD---LGIVH 139
Query: 471 RDLKASNIL---LDAEMNPKISDFGMARIFGVDQTQGNT-SRIVGTYGYMAPEYAMHGQF 526
           RDLK  N+L   LD +    ISDFG++++    +  G+  S   GT GY+APE      +
Sbjct: 140 RDLKPENLLYYSLDEDSKIMISDFGLSKM----EDPGSVLSTACGTPGYVAPEVLAQKPY 195
Query: 527 SVKSDVYSFGVLVLEIITG 545
           S   D +S GV+   ++ G
Sbjct: 196 SKAVDCWSIGVIAYILLCG 214

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 72/251 (28%), Positives = 115/251 (45%), Gaps = 42/251 (16%)
Query: 313 KKYNAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEV---YKGVLPSG 369
           K YN + +S  DN   ++E     F  ++    ++     +G G  G V   Y  VL   
Sbjct: 35  KHYN-MSKSKVDNQFYSVEVGDSTFTVLK----RYQNLKPIGSGAQGIVCAAYDAVL--D 87
Query: 370 QEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKS 427
           + +A+K+LS+   +   A+    E+VL+  + H+N++ LL              F P K+
Sbjct: 88  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV------------FTPQKT 135
Query: 428 LDYF--------LYDPEK----QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKA 475
           L+ F        L D       Q +LD  R   ++  +  GI +LH      IIHRDLK 
Sbjct: 136 LEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKP 192
Query: 476 SNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSF 535
           SNI++ ++   KI DFG+AR  G   T    +  V T  Y APE  +   +    D++S 
Sbjct: 193 SNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV 249
Query: 536 GVLVLEIITGK 546
           G ++ E++  K
Sbjct: 250 GCIMGEMVRHK 260

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 99/199 (49%), Gaps = 16/199 (8%)
Query: 353 LGEGGFGEVYKGVLPSGQE-IAVKRLSKASGQGAE-EFKNEVVLVAKLQHRNLVRLLGFC 410
           LG G F EV        Q+ +A+K ++K + +G E   +NE+ ++ K++H N+V L    
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 411 LEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIH 470
             G    L+ + V    L   + +     + D SR   +I  +   + YLH+   L I+H
Sbjct: 86  ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LIFQVLDAVKYLHD---LGIVH 139
Query: 471 RDLKASNIL---LDAEMNPKISDFGMARIFGVDQTQGNT-SRIVGTYGYMAPEYAMHGQF 526
           RDLK  N+L   LD +    ISDFG++++    +  G+  S   GT GY+APE      +
Sbjct: 140 RDLKPENLLYYSLDEDSKIMISDFGLSKM----EDPGSVLSTACGTPGYVAPEVLAQKPY 195
Query: 527 SVKSDVYSFGVLVLEIITG 545
           S   D +S GV+   ++ G
Sbjct: 196 SKAVDCWSIGVIAYILLCG 214

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 103/201 (51%), Gaps = 21/201 (10%)
Query: 353 LGEGGFGEVY--KGVLPSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLG 408
           +G+G F +V   + +L +G+E+AVK + K   +    ++   EV ++  L H N+V+L  
Sbjct: 22  IGKGNFAKVKLARHIL-TGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 409 FCLEGEEKI-LVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRL 466
             +E E+ + LV E+     + DY +      G++           I   + Y H+    
Sbjct: 81  -VIETEKTLYLVMEYASGGEVFDYLV----AHGRMKEKEARAKFRQIVSAVQYCHQKF-- 133
Query: 467 RIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT-SRIVGTYGYMAPEYAMHGQ 525
            I+HRDLKA N+LLDA+MN KI+DFG +  F    T GN      G   Y APE     +
Sbjct: 134 -IVHRDLKAENLLLDADMNIKIADFGFSNEF----TFGNKLDAFCGAPPYAAPELFQGKK 188
Query: 526 FS-VKSDVYSFGVLVLEIITG 545
           +   + DV+S GV++  +++G
Sbjct: 189 YDGPEVDVWSLGVILYTLVSG 209

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 109/233 (46%), Gaps = 43/233 (18%)
Query: 336 DFETIEVATNKFSTDNK------LGEGGFGEV---YKGVLPSGQEIAVKRLSKA--SGQG 384
           +F ++E+  + F+   +      +G G  G V   Y  +L   + +A+K+LS+   +   
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTH 66
Query: 385 AEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF--------LYDPE 436
           A+    E+VL+  + H+N++ LL              F P KSL+ F        L D  
Sbjct: 67  AKRAYRELVLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDAN 114
Query: 437 K----QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 492
                Q +LD  R   ++  +  GI +LH      IIHRDLK SNI++ ++   KI DFG
Sbjct: 115 LCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 171
Query: 493 MARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
           +AR  G       T  +V  Y Y APE  +   +    D++S G ++ E+I G
Sbjct: 172 LARTAGTSFMM--TPEVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/234 (30%), Positives = 108/234 (46%), Gaps = 41/234 (17%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKG--VLPSGQEIAVKRLSKASGQGAEEFKNEVV 393
           DFE I V          LG+G FG+V K    L S +  A+K++ + + +      +EV+
Sbjct: 7   DFEEIAV----------LGQGAFGQVVKARNALDS-RYYAIKKI-RHTEEKLSTILSEVM 54
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKS-----LDY----FLYDPEKQGQLDWS 444
           L+A L H+ +VR     LE    +     V  KS     ++Y     LYD      L+  
Sbjct: 55  LLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQ 114
Query: 445 RR--YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR------- 495
           R   +++   I   + Y+H      IIHRDLK  NI +D   N KI DFG+A+       
Sbjct: 115 RDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLD 171
Query: 496 IFGVDQ-----TQGNTSRIVGTYGYMAPEYA-MHGQFSVKSDVYSFGVLVLEII 543
           I  +D      +  N +  +GT  Y+A E     G ++ K D+YS G++  E+I
Sbjct: 172 ILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 37/226 (16%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVL 394
           +TI     ++   + +G G +G V       +G  +AVK+LS+   S   A+    E+ L
Sbjct: 20  KTIWEVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 79
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-------------LYDPEKQGQL 441
           +  ++H N++ LL              F P +SL+ F             L +  K  +L
Sbjct: 80  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 127
Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
                  +I  I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 128 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR-----H 179
Query: 502 TQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
           T    +  V T  Y APE  ++   ++   D++S G ++ E++TG+
Sbjct: 180 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 103/223 (46%), Gaps = 19/223 (8%)
Query: 340 IEVATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFK----NEVVL 394
           I++    F     LG+G FG+V+      + Q  A+K L K      ++ +     + VL
Sbjct: 12  IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVL 71
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIA 454
               +H  L  +       E    V E++    L   +Y  +   + D SR       I 
Sbjct: 72  SLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRATFYAAEII 128
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR--IFGVDQTQGNTSRIVGT 512
            G+ +LH      I++RDLK  NILLD + + KI+DFGM +  + G       T+   GT
Sbjct: 129 LGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLG----DAKTNXFCGT 181
Query: 513 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTD 555
             Y+APE  +  +++   D +SFGVL+ E++ G+  S F+  D
Sbjct: 182 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ--SPFHGQD 222

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 353 LGEGGFGEVYKG-VLPSGQEIAVKRLSK---ASGQGAEEFKNEVVLVAKLQHRNLVRLLG 408
           LGEG F  V     L + +E A+K L K              E  ++++L H   V+L  
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 98
Query: 409 FCLEGEEKILV-YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
           F  + +EK+     +  N  L  ++    K G  D +        I   + YLH      
Sbjct: 99  FTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSALEYLHGKG--- 152
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFS 527
           IIHRDLK  NILL+ +M+ +I+DFG A++   +  Q   +  VGT  Y++PE        
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 212
Query: 528 VKSDVYSFGVLVLEIITG 545
             SD+++ G ++ +++ G
Sbjct: 213 KSSDLWALGCIIYQLVAG 230

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 101/215 (46%), Gaps = 26/215 (12%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQE----IAVKRLSKASGQGA-EEFKNEVVLV 395
           E+   +      +GEG FG+V++G+  S +     +A+K     +     E+F  E + +
Sbjct: 9   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 68
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
            +  H ++V+L+G   E    I++ E      L  FL            R+Y +   +A 
Sbjct: 69  RQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFLQ----------VRKYSL--DLAS 115
Query: 456 GILYLHEDSRL-------RIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR 508
            ILY ++ S         R +HRD+ A N+L+ +    K+ DFG++R +  D T    S+
Sbjct: 116 LILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASK 174
Query: 509 IVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEII 543
                 +MAPE     +F+  SDV+ FGV + EI+
Sbjct: 175 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 209

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 108/240 (45%), Gaps = 13/240 (5%)
Query: 311 AKKKYNAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQ 370
           A  K +A P ++ D     L+ +  D         ++     LG+GGF + Y+      +
Sbjct: 9   AIAKPSAKPSAHVDPKSAPLKEIP-DVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTK 67
Query: 371 EIAVKRLSKAS----GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNK 426
           E+   ++   S        E+   E+ +   L + ++V   GF  + +   +V E    +
Sbjct: 68  EVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRR 127
Query: 427 SLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP 486
           SL        ++   +   RY +   I +G+ YLH +   R+IHRDLK  N+ L+ +M+ 
Sbjct: 128 SL--LELHKRRKAVTEPEARYFMRQTI-QGVQYLHNN---RVIHRDLKLGNLFLNDDMDV 181
Query: 487 KISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
           KI DFG+A     D  +     + GT  Y+APE       S + D++S G ++  ++ GK
Sbjct: 182 KIGDFGLATKIEFDGERKKX--LCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 353 LGEGGFGEVYKG-VLPSGQEIAVKRLSK---ASGQGAEEFKNEVVLVAKLQHRNLVRLLG 408
           LGEG F  V     L + +E A+K L K              E  ++++L H   V+L  
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 98
Query: 409 FCLEGEEKILV-YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
           F  + +EK+     +  N  L  ++    K G  D +        I   + YLH      
Sbjct: 99  FTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSALEYLHGKG--- 152
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFS 527
           IIHRDLK  NILL+ +M+ +I+DFG A++   +  Q   +  VGT  Y++PE        
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAX 212
Query: 528 VKSDVYSFGVLVLEIITG 545
             SD+++ G ++ +++ G
Sbjct: 213 KSSDLWALGCIIYQLVAG 230

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 37/226 (16%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVL 394
           +TI     ++   + +G G +G V       +G  +AVK+LS+   S   A+    E+ L
Sbjct: 34  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 93
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-------------LYDPEKQGQL 441
           +  ++H N++ LL              F P +SL+ F             L +  K  +L
Sbjct: 94  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 141
Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
                  +I  I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 142 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 193
Query: 502 TQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
           T    +  V T  Y APE  ++   ++   D++S G ++ E++TG+
Sbjct: 194 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 108/233 (46%), Gaps = 43/233 (18%)
Query: 337 FETIEVATNKFSTDNK------LGEGGFGEV---YKGVLPSGQEIAVKRLSKA--SGQGA 385
           F ++EV  + F+   +      +G G  G V   Y  VL   + +A+K+LS+   +   A
Sbjct: 10  FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHA 67
Query: 386 EEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF--------LYDPEK 437
           +    E+VL+  + H+N++ LL              F P K+L+ F        L D   
Sbjct: 68  KRAYRELVLMKXVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANL 115
Query: 438 ----QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493
               Q +LD  R   ++  +  GI +LH      IIHRDLK SNI++ ++   KI DFG+
Sbjct: 116 CQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGL 172
Query: 494 ARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
           AR  G   T    +  V T  Y APE  +   +    D++S G ++ E++  K
Sbjct: 173 ARTAG---TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 99/199 (49%), Gaps = 16/199 (8%)
Query: 353 LGEGGFGEVYKGVLPSGQE-IAVKRLSKASGQGAE-EFKNEVVLVAKLQHRNLVRLLGFC 410
           LG G F EV        Q+ +A+K ++K + +G E   +NE+ ++ K++H N+V L    
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 411 LEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIH 470
             G    L+ + V    L   + +     + D SR   +I  +   + YLH+   L I+H
Sbjct: 86  ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LIFQVLDAVKYLHD---LGIVH 139
Query: 471 RDLKASNIL---LDAEMNPKISDFGMARIFGVDQTQGNT-SRIVGTYGYMAPEYAMHGQF 526
           RDLK  N+L   LD +    ISDFG++++    +  G+  S   GT GY+APE      +
Sbjct: 140 RDLKPENLLYYSLDEDSKIMISDFGLSKM----EDPGSVLSTACGTPGYVAPEVLAQKPY 195
Query: 527 SVKSDVYSFGVLVLEIITG 545
           S   D +S GV+   ++ G
Sbjct: 196 SKAVDCWSIGVIAYILLCG 214

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 37/226 (16%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVL 394
           +TI     ++   + +G G +G V       +G  +AVK+LS+   S   A+    E+ L
Sbjct: 35  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 94
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-------------LYDPEKQGQL 441
           +  ++H N++ LL              F P +SL+ F             L +  K  +L
Sbjct: 95  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 142
Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
                  +I  I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 143 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 194
Query: 502 TQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
           T    +  V T  Y APE  ++   ++   D++S G ++ E++TG+
Sbjct: 195 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 99/199 (49%), Gaps = 16/199 (8%)
Query: 353 LGEGGFGEVYKGVLPSGQE-IAVKRLSKASGQGAE-EFKNEVVLVAKLQHRNLVRLLGFC 410
           LG G F EV        Q+ +A+K ++K + +G E   +NE+ ++ K++H N+V L    
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 411 LEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIH 470
             G    L+ + V    L   + +     + D SR   +I  +   + YLH+   L I+H
Sbjct: 86  ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LIFQVLDAVKYLHD---LGIVH 139
Query: 471 RDLKASNIL---LDAEMNPKISDFGMARIFGVDQTQGNT-SRIVGTYGYMAPEYAMHGQF 526
           RDLK  N+L   LD +    ISDFG++++    +  G+  S   GT GY+APE      +
Sbjct: 140 RDLKPENLLYYSLDEDSKIMISDFGLSKM----EDPGSVLSTACGTPGYVAPEVLAQKPY 195
Query: 527 SVKSDVYSFGVLVLEIITG 545
           S   D +S GV+   ++ G
Sbjct: 196 SKAVDCWSIGVIAYILLCG 214

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 37/226 (16%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVL 394
           +TI     ++   + +G G +G V       +G  +AVK+LS+   S   A+    E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-------------LYDPEKQGQL 441
           +  ++H N++ LL              F P +SL+ F             L +  K  +L
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
                  +I  I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 174
Query: 502 TQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
           T    +  V T  Y APE  ++   ++   D++S G ++ E++TG+
Sbjct: 175 TDDEMTGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 106/227 (46%), Gaps = 40/227 (17%)
Query: 335 FDFETIEVATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVV 393
            DF+ IE+          +G GGFG+V+K      G+   +KR+ K + + AE    EV 
Sbjct: 11  MDFKEIEL----------IGSGGFGQVFKAKHRIDGKTYVIKRV-KYNNEKAE---REVK 56
Query: 394 LVAKLQHRNLVRLLGFCLEG---------------EEKILV--YEFVPNKSLDYFLYDPE 436
            +AKL H N+V   G C +G               + K L    EF    +L+ ++ +  
Sbjct: 57  ALAKLDHVNIVHYNG-CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKR 114
Query: 437 KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496
           +  +LD     ++   I +G+ Y+H     ++I+RDLK SNI L      KI DFG+   
Sbjct: 115 RGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTS 171
Query: 497 FGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEII 543
              D   G   R  GT  YM+PE      +  + D+Y+ G+++ E++
Sbjct: 172 LKND---GKRXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/200 (33%), Positives = 105/200 (52%), Gaps = 16/200 (8%)
Query: 353 LGEGGFGEVY---KGVLP-SGQEIAVKRLSKASGQGAEEF--KNEVVLVAKLQHRNLVRL 406
           LG+G FG+V+   K   P SG   A+K L KA+ +  +    K E  ++A + H  +V+L
Sbjct: 36  LGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVVKL 95
Query: 407 LGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSR 465
             +  + E K+ L+ +F+    L   L    K+           +  +A G+ +LH    
Sbjct: 96  -HYAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELALGLDHLHS--- 148
Query: 466 LRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQ 525
           L II+RDLK  NILLD E + K++DFG+++   +D  +   S   GT  YMAPE      
Sbjct: 149 LGIIYRDLKPENILLDEEGHIKLTDFGLSKE-AIDHEKKAYS-FCGTVEYMAPEVVNRQG 206
Query: 526 FSVKSDVYSFGVLVLEIITG 545
            S  +D +S+GVL+ E++TG
Sbjct: 207 HSHSADWWSYGVLMFEMLTG 226

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 37/226 (16%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVL 394
           +TI     ++   + +G G +G V       +G  +AVK+LS+   S   A+    E+ L
Sbjct: 12  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 71
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-------------LYDPEKQGQL 441
           +  ++H N++ LL              F P +SL+ F             L +  K  +L
Sbjct: 72  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 119
Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
                  +I  I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 120 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 171
Query: 502 TQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
           T    +  V T  Y APE  ++   ++   D++S G ++ E++TG+
Sbjct: 172 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 108/240 (45%), Gaps = 13/240 (5%)
Query: 311 AKKKYNAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQ 370
           A  K +A P ++ D     L+ +  D         ++     LG+GGF + Y+      +
Sbjct: 9   AIAKPSAKPSAHVDPKSAPLKEIP-DVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTK 67
Query: 371 EIAVKRLSKAS----GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNK 426
           E+   ++   S        E+   E+ +   L + ++V   GF  + +   +V E    +
Sbjct: 68  EVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRR 127
Query: 427 SLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP 486
           SL        ++   +   RY +   I +G+ YLH +   R+IHRDLK  N+ L+ +M+ 
Sbjct: 128 SL--LELHKRRKAVTEPEARYFMRQTI-QGVQYLHNN---RVIHRDLKLGNLFLNDDMDV 181
Query: 487 KISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
           KI DFG+A     D  +     + GT  Y+APE       S + D++S G ++  ++ GK
Sbjct: 182 KIGDFGLATKIEFDGERKKD--LCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 103/226 (45%), Gaps = 37/226 (16%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVL 394
           +TI     ++     +G G +G V       +G  +AVK+LS+   S   A+    E+ L
Sbjct: 25  KTIWEVPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 84
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-------------LYDPEKQGQL 441
           +  ++H N++ LL              F P +SL+ F             L +  K  +L
Sbjct: 85  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 132
Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
                  +I  I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 133 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 184
Query: 502 TQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
           T    +  V T  Y APE  ++   ++   D++S G ++ E++TG+
Sbjct: 185 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 103/201 (51%), Gaps = 21/201 (10%)
Query: 353 LGEGGFGEVY--KGVLPSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLG 408
           +G+G F +V   + VL +G+E+AVK + K   +    ++   EV ++  L H N+V+L  
Sbjct: 23  IGKGNFAKVKLARHVL-TGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE 81
Query: 409 FCLEGEEKI-LVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRL 466
             +E E+ + LV E+     + DY +      G++           I   + Y H+    
Sbjct: 82  -VIETEKTLYLVMEYASGGEVFDYLV----AHGRMKEKEARAKFRQIVSAVQYCHQKY-- 134
Query: 467 RIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT-SRIVGTYGYMAPEYAMHGQ 525
            I+HRDLKA N+LLD +MN KI+DFG +  F V    GN      G+  Y APE     +
Sbjct: 135 -IVHRDLKAENLLLDGDMNIKIADFGFSNEFTV----GNKLDTFCGSPPYAAPELFQGKK 189
Query: 526 FS-VKSDVYSFGVLVLEIITG 545
           +   + DV+S GV++  +++G
Sbjct: 190 YDGPEVDVWSLGVILYTLVSG 210

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 104/201 (51%), Gaps = 21/201 (10%)
Query: 353 LGEGGFGEVY--KGVLPSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLG 408
           +G+G F +V   + +L +G+E+AV+ + K   +    ++   EV ++  L H N+V+L  
Sbjct: 22  IGKGNFAKVKLARHIL-TGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 409 FCLEGEEKI-LVYEFVPN-KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRL 466
             +E E+ + LV E+    +  DY +      G++           I   + Y H+    
Sbjct: 81  -VIETEKTLYLVMEYASGGEVFDYLV----AHGRMKEKEARAKFRQIVSAVQYCHQKF-- 133
Query: 467 RIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT-SRIVGTYGYMAPEYAMHGQ 525
            I+HRDLKA N+LLDA+MN KI+DFG +  F    T GN      G+  Y APE     +
Sbjct: 134 -IVHRDLKAENLLLDADMNIKIADFGFSNEF----TFGNKLDTFCGSPPYAAPELFQGKK 188
Query: 526 FS-VKSDVYSFGVLVLEIITG 545
           +   + DV+S GV++  +++G
Sbjct: 189 YDGPEVDVWSLGVILYTLVSG 209

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 108/233 (46%), Gaps = 43/233 (18%)
Query: 337 FETIEVATNKFSTDNK------LGEGGFGEV---YKGVLPSGQEIAVKRLSKA--SGQGA 385
           F ++EV  + F+   +      +G G  G V   Y  VL   + +A+K+LS+   +   A
Sbjct: 10  FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHA 67
Query: 386 EEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF--------LYDPEK 437
           +    E+VL+  + H+N++ LL              F P K+L+ F        L D   
Sbjct: 68  KRAYRELVLMKXVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANL 115
Query: 438 ----QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493
               Q +LD  R   ++  +  GI +LH      IIHRDLK SNI++ ++   KI DFG+
Sbjct: 116 XQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGL 172
Query: 494 ARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
           AR  G   T    +  V T  Y APE  +   +    D++S G ++ E++  K
Sbjct: 173 ARTAG---TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 111/244 (45%), Gaps = 38/244 (15%)
Query: 320 ESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLS 378
           +SNA  +  T    + + +TI     ++   + +G G +G V       +G  +AVK+LS
Sbjct: 21  QSNASQERPTFYRQELN-KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS 79
Query: 379 KA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF----- 431
           +   S   A+    E+ L+  ++H N++ LL              F P +SL+ F     
Sbjct: 80  RPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYL 127
Query: 432 --------LYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE 483
                   L +  K  +L       +I  I RG+ Y+H      IIHRDLK SN+ ++ +
Sbjct: 128 VTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNED 184
Query: 484 MNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEI 542
              KI DFG+AR      T       V T  Y APE  ++   ++   D++S G ++ E+
Sbjct: 185 CELKILDFGLAR-----HTDDEMXGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 239
Query: 543 ITGK 546
           +TG+
Sbjct: 240 LTGR 243

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 37/226 (16%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVL 394
           +TI     ++   + +G G +G V       +G  +AVK+LS+   S   A+    E+ L
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-------------LYDPEKQGQL 441
           +  ++H N++ LL              F P +SL+ F             L +  K  +L
Sbjct: 71  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 118
Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
                  +I  I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 119 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 170
Query: 502 TQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
           T    +  V T  Y APE  ++   ++   D++S G ++ E++TG+
Sbjct: 171 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 104/222 (46%), Gaps = 30/222 (13%)
Query: 356 GGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE- 414
           G FG V+K  L     +AVK       Q  +  + E+     ++H NL++ +     G  
Sbjct: 26  GRFGCVWKAQL-MNDFVAVKIFPLQDKQSWQS-EREIFSTPGMKHENLLQFIAAEKRGSN 83
Query: 415 ---EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED-------- 463
              E  L+  F    SL  +L    K   + W+    +   ++RG+ YLHED        
Sbjct: 84  LEVELWLITAFHDKGSLTDYL----KGNIITWNELCHVAETMSRGLSYLHEDVPWCRGEG 139
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMH 523
            +  I HRD K+ N+LL +++   ++DFG+A  F   +  G+T   VGT  YMAPE  + 
Sbjct: 140 HKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPE-VLE 198
Query: 524 GQFS------VKSDVYSFGVLVLEIITGKKNSNFYQTDGAAD 559
           G  +      ++ D+Y+ G+++ E+++  K +     DG  D
Sbjct: 199 GAINFQRDAFLRIDMYAMGLVLWELVSRCKAA-----DGPVD 235

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 37/226 (16%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVL 394
           +TI     ++   + +G G +G V       +G  +AVK+LS+   S   A+    E+ L
Sbjct: 20  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 79
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-------------LYDPEKQGQL 441
           +  ++H N++ LL              F P +SL+ F             L +  K  +L
Sbjct: 80  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 127
Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
                  +I  I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 128 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 179
Query: 502 TQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
           T    +  V T  Y APE  ++   ++   D++S G ++ E++TG+
Sbjct: 180 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 37/226 (16%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVL 394
           +TI     ++   + +G G +G V       +G  +AVK+LS+   S   A+    E+ L
Sbjct: 12  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 71
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-------------LYDPEKQGQL 441
           +  ++H N++ LL              F P +SL+ F             L +  K  +L
Sbjct: 72  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 119
Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
                  +I  I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 120 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 171
Query: 502 TQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
           T    +  V T  Y APE  ++   ++   D++S G ++ E++TG+
Sbjct: 172 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 37/226 (16%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVL 394
           +TI     ++   + +G G +G V       +G  +AVK+LS+   S   A+    E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-------------LYDPEKQGQL 441
           +  ++H N++ LL              F P +SL+ F             L +  K  +L
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
                  +I  I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 174
Query: 502 TQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
           T    +  V T  Y APE  ++   ++   D++S G ++ E++TG+
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 37/226 (16%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVL 394
           +TI     ++   + +G G +G V       +G  +AVK+LS+   S   A+    E+ L
Sbjct: 20  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 79
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-------------LYDPEKQGQL 441
           +  ++H N++ LL              F P +SL+ F             L +  K  +L
Sbjct: 80  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 127
Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
                  +I  I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 128 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR-----H 179
Query: 502 TQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
           T    +  V T  Y APE  ++   ++   D++S G ++ E++TG+
Sbjct: 180 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 103/226 (45%), Gaps = 37/226 (16%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVL 394
           +TI     ++   + +G G +G V       +G  +AVK+LS+   S   A+    E+ L
Sbjct: 35  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 94
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-------------LYDPEKQGQL 441
           +  ++H N++ LL              F P +SL+ F             L +  K  +L
Sbjct: 95  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 142
Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
                  +I  I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 143 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 194
Query: 502 TQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
           T       V T  Y APE  ++   ++   D++S G ++ E++TG+
Sbjct: 195 TDDEMXGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 37/226 (16%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVL 394
           +TI     ++   + +G G +G V       +G  +AVK+LS+   S   A+    E+ L
Sbjct: 13  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 72
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-------------LYDPEKQGQL 441
           +  ++H N++ LL              F P +SL+ F             L +  K  +L
Sbjct: 73  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 120
Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
                  +I  I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 121 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 172
Query: 502 TQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
           T    +  V T  Y APE  ++   ++   D++S G ++ E++TG+
Sbjct: 173 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 37/226 (16%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVL 394
           +TI     ++   + +G G +G V       +G  +AVK+LS+   S   A+    E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-------------LYDPEKQGQL 441
           +  ++H N++ LL              F P +SL+ F             L +  K  +L
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
                  +I  I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 174
Query: 502 TQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
           T    +  V T  Y APE  ++   ++   D++S G ++ E++TG+
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 37/226 (16%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVL 394
           +TI     ++   + +G G +G V       +G  +AVK+LS+   S   A+    E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-------------LYDPEKQGQL 441
           +  ++H N++ LL              F P +SL+ F             L +  K  +L
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
                  +I  I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 174
Query: 502 TQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
           T    +  V T  Y APE  ++   ++   D++S G ++ E++TG+
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 109/233 (46%), Gaps = 43/233 (18%)
Query: 336 DFETIEVATNKFSTDNK------LGEGGFGEV---YKGVLPSGQEIAVKRLSKA--SGQG 384
           +F ++E+  + F+   +      +G G  G V   Y  +L   + +A+K+LS+   +   
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTH 66
Query: 385 AEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF--------LYDPE 436
           A+    E+VL+  + H+N++ LL              F P KSL+ F        L D  
Sbjct: 67  AKRAYRELVLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDAN 114
Query: 437 K----QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 492
                Q +LD  R   ++  +  GI +LH      IIHRDLK SNI++ ++   KI DFG
Sbjct: 115 LCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 171
Query: 493 MARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
           +AR  G   T    +  V T  Y APE  +   +    D++S G ++ E+I G
Sbjct: 172 LARTAG---TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 37/226 (16%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVL 394
           +TI     ++   + +G G +G V       +G  +AVK+LS+   S   A+    E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-------------LYDPEKQGQL 441
           +  ++H N++ LL              F P +SL+ F             L +  K  +L
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
                  +I  I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 174
Query: 502 TQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
           T    +  V T  Y APE  ++   ++   D++S G ++ E++TG+
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 37/226 (16%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVL 394
           +TI     ++   + +G G +G V       +G  +AVK+LS+   S   A+    E+ L
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 81
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-------------LYDPEKQGQL 441
           +  ++H N++ LL              F P +SL+ F             L +  K  +L
Sbjct: 82  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 129
Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
                  +I  I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 130 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 181
Query: 502 TQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
           T    +  V T  Y APE  ++   ++   D++S G ++ E++TG+
Sbjct: 182 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 37/226 (16%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVL 394
           +TI     ++   + +G G +G V       +G  +AVK+LS+   S   A+    E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-------------LYDPEKQGQL 441
           +  ++H N++ LL              F P +SL+ F             L +  K  +L
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
                  +I  I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 174
Query: 502 TQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
           T    +  V T  Y APE  ++   ++   D++S G ++ E++TG+
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 37/226 (16%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVL 394
           +TI     ++   + +G G +G V       +G  +AVK+LS+   S   A+    E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-------------LYDPEKQGQL 441
           +  ++H N++ LL              F P +SL+ F             L +  K  +L
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
                  +I  I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 174
Query: 502 TQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
           T    +  V T  Y APE  ++   ++   D++S G ++ E++TG+
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 37/226 (16%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVL 394
           +TI     ++   + +G G +G V       +G  +AVK+LS+   S   A+    E+ L
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 76
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-------------LYDPEKQGQL 441
           +  ++H N++ LL              F P +SL+ F             L +  K  +L
Sbjct: 77  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 124
Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
                  +I  I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 125 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 176
Query: 502 TQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
           T    +  V T  Y APE  ++   ++   D++S G ++ E++TG+
Sbjct: 177 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 99/208 (47%), Gaps = 12/208 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQE----IAVKRLSKASGQGA-EEFKNEVVLV 395
           E+   +      +GEG FG+V++G+  S +     +A+K     +     E+F  E + +
Sbjct: 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 445
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
            +  H ++V+L+G   E    I++ E      L  FL    ++  LD +        ++ 
Sbjct: 446 RQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFLQ--VRKFSLDLASLILYAYQLST 502
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGY 515
            + YL      R +HRD+ A N+L+ A    K+ DFG++R +  D T    S+      +
Sbjct: 503 ALAYLESK---RFVHRDIAARNVLVSATDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKW 558
Query: 516 MAPEYAMHGQFSVKSDVYSFGVLVLEII 543
           MAPE     +F+  SDV+ FGV + EI+
Sbjct: 559 MAPESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 37/226 (16%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVL 394
           +TI     ++   + +G G +G V       +G  +AVK+LS+   S   A+    E+ L
Sbjct: 20  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 79
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-------------LYDPEKQGQL 441
           +  ++H N++ LL              F P +SL+ F             L +  K  +L
Sbjct: 80  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 127
Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
                  +I  I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 128 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 179
Query: 502 TQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
           T    +  V T  Y APE  ++   ++   D++S G ++ E++TG+
Sbjct: 180 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 37/226 (16%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVL 394
           +TI     ++   + +G G +G V       +G  +AVK+LS+   S   A+    E+ L
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 76
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-------------LYDPEKQGQL 441
           +  ++H N++ LL              F P +SL+ F             L +  K  +L
Sbjct: 77  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 124
Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
                  +I  I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 125 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 176
Query: 502 TQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
           T    +  V T  Y APE  ++   ++   D++S G ++ E++TG+
Sbjct: 177 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 37/226 (16%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVL 394
           +TI     ++   + +G G +G V       +G  +AVK+LS+   S   A+    E+ L
Sbjct: 14  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 73
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-------------LYDPEKQGQL 441
           +  ++H N++ LL              F P +SL+ F             L +  K  +L
Sbjct: 74  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 121
Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
                  +I  I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 122 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 173
Query: 502 TQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
           T    +  V T  Y APE  ++   ++   D++S G ++ E++TG+
Sbjct: 174 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 108/233 (46%), Gaps = 43/233 (18%)
Query: 337 FETIEVATNKFSTDNK------LGEGGFGEV---YKGVLPSGQEIAVKRLSKA--SGQGA 385
           F ++EV  + F+   +      +G G  G V   Y  VL   + +A+K+LS+   +   A
Sbjct: 10  FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHA 67
Query: 386 EEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF--------LYDPEK 437
           +    E+VL+  + H+N++ LL              F P K+L+ F        L D   
Sbjct: 68  KRAYRELVLMKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANL 115
Query: 438 ----QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493
               Q +LD  R   ++  +  GI +LH      IIHRDLK SNI++ ++   KI DFG+
Sbjct: 116 XQVIQMELDHERMSYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGL 172
Query: 494 ARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
           AR  G   T    +  V T  Y APE  +   +    D++S G ++ E++  K
Sbjct: 173 ARTAG---TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 37/226 (16%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVL 394
           +TI     ++   + +G G +G V       +G  +AVK+LS+   S   A+    E+ L
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 80
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-------------LYDPEKQGQL 441
           +  ++H N++ LL              F P +SL+ F             L +  K  +L
Sbjct: 81  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 128
Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
                  +I  I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 129 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 180
Query: 502 TQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
           T    +  V T  Y APE  ++   ++   D++S G ++ E++TG+
Sbjct: 181 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 108/212 (50%), Gaps = 23/212 (10%)
Query: 344 TNKFSTDNKLGEGGFGEVY--KGVLPSGQEIAVKRLSKAS-----GQGAEEFKNEVVLVA 396
           ++++    KLG G +GEV   K  L +G E A+K + K+S       GA    +EV ++ 
Sbjct: 20  SDRYQRVKKLGSGAYGEVLLCKDKL-TGAERAIKIIKKSSVTTTSNSGA--LLDEVAVLK 76
Query: 397 KLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARG 456
           +L H N+++L  F  +     LV E      L   +   +K  ++D +    I+  +  G
Sbjct: 77  QLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAV---IMKQVLSG 133
Query: 457 ILYLHEDSRLRIIHRDLKASNILLDAEMNP---KISDFGMARIFGVDQTQGNTSRIVGTY 513
             YLH+ +   I+HRDLK  N+LL+++      KI DFG++  F V    G     +GT 
Sbjct: 134 TTYLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVG---GKMKERLGTA 187
Query: 514 GYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
            Y+APE  +  ++  K DV+S GV++  ++ G
Sbjct: 188 YYIAPE-VLRKKYDEKCDVWSCGVILYILLCG 218

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 109/233 (46%), Gaps = 43/233 (18%)
Query: 336 DFETIEVATNKFSTDNK------LGEGGFGEV---YKGVLPSGQEIAVKRLSKA--SGQG 384
           +F ++E+  + F+   +      +G G  G V   Y  +L   + +A+K+LS+   +   
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTH 66
Query: 385 AEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF--------LYDPE 436
           A+    E+VL+  + H+N++ LL              F P KSL+ F        L D  
Sbjct: 67  AKRAYRELVLMKVVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDAN 114
Query: 437 K----QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 492
                Q +LD  R   ++  +  GI +LH      IIHRDLK SNI++ ++   KI DFG
Sbjct: 115 LSQVIQMELDHERMSYLLYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFG 171
Query: 493 MARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
           +AR  G   T    +  V T  Y APE  +   +    D++S G ++ E+I G
Sbjct: 172 LARTAG---TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 37/226 (16%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVL 394
           +TI     ++   + +G G +G V       +G  +AVK+LS+   S   A+    E+ L
Sbjct: 27  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 86
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-------------LYDPEKQGQL 441
           +  ++H N++ LL              F P +SL+ F             L +  K  +L
Sbjct: 87  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 134
Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
                  +I  I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 135 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 186
Query: 502 TQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
           T    +  V T  Y APE  ++   ++   D++S G ++ E++TG+
Sbjct: 187 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 108/233 (46%), Gaps = 43/233 (18%)
Query: 337 FETIEVATNKFSTDNK------LGEGGFGEV---YKGVLPSGQEIAVKRLSKA--SGQGA 385
           F ++EV  + F+   +      +G G  G V   Y  VL   + +A+K+LS+   +   A
Sbjct: 3   FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHA 60
Query: 386 EEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF--------LYDPEK 437
           +    E+VL+  + H+N++ LL              F P K+L+ F        L D   
Sbjct: 61  KRAYRELVLMKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANL 108
Query: 438 ----QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493
               Q +LD  R   ++  +  GI +LH      IIHRDLK SNI++ ++   KI DFG+
Sbjct: 109 XQVIQMELDHERMSYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGL 165
Query: 494 ARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
           AR  G   T    +  V T  Y APE  +   +    D++S G ++ E++  K
Sbjct: 166 ARTAG---TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 37/226 (16%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVL 394
           +TI     ++   + +G G +G V       +G  +AVK+LS+   S   A+    E+ L
Sbjct: 27  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 86
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-------------LYDPEKQGQL 441
           +  ++H N++ LL              F P +SL+ F             L +  K  +L
Sbjct: 87  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 134
Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
                  +I  I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 135 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 186
Query: 502 TQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
           T    +  V T  Y APE  ++   ++   D++S G ++ E++TG+
Sbjct: 187 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 109/233 (46%), Gaps = 43/233 (18%)
Query: 336 DFETIEVATNKFSTDNK------LGEGGFGEV---YKGVLPSGQEIAVKRLSKA--SGQG 384
           +F ++E+  + F+   +      +G G  G V   Y  +L   + +A+K+LS+   +   
Sbjct: 10  NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTH 67
Query: 385 AEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF--------LYDPE 436
           A+    E+VL+  + H+N++ LL              F P KSL+ F        L D  
Sbjct: 68  AKRAYRELVLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDAN 115
Query: 437 K----QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 492
                Q +LD  R   ++  +  GI +LH      IIHRDLK SNI++ ++   KI DFG
Sbjct: 116 LCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 172
Query: 493 MARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
           +AR  G   T    +  V T  Y APE  +   +    D++S G ++ E+I G
Sbjct: 173 LARTAG---TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 37/226 (16%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVL 394
           +TI     ++   + +G G +G V       +G  +AVK+LS+   S   A+    E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-------------LYDPEKQGQL 441
           +  ++H N++ LL              F P +SL+ F             L +  K  +L
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
                  +I  I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 174
Query: 502 TQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
           T    +  V T  Y APE  ++   ++   D++S G ++ E++TG+
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 37/226 (16%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVL 394
           +TI     ++   + +G G +G V       +G  +AVK+LS+   S   A+    E+ L
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 81
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-------------LYDPEKQGQL 441
           +  ++H N++ LL              F P +SL+ F             L +  K  +L
Sbjct: 82  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 129
Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
                  +I  I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 130 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 181
Query: 502 TQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
           T    +  V T  Y APE  ++   ++   D++S G ++ E++TG+
Sbjct: 182 TADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 37/226 (16%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVL 394
           +TI     ++   + +G G +G V       +G  +AVK+LS+   S   A+    E+ L
Sbjct: 26  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 85
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-------------LYDPEKQGQL 441
           +  ++H N++ LL              F P +SL+ F             L +  K  +L
Sbjct: 86  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 133
Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
                  +I  I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 134 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR-----H 185
Query: 502 TQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
           T    +  V T  Y APE  ++   ++   D++S G ++ E++TG+
Sbjct: 186 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 37/226 (16%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVL 394
           +TI     ++   + +G G +G V       +G  +AVK+LS+   S   A+    E+ L
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 81
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-------------LYDPEKQGQL 441
           +  ++H N++ LL              F P +SL+ F             L +  K  +L
Sbjct: 82  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 129
Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
                  +I  I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 130 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 181
Query: 502 TQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
           T    +  V T  Y APE  ++   ++   D++S G ++ E++TG+
Sbjct: 182 TADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 37/226 (16%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVL 394
           +TI     ++   + +G G +G V       +G  +AVK+LS+   S   A+    E+ L
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 81
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-------------LYDPEKQGQL 441
           +  ++H N++ LL              F P +SL+ F             L +  K  +L
Sbjct: 82  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 129
Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
                  +I  I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 130 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 181
Query: 502 TQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
           T    +  V T  Y APE  ++   ++   D++S G ++ E++TG+
Sbjct: 182 TADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 37/226 (16%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVL 394
           +TI     ++   + +G G +G V       +G  +AVK+LS+   S   A+    E+ L
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 80
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-------------LYDPEKQGQL 441
           +  ++H N++ LL              F P +SL+ F             L +  K  +L
Sbjct: 81  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 128
Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
                  +I  I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 129 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 180
Query: 502 TQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
           T    +  V T  Y APE  ++   ++   D++S G ++ E++TG+
Sbjct: 181 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 37/226 (16%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVL 394
           +TI     ++   + +G G +G V       +G  +AVK+LS+   S   A+    E+ L
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 76
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-------------LYDPEKQGQL 441
           +  ++H N++ LL              F P +SL+ F             L +  K  +L
Sbjct: 77  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 124
Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
                  +I  I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 125 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLAR-----H 176
Query: 502 TQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
           T    +  V T  Y APE  ++   ++   D++S G ++ E++TG+
Sbjct: 177 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 37/226 (16%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVL 394
           +TI     ++   + +G G +G V       +G  +AVK+LS+   S   A+    E+ L
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 76
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-------------LYDPEKQGQL 441
           +  ++H N++ LL              F P +SL+ F             L +  K  +L
Sbjct: 77  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 124
Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
                  +I  I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 125 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 176
Query: 502 TQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
           T    +  V T  Y APE  ++   ++   D++S G ++ E++TG+
Sbjct: 177 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 37/226 (16%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVL 394
           +TI     ++   + +G G +G V       +G  +AVK+LS+   S   A+    E+ L
Sbjct: 35  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 94
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-------------LYDPEKQGQL 441
           +  ++H N++ LL              F P +SL+ F             L +  K  +L
Sbjct: 95  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 142
Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
                  +I  I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 143 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 194
Query: 502 TQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
           T    +  V T  Y APE  ++   ++   D++S G ++ E++TG+
Sbjct: 195 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 111/212 (52%), Gaps = 19/212 (8%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYK-GVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ 399
           E+  + F   ++LG G  G V+K    PSG  +A K +     +     +N+++   ++ 
Sbjct: 5   ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL---EIKPAIRNQIIRELQVL 61
Query: 400 HR-NLVRLLGFC----LEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIA 454
           H  N   ++GF      +GE  I + E +   SLD  L   +K G++      K+   + 
Sbjct: 62  HECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVL---KKAGRIPEQILGKVSIAVI 117
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
           +G+ YL E  + +I+HRD+K SNIL+++    K+ DFG++    +D+     +  VGT  
Sbjct: 118 KGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDEM---ANEFVGTRS 171
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
           YM+PE      +SV+SD++S G+ ++E+  G+
Sbjct: 172 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 203

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 109/233 (46%), Gaps = 43/233 (18%)
Query: 336 DFETIEVATNKFSTDNK------LGEGGFGEV---YKGVLPSGQEIAVKRLSKA--SGQG 384
           +F ++E+  + F+   +      +G G  G V   Y  +L   + +A+K+LS+   +   
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTH 66
Query: 385 AEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF--------LYDPE 436
           A+    E+VL+  + H+N++ LL              F P KSL+ F        L D  
Sbjct: 67  AKRAYRELVLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDAN 114
Query: 437 K----QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 492
                Q +LD  R   ++  +  GI +LH      IIHRDLK SNI++ ++   KI DFG
Sbjct: 115 LCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 171
Query: 493 MARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
           +AR  G   T    +  V T  Y APE  +   +    D++S G ++ E+I G
Sbjct: 172 LARTAG---TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 108/211 (51%), Gaps = 30/211 (14%)
Query: 353 LGEGGFGEVYKGVLPS----GQ----EIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLV 404
           LG+G F +++KGV       GQ    E+ +K L KA    +E F     +++KL H++LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
              G C+ G+E ILV EFV   SLD +L   +    + W  + ++   +A  + +L E++
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAAAMHFLEENT 133
Query: 465 RLRIIHRDLKASNILLDAEM-----NP---KISDFGMA-RIFGVDQTQGNTSRIVGTYGY 515
              +IH ++ A NILL  E      NP   K+SD G++  +   D  Q    RI     +
Sbjct: 134 ---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQ---ERI----PW 183
Query: 516 MAPEYAMHGQ-FSVKSDVYSFGVLVLEIITG 545
           + PE   + +  ++ +D +SFG  + EI +G
Sbjct: 184 VPPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 37/226 (16%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVL 394
           +TI     ++   + +G G +G V       +G  +AVK+LS+   S   A+    E+ L
Sbjct: 26  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 85
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-------------LYDPEKQGQL 441
           +  ++H N++ LL              F P +SL+ F             L +  K  +L
Sbjct: 86  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 133
Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
                  +I  I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 134 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 185
Query: 502 TQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
           T    +  V T  Y APE  ++   ++   D++S G ++ E++TG+
Sbjct: 186 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 113/229 (49%), Gaps = 13/229 (5%)
Query: 325 NDLTTLESLQFDF-ETIEVATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASG 382
           + L  L  LQ+ + E   +  + F     LG GGFGEV+   +  +G+  A K+L+K   
Sbjct: 164 DSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRL 223
Query: 383 QGAEEFKNEVV---LVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYD-PEK 437
           +  + ++  +V   ++AK+  R +V L  +  E +  + LV   +    + Y +Y+  E 
Sbjct: 224 KKRKGYQGAMVEKKILAKVHSRFIVSL-AYAFETKTDLCLVMTIMNGGDIRYHIYNVDED 282
Query: 438 QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497
                  R       I  G+ +LH+ +   II+RDLK  N+LLD + N +ISD G+A   
Sbjct: 283 NPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVEL 339
Query: 498 GVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
              QT+  T    GT G+MAPE  +  ++    D ++ GV + E+I  +
Sbjct: 340 KAGQTK--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 37/226 (16%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVL 394
           +TI     ++   + +G G +G V       +G  +AVK+LS+   S   A+    E+ L
Sbjct: 34  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 93
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-------------LYDPEKQGQL 441
           +  ++H N++ LL              F P +SL+ F             L +  K  +L
Sbjct: 94  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 141
Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
                  +I  I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 142 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 193
Query: 502 TQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
           T    +  V T  Y APE  ++   ++   D++S G ++ E++TG+
Sbjct: 194 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 108/233 (46%), Gaps = 43/233 (18%)
Query: 337 FETIEVATNKFSTDNK------LGEGGFGEV---YKGVLPSGQEIAVKRLSKA--SGQGA 385
           F ++EV  + F+   +      +G G  G V   Y  VL   + +A+K+LS+   +   A
Sbjct: 11  FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHA 68
Query: 386 EEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF--------LYDPEK 437
           +    E+VL+  + H+N++ LL              F P K+L+ F        L D   
Sbjct: 69  KRAYRELVLMKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANL 116
Query: 438 ----QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493
               Q +LD  R   ++  +  GI +LH      IIHRDLK SNI++ ++   KI DFG+
Sbjct: 117 CQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 173
Query: 494 ARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
           AR  G   T    +  V T  Y APE  +   +    D++S G ++ E++  K
Sbjct: 174 ARTAG---TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 109/233 (46%), Gaps = 43/233 (18%)
Query: 336 DFETIEVATNKFSTDNK------LGEGGFGEV---YKGVLPSGQEIAVKRLSKA--SGQG 384
           +F ++E+  + F+   +      +G G  G V   Y  +L   + +A+K+LS+   +   
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTH 66
Query: 385 AEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF--------LYDPE 436
           A+    E+VL+  + H+N++ LL              F P KSL+ F        L D  
Sbjct: 67  AKRAYRELVLMKVVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDAN 114
Query: 437 K----QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 492
                Q +LD  R   ++  +  GI +LH      IIHRDLK SNI++ ++   KI DFG
Sbjct: 115 LSQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFG 171
Query: 493 MARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
           +AR  G   T    +  V T  Y APE  +   +    D++S G ++ E+I G
Sbjct: 172 LARTAG---TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 108/233 (46%), Gaps = 43/233 (18%)
Query: 337 FETIEVATNKFSTDNK------LGEGGFGEV---YKGVLPSGQEIAVKRLSKA--SGQGA 385
           F ++EV  + F+   +      +G G  G V   Y  VL   + +A+K+LS+   +   A
Sbjct: 4   FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHA 61
Query: 386 EEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF--------LYDPEK 437
           +    E+VL+  + H+N++ LL              F P K+L+ F        L D   
Sbjct: 62  KRAYRELVLMKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANL 109
Query: 438 ----QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493
               Q +LD  R   ++  +  GI +LH      IIHRDLK SNI++ ++   KI DFG+
Sbjct: 110 CQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 166
Query: 494 ARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
           AR  G   T    +  V T  Y APE  +   +    D++S G ++ E++  K
Sbjct: 167 ARTAG---TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 37/226 (16%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVL 394
           +TI     ++   + +G G +G V       +G  +AVK+LS+   S   A+    E+ L
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 80
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-------------LYDPEKQGQL 441
           +  ++H N++ LL              F P +SL+ F             L +  K  +L
Sbjct: 81  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 128
Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
                  +I  I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 129 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLAR-----H 180
Query: 502 TQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
           T    +  V T  Y APE  ++   ++   D++S G ++ E++TG+
Sbjct: 181 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 108/233 (46%), Gaps = 43/233 (18%)
Query: 337 FETIEVATNKFSTDNK------LGEGGFGEV---YKGVLPSGQEIAVKRLSKA--SGQGA 385
           F ++EV  + F+   +      +G G  G V   Y  VL   + +A+K+LS+   +   A
Sbjct: 9   FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHA 66
Query: 386 EEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF--------LYDPEK 437
           +    E+VL+  + H+N++ LL              F P K+L+ F        L D   
Sbjct: 67  KRAYRELVLMKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANL 114
Query: 438 ----QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493
               Q +LD  R   ++  +  GI +LH      IIHRDLK SNI++ ++   KI DFG+
Sbjct: 115 CQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 171
Query: 494 ARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
           AR  G   T    +  V T  Y APE  +   +    D++S G ++ E++  K
Sbjct: 172 ARTAG---TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 221

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 108/233 (46%), Gaps = 43/233 (18%)
Query: 337 FETIEVATNKFSTDNK------LGEGGFGEV---YKGVLPSGQEIAVKRLSKA--SGQGA 385
           F ++EV  + F+   +      +G G  G V   Y  VL   + +A+K+LS+   +   A
Sbjct: 10  FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHA 67
Query: 386 EEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF--------LYDPEK 437
           +    E+VL+  + H+N++ LL              F P K+L+ F        L D   
Sbjct: 68  KRAYRELVLMKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANL 115
Query: 438 ----QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493
               Q +LD  R   ++  +  GI +LH      IIHRDLK SNI++ ++   KI DFG+
Sbjct: 116 CQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172
Query: 494 ARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
           AR  G   T    +  V T  Y APE  +   +    D++S G ++ E++  K
Sbjct: 173 ARTAG---TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 108/233 (46%), Gaps = 43/233 (18%)
Query: 337 FETIEVATNKFSTDNK------LGEGGFGEV---YKGVLPSGQEIAVKRLSKA--SGQGA 385
           F ++EV  + F+   +      +G G  G V   Y  VL   + +A+K+LS+   +   A
Sbjct: 3   FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHA 60
Query: 386 EEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF--------LYDPEK 437
           +    E+VL+  + H+N++ LL              F P K+L+ F        L D   
Sbjct: 61  KRAYRELVLMKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANL 108
Query: 438 ----QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493
               Q +LD  R   ++  +  GI +LH      IIHRDLK SNI++ ++   KI DFG+
Sbjct: 109 CQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165
Query: 494 ARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
           AR  G   T    +  V T  Y APE  +   +    D++S G ++ E++  K
Sbjct: 166 ARTAG---TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 37/226 (16%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVL 394
           +TI     ++   + +G G +G V       +G  +AVK+LS+   S   A+    E+ L
Sbjct: 38  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 97
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-------------LYDPEKQGQL 441
           +  ++H N++ LL              F P +SL+ F             L +  K  +L
Sbjct: 98  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 145
Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
                  +I  I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 146 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 197
Query: 502 TQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
           T    +  V T  Y APE  ++   ++   D++S G ++ E++TG+
Sbjct: 198 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 108/233 (46%), Gaps = 43/233 (18%)
Query: 337 FETIEVATNKFSTDNK------LGEGGFGEV---YKGVLPSGQEIAVKRLSKA--SGQGA 385
           F ++EV  + F+   +      +G G  G V   Y  VL   + +A+K+LS+   +   A
Sbjct: 10  FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHA 67
Query: 386 EEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF--------LYDPEK 437
           +    E+VL+  + H+N++ LL              F P K+L+ F        L D   
Sbjct: 68  KRAYRELVLMKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANL 115
Query: 438 ----QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493
               Q +LD  R   ++  +  GI +LH      IIHRDLK SNI++ ++   KI DFG+
Sbjct: 116 CQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172
Query: 494 ARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
           AR  G   T    +  V T  Y APE  +   +    D++S G ++ E++  K
Sbjct: 173 ARTAG---TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 113/229 (49%), Gaps = 13/229 (5%)
Query: 325 NDLTTLESLQFDF-ETIEVATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASG 382
           + L  L  LQ+ + E   +  + F     LG GGFGEV+   +  +G+  A K+L+K   
Sbjct: 164 DSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRL 223
Query: 383 QGAEEFKNEVV---LVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYD-PEK 437
           +  + ++  +V   ++AK+  R +V L  +  E +  + LV   +    + Y +Y+  E 
Sbjct: 224 KKRKGYQGAMVEKKILAKVHSRFIVSL-AYAFETKTDLCLVMTIMNGGDIRYHIYNVDED 282
Query: 438 QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497
                  R       I  G+ +LH+ +   II+RDLK  N+LLD + N +ISD G+A   
Sbjct: 283 NPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVEL 339
Query: 498 GVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
              QT+  T    GT G+MAPE  +  ++    D ++ GV + E+I  +
Sbjct: 340 KAGQTK--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 108/233 (46%), Gaps = 43/233 (18%)
Query: 337 FETIEVATNKFSTDNK------LGEGGFGEV---YKGVLPSGQEIAVKRLSKA--SGQGA 385
           F ++EV  + F+   +      +G G  G V   Y  VL   + +A+K+LS+   +   A
Sbjct: 4   FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHA 61
Query: 386 EEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF--------LYDPEK 437
           +    E+VL+  + H+N++ LL              F P K+L+ F        L D   
Sbjct: 62  KRAYRELVLMKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANL 109
Query: 438 ----QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493
               Q +LD  R   ++  +  GI +LH      IIHRDLK SNI++ ++   KI DFG+
Sbjct: 110 CQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 166
Query: 494 ARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
           AR  G   T    +  V T  Y APE  +   +    D++S G ++ E++  K
Sbjct: 167 ARTAG---TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 108/212 (50%), Gaps = 23/212 (10%)
Query: 344 TNKFSTDNKLGEGGFGEVY--KGVLPSGQEIAVKRLSKAS-----GQGAEEFKNEVVLVA 396
           ++++    KLG G +GEV   K  L +G E A+K + K+S       GA    +EV ++ 
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKL-TGAERAIKIIKKSSVTTTSNSGA--LLDEVAVLK 59
Query: 397 KLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARG 456
           +L H N+++L  F  +     LV E      L   +   +K  ++D +    I+  +  G
Sbjct: 60  QLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAV---IMKQVLSG 116
Query: 457 ILYLHEDSRLRIIHRDLKASNILLDAEMNP---KISDFGMARIFGVDQTQGNTSRIVGTY 513
             YLH+ +   I+HRDLK  N+LL+++      KI DFG++  F V    G     +GT 
Sbjct: 117 TTYLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVG---GKMKERLGTA 170
Query: 514 GYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
            Y+APE  +  ++  K DV+S GV++  ++ G
Sbjct: 171 YYIAPE-VLRKKYDEKCDVWSCGVILYILLCG 201

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 113/229 (49%), Gaps = 13/229 (5%)
Query: 325 NDLTTLESLQFDF-ETIEVATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASG 382
           + L  L  LQ+ + E   +  + F     LG GGFGEV+   +  +G+  A K+L+K   
Sbjct: 164 DSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRL 223
Query: 383 QGAEEFKNEVV---LVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYD-PEK 437
           +  + ++  +V   ++AK+  R +V L  +  E +  + LV   +    + Y +Y+  E 
Sbjct: 224 KKRKGYQGAMVEKKILAKVHSRFIVSL-AYAFETKTDLCLVMTIMNGGDIRYHIYNVDED 282
Query: 438 QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497
                  R       I  G+ +LH+ +   II+RDLK  N+LLD + N +ISD G+A   
Sbjct: 283 NPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVEL 339
Query: 498 GVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
              QT+  T    GT G+MAPE  +  ++    D ++ GV + E+I  +
Sbjct: 340 KAGQTK--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 347 FSTDNKLGEGGFGEVYK-----GVLPSGQEIAVKRLSKASGQGA--EEFKNEVVLVAKLQ 399
           + T  +LG G F  V K       L    +   KR +K+S +G   E+ + EV ++ ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
           H N++ L        + IL+ E V    L  FL + E    L      + +  I  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYY 129
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNP----KISDFGMARIFGVDQTQGNTSR-IVGTYG 514
           LH    L+I H DLK  NI+L     P    KI DFG+A         GN  + I GT  
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF----GNEFKNIFGTPA 182
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
           ++APE   +    +++D++S GV+   +++G
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 111/213 (52%), Gaps = 19/213 (8%)
Query: 340 IEVATNKFSTDNKLGEGGFGEVYK-GVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKL 398
           +E+  + F   ++LG G  G V+K    PSG  +A K +     +     +N+++   ++
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL---EIKPAIRNQIIRELQV 57
Query: 399 QHR-NLVRLLGFC----LEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGI 453
            H  N   ++GF      +GE  I + E +   SLD  L   +K G++      K+   +
Sbjct: 58  LHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVL---KKAGRIPEQILGKVSIAV 113
Query: 454 ARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTY 513
            +G+ YL E  + +I+HRD+K SNIL+++    K+ DFG++    +D      +  VGT 
Sbjct: 114 IKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSM---ANSFVGTR 167
Query: 514 GYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
            YM+PE      +SV+SD++S G+ ++E+  G+
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 109/233 (46%), Gaps = 43/233 (18%)
Query: 336 DFETIEVATNKFSTDNK------LGEGGFGEV---YKGVLPSGQEIAVKRLSKA--SGQG 384
           +F ++E+  + F+   +      +G G  G V   Y  +L   + +A+K+LS+   +   
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTH 66
Query: 385 AEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF--------LYDPE 436
           A+    E+VL+  + H+N++ LL              F P KSL+ F        L D  
Sbjct: 67  AKRAYRELVLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDAN 114
Query: 437 K----QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 492
                Q +LD  R   ++  +  GI +LH      IIHRDLK SNI++ ++   KI DFG
Sbjct: 115 LSQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFG 171
Query: 493 MARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
           +AR  G   T    +  V T  Y APE  +   +    D++S G ++ E+I G
Sbjct: 172 LARTAG---TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 111/213 (52%), Gaps = 19/213 (8%)
Query: 340 IEVATNKFSTDNKLGEGGFGEVYK-GVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKL 398
           +E+  + F   ++LG G  G V+K    PSG  +A K +     +     +N+++   ++
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL---EIKPAIRNQIIRELQV 57
Query: 399 QHR-NLVRLLGFC----LEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGI 453
            H  N   ++GF      +GE  I + E +   SLD  L   +K G++      K+   +
Sbjct: 58  LHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVL---KKAGRIPEQILGKVSIAV 113
Query: 454 ARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTY 513
            +G+ YL E  + +I+HRD+K SNIL+++    K+ DFG++    +D      +  VGT 
Sbjct: 114 IKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSM---ANSFVGTR 167
Query: 514 GYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
            YM+PE      +SV+SD++S G+ ++E+  G+
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 107/211 (50%), Gaps = 30/211 (14%)
Query: 353 LGEGGFGEVYKGVLPS----GQ----EIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLV 404
           LG+G F +++KGV       GQ    E+ +K L KA    +E F     +++KL H++LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
              G C  G+E ILV EFV   SLD +L   +    + W  + ++   +A  + +L E++
Sbjct: 76  LNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAWAMHFLEENT 133
Query: 465 RLRIIHRDLKASNILLDAEM-----NP---KISDFGMA-RIFGVDQTQGNTSRIVGTYGY 515
              +IH ++ A NILL  E      NP   K+SD G++  +   D  Q    RI     +
Sbjct: 134 ---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQ---ERI----PW 183
Query: 516 MAPEYAMHGQ-FSVKSDVYSFGVLVLEIITG 545
           + PE   + +  ++ +D +SFG  + EI +G
Sbjct: 184 VPPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 111/213 (52%), Gaps = 19/213 (8%)
Query: 340 IEVATNKFSTDNKLGEGGFGEVYK-GVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKL 398
           +E+  + F   ++LG G  G V+K    PSG  +A K +     +     +N+++   ++
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL---EIKPAIRNQIIRELQV 57
Query: 399 QHR-NLVRLLGFC----LEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGI 453
            H  N   ++GF      +GE  I + E +   SLD  L   +K G++      K+   +
Sbjct: 58  LHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVL---KKAGRIPEQILGKVSIAV 113
Query: 454 ARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTY 513
            +G+ YL E  + +I+HRD+K SNIL+++    K+ DFG++    +D      +  VGT 
Sbjct: 114 IKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSM---ANSFVGTR 167
Query: 514 GYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
            YM+PE      +SV+SD++S G+ ++E+  G+
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 108/233 (46%), Gaps = 43/233 (18%)
Query: 337 FETIEVATNKFSTDNK------LGEGGFGEV---YKGVLPSGQEIAVKRLSKA--SGQGA 385
           F ++EV  + F+   +      +G G  G V   Y  VL   + +A+K+LS+   +   A
Sbjct: 11  FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHA 68
Query: 386 EEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF--------LYDPEK 437
           +    E+VL+  + H+N++ LL              F P K+L+ F        L D   
Sbjct: 69  KRAYRELVLMKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANL 116
Query: 438 ----QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493
               Q +LD  R   ++  +  GI +LH      IIHRDLK SNI++ ++   KI DFG+
Sbjct: 117 CQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 173
Query: 494 ARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
           AR  G   T    +  V T  Y APE  +   +    D++S G ++ E++  K
Sbjct: 174 ARTAG---TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 100/202 (49%), Gaps = 14/202 (6%)
Query: 346 KFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRL---SKASGQGAEEFKNEVVLVAKLQHR 401
           K+    K+GEG +G V+K       EI A+KR+       G  +   + E+ L+ +L+H+
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHK 61
Query: 402 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH 461
           N+VRL       ++  LV+EF       YF       G LD       +  + +G+ + H
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYF---DSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYA 521
             +   ++HRDLK  N+L++     K+++FG+AR FG+   +  ++ +V T  Y  P+  
Sbjct: 119 SRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGI-PVRCYSAEVV-TLWYRPPDVL 173
Query: 522 MHGQ-FSVKSDVYSFGVLVLEI 542
              + +S   D++S G +  E+
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAEL 195

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 46/221 (20%)
Query: 347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNL 403
           + +   +G G +G V   +   SG+++A+K+LS+   S   A+    E++L+  +QH N+
Sbjct: 26  YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENV 85
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSL----DYFLYDPEKQGQLDWSRRYKIIG-------- 451
           + LL              F P  SL    D++L  P  Q  L      KI+G        
Sbjct: 86  IGLLDV------------FTPASSLRNFYDFYLVMPFMQTDLQ-----KIMGLKFSEEKI 128
Query: 452 -----GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT 506
                 + +G+ Y+H      ++HRDLK  N+ ++ +   KI DFG+AR           
Sbjct: 129 QYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEM 180
Query: 507 SRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
           +  V T  Y APE  +    ++   D++S G ++ E++TGK
Sbjct: 181 TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 94/198 (47%), Gaps = 12/198 (6%)
Query: 353 LGEGGFGEVYKGVLPSGQEIAVKRLSKAS----GQGAEEFKNEVVLVAKLQHRNLVRLLG 408
           LG+GGF + Y+      +E+   ++   S        E+   E+ +   L + ++V   G
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 93
Query: 409 FCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRI 468
           F  + +   +V E    +SL        ++   +   RY +   I +G+ YLH +   R+
Sbjct: 94  FFEDDDFVYVVLEICRRRSL--LELHKRRKAVTEPEARYFMRQTI-QGVQYLHNN---RV 147
Query: 469 IHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSV 528
           IHRDLK  N+ L+ +M+ KI DFG+A     D  +     + GT  Y+APE       S 
Sbjct: 148 IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKD--LCGTPNYIAPEVLCKKGHSF 205
Query: 529 KSDVYSFGVLVLEIITGK 546
           + D++S G ++  ++ GK
Sbjct: 206 EVDIWSLGCILYTLLVGK 223

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 93/198 (46%), Gaps = 12/198 (6%)
Query: 353 LGEGGFGEVYKGVLPSGQEIAVKRLSKAS----GQGAEEFKNEVVLVAKLQHRNLVRLLG 408
           LG+GGF + ++      +E+   ++   S        E+   E+ +   L H+++V   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 409 FCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRI 468
           F  + +   +V E    +SL   L+   K      +R Y  +  I  G  YLH   R R+
Sbjct: 83  FFEDNDFVFVVLELCRRRSL-LELHKRRKALTEPEARYY--LRQIVLGCQYLH---RNRV 136
Query: 469 IHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSV 528
           IHRDLK  N+ L+ ++  KI DFG+A     D  +     + GT  Y+APE       S 
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGHSF 194
Query: 529 KSDVYSFGVLVLEIITGK 546
           + DV+S G ++  ++ GK
Sbjct: 195 EVDVWSIGCIMYTLLVGK 212

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 118/260 (45%), Gaps = 38/260 (14%)
Query: 314 KYNAVPESNADNDLTTLESLQFDFE-TIEVATNKFSTDNKLGEGGFGEVYK----GVLPS 368
           ++  V E N +N +  ++  Q  ++   E   N+ S    LG G FG+V +    G++ S
Sbjct: 8   QWKVVEEINGNNXVX-IDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKS 66
Query: 369 --GQEIAVKRLSKASGQGAEE-FKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVP 424
                +AVK L  ++     E   +E+ +++ L  H N+V LLG C  G   +++ E+  
Sbjct: 67  DAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCC 126
Query: 425 NKSLDYFLYDPEKQGQLDWSRRYKIIGG-----------------IARGILYLHEDSRLR 467
              L  FL    K+     S+    I                   +A+G+ +L   +   
Sbjct: 127 YGDLLNFLR--RKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--- 181
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ---TQGNTSRIVGTYGYMAPEYAMHG 524
            IHRDL A NILL      KI DFG+AR    D     +GN    V    +MAPE   + 
Sbjct: 182 CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPV---KWMAPESIFNC 238
Query: 525 QFSVKSDVYSFGVLVLEIIT 544
            ++ +SDV+S+G+ + E+ +
Sbjct: 239 VYTFESDVWSYGIFLWELFS 258

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 93/198 (46%), Gaps = 12/198 (6%)
Query: 353 LGEGGFGEVYKGVLPSGQEIAVKRLSKAS----GQGAEEFKNEVVLVAKLQHRNLVRLLG 408
           LG+GGF + ++      +E+   ++   S        E+   E+ +   L H+++V   G
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 409 FCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRI 468
           F  + +   +V E    +SL   L+   K      +R Y  +  I  G  YLH   R R+
Sbjct: 107 FFEDNDFVFVVLELCRRRSL-LELHKRRKALTEPEARYY--LRQIVLGCQYLH---RNRV 160
Query: 469 IHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSV 528
           IHRDLK  N+ L+ ++  KI DFG+A     D  +     + GT  Y+APE       S 
Sbjct: 161 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGHSF 218
Query: 529 KSDVYSFGVLVLEIITGK 546
           + DV+S G ++  ++ GK
Sbjct: 219 EVDVWSIGCIMYTLLVGK 236

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 109/233 (46%), Gaps = 43/233 (18%)
Query: 336 DFETIEVATNKFSTDNK------LGEGGFGEV---YKGVLPSGQEIAVKRLSKA--SGQG 384
           +F ++E+  + F+   +      +G G  G V   Y  +L   + +A+K+LS+   +   
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTH 66
Query: 385 AEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF--------LYDPE 436
           A+    E+VL+  + H+N++ LL              F P KSL+ F        L D  
Sbjct: 67  AKRAYRELVLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDAN 114
Query: 437 K----QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 492
                Q +LD  R   ++  +  GI +LH      IIHRDLK SNI++ ++   KI DFG
Sbjct: 115 LSQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 171
Query: 493 MARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
           +AR  G   T    +  V T  Y APE  +   +    D++S G ++ E+I G
Sbjct: 172 LARTAG---TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 110/212 (51%), Gaps = 19/212 (8%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYK-GVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ 399
           E+  + F   ++LG G  G V+K    PSG  +A K +     +     +N+++   ++ 
Sbjct: 64  ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL---EIKPAIRNQIIRELQVL 120
Query: 400 HR-NLVRLLGFC----LEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIA 454
           H  N   ++GF      +GE  I + E +   SLD  L   +K G++      K+   + 
Sbjct: 121 HECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVL---KKAGRIPEQILGKVSIAVI 176
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
           +G+ YL E  + +I+HRD+K SNIL+++    K+ DFG++    +D      +  VGT  
Sbjct: 177 KGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSM---ANSFVGTRS 230
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
           YM+PE      +SV+SD++S G+ ++E+  G+
Sbjct: 231 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 262

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 108/233 (46%), Gaps = 43/233 (18%)
Query: 336 DFETIEVATNKFSTDNK------LGEGGFGEV---YKGVLPSGQEIAVKRLSKA--SGQG 384
           +F ++E+  + F+   +      +G G  G V   Y  +L   + +A+K+LS+   +   
Sbjct: 11  NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTH 68
Query: 385 AEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF--------LYDPE 436
           A+    E+VL+  + H+N++ LL              F P KSL+ F        L D  
Sbjct: 69  AKRAYRELVLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDAN 116
Query: 437 K----QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 492
                Q +LD  R   ++  +  GI +LH      IIHRDLK SNI++ ++   KI DFG
Sbjct: 117 LCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 173
Query: 493 MARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
           +AR  G   T       V T  Y APE  +   +    D++S G ++ E+I G
Sbjct: 174 LARTAG---TSFMMVPFVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 99/208 (47%), Gaps = 12/208 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQE----IAVKRLSKASGQGA-EEFKNEVVLV 395
           E+   +      +GEG FG+V++G+  S +     +A+K     +     E+F  E + +
Sbjct: 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 445
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
            +  H ++V+L+G   E    I++ E      L  FL    ++  LD +        ++ 
Sbjct: 446 RQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFLQ--VRKFSLDLASLILYAYQLST 502
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGY 515
            + YL      R +HRD+ A N+L+ +    K+ DFG++R +  D T    S+      +
Sbjct: 503 ALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKW 558
Query: 516 MAPEYAMHGQFSVKSDVYSFGVLVLEII 543
           MAPE     +F+  SDV+ FGV + EI+
Sbjct: 559 MAPESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 111/213 (52%), Gaps = 19/213 (8%)
Query: 340 IEVATNKFSTDNKLGEGGFGEVYK-GVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKL 398
           +E+  + F   ++LG G  G V+K    PSG  +A K +     +     +N+++   ++
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL---EIKPAIRNQIIRELQV 57
Query: 399 QHR-NLVRLLGFC----LEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGI 453
            H  N   ++GF      +GE  I + E +   SLD  L   +K G++      K+   +
Sbjct: 58  LHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVL---KKAGRIPEQILGKVSIAV 113
Query: 454 ARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTY 513
            +G+ YL E  + +I+HRD+K SNIL+++    K+ DFG++    +D      +  VGT 
Sbjct: 114 IKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSM---ANSFVGTR 167
Query: 514 GYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
            YM+PE      +SV+SD++S G+ ++E+  G+
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 111/213 (52%), Gaps = 19/213 (8%)
Query: 340 IEVATNKFSTDNKLGEGGFGEVYK-GVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKL 398
           +E+  + F   ++LG G  G V+K    PSG  +A K +     +     +N+++   ++
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL---EIKPAIRNQIIRELQV 57
Query: 399 QHR-NLVRLLGFC----LEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGI 453
            H  N   ++GF      +GE  I + E +   SLD  L   +K G++      K+   +
Sbjct: 58  LHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVL---KKAGRIPEQILGKVSIAV 113
Query: 454 ARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTY 513
            +G+ YL E  + +I+HRD+K SNIL+++    K+ DFG++    +D      +  VGT 
Sbjct: 114 IKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSM---ANSFVGTR 167
Query: 514 GYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
            YM+PE      +SV+SD++S G+ ++E+  G+
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 93/198 (46%), Gaps = 12/198 (6%)
Query: 353 LGEGGFGEVYKGVLPSGQEIAVKRLSKAS----GQGAEEFKNEVVLVAKLQHRNLVRLLG 408
           LG+GGF + ++      +E+   ++   S        E+   E+ +   L H+++V   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 409 FCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRI 468
           F  + +   +V E    +SL   L+   K      +R Y  +  I  G  YLH   R R+
Sbjct: 109 FFEDNDFVFVVLELCRRRSL-LELHKRRKALTEPEARYY--LRQIVLGCQYLH---RNRV 162
Query: 469 IHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSV 528
           IHRDLK  N+ L+ ++  KI DFG+A     D  +     + GT  Y+APE       S 
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGHSF 220
Query: 529 KSDVYSFGVLVLEIITGK 546
           + DV+S G ++  ++ GK
Sbjct: 221 EVDVWSIGCIMYTLLVGK 238

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 103/226 (45%), Gaps = 37/226 (16%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVL 394
           +TI     ++   + +G G +G V       +G  +AVK+LS+   S   A+    E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-------------LYDPEKQGQL 441
           +  ++H N++ LL              F P +SL+ F             L +  K  +L
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKSQKL 122
Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
                  +I  I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+ R      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLCR-----H 174
Query: 502 TQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
           T    +  V T  Y APE  ++   ++   D++S G ++ E++TG+
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 104/226 (46%), Gaps = 37/226 (16%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVL 394
           +TI     ++   + +G G +G V       +G  +AVK+LS+   S   A+    E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-------------LYDPEKQGQL 441
           +  ++H N++ LL              F P +SL+ F             L +  K  +L
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
                  +I  I RG+ Y+H      IIHRDLK SN+ ++ +   KI D+G+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDYGLAR-----H 174
Query: 502 TQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
           T    +  V T  Y APE  ++   ++   D++S G ++ E++TG+
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 110/234 (47%), Gaps = 22/234 (9%)
Query: 321 SNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYK-GVLPSGQEIAVKRLSK 379
           S    DL +   +    +  EV  +      +LG G +G V K   +PSGQ +AVKR+ +
Sbjct: 27  STPPRDLDSKACISIGNQNFEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRI-R 85
Query: 380 ASGQGAEEFKNEVVLVAKLQHRNL-----VRLLGFCLEGEEKILVYEFVPNKSLDYFLYD 434
           A+    E+    +++   +  R +     V   G      +  +  E + + SLD F   
Sbjct: 86  ATVNSQEQ--KRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQ 142
Query: 435 PEKQGQLDWSRRYKIIGGIARGILYL--HEDSRLRIIHRDLKASNILLDAEMNPKISDFG 492
              +GQ   +    I+G IA  I+    H  S+L +IHRD+K SN+L++A    K+ DFG
Sbjct: 143 VIDKGQ---TIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFG 199
Query: 493 MARIFGVDQTQGNTSRIVGTYGYMAPEYA----MHGQFSVKSDVYSFGVLVLEI 542
           ++  + VD          G   YMAPE          +SVKSD++S G+ ++E+
Sbjct: 200 ISG-YLVDSVAKTID--AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIEL 250

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 111/224 (49%), Gaps = 13/224 (5%)
Query: 330 LESLQFDF-ETIEVATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEE 387
           L  LQ+ + E   +  + F     LG GGFGEV+   +  +G+  A K+L+K   +  + 
Sbjct: 169 LRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKG 228
Query: 388 FKNEVV---LVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYD-PEKQGQLD 442
           ++  +V   ++AK+  R +V L  +  E +  + LV   +    + Y +Y+  E      
Sbjct: 229 YQGAMVEKKILAKVHSRFIVSL-AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ 287
Query: 443 WSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502
             R       I  G+ +LH+ +   II+RDLK  N+LLD + N +ISD G+A      QT
Sbjct: 288 EPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT 344
Query: 503 QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
           +  T    GT G+MAPE  +  ++    D ++ GV + E+I  +
Sbjct: 345 K--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 117/260 (45%), Gaps = 38/260 (14%)
Query: 314 KYNAVPESNADNDLTTLESLQFDFE-TIEVATNKFSTDNKLGEGGFGEVYK----GVLPS 368
           ++  V E N +N    ++  Q  ++   E   N+ S    LG G FG+V +    G++ S
Sbjct: 15  QWKVVEEINGNN-YVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKS 73
Query: 369 --GQEIAVKRLSKASGQGAEE-FKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVP 424
                +AVK L  ++     E   +E+ +++ L  H N+V LLG C  G   +++ E+  
Sbjct: 74  DAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCC 133
Query: 425 NKSLDYFLYDPEKQGQLDWSRRYKIIGG-----------------IARGILYLHEDSRLR 467
              L  FL    K+     S+    I                   +A+G+ +L   +   
Sbjct: 134 YGDLLNFLR--RKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--- 188
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ---TQGNTSRIVGTYGYMAPEYAMHG 524
            IHRDL A NILL      KI DFG+AR    D     +GN    V    +MAPE   + 
Sbjct: 189 CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPV---KWMAPESIFNC 245
Query: 525 QFSVKSDVYSFGVLVLEIIT 544
            ++ +SDV+S+G+ + E+ +
Sbjct: 246 VYTFESDVWSYGIFLWELFS 265

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 117/260 (45%), Gaps = 38/260 (14%)
Query: 314 KYNAVPESNADNDLTTLESLQFDFE-TIEVATNKFSTDNKLGEGGFGEVYK----GVLPS 368
           ++  V E N +N    ++  Q  ++   E   N+ S    LG G FG+V +    G++ S
Sbjct: 15  QWKVVEEINGNN-YVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKS 73
Query: 369 --GQEIAVKRLSKASGQGAEE-FKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVP 424
                +AVK L  ++     E   +E+ +++ L  H N+V LLG C  G   +++ E+  
Sbjct: 74  DAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCC 133
Query: 425 NKSLDYFLYDPEKQGQLDWSRRYKIIGG-----------------IARGILYLHEDSRLR 467
              L  FL    K+     S+    I                   +A+G+ +L   +   
Sbjct: 134 YGDLLNFLR--RKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--- 188
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ---TQGNTSRIVGTYGYMAPEYAMHG 524
            IHRDL A NILL      KI DFG+AR    D     +GN    V    +MAPE   + 
Sbjct: 189 CIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNARLPV---KWMAPESIFNC 245
Query: 525 QFSVKSDVYSFGVLVLEIIT 544
            ++ +SDV+S+G+ + E+ +
Sbjct: 246 VYTFESDVWSYGIFLWELFS 265

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 347 FSTDNKLGEGGFGEVYK-----GVLPSGQEIAVKRLSKASGQGA--EEFKNEVVLVAKLQ 399
           + T  +LG G F  V K       L    +   KR +K+S +G   E+ + EV ++ ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
           H N++ L        + IL+ E V    L  FL + E    L      + +  I  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYY 129
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNP----KISDFGMARIFGVDQTQGNTSR-IVGTYG 514
           LH    L+I H DLK  NI+L     P    KI DFG+A         GN  + I GT  
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF----GNEFKNIFGTPE 182
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
           ++APE   +    +++D++S GV+   +++G
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 46/221 (20%)
Query: 347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNL 403
           + +   +G G +G V   +   SG+++A+K+LS+   S   A+    E++L+  +QH N+
Sbjct: 44  YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENV 103
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSL----DYFLYDPEKQGQLDWSRRYKIIG-------- 451
           + LL              F P  SL    D++L  P  Q  L      KI+G        
Sbjct: 104 IGLLDV------------FTPASSLRNFYDFYLVMPFMQTDLQ-----KIMGMEFSEEKI 146
Query: 452 -----GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT 506
                 + +G+ Y+H      ++HRDLK  N+ ++ +   KI DFG+AR           
Sbjct: 147 QYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEM 198
Query: 507 SRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
           +  V T  Y APE  +    ++   D++S G ++ E++TGK
Sbjct: 199 TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 117/260 (45%), Gaps = 38/260 (14%)
Query: 314 KYNAVPESNADNDLTTLESLQFDFE-TIEVATNKFSTDNKLGEGGFGEVYK----GVLPS 368
           ++  V E N +N    ++  Q  ++   E   N+ S    LG G FG+V +    G++ S
Sbjct: 10  QWKVVEEINGNN-YVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKS 68
Query: 369 --GQEIAVKRLSKASGQGAEE-FKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVP 424
                +AVK L  ++     E   +E+ +++ L  H N+V LLG C  G   +++ E+  
Sbjct: 69  DAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCC 128
Query: 425 NKSLDYFLYDPEKQGQLDWSRRYKIIGG-----------------IARGILYLHEDSRLR 467
              L  FL    K+     S+    I                   +A+G+ +L   +   
Sbjct: 129 YGDLLNFLR--RKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--- 183
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ---TQGNTSRIVGTYGYMAPEYAMHG 524
            IHRDL A NILL      KI DFG+AR    D     +GN    V    +MAPE   + 
Sbjct: 184 CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPV---KWMAPESIFNC 240
Query: 525 QFSVKSDVYSFGVLVLEIIT 544
            ++ +SDV+S+G+ + E+ +
Sbjct: 241 VYTFESDVWSYGIFLWELFS 260

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 108/213 (50%), Gaps = 16/213 (7%)
Query: 339 TIEVATNKFSTDNKLGEGGFGEVYK-GVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAK 397
           ++EV  +      +LG G +G V K   +PSGQ +AVKR+ +A+    E+ +  + L   
Sbjct: 1   SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRI-RATVNSQEQKRLLMDLDIS 59
Query: 398 LQHRNLVRLLGF--CLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
           ++  +    + F   L  E  + +   + + SLD F      +GQ   +    I+G IA 
Sbjct: 60  MRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQ---TIPEDILGKIAV 116
Query: 456 GILYL--HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTY 513
            I+    H  S+L +IHRD+K SN+L++A    K+ DFG++  + VD    +     G  
Sbjct: 117 SIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISG-YLVDDVAKDID--AGCK 173
Query: 514 GYMAPEYA----MHGQFSVKSDVYSFGVLVLEI 542
            YMAPE          +SVKSD++S G+ ++E+
Sbjct: 174 PYMAPERINPELNQKGYSVKSDIWSLGITMIEL 206

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 102/207 (49%), Gaps = 11/207 (5%)
Query: 346 KFSTDNKLGEGGFGEV---YKGVLPSGQEIAVKRLSKASGQG-AEEFKNEVVLVAKLQHR 401
           +++  + +GEG +G V   Y  V  +   +A+K++S    Q   +    E+ ++ + +H 
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 81
Query: 402 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH 461
           N++ +         + +   ++    ++  LY   K   L        +  I RG+ Y+H
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 141
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ-GNTSRIVGTYGYMAPEY 520
             +   ++HRDLK SN+LL+   + KI DFG+AR+   D    G  +  V T  Y APE 
Sbjct: 142 SAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 521 AMHGQFSVKS-DVYSFGVLVLEIITGK 546
            ++ +   KS D++S G ++ E+++ +
Sbjct: 199 MLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 102/207 (49%), Gaps = 11/207 (5%)
Query: 346 KFSTDNKLGEGGFGEV---YKGVLPSGQEIAVKRLSKASGQG-AEEFKNEVVLVAKLQHR 401
           +++  + +GEG +G V   Y  V  +   +A+K++S    Q   +    E+ ++ + +H 
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 81
Query: 402 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH 461
           N++ +         + +   ++    ++  LY   K   L        +  I RG+ Y+H
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 141
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ-GNTSRIVGTYGYMAPEY 520
             +   ++HRDLK SN+LL+   + KI DFG+AR+   D    G  +  V T  Y APE 
Sbjct: 142 SAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 521 AMHGQFSVKS-DVYSFGVLVLEIITGK 546
            ++ +   KS D++S G ++ E+++ +
Sbjct: 199 MLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 108/232 (46%), Gaps = 43/232 (18%)
Query: 337 FETIEVATNKFSTDNK------LGEGGFGEV---YKGVLPSGQEIAVKRLSKA--SGQGA 385
           F ++EVA + F+   +      +G G  G V   +  VL  G  +AVK+LS+   +   A
Sbjct: 10  FYSVEVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHA 67
Query: 386 EEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF--------LYDPEK 437
           +    E+VL+  + H+N++ LL              F P K+L+ F        L D   
Sbjct: 68  KRAYRELVLLKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANL 115
Query: 438 ----QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493
                 +LD  R   ++  +  GI +LH      IIHRDLK SNI++ ++   KI DFG+
Sbjct: 116 CQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172
Query: 494 ARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
           AR      T    +  V T  Y APE  +   ++   D++S G ++ E++ G
Sbjct: 173 ARTAC---TNFMMTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 102/207 (49%), Gaps = 11/207 (5%)
Query: 346 KFSTDNKLGEGGFGEV---YKGVLPSGQEIAVKRLSKASGQG-AEEFKNEVVLVAKLQHR 401
           +++  + +GEG +G V   Y  V  +   +A+K++S    Q   +    E+ ++ + +H 
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 83
Query: 402 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH 461
           N++ +         + +   ++    ++  LY   K   L        +  I RG+ Y+H
Sbjct: 84  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 143
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ-GNTSRIVGTYGYMAPEY 520
             +   ++HRDLK SN+LL+   + KI DFG+AR+   D    G  +  V T  Y APE 
Sbjct: 144 SAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 200
Query: 521 AMHGQFSVKS-DVYSFGVLVLEIITGK 546
            ++ +   KS D++S G ++ E+++ +
Sbjct: 201 MLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 347 FSTDNKLGEGGFGEVYK-----GVLPSGQEIAVKRLSKASGQGA--EEFKNEVVLVAKLQ 399
           + T  +LG G F  V K       L    +   KR +K+S +G   E+ + EV ++ ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
           H N++ L        + IL+ E V    L  FL + E    L      + +  I  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYY 129
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNP----KISDFGMARIFGVDQTQGNTSR-IVGTYG 514
           LH    L+I H DLK  NI+L     P    KI DFG+A         GN  + I GT  
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF----GNEFKNIFGTPE 182
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
           ++APE   +    +++D++S GV+   +++G
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 110/212 (51%), Gaps = 19/212 (8%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYK-GVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ 399
           E+  + F   ++LG G  G V+K    PSG  +A K +     +     +N+++   ++ 
Sbjct: 29  ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL---EIKPAIRNQIIRELQVL 85
Query: 400 HR-NLVRLLGFC----LEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIA 454
           H  N   ++GF      +GE  I + E +   SLD  L   +K G++      K+   + 
Sbjct: 86  HECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVL---KKAGRIPEQILGKVSIAVI 141
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
           +G+ YL E  + +I+HRD+K SNIL+++    K+ DFG++    +D      +  VGT  
Sbjct: 142 KGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSM---ANSFVGTRS 195
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
           YM+PE      +SV+SD++S G+ ++E+  G+
Sbjct: 196 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 110/212 (51%), Gaps = 19/212 (8%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYK-GVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ 399
           E+  + F   ++LG G  G V+K    PSG  +A K +     +     +N+++   ++ 
Sbjct: 21  ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL---EIKPAIRNQIIRELQVL 77
Query: 400 HR-NLVRLLGFC----LEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIA 454
           H  N   ++GF      +GE  I + E +   SLD  L   +K G++      K+   + 
Sbjct: 78  HECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVL---KKAGRIPEQILGKVSIAVI 133
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
           +G+ YL E  + +I+HRD+K SNIL+++    K+ DFG++    +D      +  VGT  
Sbjct: 134 KGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSM---ANSFVGTRS 187
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
           YM+PE      +SV+SD++S G+ ++E+  G+
Sbjct: 188 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 219

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 106/225 (47%), Gaps = 47/225 (20%)
Query: 346 KFSTDNKLGEGGFGEV---YKGVLPSGQEIAVKRLSKASGQG-AEEFKNEVVLVAKLQHR 401
           +++  + +GEG +G V   Y  V  +   +A+K++S    Q   +    E+ ++ + +H 
Sbjct: 44  RYTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 101
Query: 402 NLVRL----------------LGFCLEGEE--KILVYEFVPNKSLDYFLYDPEKQGQLDW 443
           N++ +                L   L G +  K+L  + + N  + YFLY          
Sbjct: 102 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQ--------- 152
Query: 444 SRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ 503
                    I RG+ Y+H  +   ++HRDLK SN+LL+   + KI DFG+AR+   D   
Sbjct: 153 ---------ILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDH 200
Query: 504 -GNTSRIVGTYGYMAPEYAMHGQFSVKS-DVYSFGVLVLEIITGK 546
            G  +  V T  Y APE  ++ +   KS D++S G ++ E+++ +
Sbjct: 201 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 109/234 (46%), Gaps = 43/234 (18%)
Query: 336 DFETIEVATNKFSTDNK------LGEGGFGEV---YKGVLPSGQEIAVKRLSKA--SGQG 384
           +F ++E+  + F+   +      +G G  G V   Y  +L   + +A+K+LS+   +   
Sbjct: 3   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTH 60
Query: 385 AEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF--------LYDPE 436
           A+    E+VL+  + H+N++ LL              F P KSL+ F        L D  
Sbjct: 61  AKRAYRELVLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDAN 108
Query: 437 K----QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 492
                Q +LD  R   ++  +  GI +LH      IIHRDLK SNI++ ++   KI DFG
Sbjct: 109 LCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 165
Query: 493 MARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
           +AR  G   T    +  V T  Y APE  +   +    D++S G ++ E++  K
Sbjct: 166 LARTAG---TSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 103/226 (45%), Gaps = 37/226 (16%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVL 394
           +TI     ++   + +G G +G V       +G  +AVK+LS+   S   A+    E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-------------LYDPEKQGQL 441
           +  ++H N++ LL              F P +SL+ F             L +  K  +L
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
                  +I  I RG+ Y+H      IIHRDLK SN+ ++ +   KI DF +AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFYLAR-----H 174
Query: 502 TQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
           T    +  V T  Y APE  ++   ++   D++S G ++ E++TG+
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 347 FSTDNKLGEGGFGEVYK-----GVLPSGQEIAVKRLSKASGQGA--EEFKNEVVLVAKLQ 399
           + T  +LG G F  V K       L    +   KR +K+S +G   E+ + EV ++ ++Q
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
           H N++ L        + IL+ E V    L  FL + E    L      + +  I  G+ Y
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYY 128
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNP----KISDFGMARIFGVDQTQGNTSR-IVGTYG 514
           LH    L+I H DLK  NI+L     P    KI DFG+A         GN  + I GT  
Sbjct: 129 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF----GNEFKNIFGTPE 181
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
           ++APE   +    +++D++S GV+   +++G
Sbjct: 182 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 347 FSTDNKLGEGGFGEVYK-----GVLPSGQEIAVKRLSKASGQGA--EEFKNEVVLVAKLQ 399
           + T  +LG G F  V K       L    +   KR +K+S +G   E+ + EV ++ ++Q
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
           H N++ L        + IL+ E V    L  FL + E    L      + +  I  G+ Y
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYY 128
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNP----KISDFGMARIFGVDQTQGNTSR-IVGTYG 514
           LH    L+I H DLK  NI+L     P    KI DFG+A         GN  + I GT  
Sbjct: 129 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF----GNEFKNIFGTPE 181
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
           ++APE   +    +++D++S GV+   +++G
Sbjct: 182 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 102/207 (49%), Gaps = 11/207 (5%)
Query: 346 KFSTDNKLGEGGFGEV---YKGVLPSGQEIAVKRLSKASGQG-AEEFKNEVVLVAKLQHR 401
           +++  + +GEG +G V   Y  V  +   +A+K++S    Q   +    E+ ++ + +H 
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 81
Query: 402 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH 461
           N++ +         + +   ++    ++  LY   K   L        +  I RG+ Y+H
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 141
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ-GNTSRIVGTYGYMAPEY 520
             +   ++HRDLK SN+LL+   + KI DFG+AR+   D    G  +  V T  Y APE 
Sbjct: 142 SAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 521 AMHGQFSVKS-DVYSFGVLVLEIITGK 546
            ++ +   KS D++S G ++ E+++ +
Sbjct: 199 MLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 102/200 (51%), Gaps = 13/200 (6%)
Query: 351 NKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAE-EFKNEVVLVAKLQHRNLVRLLG 408
           +KLGEG +  VYKG    +   +A+K +     +GA      EV L+  L+H N+V L  
Sbjct: 8   DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 67
Query: 409 FCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKI-IGGIARGILYLHEDSRLR 467
                +   LV+E++ +K L  +L D    G +      K+ +  + RG+ Y H   R +
Sbjct: 68  IIHTEKSLTLVFEYL-DKDLKQYLDD---CGNIINMHNVKLFLFQLLRGLAYCH---RQK 120
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG-QF 526
           ++HRDLK  N+L++     K++DFG+AR   +  T+   + +V T  Y  P+  +    +
Sbjct: 121 VLHRDLKPQNLLINERGELKLADFGLARAKSI-PTKTYDNEVV-TLWYRPPDILLGSTDY 178
Query: 527 SVKSDVYSFGVLVLEIITGK 546
           S + D++  G +  E+ TG+
Sbjct: 179 STQIDMWGVGCIFYEMATGR 198

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 102/207 (49%), Gaps = 11/207 (5%)
Query: 346 KFSTDNKLGEGGFGEV---YKGVLPSGQEIAVKRLSKASGQG-AEEFKNEVVLVAKLQHR 401
           +++  + +GEG +G V   Y  V  +   +A+K++S    Q   +    E+ ++ + +H 
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 81
Query: 402 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH 461
           N++ +         + +   ++    ++  LY   K   L        +  I RG+ Y+H
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 141
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ-GNTSRIVGTYGYMAPEY 520
             +   ++HRDLK SN+LL+   + KI DFG+AR+   D    G  +  V T  Y APE 
Sbjct: 142 SAN---VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 521 AMHGQFSVKS-DVYSFGVLVLEIITGK 546
            ++ +   KS D++S G ++ E+++ +
Sbjct: 199 MLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 98/200 (49%), Gaps = 11/200 (5%)
Query: 353 LGEGGFGEV---YKGVLPSGQEIAVKRLSKASGQG-AEEFKNEVVLVAKLQHRNLVRLLG 408
           +GEG +G V   Y  V      +A+K++S    Q   +    E+ ++ + +H N++ +  
Sbjct: 51  IGEGAYGMVSSAYDHV--RKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRD 108
Query: 409 FCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRI 468
                  + +   ++    ++  LY   K  QL        +  I RG+ Y+H  +   +
Sbjct: 109 ILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHSAN---V 165
Query: 469 IHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ-GNTSRIVGTYGYMAPEYAMHGQFS 527
           +HRDLK SN+L++   + KI DFG+ARI   +    G  +  V T  Y APE  ++ +  
Sbjct: 166 LHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLNSKGY 225
Query: 528 VKS-DVYSFGVLVLEIITGK 546
            KS D++S G ++ E+++ +
Sbjct: 226 TKSIDIWSVGCILAEMLSNR 245

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 347 FSTDNKLGEGGFGEVYK-----GVLPSGQEIAVKRLSKASGQGA--EEFKNEVVLVAKLQ 399
           + T  +LG G F  V K       L    +   KR +K+S +G   E+ + EV ++ ++Q
Sbjct: 13  YDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
           H N++ L        + IL+ E V    L  FL + E    L      + +  I  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYY 129
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNP----KISDFGMARIFGVDQTQGNTSR-IVGTYG 514
           LH    L+I H DLK  NI+L     P    KI DFG+A         GN  + I GT  
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF----GNEFKNIFGTPE 182
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
           ++APE   +    +++D++S GV+   +++G
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 102/207 (49%), Gaps = 11/207 (5%)
Query: 346 KFSTDNKLGEGGFGEV---YKGVLPSGQEIAVKRLSKASGQG-AEEFKNEVVLVAKLQHR 401
           +++  + +GEG +G V   Y  V  +   +A+K++S    Q   +    E+ ++ + +H 
Sbjct: 32  RYTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 89
Query: 402 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH 461
           N++ +         + +   ++    ++  LY   K   L        +  I RG+ Y+H
Sbjct: 90  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 149
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ-GNTSRIVGTYGYMAPEY 520
             +   ++HRDLK SN+LL+   + KI DFG+AR+   D    G  +  V T  Y APE 
Sbjct: 150 SAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 206
Query: 521 AMHGQFSVKS-DVYSFGVLVLEIITGK 546
            ++ +   KS D++S G ++ E+++ +
Sbjct: 207 MLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 102/207 (49%), Gaps = 11/207 (5%)
Query: 346 KFSTDNKLGEGGFGEV---YKGVLPSGQEIAVKRLSKASGQG-AEEFKNEVVLVAKLQHR 401
           +++  + +GEG +G V   Y  V  +   +A+K++S    Q   +    E+ ++ + +H 
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 81
Query: 402 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH 461
           N++ +         + +   ++    ++  LY   K   L        +  I RG+ Y+H
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 141
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ-GNTSRIVGTYGYMAPEY 520
             +   ++HRDLK SN+LL+   + KI DFG+AR+   D    G  +  V T  Y APE 
Sbjct: 142 SAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 521 AMHGQFSVKS-DVYSFGVLVLEIITGK 546
            ++ +   KS D++S G ++ E+++ +
Sbjct: 199 MLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 347 FSTDNKLGEGGFGEVYK-----GVLPSGQEIAVKRLSKASGQGA--EEFKNEVVLVAKLQ 399
           + T  +LG G F  V K       L    +   KR +K+S +G   E+ + EV ++ ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
           H N++ L        + IL+ E V    L  FL + E    L      + +  I  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYY 129
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNP----KISDFGMARIFGVDQTQGNTSR-IVGTYG 514
           LH    L+I H DLK  NI+L     P    KI DFG+A         GN  + I GT  
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF----GNEFKNIFGTPE 182
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
           ++APE   +    +++D++S GV+   +++G
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 69/249 (27%), Positives = 112/249 (44%), Gaps = 37/249 (14%)
Query: 325 NDLTTLESLQFDFE-TIEVATNKFSTDNKLGEGGFGEVYK----GVLPS--GQEIAVKRL 377
           N+   ++  Q  ++   E   N+ S    LG G FG+V +    G++ S     +AVK L
Sbjct: 2   NNYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML 61
Query: 378 SKASGQGAEE-FKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDP 435
             ++     E   +E+ +++ L  H N+V LLG C  G   +++ E+     L  FL   
Sbjct: 62  KPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLR-- 119
Query: 436 EKQGQLDWSRRYKIIGG-----------------IARGILYLHEDSRLRIIHRDLKASNI 478
            K+     S+    I                   +A+G+ +L   +    IHRDL A NI
Sbjct: 120 RKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNI 176
Query: 479 LLDAEMNPKISDFGMARIFGVDQ---TQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSF 535
           LL      KI DFG+AR    D     +GN    V    +MAPE   +  ++ +SDV+S+
Sbjct: 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPV---KWMAPESIFNCVYTFESDVWSY 233
Query: 536 GVLVLEIIT 544
           G+ + E+ +
Sbjct: 234 GIFLWELFS 242

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 110/216 (50%), Gaps = 19/216 (8%)
Query: 337 FETIEVATNKFSTDNKLGEGGFGEVYKGVL----PSGQEIAVKRL--SKASGQGAEEFKN 390
           F+++E    K+    K+GEG FG   K +L      G++  +K +  S+ S +  EE + 
Sbjct: 20  FQSME----KYVRLQKIGEGSFG---KAILVKSTEDGRQYVIKEINISRMSSKEREESRR 72
Query: 391 EVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKII 450
           EV ++A ++H N+V+      E     +V ++   +  D F     ++G L   +  +I+
Sbjct: 73  EVAVLANMKHPNIVQYRESFEENGSLYIVMDYC--EGGDLFKRINAQKGVL--FQEDQIL 128
Query: 451 GGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIV 510
               +  L L      +I+HRD+K+ NI L  +   ++ DFG+AR+  ++ T       +
Sbjct: 129 DWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARV--LNSTVELARACI 186
Query: 511 GTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
           GT  Y++PE   +  ++ KSD+++ G ++ E+ T K
Sbjct: 187 GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLK 222

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 103/219 (47%), Gaps = 26/219 (11%)
Query: 352 KLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRN-----LVR 405
           ++G G +G V K V  PSGQ +AVKR+        E+ + ++++   +  R+     +V+
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD---EKEQKQLLMDLDVVMRSSDCPYIVQ 85
Query: 406 LLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL--HED 463
             G      +  +  E +      ++ Y       LD     +I+G I    +    H  
Sbjct: 86  FYGALFREGDCWICMELMSTSFDKFYKY---VYSVLDDVIPEEILGKITLATVKALNHLK 142
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEY--- 520
             L+IIHRD+K SNILLD   N K+ DFG++    VD      +R  G   YMAPE    
Sbjct: 143 ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL-VDSIA--KTRDAGCRPYMAPERIDP 199
Query: 521 -AMHGQFSVKSDVYSFGVLVLEIITG-----KKNSNFYQ 553
            A    + V+SDV+S G+ + E+ TG     K NS F Q
Sbjct: 200 SASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ 238

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 109/234 (46%), Gaps = 43/234 (18%)
Query: 336 DFETIEVATNKFSTDNK------LGEGGFGEV---YKGVLPSGQEIAVKRLSKA--SGQG 384
           +F ++E+  + F+   +      +G G  G V   Y  +L   + +A+K+LS+   +   
Sbjct: 14  NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTH 71
Query: 385 AEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF--------LYDPE 436
           A+    E+VL+  + H+N++ LL              F P KSL+ F        L D  
Sbjct: 72  AKRAYRELVLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDAN 119
Query: 437 K----QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 492
                Q +LD  R   ++  +  GI +LH      IIHRDLK SNI++ ++   KI DFG
Sbjct: 120 LCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 176
Query: 493 MARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
           +AR  G   T    +  V T  Y APE  +   +    D++S G ++ E++  K
Sbjct: 177 LARTAG---TSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 227

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 347 FSTDNKLGEGGFGEVYK-----GVLPSGQEIAVKRLSKASGQGA--EEFKNEVVLVAKLQ 399
           + T  +LG G F  V K       L    +   KR +K+S +G   E+ + EV ++ ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
           H N++ L        + IL+ E V    L  FL + E    L      + +  I  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYY 129
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNP----KISDFGMARIFGVDQTQGNTSR-IVGTYG 514
           LH    L+I H DLK  NI+L     P    KI DFG+A         GN  + I GT  
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF----GNEFKNIFGTPE 182
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
           ++APE   +    +++D++S GV+   +++G
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 102/207 (49%), Gaps = 11/207 (5%)
Query: 346 KFSTDNKLGEGGFGEV---YKGVLPSGQEIAVKRLSKASGQG-AEEFKNEVVLVAKLQHR 401
           +++  + +GEG +G V   Y  V  +   +A+K++S    Q   +    E+ ++ + +H 
Sbjct: 44  RYTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 101
Query: 402 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH 461
           N++ +         + +   ++    ++  LY   K   L        +  I RG+ Y+H
Sbjct: 102 NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 161
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ-GNTSRIVGTYGYMAPEY 520
             +   ++HRDLK SN+LL+   + KI DFG+AR+   D    G  +  V T  Y APE 
Sbjct: 162 SAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 218
Query: 521 AMHGQFSVKS-DVYSFGVLVLEIITGK 546
            ++ +   KS D++S G ++ E+++ +
Sbjct: 219 MLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 104/212 (49%), Gaps = 20/212 (9%)
Query: 342 VATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAE---EFKNEVVLVAK 397
           V    +   + LG G FG+V  G    +G ++AVK L++   +  +   + K E+  +  
Sbjct: 8   VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKL 67
Query: 398 LQHRNLVRLLGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIARG 456
            +H ++++L        +  +V E+V    L DY      K G+++     ++   I   
Sbjct: 68  FRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYIC----KHGRVEEMEARRLFQQILSA 123
Query: 457 ILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRI-VGTYGY 515
           + Y H   R  ++HRDLK  N+LLDA MN KI+DFG++ +     + G   R   G+  Y
Sbjct: 124 VDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM----SDGEFLRTSCGSPNY 176
Query: 516 MAPEYAMHGQFSV--KSDVYSFGVLVLEIITG 545
            APE  + G+     + D++S GV++  ++ G
Sbjct: 177 AAPE-VISGRLYAGPEVDIWSCGVILYALLCG 207

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 347 FSTDNKLGEGGFGEVYK-----GVLPSGQEIAVKRLSKASGQGA--EEFKNEVVLVAKLQ 399
           + T  +LG G F  V K       L    +   KR +K+S +G   E+ + EV ++ ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
           H N++ L        + IL+ E V    L  FL + E    L      + +  I  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYY 129
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNP----KISDFGMARIFGVDQTQGNTSR-IVGTYG 514
           LH    L+I H DLK  NI+L     P    KI DFG+A         GN  + I GT  
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF----GNEFKNIFGTPE 182
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
           ++APE   +    +++D++S GV+   +++G
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 108/234 (46%), Gaps = 43/234 (18%)
Query: 336 DFETIEVATNKFSTDNK------LGEGGFGEV---YKGVLPSGQEIAVKRLSKA--SGQG 384
           +F ++E+  + F+   +      +G G  G V   Y  +L   + +A+K+LS+   +   
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTH 66
Query: 385 AEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF--------LYDPE 436
           A+    E+VL+  + H+N++ LL              F P KSL+ F        L D  
Sbjct: 67  AKRAYRELVLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDAN 114
Query: 437 K----QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 492
                Q +LD  R   ++  +  GI +LH      IIHRDLK SNI++ ++   KI DFG
Sbjct: 115 LCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 171
Query: 493 MARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
           +AR  G   T       V T  Y APE  +   +    D++S G ++ E++  K
Sbjct: 172 LARTAG---TSFMMEPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVCHK 222

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 347 FSTDNKLGEGGFGEVYK-----GVLPSGQEIAVKRLSKASGQGA--EEFKNEVVLVAKLQ 399
           + T  +LG G F  V K       L    +   KR +K+S +G   E+ + EV ++ ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
           H N++ L        + IL+ E V    L  FL + E    L      + +  I  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYY 129
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNP----KISDFGMARIFGVDQTQGNTSR-IVGTYG 514
           LH    L+I H DLK  NI+L     P    KI DFG+A         GN  + I GT  
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF----GNEFKNIFGTPE 182
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
           ++APE   +    +++D++S GV+   +++G
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 347 FSTDNKLGEGGFGEVYK-----GVLPSGQEIAVKRLSKASGQGA--EEFKNEVVLVAKLQ 399
           + T  +LG G F  V K       L    +   KR +K+S +G   E+ + EV ++ ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
           H N++ L        + IL+ E V    L  FL + E    L      + +  I  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYY 129
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNP----KISDFGMARIFGVDQTQGNTSR-IVGTYG 514
           LH    L+I H DLK  NI+L     P    KI DFG+A         GN  + I GT  
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF----GNEFKNIFGTPE 182
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
           ++APE   +    +++D++S GV+   +++G
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 104/211 (49%), Gaps = 18/211 (8%)
Query: 342 VATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAE---EFKNEVVLVAK 397
           V    +   + LG G FG+V  G    +G ++AVK L++   +  +   + K E+  +  
Sbjct: 8   VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKL 67
Query: 398 LQHRNLVRLLGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIARG 456
            +H ++++L        +  +V E+V    L DY      K G+++     ++   I   
Sbjct: 68  FRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYIC----KHGRVEEMEARRLFQQILSA 123
Query: 457 ILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYM 516
           + Y H   R  ++HRDLK  N+LLDA MN KI+DFG++ +    +   ++    G+  Y 
Sbjct: 124 VDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSC---GSPNYA 177
Query: 517 APEYAMHGQFSV--KSDVYSFGVLVLEIITG 545
           APE  + G+     + D++S GV++  ++ G
Sbjct: 178 APE-VISGRLYAGPEVDIWSCGVILYALLCG 207

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 100/208 (48%), Gaps = 15/208 (7%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLS--KASGQGAEEFKNEVVLVAKLQH 400
           ++ +    +LG+G F  V + V  + G E A K ++  K S +  ++ + E  +  KLQH
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
            N+VRL     E     LV++ V    L   +   E   + D S     I  I   I Y 
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH---CIQQILESIAYC 121
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNP---KISDFGMARIFGVDQTQGNTSRIVGTYGYMA 517
           H +    I+HR+LK  N+LL ++      K++DFG+A    V+ ++       GT GY++
Sbjct: 122 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHG-FAGTPGYLS 175
Query: 518 PEYAMHGQFSVKSDVYSFGVLVLEIITG 545
           PE      +S   D+++ GV++  ++ G
Sbjct: 176 PEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 103/228 (45%), Gaps = 18/228 (7%)
Query: 349 TDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSKAS-GQG--AEEFKNEVVLVAKLQHRNLV 404
           T  +LG G F  V + +  S GQE A K L K   GQ   AE      VL        ++
Sbjct: 33  TSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVI 92
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
            L        E IL+ E+     + + L  PE    +  +   ++I  I  G+ YLH+++
Sbjct: 93  NLHEVYENTSEIILILEYAAGGEI-FSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN 151
Query: 465 RLRIIHRDLKASNILLDAEMNP----KISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEY 520
              I+H DLK  NILL + + P    KI DFGM+R  G          I+GT  Y+APE 
Sbjct: 152 ---IVHLDLKPQNILLSS-IYPLGDIKIVDFGMSRKIG---HACELREIMGTPEYLAPEI 204
Query: 521 AMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYVSINV 568
             +   +  +D+++ G++   ++T    S F   D     L+   +NV
Sbjct: 205 LNYDPITTATDMWNIGIIAYMLLT--HTSPFVGEDNQETYLNISQVNV 250

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 347 FSTDNKLGEGGFGEVYK-----GVLPSGQEIAVKRLSKASGQGA--EEFKNEVVLVAKLQ 399
           + T  +LG G F  V K       L    +   KR +K+S +G   E+ + EV ++ ++Q
Sbjct: 13  YDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
           H N++ L        + IL+ E V    L  FL + E    L      + +  I  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYY 129
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNP----KISDFGMARIFGVDQTQGNTSR-IVGTYG 514
           LH    L+I H DLK  NI+L     P    KI DFG+A         GN  + I GT  
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF----GNEFKNIFGTPE 182
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
           ++APE   +    +++D++S GV+   +++G
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 103/234 (44%), Gaps = 41/234 (17%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKG--VLPSGQEIAVKRLSKASGQGAEEFKNEVV 393
           DFE I V          LG+G FG+V K    L S +  A+K++ + + +      +EV 
Sbjct: 7   DFEEIAV----------LGQGAFGQVVKARNALDS-RYYAIKKI-RHTEEKLSTILSEVX 54
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF---------LYDPEKQGQLDWS 444
           L+A L H+ +VR     LE    +     V  KS  +          LYD      L+  
Sbjct: 55  LLASLNHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQ 114
Query: 445 RR--YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR------- 495
           R   +++   I   + Y+H      IIHR+LK  NI +D   N KI DFG+A+       
Sbjct: 115 RDEYWRLFRQILEALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLD 171
Query: 496 IFGVDQ-----TQGNTSRIVGTYGYMAPEYA-MHGQFSVKSDVYSFGVLVLEII 543
           I  +D      +  N +  +GT  Y+A E     G ++ K D YS G++  E I
Sbjct: 172 ILKLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 101/207 (48%), Gaps = 11/207 (5%)
Query: 346 KFSTDNKLGEGGFGEV---YKGVLPSGQEIAVKRLSKASGQG-AEEFKNEVVLVAKLQHR 401
           +++  + +GEG +G V   Y  V  +   +A+K++S    Q   +    E+ ++   +H 
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHE 83
Query: 402 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH 461
           N++ +         + +   ++    ++  LY   K   L        +  I RG+ Y+H
Sbjct: 84  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 143
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ-GNTSRIVGTYGYMAPEY 520
             +   ++HRDLK SN+LL+   + KI DFG+AR+   D    G  +  V T  Y APE 
Sbjct: 144 SAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 200
Query: 521 AMHGQFSVKS-DVYSFGVLVLEIITGK 546
            ++ +   KS D++S G ++ E+++ +
Sbjct: 201 MLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 347 FSTDNKLGEGGFGEVYK-----GVLPSGQEIAVKRLSKASGQGA--EEFKNEVVLVAKLQ 399
           + T  +LG G F  V K       L    +   KR +K+S +G   E+ + EV ++ ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
           H N++ L        + IL+ E V    L  FL + E    L      + +  I  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYY 129
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNP----KISDFGMARIFGVDQTQGNTSR-IVGTYG 514
           LH    L+I H DLK  NI+L     P    KI DFG+A         GN  + I GT  
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF----GNEFKNIFGTPE 182
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
           ++APE   +    +++D++S GV+   +++G
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 103/226 (45%), Gaps = 37/226 (16%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVL 394
           +TI     ++   + +G G +G V       +G  +AVK+LS+   S   A+    E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-------------LYDPEKQGQL 441
           +  ++H N++ LL              F P +SL+ F             L +  K  +L
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
                  +I  I RG+ Y+H      IIHRDLK SN+ ++ +   KI D G+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDAGLAR-----H 174
Query: 502 TQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
           T    +  V T  Y APE  ++   ++   D++S G ++ E++TG+
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 100/208 (48%), Gaps = 15/208 (7%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLS--KASGQGAEEFKNEVVLVAKLQH 400
           ++ +    +LG+G F  V + V  + G E A K ++  K S +  ++ + E  +  KLQH
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
            N+VRL     E     LV++ V    L   +   E   + D S     I  I   I Y 
Sbjct: 64  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH---CIQQILESIAYC 120
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNP---KISDFGMARIFGVDQTQGNTSRIVGTYGYMA 517
           H +    I+HR+LK  N+LL ++      K++DFG+A    V+ ++       GT GY++
Sbjct: 121 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHG-FAGTPGYLS 174
Query: 518 PEYAMHGQFSVKSDVYSFGVLVLEIITG 545
           PE      +S   D+++ GV++  ++ G
Sbjct: 175 PEVLKKDPYSKPVDIWACGVILYILLVG 202

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 106/222 (47%), Gaps = 20/222 (9%)
Query: 340 IEVATNKFSTDNKLGEGGFGEVYK-GVLPSGQEIAVKRLSKAS---GQGAEEFKNEVVLV 395
           I +  N FS    +G GGFGEVY      +G+  A+K L K      QG     NE +++
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 243
Query: 396 AKLQHRN--LVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGG 452
           + +   +   +  + +     +K+  + + +    L Y L    + G    +        
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFSEADMRFYAAE 300
Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
           I  G+ ++H  +R  +++RDLK +NILLD   + +ISD G+A  F   +   +    VGT
Sbjct: 301 IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGT 353
Query: 513 YGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQ 553
           +GYMAPE    G  +   +D +S G ++ +++ G  +S F Q
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG--HSPFRQ 393

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 106/222 (47%), Gaps = 20/222 (9%)
Query: 340 IEVATNKFSTDNKLGEGGFGEVYK-GVLPSGQEIAVKRLSKAS---GQGAEEFKNEVVLV 395
           I +  N FS    +G GGFGEVY      +G+  A+K L K      QG     NE +++
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 243
Query: 396 AKLQHRN--LVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGG 452
           + +   +   +  + +     +K+  + + +    L Y L    + G    +        
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFSEADMRFYAAE 300
Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
           I  G+ ++H  +R  +++RDLK +NILLD   + +ISD G+A  F   +   +    VGT
Sbjct: 301 IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGT 353
Query: 513 YGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQ 553
           +GYMAPE    G  +   +D +S G ++ +++ G  +S F Q
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG--HSPFRQ 393

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 74/230 (32%), Positives = 113/230 (49%), Gaps = 37/230 (16%)
Query: 349 TDNK-LGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKN-EVVLVAKLQHRNLVR 405
           TD K +G G FG VY+  L  SG+ +A+K++ +      + FKN E+ ++ KL H N+VR
Sbjct: 23  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVR 77
Query: 406 LLGFCLE-GEEKILVYEFVPNKSLDYFLYDPEKQGQL--DWSRRYKIIGGIA-------- 454
           L  F    GE+K +VY    N  LDY    PE   ++   +SR  + +  I         
Sbjct: 78  LRYFFYSSGEKKDVVYL---NLVLDYV---PETVYRVARHYSRAKQTLPVIYVKLYMYQL 131
Query: 455 -RGILYLHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMARIFGVDQTQGNTSRIVGT 512
            R + Y+H      I HRD+K  N+LLD +    K+ DFG A+   + + + N S I   
Sbjct: 132 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXICSR 186
Query: 513 YGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLL 561
           Y Y APE       ++   DV+S G ++ E++ G+     +  D   D L
Sbjct: 187 Y-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP---IFPGDSGVDQL 232

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 103/213 (48%), Gaps = 19/213 (8%)
Query: 343 ATNKFSTD----NKLGEGGFGEVYKGVLPS-GQEIAVKRLS--KASGQGAEEFKNEVVLV 395
           A+ KFS +     +LG+G F  V + V  + G E A K ++  K S +  ++ + E  + 
Sbjct: 23  ASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARIC 82
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
            KLQH N+VRL     E     LV++ V    L   +   E   + D S     I  I  
Sbjct: 83  RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH---CIQQILE 139
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNP---KISDFGMARIFGVDQTQGNTSRIVGT 512
            I Y H +    I+HR+LK  N+LL ++      K++DFG+A    V+ ++       GT
Sbjct: 140 SIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHG-FAGT 193
Query: 513 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
            GY++PE      +S   D+++ GV++  ++ G
Sbjct: 194 PGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 347 FSTDNKLGEGGFGEVYK-----GVLPSGQEIAVKRLSKASGQGA--EEFKNEVVLVAKLQ 399
           + T  +LG G F  V K       L    +   KR +K+S +G   E+ + EV ++ ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
           H N++ L        + IL+ E V    L  FL + E    L      + +  I  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYY 129
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNP----KISDFGMARIFGVDQTQGNTSR-IVGTYG 514
           LH    L+I H DLK  NI+L     P    KI DFG+A         GN  + I GT  
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF----GNEFKNIFGTPE 182
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
           ++APE   +    +++D++S GV+   +++G
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 102/207 (49%), Gaps = 11/207 (5%)
Query: 346 KFSTDNKLGEGGFGEV---YKGVLPSGQEIAVKRLSKASGQG-AEEFKNEVVLVAKLQHR 401
           +++  + +GEG +G V   Y  +  +   +A+K++S    Q   +    E+ ++ + +H 
Sbjct: 29  RYTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 86
Query: 402 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH 461
           N++ +         + +   ++    ++  LY   K   L        +  I RG+ Y+H
Sbjct: 87  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 146
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ-GNTSRIVGTYGYMAPEY 520
             +   ++HRDLK SN+LL+   + KI DFG+AR+   D    G  +  V T  Y APE 
Sbjct: 147 SAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 203
Query: 521 AMHGQFSVKS-DVYSFGVLVLEIITGK 546
            ++ +   KS D++S G ++ E+++ +
Sbjct: 204 MLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 111/242 (45%), Gaps = 27/242 (11%)
Query: 343 ATNKFSTDN-----KLGEGGFGEVYKG-VLPSGQEIAVKRLSK---ASGQGAEEFKNEVV 393
           ++N+   DN      LG+G FG+V    V  +G   AVK L K         E    E  
Sbjct: 16  SSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKR 75
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKIL-VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGG 452
           +++  ++   +  L  C +  +++  V EFV    L   ++  +K  + D +R       
Sbjct: 76  ILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAAE 132
Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR---IFGVDQTQGNTSRI 509
           I   +++LH+     II+RDLK  N+LLD E + K++DFGM +     GV      T+  
Sbjct: 133 IISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV-----TTATF 184
Query: 510 VGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYVSINVI 569
            GT  Y+APE      +    D ++ GVL+ E++ G      ++ +   DL   +  + +
Sbjct: 185 CGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP---FEAENEDDLFEAILNDEV 241
Query: 570 IY 571
           +Y
Sbjct: 242 VY 243

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 106/222 (47%), Gaps = 20/222 (9%)
Query: 340 IEVATNKFSTDNKLGEGGFGEVYK-GVLPSGQEIAVKRLSKAS---GQGAEEFKNEVVLV 395
           I +  N FS    +G GGFGEVY      +G+  A+K L K      QG     NE +++
Sbjct: 183 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 242
Query: 396 AKLQHRN--LVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGG 452
           + +   +   +  + +     +K+  + + +    L Y L    + G    +        
Sbjct: 243 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFSEADMRFYAAE 299
Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
           I  G+ ++H  +R  +++RDLK +NILLD   + +ISD G+A  F   +   +    VGT
Sbjct: 300 IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGT 352
Query: 513 YGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQ 553
           +GYMAPE    G  +   +D +S G ++ +++ G  +S F Q
Sbjct: 353 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG--HSPFRQ 392

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 100/199 (50%), Gaps = 13/199 (6%)
Query: 353 LGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGAEEFKNEVV---LVAKLQHRNLVRLLG 408
           LG+G FG+V        +E+ A+K L K      ++ +  +V   ++A L     +  L 
Sbjct: 27  LGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQLH 86
Query: 409 FCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
            C +  +++  V E+V    L   +Y  ++ G+    +       I+ G+ +LH+     
Sbjct: 87  SCFQTVDRLYFVMEYVNGGDL---MYHIQQVGKFKEPQAVFYAAEISIGLFFLHKRG--- 140
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFS 527
           II+RDLK  N++LD+E + KI+DFGM +   +D     T    GT  Y+APE   +  + 
Sbjct: 141 IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGV--TTREFCGTPDYIAPEIIAYQPYG 198
Query: 528 VKSDVYSFGVLVLEIITGK 546
              D +++GVL+ E++ G+
Sbjct: 199 KSVDWWAYGVLLYEMLAGQ 217

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 102/207 (49%), Gaps = 11/207 (5%)
Query: 346 KFSTDNKLGEGGFGEV---YKGVLPSGQEIAVKRLSKASGQG-AEEFKNEVVLVAKLQHR 401
           +++  + +GEG +G V   Y  +  +   +A+K++S    Q   +    E+ ++ + +H 
Sbjct: 30  RYTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 87
Query: 402 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH 461
           N++ +         + +   ++    ++  LY   K   L        +  I RG+ Y+H
Sbjct: 88  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 147
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ-GNTSRIVGTYGYMAPEY 520
             +   ++HRDLK SN+LL+   + KI DFG+AR+   D    G  +  V T  Y APE 
Sbjct: 148 SAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 204
Query: 521 AMHGQFSVKS-DVYSFGVLVLEIITGK 546
            ++ +   KS D++S G ++ E+++ +
Sbjct: 205 MLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 102/207 (49%), Gaps = 11/207 (5%)
Query: 346 KFSTDNKLGEGGFGEV---YKGVLPSGQEIAVKRLSKASGQG-AEEFKNEVVLVAKLQHR 401
           +++  + +GEG +G V   Y  +  +   +A+K++S    Q   +    E+ ++ + +H 
Sbjct: 21  RYTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 78
Query: 402 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH 461
           N++ +         + +   ++    ++  LY   K   L        +  I RG+ Y+H
Sbjct: 79  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 138
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ-GNTSRIVGTYGYMAPEY 520
             +   ++HRDLK SN+LL+   + KI DFG+AR+   D    G  +  V T  Y APE 
Sbjct: 139 SAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 195
Query: 521 AMHGQFSVKS-DVYSFGVLVLEIITGK 546
            ++ +   KS D++S G ++ E+++ +
Sbjct: 196 MLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 102/207 (49%), Gaps = 11/207 (5%)
Query: 346 KFSTDNKLGEGGFGEV---YKGVLPSGQEIAVKRLSKASGQG-AEEFKNEVVLVAKLQHR 401
           +++  + +GEG +G V   Y  +  +   +A+K++S    Q   +    E+ ++ + +H 
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 85
Query: 402 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH 461
           N++ +         + +   ++    ++  LY   K   L        +  I RG+ Y+H
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 145
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ-GNTSRIVGTYGYMAPEY 520
             +   ++HRDLK SN+LL+   + KI DFG+AR+   D    G  +  V T  Y APE 
Sbjct: 146 SAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 521 AMHGQFSVKS-DVYSFGVLVLEIITGK 546
            ++ +   KS D++S G ++ E+++ +
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 100/208 (48%), Gaps = 15/208 (7%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLS--KASGQGAEEFKNEVVLVAKLQH 400
           ++ +    +LG+G F  V + V  + G E A K ++  K S +  ++ + E  +  KLQH
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
            N+VRL     E     LV++ V    L   +   E   + D S     I  I   I Y 
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH---CIQQILESIAYC 121
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNP---KISDFGMARIFGVDQTQGNTSRIVGTYGYMA 517
           H +    I+HR+LK  N+LL ++      K++DFG+A    V+ ++       GT GY++
Sbjct: 122 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHG-FAGTPGYLS 175
Query: 518 PEYAMHGQFSVKSDVYSFGVLVLEIITG 545
           PE      +S   D+++ GV++  ++ G
Sbjct: 176 PEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 99/201 (49%), Gaps = 14/201 (6%)
Query: 351 NKLGEGGFGEVYKGV-LPSGQEIAVKRLS--KASGQGAEEFKNEVVLVAKLQHRNLVRLL 407
            +LG+G F  V + V + +GQE A K ++  K S +  ++ + E  +   L+H N+VRL 
Sbjct: 28  EELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 87
Query: 408 GFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
               E     L+++ V    L   +   E   + D S     I  I   +L+ H+   + 
Sbjct: 88  DSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASH---CIQQILEAVLHCHQ---MG 141
Query: 468 IIHRDLKASNILLDAEMNP---KISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG 524
           ++HRDLK  N+LL +++     K++DFG+A    V+  Q       GT GY++PE     
Sbjct: 142 VVHRDLKPENLLLASKLKGAAVKLADFGLA--IEVEGEQQAWFGFAGTPGYLSPEVLRKD 199
Query: 525 QFSVKSDVYSFGVLVLEIITG 545
            +    D+++ GV++  ++ G
Sbjct: 200 PYGKPVDLWACGVILYILLVG 220

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 106/222 (47%), Gaps = 20/222 (9%)
Query: 340 IEVATNKFSTDNKLGEGGFGEVYK-GVLPSGQEIAVKRLSKAS---GQGAEEFKNEVVLV 395
           I +  N FS    +G GGFGEVY      +G+  A+K L K      QG     NE +++
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 243
Query: 396 AKLQHRN--LVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGG 452
           + +   +   +  + +     +K+  + + +    L Y L    + G    +        
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFSEADMRFYAAE 300
Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
           I  G+ ++H  +R  +++RDLK +NILLD   + +ISD G+A  F   +   +    VGT
Sbjct: 301 IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGT 353
Query: 513 YGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQ 553
           +GYMAPE    G  +   +D +S G ++ +++ G  +S F Q
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG--HSPFRQ 393

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 102/207 (49%), Gaps = 11/207 (5%)
Query: 346 KFSTDNKLGEGGFGEV---YKGVLPSGQEIAVKRLSKASGQG-AEEFKNEVVLVAKLQHR 401
           +++  + +GEG +G V   Y  +  +   +A+K++S    Q   +    E+ ++ + +H 
Sbjct: 22  RYTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 79
Query: 402 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH 461
           N++ +         + +   ++    ++  LY   K   L        +  I RG+ Y+H
Sbjct: 80  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 139
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ-GNTSRIVGTYGYMAPEY 520
             +   ++HRDLK SN+LL+   + KI DFG+AR+   D    G  +  V T  Y APE 
Sbjct: 140 SAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 196
Query: 521 AMHGQFSVKS-DVYSFGVLVLEIITGK 546
            ++ +   KS D++S G ++ E+++ +
Sbjct: 197 MLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 103/226 (45%), Gaps = 37/226 (16%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVL 394
           +TI     ++   + +G G +G V       +G  +AVK+LS+   S   A+    E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-------------LYDPEKQGQL 441
           +  ++H N++ LL              F P +SL+ F             L +  K  +L
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
                  +I  I RG+ Y+H      IIHRDLK SN+ ++ +   KI  FG+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILGFGLAR-----H 174
Query: 502 TQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
           T    +  V T  Y APE  ++   ++   D++S G ++ E++TG+
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 102/207 (49%), Gaps = 11/207 (5%)
Query: 346 KFSTDNKLGEGGFGEV---YKGVLPSGQEIAVKRLSKASGQG-AEEFKNEVVLVAKLQHR 401
           +++  + +GEG +G V   Y  +  +   +A+K++S    Q   +    E+ ++ + +H 
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 85
Query: 402 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH 461
           N++ +         + +   ++    ++  LY   K   L        +  I RG+ Y+H
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 145
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ-GNTSRIVGTYGYMAPEY 520
             +   ++HRDLK SN+LL+   + KI DFG+AR+   D    G  +  V T  Y APE 
Sbjct: 146 SAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 521 AMHGQFSVKS-DVYSFGVLVLEIITGK 546
            ++ +   KS D++S G ++ E+++ +
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 103/226 (45%), Gaps = 37/226 (16%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVL 394
           +TI     ++   + +G G +G V       +G  +AVK+LS+   S   A+    E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-------------LYDPEKQGQL 441
           +  ++H N++ LL              F P +SL+ F             L +  K  +L
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
                  +I  I RG+ Y+H      IIHRDLK SN+ ++ +   KI D G+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDRGLAR-----H 174
Query: 502 TQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
           T    +  V T  Y APE  ++   ++   D++S G ++ E++TG+
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 108/234 (46%), Gaps = 43/234 (18%)
Query: 336 DFETIEVATNKFSTDNK------LGEGGFGEV---YKGVLPSGQEIAVKRLSKA--SGQG 384
           +F ++E+  + F+   +      +G G  G V   Y  +L   + +A+K+LS+   +   
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTH 66
Query: 385 AEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF--------LYDPE 436
           A+    E+VL+  + H+N++ LL              F P KSL+ F        L D  
Sbjct: 67  AKRAYRELVLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDAN 114
Query: 437 K----QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 492
                Q +LD  R   ++  +  GI +LH      IIHRDLK SNI++ ++   KI DFG
Sbjct: 115 LCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 171
Query: 493 MARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
           +AR  G   T       V T  Y APE  +   +    D++S G ++ E++  K
Sbjct: 172 LARTAG---TSFMMEPEVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 222

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 102/207 (49%), Gaps = 11/207 (5%)
Query: 346 KFSTDNKLGEGGFGEV---YKGVLPSGQEIAVKRLSKASGQG-AEEFKNEVVLVAKLQHR 401
           +++  + +GEG +G V   Y  +  +   +A+K++S    Q   +    E+ ++ + +H 
Sbjct: 22  RYTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 79
Query: 402 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH 461
           N++ +         + +   ++    ++  LY   K   L        +  I RG+ Y+H
Sbjct: 80  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 139
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ-GNTSRIVGTYGYMAPEY 520
             +   ++HRDLK SN+LL+   + KI DFG+AR+   D    G  +  V T  Y APE 
Sbjct: 140 SAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 196
Query: 521 AMHGQFSVKS-DVYSFGVLVLEIITGK 546
            ++ +   KS D++S G ++ E+++ +
Sbjct: 197 MLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 103/200 (51%), Gaps = 19/200 (9%)
Query: 353 LGEGGFGEVY--KGVLPSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLG 408
           +G+G F +V   + +L +G+E+AVK + K   +    ++   EV +   L H N+V+L  
Sbjct: 22  IGKGNFAKVKLARHIL-TGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFE 80
Query: 409 FCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
             +E E+ + LV E+     +  +L    +  + +   +++    I   + Y H+     
Sbjct: 81  -VIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFR---QIVSAVQYCHQKF--- 133
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT-SRIVGTYGYMAPEYAMHGQF 526
           I+HRDLKA N+LLDA+ N KI+DFG +  F    T GN      G   Y APE     ++
Sbjct: 134 IVHRDLKAENLLLDADXNIKIADFGFSNEF----TFGNKLDAFCGAPPYAAPELFQGKKY 189
Query: 527 S-VKSDVYSFGVLVLEIITG 545
              + DV+S GV++  +++G
Sbjct: 190 DGPEVDVWSLGVILYTLVSG 209

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 102/207 (49%), Gaps = 11/207 (5%)
Query: 346 KFSTDNKLGEGGFGEV---YKGVLPSGQEIAVKRLSKASGQG-AEEFKNEVVLVAKLQHR 401
           +++  + +GEG +G V   Y  +  +   +A+K++S    Q   +    E+ ++ + +H 
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHE 85
Query: 402 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH 461
           N++ +         + +   ++    ++  LY   K   L        +  I RG+ Y+H
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 145
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ-GNTSRIVGTYGYMAPEY 520
             +   ++HRDLK SN+LL+   + KI DFG+AR+   D    G  +  V T  Y APE 
Sbjct: 146 SAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 521 AMHGQFSVKS-DVYSFGVLVLEIITGK 546
            ++ +   KS D++S G ++ E+++ +
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 101/207 (48%), Gaps = 11/207 (5%)
Query: 346 KFSTDNKLGEGGFGEV---YKGVLPSGQEIAVKRLSKASGQG-AEEFKNEVVLVAKLQHR 401
           +++  + +GEG +G V   Y  V  +   +A+K++S    Q   +    E+ ++   +H 
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHE 83
Query: 402 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH 461
           N++ +         + +   ++    ++  LY   K   L        +  I RG+ Y+H
Sbjct: 84  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 143
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ-GNTSRIVGTYGYMAPEY 520
             +   ++HRDLK SN+LL+   + KI DFG+AR+   D    G  +  V T  Y APE 
Sbjct: 144 SAN---VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 200
Query: 521 AMHGQFSVKS-DVYSFGVLVLEIITGK 546
            ++ +   KS D++S G ++ E+++ +
Sbjct: 201 MLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 108/234 (46%), Gaps = 20/234 (8%)
Query: 319 PESNADNDLTTLESLQ-FDFETIEVATNKFSTDNKLGEGGFGEVYK-GVLPSGQEIAVKR 376
           PE+  +  +   E L+  D+E  E   +  +   +LG G FGEV++     +G + AVK+
Sbjct: 46  PETEDNEGVLLTEKLKPVDYEYRE-EVHWMTHQPRLGRGSFGEVHRMKDKQTGFQCAVKK 104
Query: 377 LSKASGQGAEEFK-NEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDP 435
           +        E F+  E+V  A L    +V L G   EG    +  E +   SL   +   
Sbjct: 105 VR------LEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI--- 155
Query: 436 EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN-PKISDFGMA 494
           ++ G L   R    +G    G+ YLH     RI+H D+KA N+LL ++ +   + DFG A
Sbjct: 156 KQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHA 212
Query: 495 RIF---GVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
                 G+ ++      I GT  +MAPE  M      K D++S   ++L ++ G
Sbjct: 213 LCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 266

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 13/205 (6%)
Query: 347 FSTDNKLGEGGFGEVY-KGVLPSGQEIAVKRLSKASGQ-GAEEFKNEVVLVAKLQHRNLV 404
           F    KLG G FG+V+      SG E  +K ++K   Q   E+ + E+ ++  L H N++
Sbjct: 24  FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQ-LDWSRRYKIIGGIARGILYLHED 463
           ++     +     +V E      L   +   + +G+ L      +++  +   + Y H  
Sbjct: 84  KIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ 143
Query: 464 SRLRIIHRDLKASNILLD--AEMNP-KISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEY 520
               ++H+DLK  NIL    +  +P KI DFG+A +F  D+   N +   GT  YMAPE 
Sbjct: 144 ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA---GTALYMAPE- 196
Query: 521 AMHGQFSVKSDVYSFGVLVLEIITG 545
                 + K D++S GV++  ++TG
Sbjct: 197 VFKRDVTFKCDIWSAGVVMYFLLTG 221

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 103/226 (45%), Gaps = 37/226 (16%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVL 394
           +TI     ++   + +G G +G V       +G  +AVK+LS+   S   A+    E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-------------LYDPEKQGQL 441
           +  ++H N++ LL              F P +SL+ F             L +  K  +L
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
                  +I  I RG+ Y+H      IIHRDLK SN+ ++ +   KI D G+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDGGLAR-----H 174
Query: 502 TQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
           T    +  V T  Y APE  ++   ++   D++S G ++ E++TG+
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 102/207 (49%), Gaps = 11/207 (5%)
Query: 346 KFSTDNKLGEGGFGEV---YKGVLPSGQEIAVKRLSKASGQG-AEEFKNEVVLVAKLQHR 401
           +++  + +GEG +G V   Y  +  +   +A+K++S    Q   +    E+ ++ + +H 
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 85
Query: 402 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH 461
           N++ +         + +   ++    ++  LY   K   L        +  I RG+ Y+H
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKYIH 145
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ-GNTSRIVGTYGYMAPEY 520
             +   ++HRDLK SN+LL+   + KI DFG+AR+   D    G  +  V T  Y APE 
Sbjct: 146 SAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 521 AMHGQFSVKS-DVYSFGVLVLEIITGK 546
            ++ +   KS D++S G ++ E+++ +
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 101/211 (47%), Gaps = 37/211 (17%)
Query: 353 LGEGGFGEVYKGVL-PSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGF 409
           +G G +G V   V   +G ++A+K+L +   S   A+    E+ L+  ++H N++ LL  
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 410 CLEGEEKILVYEFVPNKSLD----YFLYDP---------EKQGQLDWSRRYKIIGGIARG 456
                       F P+++LD    ++L  P          K  +L   R   ++  + +G
Sbjct: 93  ------------FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKG 140
Query: 457 ILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYM 516
           + Y+H      IIHRDLK  N+ ++ +   KI DFG+AR     Q        V T  Y 
Sbjct: 141 LRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMXGXVVTRWYR 192
Query: 517 APEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
           APE  ++  +++   D++S G ++ E+ITGK
Sbjct: 193 APEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 101/207 (48%), Gaps = 11/207 (5%)
Query: 346 KFSTDNKLGEGGFGEV---YKGVLPSGQEIAVKRLSKASGQG-AEEFKNEVVLVAKLQHR 401
           +++  + +GEG +G V   Y  +  +   +A+K++S    Q   +    E+ ++ + +H 
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 85
Query: 402 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH 461
           N++ +         + +   ++    ++  LY   K   L        +  I RG+ Y+H
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 145
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ-GNTSRIVGTYGYMAPEY 520
             +   ++HRDLK SN+LL+   + KI DFG+AR+   D    G     V T  Y APE 
Sbjct: 146 SAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEI 202
Query: 521 AMHGQFSVKS-DVYSFGVLVLEIITGK 546
            ++ +   KS D++S G ++ E+++ +
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 101/207 (48%), Gaps = 11/207 (5%)
Query: 346 KFSTDNKLGEGGFGEV---YKGVLPSGQEIAVKRLSKASGQG-AEEFKNEVVLVAKLQHR 401
           +++  + +GEG +G V   Y  +  +   +A+K++S    Q   +    E+ ++ + +H 
Sbjct: 29  RYTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 86
Query: 402 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH 461
           N++ +         + +   ++    ++  LY   K   L        +  I RG+ Y+H
Sbjct: 87  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 146
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ-GNTSRIVGTYGYMAPEY 520
             +   ++HRDLK SN+LL+   + KI DFG+AR+   D    G     V T  Y APE 
Sbjct: 147 SAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEI 203
Query: 521 AMHGQFSVKS-DVYSFGVLVLEIITGK 546
            ++ +   KS D++S G ++ E+++ +
Sbjct: 204 MLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 102/207 (49%), Gaps = 11/207 (5%)
Query: 346 KFSTDNKLGEGGFGEV---YKGVLPSGQEIAVKRLSKASGQG-AEEFKNEVVLVAKLQHR 401
           +++  + +GEG +G V   Y  +  +   +A++++S    Q   +    E+ ++ + +H 
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNL--NKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHE 85
Query: 402 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH 461
           N++ +         + +   ++    ++  LY   K   L        +  I RG+ Y+H
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 145
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ-GNTSRIVGTYGYMAPEY 520
             +   ++HRDLK SN+LL+   + KI DFG+AR+   D    G  +  V T  Y APE 
Sbjct: 146 SAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 521 AMHGQFSVKS-DVYSFGVLVLEIITGK 546
            ++ +   KS D++S G ++ E+++ +
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 107/232 (46%), Gaps = 43/232 (18%)
Query: 337 FETIEVATNKFSTDNK------LGEGGFGEV---YKGVLPSGQEIAVKRLSKA--SGQGA 385
           F +++VA + F+   +      +G G  G V   +  VL  G  +AVK+LS+   +   A
Sbjct: 8   FYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHA 65
Query: 386 EEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF--------LYDPEK 437
           +    E+VL+  + H+N++ LL              F P K+L+ F        L D   
Sbjct: 66  KRAYRELVLLKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANL 113
Query: 438 ----QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493
                 +LD  R   ++  +  GI +LH      IIHRDLK SNI++ ++   KI DFG+
Sbjct: 114 CQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 170
Query: 494 ARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
           AR      T    +  V T  Y APE  +   +    D++S G ++ E++ G
Sbjct: 171 ARTAS---TNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 74/230 (32%), Positives = 111/230 (48%), Gaps = 37/230 (16%)
Query: 349 TDNK-LGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKN-EVVLVAKLQHRNLVR 405
           TD K +G G FG VY+  L  SG+ +A+K++ +        FKN E+ ++ KL H N+VR
Sbjct: 23  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKA-----FKNRELQIMRKLDHCNIVR 77
Query: 406 LLGFCLE-GEEKILVYEFVPNKSLDYFLYDPEKQGQL--DWSRRYKIIGGIA-------- 454
           L  F    GE+K  VY    N  LDY    PE   ++   +SR  + +  I         
Sbjct: 78  LRYFFYSSGEKKDEVYL---NLVLDYV---PETVYRVARHYSRAKQTLPVIYVKLYMYQL 131
Query: 455 -RGILYLHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMARIFGVDQTQGNTSRIVGT 512
            R + Y+H      I HRD+K  N+LLD +    K+ DFG A+   + + + N S I   
Sbjct: 132 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYICSR 186
Query: 513 YGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLL 561
           Y Y APE       ++   DV+S G ++ E++ G+     +  D   D L
Sbjct: 187 Y-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP---IFPGDSGVDQL 232

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 74/230 (32%), Positives = 112/230 (48%), Gaps = 37/230 (16%)
Query: 349 TDNK-LGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKN-EVVLVAKLQHRNLVR 405
           TD K +G G FG VY+  L  SG+ +A+K++ +      + FKN E+ ++ KL H N+VR
Sbjct: 57  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVR 111
Query: 406 LLGFCLE-GEEKILVYEFVPNKSLDYFLYDPEKQGQL--DWSRRYKIIGGIA-------- 454
           L  F    GE+K  VY    N  LDY    PE   ++   +SR  + +  I         
Sbjct: 112 LRYFFYSSGEKKDEVYL---NLVLDYV---PETVYRVARHYSRAKQTLPVIYVKLYMYQL 165
Query: 455 -RGILYLHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMARIFGVDQTQGNTSRIVGT 512
            R + Y+H      I HRD+K  N+LLD +    K+ DFG A+   + + + N S I   
Sbjct: 166 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXICSR 220
Query: 513 YGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLL 561
           Y Y APE       ++   DV+S G ++ E++ G+     +  D   D L
Sbjct: 221 Y-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP---IFPGDSGVDQL 266

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 74/230 (32%), Positives = 112/230 (48%), Gaps = 37/230 (16%)
Query: 349 TDNK-LGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKN-EVVLVAKLQHRNLVR 405
           TD K +G G FG VY+  L  SG+ +A+K++ +      + FKN E+ ++ KL H N+VR
Sbjct: 51  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVR 105
Query: 406 LLGFCLE-GEEKILVYEFVPNKSLDYFLYDPEKQGQL--DWSRRYKIIGGIA-------- 454
           L  F    GE+K  VY    N  LDY    PE   ++   +SR  + +  I         
Sbjct: 106 LRYFFYSSGEKKDEVYL---NLVLDYV---PETVYRVARHYSRAKQTLPVIYVKLYMYQL 159
Query: 455 -RGILYLHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMARIFGVDQTQGNTSRIVGT 512
            R + Y+H      I HRD+K  N+LLD +    K+ DFG A+   + + + N S I   
Sbjct: 160 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYICSR 214
Query: 513 YGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLL 561
           Y Y APE       ++   DV+S G ++ E++ G+     +  D   D L
Sbjct: 215 Y-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP---IFPGDSGVDQL 260

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 74/230 (32%), Positives = 111/230 (48%), Gaps = 37/230 (16%)
Query: 349 TDNK-LGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKN-EVVLVAKLQHRNLVR 405
           TD K +G G FG VY+  L  SG+ +A+K++ +        FKN E+ ++ KL H N+VR
Sbjct: 23  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKA-----FKNRELQIMRKLDHCNIVR 77
Query: 406 LLGFCLE-GEEKILVYEFVPNKSLDYFLYDPEKQGQL--DWSRRYKIIGGIA-------- 454
           L  F    GE+K  VY    N  LDY    PE   ++   +SR  + +  I         
Sbjct: 78  LRYFFYSSGEKKDEVYL---NLVLDYV---PETVYRVARHYSRAKQTLPVIYVKLYMYQL 131
Query: 455 -RGILYLHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMARIFGVDQTQGNTSRIVGT 512
            R + Y+H      I HRD+K  N+LLD +    K+ DFG A+   + + + N S I   
Sbjct: 132 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYICSR 186
Query: 513 YGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLL 561
           Y Y APE       ++   DV+S G ++ E++ G+     +  D   D L
Sbjct: 187 Y-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP---IFPGDSGVDQL 232

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 74/230 (32%), Positives = 112/230 (48%), Gaps = 37/230 (16%)
Query: 349 TDNK-LGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKN-EVVLVAKLQHRNLVR 405
           TD K +G G FG VY+  L  SG+ +A+K++ +      + FKN E+ ++ KL H N+VR
Sbjct: 31  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVR 85
Query: 406 LLGFCLE-GEEKILVYEFVPNKSLDYFLYDPEKQGQL--DWSRRYKIIGGIA-------- 454
           L  F    GE+K  VY    N  LDY    PE   ++   +SR  + +  I         
Sbjct: 86  LRYFFYSSGEKKDEVYL---NLVLDYV---PETVYRVARHYSRAKQTLPVIYVKLYMYQL 139
Query: 455 -RGILYLHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMARIFGVDQTQGNTSRIVGT 512
            R + Y+H      I HRD+K  N+LLD +    K+ DFG A+   + + + N S I   
Sbjct: 140 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXICSR 194
Query: 513 YGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLL 561
           Y Y APE       ++   DV+S G ++ E++ G+     +  D   D L
Sbjct: 195 Y-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP---IFPGDSGVDQL 240

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 74/230 (32%), Positives = 112/230 (48%), Gaps = 37/230 (16%)
Query: 349 TDNK-LGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKN-EVVLVAKLQHRNLVR 405
           TD K +G G FG VY+  L  SG+ +A+K++ +      + FKN E+ ++ KL H N+VR
Sbjct: 28  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVR 82
Query: 406 LLGFCLE-GEEKILVYEFVPNKSLDYFLYDPEKQGQL--DWSRRYKIIGGIA-------- 454
           L  F    GE+K  VY    N  LDY    PE   ++   +SR  + +  I         
Sbjct: 83  LRYFFYSSGEKKDEVYL---NLVLDYV---PETVYRVARHYSRAKQTLPVIYVKLYMYQL 136
Query: 455 -RGILYLHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMARIFGVDQTQGNTSRIVGT 512
            R + Y+H      I HRD+K  N+LLD +    K+ DFG A+   + + + N S I   
Sbjct: 137 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYICSR 191
Query: 513 YGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLL 561
           Y Y APE       ++   DV+S G ++ E++ G+     +  D   D L
Sbjct: 192 Y-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP---IFPGDSGVDQL 237

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 74/230 (32%), Positives = 112/230 (48%), Gaps = 37/230 (16%)
Query: 349 TDNK-LGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKN-EVVLVAKLQHRNLVR 405
           TD K +G G FG VY+  L  SG+ +A+K++ +      + FKN E+ ++ KL H N+VR
Sbjct: 57  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVR 111
Query: 406 LLGFCLE-GEEKILVYEFVPNKSLDYFLYDPEKQGQL--DWSRRYKIIGGIA-------- 454
           L  F    GE+K  VY    N  LDY    PE   ++   +SR  + +  I         
Sbjct: 112 LRYFFYSSGEKKDEVYL---NLVLDYV---PETVYRVARHYSRAKQTLPVIYVKLYMYQL 165
Query: 455 -RGILYLHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMARIFGVDQTQGNTSRIVGT 512
            R + Y+H      I HRD+K  N+LLD +    K+ DFG A+   + + + N S I   
Sbjct: 166 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYICSR 220
Query: 513 YGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLL 561
           Y Y APE       ++   DV+S G ++ E++ G+     +  D   D L
Sbjct: 221 Y-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP---IFPGDSGVDQL 266

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 74/230 (32%), Positives = 112/230 (48%), Gaps = 37/230 (16%)
Query: 349 TDNK-LGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKN-EVVLVAKLQHRNLVR 405
           TD K +G G FG VY+  L  SG+ +A+K++ +      + FKN E+ ++ KL H N+VR
Sbjct: 35  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVR 89
Query: 406 LLGFCLE-GEEKILVYEFVPNKSLDYFLYDPEKQGQL--DWSRRYKIIGGIA-------- 454
           L  F    GE+K  VY    N  LDY    PE   ++   +SR  + +  I         
Sbjct: 90  LRYFFYSSGEKKDEVYL---NLVLDYV---PETVYRVARHYSRAKQTLPVIYVKLYMYQL 143
Query: 455 -RGILYLHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMARIFGVDQTQGNTSRIVGT 512
            R + Y+H      I HRD+K  N+LLD +    K+ DFG A+   + + + N S I   
Sbjct: 144 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXICSR 198
Query: 513 YGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLL 561
           Y Y APE       ++   DV+S G ++ E++ G+     +  D   D L
Sbjct: 199 Y-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP---IFPGDSGVDQL 244

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 108/234 (46%), Gaps = 20/234 (8%)
Query: 319 PESNADNDLTTLESLQ-FDFETIEVATNKFSTDNKLGEGGFGEVYK-GVLPSGQEIAVKR 376
           PE+  +  +   E L+  D+E  E   +  +   ++G G FGEV++     +G + AVK+
Sbjct: 32  PETEDNEGVLLTEKLKPVDYEYRE-EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKK 90
Query: 377 LSKASGQGAEEFK-NEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDP 435
           +        E F+  E+V  A L    +V L G   EG    +  E +   SL   +   
Sbjct: 91  VR------LEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI--- 141
Query: 436 EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN-PKISDFGMA 494
           ++ G L   R    +G    G+ YLH     RI+H D+KA N+LL ++ +   + DFG A
Sbjct: 142 KQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHA 198
Query: 495 RIF---GVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
                 G+ ++      I GT  +MAPE  M      K D++S   ++L ++ G
Sbjct: 199 LCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 252

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 74/230 (32%), Positives = 112/230 (48%), Gaps = 37/230 (16%)
Query: 349 TDNK-LGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKN-EVVLVAKLQHRNLVR 405
           TD K +G G FG VY+  L  SG+ +A+K++ +      + FKN E+ ++ KL H N+VR
Sbjct: 23  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVR 77
Query: 406 LLGFCLE-GEEKILVYEFVPNKSLDYFLYDPEKQGQL--DWSRRYKIIGGIA-------- 454
           L  F    GE+K  VY    N  LDY    PE   ++   +SR  + +  I         
Sbjct: 78  LRYFFYSSGEKKDEVYL---NLVLDYV---PETVYRVARHYSRAKQTLPVIYVKLYMYQL 131
Query: 455 -RGILYLHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMARIFGVDQTQGNTSRIVGT 512
            R + Y+H      I HRD+K  N+LLD +    K+ DFG A+   + + + N S I   
Sbjct: 132 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXICSR 186
Query: 513 YGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLL 561
           Y Y APE       ++   DV+S G ++ E++ G+     +  D   D L
Sbjct: 187 Y-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP---IFPGDSGVDQL 232

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 74/230 (32%), Positives = 112/230 (48%), Gaps = 37/230 (16%)
Query: 349 TDNK-LGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKN-EVVLVAKLQHRNLVR 405
           TD K +G G FG VY+  L  SG+ +A+K++ +      + FKN E+ ++ KL H N+VR
Sbjct: 42  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVR 96
Query: 406 LLGFCLE-GEEKILVYEFVPNKSLDYFLYDPEKQGQL--DWSRRYKIIGGIA-------- 454
           L  F    GE+K  VY    N  LDY    PE   ++   +SR  + +  I         
Sbjct: 97  LRYFFYSSGEKKDEVYL---NLVLDYV---PETVYRVARHYSRAKQTLPVIYVKLYMYQL 150
Query: 455 -RGILYLHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMARIFGVDQTQGNTSRIVGT 512
            R + Y+H      I HRD+K  N+LLD +    K+ DFG A+   + + + N S I   
Sbjct: 151 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXICSR 205
Query: 513 YGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLL 561
           Y Y APE       ++   DV+S G ++ E++ G+     +  D   D L
Sbjct: 206 Y-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP---IFPGDSGVDQL 251

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 74/230 (32%), Positives = 112/230 (48%), Gaps = 37/230 (16%)
Query: 349 TDNK-LGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKN-EVVLVAKLQHRNLVR 405
           TD K +G G FG VY+  L  SG+ +A+K++ +      + FKN E+ ++ KL H N+VR
Sbjct: 24  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVR 78
Query: 406 LLGFCLE-GEEKILVYEFVPNKSLDYFLYDPEKQGQL--DWSRRYKIIGGIA-------- 454
           L  F    GE+K  VY    N  LDY    PE   ++   +SR  + +  I         
Sbjct: 79  LRYFFYSSGEKKDEVYL---NLVLDYV---PETVYRVARHYSRAKQTLPVIYVKLYMYQL 132
Query: 455 -RGILYLHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMARIFGVDQTQGNTSRIVGT 512
            R + Y+H      I HRD+K  N+LLD +    K+ DFG A+   + + + N S I   
Sbjct: 133 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXICSR 187
Query: 513 YGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLL 561
           Y Y APE       ++   DV+S G ++ E++ G+     +  D   D L
Sbjct: 188 Y-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP---IFPGDSGVDQL 233

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 74/230 (32%), Positives = 112/230 (48%), Gaps = 37/230 (16%)
Query: 349 TDNK-LGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKN-EVVLVAKLQHRNLVR 405
           TD K +G G FG VY+  L  SG+ +A+K++ +      + FKN E+ ++ KL H N+VR
Sbjct: 23  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVR 77
Query: 406 LLGFCLE-GEEKILVYEFVPNKSLDYFLYDPEKQGQL--DWSRRYKIIGGIA-------- 454
           L  F    GE+K  VY    N  LDY    PE   ++   +SR  + +  I         
Sbjct: 78  LRYFFYSSGEKKDEVYL---NLVLDYV---PETVYRVARHYSRAKQTLPVIYVKLYMYQL 131
Query: 455 -RGILYLHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMARIFGVDQTQGNTSRIVGT 512
            R + Y+H      I HRD+K  N+LLD +    K+ DFG A+   + + + N S I   
Sbjct: 132 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXICSR 186
Query: 513 YGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLL 561
           Y Y APE       ++   DV+S G ++ E++ G+     +  D   D L
Sbjct: 187 Y-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP---IFPGDSGVDQL 232

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 109/223 (48%), Gaps = 23/223 (10%)
Query: 330 LESLQFDF-ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEE 387
           L+ + +++ E +  AT++     +LG G FGEV++     +G + AVK++        E 
Sbjct: 81  LKPVDYEYREEVHWATHQL----RLGRGSFGEVHRMEDKQTGFQCAVKKVR------LEV 130
Query: 388 FK-NEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRR 446
           F+  E++  A L    +V L G   EG    +  E +   SL   +   ++QG L   R 
Sbjct: 131 FRAEELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLV---KEQGCLPEDRA 187
Query: 447 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE-MNPKISDFGMARIF---GVDQT 502
              +G    G+ YLH  SR RI+H D+KA N+LL ++  +  + DFG A      G+ ++
Sbjct: 188 LYYLGQALEGLEYLH--SR-RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKS 244
Query: 503 QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
                 I GT  +MAPE  +      K DV+S   ++L ++ G
Sbjct: 245 LLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 287

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 99/208 (47%), Gaps = 14/208 (6%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLS--KASGQGAEEFKNEVVLVAKLQH 400
           T+++     +G+G F  V + V L +G E A K ++  K S +  ++ + E  +   L+H
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
            N+VRL     E     LV++ V    L   +   E   + D S     I  I   +L+ 
Sbjct: 63  SNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASH---CIQQILEAVLHC 119
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNP---KISDFGMARIFGVDQTQGNTSRIVGTYGYMA 517
           H+   + ++HRDLK  N+LL ++      K++DFG+A    V   Q       GT GY++
Sbjct: 120 HQ---MGVVHRDLKPENLLLASKCKGAAVKLADFGLA--IEVQGDQQAWFGFAGTPGYLS 174
Query: 518 PEYAMHGQFSVKSDVYSFGVLVLEIITG 545
           PE      +    D+++ GV++  ++ G
Sbjct: 175 PEVLRKEAYGKPVDIWACGVILYILLVG 202

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 74/230 (32%), Positives = 112/230 (48%), Gaps = 37/230 (16%)
Query: 349 TDNK-LGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKN-EVVLVAKLQHRNLVR 405
           TD K +G G FG VY+  L  SG+ +A+K++ +      + FKN E+ ++ KL H N+VR
Sbjct: 27  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVR 81
Query: 406 LLGFCLE-GEEKILVYEFVPNKSLDYFLYDPEKQGQL--DWSRRYKIIGGIA-------- 454
           L  F    GE+K  VY    N  LDY    PE   ++   +SR  + +  I         
Sbjct: 82  LRYFFYSSGEKKDEVYL---NLVLDYV---PETVYRVARHYSRAKQTLPVIYVKLYMYQL 135
Query: 455 -RGILYLHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMARIFGVDQTQGNTSRIVGT 512
            R + Y+H      I HRD+K  N+LLD +    K+ DFG A+   + + + N S I   
Sbjct: 136 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXICSR 190
Query: 513 YGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLL 561
           Y Y APE       ++   DV+S G ++ E++ G+     +  D   D L
Sbjct: 191 Y-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP---IFPGDSGVDQL 236

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 74/230 (32%), Positives = 112/230 (48%), Gaps = 37/230 (16%)
Query: 349 TDNK-LGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKN-EVVLVAKLQHRNLVR 405
           TD K +G G FG VY+  L  SG+ +A+K++ +      + FKN E+ ++ KL H N+VR
Sbjct: 35  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVR 89
Query: 406 LLGFCLE-GEEKILVYEFVPNKSLDYFLYDPEKQGQL--DWSRRYKIIGGIA-------- 454
           L  F    GE+K  VY    N  LDY    PE   ++   +SR  + +  I         
Sbjct: 90  LRYFFYSSGEKKDEVYL---NLVLDYV---PETVYRVARHYSRAKQTLPVIYVKLYMYQL 143
Query: 455 -RGILYLHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMARIFGVDQTQGNTSRIVGT 512
            R + Y+H      I HRD+K  N+LLD +    K+ DFG A+   + + + N S I   
Sbjct: 144 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXICSR 198
Query: 513 YGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLL 561
           Y Y APE       ++   DV+S G ++ E++ G+     +  D   D L
Sbjct: 199 Y-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP---IFPGDSGVDQL 244

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 74/230 (32%), Positives = 112/230 (48%), Gaps = 37/230 (16%)
Query: 349 TDNK-LGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKN-EVVLVAKLQHRNLVR 405
           TD K +G G FG VY+  L  SG+ +A+K++ +      + FKN E+ ++ KL H N+VR
Sbjct: 59  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVR 113
Query: 406 LLGFCLE-GEEKILVYEFVPNKSLDYFLYDPEKQGQL--DWSRRYKIIGGIA-------- 454
           L  F    GE+K  VY    N  LDY    PE   ++   +SR  + +  I         
Sbjct: 114 LRYFFYSSGEKKDEVYL---NLVLDYV---PETVYRVARHYSRAKQTLPVIYVKLYMYQL 167
Query: 455 -RGILYLHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMARIFGVDQTQGNTSRIVGT 512
            R + Y+H      I HRD+K  N+LLD +    K+ DFG A+   + + + N S I   
Sbjct: 168 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYICSR 222
Query: 513 YGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLL 561
           Y Y APE       ++   DV+S G ++ E++ G+     +  D   D L
Sbjct: 223 Y-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP---IFPGDSGVDQL 268

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 74/230 (32%), Positives = 112/230 (48%), Gaps = 37/230 (16%)
Query: 349 TDNK-LGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKN-EVVLVAKLQHRNLVR 405
           TD K +G G FG VY+  L  SG+ +A+K++ +      + FKN E+ ++ KL H N+VR
Sbjct: 36  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVR 90
Query: 406 LLGFCLE-GEEKILVYEFVPNKSLDYFLYDPEKQGQL--DWSRRYKIIGGIA-------- 454
           L  F    GE+K  VY    N  LDY    PE   ++   +SR  + +  I         
Sbjct: 91  LRYFFYSSGEKKDEVYL---NLVLDYV---PETVYRVARHYSRAKQTLPVIYVKLYMYQL 144
Query: 455 -RGILYLHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMARIFGVDQTQGNTSRIVGT 512
            R + Y+H      I HRD+K  N+LLD +    K+ DFG A+   + + + N S I   
Sbjct: 145 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYICSR 199
Query: 513 YGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLL 561
           Y Y APE       ++   DV+S G ++ E++ G+     +  D   D L
Sbjct: 200 Y-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP---IFPGDSGVDQL 245

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 74/230 (32%), Positives = 112/230 (48%), Gaps = 37/230 (16%)
Query: 349 TDNK-LGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKN-EVVLVAKLQHRNLVR 405
           TD K +G G FG VY+  L  SG+ +A+K++ +      + FKN E+ ++ KL H N+VR
Sbjct: 61  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVR 115
Query: 406 LLGFCLE-GEEKILVYEFVPNKSLDYFLYDPEKQGQL--DWSRRYKIIGGIA-------- 454
           L  F    GE+K  VY    N  LDY    PE   ++   +SR  + +  I         
Sbjct: 116 LRYFFYSSGEKKDEVYL---NLVLDYV---PETVYRVARHYSRAKQTLPVIYVKLYMYQL 169
Query: 455 -RGILYLHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMARIFGVDQTQGNTSRIVGT 512
            R + Y+H      I HRD+K  N+LLD +    K+ DFG A+   + + + N S I   
Sbjct: 170 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYICSR 224
Query: 513 YGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLL 561
           Y Y APE       ++   DV+S G ++ E++ G+     +  D   D L
Sbjct: 225 Y-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP---IFPGDSGVDQL 270

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 100/208 (48%), Gaps = 14/208 (6%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLS--KASGQGAEEFKNEVVLVAKLQH 400
           T+++    +LG+G F  V + + +P+GQE A K ++  K S +  ++ + E  +   L+H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
            N+VRL     E     LV++ V    L   +   E   + D S     I  I   + + 
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASH---CIQQILESVNHC 119
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNP---KISDFGMARIFGVDQTQGNTSRIVGTYGYMA 517
           H +    I+HRDLK  N+LL ++      K++DFG+A    V   Q       GT GY++
Sbjct: 120 HLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLA--IEVQGDQQAWFGFAGTPGYLS 174
Query: 518 PEYAMHGQFSVKSDVYSFGVLVLEIITG 545
           PE      +    D+++ GV++  ++ G
Sbjct: 175 PEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 74/230 (32%), Positives = 112/230 (48%), Gaps = 37/230 (16%)
Query: 349 TDNK-LGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKN-EVVLVAKLQHRNLVR 405
           TD K +G G FG VY+  L  SG+ +A+K++ +      + FKN E+ ++ KL H N+VR
Sbjct: 102 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVR 156
Query: 406 LLGFCLE-GEEKILVYEFVPNKSLDYFLYDPEKQGQL--DWSRRYKIIGGIA-------- 454
           L  F    GE+K  VY    N  LDY    PE   ++   +SR  + +  I         
Sbjct: 157 LRYFFYSSGEKKDEVYL---NLVLDYV---PETVYRVARHYSRAKQTLPVIYVKLYMYQL 210
Query: 455 -RGILYLHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMARIFGVDQTQGNTSRIVGT 512
            R + Y+H      I HRD+K  N+LLD +    K+ DFG A+   + + + N S I   
Sbjct: 211 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYICSR 265
Query: 513 YGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLL 561
           Y Y APE       ++   DV+S G ++ E++ G+     +  D   D L
Sbjct: 266 Y-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP---IFPGDSGVDQL 311

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 103/211 (48%), Gaps = 21/211 (9%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQ 399
           E+ + +F+   K  + G G+ Y     + + I  +RLS +  G   EE + EV ++ +++
Sbjct: 19  ELGSGQFAIVRKCRQKGTGKEY-----AAKFIKKRRLSSSRRGVSREEIEREVNILREIR 73
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
           H N++ L        + +L+ E V    L  FL + E    L      + +  I  G+ Y
Sbjct: 74  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE---SLTEDEATQFLKQILDGVHY 130
Query: 460 LHEDSRLRIIHRDLKASNI-LLDAEM-NPKIS--DFGMARIFGVDQTQGNTSR-IVGTYG 514
           LH     RI H DLK  NI LLD  + NP+I   DFG+A         GN  + I GT  
Sbjct: 131 LHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI----EAGNEFKNIFGTPE 183
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
           ++APE   +    +++D++S GV+   +++G
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 104/226 (46%), Gaps = 16/226 (7%)
Query: 327 LTTLESLQFD--FETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRL-SKASG 382
           + T E+L F    E  EV  +      +LG G +G V K   +PSGQ  AVKR+ +  + 
Sbjct: 14  IPTTENLYFQGAXENFEVKADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNS 73
Query: 383 QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLD 442
           Q  +    ++ +  +             L  E  + +   + + SLD F      +GQ  
Sbjct: 74  QEQKRLLXDLDISXRTVDCPFTVTFYGALFREGDVWICXELXDTSLDKFYKQVIDKGQ-- 131
Query: 443 WSRRYKIIGGIARGILYL--HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500
            +    I+G IA  I+    H  S+L +IHRD+K SN+L++A    K  DFG++  + VD
Sbjct: 132 -TIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKXCDFGISG-YLVD 189
Query: 501 QTQGNTSRIVGTYGYMAPEYA----MHGQFSVKSDVYSFGVLVLEI 542
               +     G   Y APE          +SVKSD++S G+  +E+
Sbjct: 190 DVAKDID--AGCKPYXAPERINPELNQKGYSVKSDIWSLGITXIEL 233

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 74/230 (32%), Positives = 112/230 (48%), Gaps = 37/230 (16%)
Query: 349 TDNK-LGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKN-EVVLVAKLQHRNLVR 405
           TD K +G G FG VY+  L  SG+ +A+K++ +      + FKN E+ ++ KL H N+VR
Sbjct: 23  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVR 77
Query: 406 LLGFCLE-GEEKILVYEFVPNKSLDYFLYDPEKQGQL--DWSRRYKIIGGIA-------- 454
           L  F    GE+K  VY    N  LDY    PE   ++   +SR  + +  I         
Sbjct: 78  LRYFFYSSGEKKDEVYL---NLVLDYV---PETVYRVARHYSRAKQTLPVIYVKLYMYQL 131
Query: 455 -RGILYLHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMARIFGVDQTQGNTSRIVGT 512
            R + Y+H      I HRD+K  N+LLD +    K+ DFG A+   + + + N S I   
Sbjct: 132 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYICSR 186
Query: 513 YGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLL 561
           Y Y APE       ++   DV+S G ++ E++ G+     +  D   D L
Sbjct: 187 Y-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP---IFPGDSGVDQL 232

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 108/234 (46%), Gaps = 20/234 (8%)
Query: 319 PESNADNDLTTLESLQ-FDFETIEVATNKFSTDNKLGEGGFGEVYK-GVLPSGQEIAVKR 376
           PE+  +  +   E L+  D+E  E   +  +   ++G G FGEV++     +G + AVK+
Sbjct: 48  PETEDNEGVLLTEKLKPVDYEYRE-EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKK 106
Query: 377 LSKASGQGAEEFK-NEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDP 435
           +        E F+  E+V  A L    +V L G   EG    +  E +   SL   +   
Sbjct: 107 VR------LEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI--- 157
Query: 436 EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN-PKISDFGMA 494
           ++ G L   R    +G    G+ YLH     RI+H D+KA N+LL ++ +   + DFG A
Sbjct: 158 KQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHA 214
Query: 495 RIF---GVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
                 G+ ++      I GT  +MAPE  M      K D++S   ++L ++ G
Sbjct: 215 LCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 268

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 103/211 (48%), Gaps = 21/211 (9%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQ 399
           E+ + +F+   K  + G G+ Y     + + I  +RLS +  G   EE + EV ++ +++
Sbjct: 12  ELGSGQFAIVRKCRQKGTGKEY-----AAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
           H N++ L        + +L+ E V    L  FL + E    L      + +  I  G+ Y
Sbjct: 67  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE---SLTEDEATQFLKQILDGVHY 123
Query: 460 LHEDSRLRIIHRDLKASNI-LLDAEM-NPKIS--DFGMARIFGVDQTQGNTSR-IVGTYG 514
           LH     RI H DLK  NI LLD  + NP+I   DFG+A         GN  + I GT  
Sbjct: 124 LHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI----EAGNEFKNIFGTPE 176
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
           ++APE   +    +++D++S GV+   +++G
Sbjct: 177 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 207

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 100/208 (48%), Gaps = 14/208 (6%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLS--KASGQGAEEFKNEVVLVAKLQH 400
           T+++    +LG+G F  V + + +P+GQE A K ++  K S +  ++ + E  +   L+H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
            N+VRL     E     LV++ V    L   +   E   + D S     I  I   + + 
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASH---CIQQILESVNHC 119
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNP---KISDFGMARIFGVDQTQGNTSRIVGTYGYMA 517
           H +    I+HRDLK  N+LL ++      K++DFG+A    V   Q       GT GY++
Sbjct: 120 HLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLA--IEVQGDQQAWFGFAGTPGYLS 174
Query: 518 PEYAMHGQFSVKSDVYSFGVLVLEIITG 545
           PE      +    D+++ GV++  ++ G
Sbjct: 175 PEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 72/228 (31%), Positives = 109/228 (47%), Gaps = 33/228 (14%)
Query: 349 TDNK-LGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKN-EVVLVAKLQHRNLVR 405
           TD K +G G FG VY+  L  SG+ +A+K++ +        FKN E+ ++ KL H N+VR
Sbjct: 23  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKA-----FKNRELQIMRKLDHCNIVR 77
Query: 406 LLGFCLE-GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIA---------R 455
           L  F    GE+K  VY    N  LDY      +  +  +SR  + +  I          R
Sbjct: 78  LRYFFYSSGEKKDEVYL---NLVLDYVPATVYRVAR-HYSRAKQTLPVIYVKLYMYQLFR 133
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMARIFGVDQTQGNTSRIVGTYG 514
            + Y+H      I HRD+K  N+LLD +    K+ DFG A+   + + + N S I   Y 
Sbjct: 134 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXICSRY- 187
Query: 515 YMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLL 561
           Y APE       ++   DV+S G ++ E++ G+     +  D   D L
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP---IFPGDSGVDQL 232

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 103/200 (51%), Gaps = 16/200 (8%)
Query: 353 LGEGGFGEVYKGVLPSG----QEIAVKRLSKASGQGAEEF--KNEVVLVAKLQHRNLVRL 406
           LG+G FG+V+     SG    Q  A+K L KA+ +  +    K E  ++ ++ H  +V+L
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 407 LGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSR 465
             +  + E K+ L+ +F+    L   L    K+           +  +A  + +LH    
Sbjct: 92  -HYAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELALALDHLHS--- 144
Query: 466 LRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQ 525
           L II+RDLK  NILLD E + K++DFG+++   +D  +   S   GT  YMAPE      
Sbjct: 145 LGIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKKAYS-FCGTVEYMAPEVVNRRG 202
Query: 526 FSVKSDVYSFGVLVLEIITG 545
            +  +D +SFGVL+ E++TG
Sbjct: 203 HTQSADWWSFGVLMFEMLTG 222

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 101/210 (48%), Gaps = 25/210 (11%)
Query: 351 NKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKN-EVVLVAKLQHRNLVRLLGF 409
            ++G+G +GEV+ G    G+++AVK     + + A  F+  E+     ++H N++  +  
Sbjct: 43  KQIGKGRYGEVWMGKW-RGEKVAVKVF--FTTEEASWFRETEIYQTVLMRHENILGFIAA 99
Query: 410 CLEGE----EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED-- 463
            ++G     +  L+ ++  N SL    YD  K   LD     K+      G+ +LH +  
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSL----YDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIF 155
Query: 464 ---SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT--SRIVGTYGYMAP 518
               +  I HRDLK+ NIL+       I+D G+A  F  D  + +   +  VGT  YM P
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215
Query: 519 EY------AMHGQFSVKSDVYSFGVLVLEI 542
           E         H Q  + +D+YSFG+++ E+
Sbjct: 216 EVLDESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 101/227 (44%), Gaps = 29/227 (12%)
Query: 330 LESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFK 389
           L+     FE +E+          +G+G FG+VY G       I +  + + +    + FK
Sbjct: 25  LQEWDIPFEQLEIG-------ELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFK 77
Query: 390 NEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKI 449
            EV+   + +H N+V  +G C+      ++      ++L   + D   +  LD ++  +I
Sbjct: 78  REVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQI 135
Query: 450 IGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPK--ISDFGMARIFGVDQTQGNTS 507
              I +G+ YLH      I+H+DLK+ N+  D   N K  I+DFG+  I GV Q      
Sbjct: 136 AQEIVKGMGYLHAKG---ILHKDLKSKNVFYD---NGKVVITDFGLFSISGVLQAGRRED 189
Query: 508 RIV---GTYGYMAPEYAMHGQ---------FSVKSDVYSFGVLVLEI 542
           ++    G   ++APE               FS  SDV++ G +  E+
Sbjct: 190 KLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYEL 236

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 112/216 (51%), Gaps = 27/216 (12%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYK-GVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ 399
           E+  + F   ++LG G  G V K    PSG  I  ++L     + A   +N+++   ++ 
Sbjct: 12  ELKDDDFERISELGAGNGGVVTKVQHRPSGL-IMARKLIHLEIKPA--IRNQIIRELQVL 68
Query: 400 HR-NLVRLLGFC----LEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIA 454
           H  N   ++GF      +GE  I + E +   SLD  L + ++  +       +I+G ++
Sbjct: 69  HECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKEAKRIPE-------EILGKVS 120
Query: 455 ----RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIV 510
               RG+ YL E  + +I+HRD+K SNIL+++    K+ DFG++    +D      +  V
Sbjct: 121 IAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSM---ANSFV 174
Query: 511 GTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
           GT  YMAPE      +SV+SD++S G+ ++E+  G+
Sbjct: 175 GTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGR 210

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 96/232 (41%), Gaps = 37/232 (15%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQ-EIAVKRLSKASGQGA-EEFKNEVV 393
           DFE I+           LG GGFG V++          A+KR+   + + A E+   EV 
Sbjct: 6   DFEPIQC----------LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVK 55
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDW---------- 443
            +AKL+H  +VR     LE      +    P   L   +    K+   DW          
Sbjct: 56  ALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEER 115
Query: 444 --SRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
             S    I   IA  + +LH      ++HRDLK SNI    +   K+ DFG+      D+
Sbjct: 116 ERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDE 172
Query: 502 TQ----------GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEII 543
            +             +  VGT  YM+PE      +S K D++S G+++ E++
Sbjct: 173 EEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 100/208 (48%), Gaps = 14/208 (6%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIA--VKRLSKASGQGAEEFKNEVVLVAKLQH 400
           T ++    +LG+G F  V + V + +GQE A  +    K S +  ++ + E  +   L+H
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
            N+VRL     E     L+++ V    L   +   E   + D S     I  I   +L+ 
Sbjct: 70  PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASH---CIQQILEAVLHC 126
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNP---KISDFGMARIFGVDQTQGNTSRIVGTYGYMA 517
           H+   + ++HR+LK  N+LL +++     K++DFG+A    V+  Q       GT GY++
Sbjct: 127 HQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLA--IEVEGEQQAWFGFAGTPGYLS 181
Query: 518 PEYAMHGQFSVKSDVYSFGVLVLEIITG 545
           PE      +    D+++ GV++  ++ G
Sbjct: 182 PEVLRKDPYGKPVDLWACGVILYILLVG 209

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 109/225 (48%), Gaps = 27/225 (12%)
Query: 330 LESLQFDF-ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEE 387
           L+ + +++ E +  AT++     +LG G FGEV++     +G + AVK++        E 
Sbjct: 62  LKPVDYEYREEVHWATHQL----RLGRGSFGEVHRMEDKQTGFQCAVKKVR------LEV 111
Query: 388 FK-NEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRR 446
           F+  E++  A L    +V L G   EG    +  E +   SL   +   ++QG L   R 
Sbjct: 112 FRAEELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLV---KEQGCLPEDRA 168
Query: 447 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE-MNPKISDFGMARIF-----GVD 500
              +G    G+ YLH  SR RI+H D+KA N+LL ++  +  + DFG A        G D
Sbjct: 169 LYYLGQALEGLEYLH--SR-RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKD 225
Query: 501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
              G+   I GT  +MAPE  +      K DV+S   ++L ++ G
Sbjct: 226 LLTGDY--IPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 268

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 106/208 (50%), Gaps = 16/208 (7%)
Query: 345 NKFSTDNKLGEGGFGEVYKGVLPSG----QEIAVKRLSKASGQGAEEF--KNEVVLVAKL 398
           ++F     LG+G FG+V+     SG    Q  A+K L KA+ +  +    K E  ++ ++
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 399 QHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGI 457
            H  +V+L  +  + E K+ L+ +F+    L   L    K+           +  +A  +
Sbjct: 84  NHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELALAL 139
Query: 458 LYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMA 517
            +LH    L II+RDLK  NILLD E + K++DFG+++   +D  +   S   GT  YMA
Sbjct: 140 DHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKKAYS-FCGTVEYMA 194
Query: 518 PEYAMHGQFSVKSDVYSFGVLVLEIITG 545
           PE       +  +D +SFGVL+ E++TG
Sbjct: 195 PEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 99/198 (50%), Gaps = 15/198 (7%)
Query: 353 LGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKN-----EVVLVAKLQHRNLVRL 406
           LGEG F  VYK     + Q +A+K++       A++  N     E+ L+ +L H N++ L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 407 LGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRL 466
           L          LV++F+    L+  + D          + Y ++    +G+ YLH+    
Sbjct: 78  LDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLM--TLQGLEYLHQHW-- 132
Query: 467 RIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQ- 525
            I+HRDLK +N+LLD     K++DFG+A+ FG    +    ++V T  Y APE     + 
Sbjct: 133 -ILHRDLKPNNLLLDENGVLKLADFGLAKSFG-SPNRAYXHQVV-TRWYRAPELLFGARM 189
Query: 526 FSVKSDVYSFGVLVLEII 543
           + V  D+++ G ++ E++
Sbjct: 190 YGVGVDMWAVGCILAELL 207

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 106/208 (50%), Gaps = 16/208 (7%)
Query: 345 NKFSTDNKLGEGGFGEVYKGVLPSG----QEIAVKRLSKASGQGAEEF--KNEVVLVAKL 398
           ++F     LG+G FG+V+     SG    Q  A+K L KA+ +  +    K E  ++ ++
Sbjct: 25  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 84
Query: 399 QHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGI 457
            H  +V+L  +  + E K+ L+ +F+    L   L    K+           +  +A  +
Sbjct: 85  NHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELALAL 140
Query: 458 LYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMA 517
            +LH    L II+RDLK  NILLD E + K++DFG+++   +D  +   S   GT  YMA
Sbjct: 141 DHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKKAYS-FCGTVEYMA 195
Query: 518 PEYAMHGQFSVKSDVYSFGVLVLEIITG 545
           PE       +  +D +SFGVL+ E++TG
Sbjct: 196 PEVVNRRGHTQSADWWSFGVLMFEMLTG 223

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRL-SKASGQGAEEFKNEVVLVAKLQ 399
           E+ + +F+   K  + G G+ Y     + + I  +RL S   G   EE + EV ++ +++
Sbjct: 33  ELGSGQFAIVRKCRQKGTGKEY-----AAKFIKKRRLXSSRRGVSREEIEREVNILREIR 87
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
           H N++ L        + +L+ E V    L  FL + E    L      + +  I  G+ Y
Sbjct: 88  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE---SLTEDEATQFLKQILDGVHY 144
Query: 460 LHEDSRLRIIHRDLKASNI-LLDAEM-NPKIS--DFGMARIFGVDQTQGNTSR-IVGTYG 514
           LH     RI H DLK  NI LLD  + NP+I   DFG+A         GN  + I GT  
Sbjct: 145 LHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI----EAGNEFKNIFGTPE 197
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
           ++APE   +    +++D++S GV+   +++G
Sbjct: 198 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 228

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 112/218 (51%), Gaps = 26/218 (11%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFK----NEVVLVAKL 398
            +K+    K+G+G FGEV+K     +GQ++A+K++   + +  E F      E+ ++  L
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKILQLL 74
Query: 399 QHRNLVRLLGFCLEGEEKI--------LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKII 450
           +H N+V L+  C               LV++F  +  L   L +   +  L   +R  ++
Sbjct: 75  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR--VM 131
Query: 451 GGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ-TQGN--TS 507
             +  G+ Y+H   R +I+HRD+KA+N+L+  +   K++DFG+AR F + + +Q N   +
Sbjct: 132 QMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXN 188
Query: 508 RIVGTYGYMAPEYAM-HGQFSVKSDVYSFGVLVLEIIT 544
           R+V T  Y  PE  +    +    D++  G ++ E+ T
Sbjct: 189 RVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 18/221 (8%)
Query: 331 ESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEI--AVKRLSKASGQGAEEF 388
           E+L F   T       ++ +N +G G +GEV K  +  G  I  A K++ K   +  + F
Sbjct: 12  ENLYFQGSTKGDINQYYTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRF 70
Query: 389 KNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYK 448
           K E+ ++  L H N++RL     +  +  LV E      L   +       + D +R   
Sbjct: 71  KQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR--- 127
Query: 449 IIGGIARGILYLHEDSRLRIIHRDLKASNILL--DAEMNP-KISDFGMARIFGVDQTQGN 505
           I+  +   + Y H   +L + HRDLK  N L   D+  +P K+ DFG+A  F      G 
Sbjct: 128 IMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF----KPGK 180
Query: 506 TSRI-VGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
             R  VGT  Y++P+  + G +  + D +S GV++  ++ G
Sbjct: 181 MMRTKVGTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCG 220

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 98/205 (47%), Gaps = 18/205 (8%)
Query: 347 FSTDNKLGEGGFGEVYKGVLPSGQEI--AVKRLSKASGQGAEEFKNEVVLVAKLQHRNLV 404
           ++ +N +G G +GEV K  +  G  I  A K++ K   +  + FK E+ ++  L H N++
Sbjct: 11  YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 69
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
           RL     +  +  LV E      L   +       + D +R   I+  +   + Y H   
Sbjct: 70  RLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR---IMKDVLSAVAYCH--- 123
Query: 465 RLRIIHRDLKASNILL--DAEMNP-KISDFGMARIFGVDQTQGNTSRI-VGTYGYMAPEY 520
           +L + HRDLK  N L   D+  +P K+ DFG+A  F      G   R  VGT  Y++P+ 
Sbjct: 124 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF----KPGKMMRTKVGTPYYVSPQ- 178
Query: 521 AMHGQFSVKSDVYSFGVLVLEIITG 545
            + G +  + D +S GV++  ++ G
Sbjct: 179 VLEGLYGPECDEWSAGVMMYVLLCG 203

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 112/218 (51%), Gaps = 26/218 (11%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFK----NEVVLVAKL 398
            +K+    K+G+G FGEV+K     +GQ++A+K++   + +  E F      E+ ++  L
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKILQLL 74
Query: 399 QHRNLVRLLGFCLEGEEKI--------LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKII 450
           +H N+V L+  C               LV++F  +  L   L +   +  L   +R  ++
Sbjct: 75  KHENVVNLIEICRTKASPYNRCKASIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR--VM 131
Query: 451 GGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ-TQGN--TS 507
             +  G+ Y+H   R +I+HRD+KA+N+L+  +   K++DFG+AR F + + +Q N   +
Sbjct: 132 QMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXN 188
Query: 508 RIVGTYGYMAPEYAM-HGQFSVKSDVYSFGVLVLEIIT 544
           R+V T  Y  PE  +    +    D++  G ++ E+ T
Sbjct: 189 RVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 112/218 (51%), Gaps = 26/218 (11%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFK----NEVVLVAKL 398
            +K+    K+G+G FGEV+K     +GQ++A+K++   + +  E F      E+ ++  L
Sbjct: 16  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKILQLL 73
Query: 399 QHRNLVRLLGFCLEGEEKI--------LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKII 450
           +H N+V L+  C               LV++F  +  L   L +   +  L   +R  ++
Sbjct: 74  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR--VM 130
Query: 451 GGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ-TQGN--TS 507
             +  G+ Y+H   R +I+HRD+KA+N+L+  +   K++DFG+AR F + + +Q N   +
Sbjct: 131 QMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXN 187
Query: 508 RIVGTYGYMAPEYAM-HGQFSVKSDVYSFGVLVLEIIT 544
           R+V T  Y  PE  +    +    D++  G ++ E+ T
Sbjct: 188 RVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 224

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 96/205 (46%), Gaps = 19/205 (9%)
Query: 353 LGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE 412
           +G+G +GEV++G    G+ +AVK  S +  + +   + E+     L+H N++  +   + 
Sbjct: 45  VGKGRYGEVWRGSW-QGENVAVKIFS-SRDEKSWFRETELYNTVMLRHENILGFIASDMT 102
Query: 413 GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED-----SRLR 467
                     + +      LYD  +   LD     +I+  IA G+ +LH +      +  
Sbjct: 103 SRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA 162
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ---GNTSRIVGTYGYMAPEYAMHG 524
           I HRDLK+ NIL+       I+D G+A +      Q   GN  R VGT  YMAPE  +  
Sbjct: 163 IAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR-VGTKRYMAPE-VLDE 220
Query: 525 QFSV-------KSDVYSFGVLVLEI 542
              V       + D+++FG+++ E+
Sbjct: 221 TIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 115/241 (47%), Gaps = 23/241 (9%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEI----AVKRLSKAS----GQGAEEFKNEV 392
           +V    F     LG G +G+V+     SG +     A+K L KA+     +  E  + E 
Sbjct: 50  KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER 109
Query: 393 VLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKI-I 450
            ++  ++    +  L +  + E K+ L+ +++    L   L   E+  +       +I +
Sbjct: 110 QVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTE----HEVQIYV 165
Query: 451 GGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIV 510
           G I   + +LH   +L II+RD+K  NILLD+  +  ++DFG+++ F  D+T+       
Sbjct: 166 GEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFC 221
Query: 511 GTYGYMAPEYAMHGQ--FSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYVSINV 568
           GT  YMAP+    G        D +S GVL+ E++TG   ++ +  DG  +  + +S  +
Sbjct: 222 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG---ASPFTVDGEKNSQAEISRRI 278
Query: 569 I 569
           +
Sbjct: 279 L 279

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 112/218 (51%), Gaps = 26/218 (11%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFK----NEVVLVAKL 398
            +K+    K+G+G FGEV+K     +GQ++A+K++   + +  E F      E+ ++  L
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKILQLL 74
Query: 399 QHRNLVRLLGFCLEGEEKI--------LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKII 450
           +H N+V L+  C               LV++F  +  L   L +   +  L   +R  ++
Sbjct: 75  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR--VM 131
Query: 451 GGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ-TQGN--TS 507
             +  G+ Y+H   R +I+HRD+KA+N+L+  +   K++DFG+AR F + + +Q N   +
Sbjct: 132 QMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXN 188
Query: 508 RIVGTYGYMAPEYAM-HGQFSVKSDVYSFGVLVLEIIT 544
           R+V T  Y  PE  +    +    D++  G ++ E+ T
Sbjct: 189 RVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 101/201 (50%), Gaps = 16/201 (7%)
Query: 353 LGEGGFGEVYK----GVLPSGQEIAVKRLSKA----SGQGAEEFKNEVVLVAKLQHRNLV 404
           LG+GG+G+V++        +G+  A+K L KA    + +     K E  ++ +++H  +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
            L+     G +  L+ E++    L   L   E++G          +  I+  + +LH+  
Sbjct: 85  DLIYAFQTGGKLYLILEYLSGGELFMQL---EREGIFMEDTACFYLAEISMALGHLHQKG 141
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG 524
              II+RDLK  NI+L+ + + K++DFG+ +    D T  +T    GT  YMAPE  M  
Sbjct: 142 ---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGTIEYMAPEILMRS 196
Query: 525 QFSVKSDVYSFGVLVLEIITG 545
             +   D +S G L+ +++TG
Sbjct: 197 GHNRAVDWWSLGALMYDMLTG 217

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 94/198 (47%), Gaps = 17/198 (8%)
Query: 353 LGEGGFGEVYK-GVLPSGQEIAVKRLSK---ASGQGAEEFKNEVVLVAKLQHRNLVRLLG 408
           LG G FG V+      +G+  A+K L K      +  E   +E ++++ + H  ++R+ G
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73
Query: 409 FCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGG-IARGILYLHEDSRLR 467
              + ++  ++ +++    L   L    ++ Q   +   K     +   + YLH      
Sbjct: 74  TFQDAQQIFMIMDYIEGGELFSLL----RKSQRFPNPVAKFYAAEVCLALEYLHSKD--- 126
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFS 527
           II+RDLK  NILLD   + KI+DFG A+          T  + GT  Y+APE      ++
Sbjct: 127 IIYRDLKPENILLDKNGHIKITDFGFAKY-----VPDVTYXLCGTPDYIAPEVVSTKPYN 181
Query: 528 VKSDVYSFGVLVLEIITG 545
              D +SFG+L+ E++ G
Sbjct: 182 KSIDWWSFGILIYEMLAG 199

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 96/205 (46%), Gaps = 19/205 (9%)
Query: 353 LGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE 412
           +G+G +GEV++G    G+ +AVK  S +  + +   + E+     L+H N++  +   + 
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFS-SRDEKSWFRETELYNTVMLRHENILGFIASDMT 73
Query: 413 GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED-----SRLR 467
                     + +      LYD  +   LD     +I+  IA G+ +LH +      +  
Sbjct: 74  SRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA 133
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ---GNTSRIVGTYGYMAPEYAMHG 524
           I HRDLK+ NIL+       I+D G+A +      Q   GN  R VGT  YMAPE  +  
Sbjct: 134 IAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR-VGTKRYMAPE-VLDE 191
Query: 525 QFSV-------KSDVYSFGVLVLEI 542
              V       + D+++FG+++ E+
Sbjct: 192 TIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 96/205 (46%), Gaps = 19/205 (9%)
Query: 353 LGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE 412
           +G+G +GEV++G    G+ +AVK  S +  + +   + E+     L+H N++  +   + 
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFS-SRDEKSWFRETELYNTVMLRHENILGFIASDMT 73
Query: 413 GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED-----SRLR 467
                     + +      LYD  +   LD     +I+  IA G+ +LH +      +  
Sbjct: 74  SRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA 133
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ---GNTSRIVGTYGYMAPEYAMHG 524
           I HRDLK+ NIL+       I+D G+A +      Q   GN  R VGT  YMAPE  +  
Sbjct: 134 IAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR-VGTKRYMAPE-VLDE 191
Query: 525 QFSV-------KSDVYSFGVLVLEI 542
              V       + D+++FG+++ E+
Sbjct: 192 TIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 100/201 (49%), Gaps = 16/201 (7%)
Query: 353 LGEGGFGEVYK----GVLPSGQEIAVKRLSKA----SGQGAEEFKNEVVLVAKLQHRNLV 404
           LG+GG+G+V++        +G+  A+K L KA    + +     K E  ++ +++H  +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
            L+     G +  L+ E++    L   L   E++G          +  I+  + +LH+  
Sbjct: 85  DLIYAFQTGGKLYLILEYLSGGELFMQL---EREGIFMEDTACFYLAEISMALGHLHQKG 141
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG 524
              II+RDLK  NI+L+ + + K++DFG+ +    D T   T    GT  YMAPE  M  
Sbjct: 142 ---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV--THXFCGTIEYMAPEILMRS 196
Query: 525 QFSVKSDVYSFGVLVLEIITG 545
             +   D +S G L+ +++TG
Sbjct: 197 GHNRAVDWWSLGALMYDMLTG 217

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 110/244 (45%), Gaps = 17/244 (6%)
Query: 335 FDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGAEEFKN--- 390
           FD E  +V  + F     +G+G FG+V        +++ A+K ++K       E +N   
Sbjct: 6   FD-ENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFK 64
Query: 391 EVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKII 450
           E+ ++  L+H  LV L     + E+  +V + +    L Y L   ++            I
Sbjct: 65  ELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHL---QQNVHFKEETVKLFI 121
Query: 451 GGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIV 510
             +   + YL      RIIHRD+K  NILLD   +  I+DF +A +    +TQ  T  + 
Sbjct: 122 CELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLP-RETQITT--MA 175
Query: 511 GTYGYMAPEYAMHGQ---FSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYVSIN 567
           GT  YMAPE     +   +S   D +S GV   E++ G++  +   +  + +++      
Sbjct: 176 GTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT 235
Query: 568 VIIY 571
           V+ Y
Sbjct: 236 VVTY 239

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 92/204 (45%), Gaps = 12/204 (5%)
Query: 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLV 404
            K+     LG G FG V++ V  S ++  + +  K  G      K E+ ++   +HRN++
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNIL 64
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
            L       EE ++++EF+    LD F        +L+       +  +   + +LH  +
Sbjct: 65  HLHESFESMEELVMIFEFISG--LDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN 122
Query: 465 RLRIIHRDLKASNILLDAEMNP--KISDFGMARIFGVDQTQGNTSRIVGTY-GYMAPEYA 521
              I H D++  NI+     +   KI +FG AR        G+  R++ T   Y APE  
Sbjct: 123 ---IGHFDIRPENIIYQTRRSSTIKIIEFGQAR----QLKPGDNFRLLFTAPEYYAPEVH 175
Query: 522 MHGQFSVKSDVYSFGVLVLEIITG 545
            H   S  +D++S G LV  +++G
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSG 199

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 70/245 (28%), Positives = 113/245 (46%), Gaps = 30/245 (12%)
Query: 322 NADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSK- 379
           N DN L   E +      +++    +     +G G FGEV      + Q++ A+K LSK 
Sbjct: 52  NIDNFLNRYEKIVKKIRGLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKF 111
Query: 380 --ASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL--VYEFVPNKSLDYFL--Y 433
                  +  F  E  ++A      +V+L  FC   ++K L  V E++P   L   +  Y
Sbjct: 112 EMIKRSDSAFFWEERDIMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSNY 169
Query: 434 D-PEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 492
           D PEK     W++ Y      A  +L L     + +IHRD+K  N+LLD   + K++DFG
Sbjct: 170 DVPEK-----WAKFY-----TAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFG 219
Query: 493 MARIFGVDQT-QGNTSRIVGTYGYMAPEY----AMHGQFSVKSDVYSFGVLVLEIITGKK 547
                 +D+T   +    VGT  Y++PE        G +  + D +S GV + E++ G  
Sbjct: 220 TC--MKMDETGMVHCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG-- 275
Query: 548 NSNFY 552
           ++ FY
Sbjct: 276 DTPFY 280

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 97/208 (46%), Gaps = 14/208 (6%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGVLPSG-QEIAVKRLS--KASGQGAEEFKNEVVLVAKLQH 400
           T+ +    +LG+G F  V + V  +  QE A K ++  K S +  ++ + E  +   L+H
Sbjct: 30  TDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKH 89
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
            N+VRL     E     LV++ V    L   +   E   + D S     I  I   + ++
Sbjct: 90  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASH---CIHQILESVNHI 146
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNP---KISDFGMARIFGVDQTQGNTSRIVGTYGYMA 517
           H+     I+HRDLK  N+LL ++      K++DFG+A    V   Q       GT GY++
Sbjct: 147 HQHD---IVHRDLKPENLLLASKCKGAAVKLADFGLA--IEVQGEQQAWFGFAGTPGYLS 201
Query: 518 PEYAMHGQFSVKSDVYSFGVLVLEIITG 545
           PE      +    D+++ GV++  ++ G
Sbjct: 202 PEVLRKDPYGKPVDIWACGVILYILLVG 229

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 84/167 (50%), Gaps = 34/167 (20%)
Query: 386 EEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQL---- 441
           E+   E+ ++ KL H N+V+L+    +           PN+   Y +++   QG +    
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDD-----------PNEDHLYMVFELVNQGPVMEVP 129
Query: 442 -------DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494
                  D +R Y     + +GI YLH     +IIHRD+K SN+L+  + + KI+DFG++
Sbjct: 130 TLKPLSEDQARFY--FQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVS 184
Query: 495 RIF-GVDQTQGNTSRIVGTYGYMAPEYAMHGQ--FSVKS-DVYSFGV 537
             F G D    NT   VGT  +MAPE     +  FS K+ DV++ GV
Sbjct: 185 NEFKGSDALLSNT---VGTPAFMAPESLSETRKIFSGKALDVWAMGV 228

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 106/236 (44%), Gaps = 19/236 (8%)
Query: 316 NAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQE-IAV 374
           ++V  S A    + +     D    +  ++ F  +++LG G    VY+      Q+  A+
Sbjct: 24  SSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYAL 83
Query: 375 KRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYD 434
           K L K   +     + E+ ++ +L H N+++L        E  LV E V    L   + +
Sbjct: 84  KVLKKTVDKKI--VRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVE 141
Query: 435 PEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL-----DAEMNPKIS 489
                + D +   K    I   + YLHE+    I+HRDLK  N+L      DA +  KI+
Sbjct: 142 KGYYSERDAADAVK---QILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPL--KIA 193
Query: 490 DFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
           DFG+++I    + Q     + GT GY APE      +  + D++S G++   ++ G
Sbjct: 194 DFGLSKIV---EHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/173 (31%), Positives = 81/173 (46%), Gaps = 14/173 (8%)
Query: 334 QFDF--ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKN 390
           Q DF  +T+E+   +      L EGGF  VY+   + SG+E A+KRL     +       
Sbjct: 15  QSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQ 74
Query: 391 EVVLVAKLQ-HRNLVRLLGFCLEGEEK--------ILVYEFVPNKSLDYFLYDPEKQGQL 441
           EV  + KL  H N+V+       G+E+        +L+ E    + ++ FL   E +G L
Sbjct: 75  EVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVE-FLKKMESRGPL 133
Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494
                 KI     R + ++H   +  IIHRDLK  N+LL  +   K+ DFG A
Sbjct: 134 SCDTVLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 39/94 (41%), Positives = 53/94 (56%), Gaps = 7/94 (7%)
Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF--GVDQTQGNTSRIV 510
           +ARG+ +L   S  + IHRDL A NILL      KI DFG+AR      D  +   +R+ 
Sbjct: 208 VARGMEFL---SSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRL- 263
Query: 511 GTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
               +MAPE      +S KSDV+S+GVL+ EI +
Sbjct: 264 -PLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 99/212 (46%), Gaps = 24/212 (11%)
Query: 347 FSTDNKLGEGGFGEVYKGVLPS-GQEIAVK----RLSKASGQGA--EEFKNEVVLVAKLQ 399
           +    +LG G F  V K    S G E A K    R S+AS +G   EE + EV ++ ++ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
           H N++ L        + +L+ E V    L  FL   E   + + +     I  I  G+ Y
Sbjct: 74  HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT---SFIKQILDGVNY 130
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNP----KISDFGMARIF--GVDQTQGNTSRIVGTY 513
           LH     +I H DLK  NI+L  +  P    K+ DFG+A     GV+        I GT 
Sbjct: 131 LHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-----FKNIFGTP 182
Query: 514 GYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
            ++APE   +    +++D++S GV+   +++G
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 41/213 (19%)
Query: 353 LGEGGFGEV---YKGVLPSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLL 407
           +G G +G V   Y   L   Q++AVK+LS+   S   A     E+ L+  L+H N++ LL
Sbjct: 36  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 408 GFCLEGEEKILVYEFVPNKSLDYF-------------LYDPEKQGQLDWSRRYKIIGGIA 454
                         F P  S++ F             L +  K   L       ++  + 
Sbjct: 94  DV------------FTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLL 141
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
           RG+ Y+H      IIHRDLK SN+ ++ +   +I DFG+AR     Q     +  V T  
Sbjct: 142 RGLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLAR-----QADEEMTGYVATRW 193
Query: 515 YMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
           Y APE  ++   ++   D++S G ++ E++ GK
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 104/234 (44%), Gaps = 36/234 (15%)
Query: 334 QFDFETIEVATNKFSTDNK-------LGEGGFGEVYKG------VLPSGQEIAVKRLSKA 380
           Q D E +E      S D +       +G G F  VYKG      V  +  E+  ++L+K+
Sbjct: 8   QDDIEELETKAVGXSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS 67
Query: 381 SGQGAEEFKNEVVLVAKLQHRNLVRL---LGFCLEGEEKI-LVYEFVPNKSLDYFL--YD 434
             Q    FK E   +  LQH N+VR        ++G++ I LV E   + +L  +L  + 
Sbjct: 68  ERQ---RFKEEAEXLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFK 124
Query: 435 PEKQGQL-DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP-KISDFG 492
             K   L  W R+      I +G+ +LH  +   IIHRDLK  NI +       KI D G
Sbjct: 125 VXKIKVLRSWCRQ------ILKGLQFLHTRTPP-IIHRDLKCDNIFITGPTGSVKIGDLG 177
Query: 493 MARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
           +A +    +       ++GT  + APE     ++    DVY+FG   LE  T +
Sbjct: 178 LATL----KRASFAKAVIGTPEFXAPE-XYEEKYDESVDVYAFGXCXLEXATSE 226

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 97/212 (45%), Gaps = 24/212 (11%)
Query: 347 FSTDNKLGEGGFGEVYKGVLPS-GQEIAVK----RLSKASGQGA--EEFKNEVVLVAKLQ 399
           +    +LG G F  V K    S G E A K    R S+AS +G   EE + EV ++ ++ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
           H N++ L        + +L+ E V    L  FL   E    L        I  I  G+ Y
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNY 130
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNP----KISDFGMARIF--GVDQTQGNTSRIVGTY 513
           LH     +I H DLK  NI+L  +  P    K+ DFG+A     GV+        I GT 
Sbjct: 131 LHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-----FKNIFGTP 182
Query: 514 GYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
            ++APE   +    +++D++S GV+   +++G
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 103/238 (43%), Gaps = 31/238 (13%)
Query: 331 ESLQFDFETIEVATNKFSTDNKLGEGGFG--EVYKGVLPSGQEIAVKRLSKASGQGAEEF 388
           E+L F    + +    +    KLGEGGF   ++ +G L  G   A+KR+     Q  EE 
Sbjct: 15  ENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEG-LHDGHFYALKRILCHEQQDREEA 73
Query: 389 KNEVVLVAKLQHRNLVRLLGFCLE----GEEKILVYEFVPNKSLDYFLYDPEKQG----- 439
           + E  +     H N++RL+ +CL       E  L+  F    +L   +   + +G     
Sbjct: 74  QREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTE 133
Query: 440 -QLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA---- 494
            Q+ W     ++ GI RG+  +H        HRDLK +NILL  E  P + D G      
Sbjct: 134 DQILW-----LLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQAC 185
Query: 495 -RIFGVDQ--TQGNTSRIVGTYGYMAPEY---AMHGQFSVKSDVYSFGVLVLEIITGK 546
             + G  Q  T  + +    T  Y APE      H     ++DV+S G ++  ++ G+
Sbjct: 186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 97/212 (45%), Gaps = 24/212 (11%)
Query: 347 FSTDNKLGEGGFGEVYKGVLPS-GQEIAVK----RLSKASGQGA--EEFKNEVVLVAKLQ 399
           +    +LG G F  V K    S G E A K    R S+AS +G   EE + EV ++ ++ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
           H N++ L        + +L+ E V    L  FL   E    L        I  I  G+ Y
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNY 130
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNP----KISDFGMARIF--GVDQTQGNTSRIVGTY 513
           LH     +I H DLK  NI+L  +  P    K+ DFG+A     GV+        I GT 
Sbjct: 131 LHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-----FKNIFGTP 182
Query: 514 GYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
            ++APE   +    +++D++S GV+   +++G
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 41/213 (19%)
Query: 353 LGEGGFGEV---YKGVLPSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLL 407
           +G G +G V   Y   L   Q++AVK+LS+   S   A     E+ L+  L+H N++ LL
Sbjct: 28  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 408 GFCLEGEEKILVYEFVPNKSLDYF-------------LYDPEKQGQLDWSRRYKIIGGIA 454
                         F P  S++ F             L +  K   L       ++  + 
Sbjct: 86  DV------------FTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLL 133
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
           RG+ Y+H      IIHRDLK SN+ ++ +   +I DFG+AR     Q     +  V T  
Sbjct: 134 RGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR-----QADEEMTGYVATRW 185
Query: 515 YMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
           Y APE  ++   ++   D++S G ++ E++ GK
Sbjct: 186 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 97/212 (45%), Gaps = 24/212 (11%)
Query: 347 FSTDNKLGEGGFGEVYKGVLPS-GQEIAVK----RLSKASGQGA--EEFKNEVVLVAKLQ 399
           +    +LG G F  V K    S G E A K    R S+AS +G   EE + EV ++ ++ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
           H N++ L        + +L+ E V    L  FL   E    L        I  I  G+ Y
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNY 130
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNP----KISDFGMARIF--GVDQTQGNTSRIVGTY 513
           LH     +I H DLK  NI+L  +  P    K+ DFG+A     GV+        I GT 
Sbjct: 131 LHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-----FKNIFGTP 182
Query: 514 GYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
            ++APE   +    +++D++S GV+   +++G
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 97/212 (45%), Gaps = 24/212 (11%)
Query: 347 FSTDNKLGEGGFGEVYKGVLPS-GQEIAVK----RLSKASGQGA--EEFKNEVVLVAKLQ 399
           +    +LG G F  V K    S G E A K    R S+AS +G   EE + EV ++ ++ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
           H N++ L        + +L+ E V    L  FL   E    L        I  I  G+ Y
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNY 130
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNP----KISDFGMARIF--GVDQTQGNTSRIVGTY 513
           LH     +I H DLK  NI+L  +  P    K+ DFG+A     GV+        I GT 
Sbjct: 131 LHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-----FKNIFGTP 182
Query: 514 GYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
            ++APE   +    +++D++S GV+   +++G
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 35/94 (37%), Positives = 53/94 (56%), Gaps = 5/94 (5%)
Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
           IA G+ +L       II+RDLK  N++LD+E + KI+DFGM +    D     T    GT
Sbjct: 451 IAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV--TTKXFCGT 505
Query: 513 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
             Y+APE   +  +    D ++FGVL+ E++ G+
Sbjct: 506 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 97/206 (47%), Gaps = 21/206 (10%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVK-----RLSKASGQGAEEFKNEVVLVAKLQHRNLVRL 406
           +G+G F  V + +   +GQ+ AVK     + + + G   E+ K E  +   L+H ++V L
Sbjct: 32  IGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 407 LGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGIL----YLHE 462
           L          +V+EF+    L    ++  K+    +     +     R IL    Y H+
Sbjct: 92  LETYSSDGMLYMVFEFMDGADL---CFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD 148
Query: 463 DSRLRIIHRDLKASNILLDAEMNP---KISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE 519
           ++   IIHRD+K  N+LL ++ N    K+ DFG+A   G  ++       VGT  +MAPE
Sbjct: 149 NN---IIHRDVKPENVLLASKENSAPVKLGDFGVAIQLG--ESGLVAGGRVGTPHFMAPE 203
Query: 520 YAMHGQFSVKSDVYSFGVLVLEIITG 545
                 +    DV+  GV++  +++G
Sbjct: 204 VVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 94/199 (47%), Gaps = 13/199 (6%)
Query: 353 LGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGAEEFKNEVV---LVAKLQHRNLVRLLG 408
           LG+G FG+V         E+ AVK L K      ++ +  +V   ++A       +  L 
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87
Query: 409 FCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
            C +  +++  V E+V    L   +Y  ++ G+            IA G+ +L       
Sbjct: 88  SCFQTMDRLYFVMEYVNGGDL---MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG--- 141
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFS 527
           II+RDLK  N++LD+E + KI+DFGM +    D     T    GT  Y+APE   +  + 
Sbjct: 142 IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV--TTKXFCGTPDYIAPEIIAYQPYG 199
Query: 528 VKSDVYSFGVLVLEIITGK 546
              D ++FGVL+ E++ G+
Sbjct: 200 KSVDWWAFGVLLYEMLAGQ 218

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 41/213 (19%)
Query: 353 LGEGGFGEV---YKGVLPSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLL 407
           +G G +G V   Y   L   Q++AVK+LS+   S   A     E+ L+  L+H N++ LL
Sbjct: 36  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 408 GFCLEGEEKILVYEFVPNKSLDYF-------------LYDPEKQGQLDWSRRYKIIGGIA 454
                         F P  S++ F             L +  K   L       ++  + 
Sbjct: 94  DV------------FTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLL 141
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
           RG+ Y+H      IIHRDLK SN+ ++ +   +I DFG+AR     Q     +  V T  
Sbjct: 142 RGLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLAR-----QADEEMTGYVATRW 193
Query: 515 YMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
           Y APE  ++   ++   D++S G ++ E++ GK
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 97/212 (45%), Gaps = 24/212 (11%)
Query: 347 FSTDNKLGEGGFGEVYKGVLPS-GQEIAVK----RLSKASGQGA--EEFKNEVVLVAKLQ 399
           +    +LG G F  V K    S G E A K    R S+AS +G   EE + EV ++ ++ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
           H N++ L        + +L+ E V    L  FL   E    L        I  I  G+ Y
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNY 130
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNP----KISDFGMARIF--GVDQTQGNTSRIVGTY 513
           LH     +I H DLK  NI+L  +  P    K+ DFG+A     GV+        I GT 
Sbjct: 131 LHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-----FKNIFGTP 182
Query: 514 GYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
            ++APE   +    +++D++S GV+   +++G
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 92/196 (46%), Gaps = 27/196 (13%)
Query: 367 PSGQEIAVKRLSKASGQG--AEEFK-------NEVVLVAKLQ-HRNLVRLLGFCLEGEEK 416
           P+ +E AVK +    G    AEE +        EV ++ K+  H N+++L          
Sbjct: 27  PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFF 86
Query: 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKAS 476
            LV++ +    L  F Y  EK    +   R KI+  +   I  LH   +L I+HRDLK  
Sbjct: 87  FLVFDLMKKGEL--FDYLTEKVTLSEKETR-KIMRALLEVICALH---KLNIVHRDLKPE 140
Query: 477 NILLDAEMNPKISDFGMARIFGVDQTQGNTSR-IVGTYGYMAPEYAM------HGQFSVK 529
           NILLD +MN K++DFG    F      G   R + GT  Y+APE         H  +  +
Sbjct: 141 NILLDDDMNIKLTDFG----FSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKE 196
Query: 530 SDVYSFGVLVLEIITG 545
            D++S GV++  ++ G
Sbjct: 197 VDMWSTGVIMYTLLAG 212

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 93/196 (47%), Gaps = 27/196 (13%)
Query: 367 PSGQEIAVKRLSKASGQG--AEEFK-------NEVVLVAKLQ-HRNLVRLLGFCLEGEEK 416
           P+ +E AVK +    G    AEE +        EV ++ K+  H N+++L          
Sbjct: 40  PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFF 99
Query: 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKAS 476
            LV++ +  K  + F Y  EK    +   R KI+  +   I  LH   +L I+HRDLK  
Sbjct: 100 FLVFDLM--KKGELFDYLTEKVTLSEKETR-KIMRALLEVICALH---KLNIVHRDLKPE 153
Query: 477 NILLDAEMNPKISDFGMARIFGVDQTQGNTSR-IVGTYGYMAPEYAM------HGQFSVK 529
           NILLD +MN K++DFG    F      G   R + GT  Y+APE         H  +  +
Sbjct: 154 NILLDDDMNIKLTDFG----FSCQLDPGEKLRSVCGTPSYLAPEIIECSMNDNHPGYGKE 209
Query: 530 SDVYSFGVLVLEIITG 545
            D++S GV++  ++ G
Sbjct: 210 VDMWSTGVIMYTLLAG 225

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 94/204 (46%), Gaps = 11/204 (5%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNL 403
           + +    +LG G FG V++     +G   A K +        E  + E+  ++ L+H  L
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
           V L     +  E +++YEF+    L   + D   +   D +  Y  +  + +G+ ++HE+
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY--MRQVCKGLCHMHEN 274
Query: 464 SRLRIIHRDLKASNILLDAEMNP--KISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYA 521
           +    +H DLK  NI+   + +   K+ DFG+       Q+   T+   GT  + APE A
Sbjct: 275 N---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVA 328
Query: 522 MHGQFSVKSDVYSFGVLVLEIITG 545
                   +D++S GVL   +++G
Sbjct: 329 EGKPVGYYTDMWSVGVLSYILLSG 352

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 93/196 (47%), Gaps = 27/196 (13%)
Query: 367 PSGQEIAVKRLSKASGQG--AEEFK-------NEVVLVAKLQ-HRNLVRLLGFCLEGEEK 416
           P+ +E AVK +    G    AEE +        EV ++ K+  H N+++L          
Sbjct: 40  PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFF 99
Query: 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKAS 476
            LV++ +  K  + F Y  EK    +   R KI+  +   I  LH   +L I+HRDLK  
Sbjct: 100 FLVFDLM--KKGELFDYLTEKVTLSEKETR-KIMRALLEVICALH---KLNIVHRDLKPE 153
Query: 477 NILLDAEMNPKISDFGMARIFGVDQTQGNTSR-IVGTYGYMAPEYAM------HGQFSVK 529
           NILLD +MN K++DFG    F      G   R + GT  Y+APE         H  +  +
Sbjct: 154 NILLDDDMNIKLTDFG----FSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKE 209
Query: 530 SDVYSFGVLVLEIITG 545
            D++S GV++  ++ G
Sbjct: 210 VDMWSTGVIMYTLLAG 225

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 94/204 (46%), Gaps = 11/204 (5%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNL 403
           + +    +LG G FG V++     +G   A K +        E  + E+  ++ L+H  L
Sbjct: 51  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 110
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
           V L     +  E +++YEF+    L   + D   +   D +  Y  +  + +G+ ++HE+
Sbjct: 111 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY--MRQVCKGLCHMHEN 168
Query: 464 SRLRIIHRDLKASNILLDAEMNP--KISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYA 521
           +    +H DLK  NI+   + +   K+ DFG+       Q+   T+   GT  + APE A
Sbjct: 169 N---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVA 222
Query: 522 MHGQFSVKSDVYSFGVLVLEIITG 545
                   +D++S GVL   +++G
Sbjct: 223 EGKPVGYYTDMWSVGVLSYILLSG 246

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 72/138 (52%), Gaps = 9/138 (6%)
Query: 410 CLEGEEKIL-VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRI 468
           C + E ++  V E+V    L   ++  ++Q +L           I+  + YLHE     I
Sbjct: 89  CFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNYLHERG---I 142
Query: 469 IHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSV 528
           I+RDLK  N+LLD+E + K++D+GM +  G+ +    TS   GT  Y+APE      +  
Sbjct: 143 IYRDLKLDNVLLDSEGHIKLTDYGMCKE-GL-RPGDTTSXFCGTPNYIAPEILRGEDYGF 200
Query: 529 KSDVYSFGVLVLEIITGK 546
             D ++ GVL+ E++ G+
Sbjct: 201 SVDWWALGVLMFEMMAGR 218

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 51/92 (55%), Gaps = 3/92 (3%)
Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
           +A+G+ +L   +  + IHRDL A NILL  +   KI DFG+AR    D            
Sbjct: 207 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 263
Query: 513 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
             +MAPE      ++++SDV+SFGVL+ EI +
Sbjct: 264 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 295

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 51/92 (55%), Gaps = 3/92 (3%)
Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
           +A+G+ +L   +  + IHRDL A NILL  +   KI DFG+AR    D            
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 513 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
             +MAPE      ++++SDV+SFGVL+ EI +
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 105/229 (45%), Gaps = 29/229 (12%)
Query: 352 KLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFK-NEVVLVAKLQHRNLVRLLG-F 409
           K+G G +G VYK     G++     L +  G G       E+ L+ +L+H N++ L   F
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 87
Query: 410 CLEGEEKI-LVYEFVPNKSLDYFLYDP-----EKQGQLDWSRRYKIIGGIARGILYLHED 463
               + K+ L++++  +       +       +K  QL       ++  I  GI YLH +
Sbjct: 88  LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 147
Query: 464 SRLRIIHRDLKASNILLDAEMNP-----KISDFGMARIFGVD-QTQGNTSRIVGTYGYMA 517
               ++HRDLK +NIL+  E  P     KI+D G AR+F    +   +   +V T+ Y A
Sbjct: 148 W---VLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 203
Query: 518 PEYAMHGQFSVKS-DVYSFGVLVLEIITGK----------KNSNFYQTD 555
           PE  +  +   K+ D+++ G +  E++T +          K SN Y  D
Sbjct: 204 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 252

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 51/92 (55%), Gaps = 3/92 (3%)
Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
           +A+G+ +L   +  + IHRDL A NILL  +   KI DFG+AR    D            
Sbjct: 200 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 513 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
             +MAPE      ++++SDV+SFGVL+ EI +
Sbjct: 257 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 288

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 100/217 (46%), Gaps = 22/217 (10%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ 399
           +   N      ++G G  G+V+K     +G  IAVK++ + SG   E  +  + L   L+
Sbjct: 21  QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRR-SGNKEENKRILMDLDVVLK 79
Query: 400 HRN---LVRLLGFCLEGEEKILVYEFVPN--KSLDYFLYDPEKQGQLDWSRRYKIIGGIA 454
             +   +V+  G  +   +  +  E +    + L   +  P  +  L      K+   I 
Sbjct: 80  SHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILG-----KMTVAIV 134
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
           + + YL E  +  +IHRD+K SNILLD     K+ DFG++     D+ +    R  G   
Sbjct: 135 KALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK---DRSAGCAA 189
Query: 515 YMAPEY-----AMHGQFSVKSDVYSFGVLVLEIITGK 546
           YMAPE           + +++DV+S G+ ++E+ TG+
Sbjct: 190 YMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/245 (26%), Positives = 112/245 (45%), Gaps = 30/245 (12%)
Query: 316 NAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVK 375
           N V  +  D+    ++ L  D +T E     ++    +G G FG V++  L    E+A+K
Sbjct: 11  NGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIK 70
Query: 376 RLSKASGQGAEEFKN-EVVLVAKLQHRNLVRLLGFCLEGEEKI------LVYEFVPNKSL 428
           ++ +      + FKN E+ ++  ++H N+V L  F     +K       LV E+VP    
Sbjct: 71  KVLQ-----DKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPET-- 123
Query: 429 DYFLYDPEKQ-GQLDWSRRYKIIG----GIARGILYLHEDSRLRIIHRDLKASNILLDAE 483
              +Y   +   +L  +    +I      + R + Y+H    + I HRD+K  N+LLD  
Sbjct: 124 ---VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPP 177
Query: 484 MNP-KISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLE 541
               K+ DFG A+I    +   N S I   Y Y APE       ++   D++S G ++ E
Sbjct: 178 SGVLKLIDFGSAKILIAGEP--NVSXICSRY-YRAPELIFGATNYTTNIDIWSTGCVMAE 234
Query: 542 IITGK 546
           ++ G+
Sbjct: 235 LMQGQ 239

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 51/92 (55%), Gaps = 3/92 (3%)
Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
           +A+G+ +L   +  + IHRDL A NILL  +   KI DFG+AR    D            
Sbjct: 209 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 265
Query: 513 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
             +MAPE      ++++SDV+SFGVL+ EI +
Sbjct: 266 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 297

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 102/212 (48%), Gaps = 21/212 (9%)
Query: 349 TDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ-HRNLVRL 406
           T   LGEG + +V   V L +G+E AVK + K +G        EV  + + Q ++N++ L
Sbjct: 17  TSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILEL 76
Query: 407 LGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRL 466
           + F  +     LV+E +   S+   L   +KQ   +     +++  +A  + +LH     
Sbjct: 77  IEFFEDDTRFYLVFEKLQGGSI---LAHIQKQKHFNEREASRVVRDVAAALDFLHTKG-- 131
Query: 467 RIIHRDLKASNILLDA--EMNP-KISDFGMARIFGVDQ-----TQGNTSRIVGTYGYMAP 518
            I HRDLK  NIL ++  +++P KI DF +     ++      T    +   G+  YMAP
Sbjct: 132 -IAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAP 190
Query: 519 E----YAMHGQF-SVKSDVYSFGVLVLEIITG 545
           E    +     F   + D++S GV++  +++G
Sbjct: 191 EVVEVFTDQATFYDKRCDLWSLGVVLYIMLSG 222

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 72/138 (52%), Gaps = 9/138 (6%)
Query: 410 CLEGEEKIL-VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRI 468
           C + E ++  V E+V    L   ++  ++Q +L           I+  + YLHE     I
Sbjct: 121 CFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNYLHERG---I 174
Query: 469 IHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSV 528
           I+RDLK  N+LLD+E + K++D+GM +  G+ +    TS   GT  Y+APE      +  
Sbjct: 175 IYRDLKLDNVLLDSEGHIKLTDYGMCKE-GL-RPGDTTSTFCGTPNYIAPEILRGEDYGF 232
Query: 529 KSDVYSFGVLVLEIITGK 546
             D ++ GVL+ E++ G+
Sbjct: 233 SVDWWALGVLMFEMMAGR 250

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 72/138 (52%), Gaps = 9/138 (6%)
Query: 410 CLEGEEKIL-VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRI 468
           C + E ++  V E+V    L   ++  ++Q +L           I+  + YLHE     I
Sbjct: 74  CFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNYLHERG---I 127
Query: 469 IHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSV 528
           I+RDLK  N+LLD+E + K++D+GM +  G+ +    TS   GT  Y+APE      +  
Sbjct: 128 IYRDLKLDNVLLDSEGHIKLTDYGMCKE-GL-RPGDTTSXFCGTPNYIAPEILRGEDYGF 185
Query: 529 KSDVYSFGVLVLEIITGK 546
             D ++ GVL+ E++ G+
Sbjct: 186 SVDWWALGVLMFEMMAGR 203

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 345 NKFSTDNKLGEGGFGEVY-KGVLPSGQEIAVKRLSKASGQGAEEFK---NEVVLVAKLQH 400
           ++F     LG G FG V     + +G   A+K L K      +E +   NE  ++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
             LV+L     +     +V E+ P   +   L    + G+            I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEY 520
           H    L +I+RDLK  N+++D +   K++DFG+A+     + +G T  + GT  Y+APE 
Sbjct: 158 HS---LDLIYRDLKPENLMIDQQGYIKVTDFGLAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 521 AMHGQFSVKSDVYSFGVLVLEIITG 545
            +   ++   D ++ GVL+ E+  G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 103/226 (45%), Gaps = 25/226 (11%)
Query: 337 FETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVK--RLSKASGQGAEEFKNEVVL 394
           F+++ V    +S   ++G GG  +V++ +    Q  A+K   L +A  Q  + ++NE+  
Sbjct: 20  FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAY 79
Query: 395 VAKLQHRN--LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGG 452
           + KLQ  +  ++RL  + +  +   +V E   N  L+ +L   +K+  +D   R      
Sbjct: 80  LNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWL---KKKKSIDPWERKSYWKN 135
Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
           +   +  +H+     I+H DLK +N L+   M  K+ DFG+A     D T       VGT
Sbjct: 136 MLEAVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGT 191
Query: 513 YGYMAPEYAMHGQFSVKS------------DVYSFGVLVLEIITGK 546
             YM PE A+    S +             DV+S G ++  +  GK
Sbjct: 192 VNYMPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 72/138 (52%), Gaps = 9/138 (6%)
Query: 410 CLEGEEKIL-VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRI 468
           C + E ++  V E+V    L   ++  ++Q +L           I+  + YLHE     I
Sbjct: 78  CFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNYLHERG---I 131
Query: 469 IHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSV 528
           I+RDLK  N+LLD+E + K++D+GM +  G+ +    TS   GT  Y+APE      +  
Sbjct: 132 IYRDLKLDNVLLDSEGHIKLTDYGMCKE-GL-RPGDTTSXFCGTPNYIAPEILRGEDYGF 189
Query: 529 KSDVYSFGVLVLEIITGK 546
             D ++ GVL+ E++ G+
Sbjct: 190 SVDWWALGVLMFEMMAGR 207

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 19/205 (9%)
Query: 353 LGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE 412
           +G+G +GEV++G L  G+ +AVK  S    Q     + E+     L+H N++  +   + 
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFSSRDEQSWFR-ETEIYNTVLLRHDNILGFIASDMT 73
Query: 413 GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED-----SRLR 467
                     + +      LYD  ++  L+     ++    A G+ +LH +      +  
Sbjct: 74  SRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLALRLAVSAACGLAHLHVEIFGTQGKPA 133
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIF--GVDQTQ-GNTSRIVGTYGYMAPEYAMHG 524
           I HRD K+ N+L+ + +   I+D G+A +   G D    GN  R VGT  YMAPE  +  
Sbjct: 134 IAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPR-VGTKRYMAPE-VLDE 191
Query: 525 QFSVK-------SDVYSFGVLVLEI 542
           Q           +D+++FG+++ EI
Sbjct: 192 QIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 79/159 (49%), Gaps = 13/159 (8%)
Query: 386 EEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL-----DYFLYDPEKQGQ 440
           ++FKNE+ ++  +++   +   G     +E  ++YE++ N S+      +F+ D      
Sbjct: 88  DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCF 147
Query: 441 LDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500
           +       II  +     Y+H +    I HRD+K SNIL+D     K+SDFG +      
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK 205
Query: 501 QTQGNTSRIVGTYGYMAPE-YAMHGQFS-VKSDVYSFGV 537
           + +G  SR  GTY +M PE ++    ++  K D++S G+
Sbjct: 206 KIKG--SR--GTYEFMPPEFFSNESSYNGAKVDIWSLGI 240

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 91/205 (44%), Gaps = 15/205 (7%)
Query: 345 NKFSTDNKLGEGGFGEVY-KGVLPSGQEIAVKRLSK---ASGQGAEEFKNEVVLVAKLQH 400
           ++F     LG G FG V     + +G   A+K L K      +  E   NE  ++  +  
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 86
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
             LV+L     +     +V E+VP   +   L    + G+            I     YL
Sbjct: 87  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 143
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEY 520
           H    L +I+RDLK  N+L+D +   +++DFG A+     + +G T  + GT  Y+APE 
Sbjct: 144 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEYLAPEI 195
Query: 521 AMHGQFSVKSDVYSFGVLVLEIITG 545
            +   ++   D ++ GVL+ E+  G
Sbjct: 196 ILSKGYNKAVDWWALGVLIYEMAAG 220

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 91/205 (44%), Gaps = 15/205 (7%)
Query: 345 NKFSTDNKLGEGGFGEVY-KGVLPSGQEIAVKRLSK---ASGQGAEEFKNEVVLVAKLQH 400
           ++F     +G G FG V     + +G   A+K L K      +  E   NE  ++  +  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
             LV+L     +     +V E+VP   +   L    + G+            I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEY 520
           H    L +I+RDLK  N+L+D +   K++DFG A+     + +G T  + GT  Y+APE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 521 AMHGQFSVKSDVYSFGVLVLEIITG 545
            +   ++   D ++ GVL+ E+  G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 91/205 (44%), Gaps = 15/205 (7%)
Query: 345 NKFSTDNKLGEGGFGEVY-KGVLPSGQEIAVKRLSK---ASGQGAEEFKNEVVLVAKLQH 400
           ++F     LG G FG V     + +G   A+K L K      +  E   NE  ++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
             LV+L     +     +V E+VP   +   L    + G+            I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEY 520
           H    L +I+RDLK  N+L+D +   +++DFG A+     + +G T  + GT  Y+APE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 521 AMHGQFSVKSDVYSFGVLVLEIITG 545
            +   ++   D ++ GVL+ E+  G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 91/205 (44%), Gaps = 15/205 (7%)
Query: 345 NKFSTDNKLGEGGFGEVY-KGVLPSGQEIAVKRLSK---ASGQGAEEFKNEVVLVAKLQH 400
           ++F     LG G FG V     + +G   A+K L K      +  E   NE  ++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
             LV+L     +     +V E+VP   +   L    + G+            I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEY 520
           H    L +I+RDLK  N+L+D +   +++DFG A+     + +G T  + GT  Y+APE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 521 AMHGQFSVKSDVYSFGVLVLEIITG 545
            +   ++   D ++ GVL+ E+  G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 91/205 (44%), Gaps = 15/205 (7%)
Query: 345 NKFSTDNKLGEGGFGEVY-KGVLPSGQEIAVKRLSK---ASGQGAEEFKNEVVLVAKLQH 400
           ++F     LG G FG V     + +G   A+K L K      +  E   NE  ++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
             LV+L     +     +V E+VP   +   L    + G+            I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEY 520
           H    L +I+RDLK  N+L+D +   +++DFG A+     + +G T  + GT  Y+APE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 521 AMHGQFSVKSDVYSFGVLVLEIITG 545
            +   ++   D ++ GVL+ E+  G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 91/205 (44%), Gaps = 15/205 (7%)
Query: 345 NKFSTDNKLGEGGFGEVY-KGVLPSGQEIAVKRLSK---ASGQGAEEFKNEVVLVAKLQH 400
           ++F     LG G FG V     + +G   A+K L K      +  E   NE  ++  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
             LV+L     +     +V E+VP   +   L    + G+            I     YL
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 158
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEY 520
           H    L +I+RDLK  N+L+D +   +++DFG A+     + +G T  + GT  Y+APE 
Sbjct: 159 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 210
Query: 521 AMHGQFSVKSDVYSFGVLVLEIITG 545
            +   ++   D ++ GVL+ E+  G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 96/213 (45%), Gaps = 35/213 (16%)
Query: 353 LGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKN-EVVLVAKLQHRNLVRLLGFCL 411
           +G+G FGEV++G    G+E+AVK  S  S +    F+  E+     L+H N+   LGF  
Sbjct: 50  IGKGRFGEVWRGKW-RGEEVAVKIFS--SREERSWFREAEIYQTVMLRHENI---LGFIA 103
Query: 412 EGEEKILVYEFVPNKSLDYFLYDPEKQGQL-DWSRRY--------KIIGGIARGILYLHE 462
              +    +  +      + + D  + G L D+  RY        K+    A G+ +LH 
Sbjct: 104 ADNKDNGTWTQL------WLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHM 157
Query: 463 D-----SRLRIIHRDLKASNILLDAEMNPKISDFGMA--RIFGVDQTQGNTSRIVGTYGY 515
           +      +  I HRDLK+ NIL+       I+D G+A       D      +  VGT  Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
Query: 516 MAPEY------AMHGQFSVKSDVYSFGVLVLEI 542
           MAPE         H +   ++D+Y+ G++  EI
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 91/205 (44%), Gaps = 15/205 (7%)
Query: 345 NKFSTDNKLGEGGFGEVY-KGVLPSGQEIAVKRLSK---ASGQGAEEFKNEVVLVAKLQH 400
           ++F     LG G FG V     + +G   A+K L K      +  E   NE  ++  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
             LV+L     +     +V E+VP   +   L    + G+            I     YL
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 158
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEY 520
           H    L +I+RDLK  N+L+D +   +++DFG A+     + +G T  + GT  Y+APE 
Sbjct: 159 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEYLAPEI 210
Query: 521 AMHGQFSVKSDVYSFGVLVLEIITG 545
            +   ++   D ++ GVL+ E+  G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 96/213 (45%), Gaps = 35/213 (16%)
Query: 353 LGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKN-EVVLVAKLQHRNLVRLLGFCL 411
           +G+G FGEV++G    G+E+AVK  S  S +    F+  E+     L+H N+   LGF  
Sbjct: 37  IGKGRFGEVWRGKW-RGEEVAVKIFS--SREERSWFREAEIYQTVMLRHENI---LGFIA 90
Query: 412 EGEEKILVYEFVPNKSLDYFLYDPEKQGQL-DWSRRY--------KIIGGIARGILYLHE 462
              +    +  +      + + D  + G L D+  RY        K+    A G+ +LH 
Sbjct: 91  ADNKDNGTWTQL------WLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHM 144
Query: 463 D-----SRLRIIHRDLKASNILLDAEMNPKISDFGMA--RIFGVDQTQGNTSRIVGTYGY 515
           +      +  I HRDLK+ NIL+       I+D G+A       D      +  VGT  Y
Sbjct: 145 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 204
Query: 516 MAPEY------AMHGQFSVKSDVYSFGVLVLEI 542
           MAPE         H +   ++D+Y+ G++  EI
Sbjct: 205 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 96/213 (45%), Gaps = 35/213 (16%)
Query: 353 LGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKN-EVVLVAKLQHRNLVRLLGFCL 411
           +G+G FGEV++G    G+E+AVK  S  S +    F+  E+     L+H N+   LGF  
Sbjct: 12  IGKGRFGEVWRGKW-RGEEVAVKIFS--SREERSWFREAEIYQTVMLRHENI---LGFIA 65
Query: 412 EGEEKILVYEFVPNKSLDYFLYDPEKQGQL-DWSRRY--------KIIGGIARGILYLHE 462
              +    +  +      + + D  + G L D+  RY        K+    A G+ +LH 
Sbjct: 66  ADNKDNGTWTQL------WLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHM 119
Query: 463 D-----SRLRIIHRDLKASNILLDAEMNPKISDFGMA--RIFGVDQTQGNTSRIVGTYGY 515
           +      +  I HRDLK+ NIL+       I+D G+A       D      +  VGT  Y
Sbjct: 120 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 179
Query: 516 MAPEY------AMHGQFSVKSDVYSFGVLVLEI 542
           MAPE         H +   ++D+Y+ G++  EI
Sbjct: 180 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 91/205 (44%), Gaps = 15/205 (7%)
Query: 345 NKFSTDNKLGEGGFGEVY-KGVLPSGQEIAVKRLSK---ASGQGAEEFKNEVVLVAKLQH 400
           ++F     LG G FG V     + +G   A+K L K      +  E   NE  ++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
             LV+L     +     +V E+VP   +   L    + G+            I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFXEPHARFYAAQIVLTFEYL 157
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEY 520
           H    L +I+RDLK  N+L+D +   +++DFG A+     + +G T  + GT  Y+APE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 521 AMHGQFSVKSDVYSFGVLVLEIITG 545
            +   ++   D ++ GVL+ E+  G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 65/253 (25%), Positives = 112/253 (44%), Gaps = 28/253 (11%)
Query: 310 KAKKKYNAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSG 369
           K ++++   P+   D+D     S     E I V    +S   ++G GG  +V++ +    
Sbjct: 24  KFERQHMDSPDLGTDDDDKASSSAN---ECISVKGRIYSILKQIGSGGSSKVFQVLNEKK 80
Query: 370 QEIAVK--RLSKASGQGAEEFKNEVVLVAKLQHRN--LVRLLGFCLEGEEKILVYEFVPN 425
           Q  A+K   L +A  Q  + ++NE+  + KLQ  +  ++RL  + +  +   +V E   N
Sbjct: 81  QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGN 139
Query: 426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN 485
             L+ +L   +K+  +D   R      +   +  +H+     I+H DLK +N L+   M 
Sbjct: 140 IDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDGM- 192
Query: 486 PKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKS------------DVY 533
            K+ DFG+A     D T       VGT  YM PE A+    S +             DV+
Sbjct: 193 LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE-AIKDMSSSRENGKSKSKISPKSDVW 251
Query: 534 SFGVLVLEIITGK 546
           S G ++  +  GK
Sbjct: 252 SLGCILYYMTYGK 264

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 91/205 (44%), Gaps = 15/205 (7%)
Query: 345 NKFSTDNKLGEGGFGEVY-KGVLPSGQEIAVKRLSK---ASGQGAEEFKNEVVLVAKLQH 400
           ++F     LG G FG V     + +G   A+K L K      +  E   NE  ++  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
             LV+L     +     +V E+VP   +   L    + G+            I     YL
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFXEPHARFYAAQIVLTFEYL 158
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEY 520
           H    L +I+RDLK  N+L+D +   +++DFG A+     + +G T  + GT  Y+APE 
Sbjct: 159 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 210
Query: 521 AMHGQFSVKSDVYSFGVLVLEIITG 545
            +   ++   D ++ GVL+ E+  G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 68/279 (24%), Positives = 107/279 (38%), Gaps = 86/279 (30%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQ-EIAVKRLSKASGQGA-EEFKNEVV 393
           DFE I+           +G GGFG V++          A+KR+   + + A E+   EV 
Sbjct: 7   DFEPIQC----------MGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVK 56
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYE----FVPNKSLDYFLYDPEKQ----------- 438
            +AKL+H  +VR     LE   +    E    ++ ++S D+ L  P              
Sbjct: 57  ALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMD 116
Query: 439 --------GQL----------------------DWSRR------------YKIIGGIARG 456
                   GQL                      DW  R              I   IA  
Sbjct: 117 PFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEA 176
Query: 457 ILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRI------- 509
           + +LH      ++HRDLK SNI    +   K+ DFG+  +  +DQ +   + +       
Sbjct: 177 VEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGL--VTAMDQDEEEQTVLTPMPAYA 231
Query: 510 -----VGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEII 543
                VGT  YM+PE      +S K D++S G+++ E++
Sbjct: 232 THXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 91/205 (44%), Gaps = 15/205 (7%)
Query: 345 NKFSTDNKLGEGGFGEVY-KGVLPSGQEIAVKRLSK---ASGQGAEEFKNEVVLVAKLQH 400
           ++F     LG G FG V     + +G   A+K L K      +  E   NE  ++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
             LV+L     +     +V E+VP   +   L    + G+            I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFXEPHARFYAAQIVLTFEYL 157
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEY 520
           H    L +I+RDLK  N+L+D +   +++DFG A+     + +G T  + GT  Y+APE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 521 AMHGQFSVKSDVYSFGVLVLEIITG 545
            +   ++   D ++ GVL+ E+  G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 96/213 (45%), Gaps = 35/213 (16%)
Query: 353 LGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKN-EVVLVAKLQHRNLVRLLGFCL 411
           +G+G FGEV++G    G+E+AVK  S  S +    F+  E+     L+H N+   LGF  
Sbjct: 17  IGKGRFGEVWRGKW-RGEEVAVKIFS--SREERSWFREAEIYQTVMLRHENI---LGFIA 70
Query: 412 EGEEKILVYEFVPNKSLDYFLYDPEKQGQL-DWSRRY--------KIIGGIARGILYLHE 462
              +    +  +      + + D  + G L D+  RY        K+    A G+ +LH 
Sbjct: 71  ADNKDNGTWTQL------WLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHM 124
Query: 463 D-----SRLRIIHRDLKASNILLDAEMNPKISDFGMA--RIFGVDQTQGNTSRIVGTYGY 515
           +      +  I HRDLK+ NIL+       I+D G+A       D      +  VGT  Y
Sbjct: 125 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 184
Query: 516 MAPEY------AMHGQFSVKSDVYSFGVLVLEI 542
           MAPE         H +   ++D+Y+ G++  EI
Sbjct: 185 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 31/87 (35%), Positives = 50/87 (57%), Gaps = 8/87 (9%)
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
           YLH    L +I+RDLK  N+L+D +   K++DFG A+     + +G T  + GT  Y+AP
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCGTPEYLAP 208
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITG 545
           E  +   ++   D ++ GVL+ E+  G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 96/213 (45%), Gaps = 35/213 (16%)
Query: 353 LGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKN-EVVLVAKLQHRNLVRLLGFCL 411
           +G+G FGEV++G    G+E+AVK  S  S +    F+  E+     L+H N+   LGF  
Sbjct: 11  IGKGRFGEVWRGKW-RGEEVAVKIFS--SREERSWFREAEIYQTVMLRHENI---LGFIA 64
Query: 412 EGEEKILVYEFVPNKSLDYFLYDPEKQGQL-DWSRRY--------KIIGGIARGILYLHE 462
              +    +  +      + + D  + G L D+  RY        K+    A G+ +LH 
Sbjct: 65  ADNKDNGTWTQL------WLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHM 118
Query: 463 D-----SRLRIIHRDLKASNILLDAEMNPKISDFGMA--RIFGVDQTQGNTSRIVGTYGY 515
           +      +  I HRDLK+ NIL+       I+D G+A       D      +  VGT  Y
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 178
Query: 516 MAPEY------AMHGQFSVKSDVYSFGVLVLEI 542
           MAPE         H +   ++D+Y+ G++  EI
Sbjct: 179 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 345 NKFSTDNKLGEGGFGEVY-KGVLPSGQEIAVKRLSKASGQGAEEFK---NEVVLVAKLQH 400
           ++F     LG G FG V     + +G   A+K L K      +E +   NE  ++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
             LV+L     +     +V E+ P   +   L    + G+            I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEY 520
           H    L +I+RDLK  N+++D +   +++DFG+A+     + +G T  + GT  Y+APE 
Sbjct: 158 HS---LDLIYRDLKPENLMIDQQGYIQVTDFGLAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 521 AMHGQFSVKSDVYSFGVLVLEIITG 545
            +   ++   D ++ GVL+ E+  G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 96/213 (45%), Gaps = 35/213 (16%)
Query: 353 LGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKN-EVVLVAKLQHRNLVRLLGFCL 411
           +G+G FGEV++G    G+E+AVK  S  S +    F+  E+     L+H N+   LGF  
Sbjct: 14  IGKGRFGEVWRGKW-RGEEVAVKIFS--SREERSWFREAEIYQTVMLRHENI---LGFIA 67
Query: 412 EGEEKILVYEFVPNKSLDYFLYDPEKQGQL-DWSRRY--------KIIGGIARGILYLHE 462
              +    +  +      + + D  + G L D+  RY        K+    A G+ +LH 
Sbjct: 68  ADNKDNGTWTQL------WLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHM 121
Query: 463 D-----SRLRIIHRDLKASNILLDAEMNPKISDFGMA--RIFGVDQTQGNTSRIVGTYGY 515
           +      +  I HRDLK+ NIL+       I+D G+A       D      +  VGT  Y
Sbjct: 122 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 181
Query: 516 MAPEY------AMHGQFSVKSDVYSFGVLVLEI 542
           MAPE         H +   ++D+Y+ G++  EI
Sbjct: 182 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 101/225 (44%), Gaps = 25/225 (11%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVK--RLSKASGQGAEEFKNEVVLV 395
           E I V    +S   ++G GG  +V++ +    Q  A+K   L +A  Q  + ++NE+  +
Sbjct: 5   ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 64
Query: 396 AKLQHRN--LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGI 453
            KLQ  +  ++RL  + +  +   +V E   N  L+ +L   +K+  +D   R      +
Sbjct: 65  NKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWL---KKKKSIDPWERKSYWKNM 120
Query: 454 ARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTY 513
              +  +H+     I+H DLK +N L+   M  K+ DFG+A     D T       VGT 
Sbjct: 121 LEAVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTV 176
Query: 514 GYMAPEYAMHGQFSVKS------------DVYSFGVLVLEIITGK 546
            YM PE A+    S +             DV+S G ++  +  GK
Sbjct: 177 NYMPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 220

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 31/87 (35%), Positives = 50/87 (57%), Gaps = 8/87 (9%)
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
           YLH    L +I+RDLK  N+L+D +   K++DFG A+     + +G T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCGTPEYLAP 207
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITG 545
           E  +   ++   D ++ GVL+ E+  G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 31/87 (35%), Positives = 50/87 (57%), Gaps = 8/87 (9%)
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
           YLH    L +I+RDLK  N+L+D +   K++DFG A+     + +G T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCGTPEYLAP 207
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITG 545
           E  +   ++   D ++ GVL+ E+  G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 100/216 (46%), Gaps = 26/216 (12%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQ-GAEEFKNEVVLVAKLQHR 401
           ++ F   + LGEG +G V      P+G+ +A+K++        A     E+ ++   +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 402 NLVRLLGF----CLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGI 457
           N++ +         E   ++ + + +    L   +     Q   D   +Y I   + R +
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI---STQMLSDDHIQYFIYQTL-RAV 125
Query: 458 LYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTS---------- 507
             LH  +   +IHRDLK SN+L+++  + K+ DFG+ARI  +D++  + S          
Sbjct: 126 KVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI--IDESAADNSEPTGQQSGMV 180
Query: 508 RIVGTYGYMAPEYAM-HGQFSVKSDVYSFGVLVLEI 542
             V T  Y APE  +   ++S   DV+S G ++ E+
Sbjct: 181 EFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 100/216 (46%), Gaps = 26/216 (12%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQ-GAEEFKNEVVLVAKLQHR 401
           ++ F   + LGEG +G V      P+G+ +A+K++        A     E+ ++   +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 402 NLVRLLGF----CLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGI 457
           N++ +         E   ++ + + +    L   +     Q   D   +Y I   + R +
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI---STQMLSDDHIQYFIYQTL-RAV 125
Query: 458 LYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVG------ 511
             LH  +   +IHRDLK SN+L+++  + K+ DFG+ARI  +D++  + S   G      
Sbjct: 126 KVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI--IDESAADNSEPTGQQSGMT 180
Query: 512 ----TYGYMAPEYAM-HGQFSVKSDVYSFGVLVLEI 542
               T  Y APE  +   ++S   DV+S G ++ E+
Sbjct: 181 EYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 100/216 (46%), Gaps = 26/216 (12%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQ-GAEEFKNEVVLVAKLQHR 401
           ++ F   + LGEG +G V      P+G+ +A+K++        A     E+ ++   +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 402 NLVRLLGF----CLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGI 457
           N++ +         E   ++ + + +    L   +     Q   D   +Y I   + R +
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI---STQMLSDDHIQYFIYQTL-RAV 125
Query: 458 LYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT----------QGNTS 507
             LH  +   +IHRDLK SN+L+++  + K+ DFG+ARI  +D++          Q   +
Sbjct: 126 KVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI--IDESAADNSEPTGQQSGMT 180
Query: 508 RIVGTYGYMAPEYAM-HGQFSVKSDVYSFGVLVLEI 542
             V T  Y APE  +   ++S   DV+S G ++ E+
Sbjct: 181 EXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 101/225 (44%), Gaps = 25/225 (11%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVK--RLSKASGQGAEEFKNEVVLV 395
           E I V    +S   ++G GG  +V++ +    Q  A+K   L +A  Q  + ++NE+  +
Sbjct: 1   ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 60
Query: 396 AKLQHRN--LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGI 453
            KLQ  +  ++RL  + +  +   +V E   N  L+ +L   +K+  +D   R      +
Sbjct: 61  NKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWL---KKKKSIDPWERKSYWKNM 116
Query: 454 ARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTY 513
              +  +H+     I+H DLK +N L+   M  K+ DFG+A     D T       VGT 
Sbjct: 117 LEAVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTV 172
Query: 514 GYMAPEYAMHGQFSVKS------------DVYSFGVLVLEIITGK 546
            YM PE A+    S +             DV+S G ++  +  GK
Sbjct: 173 NYMPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 216

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 101/225 (44%), Gaps = 25/225 (11%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVK--RLSKASGQGAEEFKNEVVLV 395
           E I V    +S   ++G GG  +V++ +    Q  A+K   L +A  Q  + ++NE+  +
Sbjct: 2   ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 61
Query: 396 AKLQHRN--LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGI 453
            KLQ  +  ++RL  + +  +   +V E   N  L+ +L   +K+  +D   R      +
Sbjct: 62  NKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWL---KKKKSIDPWERKSYWKNM 117
Query: 454 ARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTY 513
              +  +H+     I+H DLK +N L+   M  K+ DFG+A     D T       VGT 
Sbjct: 118 LEAVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTV 173
Query: 514 GYMAPEYAMHGQFSVKS------------DVYSFGVLVLEIITGK 546
            YM PE A+    S +             DV+S G ++  +  GK
Sbjct: 174 NYMPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/253 (25%), Positives = 112/253 (44%), Gaps = 28/253 (11%)
Query: 310 KAKKKYNAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSG 369
           K ++++   P+   D+D     S     E I V    +S   ++G GG  +V++ +    
Sbjct: 24  KFERQHMDSPDLGTDDDDKASSSAN---ECISVKGRIYSILKQIGSGGSSKVFQVLNEKK 80
Query: 370 QEIAVK--RLSKASGQGAEEFKNEVVLVAKLQHRN--LVRLLGFCLEGEEKILVYEFVPN 425
           Q  A+K   L +A  Q  + ++NE+  + KLQ  +  ++RL  + +  +   +V E   N
Sbjct: 81  QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGN 139
Query: 426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN 485
             L+ +L   +K+  +D   R      +   +  +H+     I+H DLK +N L+   M 
Sbjct: 140 IDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDGM- 192
Query: 486 PKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKS------------DVY 533
            K+ DFG+A     D T       VGT  YM PE A+    S +             DV+
Sbjct: 193 LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE-AIKDMSSSRENGKSKSKISPKSDVW 251
Query: 534 SFGVLVLEIITGK 546
           S G ++  +  GK
Sbjct: 252 SLGCILYYMTYGK 264

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 90/205 (43%), Gaps = 15/205 (7%)
Query: 345 NKFSTDNKLGEGGFGEVY-KGVLPSGQEIAVKRLSK---ASGQGAEEFKNEVVLVAKLQH 400
           ++F     LG G FG V     + +G   A+K L K      +  E   NE  ++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
             LV+L     +     +V E+ P   +   L    + G+            I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEY 520
           H    L +I+RDLK  N+++D +   K++DFG A+     + +G T  + GT  Y+APE 
Sbjct: 158 HS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 521 AMHGQFSVKSDVYSFGVLVLEIITG 545
            +   ++   D ++ GVL+ E+  G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 16/207 (7%)
Query: 344 TNKFSTDNKLGEGGFG--EVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHR 401
           ++++     +G G FG   + +  L + + +AVK + + +    E  + E++    L+H 
Sbjct: 19  SDRYDFVKDIGSGNFGVARLMRDKL-TKELVAVKYIERGAAID-ENVQREIINHRSLRHP 76
Query: 402 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH 461
           N+VR     L      ++ E+     L   + +    G+            +  G+ Y H
Sbjct: 77  NIVRFKEVILTPTHLAIIMEYASGGELYERICN---AGRFSEDEARFFFQQLLSGVSYCH 133
Query: 462 EDSRLRIIHRDLKASNILLDAEMNP--KISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE 519
               ++I HRDLK  N LLD    P  KI DFG ++   V  +Q  ++  VGT  Y+APE
Sbjct: 134 S---MQICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKST--VGTPAYIAPE 187
Query: 520 YAMHGQFSVK-SDVYSFGVLVLEIITG 545
             +  ++  K +DV+S GV +  ++ G
Sbjct: 188 VLLRQEYDGKIADVWSCGVTLYVMLVG 214

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 90/205 (43%), Gaps = 15/205 (7%)
Query: 345 NKFSTDNKLGEGGFGEVY-KGVLPSGQEIAVKRLSK---ASGQGAEEFKNEVVLVAKLQH 400
           ++F     LG G FG V       +G   A+K L K      +  E   NE  ++  +  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
             LV+L     +     +V E+VP   +   L    + G+            I     YL
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 150
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEY 520
           H    L +I+RDLK  N+L+D +   +++DFG A+     + +G T  + GT  Y+APE 
Sbjct: 151 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 202
Query: 521 AMHGQFSVKSDVYSFGVLVLEIITG 545
            +   ++   D ++ GVL+ E+  G
Sbjct: 203 ILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 50/87 (57%), Gaps = 8/87 (9%)
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
           YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +G T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLAGTPEYLAP 207
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITG 545
           E  +   ++   D ++ GVL+ E+  G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 50/87 (57%), Gaps = 8/87 (9%)
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
           YLH    L +I+RDLK  N+++D +   K++DFG A+     + +G T  + GT  Y+AP
Sbjct: 157 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEYLAP 208
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITG 545
           E  +   ++   D ++ GVL+ E+  G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 50/87 (57%), Gaps = 8/87 (9%)
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
           YLH    L +I+RDLK  N+++D +   K++DFG A+     + +G T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEYLAP 207
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITG 545
           E  +   ++   D ++ GVL+ E+  G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 50/87 (57%), Gaps = 8/87 (9%)
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
           YLH    L +I+RDLK  N+++D +   K++DFG A+     + +G T  + GT  Y+AP
Sbjct: 157 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEYLAP 208
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITG 545
           E  +   ++   D ++ GVL+ E+  G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 90/205 (43%), Gaps = 15/205 (7%)
Query: 345 NKFSTDNKLGEGGFGEVY-KGVLPSGQEIAVKRLSK---ASGQGAEEFKNEVVLVAKLQH 400
           ++F     LG G FG V       +G   A+K L K      +  E   NE  ++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
             LV+L     +     +V E+VP   +   L    + G+            I     YL
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEY 520
           H    L +I+RDLK  N+L+D +   +++DFG A+     + +G T  + GT  Y+APE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 521 AMHGQFSVKSDVYSFGVLVLEIITG 545
            +   ++   D ++ GVL+ E+  G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 90/205 (43%), Gaps = 15/205 (7%)
Query: 345 NKFSTDNKLGEGGFGEVY-KGVLPSGQEIAVKRLSK---ASGQGAEEFKNEVVLVAKLQH 400
           ++F     LG G FG V       +G   A+K L K      +  E   NE  ++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
             LV+L     +     +V E+VP   +   L    + G+            I     YL
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEY 520
           H    L +I+RDLK  N+L+D +   +++DFG A+     + +G T  + GT  Y+APE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 521 AMHGQFSVKSDVYSFGVLVLEIITG 545
            +   ++   D ++ GVL+ E+  G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 50/87 (57%), Gaps = 8/87 (9%)
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
           YLH    L +I+RDLK  N+++D +   K++DFG A+     + +G T  + GT  Y+AP
Sbjct: 157 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEYLAP 208
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITG 545
           E  +   ++   D ++ GVL+ E+  G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 50/87 (57%), Gaps = 8/87 (9%)
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
           YLH    L +I+RDLK  N+++D +   K++DFG A+     + +G T  + GT  Y+AP
Sbjct: 157 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEYLAP 208
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITG 545
           E  +   ++   D ++ GVL+ E+  G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 100/212 (47%), Gaps = 26/212 (12%)
Query: 353 LGEGGFGEVYKGVLPS-GQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRL----- 406
           LG GG G V+  V     + +A+K++     Q  +    E+ ++ +L H N+V++     
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 407 ---------LGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGI 457
                    +G   E     +V E++        L +  +QG L        +  + RG+
Sbjct: 79  PSGSQLTDDVGSLTELNSVYIVQEYMETD-----LANVLEQGPLLEEHARLFMYQLLRGL 133
Query: 458 LYLHEDSRLRIIHRDLKASNILLDAE-MNPKISDFGMARIFGVDQT-QGNTSRIVGTYGY 515
            Y+H  +   ++HRDLK +N+ ++ E +  KI DFG+ARI     + +G+ S  + T  Y
Sbjct: 134 KYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWY 190
Query: 516 MAPEYAMHGQFSVKS-DVYSFGVLVLEIITGK 546
            +P   +      K+ D+++ G +  E++TGK
Sbjct: 191 RSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 90/205 (43%), Gaps = 15/205 (7%)
Query: 345 NKFSTDNKLGEGGFGEVY-KGVLPSGQEIAVKRLSK---ASGQGAEEFKNEVVLVAKLQH 400
           ++F     LG G FG V       +G   A+K L K      +  E   NE  ++  +  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
             LV+L     +     +V E+VP   +   L    + G+            I     YL
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFXEPHARFYAAQIVLTFEYL 150
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEY 520
           H    L +I+RDLK  N+L+D +   +++DFG A+     + +G T  + GT  Y+APE 
Sbjct: 151 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 202
Query: 521 AMHGQFSVKSDVYSFGVLVLEIITG 545
            +   ++   D ++ GVL+ E+  G
Sbjct: 203 ILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 90/205 (43%), Gaps = 15/205 (7%)
Query: 345 NKFSTDNKLGEGGFGEVY-KGVLPSGQEIAVKRLSK---ASGQGAEEFKNEVVLVAKLQH 400
           ++F     LG G FG V       +G   A+K L K      +  E   NE  ++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
             LV+L     +     +V E+VP   +   L    + G+            I     YL
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEY 520
           H    L +I+RDLK  N+L+D +   +++DFG A+     + +G T  + GT  Y+APE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 521 AMHGQFSVKSDVYSFGVLVLEIITG 545
            +   ++   D ++ GVL+ E+  G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 102/226 (45%), Gaps = 25/226 (11%)
Query: 337 FETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVK--RLSKASGQGAEEFKNEVVL 394
           F+++ V    +S   ++G GG  +V++ +    Q  A+K   L +A  Q  + ++NE+  
Sbjct: 20  FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAY 79
Query: 395 VAKLQHRN--LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGG 452
           + KLQ  +  ++RL  + +  +   +V E   N  L+ +L   +K+  +D   R      
Sbjct: 80  LNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWL---KKKKSIDPWERKSYWKN 135
Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
           +   +  +H+     I+H DLK +N L+   M  K+ DFG+A     D         VGT
Sbjct: 136 MLEAVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDXXXVVKDSQVGT 191
Query: 513 YGYMAPEYAMHGQFSVKS------------DVYSFGVLVLEIITGK 546
             YM PE A+    S +             DV+S G ++  +  GK
Sbjct: 192 VNYMPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 50/87 (57%), Gaps = 8/87 (9%)
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
           YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +G T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLXGTPEYLAP 207
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITG 545
           E  +   ++   D ++ GVL+ E+  G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 90/205 (43%), Gaps = 15/205 (7%)
Query: 345 NKFSTDNKLGEGGFGEVY-KGVLPSGQEIAVKRLSK---ASGQGAEEFKNEVVLVAKLQH 400
           ++F     LG G FG V       +G   A+K L K      +  E   NE  ++  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
             LV+L     +     +V E+VP   +   L    + G+            I     YL
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 158
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEY 520
           H    L +I+RDLK  N+L+D +   +++DFG A+     + +G T  + GT  Y+APE 
Sbjct: 159 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 210
Query: 521 AMHGQFSVKSDVYSFGVLVLEIITG 545
            +   ++   D ++ GVL+ E+  G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 50/87 (57%), Gaps = 8/87 (9%)
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
           YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +G T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 207
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITG 545
           E  +   ++   D ++ GVL+ E+  G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 50/87 (57%), Gaps = 8/87 (9%)
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
           YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +G T  + GT  Y+AP
Sbjct: 143 YLHS---LDLIYRDLKPENLLIDEQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 194
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITG 545
           E  +   ++   D ++ GVL+ E+  G
Sbjct: 195 EIILSKGYNKAVDWWALGVLIYEMAAG 221

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 50/87 (57%), Gaps = 8/87 (9%)
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
           YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +G T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 207
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITG 545
           E  +   ++   D ++ GVL+ E+  G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 50/87 (57%), Gaps = 8/87 (9%)
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
           YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +G T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 207
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITG 545
           E  +   ++   D ++ GVL+ E+  G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 50/87 (57%), Gaps = 8/87 (9%)
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
           YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +G T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 207
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITG 545
           E  +   ++   D ++ GVL+ E+  G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 50/87 (57%), Gaps = 8/87 (9%)
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
           YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +G T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 207
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITG 545
           E  +   ++   D ++ GVL+ E+  G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 50/87 (57%), Gaps = 8/87 (9%)
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
           YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +G T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 207
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITG 545
           E  +   ++   D ++ GVL+ E+  G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 50/87 (57%), Gaps = 8/87 (9%)
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
           YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +G T  + GT  Y+AP
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 208
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITG 545
           E  +   ++   D ++ GVL+ E+  G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 50/87 (57%), Gaps = 8/87 (9%)
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
           YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +G T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 207
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITG 545
           E  +   ++   D ++ GVL+ E+  G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 50/87 (57%), Gaps = 8/87 (9%)
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
           YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +G T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 207
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITG 545
           E  +   ++   D ++ GVL+ E+  G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 50/87 (57%), Gaps = 8/87 (9%)
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
           YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +G T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 207
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITG 545
           E  +   ++   D ++ GVL+ E+  G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 50/87 (57%), Gaps = 8/87 (9%)
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
           YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +G T  + GT  Y+AP
Sbjct: 151 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 202
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITG 545
           E  +   ++   D ++ GVL+ E+  G
Sbjct: 203 EIILSKGYNKAVDWWALGVLIYEMAAG 229

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 90/205 (43%), Gaps = 15/205 (7%)
Query: 345 NKFSTDNKLGEGGFGEVY-KGVLPSGQEIAVKRLSK---ASGQGAEEFKNEVVLVAKLQH 400
           ++F     LG G FG V       +G   A+K L K      +  E   NE  ++  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
             LV+L     +     +V E+VP   +   L    + G+            I     YL
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 158
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEY 520
           H    L +I+RDLK  N+L+D +   +++DFG A+     + +G T  + GT  Y+APE 
Sbjct: 159 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 210
Query: 521 AMHGQFSVKSDVYSFGVLVLEIITG 545
            +   ++   D ++ GVL+ E+  G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 22/206 (10%)
Query: 353 LGEGGFGEVYKG-VLPSGQEIAVKRLSKASGQGAEEFKN------EVVLVAKLQ----HR 401
           LG+GGFG V+ G  L    ++A+K + +    G     +      EV L+ K+     H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 402 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH 461
            ++RLL +  E +E  ++    P  + D F Y  EK G L         G +   I + H
Sbjct: 99  GVIRLLDW-FETQEGFMLVLERPLPAQDLFDYITEK-GPLGEGPSRCFFGQVVAAIQHCH 156
Query: 462 EDSRLRIIHRDLKASNILLDAEMN-PKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEY 520
                 ++HRD+K  NIL+D      K+ DFG   +   D+   +     GT  Y  PE+
Sbjct: 157 SRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLH-DEPYTDFD---GTRVYSPPEW 209
Query: 521 -AMHGQFSVKSDVYSFGVLVLEIITG 545
            + H   ++ + V+S G+L+ +++ G
Sbjct: 210 ISRHQYHALPATVWSLGILLYDMVCG 235

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 90/205 (43%), Gaps = 15/205 (7%)
Query: 345 NKFSTDNKLGEGGFGEVY-KGVLPSGQEIAVKRLSK---ASGQGAEEFKNEVVLVAKLQH 400
           ++F     LG G FG V       +G   A+K L K      +  E   NE  ++  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
             LV+L     +     +V E+VP   +   L    + G+            I     YL
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 158
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEY 520
           H    L +I+RDLK  N+L+D +   +++DFG A+     + +G T  + GT  Y+APE 
Sbjct: 159 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 210
Query: 521 AMHGQFSVKSDVYSFGVLVLEIITG 545
            +   ++   D ++ GVL+ E+  G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 50/87 (57%), Gaps = 8/87 (9%)
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
           YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +G T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 207
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITG 545
           E  +   ++   D ++ GVL+ E+  G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 98/202 (48%), Gaps = 21/202 (10%)
Query: 353 LGEGGFGEVYKGVLPSGQEI--AVKRLSKASGQGAEEFKNEV----VLVAKLQHRNLVRL 406
           +G+G FG+V        +E+  AVK L K +    +E K+ +    VL+  ++H  LV L
Sbjct: 46  IGKGSFGKVLLARH-KAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104
Query: 407 LGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSR 465
             F  +  +K+  V +++    L Y L   +++      R       IA  + YLH    
Sbjct: 105 -HFSFQTADKLYFVLDYINGGELFYHL---QRERCFLEPRARFYAAEIASALGYLHS--- 157
Query: 466 LRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN--TSRIVGTYGYMAPEYAMH 523
           L I++RDLK  NILLD++ +  ++DFG+ +    +  + N  TS   GT  Y+APE    
Sbjct: 158 LNIVYRDLKPENILLDSQGHIVLTDFGLCK----ENIEHNSTTSTFCGTPEYLAPEVLHK 213
Query: 524 GQFSVKSDVYSFGVLVLEIITG 545
             +    D +  G ++ E++ G
Sbjct: 214 QPYDRTVDWWCLGAVLYEMLYG 235

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 50/87 (57%), Gaps = 8/87 (9%)
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
           YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +G T  + GT  Y+AP
Sbjct: 177 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 228
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITG 545
           E  +   ++   D ++ GVL+ E+  G
Sbjct: 229 EIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 104/223 (46%), Gaps = 31/223 (13%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGAEE---FKNE 391
           DFE I+V          +G G FGEV    + + + I A+K L+K       E   F+ E
Sbjct: 75  DFEIIKV----------IGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREE 124
Query: 392 --VVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYK 448
             V++    Q    +  L +  + E  + LV ++     L   L   E +   D +R Y 
Sbjct: 125 RDVLVNGDCQ---WITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFY- 180
Query: 449 IIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR 508
            IG +   I  +H+   L  +HRD+K  N+LLD   + +++DFG       D T   +S 
Sbjct: 181 -IGEMVLAIDSIHQ---LHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTV-QSSV 235
Query: 509 IVGTYGYMAPEY--AMH---GQFSVKSDVYSFGVLVLEIITGK 546
            VGT  Y++PE   AM    G++  + D +S GV + E++ G+
Sbjct: 236 AVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 278

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 50/87 (57%), Gaps = 8/87 (9%)
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
           YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +G T  + GT  Y+AP
Sbjct: 177 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 228
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITG 545
           E  +   ++   D ++ GVL+ E+  G
Sbjct: 229 EIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 18/210 (8%)
Query: 342 VATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
           V ++ +     +G G + E  + V   +  E AVK + K+    +EE +   +L+   QH
Sbjct: 24  VFSDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIE---ILLRYGQH 80
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
            N++ L     +G+   LV E +    L D  L    +Q          ++  I + + Y
Sbjct: 81  PNIITLKDVYDDGKHVYLVTELMRGGELLDKIL----RQKFFSEREASFVLHTIGKTVEY 136
Query: 460 LHEDSRLRIIHRDLKASNIL-LDAEMNP---KISDFGMARIFGVDQTQGNTSRIVGTYGY 515
           LH      ++HRDLK SNIL +D   NP   +I DFG A+    +   G       T  +
Sbjct: 137 LHSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAE--NGLLMTPCYTANF 191
Query: 516 MAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
           +APE      +    D++S G+L+  ++ G
Sbjct: 192 VAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 16/207 (7%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNL 403
           ++++     +G G FG           E+   +  +   +  E  K E++    L+H N+
Sbjct: 18  SDRYELVKDIGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREIINHRSLRHPNI 77
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRY--KIIGGIARGILYLH 461
           VR     L      +V E+     L   + +  +  + D +R +  ++I G++    Y H
Sbjct: 78  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE-DEARFFFQQLISGVS----YAH 132
Query: 462 EDSRLRIIHRDLKASNILLDAEMNP--KISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE 519
               +++ HRDLK  N LLD    P  KI+DFG ++   V  +Q  ++  VGT  Y+APE
Sbjct: 133 A---MQVAHRDLKLENTLLDGSPAPRLKIADFGYSKA-SVLHSQPKSA--VGTPAYIAPE 186
Query: 520 YAMHGQFSVK-SDVYSFGVLVLEIITG 545
             +  ++  K +DV+S GV +  ++ G
Sbjct: 187 VLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 95/211 (45%), Gaps = 26/211 (12%)
Query: 353 LGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFK-NEVVLVAKLQHRNLVRLLGFC 410
           LG+G    V++G    +G   A+K  +  S     + +  E  ++ KL H+N+V+L  F 
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKL--FA 74
Query: 411 LEGE----EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRL 466
           +E E     K+L+ EF P  SL   L +P     L  S    ++  +  G+ +L E+   
Sbjct: 75  IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG-- 132
Query: 467 RIIHRDLKASNILL----DAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEY-- 520
            I+HR++K  NI+     D +   K++DFG AR    D+       + GT  Y+ P+   
Sbjct: 133 -IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVSLYGTEEYLHPDMYE 188
Query: 521 ------AMHGQFSVKSDVYSFGVLVLEIITG 545
                     ++    D++S GV      TG
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 104/223 (46%), Gaps = 31/223 (13%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGAEE---FKNE 391
           DFE I+V          +G G FGEV    + + + I A+K L+K       E   F+ E
Sbjct: 91  DFEIIKV----------IGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREE 140
Query: 392 --VVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYK 448
             V++    Q    +  L +  + E  + LV ++     L   L   E +   D +R Y 
Sbjct: 141 RDVLVNGDCQ---WITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFY- 196
Query: 449 IIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR 508
            IG +   I  +H+   L  +HRD+K  N+LLD   + +++DFG       D T   +S 
Sbjct: 197 -IGEMVLAIDSIHQ---LHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTV-QSSV 251
Query: 509 IVGTYGYMAPEY--AMH---GQFSVKSDVYSFGVLVLEIITGK 546
            VGT  Y++PE   AM    G++  + D +S GV + E++ G+
Sbjct: 252 AVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 294

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 95/211 (45%), Gaps = 26/211 (12%)
Query: 353 LGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFK-NEVVLVAKLQHRNLVRLLGFC 410
           LG+G    V++G    +G   A+K  +  S     + +  E  ++ KL H+N+V+L  F 
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKL--FA 74
Query: 411 LEGE----EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRL 466
           +E E     K+L+ EF P  SL   L +P     L  S    ++  +  G+ +L E+   
Sbjct: 75  IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG-- 132
Query: 467 RIIHRDLKASNILL----DAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEY-- 520
            I+HR++K  NI+     D +   K++DFG AR    D+       + GT  Y+ P+   
Sbjct: 133 -IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVXLYGTEEYLHPDMYE 188
Query: 521 ------AMHGQFSVKSDVYSFGVLVLEIITG 545
                     ++    D++S GV      TG
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/265 (23%), Positives = 116/265 (43%), Gaps = 53/265 (20%)
Query: 310 KAKKKYNAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLP-S 368
           KA+  + A   S A  +L  L++  FD  T +V  +++     +G G +G V       +
Sbjct: 24  KAEPAHTAA--SVAAKNLALLKARSFDV-TFDVG-DEYEIIETIGNGAYGVVSSARRRLT 79
Query: 369 GQEIAVKRLSKASG--QGAEEFKNEVVLVAKLQHRNLVRLLGFC---------------- 410
           GQ++A+K++  A      A+    E+ ++   +H N++ +                    
Sbjct: 80  GQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVL 139
Query: 411 --LEGEEKILVYEFVPN--KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRL 466
             +E +   +++   P   + + YFLY                   + RG+ Y+H     
Sbjct: 140 DLMESDLHQIIHSSQPLTLEHVRYFLYQ------------------LLRGLKYMHS---A 178
Query: 467 RIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN--TSRIVGTYGYMAPE--YAM 522
           ++IHRDLK SN+L++     KI DFGMAR       +     +  V T  Y APE   ++
Sbjct: 179 QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSL 238
Query: 523 HGQFSVKSDVYSFGVLVLEIITGKK 547
           H +++   D++S G +  E++  ++
Sbjct: 239 H-EYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 90/205 (43%), Gaps = 15/205 (7%)
Query: 345 NKFSTDNKLGEGGFGEVY-KGVLPSGQEIAVKRLSK---ASGQGAEEFKNEVVLVAKLQH 400
           ++F     LG G FG V     + +G   A+K L K      +  E   NE  ++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
             LV+L     +     +V E+ P   +   L    + G+            I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEY 520
           H    L +I+RDLK  N+++D +   +++DFG A+     + +G T  + GT  Y+APE 
Sbjct: 158 HS---LDLIYRDLKPENLMIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 521 AMHGQFSVKSDVYSFGVLVLEIITG 545
            +   ++   D ++ GVL+ E+  G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 18/210 (8%)
Query: 342 VATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
           V ++ +     +G G + E  + V   +  E AVK + K+    +EE +   +L+   QH
Sbjct: 24  VFSDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIE---ILLRYGQH 80
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
            N++ L     +G+   LV E +    L D  L    +Q          ++  I + + Y
Sbjct: 81  PNIITLKDVYDDGKHVYLVTELMRGGELLDKIL----RQKFFSEREASFVLHTIGKTVEY 136
Query: 460 LHEDSRLRIIHRDLKASNIL-LDAEMNP---KISDFGMARIFGVDQTQGNTSRIVGTYGY 515
           LH      ++HRDLK SNIL +D   NP   +I DFG A+    +   G       T  +
Sbjct: 137 LHSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAE--NGLLMTPCYTANF 191
Query: 516 MAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
           +APE      +    D++S G+L+  ++ G
Sbjct: 192 VAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 54/104 (51%), Gaps = 14/104 (13%)
Query: 449 IIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR 508
           I+  +   + +LH ++   I+HRDLK  NILLD  M  ++SDFG    F      G   R
Sbjct: 205 IMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFG----FSCHLEPGEKLR 257
Query: 509 -IVGTYGYMAPEY------AMHGQFSVKSDVYSFGVLVLEIITG 545
            + GT GY+APE         H  +  + D+++ GV++  ++ G
Sbjct: 258 ELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 16/207 (7%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNL 403
           ++++     +G G FG           E+   +  +   +  E  K E++    L+H N+
Sbjct: 17  SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNI 76
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRY--KIIGGIARGILYLH 461
           VR     L      +V E+     L   + +  +  + D +R +  ++I G++    Y H
Sbjct: 77  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE-DEARFFFQQLISGVS----YCH 131
Query: 462 EDSRLRIIHRDLKASNILLDAEMNP--KISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE 519
               +++ HRDLK  N LLD    P  KI DFG ++   V  +Q  ++  VGT  Y+APE
Sbjct: 132 A---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKST--VGTPAYIAPE 185
Query: 520 YAMHGQFSVK-SDVYSFGVLVLEIITG 545
             +  ++  K +DV+S GV +  ++ G
Sbjct: 186 VLLKKEYDGKVADVWSCGVTLYVMLVG 212

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 50/87 (57%), Gaps = 8/87 (9%)
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
           YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +G T  + GT  Y+AP
Sbjct: 177 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGATWTLCGTPEYLAP 228
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITG 545
           E  +   ++   D ++ GVL+ E+  G
Sbjct: 229 EIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 12/205 (5%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEE--FKNEVVLVAKLQHR 401
            K+    K+GEG +G V+K     +GQ +A+K+  ++      +     E+ ++ +L+H 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 402 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH 461
           NLV LL          LV+E+  +  L     D  ++G  +   +  I     + + + H
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYCDHTVLHEL--DRYQRGVPEHLVK-SITWQTLQAVNFCH 119
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYA 521
           + +    IHRD+K  NIL+      K+ DFG AR+        +    V T  Y +PE  
Sbjct: 120 KHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDE--VATRWYRSPELL 174
Query: 522 M-HGQFSVKSDVYSFGVLVLEIITG 545
           +   Q+    DV++ G +  E+++G
Sbjct: 175 VGDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 64/253 (25%), Positives = 111/253 (43%), Gaps = 28/253 (11%)
Query: 310 KAKKKYNAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSG 369
           K ++++   P+   D+D     S     E I V    +S   ++G GG  +V++ +    
Sbjct: 24  KFERQHMDSPDLGTDDDDKASSSAN---ECISVKGRIYSILKQIGSGGSSKVFQVLNEKK 80
Query: 370 QEIAVK--RLSKASGQGAEEFKNEVVLVAKLQHRN--LVRLLGFCLEGEEKILVYEFVPN 425
           Q  A+K   L +A  Q  + ++NE+  + KLQ  +  ++RL  + +  +   +V E   N
Sbjct: 81  QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGN 139
Query: 426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN 485
             L+ +L   +K+  +D   R      +   +  +H+     I+H DLK +N L+   M 
Sbjct: 140 IDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDGM- 192
Query: 486 PKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKS------------DVY 533
            K+ DFG+A     D T       VG   YM PE A+    S +             DV+
Sbjct: 193 LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE-AIKDMSSSRENGKSKSKISPKSDVW 251
Query: 534 SFGVLVLEIITGK 546
           S G ++  +  GK
Sbjct: 252 SLGCILYYMTYGK 264

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 50/87 (57%), Gaps = 8/87 (9%)
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
           YLH    L +I+RDLK  N+++D +   +++DFG A+     + +G T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLIIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 207
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITG 545
           E  +   ++   D ++ GVL+ E+  G
Sbjct: 208 EIIISKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/265 (23%), Positives = 116/265 (43%), Gaps = 53/265 (20%)
Query: 310 KAKKKYNAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLP-S 368
           KA+  + A   S A  +L  L++  FD  T +V  +++     +G G +G V       +
Sbjct: 23  KAEPAHTAA--SVAAKNLALLKARSFDV-TFDVG-DEYEIIETIGNGAYGVVSSARRRLT 78
Query: 369 GQEIAVKRLSKASG--QGAEEFKNEVVLVAKLQHRNLVRLLGFC---------------- 410
           GQ++A+K++  A      A+    E+ ++   +H N++ +                    
Sbjct: 79  GQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVL 138
Query: 411 --LEGEEKILVYEFVPN--KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRL 466
             +E +   +++   P   + + YFLY                   + RG+ Y+H     
Sbjct: 139 DLMESDLHQIIHSSQPLTLEHVRYFLYQ------------------LLRGLKYMHS---A 177
Query: 467 RIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN--TSRIVGTYGYMAPE--YAM 522
           ++IHRDLK SN+L++     KI DFGMAR       +     +  V T  Y APE   ++
Sbjct: 178 QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSL 237
Query: 523 HGQFSVKSDVYSFGVLVLEIITGKK 547
           H +++   D++S G +  E++  ++
Sbjct: 238 H-EYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 50/87 (57%), Gaps = 8/87 (9%)
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
           YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +G T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 207
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITG 545
           E  +   ++   D ++ GVL+ ++  G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYQMAAG 234

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 89/205 (43%), Gaps = 12/205 (5%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNL 403
           ++++     +G G FG           E+   +  +   + A   K E++    L+H N+
Sbjct: 18  SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINHRSLRHPNI 77
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
           VR     L      +V E+     L   + +    G+            +  G+ Y H  
Sbjct: 78  VRFKEVILTPTHLAIVMEYASGGELFERICN---AGRFSEDEARFFFQQLISGVSYCHA- 133
Query: 464 SRLRIIHRDLKASNILLDAEMNP--KISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYA 521
             +++ HRDLK  N LLD    P  KI DFG ++   V  +Q  ++  VGT  Y+APE  
Sbjct: 134 --MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKST--VGTPAYIAPEVL 188
Query: 522 MHGQFSVK-SDVYSFGVLVLEIITG 545
           +  ++  K +DV+S GV +  ++ G
Sbjct: 189 LKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 92/208 (44%), Gaps = 18/208 (8%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRN 402
           T+ +     +G G +    + +   +  E AVK + K+     EE +   +L+   QH N
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIE---ILLRYGQHPN 77
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH 461
           ++ L     +G+   +V E +    L D  L    +Q          ++  I + + YLH
Sbjct: 78  IITLKDVYDDGKYVYVVTELMKGGELLDKIL----RQKFFSEREASAVLFTITKTVEYLH 133
Query: 462 EDSRLRIIHRDLKASNIL-LDAEMNP---KISDFGMARIFGVDQTQGNTSRIVGTYGYMA 517
                 ++HRDLK SNIL +D   NP   +I DFG A+    +   G       T  ++A
Sbjct: 134 AQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN--GLLMTPCYTANFVA 188
Query: 518 PEYAMHGQFSVKSDVYSFGVLVLEIITG 545
           PE      +    D++S GVL+  ++TG
Sbjct: 189 PEVLERQGYDAACDIWSLGVLLYTMLTG 216

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 106/214 (49%), Gaps = 27/214 (12%)
Query: 350 DNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ-HRNLVRLL 407
           ++ LGEG    V   + L + QE AVK + K  G        EV ++ + Q HRN++ L+
Sbjct: 18  EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 408 GFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
            F  E +   LV+E +   S+   ++      +L+ S    ++  +A  + +LH      
Sbjct: 78  EFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEAS---VVVQDVASALDFLHNKG--- 131
Query: 468 IIHRDLKASNILLDA--EMNP-KISDFGMARIFGVDQTQGNTSRI--------VGTYGYM 516
           I HRDLK  NIL +   +++P KI DFG+    G+ +  G+ S I         G+  YM
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFGLGS--GI-KLNGDCSPISTPELLTPCGSAEYM 188
Query: 517 APEY--AMHGQFSV---KSDVYSFGVLVLEIITG 545
           APE   A   + S+   + D++S GV++  +++G
Sbjct: 189 APEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
           YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +G T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 207
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITG 545
              +   ++   D ++ GVL+ E+  G
Sbjct: 208 AIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 101/221 (45%), Gaps = 19/221 (8%)
Query: 342 VATNKFSTDNKLGEGGFGEVYKGVL----PSGQEIAVKRLSKASGQGAEEFKNEVVLVAK 397
           V  N+F     LG+G FG+V   +L     +G+  A+K L K      +E  + +     
Sbjct: 5   VTMNEFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRV 61
Query: 398 LQH--RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIA 454
           LQ+     +  L +  +  +++  V E+     L +F    E+    D +R Y     I 
Sbjct: 62  LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL-FFHLSRERVFSEDRARFYG--AEIV 118
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
             + YLH  S   +++RDLK  N++LD + + KI+DFG+ +  G+ +         GT  
Sbjct: 119 SALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE-GI-KDGATMKXFCGTPE 174
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTD 555
           Y+APE      +    D +  GV++ E++ G+    FY  D
Sbjct: 175 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 213

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 101/221 (45%), Gaps = 19/221 (8%)
Query: 342 VATNKFSTDNKLGEGGFGEVYKGVL----PSGQEIAVKRLSKASGQGAEEFKNEVVLVAK 397
           V  N+F     LG+G FG+V   +L     +G+  A+K L K      +E  + +     
Sbjct: 7   VTMNEFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRV 63
Query: 398 LQH--RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIA 454
           LQ+     +  L +  +  +++  V E+     L +F    E+    D +R Y     I 
Sbjct: 64  LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL-FFHLSRERVFSEDRARFYG--AEIV 120
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
             + YLH  S   +++RDLK  N++LD + + KI+DFG+ +  G+ +         GT  
Sbjct: 121 SALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE-GI-KDGATMKXFCGTPE 176
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTD 555
           Y+APE      +    D +  GV++ E++ G+    FY  D
Sbjct: 177 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 215

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 101/221 (45%), Gaps = 19/221 (8%)
Query: 342 VATNKFSTDNKLGEGGFGEVYKGVL----PSGQEIAVKRLSKASGQGAEEFKNEVVLVAK 397
           V  N+F     LG+G FG+V   +L     +G+  A+K L K      +E  + +     
Sbjct: 6   VTMNEFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRV 62
Query: 398 LQH--RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIA 454
           LQ+     +  L +  +  +++  V E+     L +F    E+    D +R Y     I 
Sbjct: 63  LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL-FFHLSRERVFSEDRARFYG--AEIV 119
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
             + YLH  S   +++RDLK  N++LD + + KI+DFG+ +  G+ +         GT  
Sbjct: 120 SALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE-GI-KDGATMKXFCGTPE 175
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTD 555
           Y+APE      +    D +  GV++ E++ G+    FY  D
Sbjct: 176 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 214

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 85/201 (42%), Gaps = 14/201 (6%)
Query: 350 DNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLG 408
           D  LGEG F    K V   S Q  AVK +SK      +  K    L     H N+V+L  
Sbjct: 16  DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ--KEITALKLCEGHPNIVKLHE 73
Query: 409 FCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRI 468
              +     LV E +    L       +K+     +    I+  +   + ++H+   + +
Sbjct: 74  VFHDQLHTFLVMELLNGGEL---FERIKKKKHFSETEASYIMRKLVSAVSHMHD---VGV 127
Query: 469 IHRDLKASNILLDAE---MNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQ 525
           +HRDLK  N+L   E   +  KI DFG AR+   D     T     T  Y APE      
Sbjct: 128 VHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCF--TLHYAAPELLNQNG 185
Query: 526 FSVKSDVYSFGVLVLEIITGK 546
           +    D++S GV++  +++G+
Sbjct: 186 YDESCDLWSLGVILYTMLSGQ 206

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 23/207 (11%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVK-----RLSKASGQGAEEFKNEVVLVAKLQHRNLVRL 406
           +G+G F  V + +   +GQ+ AVK     + + + G   E+ K E  +   L+H ++V L
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 407 LGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGIL----YLHE 462
           L          +V+EF+    L    ++  K+    +     +     R IL    Y H+
Sbjct: 92  LETYSSDGMLYMVFEFMDGADL---CFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD 148
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRI----VGTYGYMAP 518
           ++   IIHRD+K   +LL ++ N      G    FGV    G +  +    VGT  +MAP
Sbjct: 149 NN---IIHRDVKPHCVLLASKENSAPVKLGG---FGVAIQLGESGLVAGGRVGTPHFMAP 202
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITG 545
           E      +    DV+  GV++  +++G
Sbjct: 203 EVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 20/216 (9%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQ-EIAVKRLSKASGQGAEEFKN------EVV 393
           E   +++     LG GGFG VY G+  S    +A+K + K       E  N      EVV
Sbjct: 33  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 92
Query: 394 LVAKLQH--RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIG 451
           L+ K+      ++RLL +    +  +L+ E  P    D F +  E+ G L          
Sbjct: 93  LLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITER-GALQEELARSFFW 150
Query: 452 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMARIFGVDQTQGNTSRIV 510
            +   + + H      ++HRD+K  NIL+D      K+ DFG   +          +   
Sbjct: 151 QVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFD 203
Query: 511 GTYGYMAPEYAMHGQFSVKS-DVYSFGVLVLEIITG 545
           GT  Y  PE+  + ++  +S  V+S G+L+ +++ G
Sbjct: 204 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 20/216 (9%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQ-EIAVKRLSKASGQGAEEFKN------EVV 393
           E   +++     LG GGFG VY G+  S    +A+K + K       E  N      EVV
Sbjct: 32  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 91
Query: 394 LVAKLQH--RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIG 451
           L+ K+      ++RLL +    +  +L+ E  P    D F +  E+ G L          
Sbjct: 92  LLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITER-GALQEELARSFFW 149
Query: 452 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMARIFGVDQTQGNTSRIV 510
            +   + + H      ++HRD+K  NIL+D      K+ DFG   +          +   
Sbjct: 150 QVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFD 202
Query: 511 GTYGYMAPEYAMHGQFSVKS-DVYSFGVLVLEIITG 545
           GT  Y  PE+  + ++  +S  V+S G+L+ +++ G
Sbjct: 203 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 20/216 (9%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQ-EIAVKRLSKASGQGAEEFKN------EVV 393
           E   +++     LG GGFG VY G+  S    +A+K + K       E  N      EVV
Sbjct: 19  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 78
Query: 394 LVAKLQH--RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIG 451
           L+ K+      ++RLL +    +  +L+ E  P    D F +  E+ G L          
Sbjct: 79  LLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITER-GALQEELARSFFW 136
Query: 452 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMARIFGVDQTQGNTSRIV 510
            +   + + H      ++HRD+K  NIL+D      K+ DFG   +          +   
Sbjct: 137 QVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFD 189
Query: 511 GTYGYMAPEYAMHGQFSVKS-DVYSFGVLVLEIITG 545
           GT  Y  PE+  + ++  +S  V+S G+L+ +++ G
Sbjct: 190 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 93/211 (44%), Gaps = 40/211 (18%)
Query: 329 TLESLQFDFETIEVATNK--FSTDNKLGEGGFGE-VYKGVLPSGQEIAVKRLSKASGQGA 385
           +LE    D ET  V   K  F   + LG G  G  VY+G+    +++AVKR+       A
Sbjct: 6   SLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMF-DNRDVAVKRILPECFSFA 64
Query: 386 EEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKI----------LVYEFVPNKSLDYFLYD 434
           +    EV L+ +  +H N++R   FC E + +            + E+V  K   +   +
Sbjct: 65  D---REVQLLRESDEHPNVIRY--FCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLE 119
Query: 435 PEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL-----DAEMNPKIS 489
           P             ++     G+ +LH    L I+HRDLK  NIL+       ++   IS
Sbjct: 120 P-----------ITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMIS 165
Query: 490 DFGMARIFGVDQTQ-GNTSRIVGTYGYMAPE 519
           DFG+ +   V +      S + GT G++APE
Sbjct: 166 DFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 90/208 (43%), Gaps = 18/208 (8%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRN 402
           T+ +     +G G +    + +   +  E AVK + K+     EE +   +L+   QH N
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTEEIE---ILLRYGQHPN 77
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH 461
           ++ L     +G+   +V E      L D  L    +Q          ++  I + + YLH
Sbjct: 78  IITLKDVYDDGKYVYVVTELXKGGELLDKIL----RQKFFSEREASAVLFTITKTVEYLH 133
Query: 462 EDSRLRIIHRDLKASNIL-LDAEMNP---KISDFGMARIFGVDQTQGNTSRIVGTYGYMA 517
                 ++HRDLK SNIL +D   NP   +I DFG A+    +   G       T  ++A
Sbjct: 134 AQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN--GLLXTPCYTANFVA 188
Query: 518 PEYAMHGQFSVKSDVYSFGVLVLEIITG 545
           PE      +    D++S GVL+   +TG
Sbjct: 189 PEVLERQGYDAACDIWSLGVLLYTXLTG 216

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 23/207 (11%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVK-----RLSKASGQGAEEFKNEVVLVAKLQHRNLVRL 406
           +G+G F  V + +   +GQ+ AVK     + + + G   E+ K E  +   L+H ++V L
Sbjct: 34  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 93
Query: 407 LGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGIL----YLHE 462
           L          +V+EF+    L    ++  K+    +     +     R IL    Y H+
Sbjct: 94  LETYSSDGMLYMVFEFMDGADL---CFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD 150
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRI----VGTYGYMAP 518
           ++   IIHRD+K   +LL ++ N      G    FGV    G +  +    VGT  +MAP
Sbjct: 151 NN---IIHRDVKPHCVLLASKENSAPVKLGG---FGVAIQLGESGLVAGGRVGTPHFMAP 204
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITG 545
           E      +    DV+  GV++  +++G
Sbjct: 205 EVVKREPYGKPVDVWGCGVILFILLSG 231

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 20/216 (9%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQ-EIAVKRLSKASGQGAEEFKN------EVV 393
           E   +++     LG GGFG VY G+  S    +A+K + K       E  N      EVV
Sbjct: 33  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 92
Query: 394 LVAKLQH--RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIG 451
           L+ K+      ++RLL +    +  +L+ E  P    D F +  E+ G L          
Sbjct: 93  LLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITER-GALQEELARSFFW 150
Query: 452 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMARIFGVDQTQGNTSRIV 510
            +   + + H      ++HRD+K  NIL+D      K+ DFG   +          +   
Sbjct: 151 QVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFD 203
Query: 511 GTYGYMAPEYAMHGQFSVKS-DVYSFGVLVLEIITG 545
           GT  Y  PE+  + ++  +S  V+S G+L+ +++ G
Sbjct: 204 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 20/216 (9%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQ-EIAVKRLSKASGQGAEEFKN------EVV 393
           E   +++     LG GGFG VY G+  S    +A+K + K       E  N      EVV
Sbjct: 32  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 91
Query: 394 LVAKLQH--RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIG 451
           L+ K+      ++RLL +    +  +L+ E  P    D F +  E+ G L          
Sbjct: 92  LLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITER-GALQEELARSFFW 149
Query: 452 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMARIFGVDQTQGNTSRIV 510
            +   + + H      ++HRD+K  NIL+D      K+ DFG   +          +   
Sbjct: 150 QVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFD 202
Query: 511 GTYGYMAPEYAMHGQFSVKS-DVYSFGVLVLEIITG 545
           GT  Y  PE+  + ++  +S  V+S G+L+ +++ G
Sbjct: 203 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 20/216 (9%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQ-EIAVKRLSKASGQGAEEFKN------EVV 393
           E   +++     LG GGFG VY G+  S    +A+K + K       E  N      EVV
Sbjct: 19  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 78
Query: 394 LVAKLQH--RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIG 451
           L+ K+      ++RLL +    +  +L+ E  P    D F +  E+ G L          
Sbjct: 79  LLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITER-GALQEELARSFFW 136
Query: 452 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMARIFGVDQTQGNTSRIV 510
            +   + + H      ++HRD+K  NIL+D      K+ DFG   +          +   
Sbjct: 137 QVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFD 189
Query: 511 GTYGYMAPEYAMHGQFSVKS-DVYSFGVLVLEIITG 545
           GT  Y  PE+  + ++  +S  V+S G+L+ +++ G
Sbjct: 190 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 20/216 (9%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQ-EIAVKRLSKASGQGAEEFKN------EVV 393
           E   +++     LG GGFG VY G+  S    +A+K + K       E  N      EVV
Sbjct: 32  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 91
Query: 394 LVAKLQH--RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIG 451
           L+ K+      ++RLL +    +  +L+ E  P    D F +  E+ G L          
Sbjct: 92  LLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITER-GALQEELARSFFW 149
Query: 452 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMARIFGVDQTQGNTSRIV 510
            +   + + H      ++HRD+K  NIL+D      K+ DFG   +          +   
Sbjct: 150 QVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFD 202
Query: 511 GTYGYMAPEYAMHGQFSVKS-DVYSFGVLVLEIITG 545
           GT  Y  PE+  + ++  +S  V+S G+L+ +++ G
Sbjct: 203 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 20/216 (9%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQ-EIAVKRLSKASGQGAEEFKN------EVV 393
           E   +++     LG GGFG VY G+  S    +A+K + K       E  N      EVV
Sbjct: 33  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 92
Query: 394 LVAKLQH--RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIG 451
           L+ K+      ++RLL +    +  +L+ E  P    D F +  E+ G L          
Sbjct: 93  LLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITER-GALQEELARSFFW 150
Query: 452 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMARIFGVDQTQGNTSRIV 510
            +   + + H      ++HRD+K  NIL+D      K+ DFG   +          +   
Sbjct: 151 QVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFD 203
Query: 511 GTYGYMAPEYAMHGQFSVKS-DVYSFGVLVLEIITG 545
           GT  Y  PE+  + ++  +S  V+S G+L+ +++ G
Sbjct: 204 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 20/216 (9%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQ-EIAVKRLSKASGQGAEEFKN------EVV 393
           E   +++     LG GGFG VY G+  S    +A+K + K       E  N      EVV
Sbjct: 33  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 92
Query: 394 LVAKLQH--RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIG 451
           L+ K+      ++RLL +    +  +L+ E  P    D F +  E+ G L          
Sbjct: 93  LLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITER-GALQEELARSFFW 150
Query: 452 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMARIFGVDQTQGNTSRIV 510
            +   + + H      ++HRD+K  NIL+D      K+ DFG   +          +   
Sbjct: 151 QVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFD 203
Query: 511 GTYGYMAPEYAMHGQFSVKS-DVYSFGVLVLEIITG 545
           GT  Y  PE+  + ++  +S  V+S G+L+ +++ G
Sbjct: 204 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 20/216 (9%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQ-EIAVKRLSKASGQGAEEFKN------EVV 393
           E   +++     LG GGFG VY G+  S    +A+K + K       E  N      EVV
Sbjct: 47  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 106
Query: 394 LVAKLQH--RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIG 451
           L+ K+      ++RLL +    +  +L+ E  P    D F +  E+ G L          
Sbjct: 107 LLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITER-GALQEELARSFFW 164
Query: 452 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMARIFGVDQTQGNTSRIV 510
            +   + + H      ++HRD+K  NIL+D      K+ DFG   +          +   
Sbjct: 165 QVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFD 217
Query: 511 GTYGYMAPEYAMHGQFSVKS-DVYSFGVLVLEIITG 545
           GT  Y  PE+  + ++  +S  V+S G+L+ +++ G
Sbjct: 218 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 20/216 (9%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQ-EIAVKRLSKASGQGAEEFKN------EVV 393
           E   +++     LG GGFG VY G+  S    +A+K + K       E  N      EVV
Sbjct: 32  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 91
Query: 394 LVAKLQH--RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIG 451
           L+ K+      ++RLL +    +  +L+ E  P    D F +  E+ G L          
Sbjct: 92  LLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITER-GALQEELARSFFW 149
Query: 452 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMARIFGVDQTQGNTSRIV 510
            +   + + H      ++HRD+K  NIL+D      K+ DFG   +          +   
Sbjct: 150 QVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFD 202
Query: 511 GTYGYMAPEYAMHGQFSVKS-DVYSFGVLVLEIITG 545
           GT  Y  PE+  + ++  +S  V+S G+L+ +++ G
Sbjct: 203 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 20/216 (9%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQ-EIAVKRLSKASGQGAEEFKN------EVV 393
           E   +++     LG GGFG VY G+  S    +A+K + K       E  N      EVV
Sbjct: 20  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 79
Query: 394 LVAKLQH--RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIG 451
           L+ K+      ++RLL +    +  +L+ E  P    D F +  E+ G L          
Sbjct: 80  LLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITER-GALQEELARSFFW 137
Query: 452 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMARIFGVDQTQGNTSRIV 510
            +   + + H      ++HRD+K  NIL+D      K+ DFG   +          +   
Sbjct: 138 QVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFD 190
Query: 511 GTYGYMAPEYAMHGQFSVKS-DVYSFGVLVLEIITG 545
           GT  Y  PE+  + ++  +S  V+S G+L+ +++ G
Sbjct: 191 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 20/216 (9%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQ-EIAVKRLSKASGQGAEEFKN------EVV 393
           E   +++     LG GGFG VY G+  S    +A+K + K       E  N      EVV
Sbjct: 47  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 106
Query: 394 LVAKLQH--RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIG 451
           L+ K+      ++RLL +    +  +L+ E  P    D F +  E+ G L          
Sbjct: 107 LLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITER-GALQEELARSFFW 164
Query: 452 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMARIFGVDQTQGNTSRIV 510
            +   + + H      ++HRD+K  NIL+D      K+ DFG   +          +   
Sbjct: 165 QVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFD 217
Query: 511 GTYGYMAPEYAMHGQFSVKS-DVYSFGVLVLEIITG 545
           GT  Y  PE+  + ++  +S  V+S G+L+ +++ G
Sbjct: 218 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 108/243 (44%), Gaps = 26/243 (10%)
Query: 322 NADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSK- 379
           N DN L+  +        + +    +     +G G FGEV      S +++ A+K LSK 
Sbjct: 46  NIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKF 105
Query: 380 --ASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL--YD- 434
                  +  F  E  ++A      +V+L     +     +V E++P   L   +  YD 
Sbjct: 106 EMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDV 165
Query: 435 PEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM- 493
           PEK     W+R Y      A  +L L     +  IHRD+K  N+LLD   + K++DFG  
Sbjct: 166 PEK-----WARFY-----TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC 215
Query: 494 ARIFGVDQTQGNTSRIVGTYGYMAPEY----AMHGQFSVKSDVYSFGVLVLEIITGKKNS 549
            ++      + +T+  VGT  Y++PE        G +  + D +S GV + E++ G  ++
Sbjct: 216 MKMNKEGMVRCDTA--VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG--DT 271
Query: 550 NFY 552
            FY
Sbjct: 272 PFY 274

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 20/216 (9%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQ-EIAVKRLSKASGQGAEEFKN------EVV 393
           E   +++     LG GGFG VY G+  S    +A+K + K       E  N      EVV
Sbjct: 20  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 79
Query: 394 LVAKLQH--RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIG 451
           L+ K+      ++RLL +    +  +L+ E  P    D F +  E+ G L          
Sbjct: 80  LLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITER-GALQEELARSFFW 137
Query: 452 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMARIFGVDQTQGNTSRIV 510
            +   + + H      ++HRD+K  NIL+D      K+ DFG   +          +   
Sbjct: 138 QVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFD 190
Query: 511 GTYGYMAPEYAMHGQFSVKS-DVYSFGVLVLEIITG 545
           GT  Y  PE+  + ++  +S  V+S G+L+ +++ G
Sbjct: 191 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 20/216 (9%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQ-EIAVKRLSKASGQGAEEFKN------EVV 393
           E   +++     LG GGFG VY G+  S    +A+K + K       E  N      EVV
Sbjct: 20  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 79
Query: 394 LVAKLQH--RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIG 451
           L+ K+      ++RLL +    +  +L+ E  P    D F +  E+ G L          
Sbjct: 80  LLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITER-GALQEELARSFFW 137
Query: 452 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMARIFGVDQTQGNTSRIV 510
            +   + + H      ++HRD+K  NIL+D      K+ DFG   +          +   
Sbjct: 138 QVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFD 190
Query: 511 GTYGYMAPEYAMHGQFSVKS-DVYSFGVLVLEIITG 545
           GT  Y  PE+  + ++  +S  V+S G+L+ +++ G
Sbjct: 191 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 100/221 (45%), Gaps = 19/221 (8%)
Query: 342 VATNKFSTDNKLGEGGFGEVYKGVL----PSGQEIAVKRLSKASGQGAEEFKNEVVLVAK 397
           V  N+F     LG+G FG+V   +L     +G+  A+K L K      +E  + +     
Sbjct: 145 VTMNEFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRV 201
Query: 398 LQH--RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIA 454
           LQ+     +  L +  +  +++  V E+     L +F    E+    D +R Y     I 
Sbjct: 202 LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL-FFHLSRERVFSEDRARFYG--AEIV 258
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
             + YLH  S   +++RDLK  N++LD + + KI+DFG+ +    D     T    GT  
Sbjct: 259 SALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPE 314
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTD 555
           Y+APE      +    D +  GV++ E++ G+    FY  D
Sbjct: 315 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 353

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 93/212 (43%), Gaps = 20/212 (9%)
Query: 345 NKFSTDNKLGEGGFGEVYKGVLPSGQ-EIAVKRLSKASGQGAEEFKN------EVVLVAK 397
           +++     LG GGFG VY G+  S    +A+K + K       E  N      EVVL+ K
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 398 LQH--RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
           +      ++RLL +    +  +L+ E  P    D F +  E+ G L           +  
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITER-GALQEELARSFFWQVLE 121
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMARIFGVDQTQGNTSRIVGTYG 514
            + + H      ++HRD+K  NIL+D      K+ DFG   +          +   GT  
Sbjct: 122 AVRHCHNXG---VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRV 174
Query: 515 YMAPEYAMHGQFSVKS-DVYSFGVLVLEIITG 545
           Y  PE+  + ++  +S  V+S G+L+ +++ G
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
           YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +G T  + GT   +AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEALAP 207
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITG 545
           E  +   ++   D ++ GVL+ E+  G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 20/216 (9%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQ-EIAVKRLSKASGQGAEEFKN------EVV 393
           E   +++     LG GGFG VY G+  S    +A+K + K       E  N      EVV
Sbjct: 3   EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 62
Query: 394 LVAKLQH--RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIG 451
           L+ K+      ++RLL +    +  +L+ E  P    D F +  E+ G L          
Sbjct: 63  LLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITER-GALQEELARSFFW 120
Query: 452 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMARIFGVDQTQGNTSRIV 510
            +   + + H      ++HRD+K  NIL+D      K+ DFG   +          +   
Sbjct: 121 QVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFD 173
Query: 511 GTYGYMAPEYAMHGQFSVKS-DVYSFGVLVLEIITG 545
           GT  Y  PE+  + ++  +S  V+S G+L+ +++ G
Sbjct: 174 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 209

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 20/216 (9%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQ-EIAVKRLSKASGQGAEEFKN------EVV 393
           E   +++     LG GGFG VY G+  S    +A+K + K       E  N      EVV
Sbjct: 5   EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 64
Query: 394 LVAKLQH--RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIG 451
           L+ K+      ++RLL +    +  +L+ E  P    D F +  E+ G L          
Sbjct: 65  LLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITER-GALQEELARSFFW 122
Query: 452 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMARIFGVDQTQGNTSRIV 510
            +   + + H      ++HRD+K  NIL+D      K+ DFG   +          +   
Sbjct: 123 QVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFD 175
Query: 511 GTYGYMAPEYAMHGQFSVKS-DVYSFGVLVLEIITG 545
           GT  Y  PE+  + ++  +S  V+S G+L+ +++ G
Sbjct: 176 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 25/205 (12%)
Query: 351 NKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGF 409
            +LG G FG V++ V   +G+    K ++          KNE+ ++ +L H  L+ L   
Sbjct: 57  EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 116
Query: 410 CLEGEEKILVYEFVPNKSL-------DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
             +  E +L+ EF+    L       DY + + E    +++ R+         G+ ++HE
Sbjct: 117 FEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAE---VINYMRQ------ACEGLKHMHE 167
Query: 463 DSRLRIIHRDLKASNILLDAEM--NPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEY 520
            S   I+H D+K  NI+ + +   + KI DFG+A     D+    T+    T  + APE 
Sbjct: 168 HS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAPEI 221
Query: 521 AMHGQFSVKSDVYSFGVLVLEIITG 545
                    +D+++ GVL   +++G
Sbjct: 222 VDREPVGFYTDMWAIGVLGYVLLSG 246

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 108/243 (44%), Gaps = 26/243 (10%)
Query: 322 NADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSK- 379
           N DN L+  +        + +    +     +G G FGEV      S +++ A+K LSK 
Sbjct: 51  NIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKF 110
Query: 380 --ASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL--YD- 434
                  +  F  E  ++A      +V+L     +     +V E++P   L   +  YD 
Sbjct: 111 EMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDV 170
Query: 435 PEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM- 493
           PEK     W+R Y      A  +L L     +  IHRD+K  N+LLD   + K++DFG  
Sbjct: 171 PEK-----WARFY-----TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC 220
Query: 494 ARIFGVDQTQGNTSRIVGTYGYMAPEY----AMHGQFSVKSDVYSFGVLVLEIITGKKNS 549
            ++      + +T+  VGT  Y++PE        G +  + D +S GV + E++ G  ++
Sbjct: 221 MKMNKEGMVRCDTA--VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG--DT 276
Query: 550 NFY 552
            FY
Sbjct: 277 PFY 279

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 20/216 (9%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQ-EIAVKRLSKASGQGAEEFKN------EVV 393
           E   +++     LG GGFG VY G+  S    +A+K + K       E  N      EVV
Sbjct: 4   EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 63
Query: 394 LVAKLQH--RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIG 451
           L+ K+      ++RLL +    +  +L+ E  P    D F +  E+ G L          
Sbjct: 64  LLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITER-GALQEELARSFFW 121
Query: 452 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMARIFGVDQTQGNTSRIV 510
            +   + + H      ++HRD+K  NIL+D      K+ DFG   +          +   
Sbjct: 122 QVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFD 174
Query: 511 GTYGYMAPEYAMHGQFSVKS-DVYSFGVLVLEIITG 545
           GT  Y  PE+  + ++  +S  V+S G+L+ +++ G
Sbjct: 175 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 210

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 20/216 (9%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQ-EIAVKRLSKASGQGAEEFKN------EVV 393
           E   +++     LG GGFG VY G+  S    +A+K + K       E  N      EVV
Sbjct: 5   EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 64
Query: 394 LVAKLQH--RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIG 451
           L+ K+      ++RLL +    +  +L+ E  P    D F +  E+ G L          
Sbjct: 65  LLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITER-GALQEELARSFFW 122
Query: 452 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMARIFGVDQTQGNTSRIV 510
            +   + + H      ++HRD+K  NIL+D      K+ DFG   +          +   
Sbjct: 123 QVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFD 175
Query: 511 GTYGYMAPEYAMHGQFSVKS-DVYSFGVLVLEIITG 545
           GT  Y  PE+  + ++  +S  V+S G+L+ +++ G
Sbjct: 176 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 100/221 (45%), Gaps = 19/221 (8%)
Query: 342 VATNKFSTDNKLGEGGFGEVYKGVL----PSGQEIAVKRLSKASGQGAEEFKNEVVLVAK 397
           V  N+F     LG+G FG+V   +L     +G+  A+K L K      +E  + +     
Sbjct: 148 VTMNEFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRV 204
Query: 398 LQH--RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIA 454
           LQ+     +  L +  +  +++  V E+     L +F    E+    D +R Y     I 
Sbjct: 205 LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL-FFHLSRERVFSEDRARFYG--AEIV 261
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
             + YLH  S   +++RDLK  N++LD + + KI+DFG+ +    D     T    GT  
Sbjct: 262 SALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPE 317
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTD 555
           Y+APE      +    D +  GV++ E++ G+    FY  D
Sbjct: 318 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 356

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 108/243 (44%), Gaps = 26/243 (10%)
Query: 322 NADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSK- 379
           N DN L+  +        + +    +     +G G FGEV      S +++ A+K LSK 
Sbjct: 51  NIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKF 110
Query: 380 --ASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL--YD- 434
                  +  F  E  ++A      +V+L     +     +V E++P   L   +  YD 
Sbjct: 111 EMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDV 170
Query: 435 PEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM- 493
           PEK     W+R Y      A  +L L     +  IHRD+K  N+LLD   + K++DFG  
Sbjct: 171 PEK-----WARFY-----TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC 220
Query: 494 ARIFGVDQTQGNTSRIVGTYGYMAPEY----AMHGQFSVKSDVYSFGVLVLEIITGKKNS 549
            ++      + +T+  VGT  Y++PE        G +  + D +S GV + E++ G  ++
Sbjct: 221 MKMNKEGMVRCDTA--VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG--DT 276
Query: 550 NFY 552
            FY
Sbjct: 277 PFY 279

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 20/216 (9%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQ-EIAVKRLSKASGQGAEEFKN------EVV 393
           E   +++     LG GGFG VY G+  S    +A+K + K       E  N      EVV
Sbjct: 5   EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 64
Query: 394 LVAKLQH--RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIG 451
           L+ K+      ++RLL +    +  +L+ E  P    D F +  E+ G L          
Sbjct: 65  LLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITER-GALQEELARSFFW 122
Query: 452 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMARIFGVDQTQGNTSRIV 510
            +   + + H      ++HRD+K  NIL+D      K+ DFG   +          +   
Sbjct: 123 QVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFD 175
Query: 511 GTYGYMAPEYAMHGQFSVKS-DVYSFGVLVLEIITG 545
           GT  Y  PE+  + ++  +S  V+S G+L+ +++ G
Sbjct: 176 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 20/216 (9%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQ-EIAVKRLSKASGQGAEEFKN------EVV 393
           E   +++     LG GGFG VY G+  S    +A+K + K       E  N      EVV
Sbjct: 52  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 111
Query: 394 LVAKLQH--RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIG 451
           L+ K+      ++RLL +    +  +L+ E  P    D F +  E+ G L          
Sbjct: 112 LLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITER-GALQEELARSFFW 169
Query: 452 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMARIFGVDQTQGNTSRIV 510
            +   + + H      ++HRD+K  NIL+D      K+ DFG   +          +   
Sbjct: 170 QVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFD 222
Query: 511 GTYGYMAPEYAMHGQFSVKS-DVYSFGVLVLEIITG 545
           GT  Y  PE+  + ++  +S  V+S G+L+ +++ G
Sbjct: 223 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 258

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 101/217 (46%), Gaps = 27/217 (12%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSK---ASGQGAE-----EFKNEVVLV 395
           +++     LG G  GEV       + +++A+K +SK   A G   E       + E+ ++
Sbjct: 9   DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 68
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIA 454
            KL H  ++++  F  + E+  +V E +    L D  + +   +        Y+++  + 
Sbjct: 69  KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 127
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNP---KISDFGMARIFGVDQTQGNTSRIVG 511
               YLHE+    IIHRDLK  N+LL ++      KI+DFG ++I G          + G
Sbjct: 128 ----YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT---LCG 177
Query: 512 TYGYMAPEYAMH---GQFSVKSDVYSFGVLVLEIITG 545
           T  Y+APE  +      ++   D +S GV++   ++G
Sbjct: 178 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 214

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 101/217 (46%), Gaps = 27/217 (12%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSK---ASGQGAE-----EFKNEVVLV 395
           +++     LG G  GEV       + +++A+K +SK   A G   E       + E+ ++
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIA 454
            KL H  ++++  F  + E+  +V E +    L D  + +   +        Y+++  + 
Sbjct: 70  KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNP---KISDFGMARIFGVDQTQGNTSRIVG 511
               YLHE+    IIHRDLK  N+LL ++      KI+DFG ++I G          + G
Sbjct: 129 ----YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT---LCG 178
Query: 512 TYGYMAPEYAMH---GQFSVKSDVYSFGVLVLEIITG 545
           T  Y+APE  +      ++   D +S GV++   ++G
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 93/212 (43%), Gaps = 20/212 (9%)
Query: 345 NKFSTDNKLGEGGFGEVYKGVLPSGQ-EIAVKRLSKASGQGAEEFKN------EVVLVAK 397
           +++     LG GGFG VY G+  S    +A+K + K       E  N      EVVL+ K
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 398 LQH--RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
           +      ++RLL +    +  +L+ E  P    D F +  E+ G L           +  
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITER-GALQEELARSFFWQVLE 121
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMARIFGVDQTQGNTSRIVGTYG 514
            + + H      ++HRD+K  NIL+D      K+ DFG   +          +   GT  
Sbjct: 122 AVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRV 174
Query: 515 YMAPEYAMHGQFSVKS-DVYSFGVLVLEIITG 545
           Y  PE+  + ++  +S  V+S G+L+ +++ G
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 20/216 (9%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQ-EIAVKRLSKASGQGAEEFKN------EVV 393
           E   +++     LG GGFG VY G+  S    +A+K + K       E  N      EVV
Sbjct: 39  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 98
Query: 394 LVAKLQH--RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIG 451
           L+ K+      ++RLL +    +  +L+ E  P    D F +  E+ G L          
Sbjct: 99  LLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITER-GALQEELARSFFW 156
Query: 452 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMARIFGVDQTQGNTSRIV 510
            +   + + H      ++HRD+K  NIL+D      K+ DFG   +          +   
Sbjct: 157 QVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFD 209
Query: 511 GTYGYMAPEYAMHGQFSVKS-DVYSFGVLVLEIITG 545
           GT  Y  PE+  + ++  +S  V+S G+L+ +++ G
Sbjct: 210 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 245

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 101/217 (46%), Gaps = 27/217 (12%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSK---ASGQGAE-----EFKNEVVLV 395
           +++     LG G  GEV       + +++A+K +SK   A G   E       + E+ ++
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIA 454
            KL H  ++++  F  + E+  +V E +    L D  + +   +        Y+++  + 
Sbjct: 70  KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNP---KISDFGMARIFGVDQTQGNTSRIVG 511
               YLHE+    IIHRDLK  N+LL ++      KI+DFG ++I G          + G
Sbjct: 129 ----YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT---LCG 178
Query: 512 TYGYMAPEYAMH---GQFSVKSDVYSFGVLVLEIITG 545
           T  Y+APE  +      ++   D +S GV++   ++G
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 101/217 (46%), Gaps = 27/217 (12%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSK---ASGQGAE-----EFKNEVVLV 395
           +++     LG G  GEV       + +++A+K +SK   A G   E       + E+ ++
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIA 454
            KL H  ++++  F  + E+  +V E +    L D  + +   +        Y+++  + 
Sbjct: 70  KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNP---KISDFGMARIFGVDQTQGNTSRIVG 511
               YLHE+    IIHRDLK  N+LL ++      KI+DFG ++I G          + G
Sbjct: 129 ----YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT---LCG 178
Query: 512 TYGYMAPEYAMH---GQFSVKSDVYSFGVLVLEIITG 545
           T  Y+APE  +      ++   D +S GV++   ++G
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 101/217 (46%), Gaps = 27/217 (12%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSK---ASGQGAE-----EFKNEVVLV 395
           +++     LG G  GEV       + +++A++ +SK   A G   E       + E+ ++
Sbjct: 149 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 208
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIA 454
            KL H  ++++  F  + E+  +V E +    L D  + +   +        Y+++  + 
Sbjct: 209 KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 267
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNP---KISDFGMARIFGVDQTQGNTSRIVG 511
               YLHE+    IIHRDLK  N+LL ++      KI+DFG ++I G          + G
Sbjct: 268 ----YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT---LCG 317
Query: 512 TYGYMAPEYAMH---GQFSVKSDVYSFGVLVLEIITG 545
           T  Y+APE  +      ++   D +S GV++   ++G
Sbjct: 318 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 354

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 93/212 (43%), Gaps = 20/212 (9%)
Query: 345 NKFSTDNKLGEGGFGEVYKGVLPSGQ-EIAVKRLSKASGQGAEEFKN------EVVLVAK 397
           +++     LG GGFG VY G+  S    +A+K + K       E  N      EVVL+ K
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 398 LQH--RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
           +      ++RLL +    +  +L+ E  P    D F +  E+ G L           +  
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITER-GALQEELARSFFWQVLE 121
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMARIFGVDQTQGNTSRIVGTYG 514
            + + H      ++HRD+K  NIL+D      K+ DFG   +          +   GT  
Sbjct: 122 AVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRV 174
Query: 515 YMAPEYAMHGQFSVKS-DVYSFGVLVLEIITG 545
           Y  PE+  + ++  +S  V+S G+L+ +++ G
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 101/217 (46%), Gaps = 27/217 (12%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSK---ASGQGAE-----EFKNEVVLV 395
           +++     LG G  GEV       + +++A++ +SK   A G   E       + E+ ++
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIA 454
            KL H  ++++  F  + E+  +V E +    L D  + +   +        Y+++  + 
Sbjct: 195 KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 253
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNP---KISDFGMARIFGVDQTQGNTSRIVG 511
               YLHE+    IIHRDLK  N+LL ++      KI+DFG ++I G          + G
Sbjct: 254 ----YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT---LCG 303
Query: 512 TYGYMAPEYAMH---GQFSVKSDVYSFGVLVLEIITG 545
           T  Y+APE  +      ++   D +S GV++   ++G
Sbjct: 304 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 20/216 (9%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQ-EIAVKRLSKASGQGAEEFKN------EVV 393
           E   +++     LG GGFG VY G+  S    +A+K + K       E  N      EVV
Sbjct: 27  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 86
Query: 394 LVAKLQH--RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIG 451
           L+ K+      ++RLL +    +  +L+ E  P    D F +  E+ G L          
Sbjct: 87  LLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITER-GALQEELARSFFW 144
Query: 452 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMARIFGVDQTQGNTSRIV 510
            +   + + H      ++HRD+K  NIL+D      K+ DFG   +          +   
Sbjct: 145 QVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFD 197
Query: 511 GTYGYMAPEYAMHGQFSVKS-DVYSFGVLVLEIITG 545
           GT  Y  PE+  + ++  +S  V+S G+L+ +++ G
Sbjct: 198 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 233

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 88/205 (42%), Gaps = 12/205 (5%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNL 403
           ++++     +G G FG           E+   +  +   +  E  K E++    L+H N+
Sbjct: 18  SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNI 77
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
           VR     L      +V E+     L   + +    G+            +  G+ Y H  
Sbjct: 78  VRFKEVILTPTHLAIVMEYASGGELFERICN---AGRFSEDEARFFFQQLISGVSYCHA- 133
Query: 464 SRLRIIHRDLKASNILLDAEMNP--KISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYA 521
             +++ HRDLK  N LLD    P  KI  FG ++   V  +Q  ++  VGT  Y+APE  
Sbjct: 134 --MQVCHRDLKLENTLLDGSPAPRLKICAFGYSK-SSVLHSQPKST--VGTPAYIAPEVL 188
Query: 522 MHGQFSVK-SDVYSFGVLVLEIITG 545
           +  ++  K +DV+S GV +  ++ G
Sbjct: 189 LKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 101/217 (46%), Gaps = 27/217 (12%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSK---ASGQGAE-----EFKNEVVLV 395
           +++     LG G  GEV       + +++A+K +SK   A G   E       + E+ ++
Sbjct: 16  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 75
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIA 454
            KL H  ++++  F  + E+  +V E +    L D  + +   +        Y+++  + 
Sbjct: 76  KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 134
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNP---KISDFGMARIFGVDQTQGNTSRIVG 511
               YLHE+    IIHRDLK  N+LL ++      KI+DFG ++I G          + G
Sbjct: 135 ----YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT---LCG 184
Query: 512 TYGYMAPEYAMH---GQFSVKSDVYSFGVLVLEIITG 545
           T  Y+APE  +      ++   D +S GV++   ++G
Sbjct: 185 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 221

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 103/223 (46%), Gaps = 22/223 (9%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL----PSGQEIAVKRLSKASGQGAEEFKNEVVLVA 396
           +V  N F     LG+G FG+V   +L     +G+  A+K L K      +E  + V    
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR 57
Query: 397 KLQH--RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGI 453
            LQ+     +  L +  +  +++  V E+     L +F    E+    + +R Y     I
Sbjct: 58  VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL-FFHLSRERVFTEERARFYG--AEI 114
Query: 454 ARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR-IVGT 512
              + YLH      +++RD+K  N++LD + + KI+DFG+ +  G+  + G T +   GT
Sbjct: 115 VSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKE-GI--SDGATMKTFCGT 168
Query: 513 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTD 555
             Y+APE      +    D +  GV++ E++ G+    FY  D
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 209

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 103/223 (46%), Gaps = 22/223 (9%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL----PSGQEIAVKRLSKASGQGAEEFKNEVVLVA 396
           +V  N F     LG+G FG+V   +L     +G+  A+K L K      +E  + V    
Sbjct: 4   KVTMNDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR 60
Query: 397 KLQH--RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGI 453
            LQ+     +  L +  +  +++  V E+     L +F    E+    + +R Y     I
Sbjct: 61  VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL-FFHLSRERVFTEERARFYG--AEI 117
Query: 454 ARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR-IVGT 512
              + YLH      +++RD+K  N++LD + + KI+DFG+ +  G+  + G T +   GT
Sbjct: 118 VSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKE-GI--SDGATMKTFCGT 171
Query: 513 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTD 555
             Y+APE      +    D +  GV++ E++ G+    FY  D
Sbjct: 172 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 212

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 86/205 (41%), Gaps = 12/205 (5%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNL 403
           ++++     +G G FG           E+   +  +   +  E  K E++    L+H N+
Sbjct: 18  SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNI 77
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
           VR     L      +V E+     L   + +    G+            +  G+ Y H  
Sbjct: 78  VRFKEVILTPTHLAIVMEYASGGELFERICN---AGRFSEDEARFFFQQLISGVSYCHA- 133
Query: 464 SRLRIIHRDLKASNILLDAEMNP--KISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYA 521
             +++ HRDLK  N LLD    P  KI  FG ++   +     +T   VGT  Y+APE  
Sbjct: 134 --MQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDT---VGTPAYIAPEVL 188
Query: 522 MHGQFSVK-SDVYSFGVLVLEIITG 545
           +  ++  K +DV+S GV +  ++ G
Sbjct: 189 LKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 103/223 (46%), Gaps = 22/223 (9%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL----PSGQEIAVKRLSKASGQGAEEFKNEVVLVA 396
           +V  N F     LG+G FG+V   +L     +G+  A+K L K      +E  + V    
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR 57
Query: 397 KLQH--RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGI 453
            LQ+     +  L +  +  +++  V E+     L +F    E+    + +R Y     I
Sbjct: 58  VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL-FFHLSRERVFTEERARFYG--AEI 114
Query: 454 ARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR-IVGT 512
              + YLH      +++RD+K  N++LD + + KI+DFG+ +  G+  + G T +   GT
Sbjct: 115 VSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKE-GI--SDGATMKXFCGT 168
Query: 513 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTD 555
             Y+APE      +    D +  GV++ E++ G+    FY  D
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 209

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 101/219 (46%), Gaps = 32/219 (14%)
Query: 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKR--------LSKASGQGAEEFKNEVVLVA 396
            K+   + LGEG +G+V K VL S  E   +R          +    G    K E+ L+ 
Sbjct: 5   GKYLMGDLLGEGSYGKV-KEVLDS--ETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLR 61
Query: 397 KLQHRNLVRLLGFCLEGEEK---ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRY--KIIG 451
           +L+H+N+++L+   L  EEK    +V E+      +     PEK+  +  +  Y  ++I 
Sbjct: 62  RLRHKNVIQLVDV-LYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLID 120
Query: 452 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI---FGVDQTQGNTSR 508
           G+     YLH      I+H+D+K  N+LL      KIS  G+A     F  D T   TS+
Sbjct: 121 GLE----YLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDT-CRTSQ 172
Query: 509 IVGTYGYMAPEYA--MHGQFSVKSDVYSFGVLVLEIITG 545
             G+  +  PE A  +      K D++S GV +  I TG
Sbjct: 173 --GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTG 209

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 103/223 (46%), Gaps = 22/223 (9%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL----PSGQEIAVKRLSKASGQGAEEFKNEVVLVA 396
           +V  N F     LG+G FG+V   +L     +G+  A+K L K      +E  + V    
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR 57
Query: 397 KLQH--RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGI 453
            LQ+     +  L +  +  +++  V E+     L +F    E+    + +R Y     I
Sbjct: 58  VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL-FFHLSRERVFTEERARFYG--AEI 114
Query: 454 ARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR-IVGT 512
              + YLH      +++RD+K  N++LD + + KI+DFG+ +  G+  + G T +   GT
Sbjct: 115 VSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKE-GI--SDGATMKTFCGT 168
Query: 513 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTD 555
             Y+APE      +    D +  GV++ E++ G+    FY  D
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 209

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 105/214 (49%), Gaps = 27/214 (12%)
Query: 350 DNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ-HRNLVRLL 407
           ++ LGEG    V   + L + QE AVK + K  G        EV ++ + Q HRN++ L+
Sbjct: 18  EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 408 GFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
            F  E +   LV+E +   S+   ++      +L+ S    ++  +A  + +LH      
Sbjct: 78  EFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEAS---VVVQDVASALDFLHNKG--- 131
Query: 468 IIHRDLKASNILLDA--EMNP-KISDFGMARIFGVDQTQGNTSRI--------VGTYGYM 516
           I HRDLK  NIL +   +++P KI DF +    G+ +  G+ S I         G+  YM
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFDLGS--GI-KLNGDCSPISTPELLTPCGSAEYM 188
Query: 517 APEY--AMHGQFSV---KSDVYSFGVLVLEIITG 545
           APE   A   + S+   + D++S GV++  +++G
Sbjct: 189 APEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 103/223 (46%), Gaps = 22/223 (9%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL----PSGQEIAVKRLSKASGQGAEEFKNEVVLVA 396
           +V  N F     LG+G FG+V   +L     +G+  A+K L K      +E  + V    
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR 57
Query: 397 KLQH--RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGI 453
            LQ+     +  L +  +  +++  V E+     L +F    E+    + +R Y     I
Sbjct: 58  VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL-FFHLSRERVFTEERARFYG--AEI 114
Query: 454 ARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR-IVGT 512
              + YLH      +++RD+K  N++LD + + KI+DFG+ +  G+  + G T +   GT
Sbjct: 115 VSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKE-GI--SDGATMKXFCGT 168
Query: 513 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTD 555
             Y+APE      +    D +  GV++ E++ G+    FY  D
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 209

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 105/223 (47%), Gaps = 22/223 (9%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL----PSGQEIAVKRLSKASGQGAEEFKNEVVLVA 396
           +V  N F     LG+G FG+V   +L     +G+  A+K L K      +E  + V    
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR 57
Query: 397 KLQH--RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGI 453
            LQ+     +  L +  +  +++  V E+     L +F    E+    + +R Y     I
Sbjct: 58  VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL-FFHLSRERVFTEERARFYG--AEI 114
Query: 454 ARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR-IVGT 512
              + YLH  SR  +++RD+K  N++LD + + KI+DFG+ +  G+  + G T +   GT
Sbjct: 115 VSALEYLH--SR-DVVYRDIKLENLMLDKDGHIKITDFGLCKE-GI--SDGATMKXFCGT 168
Query: 513 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTD 555
             Y+APE      +    D +  GV++ E++ G+    FY  D
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 209

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 102/221 (46%), Gaps = 27/221 (12%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGAEE---FKNE 391
           DFE ++V          +G G FGEV    L +  ++ A+K L+K       E   F+ E
Sbjct: 75  DFEILKV----------IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREE 124
Query: 392 VVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKII 450
             ++     +  +  L +  + +  + LV ++     L   L   E +   + +R Y   
Sbjct: 125 RDVLVNGDSK-WITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFY--- 180
Query: 451 GGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIV 510
             +A  ++ +    +L  +HRD+K  NIL+D   + +++DFG       D T   +S  V
Sbjct: 181 --LAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV-QSSVAV 237
Query: 511 GTYGYMAPEY--AMH---GQFSVKSDVYSFGVLVLEIITGK 546
           GT  Y++PE   AM    G++  + D +S GV + E++ G+
Sbjct: 238 GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 105/223 (47%), Gaps = 22/223 (9%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL----PSGQEIAVKRLSKASGQGAEEFKNEVVLVA 396
           +V  N F     LG+G FG+V   +L     +G+  A+K L K      +E  + V    
Sbjct: 6   KVTMNDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR 62
Query: 397 KLQH--RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGI 453
            LQ+     +  L +  +  +++  V E+     L +F    E+    + +R Y     I
Sbjct: 63  VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL-FFHLSRERVFTEERARFYG--AEI 119
Query: 454 ARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR-IVGT 512
              + YLH  SR  +++RD+K  N++LD + + KI+DFG+ +  G+  + G T +   GT
Sbjct: 120 VSALEYLH--SR-DVVYRDIKLENLMLDKDGHIKITDFGLCKE-GI--SDGATMKXFCGT 173
Query: 513 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTD 555
             Y+APE      +    D +  GV++ E++ G+    FY  D
Sbjct: 174 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 214

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 89/217 (41%), Gaps = 23/217 (10%)
Query: 353 LGEGGFGEVYKGVLPSGQEIAVKRLSKASGQG-----------AEEFKNEVVLVAKLQHR 401
           +  G +G V  GV   G  +A+KR+      G            +    E+ L+    H 
Sbjct: 30  ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 402 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRY--KIIGGIARGILY 459
           N++ L    +  EE  +   ++  + +   L       ++  S ++    +  I  G+  
Sbjct: 90  NILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHV 149
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE 519
           LHE     ++HRDL   NILL    +  I DF +AR    D    N +  V    Y APE
Sbjct: 150 LHEAG---VVHRDLHPGNILLADNNDITICDFNLAR---EDTADANKTHYVTHRWYRAPE 203
Query: 520 YAMHGQ-FSVKSDVYSFGVLVLEIITGK---KNSNFY 552
             M  + F+   D++S G ++ E+   K   + S FY
Sbjct: 204 LVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY 240

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 96/217 (44%), Gaps = 22/217 (10%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQ-EIAVKRLSKASGQGAEEFKN------EVV 393
           E   +++     LG GGFG VY G+  S    +A+K + K       E  N      EVV
Sbjct: 4   EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 63
Query: 394 LVAKLQH--RNLVRLLGFCLEGEEKILVYEFV-PNKSLDYFLYDPEKQGQLDWSRRYKII 450
           L+ K+      ++RLL +    +  +L+ E + P + L  F+ +   +G L         
Sbjct: 64  LLKKVSSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITE---RGALQEELARSFF 120
Query: 451 GGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMARIFGVDQTQGNTSRI 509
             +   + + H      ++HRD+K  NIL+D      K+ DFG   +          +  
Sbjct: 121 WQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDF 173
Query: 510 VGTYGYMAPEYAMHGQFSVKS-DVYSFGVLVLEIITG 545
            GT  Y  PE+  + ++  +S  V+S G+L+ +++ G
Sbjct: 174 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 210

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 89/217 (41%), Gaps = 23/217 (10%)
Query: 353 LGEGGFGEVYKGVLPSGQEIAVKRLSKASGQG-----------AEEFKNEVVLVAKLQHR 401
           +  G +G V  GV   G  +A+KR+      G            +    E+ L+    H 
Sbjct: 30  ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 402 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRY--KIIGGIARGILY 459
           N++ L    +  EE  +   ++  + +   L       ++  S ++    +  I  G+  
Sbjct: 90  NILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHV 149
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE 519
           LHE     ++HRDL   NILL    +  I DF +AR    D    N +  V    Y APE
Sbjct: 150 LHEAG---VVHRDLHPGNILLADNNDITICDFNLAR---EDTADANKTHYVTHRWYRAPE 203
Query: 520 YAMHGQ-FSVKSDVYSFGVLVLEIITGK---KNSNFY 552
             M  + F+   D++S G ++ E+   K   + S FY
Sbjct: 204 LVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY 240
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	571
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-132
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-127
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-117
3soc_A	322	Activin receptor type-2A; structural genomics cons	3e-93
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-73
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-70
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	7e-67
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	4e-65
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-64
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	3e-64
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	4e-62
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	4e-61
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	7e-61
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	4e-59
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	8e-54
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-53
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-52
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	8e-51
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	4e-49
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-48
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-48
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	3e-48
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	3e-48
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	8e-48
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	8e-48
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-47
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-47
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	3e-47
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	3e-47
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	3e-47
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	4e-47
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	5e-47
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	7e-47
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	8e-47
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	9e-47
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-46
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-46
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	3e-46
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-46
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	3e-46
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	5e-46
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	9e-46
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-45
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-45
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-45
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-45
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-45
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	9e-45
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-44
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-44
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-44
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-44
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-44
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-44
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	6e-44
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	6e-44
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-43
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-43
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	3e-43
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	6e-43
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-42
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-42
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-42
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	4e-42
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	4e-42
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	5e-42
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	6e-42
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	7e-42
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-41
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-41
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-41
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	3e-41
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	6e-41
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-40
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-40
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	8e-40
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-39
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	4e-39
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	5e-39
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-38
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-38
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-38
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-38
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	3e-38
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-37
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	5e-37
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-36
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-36
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	4e-36
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	6e-36
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	6e-36
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	9e-36
3an0_A	340	Dual specificity mitogen-activated protein kinase;	5e-35
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-34
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-34
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-34
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	5e-34
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	5e-34
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	6e-34
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-33
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-33
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-33
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	5e-33
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	6e-33
3aln_A	327	Dual specificity mitogen-activated protein kinase;	6e-33
3ork_A	311	Serine/threonine protein kinase; structural genomi	7e-33
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-32
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-32
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	3e-32
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	4e-32
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-31
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-31
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	4e-31
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	6e-31
2dyl_A	318	Dual specificity mitogen-activated protein kinase	7e-31
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-30
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-30
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	3e-30
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-30
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	5e-30
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	7e-30
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	8e-30
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	8e-30
2e79_A	108	Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect	8e-30
2e79_A	108	Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect	4e-29
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-29
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-29
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-29
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-29
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	6e-29
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	6e-29
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	6e-29
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	8e-29
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-28
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-28
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	4e-28
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	5e-28
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	8e-28
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	8e-28
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-27
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-27
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-27
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-27
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-27
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-27
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-27
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-27
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-27
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-27
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	5e-27
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	6e-27
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	7e-27
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	8e-27
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-26
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-26
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-26
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-26
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	6e-26
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	6e-26
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	7e-26
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	9e-26
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-25
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-25
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-25
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-25
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	3e-25
3niz_A	311	Rhodanese family protein; structural genomics, str	4e-25
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	4e-25
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	4e-25
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	4e-25
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	5e-25
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	7e-25
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	7e-25
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	7e-25
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	8e-25
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	9e-25
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-24
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-24
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-24
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-24
3o0g_A	292	Cell division protein kinase 5; kinase activator c	3e-24
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	6e-24
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	9e-24
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	3e-23
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	4e-23
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	5e-23
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	8e-23
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	9e-23
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-22
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	5e-22
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	8e-22
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	4e-21
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	4e-21
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	5e-21
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	6e-21
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-20
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-20
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	4e-20
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	4e-20
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	4e-20
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-19
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-19
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-19
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-19
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	3e-19
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	3e-19
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	3e-19
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	4e-19
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	4e-19
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	6e-19
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	6e-19
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	4e-12
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	8e-19
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-18
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-18
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-18
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-18
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	7e-18
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-17
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	4e-17
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	4e-17
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-16
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	4e-16
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-15
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-14
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	5e-14
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	8e-14
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	3e-11
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	3e-11
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	6e-11
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-10
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	7e-10
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	9e-10
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-09
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-09
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	4e-09
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-07
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	6e-07
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	1e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	9e-06
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	4e-05

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  387 bits (997), Expect = e-132
 Identities = 101/242 (41%), Positives = 139/242 (57%), Gaps = 15/242 (6%)

Query: 322 NADNDLTTLESLQFDFETIEVATNKFS------TDNKLGEGGFGEVYKGVLPSGQEIAVK 375
           N   +++      F F  ++  TN F         NK+GEGGFG VYKG +     +AVK
Sbjct: 2   NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVK 60

Query: 376 RLSK----ASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF 431
           +L+      + +  ++F  E+ ++AK QH NLV LLGF  +G++  LVY ++PN SL   
Sbjct: 61  KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR 120

Query: 432 LYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDF 491
           L   +    L W  R KI  G A GI +LHE+     IHRD+K++NILLD     KISDF
Sbjct: 121 LSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDF 177

Query: 492 GMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF 551
           G+AR          TSRIVGT  YMAPE  + G+ + KSD+YSFGV++LEIITG    + 
Sbjct: 178 GLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDE 236

Query: 552 YQ 553
           ++
Sbjct: 237 HR 238

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  375 bits (966), Expect = e-127
 Identities = 102/234 (43%), Positives = 148/234 (63%), Gaps = 5/234 (2%)

Query: 335 FDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAE-EFKNEVV 393
           F    ++VA++ FS  N LG GGFG+VYKG L  G  +AVKRL +   QG E +F+ EV 
Sbjct: 20  FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79

Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYD-PEKQGQLDWSRRYKIIGG 452
           +++   HRNL+RL GFC+   E++LVY ++ N S+   L + PE Q  LDW +R +I  G
Sbjct: 80  MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139

Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
            ARG+ YLH+    +IIHRD+KA+NILLD E    + DFG+A++     T   T  + GT
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-AVRGT 198

Query: 513 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAAD--LLSYV 564
            G++APEY   G+ S K+DV+ +GV++LE+ITG++  +  +     D  LL +V
Sbjct: 199 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  349 bits (898), Expect = e-117
 Identities = 98/255 (38%), Positives = 149/255 (58%), Gaps = 6/255 (2%)

Query: 309 RKAKKKYNAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPS 368
            K  K  N++ ++ + + L   ES +     +E ATN F     +G G FG+VYKGVL  
Sbjct: 3   SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62

Query: 369 GQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL 428
           G ++A+KR +  S QG EEF+ E+  ++  +H +LV L+GFC E  E IL+Y+++ N +L
Sbjct: 63  GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNL 122

Query: 429 DYFLYDPEKQGQ-LDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPK 487
              LY  +     + W +R +I  G ARG+ YLH  +   IIHRD+K+ NILLD    PK
Sbjct: 123 KRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPK 179

Query: 488 ISDFGMARIF-GVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
           I+DFG+++    +DQT  +T  + GT GY+ PEY + G+ + KSDVYSFGV++ E++  +
Sbjct: 180 ITDFGISKKGTELDQTHLST-VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR 238

Query: 547 KNSNFYQTDGAADLL 561
                       +L 
Sbjct: 239 SAIVQSLPREMVNLA 253

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  287 bits (737), Expect = 3e-93
 Identities = 62/235 (26%), Positives = 104/235 (44%), Gaps = 22/235 (9%)

Query: 332 SLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNE 391
            +    E +   +           G FG V+K  L   + +AVK       Q   + + E
Sbjct: 11  GVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQS-WQNEYE 68

Query: 392 VVLVAKLQHRNLVRLLGFCLEGE----EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRY 447
           V  +  ++H N+++ +G    G     +  L+  F    SL  FL    K   + W+   
Sbjct: 69  VYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELC 124

Query: 448 KIIGGIARGILYLHED-------SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500
            I   +ARG+ YLHED        +  I HRD+K+ N+LL   +   I+DFG+A  F   
Sbjct: 125 HIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAG 184

Query: 501 QTQGNTSRIVGTYGYMAPEYAMHG-----QFSVKSDVYSFGVLVLEIITGKKNSN 550
           ++ G+T   VGT  YMAPE             ++ D+Y+ G+++ E+ +    ++
Sbjct: 185 KSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  236 bits (603), Expect = 3e-73
 Identities = 62/248 (25%), Positives = 100/248 (40%), Gaps = 34/248 (13%)

Query: 333 LQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNE- 391
           ++       +  +       +G G +G VYKG L   + +AVK  S A+ Q    F NE 
Sbjct: 1   MEAAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEK 56

Query: 392 -VVLVAKLQHRNLVRLLGFCLEGE-----EKILVYEFVPNKSLDYFLYDPEKQGQLDWSR 445
            +  V  ++H N+ R +            E +LV E+ PN SL  +L         DW  
Sbjct: 57  NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH----TSDWVS 112

Query: 446 RYKIIGGIARGILYLHED------SRLRIIHRDLKASNILLDAEMNPKISDFGMARIF-- 497
             ++   + RG+ YLH +       +  I HRDL + N+L+  +    ISDFG++     
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172

Query: 498 ----GVDQTQGNTSRIVGTYGYMAPEYAM-------HGQFSVKSDVYSFGVLVLEIITGK 546
                  +        VGT  YMAPE                + D+Y+ G++  EI    
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232

Query: 547 KNSNFYQT 554
            +    ++
Sbjct: 233 TDLFPGES 240

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  228 bits (584), Expect = 1e-70
 Identities = 68/239 (28%), Positives = 118/239 (49%), Gaps = 6/239 (2%)

Query: 310 KAKKKYNAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSG 369
           K    ++ + + +             D + +++     +   K+G G FG V++     G
Sbjct: 2   KHHHHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HG 60

Query: 370 QEIAVKRL--SKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKS 427
            ++AVK L       +   EF  EV ++ +L+H N+V  +G   +     +V E++   S
Sbjct: 61  SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGS 120

Query: 428 LDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPK 487
           L   L+    + QLD  RR  +   +A+G+ YLH      I+HR+LK+ N+L+D +   K
Sbjct: 121 LYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVK 179

Query: 488 ISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
           + DFG++R+     T  ++    GT  +MAPE       + KSDVYSFGV++ E+ T +
Sbjct: 180 VCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQ 236

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  218 bits (558), Expect = 7e-67
 Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 11/208 (5%)

Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
            +   +   +  +G G FG V K      +++A+K++   S    + F  E+  ++++ H
Sbjct: 4   MIDYKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIE--SESERKAFIVELRQLSRVNH 60

Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
            N+V+L G CL      LV E+    SL   L+  E       +         ++G+ YL
Sbjct: 61  PNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 118

Query: 461 HEDSRLRIIHRDLKASNILLDAEMN-PKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE 519
           H      +IHRDLK  N+LL A     KI DFG A        Q + +   G+  +MAPE
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD-----IQTHMTNNKGSAAWMAPE 173

Query: 520 YAMHGQFSVKSDVYSFGVLVLEIITGKK 547
                 +S K DV+S+G+++ E+IT +K
Sbjct: 174 VFEGSNYSEKCDVFSWGIILWEVITRRK 201

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  214 bits (546), Expect = 4e-65
 Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 18/210 (8%)

Query: 351 NKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGF 409
             LG+G FG+  K     +G+ + +K L +   +    F  EV ++  L+H N+++ +G 
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75

Query: 410 CLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRII 469
             + +    + E++   +L   +   +   Q  WS+R      IA G+ YLH    + II
Sbjct: 76  LYKDKRLNFITEYIKGGTLRGIIKSMD--SQYPWSQRVSFAKDIASGMAYLH---SMNII 130

Query: 470 HRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR------------IVGTYGYMA 517
           HRDL + N L+    N  ++DFG+AR+   ++TQ    R            +VG   +MA
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190

Query: 518 PEYAMHGQFSVKSDVYSFGVLVLEIITGKK 547
           PE      +  K DV+SFG+++ EII    
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEIIGRVN 220

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  212 bits (541), Expect = 1e-64
 Identities = 68/240 (28%), Positives = 117/240 (48%), Gaps = 32/240 (13%)

Query: 323 ADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSKAS 381
             ++             IE        + ++G+GGFG V+KG L      +A+K L    
Sbjct: 4   GGSEFPKSRLPTLADNEIEY-------EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGD 56

Query: 382 GQGA-------EEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYD 434
            +G        +EF+ EV +++ L H N+V+L G         +V EFVP   L + L D
Sbjct: 57  SEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLD 114

Query: 435 PEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD-----AEMNPKIS 489
                 + WS + +++  IA GI Y+  +    I+HRDL++ NI L      A +  K++
Sbjct: 115 KAH--PIKWSVKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171

Query: 490 DFGMARIFGVDQTQGNTSRIVGTYGYMAPE--YAMHGQFSVKSDVYSFGVLVLEIITGKK 547
           DFG+++      +  + S ++G + +MAPE   A    ++ K+D YSF +++  I+TG+ 
Sbjct: 172 DFGLSQQ-----SVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG 226

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  210 bits (536), Expect = 3e-64
 Identities = 75/223 (33%), Positives = 109/223 (48%), Gaps = 28/223 (12%)

Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRL----SKASGQGAEEFKNE 391
           DF  + +       +  +G GGFG+VY+     G E+AVK       +   Q  E  + E
Sbjct: 5   DFAELTL-------EEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQE 56

Query: 392 VVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIG 451
             L A L+H N++ L G CL+     LV EF     L+  L        +          
Sbjct: 57  AKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR----IPPDILVNWAV 112

Query: 452 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP--------KISDFGMARIFGVDQTQ 503
            IARG+ YLH+++ + IIHRDLK+SNIL+  ++          KI+DFG+AR       +
Sbjct: 113 QIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE----WHR 168

Query: 504 GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
                  G Y +MAPE      FS  SDV+S+GVL+ E++TG+
Sbjct: 169 TTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE 211

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  202 bits (515), Expect = 4e-61
 Identities = 52/213 (24%), Positives = 93/213 (43%), Gaps = 17/213 (7%)

Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRL--SKASGQGAEEFKNEVVLVAKL 398
            +   + +   KL E   GE++KG    G +I VK L     S + + +F  E   +   
Sbjct: 6   GIDFKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF 64

Query: 399 QHRNLVRLLGFCLEGEEKIL--VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARG 456
            H N++ +LG C          +  ++P  SL   L++      +D S+  K    +ARG
Sbjct: 65  SHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNF-VVDQSQAVKFALDMARG 123

Query: 457 ILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYM 516
           + +LH    L I    L + ++++D +M  +IS   +   F   Q+ G          ++
Sbjct: 124 MAFLHTLEPL-IPRHALNSRSVMIDEDMTARISMADVKFSF---QSPGRM----YAPAWV 175

Query: 517 APEYAMHGQ---FSVKSDVYSFGVLVLEIITGK 546
           APE             +D++SF VL+ E++T +
Sbjct: 176 APEALQKKPEDTNRRSADMWSFAVLLWELVTRE 208

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  202 bits (515), Expect = 7e-61
 Identities = 67/211 (31%), Positives = 110/211 (52%), Gaps = 13/211 (6%)

Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKL 398
           E+   + +   ++G G FG VYKG      ++AVK L+    + Q  + FKNEV ++ K 
Sbjct: 20  EIPDGQITVGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 77

Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGIL 458
           +H N++  +G+    +  I V ++    SL + L+  E   + +  +   I    ARG+ 
Sbjct: 78  RHVNILLFMGYSTAPQLAI-VTQWCEGSSLYHHLHASE--TKFEMKKLIDIARQTARGMD 134

Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
           YLH      IIHRDLK++NI L  +   KI DFG+A             ++ G+  +MAP
Sbjct: 135 YLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 191

Query: 519 E---YAMHGQFSVKSDVYSFGVLVLEIITGK 546
           E         +S +SDVY+FG+++ E++TG+
Sbjct: 192 EVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  198 bits (506), Expect = 4e-59
 Identities = 59/240 (24%), Positives = 104/240 (43%), Gaps = 29/240 (12%)

Query: 321 SNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRL--S 378
             A      L+     FE +E+          +G+G FG+VY G      E+A++ +   
Sbjct: 16  RKASQTSIFLQEWDIPFEQLEI-------GELIGKGRFGQVYHGRW--HGEVAIRLIDIE 66

Query: 379 KASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQ 438
           + +    + FK EV+   + +H N+V  +G C+      ++      ++L   + D +  
Sbjct: 67  RDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKI- 125

Query: 439 GQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498
             LD ++  +I   I +G+ YLH      I+H+DLK+ N+  D      I+DFG+  I G
Sbjct: 126 -VLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISG 180

Query: 499 VDQTQGNTSRI---VGTYGYMAPE---------YAMHGQFSVKSDVYSFGVLVLEIITGK 546
           V Q      ++    G   ++APE               FS  SDV++ G +  E+   +
Sbjct: 181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE 240

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  185 bits (471), Expect = 8e-54
 Identities = 58/216 (26%), Positives = 94/216 (43%), Gaps = 29/216 (13%)

Query: 350 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNE--VVLVAKLQHRNLVRLL 407
             ++G+G +GEV+ G    G+++AVK            +  E  +     ++H N++  +
Sbjct: 42  VKQIGKGRYGEVWMGKW-RGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFI 97

Query: 408 GFCLEGEEKI----LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
              ++G        L+ ++  N SL  +L    K   LD     K+      G+ +LH +
Sbjct: 98  AADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLCHLHTE 153

Query: 464 SRLR-----IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRI--VGTYGYM 516
                    I HRDLK+ NIL+       I+D G+A  F  D  + +      VGT  YM
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213

Query: 517 APE------YAMHGQFSVKSDVYSFGVLVL-EIITG 545
            PE         H Q  + +D+YSFG L+L E+   
Sbjct: 214 PPEVLDESLNRNHFQSYIMADMYSFG-LILWEVARR 248

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  183 bits (466), Expect = 1e-53
 Identities = 53/214 (24%), Positives = 92/214 (42%), Gaps = 27/214 (12%)

Query: 351 NKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNE--VVLVAKLQHRNLVRLLG 408
             +G+G +GEV++G    G+ +AVK  S    +  + +  E  +     L+H N++  + 
Sbjct: 14  ECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIA 69

Query: 409 FCLEGEEKI----LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
             +          L+  +    SL  +L    +   LD     +I+  IA G+ +LH + 
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEI 125

Query: 465 RLR-----IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRI--VGTYGYMA 517
                   I HRDLK+ NIL+       I+D G+A +      Q +      VGT  YMA
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185

Query: 518 PE------YAMHGQFSVKSDVYSFGVLVLEIITG 545
           PE               + D+++FG+++ E+   
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  177 bits (450), Expect = 8e-51
 Identities = 54/215 (25%), Positives = 92/215 (42%), Gaps = 27/215 (12%)

Query: 350 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNE--VVLVAKLQHRNLVRLL 407
              +G+G FGEV++G    G+E+AVK  S    +    +  E  +     L+H N++  +
Sbjct: 47  QESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFI 102

Query: 408 GFCLEGEEKI----LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
               +         LV ++  + SL  +L     +  +      K+    A G+ +LH +
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHME 158

Query: 464 -----SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRI--VGTYGYM 516
                 +  I HRDLK+ NIL+       I+D G+A          + +    VGT  YM
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218

Query: 517 APE------YAMHGQFSVKSDVYSFGVLVLEIITG 545
           APE         H +   ++D+Y+ G++  EI   
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 253

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  173 bits (441), Expect = 4e-49
 Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 15/210 (7%)

Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRL-SKASGQGAEEFKNEVVLVAKL 398
            +         ++G G FGEV+ G L      +AVK            +F  E  ++ + 
Sbjct: 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQY 169

Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGIL 458
            H N+VRL+G C + +   +V E V       FL    +  +L      +++G  A G+ 
Sbjct: 170 SHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLR--TEGARLRVKTLLQMVGDAAAGME 227

Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGY--- 515
           YL        IHRDL A N L+  +   KISDFGM+R    ++  G  +   G       
Sbjct: 228 YLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSR----EEADGVYAASGGLRQVPVK 280

Query: 516 -MAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
             APE   +G++S +SDV+SFG+L+ E  +
Sbjct: 281 WTAPEALNYGRYSSESDVWSFGILLWETFS 310

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  169 bits (431), Expect = 1e-48
 Identities = 64/206 (31%), Positives = 106/206 (51%), Gaps = 21/206 (10%)

Query: 351 NKLGEGGFGEVYKGVLP-----SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVR 405
            +LG+G FG V           +G+ +AVK+L  ++ +   +F+ E+ ++  LQH N+V+
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75

Query: 406 LLGFCLEGEEK--ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
             G C     +   L+ E++P  SL  +L   + + ++D  +  +    I +G+ YL   
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGT- 132

Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ-----TQGNTSRIVGTYGYMAP 518
              R IHRDL   NIL++ E   KI DFG+ ++   D+      +   S I     + AP
Sbjct: 133 --KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPI----FWYAP 186

Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIIT 544
           E     +FSV SDV+SFGV++ E+ T
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFT 212

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  170 bits (433), Expect = 2e-48
 Identities = 64/221 (28%), Positives = 107/221 (48%), Gaps = 33/221 (14%)

Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL--PSGQEI--AVKRL-SKASGQGAEEFKNEVVLV 395
           E+  ++   +  +G G  GEV  G L  P  +++  A+K L +  + +   +F +E  ++
Sbjct: 45  EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIM 104

Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
            +  H N++RL G    G   ++V E++ N SLD FL   +  GQ    +   ++ G+  
Sbjct: 105 GQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHD--GQFTIMQLVGMLRGVGA 162

Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGY 515
           G+ YL   S L  +HRDL A N+L+D+ +  K+SDFG++R+   D               
Sbjct: 163 GMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP-----------DAA 208

Query: 516 ------------MAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
                        APE      FS  SDV+SFGV++ E++ 
Sbjct: 209 YTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  169 bits (431), Expect = 3e-48
 Identities = 66/220 (30%), Positives = 122/220 (55%), Gaps = 23/220 (10%)

Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL--PSGQE---IAVKRLSK-ASGQGAEEFKNEVVL 394
           E+  +  +    +G G FGEVYKG+L   SG++   +A+K L    + +   +F  E  +
Sbjct: 40  EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 99

Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIA 454
           + +  H N++RL G   + +  +++ E++ N +LD FL + +  G+    +   ++ GIA
Sbjct: 100 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIA 157

Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
            G+ YL   + +  +HRDL A NIL+++ +  K+SDFG++R+   D     T+      G
Sbjct: 158 AGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS-----G 209

Query: 515 ------YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKK 547
                 + APE   + +F+  SDV+SFG+++ E++T G++
Sbjct: 210 GKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER 249

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  169 bits (431), Expect = 3e-48
 Identities = 64/206 (31%), Positives = 106/206 (51%), Gaps = 21/206 (10%)

Query: 351 NKLGEGGFGEVYKGVLP-----SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVR 405
            +LG+G FG V           +G+ +AVK+L  ++ +   +F+ E+ ++  LQH N+V+
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106

Query: 406 LLGFCLEGEEK--ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
             G C     +   L+ E++P  SL  +L   + + ++D  +  +    I +G+ YL   
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGT- 163

Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ-----TQGNTSRIVGTYGYMAP 518
              R IHRDL   NIL++ E   KI DFG+ ++   D+      +   S I     + AP
Sbjct: 164 --KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPI----FWYAP 217

Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIIT 544
           E     +FSV SDV+SFGV++ E+ T
Sbjct: 218 ESLTESKFSVASDVWSFGVVLYELFT 243

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  167 bits (426), Expect = 8e-48
 Identities = 65/227 (28%), Positives = 112/227 (49%), Gaps = 23/227 (10%)

Query: 351 NKLGEGGFGEVYKGVLP-----SGQEIAVKRL-SKASGQGAEEFKNEVVLVAKLQHRNLV 404
             LGEG FG+V           +G+++AVK L  ++ G    + K E+ ++  L H N+V
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86

Query: 405 RLLGFCLEGEEK--ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
           +  G C E       L+ EF+P+ SL  +L  P+ + +++  ++ K    I +G+ YL  
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYLGS 144

Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ-----TQGNTSRIVGTYGYMA 517
               + +HRDL A N+L+++E   KI DFG+ +    D+          S +     + A
Sbjct: 145 ---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPV----FWYA 197

Query: 518 PEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSY 563
           PE  M  +F + SDV+SFGV + E++T    +S+           ++
Sbjct: 198 PECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTH 244

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  166 bits (423), Expect = 8e-48
 Identities = 63/206 (30%), Positives = 97/206 (47%), Gaps = 11/206 (5%)

Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
            +  ++ +   ++G G FG V+ G   +  ++A+K + +      E+F  E  ++ KL H
Sbjct: 4   VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSH 62

Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
             LV+L G CLE     LV EF+ +  L  +L      G         +   +  G+ YL
Sbjct: 63  PKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYL 120

Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGY--MAP 518
                  +IHRDL A N L+      K+SDFGM R    DQ    TS     +     +P
Sbjct: 121 ---EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY---TSSTGTKFPVKWASP 174

Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIIT 544
           E     ++S KSDV+SFGVL+ E+ +
Sbjct: 175 EVFSFSRYSSKSDVWSFGVLMWEVFS 200

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  169 bits (431), Expect = 1e-47
 Identities = 68/212 (32%), Positives = 114/212 (53%), Gaps = 15/212 (7%)

Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL--PSGQEI--AVKRLSK-ASGQGAEEFKNEVVLV 395
           E+     S D  +G G FGEV  G L  PS +EI  A+K L    + +   +F  E  ++
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100

Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
            +  H N++RL G   + +  ++V E++ N SLD FL   +   Q    +   ++ GIA 
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD--AQFTVIQLVGMLRGIAS 158

Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT--- 512
           G+ YL   S +  +HRDL A NIL+++ +  K+SDFG+ R+   D     T+R  G    
Sbjct: 159 GMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR--GGKIP 213

Query: 513 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
             + +PE   + +F+  SDV+S+G+++ E+++
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  166 bits (422), Expect = 2e-47
 Identities = 58/213 (27%), Positives = 103/213 (48%), Gaps = 13/213 (6%)

Query: 335 FDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVL 394
             + + E+     +   +LG G FG V  G      ++A+K + K      +EF  E  +
Sbjct: 14  LGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKV 72

Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIA 454
           +  L H  LV+L G C +     ++ E++ N  L  +L   E + +    +  ++   + 
Sbjct: 73  MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR--EMRHRFQTQQLLEMCKDVC 130

Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT-- 512
             + YL      + +HRDL A N L++ +   K+SDFG++R    D+     +  VG+  
Sbjct: 131 EAMEYL---ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY----TSSVGSKF 183

Query: 513 -YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
              +  PE  M+ +FS KSD+++FGVL+ EI +
Sbjct: 184 PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  166 bits (422), Expect = 3e-47
 Identities = 67/206 (32%), Positives = 107/206 (51%), Gaps = 9/206 (4%)

Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ 399
           E+     +  +KLG G +GEVY+GV       +AVK L K      EEF  E  ++ +++
Sbjct: 9   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIK 67

Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
           H NLV+LLG C       ++ EF+   +L  +L +  +Q ++       +   I+  + Y
Sbjct: 68  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEY 126

Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ-TQGNTSRIVGTYGYMAP 518
           L    +   IHRDL A N L+      K++DFG++R+   D  T    ++      + AP
Sbjct: 127 L---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAP 181

Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIIT 544
           E   + +FS+KSDV++FGVL+ EI T
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIAT 207

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  165 bits (420), Expect = 3e-47
 Identities = 64/207 (30%), Positives = 101/207 (48%), Gaps = 13/207 (6%)

Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
           E+   + +   +LG G FG V  G      ++AVK + K      +EF  E   + KL H
Sbjct: 4   ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSH 62

Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
             LV+  G C +     +V E++ N  L  +L        L+ S+  ++   +  G+ +L
Sbjct: 63  PKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLR--SHGKGLEPSQLLEMCYDVCEGMAFL 120

Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT---YGYMA 517
                 + IHRDL A N L+D ++  K+SDFGM R    DQ        VGT     + A
Sbjct: 121 ---ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY----VSSVGTKFPVKWSA 173

Query: 518 PEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           PE   + ++S KSDV++FG+L+ E+ +
Sbjct: 174 PEVFHYFKYSSKSDVWAFGILMWEVFS 200

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  167 bits (424), Expect = 3e-47
 Identities = 64/206 (31%), Positives = 104/206 (50%), Gaps = 21/206 (10%)

Query: 351 NKLGEGGFGEVYKGVLP-----SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVR 405
           ++LG+G FG V           +G  +AVK+L  +      +F+ E+ ++  L    +V+
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88

Query: 406 LLGFCLEGEEK--ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
             G       +   LV E++P+  L  FL     + +LD SR       I +G+ YL   
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLGS- 145

Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ-----TQGNTSRIVGTYGYMAP 518
              R +HRDL A NIL+++E + KI+DFG+A++  +D+      +   S I     + AP
Sbjct: 146 --RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPI----FWYAP 199

Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIIT 544
           E      FS +SDV+SFGV++ E+ T
Sbjct: 200 ESLSDNIFSRQSDVWSFGVVLYELFT 225

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  165 bits (421), Expect = 4e-47
 Identities = 68/223 (30%), Positives = 96/223 (43%), Gaps = 29/223 (13%)

Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL--PSGQEI--AVKRL---SKASGQGAEEFKNEVV 393
            +         KLG+G FG V +G    PSG+ +  AVK L     +  +  ++F  EV 
Sbjct: 14  LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVN 73

Query: 394 LVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQ---GQL-DWSRRYK 448
            +  L HRNL+RL G  L     + +V E  P  SL   L   +     G L  ++    
Sbjct: 74  AMHSLDHRNLIRLYGVVLT--PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--- 128

Query: 449 IIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR 508
               +A G+ YL      R IHRDL A N+LL      KI DFG+ R    +        
Sbjct: 129 ---QVAEGMGYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE 182

Query: 509 IVGT---YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKK 547
                  + + APE      FS  SD + FGV + E+ T G++
Sbjct: 183 --HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  165 bits (419), Expect = 5e-47
 Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 21/205 (10%)

Query: 350 DNKLGEGGFGEVYKGVLPSGQE---IAVKRLSK-ASGQGAEEFKNEVVLVAKLQHRNLVR 405
           D +LG G FG V +GV    ++   +A+K L +       EE   E  ++ +L +  +VR
Sbjct: 15  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74

Query: 406 LLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSR 465
           L+G C   E  +LV E      L  FL    K+ ++  S   +++  ++ G+ YL     
Sbjct: 75  LIGVCQA-EALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---EE 128

Query: 466 LRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG------YMAPE 519
              +HRDL A N+LL      KISDFG+++  G D +                  + APE
Sbjct: 129 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS-----AGKWPLKWYAPE 183

Query: 520 YAMHGQFSVKSDVYSFGVLVLEIIT 544
                +FS +SDV+S+GV + E ++
Sbjct: 184 CINFRKFSSRSDVWSYGVTMWEALS 208

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  166 bits (422), Expect = 7e-47
 Identities = 64/210 (30%), Positives = 108/210 (51%), Gaps = 23/210 (10%)

Query: 350 DNKLGEGGFGEVYKGVLPSGQE-----IAVKRLSKASGQGA-EEFKNEVVLVAKLQHRNL 403
              LG G FG VYKG+     E     +A+K L +A+   A +E  +E  ++A + + ++
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
            RLLG CL      L+ + +P   L  ++   E +  +           IA+G+ YL   
Sbjct: 80  CRLLGICLT-STVQLITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMNYL--- 133

Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG-----YMAP 518
              R++HRDL A N+L+    + KI+DFG+A++ G ++ + +        G     +MA 
Sbjct: 134 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPIKWMAL 188

Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIIT-GKK 547
           E  +H  ++ +SDV+S+GV V E++T G K
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSK 218

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  164 bits (418), Expect = 8e-47
 Identities = 58/221 (26%), Positives = 102/221 (46%), Gaps = 28/221 (12%)

Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL--------PSGQEIAVKRLSKASGQGAEEFKNEV 392
           ++       +  LG+G F +++KGV             E+ +K L KA    +E F    
Sbjct: 4   KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAA 63

Query: 393 VLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGG 452
            +++KL H++LV   G C+ G+E ILV EFV   SLD +L   + +  ++   + ++   
Sbjct: 64  SMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLK--KNKNCINILWKLEVAKQ 121

Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNP--------KISDFGMARIFGVDQTQG 504
           +A  + +L       +IH ++ A NILL  E +         K+SD G++    V     
Sbjct: 122 LAAAMHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT--VLPKDI 176

Query: 505 NTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIIT 544
              RI     ++ PE   +    ++ +D +SFG  + EI +
Sbjct: 177 LQERI----PWVPPECIENPKNLNLATDKWSFGTTLWEICS 213

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  164 bits (417), Expect = 9e-47
 Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 25/211 (11%)

Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
            +   +      +G+G FG+V  G    G ++AVK +   +   A+ F  E  ++ +L+H
Sbjct: 17  ALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIK--NDATAQAFLAEASVMTQLRH 73

Query: 401 RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
            NLV+LLG  +E +  + +V E++   SL  +L    +   L      K    +   + Y
Sbjct: 74  SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEY 132

Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG----- 514
           L        +HRDL A N+L+  +   K+SDFG+ +    + +                 
Sbjct: 133 L---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EAS-------STQDTGKLPV 178

Query: 515 -YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
            + APE     +FS KSDV+SFG+L+ EI +
Sbjct: 179 KWTAPEALREKKFSTKSDVWSFGILLWEIYS 209

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  168 bits (427), Expect = 2e-46
 Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 25/211 (11%)

Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
            +   +      +G+G FG+V  G    G ++AVK +   +   A+ F  E  ++ +L+H
Sbjct: 189 ALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRH 245

Query: 401 RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
            NLV+LLG  +E +  + +V E++   SL  +L    +   L      K    +   + Y
Sbjct: 246 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEY 304

Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG----- 514
           L        +HRDL A N+L+  +   K+SDFG+ +                        
Sbjct: 305 L---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----------EASSTQDTGKLPV 350

Query: 515 -YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
            + APE     +FS KSDV+SFG+L+ EI +
Sbjct: 351 KWTAPEALREKKFSTKSDVWSFGILLWEIYS 381

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  164 bits (418), Expect = 2e-46
 Identities = 69/228 (30%), Positives = 112/228 (49%), Gaps = 33/228 (14%)

Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL----PSGQEI--AVKRLSKASGQGAEEFKNEVVL 394
            +         +LGEG FG+V+        P   ++  AVK L +AS    ++F+ E  L
Sbjct: 37  HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAEL 96

Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL------------YDPEKQGQLD 442
           +  LQH+++VR  G C EG   ++V+E++ +  L+ FL             +    G L 
Sbjct: 97  LTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLG 156

Query: 443 WSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVDQ 501
             +   +   +A G++YL   + L  +HRDL   N L+   +  KI DFGM+R I+  D 
Sbjct: 157 LGQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY 213

Query: 502 TQGNTSRIVGTYG-----YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
            +      VG        +M PE  ++ +F+ +SDV+SFGV++ EI T
Sbjct: 214 YR------VGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  164 bits (417), Expect = 3e-46
 Identities = 68/261 (26%), Positives = 107/261 (40%), Gaps = 27/261 (10%)

Query: 322 NADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVL-----PSGQEIAVKR 376
           +    L  L     D  T             LGEG FG+V           +G+ +AVK 
Sbjct: 10  HHHGALEVLFQGPGD-PT-VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKA 67

Query: 377 L-SKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEK--ILVYEFVPNKSLDYFLY 433
           L + A  Q    +K E+ ++  L H ++++  G C +       LV E+VP  SL  +L 
Sbjct: 68  LKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL- 126

Query: 434 DPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493
               +  +  ++       I  G+ YLH       IHRDL A N+LLD +   KI DFG+
Sbjct: 127 ---PRHSIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGL 180

Query: 494 ARIFGVDQ-----TQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKK 547
           A+            +   S +     + APE     +F   SDV+SFGV + E++T    
Sbjct: 181 AKAVPEGHEYYRVREDGDSPV----FWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDS 236

Query: 548 NSNFYQTDGAADLLSYVSINV 568
           + +          ++   + V
Sbjct: 237 SQSPPTKFLELIGIAQGQMTV 257

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  163 bits (415), Expect = 3e-46
 Identities = 67/229 (29%), Positives = 110/229 (48%), Gaps = 34/229 (14%)

Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSKASGQGAEEFKNEVVL 394
            +         +LGEG FG+V+               +AVK L   +    ++F+ E  L
Sbjct: 11  HIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAEL 70

Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL-------------YDPEKQGQL 441
           +  LQH ++V+  G C +G+  I+V+E++ +  L+ FL                + +G+L
Sbjct: 71  LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 130

Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVD 500
             S+   I   IA G++YL   +    +HRDL   N L+ A +  KI DFGM+R ++  D
Sbjct: 131 GLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD 187

Query: 501 QTQGNTS-----RIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
             +         R      +M PE  M+ +F+ +SDV+SFGV++ EI T
Sbjct: 188 YYRVGGHTMLPIR------WMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  162 bits (413), Expect = 3e-46
 Identities = 71/206 (34%), Positives = 110/206 (53%), Gaps = 11/206 (5%)

Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
           EV         +LG G FGEV+ G      ++AVK L K      + F  E  L+ +LQH
Sbjct: 9   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQH 67

Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
           + LVRL     + E   ++ E++ N SL  FL  P    +L  ++   +   IA G+ ++
Sbjct: 68  QRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDMAAQIAEGMAFI 125

Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGY--MAP 518
                   IHRDL+A+NIL+   ++ KI+DFG+AR+   ++    T+R    +     AP
Sbjct: 126 ---EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY---TAREGAKFPIKWTAP 179

Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIIT 544
           E   +G F++KSDV+SFG+L+ EI+T
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVT 205

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  162 bits (412), Expect = 5e-46
 Identities = 62/211 (29%), Positives = 104/211 (49%), Gaps = 16/211 (7%)

Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL--PSGQEI--AVKRLSK-ASGQGAEEFKNEVVLV 395
            +A      +  LGEG FGEVY+GV     G++I  AVK   K  +    E+F +E V++
Sbjct: 8   GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIM 67

Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
             L H ++V+L+G   E E   ++ E  P   L ++L     +  L           I +
Sbjct: 68  KNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICK 124

Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVDQTQGNTSRI-VGTY 513
            + YL     +  +HRD+   NIL+ +    K+ DFG++R I   D  + + +R+ +   
Sbjct: 125 AMAYL---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK-- 179

Query: 514 GYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
            +M+PE     +F+  SDV+ F V + EI++
Sbjct: 180 -WMSPESINFRRFTTASDVWMFAVCMWEILS 209

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  163 bits (414), Expect = 9e-46
 Identities = 60/219 (27%), Positives = 100/219 (45%), Gaps = 30/219 (13%)

Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQE-----IAVKRLSKASGQGA-EEFKNEVVL 394
                +      LG G FG V+KGV     E     + +K +   SG+ + +   + ++ 
Sbjct: 9   IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLA 68

Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQ---GQL-DWSRRYKII 450
           +  L H ++VRLLG C       LV +++P  SL   +           L +W       
Sbjct: 69  IGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGV----- 122

Query: 451 GGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIV 510
             IA+G+ YL       ++HR+L A N+LL +    +++DFG+A +   D  Q   S   
Sbjct: 123 -QIAKGMYYL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE-- 176

Query: 511 GTYG-----YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
                    +MA E    G+++ +SDV+S+GV V E++T
Sbjct: 177 ---AKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  161 bits (410), Expect = 1e-45
 Identities = 53/210 (25%), Positives = 96/210 (45%), Gaps = 14/210 (6%)

Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL--PSGQEI--AVKRLSK-ASGQGAEEFKNEVVLV 395
           E+   +      +GEG FG+V++G+   P    +  A+K      S    E+F  E + +
Sbjct: 11  EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 70

Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
            +  H ++V+L+G   E     ++ E      L  FL   +    LD +        ++ 
Sbjct: 71  RQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLST 127

Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVDQTQGNTSRIVGTYG 514
            + YL      R +HRD+ A N+L+ +    K+ DFG++R +      + +  ++     
Sbjct: 128 ALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIK 182

Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           +MAPE     +F+  SDV+ FGV + EI+ 
Sbjct: 183 WMAPESINFRRFTSASDVWMFGVCMWEILM 212

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  161 bits (410), Expect = 1e-45
 Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 24/210 (11%)

Query: 350 DNKLGEGGFGEVYKGVLPSG---QEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLV 404
           D +LG G FG V KG        + +AVK L          +E   E  ++ +L +  +V
Sbjct: 22  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81

Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
           R++G C   E  +LV E      L+ +L   ++   +      +++  ++ G+ YL    
Sbjct: 82  RMIGICE-AESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYL---E 134

Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG------YMAP 518
               +HRDL A N+LL  +   KISDFG+++    D+                   + AP
Sbjct: 135 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT-----HGKWPVKWYAP 189

Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIIT-GKK 547
           E   + +FS KSDV+SFGVL+ E  + G+K
Sbjct: 190 ECINYYKFSSKSDVWSFGVLMWEAFSYGQK 219

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  165 bits (420), Expect = 2e-45
 Identities = 68/206 (33%), Positives = 105/206 (50%), Gaps = 11/206 (5%)

Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
           E+       + KLG G FGEV+        ++AVK + K      E F  E  ++  LQH
Sbjct: 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQH 242

Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
             LV+L     + E   ++ EF+   SL  FL   E   +    +       IA G+ ++
Sbjct: 243 DKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGS-KQPLPKLIDFSAQIAEGMAFI 300

Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGY--MAP 518
               +   IHRDL+A+NIL+ A +  KI+DFG+AR+   ++    T+R    +     AP
Sbjct: 301 ---EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY---TAREGAKFPIKWTAP 354

Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIIT 544
           E    G F++KSDV+SFG+L++EI+T
Sbjct: 355 EAINFGSFTIKSDVWSFGILLMEIVT 380

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  166 bits (422), Expect = 2e-45
 Identities = 67/219 (30%), Positives = 113/219 (51%), Gaps = 9/219 (4%)

Query: 328 TTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAE 386
            T+  +  +++  E+     +  +KLG G +GEVY+GV       +AVK L K      E
Sbjct: 203 PTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVE 261

Query: 387 EFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRR 446
           EF  E  ++ +++H NLV+LLG C       ++ EF+   +L  +L +  +Q ++     
Sbjct: 262 EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVL 320

Query: 447 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ-TQGN 505
             +   I+  + YL    +   IHR+L A N L+      K++DFG++R+   D  T   
Sbjct: 321 LYMATQISSAMEYL---EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 377

Query: 506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
            ++      + APE   + +FS+KSDV++FGVL+ EI T
Sbjct: 378 GAKF--PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 414

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  160 bits (408), Expect = 2e-45
 Identities = 72/230 (31%), Positives = 119/230 (51%), Gaps = 35/230 (15%)

Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSK-ASGQGAEEFKNEVV 393
           E++ +      +LGE  FG+VYKG L         Q +A+K L   A G   EEF++E +
Sbjct: 5   EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAM 64

Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL-------------YDPEKQGQ 440
           L A+LQH N+V LLG   + +   +++ +  +  L  FL              D   +  
Sbjct: 65  LRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSA 124

Query: 441 LDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGV 499
           L+      ++  IA G+ YL   S   ++H+DL   N+L+  ++N KISD G+ R ++  
Sbjct: 125 LEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAA 181

Query: 500 D--QTQGNTS---RIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           D  +  GN+    R      +MAPE  M+G+FS+ SD++S+GV++ E+ +
Sbjct: 182 DYYKLLGNSLLPIR------WMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  160 bits (407), Expect = 9e-45
 Identities = 72/224 (32%), Positives = 101/224 (45%), Gaps = 29/224 (12%)

Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSK-ASGQGAEEFKNEVV 393
           EV     +    LG G FGEVY+G +      PS  ++AVK L +  S Q   +F  E +
Sbjct: 26  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 85

Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL----YDPEKQGQLDWSRRYKI 449
           +++K  H+N+VR +G  L+   + ++ E +    L  FL      P +   L       +
Sbjct: 86  IISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 145

Query: 450 IGGIARGILYLHEDSRLRIIHRDLKASNILLDAE---MNPKISDFGMAR-IFGVDQTQGN 505
              IA G  YL        IHRD+ A N LL         KI DFGMAR I+     +  
Sbjct: 146 ARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR-- 200

Query: 506 TSRIVGTYGY-----MAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
                G         M PE  M G F+ K+D +SFGVL+ EI +
Sbjct: 201 ----KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  159 bits (404), Expect = 1e-44
 Identities = 64/217 (29%), Positives = 101/217 (46%), Gaps = 21/217 (9%)

Query: 340 IEVATNKFSTDNKLGEGGFGEVYKGVL--PSGQEI--AVKRLSK-ASGQGAEEFKNEVVL 394
           I  ++     +  +G G FG VY G L    G++I  AVK L++        +F  E ++
Sbjct: 20  IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII 79

Query: 395 VAKLQHRNLVRLLGFCLEGEEKIL-VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGI 453
           +    H N++ LLG CL  E   L V  ++ +  L  F+ +                  +
Sbjct: 80  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQV 137

Query: 454 ARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTY 513
           A+G+ YL      + +HRDL A N +LD +   K++DFG+AR    D        +    
Sbjct: 138 AKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKT 190

Query: 514 G------YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           G      +MA E     +F+ KSDV+SFGVL+ E++T
Sbjct: 191 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 227

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  159 bits (405), Expect = 1e-44
 Identities = 69/224 (30%), Positives = 109/224 (48%), Gaps = 29/224 (12%)

Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSK-ASGQGAEEFKNEVV 393
           EVA  K +   +LG+G FG VY+GV            +A+K +++ AS +   EF NE  
Sbjct: 21  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 80

Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL-------YDPEKQGQLDWSRR 446
           ++ +    ++VRLLG   +G+  +++ E +    L  +L        +         S+ 
Sbjct: 81  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 140

Query: 447 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVDQTQGN 505
            ++ G IA G+ YL+     + +HRDL A N ++  +   KI DFGM R I+  D  +  
Sbjct: 141 IQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR-- 195

Query: 506 TSRIVGTYGY-----MAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
                G  G      M+PE    G F+  SDV+SFGV++ EI T
Sbjct: 196 ----KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  158 bits (403), Expect = 2e-44
 Identities = 69/231 (29%), Positives = 109/231 (47%), Gaps = 23/231 (9%)

Query: 331 ESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVL--PSGQEI--AVKRLSK--ASGQG 384
           E LQ   E + +  N       LGEG FG V +G L    G  +  AVK +    +S + 
Sbjct: 20  EELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQRE 79

Query: 385 AEEFKNEVVLVAKLQHRNLVRLLGFCLEGE-----EKILVYEFVPNKSLDYFL---YDPE 436
            EEF +E   +    H N++RLLG C+E       + +++  F+    L  +L       
Sbjct: 80  IEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLET 139

Query: 437 KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR- 495
               +      K +  IA G+ YL   S    +HRDL A N +L  +M   ++DFG+++ 
Sbjct: 140 GPKHIPLQTLLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKK 196

Query: 496 IFGVDQ-TQGNTSRI-VGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           I+  D   QG  +++ V    ++A E      ++ KSDV++FGV + EI T
Sbjct: 197 IYSGDYYRQGRIAKMPV---KWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  159 bits (404), Expect = 2e-44
 Identities = 63/211 (29%), Positives = 108/211 (51%), Gaps = 22/211 (10%)

Query: 345 NKFSTDNKLGEGGFGEVYKGVLPSGQE-----IAVKRLSKASGQGA-EEFKNEVVLVAKL 398
            +F     LG G FG VYKG+     E     +A+K L +A+   A +E  +E  ++A +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74

Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGIL 458
            + ++ RLLG CL      L+ + +P   L  ++   E +  +           IA+G+ 
Sbjct: 75  DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMN 131

Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG---- 514
           YL      R++HRDL A N+L+    + KI+DFG+A++ G ++ + +        G    
Sbjct: 132 YL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPI 183

Query: 515 -YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
            +MA E  +H  ++ +SDV+S+GV V E++T
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  165 bits (419), Expect = 3e-44
 Identities = 61/203 (30%), Positives = 97/203 (47%), Gaps = 15/203 (7%)

Query: 349 TDNKLGEGGFGEVYKGVL-PSGQEI--AVKRL-SKASGQGAEEFKNEVVLVAKLQHRNLV 404
            D +LG G FG V +GV     ++I  A+K L         EE   E  ++ +L +  +V
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 399

Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
           RL+G C   E  +LV E      L  FL    K+ ++  S   +++  ++ G+ YL    
Sbjct: 400 RLIGVCQA-EALMLVMEMAGGGPLHKFLV--GKREEIPVSNVAELLHQVSMGMKYL---E 453

Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT---YGYMAPEYA 521
               +HR+L A N+LL      KISDFG+++  G D +               + APE  
Sbjct: 454 EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR--SAGKWPLKWYAPECI 511

Query: 522 MHGQFSVKSDVYSFGVLVLEIIT 544
              +FS +SDV+S+GV + E ++
Sbjct: 512 NFRKFSSRSDVWSYGVTMWEALS 534

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  158 bits (401), Expect = 3e-44
 Identities = 61/207 (29%), Positives = 96/207 (46%), Gaps = 21/207 (10%)

Query: 350 DNKLGEGGFGEVYKGVLPSGQE----IAVKRLSK-ASGQGAEEFKNEVVLVAKLQHRNLV 404
           D  +G+G FG VY G      +     A+K LS+    Q  E F  E +L+  L H N++
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85

Query: 405 RLLGFCLEGEEKIL-VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
            L+G  L  E     +  ++ +  L  F+  P++               +ARG+ YL   
Sbjct: 86  ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN--PTVKDLISFGLQVARGMEYL--- 140

Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVDQTQGNTSRIVGTYG-----YMA 517
           +  + +HRDL A N +LD     K++DFG+AR I   +            +      + A
Sbjct: 141 AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQ----HRHARLPVKWTA 196

Query: 518 PEYAMHGQFSVKSDVYSFGVLVLEIIT 544
            E     +F+ KSDV+SFGVL+ E++T
Sbjct: 197 LESLQTYRFTTKSDVWSFGVLLWELLT 223

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  159 bits (404), Expect = 6e-44
 Identities = 72/224 (32%), Positives = 101/224 (45%), Gaps = 29/224 (12%)

Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSK-ASGQGAEEFKNEVV 393
           EV     +    LG G FGEVY+G +      PS  ++AVK L +  S Q   +F  E +
Sbjct: 67  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 126

Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL----YDPEKQGQLDWSRRYKI 449
           +++K  H+N+VR +G  L+   + ++ E +    L  FL      P +   L       +
Sbjct: 127 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 186

Query: 450 IGGIARGILYLHEDSRLRIIHRDLKASNILLDAE---MNPKISDFGMAR-IFGVDQTQGN 505
              IA G  YL        IHRD+ A N LL         KI DFGMAR I+     +  
Sbjct: 187 ARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR-- 241

Query: 506 TSRIVGTYGY-----MAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
                G         M PE  M G F+ K+D +SFGVL+ EI +
Sbjct: 242 ----KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  157 bits (400), Expect = 6e-44
 Identities = 67/232 (28%), Positives = 108/232 (46%), Gaps = 24/232 (10%)

Query: 331 ESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVL----PSGQEIAVKRLSK--ASGQG 384
           + L+   E + +   +F+    LG+G FG V +  L     S  ++AVK L     +   
Sbjct: 9   DELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSD 68

Query: 385 AEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI------LVYEFVPNKSLDYFL---YDP 435
            EEF  E   + +  H ++ +L+G  L    K       ++  F+ +  L  FL      
Sbjct: 69  IEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIG 128

Query: 436 EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
           E    L      + +  IA G+ YL   S    IHRDL A N +L  +M   ++DFG++R
Sbjct: 129 ENPFNLPLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR 185

Query: 496 -IFGVDQ-TQGNTSRI-VGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
            I+  D   QG  S++ V    ++A E      ++V SDV++FGV + EI+T
Sbjct: 186 KIYSGDYYRQGCASKLPV---KWLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  158 bits (402), Expect = 1e-43
 Identities = 74/301 (24%), Positives = 122/301 (40%), Gaps = 30/301 (9%)

Query: 264 LSPPPPGSVTTSRGKSGISSSTIIAIVAPIAVTAVLFILGFCFLRRKAKKKYNAVPESNA 323
           +SP  P             +S    I+ P     +  I     L     KK  +      
Sbjct: 1   MSPIDPMGHHHHH-HGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQ 59

Query: 324 DNDLTTLESLQFDFET--------IEVATNKFSTDNKLGEGGFGEVYKGVL--PSGQEI- 372
             +   ++    + E         I  ++     +  +G G FG VY G L    G++I 
Sbjct: 60  GANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIH 119

Query: 373 -AVKRLSK-ASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL-VYEFVPNKSLD 429
            AVK L++        +F  E +++    H N++ LLG CL  E   L V  ++ +  L 
Sbjct: 120 CAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 179

Query: 430 YFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKIS 489
            F+ +                  +A+G+ +L   +  + +HRDL A N +LD +   K++
Sbjct: 180 NFIRNET--HNPTVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVA 234

Query: 490 DFGMARIFGVDQTQGNTSRIVGTYG------YMAPEYAMHGQFSVKSDVYSFGVLVLEII 543
           DFG+AR    D        +    G      +MA E     +F+ KSDV+SFGVL+ E++
Sbjct: 235 DFGLAR----DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 290

Query: 544 T 544
           T
Sbjct: 291 T 291

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  159 bits (405), Expect = 2e-43
 Identities = 67/204 (32%), Positives = 107/204 (52%), Gaps = 7/204 (3%)

Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
           E+       + KLG+G FGEV+ G       +A+K L K      E F  E  ++ KL+H
Sbjct: 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRH 238

Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
             LV+L     E E   +V E++   SL  FL     +  L   +   +   IA G+ Y+
Sbjct: 239 EKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYV 296

Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEY 520
               R+  +HRDL+A+NIL+   +  K++DFG+AR+   ++             + APE 
Sbjct: 297 ---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEA 352

Query: 521 AMHGQFSVKSDVYSFGVLVLEIIT 544
           A++G+F++KSDV+SFG+L+ E+ T
Sbjct: 353 ALYGRFTIKSDVWSFGILLTELTT 376

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  155 bits (395), Expect = 3e-43
 Identities = 60/234 (25%), Positives = 104/234 (44%), Gaps = 23/234 (9%)

Query: 328 TTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKR--LSKASGQGA 385
             L +    F+++ V    +S   ++G GG  +V++ +    Q  A+K   L +A  Q  
Sbjct: 11  VDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTL 70

Query: 386 EEFKNEVVLVAKLQHRNL--VRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDW 443
           + ++NE+  + KLQ  +   +RL  + +  +   +V E   N  L+ +L   +K+  +D 
Sbjct: 71  DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWL---KKKKSIDP 126

Query: 444 SRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ 503
             R      +   +  +H+     I+H DLK +N L+  +   K+ DFG+A     D T 
Sbjct: 127 WERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 182

Query: 504 GNTSRIVGTYGYMAPE-----------YAMHGQFSVKSDVYSFGVLVLEIITGK 546
                 VGT  YM PE                + S KSDV+S G ++  +  GK
Sbjct: 183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  160 bits (406), Expect = 6e-43
 Identities = 67/209 (32%), Positives = 107/209 (51%), Gaps = 17/209 (8%)

Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
           E+       + KLG+G FGEV+ G       +A+K L K      E F  E  ++ KL+H
Sbjct: 263 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRH 321

Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQG-----QLDWSRRYKIIGGIAR 455
             LV+L     E E   +V E++   SL  FL     +       +D +        IA 
Sbjct: 322 EKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA------QIAS 374

Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGY 515
           G+ Y+    R+  +HRDL+A+NIL+   +  K++DFG+AR+   ++             +
Sbjct: 375 GMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKW 430

Query: 516 MAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
            APE A++G+F++KSDV+SFG+L+ E+ T
Sbjct: 431 TAPEAALYGRFTIKSDVWSFGILLTELTT 459

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  154 bits (392), Expect = 2e-42
 Identities = 60/225 (26%), Positives = 101/225 (44%), Gaps = 25/225 (11%)

Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSK--ASGQGAEEFKNEVVLV 395
           E I V    +S   ++G GG  +V++ +    Q  A+K ++   A  Q  + ++NE+  +
Sbjct: 2   ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 61

Query: 396 AKLQHRNL--VRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGG 452
            KLQ  +   +RL  +    ++ I +V E   N  L+ +L   +K+  +D   R      
Sbjct: 62  NKLQQHSDKIIRLYDY-EITDQYIYMVMECG-NIDLNSWL---KKKKSIDPWERKSYWKN 116

Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
           +   +  +H+     I+H DLK +N L+  +   K+ DFG+A     D T       VGT
Sbjct: 117 MLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGT 172

Query: 513 YGYMAPE-----------YAMHGQFSVKSDVYSFGVLVLEIITGK 546
             YM PE                + S KSDV+S G ++  +  GK
Sbjct: 173 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  154 bits (391), Expect = 2e-42
 Identities = 64/233 (27%), Positives = 105/233 (45%), Gaps = 38/233 (16%)

Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLP--------SGQEIAVKRL-SKASGQGAEEFKNE 391
           E   +K +    LGEG FG+V                  +AVK L   A+ +   +  +E
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90

Query: 392 VVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL-------------YDPEK 437
           + ++  + +H+N++ LLG C +     ++ E+    +L  +L              +   
Sbjct: 91  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 150

Query: 438 QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-I 496
           + Q+ +         +ARG+ YL   +  + IHRDL A N+L+      KI+DFG+AR I
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDI 207

Query: 497 FGVDQTQGNTSRIVGTYG-----YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
             +D           T G     +MAPE      ++ +SDV+SFGVL+ EI T
Sbjct: 208 NNID------YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  153 bits (389), Expect = 3e-42
 Identities = 65/225 (28%), Positives = 100/225 (44%), Gaps = 30/225 (13%)

Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQE---IAVKRL-SKASGQGAEEFKNEVVLVA 396
            +  N     + +GEG FG+V K  +         A+KR+   AS     +F  E+ ++ 
Sbjct: 21  VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLC 80

Query: 397 KL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL-------------YDPEKQGQLD 442
           KL  H N++ LLG C       L  E+ P+ +L  FL                     L 
Sbjct: 81  KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 140

Query: 443 WSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502
             +       +ARG+ YL   S+ + IHRDL A NIL+      KI+DFG++R   V   
Sbjct: 141 SQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK 197

Query: 503 QGNTS---RIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           +       R      +MA E   +  ++  SDV+S+GVL+ EI++
Sbjct: 198 KTMGRLPVR------WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  154 bits (391), Expect = 4e-42
 Identities = 64/233 (27%), Positives = 105/233 (45%), Gaps = 38/233 (16%)

Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL--------PSGQEIAVKRL-SKASGQGAEEFKNE 391
           E   +K +    LGEG FG+V                  +AVK L   A+ +   +  +E
Sbjct: 77  EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 136

Query: 392 VVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL-------------YDPEK 437
           + ++  + +H+N++ LLG C +     ++ E+    +L  +L              +   
Sbjct: 137 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 196

Query: 438 QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-I 496
           + Q+ +         +ARG+ YL   +  + IHRDL A N+L+      KI+DFG+AR I
Sbjct: 197 EEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDI 253

Query: 497 FGVDQTQGNTSRIVGTYG-----YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
             +D           T G     +MAPE      ++ +SDV+SFGVL+ EI T
Sbjct: 254 NNID------YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  153 bits (388), Expect = 4e-42
 Identities = 73/272 (26%), Positives = 110/272 (40%), Gaps = 50/272 (18%)

Query: 308 RRKAKKKYN---AVPESNADNDLTTLESLQFDF-ETIEVATNKFSTDNKLGEGGFGEVYK 363
           + K K KY     + ES   N  T ++  Q  + E  E   N       LG G FG+V +
Sbjct: 5   KYKQKPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVE 64

Query: 364 GVL------PSGQEIAVKRL-SKASGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEE 415
                     +  ++AVK L S A     E   +E+ +++ L QH N+V LLG C  G  
Sbjct: 65  ATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124

Query: 416 KILVYEFVPNKSLDYFL-----------YDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
            +++ E+     L  FL                               +A+G+ +L   +
Sbjct: 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFL---A 181

Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGY--------- 515
               IHRD+ A N+LL      KI DFG+AR             I+    Y         
Sbjct: 182 SKNCIHRDVAARNVLLTNGHVAKIGDFGLARD------------IMNDSNYIVKGNARLP 229

Query: 516 ---MAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
              MAPE      ++V+SDV+S+G+L+ EI +
Sbjct: 230 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  153 bits (389), Expect = 5e-42
 Identities = 66/238 (27%), Positives = 109/238 (45%), Gaps = 43/238 (18%)

Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSG------QEIAVKRL-SKASGQGAEEFKNEVV 393
           E   N       +GEG FG V++   P          +AVK L  +AS     +F+ E  
Sbjct: 43  EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 102

Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL--------------------- 432
           L+A+  + N+V+LLG C  G+   L++E++    L+ FL                     
Sbjct: 103 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 162

Query: 433 YDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 492
                   L  + +  I   +A G+ YL   S  + +HRDL   N L+   M  KI+DFG
Sbjct: 163 VSSPGPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFG 219

Query: 493 MAR-IFGVD--QTQGNTS---RIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           ++R I+  D  +  GN +   R      +M PE   + +++ +SDV+++GV++ EI +
Sbjct: 220 LSRNIYSADYYKADGNDAIPIR------WMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  152 bits (386), Expect = 6e-42
 Identities = 64/242 (26%), Positives = 104/242 (42%), Gaps = 37/242 (15%)

Query: 331 ESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRL-SKASGQ 383
           E L +D    E   ++      LG G FG+V +          + + +AVK L   A+  
Sbjct: 13  ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 72

Query: 384 GAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILV-YEFVPNKSLDYFL--------- 432
                 +E+ ++  +  H N+V LLG C +    ++V  EF    +L  +L         
Sbjct: 73  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 132

Query: 433 ----YDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKI 488
                +   +  L           +A+G+ +L   +  + IHRDL A NILL  +   KI
Sbjct: 133 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKI 189

Query: 489 SDFGMAR-IFGVDQTQGNTSRIVGTYG-----YMAPEYAMHGQFSVKSDVYSFGVLVLEI 542
            DFG+AR I+           +          +MAPE      ++++SDV+SFGVL+ EI
Sbjct: 190 CDFGLARDIYKDP------DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243

Query: 543 IT 544
            +
Sbjct: 244 FS 245

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  159 bits (403), Expect = 7e-42
 Identities = 53/210 (25%), Positives = 98/210 (46%), Gaps = 14/210 (6%)

Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL--PSGQEI--AVKRL-SKASGQGAEEFKNEVVLV 395
           E+   +      +GEG FG+V++G+   P    +  A+K   +  S    E+F  E + +
Sbjct: 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 445

Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
            +  H ++V+L+G   E     ++ E      L  FL    ++  LD +        ++ 
Sbjct: 446 RQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQ--VRKFSLDLASLILYAYQLST 502

Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVDQTQGNTSRIVGTYG 514
            + YL      R +HRD+ A N+L+ +    K+ DFG++R +      + +  ++     
Sbjct: 503 ALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIK 557

Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           +MAPE     +F+  SDV+ FGV + EI+ 
Sbjct: 558 WMAPESINFRRFTSASDVWMFGVCMWEILM 587

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  151 bits (383), Expect = 2e-41
 Identities = 63/239 (26%), Positives = 96/239 (40%), Gaps = 50/239 (20%)

Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRL-SKASGQGAEEFKNEVV 393
           E   N+ S    LG G FG+V +          +   +AVK L   A     E   +E+ 
Sbjct: 19  EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 78

Query: 394 LVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL---------------YDPEK 437
           +++ L  H N+V LLG C  G   +++ E+     L  FL                  + 
Sbjct: 79  VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138

Query: 438 QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497
           +  LD          +A+G+ +L   +    IHRDL A NILL      KI DFG+AR  
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARD- 194

Query: 498 GVDQTQGNTSRIVGTYGY------------MAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
                      I     Y            MAPE   +  ++ +SDV+S+G+ + E+ +
Sbjct: 195 -----------IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  151 bits (383), Expect = 2e-41
 Identities = 62/238 (26%), Positives = 101/238 (42%), Gaps = 43/238 (18%)

Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRL-SKASGQGAEEFKNEVV 393
           E           LGEG FG+V K              +AVK L   AS     +  +E  
Sbjct: 19  EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFN 78

Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYD--PEKQGQLDWSRRYKIIG 451
           ++ ++ H ++++L G C +    +L+ E+    SL  FL +      G L          
Sbjct: 79  VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138

Query: 452 G-------------------IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 492
                               I++G+ YL   + ++++HRDL A NIL+      KISDFG
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFG 195

Query: 493 MAR-IFGVDQTQGNTS-----RIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           ++R ++  D     +      +      +MA E      ++ +SDV+SFGVL+ EI+T
Sbjct: 196 LSRDVYEEDSYVKRSQGRIPVK------WMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  150 bits (380), Expect = 2e-41
 Identities = 57/205 (27%), Positives = 96/205 (46%), Gaps = 17/205 (8%)

Query: 350 DNKLGEGGFGEVYKGV-LPSGQEIAVK--RLSKASGQGAEEFKNEVVLVAKLQHRNLVRL 406
           D ++G G F  VYKG+   +  E+A    +  K +    + FK E  ++  LQH N+VR 
Sbjct: 31  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90

Query: 407 LGFCLEGEEK----ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
                   +     +LV E + + +L  +L   ++   +           I +G+ +LH 
Sbjct: 91  YDSWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHT 147

Query: 463 DSRLRIIHRDLKASNILLDAEM-NPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYA 521
            +   IIHRDLK  NI +     + KI D G+A +    +       ++GT  +MAPE  
Sbjct: 148 RTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEFMAPEM- 201

Query: 522 MHGQFSVKSDVYSFGVLVLEIITGK 546
              ++    DVY+FG+ +LE+ T +
Sbjct: 202 YEEKYDESVDVYAFGMCMLEMATSE 226

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  151 bits (382), Expect = 3e-41
 Identities = 64/246 (26%), Positives = 101/246 (41%), Gaps = 20/246 (8%)

Query: 308 RRKAKKKYNAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGV-L 366
              + K     PE+  +  +   E L+          +  +   ++G G FGEV++    
Sbjct: 21  SSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDK 80

Query: 367 PSGQEIAVK--RLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVP 424
            +G + AVK  RL             E+V  A L    +V L G   EG    +  E + 
Sbjct: 81  QTGFQCAVKKVRLEVFR-------VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLE 133

Query: 425 NKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM 484
             SL   +   ++ G L   R    +G    G+ YLH     RI+H D+KA N+LL ++ 
Sbjct: 134 GGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDG 187

Query: 485 NP-KISDFGMARIFGVDQTQGNTSR---IVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVL 540
           +   + DFG A     D    +      I GT  +MAPE  M      K D++S   ++L
Sbjct: 188 SRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMML 247

Query: 541 EIITGK 546
            ++ G 
Sbjct: 248 HMLNGC 253

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  151 bits (383), Expect = 6e-41
 Identities = 64/252 (25%), Positives = 110/252 (43%), Gaps = 26/252 (10%)

Query: 310 KAKKKYNAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSG 369
           K ++++   P+   D+D     S     E I V    +S   ++G GG  +V++ +    
Sbjct: 24  KFERQHMDSPDLGTDDDDKASSS---ANECISVKGRIYSILKQIGSGGSSKVFQVLNEKK 80

Query: 370 QEIAVKR--LSKASGQGAEEFKNEVVLVAKLQHRNL--VRLLGFCLEGEEKILVYEFVPN 425
           Q  A+K   L +A  Q  + ++NE+  + KLQ  +   +RL  + +  +   +V E   N
Sbjct: 81  QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-N 139

Query: 426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN 485
             L+ +L   +K+  +D   R      +   +  +H+     I+H DLK +N L+  +  
Sbjct: 140 IDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGM 192

Query: 486 PKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE-----------YAMHGQFSVKSDVYS 534
            K+ DFG+A     D T       VG   YM PE                + S KSDV+S
Sbjct: 193 LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWS 252

Query: 535 FGVLVLEIITGK 546
            G ++  +  GK
Sbjct: 253 LGCILYYMTYGK 264

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  149 bits (379), Expect = 1e-40
 Identities = 65/282 (23%), Positives = 109/282 (38%), Gaps = 56/282 (19%)

Query: 304 FCFLRRKAKKKYNAVPESNADNDLTTLESLQFDFETI-EVATNKFSTDNKLGEGGFGEVY 362
           +    R   +        ++DN+   ++  +++++   E           LG G FG+V 
Sbjct: 3   YKKQFRYESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVM 62

Query: 363 KGVL------PSGQEIAVKRL-SKASGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGE 414
                         ++AVK L  KA     E   +E+ ++ +L  H N+V LLG C    
Sbjct: 63  NATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122

Query: 415 EKILVYEFVPNKSLDYFL--------------------YDPEKQGQLDWSRRYKIIGGIA 454
              L++E+     L  +L                     + E    L +         +A
Sbjct: 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVA 182

Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
           +G+ +L        +HRDL A N+L+      KI DFG+AR             I+    
Sbjct: 183 KGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARD------------IMSDSN 227

Query: 515 Y------------MAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
           Y            MAPE    G +++KSDV+S+G+L+ EI +
Sbjct: 228 YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  150 bits (382), Expect = 1e-40
 Identities = 64/233 (27%), Positives = 108/233 (46%), Gaps = 38/233 (16%)

Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLP--------SGQEIAVKRL-SKASGQGAEEFKNE 391
           E+  ++      LGEG FG+V                 ++AVK L S A+ +   +  +E
Sbjct: 65  ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 124

Query: 392 VVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL-------------YDPEK 437
           + ++  + +H+N++ LLG C +     ++ E+    +L  +L                  
Sbjct: 125 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 184

Query: 438 QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-I 496
           + QL           +ARG+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR I
Sbjct: 185 EEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 241

Query: 497 FGVDQTQGNTS-----RIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
             +D  +  T+     +      +MAPE      ++ +SDV+SFGVL+ EI T
Sbjct: 242 HHIDYYKKTTNGRLPVK------WMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  145 bits (369), Expect = 8e-40
 Identities = 64/230 (27%), Positives = 105/230 (45%), Gaps = 14/230 (6%)

Query: 321 SNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSK 379
            + +      + L++D+E  E           LG+G +G VY G  L +   IA+K + +
Sbjct: 3   RSTEEGDCESDLLEYDYEYDENGDRVV-----LGKGTYGIVYAGRDLSNQVRIAIKEIPE 57

Query: 380 ASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQG 439
              + ++    E+ L   L+H+N+V+ LG   E     +  E VP  SL   L       
Sbjct: 58  RDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPL 117

Query: 440 QLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM-NPKISDFGMARIFG 498
           + +          I  G+ YLH++   +I+HRD+K  N+L++      KISDFG ++   
Sbjct: 118 KDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA 174

Query: 499 VDQTQGNTSRIVGTYGYMAPEYAMHGQ--FSVKSDVYSFGVLVLEIITGK 546
                  T    GT  YMAPE    G   +   +D++S G  ++E+ TGK
Sbjct: 175 GINPCTET--FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 222

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  144 bits (365), Expect = 2e-39
 Identities = 58/228 (25%), Positives = 98/228 (42%), Gaps = 36/228 (15%)

Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVL 394
           DF+ IE           +G GGFG+V+K      G+   +KR+   +    E+ + EV  
Sbjct: 12  DFKEIE----------LIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKA 57

Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLY---------------DPEKQG 439
           +AKL H N+V   G     +          ++S    L+               +  +  
Sbjct: 58  LAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE 117

Query: 440 QLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499
           +LD     ++   I +G+ Y+H     ++I+RDLK SNI L      KI DFG+      
Sbjct: 118 KLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSL-- 172

Query: 500 DQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKK 547
            +  G  +R  GT  YM+PE      +  + D+Y+ G+++ E++    
Sbjct: 173 -KNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD 219

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  144 bits (365), Expect = 4e-39
 Identities = 60/227 (26%), Positives = 95/227 (41%), Gaps = 29/227 (12%)

Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRN 402
            + F     LG+G FG+V K       +  A+K++     +      +EV+L+A L H+ 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63

Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYF---------LYD--PEKQGQLDWSRRYKIIG 451
           +VR     LE    +     V  KS  +          LYD    +         +++  
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123

Query: 452 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF------------GV 499
            I   + Y+H      IIHRDLK  NI +D   N KI DFG+A+               +
Sbjct: 124 QILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180

Query: 500 DQTQGNTSRIVGTYGYMAPE-YAMHGQFSVKSDVYSFGVLVLEIITG 545
             +  N +  +GT  Y+A E     G ++ K D+YS G++  E+I  
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  144 bits (365), Expect = 5e-39
 Identities = 55/221 (24%), Positives = 94/221 (42%), Gaps = 22/221 (9%)

Query: 342 VATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEE-FKNEVVLVAKLQ 399
            + + +   + LG+G    V++G    +G   A+K  +  S     +    E  ++ KL 
Sbjct: 6   TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65

Query: 400 HRNLVRLLGF--CLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGI 457
           H+N+V+L           K+L+ EF P  SL   L +P     L  S    ++  +  G+
Sbjct: 66  HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125

Query: 458 LYLHEDSRLRIIHRDLKASNILL----DAEMNPKISDFGMARIFGVDQTQGNTSRIVGTY 513
            +L E     I+HR++K  NI+     D +   K++DFG AR    D  Q  +  + GT 
Sbjct: 126 NHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVS--LYGTE 179

Query: 514 GYMAPE--------YAMHGQFSVKSDVYSFGVLVLEIITGK 546
            Y+ P+             ++    D++S GV      TG 
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  142 bits (361), Expect = 1e-38
 Identities = 58/207 (28%), Positives = 86/207 (41%), Gaps = 16/207 (7%)

Query: 346 KFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFK--NEVVLVAKL-QHR 401
            F   ++LG G +GEV+K      G+  AVKR         +  +   EV    K+ QH 
Sbjct: 58  SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117

Query: 402 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQ-LDWSRRYKIIGGIARGILYL 460
             VRL     EG    L  E     SL       E  G  L  ++ +  +      + +L
Sbjct: 118 CCVRLEQAWEEGGILYLQTELC-GPSLQQHC---EAWGASLPEAQVWGYLRDTLLALAHL 173

Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEY 520
           H      ++H D+K +NI L      K+ DFG+    G   T G      G   YMAPE 
Sbjct: 174 HS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG---TAGAGEVQEGDPRYMAPE- 226

Query: 521 AMHGQFSVKSDVYSFGVLVLEIITGKK 547
            + G +   +DV+S G+ +LE+    +
Sbjct: 227 LLQGSYGTAADVFSLGLTILEVACNME 253

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  142 bits (361), Expect = 2e-38
 Identities = 58/224 (25%), Positives = 92/224 (41%), Gaps = 19/224 (8%)

Query: 339 TIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAK 397
            + +    +    KLGEGGF  V     L  G   A+KR+     Q  EE + E  +   
Sbjct: 23  MVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRL 82

Query: 398 LQHRNLVRLLGFCLE----GEEKILVYEFVPNKSLDYFLYDPEKQGQ-LDWSRRYKIIGG 452
             H N++RL+ +CL       E  L+  F    +L   +   + +G  L   +   ++ G
Sbjct: 83  FNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLG 142

Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIV-- 510
           I RG+  +H        HRDLK +NILL  E  P + D G      +       +  +  
Sbjct: 143 ICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQD 199

Query: 511 -----GTYGYMAPE---YAMHGQFSVKSDVYSFGVLVLEIITGK 546
                 T  Y APE      H     ++DV+S G ++  ++ G+
Sbjct: 200 WAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  142 bits (360), Expect = 2e-38
 Identities = 54/207 (26%), Positives = 98/207 (47%), Gaps = 10/207 (4%)

Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEE---FKNEVVLVAKLQH 400
             F  + K+G G F EVY+   L  G  +A+K++       A+       E+ L+ +L H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQ-LDWSRRYKIIGGIARGILY 459
            N+++     +E  E  +V E      L   +   +KQ + +     +K    +   + +
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151

Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE 519
           +H     R++HRD+K +N+ + A    K+ D G+ R F    T  ++  +VGT  YM+PE
Sbjct: 152 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPE 206

Query: 520 YAMHGQFSVKSDVYSFGVLVLEIITGK 546
                 ++ KSD++S G L+ E+   +
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQ 233

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  143 bits (362), Expect = 3e-38
 Identities = 51/236 (21%), Positives = 104/236 (44%), Gaps = 23/236 (9%)

Query: 314 KYNAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEI 372
             + V     +    ++E     +  ++          K+GEG FG+         G++ 
Sbjct: 7   HSSGVDLGTENLYFQSME----KYVRLQ----------KIGEGSFGKAILVKSTEDGRQY 52

Query: 373 AVK--RLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDY 430
            +K   +S+ S +  EE + EV ++A ++H N+V+      E     +V ++     L  
Sbjct: 53  VIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFK 112

Query: 431 FLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISD 490
            +   +K       +       I   + ++H+    +I+HRD+K+ NI L  +   ++ D
Sbjct: 113 RINA-QKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGD 168

Query: 491 FGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
           FG+AR+             +GT  Y++PE   +  ++ KSD+++ G ++ E+ T K
Sbjct: 169 FGIARVLNSTVELARA--CIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLK 222

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  144 bits (364), Expect = 3e-38
 Identities = 55/221 (24%), Positives = 94/221 (42%), Gaps = 22/221 (9%)

Query: 342 VATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEE-FKNEVVLVAKLQ 399
            + + +   + LG+G    V++G    +G   A+K  +  S     +    E  ++ KL 
Sbjct: 6   TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65

Query: 400 HRNLVRLLGF--CLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGI 457
           H+N+V+L           K+L+ EF P  SL   L +P     L  S    ++  +  G+
Sbjct: 66  HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125

Query: 458 LYLHEDSRLRIIHRDLKASNILL----DAEMNPKISDFGMARIFGVDQTQGNTSRIVGTY 513
            +L E     I+HR++K  NI+     D +   K++DFG AR    D  Q  +  + GT 
Sbjct: 126 NHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVS--LYGTE 179

Query: 514 GYMAPE--------YAMHGQFSVKSDVYSFGVLVLEIITGK 546
            Y+ P+             ++    D++S GV      TG 
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  139 bits (351), Expect = 3e-37
 Identities = 61/233 (26%), Positives = 100/233 (42%), Gaps = 37/233 (15%)

Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGA-EEFKNEVV 393
           DFE I+           LG GGFG V++          A+KR+   + + A E+   EV 
Sbjct: 6   DFEPIQC----------LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVK 55

Query: 394 LVAKLQHRNLVRLLGFCLEGEE---------KILVY---EFVPNKSLDYFLYDPEKQGQL 441
            +AKL+H  +VR     LE            K+ +Y   +    ++L  ++       + 
Sbjct: 56  ALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEER 115

Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
           + S    I   IA  + +LH      ++HRDLK SNI    +   K+ DFG+      D+
Sbjct: 116 ERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDE 172

Query: 502 TQGNT----------SRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
            +             +  VGT  YM+PE      +S K D++S G+++ E++ 
Sbjct: 173 EEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  141 bits (358), Expect = 5e-37
 Identities = 56/230 (24%), Positives = 96/230 (41%), Gaps = 23/230 (10%)

Query: 329 TLESLQFDFETIEVATNK--FSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAE 386
           +LE    D ET  V   K  F   + LG G  G +    +   +++AVKR+       A+
Sbjct: 6   SLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFAD 65

Query: 387 EFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWS 444
               EV L+ +  +H N++R      +  +   +  E       +Y     +K       
Sbjct: 66  ---REVQLLRESDEHPNVIRYFCTE-KDRQFQYIAIELCAATLQEYVE---QKDFAHLGL 118

Query: 445 RRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL-----DAEMNPKISDFGMARIFGV 499
               ++     G+ +LH    L I+HRDLK  NIL+       ++   ISDFG+ +   V
Sbjct: 119 EPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175

Query: 500 DQ-TQGNTSRIVGTYGYMAPEY---AMHGQFSVKSDVYSFGVLVLEIITG 545
            + +    S + GT G++APE          +   D++S G +   +I+ 
Sbjct: 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  137 bits (346), Expect = 1e-36
 Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 10/210 (4%)

Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVK--RLSKASGQGAEEFKNEVVLVAKLQHR 401
             +     +G G +G   K      G+ +  K       +    +   +EV L+ +L+H 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65

Query: 402 NLVRLLGFCLEGEEKIL--VYEFVPNKSLDYFLYDPEKQGQ-LDWSRRYKIIGGIARGIL 458
           N+VR     ++     L  V E+     L   +    K+ Q LD     +++  +   + 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125

Query: 459 YLHE--DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYM 516
             H   D    ++HRDLK +N+ LD + N K+ DFG+ARI   D +   T   VGT  YM
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYM 183

Query: 517 APEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
           +PE      ++ KSD++S G L+ E+    
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALM 213

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  143 bits (362), Expect = 1e-36
 Identities = 61/212 (28%), Positives = 92/212 (43%), Gaps = 17/212 (8%)

Query: 346 KFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEE-FKNEVVLVAKLQHRNL 403
            +    +LG GGFG V + +   +G+++A+K+  +       E +  E+ ++ KL H N+
Sbjct: 15  PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74

Query: 404 VRLL------GFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGI 457
           V               +  +L  E+     L  +L   E    L       ++  I+  +
Sbjct: 75  VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSAL 134

Query: 458 LYLHEDSRLRIIHRDLKASNILLDAEMNP---KISDFGMARIFGVDQTQGNTSRIVGTYG 514
            YLHE    RIIHRDLK  NI+L         KI D G A+              VGT  
Sbjct: 135 RYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTEF--VGTLQ 188

Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
           Y+APE     +++V  D +SFG L  E ITG 
Sbjct: 189 YLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  135 bits (343), Expect = 4e-36
 Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 20/202 (9%)

Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGA---EEFKNEVVLVAKLQHRNLVRLLG 408
           LG+GGF + ++     + +  A K + K+        E+   E+ +   L H+++V   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82

Query: 409 FCLEGEEKI-LVYEFVPNKSL-DYFLYDPEKQGQL--DWSRRYKIIGGIARGILYLHEDS 464
              E  + + +V E    +SL +      +++  L    +R Y  +  I  G  YLH   
Sbjct: 83  -FFEDNDFVFVVLELCRRRSLLELH----KRRKALTEPEARYY--LRQIVLGCQYLH--- 132

Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG 524
           R R+IHRDLK  N+ L+ ++  KI DFG+A     D  +     + GT  Y+APE     
Sbjct: 133 RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKK 190

Query: 525 QFSVKSDVYSFGVLVLEIITGK 546
             S + DV+S G ++  ++ GK
Sbjct: 191 GHSFEVDVWSIGCIMYTLLVGK 212

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  135 bits (342), Expect = 6e-36
 Identities = 58/201 (28%), Positives = 100/201 (49%), Gaps = 15/201 (7%)

Query: 352 KLGEGGFGEVYKG---VLPSGQEIAVK--RLSKASGQGAEE-FKNEVVLVAKLQHRNLVR 405
           KLG GG   VY     +L    ++A+K   +     +   + F+ EV   ++L H+N+V 
Sbjct: 18  KLGGGGMSTVYLAEDTIL--NIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75

Query: 406 LLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSR 465
           ++    E +   LV E++   +L  ++   E  G L           I  GI + H    
Sbjct: 76  MIDVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAH---D 129

Query: 466 LRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQ 525
           +RI+HRD+K  NIL+D+    KI DFG+A+    + +   T+ ++GT  Y +PE A    
Sbjct: 130 MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSPEQAKGEA 188

Query: 526 FSVKSDVYSFGVLVLEIITGK 546
               +D+YS G+++ E++ G+
Sbjct: 189 TDECTDIYSIGIVLYEMLVGE 209

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  134 bits (340), Expect = 6e-36
 Identities = 61/201 (30%), Positives = 101/201 (50%), Gaps = 17/201 (8%)

Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSKAS--GQGAEE-FKNEVVLVAKLQHRNLVRLLG 408
           LG+G F  VY+   + +G E+A+K + K +    G  +  +NEV +  +L+H +++ L  
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78

Query: 409 FCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQL--DWSRRYKIIGGIARGILYLHEDSR 465
              E    + LV E   N  +    Y   +      + +R +  +  I  G+LYLH    
Sbjct: 79  -YFEDSNYVYLVLEMCHNGEM--NRYLKNRVKPFSENEARHF--MHQIITGMLYLH---S 130

Query: 466 LRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQ 525
             I+HRDL  SN+LL   MN KI+DFG+A    +   +  T  + GT  Y++PE A    
Sbjct: 131 HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYISPEIATRSA 188

Query: 526 FSVKSDVYSFGVLVLEIITGK 546
             ++SDV+S G +   ++ G+
Sbjct: 189 HGLESDVWSLGCMFYTLLIGR 209

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  135 bits (343), Expect = 9e-36
 Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 20/202 (9%)

Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGA---EEFKNEVVLVAKLQHRNLVRLLG 408
           LG+GGF + ++     + +  A K + K+        E+   E+ +   L H+++V   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108

Query: 409 FCLEGEEKI-LVYEFVPNKSL-DYFLYDPEKQGQL--DWSRRYKIIGGIARGILYLHEDS 464
              E  + + +V E    +SL +      +++  L    +R Y  +  I  G  YLH   
Sbjct: 109 -FFEDNDFVFVVLELCRRRSLLELH----KRRKALTEPEARYY--LRQIVLGCQYLH--- 158

Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG 524
           R R+IHRDLK  N+ L+ ++  KI DFG+A     D  +     + GT  Y+APE     
Sbjct: 159 RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKK 216

Query: 525 QFSVKSDVYSFGVLVLEIITGK 546
             S + DV+S G ++  ++ GK
Sbjct: 217 GHSFEVDVWSIGCIMYTLLVGK 238

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  131 bits (332), Expect = 1e-34
 Identities = 64/222 (28%), Positives = 105/222 (47%), Gaps = 26/222 (11%)

Query: 339 TIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFK---NEV-V 393
           ++EV  +      +LG G +G V K   +PSGQ +AVKR+        +E K    ++ +
Sbjct: 1   SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS--QEQKRLLMDLDI 58

Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL-YDPEKQGQLDWSRRYKIIGG 452
            +  +     V   G      +  +  E + + SLD F     +K   +       I+G 
Sbjct: 59  SMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIP----EDILGK 113

Query: 453 IARGIL----YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR 508
           IA  I+    +LH  S+L +IHRD+K SN+L++A    K+ DFG++    VD    +   
Sbjct: 114 IAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL-VDDVAKDID- 169

Query: 509 IVGTYGYMAPE----YAMHGQFSVKSDVYSFGVLVLEIITGK 546
             G   YMAPE          +SVKSD++S G+ ++E+   +
Sbjct: 170 -AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  131 bits (331), Expect = 2e-34
 Identities = 53/202 (26%), Positives = 86/202 (42%), Gaps = 17/202 (8%)

Query: 352 KLGEGGFGEVYKGVLPS-GQEIAVKRLSK--ASGQGAEE-FKNEVVLVAKLQHRNLVRLL 407
            +G GG G+VY+       + +A+K +S+  +S        + E     +LQ  ++V + 
Sbjct: 41  LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100

Query: 408 GFCLEGEEKILVY---EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
            F   GE    +Y     +    L   L    +QG L   R   I+  I   +   H   
Sbjct: 101 DF---GEIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSALDAAHAA- 153

Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG 524
                HRD+K  NIL+ A+    + DFG+A     D+        VGT  YMAPE     
Sbjct: 154 --GATHRDVKPENILVSADDFAYLVDFGIASATT-DEKLTQLGNTVGTLYYMAPERFSES 210

Query: 525 QFSVKSDVYSFGVLVLEIITGK 546
             + ++D+Y+   ++ E +TG 
Sbjct: 211 HATYRADIYALTCVLYECLTGS 232

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  130 bits (330), Expect = 2e-34
 Identities = 57/204 (27%), Positives = 112/204 (54%), Gaps = 10/204 (4%)

Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRN 402
             K++   K+G+G  G VY  + + +GQE+A+++++       E   NE++++ + ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
           +V  L   L G+E  +V E++   SL     D   +  +D  +   +     + + +LH 
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHS 134

Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM 522
           +   ++IHRD+K+ NILL  + + K++DFG       +Q++ +T  +VGT  +MAPE   
Sbjct: 135 N---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVT 189

Query: 523 HGQFSVKSDVYSFGVLVLEIITGK 546
              +  K D++S G++ +E+I G+
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGE 213

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  131 bits (332), Expect = 5e-34
 Identities = 62/225 (27%), Positives = 107/225 (47%), Gaps = 25/225 (11%)

Query: 331 ESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFK 389
             L    +  E+  + F   ++LG G  G V+K    PSG  +A K +            
Sbjct: 19  AFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP--AIRN 76

Query: 390 ---NEVVLVAKLQHRNLVRLLG-FCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSR 445
               E+ ++ +     +V   G F  +GE  I   E +   SLD  L   +K G++    
Sbjct: 77  QIIRELQVLHECNSPYIVGFYGAFYSDGEISI-CMEHMDGGSLDQVL---KKAGRIP--- 129

Query: 446 RYKIIGGIARGIL----YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
             +I+G ++  ++    YL E    +I+HRD+K SNIL+++    K+ DFG++       
Sbjct: 130 -EQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--ID 184

Query: 502 TQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
           +  N+   VGT  YM+PE      +SV+SD++S G+ ++E+  G+
Sbjct: 185 SMANS--FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  129 bits (327), Expect = 5e-34
 Identities = 61/207 (29%), Positives = 95/207 (45%), Gaps = 16/207 (7%)

Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQH 400
             F     LG+G FG VY      S   +A+K L KA         + + EV + + L+H
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68

Query: 401 RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
            N++RL G+      ++ L+ E+ P  ++   L   +K  + D  R    I  +A  + Y
Sbjct: 69  PNILRLYGY-FHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSY 124

Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE 519
            H     R+IHRD+K  N+LL +    KI+DFG +       ++     + GT  Y+ PE
Sbjct: 125 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH--APSSRRTD--LCGTLDYLPPE 177

Query: 520 YAMHGQFSVKSDVYSFGVLVLEIITGK 546
                    K D++S GVL  E + GK
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  130 bits (329), Expect = 6e-34
 Identities = 61/204 (29%), Positives = 103/204 (50%), Gaps = 10/204 (4%)

Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRN 402
                +  K+GEG  G V       SG+++AVK +     Q  E   NEVV++   QH N
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103

Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
           +V +    L GEE  ++ EF+   +L     D   Q +L+  +   +   + + + YLH 
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLHA 159

Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM 522
                +IHRD+K+ +ILL  +   K+SDFG       D  +  +  +VGT  +MAPE   
Sbjct: 160 Q---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVIS 214

Query: 523 HGQFSVKSDVYSFGVLVLEIITGK 546
              ++ + D++S G++V+E++ G+
Sbjct: 215 RSLYATEVDIWSLGIMVIEMVDGE 238

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  129 bits (327), Expect = 1e-33
 Identities = 58/231 (25%), Positives = 95/231 (41%), Gaps = 23/231 (9%)

Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVA 396
           +T+E+   +      L EGGF  VY+   + SG+E A+KRL     +       EV  + 
Sbjct: 21  QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMK 80

Query: 397 KLQ-HRNLVRLLGFCL-------EGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYK 448
           KL  H N+V+              G+ + L+   +    L  FL   E +G L      K
Sbjct: 81  KLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLK 140

Query: 449 IIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR 508
           I     R + ++H   +  IIHRDLK  N+LL  +   K+ DFG A           +++
Sbjct: 141 IFYQTCRAVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQ 199

Query: 509 I----------VGTYGYMAPE-YAMHGQFSV--KSDVYSFGVLVLEIITGK 546
                        T  Y  PE   ++  F +  K D+++ G ++  +   +
Sbjct: 200 RRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  134 bits (338), Expect = 2e-33
 Identities = 45/207 (21%), Positives = 83/207 (40%), Gaps = 32/207 (15%)

Query: 352 KLGEGGFGEVYKG---VLPSGQEIAVKRLSKASGQGAEE-FKNEVVLVAKLQHRNLVRLL 407
            +  GG G +Y      + +G+ + +K L  +    A+     E   +A++ H ++V++ 
Sbjct: 87  CIAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145

Query: 408 GFCLEGEEKI--------LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
            F    E           +V E+V  +SL           +L  +     +  I   + Y
Sbjct: 146 NF---VEHTDRHGDPVGYIVMEYVGGQSLKRSK-----GQKLPVAEAIAYLLEILPALSY 197

Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE 519
           LH    + +++ DLK  NI+L  E   K+ D G            +   + GT G+ APE
Sbjct: 198 LH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVS------RINSFGYLYGTPGFQAPE 247

Query: 520 YAMHGQFSVKSDVYSFGVLVLEIITGK 546
               G  +V +D+Y+ G  +  +    
Sbjct: 248 IVRTGP-TVATDIYTVGRTLAALTLDL 273

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  129 bits (326), Expect = 3e-33
 Identities = 34/228 (14%), Positives = 70/228 (30%), Gaps = 22/228 (9%)

Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV------LPSGQEIAVKRLSKASGQGAEEFKNE 391
              ++ +      + LGEG F +VY+          + Q+  +K    A+          
Sbjct: 58  TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117

Query: 392 VVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL--YDPEKQGQLDWSRRYKI 449
           +  +        ++     L     +LV E     +L   +  Y    +  +        
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177

Query: 450 IGGIARGILYLHEDSRLRIIHRDLKASNILL-----------DAEMNPKISDFGMARIFG 498
              +   I  +H+     IIH D+K  N +L           D      + D G +    
Sbjct: 178 AMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234

Query: 499 VDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
           +       +    T G+   E   +  ++ + D +     V  ++ G 
Sbjct: 235 LFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  127 bits (320), Expect = 5e-33
 Identities = 49/229 (21%), Positives = 86/229 (37%), Gaps = 36/229 (15%)

Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKR--LSKASGQGAEEFKNEVVLVAKL-Q 399
           T +F    K+G G FG V+K V    G   A+KR     A     +    EV   A L Q
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQ-LDWSRRYKIIGGIARGIL 458
           H ++VR      E +  ++  E+    SL   + +  +       +    ++  + RG+ 
Sbjct: 70  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129

Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNP-------------------KISDFGMARIFGV 499
           Y+H      ++H D+K SNI +     P                   KI D G       
Sbjct: 130 YIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186

Query: 500 DQTQGNTSRIVGTYGYMAPEYAMHGQFS--VKSDVYSFGVLVLEIITGK 546
            Q +       G   ++A E  +   ++   K+D+++  + V+     +
Sbjct: 187 PQVE------EGDSRFLANE-VLQENYTHLPKADIFALALTVVCAAGAE 228

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  128 bits (323), Expect = 6e-33
 Identities = 47/256 (18%), Positives = 98/256 (38%), Gaps = 43/256 (16%)

Query: 321 SNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKA 380
            +  ++ + L  L    +  +   N +     L +G F ++        +  A+K+  K+
Sbjct: 7   KDILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKS 65

Query: 381 -----------------SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEF 422
                                 ++FKNE+ ++  +++   +   G  +   +++ ++YE+
Sbjct: 66  LLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEY 124

Query: 423 VPNKSL-DY------FLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKA 475
           + N S+  +         +      +   +    I  +     Y+H  +   I HRD+K 
Sbjct: 125 MENDSILKFDEYFFVLDKNYTCFIPIQVIKCI--IKSVLNSFSYIH--NEKNICHRDVKP 180

Query: 476 SNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE-----YAMHGQFSVKS 530
           SNIL+D     K+SDFG +                GTY +M PE      + +G    K 
Sbjct: 181 SNILMDKNGRVKLSDFGESEYM----VDKKIKGSRGTYEFMPPEFFSNESSYNGA---KV 233

Query: 531 DVYSFGVLVLEIITGK 546
           D++S G+ +  +    
Sbjct: 234 DIWSLGICLYVMFYNV 249

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  127 bits (322), Expect = 6e-33
 Identities = 64/233 (27%), Positives = 101/233 (43%), Gaps = 30/233 (12%)

Query: 331 ESLQFDFE-TIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEF 388
             L+   E   +          ++G G +G V K V  PSGQ +AVKR+        E+ 
Sbjct: 7   GKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRS---TVDEKE 63

Query: 389 KNEV-----VLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDW 443
           + ++     V++       +V+  G      +  +  E + + S D F     K      
Sbjct: 64  QKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFY----KYVYSVL 118

Query: 444 SRRY--KIIGGIARGIL----YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497
                 +I+G I    +    +L E+  L+IIHRD+K SNILLD   N K+ DFG++   
Sbjct: 119 DDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176

Query: 498 GVDQTQGNTSRIVGTYGYMAPE----YAMHGQFSVKSDVYSFGVLVLEIITGK 546
                +       G   YMAPE     A    + V+SDV+S G+ + E+ TG+
Sbjct: 177 VDSIAKTRD---AGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  126 bits (320), Expect = 7e-33
 Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 19/206 (9%)

Query: 352 KLGEGGFGEVYKG---VLPSGQEIAVK--RLSKASGQGAEE-FKNEVVLVAKLQHRNLVR 405
            LG GG  EV+          +++AVK  R   A        F+ E    A L H  +V 
Sbjct: 19  ILGFGGMSEVHLARDLRD--HRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76

Query: 406 LL--GFCLEGEEKI--LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH 461
           +   G        +  +V E+V   +L   +     +G +   R  ++I    + + + H
Sbjct: 77  VYDTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQALNFSH 133

Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVDQTQGNTSRIVGTYGYMAPEY 520
              +  IIHRD+K +NI++ A    K+ DFG+AR I     +   T+ ++GT  Y++PE 
Sbjct: 134 ---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190

Query: 521 AMHGQFSVKSDVYSFGVLVLEIITGK 546
           A       +SDVYS G ++ E++TG+
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLTGE 216

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  126 bits (318), Expect = 1e-32
 Identities = 65/233 (27%), Positives = 116/233 (49%), Gaps = 25/233 (10%)

Query: 320 ESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLS 378
            S   + L  +++L+ D E +      F+   K+G+G FGEV+KG+   + + +A+K + 
Sbjct: 3   HSPVQSGLPGMQNLKADPEEL------FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIID 56

Query: 379 KASGQGA-EEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEK 437
               +   E+ + E+ ++++     + +  G  L+  +  ++ E++   S      D  +
Sbjct: 57  LEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSAL----DLLE 112

Query: 438 QGQLDWSRRYKIIGGIARGIL----YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493
            G LD       I  I R IL    YLH +   + IHRD+KA+N+LL      K++DFG+
Sbjct: 113 PGPLD----ETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGV 165

Query: 494 ARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
           A      Q + NT   VGT  +MAPE      +  K+D++S G+  +E+  G+
Sbjct: 166 AGQLTDTQIKRNT--FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGE 216

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  127 bits (320), Expect = 2e-32
 Identities = 21/229 (9%), Positives = 51/229 (22%), Gaps = 43/229 (18%)

Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSK---ASGQGAEEFKNEVVLVAKLQHRNLVRLLG 408
           L  G    V+    +   ++ A+K  +     S    E         A+L   +      
Sbjct: 70  LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129

Query: 409 FC----------LEGEEKI----------------LVYEFVP---NKSLDYFLYDPEKQG 439
                       ++ +                   L+                +    +G
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRG 189

Query: 440 QLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499
                  + +   + R    L       ++H      N+ +  +    + D       G 
Sbjct: 190 DEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT 246

Query: 500 DQTQGNTSRIVGTYGYMAPEYAMHG--QFSVKSDVYSFGVLVLEIITGK 546
                          Y   E+       F+   + +  G+ +  +    
Sbjct: 247 -----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  124 bits (314), Expect = 3e-32
 Identities = 53/201 (26%), Positives = 87/201 (43%), Gaps = 15/201 (7%)

Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEE-FKNEVVLVAKLQHR 401
            + F    KLG G FG+V+      SG E  +K ++K   Q   E  + E+ ++  L H 
Sbjct: 21  DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80

Query: 402 NLVRLLGFCLEGEEKI-LVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
           N++++     E    + +V E      L +  +    +   L      +++  +   + Y
Sbjct: 81  NIIKIFEVF-EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAY 139

Query: 460 LHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYM 516
            H      ++H+DLK  NIL          KI DFG+A +F  D+     +   GT  YM
Sbjct: 140 FHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS---TNAAGTALYM 193

Query: 517 APEYAMHGQFSVKSDVYSFGV 537
           APE       + K D++S GV
Sbjct: 194 APE-VFKRDVTFKCDIWSAGV 213

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  127 bits (321), Expect = 4e-32
 Identities = 52/228 (22%), Positives = 84/228 (36%), Gaps = 34/228 (14%)

Query: 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEV-VLVAKLQHRNL 403
           N   ++  LG G  G V       G+ +AVKR+        +    E+ +L     H N+
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNV 71

Query: 404 VRLLGFCLEGEEKI-LVYEFVPNKSLDYFL---YDPEKQGQLDWSRRYKIIGGIARGILY 459
           +R        +  + +  E       D         E            ++  IA G+ +
Sbjct: 72  IRYYCSE-TTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130

Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNP-------------KISDFGMARIFGVDQT--QG 504
           LH    L+IIHRDLK  NIL+                    ISDFG+ +     Q+  + 
Sbjct: 131 LHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187

Query: 505 NTSRIVGTYGYMAPE-------YAMHGQFSVKSDVYSFGVLVLEIITG 545
           N +   GT G+ APE            + +   D++S G +   I++ 
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  122 bits (308), Expect = 2e-31
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 20/209 (9%)

Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQH 400
           + F     LG+G FG VY      +   +A+K L K+         + + E+ + + L+H
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73

Query: 401 RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQL--DWSRRYKIIGGIARGI 457
            N++R+  +     ++I L+ EF P   L   L   +K G+     S  +  +  +A  +
Sbjct: 74  PNILRMYNY-FHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSATF--MEELADAL 127

Query: 458 LYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMA 517
            Y H     ++IHRD+K  N+L+  +   KI+DFG +        +  T    GT  Y+ 
Sbjct: 128 HYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVH--APSLRRRTM--CGTLDYLP 180

Query: 518 PEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
           PE         K D++  GVL  E + G 
Sbjct: 181 PEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  126 bits (318), Expect = 2e-31
 Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 20/211 (9%)

Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQH 400
           +  +    KLG G +GEV       +  E A+K + K   S     +   EV ++  L H
Sbjct: 36  SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95

Query: 401 RNLVRLLGFCLEGEEKI-LVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIARGIL 458
            N+++L  F  E +    LV E      L D  +     + + +      II  +  G+ 
Sbjct: 96  PNIMKLYDFF-EDKRNYYLVMECYKGGELFDEII----HRMKFNEVDAAVIIKQVLSGVT 150

Query: 459 YLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGY 515
           YLH+     I+HRDLK  N+LL   + +   KI DFG++ +F   +        +GT  Y
Sbjct: 151 YLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM---KERLGTAYY 204

Query: 516 MAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
           +APE  +  ++  K DV+S GV++  ++ G 
Sbjct: 205 IAPE-VLRKKYDEKCDVWSIGVILFILLAGY 234

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  122 bits (307), Expect = 4e-31
 Identities = 55/209 (26%), Positives = 101/209 (48%), Gaps = 13/209 (6%)

Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRN 402
              +    +LG+G FG+VYK     +G   A K +   S +  E++  E+ ++A   H  
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77

Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
           +V+LLG      +  ++ EF P  ++D  +   E    L   +   +   +   + +LH 
Sbjct: 78  IVKLLGAYYHDGKLWIMIEFCPGGAVDAIM--LELDRGLTEPQIQVVCRQMLEALNFLHS 135

Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM 522
               RIIHRDLKA N+L+  E + +++DFG++        + ++   +GT  +MAPE  M
Sbjct: 136 K---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVM 190

Query: 523 HGQFS-----VKSDVYSFGVLVLEIITGK 546
                      K+D++S G+ ++E+   +
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMAQIE 219

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  125 bits (315), Expect = 6e-31
 Identities = 67/224 (29%), Positives = 106/224 (47%), Gaps = 24/224 (10%)

Query: 332 SLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEF 388
           S + +         +++    LG+G FGEV K     + QE AVK ++KA    +     
Sbjct: 9   SGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTI 68

Query: 389 KNEVVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSL-DYFLYDPEKQGQLDWSRR 446
             EV L+ KL H N+++L     E      +V E      L D  +    K+ +   S  
Sbjct: 69  LREVELLKKLDHPNIMKLFEIL-EDSSSFYIVGELYTGGELFDEII----KRKRF--SEH 121

Query: 447 Y--KIIGGIARGILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMARIFGVDQ 501
              +II  +  GI Y+H+     I+HRDLK  NILL   + + + KI DFG++  F  + 
Sbjct: 122 DAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178

Query: 502 TQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
                   +GT  Y+APE  + G +  K DV+S GV++  +++G
Sbjct: 179 KM---KDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  121 bits (306), Expect = 7e-31
 Identities = 60/240 (25%), Positives = 105/240 (43%), Gaps = 30/240 (12%)

Query: 321 SNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSK 379
           S +    T    L    +  +   N      ++G G  G+V+K     +G  IAVK++ +
Sbjct: 3   SGSSGKQTGY--LTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRR 60

Query: 380 ASGQGAEEFKN---EV-VLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDP 435
           +  +  EE K    ++ V++       +V+  G  +   +  +  E +     +      
Sbjct: 61  SGNK--EENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKK-- 115

Query: 436 EKQGQLDWSRRYKIIGGIARGIL----YLHEDSRLRIIHRDLKASNILLDAEMNPKISDF 491
             QG +      +I+G +   I+    YL E     +IHRD+K SNILLD     K+ DF
Sbjct: 116 RMQGPIP----ERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDF 169

Query: 492 GMARIFGVDQTQGNTSRIVGTYGYMAPE-----YAMHGQFSVKSDVYSFGVLVLEIITGK 546
           G++    VD    + S   G   YMAPE           + +++DV+S G+ ++E+ TG+
Sbjct: 170 GISGRL-VDDKAKDRS--AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  124 bits (312), Expect = 1e-30
 Identities = 65/216 (30%), Positives = 102/216 (47%), Gaps = 31/216 (14%)

Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEE---FKNEVVLVAKLQ 399
           ++++     LG+G FGEV       +GQE AVK +SK   +   +      EV L+ +L 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84

Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSL-------DYFLYDPEKQGQLDWSRRYKIIGG 452
           H N+++L  F  +     LV E      L         F    E           +II  
Sbjct: 85  HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRF---SEVDAA-------RIIRQ 134

Query: 453 IARGILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMARIFGVDQTQGNTSRI 509
           +  GI Y+H+    +I+HRDLK  N+LL     + N +I DFG++  F   +        
Sbjct: 135 VLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM---KDK 188

Query: 510 VGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
           +GT  Y+APE  +HG +  K DV+S GV++  +++G
Sbjct: 189 IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  121 bits (306), Expect = 2e-30
 Identities = 45/221 (20%), Positives = 80/221 (36%), Gaps = 28/221 (12%)

Query: 344 TNKFSTDNKLGEG--GFGEVYKGV-LPSGQEIAVKR--LSKASGQGAEEFKNEVVLVAKL 398
              +     +G+G      V      P+G+ + V+R  L   S +     + E+ +    
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83

Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIARGI 457
            H N+V      +   E  +V  F+   S  D  L        ++       I  I +G+
Sbjct: 84  NHPNIVPYRATFIADNELWVVTSFMAYGSAKD--LICTHFMDGMN----ELAIAYILQGV 137

Query: 458 L----YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT-----SR 508
           L    Y+H       +HR +KAS+IL+  +    +S             +          
Sbjct: 138 LKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKY 194

Query: 509 IVGTYGYMAPE---YAMHGQFSVKSDVYSFGVLVLEIITGK 546
            V    +++PE     + G +  KSD+YS G+   E+  G 
Sbjct: 195 SVKVLPWLSPEVLQQNLQG-YDAKSDIYSVGITACELANGH 234

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  120 bits (302), Expect = 3e-30
 Identities = 58/204 (28%), Positives = 101/204 (49%), Gaps = 10/204 (4%)

Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRN 402
              F    KLGEG +G VYK +   +GQ +A+K++        +E   E+ ++ +    +
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPH 85

Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
           +V+  G   +  +  +V E+    S+   +    +   L       I+    +G+ YLH 
Sbjct: 86  VVKYYGSYFKNTDLWIVMEYCGAGSVSDII--RLRNKTLTEDEIATILQSTLKGLEYLHF 143

Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM 522
               R IHRD+KA NILL+ E + K++DFG+A        + NT  ++GT  +MAPE   
Sbjct: 144 M---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT--VIGTPFWMAPEVIQ 198

Query: 523 HGQFSVKSDVYSFGVLVLEIITGK 546
              ++  +D++S G+  +E+  GK
Sbjct: 199 EIGYNCVADIWSLGITAIEMAEGK 222

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  119 bits (301), Expect = 3e-30
 Identities = 59/217 (27%), Positives = 99/217 (45%), Gaps = 22/217 (10%)

Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLS-KASGQGAEEFKNEVVLVAKLQHRN 402
           + +     +G G    V      P  +++A+KR++ +      +E   E+  +++  H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSL-----DYFLYDPEKQGQLDWSRRYKIIGGIARGI 457
           +V      +  +E  LV + +   S+             K G LD       I  I R +
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLD----ESTIATILREV 130

Query: 458 L----YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM-ARIFGVDQTQGNTSR--IV 510
           L    YLH++     IHRD+KA NILL  + + +I+DFG+ A +        N  R   V
Sbjct: 131 LEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187

Query: 511 GTYGYMAPEYAMHGQ-FSVKSDVYSFGVLVLEIITGK 546
           GT  +MAPE     + +  K+D++SFG+  +E+ TG 
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  119 bits (300), Expect = 5e-30
 Identities = 66/230 (28%), Positives = 101/230 (43%), Gaps = 30/230 (13%)

Query: 335 FDFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVV 393
            D   +      F     +G G +G+VYKG  + +GQ  A+K +   +G   EE K E+ 
Sbjct: 14  IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDEEEEIKQEIN 72

Query: 394 LVAKL-QHRNLVRLLGFCLEGEEKI------LVYEFVPNKSL-DYFLYDPEKQGQLDWSR 445
           ++ K   HRN+    G  ++           LV EF    S+ D  L    K   L    
Sbjct: 73  MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD--LIKNTKGNTLK--- 127

Query: 446 RYKIIGGIARGIL----YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
             + I  I R IL    +LH+    ++IHRD+K  N+LL      K+ DFG++       
Sbjct: 128 -EEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV 183

Query: 502 TQGNTSRIVGTYGYMAPEYAMHGQFS-----VKSDVYSFGVLVLEIITGK 546
            + NT   +GT  +MAPE     +        KSD++S G+  +E+  G 
Sbjct: 184 GRRNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  118 bits (298), Expect = 7e-30
 Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 26/209 (12%)

Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSKAS----GQGAEEFKNEVVLVAKLQHRNLVRLL 407
           LGEG +G+V + +   +    AVK L K        G    K E+ L+ +L+H+N+++L+
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 408 G-FCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRY--KIIGGIARGILYLHED 463
                E ++K+ +V E+      +     PEK+  +  +  Y  ++I G+     YLH  
Sbjct: 73  DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLE----YLH-- 126

Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIV-GTYGYMAPEYAM 522
               I+H+D+K  N+LL      KIS  G+A          +T R   G+  +  PE A 
Sbjct: 127 -SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALH-PFAADDTCRTSQGSPAFQPPEIAN 184

Query: 523 -----HGQFSVKSDVYSFGVLVLEIITGK 546
                 G    K D++S GV +  I TG 
Sbjct: 185 GLDTFSGF---KVDIWSAGVTLYNITTGL 210

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  117 bits (296), Expect = 8e-30
 Identities = 65/202 (32%), Positives = 98/202 (48%), Gaps = 20/202 (9%)

Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEE--FKNEVVLVAKLQH 400
             +++    LG+G FGEV K     + QE AVK ++KAS +  +      EV L+ KL H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 401 RNLVRLLGFCLEGEEKI-LVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIARGIL 458
            N+++L     E      +V E      L D  +    K+ +       +II  +  GI 
Sbjct: 81  PNIMKLFEIL-EDSSSFYIVGELYTGGELFDEII----KRKRFSEHDAARIIKQVFSGIT 135

Query: 459 YLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGY 515
           Y+H+     I+HRDLK  NILL   + + + KI DFG++  F  +         +GT  Y
Sbjct: 136 YMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYY 189

Query: 516 MAPEYAMHGQFSVKSDVYSFGV 537
           +APE  + G +  K DV+S GV
Sbjct: 190 IAPE-VLRGTYDEKCDVWSAGV 210

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  117 bits (296), Expect = 8e-30
 Identities = 52/200 (26%), Positives = 87/200 (43%), Gaps = 18/200 (9%)

Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRN 402
              ++ +N +G G +GEV   V   +    A K++ K   +  + FK E+ ++  L H N
Sbjct: 8   NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67

Query: 403 LVRLLGFCLEGEEKI-LVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
           ++RL     E    I LV E      L +  +     +     S   +I+  +   + Y 
Sbjct: 68  IIRLYETF-EDNTDIYLVMELCTGGELFERVV----HKRVFRESDAARIMKDVLSAVAYC 122

Query: 461 HEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMA 517
           H+   L + HRDLK  N L      +   K+ DFG+A  F   +        VGT  Y++
Sbjct: 123 HK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM---RTKVGTPYYVS 176

Query: 518 PEYAMHGQFSVKSDVYSFGV 537
           P+  + G +  + D +S GV
Sbjct: 177 PQ-VLEGLYGPECDEWSAGV 195

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  121 bits (306), Expect = 1e-29
 Identities = 63/223 (28%), Positives = 99/223 (44%), Gaps = 35/223 (15%)

Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGA-------------EEFK 389
              +    KLG G +GEV          E A+K + K+                  EE  
Sbjct: 35  GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94

Query: 390 NEVVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSL-DYFLYDPEKQGQLDWSRRY 447
           NE+ L+  L H N+++L     E ++   LV EF     L +  +     + +       
Sbjct: 95  NEISLLKSLDHPNIIKLFDVF-EDKKYFYLVTEFYEGGELFEQII----NRHKF--DECD 147

Query: 448 --KIIGGIARGILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMARIFGVDQT 502
              I+  I  GI YLH+     I+HRD+K  NILL   ++ +N KI DFG++  F  D  
Sbjct: 148 AANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK 204

Query: 503 QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
                  +GT  Y+APE  +  +++ K DV+S GV++  ++ G
Sbjct: 205 L---RDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  119 bits (300), Expect = 2e-29
 Identities = 51/246 (20%), Positives = 96/246 (39%), Gaps = 34/246 (13%)

Query: 309 RKAKKKYNAVPESNADNDLTTLESLQFDFETIEVAT----NKFSTDNKLGEGGFGEVYKG 364
            K + KY+    ++ D     +   ++  + +EV      + +    +LG G FG V++ 
Sbjct: 12  SKVRGKYDGPKINDYDKFYEDIWK-KYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRC 70

Query: 365 V-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 423
           V   +G+    K ++          KNE+ ++ +L H  L+ L     +  E +L+ EF+
Sbjct: 71  VEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 130

Query: 424 P---------NKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLK 474
                      +         E +           +     G+ ++HE     I+H D+K
Sbjct: 131 SGGELFDRIAAEDYKM----SEAEVI-------NYMRQACEGLKHMHE---HSIVHLDIK 176

Query: 475 ASNILLDAEMNP--KISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDV 532
             NI+ + +     KI DFG+A     D+          T  + APE          +D+
Sbjct: 177 PENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDM 233

Query: 533 YSFGVL 538
           ++ GVL
Sbjct: 234 WAIGVL 239

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  118 bits (297), Expect = 2e-29
 Identities = 65/218 (29%), Positives = 97/218 (44%), Gaps = 35/218 (16%)

Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFK---NEVVLVAKLQ 399
              FS   ++G G FG VY    + + + +A+K++S +  Q  E+++    EV  + KL+
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112

Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDP----EKQGQLDWSRRYKIIGGIAR 455
           H N ++  G  L      LV E+    + D          E +           I  +  
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVE-----------IAAVTH 161

Query: 456 GIL----YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVG 511
           G L    YLH      +IHRD+KA NILL      K+ DFG A I        N+   VG
Sbjct: 162 GALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM----APANS--FVG 212

Query: 512 TYGYMAPEYAMH---GQFSVKSDVYSFGVLVLEIITGK 546
           T  +MAPE  +    GQ+  K DV+S G+  +E+   K
Sbjct: 213 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 250

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  116 bits (292), Expect = 2e-29
 Identities = 58/199 (29%), Positives = 91/199 (45%), Gaps = 31/199 (15%)

Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEE-FKNEVVLVAKLQHRNLVRLLGFC 410
           LGEG +GEV   V   + + +AVK +         E  K E+ +   L H N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-H 73

Query: 411 LEGEEKI-LVYEFVPNKSL-DYFLYDPEKQGQL--DWSRRY--KIIGGIARGILYLHEDS 464
                   L  E+     L D      E    +    ++R+  +++ G+     YLH   
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVV----YLH--- 122

Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE----- 519
            + I HRD+K  N+LLD   N KISDFG+A +F  +  +   +++ GT  Y+APE     
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182

Query: 520 -YAMHGQFSVKSDVYSFGV 537
            +  H +     DV+S G+
Sbjct: 183 EF--HAE---PVDVWSCGI 196

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  116 bits (292), Expect = 6e-29
 Identities = 58/199 (29%), Positives = 91/199 (45%), Gaps = 31/199 (15%)

Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEE-FKNEVVLVAKLQHRNLVRLLGFC 410
           LGEG +GEV   V   + + +AVK +         E  K E+ +   L H N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-H 73

Query: 411 LEGEEKI-LVYEFVPNKSL-DYFLYDPEKQGQL--DWSRRY--KIIGGIARGILYLHEDS 464
                   L  E+     L D      E    +    ++R+  +++ G+     YLH   
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVV----YLH--- 122

Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE----- 519
            + I HRD+K  N+LLD   N KISDFG+A +F  +  +   +++ GT  Y+APE     
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182

Query: 520 -YAMHGQFSVKSDVYSFGV 537
            +  H +     DV+S G+
Sbjct: 183 EF--HAE---PVDVWSCGI 196

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  120 bits (302), Expect = 6e-29
 Identities = 53/239 (22%), Positives = 99/239 (41%), Gaps = 16/239 (6%)

Query: 308 RRKAKKKYNAVPESNADNDLTTLESLQFDFETIEVATNKFST----DNKLGEGGFGEVYK 363
            +    +      SN DN +  +   Q+  + +E+  +          +LG G FG V++
Sbjct: 117 EQGKIVRGKGTVSSNYDNYVFDIWK-QYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHR 175

Query: 364 GV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422
                +G   A K +        E  + E+  ++ L+H  LV L     +  E +++YEF
Sbjct: 176 VTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235

Query: 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA 482
           +    L  F    ++  ++      + +  + +G+ ++HE      +H DLK  NI+   
Sbjct: 236 MSGGEL--FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTT 290

Query: 483 EMNP--KISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLV 539
           + +   K+ DFG+       Q   +     GT  + APE A        +D++S GVL 
Sbjct: 291 KRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  117 bits (294), Expect = 6e-29
 Identities = 29/239 (12%), Positives = 63/239 (26%), Gaps = 54/239 (22%)

Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSK---ASGQGAEEFKNEVVLVAKLQ--------- 399
           LG+       +     +G+   V              ++ K EV+ +  L+         
Sbjct: 81  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140

Query: 400 ----------------HRNLVRLLG-FCLEGEEKILVYEFVPNKSL----DYFLYDPEKQ 438
                            + ++R+                     +L    +  L      
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200

Query: 439 GQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498
             L    R ++   + R +  LH      ++H  L+  +I+LD      ++ F      G
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257

Query: 499 VDQTQGNTSRIVGTYGYMAPEY-----------AMHGQFSVKSDVYSFGVLVLEIITGK 546
                        + G+  PE                  +   D ++ G+++  I    
Sbjct: 258 ARVV------SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  117 bits (295), Expect = 8e-29
 Identities = 28/233 (12%), Positives = 61/233 (26%), Gaps = 43/233 (18%)

Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSK---ASGQGAEEFKNEVVLVAKLQ--------- 399
           LG+       +     +G+   V              ++ K EV+ +  L+         
Sbjct: 86  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145

Query: 400 -------------HRNLVRLLGFCLEGEEKILVYEFVPNKS--------LDYFLYDPEKQ 438
                             +++   L+  +  ++  F              +  L      
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205

Query: 439 GQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498
             L    R ++   + R +  LH      ++H  L+  +I+LD      ++ F      G
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262

Query: 499 VDQTQGNTSRIVGTYGYMAPE-----YAMHGQFSVKSDVYSFGVLVLEIITGK 546
                    R        A              +   D ++ G+ +  I    
Sbjct: 263 -ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  115 bits (291), Expect = 2e-28
 Identities = 58/197 (29%), Positives = 93/197 (47%), Gaps = 13/197 (6%)

Query: 346 KFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLV 404
             S    LG G FG+V+K     +G ++A K +     +  EE KNE+ ++ +L H NL+
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149

Query: 405 RLLGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
           +L        + +LV E+V    L D  + +     +LD       +  I  GI ++H+ 
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTIL---FMKQICEGIRHMHQ- 205

Query: 464 SRLRIIHRDLKASNILLDAEMNP--KISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYA 521
             + I+H DLK  NIL         KI DFG+AR +   +         GT  ++APE  
Sbjct: 206 --MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL---KVNFGTPEFLAPEVV 260

Query: 522 MHGQFSVKSDVYSFGVL 538
            +   S  +D++S GV+
Sbjct: 261 NYDFVSFPTDMWSVGVI 277

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  114 bits (287), Expect = 2e-28
 Identities = 57/209 (27%), Positives = 86/209 (41%), Gaps = 36/209 (17%)

Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRN 402
              F     LG G F EV+      +G+  A+K + K+        +NE+ ++ K++H N
Sbjct: 8   RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67

Query: 403 LVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQL-DW--SRRY-------KIIG 451
           +V L     E      LV + V               G+L D    R          +I 
Sbjct: 68  IVTLEDIY-ESTTHYYLVMQLVSG-------------GELFDRILERGVYTEKDASLVIQ 113

Query: 452 GIARGILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMARIFGVDQTQGNTSR 508
            +   + YLHE     I+HRDLK  N+L    +      I+DFG++++       G  S 
Sbjct: 114 QVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ----NGIMST 166

Query: 509 IVGTYGYMAPEYAMHGQFSVKSDVYSFGV 537
             GT GY+APE      +S   D +S GV
Sbjct: 167 ACGTPGYVAPEVLAQKPYSKAVDCWSIGV 195

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  113 bits (286), Expect = 4e-28
 Identities = 45/207 (21%), Positives = 78/207 (37%), Gaps = 30/207 (14%)

Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRN 402
             K+     LG G FG V++ V   S +    K +    G      K E+ ++   +HRN
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRN 62

Query: 403 LVRLLGFCLEGEEKILVYEFVP---------NKSLDYFLYDPEKQGQLDWSRRYKIIGGI 453
           ++ L       EE ++++EF+            + +      E++           +  +
Sbjct: 63  ILHLHESFESMEELVMIFEFISGLDIFERINTSAFEL----NEREIV-------SYVHQV 111

Query: 454 ARGILYLHEDSRLRIIHRDLKASNILLDAEMNP--KISDFGMARIFGVDQTQGNTSRIVG 511
              + +LH      I H D++  NI+     +   KI +FG AR             +  
Sbjct: 112 CEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFT 165

Query: 512 TYGYMAPEYAMHGQFSVKSDVYSFGVL 538
              Y APE   H   S  +D++S G L
Sbjct: 166 APEYYAPEVHQHDVVSTATDMWSLGTL 192

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  115 bits (289), Expect = 5e-28
 Identities = 66/264 (25%), Positives = 114/264 (43%), Gaps = 58/264 (21%)

Query: 311 AKKKYNAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQ 370
           +    N V  +  D+    ++ L  D +T E     ++    +G G FG V++  L    
Sbjct: 6   SNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESD 65

Query: 371 EIAVKRLSKASGQGAEEFKN-EVVLVAKLQHRNLVRLLGFCLEGEEKI------LVYEFV 423
           E+A+K++ +      + FKN E+ ++  ++H N+V L  F     +K       LV E+V
Sbjct: 66  EVAIKKVLQ-----DKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV 120

Query: 424 P-------------NKSLD-----YFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSR 465
           P              +++       ++Y      QL             R + Y+H    
Sbjct: 121 PETVYRASRHYAKLKQTMPMLLIKLYMY------QL------------LRSLAYIH---S 159

Query: 466 LRIIHRDLKASNILLDAEMNP-KISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG 524
           + I HRD+K  N+LLD      K+ DFG A+I      + N S I   Y Y APE  + G
Sbjct: 160 IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNVSYICSRY-YRAPE-LIFG 215

Query: 525 --QFSVKSDVYSFGVLVLEIITGK 546
              ++   D++S G ++ E++ G+
Sbjct: 216 ATNYTTNIDIWSTGCVMAELMQGQ 239

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  112 bits (282), Expect = 8e-28
 Identities = 57/212 (26%), Positives = 89/212 (41%), Gaps = 28/212 (13%)

Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGA---------EEFKNEVV 393
              +     LG G    V + +  P+ +E AVK +    G            E    EV 
Sbjct: 16  YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75

Query: 394 LVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIG 451
           ++ K+  H N+++L           LV++ +    L DY      ++  L      KI+ 
Sbjct: 76  ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT----EKVTLSEKETRKIMR 131

Query: 452 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVG 511
            +   I  LH+   L I+HRDLK  NILLD +MN K++DFG +      +       + G
Sbjct: 132 ALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCG 185

Query: 512 TYGYMAPE------YAMHGQFSVKSDVYSFGV 537
           T  Y+APE         H  +  + D++S GV
Sbjct: 186 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGV 217

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  113 bits (285), Expect = 8e-28
 Identities = 52/213 (24%), Positives = 87/213 (40%), Gaps = 31/213 (14%)

Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVK-----RLSKASGQGAEEFKNEVVLVAK 397
            + +     +G+G F  V + +   +GQ+ AVK     + + + G   E+ K E  +   
Sbjct: 23  EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82

Query: 398 LQHRNLVRLLGFCLEGEEKILVYEFVP---------NKSLDYFLYDPEKQGQLDWSRRYK 448
           L+H ++V LL          +V+EF+           ++   F+Y  E            
Sbjct: 83  LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVY-SEAVAS-------H 134

Query: 449 IIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP---KISDFGMARIFGVDQTQGN 505
            +  I   + Y H+     IIHRD+K   +LL ++ N    K+  FG+A   G       
Sbjct: 135 YMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAG 191

Query: 506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVL 538
               VGT  +MAPE      +    DV+  GV+
Sbjct: 192 G--RVGTPHFMAPEVVKREPYGKPVDVWGCGVI 222

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  112 bits (283), Expect = 1e-27
 Identities = 61/209 (29%), Positives = 104/209 (49%), Gaps = 35/209 (16%)

Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGF 409
           +G+G F +V     + +G+E+A+K + K   +    ++   EV ++  L H N+V+L   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE- 81

Query: 410 CLEGEEKI-LVYEFVPNKSL-DYFLYDPEKQGQL--DWSRRY--KIIGGIARGILYLHED 463
            +E E+ + L+ E+     + DY +      G++    +R    +I+  +     Y H  
Sbjct: 82  VIETEKTLYLIMEYASGGEVFDYLV----AHGRMKEKEARSKFRQIVSAVQ----YCH-- 131

Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE---- 519
            + RI+HRDLKA N+LLDA+MN KI+DFG +  F V     +     G   Y APE    
Sbjct: 132 -QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL-DAF--CGAPPYAAPELFQG 187

Query: 520 --YAMHGQFSVKSDVYSFGVLVLEIITGK 546
             Y        + DV+S GV++  +++G 
Sbjct: 188 KKYD-----GPEVDVWSLGVILYTLVSGS 211

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  113 bits (285), Expect = 1e-27
 Identities = 54/213 (25%), Positives = 87/213 (40%), Gaps = 34/213 (15%)

Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKAS------GQGAEEFKNEVVLVA 396
            + +    +LG G F  V K     +G E A K + K        G   EE + EV ++ 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70

Query: 397 KLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL-------DYFLYDPEKQGQLDWSRRYKI 449
           ++ H N++ L        + +L+ E V    L       +      E++           
Sbjct: 71  QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESL---SEEEAT-------SF 120

Query: 450 IGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP----KISDFGMARIFGVDQTQGN 505
           I  I  G+ YLH     +I H DLK  NI+L  +  P    K+ DFG+A           
Sbjct: 121 IKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE--- 174

Query: 506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVL 538
              I GT  ++APE   +    +++D++S GV+
Sbjct: 175 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  113 bits (284), Expect = 1e-27
 Identities = 55/249 (22%), Positives = 97/249 (38%), Gaps = 31/249 (12%)

Query: 308 RRKAKKKYNAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGV-L 366
             K           N        E    D+   +    K+   + +G G    V + V  
Sbjct: 57  EAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHR 116

Query: 367 PSGQEIAVKRLSKASGQGAEE--------FKNEVVLVAKL-QHRNLVRLLGFCLEGEEKI 417
            +G E AVK +   + + + E         + E  ++ ++  H +++ L+          
Sbjct: 117 ATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMF 176

Query: 418 LVYEFVPNKSL-DYFLYDPEKQGQLDWSRRY--KIIGGIARGILYLHEDSRLRIIHRDLK 474
           LV++ +    L DY      ++  L  S +    I+  +   + +LH      I+HRDLK
Sbjct: 177 LVFDLMRKGELFDYLT----EKVAL--SEKETRSIMRSLLEAVSFLHA---NNIVHRDLK 227

Query: 475 ASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE------YAMHGQFSV 528
             NILLD  M  ++SDFG +      +       + GT GY+APE         H  +  
Sbjct: 228 PENILLDDNMQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGK 284

Query: 529 KSDVYSFGV 537
           + D+++ GV
Sbjct: 285 EVDLWACGV 293

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  111 bits (279), Expect = 2e-27
 Identities = 53/201 (26%), Positives = 89/201 (44%), Gaps = 17/201 (8%)

Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQH 400
           ++ +    +LG+G F  V + V   +G E A K ++    S +  ++ + E  +  KLQH
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64

Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
            N+VRL     E     LV++ V    L +  +     +     +     I  I   I Y
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV----AREFYSEADASHCIQQILESIAY 120

Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNP---KISDFGMARIFGVDQTQGNTSRIVGTYGYM 516
            H      I+HR+LK  N+LL ++      K++DFG+A      +         GT GY+
Sbjct: 121 CHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYL 174

Query: 517 APEYAMHGQFSVKSDVYSFGV 537
           +PE      +S   D+++ GV
Sbjct: 175 SPEVLKKDPYSKPVDIWACGV 195

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  112 bits (282), Expect = 2e-27
 Identities = 57/251 (22%), Positives = 101/251 (40%), Gaps = 53/251 (21%)

Query: 346 KFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--------SGQGAEEFKNEVVLVA 396
           K+ST + LG G FG V+  V     +E+ VK + K               +   E+ +++
Sbjct: 25  KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84

Query: 397 KLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQL--DWSRRY--KIIG 451
           +++H N++++L    E +    LV E   +  LD F +  ++  +L    +     +++ 
Sbjct: 85  RVEHANIIKVLDI-FENQGFFQLVMEKHGS-GLDLFAF-IDRHPRLDEPLASYIFRQLVS 141

Query: 452 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT-SRIV 510
            +     YL       IIHRD+K  NI++  +   K+ DFG A        +G       
Sbjct: 142 AVG----YLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL----ERGKLFYTFC 190

Query: 511 GTYGYMAPE------YAMHGQFSVKSDVYSFGVL--VL-----------EIITGKKNSNF 551
           GT  Y APE      Y   G    + +++S GV    L           E +    +  +
Sbjct: 191 GTIEYCAPEVLMGNPY--RGP---ELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPY 245

Query: 552 YQTDGAADLLS 562
             +     L+S
Sbjct: 246 LVSKELMSLVS 256

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  111 bits (281), Expect = 2e-27
 Identities = 54/213 (25%), Positives = 87/213 (40%), Gaps = 34/213 (15%)

Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA------SGQGAEEFKNEVVLVA 396
            + +    +LG G F  V K     +G E A K + K        G   EE + EV ++ 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70

Query: 397 KLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL-------DYFLYDPEKQGQLDWSRRYKI 449
           ++ H N++ L        + +L+ E V    L       +      E++           
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESL---SEEEAT-------SF 120

Query: 450 IGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP----KISDFGMARIFGVDQTQGN 505
           I  I  G+ YLH     +I H DLK  NI+L  +  P    K+ DFG+A           
Sbjct: 121 IKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE--- 174

Query: 506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVL 538
              I GT  ++APE   +    +++D++S GV+
Sbjct: 175 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  115 bits (290), Expect = 2e-27
 Identities = 70/229 (30%), Positives = 102/229 (44%), Gaps = 33/229 (14%)

Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSKA---SGQGAEEFKNE 391
            F    V          LG+GGFGEV    + +  ++ A K+L K      +G     NE
Sbjct: 185 TFRQYRV----------LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNE 234

Query: 392 VVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQG-QLDWSRRYKI 449
             ++ K+  R +V L  +  E ++ + LV   +    L + +Y   + G     +  Y  
Sbjct: 235 KQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFY-- 291

Query: 450 IGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRI 509
              I  G+  LH     RI++RDLK  NILLD   + +ISD G+A      QT       
Sbjct: 292 AAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGR 345

Query: 510 VGTYGYMAPE---YAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTD 555
           VGT GYMAPE      +  FS   D ++ G L+ E+I G+  S F Q  
Sbjct: 346 VGTVGYMAPEVVKNERYT-FSP--DWWALGCLLYEMIAGQ--SPFQQRK 389

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  112 bits (282), Expect = 2e-27
 Identities = 56/269 (20%), Positives = 96/269 (35%), Gaps = 54/269 (20%)

Query: 328 TTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVK-----RLSKAS 381
           +  E+L F   ++     K+     +G+G +G V   +   +    A+K     ++ + +
Sbjct: 9   SGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQIN 68

Query: 382 GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFV----------------- 423
            +  E  K EV L+ KL H N+ RL     E E+ I LV E                   
Sbjct: 69  PKDVERIKTEVRLMKKLHHPNIARLYE-VYEDEQYICLVMELCHGGHLLDKLNVFIDDST 127

Query: 424 --------------PNKSLDYFLYDPEKQGQLDWSRRY------KIIGGIARGILYLHED 463
                           +  +  +       +              I+  I   + YLH  
Sbjct: 128 GKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN- 186

Query: 464 SRLRIIHRDLKASNILL--DAEMNPKISDFGMARIFGVDQTQGNT--SRIVGTYGYMAPE 519
               I HRD+K  N L   +     K+ DFG+++ F           +   GT  ++APE
Sbjct: 187 --QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE 244

Query: 520 --YAMHGQFSVKSDVYSFGVLVLEIITGK 546
                +  +  K D +S GVL+  ++ G 
Sbjct: 245 VLNTTNESYGPKCDAWSAGVLLHLLLMGA 273

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  116 bits (291), Expect = 2e-27
 Identities = 63/229 (27%), Positives = 98/229 (42%), Gaps = 36/229 (15%)

Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKG-VLPSGQEIAVKRLSKA---SGQGAEEFKNE 391
           DF    +          +G GGFGEVY      +G+  A+K L K      QG     NE
Sbjct: 190 DFSVHRI----------IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE 239

Query: 392 ---VVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRY 447
              + LV+      +V +  +     +K+  + + +    L Y L    + G    +   
Sbjct: 240 RIMLSLVSTGDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMR 295

Query: 448 KIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTS 507
                I  G+ ++H      +++RDLK +NILLD   + +ISD G+A  F   +      
Sbjct: 296 FYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA--- 349

Query: 508 RIVGTYGYMAPEYAMHGQ---FSVKSDVYSFGVLVLEIITGKKNSNFYQ 553
             VGT+GYMAPE    G     S   D +S G ++ +++ G   S F Q
Sbjct: 350 -SVGTHGYMAPEVLQKGVAYDSSA--DWFSLGCMLFKLLRGH--SPFRQ 393

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  110 bits (278), Expect = 2e-27
 Identities = 54/213 (25%), Positives = 89/213 (41%), Gaps = 34/213 (15%)

Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA------SGQGAEEFKNEVVLVA 396
            + +    +LG G F  V K     +G+E A K + K        G   EE + EV ++ 
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63

Query: 397 KLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL-------DYFLYDPEKQGQLDWSRRYKI 449
           +++H N++ L        + +L+ E V    L       +      E +         + 
Sbjct: 64  EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESL---TEDEAT-------QF 113

Query: 450 IGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP----KISDFGMARIFGVDQTQGN 505
           +  I  G+ YLH     RI H DLK  NI+L  +  P    K+ DFG+A           
Sbjct: 114 LKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE--- 167

Query: 506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVL 538
              I GT  ++APE   +    +++D++S GV+
Sbjct: 168 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 200

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  111 bits (278), Expect = 5e-27
 Identities = 60/278 (21%), Positives = 90/278 (32%), Gaps = 76/278 (27%)

Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEE-FKNEVV 393
           DFE I+           +G GGFG V++          A+KR+   + + A E    EV 
Sbjct: 7   DFEPIQC----------MGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVK 56

Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKI---- 449
            +AKL+H  +VR     LE   +    E       D     P        +   KI    
Sbjct: 57  ALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMD 116

Query: 450 -----------IGGIARGILYLH-----------------------EDSRLRI------- 468
                           +  LY+                            L I       
Sbjct: 117 PFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEA 176

Query: 469 ---------IHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTS----------RI 509
                    +HRDLK SNI    +   K+ DFG+      D+ +                
Sbjct: 177 VEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQ 236

Query: 510 VGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKK 547
           VGT  YM+PE      +S K D++S G+++ E++    
Sbjct: 237 VGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFS 274

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  112 bits (282), Expect = 6e-27
 Identities = 51/212 (24%), Positives = 91/212 (42%), Gaps = 27/212 (12%)

Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEE--------FKNEVVL 394
            +++     LG G  GEV       + +++A++ +SK                 + E+ +
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193

Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGI 453
           + KL H  ++++  F  + E+  +V E +    L D  +       +L  +        +
Sbjct: 194 LKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQM 248

Query: 454 ARGILYLHEDSRLRIIHRDLKASNILLDAEMNP---KISDFGMARIFGVDQTQGNTSRIV 510
              + YLHE     IIHRDLK  N+LL ++      KI+DFG ++I G          + 
Sbjct: 249 LLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLC 302

Query: 511 GTYGYMAPE---YAMHGQFSVKSDVYSFGVLV 539
           GT  Y+APE         ++   D +S GV++
Sbjct: 303 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  110 bits (277), Expect = 7e-27
 Identities = 52/210 (24%), Positives = 89/210 (42%), Gaps = 27/210 (12%)

Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEE--------FKNEVVL 394
            +++     LG G  GEV       + +++A+K +SK                 + E+ +
Sbjct: 9   RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68

Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGI 453
           + KL H  ++++  F  + E+  +V E +    L D  +       +L  +        +
Sbjct: 69  LKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQM 123

Query: 454 ARGILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMARIFGVDQTQGNTSRIV 510
              + YLHE     IIHRDLK  N+LL   + +   KI+DFG ++I G          + 
Sbjct: 124 LLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLC 177

Query: 511 GTYGYMAPE---YAMHGQFSVKSDVYSFGV 537
           GT  Y+APE         ++   D +S GV
Sbjct: 178 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGV 207

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  110 bits (277), Expect = 8e-27
 Identities = 56/213 (26%), Positives = 90/213 (42%), Gaps = 34/213 (15%)

Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA------SGQGAEEFKNEVVLVA 396
            + + T  +LG G F  V K     +G + A K + K        G   E+ + EV ++ 
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69

Query: 397 KLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL-------DYFLYDPEKQGQLDWSRRYKI 449
           ++QH N++ L        + IL+ E V    L       +      E++         + 
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESL---TEEEAT-------EF 119

Query: 450 IGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP----KISDFGMARIFGVDQTQGN 505
           +  I  G+ YLH    L+I H DLK  NI+L     P    KI DFG+A           
Sbjct: 120 LKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--- 173

Query: 506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVL 538
              I GT  ++APE   +    +++D++S GV+
Sbjct: 174 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 206

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  109 bits (274), Expect = 1e-26
 Identities = 60/225 (26%), Positives = 93/225 (41%), Gaps = 57/225 (25%)

Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSKA--------------------------SGQGA 385
           +G+G +G V            A+K LSK                                
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 386 EEFKNEVVLVAKLQHRNLVRLLGFCLE-----GEEKI-LVYEFVPNKSLDYFLYDPEKQG 439
           E+   E+ ++ KL H N+V+L+    E      E+ + +V+E V    +     +     
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLV----EVLDDPNEDHLYMVFELVNQGPV----MEVPTLK 132

Query: 440 QL--DWSRRY--KIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
            L  D +R Y   +I GI     YLH     +IIHRD+K SN+L+  + + KI+DFG++ 
Sbjct: 133 PLSEDQARFYFQDLIKGIE----YLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSN 185

Query: 496 IFGVDQTQGNTSRIVGTYGYMAPE--YAMHGQFS-VKSDVYSFGV 537
            F       + +  VGT  +MAPE        FS    DV++ GV
Sbjct: 186 EFKGSDALLSNT--VGTPAFMAPESLSETRKIFSGKALDVWAMGV 228

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  112 bits (282), Expect = 1e-26
 Identities = 65/235 (27%), Positives = 105/235 (44%), Gaps = 34/235 (14%)

Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSKA---SGQGAEEFKNE 391
            F    V          LG GGFGEV+   + +  ++ A K+L+K      +G +    E
Sbjct: 186 WFLDFRV----------LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVE 235

Query: 392 VVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQL---DWSRRY 447
             ++AK+  R +V L  +  E +  + LV   +    + Y +Y+ ++         +  Y
Sbjct: 236 KKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294

Query: 448 KIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTS 507
                I  G+ +LH+     II+RDLK  N+LLD + N +ISD G+A      QT+    
Sbjct: 295 --TAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY 349

Query: 508 RIVGTYGYMAPE---YAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAAD 559
              GT G+MAPE      +  FSV  D ++ GV + E+I  +    F       +
Sbjct: 350 --AGTPGFMAPELLLGEEYD-FSV--DYFALGVTLYEMIAAR--GPFRARGEKVE 397

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  109 bits (274), Expect = 2e-26
 Identities = 58/241 (24%), Positives = 100/241 (41%), Gaps = 47/241 (19%)

Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKN------EVVLVAKLQHR--NL 403
           LG GGFG VY G+ +     +A+K + K       E  N      EVVL+ K+      +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110

Query: 404 VRLLGFCLEGEEKI-LVYEFV-PNKSL-DYFLYDPEKQGQL--DWSRRY--KIIGGIARG 456
           +RLL +  E  +   L+ E   P + L D+      ++G L  + +R +  +++  +   
Sbjct: 111 IRLLDW-FERPDSFVLILERPEPVQDLFDFI----TERGALQEELARSFFWQVLEAVR-- 163

Query: 457 ILYLHEDSRLRIIHRDLKASNILLDAE-MNPKISDFGMARIFGVDQTQGNTSRIVGTYGY 515
             + H      ++HRD+K  NIL+D      K+ DFG   +          +   GT  Y
Sbjct: 164 --HCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVY 214

Query: 516 MAPEYAMHGQFS-VKSDVYSFGVL--VL-----------EIITGKKNSNFYQTDGAADLL 561
             PE+  + ++    + V+S G+L   +           EII G+       +     L+
Sbjct: 215 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLI 274

Query: 562 S 562
            
Sbjct: 275 R 275

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  109 bits (275), Expect = 2e-26
 Identities = 54/203 (26%), Positives = 89/203 (43%), Gaps = 21/203 (10%)

Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQH 400
           ++ +    +LG+G F  V + V   +G E A K ++    S +  ++ + E  +  KLQH
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87

Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRY--KIIGGIARGI 457
            N+VRL     E     LV++ V    L +  +     +     S       I  I   I
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV----AREFY--SEADASHCIQQILESI 141

Query: 458 LYLHEDSRLRIIHRDLKASNILLDAEMNP---KISDFGMARIFGVDQTQGNTSRIVGTYG 514
            Y H      I+HR+LK  N+LL ++      K++DFG+A      +         GT G
Sbjct: 142 AYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPG 195

Query: 515 YMAPEYAMHGQFSVKSDVYSFGV 537
           Y++PE      +S   D+++ GV
Sbjct: 196 YLSPEVLKKDPYSKPVDIWACGV 218

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  107 bits (269), Expect = 6e-26
 Identities = 59/243 (24%), Positives = 103/243 (42%), Gaps = 49/243 (20%)

Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSK------ASGQGAEEFKNEVVLVAKL----QHR 401
           LG+GGFG V+ G  L    ++A+K + +      +    +     EV L+ K+     H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 402 NLVRLLGFCLEGEEKI-LVYEF-VPNKSL-DYFLYDPEKQGQL--DWSRRY--KIIGGIA 454
            ++RLL +  E +E   LV E  +P + L DY      ++G L    SR +  +++  I 
Sbjct: 99  GVIRLLDW-FETQEGFMLVLERPLPAQDLFDYI----TEKGPLGEGPSRCFFGQVVAAIQ 153

Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMARIFGVDQTQGNTSRIVGTY 513
               + H      ++HRD+K  NIL+D      K+ DFG   +          +   GT 
Sbjct: 154 ----HCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL----HDEPYTDFDGTR 202

Query: 514 GYMAPEYAMHGQFS-VKSDVYSFGVL--VL-----------EIITGKKNSNFYQTDGAAD 559
            Y  PE+    Q+  + + V+S G+L   +           EI+  + +   + +     
Sbjct: 203 VYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHVSPDCCA 262

Query: 560 LLS 562
           L+ 
Sbjct: 263 LIR 265

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  106 bits (267), Expect = 6e-26
 Identities = 63/213 (29%), Positives = 102/213 (47%), Gaps = 42/213 (19%)

Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLG 408
           LG G FG+V  G    +G ++AVK L++    S     + K E+  +   +H ++++L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78

Query: 409 FCLEGEEKI-LVYEFVPNKSL-DYFLYDPEKQGQL--DWSRRY--KIIGGIARGILYLHE 462
             +       +V E+V    L DY      K G++    +RR   +I+  +     Y H 
Sbjct: 79  -VISTPTDFFMVMEYVSGGELFDYIC----KHGRVEEMEARRLFQQILSAVD----YCH- 128

Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN---TSRIVGTYGYMAPE 519
             R  ++HRDLK  N+LLDA MN KI+DFG++ +     + G    TS   G+  Y APE
Sbjct: 129 --RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM----SDGEFLRTS--CGSPNYAAPE 180

Query: 520 ------YAMHGQFSVKSDVYSFGVLVLEIITGK 546
                 Y   G    + D++S GV++  ++ G 
Sbjct: 181 VISGRLY--AGP---EVDIWSCGVILYALLCGT 208

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  109 bits (274), Expect = 7e-26
 Identities = 65/232 (28%), Positives = 104/232 (44%), Gaps = 59/232 (25%)

Query: 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKN-EVVLVAKLQHR 401
              ++    +G G FG VY+  L  SG+ +A+K++ +      + FKN E+ ++ KL H 
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHC 107

Query: 402 NLVRLLGFCLEGEEKI------LVYEFVP-------------NKSLD-----YFLYDPEK 437
           N+VRL  F     EK       LV ++VP              ++L       ++Y    
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY---- 163

Query: 438 QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMARI 496
             QL             R + Y+H      I HRD+K  N+LLD +    K+ DFG A+ 
Sbjct: 164 --QL------------FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206

Query: 497 FGVDQTQGNTSRIVGTYGYMAPEYAMHG--QFSVKSDVYSFGVLVLEIITGK 546
               + + N S I   Y Y APE  + G   ++   DV+S G ++ E++ G+
Sbjct: 207 L--VRGEPNVSYICSRY-YRAPE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  106 bits (268), Expect = 9e-26
 Identities = 65/218 (29%), Positives = 106/218 (48%), Gaps = 22/218 (10%)

Query: 343 ATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKN-----EVVLVA 396
           AT+++    ++G G +G VYK     SG  +A+K +   +G G           EV L+ 
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66

Query: 397 KLQ---HRNLVRLL----GFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYK 448
           +L+   H N+VRL+        + E K+ LV+E V ++ L  +L D      L       
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKD 124

Query: 449 IIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR 508
           ++    RG+ +LH +    I+HRDLK  NIL+ +    K++DFG+ARI+        T  
Sbjct: 125 LMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL--TPV 179

Query: 509 IVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
           +V T  Y APE  +   ++   D++S G +  E+   K
Sbjct: 180 VV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  106 bits (268), Expect = 1e-25
 Identities = 61/232 (26%), Positives = 100/232 (43%), Gaps = 35/232 (15%)

Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVY----KGVLPSGQEIAVKRLSKAS---GQGAEEF 388
           DF+  ++          LGEG F  V          + +E A+K L K            
Sbjct: 31  DFKFGKI----------LGEGSFSTVVLARELA---TSREYAIKILEKRHIIKENKVPYV 77

Query: 389 KNEVVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQL--DWSR 445
             E  ++++L H   V+L  F  + +EK+     +  N  L  ++    K G      +R
Sbjct: 78  TRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFDETCTR 133

Query: 446 RYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN 505
            Y     I   + YLH      IIHRDLK  NILL+ +M+ +I+DFG A++   +  Q  
Sbjct: 134 FY--TAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 188

Query: 506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK---KNSNFYQT 554
            +  VGT  Y++PE          SD+++ G ++ +++ G    +  N Y  
Sbjct: 189 ANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI 240

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  106 bits (268), Expect = 1e-25
 Identities = 53/206 (25%), Positives = 85/206 (41%), Gaps = 32/206 (15%)

Query: 349 TDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHR-NLV 404
           T  +LG G F  V + +   +GQE A K L K         E  +E+ ++   +    ++
Sbjct: 33  TSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVI 92

Query: 405 RLLGFCLEGEEKILVYEFVP---------NKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
            L        E IL+ E+            +  +      E           ++I  I  
Sbjct: 93  NLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMV---SENDVI-------RLIKQILE 142

Query: 456 GILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
           G+ YLH+     I+H DLK  NILL       + KI DFGM+R  G          I+GT
Sbjct: 143 GVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE---LREIMGT 196

Query: 513 YGYMAPEYAMHGQFSVKSDVYSFGVL 538
             Y+APE   +   +  +D+++ G++
Sbjct: 197 PEYLAPEILNYDPITTATDMWNIGII 222

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  106 bits (268), Expect = 1e-25
 Identities = 64/219 (29%), Positives = 94/219 (42%), Gaps = 38/219 (17%)

Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVK--RLSKASGQGAEEFKN----EVVLVAK 397
            K+     +GEG +G V K     +G+ +A+K    S       +  K     E+ L+ +
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDD----KMVKKIAMREIKLLKQ 80

Query: 398 LQHRNLVRLLGFCLEGEEKILVYEFVPN---KSLDYFLYDPEKQGQLDWSRRYKIIGGIA 454
           L+H NLV LL  C + +   LV+EFV +     L+           LD+    K +  I 
Sbjct: 81  LRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLE------LFPNGLDYQVVQKYLFQII 134

Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
            GI + H      IIHRD+K  NIL+      K+ DFG AR       +     +  T  
Sbjct: 135 NGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA-PGEVYDDEVA-TRW 189

Query: 515 YMAPE-------YAMHGQFSVKSDVYSFGVLVLEIITGK 546
           Y APE       Y      +V  DV++ G LV E+  G+
Sbjct: 190 YRAPELLVGDVKYGK----AV--DVWAIGCLVTEMFMGE 222

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  108 bits (271), Expect = 2e-25
 Identities = 51/210 (24%), Positives = 89/210 (42%), Gaps = 34/210 (16%)

Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEE--FKNEVVLVAKLQH 400
           T ++    +LG+G F  V + V + +GQE A   ++       +    + E  +   L+H
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69

Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQL-DW--SRRY-------KII 450
            N+VRL     E     L+++ V               G+L +   +R Y         I
Sbjct: 70  PNIVRLHDSISEEGHHYLIFDLV-------------TGGELFEDIVAREYYSEADASHCI 116

Query: 451 GGIARGILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMARIFGVDQTQGNTS 507
             I   +L+ H+   + ++HR+LK  N+LL         K++DFG+A     +Q      
Sbjct: 117 QQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG- 172

Query: 508 RIVGTYGYMAPEYAMHGQFSVKSDVYSFGV 537
              GT GY++PE      +    D+++ GV
Sbjct: 173 -FAGTPGYLSPEVLRKDPYGKPVDLWACGV 201

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  104 bits (263), Expect = 4e-25
 Identities = 65/211 (30%), Positives = 107/211 (50%), Gaps = 23/211 (10%)

Query: 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKN--------EVVLVA 396
            K+    K+GEG +G VYK     G+ +A+KR+        +            E+ L+ 
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR------LDAEDEGIPSTAIREISLLK 74

Query: 397 KLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARG 456
           +L H N+V L+          LV+EF+  K L   L +   +  L  S+    +  + RG
Sbjct: 75  ELHHPNIVSLIDVIHSERCLTLVFEFME-KDLKKVLDE--NKTGLQDSQIKIYLYQLLRG 131

Query: 457 ILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYM 516
           + + H+    RI+HRDLK  N+L++++   K++DFG+AR FG+   +  T  +V T  Y 
Sbjct: 132 VAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGI-PVRSYTHEVV-TLWYR 186

Query: 517 APEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
           AP+  M   ++S   D++S G +  E+ITGK
Sbjct: 187 APDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  105 bits (264), Expect = 4e-25
 Identities = 64/213 (30%), Positives = 107/213 (50%), Gaps = 18/213 (8%)

Query: 343 ATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKN-----EVVLVA 396
           ++++F    KLG G +  VYKG+   +G  +A+K +       +EE        E+ L+ 
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVK----LDSEEGTPSTAIREISLMK 58

Query: 397 KLQHRNLVRLLGFCLEGEEKILVYEFVPN--KSLDYFLYDPEKQGQLDWSRRYKIIGGIA 454
           +L+H N+VRL        +  LV+EF+ N  K              L+ +        + 
Sbjct: 59  ELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118

Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
           +G+ + HE+   +I+HRDLK  N+L++     K+ DFG+AR FG+      +S +V T  
Sbjct: 119 QGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGI-PVNTFSSEVV-TLW 173

Query: 515 YMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
           Y AP+  M    +S   D++S G ++ E+ITGK
Sbjct: 174 YRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  105 bits (264), Expect = 4e-25
 Identities = 60/220 (27%), Positives = 107/220 (48%), Gaps = 32/220 (14%)

Query: 345 NKFSTDNKLGEGGFGEVYKG--VLPSGQEIAVKRLSKASGQGAEEFKN--------EVVL 394
            ++    ++GEG +G+V+K   +   G+ +A+KR+        +  +         EV +
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR------VQTGEEGMPLSTIREVAV 64

Query: 395 VAKLQ---HRNLVRLL----GFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRR 446
           +  L+   H N+VRL         + E K+ LV+E V ++ L  +L D   +  +     
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETI 122

Query: 447 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT 506
             ++  + RG+ +LH     R++HRDLK  NIL+ +    K++DFG+ARI+        T
Sbjct: 123 KDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--T 177

Query: 507 SRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
           S +V T  Y APE  +   ++   D++S G +  E+   K
Sbjct: 178 SVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  105 bits (264), Expect = 5e-25
 Identities = 63/212 (29%), Positives = 105/212 (49%), Gaps = 41/212 (19%)

Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLG 408
           LGEG FG+V       + Q++A+K +S+            + E+  +  L+H ++++L  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76

Query: 409 FCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQL--DWSRRY--KIIGGIARGILYLHED 463
             +     I +V E+   +  DY +    ++ ++  D  RR+  +II  I     Y H  
Sbjct: 77  V-ITTPTDIVMVIEYAGGELFDYIV----EKKRMTEDEGRRFFQQIICAIE----YCH-- 125

Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN---TSRIVGTYGYMAPE- 519
            R +I+HRDLK  N+LLD  +N KI+DFG++ I     T GN   TS   G+  Y APE 
Sbjct: 126 -RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIM----TDGNFLKTS--CGSPNYAAPEV 178

Query: 520 -----YAMHGQFSVKSDVYSFGVLVLEIITGK 546
                Y   G    + DV+S G+++  ++ G+
Sbjct: 179 INGKLY--AGP---EVDVWSCGIVLYVMLVGR 205

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  103 bits (260), Expect = 7e-25
 Identities = 62/212 (29%), Positives = 107/212 (50%), Gaps = 25/212 (11%)

Query: 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKN--------EVVLVA 396
            K+    K+GEG +G VYK     G+  A+K++        E+           E+ ++ 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR------LEKEDEGIPSTTIREISILK 55

Query: 397 KLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
           +L+H N+V+L    +  ++++ LV+E +  + L   L     +G L+       +  +  
Sbjct: 56  ELKHSNIVKLYD-VIHTKKRLVLVFEHLD-QDLKKLLDV--CEGGLESVTAKSFLLQLLN 111

Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGY 515
           GI Y H+    R++HRDLK  N+L++ E   KI+DFG+AR FG+   +  T  IV T  Y
Sbjct: 112 GIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGI-PVRKYTHEIV-TLWY 166

Query: 516 MAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
            AP+  M   ++S   D++S G +  E++ G 
Sbjct: 167 RAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  105 bits (263), Expect = 7e-25
 Identities = 57/244 (23%), Positives = 99/244 (40%), Gaps = 35/244 (14%)

Query: 308 RRKAKKKYNAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGV-L 366
                +  ++V  S A    + +     D    +  ++ F  +++LG G    VY+    
Sbjct: 16  ENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQK 75

Query: 367 PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNK 426
            + +  A+K L K   +  +  + E+ ++ +L H N+++L        E  LV E V   
Sbjct: 76  GTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELV--- 130

Query: 427 SLDYFLYDPEKQGQL-DW--SRRY-------KIIGGIARGILYLHEDSRLRIIHRDLKAS 476
                       G+L D    + Y         +  I   + YLHE     I+HRDLK  
Sbjct: 131 ----------TGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPE 177

Query: 477 NILL---DAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVY 533
           N+L      +   KI+DFG+++I            + GT GY APE      +  + D++
Sbjct: 178 NLLYATPAPDAPLKIADFGLSKIVEHQVL---MKTVCGTPGYCAPEILRGCAYGPEVDMW 234

Query: 534 SFGV 537
           S G+
Sbjct: 235 SVGI 238

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  104 bits (263), Expect = 7e-25
 Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 23/213 (10%)

Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKN--------EVVLV 395
            ++   + LGEG F  VYK     + Q +A+K++         E K+        E+ L+
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGH---RSEAKDGINRTALREIKLL 66

Query: 396 AKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIA 454
            +L H N++ LL      +  I LV++F+    L+  + D      L  S     +    
Sbjct: 67  QELSHPNIIGLLD-AFGHKSNISLVFDFME-TDLEVIIKDN--SLVLTPSHIKAYMLMTL 122

Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
           +G+ YLH+     I+HRDLK +N+LLD     K++DFG+A+ FG    +  T ++V T  
Sbjct: 123 QGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFG-SPNRAYTHQVV-TRW 177

Query: 515 YMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
           Y APE       + V  D+++ G ++ E++   
Sbjct: 178 YRAPELLFGARMYGVGVDMWAVGCILAELLLRV 210

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  106 bits (267), Expect = 8e-25
 Identities = 66/213 (30%), Positives = 104/213 (48%), Gaps = 42/213 (19%)

Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLG 408
           LG G FG+V  G    +G ++AVK L++    S     + + E+  +   +H ++++L  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83

Query: 409 FCLEGEEKI-LVYEFVPNKSL-DYFLYDPEKQGQL--DWSRRY--KIIGGIARGILYLHE 462
             +     I +V E+V    L DY      K G+L    SRR   +I+ G+     Y H 
Sbjct: 84  V-ISTPSDIFMVMEYVSGGELFDYIC----KNGRLDEKESRRLFQQILSGVD----YCH- 133

Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN---TSRIVGTYGYMAPE 519
             R  ++HRDLK  N+LLDA MN KI+DFG++ +     + G    TS   G+  Y APE
Sbjct: 134 --RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM----SDGEFLRTS--CGSPNYAAPE 185

Query: 520 ------YAMHGQFSVKSDVYSFGVLVLEIITGK 546
                 YA       + D++S GV++  ++ G 
Sbjct: 186 VISGRLYA-----GPEVDIWSSGVILYALLCGT 213

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  103 bits (260), Expect = 9e-25
 Identities = 54/213 (25%), Positives = 90/213 (42%), Gaps = 26/213 (12%)

Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVK--RLSKASGQGAEEFKN----EVVLVAK 397
            K+    K+GEG +G V+K     +GQ +A+K    S+         K     E+ ++ +
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDD----PVIKKIALREIRMLKQ 58

Query: 398 LQHRNLVRLLGFCLEGEEKILVYEFVPN---KSLDYFLYDPEKQGQLDWSRRYKIIGGIA 454
           L+H NLV LL          LV+E+  +     LD        Q  +       I     
Sbjct: 59  LKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELD------RYQRGVPEHLVKSITWQTL 112

Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
           + + + H   +   IHRD+K  NIL+      K+ DFG AR+     +      +  T  
Sbjct: 113 QAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTG-PSDYYDDEVA-TRW 167

Query: 515 YMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
           Y +PE  +   Q+    DV++ G +  E+++G 
Sbjct: 168 YRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  105 bits (263), Expect = 1e-24
 Identities = 48/183 (26%), Positives = 88/183 (48%), Gaps = 20/183 (10%)

Query: 352 KLGEGGFGEVYKGV---LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLG 408
           K+G G +G VYK         ++ A+K++ + +G      + E+ L+ +L+H N++ L  
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALKQI-EGTGISMSACR-EIALLRELKHPNVISLQK 85

Query: 409 FCLE-GEEKI-LVYEFVPN---KSLDYFLYDPEKQGQLDWSRRY--KIIGGIARGILYLH 461
             L   + K+ L++++  +     + +       +  +   R     ++  I  GI YLH
Sbjct: 86  VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145

Query: 462 EDSRLRIIHRDLKASNILLDAEMNP----KISDFGMARIFGV-DQTQGNTSRIVGTYGYM 516
            +    ++HRDLK +NIL+  E       KI+D G AR+F    +   +   +V T+ Y 
Sbjct: 146 AN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 202

Query: 517 APE 519
           APE
Sbjct: 203 APE 205

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  104 bits (261), Expect = 2e-24
 Identities = 57/244 (23%), Positives = 96/244 (39%), Gaps = 63/244 (25%)

Query: 337 FETIEVATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKR-LSKASGQGAEEFKN---- 390
            E      ++F  +   G+G FG V  G    +G  +A+K+ +          F+N    
Sbjct: 15  DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR------FRNRELQ 68

Query: 391 EVVLVAKLQHRNLVRLLGFCLEGEEK-------ILVYEFVP-------------NKSLD- 429
            +  +A L H N+V+L  +     E+        +V E+VP               +   
Sbjct: 69  IMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPP 128

Query: 430 ----YFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN 485
                FL+      QL             R I  LH  S + + HRD+K  N+L++    
Sbjct: 129 ILIKVFLF------QL------------IRSIGCLHLPS-VNVCHRDIKPHNVLVNEADG 169

Query: 486 P-KISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG--QFSVKSDVYSFGVLVLEI 542
             K+ DFG A+     +   N + I   Y Y APE  + G   ++   D++S G +  E+
Sbjct: 170 TLKLCDFGSAKKLSPSEP--NVAYICSRY-YRAPEL-IFGNQHYTTAVDIWSVGCIFAEM 225

Query: 543 ITGK 546
           + G+
Sbjct: 226 MLGE 229

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  103 bits (258), Expect = 2e-24
 Identities = 53/202 (26%), Positives = 83/202 (41%), Gaps = 23/202 (11%)

Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ-HRNLVRLLGFC 410
           LGEG    V   + L + QE AVK + K  G        EV ++ + Q HRN++ L+ F 
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80

Query: 411 LEGEEKILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRII 469
            E +   LV+E +   S+  +      K+   +      ++  +A  + +LH      I 
Sbjct: 81  EEEDRFYLVFEKMRGGSILSHIH----KRRHFNELEASVVVQDVASALDFLHN---KGIA 133

Query: 470 HRDLKASNILL---DAEMNPKISDFGMARIF-----GVDQTQGNTSRIVGTYGYMAPE-- 519
           HRDLK  NIL    +     KI DF +             +        G+  YMAPE  
Sbjct: 134 HRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVV 193

Query: 520 ---YAMHGQFSVKSDVYSFGVL 538
                    +  + D++S GV+
Sbjct: 194 EAFSEEASIYDKRCDLWSLGVI 215

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  103 bits (259), Expect = 2e-24
 Identities = 55/203 (27%), Positives = 87/203 (42%), Gaps = 22/203 (10%)

Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRN 402
           T+ +     +G G +    + +   +  E AVK + K+     EE     +L+   QH N
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE---IEILLRYGQHPN 77

Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRY--KIIGGIARGILY 459
           ++ L     +G+   +V E +    L D  L    +Q     S R    ++  I + + Y
Sbjct: 78  IITLKDVYDDGKYVYVVTELMKGGELLDKIL----RQKFF--SEREASAVLFTITKTVEY 131

Query: 460 LHEDSRLRIIHRDLKASNILL-DAEMNP---KISDFGMARIFGVDQTQGNTSRIVGTYGY 515
           LH      ++HRDLK SNIL  D   NP   +I DFG A+    +     T     T  +
Sbjct: 132 LHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT--PCYTANF 186

Query: 516 MAPEYAMHGQFSVKSDVYSFGVL 538
           +APE      +    D++S GVL
Sbjct: 187 VAPEVLERQGYDAACDIWSLGVL 209

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  101 bits (255), Expect = 3e-24
 Identities = 54/214 (25%), Positives = 103/214 (48%), Gaps = 26/214 (12%)

Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKN--------EVVLV 395
            K+    K+GEG +G V+K     + + +A+KR+        ++           E+ L+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLL 55

Query: 396 AKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIA 454
            +L+H+N+VRL    L  ++K+ LV+EF   + L  +       G LD       +  + 
Sbjct: 56  KELKHKNIVRLHD-VLHSDKKLTLVFEFCD-QDLKKYFDS--CNGDLDPEIVKSFLFQLL 111

Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
           +G+ + H      ++HRDLK  N+L++     K+++FG+AR FG+   +  ++ +V T  
Sbjct: 112 KGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGI-PVRCYSAEVV-TLW 166

Query: 515 YMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKK 547
           Y  P+       +S   D++S G +  E+    +
Sbjct: 167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  101 bits (255), Expect = 6e-24
 Identities = 57/217 (26%), Positives = 96/217 (44%), Gaps = 30/217 (13%)

Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKN--------EVVLV 395
           +++    KLGEG +GEVYK +   + + +A+KR+        E  +         EV L+
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR------LEHEEEGVPGTAIREVSLL 87

Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
            +LQHRN++ L           L++E+     L  ++   +K   +        +  +  
Sbjct: 88  KELQHRNIIELKSVIHHNHRLHLIFEYA-ENDLKKYM---DKNPDVSMRVIKSFLYQLIN 143

Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNP-----KISDFGMARIFGVDQTQGNTSRIV 510
           G+ + H     R +HRDLK  N+LL           KI DFG+AR FG+   +  T  I+
Sbjct: 144 GVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI-PIRQFTHEII 199

Query: 511 GTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
            T  Y  PE  +    +S   D++S   +  E++   
Sbjct: 200 -TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  101 bits (254), Expect = 9e-24
 Identities = 57/210 (27%), Positives = 102/210 (48%), Gaps = 21/210 (10%)

Query: 345 NKFSTDNKLGEGGFGEVYKG-VLPSGQEIAVKRLSKASGQGAEEFKN-----EVVLVAKL 398
             +   +KLGEG +  VYKG    +   +A+K +        EE        EV L+  L
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIR----LEHEEGAPCTAIREVSLLKDL 57

Query: 399 QHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGI 457
           +H N+V L    +  E+ + LV+E++ +K L  +L D      ++       +  + RG+
Sbjct: 58  KHANIVTLHD-IIHTEKSLTLVFEYL-DKDLKQYLDDC--GNIINMHNVKLFLFQLLRGL 113

Query: 458 LYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMA 517
            Y H     +++HRDLK  N+L++     K++DFG+AR   +  T+   + +V T  Y  
Sbjct: 114 AYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSI-PTKTYDNEVV-TLWYRP 168

Query: 518 PEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
           P+  +    +S + D++  G +  E+ TG+
Sbjct: 169 PDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 99.7 bits (249), Expect = 3e-23
 Identities = 49/225 (21%), Positives = 87/225 (38%), Gaps = 33/225 (14%)

Query: 331 ESLQFDFETIEVATNKFS-----TDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQG 384
             L+  F+  E      +     +   LG G  G+V +     +GQ+ A+K L  +    
Sbjct: 10  SGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---- 65

Query: 385 AEEFKNEV-VLVAKLQHRNLVRLLGFCLEGEEKI----LVYEFVPNKSL-DYFLYDPEKQ 438
             + + EV          ++V +L              ++ E +    L         ++
Sbjct: 66  -PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQ----ER 120

Query: 439 GQLDWSRRY--KIIGGIARGILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGM 493
           G   ++ R   +I+  I   I +LH      I HRD+K  N+L    + +   K++DFG 
Sbjct: 121 GDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177

Query: 494 ARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVL 538
           A+      TQ        T  Y+APE     ++    D++S GV+
Sbjct: 178 AKET----TQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVI 218

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  100 bits (250), Expect = 4e-23
 Identities = 53/200 (26%), Positives = 90/200 (45%), Gaps = 36/200 (18%)

Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCL 411
           +G G FG         + + +AVK + + +    E  + E++    L+H N+VR     +
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAI-DENVQREIINHRSLRHPNIVRFKE-VI 85

Query: 412 EGEEKI-LVYEFVPNKSL-DYFLYDPEKQGQL--DWSRRY--KIIGGIARGILYLHEDSR 465
                + ++ E+     L +         G+   D +R +  +++ G++    Y H    
Sbjct: 86  LTPTHLAIIMEYASGGELYERIC----NAGRFSEDEARFFFQQLLSGVS----YCH---S 134

Query: 466 LRIIHRDLKASNILLDA--EMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE---- 519
           ++I HRDLK  N LLD       KI DFG ++   V  +Q  ++  VGT  Y+APE    
Sbjct: 135 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS-VLHSQPKST--VGTPAYIAPEVLLR 191

Query: 520 --YAMHGQFSVKSDVYSFGV 537
             Y   G+    +DV+S GV
Sbjct: 192 QEYD--GK---IADVWSCGV 206

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 99.6 bits (249), Expect = 5e-23
 Identities = 57/223 (25%), Positives = 106/223 (47%), Gaps = 34/223 (15%)

Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVK--RLSKASGQGAEEFKN----EVVLVAK 397
           +K+    K+G+G FGEV+K     +GQ++A+K   +        E F      E+ ++  
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK----EGFPITALREIKILQL 72

Query: 398 LQHRNLVRLLGFCLEGEEKI--------LVYEFVPN--KSLDYFLYDPEKQGQLDWSRRY 447
           L+H N+V L+  C               LV++F  +    L   L +     +   S   
Sbjct: 73  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGL---LSNV--LVKFTLSEIK 127

Query: 448 KIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN-- 505
           +++  +  G+ Y+H +   +I+HRD+KA+N+L+  +   K++DFG+AR F + +      
Sbjct: 128 RVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 184

Query: 506 -TSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
            T+R+V T  Y  PE  +    +    D++  G ++ E+ T  
Sbjct: 185 YTNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  100 bits (250), Expect = 8e-23
 Identities = 58/225 (25%), Positives = 93/225 (41%), Gaps = 35/225 (15%)

Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVY----KGVLPSGQEIAVKRLSKA---SGQGAEEF 388
           DFE ++V          +G G F EV     K    +GQ  A+K ++K           F
Sbjct: 62  DFEILKV----------IGRGAFSEVAVVKMKQ---TGQVYAMKIMNKWDMLKRGEVSCF 108

Query: 389 KNEVVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRY 447
           + E  ++     R + +L  F  + E  + LV E+     L   L    ++   + +R Y
Sbjct: 109 REERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFY 167

Query: 448 KIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTS 507
             +  I   I  +H    L  +HRD+K  NILLD   + +++DFG       D T   + 
Sbjct: 168 --LAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVR-SL 221

Query: 508 RIVGTYGYMAPE-------YAMHGQFSVKSDVYSFGVLVLEIITG 545
             VGT  Y++PE           G +  + D ++ GV   E+  G
Sbjct: 222 VAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYG 266

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 98.5 bits (246), Expect = 9e-23
 Identities = 52/197 (26%), Positives = 81/197 (41%), Gaps = 18/197 (9%)

Query: 348 STDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ-HRNLVR 405
             D  LGEG F    K V   S Q  AVK +SK         + E+  +   + H N+V+
Sbjct: 14  LKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVK 70

Query: 406 LLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
           L       +    LV E +    L       +K+     +    I+  +   + ++H+  
Sbjct: 71  LHEVF-HDQLHTFLVMELLNGGEL---FERIKKKKHFSETEASYIMRKLVSAVSHMHD-- 124

Query: 465 RLRIIHRDLKASNILL---DAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYA 521
            + ++HRDLK  N+L    +  +  KI DFG AR+   D     T     T  Y APE  
Sbjct: 125 -VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFTLHYAAPELL 181

Query: 522 MHGQFSVKSDVYSFGVL 538
               +    D++S GV+
Sbjct: 182 NQNGYDESCDLWSLGVI 198

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 99.4 bits (248), Expect = 2e-22
 Identities = 55/220 (25%), Positives = 98/220 (44%), Gaps = 27/220 (12%)

Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSKA---SGQGAEEFKNE 391
           DFE ++V          +G G FGEV    L +  ++ A+K L+K           F+ E
Sbjct: 75  DFEILKV----------IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREE 124

Query: 392 VVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKII 450
             ++     + +  L  +  + +  + LV ++     L   L   E +   + +R Y  +
Sbjct: 125 RDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFY--L 181

Query: 451 GGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIV 510
             +   I  +H+   L  +HRD+K  NIL+D   + +++DFG       D T   +S  V
Sbjct: 182 AEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAV 237

Query: 511 GTYGYMAPE-----YAMHGQFSVKSDVYSFGVLVLEIITG 545
           GT  Y++PE         G++  + D +S GV + E++ G
Sbjct: 238 GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYG 277

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 97.1 bits (242), Expect = 5e-22
 Identities = 55/249 (22%), Positives = 104/249 (41%), Gaps = 55/249 (22%)

Query: 341 EVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKN-EVVLVAKL 398
           E ++ K+S    LG G FG V +   + SG+  A+K++ +        +KN E+ ++  L
Sbjct: 3   ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP-----RYKNRELDIMKVL 57

Query: 399 QHRNLVRLLGF---CLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRR--------- 446
            H N+++L+ +     + E K        NK              +  +           
Sbjct: 58  DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117

Query: 447 -------YKIIGG-------------------IARGILYLHEDSRLRIIHRDLKASNILL 480
                  +K++                     + R + ++H    L I HRD+K  N+L+
Sbjct: 118 EYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLV 174

Query: 481 DAEMNP-KISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG--QFSVKSDVYSFGV 537
           +++ N  K+ DFG A+      ++ + + I   + Y APE  M G  +++   D++S G 
Sbjct: 175 NSKDNTLKLCDFGSAKKL--IPSEPSVAYICSRF-YRAPEL-MLGATEYTPSIDLWSIGC 230

Query: 538 LVLEIITGK 546
           +  E+I GK
Sbjct: 231 VFGELILGK 239

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 96.7 bits (241), Expect = 8e-22
 Identities = 59/302 (19%), Positives = 103/302 (34%), Gaps = 62/302 (20%)

Query: 248 FYNESATAPPAPAPVLLSPPPPGSVTTSRGKSGISSSTIIAIVAPIAVTAVLFILGFCFL 307
             N    +PP P P    PP P +       +                            
Sbjct: 2   LSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQ------------------- 42

Query: 308 RRKAKKKYNAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGV-L 366
             +   K     + NA  D         D++              LG G  G+V +    
Sbjct: 43  FPQFHVKSGLQIKKNAIID---------DYKVTS---------QVLGLGINGKVLQIFNK 84

Query: 367 PSGQEIAVKRLSKASGQGAEEFKNEV-VLVAKLQHRNLVRLLGFC---LEGEEKI-LVYE 421
            + ++ A+K L         + + EV +     Q  ++VR++        G + + +V E
Sbjct: 85  RTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME 139

Query: 422 FVPNKSLDYFLYDPEKQGQLDWSRRY--KIIGGIARGILYLHEDSRLRIIHRDLKASNIL 479
            +    L       + +G   ++ R   +I+  I   I YLH    + I HRD+K  N+L
Sbjct: 140 CLDGGEL---FSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLL 193

Query: 480 L---DAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFG 536
                     K++DFG A+      +    +    T  Y+APE     ++    D++S G
Sbjct: 194 YTSKRPNAILKLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLG 250

Query: 537 VL 538
           V+
Sbjct: 251 VI 252

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 94.7 bits (236), Expect = 4e-21
 Identities = 61/246 (24%), Positives = 107/246 (43%), Gaps = 48/246 (19%)

Query: 317 AVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVY----KGVLPSGQEI 372
           ++P    +N+    +     FE +            +G+G FG+V          + +  
Sbjct: 1   SMPPVFDENEDVNFD----HFEILRA----------IGKGSFGKVCIVQKND---TKKMY 43

Query: 373 AVKRLSKASGQGAEEFKN---EVVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSL 428
           A+K ++K       E +N   E+ ++  L+H  LV L  +  + EE + +V + +    L
Sbjct: 44  AMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDL 102

Query: 429 DYFLYDPEKQGQL--DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP 486
            Y L   ++      +  + +  I  +   + YL      RIIHRD+K  NILLD   + 
Sbjct: 103 RYHL---QQNVHFKEETVKLF--ICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHV 154

Query: 487 KISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE------YAMHGQFSVKSDVYSFGVLVL 540
            I+DF +A +   +      + + GT  YMAPE       A +  F+V  D +S GV   
Sbjct: 155 HITDFNIAAMLPRETQ---ITTMAGTKPYMAPEMFSSRKGAGYS-FAV--DWWSLGVTAY 208

Query: 541 EIITGK 546
           E++ G+
Sbjct: 209 ELLRGR 214

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 94.4 bits (235), Expect = 4e-21
 Identities = 62/244 (25%), Positives = 101/244 (41%), Gaps = 55/244 (22%)

Query: 332 SLQFDFETIEVATNKFSTDNK------LGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQG 384
               +F ++E+  + F+   +      +G G  G V         + +A+K+LS+     
Sbjct: 6   KRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP---- 61

Query: 385 AEEFKN---------EVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF---- 431
              F+N         E+VL+  + H+N++ LL              F P KSL+ F    
Sbjct: 62  ---FQNQTHAKRAYRELVLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVY 106

Query: 432 ---------LYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA 482
                    L    +         Y ++  +  GI +LH      IIHRDLK SNI++ +
Sbjct: 107 IVMELMDANLCQVIQMELDHERMSY-LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKS 162

Query: 483 EMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEI 542
           +   KI DFG+AR      +   T   V T  Y APE  +   +    D++S G ++ E+
Sbjct: 163 DCTLKILDFGLAR--TAGTSFMMTPY-VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 219

Query: 543 ITGK 546
           I G 
Sbjct: 220 IKGG 223

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 93.5 bits (233), Expect = 5e-21
 Identities = 56/234 (23%), Positives = 101/234 (43%), Gaps = 44/234 (18%)

Query: 336 DFETIEVATNKFSTDNK------LGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEF 388
            F   +V    +           +G G +G V   +   SG+++A+K+LS+        F
Sbjct: 9   GFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP-------F 61

Query: 389 KN---------EVVLVAKLQHRNLVRLL-----GFCLEGEEKI-LVYEFVPNKSLDYFLY 433
           ++         E++L+  +QH N++ LL        L       LV  F     +   L 
Sbjct: 62  QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPF-----MQTDLQ 116

Query: 434 DPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493
                   +   +Y ++  + +G+ Y+H      ++HRDLK  N+ ++ +   KI DFG+
Sbjct: 117 KIMGLKFSEEKIQY-LVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL 172

Query: 494 ARIFGVDQTQGNTSRIVGTYGYMAPEYAM-HGQFSVKSDVYSFGVLVLEIITGK 546
           AR    + T       V T  Y APE  +    ++   D++S G ++ E++TGK
Sbjct: 173 ARHADAEMTG-----YVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 94.9 bits (236), Expect = 6e-21
 Identities = 62/237 (26%), Positives = 103/237 (43%), Gaps = 41/237 (17%)

Query: 332 SLQFDFETIEVATNKFSTDNK------LGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQG 384
            +   F ++EV  + F+   +      +G G  G V         + +A+K+LS+     
Sbjct: 43  KVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP---- 98

Query: 385 AEEFKN---------EVVLVAKLQHRNLVRLL------GFCLEGEEKILVYEFVPNKSLD 429
              F+N         E+VL+  + H+N++ LL          E ++  LV E      +D
Sbjct: 99  ---FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL-----MD 150

Query: 430 YFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKIS 489
             L    +         Y ++  +  GI +LH      IIHRDLK SNI++ ++   KI 
Sbjct: 151 ANLCQVIQMELDHERMSY-LLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKIL 206

Query: 490 DFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
           DFG+AR  G   T    +  V T  Y APE  +   +    D++S G ++ E++  K
Sbjct: 207 DFGLARTAG---TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 92.7 bits (231), Expect = 1e-20
 Identities = 67/236 (28%), Positives = 111/236 (47%), Gaps = 40/236 (16%)

Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVY---KGVLPSGQEI-AVKRLSKAS----GQGAEE 387
           +FE ++V          LG G +G+V+   K       ++ A+K L KA+     +  E 
Sbjct: 55  NFELLKV----------LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEH 104

Query: 388 FKNE-VVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQL--DW 443
            + E  VL    Q   LV L  +  + E K+ L+ +++    L   L    ++ +     
Sbjct: 105 TRTERQVLEHIRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLS---QRERFTEHE 160

Query: 444 SRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ 503
            + Y  +G I   + +LH+   L II+RD+K  NILLD+  +  ++DFG+++ F  D+T+
Sbjct: 161 VQIY--VGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE 215

Query: 504 GNTSRIVGTYGYMAPE---YAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTD 555
                  GT  YMAP+       G   +V  D +S GVL+ E++TG   S F    
Sbjct: 216 R-AYDFCGTIEYMAPDIVRGGDSGHDKAV--DWWSLGVLMYELLTGA--SPFTVDG 266

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 92.2 bits (230), Expect = 1e-20
 Identities = 70/232 (30%), Positives = 113/232 (48%), Gaps = 38/232 (16%)

Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVY---KGVLPSGQEI-AVKRLSKAS--GQGAEEFK 389
            FE ++V          LG+G FG+V+   K      +++ A+K L KA+   +     K
Sbjct: 25  QFELLKV----------LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTK 74

Query: 390 NEVVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQL--DWSRR 446
            E  ++ ++ H  +V+L  +  + E K+ L+ +F+    L   L    K+     +  + 
Sbjct: 75  MERDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLS---KEVMFTEEDVKF 130

Query: 447 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT 506
           Y  +  +A  + +LH    L II+RDLK  NILLD E + K++DFG+++   +D  +   
Sbjct: 131 Y--LAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKK-A 183

Query: 507 SRIVGTYGYMAPE---YAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTD 555
               GT  YMAPE      H Q S   D +SFGVL+ E++TG     F   D
Sbjct: 184 YSFCGTVEYMAPEVVNRRGHTQ-SA--DWWSFGVLMFEMLTGT--LPFQGKD 230

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 90.7 bits (226), Expect = 4e-20
 Identities = 64/234 (27%), Positives = 113/234 (48%), Gaps = 40/234 (17%)

Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVY---KGVLPSGQEI-AVKRLSKAS----GQGAEE 387
            FE + V          LG+GG+G+V+   K    +  +I A+K L KA      +    
Sbjct: 18  CFELLRV----------LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAH 67

Query: 388 FKNEVVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQL--DWS 444
            K E  ++ +++H  +V L+ +  +   K+ L+ E++    L   L    ++G    D +
Sbjct: 68  TKAERNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLE---REGIFMEDTA 123

Query: 445 RRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG 504
             Y  +  I+  + +LH+     II+RDLK  NI+L+ + + K++DFG+ +    D T  
Sbjct: 124 CFY--LAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVT 178

Query: 505 NTSRIVGTYGYMAPE---YAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTD 555
           +T    GT  YMAPE    + H + +V  D +S G L+ +++TG     F   +
Sbjct: 179 HT--FCGTIEYMAPEILMRSGHNR-AV--DWWSLGALMYDMLTGA--PPFTGEN 225

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 91.2 bits (227), Expect = 4e-20
 Identities = 55/237 (23%), Positives = 88/237 (37%), Gaps = 38/237 (16%)

Query: 336 DFETIEVATNKFSTDNK------LGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEE-- 387
           +    ++     +  +       +  G +G V  GV   G  +A+KR+      G     
Sbjct: 7   EAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNI 66

Query: 388 FKN---------EVVLVAKLQHRNLVRLLG----FCLEGEEKI-LVYEFVPNKSLDYFLY 433
             +         E+ L+    H N++ L      F      K+ LV E      +   L 
Sbjct: 67  LSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTEL-----MRTDLA 121

Query: 434 DPEKQGQLDWSR---RYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISD 490
                 ++  S    +Y  +  I  G+  LHE     ++HRDL   NILL    +  I D
Sbjct: 122 QVIHDQRIVISPQHIQY-FMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICD 177

Query: 491 FGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM-HGQFSVKSDVYSFGVLVLEIITGK 546
           F +AR    D    N +  V    Y APE  M    F+   D++S G ++ E+   K
Sbjct: 178 FNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 90.8 bits (226), Expect = 4e-20
 Identities = 48/235 (20%), Positives = 98/235 (41%), Gaps = 49/235 (20%)

Query: 331 ESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFK 389
           ES   ++   +     +    KLG G + EV++ + + + +++ VK L        ++ K
Sbjct: 26  ESHVVEWGNQD----DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIK 78

Query: 390 NEVVLVAKLQ-HRNLVRLLGFCLEGEEK--ILVYEFVPNKSLD------------YFLYD 434
            E+ ++  L+   N++ L     +   +   LV+E V N                +++Y 
Sbjct: 79  REIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMY- 137

Query: 435 PEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE-MNPKISDFGM 493
                ++             + + Y H  S   I+HRD+K  N+++D E    ++ D+G+
Sbjct: 138 -----EI------------LKALDYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGL 177

Query: 494 ARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKS-DVYSFGVLVLEIITGKK 547
           A  +   Q      R+   Y +  PE  +  Q    S D++S G ++  +I  K+
Sbjct: 178 AEFYHPGQEY--NVRVASRY-FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 88.6 bits (220), Expect = 1e-19
 Identities = 19/201 (9%), Positives = 54/201 (26%), Gaps = 45/201 (22%)

Query: 352 KLGEGGFGEVYKG---VLPSGQEIAVKRL---SKASGQGAEEFKNEVVLVAKLQHRNLVR 405
             G     + ++     L   +++A+  +           +E  +  + ++++    + R
Sbjct: 38  FHGGVPPLQFWQALDTAL--DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 406 LLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSR 465
           +L         ++V E++   SL                   + +  +A      H   R
Sbjct: 96  VLDVVHTRAGGLVVAEWIRGGSLQEVA-----DTSPSPVGAIRAMQSLAAAADAAH---R 147

Query: 466 LRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQ 525
             +       S +         +S  G                 +     M         
Sbjct: 148 AGVALSIDHPSRVR--------VSIDGDVV--------------LAYPATMPDA------ 179

Query: 526 FSVKSDVYSFGVLVLEIITGK 546
            + + D+   G  +  ++  +
Sbjct: 180 -NPQDDIRGIGASLYALLVNR 199

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 90.1 bits (224), Expect = 1e-19
 Identities = 56/228 (24%), Positives = 96/228 (42%), Gaps = 46/228 (20%)

Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVY----KGVLPSGQEIAVKRLSKA---SGQGAEEF 388
           D+E ++V          +G G FGEV     K    + +  A+K LSK        +  F
Sbjct: 70  DYEVVKV----------IGRGAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAFF 116

Query: 389 KNEVVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYD---PEKQGQLDWS 444
             E  ++A      +V+L  +  + +  + +V E++P   L   + +   PE      W+
Sbjct: 117 WEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE-----KWA 170

Query: 445 RRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG 504
           R Y     +   +  +H    +  IHRD+K  N+LLD   + K++DFG       +    
Sbjct: 171 RFY--TAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR 225

Query: 505 NTSRIVGTYGYMAPE-------YAMHGQFSVKSDVYSFGVLVLEIITG 545
                VGT  Y++PE          +G+     D +S GV + E++ G
Sbjct: 226 -CDTAVGTPDYISPEVLKSQGGDGYYGR-EC--DWWSVGVFLYEMLVG 269

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 89.7 bits (223), Expect = 1e-19
 Identities = 61/241 (25%), Positives = 103/241 (42%), Gaps = 57/241 (23%)

Query: 336 DFETIEVATNKFSTDNK------LGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEF 388
            F   EV    +           +G G +G V   V   +G ++A+K+L +        F
Sbjct: 10  GFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-------F 62

Query: 389 KN---------EVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-------- 431
           ++         E+ L+  ++H N++ LL              F P+++LD F        
Sbjct: 63  QSELFAKRAYRELRLLKHMRHENVIGLLDV------------FTPDETLDDFTDFYLVMP 110

Query: 432 -----LYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP 486
                L    K  +L   R   ++  + +G+ Y+H      IIHRDLK  N+ ++ +   
Sbjct: 111 FMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCEL 167

Query: 487 KISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM-HGQFSVKSDVYSFGVLVLEIITG 545
           KI DFG+AR    + T       V T  Y APE  +   +++   D++S G ++ E+ITG
Sbjct: 168 KILDFGLARQADSEMTG-----YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG 222

Query: 546 K 546
           K
Sbjct: 223 K 223

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 88.8 bits (221), Expect = 2e-19
 Identities = 71/240 (29%), Positives = 108/240 (45%), Gaps = 55/240 (22%)

Query: 336 DFETIEVATNKFSTDNKLGEGGFGEV----YKGVLPSGQEIAVKRLSKASGQGAEEFKNE 391
           DF  + V          LG+G FG+V     KG   + +  AVK L K          ++
Sbjct: 21  DFNFLMV----------LGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQ----DDD 63

Query: 392 V--------VLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQL- 441
           V        VL    +   L +L   C +  +++  V E+V    L Y +    + G+  
Sbjct: 64  VECTMVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQ---QVGRFK 119

Query: 442 -DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR--IFG 498
              +  Y     IA G+ +L       II+RDLK  N++LD+E + KI+DFGM +  I+ 
Sbjct: 120 EPHAVFY--AAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 174

Query: 499 VDQTQGNTSRIVGTYGYMAPE---YAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTD 555
              T   T    GT  Y+APE   Y  +G  SV  D ++FGVL+ E++ G+  + F   D
Sbjct: 175 GVTT--KT--FCGTPDYIAPEIIAYQPYG-KSV--DWWAFGVLLYEMLAGQ--APFEGED 225

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 88.4 bits (220), Expect = 3e-19
 Identities = 64/235 (27%), Positives = 104/235 (44%), Gaps = 45/235 (19%)

Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGAEEFKNEV-- 392
           +FE I V          LG+G FG+V    +    ++ AVK L K          ++V  
Sbjct: 24  NFEFIRV----------LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQ----DDDVEC 69

Query: 393 ------VLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQL--DW 443
                 +L     H  L +L   C +  +++  V EFV    L + +    K  +     
Sbjct: 70  TMTEKRILSLARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQ---KSRRFDEAR 125

Query: 444 SRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ 503
           +R Y     I   +++LH+     II+RDLK  N+LLD E + K++DFGM +    +   
Sbjct: 126 ARFY--AAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT 180

Query: 504 GNTSRIVGTYGYMAPE---YAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTD 555
             T    GT  Y+APE     ++G  +V  D ++ GVL+ E++ G   + F   +
Sbjct: 181 TAT--FCGTPDYIAPEILQEMLYG-PAV--DWWAMGVLLYEMLCGH--APFEAEN 228

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 88.1 bits (219), Expect = 3e-19
 Identities = 64/231 (27%), Positives = 105/231 (45%), Gaps = 53/231 (22%)

Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVY----KGVLPSGQEIAVKRLSKASGQGAEEFKNE 391
           DF+ + V          +G G + +V     K    + +  A+K + K           +
Sbjct: 10  DFDLLRV----------IGRGSYAKVLLVRLKK---TDRIYAMKVVKKELVND----DED 52

Query: 392 V--------VLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQL- 441
           +        V      H  LV L   C + E ++  V E+V    L + +    +Q +L 
Sbjct: 53  IDWVQTEKHVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQ---RQRKLP 108

Query: 442 -DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR--IFG 498
            + +R Y     I+  + YLHE     II+RDLK  N+LLD+E + K++D+GM +  +  
Sbjct: 109 EEHARFY--SAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163

Query: 499 VDQTQGNTSRIVGTYGYMAPE---YAMHGQFSVKSDVYSFGVLVLEIITGK 546
            D T  +T    GT  Y+APE      +G FSV  D ++ GVL+ E++ G+
Sbjct: 164 GDTT--ST--FCGTPNYIAPEILRGEDYG-FSV--DWWALGVLMFEMMAGR 207

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 88.5 bits (220), Expect = 3e-19
 Identities = 64/237 (27%), Positives = 104/237 (43%), Gaps = 49/237 (20%)

Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGAEEFKNEV-- 392
           DF  ++V          +G+G FG+V      + +   AVK L K +       K E   
Sbjct: 39  DFHFLKV----------IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILK----KKEEKH 84

Query: 393 ------VLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQL--DW 443
                 VL+  ++H  LV L  F  +  +K+  V +++    L Y L    ++       
Sbjct: 85  IMSERNVLLKNVKHPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQ---RERCFLEPR 140

Query: 444 SRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR--IFGVDQ 501
           +R Y     IA  + YLH    L I++RDLK  NILLD++ +  ++DFG+ +  I     
Sbjct: 141 ARFY--AAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST 195

Query: 502 TQGNTSRIVGTYGYMAPE---YAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTD 555
           T  +T    GT  Y+APE      +   +V  D +  G ++ E++ G     FY  +
Sbjct: 196 T--ST--FCGTPEYLAPEVLHKQPYD-RTV--DWWCLGAVLYEMLYGL--PPFYSRN 243

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 88.1 bits (219), Expect = 4e-19
 Identities = 60/223 (26%), Positives = 95/223 (42%), Gaps = 43/223 (19%)

Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVY----KGVLPSGQEIAVKRLSKA---SGQGAEEF 388
            F+ I+           LG G FG V     K    SG   A+K L K      +  E  
Sbjct: 42  QFDRIKT----------LGTGSFGRVMLVKHKE---SGNHYAMKILDKQKVVKLKQIEHT 88

Query: 389 KNEVVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQL--DWSR 445
            NE  ++  +    LV+L  F  +    + +V E+V    +   L    + G+     +R
Sbjct: 89  LNEKRILQAVNFPFLVKLE-FSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHAR 144

Query: 446 RYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN 505
            Y     I     YLH    L +I+RDLK  N+L+D +   +++DFG A+        G 
Sbjct: 145 FY--AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GR 194

Query: 506 TSRIVGTYGYMAPEYAM---HGQFSVKSDVYSFGVLVLEIITG 545
           T  + GT   +APE  +   + + +V  D ++ GVL+ E+  G
Sbjct: 195 TWTLCGTPEALAPEIILSKGYNK-AV--DWWALGVLIYEMAAG 234

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 90.1 bits (223), Expect = 4e-19
 Identities = 69/235 (29%), Positives = 104/235 (44%), Gaps = 45/235 (19%)

Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGAEEFKNEV-- 392
           DF  + V          LG+G FG+V         E+ AVK L K          ++V  
Sbjct: 342 DFNFLMV----------LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ----DDDVEC 387

Query: 393 ------VLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSR 445
                 VL    +   L +L   C +  +++  V E+V    L Y +    + G+     
Sbjct: 388 TMVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQ---QVGRFKEPH 443

Query: 446 RYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR--IFGVDQTQ 503
                  IA G+ +L       II+RDLK  N++LD+E + KI+DFGM +  I+    T 
Sbjct: 444 AVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT- 499

Query: 504 GNTSRIVGTYGYMAPE---YAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTD 555
             T    GT  Y+APE   Y  +G  SV  D ++FGVL+ E++ G+  + F   D
Sbjct: 500 -KT--FCGTPDYIAPEIIAYQPYG-KSV--DWWAFGVLLYEMLAGQ--APFEGED 546

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 88.2 bits (219), Expect = 6e-19
 Identities = 63/231 (27%), Positives = 105/231 (45%), Gaps = 53/231 (22%)

Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVY----KGVLPSGQEIAVKRLSKASGQGAEEFKNE 391
           DF+ + V          +G G + +V     K    + +  A++ + K           +
Sbjct: 53  DFDLLRV----------IGRGSYAKVLLVRLKK---TDRIYAMRVVKKELVND----DED 95

Query: 392 V--------VLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQL- 441
           +        V      H  LV L   C + E ++  V E+V    L + +    +Q +L 
Sbjct: 96  IDWVQTEKHVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQ---RQRKLP 151

Query: 442 -DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR--IFG 498
            + +R Y     I+  + YLHE     II+RDLK  N+LLD+E + K++D+GM +  +  
Sbjct: 152 EEHARFY--SAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 206

Query: 499 VDQTQGNTSRIVGTYGYMAPE---YAMHGQFSVKSDVYSFGVLVLEIITGK 546
            D T  +T    GT  Y+APE      +G FSV  D ++ GVL+ E++ G+
Sbjct: 207 GDTT--ST--FCGTPNYIAPEILRGEDYG-FSV--DWWALGVLMFEMMAGR 250

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 87.7 bits (217), Expect = 6e-19
 Identities = 36/94 (38%), Positives = 55/94 (58%), Gaps = 7/94 (7%)

Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ--TQGNTSRIV 510
           +A+G+ +L   +  + IHRDL A NILL  +   KI DFG+AR    D    +   +R+ 
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL- 257

Query: 511 GTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
               +MAPE      ++++SDV+SFGVL+ EI +
Sbjct: 258 -PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 66.9 bits (163), Expect = 4e-12
 Identities = 38/174 (21%), Positives = 67/174 (38%), Gaps = 19/174 (10%)

Query: 331 ESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRL-SKASGQ 383
           E L +D    E   ++      LG G FG+V +          + + +AVK L   A+  
Sbjct: 8   ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 67

Query: 384 GAEEFKNEV-VLVAKLQHRNLVRLLGFCLEGEEKILV-YEFVPNKSLDYFLYDPEKQGQL 441
                 +E+ +L+    H N+V LLG C +    ++V  EF    +L  +L         
Sbjct: 68  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL--------- 118

Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
             S+R + +    +G  +      +  I  DLK     + +  +   S F   +
Sbjct: 119 -RSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 88.2 bits (219), Expect = 8e-19
 Identities = 60/228 (26%), Positives = 102/228 (44%), Gaps = 31/228 (13%)

Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGAEEF---KNE 391
           +FE +++          LG+G FG+V      +     A+K L K      +E      E
Sbjct: 149 EFEYLKL----------LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTE 198

Query: 392 VVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKII 450
             ++   +H  L  L  +  +  +++  V E+     L + L   E+    D +R Y   
Sbjct: 199 NRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSR-ERVFSEDRARFY--G 254

Query: 451 GGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIV 510
             I   + YLH  S   +++RDLK  N++LD + + KI+DFG+ +    D     T    
Sbjct: 255 AEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FC 310

Query: 511 GTYGYMAPE---YAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTD 555
           GT  Y+APE      +G+ +V  D +  GV++ E++ G+    FY  D
Sbjct: 311 GTPEYLAPEVLEDNDYGR-AV--DWWGLGVVMYEMMCGR--LPFYNQD 353

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 86.9 bits (216), Expect = 1e-18
 Identities = 70/238 (29%), Positives = 106/238 (44%), Gaps = 51/238 (21%)

Query: 336 DFETIEVATNKFSTDNKLGEGGFGEV----YKGVLPSGQEIAVKRLSKASGQGAEEFKNE 391
           DF   ++          LG+G FG+V    +K    + Q  A+K L K          ++
Sbjct: 18  DFILHKM----------LGKGSFGKVFLAEFKK---TNQFFAIKALKKDVVLM----DDD 60

Query: 392 V--------VLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLD 442
           V        VL    +H  L  +     + +E +  V E++    L Y +       + D
Sbjct: 61  VECTMVEKRVLSLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFD 116

Query: 443 WSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR--IFGVD 500
            SR       I  G+ +LH      I++RDLK  NILLD + + KI+DFGM +  + G  
Sbjct: 117 LSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 173

Query: 501 QTQGNTSRIVGTYGYMAPE---YAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTD 555
           +T  NT    GT  Y+APE      +   SV  D +SFGVL+ E++ G+  S F+  D
Sbjct: 174 KT--NT--FCGTPDYIAPEILLGQKYN-HSV--DWWSFGVLLYEMLIGQ--SPFHGQD 222

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 86.6 bits (215), Expect = 1e-18
 Identities = 61/234 (26%), Positives = 101/234 (43%), Gaps = 43/234 (18%)

Query: 336 DFETIEVATNKFSTDNK------LGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEF 388
            F   E+    +    +      +G G +G V       +G  +AVK+LS+        F
Sbjct: 14  TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-------F 66

Query: 389 KN---------EVVLVAKLQHRNLVRLL-----GFCLEGEEKI-LVYEFVPNKSLDYFLY 433
           ++         E+ L+  ++H N++ LL        LE    + LV        +   L 
Sbjct: 67  QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL-----MGADLN 121

Query: 434 DPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493
           +  K  +L       +I  I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+
Sbjct: 122 NIVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL 178

Query: 494 ARIFGVDQTQGNTSRIVGTYGYMAPEYAM-HGQFSVKSDVYSFGVLVLEIITGK 546
           AR    + T       V T  Y APE  +    ++   D++S G ++ E++TG+
Sbjct: 179 ARHTADEMTG-----YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 86.1 bits (214), Expect = 2e-18
 Identities = 60/235 (25%), Positives = 102/235 (43%), Gaps = 46/235 (19%)

Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGAEEFKNEV-- 392
           DF+ +++          LG+G FG+V      +     A+K L K         K+EV  
Sbjct: 6   DFDYLKL----------LGKGTFGKVILVREKATGRYYAMKILRKEVIIA----KDEVAH 51

Query: 393 ------VLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSR 445
                 VL    +H  L  L  +  +  +++  V E+     L + L   E+    + +R
Sbjct: 52  TVTESRVL-QNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSR-ERVFTEERAR 108

Query: 446 RYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR--IFGVDQTQ 503
            Y     I   + YLH      +++RD+K  N++LD + + KI+DFG+ +  I       
Sbjct: 109 FY--GAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM- 162

Query: 504 GNTSRIVGTYGYMAPE---YAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTD 555
             T    GT  Y+APE      +G+ +V  D +  GV++ E++ G+    FY  D
Sbjct: 163 -KT--FCGTPEYLAPEVLEDNDYGR-AV--DWWGLGVVMYEMMCGR--LPFYNQD 209

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 87.2 bits (216), Expect = 2e-18
 Identities = 40/244 (16%), Positives = 93/244 (38%), Gaps = 61/244 (25%)

Query: 311 AKKKYNAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSG 369
           ++++     + ++     ++     D++      +++   + +G G +G V +       
Sbjct: 23  SQQEGQQRKQHHSSKPTASMPRPHSDWQI----PDRYEIRHLIGTGSYGHVCEAYDKLEK 78

Query: 370 QEIAVKRLSKASGQGAEEFKN---------EVVLVAKLQHRNLVRLLGFC----LEGEEK 416
           + +A+K++ +        F++         E+ ++ +L H ++V++L       +E  ++
Sbjct: 79  RVVAIKKILRV-------FEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131

Query: 417 I-LVYEFVP---------NKSLD-----YFLYDPEKQGQLDWSRRYKIIGGIARGILYLH 461
           + +V E               L        LY                   +  G+ Y+H
Sbjct: 132 LYVVLEIADSDFKKLFRTPVYLTELHIKTLLY------N------------LLVGVKYVH 173

Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYA 521
             S   I+HRDLK +N L++ + + K+ DFG+AR     +   +   I      M     
Sbjct: 174 --SA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTF 230

Query: 522 MHGQ 525
            H +
Sbjct: 231 PHTK 234

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 83.7 bits (208), Expect = 7e-18
 Identities = 58/224 (25%), Positives = 101/224 (45%), Gaps = 45/224 (20%)

Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVY----KGVLPSGQEIAVKRLSKAS----GQGAEE 387
           DF+ +            LG G FG V+    +    +G+  A+K L K       Q  E 
Sbjct: 7   DFQILRT----------LGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVRLKQ-VEH 52

Query: 388 FKNEVVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQL--DWS 444
             +E ++++ + H  ++R+     +  ++I ++ +++    L   L    K  +     +
Sbjct: 53  TNDERLMLSIVTHPFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLLR---KSQRFPNPVA 108

Query: 445 RRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG 504
           + Y     +   + YLH      II+RDLK  NILLD   + KI+DFG A+         
Sbjct: 109 KFY--AAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP-----D 158

Query: 505 NTSRIVGTYGYMAPE---YAMHGQFSVKSDVYSFGVLVLEIITG 545
            T  + GT  Y+APE      + + S+  D +SFG+L+ E++ G
Sbjct: 159 VTYTLCGTPDYIAPEVVSTKPYNK-SI--DWWSFGILIYEMLAG 199

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 83.1 bits (206), Expect = 1e-17
 Identities = 51/230 (22%), Positives = 99/230 (43%), Gaps = 44/230 (19%)

Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKN---------EVV 393
            +++     LG GG G V+  V     + +A+K++            +         E+ 
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---------LTDPQSVKHALREIK 60

Query: 394 LVAKLQHRNLVRLL--------------GFCLEGEEKILVYEFVPNKSLDYFLYDPEKQG 439
           ++ +L H N+V++               G   E     +V E+     ++  L +  +QG
Sbjct: 61  IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEY-----METDLANVLEQG 115

Query: 440 QLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE-MNPKISDFGMARIFG 498
            L        +  + RG+ Y+H  +   ++HRDLK +N+ ++ E +  KI DFG+ARI  
Sbjct: 116 PLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMD 172

Query: 499 VDQTQGNT-SRIVGTYGYMAPEYAMHGQ-FSVKSDVYSFGVLVLEIITGK 546
              +     S  + T  Y +P   +    ++   D+++ G +  E++TGK
Sbjct: 173 PHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 82.3 bits (204), Expect = 4e-17
 Identities = 52/240 (21%), Positives = 103/240 (42%), Gaps = 59/240 (24%)

Query: 337 FETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKN----- 390
              +     +++  + +GEG +G V       +   +A+K++S         F++     
Sbjct: 19  RGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQ 70

Query: 391 ----EVVLVAKLQHRNLVRLLGF----CLEGEEKI-LVYEF--------VPNKSLD---- 429
               E+ ++ + +H N++ +        +E  + + +V +         +  + L     
Sbjct: 71  RTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI 130

Query: 430 -YFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKI 488
            YFLY      Q            I RG+ Y+H  +   ++HRDLK SN+LL+   + KI
Sbjct: 131 CYFLY------Q------------ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKI 169

Query: 489 SDFGMARIFGVDQTQGNT-SRIVGTYGYMAPEYAM-HGQFSVKSDVYSFGVLVLEIITGK 546
            DFG+AR+   D       +  V T  Y APE  +    ++   D++S G ++ E+++ +
Sbjct: 170 CDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 81.9 bits (203), Expect = 4e-17
 Identities = 53/248 (21%), Positives = 98/248 (39%), Gaps = 70/248 (28%)

Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKN------ 390
             +   ++ F   + LGEG +G V      P+G+ +A+K++          F        
Sbjct: 4   RIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALR 55

Query: 391 ---EVVLVAKLQHRNLVRLL-----GFCLEGEEKILVYEFVP--------NKSLD----- 429
              E+ ++   +H N++ +             E  ++ E +          + L      
Sbjct: 56  TLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQ 115

Query: 430 YFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKIS 489
           YF+Y      Q              R +  LH  +   +IHRDLK SN+L+++  + K+ 
Sbjct: 116 YFIY------Q------------TLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVC 154

Query: 490 DFGMARIFGVDQTQGNTSRIVGTYGYM----------APEYAM-HGQFSVKSDVYSFGVL 538
           DFG+AR   +D++  + S   G    M          APE  +   ++S   DV+S G +
Sbjct: 155 DFGLAR--IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCI 212

Query: 539 VLEIITGK 546
           + E+   +
Sbjct: 213 LAELFLRR 220

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 80.9 bits (200), Expect = 1e-16
 Identities = 38/211 (18%), Positives = 78/211 (36%), Gaps = 57/211 (27%)

Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKN---------EVV 393
            + +   + +G G +G VY      + + +A+K++++        F++         E+ 
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-------FEDLIDCKRILREIT 77

Query: 394 LVAKLQHRNLVRLLGFCL-----EGEEKILVYEFVP---------NKSLD-----YFLYD 434
           ++ +L+   ++RL    +     + +E  +V E               L        LY 
Sbjct: 78  ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILY- 136

Query: 435 PEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494
                             +  G  ++HE     IIHRDLK +N LL+ + + K+ DFG+A
Sbjct: 137 -----N------------LLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLA 176

Query: 495 RIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQ 525
           R    ++     + +            +  Q
Sbjct: 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQ 207

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 78.1 bits (193), Expect = 4e-16
 Identities = 36/161 (22%), Positives = 64/161 (39%), Gaps = 36/161 (22%)

Query: 352 KLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEV-VLVAKLQHRNLVRLLGF 409
            LG G  G+V +     + ++ A+K L         + + EV +     Q  ++VR++  
Sbjct: 25  VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDV 79

Query: 410 C---LEGEEKI-LVYEFVP---------NKSLDYFLYDPEKQGQLDWSRRYKIIGGIARG 456
                 G + + +V E +          ++    F    E++         +I+  I   
Sbjct: 80  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF---TEREAS-------EIMKSIGEA 129

Query: 457 ILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMA 494
           I YLH    + I HRD+K  N+L          K++DFG A
Sbjct: 130 IQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 77.8 bits (192), Expect = 1e-15
 Identities = 64/255 (25%), Positives = 112/255 (43%), Gaps = 74/255 (29%)

Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKN------ 390
                   K+    KLG+G +G V+K +   +G+ +AVK++  A       F+N      
Sbjct: 2   RVDRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-------FQNSTDAQR 54

Query: 391 ---EVVLVAKLQ-HRNLVRLLG-FCLEGEEKI-LVYEFVP--------NKSLD-----YF 431
              E++++ +L  H N+V LL     + +  + LV++++            L+     Y 
Sbjct: 55  TFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYV 114

Query: 432 LYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDF 491
           +Y      Q            + + I YLH  S   ++HRD+K SNILL+AE + K++DF
Sbjct: 115 VY------Q------------LIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADF 153

Query: 492 GMARIFGVDQTQGNTSRI-------------------VGTYGYMAPEYAM-HGQFSVKSD 531
           G++R F   +   N   +                   V T  Y APE  +   +++   D
Sbjct: 154 GLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGID 213

Query: 532 VYSFGVLVLEIITGK 546
           ++S G ++ EI+ GK
Sbjct: 214 MWSLGCILGEILCGK 228

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 74.4 bits (183), Expect = 2e-14
 Identities = 64/270 (23%), Positives = 104/270 (38%), Gaps = 63/270 (23%)

Query: 306 FLRRKAKKKYNAVPESNADNDLTTLESLQFDFETI--EVATNKFSTDNKLGEGGFGEVYK 363
           F    + KK   V     D+D        +D+     E   +++  D+ +G+G FG+V K
Sbjct: 20  FQSMSSHKKERKVYNDGYDDD-------NYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVK 72

Query: 364 GV-LPSGQEIAVK------RLSKASGQGAEEFKNEVVLVAKLQHR------NLVRLLGF- 409
                  + +A+K           +       + EV L+  +          +V L    
Sbjct: 73  AYDRVEQEWVAIKIIKNKKAFLNQA-------QIEVRLLELMNKHDTEMKYYIVHLKRHF 125

Query: 410 ------CLEGEEKILVYEFVPNKSLDYFLYDPEKQGQ-----LDWSRRYKIIGGIARGIL 458
                 CL       V+E      L Y LYD  +        L+ +R++     +   +L
Sbjct: 126 MFRNHLCL-------VFE-----MLSYNLYDLLRNTNFRGVSLNLTRKFAQ--QMCTALL 171

Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNP--KISDFGMARIFGVDQTQGNTSRIVGTYGYM 516
           +L     L IIH DLK  NILL        KI DFG +   G    Q   SR      Y 
Sbjct: 172 FLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF-----YR 225

Query: 517 APEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
           +PE  +   + +  D++S G +++E+ TG+
Sbjct: 226 SPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 72.8 bits (179), Expect = 5e-14
 Identities = 51/223 (22%), Positives = 95/223 (42%), Gaps = 44/223 (19%)

Query: 352 KLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ----------- 399
           KLG G F  V+    + +   +A+K + +      E  ++E+ L+ ++            
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84

Query: 400 HRNLVRLLG-FCLEGEEKI---LVYEFVPNKSLDYFLYDPEKQGQLDWSRRY--KIIGGI 453
             ++++LL  F  +G   +   +V+E      L   L    K+ +    R      +  I
Sbjct: 85  ANHILKLLDHFNHKGPNGVHVVMVFE-----VLGENLLALIKKYE---HRGIPLIYVKQI 136

Query: 454 ARGIL----YLHEDSRLRIIHRDLKASNILLDAEMNP------KISDFGMARIFGVDQTQ 503
           ++ +L    Y+H   R  IIH D+K  N+L++   +P      KI+D G A  +    T 
Sbjct: 137 SKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN 194

Query: 504 GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
              +R      Y +PE  +   +   +D++S   L+ E+ITG 
Sbjct: 195 SIQTRE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 71.8 bits (175), Expect = 8e-14
 Identities = 37/253 (14%), Positives = 73/253 (28%), Gaps = 55/253 (21%)

Query: 342 VATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRL--------SKASGQGAEEFKNEVV 393
           + T K     K+GEG FGEV++ +      +A+K +        + +  +  EE   E++
Sbjct: 17  LPTEKLQRCEKIGEGVFGEVFQTIAD-HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75

Query: 394 LVAKLQ---------HRNLVRLLGFCL-------------------EGEEKILVYEFVPN 425
           +  +L              + L                        +G        F  +
Sbjct: 76  ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135

Query: 426 KSLDYFLYDP-------EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNI 478
           +      ++         +      +    I+  +   +        LR  HRDL   N+
Sbjct: 136 QLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNV 193

Query: 479 LLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVL 538
           LL      K+      +   +     +    V    Y        G       V+    +
Sbjct: 194 LLKKTSLKKLHYTLNGKSSTI----PSCGLQVSIIDYTLSRLERDGIV-----VFCDVSM 244

Query: 539 VLEIITGKKNSNF 551
             ++ TG  +  F
Sbjct: 245 DEDLFTGDGDYQF 257

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 64.7 bits (158), Expect = 3e-11
 Identities = 50/231 (21%), Positives = 91/231 (39%), Gaps = 52/231 (22%)

Query: 341 EVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVK------RLSKASGQGAEEFKNEVV 393
           +    ++     +G+G FG+V K       Q +A+K      R  + +         E+ 
Sbjct: 93  DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA-------AEEIR 145

Query: 394 LVAKLQHR------NLVRLLGF-------CLEGEEKILVYEFVPNKSLDYFLYDPEKQGQ 440
           ++  L+ +      N++ +L         C+        +E      L   LY+  K+ +
Sbjct: 146 ILEHLRKQDKDNTMNVIHMLENFTFRNHICM-------TFE-----LLSMNLYELIKKNK 193

Query: 441 ---LDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP--KISDFGMAR 495
                     K    I + +  LH   + RIIH DLK  NILL  +     K+ DFG + 
Sbjct: 194 FQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250

Query: 496 IFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
                Q        + +  Y APE  +  ++ +  D++S G ++ E++TG 
Sbjct: 251 Y--EHQR---VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 64.0 bits (156), Expect = 3e-11
 Identities = 37/197 (18%), Positives = 68/197 (34%), Gaps = 28/197 (14%)

Query: 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEI------AVKRLSKASGQGAEEFKNEVVLVAKL 398
             +     +G+GGFG +Y   + S + +       VK     +G    E K         
Sbjct: 35  AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94

Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-----LYDPEKQGQLDWSRR---YKII 450
           Q +  +R       G  K             Y       +  + Q   + + +    K +
Sbjct: 95  QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTV 154

Query: 451 GGIARGIL----YLHEDSRLRIIHRDLKASNILLDAEMNPKI--SDFGMARIFGVDQT-- 502
             ++  IL    Y+HE      +H D+KASN+LL+ +   ++   D+G+A  +  +    
Sbjct: 155 LQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHK 211

Query: 503 ---QGNTSRIVGTYGYM 516
                      GT  + 
Sbjct: 212 AYAADPKRCHDGTIEFT 228

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 63.4 bits (154), Expect = 6e-11
 Identities = 54/269 (20%), Positives = 99/269 (36%), Gaps = 74/269 (27%)

Query: 341 EVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ 399
           ++   ++    KLG G F  V+    +   + +A+K + K++    E   +E+ L+  ++
Sbjct: 33  DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEIRLLKSVR 91

Query: 400 --------HRNLVRLLG-FCLEGEEKI---LVYEFVPNKSLDYFLYDPEKQG-QLDWSRR 446
                      +V+LL  F + G       +V+E V    L  ++     QG  L   ++
Sbjct: 92  NSDPNDPNREMVVQLLDDFKISGVNGTHICMVFE-VLGHHLLKWIIKSNYQGLPLPCVKK 150

Query: 447 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE----------------------- 483
             II  + +G+ YLH  ++ RIIH D+K  NILL                          
Sbjct: 151 --IIQQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPS 206

Query: 484 --------------------------MNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMA 517
                                     +  KI+D G A       T+      + T  Y +
Sbjct: 207 GSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTE-----DIQTRQYRS 261

Query: 518 PEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
            E  +   ++  +D++S   +  E+ TG 
Sbjct: 262 LEVLIGSGYNTPADIWSTACMAFELATGD 290

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 61.7 bits (150), Expect = 2e-10
 Identities = 34/194 (17%), Positives = 68/194 (35%), Gaps = 25/194 (12%)

Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIA---VKRLSKASGQGAEEFKNEVVLVAKLQH 400
           N++    K+G GGFG +Y        ++ A   VK   + +G    E K    +  K   
Sbjct: 37  NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCI 96

Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-----LYDPEKQGQLDWSRRY--KIIGGI 453
           +  +        G            K   Y          + Q     +  +    +  +
Sbjct: 97  KKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQL 156

Query: 454 ARGIL----YLHEDSRLRIIHRDLKASNILLDAEMNPKI--SDFGMARIFGVDQT----- 502
              +L    Y+HE+     +H D+KA+N+LL  +   ++  +D+G++  +  +       
Sbjct: 157 GIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQ 213

Query: 503 QGNTSRIVGTYGYM 516
           +       GT  + 
Sbjct: 214 ENPRKGHNGTIEFT 227

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 59.8 bits (145), Expect = 7e-10
 Identities = 30/181 (16%), Positives = 61/181 (33%), Gaps = 39/181 (21%)

Query: 345 NKFSTDNKLGEGGFGEVYKGV---------LPSGQEIAVKRLSKASGQGAEEFKNEVVLV 395
            ++   +       G +Y+            P  Q+ ++K L    G+   E        
Sbjct: 42  RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAA 100

Query: 396 AKLQHRNLVRL-----LGF-------CLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQLD 442
             LQ     +L     L           + + + LV   +  +SL       P+      
Sbjct: 101 KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSE- 158

Query: 443 WSRRYKIIGGIARGIL----YLHEDSRLRIIHRDLKASNILLDAEMNPKI--SDFGMARI 496
                + +  +A  +L    +LHE+     +H ++ A NI +D E   ++  + +G A  
Sbjct: 159 -----RSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFR 210

Query: 497 F 497
           +
Sbjct: 211 Y 211

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 58.9 bits (143), Expect = 9e-10
 Identities = 40/170 (23%), Positives = 74/170 (43%), Gaps = 27/170 (15%)

Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH-RN 402
           N++    K+G G FG++Y G  + +G+E+A+K     +     +   E  +   +Q    
Sbjct: 9   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 66

Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRY--KIIGGIARGIL- 458
           +  +     EG+  ++V E +   SL D F             R++  K +  +A  ++ 
Sbjct: 67  IPTIRWCGAEGDYNVMVMELL-GPSLEDLF----NFCS-----RKFSLKTVLLLADQMIS 116

Query: 459 ---YLHEDSRLRIIHRDLKASNILLDAEMNPK---ISDFGMARIFGVDQT 502
              Y+H  +    IHRD+K  N L+          I DFG+A+ +   +T
Sbjct: 117 RIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 58.5 bits (142), Expect = 1e-09
 Identities = 38/169 (22%), Positives = 70/169 (41%), Gaps = 33/169 (19%)

Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASG--QGAEEFKNEVVLVAKLQHR 401
             +    ++GEG FG +++G  L + Q++A+K   + S   Q  +E++            
Sbjct: 10  VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYR---TYKLLAGCT 66

Query: 402 NLVRLLGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQLDWSRR---YKIIGGIARGI 457
            +  +  F  EG   +LV + +   SL D            D   R    K +   A+ +
Sbjct: 67  GIPNVYYFGQEGLHNVLVIDLLG-PSLEDLL----------DLCGRKFSVKTVAMAAKQM 115

Query: 458 L----YLHEDSRLRIIHRDLKASNILLDAEMNPK-----ISDFGMARIF 497
           L     +HE S   +++RD+K  N L+    +       + DFGM + +
Sbjct: 116 LARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 58.2 bits (141), Expect = 2e-09
 Identities = 38/167 (22%), Positives = 63/167 (37%), Gaps = 29/167 (17%)

Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNL 403
             F    K+G G FGE+  G  L + + +A+K     S       +             +
Sbjct: 9   PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLG-SGDGI 67

Query: 404 VRLLGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQLDWSRR---YKIIGGIARGIL- 458
            ++  F   G+   +V E +   SL D F          D   R    K +  IA  ++ 
Sbjct: 68  PQVYYFGPCGKYNAMVLELL-GPSLEDLF----------DLCDRTFSLKTVLMIAIQLIS 116

Query: 459 ---YLHEDSRLRIIHRDLKASNILLDAEMNPK-----ISDFGMARIF 497
              Y+H  +   +I+RD+K  N L+    N       I DF +A+ +
Sbjct: 117 RMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 58.1 bits (140), Expect = 4e-09
 Identities = 53/221 (23%), Positives = 92/221 (41%), Gaps = 36/221 (16%)

Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNL 403
           NKF    K+G G FGE+Y G  + + +E+A+K  +  +     +   E  +   LQ    
Sbjct: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTG 64

Query: 404 V-RLLGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQLDWSRR---YKIIGGIARGIL 458
           +  +  F +EG+  +LV + +   SL D F          ++  R    K +  +A  ++
Sbjct: 65  IPNVRWFGVEGDYNVLVMDLL-GPSLEDLF----------NFCSRKLSLKTVLMLADQMI 113

Query: 459 ----YLHEDSRLRIIHRDLKASNILLDAEMNPK---ISDFGMARIFGVDQTQG-----NT 506
               ++H  S    +HRD+K  N L+          I DFG+A+ +    T         
Sbjct: 114 NRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN 170

Query: 507 SRIVGTYGYMAPEYAMHGQF-SVKSDVYSFGVLVLEIITGK 546
             + GT  Y A      G   S + D+ S G +++  + G 
Sbjct: 171 KNLTGTARY-ASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 52.7 bits (127), Expect = 1e-07
 Identities = 46/252 (18%), Positives = 91/252 (36%), Gaps = 76/252 (30%)

Query: 341 EVATNKFSTDNKLGEGGFGEVYKGV--LPSGQEIAVK------RLSKASGQGAEEFKNEV 392
           +    ++     LGEG FG+V + +       ++A+K      +  +A+       + E+
Sbjct: 15  DWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA-------RLEI 67

Query: 393 VLVAKLQHR------NLVRLLGF-------CLEGEEKILVYEFVPNKSLDYFLYDPEKQG 439
            ++ K++ +        V +  +       C+        +E      L    ++  K+ 
Sbjct: 68  NVLKKIKEKDKENKFLCVLMSDWFNFHGHMCI-------AFE-----LLGKNTFEFLKEN 115

Query: 440 QLDWSRRYKI--IGGIARGIL----YLHEDSRLRIIHRDLKASNILLDAEMNP------- 486
                + Y +  +  +A  +     +LHE    ++ H DLK  NIL              
Sbjct: 116 NF---QPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHK 169

Query: 487 ------------KISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYS 534
                       +++DFG A  F   +     + IV T  Y  PE  +   ++   DV+S
Sbjct: 170 SCEEKSVKNTSIRVADFGSA-TF-DHEHH---TTIVATRHYRPPEVILELGWAQPCDVWS 224

Query: 535 FGVLVLEIITGK 546
            G ++ E   G 
Sbjct: 225 IGCILFEYYRGF 236

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 50.8 bits (122), Expect = 6e-07
 Identities = 60/261 (22%), Positives = 93/261 (35%), Gaps = 90/261 (34%)

Query: 341 EVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVK------RLSKASGQGAEEFKNEVV 393
            +  N F    K+G+G FG V     + + +  AVK      + ++++       K E  
Sbjct: 31  MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA-------KIEAD 83

Query: 394 LVAKLQHR-----NLVRLLGF-------CLEGEEKILVYEFVPNKSLDYFLYDPEKQGQL 441
           ++ K+Q+      N+V+  G        CL       ++E      L   LY+       
Sbjct: 84  ILKKIQNDDINNNNIVKYHGKFMYYDHMCL-------IFE-----PLGPSLYE------- 124

Query: 442 DWSRRYKIIG-------GIARGIL----YLHEDSRLRIIHRDLKASNILLDAEMNP---- 486
               R    G            IL    YL +   + + H DLK  NILLD         
Sbjct: 125 -IITRNNYNGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLI 180

Query: 487 ---------------------KISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQ 525
                                K+ DFG A  F           I+ T  Y APE  ++  
Sbjct: 181 TVRRVTDGKKIQIYRTKSTGIKLIDFGCA-TF-KSDYH---GSIINTRQYRAPEVILNLG 235

Query: 526 FSVKSDVYSFGVLVLEIITGK 546
           + V SD++SFG ++ E+ TG 
Sbjct: 236 WDVSSDMWSFGCVLAELYTGS 256

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 49.6 bits (119), Expect = 1e-06
 Identities = 57/252 (22%), Positives = 97/252 (38%), Gaps = 76/252 (30%)

Query: 341 EVATNKFSTDNKLGEGGFGEVYKGV--LPSGQEIAVK------RLSKASGQGAEEFKNEV 392
           +V + ++   + LGEG FG+V + +     G+ +AVK      R  +A+       ++E+
Sbjct: 10  DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA-------RSEI 62

Query: 393 VLVAKLQHR------NLVRLLGF-------CLEGEEKILVYEFVPNKSLDYFLYDPEKQG 439
            ++  L           V++L +       C       +V+E      L    YD  K+ 
Sbjct: 63  QVLEHLNTTDPNSTFRCVQMLEWFEHHGHIC-------IVFE-----LLGLSTYDFIKEN 110

Query: 440 QLDWSRRYKI--IGGIARGIL----YLHEDSRLRIIHRDLKASNILLDAEMNP------- 486
                  +++  I  +A  I     +LH     ++ H DLK  NIL              
Sbjct: 111 GF---LPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKI 164

Query: 487 ------------KISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYS 534
                       K+ DFG A  +  D+     S +V T  Y APE  +   +S   DV+S
Sbjct: 165 KRDERTLINPDIKVVDFGSA-TY-DDEHH---STLVSTRHYRAPEVILALGWSQPCDVWS 219

Query: 535 FGVLVLEIITGK 546
            G +++E   G 
Sbjct: 220 IGCILIEYYLGF 231

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 47.9 bits (113), Expect = 9e-06
 Identities = 33/209 (15%), Positives = 73/209 (34%), Gaps = 60/209 (28%)

Query: 350 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH-------RN 402
           D + GE  +   YK +L   ++  V        +  ++    ++   ++ H        +
Sbjct: 8   DFETGEHQYQ--YKDILSVFEDAFVDNFD---CKDVQDMPKSILSKEEIDHIIMSKDAVS 62

Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSL--DY-FLYDPEKQGQLDWSRRYKIIGGIARGILY 459
               L + L  +++ +V +FV  + L  +Y FL  P K  Q   S   +         +Y
Sbjct: 63  GTLRLFWTLLSKQEEMVQKFV-EEVLRINYKFLMSPIKTEQRQPSMMTR---------MY 112

Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ-----TQGNTSRIVGTYG 514
           + +  RL   + D            N   + + ++R+    +      +   ++ V   G
Sbjct: 113 IEQRDRL---YND------------NQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDG 157

Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEII 543
                  + G  S K+       + L++ 
Sbjct: 158 -------VLG--SGKT------WVALDVC 171

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282

 Score = 44.9 bits (106), Expect = 4e-05
 Identities = 36/203 (17%), Positives = 64/203 (31%), Gaps = 37/203 (18%)

Query: 307 LRRKAKKKYNAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVL 366
           + +  +K Y     +     L +L  L    +   +          +GEG    V+    
Sbjct: 59  VVQNRQKDYEGSTFTFIGLSLYSLHRLVRSGKVDAI-------GKLMGEGKESAVFNCYS 111

Query: 367 PSGQEIAVK--RLSKAS--------GQGAEEFKNEVVLVAKLQHRNLVRLLGFC----LE 412
               E  VK  ++   S          G   F    +  A+ + R L +L G        
Sbjct: 112 EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 171

Query: 413 GEEKILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHR 471
            E   ++ E +  K L    + +P++           +I        +        I+H 
Sbjct: 172 WEGNAVLMELIDAKELYRVRVENPDEV--------LDMILEEVAKFYHRG------IVHG 217

Query: 472 DLKASNILLDAEMNPKISDFGMA 494
           DL   N+L+  E    I DF  +
Sbjct: 218 DLSQYNVLVSEEG-IWIIDFPQS 239

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	571
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	99.97
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.97
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.97
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.96
3a2e_A	108	Ginkbilobin-2; domain 26 unknown function (DUF26),	99.95
2e79_A	108	Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect	99.94
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.94
3a2e_A	108	Ginkbilobin-2; domain 26 unknown function (DUF26),	99.89
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.89
2e79_A	108	Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect	99.89
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.78
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.68
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.33
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.19
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.05
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.99
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.65
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.55
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.46
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.39
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.34
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.31
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.1
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.05
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.03
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.89
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.73
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.51
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.49
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.38
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.25
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.24
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.18
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.99
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.9
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.89
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.03
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.14
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	93.56
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	92.9
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	89.66
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	86.15
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	85.97
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	84.72
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	83.54

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=4.8e-49  Score=393.14  Aligned_cols=205  Identities=33%  Similarity=0.531  Sum_probs=179.7

Q ss_pred             hCCCCccccccccCceeEEEEEcc------CCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI  417 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  417 (571)
                      .++|.+.++||+|+||+||+|++.      ++..||||+++..+....++|.+|+++|++++|||||+++|++.+++..+
T Consensus        12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~   91 (299)
T 4asz_A           12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   91 (299)
T ss_dssp             GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence            356788899999999999999863      46789999998877777789999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceE
Q 008292          418 LVYEFVPNKSLDYFLYDP----------EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPK  487 (571)
Q Consensus       418 lv~e~~~~g~L~~~l~~~----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k  487 (571)
                      |||||+++|+|.++|+..          .....++|.++++++.||++||.|||+++   ||||||||+||||++++.+|
T Consensus        92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~K  168 (299)
T 4asz_A           92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK  168 (299)
T ss_dssp             EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEE
Confidence            999999999999999642          22357999999999999999999999987   99999999999999999999


Q ss_pred             EeeccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          488 ISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       488 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                      |+|||+++...............||+.|||||++.++.++.++|||||||++|||+| |+.||..
T Consensus       169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~  233 (299)
T 4asz_A          169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQ  233 (299)
T ss_dssp             ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence            999999987654443333445679999999999999999999999999999999999 8999853

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.5e-48  Score=394.87  Aligned_cols=204  Identities=32%  Similarity=0.533  Sum_probs=172.2

Q ss_pred             CCCCccccccccCceeEEEEEcc------CCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL  418 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  418 (571)
                      ++|.+.++||+|+||+||+|+++      +++.||||+++..+....++|.+|+++|++++|||||+++|+|.+.+..+|
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            45677889999999999999864      477899999988777777899999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCce
Q 008292          419 VYEFVPNKSLDYFLYDPE------------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP  486 (571)
Q Consensus       419 v~e~~~~g~L~~~l~~~~------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~  486 (571)
                      ||||+++|+|.++++...            ...+++|.+++.|+.||++||+|||+++   ||||||||+||||++++.+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence            999999999999986532            2346999999999999999999999987   9999999999999999999


Q ss_pred             EEeeccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          487 KISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       487 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                      ||+|||+++.+.............||+.|||||++.+..++.++|||||||++|||+| |+.||..
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~  263 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQ  263 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCC
Confidence            9999999997654444444455689999999999999999999999999999999999 8999853

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2.3e-48  Score=389.91  Aligned_cols=204  Identities=32%  Similarity=0.501  Sum_probs=177.7

Q ss_pred             CCCCccccccccCceeEEEEEcc------CCCeeEEEeeccc-CccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSKA-SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI  417 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  417 (571)
                      .++++.++||+|+||+||+|++.      +++.||||+++.. .....++|.+|+.++++++|||||+++|+|.+.+..+
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            34566789999999999999862      4678999999754 3445688999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCC
Q 008292          418 LVYEFVPNKSLDYFLYDPE-------------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM  484 (571)
Q Consensus       418 lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~  484 (571)
                      |||||+++|+|.++|....             ....++|.++++|+.||++||+|||+++   ||||||||+||||++++
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence            9999999999999996432             1346899999999999999999999987   99999999999999999


Q ss_pred             ceEEeeccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          485 NPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       485 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                      ++||+|||+++.+.............||++|||||++.++.++.++|||||||++|||+| |+.||..
T Consensus       183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~  250 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG  250 (308)
T ss_dssp             CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCC
Confidence            999999999987754444444455689999999999999999999999999999999999 8999853

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=7.6e-48  Score=383.72  Aligned_cols=201  Identities=27%  Similarity=0.428  Sum_probs=182.5

Q ss_pred             CCCCccccccccCceeEEEEEc-cCCCeeEEEeeccc---CccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY  420 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  420 (571)
                      ++|++.++||+|+||+||+++. .+|+.||||++.+.   .....+.+.+|+++|++++|||||++++++.+.+..+|||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            3588999999999999999995 46899999999753   3455678999999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCC
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD  500 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  500 (571)
                      ||+++|+|.+++.   +.+.+++.++..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+|+.+...
T Consensus       112 Ey~~gG~L~~~i~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          112 SYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  185 (311)
T ss_dssp             CCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             ecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence            9999999999984   4567999999999999999999999988   999999999999999999999999999987655


Q ss_pred             CCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .........+||+.|||||++.+..++.++||||+||++|||+||+.||..
T Consensus       186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~  236 (311)
T 4aw0_A          186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA  236 (311)
T ss_dssp             TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            444455667999999999999999999999999999999999999999863

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.8e-47  Score=386.72  Aligned_cols=198  Identities=28%  Similarity=0.435  Sum_probs=180.1

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEec
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV  423 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  423 (571)
                      +.|+..++||+|+||+||+|+.. +|+.||||+++.......+.+.+|+.+|++++|||||++++++.+.+..+|||||+
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            46888999999999999999964 68999999998766666778899999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCc
Q 008292          424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ  503 (571)
Q Consensus       424 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  503 (571)
                      ++|+|.+++.    ...+++.++..++.||+.||+|||+++   ||||||||+||||+.++.+||+|||+|+.+....  
T Consensus       154 ~gg~L~~~l~----~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--  224 (346)
T 4fih_A          154 EGGALTDIVT----HTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--  224 (346)
T ss_dssp             TTEEHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--
T ss_pred             CCCcHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCC--
Confidence            9999999984    356999999999999999999999988   9999999999999999999999999998765332  


Q ss_pred             cccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          504 GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       504 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ......+||+.|||||++.+..|+.++|||||||++|||+||+.||..
T Consensus       225 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~  272 (346)
T 4fih_A          225 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN  272 (346)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            233456899999999999999999999999999999999999999853

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.3e-47  Score=386.56  Aligned_cols=201  Identities=24%  Similarity=0.390  Sum_probs=172.7

Q ss_pred             CCCCccccccccCceeEEEEEc-cCCCeeEEEeeccc--CccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE  421 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e  421 (571)
                      ++|++.++||+|+||+||+++. .+|+.||||++++.  .....+.+.+|+++|++++|||||++++++.+.+..+||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            5899999999999999999995 46899999999754  33446789999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCC
Q 008292          422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ  501 (571)
Q Consensus       422 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  501 (571)
                      |+++|+|.+++.. .+...+++.+++.++.||+.||+|||+++   ||||||||+||||+.++.+||+|||+|+.+... 
T Consensus       104 y~~gg~L~~~i~~-~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-  178 (350)
T 4b9d_A          104 YCEGGDLFKRINA-QKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST-  178 (350)
T ss_dssp             CCTTCBHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHH-
T ss_pred             CCCCCcHHHHHHH-cCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCC-
Confidence            9999999999853 23456799999999999999999999987   999999999999999999999999999875422 


Q ss_pred             CccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          502 TQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       502 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                       .......+||+.|||||++.+..|+.++|||||||++|||+||+.||..
T Consensus       179 -~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~  227 (350)
T 4b9d_A          179 -VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEA  227 (350)
T ss_dssp             -HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             -cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence             1123456899999999999999999999999999999999999999863

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.4e-47  Score=382.72  Aligned_cols=203  Identities=31%  Similarity=0.526  Sum_probs=169.8

Q ss_pred             HHHhCCCCccccccccCceeEEEEEccCCCeeEEEeeccc--CccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEE
Q 008292          341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL  418 (571)
Q Consensus       341 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  418 (571)
                      ++..+++.+.++||+|+||+||+|++++  .||||+++..  +....++|.+|+.+|++++|||||+++|++.+ +..+|
T Consensus        32 ei~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~i  108 (307)
T 3omv_A           32 EIEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAI  108 (307)
T ss_dssp             BCCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred             EEcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEE
Confidence            3445678889999999999999999753  5899998753  34456789999999999999999999998865 56899


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccC
Q 008292          419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG  498 (571)
Q Consensus       419 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  498 (571)
                      ||||+++|+|.++|+.  ....++|.+++.|+.||++||+|||+++   ||||||||+||||++++++||+|||+|+...
T Consensus       109 VmEy~~gGsL~~~l~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~  183 (307)
T 3omv_A          109 VTQWCEGSSLYKHLHV--QETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKS  183 (307)
T ss_dssp             EEECCSSCBHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC--
T ss_pred             EEEcCCCCCHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecc
Confidence            9999999999999964  3457999999999999999999999987   9999999999999999999999999998765


Q ss_pred             CCCCccccccccccCCccccccccc---CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          499 VDQTQGNTSRIVGTYGYMAPEYAMH---GQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       499 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ...........+||+.|||||++..   +.++.++|||||||++|||+||+.||..
T Consensus       184 ~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~  239 (307)
T 3omv_A          184 RWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSH  239 (307)
T ss_dssp             ----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             cCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCC
Confidence            4333334456789999999999864   4689999999999999999999999853

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.1e-46  Score=390.10  Aligned_cols=198  Identities=28%  Similarity=0.440  Sum_probs=180.6

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      .+.|+..++||+|+||.||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..+|||||
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy  229 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  229 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence            357999999999999999999964 6899999999877666677899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT  502 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  502 (571)
                      +++|+|.+++.    ...+++.++..++.||+.||+|||+++   ||||||||+||||+.++.+||+|||+|+.+.... 
T Consensus       230 ~~gG~L~~~i~----~~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-  301 (423)
T 4fie_A          230 LEGGALTDIVT----HTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-  301 (423)
T ss_dssp             CTTEEHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-
T ss_pred             CCCCcHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC-
Confidence            99999999983    356999999999999999999999988   9999999999999999999999999998765332 


Q ss_pred             ccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          503 QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       503 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                       ......+||+.|||||++.+..|+.++|||||||++|||++|+.||.
T Consensus       302 -~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~  348 (423)
T 4fie_A          302 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYF  348 (423)
T ss_dssp             -CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             -ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence             23345689999999999999999999999999999999999999985

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=2e-46  Score=377.97  Aligned_cols=196  Identities=29%  Similarity=0.377  Sum_probs=170.7

Q ss_pred             CCCCccccccccCceeEEEEEc-cCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEec
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV  423 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  423 (571)
                      +.|+..++||+|+||+||+++. .+|+.||||+++.....     .+|+.+++.++|||||++++++.+++..+|||||+
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-----~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  132 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL  132 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-----THHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-----HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence            4677888999999999999996 46899999999754322     46999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCC-ceEEeeccCccccCCCCC
Q 008292          424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM-NPKISDFGMARIFGVDQT  502 (571)
Q Consensus       424 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGla~~~~~~~~  502 (571)
                      ++|+|.+++.   +.+.+++.++..++.||+.||+|||+++   ||||||||+||||+.++ .+||+|||+|+.+.....
T Consensus       133 ~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~  206 (336)
T 4g3f_A          133 EGGSLGQLIK---QMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL  206 (336)
T ss_dssp             TTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred             CCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence            9999999994   3467999999999999999999999987   99999999999999987 699999999997754322


Q ss_pred             c---cccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          503 Q---GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       503 ~---~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .   ......+||+.|||||++.+..++.++|||||||++|||+||+.||.-
T Consensus       207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~  258 (336)
T 4g3f_A          207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQ  258 (336)
T ss_dssp             -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTT
T ss_pred             ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCC
Confidence            1   123346899999999999999999999999999999999999999864

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=2e-46  Score=382.33  Aligned_cols=218  Identities=29%  Similarity=0.420  Sum_probs=187.9

Q ss_pred             cccccchHHHHHHhCCCCccccccccCceeEEEEEccC------CCeeEEEeecccC-ccCHHHHHHHHHHHhhcCC-Cc
Q 008292          331 ESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPS------GQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQH-RN  402 (571)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~------g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h-~n  402 (571)
                      +.+.++..+|++..++|++.++||+|+||+||+|++..      ++.||||+++... ....+.|.+|+++|.+++| ||
T Consensus        50 ~~lp~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpn  129 (353)
T 4ase_A           50 ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN  129 (353)
T ss_dssp             GGSCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTT
T ss_pred             hcCCCCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCc
Confidence            44566777888889999999999999999999998532      3579999997643 3345679999999999976 89


Q ss_pred             eeccceeEEeC-CeeEEEEEecCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCe
Q 008292          403 LVRLLGFCLEG-EEKILVYEFVPNKSLDYFLYDPE-------------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRI  468 (571)
Q Consensus       403 iv~l~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i  468 (571)
                      ||+++|+|.+. +..+|||||+++|+|.++|+...             ....+++.+++.++.||++||+|||+++   |
T Consensus       130 IV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---i  206 (353)
T 4ase_A          130 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---C  206 (353)
T ss_dssp             BCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred             EEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---e
Confidence            99999999764 56899999999999999996422             1345899999999999999999999987   9


Q ss_pred             EEecCCCCCEEECCCCceEEeeccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCC
Q 008292          469 IHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKK  547 (571)
Q Consensus       469 vH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~  547 (571)
                      |||||||+||||++++.+||+|||+|+.+..+.........+||+.|||||++.++.++.++|||||||++|||+| |+.
T Consensus       207 iHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~  286 (353)
T 4ase_A          207 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS  286 (353)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred             ecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCC
Confidence            9999999999999999999999999997755544444456689999999999999999999999999999999998 899


Q ss_pred             CCCC
Q 008292          548 NSNF  551 (571)
Q Consensus       548 p~~~  551 (571)
                      ||..
T Consensus       287 Pf~~  290 (353)
T 4ase_A          287 PYPG  290 (353)
T ss_dssp             SSTT
T ss_pred             CCCC
Confidence            9854

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1e-45  Score=366.52  Aligned_cols=195  Identities=29%  Similarity=0.456  Sum_probs=168.2

Q ss_pred             CCccccccccCceeEEEEEcc-CCCeeEEEeeccc--CccCHHHHHHHHHHHhhcCCCceeccceeEEe----CCeeEEE
Q 008292          347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE----GEEKILV  419 (571)
Q Consensus       347 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~----~~~~~lv  419 (571)
                      |+..++||+|+||+||+|... +++.||+|++...  .....+.|.+|+++|++++|||||++++++.+    .+..+||
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv  107 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence            356778999999999999964 6889999998653  33445789999999999999999999999875    2457999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECC-CCceEEeeccCccccC
Q 008292          420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-EMNPKISDFGMARIFG  498 (571)
Q Consensus       420 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGla~~~~  498 (571)
                      |||+++|+|.+++.   +...+++..+..++.||++||+|||+++ ++||||||||+||||+. ++.+||+|||+|+...
T Consensus       108 mEy~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~  183 (290)
T 3fpq_A          108 TELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             EECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EeCCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence            99999999999994   4567999999999999999999999874 45999999999999984 7899999999998543


Q ss_pred             CCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          499 VDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      .    ......+||+.|||||++.+ .++.++|||||||++|||+||+.||.
T Consensus       184 ~----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~  230 (290)
T 3fpq_A          184 A----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYS  230 (290)
T ss_dssp             T----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             C----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence            2    22345689999999998764 69999999999999999999999985

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.8e-45  Score=361.60  Aligned_cols=197  Identities=26%  Similarity=0.451  Sum_probs=161.8

Q ss_pred             CCCCccccccccCceeEEEEEc-cCCCeeEEEeeccc---CccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY  420 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  420 (571)
                      ++|++.+.||+|+||+||+++. .+|+.||||++++.   .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            5899999999999999999996 46899999999753   2344678999999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCC
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD  500 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  500 (571)
                      ||+ +|+|.+++.   +.+.+++.++..++.||+.||+|||+++   |+||||||+||||++++++||+|||+|+.....
T Consensus        93 Ey~-~g~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  165 (275)
T 3hyh_A           93 EYA-GNELFDYIV---QRDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG  165 (275)
T ss_dssp             ECC-CEEHHHHHH---HSCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred             eCC-CCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence            999 678888874   4567999999999999999999999987   999999999999999999999999999865432


Q ss_pred             CCccccccccccCCcccccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          501 QTQGNTSRIVGTYGYMAPEYAMHGQF-SVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       501 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .   .....+||+.|||||++.+..+ +.++||||+||++|||+||+.||..
T Consensus       166 ~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~  214 (275)
T 3hyh_A          166 N---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD  214 (275)
T ss_dssp             ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             C---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCC
Confidence            2   2334689999999999998876 5799999999999999999999863

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2e-46  Score=373.48  Aligned_cols=199  Identities=29%  Similarity=0.339  Sum_probs=169.2

Q ss_pred             CCCCccccccccCceeEEEEEc----cCCCeeEEEeecccC--ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVL----PSGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL  418 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~----~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  418 (571)
                      ++|++.+.||+|+||+||+++.    ..++.||||++++..  ......+.+|+++|++++|||||++++++.+.+..+|
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            5689999999999999999985    246789999997542  2233468899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccC
Q 008292          419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG  498 (571)
Q Consensus       419 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  498 (571)
                      ||||+++|+|.+++.   +.+.+++.++..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|+...
T Consensus       104 vmEy~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  177 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI  177 (304)
T ss_dssp             EECCCTTCEEHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred             EEEcCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence            999999999999984   4567999999999999999999999987   9999999999999999999999999998653


Q ss_pred             CCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          499 VDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ...  ......+||+.|||||++.+..++.++|||||||++|||+||+.||..
T Consensus       178 ~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~  228 (304)
T 3ubd_A          178 DHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG  228 (304)
T ss_dssp             -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCC
Confidence            222  223456899999999999999999999999999999999999999863

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=3.4e-45  Score=367.36  Aligned_cols=199  Identities=27%  Similarity=0.365  Sum_probs=163.6

Q ss_pred             CCCCccccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCC----eeEEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE----EKILVY  420 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----~~~lv~  420 (571)
                      ++|.+.++||+|+||+||+|++ +|+.||||+++..... ...++.|+..+.+++|||||+++|++.+.+    ..+|||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            4577889999999999999998 6899999999754321 223445777778899999999999998754    579999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-----CCCCeEEecCCCCCEEECCCCceEEeeccCcc
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED-----SRLRIIHRDLKASNILLDAEMNPKISDFGMAR  495 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-----~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  495 (571)
                      ||+++|+|.++++    ...++|..+++++.|+++||+|||++     ..++||||||||+||||+.++++||+|||+++
T Consensus        81 Ey~~~gsL~~~l~----~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~  156 (303)
T 3hmm_A           81 DYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             ECCTTCBHHHHHH----HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             cCCCCCcHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence            9999999999994    34689999999999999999999986     23469999999999999999999999999998


Q ss_pred             ccCCCCCc--cccccccccCCcccccccccC------CCCcchhHHHHHHHHHHHHhCCCCC
Q 008292          496 IFGVDQTQ--GNTSRIVGTYGYMAPEYAMHG------QFSVKSDVYSFGVLVLEIITGKKNS  549 (571)
Q Consensus       496 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~s~~~Dv~slGvvl~elltG~~p~  549 (571)
                      ........  ......+||+.|||||++.+.      .++.++|||||||++|||+||+.|+
T Consensus       157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~  218 (303)
T 3hmm_A          157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG  218 (303)
T ss_dssp             EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBT
T ss_pred             cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCC
Confidence            76543322  123346899999999998754      4678999999999999999998765

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2.1e-44  Score=360.08  Aligned_cols=197  Identities=28%  Similarity=0.454  Sum_probs=160.1

Q ss_pred             CCCCccccccccCceeEEEEEc-cCCCeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCe-------
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEE-------  415 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~-------  415 (571)
                      ++|++.+.||+|+||+||+++. .+|+.||||+++... +...+.+.+|+.+|++++|||||++++++.+.+.       
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            3588899999999999999996 468999999997543 3345678999999999999999999999876543       


Q ss_pred             -----eEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEee
Q 008292          416 -----KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISD  490 (571)
Q Consensus       416 -----~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  490 (571)
                           .++||||+++|+|.+++.........++..++.++.||++||+|||+++   |+||||||+||||+.++.+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence                 6899999999999999965444445677888999999999999999987   99999999999999999999999


Q ss_pred             ccCccccCCCCCc----------cccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh
Q 008292          491 FGMARIFGVDQTQ----------GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT  544 (571)
Q Consensus       491 fGla~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt  544 (571)
                      ||+|+.+......          ...+..+||+.|||||++.+..++.++|||||||++|||++
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~  225 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY  225 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc
Confidence            9999877543221          12234579999999999999999999999999999999997

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.6e-42  Score=354.95  Aligned_cols=200  Identities=24%  Similarity=0.388  Sum_probs=170.9

Q ss_pred             CCCCccccccccCceeEEEEEc-cCCCeeEEEeecccC--ccCHHHHHHHHHHHhhcCCCceeccceeEEe------CCe
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE------GEE  415 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~------~~~  415 (571)
                      ++|++.++||+|+||+||+++. .+|+.||||+++...  ....+.+.+|+++|+.++|||||++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            5799999999999999999996 479999999997543  2334678899999999999999999998764      356


Q ss_pred             eEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCcc
Q 008292          416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR  495 (571)
Q Consensus       416 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  495 (571)
                      .+|||||++ |+|.+++.   +.+.+++.++..++.||+.||.|||+++   ||||||||+|||++.++.+||+|||+++
T Consensus       134 ~~ivmE~~~-g~L~~~i~---~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~  206 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIH---SSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMAR  206 (398)
T ss_dssp             EEEEEECCS-EEHHHHHT---SSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEEeCCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceee
Confidence            899999996 67888883   4567999999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCC--CccccccccccCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          496 IFGVDQ--TQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       496 ~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .+....  ........+||+.|||||++.+. .++.++||||+||++|||+||+.||..
T Consensus       207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g  265 (398)
T 4b99_A          207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPG  265 (398)
T ss_dssp             CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred             ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCC
Confidence            764322  12233457899999999998875 569999999999999999999999864

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.4e-41  Score=348.77  Aligned_cols=198  Identities=22%  Similarity=0.350  Sum_probs=170.0

Q ss_pred             HhCCCCccccccccCceeEEEEEcc----CCCeeEEEeecccCccCHHHHHHHHHHHhhc-CCCceeccceeEEeCCeeE
Q 008292          343 ATNKFSTDNKLGEGGFGEVYKGVLP----SGQEIAVKRLSKASGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKI  417 (571)
Q Consensus       343 ~~~~~~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~  417 (571)
                      ..++|++.++||+|+||+||+++.+    .++.||+|++.+..  ...++.+|+++|..+ +||||+++++++.+.+..+
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~   96 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV   96 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence            4578999999999999999999753    46789999986543  346788999999988 6999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCC-CceEEeeccCccc
Q 008292          418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE-MNPKISDFGMARI  496 (571)
Q Consensus       418 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfGla~~  496 (571)
                      +||||+++|+|.+++.      .+++.++..++.||+.||+|||+++   |+||||||+|||++.+ +.+||+|||+|+.
T Consensus        97 lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~  167 (361)
T 4f9c_A           97 IAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQG  167 (361)
T ss_dssp             EEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence            9999999999999882      4899999999999999999999988   9999999999999877 7999999999986


Q ss_pred             cCCCCCc--------------------------cccccccccCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCC
Q 008292          497 FGVDQTQ--------------------------GNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNS  549 (571)
Q Consensus       497 ~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~slGvvl~elltG~~p~  549 (571)
                      .......                          ......+||+.|||||++.+. .++.++||||+||++|||+||+.||
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf  247 (361)
T 4f9c_A          168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF  247 (361)
T ss_dssp             CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred             cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence            5432110                          112335799999999999875 5899999999999999999999998


Q ss_pred             CC
Q 008292          550 NF  551 (571)
Q Consensus       550 ~~  551 (571)
                      ..
T Consensus       248 ~~  249 (361)
T 4f9c_A          248 YK  249 (361)
T ss_dssp             SC
T ss_pred             CC
Confidence            53

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1e-41  Score=368.49  Aligned_cols=199  Identities=28%  Similarity=0.404  Sum_probs=172.3

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC---ccCHHHHH---HHHHHHhhcCCCceeccceeEEeCCeeE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFK---NEVVLVAKLQHRNLVRLLGFCLEGEEKI  417 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~---~Ei~~l~~l~h~niv~l~~~~~~~~~~~  417 (571)
                      ++|++.+.||+|+||+||+++.+ +|+.||||++++..   ......+.   +++.+++.++|||||++++++.+.+..+
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            56889999999999999999964 68999999996532   22233333   4466777889999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCcccc
Q 008292          418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF  497 (571)
Q Consensus       418 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  497 (571)
                      |||||++||+|..++.   +.+.+++..+..++.||+.||+|||+++   ||||||||+||||+.+|.+||+|||+|+.+
T Consensus       269 lVmEy~~GGdL~~~l~---~~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~  342 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF  342 (689)
T ss_dssp             EEECCCCSCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeec
Confidence            9999999999999994   4567999999999999999999999987   999999999999999999999999999876


Q ss_pred             CCCCCccccccccccCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 008292          498 GVDQTQGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNFYQ  553 (571)
Q Consensus       498 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slGvvl~elltG~~p~~~~~  553 (571)
                      ....    ....+||+.|||||++.. ..|+.++|||||||++|||++|+.||....
T Consensus       343 ~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~  395 (689)
T 3v5w_A          343 SKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK  395 (689)
T ss_dssp             SSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGG
T ss_pred             CCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            4332    334689999999999975 579999999999999999999999996433

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=7.9e-41  Score=363.48  Aligned_cols=198  Identities=24%  Similarity=0.416  Sum_probs=179.0

Q ss_pred             CCCCccccccccCceeEEEEEc-cCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEec
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV  423 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  423 (571)
                      ++|++.+.||+|+||+||+++. .+|+.||+|++........+.+.+|+.+|+.++|||||++++++.+....+|||||+
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~  236 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  236 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence            5799999999999999999996 468999999998766666778999999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCC--CceEEeeccCccccCCCC
Q 008292          424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE--MNPKISDFGMARIFGVDQ  501 (571)
Q Consensus       424 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~DfGla~~~~~~~  501 (571)
                      ++|+|.+++..  +...+++.++..++.||+.||.|||+++   |+||||||+|||++.+  +.+||+|||+++.+....
T Consensus       237 ~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~  311 (573)
T 3uto_A          237 SGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ  311 (573)
T ss_dssp             CCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred             CCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence            99999998843  3457999999999999999999999988   9999999999999854  899999999999875432


Q ss_pred             CccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          502 TQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       502 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                         .....+||+.|||||++.+..++.++|||||||++|||++|+.||.
T Consensus       312 ---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~  357 (573)
T 3uto_A          312 ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFG  357 (573)
T ss_dssp             ---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSC
T ss_pred             ---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence               2334689999999999999999999999999999999999999985

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1e-39  Score=331.26  Aligned_cols=225  Identities=39%  Similarity=0.684  Sum_probs=192.7

Q ss_pred             chHHHHHHhCCCCccccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCe
Q 008292          336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEE  415 (571)
Q Consensus       336 ~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~  415 (571)
                      +..+++...++|+..+.||+|+||.||+|++++++.||||++........+.+.+|+.+++.++||||+++++++.+.+.
T Consensus        30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  109 (321)
T 2qkw_B           30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNE  109 (321)
T ss_dssp             CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTC
T ss_pred             cHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCe
Confidence            33444556789999999999999999999988899999999987766667889999999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCc
Q 008292          416 KILVYEFVPNKSLDYFLYDPE-KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA  494 (571)
Q Consensus       416 ~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla  494 (571)
                      .++||||+++|+|.+++.... ....+++..++.++.|+++||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~  186 (321)
T 2qkw_B          110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGIS  186 (321)
T ss_dssp             CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTC
T ss_pred             EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecccc
Confidence            999999999999999985432 2346899999999999999999999987   999999999999999999999999999


Q ss_pred             cccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHH
Q 008292          495 RIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSY  563 (571)
Q Consensus       495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~~~~~~~~~l~~~  563 (571)
                      +...............||+.|+|||.+.+..++.++||||||+++|||+||+.|+.........++..|
T Consensus       187 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~  255 (321)
T 2qkw_B          187 KKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEW  255 (321)
T ss_dssp             EECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHH
T ss_pred             cccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHH
Confidence            865433333333445689999999999999999999999999999999999999875444443444443

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=2.1e-38  Score=317.92  Aligned_cols=199  Identities=28%  Similarity=0.485  Sum_probs=180.0

Q ss_pred             hCCCCccccccccCceeEEEEEc-cCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      .++|+..++||+|+||+||++.. .+++.||+|++........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            46899999999999999999985 57899999999877667778899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT  502 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  502 (571)
                      +++|+|.+++.    ...+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++........
T Consensus        99 ~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  171 (297)
T 3fxz_A           99 LAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (297)
T ss_dssp             CTTCBHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             CCCCCHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence            99999999984    346899999999999999999999987   99999999999999999999999999987643322


Q ss_pred             ccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          503 QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       503 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                        ......||+.|+|||.+.+..++.++||||||+++|||+||+.||..
T Consensus       172 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  218 (297)
T 3fxz_A          172 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN  218 (297)
T ss_dssp             --CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             --ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence              23345799999999999999999999999999999999999999853

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.2e-38  Score=324.03  Aligned_cols=218  Identities=43%  Similarity=0.773  Sum_probs=189.0

Q ss_pred             ccccchHHHHHHhCCCCccccccccCceeEEEEEccCCCeeEEEeecccCc-cCHHHHHHHHHHHhhcCCCceeccceeE
Q 008292          332 SLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASG-QGAEEFKNEVVLVAKLQHRNLVRLLGFC  410 (571)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~  410 (571)
                      ...+...++....++|+..+.||+|+||.||++..++++.||||++..... .....+.+|+++++.++||||+++++++
T Consensus        17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   96 (326)
T 3uim_A           17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC   96 (326)
T ss_dssp             CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred             cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence            345778899999999999999999999999999988899999999976432 2234689999999999999999999999


Q ss_pred             EeCCeeEEEEEecCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEe
Q 008292          411 LEGEEKILVYEFVPNKSLDYFLYDPE-KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKIS  489 (571)
Q Consensus       411 ~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  489 (571)
                      ...+..++||||+++|+|.+++.... ....+++..++.++.|++.||.|||++..++|+||||||+|||++.++.+||+
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~  176 (326)
T 3uim_A           97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG  176 (326)
T ss_dssp             CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred             ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence            99999999999999999999996543 33459999999999999999999999833349999999999999999999999


Q ss_pred             eccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          490 DFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       490 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      |||+++....... .......||+.|+|||.+.+..++.++||||||+++|||+||+.||+
T Consensus       177 Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  236 (326)
T 3uim_A          177 DFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD  236 (326)
T ss_dssp             CCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred             cCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence            9999987643322 22334569999999999999999999999999999999999999985

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=7.4e-38  Score=317.54  Aligned_cols=209  Identities=30%  Similarity=0.447  Sum_probs=184.0

Q ss_pred             ccchHHHHHHhCC----------CCccccccccCceeEEEEEcc-CCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCc
Q 008292          334 QFDFETIEVATNK----------FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRN  402 (571)
Q Consensus       334 ~~~~~~~~~~~~~----------~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n  402 (571)
                      .+.+++++.+.+.          |+..++||+|+||+||+|+.. +|+.||||++........+.+.+|+.++++++|||
T Consensus        24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n  103 (321)
T 2c30_A           24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN  103 (321)
T ss_dssp             -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred             cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence            4556666655543          666789999999999999975 79999999998777777888999999999999999


Q ss_pred             eeccceeEEeCCeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECC
Q 008292          403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA  482 (571)
Q Consensus       403 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~  482 (571)
                      |+++++++...+..++||||+++++|.+++.    ...+++..+..++.|+++||.|||+++   |+||||||+|||++.
T Consensus       104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~  176 (321)
T 2c30_A          104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVS----QVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTL  176 (321)
T ss_dssp             BCCEEEEEEETTEEEEEECCCCSCBHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECT
T ss_pred             cceEEEEEEECCEEEEEEecCCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECC
Confidence            9999999999999999999999999999983    346899999999999999999999987   999999999999999


Q ss_pred             CCceEEeeccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          483 EMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       483 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ++.+||+|||+++.+.....  ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       177 ~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~  243 (321)
T 2c30_A          177 DGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFS  243 (321)
T ss_dssp             TCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             CCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            99999999999987643322  22345799999999999999999999999999999999999999853

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=7.2e-38  Score=315.93  Aligned_cols=204  Identities=29%  Similarity=0.500  Sum_probs=178.7

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      .++|...++||+|+||+||++... +++.||+|++........+.+.+|++++++++||||+++++++.+++..++||||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            357888999999999999999964 6889999999777777778899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT  502 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  502 (571)
                      +++++|.+++..  ....+++.+++.++.|+++||+|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus        89 ~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  163 (310)
T 3s95_A           89 IKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT  163 (310)
T ss_dssp             CTTCBHHHHHHH--CCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred             cCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence            999999999953  2456899999999999999999999987   99999999999999999999999999987643322


Q ss_pred             cc------------ccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 008292          503 QG------------NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFY  552 (571)
Q Consensus       503 ~~------------~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~~  552 (571)
                      ..            ......||+.|+|||.+.+..++.++||||||+++|||++|..|+...
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~  225 (310)
T 3s95_A          164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDY  225 (310)
T ss_dssp             ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTT
T ss_pred             cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcch
Confidence            11            111457999999999999999999999999999999999999987643

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=3.6e-38  Score=321.53  Aligned_cols=199  Identities=25%  Similarity=0.332  Sum_probs=177.1

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeeccc---CccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY  420 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  420 (571)
                      ++|++.+.||+|+||+||+++.+ +|+.||+|++++.   .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~   84 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence            57889999999999999999964 6899999999754   3455678899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCC
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD  500 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  500 (571)
                      ||+++|+|..++.   +...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        85 E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  158 (337)
T 1o6l_A           85 EYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             ECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             eCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence            9999999998884   3457899999999999999999999987   999999999999999999999999999854322


Q ss_pred             CCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .  ......+||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       159 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~  207 (337)
T 1o6l_A          159 G--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN  207 (337)
T ss_dssp             T--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             C--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCC
Confidence            1  223456899999999999999999999999999999999999999853

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=4.4e-38  Score=319.93  Aligned_cols=199  Identities=28%  Similarity=0.466  Sum_probs=176.7

Q ss_pred             hCCCCccccccccCceeEEEEEc-cCCCeeEEEeeccc--CccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY  420 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  420 (571)
                      .++|++.+.||+|+||.||+++. .+|+.||||++...  .....+.+.+|+++++.++||||+++++++...+..++||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            35799999999999999999996 57899999998654  3344567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCC
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD  500 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  500 (571)
                      ||+++|+|.+++.   ....+++..+..++.||++||.|||+++   |+||||||+|||++.++++||+|||+++.....
T Consensus        94 e~~~~~~L~~~l~---~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  167 (328)
T 3fe3_A           94 EYASGGEVFDYLV---AHGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG  167 (328)
T ss_dssp             CCCTTCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred             ECCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence            9999999999884   3456999999999999999999999987   999999999999999999999999999876433


Q ss_pred             CCccccccccccCCcccccccccCCCC-cchhHHHHHHHHHHHHhCCCCCCC
Q 008292          501 QTQGNTSRIVGTYGYMAPEYAMHGQFS-VKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .   .....+||+.|+|||.+.+..+. .++||||||+++|||+||+.||..
T Consensus       168 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  216 (328)
T 3fe3_A          168 G---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG  216 (328)
T ss_dssp             C---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             C---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCC
Confidence            2   23456799999999999888775 799999999999999999999864

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.5e-38  Score=334.88  Aligned_cols=210  Identities=23%  Similarity=0.315  Sum_probs=180.7

Q ss_pred             chHHHHHHhCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC---ccCHHHHHHHHHHHhhcCCCceeccceeEE
Q 008292          336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCL  411 (571)
Q Consensus       336 ~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~  411 (571)
                      ....++...++|++.++||+|+||+||+++.+ +++.||+|++++..   ....+.+.+|+.++..++||||+++++++.
T Consensus        65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  144 (437)
T 4aw2_A           65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ  144 (437)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence            34455566789999999999999999999975 47889999997532   222345889999999999999999999999


Q ss_pred             eCCeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeec
Q 008292          412 EGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDF  491 (571)
Q Consensus       412 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  491 (571)
                      +.+..++||||+++|+|.+++..  ....+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+||
T Consensus       145 ~~~~~~lV~Ey~~gg~L~~~l~~--~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DF  219 (437)
T 4aw2_A          145 DDNNLYLVMDYYVGGDLLTLLSK--FEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADF  219 (437)
T ss_dssp             CSSEEEEEECCCTTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred             eCCEEEEEEecCCCCcHHHHHHH--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcch
Confidence            99999999999999999999954  2457999999999999999999999987   999999999999999999999999


Q ss_pred             cCccccCCCCCccccccccccCCcccccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          492 GMARIFGVDQTQGNTSRIVGTYGYMAPEYAM-----HGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       492 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      |+++.+..... ......+||+.|+|||++.     ...++.++||||||+++|||+||+.||..
T Consensus       220 Gla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~  283 (437)
T 4aw2_A          220 GSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA  283 (437)
T ss_dssp             TTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             hhhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCC
Confidence            99987643322 2233468999999999987     56799999999999999999999999853

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=6.2e-38  Score=318.37  Aligned_cols=203  Identities=29%  Similarity=0.454  Sum_probs=175.5

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE  421 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e  421 (571)
                      .++|++.+.||+|+||+||+++.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            368999999999999999999965 78899999986543 2334678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCC
Q 008292          422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ  501 (571)
Q Consensus       422 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  501 (571)
                      |+++++|.+++.   ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+....
T Consensus        86 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  159 (323)
T 3tki_A           86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (323)
T ss_dssp             CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             cCCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence            999999999984   3456999999999999999999999987   9999999999999999999999999998764433


Q ss_pred             CccccccccccCCcccccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCCC
Q 008292          502 TQGNTSRIVGTYGYMAPEYAMHGQF-SVKSDVYSFGVLVLEIITGKKNSNFY  552 (571)
Q Consensus       502 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~Dv~slGvvl~elltG~~p~~~~  552 (571)
                      .........||+.|+|||++.+..+ +.++||||||+++|||++|+.||...
T Consensus       160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  211 (323)
T 3tki_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP  211 (323)
T ss_dssp             EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSS
T ss_pred             cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Confidence            3333445689999999999988776 77899999999999999999998643

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=5.2e-38  Score=324.98  Aligned_cols=205  Identities=29%  Similarity=0.444  Sum_probs=177.3

Q ss_pred             hCCCCccccccccCceeEEEEEcc--------CCCeeEEEeecccC-ccCHHHHHHHHHHHhhc-CCCceeccceeEEeC
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP--------SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEG  413 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~  413 (571)
                      .++|++.+.||+|+||.||+++..        ++..||||+++... ....+.+.+|+.+++++ +||||+++++++.+.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            467889999999999999999852        34579999997643 33456789999999999 899999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEE
Q 008292          414 EEKILVYEFVPNKSLDYFLYDPE-------------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL  480 (571)
Q Consensus       414 ~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll  480 (571)
                      +..++||||+++|+|.+++....             ....+++..++.++.||++||.|||+++   |+||||||+|||+
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence            99999999999999999986432             1245899999999999999999999987   9999999999999


Q ss_pred             CCCCceEEeeccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          481 DAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       481 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                      +.++.+||+|||+++.+.............+|+.|+|||++.+..++.++||||||+++|||+| |+.||..
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~  308 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG  308 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCC
Confidence            9999999999999987654433333444567889999999999999999999999999999999 9999864

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=7e-38  Score=325.50  Aligned_cols=200  Identities=26%  Similarity=0.375  Sum_probs=174.5

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC---ccCHHHHHHHHHHHhhc-CCCceeccceeEEeCCeeEE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKIL  418 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~l  418 (571)
                      .++|++.++||+|+||.||+++.+ +++.||+|++++..   ....+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            467899999999999999999965 57889999997643   22334678899999887 89999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccC
Q 008292          419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG  498 (571)
Q Consensus       419 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  498 (571)
                      ||||+++|+|..++.   +...+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++...
T Consensus       131 V~E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~  204 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  204 (396)
T ss_dssp             EEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEcCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence            999999999998884   3457999999999999999999999987   9999999999999999999999999998532


Q ss_pred             CCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          499 VDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ..  .......+||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       205 ~~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~  255 (396)
T 4dc2_A          205 RP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI  255 (396)
T ss_dssp             CT--TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTT
T ss_pred             cC--CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence            22  2234456899999999999999999999999999999999999999964

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.4e-37  Score=322.08  Aligned_cols=202  Identities=26%  Similarity=0.403  Sum_probs=177.3

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CCCeeEEEeeccc---CccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV  419 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  419 (571)
                      .++|.+.+.||+|+||.||++... +++.||+|++.+.   .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            357889999999999999999964 5788999998653   234567889999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCC
Q 008292          420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV  499 (571)
Q Consensus       420 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  499 (571)
                      |||+++|+|..++.   ....+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++.+..
T Consensus        94 ~e~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  167 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQ---QNVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR  167 (384)
T ss_dssp             ECCCTTEEHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence            99999999999985   3456999999999999999999999987   99999999999999999999999999987643


Q ss_pred             CCCccccccccccCCccccccccc---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 008292          500 DQTQGNTSRIVGTYGYMAPEYAMH---GQFSVKSDVYSFGVLVLEIITGKKNSNFYQT  554 (571)
Q Consensus       500 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~Dv~slGvvl~elltG~~p~~~~~~  554 (571)
                      ..   .....+||+.|+|||++..   ..++.++||||||+++|||++|+.||.....
T Consensus       168 ~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~  222 (384)
T 4fr4_A          168 ET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS  222 (384)
T ss_dssp             TC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTT
T ss_pred             CC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCC
Confidence            22   2345689999999999864   4589999999999999999999999975433

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.3e-37  Score=311.77  Aligned_cols=201  Identities=28%  Similarity=0.459  Sum_probs=172.1

Q ss_pred             hCCCCccccccccCceeEEEEEc-cCCCeeEEEeecccC---ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV  419 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  419 (571)
                      .++|++.+.||+|+||.||+++. .+++.||+|++....   ....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            46899999999999999999995 468899999986433   23346789999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCC
Q 008292          420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV  499 (571)
Q Consensus       420 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  499 (571)
                      |||+++++|.+++.   ....+++..++.++.|+++||.|||+++   |+||||||+|||++.++.+||+|||+++.+..
T Consensus        90 ~e~~~g~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  163 (294)
T 4eqm_A           90 MEYIEGPTLSEYIE---SHGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE  163 (294)
T ss_dssp             EECCCSCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred             EeCCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence            99999999999984   3457899999999999999999999987   99999999999999999999999999987643


Q ss_pred             CCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          500 DQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ... .......||+.|+|||.+.+..++.++||||||+++|||+||+.||..
T Consensus       164 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~  214 (294)
T 4eqm_A          164 TSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNG  214 (294)
T ss_dssp             ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCS
T ss_pred             ccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence            221 223345799999999999999999999999999999999999999864

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.9e-38  Score=331.44  Aligned_cols=206  Identities=22%  Similarity=0.298  Sum_probs=178.1

Q ss_pred             HHHHHHhCCCCccccccccCceeEEEEEcc-CCCeeEEEeeccc---CccCHHHHHHHHHHHhhcCCCceeccceeEEeC
Q 008292          338 ETIEVATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG  413 (571)
Q Consensus       338 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~  413 (571)
                      ..++...++|++.++||+|+||+||+++.+ +++.||+|++++.   .....+.+.+|+.++..++||||+++++++.+.
T Consensus        62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~  141 (410)
T 3v8s_A           62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  141 (410)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence            344456678999999999999999999965 5889999998652   123334578999999999999999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccC
Q 008292          414 EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM  493 (571)
Q Consensus       414 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl  493 (571)
                      +..++||||+++|+|.+++.    ...+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+
T Consensus       142 ~~~~lV~E~~~gg~L~~~l~----~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~  214 (410)
T 3v8s_A          142 RYLYMVMEYMPGGDLVNLMS----NYDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT  214 (410)
T ss_dssp             SEEEEEECCCTTEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CEEEEEEeCCCCCcHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccce
Confidence            99999999999999999884    346899999999999999999999987   99999999999999999999999999


Q ss_pred             ccccCCCCCccccccccccCCcccccccccCC----CCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          494 ARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQ----FSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       494 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ++.+..... ......+||+.|+|||++.+..    ++.++||||||+++|||+||+.||..
T Consensus       215 a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~  275 (410)
T 3v8s_A          215 CMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA  275 (410)
T ss_dssp             CEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             eEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCC
Confidence            987643321 1233568999999999997665    88999999999999999999999853

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=3.7e-38  Score=323.58  Aligned_cols=201  Identities=29%  Similarity=0.409  Sum_probs=172.8

Q ss_pred             HhCCCCccccccccCceeEEEEEcc-CCCeeEEEeeccc---CccCHHHHHHHHHHHhhc-CCCceeccceeEEeCCeeE
Q 008292          343 ATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKI  417 (571)
Q Consensus       343 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~  417 (571)
                      ..++|++.+.||+|+||.||+++.+ +++.||||++++.   .....+.+.+|..++..+ +||||+++++++.+.+..+
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  100 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF  100 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence            3578999999999999999999964 5889999999753   344567788999999988 6999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCcccc
Q 008292          418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF  497 (571)
Q Consensus       418 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  497 (571)
                      +||||+++|+|..++.   +...+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++..
T Consensus       101 lv~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~  174 (353)
T 3txo_A          101 FVMEFVNGGDLMFHIQ---KSRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG  174 (353)
T ss_dssp             EEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             EEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeec
Confidence            9999999999999884   3456999999999999999999999987   999999999999999999999999999853


Q ss_pred             CCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          498 GVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ...  .......+||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       175 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~  226 (353)
T 3txo_A          175 ICN--GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA  226 (353)
T ss_dssp             CC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ccC--CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCC
Confidence            222  2233456899999999999998999999999999999999999999864

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=3.8e-37  Score=310.05  Aligned_cols=217  Identities=46%  Similarity=0.683  Sum_probs=188.7

Q ss_pred             ccccchHHHHHHhCCCCcc------ccccccCceeEEEEEccCCCeeEEEeecccC----ccCHHHHHHHHHHHhhcCCC
Q 008292          332 SLQFDFETIEVATNKFSTD------NKLGEGGFGEVYKGVLPSGQEIAVKRLSKAS----GQGAEEFKNEVVLVAKLQHR  401 (571)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~------~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l~h~  401 (571)
                      ...+.+.++..++++|...      +.||+|+||.||+|.. +++.||+|++....    ....+.+.+|+.++++++||
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   90 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE   90 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence            3567888899999998877      8999999999999997 68899999986532    33457889999999999999


Q ss_pred             ceeccceeEEeCCeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEEC
Q 008292          402 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD  481 (571)
Q Consensus       402 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~  481 (571)
                      ||+++++++.+.+..++||||+++++|.+++........+++..++.++.|+++||.|||+++   |+||||||+||+++
T Consensus        91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~  167 (307)
T 2nru_A           91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLD  167 (307)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEC
T ss_pred             CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEc
Confidence            999999999999999999999999999999865445567999999999999999999999987   99999999999999


Q ss_pred             CCCceEEeeccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 008292          482 AEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQ  553 (571)
Q Consensus       482 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~~~  553 (571)
                      .++.+||+|||+++...............|++.|+|||.+.+ .++.++||||||+++|||+||+.||....
T Consensus       168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~  238 (307)
T 2nru_A          168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHR  238 (307)
T ss_dssp             TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTB
T ss_pred             CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCc
Confidence            999999999999987654333333345678999999998764 58999999999999999999999987543

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=2e-38  Score=319.85  Aligned_cols=211  Identities=31%  Similarity=0.491  Sum_probs=171.6

Q ss_pred             hHHHHHHhCCCCccccccccCceeEEEEEccCCCeeEEEeecccC--ccCHHHHHHHHHHHhhcCCCceeccceeEEeCC
Q 008292          337 FETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE  414 (571)
Q Consensus       337 ~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~  414 (571)
                      ...+++..++|++.+.||+|+||+||+++. +|+.||||++....  ....+++.+|++++++++||||+++++++.+.+
T Consensus        29 ~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  107 (309)
T 3p86_A           29 GDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP  107 (309)
T ss_dssp             ---CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred             cccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence            334445567899999999999999999987 68899999987543  333467899999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCc
Q 008292          415 EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA  494 (571)
Q Consensus       415 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla  494 (571)
                      ..++||||+++|+|.+++........+++..++.++.||++||+|||+++ ++|+||||||+|||++.++.+||+|||++
T Consensus       108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a  186 (309)
T 3p86_A          108 NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLS  186 (309)
T ss_dssp             CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC--
T ss_pred             ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCC
Confidence            99999999999999999965333334899999999999999999999874 34999999999999999999999999999


Q ss_pred             cccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          495 RIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      +......  .......||+.|+|||.+.+..++.++||||||+++|||+||+.||..
T Consensus       187 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~  241 (309)
T 3p86_A          187 RLKASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGN  241 (309)
T ss_dssp             -----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTT
T ss_pred             ccccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            7543222  123345789999999999999999999999999999999999999864

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=4.7e-38  Score=324.84  Aligned_cols=204  Identities=18%  Similarity=0.195  Sum_probs=175.5

Q ss_pred             HHHhCCCCccccccccCceeEEEEE------ccCCCeeEEEeecccCccCHHHHHHHHHHHhhcC---CCceeccceeEE
Q 008292          341 EVATNKFSTDNKLGEGGFGEVYKGV------LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ---HRNLVRLLGFCL  411 (571)
Q Consensus       341 ~~~~~~~~~~~~LG~G~fg~Vy~~~------~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~---h~niv~l~~~~~  411 (571)
                      +...++|.+.++||+|+||+||+|.      ..+++.||||+++..   ...++..|+.++..++   |+||+++++++.
T Consensus        61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~  137 (365)
T 3e7e_A           61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHL  137 (365)
T ss_dssp             ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred             EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence            3446789999999999999999994      456889999999754   3456778888888776   999999999999


Q ss_pred             eCCeeEEEEEecCCCChhhhhcCC--CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECC-------
Q 008292          412 EGEEKILVYEFVPNKSLDYFLYDP--EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-------  482 (571)
Q Consensus       412 ~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-------  482 (571)
                      ..+..++||||+++|+|.+++...  .....+++..++.++.||++||+|||+++   |+||||||+||||+.       
T Consensus       138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~  214 (365)
T 3e7e_A          138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDD  214 (365)
T ss_dssp             CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC--
T ss_pred             cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccc
Confidence            999999999999999999998531  13456999999999999999999999987   999999999999998       


Q ss_pred             ----CCceEEeeccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          483 ----EMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       483 ----~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                          ++.+||+|||+++.+............+||+.|||||++.+..++.++||||||+++|||+||+.||.
T Consensus       215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~  286 (365)
T 3e7e_A          215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKV  286 (365)
T ss_dssp             ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCE
T ss_pred             cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccc
Confidence                89999999999976543333334455679999999999999999999999999999999999999874

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-37  Score=314.99  Aligned_cols=196  Identities=28%  Similarity=0.409  Sum_probs=176.0

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeeccc---CccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY  420 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  420 (571)
                      ++|++.+.||+|+||.||+++.. +|+.||+|++++.   .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            57889999999999999999964 6899999999754   2345677889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCC
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD  500 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  500 (571)
                      ||+++|+|.+++.   +...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.... 
T Consensus        86 e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~-  158 (318)
T 1fot_A           86 DYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD-  158 (318)
T ss_dssp             CCCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS-
T ss_pred             eCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC-
Confidence            9999999999984   3456899999999999999999999987   99999999999999999999999999986532 


Q ss_pred             CCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                          .....+||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       159 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  205 (318)
T 1fot_A          159 ----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD  205 (318)
T ss_dssp             ----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             ----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCC
Confidence                22345799999999999999999999999999999999999999853

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=3.5e-37  Score=317.13  Aligned_cols=199  Identities=28%  Similarity=0.390  Sum_probs=176.8

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccCc------cCHHHHHHHHHHHhhcCCCceeccceeEEeCCee
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASG------QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEK  416 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  416 (571)
                      .++|++.+.||+|+||.||+++.. +|+.||+|++++...      ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            467899999999999999999964 688999999875432      2457899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCC----ceEEeecc
Q 008292          417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM----NPKISDFG  492 (571)
Q Consensus       417 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DfG  492 (571)
                      ++||||+++|+|.+++.   ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++    .+||+|||
T Consensus        91 ~lv~e~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG  164 (361)
T 2yab_A           91 VLILELVSGGELFDFLA---QKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (361)
T ss_dssp             EEEEECCCSCBHHHHHT---TCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred             EEEEEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence            99999999999999994   3457999999999999999999999987   99999999999998877    79999999


Q ss_pred             CccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          493 MARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       493 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      +++.+....   .....+||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       165 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~  220 (361)
T 2yab_A          165 LAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG  220 (361)
T ss_dssp             SCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred             CceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence            998764322   22345799999999999999999999999999999999999999853

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.2e-37  Score=318.57  Aligned_cols=203  Identities=29%  Similarity=0.438  Sum_probs=177.2

Q ss_pred             HHHhCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC---ccCHHHHHHHHHHHhhc-CCCceeccceeEEeCCe
Q 008292          341 EVATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEE  415 (571)
Q Consensus       341 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~  415 (571)
                      ....++|.+.+.||+|+||.||+++.+ +|+.||+|++++..   ....+.+..|..++..+ +||||+++++++.+.+.
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            345678999999999999999999964 68899999997642   34567788899999877 99999999999999999


Q ss_pred             eEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCcc
Q 008292          416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR  495 (571)
Q Consensus       416 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  495 (571)
                      .++||||+++|+|.+++.   +...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        93 ~~lv~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~  166 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK  166 (345)
T ss_dssp             EEEEEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             EEEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhh
Confidence            999999999999999984   3456899999999999999999999987   9999999999999999999999999998


Q ss_pred             ccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          496 IFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ......  ......+||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       167 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~  220 (345)
T 1xjd_A          167 ENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG  220 (345)
T ss_dssp             CCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             hcccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCC
Confidence            543221  223456899999999999999999999999999999999999999863

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=7.9e-38  Score=322.21  Aligned_cols=217  Identities=29%  Similarity=0.431  Sum_probs=184.5

Q ss_pred             ccccchHHHHHHhCCCCccccccccCceeEEEEEc------cCCCeeEEEeecccC-ccCHHHHHHHHHHHhhc-CCCce
Q 008292          332 SLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKL-QHRNL  403 (571)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~ni  403 (571)
                      ...++...+++..++|++.+.||+|+||.||++++      .+++.||||+++... ....+.+.+|++++.++ +||||
T Consensus         9 ~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpni   88 (359)
T 3vhe_A            9 RLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV   88 (359)
T ss_dssp             GSCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             hCCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcce
Confidence            45566778888889999999999999999999973      346789999997643 33456789999999999 78999


Q ss_pred             eccceeEEeCCe-eEEEEEecCCCChhhhhcCCCC---------------------------------------------
Q 008292          404 VRLLGFCLEGEE-KILVYEFVPNKSLDYFLYDPEK---------------------------------------------  437 (571)
Q Consensus       404 v~l~~~~~~~~~-~~lv~e~~~~g~L~~~l~~~~~---------------------------------------------  437 (571)
                      +++++++.+.+. .++||||+++|+|.+++.....                                             
T Consensus        89 v~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (359)
T 3vhe_A           89 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFV  168 (359)
T ss_dssp             CCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------
T ss_pred             eeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccc
Confidence            999999987654 8999999999999999865322                                             


Q ss_pred             ------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCC
Q 008292          438 ------------------QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV  499 (571)
Q Consensus       438 ------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  499 (571)
                                        ...+++..++.++.||++||.|||+++   |+||||||+|||++.++.+||+|||+++.+..
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  245 (359)
T 3vhe_A          169 EEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYK  245 (359)
T ss_dssp             ---------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTS
T ss_pred             cccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecc
Confidence                              122899999999999999999999987   99999999999999999999999999987644


Q ss_pred             CCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          500 DQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                      ...........||+.|+|||++.+..++.++||||||+++|||+| |+.||..
T Consensus       246 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~  298 (359)
T 3vhe_A          246 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  298 (359)
T ss_dssp             CTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             cccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCc
Confidence            433333445678999999999999999999999999999999999 9999864

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=2.8e-37  Score=316.87  Aligned_cols=202  Identities=29%  Similarity=0.370  Sum_probs=177.0

Q ss_pred             HHhCCCCccccccccCceeEEEEEcc-CCCeeEEEeeccc---CccCHHHHHHHHHHHhhc-CCCceeccceeEEeCCee
Q 008292          342 VATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEK  416 (571)
Q Consensus       342 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~  416 (571)
                      ...++|++.+.||+|+||.||+++.+ +++.||+|++++.   .....+.+.+|..++..+ +||||+++++++.+.+..
T Consensus        17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~   96 (353)
T 2i0e_A           17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL   96 (353)
T ss_dssp             --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred             CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence            34578999999999999999999975 4788999999754   234567788999999887 799999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccc
Q 008292          417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI  496 (571)
Q Consensus       417 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  496 (571)
                      ++||||+++|+|.+++.   +...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        97 ~lv~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~  170 (353)
T 2i0e_A           97 YFVMEYVNGGDLMYHIQ---QVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE  170 (353)
T ss_dssp             EEEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence            99999999999999984   3456999999999999999999999987   99999999999999999999999999985


Q ss_pred             cCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          497 FGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .....  ......+||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       171 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~  223 (353)
T 2i0e_A          171 NIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG  223 (353)
T ss_dssp             CCCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCC
Confidence            43221  223456899999999999999999999999999999999999999864

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.8e-37  Score=317.66  Aligned_cols=199  Identities=27%  Similarity=0.380  Sum_probs=175.3

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC---ccCHHHHHHHHHHHhhc-CCCceeccceeEEeCCeeEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILV  419 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv  419 (571)
                      ++|++.+.||+|+||.||+++.+ +++.||+|++++..   ....+.+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            56888999999999999999965 58899999997643   23345678899999887 899999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCC
Q 008292          420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV  499 (571)
Q Consensus       420 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  499 (571)
                      |||+++|+|..++.   +...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        89 ~e~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~  162 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  162 (345)
T ss_dssp             ECCCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred             EeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence            99999999999884   3456899999999999999999999987   99999999999999999999999999985422


Q ss_pred             CCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          500 DQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .  .......+||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       163 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  212 (345)
T 3a8x_A          163 P--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI  212 (345)
T ss_dssp             T--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             C--CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence            2  1223456899999999999999999999999999999999999999964

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.1e-36  Score=309.62  Aligned_cols=199  Identities=28%  Similarity=0.409  Sum_probs=176.3

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccCc------cCHHHHHHHHHHHhhcCCCceeccceeEEeCCee
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASG------QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEK  416 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  416 (571)
                      .++|.+.+.||+|+||.||++... +|+.||+|+++....      ...+.+.+|+.++++++||||+++++++.+....
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            356889999999999999999964 688999999875432      2467899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCC----ceEEeecc
Q 008292          417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM----NPKISDFG  492 (571)
Q Consensus       417 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DfG  492 (571)
                      ++||||+++++|.+++.   ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++    .+||+|||
T Consensus        90 ~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg  163 (326)
T 2y0a_A           90 ILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG  163 (326)
T ss_dssp             EEEEECCCSCBHHHHHT---TSSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEcCCCCCHHHHHH---hcCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence            99999999999999984   3457999999999999999999999987   99999999999999887    89999999


Q ss_pred             CccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          493 MARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       493 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      +++.+....   ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       164 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  219 (326)
T 2y0a_A          164 LAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG  219 (326)
T ss_dssp             TCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred             CCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCC
Confidence            998764322   22345799999999999999999999999999999999999999853

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.4e-38  Score=328.27  Aligned_cols=210  Identities=23%  Similarity=0.303  Sum_probs=180.3

Q ss_pred             chHHHHHHhCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC---ccCHHHHHHHHHHHhhcCCCceeccceeEE
Q 008292          336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCL  411 (571)
Q Consensus       336 ~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~  411 (571)
                      ..++++...++|++.+.||+|+||+||+++.+ +|+.||||++++..   ....+.+.+|..++..++||||+++++++.
T Consensus        52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  131 (412)
T 2vd5_A           52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ  131 (412)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence            34455566788999999999999999999964 68999999997532   223345788999999999999999999999


Q ss_pred             eCCeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeec
Q 008292          412 EGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDF  491 (571)
Q Consensus       412 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  491 (571)
                      +.+..++||||+++|+|.+++..  ....+++..+..++.||+.||+|||+++   |+||||||+||||+.++++||+||
T Consensus       132 ~~~~~~lVmE~~~gg~L~~~l~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DF  206 (412)
T 2vd5_A          132 DENYLYLVMEYYVGGDLLTLLSK--FGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADF  206 (412)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHH--HSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred             eCCEEEEEEcCCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeec
Confidence            99999999999999999999853  2346899999999999999999999987   999999999999999999999999


Q ss_pred             cCccccCCCCCccccccccccCCcccccccc-------cCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          492 GMARIFGVDQTQGNTSRIVGTYGYMAPEYAM-------HGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       492 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      |+++.+..... ......+||+.|+|||++.       ...++.++||||||+++|||++|+.||..
T Consensus       207 Gla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~  272 (412)
T 2vd5_A          207 GSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA  272 (412)
T ss_dssp             TTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             hhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCC
Confidence            99987643322 1223458999999999987       45789999999999999999999999864

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=2.2e-37  Score=314.84  Aligned_cols=200  Identities=28%  Similarity=0.393  Sum_probs=166.8

Q ss_pred             hCCCCccccccccCceeEEEEEc----cCCCeeEEEeecccC----ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCe
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVL----PSGQEIAVKRLSKAS----GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEE  415 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~  415 (571)
                      .++|++.+.||+|+||.||+++.    .+++.||+|++++..    ......+.+|+.+++.++||||+++++++...+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            46789999999999999999986    478899999997642    2344567899999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCcc
Q 008292          416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR  495 (571)
Q Consensus       416 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  495 (571)
                      .++||||+++++|.+++.   ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        96 ~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  169 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLE---REGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK  169 (327)
T ss_dssp             EEEEEECCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred             EEEEEeCCCCCcHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence            999999999999999884   3456899999999999999999999987   9999999999999999999999999997


Q ss_pred             ccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          496 IFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ......  .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       170 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  223 (327)
T 3a62_A          170 ESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTG  223 (327)
T ss_dssp             -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             ccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCC
Confidence            543221  123345799999999999999999999999999999999999999864

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=9.2e-38  Score=317.00  Aligned_cols=202  Identities=29%  Similarity=0.470  Sum_probs=171.8

Q ss_pred             hCCCCccccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCC----eeEEE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE----EKILV  419 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----~~~lv  419 (571)
                      .++|++.++||+|+||+||+|+.. ++.||||+++... .....+..|+.++++++||||+++++++.+..    ..++|
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv  100 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI  100 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence            467899999999999999999974 7899999996543 23345567999999999999999999998754    36999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-------CCCCeEEecCCCCCEEECCCCceEEeecc
Q 008292          420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED-------SRLRIIHRDLKASNILLDAEMNPKISDFG  492 (571)
Q Consensus       420 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-------~~~~ivH~Dlkp~NIll~~~~~~kl~DfG  492 (571)
                      |||+++|+|.+++.    ...+++..++.++.|+++||.|||+.       .+.+|+||||||+|||++.++.+||+|||
T Consensus       101 ~e~~~~g~L~~~l~----~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg  176 (322)
T 3soc_A          101 TAFHEKGSLSDFLK----ANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG  176 (322)
T ss_dssp             EECCTTCBHHHHHH----HCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             EecCCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence            99999999999994    34589999999999999999999987       01139999999999999999999999999


Q ss_pred             CccccCCCCCccccccccccCCcccccccccC-----CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          493 MARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG-----QFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       493 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      +++.+.............||+.|+|||.+.+.     .++.++||||||+++|||+||+.||..
T Consensus       177 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~  240 (322)
T 3soc_A          177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG  240 (322)
T ss_dssp             TCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSS
T ss_pred             cccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCC
Confidence            99877654444444456799999999998763     566789999999999999999999864

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=9.9e-37  Score=305.80  Aligned_cols=199  Identities=28%  Similarity=0.385  Sum_probs=167.8

Q ss_pred             hCCCCccccccccCceeEEEEEc-cCCCeeEEEeecccCc--------------------------cCHHHHHHHHHHHh
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASG--------------------------QGAEEFKNEVVLVA  396 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~--------------------------~~~~~~~~Ei~~l~  396 (571)
                      .++|++.+.||+|+||.||+++. .+++.||||++.....                          ...+.+.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            36799999999999999999985 4688999999865321                          12356889999999


Q ss_pred             hcCCCceeccceeEEe--CCeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCC
Q 008292          397 KLQHRNLVRLLGFCLE--GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLK  474 (571)
Q Consensus       397 ~l~h~niv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk  474 (571)
                      +++||||+++++++.+  ....++||||+++++|.+++    ....+++..++.++.||++||.|||+++   |+|||||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk  164 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK  164 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence            9999999999999987  56789999999999998765    3457999999999999999999999987   9999999


Q ss_pred             CCCEEECCCCceEEeeccCccccCCCCCccccccccccCCcccccccccCC---CCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          475 ASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQ---FSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       475 p~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      |+|||++.++.+||+|||+++.+.....  ......||+.|+|||.+.+..   .+.++||||||+++|||++|+.||..
T Consensus       165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~  242 (298)
T 2zv2_A          165 PSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD  242 (298)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             HHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence            9999999999999999999987643321  223457999999999997665   47889999999999999999999853

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=4.2e-37  Score=318.41  Aligned_cols=202  Identities=30%  Similarity=0.530  Sum_probs=163.7

Q ss_pred             hCCCCccccccccCceeEEEEEcc----CCCeeEEEeeccc-CccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP----SGQEIAVKRLSKA-SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL  418 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  418 (571)
                      .++|++.+.||+|+||.||+|+..    ++..||||+++.. .....+++.+|+.++++++||||+++++++.+.+..++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            457899999999999999999864    5678999999764 33445689999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccC
Q 008292          419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG  498 (571)
Q Consensus       419 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  498 (571)
                      ||||+++|+|.+++..  ....+++.+++.++.||++||.|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus       124 v~e~~~~~sL~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  198 (373)
T 2qol_A          124 VTEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE  198 (373)
T ss_dssp             EEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence            9999999999999953  3456899999999999999999999987   9999999999999999999999999998764


Q ss_pred             CCCCcc-ccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 008292          499 VDQTQG-NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSN  550 (571)
Q Consensus       499 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~  550 (571)
                      ...... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~  252 (373)
T 2qol_A          199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYW  252 (373)
T ss_dssp             ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTT
T ss_pred             cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCC
Confidence            332211 1222345778999999999999999999999999999998 999984

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=6.5e-37  Score=309.20  Aligned_cols=202  Identities=31%  Similarity=0.464  Sum_probs=172.2

Q ss_pred             hCCCCccccccccCceeEEEEEccCCCeeEEEeecccCc--cCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASG--QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE  421 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e  421 (571)
                      .++|++.++||+|+||+||+++..+|+.||+|+++....  ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   99 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE   99 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence            467999999999999999999998899999999875432  234678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCC
Q 008292          422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ  501 (571)
Q Consensus       422 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  501 (571)
                      |+++ +|.+++..  ....+++..+..++.|+++||.|||+++   |+||||||+|||++.++.+||+|||+++......
T Consensus       100 ~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  173 (311)
T 3niz_A          100 FMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV  173 (311)
T ss_dssp             CCSE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred             CCCC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence            9985 67666643  3456899999999999999999999987   9999999999999999999999999998764322


Q ss_pred             CccccccccccCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 008292          502 TQGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNFYQ  553 (571)
Q Consensus       502 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slGvvl~elltG~~p~~~~~  553 (571)
                      .  ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus       174 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  224 (311)
T 3niz_A          174 R--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVT  224 (311)
T ss_dssp             C-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             c--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCC
Confidence            2  2234578999999999876 568999999999999999999999986543

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=3.6e-37  Score=315.91  Aligned_cols=196  Identities=27%  Similarity=0.335  Sum_probs=176.3

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeeccc---CccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY  420 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  420 (571)
                      ++|++.+.||+|+||.||+++.. +|+.||+|++++.   .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            57888999999999999999964 6899999998653   2345678899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCC
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD  500 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  500 (571)
                      ||+++|+|.+++.   +...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus       121 e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~  194 (350)
T 1rdq_E          121 EYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             ECCTTCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             cCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC
Confidence            9999999999984   3456899999999999999999999987   999999999999999999999999999865432


Q ss_pred             CCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                           ....+||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       195 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~  240 (350)
T 1rdq_E          195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA  240 (350)
T ss_dssp             -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             -----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCC
Confidence                 2345799999999999999999999999999999999999999853

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=5.2e-37  Score=311.84  Aligned_cols=202  Identities=31%  Similarity=0.533  Sum_probs=172.7

Q ss_pred             hCCCCccccccccCceeEEEEEcc----CCCeeEEEeeccc-CccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP----SGQEIAVKRLSKA-SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL  418 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  418 (571)
                      .++|++.+.||+|+||.||+|.+.    .+..||||+++.. .....+.+.+|+.++++++||||+++++++.+++..++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            457888999999999999999974    3445999999764 34445789999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccC
Q 008292          419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG  498 (571)
Q Consensus       419 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  498 (571)
                      ||||+++++|.+++..  ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus       128 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  202 (325)
T 3kul_A          128 VTEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE  202 (325)
T ss_dssp             EEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             EeeCCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence            9999999999999953  3456999999999999999999999987   9999999999999999999999999998765


Q ss_pred             CCCCcc-ccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 008292          499 VDQTQG-NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSN  550 (571)
Q Consensus       499 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~  550 (571)
                      ...... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus       203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~  256 (325)
T 3kul_A          203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYW  256 (325)
T ss_dssp             ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcc
Confidence            432221 2223456778999999999999999999999999999999 999984

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=4.6e-37  Score=312.51  Aligned_cols=203  Identities=26%  Similarity=0.430  Sum_probs=172.9

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCe------
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEE------  415 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------  415 (571)
                      .++|++.+.||+|+||.||+++.. +|+.||||+++... ....+.+.+|++++++++||||+++++++.+...      
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            357889999999999999999975 78999999997543 3345789999999999999999999999876542      


Q ss_pred             ---------------------------------------------------eEEEEEecCCCChhhhhcCCCCCCCCCHH
Q 008292          416 ---------------------------------------------------KILVYEFVPNKSLDYFLYDPEKQGQLDWS  444 (571)
Q Consensus       416 ---------------------------------------------------~~lv~e~~~~g~L~~~l~~~~~~~~l~~~  444 (571)
                                                                         .++||||+++++|.+++.........++.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                               78999999999999999765555567788


Q ss_pred             HHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCc----------cccccccccCC
Q 008292          445 RRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ----------GNTSRIVGTYG  514 (571)
Q Consensus       445 ~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~----------~~~~~~~gt~~  514 (571)
                      .++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++........          .......||+.
T Consensus       165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            89999999999999999987   999999999999999999999999999876543211          12234579999


Q ss_pred             cccccccccCCCCcchhHHHHHHHHHHHHhCCCCC
Q 008292          515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNS  549 (571)
Q Consensus       515 y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~  549 (571)
                      |+|||.+.+..++.++||||||+++|||++|..|+
T Consensus       242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~  276 (332)
T 3qd2_B          242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQ  276 (332)
T ss_dssp             GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCH
T ss_pred             ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCCh
Confidence            99999999999999999999999999999998774

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-36  Score=316.02  Aligned_cols=200  Identities=24%  Similarity=0.343  Sum_probs=177.1

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      .++|++.+.||+|+||.||++... +|+.||+|++..........+.+|+.+++.++||||+++++++.+....++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            357999999999999999999964 6889999999776555567889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECC--CCceEEeeccCccccCCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA--EMNPKISDFGMARIFGVD  500 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~DfGla~~~~~~  500 (571)
                      +++|+|.+++..  ....+++..++.++.||+.||.|||+++   |+||||||+|||++.  ++.+||+|||+++.+...
T Consensus       130 ~~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~  204 (387)
T 1kob_A          130 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  204 (387)
T ss_dssp             CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence            999999998843  3346899999999999999999999987   999999999999974  467999999999876433


Q ss_pred             CCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .   ......||+.|+|||++.+..++.++||||||+++|||+||+.||..
T Consensus       205 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~  252 (387)
T 1kob_A          205 E---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG  252 (387)
T ss_dssp             S---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred             c---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCC
Confidence            2   22345789999999999999999999999999999999999999864

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=7.7e-37  Score=309.74  Aligned_cols=204  Identities=27%  Similarity=0.429  Sum_probs=177.1

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeEEeCC--eeEEE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE--EKILV  419 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~--~~~lv  419 (571)
                      .++|.+.++||+|+||+||+++.. +++.||||+++... ....+.+.+|++++++++||||+++++++....  ..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence            357889999999999999999965 58899999997543 345678889999999999999999999998765  67999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEE----CCCCceEEeeccCcc
Q 008292          420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL----DAEMNPKISDFGMAR  495 (571)
Q Consensus       420 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DfGla~  495 (571)
                      |||+++++|.+++........+++..++.++.||++||.|||+++   |+||||||+|||+    +.++.+||+|||+++
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            999999999999976544455999999999999999999999987   9999999999999    788889999999998


Q ss_pred             ccCCCCCccccccccccCCcccccccc--------cCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 008292          496 IFGVDQTQGNTSRIVGTYGYMAPEYAM--------HGQFSVKSDVYSFGVLVLEIITGKKNSNFYQ  553 (571)
Q Consensus       496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~s~~~Dv~slGvvl~elltG~~p~~~~~  553 (571)
                      .+.....   .....||+.|+|||.+.        +..++.++||||||+++|||+||+.||....
T Consensus       165 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  227 (319)
T 4euu_A          165 ELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE  227 (319)
T ss_dssp             ECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTT
T ss_pred             ecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            7643322   23457899999999886        5789999999999999999999999987543

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=7.9e-37  Score=311.18  Aligned_cols=204  Identities=22%  Similarity=0.290  Sum_probs=176.6

Q ss_pred             hCCCCccccccccCceeEEEEEc-cCCCeeEEEeecccCccCHHHHHHHHHHHhhc-CCCceeccceeEEeCCeeEEEEE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYE  421 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  421 (571)
                      .++|++.+.||+|+||+||+++. .+++.||||++.....  .+.+.+|+.+++++ +||||+++++++..++..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            46799999999999999999995 5788999999865432  24678999999999 99999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCc-----eEEeeccCccc
Q 008292          422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN-----PKISDFGMARI  496 (571)
Q Consensus       422 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~DfGla~~  496 (571)
                      |+ +++|.+++...  ...+++..++.++.||+.||+|||+++   |+||||||+|||++.++.     +||+|||+++.
T Consensus        86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~  159 (330)
T 2izr_A           86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE  159 (330)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred             eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence            99 99999998532  457999999999999999999999987   999999999999998887     99999999987


Q ss_pred             cCCCCCcc-----ccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 008292          497 FGVDQTQG-----NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTD  555 (571)
Q Consensus       497 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~~~~~  555 (571)
                      +.......     ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~  223 (330)
T 2izr_A          160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKAD  223 (330)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCS
T ss_pred             eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccc
Confidence            64332211     124567999999999999999999999999999999999999999765433

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.7e-37  Score=313.39  Aligned_cols=202  Identities=27%  Similarity=0.427  Sum_probs=167.6

Q ss_pred             hCCCCccccccccCceeEEEEEc-cCCCeeEEEeecccCc---cCHHHHHHHHHHHhhcCCCceeccceeEEeCCe----
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASG---QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEE----  415 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~----  415 (571)
                      .++|++.+.||+|+||.||+++. .+++.||||+++....   ...+.+.+|+.++++++||||+++++++.....    
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            46899999999999999999995 5788999999976432   334578899999999999999999999876544    


Q ss_pred             eEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCcc
Q 008292          416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR  495 (571)
Q Consensus       416 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  495 (571)
                      .++||||+++++|.+++.   ....+++..++.++.|+++||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        91 ~~lv~e~~~g~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  164 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR  164 (311)
T ss_dssp             EEEEEECCCEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred             cEEEEecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence            399999999999999984   3456899999999999999999999987   9999999999999999999999999998


Q ss_pred             ccCCCCCc-cccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          496 IFGVDQTQ-GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       496 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .+...... .......||+.|+|||.+.+..++.++||||||+++|||+||+.||..
T Consensus       165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~  221 (311)
T 3ork_A          165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG  221 (311)
T ss_dssp             -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence            76433221 223345789999999999999999999999999999999999999864

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.1e-36  Score=304.50  Aligned_cols=211  Identities=27%  Similarity=0.423  Sum_probs=175.7

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC--ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE  421 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e  421 (571)
                      ++|++.++||+|+||+||+++.. +++.||+|+++...  ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            57889999999999999999964 68899999997543  2334678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCC
Q 008292          422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ  501 (571)
Q Consensus       422 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  501 (571)
                      |++++.+..+..   ....+++..+..++.|+++||.|||+++   |+||||||+|||++.++.+||+|||+++......
T Consensus        82 ~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  155 (292)
T 3o0g_A           82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred             cCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence            998755554442   3457999999999999999999999987   9999999999999999999999999998764332


Q ss_pred             CccccccccccCCcccccccccCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHH
Q 008292          502 TQGNTSRIVGTYGYMAPEYAMHGQ-FSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYVS  565 (571)
Q Consensus       502 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~Dv~slGvvl~elltG~~p~~~~~~~~~~~l~~~~~  565 (571)
                        .......||+.|+|||.+.+.. ++.++||||||+++|||+||+.|+..  .....+.++.+.
T Consensus       156 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~--~~~~~~~~~~i~  216 (292)
T 3o0g_A          156 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP--GNDVDDQLKRIF  216 (292)
T ss_dssp             --SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC--CSSHHHHHHHHH
T ss_pred             --ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcC--CCCHHHHHHHHH
Confidence              2233457899999999998765 89999999999999999999998632  233344444443

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.4e-37  Score=310.11  Aligned_cols=199  Identities=24%  Similarity=0.340  Sum_probs=175.8

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      .++|.+.+.||+|+||+||++... +++.||+|.++... ...+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            467899999999999999999964 57889999987543 3456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECC--CCceEEeeccCccccCCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA--EMNPKISDFGMARIFGVD  500 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~DfGla~~~~~~  500 (571)
                      +++++|.+++..  ....+++..++.++.||+.||.|||+++   |+||||||+|||++.  ++.+||+|||+++.+...
T Consensus        83 ~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~  157 (321)
T 1tki_A           83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             CCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence            999999999843  3346899999999999999999999987   999999999999987  789999999999876432


Q ss_pred             CCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .   ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       158 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  205 (321)
T 1tki_A          158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA  205 (321)
T ss_dssp             C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             C---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcC
Confidence            2   23345789999999999988899999999999999999999999864

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=2.1e-37  Score=314.38  Aligned_cols=208  Identities=28%  Similarity=0.446  Sum_probs=160.4

Q ss_pred             HHHhCCCCccccccccCceeEEEEEccCCC----eeEEEeeccc--CccCHHHHHHHHHHHhhcCCCceeccceeEEeCC
Q 008292          341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQ----EIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE  414 (571)
Q Consensus       341 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~----~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~  414 (571)
                      .+..++|++.+.||+|+||.||+++.....    .||||+++..  .....+.+.+|+.++++++||||+++++++....
T Consensus        19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   98 (323)
T 3qup_A           19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR   98 (323)
T ss_dssp             BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred             ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence            344678999999999999999999965432    7999998764  3444678999999999999999999999998876


Q ss_pred             ee------EEEEEecCCCChhhhhcCC---CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCc
Q 008292          415 EK------ILVYEFVPNKSLDYFLYDP---EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN  485 (571)
Q Consensus       415 ~~------~lv~e~~~~g~L~~~l~~~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~  485 (571)
                      ..      ++||||+++|+|.+++...   .....+++..++.++.|+++||.|||+++   |+||||||+|||++.++.
T Consensus        99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~  175 (323)
T 3qup_A           99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMT  175 (323)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSC
T ss_pred             cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCC
Confidence            55      9999999999999988432   12236899999999999999999999987   999999999999999999


Q ss_pred             eEEeeccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          486 PKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       486 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                      +||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus       176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~  242 (323)
T 3qup_A          176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAG  242 (323)
T ss_dssp             EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence            99999999987654433333334457889999999999999999999999999999999 8998864

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=9.5e-37  Score=314.44  Aligned_cols=199  Identities=27%  Similarity=0.410  Sum_probs=174.9

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC--ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY  420 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  420 (571)
                      .++|.+.+.||+|+||.||++... +|+.||+|++....  ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  107 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF  107 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            467999999999999999999964 68899999996543  334567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCC---ceEEeeccCcccc
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM---NPKISDFGMARIF  497 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DfGla~~~  497 (571)
                      ||+++|+|.+.+.   ....+++..+..++.||++||.|||+++   |+||||||+|||++.++   .+||+|||++...
T Consensus       108 e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~  181 (362)
T 2bdw_A          108 DLVTGGELFEDIV---AREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  181 (362)
T ss_dssp             CCCCSCBHHHHHT---TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred             ecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence            9999999998884   3456899999999999999999999987   99999999999998654   5999999999876


Q ss_pred             CCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          498 GVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ....   ......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       182 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~  232 (362)
T 2bdw_A          182 NDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD  232 (362)
T ss_dssp             TTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence            4322   22345799999999999999999999999999999999999999853

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4e-37  Score=315.09  Aligned_cols=209  Identities=29%  Similarity=0.438  Sum_probs=177.2

Q ss_pred             HHHHhCCCCccccccccCceeEEEEEc------cCCCeeEEEeecccC-ccCHHHHHHHHHHHhhc-CCCceeccceeEE
Q 008292          340 IEVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKL-QHRNLVRLLGFCL  411 (571)
Q Consensus       340 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~  411 (571)
                      ++...++|.+.+.||+|+||.||+++.      .++..||+|++.... ....+.+.+|+.++.++ +||||+++++++.
T Consensus        40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  119 (344)
T 1rjb_A           40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT  119 (344)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            455668899999999999999999985      245679999997542 34457889999999999 8999999999999


Q ss_pred             eCCeeEEEEEecCCCChhhhhcCCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEe
Q 008292          412 EGEEKILVYEFVPNKSLDYFLYDPEK--------------------QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHR  471 (571)
Q Consensus       412 ~~~~~~lv~e~~~~g~L~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~  471 (571)
                      ..+..++||||+++|+|.+++.....                    ...+++..++.++.||++||.|||+++   |+||
T Consensus       120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~  196 (344)
T 1rjb_A          120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHR  196 (344)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEET
T ss_pred             eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccC
Confidence            99999999999999999999965322                    134799999999999999999999987   9999


Q ss_pred             cCCCCCEEECCCCceEEeeccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 008292          472 DLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSN  550 (571)
Q Consensus       472 Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~  550 (571)
                      ||||+|||++.++.+||+|||++..+.............+|+.|+|||.+.+..++.++||||||+++|||+| |+.||.
T Consensus       197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  276 (344)
T 1rjb_A          197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP  276 (344)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence            9999999999999999999999987654433333344567889999999999999999999999999999998 999986


Q ss_pred             C
Q 008292          551 F  551 (571)
Q Consensus       551 ~  551 (571)
                      .
T Consensus       277 ~  277 (344)
T 1rjb_A          277 G  277 (344)
T ss_dssp             T
T ss_pred             c
Confidence            4

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=8.3e-38  Score=324.37  Aligned_cols=205  Identities=30%  Similarity=0.455  Sum_probs=175.8

Q ss_pred             HHhCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEE
Q 008292          342 VATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV  419 (571)
Q Consensus       342 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  419 (571)
                      +..++|.+.+.||+|+||.||+|++. +++.||||+++... ....+++.+|++++++++||||+++++++.+.+..++|
T Consensus       111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  190 (377)
T 3cbl_A          111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV  190 (377)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence            34567888999999999999999975 68899999987543 23345688999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCC
Q 008292          420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV  499 (571)
Q Consensus       420 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  499 (571)
                      |||+++|+|.+++..  ....+++..++.++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus       191 ~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~  265 (377)
T 3cbl_A          191 MELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEAD  265 (377)
T ss_dssp             EECCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred             EEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence            999999999999853  2346899999999999999999999987   99999999999999999999999999986543


Q ss_pred             CCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          500 DQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                      ...........+++.|+|||.+..+.++.++||||||+++|||+| |+.|+..
T Consensus       266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~  318 (377)
T 3cbl_A          266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPN  318 (377)
T ss_dssp             SEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            322222222345778999999999999999999999999999999 9988753

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=3.2e-37  Score=315.53  Aligned_cols=209  Identities=29%  Similarity=0.491  Sum_probs=178.4

Q ss_pred             HHHHhCCCCccccccccCceeEEEEEcc------CCCeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeEEe
Q 008292          340 IEVATNKFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE  412 (571)
Q Consensus       340 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~  412 (571)
                      ++...++|++.+.||+|+||.||+++..      +++.||||+++... ....+.+.+|+.++++++||||+++++++.+
T Consensus        42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~  121 (343)
T 1luf_A           42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV  121 (343)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence            3445678999999999999999999974      34789999997643 3345678999999999999999999999999


Q ss_pred             CCeeEEEEEecCCCChhhhhcCCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEe
Q 008292          413 GEEKILVYEFVPNKSLDYFLYDPEK---------------------QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHR  471 (571)
Q Consensus       413 ~~~~~lv~e~~~~g~L~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~  471 (571)
                      ++..++||||+++++|.+++.....                     ...+++.+++.++.||++||.|||+++   |+||
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~  198 (343)
T 1luf_A          122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHR  198 (343)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred             CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence            9999999999999999999854211                     256899999999999999999999987   9999


Q ss_pred             cCCCCCEEECCCCceEEeeccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 008292          472 DLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSN  550 (571)
Q Consensus       472 Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~  550 (571)
                      ||||+|||++.++.+||+|||+++.+.............+|+.|+|||.+.+..++.++||||||+++|||+| |+.||.
T Consensus       199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  278 (343)
T 1luf_A          199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY  278 (343)
T ss_dssp             CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence            9999999999999999999999987644333233344567899999999999999999999999999999999 998985


Q ss_pred             C
Q 008292          551 F  551 (571)
Q Consensus       551 ~  551 (571)
                      .
T Consensus       279 ~  279 (343)
T 1luf_A          279 G  279 (343)
T ss_dssp             T
T ss_pred             C
Confidence            3

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=6.6e-37  Score=314.49  Aligned_cols=203  Identities=26%  Similarity=0.387  Sum_probs=175.1

Q ss_pred             hCCCCccccccccCceeEEEEEc-cCCCeeEEEeeccc-----CccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA-----SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI  417 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  417 (571)
                      .++|++.+.||+|+||+||++.. .+++.||||++...     .....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            35789999999999999999986 46899999998642     1235678999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCc---eEEeeccC
Q 008292          418 LVYEFVPNKSLDYFLYDP-EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN---PKISDFGM  493 (571)
Q Consensus       418 lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DfGl  493 (571)
                      +||||+++++|.+.+... .....+++..+..++.||++||.|||+++   |+||||||+|||++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            999999999998776432 12345899999999999999999999987   999999999999987654   99999999


Q ss_pred             ccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          494 ARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       494 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ++.+.....  ......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       180 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  235 (351)
T 3c0i_A          180 AIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG  235 (351)
T ss_dssp             CEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred             eeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCC
Confidence            987653321  22345799999999999999999999999999999999999999853

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.3e-37  Score=318.64  Aligned_cols=205  Identities=33%  Similarity=0.505  Sum_probs=175.1

Q ss_pred             hCCCCccccccccCceeEEEEEcc------CCCeeEEEeeccc-CccCHHHHHHHHHHHhhcCCCceeccceeEEeCCee
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSKA-SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEK  416 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  416 (571)
                      .++|++.+.||+|+||.||+|++.      +++.||||+++.. ......++.+|+.++++++||||+++++++.+....
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            467889999999999999999943      4668999999654 334456788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCC----CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCC---ceEEe
Q 008292          417 ILVYEFVPNKSLDYFLYDP----EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM---NPKIS  489 (571)
Q Consensus       417 ~lv~e~~~~g~L~~~l~~~----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~  489 (571)
                      ++||||+++|+|.+++...    .....+++..++.++.||++||.|||+++   |+||||||+|||++.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence            9999999999999998532    12346899999999999999999999987   99999999999999554   59999


Q ss_pred             eccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          490 DFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       490 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                      |||+++.+.............||+.|+|||.+.+..++.++||||||+++|||+| |+.||..
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~  289 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS  289 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            9999986543333333344568999999999999999999999999999999998 9888753

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=5.4e-37  Score=317.00  Aligned_cols=199  Identities=26%  Similarity=0.333  Sum_probs=166.1

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC---ccCHHHHHHHHHH-HhhcCCCceeccceeEEeCCeeEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVL-VAKLQHRNLVRLLGFCLEGEEKILV  419 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~-l~~l~h~niv~l~~~~~~~~~~~lv  419 (571)
                      ++|++.+.||+|+||.||+++.+ +++.||+|++++..   ....+.+.+|..+ ++.++||||+++++++.+.+..++|
T Consensus        38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv  117 (373)
T 2r5t_A           38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV  117 (373)
T ss_dssp             GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence            56888999999999999999965 57889999997643   2234456667766 5778999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCC
Q 008292          420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV  499 (571)
Q Consensus       420 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  499 (571)
                      |||+++|+|..++.   +...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus       118 ~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~  191 (373)
T 2r5t_A          118 LDYINGGELFYHLQ---RERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIE  191 (373)
T ss_dssp             EECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred             EeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence            99999999999884   3456899999999999999999999987   99999999999999999999999999986432


Q ss_pred             CCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          500 DQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .  .......+||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       192 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~  241 (373)
T 2r5t_A          192 H--NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS  241 (373)
T ss_dssp             C--CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             C--CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence            2  1233456899999999999999999999999999999999999999853

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.5e-36  Score=314.16  Aligned_cols=195  Identities=29%  Similarity=0.384  Sum_probs=167.7

Q ss_pred             ccccccccCceeEEEEEc-cCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEecCCCC
Q 008292          349 TDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKS  427 (571)
Q Consensus       349 ~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  427 (571)
                      ..+.||+|+||.||++.. .+|+.||+|+++.......+.+.+|+.++++++||||+++++++.+.+..++||||+++++
T Consensus        93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~  172 (373)
T 2x4f_A           93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE  172 (373)
T ss_dssp             EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred             cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence            357899999999999985 4689999999987665667789999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEE--CCCCceEEeeccCccccCCCCCccc
Q 008292          428 LDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL--DAEMNPKISDFGMARIFGVDQTQGN  505 (571)
Q Consensus       428 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll--~~~~~~kl~DfGla~~~~~~~~~~~  505 (571)
                      |.+++..  ....+++..++.++.||++||.|||+.+   |+||||||+|||+  +.++.+||+|||+++.+.....   
T Consensus       173 L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---  244 (373)
T 2x4f_A          173 LFDRIID--ESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---  244 (373)
T ss_dssp             EHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---
T ss_pred             HHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---
Confidence            9888743  2346899999999999999999999987   9999999999999  6778999999999987643322   


Q ss_pred             cccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       506 ~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .....||+.|+|||++....++.++||||||+++|||++|+.||..
T Consensus       245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~  290 (373)
T 2x4f_A          245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLG  290 (373)
T ss_dssp             CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCC
Confidence            2234699999999999999999999999999999999999999864

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=9.4e-37  Score=310.81  Aligned_cols=197  Identities=25%  Similarity=0.428  Sum_probs=172.6

Q ss_pred             CCCCccccccccCceeEEEEEc-cCCCeeEEEeeccc---CccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY  420 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  420 (571)
                      ++|.+.+.||+|+||.||++.. .+++.||+|++...   .....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   88 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI   88 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            5789999999999999999995 57899999998653   2233467899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCC
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD  500 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  500 (571)
                      ||+ +|+|.+++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||++......
T Consensus        89 E~~-~g~l~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~  161 (336)
T 3h4j_B           89 EYA-GGELFDYIV---EKKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG  161 (336)
T ss_dssp             CCC-CEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred             ECC-CCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence            999 678877773   3456999999999999999999999987   999999999999999999999999999865432


Q ss_pred             CCccccccccccCCcccccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          501 QTQGNTSRIVGTYGYMAPEYAMHGQF-SVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       501 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .   .....+||+.|+|||.+.+..+ +.++||||||+++|||++|+.||+.
T Consensus       162 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~  210 (336)
T 3h4j_B          162 N---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDD  210 (336)
T ss_dssp             B---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBC
T ss_pred             c---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCC
Confidence            2   2234579999999999988776 7899999999999999999999864

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=4.1e-37  Score=308.03  Aligned_cols=202  Identities=31%  Similarity=0.516  Sum_probs=170.9

Q ss_pred             hCCCCccccccccCceeEEEEEc-----cCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeC--Cee
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVL-----PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG--EEK  416 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~  416 (571)
                      .++|++.++||+|+||+||++++     .+++.||||++........+.+.+|+.++++++||||+++++++...  ...
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            46788999999999999999984     36789999999877766678899999999999999999999998654  458


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccc
Q 008292          417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI  496 (571)
Q Consensus       417 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  496 (571)
                      ++||||+++++|.+++...  ...+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        89 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~  163 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV  163 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred             EEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence            9999999999999998532  335899999999999999999999987   99999999999999999999999999987


Q ss_pred             cCCCCCc-cccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          497 FGVDQTQ-GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       497 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      ....... .......++..|+|||.+.+..++.++||||||+++|||+||..|+.
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~  218 (295)
T 3ugc_A          164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSK  218 (295)
T ss_dssp             ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTC
T ss_pred             ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccC
Confidence            6433221 12223457778999999999999999999999999999999988865

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1e-36  Score=304.27  Aligned_cols=199  Identities=29%  Similarity=0.476  Sum_probs=170.0

Q ss_pred             CCCCccccccccCceeEEEEEccCCCeeEEEeecccC--ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      ++|++.+.||+|+||+||+++..+|+.||+|++....  ....+.+.+|+.++++++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            4788999999999999999998889999999986543  33346788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT  502 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  502 (571)
                      +++ +|.+++..  ....+++..+..++.||++||.|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus        82 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  155 (288)
T 1ob3_A           82 LDQ-DLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR  155 (288)
T ss_dssp             CSE-EHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             cCC-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence            986 88888743  3356899999999999999999999987   99999999999999999999999999987643221


Q ss_pred             ccccccccccCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          503 QGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       503 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                        ......||+.|+|||.+.+. .++.++||||||+++|||+||+.||..
T Consensus       156 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~  203 (288)
T 1ob3_A          156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPG  203 (288)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             --ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence              22334689999999998764 589999999999999999999999853

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=6e-37  Score=311.69  Aligned_cols=202  Identities=31%  Similarity=0.541  Sum_probs=166.7

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CCCe----eEEEeeccc-CccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQE----IAVKRLSKA-SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI  417 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~----vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  417 (571)
                      .++|+..++||+|+||+||+|++. +++.    |++|.++.. .....+++.+|+.++++++||||+++++++.++. .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~   92 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence            357889999999999999999953 4444    578877543 3456678999999999999999999999998754 78


Q ss_pred             EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCcccc
Q 008292          418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF  497 (571)
Q Consensus       418 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  497 (571)
                      +|+||+++|+|.+++..  ....+++..++.++.||++||.|||+++   |+||||||+|||++.++.+||+|||+++.+
T Consensus        93 ~v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  167 (327)
T 3poz_A           93 LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEEECCTTCBHHHHHHH--STTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred             EEEEecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence            99999999999998853  3456899999999999999999999987   999999999999999999999999999877


Q ss_pred             CCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          498 GVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                      .............+|+.|+|||.+.+..++.++||||||+++|||+| |+.||..
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~  222 (327)
T 3poz_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG  222 (327)
T ss_dssp             TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccC
Confidence            65444444444567889999999999999999999999999999999 9999864

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.4e-36  Score=325.87  Aligned_cols=202  Identities=31%  Similarity=0.444  Sum_probs=178.4

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CCCeeEEEeeccc---CccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV  419 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  419 (571)
                      .++|+..+.||+|+||.||+++.. +|+.||+|++.+.   .......+.+|+.++..++||||+++++++.+.+..++|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            457888999999999999999964 6899999999653   234567788999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCC
Q 008292          420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV  499 (571)
Q Consensus       420 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  499 (571)
                      |||+++|+|..++... ....+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++.+..
T Consensus       263 mEy~~gg~L~~~l~~~-~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~  338 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHM-GQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE  338 (576)
T ss_dssp             ECCCCSCBHHHHHHSS-SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEcCCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence            9999999999988542 2345899999999999999999999987   99999999999999999999999999987643


Q ss_pred             CCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 008292          500 DQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFY  552 (571)
Q Consensus       500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~~  552 (571)
                      ..   .....+||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus       339 ~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~  388 (576)
T 2acx_A          339 GQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR  388 (576)
T ss_dssp             TC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCS
T ss_pred             Cc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCccc
Confidence            22   223458999999999999999999999999999999999999999754

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=6.3e-36  Score=302.78  Aligned_cols=202  Identities=31%  Similarity=0.487  Sum_probs=159.8

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE  421 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e  421 (571)
                      .++|++.++||+|+||+||++... +|+.||+|+++... ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            357899999999999999999964 68899999987543 3345678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCC---CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccC
Q 008292          422 FVPNKSLDYFLYDP---EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG  498 (571)
Q Consensus       422 ~~~~g~L~~~l~~~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  498 (571)
                      |++ ++|.+++...   .....+++..+..++.||++||.|||+++   |+||||||+|||++.++.+||+|||+++.+.
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            998 5888877421   12245899999999999999999999987   9999999999999999999999999998764


Q ss_pred             CCCCccccccccccCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          499 VDQTQGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       499 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ....  ......||+.|+|||.+.+ ..++.++||||||+++|||+||+.||..
T Consensus       160 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  211 (317)
T 2pmi_A          160 IPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPG  211 (317)
T ss_dssp             SCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             CCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            3221  2234578999999999876 4689999999999999999999999853

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2.3e-36  Score=319.19  Aligned_cols=200  Identities=25%  Similarity=0.359  Sum_probs=173.7

Q ss_pred             HhCCCCccccccccCceeEEEEEc-cCCCeeEEEeecccC--ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEE
Q 008292          343 ATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV  419 (571)
Q Consensus       343 ~~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  419 (571)
                      ..++|++.++||+|+||.||++.. .+|+.+|+|++....  ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            356799999999999999999985 478899999986543  33456789999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEEC---CCCceEEeeccCccc
Q 008292          420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD---AEMNPKISDFGMARI  496 (571)
Q Consensus       420 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DfGla~~  496 (571)
                      |||+++|+|.+.+.   ....+++..+..++.||++||.|||+++   |+||||||+|||++   .++.+||+|||+++.
T Consensus        89 ~E~~~gg~L~~~i~---~~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~  162 (444)
T 3soa_A           89 FDLVTGGELFEDIV---AREYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE  162 (444)
T ss_dssp             ECCCBCCBHHHHHH---HCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred             EEeCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence            99999999988884   3456999999999999999999999987   99999999999998   467899999999986


Q ss_pred             cCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          497 FGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      .....  .......||+.|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus       163 ~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~  214 (444)
T 3soa_A          163 VEGEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFW  214 (444)
T ss_dssp             CCTTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             ecCCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCC
Confidence            64332  22234579999999999999999999999999999999999999984

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.7e-37  Score=329.31  Aligned_cols=201  Identities=25%  Similarity=0.329  Sum_probs=166.7

Q ss_pred             HhCCCCccccccccCceeEEEEEc-cCCCeeEEEeeccc---CccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEE
Q 008292          343 ATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL  418 (571)
Q Consensus       343 ~~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  418 (571)
                      ..++|++.++||+|+||.||++.. .+|+.||||+++..   .......+.+|+.+++.++||||+++++++.+.+..++
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l  225 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF  225 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence            346799999999999999999995 46889999999753   33445677889999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEEecCCCCCEEECCCCceEEeeccCcccc
Q 008292          419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE-DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF  497 (571)
Q Consensus       419 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  497 (571)
                      ||||+++|+|..++.   ....+++..+..++.||+.||+|||+ .+   |+||||||+||||+.++.+||+|||+++..
T Consensus       226 v~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~  299 (446)
T 4ejn_A          226 VMEYANGGELFFHLS---RERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEG  299 (446)
T ss_dssp             EECCCSSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred             EEeeCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceec
Confidence            999999999998884   34578999999999999999999997 76   999999999999999999999999999854


Q ss_pred             CCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          498 GVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ....  ......+||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       300 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~  351 (446)
T 4ejn_A          300 IKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN  351 (446)
T ss_dssp             CC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cCCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCC
Confidence            3222  223446899999999999999999999999999999999999999854

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.1e-36  Score=300.66  Aligned_cols=201  Identities=32%  Similarity=0.508  Sum_probs=176.7

Q ss_pred             hCCCCccccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEec
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV  423 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  423 (571)
                      .++|+..+.||+|+||.||++...+++.||+|++.... ...+++.+|++++++++||||+++++++.+....++||||+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   87 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence            46788899999999999999998888999999997543 34578999999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCc
Q 008292          424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ  503 (571)
Q Consensus       424 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  503 (571)
                      ++++|.+++..  ....+++..++.++.|+++||.|||+++   |+||||||+||+++.++.+||+|||+++....... 
T Consensus        88 ~~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  161 (269)
T 4hcu_A           88 EHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-  161 (269)
T ss_dssp             TTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-
T ss_pred             CCCcHHHHHHh--cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccccc-
Confidence            99999999854  3456899999999999999999999987   99999999999999999999999999986543221 


Q ss_pred             cccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          504 GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       504 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                      .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~  210 (269)
T 4hcu_A          162 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN  210 (269)
T ss_dssp             HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCC
Confidence            12223456788999999999999999999999999999999 8988753

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.6e-36  Score=299.33  Aligned_cols=202  Identities=31%  Similarity=0.462  Sum_probs=176.9

Q ss_pred             HhCCCCccccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       343 ~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      ..++|++.+.||+|+||.||++..+++..||+|+++... ...+++.+|+.++.+++||||+++++++.+....++||||
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY   84 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence            356788999999999999999999888899999997543 3457789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT  502 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  502 (571)
                      +++++|.+++..  ....+++..++.++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||++........
T Consensus        85 ~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  159 (268)
T 3sxs_A           85 ISNGCLLNYLRS--HGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY  159 (268)
T ss_dssp             CTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred             cCCCcHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence            999999999843  2345899999999999999999999987   99999999999999999999999999986643322


Q ss_pred             ccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          503 QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       503 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                      . ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||..
T Consensus       160 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~  208 (268)
T 3sxs_A          160 V-SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDL  208 (268)
T ss_dssp             E-ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             h-cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccc
Confidence            2 2223456778999999999899999999999999999999 9999853

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.4e-36  Score=311.76  Aligned_cols=197  Identities=26%  Similarity=0.412  Sum_probs=159.4

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      .++|++.+.||+|+||.||+++.. +++.||||+++...  ..+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  129 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL  129 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence            467899999999999999999975 57889999997543  346788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECC---CCceEEeeccCccccCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA---EMNPKISDFGMARIFGV  499 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfGla~~~~~  499 (571)
                      +++++|.+++.   ....+++.+++.++.||++||.|||+.+   |+||||||+|||++.   ++.+||+|||+++....
T Consensus       130 ~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~  203 (349)
T 2w4o_A          130 VTGGELFDRIV---EKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH  203 (349)
T ss_dssp             CCSCBHHHHHT---TCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred             CCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence            99999999884   3456899999999999999999999987   999999999999975   88999999999986543


Q ss_pred             CCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          500 DQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ..   ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       204 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  252 (349)
T 2w4o_A          204 QV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYD  252 (349)
T ss_dssp             ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             cc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCC
Confidence            21   22345789999999999999999999999999999999999999853

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=4.2e-36  Score=323.15  Aligned_cols=204  Identities=30%  Similarity=0.445  Sum_probs=179.4

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC---ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV  419 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  419 (571)
                      .++|...+.||+|+||+||+++.+ +|+.||+|++.+..   ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            357888899999999999999974 68999999996532   34567889999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccC
Q 008292          420 YEFVPNKSLDYFLYDPE-KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG  498 (571)
Q Consensus       420 ~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  498 (571)
                      |||+++|+|..++.... ....+++..++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++.+.
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            99999999999886432 2456999999999999999999999987   9999999999999999999999999998764


Q ss_pred             CCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 008292          499 VDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFY  552 (571)
Q Consensus       499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~~  552 (571)
                      ....  .....+||+.|+|||++.+..++.++||||||+++|||+||+.||...
T Consensus       341 ~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~  392 (543)
T 3c4z_A          341 AGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR  392 (543)
T ss_dssp             TTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCT
T ss_pred             CCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCC
Confidence            3322  233458999999999999999999999999999999999999999653

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=4.4e-36  Score=297.64  Aligned_cols=198  Identities=25%  Similarity=0.383  Sum_probs=176.0

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      .++|++.+.||+|+||.||++... ++..||+|++........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL   87 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence            457899999999999999999965 4678999999877667788999999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEE---CCCCceEEeeccCccccCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMARIFGV  499 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfGla~~~~~  499 (571)
                      +++++|.+++.   ....+++..++.++.|++.||.|||+++   |+||||||+|||+   +.++.+||+|||++..+..
T Consensus        88 ~~~~~L~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~  161 (277)
T 3f3z_A           88 CTGGELFERVV---HKRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP  161 (277)
T ss_dssp             CCSCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred             cCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence            99999988884   3456899999999999999999999987   9999999999999   7889999999999987643


Q ss_pred             CCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          500 DQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ..   ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||..
T Consensus       162 ~~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~  209 (277)
T 3f3z_A          162 GK---MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSA  209 (277)
T ss_dssp             TS---CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cc---chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCC
Confidence            32   2234578999999998765 499999999999999999999999864

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=3.9e-37  Score=310.76  Aligned_cols=207  Identities=29%  Similarity=0.432  Sum_probs=178.0

Q ss_pred             HHhCCCCccccccccCceeEEEEEc------cCCCeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeEEeCC
Q 008292          342 VATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE  414 (571)
Q Consensus       342 ~~~~~~~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~  414 (571)
                      ...++|.+.+.||+|+||.||++..      .+++.||+|+++... ....+.+.+|+.++++++||||+++++++.+.+
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   99 (314)
T 2ivs_A           20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG   99 (314)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Confidence            3457888999999999999999985      245789999997543 344577899999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhcCCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecC
Q 008292          415 EKILVYEFVPNKSLDYFLYDPEK---------------------QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDL  473 (571)
Q Consensus       415 ~~~lv~e~~~~g~L~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dl  473 (571)
                      ..++||||+++++|.+++.....                     ...+++..++.++.||++||.|||+++   |+||||
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~di  176 (314)
T 2ivs_A          100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDL  176 (314)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred             ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Cccccc
Confidence            99999999999999999864322                     234899999999999999999999987   999999


Q ss_pred             CCCCEEECCCCceEEeeccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          474 KASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       474 kp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                      ||+|||++.++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||+| |+.||..
T Consensus       177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  255 (314)
T 2ivs_A          177 AARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG  255 (314)
T ss_dssp             SGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             chheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            99999999999999999999987654433333344567889999999999999999999999999999999 9999864

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=2.5e-36  Score=298.31  Aligned_cols=199  Identities=37%  Similarity=0.558  Sum_probs=164.7

Q ss_pred             hCCCCccccccccCceeEEEEEccCCCeeEEEeecccC----ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKAS----GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV  419 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  419 (571)
                      .++|+..+.||+|+||.||++.. .++.||||+++...    ....+.+.+|+++++.++||||+++++++.+++..++|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            46788999999999999999997 48899999987543    23457889999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECC--------CCceEEeec
Q 008292          420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA--------EMNPKISDF  491 (571)
Q Consensus       420 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~--------~~~~kl~Df  491 (571)
                      |||+++++|.+++.    ...+++..++.++.|+++||.|||+++..+|+||||||+|||++.        ++.+||+||
T Consensus        85 ~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           85 MEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             EECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            99999999999983    457899999999999999999999987556999999999999986        678999999


Q ss_pred             cCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          492 GMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       492 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      |+++......    .....|++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       161 g~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~  216 (271)
T 3dtc_A          161 GLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRG  216 (271)
T ss_dssp             CC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTT
T ss_pred             Cccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            9998654322    2234689999999999999999999999999999999999999864

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.4e-36  Score=311.16  Aligned_cols=201  Identities=27%  Similarity=0.408  Sum_probs=168.3

Q ss_pred             HhCCCCccccccccCceeEEEEEccCCCeeEEEeeccc--CccCHHHHHHHHHHHhhcCC--CceeccceeEEeCCeeEE
Q 008292          343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQH--RNLVRLLGFCLEGEEKIL  418 (571)
Q Consensus       343 ~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h--~niv~l~~~~~~~~~~~l  418 (571)
                      ..++|++.+.||+|+||.||++...+++.||||++...  .....+.+.+|+.++.+++|  |||+++++++..++..++
T Consensus         7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l   86 (343)
T 3dbq_A            7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM   86 (343)
T ss_dssp             SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence            35679999999999999999999888999999998654  33345778999999999987  999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccC
Q 008292          419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG  498 (571)
Q Consensus       419 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  498 (571)
                      ||| +.+++|.+++.   ....+++..+..++.||+.||.|||+++   |+||||||+|||++ ++.+||+|||+++.+.
T Consensus        87 v~e-~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~  158 (343)
T 3dbq_A           87 VME-CGNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQ  158 (343)
T ss_dssp             EEC-CCSEEHHHHHH---HSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred             EEe-CCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccC
Confidence            999 56889999984   3457899999999999999999999987   99999999999997 5789999999998765


Q ss_pred             CCCCccccccccccCCccccccccc-----------CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          499 VDQTQGNTSRIVGTYGYMAPEYAMH-----------GQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       499 ~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ............||+.|+|||++.+           ..++.++||||||+++|||++|+.||..
T Consensus       159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  222 (343)
T 3dbq_A          159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ  222 (343)
T ss_dssp             -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchh
Confidence            4433333445679999999999865           6789999999999999999999999863

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-36  Score=316.44  Aligned_cols=207  Identities=29%  Similarity=0.428  Sum_probs=178.2

Q ss_pred             HHhCCCCccccccccCceeEEEEEcc--------CCCeeEEEeecccC-ccCHHHHHHHHHHHhhc-CCCceeccceeEE
Q 008292          342 VATNKFSTDNKLGEGGFGEVYKGVLP--------SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKL-QHRNLVRLLGFCL  411 (571)
Q Consensus       342 ~~~~~~~~~~~LG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~  411 (571)
                      +..++|.+.++||+|+||+||+++..        .+..||||+++... ....+.+.+|+++++++ +||||+++++++.
T Consensus        66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  145 (382)
T 3tt0_A           66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT  145 (382)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence            34568889999999999999999852        23579999997643 34457789999999999 9999999999999


Q ss_pred             eCCeeEEEEEecCCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCE
Q 008292          412 EGEEKILVYEFVPNKSLDYFLYDPEK-------------QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNI  478 (571)
Q Consensus       412 ~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NI  478 (571)
                      +.+..++||||+++|+|.+++.....             ...+++..++.++.||++||.|||+.+   |+||||||+||
T Consensus       146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NI  222 (382)
T 3tt0_A          146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV  222 (382)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGE
T ss_pred             cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceE
Confidence            99999999999999999999854321             245899999999999999999999987   99999999999


Q ss_pred             EECCCCceEEeeccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          479 LLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       479 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                      |++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||+| |+.|+..
T Consensus       223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~  296 (382)
T 3tt0_A          223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG  296 (382)
T ss_dssp             EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence            999999999999999987654433333444567889999999999999999999999999999999 9999753

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=4.3e-37  Score=313.41  Aligned_cols=210  Identities=30%  Similarity=0.449  Sum_probs=178.5

Q ss_pred             HHHHHhCCCCccccccccCceeEEEEEccC-C-----CeeEEEeecccC-ccCHHHHHHHHHHHhhc-CCCceeccceeE
Q 008292          339 TIEVATNKFSTDNKLGEGGFGEVYKGVLPS-G-----QEIAVKRLSKAS-GQGAEEFKNEVVLVAKL-QHRNLVRLLGFC  410 (571)
Q Consensus       339 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~-g-----~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~  410 (571)
                      .++...++|...+.||+|+||.||++.... +     ..||+|.+.... ....+.+.+|+.++..+ +||||+++++++
T Consensus        40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  119 (333)
T 2i1m_A           40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC  119 (333)
T ss_dssp             GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            455667889999999999999999999532 2     479999987643 33456789999999999 899999999999


Q ss_pred             EeCCeeEEEEEecCCCChhhhhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEE
Q 008292          411 LEGEEKILVYEFVPNKSLDYFLYDPE-----------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNIL  479 (571)
Q Consensus       411 ~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIl  479 (571)
                      .+++..++||||+++|+|.+++....           ....+++..++.++.||+.||.|||+++   |+||||||+|||
T Consensus       120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl  196 (333)
T 2i1m_A          120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVL  196 (333)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCE
T ss_pred             ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEE
Confidence            99999999999999999999885321           1346899999999999999999999987   999999999999


Q ss_pred             ECCCCceEEeeccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          480 LDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       480 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                      ++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||+| |..||..
T Consensus       197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  269 (333)
T 2i1m_A          197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPG  269 (333)
T ss_dssp             EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcc
Confidence            99999999999999986644333223334567889999999999999999999999999999999 8888754

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2.2e-36  Score=311.63  Aligned_cols=198  Identities=25%  Similarity=0.386  Sum_probs=165.4

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      .++|++.+.||+|+||+||+++.. +++.||||++..... ..+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            467999999999999999999965 688999999975432 346788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCc--eEEeeccCccccCCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN--PKISDFGMARIFGVD  500 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~DfGla~~~~~~  500 (571)
                      +++|+|.+++.   ....+++..++.++.|++.||.|||+++   |+||||||+|||++.++.  +||+|||+++.....
T Consensus        98 ~~~~~L~~~l~---~~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~  171 (361)
T 3uc3_A           98 ASGGELYERIC---NAGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  171 (361)
T ss_dssp             CCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred             CCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence            99999999884   3456999999999999999999999987   999999999999987765  999999999743222


Q ss_pred             CCccccccccccCCcccccccccCCCCcc-hhHHHHHHHHHHHHhCCCCCCC
Q 008292          501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVK-SDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~-~Dv~slGvvl~elltG~~p~~~  551 (571)
                         .......||+.|+|||++.+..++.+ +||||||+++|||++|+.||..
T Consensus       172 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~  220 (361)
T 3uc3_A          172 ---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFED  220 (361)
T ss_dssp             ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC-
T ss_pred             ---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCC
Confidence               12234579999999999988888766 8999999999999999999864

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2.5e-36  Score=300.41  Aligned_cols=203  Identities=28%  Similarity=0.458  Sum_probs=174.6

Q ss_pred             HHhCCCCccccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEE
Q 008292          342 VATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE  421 (571)
Q Consensus       342 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e  421 (571)
                      +..++|++.+.||+|+||.||++...++..||+|+++... ...+++.+|++++.+++||||+++++++.+.+..++|||
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   99 (283)
T 3gen_A           21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE   99 (283)
T ss_dssp             CCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred             CCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence            3356788999999999999999999888899999997543 345778999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCC
Q 008292          422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ  501 (571)
Q Consensus       422 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  501 (571)
                      |+++++|.+++..  ....+++..++.++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++......
T Consensus       100 ~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  174 (283)
T 3gen_A          100 YMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE  174 (283)
T ss_dssp             CCTTCBHHHHHHC--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred             ccCCCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence            9999999999854  2456999999999999999999999987   9999999999999999999999999998654322


Q ss_pred             CccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          502 TQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       502 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                      . .......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||..
T Consensus       175 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~  224 (283)
T 3gen_A          175 Y-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER  224 (283)
T ss_dssp             H-HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             c-ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence            1 11223356788999999999999999999999999999999 9999863

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=5.9e-37  Score=325.80  Aligned_cols=207  Identities=32%  Similarity=0.508  Sum_probs=178.5

Q ss_pred             HHHHHHhCCCCccccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeE
Q 008292          338 ETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI  417 (571)
Q Consensus       338 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  417 (571)
                      ..+++..++|++.++||+|+||+||+|.++++..||||+++... ...+.|.+|+.++++++||||+++++++. .+..+
T Consensus       181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~  258 (454)
T 1qcf_A          181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIY  258 (454)
T ss_dssp             TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred             cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccE
Confidence            34455677899999999999999999999888999999997644 45788999999999999999999999986 66789


Q ss_pred             EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCcccc
Q 008292          418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF  497 (571)
Q Consensus       418 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  497 (571)
                      +||||+++|+|.+++... ....+++..++.++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus       259 lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~  334 (454)
T 1qcf_A          259 IITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVI  334 (454)
T ss_dssp             EEECCCTTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred             EEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence            999999999999999532 2236889999999999999999999987   999999999999999999999999999876


Q ss_pred             CCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          498 GVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                      ...... ......+++.|+|||.+....++.++||||||+++|||+| |+.||..
T Consensus       335 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~  388 (454)
T 1qcf_A          335 EDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG  388 (454)
T ss_dssp             CCHHHH-TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CCCcee-ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCC
Confidence            432211 1223356789999999999999999999999999999999 9999853

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=5.4e-36  Score=312.12  Aligned_cols=205  Identities=18%  Similarity=0.255  Sum_probs=176.5

Q ss_pred             hCCCCcccccccc--CceeEEEEEcc-CCCeeEEEeecccC--ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEE
Q 008292          344 TNKFSTDNKLGEG--GFGEVYKGVLP-SGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL  418 (571)
Q Consensus       344 ~~~~~~~~~LG~G--~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  418 (571)
                      .++|++.++||+|  +||+||+++.. +++.||||+++...  ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            4679999999999  99999999965 68999999997543  3345678899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccC
Q 008292          419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG  498 (571)
Q Consensus       419 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  498 (571)
                      ||||+++|+|.+++... ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++....
T Consensus       104 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~  179 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMI  179 (389)
T ss_dssp             EEECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred             EEEccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence            99999999999998542 2356899999999999999999999987   9999999999999999999999999986542


Q ss_pred             CCC-----CccccccccccCCccccccccc--CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 008292          499 VDQ-----TQGNTSRIVGTYGYMAPEYAMH--GQFSVKSDVYSFGVLVLEIITGKKNSNFY  552 (571)
Q Consensus       499 ~~~-----~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~Dv~slGvvl~elltG~~p~~~~  552 (571)
                      ...     .........||+.|+|||++.+  ..++.++||||||+++|||++|+.||...
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  240 (389)
T 3gni_B          180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM  240 (389)
T ss_dssp             ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCC
Confidence            211     1112233478999999999987  67999999999999999999999998643

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.4e-36  Score=306.53  Aligned_cols=208  Identities=30%  Similarity=0.448  Sum_probs=178.8

Q ss_pred             HHHhCCCCccccccccCceeEEEEEc------cCCCeeEEEeecccCc-cCHHHHHHHHHHHhhc-CCCceeccceeEEe
Q 008292          341 EVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSKASG-QGAEEFKNEVVLVAKL-QHRNLVRLLGFCLE  412 (571)
Q Consensus       341 ~~~~~~~~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~  412 (571)
                      +...++|++.+.||+|+||.||+++.      .+++.||+|+++.... ...+.+.+|+.++.++ +||||+++++++.+
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   98 (313)
T 1t46_A           19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI   98 (313)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence            34457889999999999999999984      3567899999975433 3457789999999999 99999999999999


Q ss_pred             CCeeEEEEEecCCCChhhhhcCCCC---------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCC
Q 008292          413 GEEKILVYEFVPNKSLDYFLYDPEK---------------QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASN  477 (571)
Q Consensus       413 ~~~~~lv~e~~~~g~L~~~l~~~~~---------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~N  477 (571)
                      ++..++||||+++|+|.+++.....               ...+++..++.++.||++||.|||+++   |+||||||+|
T Consensus        99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~N  175 (313)
T 1t46_A           99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARN  175 (313)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccce
Confidence            9999999999999999999854321               225899999999999999999999987   9999999999


Q ss_pred             EEECCCCceEEeeccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          478 ILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       478 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                      |+++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||+| |+.||..
T Consensus       176 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~  250 (313)
T 1t46_A          176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG  250 (313)
T ss_dssp             EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred             EEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCc
Confidence            9999999999999999987654433333334567889999999999999999999999999999999 9999864

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.2e-36  Score=309.08  Aligned_cols=202  Identities=31%  Similarity=0.489  Sum_probs=169.7

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CCCe----eEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQE----IAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI  417 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~----vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  417 (571)
                      .++|++.+.||+|+||+||+|++. +++.    |++|.+.... ....+.+.+|+.++++++||||+++++++. ++..+
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   90 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ   90 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence            357888999999999999999954 4554    6777765432 333456788999999999999999999886 56688


Q ss_pred             EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCcccc
Q 008292          418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF  497 (571)
Q Consensus       418 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  497 (571)
                      +||||+++|+|.+++..  ....+++..++.++.||++||.|||+++   |+||||||+|||++.++.+||+|||+++.+
T Consensus        91 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  165 (325)
T 3kex_A           91 LVTQYLPLGSLLDHVRQ--HRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLL  165 (325)
T ss_dssp             EEEECCTTCBSHHHHHS--SGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred             EEEEeCCCCCHHHHHHH--ccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCccccc
Confidence            99999999999999853  2356899999999999999999999987   999999999999999999999999999987


Q ss_pred             CCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          498 GVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                      .............++..|+|||.+.+..++.++||||||+++|||+| |+.||..
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~  220 (325)
T 3kex_A          166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAG  220 (325)
T ss_dssp             CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccc
Confidence            55444444455678889999999999999999999999999999999 9999864

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=4.3e-36  Score=319.33  Aligned_cols=198  Identities=27%  Similarity=0.478  Sum_probs=176.0

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC---ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY  420 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  420 (571)
                      ++|.+.+.||+|+||.||+|+.. +|+.||||++....   ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            57889999999999999999964 78999999996532   344678899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCC
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD  500 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  500 (571)
                      ||+++|+|.+++.   +...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        96 E~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~  169 (476)
T 2y94_A           96 EYVSGGELFDYIC---KNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  169 (476)
T ss_dssp             ECCSSEEHHHHTT---SSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred             eCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence            9999999999984   4567999999999999999999999987   999999999999999999999999999876432


Q ss_pred             CCccccccccccCCcccccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          501 QTQGNTSRIVGTYGYMAPEYAMHGQF-SVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       501 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .   .....+||+.|+|||.+.+..+ +.++||||||+++|||++|+.||..
T Consensus       170 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~  218 (476)
T 2y94_A          170 E---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD  218 (476)
T ss_dssp             C---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             c---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCC
Confidence            2   2234579999999999988776 6899999999999999999999864

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.9e-36  Score=312.35  Aligned_cols=202  Identities=30%  Similarity=0.479  Sum_probs=162.7

Q ss_pred             HHhCCCCccccccccCceeEEEEEc-cCCCeeEEEeeccc--CccCHHHHHHHHHHHhhcC-CCceeccceeEEeCC--e
Q 008292          342 VATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQ-HRNLVRLLGFCLEGE--E  415 (571)
Q Consensus       342 ~~~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~--~  415 (571)
                      ...++|++.+.||+|+||.||++.. .+|+.||||++...  .....+.+.+|+.++..+. ||||+++++++...+  .
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            3467899999999999999999985 46899999998653  3344567789999999997 999999999997654  6


Q ss_pred             eEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCcc
Q 008292          416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR  495 (571)
Q Consensus       416 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  495 (571)
                      .++||||++ ++|..++.    ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        86 ~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~  157 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIR----ANILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR  157 (388)
T ss_dssp             EEEEEECCS-EEHHHHHH----HTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEecccC-cCHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence            899999998 58888883    357899999999999999999999987   9999999999999999999999999998


Q ss_pred             ccCCCC-------------------CccccccccccCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          496 IFGVDQ-------------------TQGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       496 ~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .+....                   ........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~  233 (388)
T 3oz6_A          158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPG  233 (388)
T ss_dssp             ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCC
Confidence            653211                   1112234579999999999986 6799999999999999999999999853

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=9e-36  Score=302.16  Aligned_cols=199  Identities=28%  Similarity=0.394  Sum_probs=176.2

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccCc------cCHHHHHHHHHHHhhcCCCceeccceeEEeCCee
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASG------QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEK  416 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  416 (571)
                      .++|++.+.||+|+||.||++... +|+.||+|+++....      ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            456889999999999999999964 688999999875432      2467899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCC----ceEEeecc
Q 008292          417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM----NPKISDFG  492 (571)
Q Consensus       417 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DfG  492 (571)
                      ++||||+++++|.+++..   ...+++..++.++.|++.||.|||+++   |+||||||+|||++.++    .+||+|||
T Consensus        91 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg  164 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (321)
T ss_dssp             EEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred             EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence            999999999999999953   456899999999999999999999987   99999999999999888    79999999


Q ss_pred             CccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          493 MARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       493 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      +++......   ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       165 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  220 (321)
T 2a2a_A          165 LAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG  220 (321)
T ss_dssp             TCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred             cceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCC
Confidence            998764322   22345689999999999999999999999999999999999999853

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=5.4e-36  Score=305.57  Aligned_cols=207  Identities=29%  Similarity=0.447  Sum_probs=176.5

Q ss_pred             HHhCCCCccccccccCceeEEEEEc--------cCCCeeEEEeecccC-ccCHHHHHHHHHHHhhc-CCCceeccceeEE
Q 008292          342 VATNKFSTDNKLGEGGFGEVYKGVL--------PSGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKL-QHRNLVRLLGFCL  411 (571)
Q Consensus       342 ~~~~~~~~~~~LG~G~fg~Vy~~~~--------~~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~  411 (571)
                      ...++|.+.+.||+|+||.||+++.        .++..||+|+++... ....+.+.+|+.+++++ +||||+++++++.
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  111 (334)
T 2pvf_A           32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT  111 (334)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence            3457889999999999999999985        246789999997543 34456789999999999 8999999999999


Q ss_pred             eCCeeEEEEEecCCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCE
Q 008292          412 EGEEKILVYEFVPNKSLDYFLYDPEK-------------QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNI  478 (571)
Q Consensus       412 ~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NI  478 (571)
                      +.+..++||||+++|+|.+++.....             ...+++..++.++.||++||.|||+++   |+||||||+||
T Consensus       112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NI  188 (334)
T 2pvf_A          112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNV  188 (334)
T ss_dssp             SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGE
T ss_pred             cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceE
Confidence            99999999999999999999964321             235899999999999999999999987   99999999999


Q ss_pred             EECCCCceEEeeccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          479 LLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       479 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                      |++.++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||+| |+.||..
T Consensus       189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~  262 (334)
T 2pvf_A          189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG  262 (334)
T ss_dssp             EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCc
Confidence            999999999999999987654433333344567889999999999999999999999999999999 9999853

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=3.9e-36  Score=333.43  Aligned_cols=202  Identities=29%  Similarity=0.370  Sum_probs=176.8

Q ss_pred             HHhCCCCccccccccCceeEEEEEcc-CCCeeEEEeeccc---CccCHHHHHHHHHHHhhc-CCCceeccceeEEeCCee
Q 008292          342 VATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEK  416 (571)
Q Consensus       342 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~  416 (571)
                      ...++|++.+.||+|+||.||+++.. +++.||||++++.   .....+.+..|..++..+ +||+|+++++++.+.+..
T Consensus       338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~  417 (674)
T 3pfq_A          338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL  417 (674)
T ss_dssp             --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred             ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence            44578999999999999999999964 5788999999753   234556788899999887 799999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccc
Q 008292          417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI  496 (571)
Q Consensus       417 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  496 (571)
                      +|||||+++|+|..++.   ....+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++.
T Consensus       418 ~lV~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~  491 (674)
T 3pfq_A          418 YFVMEYVNGGDLMYHIQ---QVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE  491 (674)
T ss_dssp             EEEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred             EEEEeCcCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeec
Confidence            99999999999999984   3456999999999999999999999987   99999999999999999999999999986


Q ss_pred             cCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          497 FGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .....  ......+||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       492 ~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~  544 (674)
T 3pfq_A          492 NIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG  544 (674)
T ss_dssp             CCCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCC
Confidence            43222  234456899999999999999999999999999999999999999864

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=6.4e-36  Score=302.35  Aligned_cols=202  Identities=26%  Similarity=0.374  Sum_probs=169.5

Q ss_pred             CCCCcc-ccccccCceeEEEEEc-cCCCeeEEEeecccCccCHHHHHHHHHHHhhc-CCCceeccceeEEeCCeeEEEEE
Q 008292          345 NKFSTD-NKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYE  421 (571)
Q Consensus       345 ~~~~~~-~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  421 (571)
                      +.|.+. +.||+|+||+||++.. .+++.||||++........+.+.+|+.++.++ +||||+++++++.+.+..++|||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   91 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE   91 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence            567774 7899999999999995 46899999999877667778899999999884 79999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCc---eEEeeccCccccC
Q 008292          422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN---PKISDFGMARIFG  498 (571)
Q Consensus       422 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DfGla~~~~  498 (571)
                      |+++++|.+++.   ....+++..+..++.||++||+|||+++   |+||||||+|||++.++.   +||+|||+++...
T Consensus        92 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~  165 (316)
T 2ac3_A           92 KMRGGSILSHIH---KRRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK  165 (316)
T ss_dssp             CCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred             cCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence            999999999984   3456899999999999999999999987   999999999999998776   9999999997653


Q ss_pred             CCCC-----ccccccccccCCccccccccc-----CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 008292          499 VDQT-----QGNTSRIVGTYGYMAPEYAMH-----GQFSVKSDVYSFGVLVLEIITGKKNSNFY  552 (571)
Q Consensus       499 ~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~Dv~slGvvl~elltG~~p~~~~  552 (571)
                      ....     ........||+.|+|||.+..     ..++.++||||||+++|||++|+.||...
T Consensus       166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  229 (316)
T 2ac3_A          166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGR  229 (316)
T ss_dssp             ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred             cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccc
Confidence            2211     111223468999999999875     56889999999999999999999998643

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=7.5e-37  Score=328.26  Aligned_cols=204  Identities=31%  Similarity=0.487  Sum_probs=177.5

Q ss_pred             HHhCCCCccccccccCceeEEEEEccC-CCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEE
Q 008292          342 VATNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY  420 (571)
Q Consensus       342 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  420 (571)
                      +..++|++.++||+|+||.||+|+++. +..||||+++... ...++|.+|+.+|++++||||+++++++.+.+..++||
T Consensus       217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  295 (495)
T 1opk_A          217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT  295 (495)
T ss_dssp             CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence            345678889999999999999999764 7899999997643 35788999999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCC
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD  500 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  500 (571)
                      ||+++|+|.+++... ....+++..++.++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus       296 E~~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  371 (495)
T 1opk_A          296 EFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGD  371 (495)
T ss_dssp             ECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred             EccCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence            999999999998532 2356899999999999999999999987   999999999999999999999999999876433


Q ss_pred             CCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                      ... ......+++.|+|||.+....++.++||||||+++|||+| |+.||..
T Consensus       372 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~  422 (495)
T 1opk_A          372 TYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG  422 (495)
T ss_dssp             CEE-CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             cee-ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCC
Confidence            221 2223456789999999999999999999999999999999 8888753

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=5.7e-36  Score=296.47  Aligned_cols=203  Identities=29%  Similarity=0.454  Sum_probs=177.1

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE  421 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e  421 (571)
                      .++|++.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            357889999999999999999965 68899999987543 3345788999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCC
Q 008292          422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ  501 (571)
Q Consensus       422 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  501 (571)
                      |+++++|.+++.   ....+++..++.++.|+++||.|||+++   |+||||||+||+++.++.+||+|||++..+....
T Consensus        86 ~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  159 (276)
T 2yex_A           86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (276)
T ss_dssp             CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             ecCCCcHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence            999999999984   3456899999999999999999999987   9999999999999999999999999998664333


Q ss_pred             CccccccccccCCcccccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCCC
Q 008292          502 TQGNTSRIVGTYGYMAPEYAMHGQF-SVKSDVYSFGVLVLEIITGKKNSNFY  552 (571)
Q Consensus       502 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~Dv~slGvvl~elltG~~p~~~~  552 (571)
                      .........|++.|+|||.+.+..+ +.++||||||+++|||++|+.||...
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  211 (276)
T 2yex_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP  211 (276)
T ss_dssp             EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCS
T ss_pred             chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Confidence            2233345678999999999987765 77999999999999999999998653

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=9.3e-36  Score=300.44  Aligned_cols=199  Identities=26%  Similarity=0.357  Sum_probs=168.9

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeecccCc--cCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASG--QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE  421 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e  421 (571)
                      ++|++.++||+|+||+||+++.. +|+.||+|++.....  ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            57899999999999999999975 589999998865432  234678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCC
Q 008292          422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ  501 (571)
Q Consensus       422 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  501 (571)
                      |+++++|..++.   ....+++..+..++.|+++||.|||+++   |+||||||+||+++.++.+||+|||+++......
T Consensus        83 ~~~~~~l~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  156 (311)
T 4agu_A           83 YCDHTVLHELDR---YQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS  156 (311)
T ss_dssp             CCSEEHHHHHHH---TSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             eCCCchHHHHHh---hhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence            999999998874   3456899999999999999999999987   9999999999999999999999999998764322


Q ss_pred             CccccccccccCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          502 TQGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       502 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .  ......||+.|+|||.+.+ ..++.++||||||+++|||+||+.||..
T Consensus       157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  205 (311)
T 4agu_A          157 D--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPG  205 (311)
T ss_dssp             -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             c--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence            1  2234578999999999876 6789999999999999999999999854

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=2.2e-36  Score=301.90  Aligned_cols=203  Identities=33%  Similarity=0.539  Sum_probs=161.9

Q ss_pred             HHHhCCCCccccccccCceeEEEEEccCCCeeEEEeecccC--ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEE
Q 008292          341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL  418 (571)
Q Consensus       341 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  418 (571)
                      ++..++|++.++||+|+||+||+++..  ..||+|+++...  ....+.+.+|+.++++++||||++++++. .....++
T Consensus        20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~l   96 (289)
T 3og7_A           20 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAI   96 (289)
T ss_dssp             BCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEE
T ss_pred             ccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEE
Confidence            344678999999999999999999864  359999987543  34457789999999999999999999965 5567899


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccC
Q 008292          419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG  498 (571)
Q Consensus       419 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  498 (571)
                      ||||+++++|.+++..  ....+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus        97 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  171 (289)
T 3og7_A           97 VTQWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKS  171 (289)
T ss_dssp             EEECCCEEEHHHHHTT--C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred             EEEecCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccc
Confidence            9999999999999843  3456899999999999999999999987   9999999999999999999999999998654


Q ss_pred             CCCCccccccccccCCcccccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          499 VDQTQGNTSRIVGTYGYMAPEYAM---HGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       499 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ............||+.|+|||.+.   ...++.++||||||+++|||++|+.||..
T Consensus       172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  227 (289)
T 3og7_A          172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSN  227 (289)
T ss_dssp             ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred             cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccc
Confidence            333333334567899999999986   66789999999999999999999999864

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=5.9e-36  Score=300.23  Aligned_cols=191  Identities=28%  Similarity=0.433  Sum_probs=161.2

Q ss_pred             hCCCCccccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhh--cCCCceeccceeEEeC----CeeE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAK--LQHRNLVRLLGFCLEG----EEKI  417 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~--l~h~niv~l~~~~~~~----~~~~  417 (571)
                      .++|++.+.||+|+||+||+|+. +++.||||++...   ..+.+..|.+++..  ++||||+++++++...    ...+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~   82 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW   82 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence            56899999999999999999998 7899999998653   33455666666665  8999999999987653    4578


Q ss_pred             EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------cCCCCCeEEecCCCCCEEECCCCceEEe
Q 008292          418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH--------EDSRLRIIHRDLKASNILLDAEMNPKIS  489 (571)
Q Consensus       418 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH--------~~~~~~ivH~Dlkp~NIll~~~~~~kl~  489 (571)
                      +||||+++|+|.+++.    ...+++..++.++.||++||.|||        +.+   |+||||||+|||++.++.+||+
T Consensus        83 lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~  155 (301)
T 3q4u_A           83 LITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIA  155 (301)
T ss_dssp             EEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEEC
T ss_pred             EehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEe
Confidence            9999999999999993    456899999999999999999999        665   9999999999999999999999


Q ss_pred             eccCccccCCCCCcc--ccccccccCCcccccccccC------CCCcchhHHHHHHHHHHHHhC
Q 008292          490 DFGMARIFGVDQTQG--NTSRIVGTYGYMAPEYAMHG------QFSVKSDVYSFGVLVLEIITG  545 (571)
Q Consensus       490 DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~s~~~Dv~slGvvl~elltG  545 (571)
                      |||+++.........  ......||+.|+|||.+.+.      .++.++||||||+++|||+||
T Consensus       156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg  219 (301)
T 3q4u_A          156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR  219 (301)
T ss_dssp             CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhh
Confidence            999998664332221  12334799999999999876      455799999999999999999

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=5.1e-36  Score=318.14  Aligned_cols=198  Identities=30%  Similarity=0.463  Sum_probs=171.6

Q ss_pred             HHhCCCCccccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCC-eeEEEE
Q 008292          342 VATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE-EKILVY  420 (571)
Q Consensus       342 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-~~~lv~  420 (571)
                      +..++|++.++||+|+||.||+|.+. ++.||||+++...  ..+.|.+|+.++++++||||+++++++.+.+ ..++||
T Consensus       190 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~  266 (450)
T 1k9a_A          190 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT  266 (450)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred             cChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence            34567888999999999999999984 7899999997643  4578999999999999999999999988765 689999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCC
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD  500 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  500 (571)
                      ||+++|+|.+++... ....+++..++.++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus       267 e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  342 (450)
T 1k9a_A          267 EYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  342 (450)
T ss_dssp             ECCTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence            999999999999532 2234799999999999999999999987   999999999999999999999999999854321


Q ss_pred             CCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                           .....+++.|+|||.+.+..++.++||||||+++|||+| |+.||..
T Consensus       343 -----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~  389 (450)
T 1k9a_A          343 -----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR  389 (450)
T ss_dssp             ---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred             -----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence                 122356889999999999999999999999999999999 9999864

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=3.3e-36  Score=310.29  Aligned_cols=209  Identities=27%  Similarity=0.336  Sum_probs=180.1

Q ss_pred             cccchHHHHHHhCCCCccccccccCceeEEEEEc-cCCCeeEEEeecccCccCHHHHHHHHHHHhhcC-----CCceecc
Q 008292          333 LQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ-----HRNLVRL  406 (571)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----h~niv~l  406 (571)
                      ..+.+.......++|.+.++||+|+||+||+++. .+++.||||+++.. ....+.+..|+.+++.++     ||||+++
T Consensus        23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~  101 (360)
T 3llt_A           23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKY  101 (360)
T ss_dssp             GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred             eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence            4455666666788999999999999999999996 46889999998643 233456788999999986     9999999


Q ss_pred             ceeEEeCCeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECC----
Q 008292          407 LGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA----  482 (571)
Q Consensus       407 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~----  482 (571)
                      ++++...+..++||||+ +++|.+++... ....+++..+..++.||+.||+|||+++   |+||||||+|||++.    
T Consensus       102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~  176 (360)
T 3llt_A          102 HGKFMYYDHMCLIFEPL-GPSLYEIITRN-NYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFE  176 (360)
T ss_dssp             EEEEEETTEEEEEECCC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCC
T ss_pred             cceeeECCeeEEEEcCC-CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcccccc
Confidence            99999999999999999 99999988532 2345899999999999999999999987   999999999999975    


Q ss_pred             ---------------------CCceEEeeccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHH
Q 008292          483 ---------------------EMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLE  541 (571)
Q Consensus       483 ---------------------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~e  541 (571)
                                           ++.+||+|||+++.....     .....||+.|+|||++.+..++.++||||||+++||
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e  251 (360)
T 3llt_A          177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE  251 (360)
T ss_dssp             EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred             ccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHH
Confidence                                 789999999999864322     224578999999999999999999999999999999


Q ss_pred             HHhCCCCCCCC
Q 008292          542 IITGKKNSNFY  552 (571)
Q Consensus       542 lltG~~p~~~~  552 (571)
                      |+||+.||...
T Consensus       252 ll~g~~pf~~~  262 (360)
T 3llt_A          252 LYTGSLLFRTH  262 (360)
T ss_dssp             HHHSSCSCCCS
T ss_pred             HHHCCCCCCCC
Confidence            99999998643

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.2e-35  Score=297.56  Aligned_cols=202  Identities=21%  Similarity=0.326  Sum_probs=175.1

Q ss_pred             hCCCCccccccccCceeEEEEEc-cCCCeeEEEeecccCccCHHHHHHHHHHHhhc-CCCceeccceeEEeCCeeEEEEE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYE  421 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  421 (571)
                      .++|++.+.||+|+||.||+++. .+++.||||++....  ..+.+.+|+.++..+ +|+|++++++++.++...++|||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            56799999999999999999995 578999999986543  234578899999999 79999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCc-----eEEeeccCccc
Q 008292          422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN-----PKISDFGMARI  496 (571)
Q Consensus       422 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~DfGla~~  496 (571)
                      |+ +++|.+++..  ....+++..++.++.||++||.|||+++   |+||||||+|||++.++.     +||+|||+++.
T Consensus        87 ~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~  160 (298)
T 1csn_A           87 LL-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  160 (298)
T ss_dssp             CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             ec-CCCHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence            99 9999999853  2346999999999999999999999887   999999999999987776     99999999987


Q ss_pred             cCCCCCc-----cccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 008292          497 FGVDQTQ-----GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQ  553 (571)
Q Consensus       497 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~~~  553 (571)
                      .......     .......||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  222 (298)
T 1csn_A          161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK  222 (298)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred             cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhh
Confidence            6543221     12344679999999999999999999999999999999999999997643

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.6e-35  Score=298.34  Aligned_cols=202  Identities=30%  Similarity=0.489  Sum_probs=168.9

Q ss_pred             HHhCCCCccccccccCceeEEEEEc-cCCCeeEEEeecccC-----ccCHHHHHHHHHHHhhcC---CCceeccceeEEe
Q 008292          342 VATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS-----GQGAEEFKNEVVLVAKLQ---HRNLVRLLGFCLE  412 (571)
Q Consensus       342 ~~~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l~---h~niv~l~~~~~~  412 (571)
                      ...++|++.++||+|+||+||+++. .+++.||+|+++...     ......+.+|+.++++++   ||||+++++++..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~   85 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT   85 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence            4567999999999999999999995 568899999986432     222356677888777765   9999999999987


Q ss_pred             CC-----eeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceE
Q 008292          413 GE-----EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPK  487 (571)
Q Consensus       413 ~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k  487 (571)
                      ..     ..++||||+. ++|.+++... ....+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+|
T Consensus        86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~k  160 (308)
T 3g33_A           86 SRTDREIKVTLVFEHVD-QDLRTYLDKA-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVK  160 (308)
T ss_dssp             CCSSSEEEEEEEEECCC-CBHHHHHHTC-CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEE
T ss_pred             cCCCCceeEEEEehhhh-cCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEE
Confidence            65     4789999997 5998888542 2334899999999999999999999987   99999999999999999999


Q ss_pred             EeeccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          488 ISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       488 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      |+|||+++......   ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       161 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~  221 (308)
T 3g33_A          161 LADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCG  221 (308)
T ss_dssp             ECSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCC
T ss_pred             EeeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCC
Confidence            99999998654322   23445789999999999999999999999999999999999999853

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.1e-36  Score=308.72  Aligned_cols=211  Identities=30%  Similarity=0.502  Sum_probs=179.5

Q ss_pred             HHHHHHhCCCCccccccccCceeEEEEEcc------CCCeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeE
Q 008292          338 ETIEVATNKFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFC  410 (571)
Q Consensus       338 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~  410 (571)
                      +++++..++|.+.+.||+|+||.||+|+..      .++.||+|++.... ......+.+|+.+++.++||||+++++++
T Consensus        18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   97 (322)
T 1p4o_A           18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV   97 (322)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred             hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence            344556788999999999999999999864      36789999997543 23455788999999999999999999999


Q ss_pred             EeCCeeEEEEEecCCCChhhhhcCCC-------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCC
Q 008292          411 LEGEEKILVYEFVPNKSLDYFLYDPE-------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE  483 (571)
Q Consensus       411 ~~~~~~~lv~e~~~~g~L~~~l~~~~-------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~  483 (571)
                      .+++..++||||+++|+|.+++....       ....+++..++.++.||+.||.|||+++   |+||||||+||+++.+
T Consensus        98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~  174 (322)
T 1p4o_A           98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAED  174 (322)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTT
T ss_pred             ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCC
Confidence            99999999999999999999985311       1246799999999999999999999987   9999999999999999


Q ss_pred             CceEEeeccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          484 MNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       484 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                      +.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||+| |+.|+..
T Consensus       175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~  243 (322)
T 1p4o_A          175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG  243 (322)
T ss_dssp             CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT
T ss_pred             CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCcccc
Confidence            9999999999986644333233334467889999999999999999999999999999999 8888753

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=3.5e-36  Score=306.97  Aligned_cols=218  Identities=25%  Similarity=0.347  Sum_probs=182.3

Q ss_pred             HhCCCCccccccccCceeEEEEEc-cCCCeeEEEeecccCc--------cCHHHHHHHHHHHhhcCCCceeccceeEEeC
Q 008292          343 ATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASG--------QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG  413 (571)
Q Consensus       343 ~~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~--------~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~  413 (571)
                      ..++|++.+.||+|+||.||+++. .+++.||||+++....        ...+.+.+|+.++++++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            356899999999999999999985 5688999999875421        1334677899999999999999999999999


Q ss_pred             CeeEEEEEecCCC-ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeecc
Q 008292          414 EEKILVYEFVPNK-SLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG  492 (571)
Q Consensus       414 ~~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG  492 (571)
                      +..++||||+.+| +|..++.   ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg  175 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFID---RHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG  175 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHH---TCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred             CEEEEEEEeCCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence            9999999999777 9999884   3456999999999999999999999987   9999999999999999999999999


Q ss_pred             CccccCCCCCccccccccccCCcccccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCC----------CCcccHH
Q 008292          493 MARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQF-SVKSDVYSFGVLVLEIITGKKNSNFYQT----------DGAADLL  561 (571)
Q Consensus       493 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~Dv~slGvvl~elltG~~p~~~~~~----------~~~~~l~  561 (571)
                      +++.+....   ......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||.....          ....++.
T Consensus       176 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~l~  252 (335)
T 3dls_A          176 SAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSKELM  252 (335)
T ss_dssp             TCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTTTCCCCSSCCCHHHH
T ss_pred             cceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHhhccCCCcccCHHHH
Confidence            998764332   2234579999999999988877 7899999999999999999999853211          1234566


Q ss_pred             HHHHHhcc
Q 008292          562 SYVSINVI  569 (571)
Q Consensus       562 ~~~~~~~~  569 (571)
                      +++.++|.
T Consensus       253 ~li~~~L~  260 (335)
T 3dls_A          253 SLVSGLLQ  260 (335)
T ss_dssp             HHHHHHTC
T ss_pred             HHHHHHcc
Confidence            66666553

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=3.3e-36  Score=313.62  Aligned_cols=200  Identities=27%  Similarity=0.400  Sum_probs=168.3

Q ss_pred             hCCCCccccccccCceeEEEEEccCCCeeEEEeeccc--CccCHHHHHHHHHHHhhcC--CCceeccceeEEeCCeeEEE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQ--HRNLVRLLGFCLEGEEKILV  419 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~--h~niv~l~~~~~~~~~~~lv  419 (571)
                      .++|++.+.||+|+||.||++...+++.||||++...  .....+.+.+|+.++.+++  ||||+++++++...+..++|
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  134 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  134 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence            3569999999999999999999888999999998654  3344578899999999997  59999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCC
Q 008292          420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV  499 (571)
Q Consensus       420 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  499 (571)
                      || +.+++|.+++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||++ ++.+||+|||+++.+..
T Consensus       135 ~E-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~  206 (390)
T 2zmd_A          135 ME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  206 (390)
T ss_dssp             EE-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred             Ee-cCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence            99 678899999853   347899999999999999999999987   99999999999995 57899999999987654


Q ss_pred             CCCccccccccccCCccccccccc-----------CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          500 DQTQGNTSRIVGTYGYMAPEYAMH-----------GQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       500 ~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ..........+||+.|+|||++.+           ..++.++||||||+++|||++|+.||..
T Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~  269 (390)
T 2zmd_A          207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ  269 (390)
T ss_dssp             -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchh
Confidence            433333345679999999999865           4689999999999999999999999863

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1e-35  Score=302.34  Aligned_cols=192  Identities=28%  Similarity=0.376  Sum_probs=151.1

Q ss_pred             cccccccCceeEEEEEcc-CCCeeEEEeecccCccCHHHHHHHHHHHhhcC-CCceeccceeEEeCCeeEEEEEecCCCC
Q 008292          350 DNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEKILVYEFVPNKS  427 (571)
Q Consensus       350 ~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~  427 (571)
                      .+.||+|+||+||++... +++.||||++...   ....+.+|+.++..++ ||||+++++++.+....++||||+++|+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            478999999999999964 6889999998643   3467789999999997 9999999999999999999999999999


Q ss_pred             hhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCC---ceEEeeccCccccCCCCCcc
Q 008292          428 LDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM---NPKISDFGMARIFGVDQTQG  504 (571)
Q Consensus       428 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DfGla~~~~~~~~~~  504 (571)
                      |.+++.   ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++   .+||+|||+++......  .
T Consensus        93 L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~  164 (325)
T 3kn6_A           93 LFERIK---KKKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--Q  164 (325)
T ss_dssp             HHHHHH---HCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred             HHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCC--C
Confidence            999984   3457999999999999999999999987   99999999999997765   89999999998654322  2


Q ss_pred             ccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 008292          505 NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFY  552 (571)
Q Consensus       505 ~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~~  552 (571)
                      ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  212 (325)
T 3kn6_A          165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSH  212 (325)
T ss_dssp             -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred             cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence            223457899999999999999999999999999999999999998743

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=2.4e-36  Score=305.22  Aligned_cols=218  Identities=29%  Similarity=0.436  Sum_probs=184.7

Q ss_pred             cccccchHHHHHHhCCCCccccccccCceeEEEEEc------cCCCeeEEEeecccCc-cCHHHHHHHHHHHhhc-CCCc
Q 008292          331 ESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSKASG-QGAEEFKNEVVLVAKL-QHRN  402 (571)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~h~n  402 (571)
                      +.+.+....++...++|++.+.||+|+||.||+++.      .+++.||||+++.... ...+.+.+|+.++.++ +|||
T Consensus        13 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~   92 (316)
T 2xir_A           13 ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN   92 (316)
T ss_dssp             GGSCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTT
T ss_pred             hhccccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCC
Confidence            445566677777889999999999999999999973      3567899999976433 3446789999999999 7999


Q ss_pred             eeccceeEEeCC-eeEEEEEecCCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCe
Q 008292          403 LVRLLGFCLEGE-EKILVYEFVPNKSLDYFLYDPEK-------------QGQLDWSRRYKIIGGIARGILYLHEDSRLRI  468 (571)
Q Consensus       403 iv~l~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i  468 (571)
                      |+++++++...+ ..++||||+++++|.+++.....             ...+++..++.++.||++||.|||+++   |
T Consensus        93 iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i  169 (316)
T 2xir_A           93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---C  169 (316)
T ss_dssp             BCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred             eeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence            999999987755 48999999999999999965322             223889999999999999999999987   9


Q ss_pred             EEecCCCCCEEECCCCceEEeeccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCC
Q 008292          469 IHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKK  547 (571)
Q Consensus       469 vH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~  547 (571)
                      +||||||+||+++.++.+||+|||+++.+.............+|+.|+|||.+.+..++.++||||||+++|||+| |+.
T Consensus       170 ~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~  249 (316)
T 2xir_A          170 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS  249 (316)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred             ccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCC
Confidence            9999999999999999999999999987654433333344567889999999999999999999999999999998 999


Q ss_pred             CCCC
Q 008292          548 NSNF  551 (571)
Q Consensus       548 p~~~  551 (571)
                      ||..
T Consensus       250 p~~~  253 (316)
T 2xir_A          250 PYPG  253 (316)
T ss_dssp             SSTT
T ss_pred             CCcc
Confidence            9854

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.4e-36  Score=322.54  Aligned_cols=205  Identities=33%  Similarity=0.519  Sum_probs=171.6

Q ss_pred             HHHHhCCCCccccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEE
Q 008292          340 IEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV  419 (571)
Q Consensus       340 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  419 (571)
                      +++..++|++.++||+|+||.||+|.++++..||||+++... ...++|.+|+.++++++||||+++++++.+ +..++|
T Consensus       179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv  256 (452)
T 1fmk_A          179 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV  256 (452)
T ss_dssp             SBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             cccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEE
Confidence            344567788999999999999999999888889999997644 346789999999999999999999999876 678999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCC
Q 008292          420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV  499 (571)
Q Consensus       420 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  499 (571)
                      |||+++|+|.+++.. .....+++..++.++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus       257 ~e~~~~gsL~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  332 (452)
T 1fmk_A          257 TEYMSKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED  332 (452)
T ss_dssp             ECCCTTCBHHHHHSH-HHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred             ehhhcCCCHHHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence            999999999999942 12345899999999999999999999987   99999999999999999999999999987643


Q ss_pred             CCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          500 DQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                      .... ......+++.|+|||.+....++.++||||||+++|||+| |+.||..
T Consensus       333 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~  384 (452)
T 1fmk_A          333 NEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG  384 (452)
T ss_dssp             -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred             Ccee-cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCC
Confidence            2221 1223456789999999999999999999999999999999 8999853

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.1e-35  Score=295.07  Aligned_cols=198  Identities=30%  Similarity=0.466  Sum_probs=171.7

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CCCeeEEEeeccc---CccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV  419 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  419 (571)
                      .++|++.+.||+|+||+||++... ++..||+|++...   .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            467889999999999999999864 5678999998653   233456789999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCC
Q 008292          420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV  499 (571)
Q Consensus       420 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  499 (571)
                      |||+++++|.+++.   ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus        88 ~e~~~~~~l~~~l~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~  161 (279)
T 3fdn_A           88 LEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS  161 (279)
T ss_dssp             ECCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred             EecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence            99999999999884   3356899999999999999999999887   99999999999999999999999999865432


Q ss_pred             CCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          500 DQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .    ......|++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       162 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  209 (279)
T 3fdn_A          162 S----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA  209 (279)
T ss_dssp             ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             c----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCC
Confidence            2    22345789999999999999999999999999999999999999864

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=7.8e-36  Score=301.28  Aligned_cols=196  Identities=27%  Similarity=0.337  Sum_probs=163.3

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC--ccCHHHHHHHHHHHhhc-CCCceeccceeEEeCCeeEEE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILV  419 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv  419 (571)
                      .++|++.++||+|+||+||+|+.. +|+.||||++....  ......+..|+..+.++ +||||+++++++.+++..++|
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv  135 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ  135 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence            467999999999999999999975 78999999986533  22233445566555555 899999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCC
Q 008292          420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV  499 (571)
Q Consensus       420 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  499 (571)
                      |||+ +++|.+++..  ....+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus       136 ~e~~-~~~L~~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~  209 (311)
T 3p1a_A          136 TELC-GPSLQQHCEA--WGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT  209 (311)
T ss_dssp             EECC-CCBHHHHHHH--HCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred             Eecc-CCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence            9999 6688877743  2456999999999999999999999987   99999999999999999999999999987643


Q ss_pred             CCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCC
Q 008292          500 DQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNS  549 (571)
Q Consensus       500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~  549 (571)
                      ..   ......||+.|+|||++.+ .++.++||||||+++|||++|..|+
T Consensus       210 ~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~  255 (311)
T 3p1a_A          210 AG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELP  255 (311)
T ss_dssp             --------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCC
T ss_pred             CC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCC
Confidence            22   2234568999999998875 7999999999999999999997765

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1e-35  Score=295.10  Aligned_cols=200  Identities=30%  Similarity=0.533  Sum_probs=156.0

Q ss_pred             CCCCccccccccCceeEEEEEc-cCCCeeEEEeecccC---ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY  420 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  420 (571)
                      ++|++.+.||+|+||.||+++. .+|+.||+|++....   ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL   90 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence            5688999999999999999996 578999999986532   334578899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCC
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD  500 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  500 (571)
                      ||+++++|.+++..  ....+++..++.++.|+++||.|||+++   |+||||||+||+++.++.+||+|||++......
T Consensus        91 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~  165 (278)
T 3cok_A           91 EMCHNGEMNRYLKN--RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP  165 (278)
T ss_dssp             ECCTTEEHHHHHHT--CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred             ecCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence            99999999999853  3356899999999999999999999987   999999999999999999999999999876432


Q ss_pred             CCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ..  ......|++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       166 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  214 (278)
T 3cok_A          166 HE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDT  214 (278)
T ss_dssp             ----------------------------CTHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            21  12235689999999999999999999999999999999999999864

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.4e-35  Score=311.77  Aligned_cols=201  Identities=26%  Similarity=0.407  Sum_probs=163.7

Q ss_pred             HHhCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC--------ccCHHHHHHHHHHHhhcCCCceeccceeEEe
Q 008292          342 VATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS--------GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE  412 (571)
Q Consensus       342 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--------~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~  412 (571)
                      ...++|.+.++||+|+||+||++... +++.||||++....        ......+.+|+.++++++||||+++++++. 
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-  210 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-  210 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence            45688999999999999999999864 57899999986532        122235789999999999999999999974 


Q ss_pred             CCeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCC---ceEEe
Q 008292          413 GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM---NPKIS  489 (571)
Q Consensus       413 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~  489 (571)
                      .+..++||||+++|+|.+++.   ....+++..+..++.|+++||+|||+++   |+||||||+|||++.++   .+||+
T Consensus       211 ~~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~  284 (419)
T 3i6u_A          211 AEDYYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT  284 (419)
T ss_dssp             SSEEEEEEECCTTCBGGGGTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred             cCceEEEEEcCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence            556899999999999998884   4567999999999999999999999987   99999999999997544   59999


Q ss_pred             eccCccccCCCCCccccccccccCCccccccccc---CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 008292          490 DFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMH---GQFSVKSDVYSFGVLVLEIITGKKNSNFY  552 (571)
Q Consensus       490 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~Dv~slGvvl~elltG~~p~~~~  552 (571)
                      |||+++......   ......||+.|+|||++.+   ..++.++||||||+++|||+||+.||...
T Consensus       285 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~  347 (419)
T 3i6u_A          285 DFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH  347 (419)
T ss_dssp             CSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCC
T ss_pred             ecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence            999998764322   2334679999999999853   67889999999999999999999998643

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.5e-36  Score=308.15  Aligned_cols=209  Identities=25%  Similarity=0.300  Sum_probs=171.8

Q ss_pred             HHHHhCCCCccccccccCceeEEEEEc-cCCCeeEEEeeccc-----CccCHHHHHHHHHHHhhcCCCceeccceeEEeC
Q 008292          340 IEVATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA-----SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG  413 (571)
Q Consensus       340 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~  413 (571)
                      +....++|++.+.||+|+||.||++.. .+++.||+|++...     .....+.+.+|++++++++||||+++++++.+.
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  100 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE  100 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence            344567899999999999999999996 46788999998653     344567899999999999999999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhcCCC-------------------------------------CCCCCCHHHHHHHHHHHHHH
Q 008292          414 EEKILVYEFVPNKSLDYFLYDPE-------------------------------------KQGQLDWSRRYKIIGGIARG  456 (571)
Q Consensus       414 ~~~~lv~e~~~~g~L~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~~ia~~  456 (571)
                      +..++||||+++|+|.+++....                                     ....+++..++.++.||++|
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~  180 (345)
T 3hko_A          101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA  180 (345)
T ss_dssp             SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence            99999999999999999884100                                     01123567788999999999


Q ss_pred             HHHHHcCCCCCeEEecCCCCCEEECCCC--ceEEeeccCccccCCCCCc--cccccccccCCccccccccc--CCCCcch
Q 008292          457 ILYLHEDSRLRIIHRDLKASNILLDAEM--NPKISDFGMARIFGVDQTQ--GNTSRIVGTYGYMAPEYAMH--GQFSVKS  530 (571)
Q Consensus       457 L~yLH~~~~~~ivH~Dlkp~NIll~~~~--~~kl~DfGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~s~~~  530 (571)
                      |.|||+.+   |+||||||+|||++.++  .+||+|||+++.+......  .......||+.|+|||.+.+  ..++.++
T Consensus       181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~  257 (345)
T 3hko_A          181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC  257 (345)
T ss_dssp             HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred             HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence            99999987   99999999999998776  8999999999865432211  12334578999999999865  6789999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCC
Q 008292          531 DVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       531 Dv~slGvvl~elltG~~p~~~  551 (571)
                      ||||||+++|||++|+.||..
T Consensus       258 DiwslG~il~el~~g~~pf~~  278 (345)
T 3hko_A          258 DAWSAGVLLHLLLMGAVPFPG  278 (345)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCC
T ss_pred             HHHHHHHHHHHHHHCCCCCCC
Confidence            999999999999999999853

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=2.7e-36  Score=304.80  Aligned_cols=218  Identities=28%  Similarity=0.438  Sum_probs=168.3

Q ss_pred             cccccchHHHHHHhCCCCccccccccCceeEEEEEcc----CCCeeEEEeecccC--ccCHHHHHHHHHHHhhcCCCcee
Q 008292          331 ESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLP----SGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLV  404 (571)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv  404 (571)
                      +.+....+.+.+..++|.+.+.||+|+||.||++...    .+..||+|+++...  ....+.+.+|+.++++++||||+
T Consensus        20 eel~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv   99 (313)
T 3brb_A           20 EELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI   99 (313)
T ss_dssp             ----CCTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBC
T ss_pred             HhhhhhHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCee
Confidence            3444455556666788999999999999999999854    34579999987543  33456789999999999999999


Q ss_pred             ccceeEEeCCe-----eEEEEEecCCCChhhhhcCC---CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCC
Q 008292          405 RLLGFCLEGEE-----KILVYEFVPNKSLDYFLYDP---EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKAS  476 (571)
Q Consensus       405 ~l~~~~~~~~~-----~~lv~e~~~~g~L~~~l~~~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~  476 (571)
                      ++++++.+...     .++||||+++++|.+++...   .....+++..++.++.||++||.|||+++   |+||||||+
T Consensus       100 ~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~  176 (313)
T 3brb_A          100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAAR  176 (313)
T ss_dssp             CCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGG
T ss_pred             eeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcc
Confidence            99999987653     49999999999999988422   23456999999999999999999999987   999999999


Q ss_pred             CEEECCCCceEEeeccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          477 NILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       477 NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                      |||++.++.+||+|||+++.+.............+++.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus       177 NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~  252 (313)
T 3brb_A          177 NCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPG  252 (313)
T ss_dssp             GEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             eEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCcc
Confidence            99999999999999999987654333233334567889999999999999999999999999999999 8888754

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=5.3e-36  Score=318.75  Aligned_cols=196  Identities=29%  Similarity=0.381  Sum_probs=164.4

Q ss_pred             hCCCCccccccccCceeEEEEEc-cCCCeeEEEeeccc--CccCHHHHHHHHHHHhhcCCCceeccceeEEeC------C
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG------E  414 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~------~  414 (571)
                      .++|++.++||+|+||+||++.. .+++.||||++...  .....+.+.+|+.+++.++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            46899999999999999999985 46889999999754  334456788999999999999999999999654      3


Q ss_pred             eeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCc
Q 008292          415 EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA  494 (571)
Q Consensus       415 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla  494 (571)
                      ..++||||++++ |...+.     ..+++.++..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       141 ~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a  211 (464)
T 3ttj_A          141 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  211 (464)
T ss_dssp             EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred             eEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence            569999999876 555552     24899999999999999999999987   999999999999999999999999999


Q ss_pred             cccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          495 RIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      +.....   ......+||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       212 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g  265 (464)
T 3ttj_A          212 RTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG  265 (464)
T ss_dssp             -----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             eecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCC
Confidence            865432   123446899999999999999999999999999999999999999864

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-36  Score=310.13  Aligned_cols=201  Identities=27%  Similarity=0.381  Sum_probs=172.3

Q ss_pred             CCCCccccccccCceeEEEEEc----cCCCeeEEEeecccC----ccCHHHHHHHHHHHhhc-CCCceeccceeEEeCCe
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVL----PSGQEIAVKRLSKAS----GQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEE  415 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~  415 (571)
                      ++|++.+.||+|+||+||+++.    .+++.||||+++...    ....+.+.+|+.++.++ +||||+++++++...+.
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            5788999999999999999986    468899999987532    23445677899999999 69999999999999999


Q ss_pred             eEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCcc
Q 008292          416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR  495 (571)
Q Consensus       416 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  495 (571)
                      .++||||+++++|.+++.   ....+++..+..++.||++||.|||+++   |+||||||+||||+.++.+||+|||+++
T Consensus       134 ~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~  207 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLS---QRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK  207 (355)
T ss_dssp             EEEEECCCCSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             EEEEeecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence            999999999999999984   3456899999999999999999999987   9999999999999999999999999998


Q ss_pred             ccCCCCCccccccccccCCccccccccc--CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 008292          496 IFGVDQTQGNTSRIVGTYGYMAPEYAMH--GQFSVKSDVYSFGVLVLEIITGKKNSNFY  552 (571)
Q Consensus       496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~Dv~slGvvl~elltG~~p~~~~  552 (571)
                      .+..... .......||+.|+|||++.+  ..++.++||||||+++|||+||+.||...
T Consensus       208 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~  265 (355)
T 1vzo_A          208 EFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD  265 (355)
T ss_dssp             ECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCT
T ss_pred             ecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccC
Confidence            6543222 22334579999999999985  35789999999999999999999998643

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=6.1e-36  Score=305.90  Aligned_cols=197  Identities=25%  Similarity=0.385  Sum_probs=169.7

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccCccCHHHHHHHHHHHhhc-CCCceeccceeEEeCCeeEEEEE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYE  421 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  421 (571)
                      .++|++.+.||+|+||.||++..+ +++.||+|++++....    ..+|++++.++ +||||+++++++.+++..++|||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E   96 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE   96 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence            467899999999999999999964 6889999999765433    35678888887 79999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCC----CceEEeeccCcccc
Q 008292          422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE----MNPKISDFGMARIF  497 (571)
Q Consensus       422 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~DfGla~~~  497 (571)
                      |+++|+|.+++.   ....+++..+..++.||+.||.|||+++   |+||||||+|||+.++    +.+||+|||+++.+
T Consensus        97 ~~~gg~L~~~i~---~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~  170 (342)
T 2qr7_A           97 LMKGGELLDKIL---RQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL  170 (342)
T ss_dssp             CCCSCBHHHHHH---TCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred             CCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence            999999999884   3456899999999999999999999987   9999999999998543    35999999999876


Q ss_pred             CCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 008292          498 GVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFY  552 (571)
Q Consensus       498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~~  552 (571)
                      ....  ......+||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus       171 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~  223 (342)
T 2qr7_A          171 RAEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANG  223 (342)
T ss_dssp             BCTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred             cCCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCC
Confidence            4332  2233457899999999998888999999999999999999999999753

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2.1e-35  Score=308.46  Aligned_cols=195  Identities=24%  Similarity=0.304  Sum_probs=159.8

Q ss_pred             CCCCcc-ccccccCceeEEEEEcc-CCCeeEEEeecccCccCHHHHHHHHHHHh-hcCCCceeccceeEEe----CCeeE
Q 008292          345 NKFSTD-NKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVA-KLQHRNLVRLLGFCLE----GEEKI  417 (571)
Q Consensus       345 ~~~~~~-~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~-~l~h~niv~l~~~~~~----~~~~~  417 (571)
                      ++|.+. +.||+|+||+||++... +++.||||+++..     ..+.+|+.++. ..+||||+++++++..    ....+
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~  135 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL  135 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence            355555 68999999999999964 6889999998632     45678888874 4589999999999875    55689


Q ss_pred             EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECC---CCceEEeeccCc
Q 008292          418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA---EMNPKISDFGMA  494 (571)
Q Consensus       418 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfGla  494 (571)
                      +||||+++|+|.+++... ....+++..+..++.||+.||.|||+++   |+||||||+|||++.   ++.+||+|||++
T Consensus       136 lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a  211 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA  211 (400)
T ss_dssp             EEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccc
Confidence            999999999999999642 2346899999999999999999999987   999999999999987   789999999999


Q ss_pred             cccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          495 RIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      +......   .....+||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       212 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  265 (400)
T 1nxk_A          212 KETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS  265 (400)
T ss_dssp             EECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Confidence            8654221   22345789999999999999999999999999999999999999864

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=4.6e-35  Score=294.33  Aligned_cols=198  Identities=28%  Similarity=0.491  Sum_probs=176.6

Q ss_pred             CCCCccccccccCceeEEEEEc-cCCCeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      +.|+..+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  101 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY  101 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence            5688899999999999999985 468899999987543 45568899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT  502 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  502 (571)
                      +++++|.+++.    ...+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++..+.....
T Consensus       102 ~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~  174 (303)
T 3a7i_A          102 LGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI  174 (303)
T ss_dssp             CTTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC
T ss_pred             CCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcccc
Confidence            99999999983    357899999999999999999999987   99999999999999999999999999987643321


Q ss_pred             ccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          503 QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       503 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                        ......|++.|+|||.+.+..++.++||||||+++|||++|+.|+..
T Consensus       175 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  221 (303)
T 3a7i_A          175 --KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSE  221 (303)
T ss_dssp             --CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             --ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCC
Confidence              22345789999999999999999999999999999999999999853

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2.4e-35  Score=295.07  Aligned_cols=200  Identities=27%  Similarity=0.427  Sum_probs=176.0

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC---ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV  419 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  419 (571)
                      .++|.+.+.||+|+||.||++... +++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            357889999999999999999975 57889999986542   33456788999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCC
Q 008292          420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV  499 (571)
Q Consensus       420 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  499 (571)
                      |||+++++|.+++.   ....+++..++.++.|+++||.|||+++   |+||||||+||+++.++.+||+|||++.....
T Consensus        94 ~e~~~~~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  167 (294)
T 2rku_A           94 LELCRRRSLLELHK---RRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  167 (294)
T ss_dssp             EECCTTCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence            99999999999884   3457899999999999999999999987   99999999999999999999999999987643


Q ss_pred             CCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          500 DQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ...  ......|++.|+|||.+.+..++.++||||||+++|||+||+.||..
T Consensus       168 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~  217 (294)
T 2rku_A          168 DGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET  217 (294)
T ss_dssp             TTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             Ccc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            221  22345789999999999999999999999999999999999999864

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=2.5e-35  Score=293.24  Aligned_cols=198  Identities=27%  Similarity=0.423  Sum_probs=174.0

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC--ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY  420 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  420 (571)
                      .++|++.+.||+|+||.||++... +++.||+|++....  ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            478999999999999999999964 58899999986543  334567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCc---eEEeeccCcccc
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN---PKISDFGMARIF  497 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DfGla~~~  497 (571)
                      ||+++++|.+.+.   ....+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.   +||+|||++...
T Consensus        85 e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~  158 (284)
T 3kk8_A           85 DLVTGGELFEDIV---AREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  158 (284)
T ss_dssp             CCCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             ecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence            9999999988774   3456899999999999999999999987   999999999999987665   999999999866


Q ss_pred             CCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          498 GVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      .....   .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus       159 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~  208 (284)
T 3kk8_A          159 NDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFW  208 (284)
T ss_dssp             CSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             ccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCC
Confidence            43322   233578999999999999999999999999999999999999974

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.8e-35  Score=301.90  Aligned_cols=199  Identities=27%  Similarity=0.428  Sum_probs=175.7

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC---ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY  420 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  420 (571)
                      ++|.+.+.||+|+||.||++... +++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  120 (335)
T 2owb_A           41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL  120 (335)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence            56888999999999999999965 57889999986542   334567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCC
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD  500 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  500 (571)
                      ||+++++|.+++.   ....+++.+++.++.||++||.|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus       121 e~~~~~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  194 (335)
T 2owb_A          121 ELCRRRSLLELHK---RRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD  194 (335)
T ss_dssp             CCCTTCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             ecCCCCCHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence            9999999999884   3457899999999999999999999987   999999999999999999999999999876432


Q ss_pred             CCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .  .......|++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       195 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  243 (335)
T 2owb_A          195 G--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET  243 (335)
T ss_dssp             T--CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             c--ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCC
Confidence            2  122345789999999999999999999999999999999999999864

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=4.3e-36  Score=310.08  Aligned_cols=203  Identities=19%  Similarity=0.245  Sum_probs=167.6

Q ss_pred             HhCCCCccccccccCceeEEEEEccC------CCeeEEEeecccCccCH-----------HHHHHHHHHHhhcCCCceec
Q 008292          343 ATNKFSTDNKLGEGGFGEVYKGVLPS------GQEIAVKRLSKASGQGA-----------EEFKNEVVLVAKLQHRNLVR  405 (571)
Q Consensus       343 ~~~~~~~~~~LG~G~fg~Vy~~~~~~------g~~vavK~~~~~~~~~~-----------~~~~~Ei~~l~~l~h~niv~  405 (571)
                      ..++|++.++||+|+||.||++.+..      ++.||||++........           ..+..|+..+..++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            35689999999999999999998754      47899999865432111           12344566777889999999


Q ss_pred             cceeEEeC----CeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEEC
Q 008292          406 LLGFCLEG----EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD  481 (571)
Q Consensus       406 l~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~  481 (571)
                      +++++...    ...+|||||+ +++|.+++..  ....+++..++.++.||+.||.|||+++   |+||||||+|||++
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~  186 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN  186 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence            99998775    3479999999 9999999853  3357999999999999999999999987   99999999999998


Q ss_pred             --CCCceEEeeccCccccCCCCCcc-----ccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          482 --AEMNPKISDFGMARIFGVDQTQG-----NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       482 --~~~~~kl~DfGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                        .++.+||+|||+++.+.......     ......||+.|+|||.+.+..++.++||||||+++|||+||+.||..
T Consensus       187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~  263 (364)
T 3op5_A          187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWED  263 (364)
T ss_dssp             SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence              88999999999998764332111     12334699999999999999999999999999999999999999974

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=4.8e-36  Score=299.18  Aligned_cols=195  Identities=30%  Similarity=0.490  Sum_probs=170.8

Q ss_pred             hCCCCccccccccCceeEEEEEccC-C-------CeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCe
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLPS-G-------QEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEE  415 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~~-g-------~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~  415 (571)
                      .++|.+.+.||+|+||+||+++... +       ..||+|++........+.+.+|+.++++++||||+++++++.+++.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            4678889999999999999998643 3       4699999987777778899999999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCc--------eE
Q 008292          416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN--------PK  487 (571)
Q Consensus       416 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~--------~k  487 (571)
                      .++||||+++++|.+++..  ....+++..++.++.||++||.|||+++   |+||||||+|||++.++.        +|
T Consensus        87 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k  161 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKK--NKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK  161 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred             CEEEEECCCCCCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence            9999999999999999953  2334899999999999999999999987   999999999999998887        99


Q ss_pred             EeeccCccccCCCCCccccccccccCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCC
Q 008292          488 ISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNS  549 (571)
Q Consensus       488 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slGvvl~elltG~~p~  549 (571)
                      |+|||++.....      .....|++.|+|||.+.+ ..++.++||||||+++|||++|..|+
T Consensus       162 l~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~  218 (289)
T 4fvq_A          162 LSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP  218 (289)
T ss_dssp             ECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             eccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCC
Confidence            999999875421      223467889999999987 77999999999999999999965543

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.3e-36  Score=315.57  Aligned_cols=198  Identities=15%  Similarity=0.210  Sum_probs=162.0

Q ss_pred             hCCCCccccccccCceeEEEEEc-cCCCeeEEEeeccc---CccCHHHHHHHH---HHHhhcCCCceeccc-------ee
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA---SGQGAEEFKNEV---VLVAKLQHRNLVRLL-------GF  409 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~Ei---~~l~~l~h~niv~l~-------~~  409 (571)
                      .++|.+.+.||+|+||+||+|+. .+|+.||||++...   .....+.+.+|+   +++++++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            46788899999999999999996 46899999999743   334457889999   555666899999998       55


Q ss_pred             EEeCC-----------------eeEEEEEecCCCChhhhhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCe
Q 008292          410 CLEGE-----------------EKILVYEFVPNKSLDYFLYDPE----KQGQLDWSRRYKIIGGIARGILYLHEDSRLRI  468 (571)
Q Consensus       410 ~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i  468 (571)
                      +.+.+                 ..++||||+ +|+|.+++....    ....+++..++.++.||++||+|||+++   |
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence            55443                 278999999 689999885311    1123446888899999999999999987   9


Q ss_pred             EEecCCCCCEEECCCCceEEeeccCccccCCCCCccccccccccCCcccccccccC-----------CCCcchhHHHHHH
Q 008292          469 IHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG-----------QFSVKSDVYSFGV  537 (571)
Q Consensus       469 vH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~~~Dv~slGv  537 (571)
                      +||||||+||||+.++.+||+|||+++....     ......| +.|+|||++.+.           .++.++||||||+
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~  301 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL  301 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence            9999999999999999999999999985322     2234567 999999999887           8999999999999


Q ss_pred             HHHHHHhCCCCCCC
Q 008292          538 LVLEIITGKKNSNF  551 (571)
Q Consensus       538 vl~elltG~~p~~~  551 (571)
                      ++|||+||+.||..
T Consensus       302 il~elltg~~Pf~~  315 (377)
T 3byv_A          302 VIYWIWCADLPITK  315 (377)
T ss_dssp             HHHHHHHSSCCC--
T ss_pred             HHHHHHHCCCCCcc
Confidence            99999999999854

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.8e-35  Score=298.41  Aligned_cols=201  Identities=24%  Similarity=0.339  Sum_probs=165.6

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccCc---cCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASG---QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV  419 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  419 (571)
                      .++|++.+.||+|+||.||+++.. +++.||+|++.....   ...+.+.+|+.++.+++||||+++++++...+..++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            468999999999999999999964 688999999976433   2346789999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCC
Q 008292          420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV  499 (571)
Q Consensus       420 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  499 (571)
                      |||+++++|.+++.   ....+++..++.++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus       113 ~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  186 (309)
T 2h34_A          113 MRLINGVDLAAMLR---RQGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTD  186 (309)
T ss_dssp             EECCCCEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred             EEecCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence            99999999999984   3456899999999999999999999987   99999999999999999999999999976543


Q ss_pred             CCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          500 DQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ... .......|++.|+|||.+.+..++.++||||||+++|||+||+.||..
T Consensus       187 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  237 (309)
T 2h34_A          187 EKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQG  237 (309)
T ss_dssp             -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCS
T ss_pred             ccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCC
Confidence            221 122345689999999999999999999999999999999999999853

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1e-35  Score=295.32  Aligned_cols=205  Identities=35%  Similarity=0.538  Sum_probs=175.7

Q ss_pred             HHHHhCCCCccccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEE
Q 008292          340 IEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV  419 (571)
Q Consensus       340 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  419 (571)
                      +++..++|++.+.||+|+||.||++...++..||+|+++... ...+.+.+|++++++++||||+++++++. .+..++|
T Consensus         8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v   85 (279)
T 1qpc_A            8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYII   85 (279)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             cccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEE
Confidence            344457889999999999999999998888899999997543 34678999999999999999999999876 4568999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCC
Q 008292          420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV  499 (571)
Q Consensus       420 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  499 (571)
                      |||+++++|.+++... ....+++..++.++.|+++||.|||+++   |+||||||+||++++++.+||+|||+++....
T Consensus        86 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  161 (279)
T 1qpc_A           86 TEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIED  161 (279)
T ss_dssp             EECCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EecCCCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence            9999999999998431 1236899999999999999999999987   99999999999999999999999999987653


Q ss_pred             CCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          500 DQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                      .... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus       162 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~  213 (279)
T 1qpc_A          162 NEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG  213 (279)
T ss_dssp             SCEE-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred             cccc-cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcc
Confidence            3221 2223456789999999998899999999999999999999 8888753

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=8.9e-36  Score=303.01  Aligned_cols=202  Identities=31%  Similarity=0.541  Sum_probs=165.2

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CCCee----EEEeeccc-CccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEI----AVKRLSKA-SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI  417 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~v----avK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  417 (571)
                      .++|++.++||+|+||+||++... +++.+    ++|.+... .....+.+.+|+.++++++||||+++++++..+. .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            467999999999999999999953 45544    66766543 4456788999999999999999999999998754 78


Q ss_pred             EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCcccc
Q 008292          418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF  497 (571)
Q Consensus       418 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  497 (571)
                      +++||+++|+|.+++..  ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.+
T Consensus        93 ~v~~~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~  167 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEECCCSSCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred             EEEEecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence            99999999999998853  2456899999999999999999999987   999999999999999999999999999876


Q ss_pred             CCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          498 GVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                      .............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~  222 (327)
T 3lzb_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG  222 (327)
T ss_dssp             ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCC
Confidence            54443333344567889999999999999999999999999999999 9999864

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=8.1e-36  Score=300.57  Aligned_cols=197  Identities=30%  Similarity=0.459  Sum_probs=164.7

Q ss_pred             CCCCccccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEecC
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVP  424 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  424 (571)
                      ++|++.+.||+|+||+||+++. .++.||+|++...  ...+.+.+|++++++++||||+++++++.  +..++||||++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~   82 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE   82 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred             hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence            5688899999999999999998 4788999998643  34578899999999999999999999876  45799999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCc-eEEeeccCccccCCCCCc
Q 008292          425 NKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN-PKISDFGMARIFGVDQTQ  503 (571)
Q Consensus       425 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~-~kl~DfGla~~~~~~~~~  503 (571)
                      +++|.+++........+++..++.++.|+++||.|||+.+..+|+||||||+|||++.++. +||+|||++......   
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~---  159 (307)
T 2eva_A           83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---  159 (307)
T ss_dssp             TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred             CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence            9999999975444446889999999999999999999943234999999999999988886 799999999765322   


Q ss_pred             cccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          504 GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       504 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                        .....||+.|+|||.+.+..++.++||||||+++|||+||+.||..
T Consensus       160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  205 (307)
T 2eva_A          160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDE  205 (307)
T ss_dssp             -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTT
T ss_pred             --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchh
Confidence              2234689999999999999999999999999999999999999864

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1e-35  Score=305.04  Aligned_cols=195  Identities=32%  Similarity=0.465  Sum_probs=169.3

Q ss_pred             CCCCccccccccCceeEEEEEc-cCCCeeEEEeecccC---ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY  420 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  420 (571)
                      +.|+..+.||+|+||+||+++. .+++.||||++....   ....+++.+|++++++++||||+++++++.+.+..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            4588889999999999999995 578899999987543   233467889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCC
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD  500 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  500 (571)
                      ||++ |+|.+++..  ....+++..+..++.|+++||.|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus       134 e~~~-g~l~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~  207 (348)
T 1u5q_A          134 EYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  207 (348)
T ss_dssp             ECCS-EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred             ecCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence            9997 567666632  3456899999999999999999999987   999999999999999999999999999765321


Q ss_pred             CCccccccccccCCcccccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          501 QTQGNTSRIVGTYGYMAPEYAM---HGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       501 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                            ....||+.|+|||++.   ...++.++||||||+++|||+||+.||..
T Consensus       208 ------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~  255 (348)
T 1u5q_A          208 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN  255 (348)
T ss_dssp             ------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             ------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence                  2357899999999984   56899999999999999999999999753

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.2e-36  Score=312.92  Aligned_cols=204  Identities=27%  Similarity=0.429  Sum_probs=175.8

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeEEeCC--eeEEE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE--EKILV  419 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~--~~~lv  419 (571)
                      .++|.+.++||+|+||+||++... +|+.||||+++... ....+.+.+|++++++++||||+++++++....  ..++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            457889999999999999999965 58999999997543 345678889999999999999999999998765  67999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEE----CCCCceEEeeccCcc
Q 008292          420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL----DAEMNPKISDFGMAR  495 (571)
Q Consensus       420 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DfGla~  495 (571)
                      |||+++|+|.+++........+++..++.++.||+.||.|||+++   |+||||||+|||+    +.++.+||+|||+++
T Consensus        88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            999999999999965444445999999999999999999999987   9999999999999    778889999999998


Q ss_pred             ccCCCCCccccccccccCCccccccccc--------CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 008292          496 IFGVDQTQGNTSRIVGTYGYMAPEYAMH--------GQFSVKSDVYSFGVLVLEIITGKKNSNFYQ  553 (571)
Q Consensus       496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~~~Dv~slGvvl~elltG~~p~~~~~  553 (571)
                      ......   ......||+.|+|||.+.+        ..++.++||||||+++|||+||+.||....
T Consensus       165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~  227 (396)
T 4eut_A          165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE  227 (396)
T ss_dssp             ECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTT
T ss_pred             EccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence            764332   2234578999999998865        567889999999999999999999997543

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=2.2e-35  Score=300.66  Aligned_cols=199  Identities=31%  Similarity=0.444  Sum_probs=168.6

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeecccCc--cCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASG--QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE  421 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e  421 (571)
                      ++|++.+.||+|+||.||+++.. +|+.||+|++.....  ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  104 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE  104 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence            57888999999999999999965 588999999865432  234567899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCC
Q 008292          422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ  501 (571)
Q Consensus       422 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  501 (571)
                      |+++++|..++.   ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+....
T Consensus       105 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  178 (331)
T 4aaa_A          105 FVDHTILDDLEL---FPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  178 (331)
T ss_dssp             CCSEEHHHHHHH---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred             cCCcchHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence            999999988874   3456899999999999999999999987   9999999999999999999999999998654322


Q ss_pred             CccccccccccCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          502 TQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       502 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .  ......|++.|+|||.+.+. .++.++||||||+++|||++|+.||..
T Consensus       179 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  227 (331)
T 4aaa_A          179 E--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPG  227 (331)
T ss_dssp             -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             c--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCC
Confidence            1  22345689999999999775 789999999999999999999999864

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.6e-35  Score=297.80  Aligned_cols=198  Identities=27%  Similarity=0.414  Sum_probs=172.3

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      .++|.+.+.||+|+||+||+++.. +|+.||+|+++.......+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL   87 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence            457889999999999999999964 6899999999876555567789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEE---CCCCceEEeeccCccccCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMARIFGV  499 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfGla~~~~~  499 (571)
                      +++++|.+++.   ....+++..+..++.|++.||.|||+.+   |+||||||+||++   +.++.+||+|||+++....
T Consensus        88 ~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  161 (304)
T 2jam_A           88 VSGGELFDRIL---ERGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN  161 (304)
T ss_dssp             CCSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred             CCCccHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence            99999998884   3456899999999999999999999987   9999999999999   7889999999999875432


Q ss_pred             CCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          500 DQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .    ......|++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       162 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  209 (304)
T 2jam_A          162 G----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYE  209 (304)
T ss_dssp             B----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             C----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence            1    22345689999999999999999999999999999999999999853

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.5e-35  Score=315.61  Aligned_cols=195  Identities=22%  Similarity=0.419  Sum_probs=154.2

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeeccc--CccCHHHHHHHHHHHhhcCCCceeccceeEEeC-----Cee
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG-----EEK  416 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-----~~~  416 (571)
                      ++|++.+.||+|+||+||++... +++.||||++...  .....+.+.+|+++|++++||||+++++++...     ...
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  132 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL  132 (458)
T ss_dssp             TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence            67999999999999999999864 6889999998653  233456788999999999999999999998543     468


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccc
Q 008292          417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI  496 (571)
Q Consensus       417 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  496 (571)
                      ++||||+ +++|..++.   ....+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++.
T Consensus       133 ~lv~e~~-~~~L~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~  205 (458)
T 3rp9_A          133 YVVLEIA-DSDFKKLFR---TPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLART  205 (458)
T ss_dssp             EEEECCC-SEEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred             EEEEecc-ccchhhhcc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchh
Confidence            9999998 568888884   3456999999999999999999999987   99999999999999999999999999987


Q ss_pred             cCCCCCc-------------------------cccccccccCCccccccc-ccCCCCcchhHHHHHHHHHHHHhCC
Q 008292          497 FGVDQTQ-------------------------GNTSRIVGTYGYMAPEYA-MHGQFSVKSDVYSFGVLVLEIITGK  546 (571)
Q Consensus       497 ~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~s~~~Dv~slGvvl~elltG~  546 (571)
                      .......                         ......+||+.|+|||++ ....++.++|||||||++|||+||.
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~  281 (458)
T 3rp9_A          206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMI  281 (458)
T ss_dssp             TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTS
T ss_pred             ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhc
Confidence            6432211                         122345789999999986 4667999999999999999999953

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.2e-35  Score=293.41  Aligned_cols=199  Identities=28%  Similarity=0.431  Sum_probs=173.0

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC------ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCee
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS------GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEK  416 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~------~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  416 (571)
                      .++|++.+.||+|+||.||+++.. +++.||+|.++...      ....+.+.+|+.++++++||||+++++++.+.+..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            356889999999999999999975 68999999986532      12467899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCC----ceEEeecc
Q 008292          417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM----NPKISDFG  492 (571)
Q Consensus       417 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DfG  492 (571)
                      ++||||+++++|.+++.   ....+++..++.++.||+.||.|||+.+   |+||||||+||+++.++    .+||+|||
T Consensus        84 ~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg  157 (283)
T 3bhy_A           84 VLILELVSGGELFDFLA---EKESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFG  157 (283)
T ss_dssp             EEEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEeecCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecc
Confidence            99999999999999984   3456899999999999999999999987   99999999999998877    89999999


Q ss_pred             CccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          493 MARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       493 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ++.......   ......|++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       158 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  213 (283)
T 3bhy_A          158 IAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG  213 (283)
T ss_dssp             TCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             cceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCC
Confidence            998654322   12344689999999999999999999999999999999999999864

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=2.9e-35  Score=292.97  Aligned_cols=197  Identities=28%  Similarity=0.448  Sum_probs=174.4

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeeccc---CccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY  420 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  420 (571)
                      ++|++.+.||+|+||.||+++.. +++.||+|++...   .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            57888999999999999999965 5778999998653   2334578899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCC
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD  500 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  500 (571)
                      ||+++++|.+++.   ....+++..++.++.|+++||.|||+++   |+||||||+||+++.++.+||+|||++......
T Consensus        94 e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  167 (284)
T 2vgo_A           94 EFAPRGELYKELQ---KHGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL  167 (284)
T ss_dssp             CCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred             EeCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence            9999999999884   3356899999999999999999999987   999999999999999999999999998765322


Q ss_pred             CCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                          ......|++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       168 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  214 (284)
T 2vgo_A          168 ----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDS  214 (284)
T ss_dssp             ----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             ----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCC
Confidence                12345789999999999999999999999999999999999999864

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=2.4e-36  Score=327.24  Aligned_cols=206  Identities=32%  Similarity=0.509  Sum_probs=176.9

Q ss_pred             HHHHHhCCCCccccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEE
Q 008292          339 TIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL  418 (571)
Q Consensus       339 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  418 (571)
                      .+++..++|++.++||+|+||.||+|.+.++..||||+++... ...++|.+|+++|++++||||+++++++.+ +..+|
T Consensus       261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~l  338 (535)
T 2h8h_A          261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI  338 (535)
T ss_dssp             CSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             ceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceE
Confidence            3445567788999999999999999999888889999997644 346789999999999999999999999876 67899


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccC
Q 008292          419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG  498 (571)
Q Consensus       419 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  498 (571)
                      ||||+++|+|.+++... ....+++.+++.++.||++||+|||+++   |+||||||+||||+.++.+||+|||+++.+.
T Consensus       339 v~e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  414 (535)
T 2h8h_A          339 VTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIE  414 (535)
T ss_dssp             EECCCTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred             eeehhcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence            99999999999999421 2345899999999999999999999987   9999999999999999999999999998654


Q ss_pred             CCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          499 VDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                      .... .......++..|+|||.+....++.++||||||+++|||+| |+.||..
T Consensus       415 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~  467 (535)
T 2h8h_A          415 DNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG  467 (535)
T ss_dssp             CHHH-HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTT
T ss_pred             CCce-ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            3211 11223356789999999999999999999999999999999 8988853

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.6e-35  Score=297.40  Aligned_cols=201  Identities=31%  Similarity=0.520  Sum_probs=171.6

Q ss_pred             hCCCCccccccccCceeEEEEEc-----cCCCeeEEEeeccc-CccCHHHHHHHHHHHhhcCCCceeccceeEEeC--Ce
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVL-----PSGQEIAVKRLSKA-SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG--EE  415 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~-----~~g~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~  415 (571)
                      .+.|++.++||+|+||.||++++     .+++.||+|+++.. .....+.+.+|+.++++++||||+++++++.+.  ..
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   99 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   99 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence            34588899999999999999983     46889999999754 345567899999999999999999999999876  56


Q ss_pred             eEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCcc
Q 008292          416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR  495 (571)
Q Consensus       416 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  495 (571)
                      .++||||+++++|.+++..  ....+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus       100 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~  174 (302)
T 4e5w_A          100 IKLIMEFLPSGSLKEYLPK--NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK  174 (302)
T ss_dssp             EEEEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             EEEEEEeCCCCcHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccc
Confidence            8999999999999999843  3356899999999999999999999987   9999999999999999999999999998


Q ss_pred             ccCCCCCc-cccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCC
Q 008292          496 IFGVDQTQ-GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNS  549 (571)
Q Consensus       496 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~  549 (571)
                      ........ .......||..|+|||.+.+..++.++||||||+++|||+||+.|+
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~  229 (302)
T 4e5w_A          175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSD  229 (302)
T ss_dssp             ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGG
T ss_pred             cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCC
Confidence            76543321 2233456788899999999999999999999999999999998874

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1e-35  Score=304.90  Aligned_cols=200  Identities=21%  Similarity=0.287  Sum_probs=164.6

Q ss_pred             hCCCCccccccccCceeEEEEEcc----CCCeeEEEeecccCcc-----------CHHHHHHHHHHHhhcCCCceeccce
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP----SGQEIAVKRLSKASGQ-----------GAEEFKNEVVLVAKLQHRNLVRLLG  408 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~-----------~~~~~~~Ei~~l~~l~h~niv~l~~  408 (571)
                      .++|.+.+.||+|+||.||++...    ++..||+|++......           ....+.+|+..+..++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            467899999999999999999975    5678999998754321           1234667888999999999999999


Q ss_pred             eEEe----CCeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCC
Q 008292          409 FCLE----GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM  484 (571)
Q Consensus       409 ~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~  484 (571)
                      ++..    ....++||||+ +++|.+++..   ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~  188 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQ---NGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN  188 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBG---GGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence            9988    67889999999 9999999843   337999999999999999999999987   99999999999998877


Q ss_pred             --ceEEeeccCccccCCCCCc-----cccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          485 --NPKISDFGMARIFGVDQTQ-----GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       485 --~~kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                        .+||+|||+++.+......     .......||+.|+|||.+.+..++.++||||||+++|||+||+.||.
T Consensus       189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~  261 (345)
T 2v62_A          189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWE  261 (345)
T ss_dssp             TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTG
T ss_pred             CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence              9999999999876432211     11234579999999999999999999999999999999999999985

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.7e-35  Score=293.72  Aligned_cols=201  Identities=32%  Similarity=0.535  Sum_probs=171.9

Q ss_pred             CCCCccc-cccccCceeEEEEEcc---CCCeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEE
Q 008292          345 NKFSTDN-KLGEGGFGEVYKGVLP---SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV  419 (571)
Q Consensus       345 ~~~~~~~-~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  419 (571)
                      ++|.+.+ .||+|+||.||+|.+.   ++..||+|+++... ....+.+.+|++++++++||||+++++++ ..+..++|
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence            4555665 8999999999999853   57789999997643 34467889999999999999999999998 56678999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCC
Q 008292          420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV  499 (571)
Q Consensus       420 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  499 (571)
                      |||+++++|.+++..  ....+++..++.++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||+++....
T Consensus        88 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~  162 (287)
T 1u59_A           88 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA  162 (287)
T ss_dssp             EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence            999999999999843  3456899999999999999999999987   99999999999999999999999999987643


Q ss_pred             CCCc-cccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          500 DQTQ-GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       500 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                      .... .......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||..
T Consensus       163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~  216 (287)
T 1u59_A          163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK  216 (287)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCccc
Confidence            3221 12233456889999999998899999999999999999999 9999854

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.6e-35  Score=312.77  Aligned_cols=199  Identities=23%  Similarity=0.418  Sum_probs=166.5

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CCCeeEEEeeccc--CccCHHHHHHHHHHHhhcCCCceeccceeEEeC-----Ce
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG-----EE  415 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-----~~  415 (571)
                      .++|.+.+.||+|+||.||++... +++.||||+++..  .....+.+.+|++++++++||||+++++++...     ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            468999999999999999999964 5788999999753  233456789999999999999999999999776     56


Q ss_pred             eEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCcc
Q 008292          416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR  495 (571)
Q Consensus       416 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  495 (571)
                      .++||||++ ++|.+++.   ....+++..+..++.||++||.|||+.+   |+||||||+||||+.++.+||+|||+++
T Consensus       105 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~  177 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFK---TPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR  177 (432)
T ss_dssp             EEEEEECCS-EEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEecCC-cCHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence            899999986 58988884   3456999999999999999999999987   9999999999999999999999999998


Q ss_pred             ccCCCCCc--------------------cccccccccCCccccccc-ccCCCCcchhHHHHHHHHHHHHhCCCCC
Q 008292          496 IFGVDQTQ--------------------GNTSRIVGTYGYMAPEYA-MHGQFSVKSDVYSFGVLVLEIITGKKNS  549 (571)
Q Consensus       496 ~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~s~~~Dv~slGvvl~elltG~~p~  549 (571)
                      ........                    ......+||+.|+|||++ ....++.++|||||||++|||++|..|+
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence            76433211                    122456799999999986 5667999999999999999999876554

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=9.3e-36  Score=293.46  Aligned_cols=201  Identities=32%  Similarity=0.496  Sum_probs=176.0

Q ss_pred             hCCCCccccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEec
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV  423 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  423 (571)
                      .++|++.+.||+|+||.||++...+++.||+|++.... ...+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM   85 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred             hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence            46788899999999999999998888899999997644 34578899999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCc
Q 008292          424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ  503 (571)
Q Consensus       424 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  503 (571)
                      ++++|.+++..  ....+++..++.++.|+++||.|||+++   |+||||||+||+++.++.+||+|||+++....... 
T Consensus        86 ~~~~L~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-  159 (267)
T 3t9t_A           86 EHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-  159 (267)
T ss_dssp             TTCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-
T ss_pred             CCCcHHHHHhh--CcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccccc-
Confidence            99999999853  2356899999999999999999999987   99999999999999999999999999986542211 


Q ss_pred             cccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          504 GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       504 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                      .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~  208 (267)
T 3t9t_A          160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN  208 (267)
T ss_dssp             HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCC
Confidence            11223456788999999998999999999999999999999 8988753

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=3.1e-35  Score=294.07  Aligned_cols=201  Identities=29%  Similarity=0.433  Sum_probs=171.4

Q ss_pred             CCCCccccccccCceeEEEEEc-cCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEec
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV  423 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  423 (571)
                      +++.....||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  101 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV  101 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence            3455667999999999999995 468899999998776666788999999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECC-CCceEEeeccCccccCCCCC
Q 008292          424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-EMNPKISDFGMARIFGVDQT  502 (571)
Q Consensus       424 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGla~~~~~~~~  502 (571)
                      ++++|.+++........+++..+..++.|+++||.|||+++   |+||||||+||+++. ++.+||+|||+++...... 
T Consensus       102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-  177 (295)
T 2clq_A          102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-  177 (295)
T ss_dssp             SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred             CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC-
Confidence            99999999865444456789999999999999999999987   999999999999987 8999999999998654321 


Q ss_pred             ccccccccccCCcccccccccCC--CCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          503 QGNTSRIVGTYGYMAPEYAMHGQ--FSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       503 ~~~~~~~~gt~~y~aPE~~~~~~--~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                       .......|++.|+|||.+.+..  ++.++||||||+++|||++|+.||.
T Consensus       178 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  226 (295)
T 2clq_A          178 -PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFY  226 (295)
T ss_dssp             ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTG
T ss_pred             -CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCcc
Confidence             1223457899999999987653  8899999999999999999999985

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=4e-36  Score=299.59  Aligned_cols=206  Identities=32%  Similarity=0.485  Sum_probs=178.8

Q ss_pred             HHHHhCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEE
Q 008292          340 IEVATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL  418 (571)
Q Consensus       340 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  418 (571)
                      ++...++|++.+.||+|+||+||++... ++..||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++
T Consensus         8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   86 (288)
T 3kfa_A            8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI   86 (288)
T ss_dssp             TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred             ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEE
Confidence            3445678899999999999999999975 47889999987543 346788999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccC
Q 008292          419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG  498 (571)
Q Consensus       419 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  498 (571)
                      ||||+++++|.+++... ....+++..++.++.|++.||.|||+++   |+||||||+||+++.++.+||+|||++....
T Consensus        87 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~  162 (288)
T 3kfa_A           87 ITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT  162 (288)
T ss_dssp             EEECCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred             EEEcCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence            99999999999998532 3456899999999999999999999987   9999999999999999999999999998765


Q ss_pred             CCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          499 VDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                      .... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus       163 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~  215 (288)
T 3kfa_A          163 GDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG  215 (288)
T ss_dssp             SSSS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CCcc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            3322 22233457889999999999999999999999999999999 8888754

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=4.5e-35  Score=291.95  Aligned_cols=199  Identities=34%  Similarity=0.606  Sum_probs=168.6

Q ss_pred             hCCCCccccccccCceeEEEEEc-cCCCeeEEEeecccCccC-------HHHHHHHHHHHhhcCCCceeccceeEEeCCe
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQG-------AEEFKNEVVLVAKLQHRNLVRLLGFCLEGEE  415 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~-------~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~  415 (571)
                      .++|++.+.||+|+||+||+++. .+++.||+|++.......       .+.+.+|+.++++++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            46788999999999999999996 478899999986543221       267899999999999999999999986544 


Q ss_pred             eEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCc-----eEEee
Q 008292          416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN-----PKISD  490 (571)
Q Consensus       416 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~D  490 (571)
                       ++||||+++++|.+++..  ....+++..++.++.|++.||+|||+++ .+|+||||||+|||++.++.     +||+|
T Consensus        97 -~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             -eEEEEecCCCCHHHHHhc--ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence             799999999999888754  3457999999999999999999999874 34999999999999988776     99999


Q ss_pred             ccCccccCCCCCccccccccccCCccccccc--ccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 008292          491 FGMARIFGVDQTQGNTSRIVGTYGYMAPEYA--MHGQFSVKSDVYSFGVLVLEIITGKKNSNFY  552 (571)
Q Consensus       491 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~s~~~Dv~slGvvl~elltG~~p~~~~  552 (571)
                      ||+++....     ......||+.|+|||.+  ....++.++||||||+++|||++|+.||...
T Consensus       173 fg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~  231 (287)
T 4f0f_A          173 FGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEY  231 (287)
T ss_dssp             CTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             CCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccc
Confidence            999975332     23345789999999998  4556889999999999999999999998643

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=7.2e-36  Score=307.85  Aligned_cols=198  Identities=28%  Similarity=0.395  Sum_probs=174.0

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CCCeeEEEeeccc-CccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA-SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE  421 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e  421 (571)
                      .++|++.++||+|+||.||++... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            467899999999999999999965 6889999998764 33445678999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCCeEEecCCCCCEEECCCCceEEeeccCccccCCC
Q 008292          422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED-SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD  500 (571)
Q Consensus       422 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  500 (571)
                      |+++++|.+++.   ....+++..+..++.|++.||.|||+. +   |+||||||+|||++.++.+||+|||++......
T Consensus       112 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  185 (360)
T 3eqc_A          112 HMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  185 (360)
T ss_dssp             CCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred             CCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence            999999999984   345689999999999999999999985 6   999999999999999999999999999765321


Q ss_pred             CCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                          ......||+.|+|||.+.+..++.++||||||+++|||+||+.||..
T Consensus       186 ----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  232 (360)
T 3eqc_A          186 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP  232 (360)
T ss_dssp             ----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSC
T ss_pred             ----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence                22345789999999999999999999999999999999999999864

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=7.9e-36  Score=296.61  Aligned_cols=202  Identities=26%  Similarity=0.413  Sum_probs=161.7

Q ss_pred             HhCCCCccccccccCceeEEEEEccC----CCeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeE
Q 008292          343 ATNKFSTDNKLGEGGFGEVYKGVLPS----GQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI  417 (571)
Q Consensus       343 ~~~~~~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  417 (571)
                      ..++|++.+.||+|+||.||+|....    +..||+|+++... ....+.+.+|+.++++++||||+++++++ ..+..+
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~   91 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVW   91 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCE
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccE
Confidence            35678899999999999999998643    4569999987543 34456789999999999999999999997 456789


Q ss_pred             EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCcccc
Q 008292          418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF  497 (571)
Q Consensus       418 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  497 (571)
                      +||||+++++|.+++..  ....+++..++.++.|+++||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus        92 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  166 (281)
T 1mp8_A           92 IIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM  166 (281)
T ss_dssp             EEEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             EEEecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccccc
Confidence            99999999999999853  2346899999999999999999999987   999999999999999999999999999876


Q ss_pred             CCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          498 GVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                      ...... ......+++.|+|||.+....++.++||||||+++|||++ |+.||..
T Consensus       167 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~  220 (281)
T 1mp8_A          167 EDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG  220 (281)
T ss_dssp             -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             Cccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCc
Confidence            433221 2233456789999999999999999999999999999997 9989864

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.2e-35  Score=301.90  Aligned_cols=202  Identities=31%  Similarity=0.462  Sum_probs=175.4

Q ss_pred             hCCCCccccccccCceeEEEEEc-----cCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEe--CCee
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVL-----PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE--GEEK  416 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~~~~  416 (571)
                      .++|++.++||+|+||.||++++     .+++.||||++........+.+.+|++++++++||||+++++++..  ....
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  101 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL  101 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence            36788999999999999999983     4678899999987766667789999999999999999999999874  4568


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccc
Q 008292          417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI  496 (571)
Q Consensus       417 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  496 (571)
                      ++||||+++++|.+++..  ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus       102 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  176 (327)
T 3lxl_A          102 RLVMEYLPSGCLRDFLQR--HRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKL  176 (327)
T ss_dssp             EEEEECCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred             EEEEeecCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccccee
Confidence            899999999999999843  2345899999999999999999999987   99999999999999999999999999987


Q ss_pred             cCCCCCc-cccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          497 FGVDQTQ-GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       497 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      ....... .......+|+.|+|||.+.+..++.++||||||+++|||++|+.|+.
T Consensus       177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~  231 (327)
T 3lxl_A          177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSC  231 (327)
T ss_dssp             CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred             cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCc
Confidence            6433221 12233467888999999999999999999999999999999998863

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=3.8e-35  Score=302.92  Aligned_cols=205  Identities=24%  Similarity=0.414  Sum_probs=177.1

Q ss_pred             HHHHHHhCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccCc--------cCHHHHHHHHHHHhhc-CCCceeccc
Q 008292          338 ETIEVATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASG--------QGAEEFKNEVVLVAKL-QHRNLVRLL  407 (571)
Q Consensus       338 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--------~~~~~~~~Ei~~l~~l-~h~niv~l~  407 (571)
                      .......++|.+.+.||+|+||.||+++.. +|+.||||+++....        ...+.+.+|+.++.++ +||||++++
T Consensus        87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~  166 (365)
T 2y7j_A           87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI  166 (365)
T ss_dssp             HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred             hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence            344555678999999999999999999975 799999999865432        1245678999999999 799999999


Q ss_pred             eeEEeCCeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceE
Q 008292          408 GFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPK  487 (571)
Q Consensus       408 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k  487 (571)
                      +++......++||||+++++|.+++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+|
T Consensus       167 ~~~~~~~~~~lv~e~~~g~~L~~~l~---~~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ik  240 (365)
T 2y7j_A          167 DSYESSSFMFLVFDLMRKGELFDYLT---EKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIR  240 (365)
T ss_dssp             EEEEBSSEEEEEECCCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEE
T ss_pred             EEEeeCCEEEEEEEeCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEE
Confidence            99999999999999999999999984   3456899999999999999999999987   99999999999999999999


Q ss_pred             EeeccCccccCCCCCccccccccccCCccccccccc------CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          488 ISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMH------GQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       488 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      |+|||++..+....   ......||+.|+|||++.+      ..++.++||||||+++|||+||+.||..
T Consensus       241 l~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~  307 (365)
T 2y7j_A          241 LSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH  307 (365)
T ss_dssp             ECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             EEecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCC
Confidence            99999998765332   2234579999999998863      3688999999999999999999999853

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=5.2e-35  Score=301.58  Aligned_cols=208  Identities=25%  Similarity=0.339  Sum_probs=170.0

Q ss_pred             cchHHHHHHhCCCCccccccccCceeEEEEEccCCCeeEEEeecccCcc-----------CHHHHHHHHHHHhhcCCCce
Q 008292          335 FDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQ-----------GAEEFKNEVVLVAKLQHRNL  403 (571)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~-----------~~~~~~~Ei~~l~~l~h~ni  403 (571)
                      ....++....++|.+.+.||+|+||.||++...+|+.||||++......           ..+.+.+|+.++++++||||
T Consensus        12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   91 (362)
T 3pg1_A           12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI   91 (362)
T ss_dssp             HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence            3456677888999999999999999999999888999999998653221           13788999999999999999


Q ss_pred             eccceeEEeC-----CeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCE
Q 008292          404 VRLLGFCLEG-----EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNI  478 (571)
Q Consensus       404 v~l~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NI  478 (571)
                      +++++++...     ...++||||++ |+|.+++..  ....+++..+..++.||+.||.|||+++   |+||||||+||
T Consensus        92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NI  165 (362)
T 3pg1_A           92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNI  165 (362)
T ss_dssp             CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGE
T ss_pred             cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHE
Confidence            9999998653     35799999998 577777643  3456899999999999999999999987   99999999999


Q ss_pred             EECCCCceEEeeccCccccCCCCCccccccccccCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          479 LLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       479 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      |++.++.+||+|||+++......   ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus       166 l~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~  236 (362)
T 3pg1_A          166 LLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRG  236 (362)
T ss_dssp             EECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             EEcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCC
Confidence            99999999999999997543222   2234578999999999877 6799999999999999999999999864

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.5e-35  Score=295.37  Aligned_cols=200  Identities=27%  Similarity=0.408  Sum_probs=169.6

Q ss_pred             CCCCccccccccCceeEEEEEc-cCCCeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      ++|.+.++||+|+||.||++.. .++..||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            5788999999999999999996 468899999987643 44578899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEE---CCCCceEEeeccCccccC
Q 008292          423 VPNKSLDYFLYDP-EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMARIFG  498 (571)
Q Consensus       423 ~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfGla~~~~  498 (571)
                      +++++|.+++... .....+++..++.++.|+++||.|||+.+   |+||||||+|||+   +.++.+||+|||+++.+.
T Consensus       102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~  178 (285)
T 3is5_A          102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK  178 (285)
T ss_dssp             CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred             CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence            9999998887432 12467999999999999999999999987   9999999999999   456789999999998654


Q ss_pred             CCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          499 VDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ...   ......|++.|+|||.+. +.++.++||||||+++|||++|+.||..
T Consensus       179 ~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~  227 (285)
T 3is5_A          179 SDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTG  227 (285)
T ss_dssp             -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             Ccc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCC
Confidence            322   223457899999999875 5789999999999999999999999853

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-35  Score=304.77  Aligned_cols=195  Identities=29%  Similarity=0.454  Sum_probs=164.4

Q ss_pred             hCCCCccccccccCceeEEEEEc-cCCCeeEEEeeccc--CccCHHHHHHHHHHHhhcCCCceeccceeEEeCC------
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE------  414 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------  414 (571)
                      .++|+..+.||+|+||.||++.. .+|+.||||++...  .....+.+.+|+++++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            35788999999999999999996 46899999998653  2333567889999999999999999999997653      


Q ss_pred             eeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCc
Q 008292          415 EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA  494 (571)
Q Consensus       415 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla  494 (571)
                      ..++||||+ +++|.+++.    ...+++..+..++.||++||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~lv~e~~-~~~L~~~~~----~~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a  175 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA  175 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence            459999999 889999884    356899999999999999999999987   999999999999999999999999999


Q ss_pred             cccCCCCCccccccccccCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          495 RIFGVDQTQGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      +.....     .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus       176 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  228 (367)
T 1cm8_A          176 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG  228 (367)
T ss_dssp             EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCC
Confidence            875422     234578999999999887 6899999999999999999999999864

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.1e-35  Score=302.50  Aligned_cols=202  Identities=27%  Similarity=0.435  Sum_probs=163.6

Q ss_pred             HHHhCCCCccccccccCceeEEEEEc-cCCCeeEEEeecccCc--cCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeE
Q 008292          341 EVATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASG--QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI  417 (571)
Q Consensus       341 ~~~~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  417 (571)
                      ....++|++.++||+|+||+||+++. .+++.||||+++....  ...+.+.+|+.++++++||||+++++++.+.+..+
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (329)
T 3gbz_A           30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH  109 (329)
T ss_dssp             --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred             ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence            34457899999999999999999985 4788999999975432  23456789999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEE-----CCCCceEEeecc
Q 008292          418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL-----DAEMNPKISDFG  492 (571)
Q Consensus       418 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll-----~~~~~~kl~DfG  492 (571)
                      +||||+++ +|.+++.   ....+++..+..++.||++||.|||+++   |+||||||+|||+     +.++.+||+|||
T Consensus       110 lv~e~~~~-~L~~~~~---~~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg  182 (329)
T 3gbz_A          110 LIFEYAEN-DLKKYMD---KNPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFG  182 (329)
T ss_dssp             EEEECCSE-EHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred             EEEecCCC-CHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCC
Confidence            99999985 8888884   3456899999999999999999999987   9999999999999     445569999999


Q ss_pred             CccccCCCCCccccccccccCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          493 MARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       493 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      +++.+.....  ......||+.|+|||++.+. .++.++||||||+++|||++|+.||..
T Consensus       183 ~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  240 (329)
T 3gbz_A          183 LARAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPG  240 (329)
T ss_dssp             HHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CccccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence            9987643322  22345689999999999875 589999999999999999999999854

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=4.6e-35  Score=290.01  Aligned_cols=199  Identities=27%  Similarity=0.461  Sum_probs=167.6

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CCCeeEEEeeccc---CccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV  419 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  419 (571)
                      .++|.+.+.||+|+||.||+++.. +|+.||+|++...   .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            467899999999999999999975 7899999998653   234567889999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCC
Q 008292          420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV  499 (571)
Q Consensus       420 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  499 (571)
                      |||+++++|.+++.   ....+++..++.++.||++||.|||+++   |+|+||||+||+++.++.+||+|||++.....
T Consensus        90 ~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  163 (276)
T 2h6d_A           90 MEYVSGGELFDYIC---KHGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  163 (276)
T ss_dssp             EECCCSCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred             EeccCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence            99999999999984   3456899999999999999999999987   99999999999999999999999999986543


Q ss_pred             CCCccccccccccCCcccccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          500 DQTQGNTSRIVGTYGYMAPEYAMHGQF-SVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ..   ......|++.|+|||.+.+..+ +.++||||||+++|||++|+.||..
T Consensus       164 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~  213 (276)
T 2h6d_A          164 GE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD  213 (276)
T ss_dssp             ----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             Cc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence            22   1223468999999999987765 6899999999999999999999864

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=4.2e-35  Score=296.89  Aligned_cols=197  Identities=31%  Similarity=0.460  Sum_probs=169.6

Q ss_pred             CCccccccccCceeEEEEEc-----cCCCeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeEEeC--CeeEE
Q 008292          347 FSTDNKLGEGGFGEVYKGVL-----PSGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG--EEKIL  418 (571)
Q Consensus       347 ~~~~~~LG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~l  418 (571)
                      |++.++||+|+||+||++.+     .+++.||||+++... ....+.+.+|++++++++||||+++++++.+.  ...++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            48899999999999988864     267889999997643 34456789999999999999999999999884  56799


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccC
Q 008292          419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG  498 (571)
Q Consensus       419 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  498 (571)
                      ||||+++++|.+++.    ...+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       113 v~e~~~~~~L~~~l~----~~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  185 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLP----RHSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  185 (318)
T ss_dssp             EECCCTTCBHHHHGG----GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred             EEecccCCcHHHHHh----hCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence            999999999999994    345899999999999999999999987   9999999999999999999999999998765


Q ss_pred             CCCCc-cccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          499 VDQTQ-GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       499 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      ..... .......+++.|+|||.+.+..++.++||||||+++|||+||+.|+.
T Consensus       186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~  238 (318)
T 3lxp_A          186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQ  238 (318)
T ss_dssp             TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred             ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCccc
Confidence            43221 12234467888999999999999999999999999999999998875

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=3.9e-35  Score=301.24  Aligned_cols=201  Identities=26%  Similarity=0.456  Sum_probs=169.8

Q ss_pred             CCCCccccccccCceeEEEEEc-cCCCeeEEEeecccC--ccCHHHHHHHHHHHhhcCCCceeccceeEEeC--------
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG--------  413 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--------  413 (571)
                      ++|++.++||+|+||+||+++. .+|+.||+|++....  ......+.+|+.+++.++||||+++++++...        
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            5789999999999999999996 578999999886543  23346778999999999999999999999873        


Q ss_pred             CeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccC
Q 008292          414 EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM  493 (571)
Q Consensus       414 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl  493 (571)
                      +..++||||+++ +|...+..  ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+
T Consensus        97 ~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~  170 (351)
T 3mi9_A           97 GSIYLVFDFCEH-DLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL  170 (351)
T ss_dssp             CEEEEEEECCSE-EHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             ceEEEEEeccCC-CHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchh
Confidence            467999999986 56555533  3346899999999999999999999987   99999999999999999999999999


Q ss_pred             ccccCCCCC--ccccccccccCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          494 ARIFGVDQT--QGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       494 a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ++.+.....  ........||+.|+|||.+.+ ..++.++||||||+++|||+||+.||..
T Consensus       171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  231 (351)
T 3mi9_A          171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG  231 (351)
T ss_dssp             CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCC
Confidence            987643221  122334578999999999876 4589999999999999999999999864

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.5e-35  Score=300.28  Aligned_cols=201  Identities=28%  Similarity=0.399  Sum_probs=165.8

Q ss_pred             HhCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccCcc-----CHHHHHHHHHHHhhcCCCceeccceeEEeCCee
Q 008292          343 ATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQ-----GAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEK  416 (571)
Q Consensus       343 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-----~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  416 (571)
                      ..++|++.+.||+|+||.||+++.. +|+.||||++......     ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI   87 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence            3578999999999999999999975 5889999998753221     124678999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccc
Q 008292          417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI  496 (571)
Q Consensus       417 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  496 (571)
                      ++||||+++ +|..++..  ....+++..+..++.|+++||.|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        88 ~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (346)
T 1ua2_A           88 SLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKS  161 (346)
T ss_dssp             EEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred             EEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEeccccee
Confidence            999999986 78777743  3346889999999999999999999987   99999999999999999999999999987


Q ss_pred             cCCCCCccccccccccCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          497 FGVDQTQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      +....  .......||+.|+|||.+.+. .++.++||||||+++|||++|..|+..
T Consensus       162 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~  215 (346)
T 1ua2_A          162 FGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPG  215 (346)
T ss_dssp             TTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence            64322  223345789999999998764 589999999999999999999988753

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1e-34  Score=295.41  Aligned_cols=191  Identities=23%  Similarity=0.393  Sum_probs=168.6

Q ss_pred             CCCCccccccccCceeEEEEEc-cCCCeeEEEeecccCccCHHHHHHHHHHHhhcC-CCceeccceeEEe--CCeeEEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ-HRNLVRLLGFCLE--GEEKILVY  420 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~--~~~~~lv~  420 (571)
                      ++|++.++||+|+||+||+++. .+++.||||+++.   ...+.+.+|+.++++++ ||||+++++++.+  ....++||
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~  112 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  112 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence            5788999999999999999985 5788999999864   33578899999999997 9999999999987  56789999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCC-ceEEeeccCccccCC
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM-NPKISDFGMARIFGV  499 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGla~~~~~  499 (571)
                      ||+++++|.+++.      .+++..+..++.||++||.|||+++   |+||||||+|||++.++ .+||+|||+++.+..
T Consensus       113 e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~  183 (330)
T 3nsz_A          113 EHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  183 (330)
T ss_dssp             ECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             eccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence            9999999999883      3889999999999999999999987   99999999999999776 899999999987643


Q ss_pred             CCCccccccccccCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          500 DQTQGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       500 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      ...   .....|++.|+|||.+.+ ..++.++||||||+++|||++|+.||.
T Consensus       184 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~  232 (330)
T 3nsz_A          184 GQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF  232 (330)
T ss_dssp             TCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred             CCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcc
Confidence            322   233478999999999877 679999999999999999999999984

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.5e-35  Score=299.46  Aligned_cols=202  Identities=32%  Similarity=0.540  Sum_probs=166.8

Q ss_pred             hCCCCccccccccCceeEEEEEccC-----CCeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLPS-----GQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI  417 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~~-----g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  417 (571)
                      .++|...+.||+|+||+||+|....     +..||+|+++... ......+.+|+.++++++||||+++++++.+.+..+
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  122 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM  122 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence            4577888999999999999998643     2359999997543 334567889999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCcccc
Q 008292          418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF  497 (571)
Q Consensus       418 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  497 (571)
                      +||||+++++|.+++..  ....+++..++.++.||++||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus       123 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  197 (333)
T 1mqb_A          123 IITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL  197 (333)
T ss_dssp             EEEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             EEEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhh
Confidence            99999999999999853  3456899999999999999999999987   999999999999999999999999999876


Q ss_pred             CCCCCcc-ccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 008292          498 GVDQTQG-NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSN  550 (571)
Q Consensus       498 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~  550 (571)
                      ....... ......+++.|+|||.+.+..++.++||||||+++|||+| |+.||.
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~  252 (333)
T 1mqb_A          198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW  252 (333)
T ss_dssp             -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcc
Confidence            4332211 1223346788999999999999999999999999999999 999984

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.1e-35  Score=324.48  Aligned_cols=200  Identities=32%  Similarity=0.519  Sum_probs=166.7

Q ss_pred             CCCccc-cccccCceeEEEEEcc---CCCeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEE
Q 008292          346 KFSTDN-KLGEGGFGEVYKGVLP---SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY  420 (571)
Q Consensus       346 ~~~~~~-~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  420 (571)
                      ++.+.+ +||+|+||.||+|.+.   ++..||||+++... ....+++.+|+++|++++||||+++++++.. +..++||
T Consensus       336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~  414 (613)
T 2ozo_A          336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM  414 (613)
T ss_dssp             SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred             ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence            344444 7999999999999864   45679999998653 3467889999999999999999999999876 5689999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCC
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD  500 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  500 (571)
                      ||+++|+|.+++..  ....+++..++.++.||++||+|||+++   |+||||||+||||+.++.+||+|||+++.+...
T Consensus       415 E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~  489 (613)
T 2ozo_A          415 EMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGAD  489 (613)
T ss_dssp             ECCTTCBHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred             EeCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence            99999999999853  3456999999999999999999999987   999999999999999999999999999876433


Q ss_pred             CCcc-ccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          501 QTQG-NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       501 ~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                      .... ......+++.|+|||++.+..++.++||||||+++|||+| |+.||..
T Consensus       490 ~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~  542 (613)
T 2ozo_A          490 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK  542 (613)
T ss_dssp             ------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             CceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence            2211 1222345789999999999999999999999999999998 9999864

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.2e-35  Score=301.61  Aligned_cols=199  Identities=27%  Similarity=0.443  Sum_probs=163.4

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeecccCccC-HHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQG-AEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      ++|.+.++||+|+||+||+++.. +++.||+|+++...... ...+.+|+.++++++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            57889999999999999999965 68899999987543221 12455799999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT  502 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  502 (571)
                      ++ ++|.+++..  ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...... 
T Consensus        82 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-  154 (324)
T 3mtl_A           82 LD-KDLKQYLDD--CGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT-  154 (324)
T ss_dssp             CS-EEHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred             cc-cCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc-
Confidence            98 578777743  2446899999999999999999999987   9999999999999999999999999998653222 


Q ss_pred             ccccccccccCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          503 QGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       503 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                       .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus       155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~  203 (324)
T 3mtl_A          155 -KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPG  203 (324)
T ss_dssp             ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             -cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence             22233468999999999876 5689999999999999999999999864

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=3.8e-35  Score=296.82  Aligned_cols=205  Identities=27%  Similarity=0.368  Sum_probs=171.9

Q ss_pred             HhCCCCccccccccCceeEEEEEc-cCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEe----CCeeE
Q 008292          343 ATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE----GEEKI  417 (571)
Q Consensus       343 ~~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~----~~~~~  417 (571)
                      ..++|++.+.||+|+||.||+++. .+++.||||++........+.+.+|+++++.++||||+++++++..    ....+
T Consensus        27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  106 (317)
T 2buj_A           27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW  106 (317)
T ss_dssp             TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred             CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence            356899999999999999999996 5789999999977666667889999999999999999999999873    34678


Q ss_pred             EEEEecCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccc
Q 008292          418 LVYEFVPNKSLDYFLYDP-EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI  496 (571)
Q Consensus       418 lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  496 (571)
                      +||||+++++|.+++... .....+++..++.++.||++||.|||+++   |+||||||+|||++.++.+||+|||++..
T Consensus       107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~  183 (317)
T 2buj_A          107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQ  183 (317)
T ss_dssp             EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence            999999999999888531 13467899999999999999999999987   99999999999999999999999999876


Q ss_pred             cCCCCCcc-------ccccccccCCcccccccccCC---CCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          497 FGVDQTQG-------NTSRIVGTYGYMAPEYAMHGQ---FSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       497 ~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      ........       ......||+.|+|||.+....   ++.++||||||+++|||++|+.||+
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~  247 (317)
T 2buj_A          184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD  247 (317)
T ss_dssp             SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTH
T ss_pred             cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChh
Confidence            43211110       112345799999999987554   6899999999999999999999984

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=6.8e-35  Score=298.91  Aligned_cols=199  Identities=24%  Similarity=0.389  Sum_probs=174.6

Q ss_pred             hCCCCccccccccCceeEEEEEccCCCeeEEEeecccCccC-----------------HHHHHHHHHHHhhcCCCceecc
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQG-----------------AEEFKNEVVLVAKLQHRNLVRL  406 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~-----------------~~~~~~Ei~~l~~l~h~niv~l  406 (571)
                      .++|.+.+.||+|+||.||++.. +++.||+|++.......                 .+.+.+|+.++++++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            46899999999999999999999 89999999986532211                 1789999999999999999999


Q ss_pred             ceeEEeCCeeEEEEEecCCCChhhh------hcCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEEecCCCCCEE
Q 008292          407 LGFCLEGEEKILVYEFVPNKSLDYF------LYDPEKQGQLDWSRRYKIIGGIARGILYLHE-DSRLRIIHRDLKASNIL  479 (571)
Q Consensus       407 ~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlkp~NIl  479 (571)
                      ++++.+.+..++||||+++++|.++      +.. .....+++..++.++.|++.||.|||+ .+   |+||||||+||+
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil  184 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL  184 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence            9999999999999999999999998      522 225679999999999999999999998 76   999999999999


Q ss_pred             ECCCCceEEeeccCccccCCCCCccccccccccCCcccccccccC-CCCc-chhHHHHHHHHHHHHhCCCCCCC
Q 008292          480 LDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG-QFSV-KSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       480 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~-~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ++.++.+||+|||++......    ......|++.|+|||.+.+. .++. ++||||||+++|||++|+.||..
T Consensus       185 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  254 (348)
T 2pml_X          185 MDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSL  254 (348)
T ss_dssp             ECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             EcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCC
Confidence            999999999999999875432    23345789999999999877 6666 99999999999999999999864

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=8.5e-35  Score=295.81  Aligned_cols=209  Identities=27%  Similarity=0.396  Sum_probs=176.4

Q ss_pred             chHHHHHHhCCCCcc-ccccccCceeEEEEEcc-CCCeeEEEeeccc--CccCHHHHHHHHHHHhhcC-CCceeccceeE
Q 008292          336 DFETIEVATNKFSTD-NKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQ-HRNLVRLLGFC  410 (571)
Q Consensus       336 ~~~~~~~~~~~~~~~-~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~  410 (571)
                      .+...+...++|.+. ++||+|+||.||++... +++.||+|+++..  .......+.+|+.++..++ ||||+++++++
T Consensus        19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~   98 (327)
T 3lm5_A           19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY   98 (327)
T ss_dssp             CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred             HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence            344455566777777 89999999999999964 6899999998753  3445678999999999995 69999999999


Q ss_pred             EeCCeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECC---CCceE
Q 008292          411 LEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA---EMNPK  487 (571)
Q Consensus       411 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~k  487 (571)
                      .+.+..++||||+++|+|.+++.. .....+++..++.++.|++.||+|||+++   |+||||||+|||++.   ++.+|
T Consensus        99 ~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~k  174 (327)
T 3lm5_A           99 ENTSEIILILEYAAGGEIFSLCLP-ELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIK  174 (327)
T ss_dssp             ECSSEEEEEEECCTTEEGGGGGSS-CC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEE
T ss_pred             EeCCeEEEEEEecCCCcHHHHHHH-hcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEE
Confidence            999999999999999999998843 23457899999999999999999999987   999999999999988   78999


Q ss_pred             EeeccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          488 ISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       488 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      |+|||+++......   ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       175 L~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  235 (327)
T 3lm5_A          175 IVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVG  235 (327)
T ss_dssp             ECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             EeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            99999998764322   12345789999999999999999999999999999999999999853

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=3e-35  Score=299.05  Aligned_cols=206  Identities=33%  Similarity=0.519  Sum_probs=170.8

Q ss_pred             HhCCCCccccccccCceeEEEEEc------cCCCeeEEEeeccc-CccCHHHHHHHHHHHhhcCCCceeccceeEEeCCe
Q 008292          343 ATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSKA-SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEE  415 (571)
Q Consensus       343 ~~~~~~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~  415 (571)
                      ..++|++.+.||+|+||.||++++      .+++.||||++... ......++.+|+.++++++||||+++++++.+...
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP  107 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence            356899999999999999999984      25678999999754 33445678899999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECC---CCceEE
Q 008292          416 KILVYEFVPNKSLDYFLYDPE----KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA---EMNPKI  488 (571)
Q Consensus       416 ~~lv~e~~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kl  488 (571)
                      .++||||+++++|.+++....    ....+++..++.++.||+.||.|||+++   |+||||||+|||++.   +..+||
T Consensus       108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl  184 (327)
T 2yfx_A          108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI  184 (327)
T ss_dssp             CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEE
Confidence            999999999999999986432    1245899999999999999999999987   999999999999984   446999


Q ss_pred             eeccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          489 SDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       489 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                      +|||+++...............+++.|+|||.+.+..++.++||||||+++|||+| |+.||..
T Consensus       185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~  248 (327)
T 2yfx_A          185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS  248 (327)
T ss_dssp             CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence            99999986644333333344567899999999999999999999999999999999 8888753

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.3e-34  Score=291.21  Aligned_cols=203  Identities=26%  Similarity=0.366  Sum_probs=169.6

Q ss_pred             hCCCCccccccccCceeEEEEEc-cCCCeeEEEeecccC----ccCHHHHHHHHHHHhhcCCCceeccceeEE--eCCee
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS----GQGAEEFKNEVVLVAKLQHRNLVRLLGFCL--EGEEK  416 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~--~~~~~  416 (571)
                      .++|.+.+.||+|+||.||++.. .+++.||+|+++...    ....+.+.+|+.++++++||||+++++++.  +....
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            46899999999999999999996 468899999997532    334578899999999999999999999984  44578


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccc
Q 008292          417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI  496 (571)
Q Consensus       417 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  496 (571)
                      ++||||++++ |.+++.. .....+++..++.++.||++||.|||+++   |+||||||+||+++.++.+||+|||++..
T Consensus        84 ~lv~e~~~~~-l~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~  158 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDS-VPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA  158 (305)
T ss_dssp             EEEEECCSEE-HHHHHHH-STTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEehhccCC-HHHHHHh-CcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence            9999999987 6555533 23457899999999999999999999987   99999999999999999999999999987


Q ss_pred             cCCCCCccccccccccCCcccccccccCC--CCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          497 FGVDQTQGNTSRIVGTYGYMAPEYAMHGQ--FSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ..............|++.|+|||.+.+..  ++.++||||||+++|||++|+.||..
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  215 (305)
T 2wtk_C          159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG  215 (305)
T ss_dssp             CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCC
Confidence            65433333334456899999999987644  47899999999999999999999864

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=8.3e-35  Score=300.42  Aligned_cols=200  Identities=24%  Similarity=0.405  Sum_probs=170.4

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeEEeC-----Cee
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG-----EEK  416 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-----~~~  416 (571)
                      .++|++.+.||+|+||.||++... +++.||||++.... ....+.+.+|++++.+++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            358999999999999999999854 67889999997543 33346788999999999999999999998765     357


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccc
Q 008292          417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI  496 (571)
Q Consensus       417 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  496 (571)
                      ++||||++ ++|.+++.    ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus       106 ~iv~e~~~-~~L~~~l~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~  177 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLK----TQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV  177 (364)
T ss_dssp             EEEEECCS-EEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEcccC-cCHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence            99999997 58888883    346899999999999999999999987   99999999999999999999999999987


Q ss_pred             cCCCCCcc-ccccccccCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          497 FGVDQTQG-NTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       497 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ........ ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||..
T Consensus       178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  234 (364)
T 3qyz_A          178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG  234 (364)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCC
Confidence            64332211 2234579999999998754 4589999999999999999999999864

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-35  Score=304.89  Aligned_cols=200  Identities=30%  Similarity=0.476  Sum_probs=158.7

Q ss_pred             CCCccccccccCceeEEEEEcc--CC--CeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeEEe-CCeeEEE
Q 008292          346 KFSTDNKLGEGGFGEVYKGVLP--SG--QEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE-GEEKILV  419 (571)
Q Consensus       346 ~~~~~~~LG~G~fg~Vy~~~~~--~g--~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~-~~~~~lv  419 (571)
                      .|...+.||+|+||+||+|++.  ++  ..||+|.++... ....+++.+|+.++++++||||+++++++.+ .+..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            4566789999999999999863  22  358999886533 3446789999999999999999999998765 4578999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCC
Q 008292          420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV  499 (571)
Q Consensus       420 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  499 (571)
                      |||+++|+|.+++..  ....+++..++.++.||++||.|||+++   |+||||||+|||++.++.+||+|||+++.+..
T Consensus       170 ~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~  244 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD  244 (373)
T ss_dssp             EECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccc
Confidence            999999999999953  3456889999999999999999999987   99999999999999999999999999986643


Q ss_pred             CCCc--cccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 008292          500 DQTQ--GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSN  550 (571)
Q Consensus       500 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~  550 (571)
                      ....  .......+|+.|+|||.+.+..++.++||||||+++|||+| |..||.
T Consensus       245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~  298 (373)
T 3c1x_A          245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP  298 (373)
T ss_dssp             -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCT
T ss_pred             cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCC
Confidence            2211  12233457889999999999999999999999999999999 566664

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.9e-35  Score=299.91  Aligned_cols=207  Identities=27%  Similarity=0.340  Sum_probs=159.6

Q ss_pred             HhCCCCccccccccCceeEEEEEc-cCCCeeEEEeecccCccCHHHHHHHHHHHhhcC-CCceeccceeEEe--------
Q 008292          343 ATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ-HRNLVRLLGFCLE--------  412 (571)
Q Consensus       343 ~~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~--------  412 (571)
                      ...+|++.++||+|+||.||+++. .+++.||||++........+.+.+|+.++.++. ||||+++++++..        
T Consensus        26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~  105 (337)
T 3ll6_A           26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG  105 (337)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred             cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence            345789999999999999999995 478899999997766666778899999999996 9999999999853        


Q ss_pred             CCeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeecc
Q 008292          413 GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG  492 (571)
Q Consensus       413 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG  492 (571)
                      ....++||||+. |+|.+++........+++..++.++.||+.||.|||+++ ++|+||||||+|||++.++.+||+|||
T Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg  183 (337)
T 3ll6_A          106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFG  183 (337)
T ss_dssp             SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred             CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCc
Confidence            334789999996 788887754334567999999999999999999999864 349999999999999999999999999


Q ss_pred             CccccCCCCCcc----------ccccccccCCccccccc---ccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          493 MARIFGVDQTQG----------NTSRIVGTYGYMAPEYA---MHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       493 la~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      +++.........          ......||+.|+|||.+   .+..++.++||||||+++|||+||+.||..
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~  255 (337)
T 3ll6_A          184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED  255 (337)
T ss_dssp             TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred             cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence            998764322211          11234689999999998   567789999999999999999999999853

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=5.2e-35  Score=294.87  Aligned_cols=201  Identities=24%  Similarity=0.442  Sum_probs=164.0

Q ss_pred             CCCCccccccccCceeEEEEEc-cCCCeeEEEeecccC---ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY  420 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  420 (571)
                      ++|++.+.||+|+||.||++.. .+|+.||+|+++...   ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  111 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL  111 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence            4688899999999999999995 578999999987532   334567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCC
Q 008292          421 EFVPNKSLDYFLYDP-EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV  499 (571)
Q Consensus       421 e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  499 (571)
                      ||+++++|.+++... .....+++..++.++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||+++....
T Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~  188 (310)
T 2wqm_A          112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  188 (310)
T ss_dssp             ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred             ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence            999999999988431 12456899999999999999999999987   99999999999999999999999999986543


Q ss_pred             CCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          500 DQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      ...  ......|++.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus       189 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~  237 (310)
T 2wqm_A          189 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY  237 (310)
T ss_dssp             ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred             CCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence            221  2233568999999999999999999999999999999999999985

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-34  Score=290.45  Aligned_cols=199  Identities=31%  Similarity=0.417  Sum_probs=168.7

Q ss_pred             CCCccccccccCceeEEEEEccC-C---CeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCee-EEE
Q 008292          346 KFSTDNKLGEGGFGEVYKGVLPS-G---QEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEK-ILV  419 (571)
Q Consensus       346 ~~~~~~~LG~G~fg~Vy~~~~~~-g---~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~-~lv  419 (571)
                      .|...++||+|+||+||+|.+.+ +   ..||+|++.... ....+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            45566899999999999998532 2   369999987543 34457889999999999999999999999877665 999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCC
Q 008292          420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV  499 (571)
Q Consensus       420 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  499 (571)
                      |||+.+++|.+++..  ....+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.+..
T Consensus       102 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  176 (298)
T 3pls_A          102 LPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD  176 (298)
T ss_dssp             ECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred             EecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence            999999999999954  3456899999999999999999999987   99999999999999999999999999986543


Q ss_pred             CCC--ccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCC
Q 008292          500 DQT--QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNS  549 (571)
Q Consensus       500 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~  549 (571)
                      ...  ........+++.|+|||.+.+..++.++||||||+++|||+||+.|+
T Consensus       177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~  228 (298)
T 3pls_A          177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP  228 (298)
T ss_dssp             GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCT
T ss_pred             CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCC
Confidence            221  12233456789999999999999999999999999999999976664

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=7.5e-35  Score=294.59  Aligned_cols=200  Identities=26%  Similarity=0.439  Sum_probs=164.9

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEE-----------
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCL-----------  411 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~-----------  411 (571)
                      .++|++.+.||+|+||.||++... +++.||+|++........+.+.+|++++++++||||+++++++.           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            468899999999999999999975 48899999998776666788999999999999999999998873           


Q ss_pred             ---eCCeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEEC-CCCceE
Q 008292          412 ---EGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD-AEMNPK  487 (571)
Q Consensus       412 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~k  487 (571)
                         +....++||||++ |+|.+++.    ...+++..++.++.|+++||+|||+++   |+||||||+|||++ +++.+|
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k  161 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK  161 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred             cccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence               3467799999998 68999883    356899999999999999999999987   99999999999997 567999


Q ss_pred             EeeccCccccCCCCC-ccccccccccCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          488 ISDFGMARIFGVDQT-QGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       488 l~DfGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      |+|||+++....... ........++..|+|||.+.+ ..++.++||||||+++|||+||+.||..
T Consensus       162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  227 (320)
T 2i6l_A          162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAG  227 (320)
T ss_dssp             ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCC
Confidence            999999987643221 112234467899999998865 6899999999999999999999999864

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.7e-34  Score=288.81  Aligned_cols=202  Identities=22%  Similarity=0.371  Sum_probs=172.0

Q ss_pred             hCCCCccccccccCceeEEEEEc-cCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeE-EeCCeeEEEEE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFC-LEGEEKILVYE  421 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~-~~~~~~~lv~e  421 (571)
                      .++|++.+.||+|+||.||+++. .+++.||||++......  +++.+|+.+++.++|++++..++.+ ..++..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            46899999999999999999995 57899999998654332  4688999999999998877776665 55677899999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEE---CCCCceEEeeccCccccC
Q 008292          422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMARIFG  498 (571)
Q Consensus       422 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfGla~~~~  498 (571)
                      |+ +++|.+++..  ....+++..++.++.|++.||.|||+++   |+||||||+|||+   +.++.+||+|||+++...
T Consensus        86 ~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~  159 (296)
T 3uzp_A           86 LL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             ec-CCCHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence            99 9999999852  2356999999999999999999999987   9999999999999   488899999999998765


Q ss_pred             CCCCcc-----ccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 008292          499 VDQTQG-----NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQ  553 (571)
Q Consensus       499 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~~~  553 (571)
                      ......     ......||+.|+|||.+.+..++.++||||||+++|||+||+.||....
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  219 (296)
T 3uzp_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK  219 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred             ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcC
Confidence            433211     1234579999999999999999999999999999999999999997543

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=3.6e-35  Score=289.60  Aligned_cols=198  Identities=25%  Similarity=0.351  Sum_probs=170.1

Q ss_pred             hCCCCccccccccCceeEEEEEccCCCeeEEEeecccC--ccCHHHHHHHHHHHhhcCCCceeccceeEEeC--CeeEEE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG--EEKILV  419 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~lv  419 (571)
                      .++|++.+.||+|+||.||+|+. +++.||||+++...  ....+.+.+|+.++++++||||+++++++.+.  ...++|
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI   87 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence            35788999999999999999998 48899999987543  34456799999999999999999999999887  678999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCC
Q 008292          420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV  499 (571)
Q Consensus       420 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  499 (571)
                      |||+++|+|.+++... ....+++..++.++.|+++||.|||+.+ .+|+||||||+||+++.++.++|.|||++.... 
T Consensus        88 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~-  164 (271)
T 3kmu_A           88 THWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ-  164 (271)
T ss_dssp             EECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS-
T ss_pred             ecccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec-
Confidence            9999999999999642 2336899999999999999999999864 359999999999999999999999999875422 


Q ss_pred             CCCccccccccccCCcccccccccCCCCc---chhHHHHHHHHHHHHhCCCCCCC
Q 008292          500 DQTQGNTSRIVGTYGYMAPEYAMHGQFSV---KSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~---~~Dv~slGvvl~elltG~~p~~~  551 (571)
                            .....||+.|+|||.+.+..++.   ++||||||+++|||+||+.||..
T Consensus       165 ------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  213 (271)
T 3kmu_A          165 ------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFAD  213 (271)
T ss_dssp             ------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTT
T ss_pred             ------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence                  12346789999999998765544   89999999999999999999853

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=6.8e-35  Score=290.18  Aligned_cols=197  Identities=25%  Similarity=0.339  Sum_probs=168.7

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC--ccCHHHHHHHHHHHhhc-CCCceeccceeEEeCCeeEEE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILV  419 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv  419 (571)
                      .++|++.+.||+|+||+||+++.. +++.||+|+++...  .....++.+|+..+..+ +||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            467899999999999999999975 78999999987643  33456788899999998 999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCC---------------
Q 008292          420 YEFVPNKSLDYFLYDPE-KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE---------------  483 (571)
Q Consensus       420 ~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~---------------  483 (571)
                      |||+++++|.+++.... ....+++..++.++.||++||.|||+++   |+||||||+|||++.+               
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~  166 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDW  166 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------------
T ss_pred             EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence            99999999999985321 1256899999999999999999999987   9999999999999844               


Q ss_pred             ----CceEEeeccCccccCCCCCccccccccccCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCC
Q 008292          484 ----MNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNS  549 (571)
Q Consensus       484 ----~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~slGvvl~elltG~~p~  549 (571)
                          ..+||+|||++.......      ...||+.|+|||.+.+. .++.++||||||+++|||++|+.++
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~  231 (289)
T 1x8b_A          167 ASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP  231 (289)
T ss_dssp             ---CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred             cCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCC
Confidence                479999999998754322      23589999999999766 6678999999999999999999865

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.4e-34  Score=289.47  Aligned_cols=203  Identities=22%  Similarity=0.369  Sum_probs=168.7

Q ss_pred             HhCCCCccccccccCceeEEEEEc-cCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeE-EeCCeeEEEE
Q 008292          343 ATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFC-LEGEEKILVY  420 (571)
Q Consensus       343 ~~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~-~~~~~~~lv~  420 (571)
                      ..++|++.+.||+|+||.||+++. .+++.||||++......  +.+.+|++++..++|++++..++.+ ..++..++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            357899999999999999999995 57889999987544322  3578899999999998887777666 5667789999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEE---CCCCceEEeeccCcccc
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMARIF  497 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfGla~~~  497 (571)
                      ||+ +++|.+++..  ....+++..++.++.||+.||.|||+++   |+||||||+|||+   +.++.+||+|||+++..
T Consensus        85 e~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~  158 (296)
T 4hgt_A           85 ELL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             ECC-CCBHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             Ecc-CCCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence            999 9999998852  2446999999999999999999999987   9999999999999   78899999999999876


Q ss_pred             CCCCCc-----cccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 008292          498 GVDQTQ-----GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQ  553 (571)
Q Consensus       498 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~~~  553 (571)
                      ......     .......||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  219 (296)
T 4hgt_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK  219 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred             cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccc
Confidence            543221     12234578999999999999999999999999999999999999997543

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.6e-35  Score=302.16  Aligned_cols=198  Identities=31%  Similarity=0.485  Sum_probs=159.2

Q ss_pred             hCCCCccccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHH--HHHHhhcCCCceeccceeEEe-----CCee
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNE--VVLVAKLQHRNLVRLLGFCLE-----GEEK  416 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E--i~~l~~l~h~niv~l~~~~~~-----~~~~  416 (571)
                      .++|++.++||+|+||.||+|+. +++.||||+++...   ...+..|  +..+..++||||+++++.+..     ....
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            46889999999999999999987 78999999986543   2334444  444556899999999986543     2356


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC------CCCeEEecCCCCCEEECCCCceEEee
Q 008292          417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS------RLRIIHRDLKASNILLDAEMNPKISD  490 (571)
Q Consensus       417 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------~~~ivH~Dlkp~NIll~~~~~~kl~D  490 (571)
                      ++||||+++|+|.+++.    ....++..++.++.||++||.|||+..      .++|+||||||+|||++.++.+||+|
T Consensus        88 ~lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D  163 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLS----LHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD  163 (336)
T ss_dssp             EEEECCCTTCBHHHHHH----HCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred             EEEEecCCCCcHHHHHh----hcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence            89999999999999994    334589999999999999999999880      11399999999999999999999999


Q ss_pred             ccCccccCCCCC------ccccccccccCCccccccccc-------CCCCcchhHHHHHHHHHHHHhCCCCC
Q 008292          491 FGMARIFGVDQT------QGNTSRIVGTYGYMAPEYAMH-------GQFSVKSDVYSFGVLVLEIITGKKNS  549 (571)
Q Consensus       491 fGla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~s~~~Dv~slGvvl~elltG~~p~  549 (571)
                      ||+++.+.....      ........||+.|+|||.+.+       ..++.++||||||+++|||+||..|+
T Consensus       164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~  235 (336)
T 3g2f_A          164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL  235 (336)
T ss_dssp             CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGG
T ss_pred             ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcC
Confidence            999987643321      112234579999999999876       45678999999999999999997775

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=3.2e-35  Score=292.20  Aligned_cols=196  Identities=29%  Similarity=0.480  Sum_probs=171.1

Q ss_pred             HhCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEe---------
Q 008292          343 ATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE---------  412 (571)
Q Consensus       343 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~---------  412 (571)
                      ..++|++.+.||+|+||.||+++.. +++.||+|+++...    +.+.+|++++++++||||+++++++..         
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            4567899999999999999999975 78999999997543    356789999999999999999998864         


Q ss_pred             -------CCeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCc
Q 008292          413 -------GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN  485 (571)
Q Consensus       413 -------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~  485 (571)
                             ....++||||+++++|.+++... ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~  160 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ  160 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence                   34579999999999999998532 2357899999999999999999999987   999999999999999999


Q ss_pred             eEEeeccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCC
Q 008292          486 PKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNS  549 (571)
Q Consensus       486 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~  549 (571)
                      +||+|||++.......   ......|++.|+|||.+.+..++.++||||||+++|||++|..|+
T Consensus       161 ~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~  221 (284)
T 2a19_B          161 VKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA  221 (284)
T ss_dssp             EEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSH
T ss_pred             EEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcc
Confidence            9999999998764332   223346899999999999999999999999999999999999875

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=3.8e-35  Score=302.97  Aligned_cols=195  Identities=29%  Similarity=0.447  Sum_probs=153.8

Q ss_pred             hCCCCccccccccCceeEEEEEc-cCCCeeEEEeeccc--CccCHHHHHHHHHHHhhcCCCceeccceeEEeC------C
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG------E  414 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~------~  414 (571)
                      .++|++.+.||+|+||.||++.. .+|+.||||++...  .....+.+.+|+.+++.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            36899999999999999999985 56889999998653  233456788999999999999999999998754      4


Q ss_pred             eeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCc
Q 008292          415 EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA  494 (571)
Q Consensus       415 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla  494 (571)
                      ..++|+|++ +++|.+++.    ...+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       108 ~~~lv~e~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a  179 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA  179 (367)
T ss_dssp             CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred             eEEEEeccc-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence            579999999 788988873    356999999999999999999999987   999999999999999999999999999


Q ss_pred             cccCCCCCccccccccccCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          495 RIFGVDQTQGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      +.....     .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus       180 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  232 (367)
T 2fst_X          180 RHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG  232 (367)
T ss_dssp             ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            865322     234578999999999877 6899999999999999999999999864

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.6e-34  Score=289.55  Aligned_cols=199  Identities=27%  Similarity=0.395  Sum_probs=173.3

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC---------ccCHHHHHHHHHHHhhcC-CCceeccceeEEe
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---------GQGAEEFKNEVVLVAKLQ-HRNLVRLLGFCLE  412 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---------~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~  412 (571)
                      .++|++.+.||+|+||.||++... +++.||||+++...         ....+.+.+|+.++++++ ||||+++++++..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            468999999999999999999964 68899999986543         122456789999999996 9999999999999


Q ss_pred             CCeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeecc
Q 008292          413 GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG  492 (571)
Q Consensus       413 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG  492 (571)
                      ....++||||+++++|.+++.   ....+++..++.++.||+.||.|||+++   |+||||||+||+++.++.+||+|||
T Consensus        96 ~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg  169 (298)
T 1phk_A           96 NTFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG  169 (298)
T ss_dssp             SSEEEEEEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred             CCeEEEEEeccCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEeccc
Confidence            999999999999999999984   3457899999999999999999999987   9999999999999999999999999


Q ss_pred             CccccCCCCCccccccccccCCcccccccc------cCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          493 MARIFGVDQTQGNTSRIVGTYGYMAPEYAM------HGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       493 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ++..+....   ......|++.|+|||.+.      ...++.++||||||+++|||++|+.||..
T Consensus       170 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~  231 (298)
T 1phk_A          170 FSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH  231 (298)
T ss_dssp             TCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             chhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcC
Confidence            998764332   223456899999999885      45789999999999999999999999853

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.6e-34  Score=288.37  Aligned_cols=199  Identities=29%  Similarity=0.430  Sum_probs=169.1

Q ss_pred             hCCCCccccccccCceeEEEEEc-cCCCeeEEEeeccc--CccCHHHHHHHHHHHhhcCCCceeccceeEEe----CCee
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE----GEEK  416 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~----~~~~  416 (571)
                      .+.|++.+.||+|+||+||+|.. .++..|++|++...  .....+.+.+|+.++++++||||+++++++..    ....
T Consensus        25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  104 (290)
T 1t4h_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI  104 (290)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred             ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence            34577888999999999999986 45778999998653  33445778999999999999999999999875    3457


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEEC-CCCceEEeeccCcc
Q 008292          417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD-AEMNPKISDFGMAR  495 (571)
Q Consensus       417 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DfGla~  495 (571)
                      ++||||+++++|.+++.   ....+++..++.++.||+.||.|||+.+ .+|+||||||+|||++ .++.+||+|||++.
T Consensus       105 ~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~  180 (290)
T 1t4h_A          105 VLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EEEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EEEEEecCCCCHHHHHH---HccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence            99999999999999984   3356899999999999999999999874 3599999999999997 78999999999997


Q ss_pred             ccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          496 IFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .....    ......|++.|+|||.+. +.++.++||||||+++|||++|+.||..
T Consensus       181 ~~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~  231 (290)
T 1t4h_A          181 LKRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSE  231 (290)
T ss_dssp             GCCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             ccccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCC
Confidence            54322    223456899999999776 5699999999999999999999999864

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=2.7e-35  Score=294.28  Aligned_cols=201  Identities=31%  Similarity=0.485  Sum_probs=168.6

Q ss_pred             hCCCCccc-cccccCceeEEEEEc---cCCCeeEEEeecccCc--cCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeE
Q 008292          344 TNKFSTDN-KLGEGGFGEVYKGVL---PSGQEIAVKRLSKASG--QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI  417 (571)
Q Consensus       344 ~~~~~~~~-~LG~G~fg~Vy~~~~---~~g~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  417 (571)
                      .++|.+.+ .||+|+||+||++.+   ..++.||||+++....  ...+++.+|+.+++.++||||+++++++ ..+..+
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~   93 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM   93 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence            45677777 999999999999964   3467899999976432  3357899999999999999999999998 667789


Q ss_pred             EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCcccc
Q 008292          418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF  497 (571)
Q Consensus       418 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  497 (571)
                      +||||+++++|.+++..   ...+++..++.++.|+++||.|||+++   |+||||||+||+++.++.+||+|||+++..
T Consensus        94 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  167 (291)
T 1xbb_A           94 LVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKAL  167 (291)
T ss_dssp             EEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence            99999999999999853   456899999999999999999999987   999999999999999999999999999876


Q ss_pred             CCCCCcc-ccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          498 GVDQTQG-NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       498 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                      ....... ......+++.|+|||.+.+..++.++||||||+++|||+| |+.||..
T Consensus       168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~  223 (291)
T 1xbb_A          168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG  223 (291)
T ss_dssp             CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred             ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCC
Confidence            4433221 1222346788999999998899999999999999999999 9999864

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=3.5e-35  Score=306.34  Aligned_cols=198  Identities=24%  Similarity=0.371  Sum_probs=164.7

Q ss_pred             hCCCCccccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCe------eE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEE------KI  417 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------~~  417 (571)
                      ..+|+..+.||+|+||+||+++...+..||+|++......    ..+|+.+++.++||||+++++++.....      .+
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            3568899999999999999999877777999988643322    2369999999999999999999965443      78


Q ss_pred             EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEEC-CCCceEEeeccCccc
Q 008292          418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD-AEMNPKISDFGMARI  496 (571)
Q Consensus       418 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DfGla~~  496 (571)
                      +||||++++.+............+++..+..++.||++||+|||+++   |+||||||+||||+ .++.+||+|||+++.
T Consensus       115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~  191 (394)
T 4e7w_A          115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI  191 (394)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence            99999988765544422223567899999999999999999999987   99999999999998 789999999999987


Q ss_pred             cCCCCCccccccccccCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          497 FGVDQTQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      +.....   .....||+.|+|||.+.+. .++.++||||||+++|||++|+.||..
T Consensus       192 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~  244 (394)
T 4e7w_A          192 LIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPG  244 (394)
T ss_dssp             CCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            643322   2234689999999998765 589999999999999999999999864

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=8e-35  Score=295.26  Aligned_cols=200  Identities=26%  Similarity=0.407  Sum_probs=167.4

Q ss_pred             HhCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC--------ccCHHHHHHHHHHHhhcCCCceeccceeEEeC
Q 008292          343 ATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS--------GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG  413 (571)
Q Consensus       343 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--------~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~  413 (571)
                      ..++|.+.+.||+|+||.||++... +++.||||++....        ......+.+|+.++++++||||+++++++...
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            3467999999999999999999964 57899999986532        12234588999999999999999999998665


Q ss_pred             CeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCc---eEEee
Q 008292          414 EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN---PKISD  490 (571)
Q Consensus       414 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~D  490 (571)
                      . .++||||+++++|.+++.   ....+++..++.++.||++||.|||+++   |+||||||+|||++.++.   +||+|
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~D  160 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD  160 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHS---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECC
T ss_pred             c-eEEEEecCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEcc
Confidence            4 899999999999999884   3457899999999999999999999987   999999999999987664   99999


Q ss_pred             ccCccccCCCCCccccccccccCCcccccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 008292          491 FGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM---HGQFSVKSDVYSFGVLVLEIITGKKNSNFY  552 (571)
Q Consensus       491 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~Dv~slGvvl~elltG~~p~~~~  552 (571)
                      ||+++......   ......||+.|+|||.+.   ...++.++||||||+++|||++|+.||...
T Consensus       161 fg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  222 (322)
T 2ycf_A          161 FGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH  222 (322)
T ss_dssp             CTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCST
T ss_pred             Cccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence            99998754221   123456899999999874   567899999999999999999999998643

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=3.1e-35  Score=292.22  Aligned_cols=202  Identities=30%  Similarity=0.456  Sum_probs=169.2

Q ss_pred             HhCCCCccccccccCceeEEEEEccC----CCeeEEEeeccc-CccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeE
Q 008292          343 ATNKFSTDNKLGEGGFGEVYKGVLPS----GQEIAVKRLSKA-SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI  417 (571)
Q Consensus       343 ~~~~~~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  417 (571)
                      ..++|.+.+.||+|+||+||++...+    +..||+|.+... .....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~   88 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW   88 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence            35678899999999999999998543    235999998765 33446788999999999999999999999764 4568


Q ss_pred             EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCcccc
Q 008292          418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF  497 (571)
Q Consensus       418 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  497 (571)
                      +||||+++++|.+++..  ....+++..++.++.|+++||.|||+++   |+||||||+||+++.++.+||+|||+++..
T Consensus        89 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  163 (281)
T 3cc6_A           89 IIMELYPYGELGHYLER--NKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI  163 (281)
T ss_dssp             EEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred             EEEecCCCCCHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence            99999999999999853  3356899999999999999999999987   999999999999999999999999999866


Q ss_pred             CCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          498 GVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                      ...... ......+++.|+|||.+.+..++.++||||||+++|||+| |+.||..
T Consensus       164 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~  217 (281)
T 3cc6_A          164 EDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFW  217 (281)
T ss_dssp             ----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             cccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCccc
Confidence            432221 2233456889999999999999999999999999999999 9999853

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=4.3e-35  Score=314.24  Aligned_cols=198  Identities=32%  Similarity=0.472  Sum_probs=174.6

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC---ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV  419 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  419 (571)
                      .++|++.+.||+|+||.||+++.. +++.||||++....   ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            457899999999999999999965 78999999986532   44577899999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEE---CCCCceEEeeccCccc
Q 008292          420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMARI  496 (571)
Q Consensus       420 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfGla~~  496 (571)
                      |||+.+|+|.+.+.   ....+++..+..++.||+.||.|||+++   |+||||||+|||+   +.++.+||+|||+++.
T Consensus       105 ~e~~~~~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  178 (484)
T 3nyv_A          105 GEVYTGGELFDEII---SRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH  178 (484)
T ss_dssp             ECCCCSCBHHHHHH---TCSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred             EecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence            99999999988884   3456899999999999999999999987   9999999999999   5678999999999987


Q ss_pred             cCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          497 FGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      +....   ......||+.|+|||++.+ .++.++||||||+++|||++|+.||..
T Consensus       179 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~  229 (484)
T 3nyv_A          179 FEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNG  229 (484)
T ss_dssp             BCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCC
Confidence            64332   2234579999999998865 799999999999999999999999864

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=3.4e-35  Score=294.93  Aligned_cols=201  Identities=26%  Similarity=0.434  Sum_probs=170.4

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      .++|++.+.||+|+||.||+++.. +++.|++|++........+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   97 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF   97 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence            467899999999999999999975 5889999999877777788999999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT  502 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  502 (571)
                      +++++|..++..  ....+++..++.++.||++||.|||+.+   |+||||||+||+++.++.+||+|||++....... 
T Consensus        98 ~~~~~l~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  171 (302)
T 2j7t_A           98 CPGGAVDAIMLE--LDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-  171 (302)
T ss_dssp             CTTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-
T ss_pred             CCCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccc-
Confidence            999999988743  2456899999999999999999999987   9999999999999999999999999976432111 


Q ss_pred             ccccccccccCCccccccc-----ccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          503 QGNTSRIVGTYGYMAPEYA-----MHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       503 ~~~~~~~~gt~~y~aPE~~-----~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                       .......|++.|+|||.+     .+..++.++||||||+++|||++|+.|+..
T Consensus       172 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  224 (302)
T 2j7t_A          172 -QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE  224 (302)
T ss_dssp             -HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             -cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCcc
Confidence             112234689999999988     367789999999999999999999999864

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=2e-35  Score=296.47  Aligned_cols=209  Identities=26%  Similarity=0.425  Sum_probs=158.5

Q ss_pred             HHHHhCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeE
Q 008292          340 IEVATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI  417 (571)
Q Consensus       340 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  417 (571)
                      +.+..++|++.+.||+|+||.||++... +++.||||++.... ....+++.+|+.++.+++||||+++++++...+..+
T Consensus        10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   89 (303)
T 2vwi_A           10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW   89 (303)
T ss_dssp             ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred             cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence            3455688999999999999999999964 68899999986543 344567889999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhcC-----CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeecc
Q 008292          418 LVYEFVPNKSLDYFLYD-----PEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG  492 (571)
Q Consensus       418 lv~e~~~~g~L~~~l~~-----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG  492 (571)
                      +||||+++++|.+++..     ......+++..++.++.||++||.|||+++   |+||||||+||+++.++.+||+|||
T Consensus        90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg  166 (303)
T 2vwi_A           90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFG  166 (303)
T ss_dssp             EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCH
T ss_pred             EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEecc
Confidence            99999999999998842     123456899999999999999999999987   9999999999999999999999999


Q ss_pred             CccccCCCCC---ccccccccccCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          493 MARIFGVDQT---QGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       493 la~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ++..+.....   ........||+.|+|||.+.+ ..++.++||||||+++|||+||+.||..
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  229 (303)
T 2vwi_A          167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHK  229 (303)
T ss_dssp             HHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             chheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence            9986543211   112234578999999999875 5789999999999999999999999864

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=7.7e-35  Score=312.93  Aligned_cols=198  Identities=29%  Similarity=0.441  Sum_probs=168.3

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC--ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY  420 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  420 (571)
                      .++|++.++||+|+||+||+++.. ++..||+|++....  ......+.+|+.+++.++||||+++++++.+....++||
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            356889999999999999999965 68899999987543  344578899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCC---CceEEeeccCcccc
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE---MNPKISDFGMARIF  497 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DfGla~~~  497 (571)
                      ||+++|+|.+.+.   ....+++..+..++.||+.||.|||+++   |+||||||+|||++.+   +.+||+|||+++.+
T Consensus       116 e~~~~g~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~  189 (494)
T 3lij_A          116 ECYKGGELFDEII---HRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF  189 (494)
T ss_dssp             ECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             ecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence            9999999988774   3456899999999999999999999987   9999999999999764   45999999999876


Q ss_pred             CCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          498 GVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ....   ......||+.|+|||++. +.++.++||||||+++|||++|+.||..
T Consensus       190 ~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~  239 (494)
T 3lij_A          190 ENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGG  239 (494)
T ss_dssp             BTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCC
Confidence            4332   223457999999999875 5799999999999999999999999853

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.4e-34  Score=292.26  Aligned_cols=201  Identities=28%  Similarity=0.454  Sum_probs=171.4

Q ss_pred             HHhCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEE
Q 008292          342 VATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY  420 (571)
Q Consensus       342 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  420 (571)
                      ...++|++.+.||+|+||.||++... +|+.||+|++....  ..+.+.+|+.++..++||||+++++++...+..++||
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  103 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM  103 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence            34578999999999999999999965 58999999987543  3467899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCC
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD  500 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  500 (571)
                      ||+++++|.+++..  ....+++..++.++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||++......
T Consensus       104 e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (314)
T 3com_A          104 EYCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT  178 (314)
T ss_dssp             ECCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred             ecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence            99999999998842  3457899999999999999999999987   999999999999999999999999999866432


Q ss_pred             CCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ..  ......|++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       179 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  227 (314)
T 3com_A          179 MA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYAD  227 (314)
T ss_dssp             BS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             cc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence            21  22345689999999999999999999999999999999999999864

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=9.1e-35  Score=295.54  Aligned_cols=201  Identities=32%  Similarity=0.483  Sum_probs=168.8

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCe--eEEEeeccc-CccCHHHHHHHHHHHhhc-CCCceeccceeEEeCCeeEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQE--IAVKRLSKA-SGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILV  419 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~--vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv  419 (571)
                      ++|++.+.||+|+||.||+++.. ++..  +++|+++.. .....+.+.+|++++.++ +||||+++++++.+.+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            57889999999999999999964 4554  489988653 334456789999999999 899999999999999999999


Q ss_pred             EEecCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCce
Q 008292          420 YEFVPNKSLDYFLYDPE-------------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP  486 (571)
Q Consensus       420 ~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~  486 (571)
                      |||+++++|.+++....             ....+++..++.++.||++||.|||+++   |+||||||+|||++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence            99999999999996432             2347899999999999999999999987   9999999999999999999


Q ss_pred             EEeeccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          487 KISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       487 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                      ||+|||+++.....   .......+++.|+|||.+.+..++.++||||||+++|||+| |+.||..
T Consensus       182 kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~  244 (327)
T 1fvr_A          182 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG  244 (327)
T ss_dssp             EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             EEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCC
Confidence            99999998743211   12223456889999999998899999999999999999998 9999853

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=3.5e-35  Score=291.40  Aligned_cols=207  Identities=26%  Similarity=0.403  Sum_probs=171.6

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC--ccCHHHHHHHHHHHhhcCCCceeccceeEEe--CCeeEE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE--GEEKIL  418 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~~~~~l  418 (571)
                      .++|++.+.||+|+||.||++... +++.|++|++....  ....+.+.+|+.++++++||||+++++++.+  ....++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            357889999999999999999964 68899999987543  3445678999999999999999999998864  567899


Q ss_pred             EEEecCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHcCC--CCCeEEecCCCCCEEECCCCceEEeeccCcc
Q 008292          419 VYEFVPNKSLDYFLYDPE-KQGQLDWSRRYKIIGGIARGILYLHEDS--RLRIIHRDLKASNILLDAEMNPKISDFGMAR  495 (571)
Q Consensus       419 v~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  495 (571)
                      ||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+  ..+|+||||||+||+++.++.+||+|||+++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~  164 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  164 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence            999999999999985322 2345899999999999999999999865  1349999999999999999999999999998


Q ss_pred             ccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 008292          496 IFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFY  552 (571)
Q Consensus       496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~~  552 (571)
                      .......  ......|++.|+|||.+.+..++.++||||||+++|||+||+.||...
T Consensus       165 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  219 (279)
T 2w5a_A          165 ILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF  219 (279)
T ss_dssp             HC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             eeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCccc
Confidence            7543221  122356899999999999999999999999999999999999998643

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.5e-34  Score=311.54  Aligned_cols=198  Identities=32%  Similarity=0.458  Sum_probs=170.7

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC-------------ccCHHHHHHHHHHHhhcCCCceecccee
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS-------------GQGAEEFKNEVVLVAKLQHRNLVRLLGF  409 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-------------~~~~~~~~~Ei~~l~~l~h~niv~l~~~  409 (571)
                      .++|.+.++||+|+||+||+++.. +++.||+|++....             ....+.+.+|+.++++++||||++++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            467999999999999999999964 57889999986532             1345788999999999999999999999


Q ss_pred             EEeCCeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCC---ce
Q 008292          410 CLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM---NP  486 (571)
Q Consensus       410 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~  486 (571)
                      +.+....++||||+++|+|.+.+.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++   .+
T Consensus       115 ~~~~~~~~lv~e~~~gg~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~  188 (504)
T 3q5i_A          115 FEDKKYFYLVTEFYEGGELFEQII---NRHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNI  188 (504)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSE
T ss_pred             EEcCCEEEEEEecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccE
Confidence            999999999999999999988884   3456999999999999999999999987   99999999999998776   69


Q ss_pred             EEeeccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          487 KISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       487 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ||+|||+++.+....   ......||+.|+|||++. +.++.++||||||+++|||++|+.||..
T Consensus       189 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~  249 (504)
T 3q5i_A          189 KIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGG  249 (504)
T ss_dssp             EECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             EEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCC
Confidence            999999998764332   223457999999999876 5799999999999999999999999864

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-34  Score=294.49  Aligned_cols=200  Identities=27%  Similarity=0.413  Sum_probs=162.6

Q ss_pred             HHHHHHhCCCCccccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhh--cCCCceeccceeEEeC--
Q 008292          338 ETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAK--LQHRNLVRLLGFCLEG--  413 (571)
Q Consensus       338 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~--l~h~niv~l~~~~~~~--  413 (571)
                      .......++|++.++||+|+||.||+++.. ++.||||++....   ...+..|.+++..  ++||||+++++++...  
T Consensus        30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~  105 (337)
T 3mdy_A           30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTG  105 (337)
T ss_dssp             HHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred             ccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence            334455678999999999999999999984 8999999986432   2344455555544  4999999999999887  


Q ss_pred             --CeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-----CCCeEEecCCCCCEEECCCCce
Q 008292          414 --EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS-----RLRIIHRDLKASNILLDAEMNP  486 (571)
Q Consensus       414 --~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~ivH~Dlkp~NIll~~~~~~  486 (571)
                        ...++||||+++|+|.+++.    ...+++..++.++.|++.||.|||++.     +++|+||||||+|||++.++.+
T Consensus       106 ~~~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~  181 (337)
T 3mdy_A          106 SWTQLYLITDYHENGSLYDYLK----STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTC  181 (337)
T ss_dssp             GGCEEEEEECCCTTCBHHHHHH----HCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred             CCCceEEEEeccCCCcHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCE
Confidence              67899999999999999994    346899999999999999999999871     1239999999999999999999


Q ss_pred             EEeeccCccccCCCCCcc--ccccccccCCcccccccccCCCCcc------hhHHHHHHHHHHHHhC
Q 008292          487 KISDFGMARIFGVDQTQG--NTSRIVGTYGYMAPEYAMHGQFSVK------SDVYSFGVLVLEIITG  545 (571)
Q Consensus       487 kl~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~------~Dv~slGvvl~elltG  545 (571)
                      ||+|||+++.+.......  ......||+.|+|||.+.+...+.+      +||||||+++|||+||
T Consensus       182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg  248 (337)
T 3mdy_A          182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR  248 (337)
T ss_dssp             EECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhc
Confidence            999999998664332221  1224579999999999988776665      9999999999999999

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.1e-34  Score=290.79  Aligned_cols=200  Identities=29%  Similarity=0.453  Sum_probs=166.1

Q ss_pred             hCCCCccccccccCceeEEEEEccC----CCeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeEEe-CCeeE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLPS----GQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE-GEEKI  417 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~-~~~~~  417 (571)
                      ..+|++.+.||+|+||+||+|...+    ...|++|.+.... ....+.+.+|+.++++++||||+++++++.+ .+..+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            3467888999999999999998542    2358999887533 3445778999999999999999999998654 45779


Q ss_pred             EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCcccc
Q 008292          418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF  497 (571)
Q Consensus       418 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  497 (571)
                      +||||+++++|.+++..  ....+++..++.++.|+++||.|||+++   |+||||||+||+++.++.+||+|||+++.+
T Consensus       104 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~  178 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM  178 (298)
T ss_dssp             EEEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred             EEEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccc
Confidence            99999999999999954  3456899999999999999999999987   999999999999999999999999999866


Q ss_pred             CCCCCc--cccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCC
Q 008292          498 GVDQTQ--GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKN  548 (571)
Q Consensus       498 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p  548 (571)
                      ......  .......+|+.|+|||.+.+..++.++||||||+++|||++|..|
T Consensus       179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~  231 (298)
T 3f66_A          179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP  231 (298)
T ss_dssp             SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred             cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCC
Confidence            433211  122334678899999999999999999999999999999995544

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=8.2e-35  Score=301.22  Aligned_cols=196  Identities=29%  Similarity=0.388  Sum_probs=161.2

Q ss_pred             hCCCCccccccccCceeEEEEEc-cCCCeeEEEeeccc--CccCHHHHHHHHHHHhhcCCCceeccceeEEeCC------
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE------  414 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------  414 (571)
                      .++|++.+.||+|+||.||++.. .+++.||||++...  .....+.+.+|+.+++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            36899999999999999999985 46889999998753  2334567889999999999999999999997654      


Q ss_pred             eeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCc
Q 008292          415 EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA  494 (571)
Q Consensus       415 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla  494 (571)
                      ..++||||+++ +|.+.+.     ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  174 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  174 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred             ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence            67999999975 6777763     34899999999999999999999987   999999999999999999999999999


Q ss_pred             cccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          495 RIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      +......   ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       175 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  228 (371)
T 2xrw_A          175 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG  228 (371)
T ss_dssp             ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence            8654321   22345789999999999999999999999999999999999999864

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=7.8e-35  Score=312.30  Aligned_cols=198  Identities=31%  Similarity=0.465  Sum_probs=172.0

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CCCeeEEEeeccc--CccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY  420 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  420 (571)
                      .++|++.++||+|+||+||+++.. +++.||||++...  .......+.+|++++++++||||+++++++.+....++||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  100 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence            467999999999999999999964 6889999998653  2345678999999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEEC---CCCceEEeeccCcccc
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD---AEMNPKISDFGMARIF  497 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DfGla~~~  497 (571)
                      ||+++++|.+.+.   ....+++..+..++.||+.||.|||+++   |+||||||+|||++   .++.+||+|||+++.+
T Consensus       101 e~~~~~~L~~~~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  174 (486)
T 3mwu_A          101 ELYTGGELFDEII---KRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF  174 (486)
T ss_dssp             CCCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred             EcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence            9999999988874   3456899999999999999999999987   99999999999995   4567999999999866


Q ss_pred             CCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          498 GVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ....   ......||+.|+|||++.+ .++.++||||||+++|||++|+.||..
T Consensus       175 ~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~  224 (486)
T 3mwu_A          175 QQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYG  224 (486)
T ss_dssp             CCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            4332   2234579999999998875 599999999999999999999999853

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1e-34  Score=299.03  Aligned_cols=207  Identities=23%  Similarity=0.316  Sum_probs=159.7

Q ss_pred             HHHHHHhCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCe-
Q 008292          338 ETIEVATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEE-  415 (571)
Q Consensus       338 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~-  415 (571)
                      .......++|++.+.||+|+||.||+++.. +|+.||||++.... .....+.+|++.+..++||||+++++++..... 
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            445666789999999999999999999964 68899999886543 223455778888999999999999999976443 


Q ss_pred             ------eEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH--cCCCCCeEEecCCCCCEEECC-CCce
Q 008292          416 ------KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH--EDSRLRIIHRDLKASNILLDA-EMNP  486 (571)
Q Consensus       416 ------~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH--~~~~~~ivH~Dlkp~NIll~~-~~~~  486 (571)
                            .++||||++++.+..+.........+++..+..++.|++.||.|||  +.+   |+||||||+|||++. ++.+
T Consensus        95 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~  171 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTL  171 (360)
T ss_dssp             CTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEE
T ss_pred             cccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcE
Confidence                  7899999987544333221234567899999999999999999999  766   999999999999996 8999


Q ss_pred             EEeeccCccccCCCCCccccccccccCCcccccccccCC-CCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          487 KISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQ-FSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       487 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ||+|||+++.+.....   .....||+.|+|||.+.+.. ++.++||||||+++|||+||+.||..
T Consensus       172 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~  234 (360)
T 3e3p_A          172 KLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRG  234 (360)
T ss_dssp             EECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             EEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCC
Confidence            9999999987643322   23456899999999987654 89999999999999999999999864

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.7e-34  Score=300.21  Aligned_cols=200  Identities=25%  Similarity=0.387  Sum_probs=164.1

Q ss_pred             HHHhCCCCccccccccCceeEEEEEc-cCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeC------
Q 008292          341 EVATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG------  413 (571)
Q Consensus       341 ~~~~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~------  413 (571)
                      +...++|++.+.||+|+||+||+++. .+|+.||||++......    ..+|+.+++.++||||+++++++...      
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            45567899999999999999999985 57899999998654322    24799999999999999999998543      


Q ss_pred             --------------------------------CeeEEEEEecCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHH
Q 008292          414 --------------------------------EEKILVYEFVPNKSLDYFLYDP-EKQGQLDWSRRYKIIGGIARGILYL  460 (571)
Q Consensus       414 --------------------------------~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yL  460 (571)
                                                      ...++||||+++ +|.+.+... .....+++..+..++.||++||.||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             -------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                            237899999984 766665321 2346799999999999999999999


Q ss_pred             HcCCCCCeEEecCCCCCEEEC-CCCceEEeeccCccccCCCCCccccccccccCCcccccccccC-CCCcchhHHHHHHH
Q 008292          461 HEDSRLRIIHRDLKASNILLD-AEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVL  538 (571)
Q Consensus       461 H~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~slGvv  538 (571)
                      |+.+   |+||||||+|||++ .++.+||+|||+++.+.....   .....+|+.|+|||.+.+. .++.++||||||++
T Consensus       158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i  231 (383)
T 3eb0_A          158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV  231 (383)
T ss_dssp             HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred             HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence            9887   99999999999997 688999999999987643322   2234689999999998765 58999999999999


Q ss_pred             HHHHHhCCCCCCC
Q 008292          539 VLEIITGKKNSNF  551 (571)
Q Consensus       539 l~elltG~~p~~~  551 (571)
                      +|||++|+.||..
T Consensus       232 l~ell~g~~pf~~  244 (383)
T 3eb0_A          232 FGELILGKPLFSG  244 (383)
T ss_dssp             HHHHHHSSCSSCC
T ss_pred             HHHHHhCCCCCCC
Confidence            9999999999864

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.7e-35  Score=298.27  Aligned_cols=202  Identities=31%  Similarity=0.514  Sum_probs=173.9

Q ss_pred             hCCCCccccccccCceeEEEEEc-----cCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCC--ee
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVL-----PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE--EK  416 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~--~~  416 (571)
                      .++|++.+.||+|+||.||++++     .+++.||||++........+.+.+|++++++++||||+++++++...+  ..
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            45688899999999999999983     468899999998776666788999999999999999999999987654  67


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccc
Q 008292          417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI  496 (571)
Q Consensus       417 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  496 (571)
                      ++||||+++++|.+++..  ....+++..++.++.|+++||.|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus       120 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~  194 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV  194 (326)
T ss_dssp             EEEECCCTTCBHHHHHHH--STTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEECCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence            999999999999999853  2346899999999999999999999987   99999999999999999999999999987


Q ss_pred             cCCCCCcc-ccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          497 FGVDQTQG-NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       497 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      ........ ......++..|+|||.+.+..++.++||||||+++|||+||+.|+.
T Consensus       195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~  249 (326)
T 2w1i_A          195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSK  249 (326)
T ss_dssp             CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGG
T ss_pred             ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCC
Confidence            65432211 1223456778999999999899999999999999999999988764

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=5.7e-35  Score=307.31  Aligned_cols=196  Identities=27%  Similarity=0.400  Sum_probs=160.7

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCC------eeE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE------EKI  417 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------~~~  417 (571)
                      .+|+..+.||+|+||.||+++.. +|+.||||++.....    .+.+|++++++++||||+++++++....      ..+
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            35888899999999999999974 589999999865432    2347999999999999999999886421      257


Q ss_pred             EEEEecCCCChhhhhcC-CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCC-CceEEeeccCcc
Q 008292          418 LVYEFVPNKSLDYFLYD-PEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE-MNPKISDFGMAR  495 (571)
Q Consensus       418 lv~e~~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfGla~  495 (571)
                      +||||+++ +|..++.. ......+++..+..++.||++||.|||+++   |+||||||+||||+.+ +.+||+|||+++
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            89999986 44444321 123467999999999999999999999987   9999999999999965 578999999998


Q ss_pred             ccCCCCCccccccccccCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          496 IFGVDQTQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .+.....   .....||+.|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus       206 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~  259 (420)
T 1j1b_A          206 QLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG  259 (420)
T ss_dssp             ECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             hcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCC
Confidence            7643221   2235789999999998765 799999999999999999999999864

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-34  Score=294.74  Aligned_cols=204  Identities=29%  Similarity=0.475  Sum_probs=168.2

Q ss_pred             HHHhCCCCccccccccCceeEEEEEc-cCCCeeEEEeecccCccCHHHHHHHHHHHhhc-CCCceeccceeEEe------
Q 008292          341 EVATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLE------  412 (571)
Q Consensus       341 ~~~~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~------  412 (571)
                      ....++|++.+.||+|+||.||+++. .+++.||+|++.... ...+.+.+|+.+++++ +||||+++++++..      
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   98 (326)
T 2x7f_A           20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM   98 (326)
T ss_dssp             CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CC
T ss_pred             cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccc
Confidence            34567899999999999999999996 478899999986543 3456789999999999 79999999999987      


Q ss_pred             CCeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeecc
Q 008292          413 GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG  492 (571)
Q Consensus       413 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG  492 (571)
                      ....++||||+++++|.+++... ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||
T Consensus        99 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg  174 (326)
T 2x7f_A           99 DDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFG  174 (326)
T ss_dssp             CCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCT
T ss_pred             cceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeCc
Confidence            45789999999999999998532 2357899999999999999999999987   9999999999999999999999999


Q ss_pred             CccccCCCCCccccccccccCCcccccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          493 MARIFGVDQTQGNTSRIVGTYGYMAPEYAM-----HGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       493 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ++..+....  .......|++.|+|||.+.     +..++.++||||||+++|||+||+.||..
T Consensus       175 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  236 (326)
T 2x7f_A          175 VSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD  236 (326)
T ss_dssp             TTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             CceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence            998654321  1223457899999999987     56789999999999999999999999853

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=3.4e-35  Score=323.74  Aligned_cols=194  Identities=31%  Similarity=0.487  Sum_probs=163.7

Q ss_pred             ccccccCceeEEEEEcc---CCCeeEEEeecccC--ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEecCC
Q 008292          351 NKLGEGGFGEVYKGVLP---SGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPN  425 (571)
Q Consensus       351 ~~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  425 (571)
                      ++||+|+||.||+|.+.   .++.||||+++...  ....+++.+|++++.+++||||+++++++. .+..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence            47999999999999653   46789999997643  344688999999999999999999999986 4568899999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCc-c
Q 008292          426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ-G  504 (571)
Q Consensus       426 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~-~  504 (571)
                      |+|.+++.   ....+++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++.+...... .
T Consensus       454 g~L~~~l~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  527 (635)
T 4fl3_A          454 GPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  527 (635)
T ss_dssp             EEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred             CCHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence            99999994   3457899999999999999999999987   999999999999999999999999999876543221 1


Q ss_pred             ccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          505 NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       505 ~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                      ......+|+.|+|||++....++.++||||||+++|||+| |+.||..
T Consensus       528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~  575 (635)
T 4fl3_A          528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG  575 (635)
T ss_dssp             -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred             cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            2233456789999999999999999999999999999999 9999854

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.5e-35  Score=301.82  Aligned_cols=199  Identities=19%  Similarity=0.244  Sum_probs=169.6

Q ss_pred             hCCCCccccccccCceeEEEEEccC---------CCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceec---------
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLPS---------GQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVR---------  405 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~~---------g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~---------  405 (571)
                      .++|.+.+.||+|+||.||+++...         ++.||+|++...     +.+.+|++++++++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            4689999999999999999999753         789999998754     46789999999999999988         


Q ss_pred             ------cceeEEe-CCeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCE
Q 008292          406 ------LLGFCLE-GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNI  478 (571)
Q Consensus       406 ------l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NI  478 (571)
                            +++++.. +...++||||+ +++|.+++... ....+++..++.++.||++||.|||+++   |+||||||+||
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI  190 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI  190 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence                  5667766 67889999999 99999999532 2367999999999999999999999987   99999999999


Q ss_pred             EECCCC--ceEEeeccCccccCCCCCc-----cccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          479 LLDAEM--NPKISDFGMARIFGVDQTQ-----GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       479 ll~~~~--~~kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      |++.++  .+||+|||+++.+......     .......||+.|+|||.+.+..++.++||||||+++|||+||+.||..
T Consensus       191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  270 (352)
T 2jii_A          191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN  270 (352)
T ss_dssp             EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            999998  9999999999876432211     122345799999999999999999999999999999999999999875


Q ss_pred             C
Q 008292          552 Y  552 (571)
Q Consensus       552 ~  552 (571)
                      .
T Consensus       271 ~  271 (352)
T 2jii_A          271 C  271 (352)
T ss_dssp             G
T ss_pred             C
Confidence            3

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=2.9e-34  Score=297.10  Aligned_cols=194  Identities=26%  Similarity=0.456  Sum_probs=165.8

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC--ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCee----
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEK----  416 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~----  416 (571)
                      .++|...+.||+|+||.||++... +|+.||||++....  ....+.+.+|+.+++.++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            468899999999999999999854 68899999997643  33356788999999999999999999999877654    


Q ss_pred             --EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCc
Q 008292          417 --ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA  494 (571)
Q Consensus       417 --~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla  494 (571)
                        ++||||+. ++|.+++     ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       121 ~~~lv~e~~~-~~l~~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a  191 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIM-----GMEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA  191 (371)
T ss_dssp             CCEEEEECCC-EEHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred             eEEEEEcccc-ccHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence              99999997 6787776     234899999999999999999999987   999999999999999999999999999


Q ss_pred             cccCCCCCccccccccccCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          495 RIFGVDQTQGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      +.....     .....||+.|+|||.+.+ ..++.++||||||+++|||+||+.||..
T Consensus       192 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  244 (371)
T 4exu_A          192 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKG  244 (371)
T ss_dssp             -------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCC
Confidence            865322     233578999999999887 7899999999999999999999999864

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=4.3e-34  Score=299.41  Aligned_cols=200  Identities=27%  Similarity=0.436  Sum_probs=152.0

Q ss_pred             CCCc-cccccccCceeEEEEEcc---CCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEe--CCeeEEE
Q 008292          346 KFST-DNKLGEGGFGEVYKGVLP---SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE--GEEKILV  419 (571)
Q Consensus       346 ~~~~-~~~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~~~~~lv  419 (571)
                      .|.+ .++||+|+||+||+++.+   +++.||||++....  ..+.+.+|+.++++++||||+++++++..  ....++|
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv   98 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL   98 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence            3554 458999999999999964   57889999997543  23567899999999999999999999965  6678999


Q ss_pred             EEecCCCChhhhhcC------CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEE----CCCCceEEe
Q 008292          420 YEFVPNKSLDYFLYD------PEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL----DAEMNPKIS  489 (571)
Q Consensus       420 ~e~~~~g~L~~~l~~------~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~  489 (571)
                      |||+++ +|.+++..      ......+++..++.++.||+.||.|||+++   |+||||||+||||    +.++.+||+
T Consensus        99 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~  174 (405)
T 3rgf_A           99 FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIA  174 (405)
T ss_dssp             EECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred             EeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEE
Confidence            999975 66665531      112235899999999999999999999987   9999999999999    677899999


Q ss_pred             eccCccccCCCCCc-cccccccccCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          490 DFGMARIFGVDQTQ-GNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       490 DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      |||+++.+...... .......||+.|+|||++.+. .++.++|||||||++|||+||+.||..
T Consensus       175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~  238 (405)
T 3rgf_A          175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  238 (405)
T ss_dssp             CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCC
Confidence            99999876432211 223446789999999999874 589999999999999999999999963

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=8.5e-35  Score=290.19  Aligned_cols=202  Identities=28%  Similarity=0.368  Sum_probs=158.1

Q ss_pred             HhCCCCccccccccCceeEEEEEc-cCCCeeEEEeecccCc--cCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEE
Q 008292          343 ATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASG--QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV  419 (571)
Q Consensus       343 ~~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  419 (571)
                      ..++|++.+.||+|+||+||+++. .+|+.||+|+++....  ...+.+.++...++.++||||+++++++.+++..++|
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv   84 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC   84 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence            356889999999999999999996 5788999999975422  2233445566668889999999999999999999999


Q ss_pred             EEecCCCChhhhhcC-CCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCCeEEecCCCCCEEECCCCceEEeeccCcccc
Q 008292          420 YEFVPNKSLDYFLYD-PEKQGQLDWSRRYKIIGGIARGILYLHED-SRLRIIHRDLKASNILLDAEMNPKISDFGMARIF  497 (571)
Q Consensus       420 ~e~~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  497 (571)
                      |||+++ +|.+++.. ......+++..++.++.|++.||.|||++ +   |+||||||+||+++.++.+||+|||+++..
T Consensus        85 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T 3fme_A           85 MELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYL  160 (290)
T ss_dssp             EECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred             Eehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            999974 77666532 12345799999999999999999999987 6   999999999999999999999999999865


Q ss_pred             CCCCCccccccccccCCccccccc----ccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          498 GVDQTQGNTSRIVGTYGYMAPEYA----MHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       498 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .....   .....||+.|+|||.+    .+..++.++||||||+++|||+||+.||..
T Consensus       161 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  215 (290)
T 3fme_A          161 VDDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDS  215 (290)
T ss_dssp             ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred             ccccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccc
Confidence            43322   2234689999999996    566789999999999999999999999864

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=2.4e-34  Score=295.45  Aligned_cols=200  Identities=25%  Similarity=0.399  Sum_probs=168.6

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeEEeC-----Cee
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG-----EEK  416 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-----~~~  416 (571)
                      .++|.+.+.||+|+||.||++... +|+.||||+++... ......+.+|+.++++++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            468899999999999999999964 68899999997533 33456788999999999999999999988764     568


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccc
Q 008292          417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI  496 (571)
Q Consensus       417 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  496 (571)
                      ++||||++ ++|.+++.    ...+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        90 ~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVIS----TQMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI  161 (353)
T ss_dssp             EEEECCCS-EEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEeccC-ccHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence            99999997 58888873    356899999999999999999999987   99999999999999999999999999987


Q ss_pred             cCCCCCcc--------ccccccccCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          497 FGVDQTQG--------NTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       497 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      +.......        ......||+.|+|||.+.. ..++.++||||||+++|||++|+.||..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  225 (353)
T 2b9h_A          162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPG  225 (353)
T ss_dssp             CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCC
Confidence            64322111        1223478999999998764 7799999999999999999999999864

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=4.1e-35  Score=303.50  Aligned_cols=198  Identities=11%  Similarity=0.105  Sum_probs=151.2

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccCc---cCHHHHHHHHHHHhhc--CCCceeccc-------eeE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASG---QGAEEFKNEVVLVAKL--QHRNLVRLL-------GFC  410 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l--~h~niv~l~-------~~~  410 (571)
                      ..+|...+.||+|+||.||+++.. +|+.||||++.....   ...+.+.+|+.++..+  +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            345888999999999999999964 788999999987542   3345677885544444  699987755       444


Q ss_pred             EeC-----------------CeeEEEEEecCCCChhhhhcCCCCCCCCCHHHH------HHHHHHHHHHHHHHHcCCCCC
Q 008292          411 LEG-----------------EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRR------YKIIGGIARGILYLHEDSRLR  467 (571)
Q Consensus       411 ~~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~------~~i~~~ia~~L~yLH~~~~~~  467 (571)
                      ...                 ...++||||++ |+|.+++...  ...+.+..+      +.++.||++||+|||+++   
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---  214 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL--DFVYVFRGDEGILALHILTAQLIRLAANLQSKG---  214 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH--HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh--ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---
Confidence            332                 33799999999 8999998532  223455555      778899999999999987   


Q ss_pred             eEEecCCCCCEEECCCCceEEeeccCccccCCCCCccccccccccCCccccccccc--CCCCcchhHHHHHHHHHHHHhC
Q 008292          468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMH--GQFSVKSDVYSFGVLVLEIITG  545 (571)
Q Consensus       468 ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~Dv~slGvvl~elltG  545 (571)
                      |+||||||+||||+.++.+||+|||+++.....     .....+|+.|+|||.+.+  ..++.++||||||+++|||+||
T Consensus       215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg  289 (371)
T 3q60_A          215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL  289 (371)
T ss_dssp             EEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred             CccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence            999999999999999999999999999865321     113456799999999987  6899999999999999999999


Q ss_pred             CCCCCCC
Q 008292          546 KKNSNFY  552 (571)
Q Consensus       546 ~~p~~~~  552 (571)
                      +.||...
T Consensus       290 ~~Pf~~~  296 (371)
T 3q60_A          290 FLPFGLV  296 (371)
T ss_dssp             SCSTTBC
T ss_pred             CCCCCCc
Confidence            9998644

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.6e-34  Score=291.74  Aligned_cols=203  Identities=28%  Similarity=0.402  Sum_probs=167.8

Q ss_pred             HHHhCCCCccccccccCceeEEEEEccCCCeeEEEeeccc--CccCHHHHHHHHHHHhhcC--CCceeccceeEEeCCee
Q 008292          341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQ--HRNLVRLLGFCLEGEEK  416 (571)
Q Consensus       341 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~--h~niv~l~~~~~~~~~~  416 (571)
                      ....++|++.+.||+|+||.||++...+++.||||++...  .....+.+.+|+.++.+++  |+||+++++++...+..
T Consensus        24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~  103 (313)
T 3cek_A           24 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI  103 (313)
T ss_dssp             EETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEE
T ss_pred             eeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEE
Confidence            3445779999999999999999999888999999998653  2344578899999999997  59999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccc
Q 008292          417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI  496 (571)
Q Consensus       417 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  496 (571)
                      ++||| +.+++|.+++.   ....+++..++.++.||++||.|||+++   |+||||||+|||+++ +.+||+|||+++.
T Consensus       104 ~lv~e-~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~  175 (313)
T 3cek_A          104 YMVME-CGNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQ  175 (313)
T ss_dssp             EEEEC-CCSEEHHHHHH---HCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC
T ss_pred             EEEEe-cCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeecccccc
Confidence            99999 67889999984   3457899999999999999999999987   999999999999964 8999999999987


Q ss_pred             cCCCCCccccccccccCCccccccccc-----------CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          497 FGVDQTQGNTSRIVGTYGYMAPEYAMH-----------GQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      +.............|++.|+|||.+.+           ..++.++||||||+++|||++|+.||..
T Consensus       176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  241 (313)
T 3cek_A          176 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ  241 (313)
T ss_dssp             --------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             ccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhh
Confidence            654333323344578999999999865           4788999999999999999999999864

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2.1e-34  Score=300.55  Aligned_cols=201  Identities=24%  Similarity=0.334  Sum_probs=169.0

Q ss_pred             hCCCCccccccccCceeEEEEEc-cCCCeeEEEeecccCccCHHHHHHHHHHHhhcC--------CCceeccceeEE---
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ--------HRNLVRLLGFCL---  411 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~--------h~niv~l~~~~~---  411 (571)
                      .++|++.++||+|+||+||+++. .+++.||||+++.. ....+.+.+|+.+++.++        |+||+++++++.   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            57899999999999999999985 46889999999743 334567889999999986        788999999987   


Q ss_pred             -eCCeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCCeEEecCCCCCEEECCCC-----
Q 008292          412 -EGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED-SRLRIIHRDLKASNILLDAEM-----  484 (571)
Q Consensus       412 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivH~Dlkp~NIll~~~~-----  484 (571)
                       .+...++||||+.++.+..++..  ....+++..++.++.||++||.|||++ +   |+||||||+||||+.++     
T Consensus       115 ~~~~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~  189 (397)
T 1wak_A          115 VNGTHICMVFEVLGHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRR  189 (397)
T ss_dssp             TTEEEEEEEECCCCCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHH
T ss_pred             CCCceEEEEEeccCccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhh
Confidence             45678999999955444444422  235689999999999999999999997 6   99999999999999775     


Q ss_pred             --------------------------------------------ceEEeeccCccccCCCCCccccccccccCCcccccc
Q 008292          485 --------------------------------------------NPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEY  520 (571)
Q Consensus       485 --------------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~  520 (571)
                                                                  .+||+|||+++.....     .....||+.|+|||+
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~  264 (397)
T 1wak_A          190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEV  264 (397)
T ss_dssp             HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHH
T ss_pred             hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChh
Confidence                                                        7999999999865432     233478999999999


Q ss_pred             cccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 008292          521 AMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTD  555 (571)
Q Consensus       521 ~~~~~~s~~~Dv~slGvvl~elltG~~p~~~~~~~  555 (571)
                      +.+..++.++||||||+++|||+||+.||......
T Consensus       265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~  299 (397)
T 1wak_A          265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGE  299 (397)
T ss_dssp             HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCS
T ss_pred             hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCccc
Confidence            99999999999999999999999999999765433

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=5.9e-34  Score=303.40  Aligned_cols=202  Identities=23%  Similarity=0.374  Sum_probs=171.1

Q ss_pred             hCCCCccccccccCceeEEEEEc-cCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCC-ceeccceeEEeCCeeEEEEE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHR-NLVRLLGFCLEGEEKILVYE  421 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~-niv~l~~~~~~~~~~~lv~e  421 (571)
                      .++|++.++||+|+||.||+++. .+++.||||++......  +++.+|++++..++|+ +|..+..++...+..+||||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            46899999999999999999995 56899999987654332  3578899999999874 55556666677888899999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEE---CCCCceEEeeccCccccC
Q 008292          422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMARIFG  498 (571)
Q Consensus       422 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfGla~~~~  498 (571)
                      |+ +++|.+++..  ....+++..++.++.||+.||.|||+++   |+||||||+||||   +.++.+||+|||+++.+.
T Consensus        84 ~~-g~sL~~ll~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~  157 (483)
T 3sv0_A           84 LL-GPSLEDLFNF--CSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR  157 (483)
T ss_dssp             CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             CC-CCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence            99 9999999852  2456999999999999999999999987   9999999999999   688999999999998765


Q ss_pred             CCCCcc-----ccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 008292          499 VDQTQG-----NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQ  553 (571)
Q Consensus       499 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~~~  553 (571)
                      ......     ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~  217 (483)
T 3sv0_A          158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK  217 (483)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred             CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccc
Confidence            433211     2235679999999999999999999999999999999999999997543

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=2.6e-34  Score=293.73  Aligned_cols=200  Identities=27%  Similarity=0.387  Sum_probs=169.7

Q ss_pred             cchHHHHHHhCCCCccccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhh--cCCCceeccceeEEe
Q 008292          335 FDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAK--LQHRNLVRLLGFCLE  412 (571)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~--l~h~niv~l~~~~~~  412 (571)
                      .+....+...++|.+.+.||+|+||.||+++. +++.||||++...   ....+.+|++++..  ++||||+++++++..
T Consensus        32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~  107 (342)
T 1b6c_B           32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNK  107 (342)
T ss_dssp             SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred             CceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence            34445566778999999999999999999998 5899999998643   34567788888877  799999999999988


Q ss_pred             CC----eeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------cCCCCCeEEecCCCCCEEE
Q 008292          413 GE----EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH--------EDSRLRIIHRDLKASNILL  480 (571)
Q Consensus       413 ~~----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH--------~~~~~~ivH~Dlkp~NIll  480 (571)
                      ..    ..++||||+++|+|.+++.    ...+++..++.++.|++.||.|||        +.+   |+||||||+|||+
T Consensus       108 ~~~~~~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll  180 (342)
T 1b6c_B          108 DNGTWTQLWLVSDYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILV  180 (342)
T ss_dssp             CCSSCCCEEEEECCCTTCBHHHHHH----HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEE
T ss_pred             cCCccceeEEEEeecCCCcHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEE
Confidence            76    7899999999999999994    346899999999999999999999        665   9999999999999


Q ss_pred             CCCCceEEeeccCccccCCCCCcc--ccccccccCCcccccccccC------CCCcchhHHHHHHHHHHHHhC
Q 008292          481 DAEMNPKISDFGMARIFGVDQTQG--NTSRIVGTYGYMAPEYAMHG------QFSVKSDVYSFGVLVLEIITG  545 (571)
Q Consensus       481 ~~~~~~kl~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~s~~~Dv~slGvvl~elltG  545 (571)
                      +.++++||+|||+++.........  ......||+.|+|||.+.+.      .++.++||||||+++|||+||
T Consensus       181 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg  253 (342)
T 1b6c_B          181 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR  253 (342)
T ss_dssp             CTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhc
Confidence            999999999999998764433211  22345789999999998765      234789999999999999999

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=4.3e-34  Score=290.17  Aligned_cols=201  Identities=28%  Similarity=0.467  Sum_probs=168.9

Q ss_pred             HhCCCCccccccccCceeEEEEEc--cCCCeeEEEeecccC--ccCHHHHHHHHHHHhhc---CCCceeccceeEE----
Q 008292          343 ATNKFSTDNKLGEGGFGEVYKGVL--PSGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKL---QHRNLVRLLGFCL----  411 (571)
Q Consensus       343 ~~~~~~~~~~LG~G~fg~Vy~~~~--~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l---~h~niv~l~~~~~----  411 (571)
                      ..++|++.+.||+|+||.||++..  .+++.||+|+++...  ......+.+|+.+++.+   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            357899999999999999999996  467889999986532  22233566777777766   8999999999987    


Q ss_pred             -eCCeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEee
Q 008292          412 -EGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISD  490 (571)
Q Consensus       412 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  490 (571)
                       .....++||||++ |+|.+++... ....+++..++.++.||++||.|||+++   |+||||||+||+++.++.+||+|
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D  163 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD  163 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence             4567899999998 6898888532 2345899999999999999999999987   99999999999999999999999


Q ss_pred             ccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          491 FGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       491 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ||+++......   ......|++.|+|||.+.+..++.++||||||+++|||+||+.||..
T Consensus       164 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  221 (326)
T 1blx_A          164 FGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG  221 (326)
T ss_dssp             CCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             CcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCC
Confidence            99998654221   22345789999999999999999999999999999999999999864

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=4e-34  Score=301.61  Aligned_cols=197  Identities=22%  Similarity=0.306  Sum_probs=169.2

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccCccCHHHHHHHHHHHhhc------CCCceeccceeEEeCCee
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKL------QHRNLVRLLGFCLEGEEK  416 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l------~h~niv~l~~~~~~~~~~  416 (571)
                      ..+|++.++||+|+||+||++... +++.||||+++.. ....+.+.+|+.++..+      +|+||+++++++......
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            467999999999999999999864 5889999999753 23345677888888877      577999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCc--eEEeeccCc
Q 008292          417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN--PKISDFGMA  494 (571)
Q Consensus       417 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~DfGla  494 (571)
                      ++||||+. ++|.+++... ....+++..+..++.||+.||+|||+++   |+||||||+||||+.++.  +||+|||++
T Consensus       175 ~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a  249 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKN-KFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS  249 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             EEEEeccC-CCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccc
Confidence            99999996 5888877432 2345899999999999999999999987   999999999999999887  999999999


Q ss_pred             cccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          495 RIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      +.....     .....||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus       250 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~  301 (429)
T 3kvw_A          250 CYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPG  301 (429)
T ss_dssp             EETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             eecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCC
Confidence            764322     2235789999999999999999999999999999999999999864

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=8.7e-35  Score=288.54  Aligned_cols=196  Identities=31%  Similarity=0.466  Sum_probs=163.3

Q ss_pred             hCCCCccccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeC-CeeEEEEEe
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG-EEKILVYEF  422 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~  422 (571)
                      .++|++.+.||+|+||+||+++. .|+.||||+++..  ...+.+.+|+.++++++||||+++++++.+. +..++||||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            46788999999999999999987 5889999998754  3457889999999999999999999997655 468999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT  502 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  502 (571)
                      +++++|.+++... ....+++..++.++.|+++||.|||+++   |+||||||+||+++.++.+||+|||+++...... 
T Consensus        97 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  171 (278)
T 1byg_A           97 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-  171 (278)
T ss_dssp             CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             CCCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccccc-
Confidence            9999999998431 1223789999999999999999999987   9999999999999999999999999997543221 


Q ss_pred             ccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          503 QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       503 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                          ....+++.|+|||.+.+..++.++||||||+++|||+| |+.||..
T Consensus       172 ----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~  217 (278)
T 1byg_A          172 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR  217 (278)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT
T ss_pred             ----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCC
Confidence                22357889999999999999999999999999999998 9999864

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=6.4e-34  Score=292.47  Aligned_cols=194  Identities=26%  Similarity=0.447  Sum_probs=165.1

Q ss_pred             hCCCCccccccccCceeEEEEEc-cCCCeeEEEeecccC--ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCe-----
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEE-----  415 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~-----  415 (571)
                      .++|...+.||+|+||.||++.. .+|+.||||++....  ....+.+.+|+.+++.++||||+++++++.....     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            36788999999999999999996 468999999997542  3335678899999999999999999999987654     


Q ss_pred             -eEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCc
Q 008292          416 -KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA  494 (571)
Q Consensus       416 -~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla  494 (571)
                       .++||||++ ++|.+++.     ..+++..+..++.||++||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~  173 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA  173 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred             eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence             499999997 58877762     34899999999999999999999987   999999999999999999999999999


Q ss_pred             cccCCCCCccccccccccCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          495 RIFGVDQTQGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      +.....     .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus       174 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  226 (353)
T 3coi_A          174 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKG  226 (353)
T ss_dssp             TC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBS
T ss_pred             cCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            864322     223578999999999877 6889999999999999999999999864

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2e-34  Score=287.67  Aligned_cols=202  Identities=33%  Similarity=0.447  Sum_probs=162.3

Q ss_pred             hCCCCccccccccCceeEEEEEcc--CCC--eeEEEeeccc---CccCHHHHHHHHHHHhhcCCCceeccceeEEeCCee
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP--SGQ--EIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEK  416 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~--~g~--~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  416 (571)
                      .++|++.+.||+|+||+||++++.  +++  .||+|+++..   .....+.+.+|++++++++||||+++++++.... .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            457889999999999999999853  233  5899998754   2344578899999999999999999999987754 8


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccc
Q 008292          417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI  496 (571)
Q Consensus       417 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  496 (571)
                      ++|+||+++++|.+++..  ....+++..++.++.|+++||.|||+++   |+||||||+||+++.++.+||+|||+++.
T Consensus        96 ~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~  170 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA  170 (291)
T ss_dssp             EEEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             eeeEecccCCCHHHHHHh--ccCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence            899999999999998853  2356899999999999999999999987   99999999999999999999999999987


Q ss_pred             cCCCCCcc-ccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          497 FGVDQTQG-NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       497 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                      ........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~  227 (291)
T 1u46_A          171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG  227 (291)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence            64332211 2233457888999999998899999999999999999999 9999853

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.2e-34  Score=293.33  Aligned_cols=207  Identities=26%  Similarity=0.439  Sum_probs=169.8

Q ss_pred             hHHHHHHhCCCCccccccccCceeEEEEEccCCCeeEEEeecccC--ccCHHHHHHHHHHHhhcCCCceeccceeEEeCC
Q 008292          337 FETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE  414 (571)
Q Consensus       337 ~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~  414 (571)
                      ...+++..++|++.+.||+|+||.||+|..+.  .|++|+++...  ....+.+.+|+.++++++||||+++++++.+.+
T Consensus        25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  102 (319)
T 2y4i_B           25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP  102 (319)
T ss_dssp             GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred             cccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence            34445557889999999999999999999743  59999886532  334456788999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCc
Q 008292          415 EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA  494 (571)
Q Consensus       415 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla  494 (571)
                      ..++||||+++++|.+++..  ....+++..++.++.||++||.|||+++   |+||||||+|||++ ++.+||+|||++
T Consensus       103 ~~~iv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~  176 (319)
T 2y4i_B          103 HLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLF  176 (319)
T ss_dssp             CEEEECBCCCSEEHHHHTTS--SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCC
T ss_pred             ceEEEeecccCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCc
Confidence            99999999999999999943  3346899999999999999999999987   99999999999998 679999999998


Q ss_pred             cccCCCC---CccccccccccCCccccccccc---------CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          495 RIFGVDQ---TQGNTSRIVGTYGYMAPEYAMH---------GQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       495 ~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      +......   .........|++.|+|||.+..         ..++.++||||||+++|||++|+.||..
T Consensus       177 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  245 (319)
T 2y4i_B          177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT  245 (319)
T ss_dssp             C----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSS
T ss_pred             cccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            7653211   1122233468999999999864         4578999999999999999999999853

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=6.8e-34  Score=289.83  Aligned_cols=198  Identities=25%  Similarity=0.376  Sum_probs=171.1

Q ss_pred             hCCCCccccccccCceeEEEEEc--cCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCc------eeccceeEEeCCe
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVL--PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRN------LVRLLGFCLEGEE  415 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~--~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n------iv~l~~~~~~~~~  415 (571)
                      .++|++.+.||+|+||+||++..  .+++.||||+++.. ....+.+.+|+.++..++|++      ++++++++...+.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            56899999999999999999985  36789999998753 234567889999999987664      9999999999999


Q ss_pred             eEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECC-------------
Q 008292          416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-------------  482 (571)
Q Consensus       416 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-------------  482 (571)
                      .++||||+ +++|.+++... ....+++..+..++.||++||+|||+++   |+||||||+|||++.             
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~  166 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR  166 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred             EEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence            99999999 88998888532 2346899999999999999999999987   999999999999987             


Q ss_pred             ------CCceEEeeccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 008292          483 ------EMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFY  552 (571)
Q Consensus       483 ------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~~  552 (571)
                            ++.+||+|||+++.....     .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       167 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  237 (339)
T 1z57_A          167 DERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTH  237 (339)
T ss_dssp             EEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence                  668999999999864322     23457899999999999999999999999999999999999998754

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=7.2e-34  Score=283.32  Aligned_cols=201  Identities=31%  Similarity=0.455  Sum_probs=173.6

Q ss_pred             HHHhCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC--ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeE
Q 008292          341 EVATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI  417 (571)
Q Consensus       341 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  417 (571)
                      ....++|++.+.||+|+||.||+++.. +++.||+|++....  ....+.+.+|++++++++||||+++++++.+.+..+
T Consensus        18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   97 (287)
T 2wei_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY   97 (287)
T ss_dssp             HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence            344578999999999999999999965 68899999986543  345778999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCC---CceEEeeccCc
Q 008292          418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE---MNPKISDFGMA  494 (571)
Q Consensus       418 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DfGla  494 (571)
                      +|+||+++++|.+++.   ....+++..++.++.||++||.|||+++   |+||||||+||+++.+   +.+||+|||++
T Consensus        98 lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~  171 (287)
T 2wei_A           98 IVGELYTGGELFDEII---KRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS  171 (287)
T ss_dssp             EEECCCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred             EEEEccCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcc
Confidence            9999999999988874   3356899999999999999999999987   9999999999999764   46999999999


Q ss_pred             cccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          495 RIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ........   .....|++.|+|||.+.+ .++.++||||||+++|||++|+.||..
T Consensus       172 ~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~  224 (287)
T 2wei_A          172 TCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYG  224 (287)
T ss_dssp             GTBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             eeecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCC
Confidence            86543221   223468899999998765 589999999999999999999999853

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=2.6e-34  Score=291.25  Aligned_cols=200  Identities=25%  Similarity=0.422  Sum_probs=171.3

Q ss_pred             HHHhCCCCccccccccCceeEEEEEc-cCCCeeEEEeecccCcc------CHHHHHHHHHHHhhcC--CCceeccceeEE
Q 008292          341 EVATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQ------GAEEFKNEVVLVAKLQ--HRNLVRLLGFCL  411 (571)
Q Consensus       341 ~~~~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~------~~~~~~~Ei~~l~~l~--h~niv~l~~~~~  411 (571)
                      +...++|++.+.||+|+||.||+++. .+++.||||+++.....      ..+.+.+|+.++++++  |+||+++++++.
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~  118 (320)
T 3a99_A           39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE  118 (320)
T ss_dssp             -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred             CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence            44467899999999999999999985 56889999998754321      2245678999999996  599999999999


Q ss_pred             eCCeeEEEEEecCC-CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEEC-CCCceEEe
Q 008292          412 EGEEKILVYEFVPN-KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD-AEMNPKIS  489 (571)
Q Consensus       412 ~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~  489 (571)
                      ..+..++|+|++.+ ++|.+++.   ....+++..++.++.||++||.|||+.+   |+||||||+|||++ +++.+||+
T Consensus       119 ~~~~~~lv~e~~~~~~~L~~~l~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~  192 (320)
T 3a99_A          119 RPDSFVLILERPEPVQDLFDFIT---ERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLI  192 (320)
T ss_dssp             CSSEEEEEEECCSSEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEEC
T ss_pred             cCCcEEEEEEcCCCCccHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEe
Confidence            99999999999986 89999884   3457899999999999999999999987   99999999999999 78899999


Q ss_pred             eccCccccCCCCCccccccccccCCcccccccccCCC-CcchhHHHHHHHHHHHHhCCCCCC
Q 008292          490 DFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQF-SVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       490 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      |||+++......    .....||+.|+|||.+.+..+ +.++||||||+++|||+||+.||.
T Consensus       193 Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~  250 (320)
T 3a99_A          193 DFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE  250 (320)
T ss_dssp             CCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             eCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCC
Confidence            999998764322    223568999999999987766 688999999999999999999985

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.3e-33  Score=286.93  Aligned_cols=201  Identities=28%  Similarity=0.386  Sum_probs=150.1

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC-ccCHHHHHHHHH-HHhhcCCCceeccceeEEeCCeeEEEE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS-GQGAEEFKNEVV-LVAKLQHRNLVRLLGFCLEGEEKILVY  420 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~-~l~~l~h~niv~l~~~~~~~~~~~lv~  420 (571)
                      .++|+..+.||+|+||.||++... +|+.||||+++... .....++..|+. +++.++||||+++++++.+.+..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            468889999999999999999974 68899999997643 233345555655 778889999999999999999999999


Q ss_pred             EecCCCChhhhhcC--CCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCCeEEecCCCCCEEECCCCceEEeeccCcccc
Q 008292          421 EFVPNKSLDYFLYD--PEKQGQLDWSRRYKIIGGIARGILYLHED-SRLRIIHRDLKASNILLDAEMNPKISDFGMARIF  497 (571)
Q Consensus       421 e~~~~g~L~~~l~~--~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  497 (571)
                      ||+++ +|.+++..  ......+++..+..++.|++.||.|||+. +   |+||||||+|||++.++.+||+|||+++.+
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            99986 67666531  11245789999999999999999999997 6   999999999999999999999999999865


Q ss_pred             CCCCCccccccccccCCccccccc----ccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          498 GVDQTQGNTSRIVGTYGYMAPEYA----MHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       498 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ....   ......|++.|+|||.+    .+..++.++||||||+++|||++|+.||..
T Consensus       177 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  231 (327)
T 3aln_A          177 VDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPK  231 (327)
T ss_dssp             --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSC
T ss_pred             cccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence            4322   12234689999999998    466789999999999999999999999854

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=5e-34  Score=287.95  Aligned_cols=199  Identities=26%  Similarity=0.447  Sum_probs=163.1

Q ss_pred             HHhCCCCccccccccCceeEEEEEc-cCCCeeEEEeecccCcc------CHHHHHHHHHHHhhc----CCCceeccceeE
Q 008292          342 VATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQ------GAEEFKNEVVLVAKL----QHRNLVRLLGFC  410 (571)
Q Consensus       342 ~~~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~------~~~~~~~Ei~~l~~l----~h~niv~l~~~~  410 (571)
                      ...++|++.+.||+|+||.||+++. .+++.||||++......      ....+.+|+.++.++    +||||+++++++
T Consensus        28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~  107 (312)
T 2iwi_A           28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF  107 (312)
T ss_dssp             -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred             hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence            3457899999999999999999986 46889999999754321      223456799999988    899999999999


Q ss_pred             EeCCeeEEEEEe-cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEEC-CCCceEE
Q 008292          411 LEGEEKILVYEF-VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD-AEMNPKI  488 (571)
Q Consensus       411 ~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~kl  488 (571)
                      ...+..++|+|+ +.+++|.+++..   ...+++..++.++.||++||.|||+++   |+||||||+||+++ .++.+||
T Consensus       108 ~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl  181 (312)
T 2iwi_A          108 ETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKL  181 (312)
T ss_dssp             -----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEE
T ss_pred             ecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEE
Confidence            999999999999 789999999843   456899999999999999999999987   99999999999999 8899999


Q ss_pred             eeccCccccCCCCCccccccccccCCcccccccccCCCC-cchhHHHHHHHHHHHHhCCCCCC
Q 008292          489 SDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFS-VKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       489 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      +|||+++......    .....|+..|+|||.+.+..+. .++||||||+++|||++|+.||.
T Consensus       182 ~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  240 (312)
T 2iwi_A          182 IDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFE  240 (312)
T ss_dssp             CCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             EEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCC
Confidence            9999998764322    2345689999999999877765 58999999999999999999985

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.4e-33  Score=312.08  Aligned_cols=205  Identities=26%  Similarity=0.410  Sum_probs=170.1

Q ss_pred             HHHHhCCCCccccccccCceeEEEEEccC----CCeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeEEeCC
Q 008292          340 IEVATNKFSTDNKLGEGGFGEVYKGVLPS----GQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE  414 (571)
Q Consensus       340 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~  414 (571)
                      +++..++|++.+.||+|+||.||+|.+..    +..||+|+++... ....+.+.+|+.++++++||||+++++++. .+
T Consensus       385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~  463 (656)
T 2j0j_A          385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN  463 (656)
T ss_dssp             TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred             cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cC
Confidence            34455678889999999999999998642    4568999887543 334578899999999999999999999985 45


Q ss_pred             eeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCc
Q 008292          415 EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA  494 (571)
Q Consensus       415 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla  494 (571)
                      ..++||||+++|+|.+++..  ....+++..++.++.|+++||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       464 ~~~lv~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a  538 (656)
T 2j0j_A          464 PVWIIMELCTLGELRSFLQV--RKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLS  538 (656)
T ss_dssp             SCEEEEECCTTCBHHHHHHH--TTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred             ceEEEEEcCCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCC
Confidence            68999999999999999853  2346899999999999999999999987   999999999999999999999999999


Q ss_pred             cccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          495 RIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                      +....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus       539 ~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~  595 (656)
T 2j0j_A          539 RYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG  595 (656)
T ss_dssp             CSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             eecCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCC
Confidence            87643322 12233457789999999999999999999999999999997 9989853

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.5e-33  Score=282.60  Aligned_cols=196  Identities=29%  Similarity=0.457  Sum_probs=161.3

Q ss_pred             hCCCCccccccccCceeEEEEEc-cCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEe----------
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE----------  412 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~----------  412 (571)
                      .++|++.+.||+|+||.||+++. .+++.||||+++.. ....+.+.+|+.++++++||||+++++++.+          
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            45788999999999999999996 47899999998643 3345778999999999999999999998865          


Q ss_pred             ---CCeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEe
Q 008292          413 ---GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKIS  489 (571)
Q Consensus       413 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  489 (571)
                         ....++||||+++++|.+++..  ....+++..++.++.|+++||+|||+++   |+||||||+|||++.++.+||+
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~  158 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHS--ENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG  158 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHH--SCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred             cccCCceEEEEecCCCCCHHHhhhc--cccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence               3467899999999999999953  2345788999999999999999999987   9999999999999999999999


Q ss_pred             eccCccccCCCCC------------ccccccccccCCcccccccccC-CCCcchhHHHHHHHHHHHHhC
Q 008292          490 DFGMARIFGVDQT------------QGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITG  545 (571)
Q Consensus       490 DfGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~slGvvl~elltG  545 (571)
                      |||+++.......            ........|++.|+|||.+.+. .++.++||||||+++|||+++
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~p  227 (303)
T 1zy4_A          159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP  227 (303)
T ss_dssp             CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHSC
T ss_pred             eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHhc
Confidence            9999986542210            1122345689999999998764 789999999999999999983

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=2.6e-33  Score=285.93  Aligned_cols=196  Identities=21%  Similarity=0.271  Sum_probs=145.7

Q ss_pred             hCCCCccc-cccccCceeEEEEEcc-CCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEe----CCeeE
Q 008292          344 TNKFSTDN-KLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE----GEEKI  417 (571)
Q Consensus       344 ~~~~~~~~-~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~----~~~~~  417 (571)
                      .++|.+.+ .||+|+||+||++... +++.||||++...    .....+....+..++||||+++++++..    +...+
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~  102 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL  102 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence            45787754 6999999999999965 6899999998643    2222333344667799999999999876    44579


Q ss_pred             EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCC---CceEEeeccCc
Q 008292          418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE---MNPKISDFGMA  494 (571)
Q Consensus       418 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DfGla  494 (571)
                      +||||+++|+|.+++... ....+++..++.++.||++||.|||+++   |+||||||+|||++.+   +.+||+|||++
T Consensus       103 lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~  178 (336)
T 3fhr_A          103 IIMECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFA  178 (336)
T ss_dssp             EEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccc
Confidence            999999999999999642 2346999999999999999999999987   9999999999999764   45999999999


Q ss_pred             cccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          495 RIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      +.....    ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       179 ~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  231 (336)
T 3fhr_A          179 KETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYS  231 (336)
T ss_dssp             EEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred             eecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence            865422    22345789999999999888999999999999999999999999853

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.6e-34  Score=294.90  Aligned_cols=191  Identities=18%  Similarity=0.195  Sum_probs=158.5

Q ss_pred             hCCCCccccccccCceeEEEEEccCCCeeEEEeecccC--------ccCHHHHHHHHHHHhhcC---------CCcee--
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKAS--------GQGAEEFKNEVVLVAKLQ---------HRNLV--  404 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~--------~~~~~~~~~Ei~~l~~l~---------h~niv--  404 (571)
                      .++|++.++||+|+||+||+++. +|+.||||+++...        ....+.+.+|+.++++++         ||||+  
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            45688899999999999999998 78999999997542        334578899999999886         55555  


Q ss_pred             ---------------ccceeEEe-------------CCeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHH
Q 008292          405 ---------------RLLGFCLE-------------GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARG  456 (571)
Q Consensus       405 ---------------~l~~~~~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~  456 (571)
                                     ++++++.+             .+..++||||+++|++.+.+.    ...+++..+..++.||+.|
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~----~~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR----TKLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT----TTCCCHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH----hcCCCHHHHHHHHHHHHHH
Confidence                           44444443             678999999999997665552    2568999999999999999


Q ss_pred             HHHHH-cCCCCCeEEecCCCCCEEECCCC--------------------ceEEeeccCccccCCCCCccccccccccCCc
Q 008292          457 ILYLH-EDSRLRIIHRDLKASNILLDAEM--------------------NPKISDFGMARIFGVDQTQGNTSRIVGTYGY  515 (571)
Q Consensus       457 L~yLH-~~~~~~ivH~Dlkp~NIll~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y  515 (571)
                      |.||| +++   |+||||||+||||+.++                    .+||+|||+++....       ...+||+.|
T Consensus       174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y  243 (336)
T 2vuw_A          174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVS  243 (336)
T ss_dssp             HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCT
T ss_pred             HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecc
Confidence            99999 887   99999999999999887                    899999999987542       134799999


Q ss_pred             ccccccccCCCCcchhHHHHHHH-HHHHHhCCCCCC
Q 008292          516 MAPEYAMHGQFSVKSDVYSFGVL-VLEIITGKKNSN  550 (571)
Q Consensus       516 ~aPE~~~~~~~s~~~Dv~slGvv-l~elltG~~p~~  550 (571)
                      ||||++.+.. +.++||||+|++ .+++++|..|+.
T Consensus       244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~  278 (336)
T 2vuw_A          244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYS  278 (336)
T ss_dssp             TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred             cChhhhcCCC-ccceehhhhhCCCCcccccccCCCc
Confidence            9999998766 899999998777 778888999874

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.7e-33  Score=292.58  Aligned_cols=202  Identities=25%  Similarity=0.347  Sum_probs=169.3

Q ss_pred             HHHhCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccCccCHHHHHHHHHHHhhcC-CC-----ceeccceeEEeC
Q 008292          341 EVATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ-HR-----NLVRLLGFCLEG  413 (571)
Q Consensus       341 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~-----niv~l~~~~~~~  413 (571)
                      +...++|++.+.||+|+||+||++... +++.||||+++.. ....+++..|+.++..++ |+     +|+++++++...
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~  128 (382)
T 2vx3_A           50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR  128 (382)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred             CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence            344678999999999999999999864 6788999999743 233466778888888875 44     499999999999


Q ss_pred             CeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEEC--CCCceEEeec
Q 008292          414 EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD--AEMNPKISDF  491 (571)
Q Consensus       414 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~Df  491 (571)
                      +..++||||++ ++|.+++... ....+++..+..++.|++.||.|||.+ ..+|+||||||+|||++  .++.+||+||
T Consensus       129 ~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DF  205 (382)
T 2vx3_A          129 NHLCLVFEMLS-YNLYDLLRNT-NFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDF  205 (382)
T ss_dssp             TEEEEEEECCC-CBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred             CceEEEEecCC-CCHHHHHhhc-CcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence            99999999996 5888888532 224589999999999999999999953 23499999999999994  4778999999


Q ss_pred             cCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          492 GMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       492 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      |+++.....     .....||+.|+|||++.+..++.++||||||+++|||+||+.||..
T Consensus       206 G~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~  260 (382)
T 2vx3_A          206 GSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG  260 (382)
T ss_dssp             TTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            999876432     2235789999999999999999999999999999999999999874

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.7e-33  Score=291.21  Aligned_cols=199  Identities=22%  Similarity=0.344  Sum_probs=167.4

Q ss_pred             hCCCCccccccccCceeEEEEEc-cCCCeeEEEeecccCccCHHHHHHHHHHHhhcC-----------CCceeccceeEE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ-----------HRNLVRLLGFCL  411 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----------h~niv~l~~~~~  411 (571)
                      .++|.+.+.||+|+||+||+++. .+++.||||++... ....+.+.+|++++.+++           ||||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            36799999999999999999995 57889999998743 234567889999999886           899999999998


Q ss_pred             eCC----eeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCCeEEecCCCCCEEEC-----
Q 008292          412 EGE----EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED-SRLRIIHRDLKASNILLD-----  481 (571)
Q Consensus       412 ~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivH~Dlkp~NIll~-----  481 (571)
                      ..+    ..++||||+ +++|.+++... ....+++..+..++.||+.||.|||++ +   |+||||||+|||++     
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~  171 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP  171 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHh-hccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence            654    679999999 88999888532 234589999999999999999999997 7   99999999999994     


Q ss_pred             -CCCceEEeeccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 008292          482 -AEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQ  553 (571)
Q Consensus       482 -~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~~~  553 (571)
                       ..+.+||+|||+++.....     .....||+.|+|||++.+..++.++||||||+++|||+||+.||....
T Consensus       172 ~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  239 (373)
T 1q8y_A          172 ENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE  239 (373)
T ss_dssp             TTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             cCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence             4458999999999865432     223478999999999999999999999999999999999999997543

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.6e-33  Score=314.14  Aligned_cols=191  Identities=23%  Similarity=0.384  Sum_probs=164.9

Q ss_pred             hCCCCccccccccCceeEEEEEcc--CCCeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCe-----
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP--SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEE-----  415 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~--~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~-----  415 (571)
                      .++|++.+.||+|+||.||++.+.  +++.||||++.... ....+.+.+|+.++.+++||||+++++++...+.     
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            478999999999999999999964  58899999986533 3445678899999999999999999999987665     


Q ss_pred             eEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCcc
Q 008292          416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR  495 (571)
Q Consensus       416 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  495 (571)
                      .+|||||+++++|.+++.     ..+++.+++.++.||++||.|||+++   |+||||||+|||++.+ .+||+|||+++
T Consensus       159 ~~lv~E~~~g~~L~~~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~  229 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKG-----QKLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVS  229 (681)
T ss_dssp             EEEEEECCCCEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred             eEEEEEeCCCCcHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccch
Confidence            699999999999988762     26899999999999999999999987   9999999999999886 89999999998


Q ss_pred             ccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          496 IFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      .....      ....||+.|+|||++.+.. +.++||||||+++|||++|..|+.
T Consensus       230 ~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~  277 (681)
T 2pzi_A          230 RINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRN  277 (681)
T ss_dssp             ETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEET
T ss_pred             hcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCc
Confidence            65432      3457999999999887654 899999999999999999998865

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.2e-33  Score=307.76  Aligned_cols=201  Identities=30%  Similarity=0.479  Sum_probs=173.0

Q ss_pred             hCCCCccccccccCceeEEEEEc-cCCCeeEEEeeccc-CccCHHHHHHHHHHHhhcCCCceeccceeEEe------CCe
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA-SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE------GEE  415 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~------~~~  415 (571)
                      .++|++.++||+|+||.||++.. .+|+.||||+++.. .....+.+.+|++++++++||||+++++++..      ++.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            36899999999999999999996 46899999998754 34445778999999999999999999998765      667


Q ss_pred             eEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCc---eEEeecc
Q 008292          416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN---PKISDFG  492 (571)
Q Consensus       416 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DfG  492 (571)
                      .++||||+++|+|.+++........+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.   +||+|||
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence            7999999999999999976555557899999999999999999999987   999999999999987765   9999999


Q ss_pred             CccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          493 MARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       493 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      ++.......   ......||+.|+|||.+.+..++.++||||||+++|||+||+.||.
T Consensus       170 ~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~  224 (676)
T 3qa8_A          170 YAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFL  224 (676)
T ss_dssp             CCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence            998764332   2234578999999999999999999999999999999999999984

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2e-33  Score=296.74  Aligned_cols=200  Identities=26%  Similarity=0.322  Sum_probs=156.0

Q ss_pred             CCCCccccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhc-CCCceeccceeEEeCCeeEEEEEec
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFV  423 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~  423 (571)
                      +.|...+.||+|+||+||.....+|+.||||++...   ..+.+.+|+.++.++ +||||+++++++.+++..++||||+
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~   91 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC   91 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred             heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence            345566889999999998766668999999998653   245678899999876 8999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCC----CCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCC-------------Cce
Q 008292          424 PNKSLDYFLYDPEKQG----QLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE-------------MNP  486 (571)
Q Consensus       424 ~~g~L~~~l~~~~~~~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-------------~~~  486 (571)
                      + |+|.+++.......    ..++..++.++.||+.||+|||+++   |+||||||+|||++.+             +.+
T Consensus        92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~  167 (434)
T 2rio_A           92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI  167 (434)
T ss_dssp             S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred             C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence            6 69999986432211    1133356789999999999999987   9999999999999654             489


Q ss_pred             EEeeccCccccCCCCCcc--ccccccccCCccccccccc-------CCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          487 KISDFGMARIFGVDQTQG--NTSRIVGTYGYMAPEYAMH-------GQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       487 kl~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                      ||+|||+++.+.......  ......||+.|+|||++.+       ..++.++||||||+++|||+| |+.||..
T Consensus       168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~  242 (434)
T 2rio_A          168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD  242 (434)
T ss_dssp             EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred             EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCC
Confidence            999999998765432211  2234579999999999865       678999999999999999999 8999853

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=3.8e-33  Score=286.28  Aligned_cols=198  Identities=23%  Similarity=0.362  Sum_probs=167.4

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CC-CeeEEEeecccCccCHHHHHHHHHHHhhcCCCc------eeccceeEEeCCe
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SG-QEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRN------LVRLLGFCLEGEE  415 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g-~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n------iv~l~~~~~~~~~  415 (571)
                      .++|++.+.||+|+||+||++... ++ +.||+|+++.. ....+.+.+|+.++++++|++      ++.+.+++...+.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            478999999999999999999964 34 68999999753 234567888999999998766      8999999999999


Q ss_pred             eEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEE---------------
Q 008292          416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL---------------  480 (571)
Q Consensus       416 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll---------------  480 (571)
                      .++||||+ +++|.+++.. .....+++..++.++.||+.||.|||+++   |+||||||+|||+               
T Consensus        97 ~~lv~e~~-~~~l~~~l~~-~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~  171 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKE-NNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC  171 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred             EEEEEecc-CCChHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence            99999999 5555555532 22346899999999999999999999987   9999999999999               


Q ss_pred             ----CCCCceEEeeccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 008292          481 ----DAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFY  552 (571)
Q Consensus       481 ----~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~~  552 (571)
                          +.++.+||+|||+++.....     .....||+.|+|||.+.+..++.++||||||+++|||+||+.||...
T Consensus       172 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  242 (355)
T 2eu9_A          172 EEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH  242 (355)
T ss_dssp             CEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence                56789999999999864322     23357899999999999999999999999999999999999998743

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=3.2e-33  Score=282.55  Aligned_cols=199  Identities=26%  Similarity=0.434  Sum_probs=151.1

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccCc--cCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASG--QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY  420 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  420 (571)
                      .++|+..+.||+|+||.||++... +|+.||||++.....  ...+.+.++..+++.++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            457888999999999999999974 689999999975432  22234455566788889999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCCeEEecCCCCCEEECCCCceEEeeccCccccCC
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED-SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV  499 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  499 (571)
                      ||+ ++.+..+...  ....+++..++.++.|+++||.|||+. +   |+||||||+||+++.++.+||+|||++..+..
T Consensus       104 e~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  177 (318)
T 2dyl_A          104 ELM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVD  177 (318)
T ss_dssp             CCC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             ecc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence            999 5555555421  245689999999999999999999985 6   99999999999999999999999999976543


Q ss_pred             CCCccccccccccCCcccccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          500 DQTQGNTSRIVGTYGYMAPEYAM-----HGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       500 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ..   ......|++.|+|||.+.     ...++.++||||||+++|||++|+.||..
T Consensus       178 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  231 (318)
T 2dyl_A          178 DK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKN  231 (318)
T ss_dssp             ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             Cc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCC
Confidence            22   123346899999999984     55788999999999999999999999864

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.4e-33  Score=293.54  Aligned_cols=198  Identities=24%  Similarity=0.363  Sum_probs=156.8

Q ss_pred             hCCCCccccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhc-CCCceeccceeEEeCCeeEEEEEe
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      ..+|...+.||+|+||+|+.....+++.||||++......   .+.+|+.+++++ +||||+++++++.+....++||||
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~   99 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL   99 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence            3468888999999999966555558999999999654322   346799999999 799999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECC-----CCceEEeeccCcccc
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-----EMNPKISDFGMARIF  497 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~DfGla~~~  497 (571)
                      ++ |+|.+++...  ...+.+..++.++.||++||.|||+++   |+||||||+|||++.     ...+||+|||+++.+
T Consensus       100 ~~-g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~  173 (432)
T 3p23_A          100 CA-ATLQEYVEQK--DFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL  173 (432)
T ss_dssp             CS-EEHHHHHHSS--SCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred             CC-CCHHHHHHhc--CCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence            96 5898888542  233455567789999999999999987   999999999999953     336889999999876


Q ss_pred             CCCCCc-cccccccccCCcccccccc---cCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 008292          498 GVDQTQ-GNTSRIVGTYGYMAPEYAM---HGQFSVKSDVYSFGVLVLEIIT-GKKNSN  550 (571)
Q Consensus       498 ~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~s~~~Dv~slGvvl~ellt-G~~p~~  550 (571)
                      ...... .......||+.|+|||++.   ...++.++||||||+++|||+| |+.||.
T Consensus       174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~  231 (432)
T 3p23_A          174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFG  231 (432)
T ss_dssp             ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTB
T ss_pred             cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcc
Confidence            433211 2234467999999999997   4577889999999999999999 888874

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.97  E-value=1.3e-31  Score=266.82  Aligned_cols=171  Identities=9%  Similarity=0.067  Sum_probs=149.9

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccCc---cCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASG---QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV  419 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  419 (571)
                      .++|++.+.||+|+||.||++... +++.||||++.....   ...+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  109 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV  109 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence            357899999999999999999975 489999999976533   2346789999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCC
Q 008292          420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV  499 (571)
Q Consensus       420 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  499 (571)
                      |||+++++|.+++..    + ....++.+++.|+++||.|||+++   |+||||||+|||++.++.+||+++|       
T Consensus       110 ~e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~-------  174 (286)
T 3uqc_A          110 AEWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA-------  174 (286)
T ss_dssp             EECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred             EEecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-------
Confidence            999999999999832    2 356678899999999999999987   9999999999999999999998443       


Q ss_pred             CCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          500 DQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                                     |++       .++.++||||||+++|||+||+.||..
T Consensus       175 ---------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~  204 (286)
T 3uqc_A          175 ---------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPE  204 (286)
T ss_dssp             ---------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCC
T ss_pred             ---------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence                           333       368899999999999999999999864

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.97  E-value=2.3e-32  Score=286.82  Aligned_cols=198  Identities=16%  Similarity=0.199  Sum_probs=153.1

Q ss_pred             CCCCccccccccCceeEEEEEc-cCCCeeEEEeecccC---ccCHHHHHHHHHHHhhcCC-Cceeccc---------e--
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQH-RNLVRLL---------G--  408 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h-~niv~l~---------~--  408 (571)
                      .+|...+.||+|+||+||++++ .+|+.||||+++...   ....+.+++|+.++..++| +|.....         .  
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            4577788999999999999994 578999999987433   2335789999999999987 3221111         1  


Q ss_pred             ----------eEEe-----CCeeEEEEEecCCCChhhhhcC----CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeE
Q 008292          409 ----------FCLE-----GEEKILVYEFVPNKSLDYFLYD----PEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRII  469 (571)
Q Consensus       409 ----------~~~~-----~~~~~lv~e~~~~g~L~~~l~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iv  469 (571)
                                +...     ....+++|+++ +++|.+++..    ......+++..++.++.||++||+|||+++   |+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ii  233 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LV  233 (413)
T ss_dssp             ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred             ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence                      1111     12345666654 6889888731    123445788899999999999999999987   99


Q ss_pred             EecCCCCCEEECCCCceEEeeccCccccCCCCCccccccccccCCccccccc----------ccCCCCcchhHHHHHHHH
Q 008292          470 HRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYA----------MHGQFSVKSDVYSFGVLV  539 (571)
Q Consensus       470 H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~s~~~Dv~slGvvl  539 (571)
                      ||||||+||||+.++.+||+|||+++.....     ....+| +.|+|||++          ....++.++||||||+++
T Consensus       234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil  307 (413)
T 3dzo_A          234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI  307 (413)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred             cCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence            9999999999999999999999999865322     334567 999999999          555688999999999999


Q ss_pred             HHHHhCCCCCCCC
Q 008292          540 LEIITGKKNSNFY  552 (571)
Q Consensus       540 ~elltG~~p~~~~  552 (571)
                      |||+||+.||...
T Consensus       308 ~elltg~~Pf~~~  320 (413)
T 3dzo_A          308 YWIWCADLPNTDD  320 (413)
T ss_dssp             HHHHHSSCCCCTT
T ss_pred             HHHHHCCCCCCCc
Confidence            9999999998643

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.97  E-value=1.3e-30  Score=261.53  Aligned_cols=173  Identities=24%  Similarity=0.339  Sum_probs=148.8

Q ss_pred             CCCCcc-ccccccCceeEEEEEc-cCCCeeEEEeecccCccCHHHHHHHHHHH-hhcCCCceeccceeEEe----CCeeE
Q 008292          345 NKFSTD-NKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLV-AKLQHRNLVRLLGFCLE----GEEKI  417 (571)
Q Consensus       345 ~~~~~~-~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l-~~l~h~niv~l~~~~~~----~~~~~  417 (571)
                      ++|.+. +.||+|+||.||++.. .+++.||+|+++..     ..+.+|+.++ +..+||||+++++++..    ....+
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   91 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   91 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence            456666 7799999999999996 46889999998642     4567888887 56699999999999887    66789


Q ss_pred             EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECC---CCceEEeeccCc
Q 008292          418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA---EMNPKISDFGMA  494 (571)
Q Consensus       418 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfGla  494 (571)
                      +||||+++++|.+++... ....+++..++.++.|++.||.|||+++   |+||||||+|||++.   ++.+||+|||++
T Consensus        92 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a  167 (299)
T 3m2w_A           92 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA  167 (299)
T ss_dssp             EEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence            999999999999998542 2346999999999999999999999987   999999999999998   788999999998


Q ss_pred             cccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          495 RIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      ....                        +..++.++||||||+++|||+||+.||.
T Consensus       168 ~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~  199 (299)
T 3m2w_A          168 KETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFY  199 (299)
T ss_dssp             EECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             cccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCC
Confidence            6432                        2356789999999999999999999984

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.96  E-value=6.1e-30  Score=277.88  Aligned_cols=185  Identities=18%  Similarity=0.183  Sum_probs=129.8

Q ss_pred             cccccCceeEEEEE-ccCCCeeEEEeecccC----------ccCHHHHHHHHHHHhhc-CCCceeccceeEEeCCeeEEE
Q 008292          352 KLGEGGFGEVYKGV-LPSGQEIAVKRLSKAS----------GQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILV  419 (571)
Q Consensus       352 ~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~----------~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv  419 (571)
                      ..+.|++|.+..+. .--|+.+++|.+.+..          +...++|.+|+++|+++ .|+||+++++++.++...|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            34566666555544 2358899999986531          23346799999999999 699999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCC
Q 008292          420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV  499 (571)
Q Consensus       420 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  499 (571)
                      |||++|++|.+.+.   ..+.++..   +|+.||+.||+|||+++   ||||||||+||||++++++||+|||+++....
T Consensus       321 MEyv~G~~L~d~i~---~~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~  391 (569)
T 4azs_A          321 MEKLPGRLLSDMLA---AGEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ  391 (569)
T ss_dssp             EECCCSEEHHHHHH---TTCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred             EecCCCCcHHHHHH---hCCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence            99999999999994   34566654   47899999999999998   99999999999999999999999999987643


Q ss_pred             CCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCC
Q 008292          500 DQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKN  548 (571)
Q Consensus       500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p  548 (571)
                      ..  ......+||+.|||||++.+ .+..++|+||+|++++++.++..+
T Consensus       392 ~~--~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          392 DC--SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             ----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             CC--ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            32  23345689999999998865 567789999999998877665443

>3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba}

Probab=99.95  E-value=4.7e-28  Score=201.69  Aligned_cols=106  Identities=19%  Similarity=0.505  Sum_probs=95.0

Q ss_pred             CcccccccCCCCcccCCCchHHHHHHHHHHhcccccCCCCCCCCCceeeccCC-CCCcEEEEEeccCCCCccchHHHHHH
Q 008292           28 DREYATHVCSTTANFTRNSTYEKNLNLLLSSIPTNASRGNGFSSGFFNATAGQ-DPNRVYGLFLCRGDQTTSDCQDCVTF  106 (571)
Q Consensus        28 ~~~~~~~~C~~~~~~~~~s~~~~nl~~l~~~l~~~~~~~~~~~~~f~~~~~g~-~~~~vyg~~~C~~D~~~~~C~~Cl~~  106 (571)
                      ...++++.|++ ++|+++++|++||+.||++|+++++.   ...+|+++..|. ++++||||+|||||+++++|..||+.
T Consensus         2 ~t~~v~~~Cn~-~~~t~~s~f~~nl~~ll~~L~~~a~~---s~~~~~t~~~~~~~~~~vygl~qC~~Dls~~~C~~Cl~~   77 (108)
T 3a2e_A            2 NTAFVSSACNT-QKIPSGSPFNRNLRAMLADLRQNTAF---SGYDYKTSRAGSGGAPTAYGRATCKQSISQSDCTACLSN   77 (108)
T ss_dssp             CCCEEEEEECS-SBCCTTCTHHHHHHHHHHHHHHHGGG---TTSEEEEEECCSTTCCCEEEEEEECTTSCHHHHHHHHHH
T ss_pred             CcceeeeecCC-CccCCCChHHHHHHHHHHHHHhhCcc---ccCCceEeeccCCCCceEEEEEEEcCCCCHHHHHHHHHH
Confidence            34678899964 79999999999999999999999863   345677776664 56899999999999999999999999


Q ss_pred             HHHHHhhhCCCCceeEEEcceeEEEEcCCcc
Q 008292          107 AARDVLQLCPVSKETILWYAECLLRYSDQSI  137 (571)
Q Consensus       107 a~~~~~~~C~~~~~a~~~~~~C~~ry~~~~f  137 (571)
                      |+.++.++|+++++|+||++.|+||||+++|
T Consensus        78 a~~~~~~~C~~~~g~~i~~~~C~lRY~~~~F  108 (108)
T 3a2e_A           78 LVNRIFSICNNAIGARVQLVDCFIQYEQRSF  108 (108)
T ss_dssp             HHTTHHHHTTSBSSEEEEETTEEEEEESSCC
T ss_pred             HHHHHHHHCCCCceEEEECCCEEEEEeCCcC
Confidence            9999999999999999999999999999998

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.94  E-value=2.2e-27  Score=256.44  Aligned_cols=185  Identities=16%  Similarity=0.221  Sum_probs=147.0

Q ss_pred             CccccccccCceeEEEEEccCCCeeEEEeecccCc--------cCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEE
Q 008292          348 STDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASG--------QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV  419 (571)
Q Consensus       348 ~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~--------~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  419 (571)
                      ...++||+|+||+||++.. .++.+++|+......        ...+++.+|++++++++||||+++..++...+..+||
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            4467899999999999965 578888887643221        1134589999999999999999887777788889999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCC
Q 008292          420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV  499 (571)
Q Consensus       420 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  499 (571)
                      |||+++++|.+++..           +..++.|+++||.|||+++   |+||||||+|||++.  ++||+|||+++....
T Consensus       418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~  481 (540)
T 3en9_A          418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL  481 (540)
T ss_dssp             EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred             EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence            999999999999843           5689999999999999987   999999999999998  999999999997643


Q ss_pred             CCCcc-----ccccccccCCccccccccc--CCCCcchhHHHHHHHHHHHHhCCCCC
Q 008292          500 DQTQG-----NTSRIVGTYGYMAPEYAMH--GQFSVKSDVYSFGVLVLEIITGKKNS  549 (571)
Q Consensus       500 ~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~s~~~Dv~slGvvl~elltG~~p~  549 (571)
                      .....     ......||+.|||||++..  ..|+..+|+|+..+-..+-+.++.++
T Consensus       482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            22111     1235679999999999976  56888899999999999999888775

>3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba}

Probab=99.89  E-value=1.8e-23  Score=174.02  Aligned_cols=106  Identities=27%  Similarity=0.446  Sum_probs=96.8

Q ss_pred             CCCceEeeccccCCchhHHHHHHHHHHHHHHHHhhccCCceeeeecccCCccceeEEEEeecCCCccchhhHHHHHHhcc
Q 008292          143 TSPTVSLLNTQNVTDQGRLNELVGTQMSQVVTQAVSNTKRFATRKANFTTFQTLYSLAQCTPDLSSSDCNTCLRGAVARL  222 (571)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~f~~~~~~ll~~l~~~a~~~~~~~a~~~~~~~~~~~vy~l~QC~~Dls~~~C~~Cl~~~~~~~  222 (571)
                      +......||..++++.+.|+++++.||..|...|+.++.+|+++.....+.++||||+||+||+++.+|+.||+.++.++
T Consensus         3 t~~v~~~Cn~~~~t~~s~f~~nl~~ll~~L~~~a~~s~~~~~t~~~~~~~~~~vygl~qC~~Dls~~~C~~Cl~~a~~~~   82 (108)
T 3a2e_A            3 TAFVSSACNTQKIPSGSPFNRNLRAMLADLRQNTAFSGYDYKTSRAGSGGAPTAYGRATCKQSISQSDCTACLSNLVNRI   82 (108)
T ss_dssp             CCEEEEEECSSBCCTTCTHHHHHHHHHHHHHHHGGGTTSEEEEEECCSTTCCCEEEEEEECTTSCHHHHHHHHHHHHTTH
T ss_pred             cceeeeecCCCccCCCChHHHHHHHHHHHHHhhCccccCCceEeeccCCCCceEEEEEEEcCCCCHHHHHHHHHHHHHHH
Confidence            44567789999999999999999999999999988877788887766556789999999999999999999999999999


Q ss_pred             ccCCCCCcccEEEccccccccccCcc
Q 008292          223 PSCCSGKQGGRVLFPSCNVRYELYPF  248 (571)
Q Consensus       223 ~~~c~~~~g~~v~~~~C~lry~~~~f  248 (571)
                      +++|+++.||+|++++|++|||.++|
T Consensus        83 ~~~C~~~~g~~i~~~~C~lRY~~~~F  108 (108)
T 3a2e_A           83 FSICNNAIGARVQLVDCFIQYEQRSF  108 (108)
T ss_dssp             HHHTTSBSSEEEEETTEEEEEESSCC
T ss_pred             HHHCCCCceEEEECCCEEEEEeCCcC
Confidence            99999999999999999999999987

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.89  E-value=1.1e-23  Score=208.77  Aligned_cols=150  Identities=19%  Similarity=0.120  Sum_probs=120.9

Q ss_pred             HHHHhCCCCccccccccCceeEEEEEccCCCeeEEEeecccCc------------------cCHHHHHHHHHHHhhcCCC
Q 008292          340 IEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASG------------------QGAEEFKNEVVLVAKLQHR  401 (571)
Q Consensus       340 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~------------------~~~~~~~~Ei~~l~~l~h~  401 (571)
                      +......|.+.+.||+|+||.||++...+|+.||+|.++....                  .....+.+|+.++++++  
T Consensus        85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--  162 (282)
T 1zar_A           85 LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--  162 (282)
T ss_dssp             HHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--
T ss_pred             HHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--
Confidence            3344566778899999999999999997799999999964321                  12456889999999999  


Q ss_pred             ceeccceeEEeCCeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEEC
Q 008292          402 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD  481 (571)
Q Consensus       402 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~  481 (571)
                      | +++.+++. .+..++||||+++++|.+ +..         .....++.|+++||.|||+.+   |+||||||+|||++
T Consensus       163 ~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~  227 (282)
T 1zar_A          163 G-LAVPKVYA-WEGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS  227 (282)
T ss_dssp             T-SSSCCEEE-EETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE
T ss_pred             C-CCcCeEEe-ccceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE
Confidence            5 67777553 356799999999999988 411         224569999999999999987   99999999999999


Q ss_pred             CCCceEEeeccCccccCCCCCccccccccccCCcccccccc
Q 008292          482 AEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM  522 (571)
Q Consensus       482 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~  522 (571)
                       ++.+||+|||+++.               +..++|||++.
T Consensus       228 -~~~vkl~DFG~a~~---------------~~~~~a~e~l~  252 (282)
T 1zar_A          228 -EEGIWIIDFPQSVE---------------VGEEGWREILE  252 (282)
T ss_dssp             -TTEEEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred             -CCcEEEEECCCCeE---------------CCCCCHHHHHH
Confidence             99999999999863               23578999874

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.78  E-value=1.6e-19  Score=176.54  Aligned_cols=136  Identities=17%  Similarity=0.182  Sum_probs=105.7

Q ss_pred             CCccccccccCceeEEEEEc-cCCCe--eEEEeecccCcc------------------------CHHHHHHHHHHHhhcC
Q 008292          347 FSTDNKLGEGGFGEVYKGVL-PSGQE--IAVKRLSKASGQ------------------------GAEEFKNEVVLVAKLQ  399 (571)
Q Consensus       347 ~~~~~~LG~G~fg~Vy~~~~-~~g~~--vavK~~~~~~~~------------------------~~~~~~~Ei~~l~~l~  399 (571)
                      |++.+.||+|+||.||++.. .+|+.  ||||+++.....                        ....+.+|+.++.+++
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            56788999999999999997 68888  999987543211                        0136788999999998


Q ss_pred             CCce--eccceeEEeCCeeEEEEEecCC-C----ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH-cCCCCCeEEe
Q 008292          400 HRNL--VRLLGFCLEGEEKILVYEFVPN-K----SLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH-EDSRLRIIHR  471 (571)
Q Consensus       400 h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH-~~~~~~ivH~  471 (571)
                      |+++  ..+++.    ...+|||||+.+ |    +|.++...      .++..+..++.|++.+|.||| +.+   |+||
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivHr  195 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVHA  195 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EECS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEeC
Confidence            8864  333332    356899999942 4    56655421      234467789999999999999 877   9999


Q ss_pred             cCCCCCEEECCCCceEEeeccCcccc
Q 008292          472 DLKASNILLDAEMNPKISDFGMARIF  497 (571)
Q Consensus       472 Dlkp~NIll~~~~~~kl~DfGla~~~  497 (571)
                      ||||+|||+++  .++|+|||++...
T Consensus       196 Dlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          196 DLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SCSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCCHHHEEEcC--cEEEEECcccccC
Confidence            99999999998  8999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.68  E-value=1.5e-17  Score=169.14  Aligned_cols=141  Identities=16%  Similarity=0.178  Sum_probs=100.4

Q ss_pred             CCCCccccccccCceeEEEEEccCCCeeEEEeecccC--------------ccCHHHHHHHHHHHhhcCCCceeccceeE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKAS--------------GQGAEEFKNEVVLVAKLQHRNLVRLLGFC  410 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~--------------~~~~~~~~~Ei~~l~~l~h~niv~l~~~~  410 (571)
                      .-|++.++||+|++|.||+|..++|+.||||+++...              .........+++++....|+|+.++....
T Consensus        95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g  174 (397)
T 4gyi_A           95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG  174 (397)
T ss_dssp             SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence            3488999999999999999999899999999875321              01112223333343334444444443221


Q ss_pred             E------eCCeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCC
Q 008292          411 L------EGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM  484 (571)
Q Consensus       411 ~------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~  484 (571)
                      .      .....+|||||+++++|..+...         .....++.|++.+|.+||+.+   ||||||||.||||++++
T Consensus       175 v~vp~p~~~~~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dg  242 (397)
T 4gyi_A          175 FPVPEPIAQSRHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEK  242 (397)
T ss_dssp             CSCCCEEEEETTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEE
T ss_pred             CCCCeeeeccCceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCC
Confidence            1      11234799999999988765411         123567899999999999987   99999999999998776


Q ss_pred             ----------ceEEeeccCcccc
Q 008292          485 ----------NPKISDFGMARIF  497 (571)
Q Consensus       485 ----------~~kl~DfGla~~~  497 (571)
                                .+.|+||+-+...
T Consensus       243 d~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          243 DAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             CSSCTTSEEEEEEECCCTTCEET
T ss_pred             CcccccccccceEEEEeCCcccC
Confidence                      3899999987543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.33  E-value=3.3e-12  Score=124.65  Aligned_cols=144  Identities=19%  Similarity=0.099  Sum_probs=113.0

Q ss_pred             hCCCCccccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhcC-CCceeccceeEEeCCeeEEEEEe
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      -..|+....++.|+.+.||+... ++..+++|+...........+.+|+.+++.+. +..+.+++++....+..++||||
T Consensus        13 l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~   91 (263)
T 3tm0_A           13 IEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE   91 (263)
T ss_dssp             HTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred             hccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence            35688888889899999999986 46889999987532233346889999999885 67788899999888899999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC---------------------------------------
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED---------------------------------------  463 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~---------------------------------------  463 (571)
                      ++|.+|.+.+..        ......++.+++++|..||+.                                       
T Consensus        92 i~G~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (263)
T 3tm0_A           92 ADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP  163 (263)
T ss_dssp             CSSEEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred             cCCeehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence            999999876411        122346788999999999981                                       


Q ss_pred             -----------------CCCCeEEecCCCCCEEECCCCceEEeeccCccc
Q 008292          464 -----------------SRLRIIHRDLKASNILLDAEMNPKISDFGMARI  496 (571)
Q Consensus       464 -----------------~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  496 (571)
                                       ....++|+|++|.|||++++..+.|+||+.+..
T Consensus       164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                             113489999999999998766667999998753

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.19  E-value=1.8e-11  Score=119.03  Aligned_cols=129  Identities=18%  Similarity=0.151  Sum_probs=97.8

Q ss_pred             cccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCc--eeccceeEEeCCeeEEEEEecCCCChhhh
Q 008292          354 GEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRN--LVRLLGFCLEGEEKILVYEFVPNKSLDYF  431 (571)
Q Consensus       354 G~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~  431 (571)
                      +.|..+.||+....+|..+++|.....   ....+.+|+.+++.+.+.+  +.+++++...++..++||||++|.+|.  
T Consensus        29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--  103 (264)
T 1nd4_A           29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--  103 (264)
T ss_dssp             CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred             cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence            456669999998877888999987654   2245788999999886555  456888887777889999999999884  


Q ss_pred             hcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-----------------------------------------------
Q 008292          432 LYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS-----------------------------------------------  464 (571)
Q Consensus       432 l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----------------------------------------------  464 (571)
                      ...      .+   ...++.++++.|..||+..                                               
T Consensus       104 ~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  174 (264)
T 1nd4_A          104 SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARL  174 (264)
T ss_dssp             TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHH
T ss_pred             cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHH
Confidence            211      11   2256778888888888642                                               


Q ss_pred             --------CCCeEEecCCCCCEEECCCCceEEeeccCccc
Q 008292          465 --------RLRIIHRDLKASNILLDAEMNPKISDFGMARI  496 (571)
Q Consensus       465 --------~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  496 (571)
                              ...++|+|++|.|||+++++.++|+||+.+..
T Consensus       175 ~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          175 KARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             HHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                    12299999999999998776677999998753

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.05  E-value=4.8e-10  Score=114.59  Aligned_cols=142  Identities=18%  Similarity=0.272  Sum_probs=106.3

Q ss_pred             ccccccccCceeEEEEEccCCCeeEEEeec--ccC-ccCHHHHHHHHHHHhhcCC--CceeccceeEEeC---CeeEEEE
Q 008292          349 TDNKLGEGGFGEVYKGVLPSGQEIAVKRLS--KAS-GQGAEEFKNEVVLVAKLQH--RNLVRLLGFCLEG---EEKILVY  420 (571)
Q Consensus       349 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~--~~~-~~~~~~~~~Ei~~l~~l~h--~niv~l~~~~~~~---~~~~lv~  420 (571)
                      ..+.|+.|.++.||+.... +..+++|+..  ... ......+.+|..+++.+.+  ..+.+++.++.+.   ...++||
T Consensus        42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            4567899999999999875 4678888775  322 1234577889999999874  4578888887766   3479999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC------------------------------------
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS------------------------------------  464 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------------------------------------  464 (571)
                      ||++|..+.+..     ...++..++..++.++++.|..||...                                    
T Consensus       121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            999998874322     224678888899999999999999731                                    


Q ss_pred             -------------------CCCeEEecCCCCCEEECCCCc--eEEeeccCccc
Q 008292          465 -------------------RLRIIHRDLKASNILLDAEMN--PKISDFGMARI  496 (571)
Q Consensus       465 -------------------~~~ivH~Dlkp~NIll~~~~~--~kl~DfGla~~  496 (571)
                                         ...++|+|+++.|||+++++.  +.|.||+.+..
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                               246999999999999997753  68999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.99  E-value=1.8e-10  Score=114.92  Aligned_cols=187  Identities=20%  Similarity=0.218  Sum_probs=120.9

Q ss_pred             cccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhcC-CCc--eeccceeEEeCC---eeEEEEEec
Q 008292          350 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ-HRN--LVRLLGFCLEGE---EKILVYEFV  423 (571)
Q Consensus       350 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~e~~  423 (571)
                      .+.++.|....||+..    ..+++|+....  .....+.+|..+++.+. +..  +.+++.......   ..++|||++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            4568999999999853    56888886533  33567889999998874 333  334444433332   347899999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC----------------------------------------
Q 008292          424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED----------------------------------------  463 (571)
Q Consensus       424 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~----------------------------------------  463 (571)
                      +|..|.....     ..++..++..++.++++.|..||+.                                        
T Consensus        99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  173 (304)
T 3sg8_A           99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV  173 (304)
T ss_dssp             CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred             CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence            9988865331     2467777788888888888888851                                        


Q ss_pred             ---------------CCCCeEEecCCCCCEEECC--CCceEEeeccCccccCCCCCcccccc------------ccccCC
Q 008292          464 ---------------SRLRIIHRDLKASNILLDA--EMNPKISDFGMARIFGVDQTQGNTSR------------IVGTYG  514 (571)
Q Consensus       464 ---------------~~~~ivH~Dlkp~NIll~~--~~~~kl~DfGla~~~~~~~~~~~~~~------------~~gt~~  514 (571)
                                     ..+.++|+|++|.||++++  +..+.|+||+.+..-...........            ......
T Consensus       174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~  253 (304)
T 3sg8_A          174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK  253 (304)
T ss_dssp             HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred             HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence                           1245899999999999988  55688999999865322110000000            000001


Q ss_pred             ccc-ccccccCCCCcchhHHHHHHHHHHHHhCCCCC
Q 008292          515 YMA-PEYAMHGQFSVKSDVYSFGVLVLEIITGKKNS  549 (571)
Q Consensus       515 y~a-PE~~~~~~~s~~~Dv~slGvvl~elltG~~p~  549 (571)
                      ... |+...  ......+.|+++.++|++.+|+.++
T Consensus       254 ~~~~~~~~~--r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          254 HKDIPTVLE--KYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             CSCHHHHHH--HHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CCCcHHHHH--HHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            111 22111  0112368999999999999999874

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.46  E-value=9.1e-07  Score=87.99  Aligned_cols=137  Identities=22%  Similarity=0.171  Sum_probs=95.3

Q ss_pred             cccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCC---ceeccceeEE-eCCeeEEEEEecCC
Q 008292          350 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHR---NLVRLLGFCL-EGEEKILVYEFVPN  425 (571)
Q Consensus       350 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~~  425 (571)
                      .+.++.|....||+.    |..+++|+...  ......+.+|..+|..+.+.   .+.+.+.+.. ..+..++||||++|
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            456788888899987    57788888532  23356788999999998753   2556666654 33457899999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC------------------------------------------
Q 008292          426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED------------------------------------------  463 (571)
Q Consensus       426 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~------------------------------------------  463 (571)
                      ..+.....     ..++..+...++.++++.|..||+.                                          
T Consensus        98 ~~l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l  172 (306)
T 3tdw_A           98 QILGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL  172 (306)
T ss_dssp             EECHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred             eECchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence            88865321     1234455555566666666655542                                          


Q ss_pred             ---------------CCCCeEEecCCCCCEEECC---CCc-eEEeeccCcccc
Q 008292          464 ---------------SRLRIIHRDLKASNILLDA---EMN-PKISDFGMARIF  497 (571)
Q Consensus       464 ---------------~~~~ivH~Dlkp~NIll~~---~~~-~kl~DfGla~~~  497 (571)
                                     ..+.++|+|+++.||++++   ++. +.|+||+.+..-
T Consensus       173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                           2234799999999999987   455 489999988653

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.39  E-value=9.9e-07  Score=85.87  Aligned_cols=135  Identities=19%  Similarity=0.186  Sum_probs=94.6

Q ss_pred             cccccCce-eEEEEEcc-CCCeeEEEeecccCccCHHHHHHHHHHHhhcC-CCceeccceeEEeCCeeEEEEEecCCCCh
Q 008292          352 KLGEGGFG-EVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEKILVYEFVPNKSL  428 (571)
Q Consensus       352 ~LG~G~fg-~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~L  428 (571)
                      .+..|..| .||+.... ++..+++|+-...   ...++.+|...|+.+. +--+.++++++.+.+..++|||++++.++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence            34455554 68987754 4567888876543   3456788999888774 33367788888888999999999999887


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC---------------------------------------------
Q 008292          429 DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED---------------------------------------------  463 (571)
Q Consensus       429 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~---------------------------------------------  463 (571)
                      .+....       .......+..++++.|.-||..                                             
T Consensus       108 ~~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (272)
T 4gkh_A          108 FQVLEE-------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW  180 (272)
T ss_dssp             HHHHHH-------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred             cccccC-------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence            665421       1112234555666666666642                                             


Q ss_pred             ----------CCCCeEEecCCCCCEEECCCCceEEeeccCccc
Q 008292          464 ----------SRLRIIHRDLKASNILLDAEMNPKISDFGMARI  496 (571)
Q Consensus       464 ----------~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  496 (571)
                                ..+.++|+|+.+.|||+++++.+-|+||+.+..
T Consensus       181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                      112389999999999999887778999998864

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.34  E-value=6.9e-07  Score=90.84  Aligned_cols=81  Identities=9%  Similarity=0.043  Sum_probs=55.8

Q ss_pred             cccc-cccCceeEEEEEcc-------CCCeeEEEeecccC---ccCHHHHHHHHHHHhhcCC---CceeccceeEEeC--
Q 008292          350 DNKL-GEGGFGEVYKGVLP-------SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQH---RNLVRLLGFCLEG--  413 (571)
Q Consensus       350 ~~~L-G~G~fg~Vy~~~~~-------~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h---~niv~l~~~~~~~--  413 (571)
                      .+.| +.|....+|+....       ++..+++|+.....   ......+.+|+.+++.+..   -.+.+++.++.++  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            4567 88888999998764       26678888765432   1112456788888887743   3466777776554  


Q ss_pred             -CeeEEEEEecCCCChhh
Q 008292          414 -EEKILVYEFVPNKSLDY  430 (571)
Q Consensus       414 -~~~~lv~e~~~~g~L~~  430 (571)
                       ...++||||++|..+.+
T Consensus       105 ~g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             TSSCEEEEECCCCBCCCB
T ss_pred             cCCceEEEEecCCCChhh
Confidence             34689999999877653

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=98.10  E-value=1.1e-05  Score=79.28  Aligned_cols=82  Identities=17%  Similarity=0.263  Sum_probs=60.6

Q ss_pred             HhCCCCccccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCC---ceeccceeEEeCCeeEEE
Q 008292          343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHR---NLVRLLGFCLEGEEKILV  419 (571)
Q Consensus       343 ~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~---niv~l~~~~~~~~~~~lv  419 (571)
                      ...++...+.+|.|..+.||+.++.+|+.|++|+...........|..|...|+.+...   -+.+.+++    +..++|
T Consensus        13 ~G~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv   88 (288)
T 3f7w_A           13 TGREVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLA   88 (288)
T ss_dssp             HCCCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEE
T ss_pred             cCCCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEE
Confidence            34566677889999999999999999999999987655444455678899988887432   23444443    234789


Q ss_pred             EEecCCCCh
Q 008292          420 YEFVPNKSL  428 (571)
Q Consensus       420 ~e~~~~g~L  428 (571)
                      |||++++..
T Consensus        89 ~e~l~~~~~   97 (288)
T 3f7w_A           89 MEWVDERPP   97 (288)
T ss_dssp             EECCCCCCC
T ss_pred             EEeecccCC
Confidence            999987654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.05  E-value=1.2e-05  Score=82.83  Aligned_cols=75  Identities=12%  Similarity=0.143  Sum_probs=50.0

Q ss_pred             cccccccCceeEEEEEcc-CCCeeEEEeecccC-------ccCHHHHHHHHHHHhhcCC--Cc-eeccceeEEeCCeeEE
Q 008292          350 DNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS-------GQGAEEFKNEVVLVAKLQH--RN-LVRLLGFCLEGEEKIL  418 (571)
Q Consensus       350 ~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-------~~~~~~~~~Ei~~l~~l~h--~n-iv~l~~~~~~~~~~~l  418 (571)
                      .+.||.|..+.||++... +++.++||......       ....+.+..|.++++.+..  +. +.+++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            467899999999999764 46789999764321       1233456788888887743  33 3344443  4556789


Q ss_pred             EEEecCCC
Q 008292          419 VYEFVPNK  426 (571)
Q Consensus       419 v~e~~~~g  426 (571)
                      |||++++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999874

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.03  E-value=6.1e-06  Score=83.05  Aligned_cols=141  Identities=15%  Similarity=0.196  Sum_probs=80.4

Q ss_pred             ccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhcC-----CCceeccc-e--eEEeCCeeEEEEEe
Q 008292          351 NKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ-----HRNLVRLL-G--FCLEGEEKILVYEF  422 (571)
Q Consensus       351 ~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----h~niv~l~-~--~~~~~~~~~lv~e~  422 (571)
                      +.|+.|..+.||+....+| .+++|+....    ..++..|..++..+.     .|.++.-. |  +....+..+++|||
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            4566677889999887555 4889988652    234445555555543     23333311 1  12345678999999


Q ss_pred             cCCCChhh--------------hhcC----C--CCC-----CCCCHHHH-------------------------------
Q 008292          423 VPNKSLDY--------------FLYD----P--EKQ-----GQLDWSRR-------------------------------  446 (571)
Q Consensus       423 ~~~g~L~~--------------~l~~----~--~~~-----~~l~~~~~-------------------------------  446 (571)
                      ++|..+..              -+|.    .  ...     ....|...                               
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            99865420              0110    0  000     01123211                               


Q ss_pred             HHHHHHHHHHHHHHHc----------CCCCCeEEecCCCCCEEECCCCceEEeeccCccc
Q 008292          447 YKIIGGIARGILYLHE----------DSRLRIIHRDLKASNILLDAEMNPKISDFGMARI  496 (571)
Q Consensus       447 ~~i~~~ia~~L~yLH~----------~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  496 (571)
                      ..+..++.+++.+|+.          .....++|+|+++.|||++.++.+.|+||+.+..
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            1111223445666653          1234699999999999998888999999998753

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.89  E-value=4.7e-05  Score=75.52  Aligned_cols=141  Identities=18%  Similarity=0.174  Sum_probs=93.4

Q ss_pred             CCccccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhcC---CCceeccceeEEeCCeeEEEEEec
Q 008292          347 FSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ---HRNLVRLLGFCLEGEEKILVYEFV  423 (571)
Q Consensus       347 ~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~  423 (571)
                      ....+.|+.|....+|+... ++..+++|+....   ....+..|...|+.+.   ...+.+++++....+..++||||+
T Consensus        38 i~~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l  113 (312)
T 3jr1_A           38 IKHKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEAL  113 (312)
T ss_dssp             CCEEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECC
T ss_pred             eeeeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEec
Confidence            34457799999999999887 5678888887543   3567888988888874   356788888887778899999999


Q ss_pred             CCCChhh-----------hhcCCCC-C----------C--------CCCHHHHH---HHH----------------HHHH
Q 008292          424 PNKSLDY-----------FLYDPEK-Q----------G--------QLDWSRRY---KII----------------GGIA  454 (571)
Q Consensus       424 ~~g~L~~-----------~l~~~~~-~----------~--------~l~~~~~~---~i~----------------~~ia  454 (571)
                      ++..+..           -||.... .          +        .-+|....   ++.                .++.
T Consensus       114 ~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~  193 (312)
T 3jr1_A          114 NKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIV  193 (312)
T ss_dssp             CCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHH
T ss_pred             cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHH
Confidence            9886521           1121111 0          0        12454321   111                1111


Q ss_pred             HH-HHHHHc-CCCCCeEEecCCCCCEEECCCCceEEeecc
Q 008292          455 RG-ILYLHE-DSRLRIIHRDLKASNILLDAEMNPKISDFG  492 (571)
Q Consensus       455 ~~-L~yLH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG  492 (571)
                      +- ...|.. ...+.++|+|+.+.||+++.++ +.|.|+.
T Consensus       194 ~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          194 QIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            11 223421 2356799999999999999887 8999984

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.73  E-value=9.4e-05  Score=76.78  Aligned_cols=80  Identities=10%  Similarity=0.049  Sum_probs=48.0

Q ss_pred             CCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCccccccccccCCcccccccccC---CCCcchhHHHHHHHHHH
Q 008292          465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG---QFSVKSDVYSFGVLVLE  541 (571)
Q Consensus       465 ~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~~~Dv~slGvvl~e  541 (571)
                      ...++|+|+++.|||+++++ ++|+||+.+..-......... ...-...|.+|+.....   ......++.+....+|+
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAY-LGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN  308 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHH-HHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHH-HHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence            34699999999999998876 999999988643211000000 00001345666544311   11223566678888888


Q ss_pred             HHhCC
Q 008292          542 IITGK  546 (571)
Q Consensus       542 lltG~  546 (571)
                      .++++
T Consensus       309 ~y~~~  313 (420)
T 2pyw_A          309 LFNKR  313 (420)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            87764

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.51  E-value=0.00033  Score=69.61  Aligned_cols=143  Identities=16%  Similarity=0.109  Sum_probs=79.3

Q ss_pred             ccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCc--eecccee------EEeCCeeEEEEEe
Q 008292          351 NKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRN--LVRLLGF------CLEGEEKILVYEF  422 (571)
Q Consensus       351 ~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n--iv~l~~~------~~~~~~~~lv~e~  422 (571)
                      +.|+.|....+|+....+| .+++|......  ..+++..|+.++..+...+  +.+++..      ....+..+++++|
T Consensus        28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~  104 (322)
T 2ppq_A           28 KGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF  104 (322)
T ss_dssp             EEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred             eccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence            4567788889999887555 68889876521  1234566777777664222  2333321      1234567899999


Q ss_pred             cCCCChhhh--------------hcCC----CCC--CCC---CHHHHHHH------------HHHHHHHHHHHHcC----
Q 008292          423 VPNKSLDYF--------------LYDP----EKQ--GQL---DWSRRYKI------------IGGIARGILYLHED----  463 (571)
Q Consensus       423 ~~~g~L~~~--------------l~~~----~~~--~~l---~~~~~~~i------------~~~ia~~L~yLH~~----  463 (571)
                      ++|..+...              +|..    ...  ...   .|...+.-            ...+.+.++.|++.    
T Consensus       105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~  184 (322)
T 2ppq_A          105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD  184 (322)
T ss_dssp             CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred             CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence            998654210              1110    000  001   12221110            01134445555421    


Q ss_pred             CCCCeEEecCCCCCEEECCCCceEEeeccCccc
Q 008292          464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARI  496 (571)
Q Consensus       464 ~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  496 (571)
                      ....++|+|+++.|||++++..+.|+||+.+..
T Consensus       185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             SCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             CCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence            234599999999999998876668999998753

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.49  E-value=0.0003  Score=69.36  Aligned_cols=138  Identities=14%  Similarity=0.125  Sum_probs=75.9

Q ss_pred             cccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCce-eccceeEEeCCeeEEEEEec-CCCC
Q 008292          350 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNL-VRLLGFCLEGEEKILVYEFV-PNKS  427 (571)
Q Consensus       350 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~g~  427 (571)
                      .+.|+.|....+|+.     ..+++|+........ ....+|..+++.+...++ .++++.  +.+..++++||+ ++.+
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~   94 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT   94 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence            678889999999998     568888876532221 123567777777653333 344443  344567899999 6655


Q ss_pred             hhhh------------------hcCCCC--CCCCC-HHHHHHHHHH--------------HHHHHH----HHHc-CCCCC
Q 008292          428 LDYF------------------LYDPEK--QGQLD-WSRRYKIIGG--------------IARGIL----YLHE-DSRLR  467 (571)
Q Consensus       428 L~~~------------------l~~~~~--~~~l~-~~~~~~i~~~--------------ia~~L~----yLH~-~~~~~  467 (571)
                      +...                  +|....  ....+ +..+..+...              +.+.+.    .|.. .....
T Consensus        95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~  174 (301)
T 3dxq_A           95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA  174 (301)
T ss_dssp             CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred             CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence            4310                  111100  00011 1111111110              111111    1111 22345


Q ss_pred             eEEecCCCCCEEECCCCceEEeeccCccc
Q 008292          468 IIHRDLKASNILLDAEMNPKISDFGMARI  496 (571)
Q Consensus       468 ivH~Dlkp~NIll~~~~~~kl~DfGla~~  496 (571)
                      ++|+|+.+.||+ ..++.+.|+||..+..
T Consensus       175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          175 ACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             EECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            899999999999 5666789999998764

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.38  E-value=0.0011  Score=65.91  Aligned_cols=142  Identities=16%  Similarity=0.159  Sum_probs=82.3

Q ss_pred             ccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCc--eecccee-----EEeCCeeEEEEEec
Q 008292          351 NKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRN--LVRLLGF-----CLEGEEKILVYEFV  423 (571)
Q Consensus       351 ~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n--iv~l~~~-----~~~~~~~~lv~e~~  423 (571)
                      ..|+ |....||+....+|+.+++|...... ...+.+..|..++..+....  +.+++..     ...++..+++|||+
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i  109 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV  109 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence            3466 77789999887778789999986432 23566777888887774322  3444443     12244567899999


Q ss_pred             CCCChhh-----h---------hcC----C--CCCCCCCHHHH----------------------HHHHHHHHHHHHHHH
Q 008292          424 PNKSLDY-----F---------LYD----P--EKQGQLDWSRR----------------------YKIIGGIARGILYLH  461 (571)
Q Consensus       424 ~~g~L~~-----~---------l~~----~--~~~~~l~~~~~----------------------~~i~~~ia~~L~yLH  461 (571)
                      +|..+..     .         +|.    .  ......++...                      ...+.+++..+.-+-
T Consensus       110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  189 (328)
T 1zyl_A          110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW  189 (328)
T ss_dssp             CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence            8855421     0         110    0  00111222211                      111112222222211


Q ss_pred             c-CCCCCeEEecCCCCCEEECCCCceEEeeccCccc
Q 008292          462 E-DSRLRIIHRDLKASNILLDAEMNPKISDFGMARI  496 (571)
Q Consensus       462 ~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  496 (571)
                      . .....++|+|+++.|||++ + .+.|+||+.+..
T Consensus       190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            1 1234589999999999999 4 899999988754

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.25  E-value=0.00033  Score=72.82  Aligned_cols=73  Identities=16%  Similarity=0.273  Sum_probs=49.1

Q ss_pred             cccccccCceeEEEEEccC--------CCeeEEEeecccCccCHHHHHHHHHHHhhcCCCce-eccceeEEeCCeeEEEE
Q 008292          350 DNKLGEGGFGEVYKGVLPS--------GQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNL-VRLLGFCLEGEEKILVY  420 (571)
Q Consensus       350 ~~~LG~G~fg~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~~~~~~~~~~~lv~  420 (571)
                      .+.|+.|-...+|+....+        +..+++|+....  ...+.+.+|..+++.+...++ .++++.+.+    .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence            3567888889999998653        477889887432  122455679888888754444 456665432    3899


Q ss_pred             EecCCCCh
Q 008292          421 EFVPNKSL  428 (571)
Q Consensus       421 e~~~~g~L  428 (571)
                      ||++|.+|
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99987444

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.24  E-value=0.00096  Score=66.65  Aligned_cols=141  Identities=16%  Similarity=0.164  Sum_probs=71.2

Q ss_pred             ccccccCcee-EEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCC--ceeccceeEEeCCeeEEEEEecCCCC
Q 008292          351 NKLGEGGFGE-VYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHR--NLVRLLGFCLEGEEKILVYEFVPNKS  427 (571)
Q Consensus       351 ~~LG~G~fg~-Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~--niv~l~~~~~~~~~~~lv~e~~~~g~  427 (571)
                      +.|+.|.... +|+....++..+++|.......   +++..|+.++..+...  .+.+++.+..  +..+++||++.+..
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~--~~g~ll~e~l~~~~   98 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEH--ARGLLLIEDLGDAL   98 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEET--TTTEEEECCCCSCB
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecC--CCCEEEEeeCCCcc
Confidence            4565554443 6677654467777776543321   2334566666665422  2445555532  23378999997766


Q ss_pred             hhhhhc---------------------CCCC--CCCCCHHHHH-------H-------------HHHHHHHHHHHHH---
Q 008292          428 LDYFLY---------------------DPEK--QGQLDWSRRY-------K-------------IIGGIARGILYLH---  461 (571)
Q Consensus       428 L~~~l~---------------------~~~~--~~~l~~~~~~-------~-------------i~~~ia~~L~yLH---  461 (571)
                      +.+++.                     ....  ...++.....       .             ....+.+.+..|.   
T Consensus        99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~  178 (333)
T 3csv_A           99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ  178 (333)
T ss_dssp             HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence            543321                     1000  0112211100       0             0011112222221   


Q ss_pred             cCCCCCeEEecCCCCCEEECCC----CceEEeeccCccc
Q 008292          462 EDSRLRIIHRDLKASNILLDAE----MNPKISDFGMARI  496 (571)
Q Consensus       462 ~~~~~~ivH~Dlkp~NIll~~~----~~~kl~DfGla~~  496 (571)
                      ......++|||+.+.|||++.+    +.+.|+||+.+..
T Consensus       179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            1123469999999999999875    6799999998864

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.18  E-value=0.00092  Score=68.01  Aligned_cols=141  Identities=21%  Similarity=0.268  Sum_probs=83.5

Q ss_pred             ccccccCceeEEEEEcc--------CCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCce-eccceeEEeCCeeEEEEE
Q 008292          351 NKLGEGGFGEVYKGVLP--------SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNL-VRLLGFCLEGEEKILVYE  421 (571)
Q Consensus       351 ~~LG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e  421 (571)
                      +.|..|-...+|+....        +++.+++|+.... ......+.+|..+++.+...++ .++++.+.+    .+|||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e  130 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ  130 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence            45666777889998864        2467888886332 2345667789999888753333 455655433    29999


Q ss_pred             ecCCCChhhh-----------------hcCC--CCCCCCC--HHHHHHHHHHHHH-------------------HHHHH-
Q 008292          422 FVPNKSLDYF-----------------LYDP--EKQGQLD--WSRRYKIIGGIAR-------------------GILYL-  460 (571)
Q Consensus       422 ~~~~g~L~~~-----------------l~~~--~~~~~l~--~~~~~~i~~~ia~-------------------~L~yL-  460 (571)
                      |++|..|..-                 ||..  .-.....  +.++.++..++..                   .+..| 
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            9998665311                 1111  1112222  4555555544322                   22333 


Q ss_pred             ---Hc-CCCCCeEEecCCCCCEEECCC----CceEEeeccCccc
Q 008292          461 ---HE-DSRLRIIHRDLKASNILLDAE----MNPKISDFGMARI  496 (571)
Q Consensus       461 ---H~-~~~~~ivH~Dlkp~NIll~~~----~~~kl~DfGla~~  496 (571)
                         .. .....++|+|+.+.|||++++    +.+.|+||..+..
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence               22 123469999999999999876    7899999998853

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.99  E-value=0.0025  Score=66.52  Aligned_cols=74  Identities=14%  Similarity=0.064  Sum_probs=47.8

Q ss_pred             cccccccCceeEEEEEccC-CCeeEEEeecccCccCHHHHHHHHHHHhhcCCCce-eccceeEEeCCeeEEEEEecCCCC
Q 008292          350 DNKLGEGGFGEVYKGVLPS-GQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNL-VRLLGFCLEGEEKILVYEFVPNKS  427 (571)
Q Consensus       350 ~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g~  427 (571)
                      .+.|+.|-...+|+....+ +..+++|+........ .+..+|..++..+...++ .++++.+.  +  .+|+||++|..
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~  187 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA  187 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence            4567888889999998754 4778888875433221 122578888888865555 45666652  2  35999999855


Q ss_pred             h
Q 008292          428 L  428 (571)
Q Consensus       428 L  428 (571)
                      |
T Consensus       188 l  188 (458)
T 2qg7_A          188 L  188 (458)
T ss_dssp             C
T ss_pred             C
Confidence            4

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.90  E-value=0.001  Score=67.64  Aligned_cols=73  Identities=11%  Similarity=0.099  Sum_probs=43.5

Q ss_pred             ccccccCceeEEEEEccC---------CCeeEEEeecccCccCHHHHHHHHHHHhhcCCCce-eccceeEEeCCeeEEEE
Q 008292          351 NKLGEGGFGEVYKGVLPS---------GQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNL-VRLLGFCLEGEEKILVY  420 (571)
Q Consensus       351 ~~LG~G~fg~Vy~~~~~~---------g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~~~~~~~~~~~lv~  420 (571)
                      +.|+.|....+|+....+         +..+++|+........ .+...|..+++.+...++ .++++..    ..++||
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~-~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v~  113 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDEL-YNTISEFEVYKTMSKYKIAPQLLNTF----NGGRIE  113 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGT-SCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccce-ecHHHHHHHHHHHHhcCCCCceEEec----CCcEEE
Confidence            467778788899988643         2678888875432221 123678888877753343 3555443    237899


Q ss_pred             EecCCCCh
Q 008292          421 EFVPNKSL  428 (571)
Q Consensus       421 e~~~~g~L  428 (571)
                      ||++|..+
T Consensus       114 e~i~G~~l  121 (369)
T 3c5i_A          114 EWLYGDPL  121 (369)
T ss_dssp             ECCCSEEC
T ss_pred             EEecCCcC
Confidence            99998544

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.89  E-value=0.0041  Score=62.31  Aligned_cols=32  Identities=25%  Similarity=0.412  Sum_probs=28.1

Q ss_pred             CCCeEEecCCCCCEEECCCCceEEeeccCccc
Q 008292          465 RLRIIHRDLKASNILLDAEMNPKISDFGMARI  496 (571)
Q Consensus       465 ~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  496 (571)
                      ...++|+|+.+.||++++++.+.|+||+.+..
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            34699999999999999888899999988764

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.14  E-value=0.052  Score=55.88  Aligned_cols=141  Identities=18%  Similarity=0.199  Sum_probs=83.3

Q ss_pred             cccccccCceeEEEEEccC--------CCeeEEEeecccCccCHHHHHHHHHHHhhcCCCce-eccceeEEeCCeeEEEE
Q 008292          350 DNKLGEGGFGEVYKGVLPS--------GQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNL-VRLLGFCLEGEEKILVY  420 (571)
Q Consensus       350 ~~~LG~G~fg~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~~~~~~~~~~~lv~  420 (571)
                      .+.|..|-...+|+....+        +..+++|+....... ..+..+|..+++.+...++ .++++.+    ..++|+
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~----~~~~I~  149 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADF----PEGRIE  149 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEc----CCCEEE
Confidence            3567777788899988753        578888886543322 2233578888877753333 4445432    237899


Q ss_pred             EecCCCChhh--h---------------hcC--C-----C---CCCCCCHHHHHHHHHHH-------------------H
Q 008292          421 EFVPNKSLDY--F---------------LYD--P-----E---KQGQLDWSRRYKIIGGI-------------------A  454 (571)
Q Consensus       421 e~~~~g~L~~--~---------------l~~--~-----~---~~~~l~~~~~~~i~~~i-------------------a  454 (571)
                      ||++|..|..  +               +|.  .     .   ...+.-|.++.++..++                   .
T Consensus       150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~  229 (424)
T 3mes_A          150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL  229 (424)
T ss_dssp             ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred             EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence            9999866421  1               011  0     0   11111244444443322                   1


Q ss_pred             HHHHHHH---------------------cCCCCCeEEecCCCCCEEECCCCceEEeeccCccc
Q 008292          455 RGILYLH---------------------EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI  496 (571)
Q Consensus       455 ~~L~yLH---------------------~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  496 (571)
                      +.+.+|.                     ......++|+|+.+.||+ +.++.+.|+||..+..
T Consensus       230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            2233332                     112345899999999999 7788999999998863

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=93.56  E-value=0.21  Score=45.92  Aligned_cols=120  Identities=12%  Similarity=0.073  Sum_probs=74.0

Q ss_pred             ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCcccc
Q 008292          427 SLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT  506 (571)
Q Consensus       427 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  506 (571)
                      +|.++|.  ..+.+++++++|.++.|.++.|.-+-.... + ..+=+.|..|++..+|+|.+.+ +.+.           
T Consensus        34 SL~eIL~--~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------   97 (229)
T 2yle_A           34 SLEEILR--LYNQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD-----------   97 (229)
T ss_dssp             EHHHHHH--HHTSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred             cHHHHHH--HcCCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc-----------
Confidence            6788874  356789999999999999999887621111 1 1233457899999999988764 1110           


Q ss_pred             ccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHh
Q 008292          507 SRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYVSIN  567 (571)
Q Consensus       507 ~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~  567 (571)
                         .....+.+||... ...+.+.=|||||+++|.-+-=..|-+ .+.+-..+|-+.+-.|
T Consensus        98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~-eE~eLS~~LE~LL~~M  153 (229)
T 2yle_A           98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKEN-EERELSPPLEQLIDHM  153 (229)
T ss_dssp             ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTT-EEECCCHHHHHHHHHH
T ss_pred             ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCcc-cchhhCHHHHHHHHHH
Confidence               0112456787653 455788999999999999987555533 1233344555554443

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=92.90  E-value=0.18  Score=51.38  Aligned_cols=30  Identities=27%  Similarity=0.388  Sum_probs=25.1

Q ss_pred             CeEEecCCCCCEEE------CCCCceEEeeccCccc
Q 008292          467 RIIHRDLKASNILL------DAEMNPKISDFGMARI  496 (571)
Q Consensus       467 ~ivH~Dlkp~NIll------~~~~~~kl~DfGla~~  496 (571)
                      .++|+|+.+.|||+      +++..++++||..|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            36799999999999      4567799999998854

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=89.66  E-value=0.19  Score=33.14  Aligned_cols=27  Identities=19%  Similarity=0.226  Sum_probs=13.3

Q ss_pred             eeehhHHHHHHHHHhhhhhhhhhcccc
Q 008292          288 AIVAPIAVTAVLFILGFCFLRRKAKKK  314 (571)
Q Consensus       288 ~i~~~v~~~~~l~i~~~~~~r~~~~~~  314 (571)
                      .++.+++++++++...++++|||+.++
T Consensus        16 gVVgGv~~~~ii~~~~~~~~RRr~~~~   42 (44)
T 2ks1_B           16 GMVGALLLLLVVALGIGLFMRRRHIVR   42 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHTTTCCS
T ss_pred             ehhHHHHHHHHHHHHHHHHhhhhHhhc
Confidence            333344445555555555555555443

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=86.15  E-value=2.1  Score=39.15  Aligned_cols=117  Identities=9%  Similarity=0.066  Sum_probs=77.6

Q ss_pred             cCCCceeccceeEEeCCeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCC
Q 008292          398 LQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASN  477 (571)
Q Consensus       398 l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~N  477 (571)
                      ..||+++.. ..-.+.+...+.++.-+  +...|-    .-...+...+++++..|+....+++.     -+|--|.|.|
T Consensus        42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~----~ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~N  109 (215)
T 4ann_A           42 QHSPYFIDA-ELTELRDSFQIHYDIND--NHTPFD----NIKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDE  109 (215)
T ss_dssp             SCCTTBCCE-EEEECSSEEEEEECCCT--TSEEGG----GGGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGG
T ss_pred             ccCCcccce-EEEEcccEEEEEEEcCc--ccCCHH----HHHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecce
Confidence            368888766 45555565555555433  222222    22357888999999999988866654     4788899999


Q ss_pred             EEECCCCceEEeeccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          478 ILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       478 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      |+++.++.++|.--|+-..                   ++|.     ..+...=+-.+=+++..+++++.+|+
T Consensus       110 L~f~~~~~p~i~~RGik~~-------------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          110 LFFTRDGLPIAKTRGLQNV-------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             EEECTTSCEEESCCEETTT-------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             EEEcCCCCEEEEEccCccC-------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            9999999999987776432                   1222     11222223367788888899888764

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=85.97  E-value=0.26  Score=32.36  Aligned_cols=23  Identities=22%  Similarity=0.283  Sum_probs=11.6

Q ss_pred             hHHHHHHHHHhhhhhhhhhcccc
Q 008292          292 PIAVTAVLFILGFCFLRRKAKKK  314 (571)
Q Consensus       292 ~v~~~~~l~i~~~~~~r~~~~~~  314 (571)
                      +++++++++...++++|||++++
T Consensus        19 Gv~~v~ii~~~~~~~~RRRr~~~   41 (44)
T 2l2t_A           19 GLFILVIVGLTFAVYVRRKSIKK   41 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCSSC
T ss_pred             HHHHHHHHHHHHHHHhhhhhhhh
Confidence            34444445555555555555443

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=84.72  E-value=0.26  Score=32.35  Aligned_cols=28  Identities=29%  Similarity=0.357  Sum_probs=13.7

Q ss_pred             eeeeehhHHHHHHHHHhhhhhhhhhccc
Q 008292          286 IIAIVAPIAVTAVLFILGFCFLRRKAKK  313 (571)
Q Consensus       286 ii~i~~~v~~~~~l~i~~~~~~r~~~~~  313 (571)
                      +++.++++++++++.+..++++|||+.+
T Consensus        14 Ia~~vVGvll~vi~~l~~~~~~RRR~~~   41 (44)
T 2jwa_A           14 IISAVVGILLVVVLGVVFGILIKRRQQK   41 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHCSC
T ss_pred             hHHHHHHHHHHHHHHHHHHhheehhhhh
Confidence            4455555444444444445555555443

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=83.54  E-value=0.25  Score=51.43  Aligned_cols=62  Identities=8%  Similarity=0.089  Sum_probs=19.0

Q ss_pred             CccccccccCceeEEEEEccC-CCeeEE------Eeeccc--CccCHHHHHHHHHHHhhcCCCceeccceeEEe
Q 008292          348 STDNKLGEGGFGEVYKGVLPS-GQEIAV------KRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE  412 (571)
Q Consensus       348 ~~~~~LG~G~fg~Vy~~~~~~-g~~vav------K~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~  412 (571)
                      ...++||   ||.||+|.+.. ..+|||      |..+..  +.+....+.+|..++..++|||+++.+++...
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~  215 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH  215 (463)
T ss_dssp             CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred             cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence            3456776   99999999854 367888      665542  22334567889999999999999999887653

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	571
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-70
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	4e-70
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-66
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	7e-63
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	6e-62
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	9e-62
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-61
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-61
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-61
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	4e-61
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	7e-61
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-60
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-60
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-60
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	4e-60
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-59
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-59
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-59
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-58
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-58
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-58
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-58
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	5e-58
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-57
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-55
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	6e-55
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-54
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-54
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-54
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	8e-54
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-53
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	4e-52
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	6e-52
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	8e-51
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	3e-50
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-49
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-49
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-48
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-48
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	7e-48
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	4e-47
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	4e-47
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	5e-47
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	8e-47
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	4e-46
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	5e-46
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-45
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	4e-45
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-44
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-43
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-43
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	5e-42
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-41
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-41
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	3e-40
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	4e-40
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-39
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	8e-38
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	7e-37
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-35
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-34
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-33
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-27

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  226 bits (577), Expect = 1e-70
 Identities = 61/210 (29%), Positives = 110/210 (52%), Gaps = 9/210 (4%)

Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
           E+   + +   ++G G FG VYKG       + +  ++  + Q  + FKNEV ++ K +H
Sbjct: 4   EIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 63

Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
            N++  +G+     +  +V ++    SL + L+    + + +  +   I    A+G+ YL
Sbjct: 64  VNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYL 120

Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEY 520
           H  S   IIHRDLK++NI L  ++  KI DFG+A +           ++ G+  +MAPE 
Sbjct: 121 HAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 177

Query: 521 AMH---GQFSVKSDVYSFGVLVLEIITGKK 547
                   +S +SDVY+FG+++ E++TG+ 
Sbjct: 178 IRMQDKNPYSFQSDVYAFGIVLYELMTGQL 207

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  226 bits (577), Expect = 4e-70
 Identities = 56/209 (26%), Positives = 99/209 (47%), Gaps = 11/209 (5%)

Query: 340 IEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGA-EEFKNEVVLVAK 397
           +E+  + F   ++LG G  G V+K    PSG  +A K +          +   E+ ++ +
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60

Query: 398 LQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGI 457
                +V   G      E  +  E +   SLD  L    K G++      K+   + +G+
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGL 117

Query: 458 LYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMA 517
            YL    + +I+HRD+K SNIL+++    K+ DFG++            +  VGT  YM+
Sbjct: 118 TYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMS 171

Query: 518 PEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
           PE      +SV+SD++S G+ ++E+  G+
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  214 bits (546), Expect = 3e-66
 Identities = 71/224 (31%), Positives = 116/224 (51%), Gaps = 9/224 (4%)

Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
           EV         +LG G FGEV+ G      ++AVK L + S    + F  E  L+ +LQH
Sbjct: 9   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQH 67

Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
           + LVRL     + E   ++ E++ N SL  FL  P    +L  ++   +   IA G+ ++
Sbjct: 68  QRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDMAAQIAEGMAFI 125

Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEY 520
            E +    IHRDL+A+NIL+   ++ KI+DFG+AR+   ++             + APE 
Sbjct: 126 EERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG-AKFPIKWTAPEA 181

Query: 521 AMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYV 564
             +G F++KSDV+SFG+L+ EI+T  +    Y      +++  +
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGR--IPYPGMTNPEVIQNL 223

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (523), Expect = 7e-63
 Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 7/203 (3%)

Query: 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLV 404
           ++ +   ++G G FG V+ G   +  ++A+K + +      E+F  E  ++ KL H  LV
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLV 63

Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
           +L G CLE     LV+EF+ +  L    Y   ++G         +   +  G   +    
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEG---MAYLE 118

Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG 524
              +IHRDL A N L+      K+SDFGM R    DQ   +++       + +PE     
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFS 177

Query: 525 QFSVKSDVYSFGVLVLEIITGKK 547
           ++S KSDV+SFGVL+ E+ +  K
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGK 200

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (517), Expect = 6e-62
 Identities = 59/205 (28%), Positives = 97/205 (47%), Gaps = 9/205 (4%)

Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGA-EEFKNEVVLVAKLQHRN 402
             +     LGEG +GEV   V   + + +AVK +         E  K E+ +   L H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
           +V+  G   EG  + L  E+     L   +   E    +      +    +  G++YLH 
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLHG 121

Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM 522
              + I HRD+K  N+LLD   N KISDFG+A +F  +  +   +++ GT  Y+APE   
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178

Query: 523 HGQF-SVKSDVYSFGVLVLEIITGK 546
             +F +   DV+S G+++  ++ G+
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGE 203

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (515), Expect = 9e-62
 Identities = 55/203 (27%), Positives = 99/203 (48%), Gaps = 7/203 (3%)

Query: 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLV 404
              +   +LG G FG V  G      ++A+K + + S    +EF  E  ++  L H  LV
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62

Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
           +L G C +     ++ E++ N  L  +L +   + +    +  ++   +   + YL    
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK- 119

Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG 524
             + +HRDL A N L++ +   K+SDFG++R   +D    ++        +  PE  M+ 
Sbjct: 120 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYV-LDDEYTSSVGSKFPVRWSPPEVLMYS 176

Query: 525 QFSVKSDVYSFGVLVLEIITGKK 547
           +FS KSD+++FGVL+ EI +  K
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGK 199

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  203 bits (516), Expect = 1e-61
 Identities = 65/219 (29%), Positives = 112/219 (51%), Gaps = 7/219 (3%)

Query: 330 LESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEF 388
           ++    +++  E+     +  +KLG G +GEVY+GV       +AVK L + + +  EEF
Sbjct: 2   MDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEF 60

Query: 389 KNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYK 448
             E  ++ +++H NLV+LLG C       ++ EF+   +L  +L +  +Q ++       
Sbjct: 61  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLY 119

Query: 449 IIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR 508
           +   I+  + YL    +   IHRDL A N L+      K++DFG++R+   D    +   
Sbjct: 120 MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG- 175

Query: 509 IVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKK 547
                 + APE   + +FS+KSDV++FGVL+ EI T   
Sbjct: 176 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGM 214

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (514), Expect = 1e-61
 Identities = 62/225 (27%), Positives = 103/225 (45%), Gaps = 15/225 (6%)

Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
            +   +      +G+G FG+V  G    G ++AVK +   +    + F  E  ++ +L+H
Sbjct: 3   ALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRH 59

Query: 401 RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
            NLV+LLG  +E +  + +V E++   SL  +L     +  L      K    +   + Y
Sbjct: 60  SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEY 118

Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE 519
           L        +HRDL A N+L+  +   K+SDFG+ +     Q  G          + APE
Sbjct: 119 LE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK-----LPVKWTAPE 170

Query: 520 YAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYV 564
                +FS KSDV+SFG+L+ EI +  +    Y      D++  V
Sbjct: 171 ALREKKFSTKSDVWSFGILLWEIYSFGR--VPYPRIPLKDVVPRV 213

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  203 bits (517), Expect = 2e-61
 Identities = 63/210 (30%), Positives = 95/210 (45%), Gaps = 19/210 (9%)

Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAE---EFKNEVVLVAKLQ 399
              FS   ++G G FG VY    + + + +A+K++S +  Q  E   +   EV  + KL+
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
           H N ++  G  L      LV E+    + D        +  L       +  G  +G+ Y
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAY 130

Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE 519
           LH      +IHRD+KA NILL      K+ DFG A I          +  VGT  +MAPE
Sbjct: 131 LHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGTPYWMAPE 181

Query: 520 YAM---HGQFSVKSDVYSFGVLVLEIITGK 546
             +    GQ+  K DV+S G+  +E+   K
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERK 211

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (513), Expect = 4e-61
 Identities = 69/224 (30%), Positives = 112/224 (50%), Gaps = 9/224 (4%)

Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
           E+       + KLG+G FGEV+ G       +A+K L   +    E F  E  ++ KL+H
Sbjct: 13  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRH 71

Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
             LV+L       E   +V E++   SL  FL   E    L   +   +   IA G+ Y+
Sbjct: 72  EKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAYV 129

Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEY 520
               R+  +HRDL+A+NIL+   +  K++DFG+AR+   ++             + APE 
Sbjct: 130 E---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTAPEA 185

Query: 521 AMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYV 564
           A++G+F++KSDV+SFG+L+ E+ T  +    Y      ++L  V
Sbjct: 186 ALYGRFTIKSDVWSFGILLTELTTKGR--VPYPGMVNREVLDQV 227

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (511), Expect = 7e-61
 Identities = 56/202 (27%), Positives = 98/202 (48%), Gaps = 13/202 (6%)

Query: 351 NKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGF 409
            +LG+G FG+VYK     +    A K +   S +  E++  E+ ++A   H N+V+LL  
Sbjct: 18  GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77

Query: 410 CLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRII 469
                   ++ EF    ++D  + +   +  L  S+   +       + YLH+    +II
Sbjct: 78  FYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHD---NKII 132

Query: 470 HRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM-----HG 524
           HRDLKA NIL   + + K++DFG++      +T       +GT  +MAPE  M       
Sbjct: 133 HRDLKAGNILFTLDGDIKLADFGVSAKN--TRTIQRRDSFIGTPYWMAPEVVMCETSKDR 190

Query: 525 QFSVKSDVYSFGVLVLEIITGK 546
            +  K+DV+S G+ ++E+   +
Sbjct: 191 PYDYKADVWSLGITLIEMAEIE 212

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  201 bits (511), Expect = 1e-60
 Identities = 65/260 (25%), Positives = 110/260 (42%), Gaps = 33/260 (12%)

Query: 333 LQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSK-ASGQGA 385
           L     ++E   N       +GEG FG V++   P          +AVK L + AS    
Sbjct: 1   LNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ 60

Query: 386 EEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQG------ 439
            +F+ E  L+A+  + N+V+LLG C  G+   L++E++    L+ FL             
Sbjct: 61  ADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSH 120

Query: 440 ---------------QLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM 484
                           L  + +  I   +A G+ YL E    + +HRDL   N L+   M
Sbjct: 121 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENM 177

Query: 485 NPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
             KI+DFG++R                   +M PE   + +++ +SDV+++GV++ EI +
Sbjct: 178 VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 237

Query: 545 GKKNSNFYQTDGAADLLSYV 564
                  Y      +++ YV
Sbjct: 238 YGL--QPYYGMAHEEVIYYV 255

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (510), Expect = 1e-60
 Identities = 62/214 (28%), Positives = 105/214 (49%), Gaps = 12/214 (5%)

Query: 340 IEVATNKFS-TDNKLGEGGFGEVYKGVL---PSGQEIAVKRLSKASGQG-AEEFKNEVVL 394
           + +  +     D +LG G FG V +GV        ++A+K L + + +   EE   E  +
Sbjct: 3   LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQI 62

Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIA 454
           + +L +  +VRL+G C + E  +LV E      L  FL    K+ ++  S   +++  ++
Sbjct: 63  MHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVS 119

Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN-TSRIVGTY 513
            G+ YL        +HRDL A N+LL      KISDFG+++  G D +     S      
Sbjct: 120 MGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 176

Query: 514 GYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKK 547
            + APE     +FS +SDV+S+GV + E ++  +
Sbjct: 177 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ 210

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (508), Expect = 3e-60
 Identities = 60/223 (26%), Positives = 118/223 (52%), Gaps = 11/223 (4%)

Query: 325 NDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQ 383
           +D   LE L+    ++     K++   K+G+G  G VY  + + +GQE+A+++++     
Sbjct: 1   SDEEILEKLR-SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP 59

Query: 384 GAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDW 443
             E   NE++++ + ++ N+V  L   L G+E  +V E++   SL   +     +  +D 
Sbjct: 60  KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT----ETCMDE 115

Query: 444 SRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ 503
            +   +     + + +LH     ++IHRD+K+ NILL  + + K++DFG       +Q++
Sbjct: 116 GQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172

Query: 504 GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
              S +VGT  +MAPE      +  K D++S G++ +E+I G+
Sbjct: 173 --RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  199 bits (507), Expect = 4e-60
 Identities = 64/230 (27%), Positives = 115/230 (50%), Gaps = 22/230 (9%)

Query: 335 FDFETIEVATNKFST---------DNKLGEGGFGEVYKGVLPSGQE----IAVKRLSKA- 380
           F FE    A  +F+          +  +G G FGEV  G L    +    +A+K L    
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 381 SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQ 440
           + +   +F +E  ++ +  H N++ L G   +    +++ EF+ N SLD FL   +  GQ
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR--QNDGQ 124

Query: 441 LDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500
               +   ++ GIA G+ YL     +  +HRDL A NIL+++ +  K+SDFG++R    D
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181

Query: 501 QTQGNTSRIVG---TYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKK 547
            +    +  +G      + APE   + +F+  SDV+S+G+++ E+++  +
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE 231

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (502), Expect = 1e-59
 Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 10/209 (4%)

Query: 346 KFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGA--EEFKNEVVLVAKLQHRN 402
            +     +G G +G   K      G+ +  K L   S   A  +   +EV L+ +L+H N
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64

Query: 403 LVRLLGFCLEGEEKIL--VYEFVPNKSLDYFLYDPEKQGQ-LDWSRRYKIIGGIARGILY 459
           +VR     ++     L  V E+     L   +    K+ Q LD     +++  +   +  
Sbjct: 65  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124

Query: 460 LHE--DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMA 517
            H   D    ++HRDLK +N+ LD + N K+ DFG+ARI   D +       VGT  YM+
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA--FVGTPYYMS 182

Query: 518 PEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
           PE      ++ KSD++S G L+ E+    
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALM 211

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (500), Expect = 2e-59
 Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 13/204 (6%)

Query: 350 DNKLGEGGFGEVYKGVLP---SGQEIAVKRLSKASGQGA--EEFKNEVVLVAKLQHRNLV 404
           D +LG G FG V KG        + +AVK L   +   A  +E   E  ++ +L +  +V
Sbjct: 12  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71

Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
           R++G C E E  +LV E      L+ +L    +   +      +++  ++ G+ YL    
Sbjct: 72  RMIGIC-EAESWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLE--- 124

Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTS-RIVGTYGYMAPEYAMH 523
               +HRDL A N+LL  +   KISDFG+++    D+              + APE   +
Sbjct: 125 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184

Query: 524 GQFSVKSDVYSFGVLVLEIITGKK 547
            +FS KSDV+SFGVL+ E  +  +
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQ 208

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (498), Expect = 3e-59
 Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 19/210 (9%)

Query: 346 KFSTDN-----KLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGA---EEFKNEVVLVA 396
           +++ ++      LG+G FG VY      S   +A+K L KA  + A    + + EV + +
Sbjct: 2   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 61

Query: 397 KLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARG 456
            L+H N++RL G+  +     L+ E+ P  ++   L   +K  + D  R    I  +A  
Sbjct: 62  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANA 118

Query: 457 ILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYM 516
           + Y H     R+IHRD+K  N+LL +    KI+DFG +      +       + GT  Y+
Sbjct: 119 LSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----TLCGTLDYL 171

Query: 517 APEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
            PE         K D++S GVL  E + GK
Sbjct: 172 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 201

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (495), Expect = 1e-58
 Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 17/206 (8%)

Query: 350 DNKLGEGGFGEVYKGVLP-SGQEIAVKRLSK--ASGQGAEEFKNEVVLVAKLQHRNLVRL 406
           D ++G G F  VYKG+   +  E+A   L     +    + FK E  ++  LQH N+VR 
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 407 LGFCLEGEEK----ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
                   +     +LV E + + +L  +L   ++   +           I +G+ +LH 
Sbjct: 74  YDSWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHT 130

Query: 463 DSRLRIIHRDLKASNILLDAE-MNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYA 521
            +   IIHRDLK  NI +     + KI D G+A +      +     ++GT  +MAPE  
Sbjct: 131 RTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK----AVIGTPEFMAPEM- 184

Query: 522 MHGQFSVKSDVYSFGVLVLEIITGKK 547
              ++    DVY+FG+ +LE+ T + 
Sbjct: 185 YEEKYDESVDVYAFGMCMLEMATSEY 210

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (495), Expect = 2e-58
 Identities = 55/221 (24%), Positives = 95/221 (42%), Gaps = 23/221 (10%)

Query: 352 KLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCL 411
            +G+G FGEV++G    G+E+AVK  S    + +   + E+     L+H N++  +    
Sbjct: 10  SIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADN 67

Query: 412 EGEEKI----LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED---- 463
           +         LV ++  + SL  +L     +  +      K+    A G+ +LH +    
Sbjct: 68  KDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 123

Query: 464 -SRLRIIHRDLKASNILLDAEMNPKISDFGMARIF--GVDQTQGNTSRIVGTYGYMAPEY 520
             +  I HRDLK+ NIL+       I+D G+A       D      +  VGT  YMAPE 
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183

Query: 521 ------AMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTD 555
                   H +   ++D+Y+ G++  EI         ++  
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 224

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (495), Expect = 3e-58
 Identities = 63/255 (24%), Positives = 104/255 (40%), Gaps = 27/255 (10%)

Query: 325 NDLTTLESLQFDFETI-EVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRL 377
           N+   ++  Q  ++   E   N+ S    LG G FG+V +          +   +AVK L
Sbjct: 2   NNYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML 61

Query: 378 SKASGQG-AEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYD- 434
             ++     E   +E+ +++ L  H N+V LLG C  G   +++ E+     L  FL   
Sbjct: 62  KPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRK 121

Query: 435 --------------PEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL 480
                          + +  LD          +A+G+ +L        IHRDL A NILL
Sbjct: 122 RDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILL 178

Query: 481 DAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVL 540
                 KI DFG+AR    D              +MAPE   +  ++ +SDV+S+G+ + 
Sbjct: 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLW 238

Query: 541 EIITGKKNSNFYQTD 555
           E+ +   +       
Sbjct: 239 ELFSLGSSPYPGMPV 253

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (496), Expect = 3e-58
 Identities = 60/256 (23%), Positives = 105/256 (41%), Gaps = 32/256 (12%)

Query: 321 SNADNDLTTLESLQFDFETI-EVATNKFSTDNKLGEGGFGEVYKGVLPS------GQEIA 373
            ++DN+   ++  +++++   E           LG G FG+V               ++A
Sbjct: 12  GSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVA 71

Query: 374 VKRLSKASGQGA-EEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF 431
           VK L + +     E   +E+ ++ +L  H N+V LLG C       L++E+     L  +
Sbjct: 72  VKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNY 131

Query: 432 LYDPEKQ--------------------GQLDWSRRYKIIGGIARGILYLHEDSRLRIIHR 471
           L    ++                      L +         +A+G+ +L        +HR
Sbjct: 132 LRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHR 188

Query: 472 DLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSD 531
           DL A N+L+      KI DFG+AR    D              +MAPE    G +++KSD
Sbjct: 189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSD 248

Query: 532 VYSFGVLVLEIITGKK 547
           V+S+G+L+ EI +   
Sbjct: 249 VWSYGILLWEIFSLGV 264

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (491), Expect = 5e-58
 Identities = 62/224 (27%), Positives = 115/224 (51%), Gaps = 12/224 (5%)

Query: 339 TIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQE-----IAVKRLSKASGQGA-EEFKNEV 392
           T E+  +  +    +G G FGEVYKG+L +        +A+K L     +    +F  E 
Sbjct: 1   TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEA 60

Query: 393 VLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGG 452
            ++ +  H N++RL G   + +  +++ E++ N +     +  EK G+    +   ++ G
Sbjct: 61  GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGA--LDKFLREKDGEFSVLQLVGMLRG 118

Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT-SRIVG 511
           IA G+ YL     +  +HRDL A NIL+++ +  K+SDFG++R+   D     T S    
Sbjct: 119 IAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 175

Query: 512 TYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTD 555
              + APE   + +F+  SDV+SFG+++ E++T  +   +  ++
Sbjct: 176 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN 219

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (489), Expect = 2e-57
 Identities = 62/250 (24%), Positives = 108/250 (43%), Gaps = 18/250 (7%)

Query: 326 DLTTLES-LQFDFETIEVATNKFST--DNKLGEGGFGEVYKGVLP----SGQEIAVKRLS 378
           DL+ L   L    + + +  +      +  +G G FG VY G L          AVK L+
Sbjct: 5   DLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN 64

Query: 379 KASGQG-AEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPE 436
           + +  G   +F  E +++    H N++ LLG CL  E    +V  ++ +  L  F+ +  
Sbjct: 65  RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET 124

Query: 437 KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496
               +     + +          +   +  + +HRDL A N +LD +   K++DFG+AR 
Sbjct: 125 HNPTVKDLIGFGLQVAKG-----MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD 179

Query: 497 FGVDQTQGNTSR--IVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQT 554
               +     ++        +MA E     +F+ KSDV+SFGVL+ E++T       Y  
Sbjct: 180 MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA--PPYPD 237

Query: 555 DGAADLLSYV 564
               D+  Y+
Sbjct: 238 VNTFDITVYL 247

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (477), Expect = 1e-55
 Identities = 66/224 (29%), Positives = 115/224 (51%), Gaps = 14/224 (6%)

Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQE----IAVKRLSKA-SGQGAEEFKNEVVLVAKLQH 400
           F     LG G FG VYKG+ +P G++    +A+K L +A S +  +E  +E  ++A + +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
            ++ RLLG CL    +++         LDY     E +  +           IA+G+ YL
Sbjct: 71  PHVCRLLGICLTSTVQLITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAKGMNYL 127

Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEY 520
                 R++HRDL A N+L+    + KI+DFG+A++ G ++ + +         +MA E 
Sbjct: 128 E---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184

Query: 521 AMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYV 564
            +H  ++ +SDV+S+GV V E++T       Y    A+++ S +
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGS--KPYDGIPASEISSIL 226

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 6e-55
 Identities = 56/205 (27%), Positives = 90/205 (43%), Gaps = 10/205 (4%)

Query: 346 KFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHR 401
            F     LGEG F  V     L + +E A+K L K              E  ++++L H 
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68

Query: 402 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH 461
             V+L     + E+      +  N  L  ++    K G  D +        I   + YLH
Sbjct: 69  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLH 125

Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYA 521
                 IIHRDLK  NILL+ +M+ +I+DFG A++   +  Q   +  VGT  Y++PE  
Sbjct: 126 G---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182

Query: 522 MHGQFSVKSDVYSFGVLVLEIITGK 546
                   SD+++ G ++ +++ G 
Sbjct: 183 TEKSACKSSDLWALGCIIYQLVAGL 207

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 1e-54
 Identities = 65/238 (27%), Positives = 104/238 (43%), Gaps = 26/238 (10%)

Query: 345 NKFSTDNKLGEGGFGEVYKGVLPSG---QEIAVKRLSK-ASGQGAEEFKNEVVLVAKL-Q 399
           N     + +GEG FG+V K  +       + A+KR+ + AS     +F  E+ ++ KL  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL-------------YDPEKQGQLDWSRR 446
           H N++ LLG C       L  E+ P+ +L  FL                     L   + 
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 447 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT 506
                 +ARG+ YL +    + IHRDL A NIL+      KI+DFG++R     +     
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQ---EVYVKK 183

Query: 507 SRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYV 564
           +       +MA E   +  ++  SDV+S+GVL+ EI++       Y     A+L   +
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG--TPYCGMTCAELYEKL 239

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  186 bits (473), Expect = 1e-54
 Identities = 47/205 (22%), Positives = 90/205 (43%), Gaps = 11/205 (5%)

Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNL 403
           + +    +LG G FG V++     +G   A K +        E  + E+  ++ L+H  L
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85

Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
           V L     +  E +++YEF+    L   + D  +  ++      + +  + +G+ ++HE 
Sbjct: 86  VNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHE- 142

Query: 464 SRLRIIHRDLKASNILLDAEMNP--KISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYA 521
                +H DLK  NI+   + +   K+ DFG+         + +     GT  + APE A
Sbjct: 143 --NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFAAPEVA 197

Query: 522 MHGQFSVKSDVYSFGVLVLEIITGK 546
                   +D++S GVL   +++G 
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGL 222

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 1e-54
 Identities = 65/217 (29%), Positives = 90/217 (41%), Gaps = 14/217 (6%)

Query: 339 TIEVATNKFSTDNKLGEGGFGEVYKGVLPS----GQEIAVKRLSK---ASGQGAEEFKNE 391
           T  +         KLG+G FG V +G   +       +AVK L     +  +  ++F  E
Sbjct: 2   TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 61

Query: 392 VVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIG 451
           V  +  L HRNL+RL G  L    K+ V E  P  SL       + QG        +   
Sbjct: 62  VNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLD--RLRKHQGHFLLGTLSRYAV 118

Query: 452 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG-NTSRIV 510
            +A G+ YL      R IHRDL A N+LL      KI DFG+ R    +           
Sbjct: 119 QVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 175

Query: 511 GTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKK 547
             + + APE      FS  SD + FGV + E+ T  +
Sbjct: 176 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ 212

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (461), Expect = 8e-54
 Identities = 53/220 (24%), Positives = 96/220 (43%), Gaps = 12/220 (5%)

Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPS----GQEIAVKRLSKASGQGA-EEFKNEVVLV 395
           E+   +      +GEG FG+V++G+  S       +A+K     +     E+F  E + +
Sbjct: 3   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 62

Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
            +  H ++V+L+G   E     ++ E      L    +   ++  LD +        ++ 
Sbjct: 63  RQFDHPHIVKLIGVITENP-VWIIMELCTLGELRS--FLQVRKYSLDLASLILYAYQLST 119

Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGY 515
            + YL      R +HRD+ A N+L+ +    K+ DFG++R    D T    S+      +
Sbjct: 120 ALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKW 175

Query: 516 MAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTD 555
           MAPE     +F+  SDV+ FGV + EI+           +
Sbjct: 176 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 215

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (463), Expect = 1e-53
 Identities = 69/238 (28%), Positives = 114/238 (47%), Gaps = 19/238 (7%)

Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSK-ASGQGAEEFKNEVV 393
           EVA  K +   +LG+G FG VY+GV            +A+K +++ AS +   EF NE  
Sbjct: 16  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 75

Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLY-------DPEKQGQLDWSRR 446
           ++ +    ++VRLLG   +G+  +++ E +    L  +L        +         S+ 
Sbjct: 76  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 135

Query: 447 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT 506
            ++ G IA G+ YL+ +   + +HRDL A N ++  +   KI DFGM R           
Sbjct: 136 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 192

Query: 507 SRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYV 564
            + +    +M+PE    G F+  SDV+SFGV++ EI T  +    YQ      +L +V
Sbjct: 193 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE--QPYQGLSNEQVLRFV 248

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  179 bits (456), Expect = 4e-52
 Identities = 46/205 (22%), Positives = 88/205 (42%), Gaps = 11/205 (5%)

Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNL 403
           + +    +LG G FG V++ V   +G+    K ++          KNE+ ++ +L H  L
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88

Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
           + L     +  E +L+ EF+    L   +    +  ++  +     +     G+ ++HE 
Sbjct: 89  INLHDAFEDKYEMVLILEFLSGGELFDRIA--AEDYKMSEAEVINYMRQACEGLKHMHE- 145

Query: 464 SRLRIIHRDLKASNILLDAEMNP--KISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYA 521
               I+H D+K  NI+ + +     KI DFG+A     D+          T  + APE  
Sbjct: 146 --HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIV 200

Query: 522 MHGQFSVKSDVYSFGVLVLEIITGK 546
                   +D+++ GVL   +++G 
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGL 225

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (454), Expect = 6e-52
 Identities = 50/207 (24%), Positives = 97/207 (46%), Gaps = 7/207 (3%)

Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQG-AEEFKNEVVLVAKLQHR 401
             +++  + +GEG +G V       +   +A+K++S    Q   +    E+ ++ + +H 
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 402 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH 461
           N++ +         + +   ++    +   LY   K   L        +  I RG+ Y+H
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126

Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT-SRIVGTYGYMAPEY 520
                 ++HRDLK SN+LL+   + KI DFG+AR+   D       +  V T  Y APE 
Sbjct: 127 S---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183

Query: 521 AMHGQFSVKS-DVYSFGVLVLEIITGK 546
            ++ +   KS D++S G ++ E+++ +
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNR 210

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (442), Expect = 8e-51
 Identities = 61/237 (25%), Positives = 97/237 (40%), Gaps = 25/237 (10%)

Query: 333 LQFDFETIEVATNKFSTDNKLGEGGFGEVYKGV------LPSGQEIAVKRLSKASGQGAE 386
           L +D    E   ++      LG G FG+V +          + + +AVK L + +     
Sbjct: 1   LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH 60

Query: 387 E--FKNEVVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLY---------- 433
                   +L+    H N+V LLG C +    + ++ EF    +L  +L           
Sbjct: 61  RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 120

Query: 434 ---DPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISD 490
              +   +  L           +A+G+ +L      + IHRDL A NILL  +   KI D
Sbjct: 121 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICD 177

Query: 491 FGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKK 547
           FG+AR    D              +MAPE      ++++SDV+SFGVL+ EI +   
Sbjct: 178 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 234

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (438), Expect = 3e-50
 Identities = 61/230 (26%), Positives = 101/230 (43%), Gaps = 26/230 (11%)

Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPS--------GQEIAVKRLSK-ASGQGAEEFKNE 391
           E+  ++      LGEG FG+V                 ++AVK L   A+ +   +  +E
Sbjct: 9   ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 68

Query: 392 VVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLY-------------DPEK 437
           + ++  + +H+N++ LLG C +     ++ E+    +L  +L                  
Sbjct: 69  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 128

Query: 438 QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497
           + QL           +ARG+ YL      + IHRDL A N+L+  +   KI+DFG+AR  
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDI 185

Query: 498 GVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKK 547
                   T+       +MAPE      ++ +SDV+SFGVL+ EI T   
Sbjct: 186 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG 235

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  173 bits (440), Expect = 1e-49
 Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 18/210 (8%)

Query: 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA---SGQGAEEFKNEVV---LVAK 397
           N FS    +G GGFGEVY      +G+  A+K L K      QG     NE +   LV+ 
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 398 LQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGI 457
                +V +       ++   + + +    L Y L    + G    +        I  G+
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFSEADMRFYAAEIILGL 120

Query: 458 LYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMA 517
            ++H      +++RDLK +NILLD   + +ISD G+A  F     +      VGT+GYMA
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPHASVGTHGYMA 173

Query: 518 PEYAMHGQ-FSVKSDVYSFGVLVLEIITGK 546
           PE    G  +   +D +S G ++ +++ G 
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGH 203

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  170 bits (431), Expect = 2e-49
 Identities = 57/212 (26%), Positives = 99/212 (46%), Gaps = 15/212 (7%)

Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGA---EEFKNEVVLVAKLQ 399
           ++++     LG GG  EV+    L   +++AVK L     +       F+ E    A L 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 400 HRNLVRLLGFCLE----GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
           H  +V +          G    +V E+V   +L   ++    +G +   R  ++I    +
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQ 122

Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG-NTSRIVGTYG 514
            + + H+     IIHRD+K +NI++ A    K+ DFG+AR           T+ ++GT  
Sbjct: 123 ALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179

Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
           Y++PE A       +SDVYS G ++ E++TG+
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 211

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  169 bits (428), Expect = 1e-48
 Identities = 56/215 (26%), Positives = 99/215 (46%), Gaps = 14/215 (6%)

Query: 337 FETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEE-FKNEVVL 394
           ++  E   + +   + LG G F EV       + + +A+K ++K + +G E   +NE+ +
Sbjct: 1   WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60

Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIA 454
           + K++H N+V L      G    L+ + V    L   +    ++G        ++I  + 
Sbjct: 61  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV---EKGFYTERDASRLIFQVL 117

Query: 455 RGILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMARIFGVDQTQGNTSRIVG 511
             + YLH+     I+HRDLK  N+L    D +    ISDFG++++          S   G
Sbjct: 118 DAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACG 171

Query: 512 TYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
           T GY+APE      +S   D +S GV+   ++ G 
Sbjct: 172 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY 206

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 1e-48
 Identities = 49/204 (24%), Positives = 85/204 (41%), Gaps = 12/204 (5%)

Query: 346 KFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLV 404
           K+     LG G FG V++ V   S +    K + K  G      K E+ ++   +HRN++
Sbjct: 6   KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNIL 64

Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
            L       EE ++++EF+    +   +       +L+       +  +   + +LH   
Sbjct: 65  HLHESFESMEELVMIFEFISGLDIFERIN--TSAFELNEREIVSYVHQVCEALQFLHS-- 120

Query: 465 RLRIIHRDLKASNILLDAEMNP--KISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM 522
              I H D++  NI+     +   KI +FG AR         N   +     Y APE   
Sbjct: 121 -HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQ 176

Query: 523 HGQFSVKSDVYSFGVLVLEIITGK 546
           H   S  +D++S G LV  +++G 
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSGI 200

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  167 bits (424), Expect = 7e-48
 Identities = 52/207 (25%), Positives = 90/207 (43%), Gaps = 15/207 (7%)

Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSK---ASGQGAEEFKNEVVLVAKLQH 400
             F     LG G FG V+      +G+  A+K L K      +  E   +E ++++ + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
             ++R+ G   + ++  ++ +++    L   L   ++            +       L L
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV------CLAL 117

Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEY 520
                  II+RDLK  NILLD   + KI+DFG A+          T  + GT  Y+APE 
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV-----PDVTYTLCGTPDYIAPEV 172

Query: 521 AMHGQFSVKSDVYSFGVLVLEIITGKK 547
                ++   D +SFG+L+ E++ G  
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYT 199

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  164 bits (415), Expect = 4e-47
 Identities = 57/218 (26%), Positives = 94/218 (43%), Gaps = 26/218 (11%)

Query: 346 KFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGA---------EEFKNEVVLV 395
            +     LG G    V + +  P+ +E AVK +    G            E    EV ++
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 396 AKLQ-HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIA 454
            K+  H N+++L           LV++ +    L  +L    ++  L      KI+  + 
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRALL 120

Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
             I  LH+   L I+HRDLK  NILLD +MN K++DFG +      +       + GT  
Sbjct: 121 EVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPS 174

Query: 515 YMAPEYAM------HGQFSVKSDVYSFGVLVLEIITGK 546
           Y+APE         H  +  + D++S GV++  ++ G 
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (419), Expect = 4e-47
 Identities = 60/207 (28%), Positives = 96/207 (46%), Gaps = 13/207 (6%)

Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKN----EVVLVAKLQ 399
             F     LG+G FG+V+      + Q  A+K L K      ++ +     + VL    +
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
           H  L  +       E    V E++    L Y +   +   + D SR       I  G+ +
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI---QSCHKFDLSRATFYAAEIILGLQF 118

Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE 519
           LH      I++RDLK  NILLD + + KI+DFGM +   +   + NT    GT  Y+APE
Sbjct: 119 LHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPE 173

Query: 520 YAMHGQFSVKSDVYSFGVLVLEIITGK 546
             +  +++   D +SFGVL+ E++ G+
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQ 200

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  164 bits (416), Expect = 5e-47
 Identities = 45/212 (21%), Positives = 86/212 (40%), Gaps = 18/212 (8%)

Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNL 403
           N++    K+G G FG++Y G  + +G+E+A+K     +     +   E  +   +Q    
Sbjct: 7   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 64

Query: 404 VRLLGFCL-EGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
           +  + +C  EG+  ++V E +     D F +      +        +   +   I Y+H 
Sbjct: 65  IPTIRWCGAEGDYNVMVMELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHS 121

Query: 463 DSRLRIIHRDLKASNIL---LDAEMNPKISDFGMARIFGVDQTQGN-----TSRIVGTYG 514
                 IHRD+K  N L           I DFG+A+ +   +T  +        + GT  
Sbjct: 122 ---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 178

Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
           Y +    +  + S + D+ S G +++    G 
Sbjct: 179 YASINTHLGIEQSRRDDLESLGYVLMYFNLGS 210

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  163 bits (414), Expect = 8e-47
 Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 11/205 (5%)

Query: 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVK--RLSKASGQGAEEFKNEVVLVAKLQHRN 402
            K+    K+GEG +G VYK     G+  A+K  RL K           E+ ++ +L+H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
           +V+L       +  +LV+E +              +G L+       +  +  GI Y H+
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD 118

Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM 522
               R++HRDLK  N+L++ E   KI+DFG+AR FG+   +      + T  Y AP+  M
Sbjct: 119 ---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH--EIVTLWYRAPDVLM 173

Query: 523 -HGQFSVKSDVYSFGVLVLEIITGK 546
              ++S   D++S G +  E++ G 
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGT 198

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (410), Expect = 4e-46
 Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 15/203 (7%)

Query: 351 NKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEE-----FKNEVVLVAKLQHRNLV 404
           + LGEG F  VYK     + Q +A+K++       A++        E+ L+ +L H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
            LL          LV++F+            +    L  S     +    +G+ YLH+  
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEVII---KDNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119

Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG 524
              I+HRDLK +N+LLD     K++DFG+A+ FG        +  V T  Y APE     
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA--YTHQVVTRWYRAPELLFGA 175

Query: 525 Q-FSVKSDVYSFGVLVLEIITGK 546
           + + V  D+++ G ++ E++   
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRV 198

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (409), Expect = 5e-46
 Identities = 54/214 (25%), Positives = 99/214 (46%), Gaps = 16/214 (7%)

Query: 343 ATNKFSTDNKLGEGGFGEVYKG--VLPSGQEIAVKRLSKASGQG--AEEFKNEVVLVAKL 398
           A  ++    ++GEG +G+V+K   +   G+ +A+KR+   +G+         EV ++  L
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 399 ---QHRNLVRLLGFCLEGEEKILVYEFVPNKSLD---YFLYDPEKQGQLDWSRRYKIIGG 452
              +H N+VRL   C            +  + +D       D   +  +       ++  
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124

Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
           + RG+ +LH     R++HRDLK  NIL+ +    K++DFG+ARI+         + +V T
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---TSVVVT 178

Query: 513 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
             Y APE  +   ++   D++S G +  E+   K
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 212

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (410), Expect = 1e-45
 Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 17/208 (8%)

Query: 347 FSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVR 405
           ++    +G G FG VY+  L  SG+ +A+K++ +           E+ ++ KL H N+VR
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVR 77

Query: 406 LLGFCLEGEEK------ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
           L  F     EK       LV ++VP        +    +  L        +  + R + Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137

Query: 460 LHEDSRLRIIHRDLKASNILLDAE-MNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
           +H      I HRD+K  N+LLD +    K+ DFG A+     + + N S I   Y     
Sbjct: 138 IHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRYYRAPE 192

Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITGK 546
                  ++   DV+S G ++ E++ G+
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (402), Expect = 4e-45
 Identities = 57/205 (27%), Positives = 96/205 (46%), Gaps = 11/205 (5%)

Query: 346 KFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSK--ASGQGAEEFKNEVVLVAKLQHRN 402
            F    K+GEG +G VYK     +G+ +A+K++     +         E+ L+ +L H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
           +V+LL       +  LV+EF+      +   D      +        +  + +G+ + H 
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCHS 120

Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE-YA 521
               R++HRDLK  N+L++ E   K++DFG+AR FGV          V T  Y APE   
Sbjct: 121 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH--EVVTLWYRAPEILL 175

Query: 522 MHGQFSVKSDVYSFGVLVLEIITGK 546
               +S   D++S G +  E++T +
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRR 200

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  158 bits (399), Expect = 1e-44
 Identities = 39/220 (17%), Positives = 83/220 (37%), Gaps = 20/220 (9%)

Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRN- 402
             +    ++GEG FG +++G  L + Q++A+K   + S     + ++E      L     
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62

Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
           +  +  F  EG   +LV + +     D          +            +   +  +HE
Sbjct: 63  IPNVYYFGQEGLHNVLVIDLLGPSLEDLLD---LCGRKFSVKTVAMAAKQMLARVQSIHE 119

Query: 463 DSRLRIIHRDLKASNILLDAEMNP-----KISDFGMARIFGVDQTQGN-----TSRIVGT 512
                +++RD+K  N L+    +       + DFGM + +    T+ +        + GT
Sbjct: 120 ---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 176

Query: 513 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFY 552
             YM+    +  + S + D+ + G + +  + G       
Sbjct: 177 ARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 216

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 1e-43
 Identities = 48/213 (22%), Positives = 88/213 (41%), Gaps = 20/213 (9%)

Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEE------FKNEVVLVAK 397
           +++     LG GGFG VY G+ +     +A+K + K       E         EVVL+ K
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63

Query: 398 LQ--HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
           +      ++RLL +    +  +L+ E        +      ++G L           +  
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLE 121

Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAE-MNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
            + + H      ++HRD+K  NIL+D      K+ DFG   +          +   GT  
Sbjct: 122 AVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRV 174

Query: 515 YMAPEYAMHGQF-SVKSDVYSFGVLVLEIITGK 546
           Y  PE+  + ++    + V+S G+L+ +++ G 
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 207

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 2e-43
 Identities = 56/213 (26%), Positives = 93/213 (43%), Gaps = 20/213 (9%)

Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKAS------GQGAEEFKNEVVLVAK 397
           + + T  +LG G F  V K     +G + A K + K        G   E+ + EV ++ +
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 398 LQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGI 457
           +QH N++ L        + IL+ E V    L  FL    ++  L      + +  I  G 
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNG- 125

Query: 458 LYLHEDSRLRIIHRDLKASNILLDAEMNP----KISDFGMARIFGVDQTQGNTSRIVGTY 513
             ++    L+I H DLK  NI+L     P    KI DFG+A              I GT 
Sbjct: 126 --VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTP 180

Query: 514 GYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
            ++APE   +    +++D++S GV+   +++G 
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 213

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 5e-42
 Identities = 51/216 (23%), Positives = 100/216 (46%), Gaps = 20/216 (9%)

Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGA--EEFKNEVVLVAKLQHR 401
           +K+    K+G+G FGEV+K     +GQ++A+K++   + +         E+ ++  L+H 
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69

Query: 402 NLVRLLGFCLEGEEKI--------LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGI 453
           N+V L+  C               LV++F  +              +   S   +++  +
Sbjct: 70  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQML 126

Query: 454 ARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT--SRIVG 511
             G   L+   R +I+HRD+KA+N+L+  +   K++DFG+AR F + +       +  V 
Sbjct: 127 LNG---LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183

Query: 512 TYGYMAPEYAMHGQ-FSVKSDVYSFGVLVLEIITGK 546
           T  Y  PE  +  + +    D++  G ++ E+ T  
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 219

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (381), Expect = 1e-41
 Identities = 48/207 (23%), Positives = 85/207 (41%), Gaps = 21/207 (10%)

Query: 349 TDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKL-QHRNLVRL 406
           T   LG G  G+V +     + ++ A+K L         + + EV L  +  Q  ++VR+
Sbjct: 16  TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRI 70

Query: 407 LGFCLEGEEK----ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
           +             ++V E +    L   + D   Q         +I+  I   I YLH 
Sbjct: 71  VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMKSIGEAIQYLHS 129

Query: 463 DSRLRIIHRDLKASNILLDAEMNP---KISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE 519
              + I HRD+K  N+L  ++      K++DFG A+      +         T  Y+APE
Sbjct: 130 ---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPE 183

Query: 520 YAMHGQFSVKSDVYSFGVLVLEIITGK 546
                ++    D++S GV++  ++ G 
Sbjct: 184 VLGPEKYDKSCDMWSLGVIMYILLCGY 210

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (376), Expect = 2e-41
 Identities = 56/224 (25%), Positives = 99/224 (44%), Gaps = 14/224 (6%)

Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHR 401
            K+    K+GEG +G V+K     + + +A+KR+               E+ L+ +L+H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 402 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH 461
           N+VRL       ++  LV+EF       YF       G LD       +  + +G+ + H
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCH 118

Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE-Y 520
                 ++HRDLK  N+L++     K+++FG+AR FG+       S  V T  Y  P+  
Sbjct: 119 ---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC--YSAEVVTLWYRPPDVL 173

Query: 521 AMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYV 564
                +S   D++S G +  E+    +    +  +   D L  +
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGR--PLFPGNDVDDQLKRI 215

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 3e-40
 Identities = 48/209 (22%), Positives = 81/209 (38%), Gaps = 12/209 (5%)

Query: 342 VATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA---SGQGAEEFKNEVVLVAK 397
           V  N F     LG+G FG+V       +G+  A+K L K    +         E  ++  
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61

Query: 398 LQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGI 457
            +H  L  L       +    V E+     L + L    ++      R       I    
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSA- 117

Query: 458 LYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMA 517
             L       +++RD+K  N++LD + + KI+DFG+ +    D          GT  Y+A
Sbjct: 118 --LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYLA 173

Query: 518 PEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
           PE      +    D +  GV++ E++ G+
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  147 bits (371), Expect = 4e-40
 Identities = 54/206 (26%), Positives = 88/206 (42%), Gaps = 15/206 (7%)

Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSK---ASGQGAEEFKNEVVLVAKLQH 400
           ++F     LG G FG V       SG   A+K L K      +  E   NE  ++  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
             LV+L     +     +V E+V    +   L    + G+            I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYL 157

Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEY 520
           H    L +I+RDLK  N+L+D +   +++DFG A+     + +G T  + GT   +APE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEI 209

Query: 521 AMHGQFSVKSDVYSFGVLVLEIITGK 546
            +   ++   D ++ GVL+ E+  G 
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGY 235

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 1e-39
 Identities = 57/212 (26%), Positives = 97/212 (45%), Gaps = 23/212 (10%)

Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSK--ASGQGAEEFKNEVVLVAKLQHR 401
             +     +G G +G V   V   +G ++A+K+L +   S   A+    E+ L+  ++H 
Sbjct: 18  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77

Query: 402 NLVRLLGFCLEGE------EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
           N++ LL      E      +  LV  F+             K  +L   R   ++  + +
Sbjct: 78  NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM-----KHEKLGEDRIQFLVYQMLK 132

Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGY 515
           G+ Y+H      IIHRDLK  N+ ++ +   KI DFG+AR     Q     +  V T  Y
Sbjct: 133 GLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMTGYVVTRWY 184

Query: 516 MAPEYAMHGQ-FSVKSDVYSFGVLVLEIITGK 546
            APE  ++   ++   D++S G ++ E+ITGK
Sbjct: 185 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 216

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 8e-38
 Identities = 61/226 (26%), Positives = 102/226 (45%), Gaps = 27/226 (11%)

Query: 336 DFETIEVATNKFSTDNK------LGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAE 386
            F ++EV  + F+   +      +G G  G V         + +A+K+LS+   +   A+
Sbjct: 2   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK 61

Query: 387 EFKNEVVLVAKLQHRNLVRLLGFCL------EGEEKILVYEFVPNKSLDYFLYDPEKQGQ 440
               E+VL+  + H+N++ LL          E ++  LV E +              Q +
Sbjct: 62  RAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI------QME 115

Query: 441 LDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500
           LD  R   ++  +  GI +LH      IIHRDLK SNI++ ++   KI DFG+AR  G  
Sbjct: 116 LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172

Query: 501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
                 +  V T  Y APE  +   +    D++S G ++ E++  K
Sbjct: 173 FM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  137 bits (346), Expect = 7e-37
 Identities = 46/221 (20%), Positives = 96/221 (43%), Gaps = 24/221 (10%)

Query: 335 FDFETIEVAT---NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKN 390
           +D+E+  V     + +    KLG G + EV++ + + + +++ VK L        ++ K 
Sbjct: 22  WDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKR 78

Query: 391 EVVLVAKLQ-HRNLVRLLGFCLEGEEK--ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRY 447
           E+ ++  L+   N++ L     +   +   LV+E V N               L      
Sbjct: 79  EIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIR 132

Query: 448 KIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE-MNPKISDFGMARIFGVDQTQGNT 506
             +  I + + Y H    + I+HRD+K  N+++D E    ++ D+G+A  +   Q     
Sbjct: 133 FYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--- 186

Query: 507 SRIVGTYGYMAPEYAM-HGQFSVKSDVYSFGVLVLEIITGK 546
           +  V +  +  PE  + +  +    D++S G ++  +I  K
Sbjct: 187 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 227

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 2e-35
 Identities = 59/228 (25%), Positives = 100/228 (43%), Gaps = 18/228 (7%)

Query: 330 LESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVL----PSGQEIAVKRLSKAS---- 381
           L +        +V    F     LG G +G+V+         +G+  A+K L KA+    
Sbjct: 9   LRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQK 68

Query: 382 GQGAEEFKNEVVLVAKLQHR-NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQ 440
            +  E  + E  ++  ++    LV L        +  L+ +++    L   L   E+   
Sbjct: 69  AKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER--- 125

Query: 441 LDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500
                    +G I   + +LH+   L II+RD+K  NILLD+  +  ++DFG+++ F  D
Sbjct: 126 FTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD 182

Query: 501 QTQGNTSRIVGTYGYMAPEYAMHGQ--FSVKSDVYSFGVLVLEIITGK 546
           +T+       GT  YMAP+    G        D +S GVL+ E++TG 
Sbjct: 183 ETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 3e-34
 Identities = 57/214 (26%), Positives = 100/214 (46%), Gaps = 13/214 (6%)

Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVL 394
           +TI     ++   + +G G +G V       +G  +AVK+LS+   S   A+    E+ L
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 70

Query: 395 VAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGI 453
           +  ++H N++ LL               ++    +   L +  K  +L       +I  I
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 130

Query: 454 ARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTY 513
            RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR    + T    +R     
Sbjct: 131 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRW---- 183

Query: 514 GYMAPEYAMHGQ-FSVKSDVYSFGVLVLEIITGK 546
            Y APE  ++   ++   D++S G ++ E++TG+
Sbjct: 184 -YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  129 bits (324), Expect = 1e-33
 Identities = 38/217 (17%), Positives = 83/217 (38%), Gaps = 18/217 (8%)

Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNL 403
            ++    KLG G F  V+    + +   +A+K +        E  ++E+ L+ ++   + 
Sbjct: 13  ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADN 71

Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPE-------------KQGQLDWSRRYKII 450
            +          K+L +      +  + +   E             +   +      +I 
Sbjct: 72  TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQIS 131

Query: 451 GGIARGILYLHEDSRLRIIHRDLKASNILLDAE-MNPKISDFGMARIFGVDQTQGNTSRI 509
             +  G+ Y+H   R  IIH D+K  N+L++       +    +A +        + +  
Sbjct: 132 KQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS 189

Query: 510 VGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
           + T  Y +PE  +   +   +D++S   L+ E+ITG 
Sbjct: 190 IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score =  107 bits (267), Expect = 2e-27
 Identities = 38/202 (18%), Positives = 72/202 (35%), Gaps = 27/202 (13%)

Query: 351 NKLGEGGFGEVYKGVLPSGQEIAVK--RLSKASGQ--------GAEEFKNEVVLVAKLQH 400
             +GEG    V+        E  VK  ++   S +        G   F    +  A+ + 
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
           R L +L G  +       VY +  N ++   L D ++  ++      +++  I   +   
Sbjct: 66  RALQKLQGLAV-----PKVYAWEGN-AVLMELIDAKELYRVRVENPDEVLDMILEEVAKF 119

Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR-IVGTYGYMAPE 519
           +      I+H DL   N+L+  E    I DF  +   G +  +    R +     Y +  
Sbjct: 120 YHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIITYFSRT 175

Query: 520 YAMHGQFSVKSDVYSFGVLVLE 541
           Y        + D+ S    +L+
Sbjct: 176 Y------RTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	571
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.98
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.88
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.6
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.1
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.67
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.36
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.39
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.71

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-46  Score=366.75  Aligned_cols=202  Identities=29%  Similarity=0.455  Sum_probs=176.6

Q ss_pred             CCCCccccccccCceeEEEEEc-cCCCeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      ++|++.++||+|+||+||+++. .+|+.||||+++... ....+.+.+|+.++++++||||+++++++.+++..+|||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy   84 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   84 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence            5788999999999999999996 468999999987543 33456789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT  502 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  502 (571)
                      +++|+|.+++.   +...+++.++..++.||++||+|||+++   |+||||||+|||+++++++||+|||+|+.+.....
T Consensus        85 ~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~  158 (271)
T d1nvra_          85 CSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  158 (271)
T ss_dssp             CTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             cCCCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence            99999999984   3457999999999999999999999987   99999999999999999999999999997754443


Q ss_pred             ccccccccccCCcccccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCCC
Q 008292          503 QGNTSRIVGTYGYMAPEYAMHGQF-SVKSDVYSFGVLVLEIITGKKNSNFY  552 (571)
Q Consensus       503 ~~~~~~~~gt~~y~aPE~~~~~~~-s~~~Dv~slGvvl~elltG~~p~~~~  552 (571)
                      .......+||+.|||||++.+..+ +.++|||||||++|||+||+.||...
T Consensus       159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~  209 (271)
T d1nvra_         159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP  209 (271)
T ss_dssp             ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSS
T ss_pred             cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCC
Confidence            344456789999999999988876 57899999999999999999998643

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-45  Score=365.63  Aligned_cols=197  Identities=28%  Similarity=0.493  Sum_probs=179.7

Q ss_pred             CCCCccccccccCceeEEEEEc-cCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEec
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV  423 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  423 (571)
                      ++|++.++||+|+||+||+++. .+|+.||||+++.......+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            5799999999999999999995 468999999998776667788999999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCc
Q 008292          424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ  503 (571)
Q Consensus       424 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  503 (571)
                      ++|+|.+++.    ...+++.++..++.||+.||+|||+++   |+||||||+|||++.++++||+|||+++.+....  
T Consensus       100 ~gg~L~~~~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~--  170 (293)
T d1yhwa1         100 AGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--  170 (293)
T ss_dssp             TTCBHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--
T ss_pred             CCCcHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc--
Confidence            9999998873    346999999999999999999999987   9999999999999999999999999998765332  


Q ss_pred             cccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          504 GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       504 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      ......+||+.|||||++.+..++.++|||||||++|||+||+.||.
T Consensus       171 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~  217 (293)
T d1yhwa1         171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL  217 (293)
T ss_dssp             CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCC
Confidence            22345679999999999999999999999999999999999999985

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-46  Score=366.61  Aligned_cols=203  Identities=32%  Similarity=0.535  Sum_probs=169.7

Q ss_pred             HHHhCCCCccccccccCceeEEEEEccCCCeeEEEeeccc--CccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEE
Q 008292          341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL  418 (571)
Q Consensus       341 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  418 (571)
                      ++..++|++.++||+|+||+||+|+++  ..||||+++..  +....+.|.+|+.++++++||||+++++++.+ +..++
T Consensus         4 ei~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~l   80 (276)
T d1uwha_           4 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAI   80 (276)
T ss_dssp             BCCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred             ccccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEE
Confidence            344678999999999999999999874  35999998754  34556789999999999999999999998754 56899


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccC
Q 008292          419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG  498 (571)
Q Consensus       419 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  498 (571)
                      ||||+++|+|.+++..  ....+++..++.++.||++||+|||+++   ||||||||+||||+.++.+||+|||+++...
T Consensus        81 v~Ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~  155 (276)
T d1uwha_          81 VTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKS  155 (276)
T ss_dssp             EEECCCEEEHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred             EEecCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeecc
Confidence            9999999999999854  3456999999999999999999999987   9999999999999999999999999998765


Q ss_pred             CCCCccccccccccCCccccccccc---CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          499 VDQTQGNTSRIVGTYGYMAPEYAMH---GQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       499 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ............||+.|||||++..   ..++.++|||||||++|||+||+.||..
T Consensus       156 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~  211 (276)
T d1uwha_         156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN  211 (276)
T ss_dssp             ----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             ccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCC
Confidence            4444344456689999999999864   3589999999999999999999999853

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-45  Score=356.70  Aligned_cols=197  Identities=30%  Similarity=0.471  Sum_probs=176.8

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeeccc---CccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY  420 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  420 (571)
                      ++|++.+.||+|+||+||+++.+ +++.||+|++.+.   .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            46888999999999999999974 6889999998643   3445678899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCC
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD  500 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  500 (571)
                      ||+++|+|.+++.   +...+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        86 Ey~~~g~L~~~l~---~~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~  159 (263)
T d2j4za1          86 EYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  159 (263)
T ss_dssp             ECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred             eecCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence            9999999999984   3457999999999999999999999987   999999999999999999999999999865422


Q ss_pred             CCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                          ......||+.|||||++.+..++.++|||||||++|||+||+.||+.
T Consensus       160 ----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~  206 (263)
T d2j4za1         160 ----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA  206 (263)
T ss_dssp             ----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             ----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCC
Confidence                23346799999999999999999999999999999999999999853

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-45  Score=356.46  Aligned_cols=198  Identities=32%  Similarity=0.510  Sum_probs=166.2

Q ss_pred             CCCCccccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEecC
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVP  424 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  424 (571)
                      ++|+..++||+|+||+||+|++.+++.||||+++.. ....++|.+|++++++++||||++++|++.+.+..++||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            578889999999999999999988889999999764 3456789999999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCcc
Q 008292          425 NKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG  504 (571)
Q Consensus       425 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  504 (571)
                      +|+|.+++..  ....+++..++.++.||++||.|||+++   |+||||||+||||++++.+||+|||+++.+...... 
T Consensus        84 ~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-  157 (263)
T d1sm2a_          84 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-  157 (263)
T ss_dssp             TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred             CCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCce-
Confidence            9999998854  3456899999999999999999999987   999999999999999999999999999876433222 


Q ss_pred             ccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCC
Q 008292          505 NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNS  549 (571)
Q Consensus       505 ~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~  549 (571)
                      ......||+.|||||++.+..++.++||||||+++|||+|+..|+
T Consensus       158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~  202 (263)
T d1sm2a_         158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP  202 (263)
T ss_dssp             -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCC
Confidence            223457899999999999999999999999999999999965543

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-45  Score=362.94  Aligned_cols=201  Identities=27%  Similarity=0.428  Sum_probs=176.3

Q ss_pred             CCCCccccccccCceeEEEEEc-cCCCeeEEEeeccc---CccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY  420 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  420 (571)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++++.   .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            4689999999999999999996 46899999998753   3455678999999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCC
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD  500 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  500 (571)
                      ||+++|+|.+++.   ..+.+++..+..++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+++.+...
T Consensus        88 Ey~~gg~L~~~~~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~  161 (288)
T d1uu3a_          88 SYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  161 (288)
T ss_dssp             CCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EccCCCCHHHhhh---ccCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence            9999999998884   4567999999999999999999999987   999999999999999999999999999987654


Q ss_pred             CCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .........+||+.|||||++.+..++.++|||||||++|||+||+.||..
T Consensus       162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~  212 (288)
T d1uu3a_         162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA  212 (288)
T ss_dssp             --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCC
Confidence            444444556899999999999999999999999999999999999999863

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.5e-45  Score=361.99  Aligned_cols=206  Identities=31%  Similarity=0.484  Sum_probs=180.4

Q ss_pred             HHHHHHhCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCee
Q 008292          338 ETIEVATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEK  416 (571)
Q Consensus       338 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  416 (571)
                      ++|++..++|++.++||+|+||+||+|+++ +++.||||+++.. ....++|.+|+.+|++++|||||+++|++.+++..
T Consensus        10 ~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (287)
T d1opja_          10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF   88 (287)
T ss_dssp             CTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             cccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCee
Confidence            345555678899999999999999999975 5889999998754 34567899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccc
Q 008292          417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI  496 (571)
Q Consensus       417 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  496 (571)
                      ++||||+++|+|..++... ....+++..++.++.||++||+|||+++   |+||||||+||||++++.+||+|||+++.
T Consensus        89 ~iv~E~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~  164 (287)
T d1opja_          89 YIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRL  164 (287)
T ss_dssp             EEEEECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred             EEEeecccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceee
Confidence            9999999999999988542 3457899999999999999999999987   99999999999999999999999999987


Q ss_pred             cCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCC
Q 008292          497 FGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNS  549 (571)
Q Consensus       497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~  549 (571)
                      ....... ......|++.|||||++.++.++.++||||||+++|||++|+.|+
T Consensus       165 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~  216 (287)
T d1opja_         165 MTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP  216 (287)
T ss_dssp             CCSSSSE-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             cCCCCce-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCC
Confidence            6543322 233456889999999999999999999999999999999987775

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-45  Score=359.50  Aligned_cols=203  Identities=34%  Similarity=0.532  Sum_probs=175.8

Q ss_pred             HHHHhCCCCccccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEE
Q 008292          340 IEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV  419 (571)
Q Consensus       340 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  419 (571)
                      +++..++|++.++||+|+||+||+|++++++.||||+++... ...++|.+|++++++++|||||+++|++.+ +..++|
T Consensus         8 wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv   85 (272)
T d1qpca_           8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII   85 (272)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             eecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEE
Confidence            344557888999999999999999999888899999997543 456789999999999999999999998754 567899


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCC
Q 008292          420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV  499 (571)
Q Consensus       420 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  499 (571)
                      |||+++|+|.+++.. .....+++.++++++.||++||.|||+++   |+||||||+||||++++.+||+|||+++.+..
T Consensus        86 ~Ey~~~g~L~~~~~~-~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~  161 (272)
T d1qpca_          86 TEYMENGSLVDFLKT-PSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIED  161 (272)
T ss_dssp             EECCTTCBHHHHTTS-HHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EEeCCCCcHHHHHhh-cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccC
Confidence            999999999988743 22346899999999999999999999987   99999999999999999999999999997754


Q ss_pred             CCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCC
Q 008292          500 DQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNS  549 (571)
Q Consensus       500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~  549 (571)
                      ... .......||+.|||||++.++.++.++|||||||++|||+||+.|+
T Consensus       162 ~~~-~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~  210 (272)
T d1qpca_         162 NEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP  210 (272)
T ss_dssp             SCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCS
T ss_pred             Ccc-ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCC
Confidence            322 2233457899999999999999999999999999999999976664

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-45  Score=360.71  Aligned_cols=200  Identities=28%  Similarity=0.426  Sum_probs=176.7

Q ss_pred             CCCCccccccccCceeEEEEEc-cCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEec
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV  423 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  423 (571)
                      +.|++.++||+|+||+||+|+. .+|+.||||+++.......+.+.+|+++|++++||||+++++++.+.+..++||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            4688899999999999999996 468899999998777677788999999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCc
Q 008292          424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ  503 (571)
Q Consensus       424 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  503 (571)
                      ++|+|.+++..  ....+++.++..++.||++||.|||+++   |+||||||+|||++.++++||+|||+++.....  .
T Consensus        92 ~~g~L~~~~~~--~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--~  164 (288)
T d2jfla1          92 AGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--I  164 (288)
T ss_dssp             TTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHH--H
T ss_pred             CCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCC--c
Confidence            99999998743  3456999999999999999999999987   999999999999999999999999999764321  1


Q ss_pred             cccccccccCCcccccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          504 GNTSRIVGTYGYMAPEYAM-----HGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       504 ~~~~~~~gt~~y~aPE~~~-----~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .......||+.|||||++.     +..++.++|||||||++|||+||+.||..
T Consensus       165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~  217 (288)
T d2jfla1         165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHE  217 (288)
T ss_dssp             HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCC
Confidence            1233467999999999984     45689999999999999999999999854

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-45  Score=357.28  Aligned_cols=205  Identities=26%  Similarity=0.401  Sum_probs=165.1

Q ss_pred             CCCCccccccccCceeEEEEEc-cCCCeeEEEeecccC--ccCHHHHHHHHHHHhhcCCCceeccceeEEe--CCeeEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE--GEEKILV  419 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~~~~~lv  419 (571)
                      ++|++.+.||+|+||+||+++. .+|+.||||++....  +...+.+.+|++++++++||||+++++++.+  .+..++|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            5789999999999999999986 468999999987543  3345678999999999999999999999875  3457899


Q ss_pred             EEecCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHcCC--CCCeEEecCCCCCEEECCCCceEEeeccCccc
Q 008292          420 YEFVPNKSLDYFLYDP-EKQGQLDWSRRYKIIGGIARGILYLHEDS--RLRIIHRDLKASNILLDAEMNPKISDFGMARI  496 (571)
Q Consensus       420 ~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  496 (571)
                      |||+++|+|.+++... .....+++..++.++.||+.||.|||+.+  ..+|+||||||+||||+.++.+||+|||+++.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            9999999999988532 23457999999999999999999999854  23599999999999999999999999999987


Q ss_pred             cCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          497 FGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      +.....  ......||+.|||||++.+..++.++|||||||++|||+||+.||..
T Consensus       164 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~  216 (269)
T d2java1         164 LNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA  216 (269)
T ss_dssp             C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCC
Confidence            653322  23346899999999999999999999999999999999999999863

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-45  Score=369.13  Aligned_cols=199  Identities=28%  Similarity=0.403  Sum_probs=176.7

Q ss_pred             HhCCCCccccccccCceeEEEEEc-cCCCeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEE
Q 008292          343 ATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY  420 (571)
Q Consensus       343 ~~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  420 (571)
                      ..++|++.++||+|+||+||+|+. .+|+.||+|+++... ....+.+.+|+.+|++++|||||++++++.+.+..++||
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm   83 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   83 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            357899999999999999999996 468999999997643 333567899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCCeEEecCCCCCEEECCCCceEEeeccCccccCC
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED-SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV  499 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  499 (571)
                      ||+++|+|.+++.   +.+.+++..+..++.|+++||.|||+. +   |+||||||+||||++++++||+|||+|+.+..
T Consensus        84 Ey~~gg~L~~~l~---~~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  157 (322)
T d1s9ja_          84 EHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  157 (322)
T ss_dssp             ECCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             EcCCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence            9999999999984   345799999999999999999999974 5   99999999999999999999999999987642


Q ss_pred             CCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          500 DQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .    .....+||+.|||||++.+..++.++||||+||++|||+||+.||..
T Consensus       158 ~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~  205 (322)
T d1s9ja_         158 S----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP  205 (322)
T ss_dssp             H----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSC
T ss_pred             C----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            2    22346899999999999999999999999999999999999999864

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-44  Score=347.67  Aligned_cols=200  Identities=28%  Similarity=0.462  Sum_probs=179.1

Q ss_pred             CCCCccccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEecC
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVP  424 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  424 (571)
                      ++|+..++||+|+||+||+|++++++.||||+++... ...++|.+|+.++++++||||++++|++.+.+..++||||++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            6789999999999999999999888899999997643 456789999999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCcc
Q 008292          425 NKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG  504 (571)
Q Consensus       425 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  504 (571)
                      +|+|..++..  ....+++..+++++.||++||.|||+++   |+||||||+|||+++++.+||+|||+++.+...... 
T Consensus        83 ~g~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-  156 (258)
T d1k2pa_          83 NGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-  156 (258)
T ss_dssp             TEEHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-
T ss_pred             CCcHHHhhhc--cccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCce-
Confidence            9999988753  4557899999999999999999999987   999999999999999999999999999876543322 


Q ss_pred             ccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          505 NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       505 ~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                      ......||+.|+|||.+.+..++.++||||||+++|||+| |+.||+.
T Consensus       157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~  204 (258)
T d1k2pa_         157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER  204 (258)
T ss_dssp             CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCC
Confidence            3334578999999999999999999999999999999998 7888764

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.6e-44  Score=357.94  Aligned_cols=201  Identities=30%  Similarity=0.525  Sum_probs=162.7

Q ss_pred             CCCCccccccccCceeEEEEEccC-CC---eeEEEeeccc-CccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLPS-GQ---EIAVKRLSKA-SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV  419 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~~-g~---~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  419 (571)
                      ++|++.++||+|+||+||+|+++. ++   .||||++... .....++|.+|+++|++++|||||+++|++.+++..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            457778999999999999999642 32   5888988654 344567899999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCC
Q 008292          420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV  499 (571)
Q Consensus       420 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  499 (571)
                      |||+++|+|.+++..  ....+++.+++.++.||++||.|||+++   |+||||||+||||+.++.+||+|||+++.+..
T Consensus       106 ~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  180 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED  180 (299)
T ss_dssp             EECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence            999999999998853  3456999999999999999999999987   99999999999999999999999999987654


Q ss_pred             CCCccc---cccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 008292          500 DQTQGN---TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSN  550 (571)
Q Consensus       500 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~  550 (571)
                      ......   .....||+.|||||.+.++.++.++|||||||++|||+| |+.||.
T Consensus       181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~  235 (299)
T d1jpaa_         181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYW  235 (299)
T ss_dssp             ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCC
Confidence            332221   222457899999999999999999999999999999998 899975

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-43  Score=346.94  Aligned_cols=194  Identities=29%  Similarity=0.454  Sum_probs=166.9

Q ss_pred             CccccccccCceeEEEEEcc-CCCeeEEEeeccc--CccCHHHHHHHHHHHhhcCCCceeccceeEEe----CCeeEEEE
Q 008292          348 STDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE----GEEKILVY  420 (571)
Q Consensus       348 ~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~----~~~~~lv~  420 (571)
                      +..++||+|+||+||+|+.. +++.||+|++...  .....+.+.+|+++|++++||||+++++++.+    ....++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            56678999999999999964 6889999998653  33445678999999999999999999999875    34578999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEEC-CCCceEEeeccCccccCC
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD-AEMNPKISDFGMARIFGV  499 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DfGla~~~~~  499 (571)
                      ||+++|+|.+++.   +...+++..+..++.||++||+|||+++ ++|+||||||+||||+ +++.+||+|||+++....
T Consensus        92 E~~~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~  167 (270)
T d1t4ha_          92 ELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  167 (270)
T ss_dssp             ECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCcHHHHHh---ccccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence            9999999999984   3457999999999999999999999874 4599999999999996 578999999999986432


Q ss_pred             CCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          500 DQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      .    .....+||+.|||||++.+ +++.++|||||||++|||+||+.||.
T Consensus       168 ~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~  213 (270)
T d1t4ha_         168 S----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYS  213 (270)
T ss_dssp             T----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             C----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCC
Confidence            2    2335689999999998765 69999999999999999999999985

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-43  Score=356.78  Aligned_cols=199  Identities=25%  Similarity=0.334  Sum_probs=179.0

Q ss_pred             CCCCccccccccCceeEEEEEc-cCCCeeEEEeeccc---CccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY  420 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  420 (571)
                      ++|++.+.||+|+||+||+++. .+|+.||||++++.   .....+.+.+|+.+|++++||||+++++++.+.+..++||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            5789999999999999999996 57899999999753   3445678899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCC
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD  500 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  500 (571)
                      ||+++|+|..++.   +...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        85 ey~~gg~L~~~~~---~~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~  158 (337)
T d1o6la_          85 EYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             ECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             eccCCCchhhhhh---cccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence            9999999999884   4567899999999999999999999987   999999999999999999999999999865432


Q ss_pred             CCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .  ......+||+.|||||++.+..++.++|||||||++|||++|+.||..
T Consensus       159 ~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~  207 (337)
T d1o6la_         159 G--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN  207 (337)
T ss_dssp             T--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             C--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCC
Confidence            2  233456899999999999999999999999999999999999999864

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-44  Score=351.71  Aligned_cols=201  Identities=32%  Similarity=0.529  Sum_probs=172.1

Q ss_pred             CCCCccc-cccccCceeEEEEEcc---CCCeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEE
Q 008292          345 NKFSTDN-KLGEGGFGEVYKGVLP---SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV  419 (571)
Q Consensus       345 ~~~~~~~-~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  419 (571)
                      +++.+.+ +||+|+||+||+|.++   ++..||||+++... ....++|.+|+++|++++|||||+++|++.+ +..++|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            4555666 4999999999999864   34579999997643 3446789999999999999999999999864 568999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCC
Q 008292          420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV  499 (571)
Q Consensus       420 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  499 (571)
                      |||+++|+|.+++..  ....+++..+++++.||++||+|||+++   |+||||||+||||+.++.+||+|||+++.+..
T Consensus        87 mE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~  161 (285)
T d1u59a_          87 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA  161 (285)
T ss_dssp             EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence            999999999998743  3457999999999999999999999987   99999999999999999999999999997754


Q ss_pred             CCCc-cccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          500 DQTQ-GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       500 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                      .... .......||+.|||||++.++.++.++|||||||++|||+| |+.||..
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~  215 (285)
T d1u59a_         162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK  215 (285)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCC
Confidence            3322 22334568999999999999999999999999999999998 8999864

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.8e-43  Score=358.91  Aligned_cols=199  Identities=24%  Similarity=0.404  Sum_probs=178.7

Q ss_pred             CCCCccccccccCceeEEEEEc-cCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEec
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV  423 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  423 (571)
                      ++|++.+.||+|+||+||+++. .+|+.||||++........+.+.+|+.+|++++||||+++++++.+.+..+|||||+
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  105 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  105 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            5799999999999999999996 468999999998776666778999999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECC--CCceEEeeccCccccCCCC
Q 008292          424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA--EMNPKISDFGMARIFGVDQ  501 (571)
Q Consensus       424 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~DfGla~~~~~~~  501 (571)
                      ++|+|.+++..  ..+.+++..+..++.||+.||.|||+++   |+||||||+|||++.  ++.+||+|||+++.+....
T Consensus       106 ~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~  180 (350)
T d1koaa2         106 SGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ  180 (350)
T ss_dssp             CSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred             CCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence            99999998843  3456999999999999999999999987   999999999999954  5789999999998765332


Q ss_pred             CccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          502 TQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       502 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                         ......||+.|||||++.+..++.++|||||||++|||+||+.||..
T Consensus       181 ---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~  227 (350)
T d1koaa2         181 ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG  227 (350)
T ss_dssp             ---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCC
Confidence               23346799999999999999999999999999999999999999853

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-44  Score=360.17  Aligned_cols=209  Identities=29%  Similarity=0.436  Sum_probs=176.4

Q ss_pred             HHHHhCCCCccccccccCceeEEEEEccC-C-----CeeEEEeeccc-CccCHHHHHHHHHHHhhc-CCCceeccceeEE
Q 008292          340 IEVATNKFSTDNKLGEGGFGEVYKGVLPS-G-----QEIAVKRLSKA-SGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCL  411 (571)
Q Consensus       340 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~-g-----~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~  411 (571)
                      +++..++|++.++||+|+||+||+|++.. +     ..||+|++... .......+.+|+.++.++ +|||||++++++.
T Consensus        32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~  111 (325)
T d1rjba_          32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT  111 (325)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe
Confidence            44556789999999999999999998643 2     25899988653 334456789999999998 8999999999999


Q ss_pred             eCCeeEEEEEecCCCChhhhhcCCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEe
Q 008292          412 EGEEKILVYEFVPNKSLDYFLYDPEK--------------------QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHR  471 (571)
Q Consensus       412 ~~~~~~lv~e~~~~g~L~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~  471 (571)
                      +.+..++||||+++|+|.+++.....                    ...+++..++.++.||++||+|||+++   |+||
T Consensus       112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHR  188 (325)
T d1rjba_         112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHR  188 (325)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEET
T ss_pred             eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeec
Confidence            99999999999999999999965321                    235899999999999999999999987   9999


Q ss_pred             cCCCCCEEECCCCceEEeeccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 008292          472 DLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSN  550 (571)
Q Consensus       472 Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~  550 (571)
                      ||||+|||++.++.+||+|||+|+...............||+.|||||++.++.++.++|||||||++|||+| |+.||.
T Consensus       189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~  268 (325)
T d1rjba_         189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP  268 (325)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             cCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence            9999999999999999999999987654444333445678999999999999999999999999999999998 899985


Q ss_pred             C
Q 008292          551 F  551 (571)
Q Consensus       551 ~  551 (571)
                      .
T Consensus       269 ~  269 (325)
T d1rjba_         269 G  269 (325)
T ss_dssp             T
T ss_pred             C
Confidence            3

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-43  Score=354.20  Aligned_cols=198  Identities=26%  Similarity=0.399  Sum_probs=160.1

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE  421 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e  421 (571)
                      .+.|++.+.||+|+||+||+++.+ +|+.||||++.+.. ....+.+.+|+.+|++++||||+++++++.+++..+||||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            356899999999999999999964 68899999997543 2334568899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEEC---CCCceEEeeccCccccC
Q 008292          422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD---AEMNPKISDFGMARIFG  498 (571)
Q Consensus       422 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DfGla~~~~  498 (571)
                      |+++|+|.+++.   ....+++.++..++.||+.||+|||+++   |+||||||+|||+.   +++.+||+|||+++...
T Consensus        88 ~~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~  161 (307)
T d1a06a_          88 LVSGGELFDRIV---EKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED  161 (307)
T ss_dssp             CCCSCBHHHHHH---TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred             ccCCCcHHHhhh---cccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence            999999999985   3457999999999999999999999987   99999999999994   57899999999998654


Q ss_pred             CCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          499 VDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      ...   .....+||+.|||||++.+..++.++|||||||++|||+||+.||.
T Consensus       162 ~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~  210 (307)
T d1a06a_         162 PGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFY  210 (307)
T ss_dssp             --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             CCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCC
Confidence            322   2334679999999999999999999999999999999999999985

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=3.4e-43  Score=357.11  Aligned_cols=199  Identities=24%  Similarity=0.348  Sum_probs=178.2

Q ss_pred             CCCCccccccccCceeEEEEEc-cCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEec
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV  423 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  423 (571)
                      ++|++.++||+|+||+||+++. .+|+.||||+++.......+.+.+|+.+|++++||||+++++++.+++..+|||||+
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  108 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  108 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            5799999999999999999996 479999999998766556678899999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEEC--CCCceEEeeccCccccCCCC
Q 008292          424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD--AEMNPKISDFGMARIFGVDQ  501 (571)
Q Consensus       424 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~DfGla~~~~~~~  501 (571)
                      ++|+|.+++.  .....+++.++..++.||+.||.|||+++   |+||||||+||||+  .++.+||+|||+++.+....
T Consensus       109 ~gg~L~~~~~--~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~  183 (352)
T d1koba_         109 SGGELFDRIA--AEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE  183 (352)
T ss_dssp             CCCBHHHHTT--CTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred             CCChHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCC
Confidence            9999988773  23456999999999999999999999987   99999999999997  57899999999998775432


Q ss_pred             CccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          502 TQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       502 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                         ......||+.|||||++.+..++.++|||||||++|||+||+.||..
T Consensus       184 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~  230 (352)
T d1koba_         184 ---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG  230 (352)
T ss_dssp             ---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred             ---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence               23345789999999999999999999999999999999999999853

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.8e-43  Score=352.92  Aligned_cols=194  Identities=31%  Similarity=0.477  Sum_probs=171.3

Q ss_pred             CCCCccccccccCceeEEEEEc-cCCCeeEEEeecccCc---cCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASG---QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY  420 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  420 (571)
                      +.|+..++||+|+||+||+|+. .+|+.||||+++....   ...+.+.+|+++|++++|||||++++++.+.+..++||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            3588999999999999999985 4688999999875432   33457889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCC
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD  500 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  500 (571)
                      ||+++|+|..++.   ....+++.++..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++.... 
T Consensus        95 E~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-  167 (309)
T d1u5ra_          95 EYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-  167 (309)
T ss_dssp             ECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred             EecCCCchHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence            9999999987663   3457999999999999999999999987   99999999999999999999999999986432 


Q ss_pred             CCccccccccccCCccccccccc---CCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          501 QTQGNTSRIVGTYGYMAPEYAMH---GQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       501 ~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                           .....||+.|||||++.+   +.++.++|||||||++|||++|+.||.
T Consensus       168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~  215 (309)
T d1u5ra_         168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF  215 (309)
T ss_dssp             -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCC
Confidence                 234579999999999863   468999999999999999999999984

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.7e-43  Score=352.87  Aligned_cols=196  Identities=28%  Similarity=0.407  Sum_probs=176.6

Q ss_pred             CCCCccccccccCceeEEEEEc-cCCCeeEEEeeccc---CccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY  420 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  420 (571)
                      ++|++.++||+|+||+||+++. .+|+.||||++++.   .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            4688999999999999999996 46899999999753   3455678999999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCC
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD  500 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  500 (571)
                      ||+++|+|..++.   ....+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++.....
T Consensus        84 E~~~gg~l~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~  157 (316)
T d1fota_          84 DYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  157 (316)
T ss_dssp             CCCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             eecCCcccccccc---ccccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence            9999999998884   4556889999999999999999999987   999999999999999999999999999876432


Q ss_pred             CCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                           ....+||+.|||||++.+..++.++|||||||++|||+||+.||..
T Consensus       158 -----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~  203 (316)
T d1fota_         158 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD  203 (316)
T ss_dssp             -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             -----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCC
Confidence                 2346899999999999999999999999999999999999999853

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-43  Score=349.57  Aligned_cols=194  Identities=31%  Similarity=0.480  Sum_probs=165.0

Q ss_pred             ccccccCceeEEEEEccC---CCeeEEEeecccC--ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEecCC
Q 008292          351 NKLGEGGFGEVYKGVLPS---GQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPN  425 (571)
Q Consensus       351 ~~LG~G~fg~Vy~~~~~~---g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  425 (571)
                      ++||+|+||+||+|.+++   ++.||||+++...  ....++|.+|+++|++++|||||+++|++.. +..+|||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            579999999999998643   4679999997533  3335689999999999999999999999854 567899999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCcc-
Q 008292          426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG-  504 (571)
Q Consensus       426 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~-  504 (571)
                      |+|.+++.   +...+++..++.++.||++||+|||+++   |+||||||+||||+.++.+||+|||+++.+....... 
T Consensus        92 g~L~~~l~---~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~  165 (277)
T d1xbba_          92 GPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  165 (277)
T ss_dssp             EEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred             CcHHHHHh---hccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence            99999984   4467999999999999999999999987   9999999999999999999999999998765433222 


Q ss_pred             ccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          505 NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       505 ~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                      ......||+.|||||.+.+..++.++|||||||++|||+| |+.||..
T Consensus       166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~  213 (277)
T d1xbba_         166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG  213 (277)
T ss_dssp             C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred             cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCC
Confidence            2334578999999999999999999999999999999998 8999853

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-43  Score=346.21  Aligned_cols=199  Identities=29%  Similarity=0.424  Sum_probs=176.6

Q ss_pred             hCCCCccccccccCceeEEEEEc-cCCCeeEEEeecccC------ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCee
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS------GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEK  416 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~------~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  416 (571)
                      .++|++.++||+|+||+||+|+. .+|+.||||++++..      ....+.+.+|+.+|++++||||+++++++.+.+..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            36799999999999999999996 478999999986432      23467899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCC----ceEEeecc
Q 008292          417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM----NPKISDFG  492 (571)
Q Consensus       417 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DfG  492 (571)
                      +|||||+++|+|.+++.   ....+++..+..++.||+.||+|||+++   |+||||||+|||++.++    .+||+|||
T Consensus        89 ~iv~E~~~gg~L~~~i~---~~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG  162 (293)
T d1jksa_          89 ILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG  162 (293)
T ss_dssp             EEEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEcCCCccccchhc---cccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence            99999999999999984   3457999999999999999999999987   99999999999998776    49999999


Q ss_pred             CccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          493 MARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       493 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      +++......   ......||+.|||||++.+..++.++|||||||++|||+||+.||..
T Consensus       163 ~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~  218 (293)
T d1jksa_         163 LAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG  218 (293)
T ss_dssp             TCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             hhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCC
Confidence            998764332   22345789999999999999999999999999999999999999863

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-44  Score=350.63  Aligned_cols=201  Identities=31%  Similarity=0.499  Sum_probs=169.5

Q ss_pred             HhCCCCccccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       343 ~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      ..++|++.++||+|+||+||+|++++++.||||+++.. ....+.|.+|+.++++++|||||+++|++. .+..++||||
T Consensus        15 ~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey   92 (285)
T d1fmka3          15 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY   92 (285)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred             CHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEe
Confidence            34678999999999999999999988889999999654 345678999999999999999999999985 4568999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT  502 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  502 (571)
                      +++|+|..++... ....++|.+++.++.||++||+|||+++   |+||||||+||||+.++++||+|||+++.+.....
T Consensus        93 ~~~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~  168 (285)
T d1fmka3          93 MSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  168 (285)
T ss_dssp             CTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred             cCCCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCc
Confidence            9999999888432 3346999999999999999999999987   99999999999999999999999999987643332


Q ss_pred             ccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          503 QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       503 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                       .......||+.|+|||++.++.++.++||||||+++|||+||..|+.
T Consensus       169 -~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~  215 (285)
T d1fmka3         169 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY  215 (285)
T ss_dssp             --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred             -eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCC
Confidence             22334578999999999999999999999999999999999877653

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-43  Score=348.57  Aligned_cols=201  Identities=31%  Similarity=0.528  Sum_probs=165.9

Q ss_pred             hCCCCccccccccCceeEEEEEccCC-----CeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLPSG-----QEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI  417 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~~g-----~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  417 (571)
                      .+.|++.++||+|+||+||+|.++..     ..||||+++... ....++|.+|++++++++|||||+++|++.+.+..+
T Consensus         6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~   85 (283)
T d1mqba_           6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM   85 (283)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence            35688889999999999999997542     369999986543 344567899999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCcccc
Q 008292          418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF  497 (571)
Q Consensus       418 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  497 (571)
                      +||||+.++++.+++..  ....+++.++++++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++.+
T Consensus        86 ~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~  160 (283)
T d1mqba_          86 IITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL  160 (283)
T ss_dssp             EEEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             EEEEecccCcchhhhhc--ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcc
Confidence            99999999999887743  3456999999999999999999999987   999999999999999999999999999876


Q ss_pred             CCCCCc-cccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCC
Q 008292          498 GVDQTQ-GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNS  549 (571)
Q Consensus       498 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~  549 (571)
                      ...... .......||+.|||||++.++.++.++||||||+++|||+||+.|+
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~  213 (283)
T d1mqba_         161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP  213 (283)
T ss_dssp             -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCc
Confidence            443222 2233456899999999999999999999999999999999976665

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.8e-42  Score=351.72  Aligned_cols=196  Identities=27%  Similarity=0.335  Sum_probs=176.9

Q ss_pred             CCCCccccccccCceeEEEEEc-cCCCeeEEEeeccc---CccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY  420 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  420 (571)
                      ++|++.++||+|+||+||+++. .+|+.||||++.+.   .....+.+.+|+++|+.++||||+++++++.+....++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            4789999999999999999996 46999999998643   3355678899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCC
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD  500 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  500 (571)
                      ||+.+|+|..++.   +.+.+++..+..++.||+.||.|||+++   ||||||||+||||+.++.+||+|||+++.+...
T Consensus       121 e~~~~g~l~~~l~---~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             ECCTTCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             ccccccchhhhHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence            9999999998884   4457999999999999999999999987   999999999999999999999999999876432


Q ss_pred             CCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                           .....||+.|||||++.+..++.++|||||||++|||+||+.||..
T Consensus       195 -----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~  240 (350)
T d1rdqe_         195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA  240 (350)
T ss_dssp             -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             -----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCC
Confidence                 2345799999999999999999999999999999999999999853

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8e-43  Score=348.00  Aligned_cols=209  Identities=28%  Similarity=0.480  Sum_probs=177.7

Q ss_pred             HHHHHhCCCCccccccccCceeEEEEEcc------CCCeeEEEeecccCc-cCHHHHHHHHHHHhhcCCCceeccceeEE
Q 008292          339 TIEVATNKFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSKASG-QGAEEFKNEVVLVAKLQHRNLVRLLGFCL  411 (571)
Q Consensus       339 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~  411 (571)
                      .++...++|++.++||+|+||+||+|+++      +++.||||+++.... ...++|.+|+.++++++||||+++++++.
T Consensus         7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~   86 (301)
T d1lufa_           7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA   86 (301)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence            34445678999999999999999999863      457899999976433 34567999999999999999999999999


Q ss_pred             eCCeeEEEEEecCCCChhhhhcCCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEE
Q 008292          412 EGEEKILVYEFVPNKSLDYFLYDPE---------------------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIH  470 (571)
Q Consensus       412 ~~~~~~lv~e~~~~g~L~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH  470 (571)
                      ..+..+++|||+++|+|.++++...                     ....+++..++.++.|+++||+|||+++   |||
T Consensus        87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivH  163 (301)
T d1lufa_          87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVH  163 (301)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEe
Confidence            9999999999999999999985321                     2235899999999999999999999987   999


Q ss_pred             ecCCCCCEEECCCCceEEeeccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCC-CC
Q 008292          471 RDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKK-NS  549 (571)
Q Consensus       471 ~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~-p~  549 (571)
                      |||||+||||+.++.+||+|||+++.+.............|++.|+|||.+.+..++.++|||||||++|||++|.. |+
T Consensus       164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~  243 (301)
T d1lufa_         164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY  243 (301)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence            99999999999999999999999987654444444445678999999999999999999999999999999999975 55


Q ss_pred             C
Q 008292          550 N  550 (571)
Q Consensus       550 ~  550 (571)
                      .
T Consensus       244 ~  244 (301)
T d1lufa_         244 Y  244 (301)
T ss_dssp             T
T ss_pred             C
Confidence            3

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-42  Score=347.48  Aligned_cols=201  Identities=31%  Similarity=0.541  Sum_probs=167.8

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCC----eeEEEeeccc-CccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQ----EIAVKRLSKA-SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL  418 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~----~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  418 (571)
                      ++|++.++||+|+||+||+|++. +|+    +||+|+++.. +....++|.+|++++++++|||||+++|++.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            46889999999999999999864 444    5888888653 455678899999999999999999999999865 5678


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccC
Q 008292          419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG  498 (571)
Q Consensus       419 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  498 (571)
                      ++||+.+|+|.+++..  ....+++..+++++.||++||+|||+++   |+||||||+||||+.++.+||+|||+++.+.
T Consensus        88 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~  162 (317)
T d1xkka_          88 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  162 (317)
T ss_dssp             EEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred             EEEeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence            8899999999887753  3567899999999999999999999987   9999999999999999999999999999876


Q ss_pred             CCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          499 VDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                      ............||+.|||||++.++.++.++||||||+++|||+| |+.||+.
T Consensus       163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~  216 (317)
T d1xkka_         163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG  216 (317)
T ss_dssp             TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCC
Confidence            5544444445678999999999999999999999999999999999 7888754

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=4.9e-42  Score=350.33  Aligned_cols=198  Identities=29%  Similarity=0.413  Sum_probs=171.0

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC---ccCHHHHHH---HHHHHhhcCCCceeccceeEEeCCeeE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKN---EVVLVAKLQHRNLVRLLGFCLEGEEKI  417 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~---Ei~~l~~l~h~niv~l~~~~~~~~~~~  417 (571)
                      ++|++.++||+|+||.||+|+.. +|+.||||++.+..   ......+.+   |+.+++.++||||+++++++.+.+..+
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            57899999999999999999964 68999999986422   223333444   467777888999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCcccc
Q 008292          418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF  497 (571)
Q Consensus       418 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  497 (571)
                      +||||+++|+|.+++.   +...+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++.+
T Consensus        84 ivmE~~~gg~L~~~l~---~~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~  157 (364)
T d1omwa3          84 FILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF  157 (364)
T ss_dssp             EEECCCCSCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred             EEEEecCCCcHHHHHH---hcccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence            9999999999999984   4567899999999999999999999987   999999999999999999999999999876


Q ss_pred             CCCCCccccccccccCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 008292          498 GVDQTQGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNFY  552 (571)
Q Consensus       498 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slGvvl~elltG~~p~~~~  552 (571)
                      ...    ......||+.|||||++.. ..++.++|||||||++|||+||+.||...
T Consensus       158 ~~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~  209 (364)
T d1omwa3         158 SKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH  209 (364)
T ss_dssp             SSS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred             CCC----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCC
Confidence            433    2334579999999999975 56899999999999999999999998643

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-42  Score=343.01  Aligned_cols=199  Identities=30%  Similarity=0.447  Sum_probs=175.2

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeeccc---CccCHHHHHHHHHHHh-hcCCCceeccceeEEeCCeeEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA---SGQGAEEFKNEVVLVA-KLQHRNLVRLLGFCLEGEEKILV  419 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~-~l~h~niv~l~~~~~~~~~~~lv  419 (571)
                      ++|++.++||+|+||+||+|+.. +|+.||||++++.   .....+.+..|+.++. .++||||+++++++.+++..+||
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            57889999999999999999964 6899999999753   2345566677777665 68999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCC
Q 008292          420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV  499 (571)
Q Consensus       420 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  499 (571)
                      |||+++|+|.+++.   ....+++.++..++.||+.||+|||+++   |+||||||+|||+++++++||+|||+++....
T Consensus        82 mEy~~~g~L~~~i~---~~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~  155 (320)
T d1xjda_          82 MEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML  155 (320)
T ss_dssp             EECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EeecCCCcHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence            99999999999984   4557899999999999999999999987   99999999999999999999999999986543


Q ss_pred             CCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          500 DQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ..  .......||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus       156 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~  205 (320)
T d1xjda_         156 GD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG  205 (320)
T ss_dssp             TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCC
Confidence            32  233456899999999999999999999999999999999999999863

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-42  Score=342.88  Aligned_cols=213  Identities=28%  Similarity=0.413  Sum_probs=169.8

Q ss_pred             cchHHHHHHhCCCCccccccccCceeEEEEEcc------CCCeeEEEeecccC-ccCHHHHHHHHHHHhhc-CCCceecc
Q 008292          335 FDFETIEVATNKFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKL-QHRNLVRL  406 (571)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l  406 (571)
                      ++...+++..++|++.++||+|+||.||+|++.      +++.||||+++... ....+.+.+|+.++.++ +|+||+.+
T Consensus         3 ~~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~   82 (299)
T d1ywna1           3 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   82 (299)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEe
Confidence            345566677788999999999999999999853      34679999997543 33456677888888776 68999999


Q ss_pred             ceeEEeC-CeeEEEEEecCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEec
Q 008292          407 LGFCLEG-EEKILVYEFVPNKSLDYFLYDPE-------------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRD  472 (571)
Q Consensus       407 ~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~D  472 (571)
                      ++++.+. ...++||||+++|+|.+++....             ....+++.+++.++.||++||.|||+++   |+|||
T Consensus        83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrD  159 (299)
T d1ywna1          83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD  159 (299)
T ss_dssp             EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred             eeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCc
Confidence            9988765 46799999999999999985322             1345899999999999999999999987   99999


Q ss_pred             CCCCCEEECCCCceEEeeccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCC-CCC
Q 008292          473 LKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKK-NSN  550 (571)
Q Consensus       473 lkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~-p~~  550 (571)
                      |||+||||++++.+||+|||+++...............||+.|||||.+.++.++.++|||||||++|||+||.. ||.
T Consensus       160 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~  238 (299)
T d1ywna1         160 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP  238 (299)
T ss_dssp             CCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             CCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCC
Confidence            999999999999999999999987655444444556689999999999999999999999999999999999765 554

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=7.3e-42  Score=337.02  Aligned_cols=202  Identities=27%  Similarity=0.417  Sum_probs=168.3

Q ss_pred             hCCCCccccccccCceeEEEEEc-cCCCeeEEEeecccCc---cCHHHHHHHHHHHhhcCCCceeccceeEEeCC----e
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASG---QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE----E  415 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----~  415 (571)
                      .++|++.+.||+|+||+||+++. .+|+.||||+++....   ...+.+.+|+++++.++||||+++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            46799999999999999999995 5789999999976432   33457899999999999999999999987654    3


Q ss_pred             eEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCcc
Q 008292          416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR  495 (571)
Q Consensus       416 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  495 (571)
                      .++||||+++++|.+++.   ..+.+++.+++.++.||++||+|||+++   |+||||||+|||++.++.++|+|||.++
T Consensus        86 ~~lvmE~~~g~~L~~~~~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~  159 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR  159 (277)
T ss_dssp             EEEEEECCCEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred             EEEEEECCCCCEehhhhc---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence            789999999999998884   4567999999999999999999999987   9999999999999999999999999987


Q ss_pred             ccCCCCC-ccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          496 IFGVDQT-QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       496 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ....... .......+||+.|||||++.+..++.++|||||||++|||+||+.||..
T Consensus       160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~  216 (277)
T d1o6ya_         160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG  216 (277)
T ss_dssp             ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCC
Confidence            6543322 2233456799999999999999999999999999999999999999863

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.1e-41  Score=332.61  Aligned_cols=198  Identities=28%  Similarity=0.413  Sum_probs=173.8

Q ss_pred             CCCCccccccccCceeEEEEEc-cCCCeeEEEeecccCc---------cCHHHHHHHHHHHhhcC-CCceeccceeEEeC
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASG---------QGAEEFKNEVVLVAKLQ-HRNLVRLLGFCLEG  413 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---------~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~  413 (571)
                      ++|++.+.||+|+||+||+++. .+|+.||||++++...         ...+.+.+|+.++++++ ||||+++++++.+.
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            6889999999999999999996 5789999999865431         12246889999999997 99999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccC
Q 008292          414 EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM  493 (571)
Q Consensus       414 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl  493 (571)
                      +..+|||||+++|+|.+++.   ..+.+++.++..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~---~~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~  156 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF  156 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             cceEEEEEcCCCchHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence            99999999999999999994   3557999999999999999999999987   99999999999999999999999999


Q ss_pred             ccccCCCCCccccccccccCCccccccccc------CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          494 ARIFGVDQTQGNTSRIVGTYGYMAPEYAMH------GQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       494 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ++.+.....   .....||+.|+|||.+.+      ..++.++||||+||++|||+||+.||.-
T Consensus       157 a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~  217 (277)
T d1phka_         157 SCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH  217 (277)
T ss_dssp             CEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             eeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCC
Confidence            987654322   234579999999999853      3578899999999999999999999863

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-42  Score=340.05  Aligned_cols=202  Identities=26%  Similarity=0.407  Sum_probs=162.3

Q ss_pred             HhCCCCccccccccCceeEEEEEccC----CCeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeE
Q 008292          343 ATNKFSTDNKLGEGGFGEVYKGVLPS----GQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI  417 (571)
Q Consensus       343 ~~~~~~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  417 (571)
                      ..++|++.+.||+|+||+||+|++..    +..||||+++... ....+.|.+|+.++++++||||++++|++. .+..+
T Consensus         5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~   83 (273)
T d1mp8a_           5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW   83 (273)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred             CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEE
Confidence            35678899999999999999998643    3468899886543 344567999999999999999999999985 46789


Q ss_pred             EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCcccc
Q 008292          418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF  497 (571)
Q Consensus       418 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  497 (571)
                      +||||+++|+|..++..  ....+++..++.++.||++||.|||+++   |+||||||+||++++++.+||+|||+++.+
T Consensus        84 iv~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~  158 (273)
T d1mp8a_          84 IIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM  158 (273)
T ss_dssp             EEEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             EEEEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheec
Confidence            99999999999988743  3457899999999999999999999987   999999999999999999999999999876


Q ss_pred             CCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          498 GVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                      ..... .......||+.|+|||.+.+..++.++|||||||++|||+| |+.|+..
T Consensus       159 ~~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~  212 (273)
T d1mp8a_         159 EDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG  212 (273)
T ss_dssp             -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             cCCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCC
Confidence            43322 23344578999999999999999999999999999999998 8888764

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-41  Score=339.03  Aligned_cols=199  Identities=24%  Similarity=0.338  Sum_probs=175.2

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      .++|++.+.||+|+||+||+|... +|+.||||+++.... ....+.+|+++|+.++||||+++++++.+.+..+|||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            467999999999999999999964 688999999976532 345688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCC--CceEEeeccCccccCCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE--MNPKISDFGMARIFGVD  500 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~DfGla~~~~~~  500 (571)
                      +++|+|.+++..  ....+++.++..++.||+.||+|||+++   |+||||||+|||++.+  ..+||+|||+++.....
T Consensus        83 ~~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~  157 (321)
T d1tkia_          83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             CCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence            999999999843  3447999999999999999999999987   9999999999999854  48999999999876432


Q ss_pred             CCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .   ......+|+.|+|||.+.+..++.++||||+||++|||++|+.||..
T Consensus       158 ~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~  205 (321)
T d1tkia_         158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA  205 (321)
T ss_dssp             C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             C---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCC
Confidence            2   23345789999999999999999999999999999999999999864

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-42  Score=335.57  Aligned_cols=196  Identities=30%  Similarity=0.461  Sum_probs=163.0

Q ss_pred             hCCCCccccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeC-CeeEEEEEe
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG-EEKILVYEF  422 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~  422 (571)
                      .++|++.++||+|+||.||+|++ .|+.||||+++..  ...+.|.+|++++++++||||++++|++.+. +..++||||
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey   82 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   82 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             HHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence            35677889999999999999998 5789999999653  3457899999999999999999999999764 567999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT  502 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  502 (571)
                      +++|+|.+++... ....+++..+++++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++.....  
T Consensus        83 ~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--  156 (262)
T d1byga_          83 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--  156 (262)
T ss_dssp             CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             cCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC--
Confidence            9999999998531 2235899999999999999999999987   999999999999999999999999999865322  


Q ss_pred             ccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 008292          503 QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF  551 (571)
Q Consensus       503 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~~  551 (571)
                         .....+++.|+|||++.++.++.++||||||+++|||+| |+.|+..
T Consensus       157 ---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~  203 (262)
T d1byga_         157 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR  203 (262)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT
T ss_pred             ---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCC
Confidence               223467889999999999999999999999999999999 6766643

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-41  Score=335.25  Aligned_cols=195  Identities=28%  Similarity=0.366  Sum_probs=165.4

Q ss_pred             ccccccccCceeEEEEEcc-CCCeeEEEeecccCcc-----CHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          349 TDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQ-----GAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       349 ~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-----~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      ..++||+|+||+||+|+.+ +|+.||||+++.....     ..+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            3578999999999999964 6899999998654322     124688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT  502 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  502 (571)
                      +.++++..+.   .....+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus        82 ~~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~  155 (299)
T d1ua2a_          82 METDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR  155 (299)
T ss_dssp             CSEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred             hcchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc
Confidence            9998887666   24566899999999999999999999987   99999999999999999999999999987643322


Q ss_pred             ccccccccccCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          503 QGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       503 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                        .....+||+.|||||++... .++.++|||||||++|||+||+.||..
T Consensus       156 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~  203 (299)
T d1ua2a_         156 --AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPG  203 (299)
T ss_dssp             --CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             --cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCC
Confidence              22345799999999998754 579999999999999999999998853

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-40  Score=331.49  Aligned_cols=196  Identities=29%  Similarity=0.475  Sum_probs=168.4

Q ss_pred             cccccccCceeEEEEEccCC----CeeEEEeeccc-CccCHHHHHHHHHHHhhcCCCceeccceeEEeC-CeeEEEEEec
Q 008292          350 DNKLGEGGFGEVYKGVLPSG----QEIAVKRLSKA-SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG-EEKILVYEFV  423 (571)
Q Consensus       350 ~~~LG~G~fg~Vy~~~~~~g----~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~~  423 (571)
                      .++||+|+||+||+|++.++    ..||||+++.. +....++|.+|+++|++++||||++++|++.+. ...++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            46899999999999996432    25899999753 445567899999999999999999999998764 5789999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCCc
Q 008292          424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ  503 (571)
Q Consensus       424 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  503 (571)
                      ++|+|.+++..  ....+++..+++++.|+++||.|||+.+   |+||||||+||||++++.+||+|||+++........
T Consensus       112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~  186 (311)
T d1r0pa_         112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  186 (311)
T ss_dssp             TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred             ecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence            99999998864  3456788999999999999999999987   999999999999999999999999999876543322


Q ss_pred             c--ccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          504 G--NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       504 ~--~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      .  ......||+.|+|||.+.+..++.++||||||+++|||+||+.|+.
T Consensus       187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~  235 (311)
T d1r0pa_         187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY  235 (311)
T ss_dssp             CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSC
T ss_pred             cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCC
Confidence            2  2234578999999999999999999999999999999999888864

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-41  Score=333.51  Aligned_cols=200  Identities=33%  Similarity=0.457  Sum_probs=162.0

Q ss_pred             CCCCccccccccCceeEEEEEcc--CC--CeeEEEeeccc---CccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP--SG--QEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI  417 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~--~g--~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  417 (571)
                      ++|++.+.||+|+||+||+|++.  ++  ..||||++++.   .....++|.+|+.+|++++||||++++|++.+ +..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            56888999999999999999853  22  36899998753   23445789999999999999999999999965 4678


Q ss_pred             EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCcccc
Q 008292          418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF  497 (571)
Q Consensus       418 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  497 (571)
                      +||||+++|++.+.+..  ....+++..++.++.||++||.|||+++   |+||||||+||||+.++.+||+|||+++.+
T Consensus        87 lv~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~  161 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL  161 (273)
T ss_dssp             EEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eeeeeecCcchhhhhhc--ccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence            99999999999887743  3456999999999999999999999987   999999999999999999999999999977


Q ss_pred             CCCCCcc-ccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 008292          498 GVDQTQG-NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSN  550 (571)
Q Consensus       498 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~  550 (571)
                      ....... ......|+..|+|||.+.+..++.++||||||+++|||+| |+.||.
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~  216 (273)
T d1u46a_         162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI  216 (273)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCC
Confidence            5443322 2334567889999999999999999999999999999998 899974

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-41  Score=337.69  Aligned_cols=208  Identities=29%  Similarity=0.437  Sum_probs=178.6

Q ss_pred             HHHHHhCCCCccccccccCceeEEEEEc------cCCCeeEEEeecccC-ccCHHHHHHHHHHHhhc-CCCceeccceeE
Q 008292          339 TIEVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKL-QHRNLVRLLGFC  410 (571)
Q Consensus       339 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~  410 (571)
                      .+++..++|++.++||+|+||.||+|++      .+++.||||+++... .....+|.+|+.++.++ +|||||+++|++
T Consensus        17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~   96 (311)
T d1t46a_          17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC   96 (311)
T ss_dssp             GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence            3455567899999999999999999985      245689999997644 33456789999999999 699999999999


Q ss_pred             EeCCeeEEEEEecCCCChhhhhcCCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCC
Q 008292          411 LEGEEKILVYEFVPNKSLDYFLYDPE---------------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKA  475 (571)
Q Consensus       411 ~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp  475 (571)
                      .+.+..++||||+++|+|.++++...               ....+++..+..++.||++||+|||+++   |+||||||
T Consensus        97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp  173 (311)
T d1t46a_          97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAA  173 (311)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred             eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccc
Confidence            99999999999999999999986422               2336899999999999999999999987   99999999


Q ss_pred             CCEEECCCCceEEeeccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCC
Q 008292          476 SNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNS  549 (571)
Q Consensus       476 ~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~  549 (571)
                      +|||++.++.+||+|||+++...............||+.|+|||.+.++.++.++||||||+++|||+|++.|+
T Consensus       174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~  247 (311)
T d1t46a_         174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP  247 (311)
T ss_dssp             GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred             ccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCC
Confidence            99999999999999999999775544444445568999999999999999999999999999999999955543

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-40  Score=336.34  Aligned_cols=194  Identities=24%  Similarity=0.317  Sum_probs=167.0

Q ss_pred             CCCCccc-cccccCceeEEEEEc-cCCCeeEEEeecccCccCHHHHHHHHHHHhhc-CCCceeccceeEEe----CCeeE
Q 008292          345 NKFSTDN-KLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLE----GEEKI  417 (571)
Q Consensus       345 ~~~~~~~-~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~----~~~~~  417 (571)
                      ++|.+.+ .||+|+||+||+|+. .+++.||||+++..     +.+.+|+.++.++ +||||+++++++.+    ....+
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~   85 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   85 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence            5787765 599999999999995 57899999998642     4677899987654 89999999999875    35679


Q ss_pred             EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECC---CCceEEeeccCc
Q 008292          418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA---EMNPKISDFGMA  494 (571)
Q Consensus       418 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfGla  494 (571)
                      +||||+++|+|.+++... ....+++.++..++.||+.||+|||+++   |+||||||+|||++.   ++.+||+|||++
T Consensus        86 ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a  161 (335)
T d2ozaa1          86 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA  161 (335)
T ss_dssp             EEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccccccccccee
Confidence            999999999999999542 2356999999999999999999999987   999999999999985   457999999999


Q ss_pred             cccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          495 RIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      +......   ......||+.|||||++.+..++.++|||||||++|||+||+.||.
T Consensus       162 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~  214 (335)
T d2ozaa1         162 KETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY  214 (335)
T ss_dssp             EECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCE
T ss_pred             eeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCC
Confidence            8764332   2334579999999999999999999999999999999999999985

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-41  Score=335.79  Aligned_cols=207  Identities=29%  Similarity=0.443  Sum_probs=174.0

Q ss_pred             HHHhCCCCccccccccCceeEEEEEccC--------CCeeEEEeecccCc-cCHHHHHHHHHHHhhc-CCCceeccceeE
Q 008292          341 EVATNKFSTDNKLGEGGFGEVYKGVLPS--------GQEIAVKRLSKASG-QGAEEFKNEVVLVAKL-QHRNLVRLLGFC  410 (571)
Q Consensus       341 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~--------g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~h~niv~l~~~~  410 (571)
                      ++..++|.+.++||+|+||.||+|+...        +..||||++++... ....++.+|...+.++ +||||+++++++
T Consensus         9 ~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~   88 (299)
T d1fgka_           9 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC   88 (299)
T ss_dssp             BCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccc
Confidence            3445788889999999999999998532        24699999976543 4457788899998888 899999999999


Q ss_pred             EeCCeeEEEEEecCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCC
Q 008292          411 LEGEEKILVYEFVPNKSLDYFLYDPE-------------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASN  477 (571)
Q Consensus       411 ~~~~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~N  477 (571)
                      .+.+..++||||+++|+|.+++....             ....+++.+++.++.||+.||+|||+++   ||||||||+|
T Consensus        89 ~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~N  165 (299)
T d1fgka_          89 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARN  165 (299)
T ss_dssp             CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred             ccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccc
Confidence            99999999999999999999996432             1346899999999999999999999987   9999999999


Q ss_pred             EEECCCCceEEeeccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 008292          478 ILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSN  550 (571)
Q Consensus       478 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~ellt-G~~p~~  550 (571)
                      ||++.++.+||+|||+++...............|++.|+|||.+.++.++.++||||||+++|||+| |+.||.
T Consensus       166 iLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~  239 (299)
T d1fgka_         166 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP  239 (299)
T ss_dssp             EEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             eeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCC
Confidence            9999999999999999997765555555556678999999999999999999999999999999998 677764

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-41  Score=334.69  Aligned_cols=200  Identities=32%  Similarity=0.480  Sum_probs=168.7

Q ss_pred             CCCCccccccccCceeEEEEEccC-CC--eeEEEeeccc-CccCHHHHHHHHHHHhhc-CCCceeccceeEEeCCeeEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLPS-GQ--EIAVKRLSKA-SGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILV  419 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~~-g~--~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv  419 (571)
                      ++|++.++||+|+||+||+|++++ |.  .||||+++.. .....++|.+|+++|.++ +||||++++|++.+.+..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            578888999999999999999754 43  4788887643 344567899999999998 799999999999999999999


Q ss_pred             EEecCCCChhhhhcCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCce
Q 008292          420 YEFVPNKSLDYFLYDP-------------EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP  486 (571)
Q Consensus       420 ~e~~~~g~L~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~  486 (571)
                      |||+++|+|.++++..             .....+++..+++++.||++||.|||+++   |+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence            9999999999999653             23467999999999999999999999987   9999999999999999999


Q ss_pred             EEeeccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCC-CCC
Q 008292          487 KISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKK-NSN  550 (571)
Q Consensus       487 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~-p~~  550 (571)
                      ||+|||+++......   ......||..|+|||.+.++.++.++||||||+++|||++|.. |+.
T Consensus       167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~  228 (309)
T d1fvra_         167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC  228 (309)
T ss_dssp             EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             EEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCC
Confidence            999999998653222   2234468999999999999999999999999999999999765 553

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-40  Score=331.76  Aligned_cols=200  Identities=28%  Similarity=0.445  Sum_probs=170.6

Q ss_pred             CCCCccccccccCceeEEEEEc-cCCCeeEEEeecccC--ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE  421 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e  421 (571)
                      ++|++.++||+|+||+||+|+. .+|+.||||+++...  +...+.+.+|++++++++||||+++++++.+++..++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            5789999999999999999996 578999999996543  2345788999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCC
Q 008292          422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ  501 (571)
Q Consensus       422 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  501 (571)
                      |+.++.+.....  .....+++..+..++.||+.||+|||+++   ||||||||+|||++.++.+||+|||+++......
T Consensus        82 ~~~~~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~  156 (298)
T d1gz8a_          82 FLHQDLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  156 (298)
T ss_dssp             CCSEEHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred             ecCCchhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence            998765554432  23456999999999999999999999987   9999999999999999999999999998764332


Q ss_pred             CccccccccccCCcccccccccCC-CCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          502 TQGNTSRIVGTYGYMAPEYAMHGQ-FSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       502 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                        .......||+.|+|||.+.... ++.++|||||||++|||++|+.||..
T Consensus       157 --~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~  205 (298)
T d1gz8a_         157 --RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG  205 (298)
T ss_dssp             --BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             --ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCC
Confidence              2233457999999999887665 57899999999999999999999863

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-41  Score=338.26  Aligned_cols=208  Identities=31%  Similarity=0.501  Sum_probs=179.0

Q ss_pred             HHHHhCCCCccccccccCceeEEEEEcc------CCCeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeEEe
Q 008292          340 IEVATNKFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE  412 (571)
Q Consensus       340 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~  412 (571)
                      |++..++|...++||+|+||+||+|.++      +++.||||+++... ......|.+|+.++++++||||++++|++..
T Consensus        15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~   94 (308)
T d1p4oa_          15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   94 (308)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred             eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence            4444578889999999999999999863      35789999997543 3444578999999999999999999999999


Q ss_pred             CCeeEEEEEecCCCChhhhhcCC-------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCc
Q 008292          413 GEEKILVYEFVPNKSLDYFLYDP-------EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN  485 (571)
Q Consensus       413 ~~~~~lv~e~~~~g~L~~~l~~~-------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~  485 (571)
                      .+..++||||+++|+|.+++...       .....+++..+.+++.|+++||.|||+++   |+||||||+||||+.+++
T Consensus        95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~  171 (308)
T d1p4oa_          95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFT  171 (308)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCC
T ss_pred             CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCce
Confidence            99999999999999999987531       22345799999999999999999999987   999999999999999999


Q ss_pred             eEEeeccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCC-CCCC
Q 008292          486 PKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK-KNSN  550 (571)
Q Consensus       486 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~-~p~~  550 (571)
                      +||+|||+++.+.............||+.|+|||.+.++.++.++||||||+++|||+||. .|+.
T Consensus       172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~  237 (308)
T d1p4oa_         172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ  237 (308)
T ss_dssp             EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTT
T ss_pred             EEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCC
Confidence            9999999998776554444455567899999999999999999999999999999999986 5553

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-41  Score=334.06  Aligned_cols=200  Identities=27%  Similarity=0.354  Sum_probs=162.8

Q ss_pred             CCCCccccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCC----eeEEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE----EKILVY  420 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----~~~lv~  420 (571)
                      ++|...++||+|+||+||+|++ +|+.||||+++.... ....++.|+..+..++||||+++++++.+.+    ..++||
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~   80 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence            4567788999999999999997 689999999864422 1222344666667889999999999998754    578999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-----CCCCeEEecCCCCCEEECCCCceEEeeccCcc
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED-----SRLRIIHRDLKASNILLDAEMNPKISDFGMAR  495 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-----~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  495 (571)
                      ||+++|+|.++++    ...++|..+++++.|++.||+|||+.     ...+|+||||||+||||+.++++||+|||+++
T Consensus        81 Ey~~~g~L~~~l~----~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~  156 (303)
T d1vjya_          81 DYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             ECCTTCBHHHHHH----HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             ecccCCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence            9999999999994    34689999999999999999999974     12359999999999999999999999999998


Q ss_pred             ccCCCCCc--cccccccccCCcccccccccCC------CCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          496 IFGVDQTQ--GNTSRIVGTYGYMAPEYAMHGQ------FSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       496 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      ........  .......||+.|||||++.+..      ++.|+|||||||++|||+||..|+.
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~  219 (303)
T d1vjya_         157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG  219 (303)
T ss_dssp             EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred             cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCC
Confidence            76443222  1234567999999999986543      5778999999999999999988764

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2.4e-40  Score=327.83  Aligned_cols=199  Identities=28%  Similarity=0.459  Sum_probs=172.3

Q ss_pred             CCCCccccccccCceeEEEEEccCCCeeEEEeeccc--CccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEEe
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF  422 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  422 (571)
                      ++|++.++||+|+||+||+|+.++|+.||||+++..  .+...+.+.+|+.+|++++||||+++++++...+..++++|+
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            578999999999999999999989999999999654  334467899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCCC
Q 008292          423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT  502 (571)
Q Consensus       423 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  502 (571)
                      +.++.+..+.   .....+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||++........
T Consensus        82 ~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~  155 (286)
T d1ob3a_          82 LDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR  155 (286)
T ss_dssp             CSEEHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             ehhhhHHHHH---hhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence            9988887776   34567999999999999999999999987   99999999999999999999999999987653322


Q ss_pred             ccccccccccCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          503 QGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       503 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                        ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||..
T Consensus       156 --~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~  203 (286)
T d1ob3a_         156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPG  203 (286)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             --ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCC
Confidence              23344689999999998754 568999999999999999999999853

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-40  Score=327.25  Aligned_cols=198  Identities=25%  Similarity=0.422  Sum_probs=168.5

Q ss_pred             hCCCCccccccccCceeEEEEEc-cCCCeeEEEeecccCc------cCHHHHHHHHHHHhhcC--CCceeccceeEEeCC
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASG------QGAEEFKNEVVLVAKLQ--HRNLVRLLGFCLEGE  414 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l~--h~niv~l~~~~~~~~  414 (571)
                      .++|++.++||+|+||+||+|+. .+|+.||||++++...      ....++.+|+.++++++  ||||+++++++.+.+
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            36799999999999999999996 4789999999865321      12234678999999987  899999999999999


Q ss_pred             eeEEEEEecCC-CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCC-CceEEeecc
Q 008292          415 EKILVYEFVPN-KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE-MNPKISDFG  492 (571)
Q Consensus       415 ~~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfG  492 (571)
                      ..++||||+.+ +++.+++.   ....+++.++..++.||++||+|||+++   |+||||||+|||++.+ +.+||+|||
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~---~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG  156 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFIT---ERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG  156 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             eEEEEEEeccCcchHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccc
Confidence            99999999976 57777763   3567999999999999999999999987   9999999999999854 799999999


Q ss_pred             CccccCCCCCccccccccccCCcccccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          493 MARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQF-SVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       493 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      +++.....    ..+...||+.|||||++.+..+ +.++|||||||++|||+||+.||..
T Consensus       157 ~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~  212 (273)
T d1xwsa_         157 SGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH  212 (273)
T ss_dssp             TCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred             cceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCC
Confidence            99865332    2334679999999999987776 5678999999999999999999864

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-39  Score=325.72  Aligned_cols=200  Identities=27%  Similarity=0.443  Sum_probs=166.9

Q ss_pred             hCCCCccccccccCceeEEEEEc-cC-CCeeEEEeecccC--ccCHHHHHHHHHHHhhc---CCCceeccceeEEe----
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVL-PS-GQEIAVKRLSKAS--GQGAEEFKNEVVLVAKL---QHRNLVRLLGFCLE----  412 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~-~~-g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l---~h~niv~l~~~~~~----  412 (571)
                      .++|++.++||+|+||+||+++. ++ ++.||||+++...  ......+.+|+.+++.+   +||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            46899999999999999999986 34 5679999986532  22233456777777665   79999999999864    


Q ss_pred             -CCeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeec
Q 008292          413 -GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDF  491 (571)
Q Consensus       413 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  491 (571)
                       ....+++|||++++++.....  .....+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+||
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df  160 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF  160 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred             cCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence             235789999999988765543  24556899999999999999999999987   999999999999999999999999


Q ss_pred             cCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          492 GMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       492 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      |+++.....   .......||+.|||||++.+..++.++||||+||++|||+||+.||..
T Consensus       161 g~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~  217 (305)
T d1blxa_         161 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG  217 (305)
T ss_dssp             CSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             hhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCC
Confidence            998764322   233456899999999999999999999999999999999999999864

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=9.2e-39  Score=317.06  Aligned_cols=203  Identities=21%  Similarity=0.322  Sum_probs=172.6

Q ss_pred             hCCCCccccccccCceeEEEEEcc-CCCeeEEEeecccCccCHHHHHHHHHHHhhcCC-CceeccceeEEeCCeeEEEEE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH-RNLVRLLGFCLEGEEKILVYE  421 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h-~niv~l~~~~~~~~~~~lv~e  421 (571)
                      .++|++.++||+|+||+||+|+.. +|+.||||+++....  .+.+.+|++.+..++| +|++.+++++..+...++|||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            468999999999999999999954 688999998865432  2356788899998876 899999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECC-----CCceEEeeccCccc
Q 008292          422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-----EMNPKISDFGMARI  496 (571)
Q Consensus       422 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~DfGla~~  496 (571)
                      |+ +++|.+++..  ....+++.++..++.|++.||+|||+++   |+||||||+|||++.     ++.+||+|||+++.
T Consensus        82 ~~-~~~l~~~~~~--~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~  155 (293)
T d1csna_          82 LL-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  155 (293)
T ss_dssp             CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             ec-CCCHHHHHHh--hccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence            98 6888888743  3456899999999999999999999987   999999999999964     57899999999987


Q ss_pred             cCCCCCc-----cccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 008292          497 FGVDQTQ-----GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQT  554 (571)
Q Consensus       497 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~~~~  554 (571)
                      +......     .......||+.|||||.+.+..++.++||||||+++|||+||+.||.....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~  218 (293)
T d1csna_         156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA  218 (293)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCS
T ss_pred             cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccc
Confidence            6433221     123446799999999999999999999999999999999999999975433

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-39  Score=321.39  Aligned_cols=201  Identities=25%  Similarity=0.442  Sum_probs=168.2

Q ss_pred             CCCCccccccccCceeEEEEEc-cCCCeeEEEeeccc--CccCHHHHHHHHHHHhhcCCCceeccceeEEeC--------
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG--------  413 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--------  413 (571)
                      ++|++.++||+|+||+||+|+. .+|+.||||++...  .....+++.+|+++|++++||||+++++.+...        
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            6899999999999999999996 57899999998643  334457788999999999999999999988653        


Q ss_pred             CeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccC
Q 008292          414 EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM  493 (571)
Q Consensus       414 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl  493 (571)
                      ...++||||++++.+....   .....+++..+..++.||++||.|||+++   |+||||||+|||++.++.+||+|||+
T Consensus        90 ~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~  163 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL  163 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred             ceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecce
Confidence            3578999999988877665   34557899999999999999999999987   99999999999999999999999999


Q ss_pred             ccccCCCCCc--cccccccccCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          494 ARIFGVDQTQ--GNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       494 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ++.+......  ......+||+.|+|||.+.+. .++.++|||||||++|||++|+.||..
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~  224 (318)
T d3blha1         164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG  224 (318)
T ss_dssp             CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCC
Confidence            9876533222  122335799999999998765 689999999999999999999999864

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.3e-39  Score=325.29  Aligned_cols=196  Identities=27%  Similarity=0.390  Sum_probs=163.7

Q ss_pred             CCCccccccccCceeEEEEEcc-CCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccceeEEeCC------eeEE
Q 008292          346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE------EKIL  418 (571)
Q Consensus       346 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------~~~l  418 (571)
                      +|+..++||+|+||+||+|+.. +|+.||||+++.....    +.+|+++|++++||||+++++++....      ..+|
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            5778899999999999999964 6899999999765432    247999999999999999999986532      3689


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCC-ceEEeeccCcccc
Q 008292          419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM-NPKISDFGMARIF  497 (571)
Q Consensus       419 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGla~~~  497 (571)
                      ||||++++.+..+.+.......+++.++..++.||++||+|||+++   |+||||||+|||++.++ .+||+|||+++.+
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence            9999987765554432234567999999999999999999999987   99999999999999775 8999999999876


Q ss_pred             CCCCCccccccccccCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          498 GVDQTQGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       498 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      .....   .....|++.|+|||.+.+ ..++.++||||+||++|||++|+.||..
T Consensus       174 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~  225 (350)
T d1q5ka_         174 VRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG  225 (350)
T ss_dssp             CTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred             cCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCC
Confidence            43332   233578999999998875 4789999999999999999999999864

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-38  Score=323.35  Aligned_cols=201  Identities=23%  Similarity=0.400  Sum_probs=167.5

Q ss_pred             hCCCCccccccccCceeEEEEEc-cCCCeeEEEeecccC-ccCHHHHHHHHHHHhhcCCCceeccceeEEeCC----eeE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE----EKI  417 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----~~~  417 (571)
                      +++|++.++||+|+||+||+|+. .+|+.||||++++.. ....+.+.+|+.+|+.++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            35799999999999999999985 579999999997543 334567889999999999999999999987643    235


Q ss_pred             EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCcccc
Q 008292          418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF  497 (571)
Q Consensus       418 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  497 (571)
                      ++++++.+|+|.+++.    ...+++..+..++.||+.||+|||+++   ||||||||+||||+.++.+||+|||+++..
T Consensus        87 ~l~~~~~~g~L~~~l~----~~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~  159 (345)
T d1pmea_          87 YLVTHLMGADLYKLLK----TQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA  159 (345)
T ss_dssp             EEEEECCCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEeecCCchhhhhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence            5667788999999984    346999999999999999999999987   999999999999999999999999999866


Q ss_pred             CCCCCc-cccccccccCCcccccccc-cCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          498 GVDQTQ-GNTSRIVGTYGYMAPEYAM-HGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       498 ~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ...... ......+||+.|+|||.+. ...++.++||||+|+++|||++|+.||.-
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~  215 (345)
T d1pmea_         160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG  215 (345)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCC
Confidence            433222 2234567999999999985 45678999999999999999999999864

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-38  Score=311.68  Aligned_cols=198  Identities=27%  Similarity=0.447  Sum_probs=173.5

Q ss_pred             CCCCccccccccCceeEEEEEc-cCCCeeEEEeecccC--ccCHHHHHHHHHHHhhcCCCceeccceeEEeCCeeEEEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE  421 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e  421 (571)
                      ++|++.++||+|+||+||+|+. .+++.||||+++...  ....+.+.+|+.+++.++||||+++++++.+....++++|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            5799999999999999999996 578899999986543  3345788999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCccccCCCC
Q 008292          422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ  501 (571)
Q Consensus       422 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  501 (571)
                      ++.+++|..++.   ..+.+++..+..++.|+++||+|||+++   |+||||||+|||++.++.+||+|||.++......
T Consensus        82 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~  155 (292)
T d1unla_          82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred             eccccccccccc---cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence            999999988874   4567899999999999999999999987   9999999999999999999999999998765433


Q ss_pred             CccccccccccCCcccccccccCC-CCcchhHHHHHHHHHHHHhCCCCCC
Q 008292          502 TQGNTSRIVGTYGYMAPEYAMHGQ-FSVKSDVYSFGVLVLEIITGKKNSN  550 (571)
Q Consensus       502 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~Dv~slGvvl~elltG~~p~~  550 (571)
                      .  ......+++.|+|||.+.... ++.++|||||||++|||++|+.|+.
T Consensus       156 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  203 (292)
T d1unla_         156 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF  203 (292)
T ss_dssp             S--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC
T ss_pred             c--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCC
Confidence            2  223345778899999887665 6899999999999999999999974

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.9e-38  Score=313.81  Aligned_cols=202  Identities=22%  Similarity=0.329  Sum_probs=165.6

Q ss_pred             hCCCCccccccccCceeEEEEEc-cCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCceeccc-eeEEeCCeeEEEEE
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLL-GFCLEGEEKILVYE  421 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~-~~~~~~~~~~lv~e  421 (571)
                      .++|++.++||+|+||+||+|+. .+|+.||||++.....  .+++..|+++++.++|+|++..+ ++..+++..++|||
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme   83 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   83 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence            35799999999999999999985 5688999998865432  24578899999999887765554 55577788899999


Q ss_pred             ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECC---CCceEEeeccCccccC
Q 008292          422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA---EMNPKISDFGMARIFG  498 (571)
Q Consensus       422 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfGla~~~~  498 (571)
                      |+.+ +|...+.  .....+++..+..++.|+++||+|||+++   |+||||||+|||++.   +..+||+|||+++.+.
T Consensus        84 ~~~~-~l~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~  157 (299)
T d1ckia_          84 LLGP-SLEDLFN--FCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  157 (299)
T ss_dssp             CCCC-BHHHHHH--HTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred             EcCC-chhhhhh--hccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence            9954 5544442  23457999999999999999999999987   999999999999864   4579999999999775


Q ss_pred             CCCCc-----cccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 008292          499 VDQTQ-----GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQ  553 (571)
Q Consensus       499 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~~~  553 (571)
                      .....     .......||+.|||||.+.+..++.++||||||+++|||+||+.||....
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~  217 (299)
T d1ckia_         158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK  217 (299)
T ss_dssp             CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred             ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccc
Confidence            43221     12345679999999999999999999999999999999999999996543

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-38  Score=321.50  Aligned_cols=195  Identities=29%  Similarity=0.453  Sum_probs=163.4

Q ss_pred             hCCCCccccccccCceeEEEEEc-cCCCeeEEEeecccC--ccCHHHHHHHHHHHhhcCCCceeccceeEEeCC------
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE------  414 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------  414 (571)
                      .++|++.++||+|+||+||+|+. .+|+.||||+++...  ....+.+.+|+++|+.++|||||++++++...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            46899999999999999999996 469999999997532  334567889999999999999999999997654      


Q ss_pred             eeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCc
Q 008292          415 EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA  494 (571)
Q Consensus       415 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla  494 (571)
                      ..++||||+ +.+|..+.    +...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus        97 ~~~lv~e~~-~~~l~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a  168 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLM----KHEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA  168 (346)
T ss_dssp             CCEEEEECC-SEEHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecc-cccHHHHH----HhccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence            469999999 56777766    3457999999999999999999999987   999999999999999999999999999


Q ss_pred             cccCCCCCccccccccccCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          495 RIFGVDQTQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      +.....     .+...||+.|+|||.+.+. .++.++||||+||++|||++|+.||..
T Consensus       169 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~  221 (346)
T d1cm8a_         169 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG  221 (346)
T ss_dssp             EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             eccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCC
Confidence            875432     2345789999999998764 578999999999999999999999864

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-38  Score=320.09  Aligned_cols=201  Identities=27%  Similarity=0.394  Sum_probs=172.2

Q ss_pred             CCCCccccccccCceeEEEEEc----cCCCeeEEEeeccc----CccCHHHHHHHHHHHhhcCC-CceeccceeEEeCCe
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVL----PSGQEIAVKRLSKA----SGQGAEEFKNEVVLVAKLQH-RNLVRLLGFCLEGEE  415 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~----~~g~~vavK~~~~~----~~~~~~~~~~Ei~~l~~l~h-~niv~l~~~~~~~~~  415 (571)
                      ++|++.++||+|+||+||+++.    .+|+.||||++++.    .....+.+.+|++++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            5699999999999999999984    24789999998653    23345678899999999977 899999999999999


Q ss_pred             eEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCcc
Q 008292          416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR  495 (571)
Q Consensus       416 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  495 (571)
                      .+++|||+.+|+|.+++.   ....+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       104 ~~~v~e~~~~~~L~~~i~---~~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~  177 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLS---QRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK  177 (322)
T ss_dssp             EEEEECCCCSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             eeeeeecccccHHHHHHH---hcccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence            999999999999999884   4456788999999999999999999987   9999999999999999999999999998


Q ss_pred             ccCCCCCccccccccccCCcccccccccC--CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 008292          496 IFGVDQTQGNTSRIVGTYGYMAPEYAMHG--QFSVKSDVYSFGVLVLEIITGKKNSNFY  552 (571)
Q Consensus       496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~~Dv~slGvvl~elltG~~p~~~~  552 (571)
                      .+...... ......|++.|+|||.+.+.  .++.++|||||||+||||+||+.||...
T Consensus       178 ~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~  235 (322)
T d1vzoa_         178 EFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD  235 (322)
T ss_dssp             ECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCT
T ss_pred             hhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence            76433222 23345799999999999754  4788999999999999999999998644

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=2e-37  Score=312.81  Aligned_cols=193  Identities=22%  Similarity=0.379  Sum_probs=167.1

Q ss_pred             CCCCccccccccCceeEEEEEc-cCCCeeEEEeecccCccCHHHHHHHHHHHhhcC-CCceeccceeEEeC--CeeEEEE
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ-HRNLVRLLGFCLEG--EEKILVY  420 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~--~~~~lv~  420 (571)
                      ++|++.++||+|+||+||+|+. .+|+.||||+++..   ..+++.+|+.+|++++ ||||+++++++...  ...++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            5799999999999999999996 56899999998653   3567899999999996 99999999998754  4589999


Q ss_pred             EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCC-ceEEeeccCccccCC
Q 008292          421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM-NPKISDFGMARIFGV  499 (571)
Q Consensus       421 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGla~~~~~  499 (571)
                      ||+++++|..+.      ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++ .+||+|||+++....
T Consensus       112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~  182 (328)
T d3bqca1         112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  182 (328)
T ss_dssp             ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred             eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence            999999997764      35899999999999999999999988   99999999999998655 699999999987643


Q ss_pred             CCCccccccccccCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 008292          500 DQTQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFY  552 (571)
Q Consensus       500 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~slGvvl~elltG~~p~~~~  552 (571)
                      ..   ......+|+.|+|||.+.+. .++.++||||+|+++|||++|+.||...
T Consensus       183 ~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~  233 (328)
T d3bqca1         183 GQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG  233 (328)
T ss_dssp             TC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred             CC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCC
Confidence            32   23345789999999998765 4799999999999999999999998643

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-37  Score=311.64  Aligned_cols=195  Identities=28%  Similarity=0.379  Sum_probs=159.3

Q ss_pred             CCCCccccccccCceeEEEEEcc-CCCeeEEEeecccC--ccCHHHHHHHHHHHhhcCCCceeccceeEEeC------Ce
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG------EE  415 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~------~~  415 (571)
                      ++|++.++||+|+||+||+|+.. +|+.||||+++...  .....++.+|+.++++++||||+++++++...      ..
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            57999999999999999999964 69999999997543  33446788999999999999999999998643      57


Q ss_pred             eEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCcc
Q 008292          416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR  495 (571)
Q Consensus       416 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  495 (571)
                      .++||||+.++.+..+.      ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+|++|||+++
T Consensus        97 ~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~  167 (355)
T d2b1pa1          97 VYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_dssp             EEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             eEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence            79999999876655442      35899999999999999999999987   9999999999999999999999999988


Q ss_pred             ccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          496 IFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ......   ......+|+.|+|||++.+..++.++||||+||+++||++|+.||..
T Consensus       168 ~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~  220 (355)
T d2b1pa1         168 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG  220 (355)
T ss_dssp             ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCC
Confidence            654322   33445789999999999999999999999999999999999999863

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-37  Score=311.16  Aligned_cols=196  Identities=27%  Similarity=0.415  Sum_probs=165.1

Q ss_pred             hCCCCccccccccCceeEEEEEc-cCCCeeEEEeecccC--ccCHHHHHHHHHHHhhcCCCceeccceeEEeC-----Ce
Q 008292          344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG-----EE  415 (571)
Q Consensus       344 ~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-----~~  415 (571)
                      .++|++.++||+|+||+||+|+. .+|+.||||++++..  ....+++.+|+.+|++++||||+++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            46899999999999999999995 579999999997543  23346788999999999999999999998643     34


Q ss_pred             eEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEeeccCcc
Q 008292          416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR  495 (571)
Q Consensus       416 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  495 (571)
                      .+++++|+.+|+|.+++.    ...+++.++..++.||+.||+|||+++   |+||||||+|||++.++.+|++|||++.
T Consensus        97 ~~~i~~~~~gg~L~~~~~----~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~  169 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR  169 (348)
T ss_dssp             CCEEEEECCSEEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred             eEEEEEeecCCchhhhcc----cccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence            467788889999999983    346999999999999999999999987   9999999999999999999999999997


Q ss_pred             ccCCCCCccccccccccCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 008292          496 IFGVDQTQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNF  551 (571)
Q Consensus       496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~slGvvl~elltG~~p~~~  551 (571)
                      ....     ......|++.|+|||.+.+. .++.++|||||||++|||++|+.||..
T Consensus       170 ~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~  221 (348)
T d2gfsa1         170 HTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG  221 (348)
T ss_dssp             CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             ccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCC
Confidence            5432     22345789999999987765 468899999999999999999999853

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.98  E-value=9e-33  Score=282.45  Aligned_cols=200  Identities=22%  Similarity=0.284  Sum_probs=159.6

Q ss_pred             CCCCccccccccCceeEEEEEc-cCCCeeEEEeecccCccCHHHHHHHHHHHhhcC-----------CCceeccceeEEe
Q 008292          345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ-----------HRNLVRLLGFCLE  412 (571)
Q Consensus       345 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----------h~niv~l~~~~~~  412 (571)
                      .+|++.++||+|+||+||+|+. .+|+.||||++++.. ...+.+.+|++++++++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            4599999999999999999996 579999999997543 22457788999888875           5789999988764


Q ss_pred             C--CeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEEecCCCCCEEECCCC-----
Q 008292          413 G--EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE-DSRLRIIHRDLKASNILLDAEM-----  484 (571)
Q Consensus       413 ~--~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlkp~NIll~~~~-----  484 (571)
                      .  ...++++++...+..............+++..+..++.||++||+|||+ .+   |+||||||+||||+.++     
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred             ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence            3  4556777776655443332223455678999999999999999999997 55   99999999999998665     


Q ss_pred             -ceEEeeccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 008292          485 -NPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQ  553 (571)
Q Consensus       485 -~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~elltG~~p~~~~~  553 (571)
                       .+||+|||.+......     ....+||+.|+|||++....++.++||||+|++++||++|+.||...+
T Consensus       169 ~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~  233 (362)
T d1q8ya_         169 IQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE  233 (362)
T ss_dssp             EEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             ceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCc
Confidence             3999999999865322     234579999999999999999999999999999999999999987543

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.88  E-value=8.6e-24  Score=194.98  Aligned_cols=170  Identities=19%  Similarity=0.180  Sum_probs=120.5

Q ss_pred             CccccccccCceeEEEEEccCCCeeEEEeecccCc------------------cCHHHHHHHHHHHhhcCCCceecccee
Q 008292          348 STDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASG------------------QGAEEFKNEVVLVAKLQHRNLVRLLGF  409 (571)
Q Consensus       348 ~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~------------------~~~~~~~~Ei~~l~~l~h~niv~l~~~  409 (571)
                      .+.++||+|+||+||+|+..+|+.||||+++....                  ........|...+.++.|.+++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            35689999999999999988999999998753210                  001234568888999999999887765


Q ss_pred             EEeCCeeEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEecCCCCCEEECCCCceEEe
Q 008292          410 CLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKIS  489 (571)
Q Consensus       410 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  489 (571)
                      .    ..+++|||+++..+..+          +......++.|++++|.|||+++   |+||||||+|||++++ .++|+
T Consensus        83 ~----~~~lvme~~~~~~~~~l----------~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~li  144 (191)
T d1zara2          83 E----GNAVLMELIDAKELYRV----------RVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWII  144 (191)
T ss_dssp             E----TTEEEEECCCCEEGGGC----------CCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEEC
T ss_pred             c----CCEEEEEeeccccccch----------hhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEE
Confidence            2    34799999988765432          23345678999999999999987   9999999999999865 58999


Q ss_pred             eccCccccCCCCCccccccccccCCcccccccccCCCCcchhHHHHHHHHH
Q 008292          490 DFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVL  540 (571)
Q Consensus       490 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slGvvl~  540 (571)
                      |||+|.....+.......+-+   ..+ .| ...+.|+.++|+||..--+.
T Consensus       145 DFG~a~~~~~~~~~~~l~rd~---~~~-~~-~f~r~y~~~~d~~s~~~~~~  190 (191)
T d1zara2         145 DFPQSVEVGEEGWREILERDV---RNI-IT-YFSRTYRTEKDINSAIDRIL  190 (191)
T ss_dssp             CCTTCEETTSTTHHHHHHHHH---HHH-HH-HHHHHHCCCCCHHHHHHHHH
T ss_pred             ECCCcccCCCCCcHHHHHHHH---HHH-HH-HHcCCCCCcccHHHHHHHHh
Confidence            999997653222111000000   000 01 12356788999999875543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.60  E-value=7.2e-08  Score=91.19  Aligned_cols=148  Identities=18%  Similarity=0.107  Sum_probs=100.4

Q ss_pred             HHHHhCCCCccccccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhcC-CCceeccceeEEeCCeeEE
Q 008292          340 IEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEKIL  418 (571)
Q Consensus       340 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~l  418 (571)
                      +...-..|+..+..+-++...||+... ++..+++|+...........+.+|...+..+. +--+.+++.+..+++..++
T Consensus         9 l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~l   87 (263)
T d1j7la_           9 LKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL   87 (263)
T ss_dssp             HHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred             HHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEE
Confidence            344445666665544445578999875 56667888887655555556778888877764 3335677888888888999


Q ss_pred             EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-----------------------------------
Q 008292          419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED-----------------------------------  463 (571)
Q Consensus       419 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-----------------------------------  463 (571)
                      ||+++++..+.......        .....++.++++.+..||+.                                   
T Consensus        88 v~~~l~G~~~~~~~~~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (263)
T d1j7la_          88 LMSEADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE  159 (263)
T ss_dssp             EEECCSSEEHHHHTTTC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred             EEEeccccccccccccc--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence            99999998886554211        11223445555556666632                                   


Q ss_pred             ---------------------CCCCeEEecCCCCCEEECCCCceEEeeccCccc
Q 008292          464 ---------------------SRLRIIHRDLKASNILLDAEMNPKISDFGMARI  496 (571)
Q Consensus       464 ---------------------~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  496 (571)
                                           ....++|+|+.|.|||+++++.+-|+||+.+..
T Consensus       160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                 012279999999999999877677999998753

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.10  E-value=5.6e-06  Score=77.28  Aligned_cols=131  Identities=18%  Similarity=0.161  Sum_probs=85.5

Q ss_pred             cccccCc-eeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCC--ceeccceeEEeCCeeEEEEEecCCCCh
Q 008292          352 KLGEGGF-GEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHR--NLVRLLGFCLEGEEKILVYEFVPNKSL  428 (571)
Q Consensus       352 ~LG~G~f-g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~--niv~l~~~~~~~~~~~lv~e~~~~g~L  428 (571)
                      .+..|.. ..||+...+++..+++|.......   ..+..|...++.+...  .+.+++++..+++..++||++++|.++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            3444543 679999987888888897654432   3456777777766433  356677887888888999999998766


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHc----------------------------------------------
Q 008292          429 DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE----------------------------------------------  462 (571)
Q Consensus       429 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~----------------------------------------------  462 (571)
                      .+..        ....   ..+.++++.|.-||+                                              
T Consensus        94 ~~~~--------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (255)
T d1nd4a_          94 LSSH--------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF  162 (255)
T ss_dssp             TTSC--------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred             cccc--------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence            4321        1111   112223333333331                                              


Q ss_pred             -----C----CCCCeEEecCCCCCEEECCCCceEEeeccCccc
Q 008292          463 -----D----SRLRIIHRDLKASNILLDAEMNPKISDFGMARI  496 (571)
Q Consensus       463 -----~----~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  496 (571)
                           .    ..+.++|+|+.|.|||++++..+-|+||+.+..
T Consensus       163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence                 1    122389999999999999877678999998753

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.67  E-value=5.9e-05  Score=75.07  Aligned_cols=76  Identities=13%  Similarity=0.140  Sum_probs=48.6

Q ss_pred             cccccccCceeEEEEEccC-CCeeEEEeeccc-------CccCHHHHHHHHHHHhhcC-C--CceeccceeEEeCCeeEE
Q 008292          350 DNKLGEGGFGEVYKGVLPS-GQEIAVKRLSKA-------SGQGAEEFKNEVVLVAKLQ-H--RNLVRLLGFCLEGEEKIL  418 (571)
Q Consensus       350 ~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~-------~~~~~~~~~~Ei~~l~~l~-h--~niv~l~~~~~~~~~~~l  418 (571)
                      .+.||.|....||+....+ ++.++||.-...       .+...++...|.+.|+.+. +  ..+.+++.  .+.+..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE--EcCCCCEE
Confidence            3578999999999998754 677888864321       1223345566777776653 2  23444544  35667789


Q ss_pred             EEEecCCCC
Q 008292          419 VYEFVPNKS  427 (571)
Q Consensus       419 v~e~~~~g~  427 (571)
                      |||++++..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999998754

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.36  E-value=0.00016  Score=69.94  Aligned_cols=135  Identities=17%  Similarity=0.134  Sum_probs=79.2

Q ss_pred             eeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCce-----eccc--eeEEeCCeeEEEEEecCCCChhhh
Q 008292          359 GEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNL-----VRLL--GFCLEGEEKILVYEFVPNKSLDYF  431 (571)
Q Consensus       359 g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-----v~l~--~~~~~~~~~~lv~e~~~~g~L~~~  431 (571)
                      -.||+...++|+.+++|+.+.. ....+++..|+..+..+....|     +..-  .....+...+.++++++|..+...
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~  114 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD  114 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred             ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence            4799999999999999998654 2356778889988887753322     1111  122345567889999987443210


Q ss_pred             ----h----------c----C--CCCCCCCCHH----------------------HHHHHHHHHHHHHHHH-HcCCCCCe
Q 008292          432 ----L----------Y----D--PEKQGQLDWS----------------------RRYKIIGGIARGILYL-HEDSRLRI  468 (571)
Q Consensus       432 ----l----------~----~--~~~~~~l~~~----------------------~~~~i~~~ia~~L~yL-H~~~~~~i  468 (571)
                          +          +    .  ......+++.                      .....+.++...+.-+ .+.....+
T Consensus       115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l  194 (325)
T d1zyla1         115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR  194 (325)
T ss_dssp             CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred             CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence                0          0    0  0011111211                      1122223333322222 12233458


Q ss_pred             EEecCCCCCEEECCCCceEEeeccCccc
Q 008292          469 IHRDLKASNILLDAEMNPKISDFGMARI  496 (571)
Q Consensus       469 vH~Dlkp~NIll~~~~~~kl~DfGla~~  496 (571)
                      ||+|+.+.|||++++  ..++||+.+..
T Consensus       195 iHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         195 LHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             ecCCCCcccEEEeCC--ceEEechhccc
Confidence            999999999999754  45899998863

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.39  E-value=0.003  Score=62.28  Aligned_cols=73  Identities=16%  Similarity=0.257  Sum_probs=48.4

Q ss_pred             cccccccCceeEEEEEccCC--------CeeEEEeecccCccCHHHHHHHHHHHhhcCCCce-eccceeEEeCCeeEEEE
Q 008292          350 DNKLGEGGFGEVYKGVLPSG--------QEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNL-VRLLGFCLEGEEKILVY  420 (571)
Q Consensus       350 ~~~LG~G~fg~Vy~~~~~~g--------~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~~~~~~~~~~~lv~  420 (571)
                      .+.|+.|-.=.+|+...+++        +.|.+++...  ........+|..+++.+.-.++ .++++++.+    .+|+
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~  120 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  120 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence            35677788889999886543        4466666542  2334556789988888754444 466666532    6899


Q ss_pred             EecCCCCh
Q 008292          421 EFVPNKSL  428 (571)
Q Consensus       421 e~~~~g~L  428 (571)
                      ||+++..+
T Consensus       121 efi~g~~l  128 (395)
T d1nw1a_         121 EYIPSRPL  128 (395)
T ss_dssp             CCCCEEEC
T ss_pred             EEeccccC
Confidence            99987554

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.71  E-value=0.05  Score=51.12  Aligned_cols=157  Identities=13%  Similarity=0.060  Sum_probs=80.5

Q ss_pred             hHHHHHHhCCCCcccc-----ccccCceeEEEEEccCCCeeEEEeecccCccCHHHHHHHHHHHhhcCCCce-----ecc
Q 008292          337 FETIEVATNKFSTDNK-----LGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNL-----VRL  406 (571)
Q Consensus       337 ~~~~~~~~~~~~~~~~-----LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-----v~l  406 (571)
                      .++++....+|.+.+.     |..|---+.|+.+..+| .+++|+.....  ..+++..|++++..+...++     +..
T Consensus         5 ~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~~   81 (316)
T d2ppqa1           5 EDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPR   81 (316)
T ss_dssp             HHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCB
T ss_pred             HHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhcccccccccee
Confidence            3455555566765433     44566677899887655 58899886532  22345556777766643222     111


Q ss_pred             c-e--eEEeCCeeEEEEEecCCCChhhhh--------------c----C--CCCCCCCCHH------------------H
Q 008292          407 L-G--FCLEGEEKILVYEFVPNKSLDYFL--------------Y----D--PEKQGQLDWS------------------R  445 (571)
Q Consensus       407 ~-~--~~~~~~~~~lv~e~~~~g~L~~~l--------------~----~--~~~~~~l~~~------------------~  445 (571)
                      . |  +.........++.++.+.......              +    .  ..........                  .
T Consensus        82 ~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (316)
T d2ppqa1          82 KDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKG  161 (316)
T ss_dssp             TTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTT
T ss_pred             cCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchh
Confidence            1 1  122244556777777664432110              0    0  0000000000                  1


Q ss_pred             HHHHHHHHHHHHHHHHc-CCCCCeEEecCCCCCEEECCCCceEEeeccCccc
Q 008292          446 RYKIIGGIARGILYLHE-DSRLRIIHRDLKASNILLDAEMNPKISDFGMARI  496 (571)
Q Consensus       446 ~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  496 (571)
                      ....+..+...+.-.+. .-+.++||+|+.+.||+++.+...-|.||+.+..
T Consensus       162 ~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         162 LREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             HHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence            11122222222222221 1233599999999999999887778999998853